data_1jkn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jkn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 121.088 0.47 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 153.52 22.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 3.0 mmp_? -56.68 130.36 45.02 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.759 0.314 . . . . 0.0 110.617 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 1.1 t30 -152.83 153.25 32.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 53' ' ' PRO . 27.5 m -140.47 136.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.48 150.14 17.27 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 5.0 mp -122.5 103.71 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.685 0.279 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.7 t -89.43 106.76 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 33.1 tp -102.9 143.25 32.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 ptm -125.2 157.28 36.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.854 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.462 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 9.8 t30 -97.88 172.58 7.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.051 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -63.12 -17.17 62.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.858 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.45 -0.55 57.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.08 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mttm 80.99 24.86 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -95.15 170.97 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.411 ' CG2' ' CD2' ' A' ' 142' ' ' LEU . 4.7 mp -111.54 125.17 68.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 67.1 t80 -59.75 107.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.36 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.99 131.28 56.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.171 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.72 137.56 52.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.964 0.412 . . . . 0.0 111.371 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.38 155.52 24.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 2.9 mtp85 -73.35 157.27 37.29 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.0 111.411 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -4.95 52.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.897 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.97 -19.71 3.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.135 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.2 mt -119.15 112.4 36.18 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.2 131.47 28.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.951 1.768 . . . . 0.0 111.891 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.86 4.13 3.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.804 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.465 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.39 97.32 11.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.34 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 41.3 m95 -102.55 156.64 17.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.93 -176.88 2.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.981 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 20.0 mtm -111.74 155.23 43.44 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.594 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.44 131.7 30.83 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.565 2.177 . . . . 0.0 112.447 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.22 164.18 38.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.41 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -152.68 161.6 29.59 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.368 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.27 35.56 3.29 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.603 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.479 ' O ' ' O ' ' A' ' 46' ' ' GLY . 2.3 mt 51.95 159.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.287 0.565 . . . . 0.0 111.661 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.41 162.25 15.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.812 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.59 99.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.6 46.05 33.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.793 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.68 144.25 43.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.084 0.468 . . . . 0.0 111.115 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.55 143.11 71.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.806 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 88.8 Cg_exo -48.54 -62.93 0.36 Allowed 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.777 2.318 . . . . 0.0 113.689 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HD3' ' CE2' ' A' ' 108' ' ' PHE . 3.9 tpt180 -46.15 -33.72 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.81 -47.09 12.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -57.66 -35.0 69.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.05 -54.73 8.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.65 -29.8 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -80.94 -53.56 6.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 34.7 mm-40 -50.38 -40.64 50.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.326 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -56.58 -53.86 52.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.59 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.3 ttp180 -63.81 -11.67 29.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.82 -40.14 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 111.596 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.07 -36.48 16.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.0 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.78 -24.32 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.056 0.455 . . . . 0.0 110.922 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.88 6.93 80.1 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.647 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 38.4 t -58.13 112.18 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.405 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 p -91.21 -33.77 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.08 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.25 75.19 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 110.946 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 133.69 17.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.853 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.9 mt-10 -126.69 148.73 49.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.666 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -77.63 126.66 38.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.83 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.1 mm -107.56 -19.71 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.446 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -157.63 160.96 38.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.566 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 5.0 pt-20 -149.53 118.62 6.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.879 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.605 ' CG1' ' CD1' ' A' ' 78' ' ' TYR . 36.7 t -56.99 124.47 65.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 -17.97 38.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.95 2.433 . . . . 0.0 113.352 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.605 ' CD1' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.37 -175.62 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.509 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.46 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 30.7 m95 -104.35 147.47 27.49 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.566 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -103.74 117.18 33.77 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.9 p -113.81 133.14 55.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.247 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -135.67 170.18 16.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.445 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.25 158.15 42.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -108.06 152.36 41.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.345 0.345 0 C-N-CA 122.468 2.112 . . . . 0.0 112.452 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.3 m95 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -28.78 42.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.88 -145.75 5.14 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.909 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -157.81 118.6 3.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.71 0.291 . . . . 0.0 111.455 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.6 112.72 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -124.93 141.16 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -97.79 95.89 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.64 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.486 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 72.6 m95 -62.95 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 112.149 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 71.2 m-85 -125.05 130.98 53.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.258 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.0 tp -79.64 131.12 35.89 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.685 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 49.3 m-85 -125.22 127.13 46.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.241 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 73' ' ' ILE . 4.9 tptp -89.93 124.7 34.94 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -70.24 123.5 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 110.799 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 69' ' ' SER . 6.6 p -124.2 37.39 4.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.568 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.82 -144.23 4.86 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.104 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.17 154.14 46.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.838 0.352 . . . . 0.0 110.061 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -50.13 -16.51 0.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.64 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -77.41 -17.38 58.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.705 0.288 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.24 -25.23 42.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.422 HG22 ' CZ ' ' A' ' 29' ' ' PHE . 20.6 mt -70.45 104.83 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.492 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 65' ' ' THR . 56.3 t30 -122.26 95.78 4.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.14 -22.62 11.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.72 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.63 -59.28 4.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.271 0.558 . . . . 0.0 109.964 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.4 -172.13 23.99 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -92.88 38.74 1.03 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.082 0.468 . . . . 0.0 109.924 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.94 27.19 72.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.345 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.91 165.1 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 148.92 61.84 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -51.32 128.32 25.11 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.692 2.261 . . . . 0.0 112.55 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -108.45 -29.34 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.426 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 13.4 m-85 -111.67 159.46 18.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.38 -21.38 5.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.722 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 17.5 mm-40 -152.43 174.47 13.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.171 0.51 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.7 p-90 -159.13 156.57 29.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.042 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.76 161.92 40.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.473 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.462 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 73.3 m95 -93.9 124.89 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.697 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -136.6 150.89 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.151 0.501 . . . . 0.0 111.599 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 p -70.33 158.71 86.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.565 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.41 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.6 Cg_endo -55.36 -19.66 22.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.863 1.708 . . . . 0.0 111.885 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -34.34 16.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.075 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.35 -50.35 27.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.436 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.4 tp -54.39 -30.33 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.475 0.655 . . . . 0.0 109.891 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.3 mm -69.35 -28.47 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.724 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -80.19 -20.73 44.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.4 mt -84.07 -39.28 19.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.127 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.0 m -59.6 164.28 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.011 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.482 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 7.2 p -96.09 160.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -49.4 -41.7 40.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.482 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 9.2 p90 -81.3 2.85 26.31 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.454 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 4.2 mtpp -129.76 6.01 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.688 0.28 . . . . 0.0 111.197 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.2 mttt -64.02 -62.69 4.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 17.9 Cg_endo -58.1 -45.85 29.22 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.438 2.092 . . . . 0.0 112.061 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 157' ' ' VAL . 48.6 t -54.05 -29.63 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.941 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.96 -51.5 5.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.5 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -32.96 24.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.236 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.407 ' HB3' HD13 ' A' ' 80' ' ' LEU . 3.2 tp10 -64.31 -46.62 82.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.418 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.1 t -59.28 -50.97 77.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.29 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 162' ' ' ALA . 66.0 mt -62.89 -49.58 74.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.969 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -45.3 61.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.85 -25.01 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.352 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.517 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.1 m-30 -104.06 12.48 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.799 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.557 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.44 -55.26 36.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.604 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.7 Cg_endo -54.6 -22.25 27.66 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.481 2.121 . . . . 0.0 112.248 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 98.3 m-70 -91.61 -18.28 24.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.948 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.901 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.946 0.403 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.418 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -82.18 152.26 26.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.09 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 t30 -152.59 156.48 39.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.425 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 0.9 OUTLIER -127.59 130.93 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.17 154.2 20.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.052 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -131.94 102.82 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 111.411 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.5 t -89.7 103.81 16.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.0 146.22 28.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.904 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.45 157.3 41.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.005 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.46 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 13.1 t30 -94.37 173.99 7.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.1 -16.5 61.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.789 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -89.54 -0.78 57.75 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.089 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 25' ' ' ASP . 19.9 mtpt 81.74 24.77 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.594 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.3 173.05 7.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.8 mp -112.65 124.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 110.865 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 77.4 t80 -57.79 109.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.387 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.96 135.58 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.217 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -120.36 139.85 52.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 111.32 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.29 158.02 23.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.572 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.9 mtp-105 -72.22 162.61 29.22 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.376 0.608 . . . . 0.0 111.672 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -96.35 -6.47 37.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.552 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 -18.53 3.83 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.543 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 65.2 mt -120.94 112.95 33.19 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.26 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.8 Cg_endo -65.69 132.38 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.871 1.714 . . . . 0.0 111.643 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.15 1.83 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.811 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.455 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.68 97.51 11.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.181 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.403 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.9 m95 -102.65 157.03 17.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.74 -179.93 3.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.796 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -102.19 159.02 30.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.583 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.2 137.09 39.44 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.509 2.139 . . . . 0.0 112.817 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.403 ' OE1' ' CZ2' ' A' ' 107' ' ' TRP . 1.6 mm-40 -137.64 148.1 45.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.363 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.47 132.66 4.13 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.542 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.99 128.82 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 ' N ' ' A' ' 48' ' ' ASP . 4.8 mt -61.34 160.71 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.464 ' N ' HG21 ' A' ' 47' ' ' ILE . 27.1 m-20 -90.09 -176.66 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.069 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.48 98.53 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 110.22 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.07 46.01 8.57 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.661 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HB3' HG23 ' A' ' 47' ' ' ILE . 6.5 tp10 -115.51 147.29 40.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.807 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 136.03 78.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.71 -56.15 2.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.435 2.09 . . . . 0.0 112.682 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 6.1 ttp85 -58.68 -27.43 64.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.365 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.31 -48.85 9.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.575 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.17 -30.36 64.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.13 -50.38 19.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.153 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.1 mt -57.73 -29.48 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.171 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -83.2 -52.92 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.902 0.858 . . . . 0.0 109.856 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -53.77 -46.09 70.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tp -54.41 -56.06 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.504 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.3 ttp85 -60.06 -15.0 19.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.387 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.06 -42.06 10.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.47 -24.4 19.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.424 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.43 -19.66 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.21 4.48 63.83 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.175 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.65 114.08 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.23 -32.97 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.066 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.37 76.42 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.35 13.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.756 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.0 pt-20 -118.94 146.2 45.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 52.6 t -77.75 122.38 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.372 0.606 . . . . 0.0 111.535 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.2 mm -104.39 -15.95 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.621 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 164' ' ' HIS . . . -158.82 159.39 35.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.38 115.41 6.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.135 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 78' ' ' TYR . 12.2 t -57.44 126.54 75.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.21 -18.95 65.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.77 2.313 . . . . 0.0 113.237 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.613 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.3 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.38 0.61 . . . . 0.0 111.991 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.446 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.7 m95 -109.75 147.21 33.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.017 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 1.8 mt -112.45 117.59 32.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.956 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 p -112.93 131.67 55.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.606 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -130.7 163.34 27.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.07 158.36 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.119 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.4 153.86 45.54 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.771 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.275 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 57.9 m95 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.816 0.341 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -30.35 58.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -162.08 -143.07 3.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.923 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -157.72 115.77 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 0.0 111.436 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.39 105.81 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.814 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.433 ' NE2' ' ND2' ' A' ' 16' ' ' ASN . 4.0 pt20 -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -104.29 98.07 7.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.519 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 31.3 m95 -65.32 137.12 57.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.278 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 68.5 m-85 -122.27 137.93 54.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.943 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.1 tp -79.21 154.14 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.821 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 39.6 m-85 -148.08 125.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.07 0.462 . . . . 0.0 111.738 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB2' HG13 ' A' ' 73' ' ' ILE . 39.5 tttp -91.4 122.55 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -68.23 123.9 22.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 p -124.02 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.13 -144.88 4.65 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.044 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.23 154.19 46.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.02 -16.61 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -77.73 -18.49 56.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 111.252 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -25.57 42.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.439 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 18.2 mt -73.77 103.9 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.517 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.36 95.87 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.027 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 50.6 mt -55.86 -22.55 25.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.543 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.26 -56.84 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.246 0.546 . . . . 0.0 109.95 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.39 -174.66 22.8 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.51 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -91.76 38.72 0.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.13 73.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.202 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.1 m -115.24 -67.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 111.267 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -101.28 165.16 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 146.8 86.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.11 139.74 51.9 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.583 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -109.83 -31.82 7.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 20.7 m-85 -116.88 159.61 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.415 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -15.72 6.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.814 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.53 174.59 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.522 . . . . 0.0 110.592 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.4 p-90 -159.61 153.1 22.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.056 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 m -151.74 156.9 41.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.484 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 76.7 m95 -91.35 124.83 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.841 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 29.6 m -134.71 150.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.724 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.5 p -69.54 158.5 86.77 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.573 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' CB ' HD13 ' A' ' 158' ' ' LEU . 11.2 Cg_endo -55.05 -19.37 19.94 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.99 1.793 . . . . 0.0 111.98 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -34.48 14.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.225 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.6 -50.28 46.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.424 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.0 tp -53.37 -33.26 52.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.416 0.626 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.406 HD12 ' CD1' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.88 -28.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.687 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.75 -32.84 52.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.676 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD22 ' CD1' ' A' ' 40' ' ' TRP . 7.1 mt -75.08 -40.62 59.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.88 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.407 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 28.3 m -54.92 163.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.21 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.482 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 10.6 p -98.49 160.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -49.39 -36.79 22.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.482 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 16.4 p90 -84.77 6.9 22.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.446 ' HB2' HG12 ' A' ' 147' ' ' VAL . 30.8 mttt -129.94 -4.67 4.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.1 mttt -56.53 -62.13 5.5 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.351 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.4 Cg_endo -60.9 -42.77 35.06 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.444 2.096 . . . . 0.0 112.131 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.451 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 11.4 t -60.65 -27.5 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.561 . . . . 0.0 110.953 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.8 m-30 -90.87 -53.15 4.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.68 -31.12 10.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -44.71 70.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.663 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 52.0 t -57.72 -48.26 83.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.098 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 162' ' ' ALA . 61.8 mt -64.5 -48.85 73.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.774 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.8 m -50.94 -46.18 60.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.887 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.31 -24.58 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 121.019 0.437 . . . . 0.0 110.766 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.518 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.2 m-30 -100.67 -2.02 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.647 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.2 -51.46 33.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 6.7 Cg_endo -49.29 -24.57 8.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.632 2.221 . . . . 0.0 112.567 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 97.2 m-70 -100.98 -15.99 17.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.302 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.409 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 4.4 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.51 152.15 25.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -74.36 125.2 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.168 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.4 m120 -152.41 159.03 43.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.452 HG23 ' CB ' ' A' ' 56' ' ' ALA . 1.8 m -129.74 135.68 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.128 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.93 17.42 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.303 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -126.21 101.63 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.7 t -89.84 102.94 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 23.5 tp -103.16 145.75 29.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.69 157.41 40.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.7 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.435 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 31.6 p-10 -102.39 169.98 8.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -55.37 -17.95 5.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.92 0.48 56.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt 76.46 25.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.678 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -95.62 171.95 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.4 mp -109.12 119.5 58.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.12 0.486 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 5.5 t80 -53.71 108.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.21 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 137.17 52.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.723 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.86 137.97 54.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.517 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.6 158.22 23.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.3 mtp85 -75.39 159.11 31.78 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 111.302 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -94.2 -5.64 46.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.026 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.35 -16.94 3.85 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.229 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 64.9 mt -120.19 110.96 35.66 Favored Pre-proline 0 N--CA 1.454 -0.239 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.01 131.35 28.5 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.837 1.691 . . . . 0.0 111.845 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 77.58 5.22 3.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.685 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.7 97.62 11.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.354 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 31.3 m95 -103.72 156.12 18.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -168.8 -176.77 2.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.764 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 61.2 mtm -107.31 159.4 30.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.15 130.27 22.38 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.468 2.112 . . . . 0.0 112.549 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -154.1 160.23 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.12 169.34 38.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.612 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -83.92 130.88 10.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 48' ' ' ASP . 5.0 mt -60.07 160.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.713 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' N ' HG23 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.29 151.71 21.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.931 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.19 98.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.67 36.29 8.0 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.036 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HB3' HG22 ' A' ' 47' ' ' ILE . 5.0 tt0 -116.29 142.11 47.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.458 . . . . 0.0 110.861 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.46 143.15 82.18 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.04 -52.93 7.23 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.559 2.173 . . . . 0.0 112.604 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.429 ' HD3' ' CD2' ' A' ' 108' ' ' PHE . 4.4 tpp85 -59.03 -27.61 65.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -84.46 -48.44 9.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -58.98 -32.51 69.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.417 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.49 -53.57 11.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.7 mt -57.08 -29.34 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.081 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -81.7 -53.35 6.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 109.918 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.13 -45.16 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.309 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.425 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -55.74 -56.18 23.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.586 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.4 ttp180 -61.26 -12.19 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -91.6 -38.39 12.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.749 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.09 -35.37 15.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.921 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -119.02 -23.24 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.015 0.436 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.31 8.57 80.03 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.856 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 24.8 t -57.15 110.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.985 0.393 . . . . 0.0 110.313 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.0 p -89.84 -36.22 15.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.43 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.34 76.43 6.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.176 0.512 . . . . 0.0 111.086 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 128.53 12.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.78 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.6 pt-20 -119.38 147.78 43.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.098 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.6 t -78.41 123.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.344 0.593 . . . . 0.0 111.417 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -106.07 -19.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.753 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' CD2' ' A' ' 164' ' ' HIS . . . -156.85 162.94 39.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.135 0.493 . . . . 0.0 111.735 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.83 114.73 5.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.861 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.585 HG13 HD21 ' A' ' 80' ' ' LEU . 4.6 t -57.57 125.51 72.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.47 -11.6 31.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.872 2.381 . . . . 0.0 113.768 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.78 133.54 49.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.247 0.546 . . . . 0.0 111.917 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.42 ' CD2' ' HG2' ' A' ' 106' ' ' LYS . 49.2 m95 -59.79 147.09 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.226 0.536 . . . . 0.0 110.566 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 76' ' ' VAL . 1.1 mm? -102.75 117.74 35.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.42 HG23 ' CB ' ' A' ' 104' ' ' ALA . 63.8 p -113.89 134.48 54.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -133.1 170.35 15.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.533 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.48 141.6 45.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.64 151.42 42.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.776 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--N 1.343 0.281 0 C-N-CA 122.518 2.145 . . . . 0.0 112.372 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.774 0.321 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -25.69 41.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.572 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -175.43 -138.23 2.74 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.036 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -157.72 116.79 3.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.823 0.344 . . . . 0.0 111.388 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.42 ' CB ' HG23 ' A' ' 81' ' ' THR . . . -86.41 105.8 17.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.835 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.1 pt20 -124.92 145.03 50.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 2.5 mmmp? -100.59 110.49 22.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.76 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 34.2 m95 -76.23 145.2 39.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.486 . . . . 0.0 112.145 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 59.5 m-85 -127.29 132.76 50.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.295 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.9 tp -79.5 132.93 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.359 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 50.0 m-85 -126.51 127.98 46.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.663 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.552 ' HB2' HG13 ' A' ' 73' ' ' ILE . 18.3 tttp -92.02 122.29 34.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -67.87 123.07 19.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 69' ' ' SER . 1.6 p -122.8 37.01 4.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.545 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.32 -144.49 4.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -128.06 154.37 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.97 -17.49 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.585 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -74.61 -19.28 60.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.12 -25.64 52.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 119' ' ' ILE . 25.5 mt -70.16 105.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 65' ' ' THR . 59.8 t30 -123.12 95.89 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.217 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 34.7 mt -55.73 -21.0 16.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.577 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -60.18 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.329 0.585 . . . . 0.0 109.774 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.25 23.39 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.324 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -93.92 38.83 1.07 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.159 0.504 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.59 28.0 70.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.2 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 m -102.24 -62.34 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.289 . . . . 0.0 111.255 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.27 165.24 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.146 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -57.95 146.06 69.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.031 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -51.69 -176.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.675 2.25 . . . . 0.0 112.517 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -150.1 -41.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.416 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 21.0 m-85 -106.32 159.37 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.69 5.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.377 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.4 mp0 -152.19 173.73 14.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.5 p-90 -160.25 160.31 32.48 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.242 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -158.73 160.76 36.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.508 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 81.3 m95 -93.12 124.61 37.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.623 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -137.27 151.16 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 111.773 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -68.88 161.35 72.58 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.517 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 18.7 Cg_endo -59.39 -16.73 36.58 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.716 1.61 . . . . 0.0 111.768 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.98 -34.1 14.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.069 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -51.5 21.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.13 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.6 tp -54.42 -31.4 55.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.459 0.647 . . . . 0.0 109.769 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.08 -27.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.775 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.73 -14.7 50.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.216 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 40' ' ' TRP . 12.6 mt -91.28 -38.32 12.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.392 0.615 . . . . 0.0 110.238 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.4 m -56.51 161.83 2.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.252 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.453 HG13 ' CD2' ' A' ' 149' ' ' PHE . 14.0 p -87.98 162.31 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.3 -31.26 72.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 150' ' ' LYS . 11.2 p90 -82.17 2.57 30.95 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.476 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 3.3 mtmt -145.99 16.28 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 3.1 mttt -58.89 -61.96 6.73 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.073 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 22.3 Cg_endo -61.58 -42.5 32.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.462 ' O ' HD12 ' A' ' 80' ' ' LEU . 61.8 t -48.29 -29.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.248 0.547 . . . . 0.0 111.238 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -91.27 -55.0 3.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.249 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.52 -36.56 15.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.901 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' HB3' HD13 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -60.73 -46.74 89.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.475 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 44.6 t -61.29 -45.55 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.336 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' ALA . 56.3 mt -64.19 -49.04 73.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.965 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.2 t -50.63 -43.72 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 97.7 t -71.73 -25.19 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.326 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.529 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.8 m-30 -102.55 8.73 39.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.87 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.66 -56.04 26.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.5 Cg_endo -56.91 -22.78 47.71 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.374 2.049 . . . . 0.0 112.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 98.0 m-70 -91.31 -19.94 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.87 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.21 25.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -66.03 124.98 24.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 11.7 t-20 -152.53 160.66 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.997 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' CG1' HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -131.06 140.3 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -105.01 150.19 16.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.154 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -131.15 102.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.469 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -89.61 109.95 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -102.92 143.55 32.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.441 . . . . 0.0 111.171 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.6 ptm -128.93 157.29 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.421 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.5 p-10 -105.03 170.69 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.387 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -56.28 -17.5 7.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.644 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 0.61 56.56 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.775 0.322 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 mttm 76.35 26.39 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.566 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -97.91 172.27 7.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -111.15 123.19 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 73.9 t80 -56.45 109.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.57 129.97 56.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.448 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -114.81 136.09 53.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.412 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.4 p -82.46 154.86 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.748 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -70.96 159.02 35.48 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.255 0.55 . . . . 0.0 111.397 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -93.33 -6.21 47.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.944 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -128.43 -18.1 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.201 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.1 mt -119.59 112.1 35.75 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.97 131.39 28.7 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.936 1.757 . . . . 0.0 111.95 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.74 3.51 3.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.851 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.54 11.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.412 ' CE3' ' N ' ' A' ' 32' ' ' SER . 42.1 m95 -104.56 156.71 17.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.02 8.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.429 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 70.1 mtm -97.91 156.67 35.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.83 139.22 42.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.536 2.157 . . . . 0.0 112.996 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.219 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.38 145.8 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.826 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.13 138.31 43.78 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.379 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.8 mt -69.17 161.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.57 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.2 150.09 22.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.6 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.14 8.48 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.109 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HB3' HG22 ' A' ' 47' ' ' ILE . 4.7 tt0 -115.08 143.48 45.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 0.0 110.887 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.68 139.68 80.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.604 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 63.5 Cg_exo -52.02 -53.51 6.85 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.448 2.098 . . . . 0.0 112.616 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -27.28 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -82.49 -51.26 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.694 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.408 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -56.84 -31.65 64.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.561 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.79 -51.91 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.271 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.4 mt -56.82 -27.94 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -84.96 -52.71 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.931 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.84 -47.37 67.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -53.99 -56.69 15.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 66.2 ttp85 -59.32 -15.2 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.414 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -92.13 -39.98 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.821 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.4 -25.08 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.89 -19.16 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.77 5.65 65.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.112 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.18 115.74 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.618 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -34.34 12.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.23 79.25 6.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.472 . . . . 0.0 110.997 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.29 131.33 15.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.897 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.2 pt-20 -120.72 147.2 45.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.5 t -78.03 123.01 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.382 0.611 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.551 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -105.4 -21.52 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -153.41 161.9 41.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.288 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 9.0 pt-20 -148.74 115.59 6.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.148 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG11 ' O ' ' A' ' 78' ' ' TYR . 4.6 t -57.24 125.78 71.97 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.917 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.2 -13.28 39.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.975 2.45 . . . . 0.0 114.177 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.661 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -129.4 157.2 42.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 112.028 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -77.4 145.66 37.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.123 0.487 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -108.55 118.08 35.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.984 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 p -114.81 132.19 56.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.522 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -124.9 170.13 11.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.96 158.28 38.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -119.72 149.76 48.99 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.705 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.539 2.16 . . . . 0.0 112.308 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.8 m95 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.86 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.583 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.13 -142.38 3.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.984 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -157.93 116.47 3.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.54 105.86 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.854 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.8 pt20 -124.28 144.61 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -98.81 95.82 7.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.697 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.421 ' CG ' HG23 ' A' ' 157' ' ' VAL . 53.8 m95 -62.91 148.72 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.449 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 68.6 m-85 -132.09 135.05 46.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.317 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.5 tp -79.9 129.46 34.5 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.512 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.6 m-85 -123.85 126.57 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.398 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' HB2' HG13 ' A' ' 73' ' ' ILE . 50.5 tttt -89.88 124.54 34.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.39 125.43 26.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.5 p -125.64 37.61 4.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.595 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.1 -144.91 4.76 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.129 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 154.2 45.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.85 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.611 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -20.39 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.17 -25.07 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.798 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 18.1 mt -73.46 102.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.549 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -119.35 95.63 4.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.924 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 68.6 mt -54.56 -23.78 18.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.651 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.5 mt -61.3 -55.23 34.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.099 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.9 -171.03 25.03 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.429 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.75 38.96 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.151 0.5 . . . . 0.0 109.84 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.17 28.56 73.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.985 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.36 -68.28 0.91 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 111.228 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.9 165.08 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.25 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -80.93 151.18 70.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.44 165.34 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.748 2.299 . . . . 0.0 112.623 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -150.05 -45.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.502 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 13.5 m-85 -107.48 159.62 16.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.19 -18.63 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -152.54 175.24 12.97 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.1 p-90 -156.14 150.9 26.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.113 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 162.32 40.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.34 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 71.4 m95 -96.28 124.31 40.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.2 m -136.42 150.78 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 111.511 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.1 p -71.1 158.11 88.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.572 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.409 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.0 Cg_endo -54.62 -20.49 21.54 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.907 1.738 . . . . 0.0 111.853 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 -34.3 17.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.118 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -72.69 -50.69 23.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.455 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.1 tp -54.14 -29.93 47.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.403 0.62 . . . . 0.0 109.881 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.7 mm -68.44 -28.88 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.674 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.27 -20.53 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 40' ' ' TRP . 10.3 mt -85.86 -39.14 17.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.402 HG22 ' CG ' ' A' ' 154' ' ' TYR . 5.7 m -60.2 156.19 15.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 150' ' ' LYS . 9.4 p -90.08 160.52 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -50.85 -35.71 33.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.458 ' CG ' HG12 ' A' ' 147' ' ' VAL . 13.9 p90 -84.8 9.97 12.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 147' ' ' VAL . 12.6 mttm -134.57 -25.3 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.264 . . . . 0.0 111.187 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.8 mtpt -44.5 -59.87 3.5 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.408 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.0 Cg_endo -59.06 -41.52 60.23 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.278 1.985 . . . . 0.0 111.912 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 82' ' ' TYR . 64.0 t -64.99 -25.78 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.429 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.46 -49.34 6.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.697 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -35.1 22.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.681 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.4 tp10 -66.81 -44.96 79.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.7 t -58.64 -47.86 87.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.07 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 162' ' ' ALA . 66.6 mt -66.71 -49.26 66.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.703 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.2 m -50.6 -46.14 57.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.662 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.7 t -69.53 -24.68 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.516 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.5 m-30 -101.86 2.13 37.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.163 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.47 -55.21 31.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.15 -20.87 25.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.619 2.213 . . . . 0.0 112.34 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.423 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 17.9 m-70 -89.48 -21.06 23.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.729 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.933 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' CD2' ' HB ' ' A' ' 81' ' ' THR . 2.5 m-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -86.11 152.23 23.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -64.02 132.56 50.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.371 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 21.1 t-20 -152.56 156.99 40.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.443 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 56' ' ' ALA . 3.3 m -127.81 129.49 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 111.281 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.2 147.03 18.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.177 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.458 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -122.34 103.35 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.699 0.285 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' PHE . 53.4 t -89.48 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.3 tp -103.19 144.56 31.16 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.319 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.8 ptt? -129.11 157.45 41.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.606 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.8 p-10 -98.35 172.51 7.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.349 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -60.45 -15.43 26.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 0.38 56.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp 77.57 27.16 0.63 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.536 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 136' ' ' TRP . 11.6 mmtm -99.11 175.67 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -107.62 147.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -82.67 104.94 13.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.73 129.89 56.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.31 137.13 52.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.417 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -82.03 152.81 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.764 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 5.0 mtp-105 -68.04 163.37 22.48 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.8 -7.66 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.384 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.1 -18.95 4.88 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.207 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.538 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 63.1 mt -121.02 112.41 33.41 Favored Pre-proline 0 N--CA 1.457 -0.083 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.43 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.939 1.759 . . . . 0.0 111.655 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t70 78.15 1.8 2.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.767 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.467 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.3 97.24 10.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.13 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' CE3' ' N ' ' A' ' 32' ' ' SER . 55.2 m95 -103.0 159.67 15.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.166 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -168.5 -178.01 3.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 36.3 mtm -109.4 156.58 39.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.77 128.43 18.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.584 2.189 . . . . 0.0 112.674 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.32 156.69 37.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.688 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 144.82 10.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.442 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.78 140.67 43.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 48' ' ' ASP . 4.4 mt -69.9 160.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' HG21 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.19 169.12 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.208 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.26 98.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.2 9.34 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.878 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 47' ' ' ILE . 10.7 tp10 -112.53 145.16 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.093 0.473 . . . . 0.0 110.846 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.64 133.82 73.24 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.422 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.48 -39.43 74.34 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.369 2.046 . . . . 0.0 112.569 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HD3' ' CE2' ' A' ' 108' ' ' PHE . 3.0 tpp85 -72.11 -27.84 62.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -85.12 -45.18 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -60.13 -32.62 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.368 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.22 -54.06 10.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.101 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -56.2 -29.1 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.291 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 ttp85 -82.58 -52.97 6.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.753 0.787 . . . . 0.0 109.872 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -51.78 -47.12 64.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.534 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tp -54.62 -56.3 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.886 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 6.6 ttp-105 -59.8 -15.14 18.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.293 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -92.06 -40.09 11.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.846 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.5 -25.29 19.34 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.57 -20.85 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.755 0.312 . . . . 0.0 111.063 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 76.72 1.39 71.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.015 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.42 116.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 -32.37 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.59 79.32 6.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.15 13.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.706 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.4 pt-20 -118.44 146.86 44.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.968 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.6 t -79.54 121.25 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 111.436 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -101.7 -20.79 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.391 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -153.14 160.24 42.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.07 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.8 pt-20 -148.43 116.02 6.28 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.169 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 78' ' ' TYR . 4.3 t -57.38 129.14 79.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.0 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 -16.32 46.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.744 2.296 . . . . 0.0 113.612 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.632 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -127.75 -179.43 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.458 0.647 . . . . 0.0 112.533 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 11.7 m95 -104.2 147.71 27.15 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.407 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 1.4 mt -113.08 117.52 32.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.719 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.425 ' HB ' ' CD2' ' A' ' 13' ' ' TYR . 16.5 p -111.4 131.14 55.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.723 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -125.72 170.24 11.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.368 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.86 156.5 44.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -105.71 147.51 34.82 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.406 ' CD1' ' HD2' ' A' ' 14' ' ' ARG . 52.5 m95 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.868 0.366 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 2.1 mptp? -88.35 -21.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.68 -146.4 5.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.915 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -157.94 116.29 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -85.84 112.7 21.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -128.98 152.93 48.06 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.419 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.29 95.99 6.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 178.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.449 ' CD2' HG23 ' A' ' 157' ' ' VAL . 48.6 m95 -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 112.472 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.1 m-85 -133.05 134.82 44.87 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.09 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.6 tp -79.53 143.01 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.523 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 42.4 m-85 -136.97 127.5 26.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB2' HG13 ' A' ' 73' ' ' ILE . 25.8 tttp -91.71 121.24 33.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.8 127.0 30.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.204 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.1 p -126.27 37.31 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.76 -144.55 4.93 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.982 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 153.8 47.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.173 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD1' ' CH2' ' A' ' 134' ' ' TRP . 3.6 m-20 -52.12 -14.93 0.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.674 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -80.73 -20.36 42.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.254 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.54 -25.53 45.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.807 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.9 mt -67.08 104.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.459 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -122.06 95.8 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.119 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.6 mt -56.3 -21.89 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.8 -56.93 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 109.882 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.99 -175.59 22.56 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.487 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -91.98 38.97 1.0 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.76 72.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.958 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -121.15 -69.96 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.96 165.13 17.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.42 147.02 45.87 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 128.42 27.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.623 2.215 . . . . 0.0 112.53 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -111.54 -34.77 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.44 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 5.1 m-85 -108.02 159.61 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.334 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.9 -19.52 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.815 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 13.9 mm-40 -152.45 175.22 12.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.145 0.498 . . . . 0.0 110.592 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.8 p-90 -155.95 154.05 30.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.077 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.15 159.48 42.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.556 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 70.4 m95 -93.96 126.7 39.32 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.615 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 28' ' ' ILE . 35.7 m -135.88 152.84 31.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.41 . . . . 0.0 111.854 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 p -72.49 152.17 91.81 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.408 ' O ' HG12 ' A' ' 143' ' ' ILE . 5.3 Cg_endo -49.12 -22.13 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.25 -33.79 17.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -50.53 33.81 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.189 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.5 tp -53.35 -32.82 51.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.462 0.649 . . . . 0.0 109.828 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 139' ' ' PRO . 4.9 mm -67.2 -28.05 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.796 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -22.64 41.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.232 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.8 mt -83.09 -39.55 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.066 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.404 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 22.5 m -56.28 164.63 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.506 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -101.24 160.42 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -45.43 -46.09 13.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.359 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -75.29 -5.09 42.84 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 13.5 mtmt -121.73 -4.13 9.21 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mttt -57.76 -62.39 5.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.541 0.21 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.1 Cg_endo -61.14 -45.81 17.91 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.467 2.111 . . . . 0.0 112.241 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.469 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 23.0 t -56.84 -27.07 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.13 -52.32 4.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.74 -32.62 20.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.317 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.6 tp10 -64.88 -46.01 83.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.492 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.499 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.0 t -59.49 -52.36 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.191 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 162' ' ' ALA . 70.2 mt -59.97 -49.2 78.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.841 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 m -49.15 -46.43 45.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.639 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.1 t -69.61 -25.28 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.029 0.443 . . . . 0.0 110.366 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.499 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.4 m-30 -104.29 12.37 33.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.999 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.98 -58.28 14.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.0 Cg_endo -56.76 -21.81 41.7 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.433 2.088 . . . . 0.0 112.275 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.419 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 63.7 m-70 -90.01 -12.54 38.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.126 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.927 179.844 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.943 0.402 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.42 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.8 OUTLIER -87.97 152.22 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -69.93 134.33 48.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.111 0.481 . . . . 0.0 111.441 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 19.8 t-20 -152.46 158.88 43.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 53' ' ' PRO . 1.4 m -128.18 130.0 69.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 111.584 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.98 139.31 14.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.132 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.434 HG22 ' CE1' ' A' ' 110' ' ' PHE . 4.2 mp -112.93 104.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.321 . . . . 0.0 111.417 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 110' ' ' PHE . 52.5 t -89.54 105.08 17.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.4 tp -103.36 141.84 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.983 0.42 . . . . 0.0 111.126 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.63 157.39 35.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.7 p-10 -100.84 170.53 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -57.13 -16.37 7.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.418 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -0.08 57.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 111.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 77.53 26.67 0.66 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.564 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mmtt -97.85 175.87 6.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' CG2' HD21 ' A' ' 142' ' ' LEU . 4.6 mp -115.31 126.88 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.455 ' CE1' ' CG2' ' A' ' 119' ' ' ILE . 66.3 t80 -59.47 110.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.379 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.86 130.0 56.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.02 136.74 52.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 0.0 111.472 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.43 155.16 24.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.646 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -71.98 156.98 38.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.284 0.564 . . . . 0.0 111.413 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.16 -5.36 52.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -127.52 -19.62 4.16 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.039 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 59.6 mt -119.54 112.44 35.58 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.904 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.46 131.66 28.74 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.905 1.737 . . . . 0.0 111.737 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 77.17 4.21 3.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.766 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -89.66 97.4 11.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.339 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -103.93 156.94 17.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.101 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -168.76 177.23 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.774 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.451 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 35.8 mtm -103.2 155.43 36.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.809 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.46 139.9 55.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.594 2.196 . . . . 0.0 112.67 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.19 158.18 39.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.74 140.37 6.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.586 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.74 139.87 48.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.451 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 6.7 mt -71.42 160.32 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.546 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.3 148.52 22.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.85 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -49.15 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.188 0.518 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.64 40.62 14.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.884 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB3' HG23 ' A' ' 47' ' ' ILE . 5.9 tp10 -113.3 145.74 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 110.938 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 124.05 90.28 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.156 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HA ' HG12 ' A' ' 17' ' ' VAL . 5.3 Cg_endo -48.97 -50.83 11.78 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.484 2.123 . . . . 0.0 112.818 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -57.44 -30.53 65.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.009 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -83.23 -47.12 11.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.443 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -58.38 -30.32 66.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.407 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.93 14.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.109 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.02 -29.6 31.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.099 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -81.19 -53.15 6.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.877 0.846 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.98 -31.88 61.2 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.479 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.26 -62.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.5 ptt85 -61.22 -10.91 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.973 0.415 . . . . 0.0 110.456 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -91.5 -39.47 11.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.252 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.52 -33.66 15.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.158 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.93 -24.5 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 81.54 -0.21 88.28 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.668 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.68 118.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.311 . . . . 0.0 110.448 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -33.95 10.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.22 76.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.805 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.25 13.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.973 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -120.31 148.85 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 55.4 t -79.21 125.04 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.492 0.663 . . . . 0.0 111.901 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.559 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -104.93 -20.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.066 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 161' ' ' PHE . . . -152.2 161.21 42.96 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -148.16 113.25 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 78' ' ' TYR . 3.2 t -57.23 124.76 68.15 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.032 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.59 -5.72 17.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.802 2.335 . . . . 0.0 113.925 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -131.21 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 112.399 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -79.03 147.36 32.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 48.7 mt -115.97 117.74 30.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.842 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.2 p -114.78 131.67 56.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.585 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -127.56 170.07 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.52 158.44 39.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -110.55 153.54 43.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 C--N 1.345 0.346 0 C-N-CA 122.529 2.153 . . . . 0.0 112.328 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.42 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 57.1 m95 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.821 0.344 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -27.81 44.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.48 -143.42 4.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.994 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -157.92 117.28 3.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.757 0.313 . . . . 0.0 111.365 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.74 107.61 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -123.16 151.93 41.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 96.84 6.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.43 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.448 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 52.1 m95 -62.7 147.86 48.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -130.99 135.14 47.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.2 tp -79.7 147.92 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.138 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' CYS . 27.3 m-85 -140.92 128.02 20.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.87 0.367 . . . . 0.0 111.567 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.559 ' HB2' HG13 ' A' ' 73' ' ' ILE . 31.3 tttt -91.79 119.96 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -64.87 125.14 23.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.7 p -126.86 37.62 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.25 -144.92 4.75 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.066 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -127.86 154.12 45.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -50.26 -16.23 0.31 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.657 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -79.03 -18.63 53.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.731 0.3 . . . . 0.0 111.232 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.33 -25.61 42.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.455 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 22.9 mt -79.01 105.84 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -124.78 96.7 4.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.08 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.6 mt -47.62 -21.8 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.232 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.5 -59.33 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.351 0.596 . . . . 0.0 109.99 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 133.08 -176.62 19.46 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.1 p30 -89.47 38.7 0.91 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.2 26.1 72.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.271 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -100.98 -64.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.708 0.289 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -112.52 165.14 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.1 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 144.8 91.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.05 135.88 59.94 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.581 2.188 . . . . 0.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.84 -29.55 7.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.73 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 9.7 m-85 -110.2 159.27 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.14 -19.78 5.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.795 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 25.5 mm-40 -152.43 175.08 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 110.438 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.07 155.46 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.2 m -153.84 158.71 41.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.348 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.458 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 79.5 m95 -90.98 123.72 34.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.836 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 29.5 m -134.34 149.88 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.503 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -68.65 158.65 84.93 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.581 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.418 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 12.0 Cg_endo -55.74 -19.17 23.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.875 1.717 . . . . 0.0 111.923 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -90.84 -34.21 15.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.078 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.68 -50.73 27.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.988 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.7 tp -54.1 -32.72 55.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 139' ' ' PRO . 5.6 mm -67.9 -28.16 40.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.09 -20.98 40.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.2 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' A' ' 142' ' ' LEU . 11.2 mt -84.75 -39.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.2 m -59.46 151.07 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.152 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 150' ' ' LYS . 8.7 p -80.78 160.09 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.0 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -51.75 -35.26 42.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.472 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -83.41 4.9 25.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.511 ' HB2' HG13 ' A' ' 147' ' ' VAL . 22.1 mttm -133.97 6.28 3.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.532 0.206 . . . . 0.0 111.304 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.5 mttt -62.32 -62.76 5.17 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.04 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.3 Cg_endo -58.74 -41.81 59.7 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.449 2.099 . . . . 0.0 112.051 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.439 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 17.3 t -58.34 -25.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.998 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.451 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -91.1 -50.2 5.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.609 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' CG ' ' CD1' ' A' ' 143' ' ' ILE . 39.3 mttp -51.39 -33.52 30.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 3.0 tp10 -65.59 -45.81 81.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.746 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.492 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.4 t -61.02 -51.62 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.203 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 162' ' ' ALA . 72.3 mt -62.59 -49.19 76.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.902 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -49.79 -47.15 51.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.677 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.72 -25.06 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.492 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.4 m-30 -104.07 10.79 35.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.001 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.52 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -57.99 13.9 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.9 Cg_endo -55.69 -21.76 33.3 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.464 2.109 . . . . 0.0 112.084 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.42 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 63.6 m-70 -92.53 -17.7 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.933 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.0 ptt85 -79.15 152.86 30.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.133 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? -57.51 139.07 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.9 m120 -153.12 161.41 42.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.41 ' CG1' HD13 ' A' ' 47' ' ' ILE . 1.2 m -141.93 123.82 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.088 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 147.37 18.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.286 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.478 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -122.11 101.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 111.275 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.7 t -89.89 104.94 17.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 22.3 tp -102.97 148.16 26.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 ptt? -130.39 157.4 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.444 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 33.9 p-10 -104.32 169.35 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.269 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.72 -17.05 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.53 56.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.293 . . . . 0.0 111.006 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 76.42 26.71 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -98.1 172.53 7.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.1 mp -109.35 121.12 61.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.064 0.459 . . . . 0.0 111.06 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 5.0 t80 -55.28 107.82 0.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.267 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.81 141.8 47.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.758 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -126.37 139.4 53.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.345 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.71 158.29 22.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.621 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.1 mtp85 -75.12 159.69 31.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.527 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -94.49 -5.43 46.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.951 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.09 -16.99 3.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.482 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 57.7 mt -121.34 112.61 32.8 Favored Pre-proline 0 N--CA 1.454 -0.253 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.18 131.75 29.53 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.906 1.738 . . . . 0.0 111.788 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 t0 76.66 4.08 3.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.39 97.48 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.423 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -101.66 155.34 18.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -169.03 -176.61 2.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 4.3 mtm -113.71 154.4 45.75 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.73 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.46 142.35 78.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.599 2.199 . . . . 0.0 112.413 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -154.07 173.73 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.94 178.79 28.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.578 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' ILE . . . -112.92 23.91 13.76 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.689 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 46' ' ' GLY . 3.5 mt 51.26 157.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 0.0 111.643 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' N ' HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.77 176.64 6.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.71 98.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.221 0.534 . . . . 0.0 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.86 49.28 29.52 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.757 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' HG22 ' A' ' 47' ' ' ILE . 3.4 tt0 -112.65 148.14 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.254 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.14 -60.41 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.454 2.103 . . . . 0.0 112.864 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -55.57 -26.53 44.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -82.34 -49.01 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.697 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -57.79 -31.1 66.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.1 -53.11 11.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.119 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.3 mt -56.08 -29.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.186 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -83.79 -52.61 6.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.785 0.802 . . . . 0.0 109.945 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.44 -48.49 65.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.668 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tp -53.6 -55.51 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.982 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.578 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.8 ttp85 -58.7 -15.25 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -91.97 -37.64 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.715 0.293 . . . . 0.0 111.759 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -90.71 -28.73 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -121.92 -21.35 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.278 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.91 5.19 69.22 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.79 108.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.929 0.364 . . . . 0.0 110.306 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -34.4 15.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.25 75.02 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 127.24 11.85 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.853 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.88 148.83 43.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.678 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 43.6 t -77.94 127.1 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.853 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -106.95 -20.32 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.28 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.427 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.87 161.97 40.5 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.4 pt-20 -148.41 113.82 5.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.257 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 78' ' ' TYR . 3.6 t -57.55 125.36 71.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.185 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.27 -10.02 25.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.811 2.341 . . . . 0.0 113.617 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.496 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.45 133.6 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.582 . . . . 0.0 112.065 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.435 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 24.8 m95 -65.39 147.21 53.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.693 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.467 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 43.9 mt -113.17 117.63 32.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.779 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.4 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 3.6 p -114.52 132.21 56.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -131.4 170.11 15.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.94 158.25 35.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -109.83 154.64 42.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.345 0.345 0 C-N-CA 122.484 2.123 . . . . 0.0 112.263 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 73.3 m95 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.759 0.314 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -30.33 63.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.723 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.47 -139.63 2.74 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.96 116.25 3.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 111.584 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -87.84 108.36 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.7 pt20 -120.16 150.85 39.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.3 mttt -107.91 95.88 5.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.19 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.46 ' CG ' HG21 ' A' ' 157' ' ' VAL . 49.4 m95 -62.97 138.96 58.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 112.259 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 54' ' ' ARG . 66.9 m-85 -124.85 132.44 53.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.937 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.2 tp -79.59 131.15 35.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.508 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.5 m-85 -125.49 129.57 50.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 111.498 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB2' HG13 ' A' ' 73' ' ' ILE . 28.1 tttt -93.53 121.08 34.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.2 123.32 19.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.1 p -124.66 37.51 4.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.613 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.47 -144.79 4.81 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.07 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -128.35 154.14 46.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -49.93 -16.72 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -20.24 57.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 111.131 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.61 -25.18 49.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 119' ' ' ILE . 20.7 mt -72.39 103.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.48 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' THR . 63.7 t30 -119.06 95.48 4.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.988 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.3 mt -54.78 -21.93 12.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.783 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.94 -59.23 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.64 -171.52 25.9 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.447 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -94.39 38.83 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.119 0.485 . . . . 0.0 109.936 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.2 27.13 72.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.4 t -106.0 -64.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.0 111.202 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -115.48 163.48 15.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.212 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.35 152.37 54.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.11 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.23 179.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.784 2.323 . . . . 0.0 112.581 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -148.39 -44.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.713 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 31.7 m-85 -110.59 159.59 17.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.421 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -113.72 -20.78 5.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.587 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.1 mm-40 -152.34 174.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.526 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.4 p-90 -159.54 157.45 29.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.073 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -154.51 160.49 41.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.455 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 82.5 m95 -93.63 123.43 36.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.54 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 30.2 m -134.88 150.43 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 111.777 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.455 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -69.59 160.64 78.72 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.598 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 16.6 Cg_endo -57.84 -17.62 30.77 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.832 1.688 . . . . 0.0 111.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.74 -34.07 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.07 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.01 -50.75 25.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.7 tp -54.24 -31.04 52.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.489 0.661 . . . . 0.0 109.83 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.8 mm -68.58 -28.44 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.621 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.78 -20.72 42.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.27 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 142' ' ' LEU . 11.7 mt -84.74 -39.11 18.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.119 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.421 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 26.0 m -56.74 163.63 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' A' ' 150' ' ' LYS . 7.5 p -91.66 164.96 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -55.23 -35.06 64.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.925 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.442 ' CE2' HG13 ' A' ' 147' ' ' VAL . 12.5 p90 -90.5 11.09 22.85 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HB2' HG11 ' A' ' 147' ' ' VAL . 2.1 mtmp? -133.23 -3.68 3.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.537 0.208 . . . . 0.0 111.513 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.43 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttm -58.98 -62.8 5.09 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.577 0.227 . . . . 0.0 111.192 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 17.3 Cg_endo -57.92 -41.61 67.1 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.467 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 20.8 t -59.75 -28.05 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.2 m-85 -91.16 -51.4 5.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.66 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -32.82 21.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -66.21 -45.65 79.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.565 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.3 t -58.97 -48.93 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.23 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 162' ' ' ALA . 77.3 mt -62.24 -48.68 78.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.723 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.9 m -49.67 -47.21 50.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.739 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.5 t -69.28 -25.43 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.494 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.6 m-30 -103.3 11.66 36.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.985 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.1 -57.69 16.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.486 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.8 Cg_endo -55.78 -22.04 35.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.511 2.141 . . . . 0.0 112.356 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 91.3 m-70 -90.33 -15.09 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.087 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.952 0.406 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.87 152.29 24.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -71.82 129.85 39.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 14.3 t-20 -152.84 161.89 41.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.523 HG11 HD13 ' A' ' 47' ' ' ILE . 1.7 m -131.54 135.53 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 111.458 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.434 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -103.8 150.62 17.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.101 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -126.7 101.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.822 0.344 . . . . 0.0 111.506 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 t -89.75 100.43 13.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.4 tp -102.79 143.65 32.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.044 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 2.8 ptt? -126.22 157.5 38.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 40.5 p-10 -98.98 170.95 8.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.76 -16.11 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.491 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -89.14 1.06 56.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 64.8 mttt 76.29 26.97 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.3 mttt -99.17 171.62 7.89 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.0 mp -109.94 122.76 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.902 0.382 . . . . 0.0 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 86.7 t80 -55.17 111.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.12 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.52 130.34 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.31 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.03 138.72 50.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.041 0.448 . . . . 0.0 111.193 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.534 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.25 158.07 23.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.632 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.3 mtp85 -73.35 159.72 32.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -93.36 -5.48 49.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.921 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.61 -17.76 3.62 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 69.6 mt -120.68 112.76 33.69 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.099 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.47 132.27 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.887 1.725 . . . . 0.0 111.684 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.76 4.82 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -90.36 97.56 11.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.41 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -103.36 155.58 18.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.126 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.72 170.95 9.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 68.1 mtm -90.04 153.87 47.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.689 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.29 139.14 41.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.156 . . . . 0.0 112.666 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.77 162.6 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.86 141.8 7.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.602 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -58.44 140.87 46.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.523 HD13 HG11 ' A' ' 17' ' ' VAL . 3.7 mt -72.66 159.29 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.496 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.58 148.66 22.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.09 99.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.225 0.536 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.23 40.42 13.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.913 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.3 tp10 -110.75 147.5 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.159 0.504 . . . . 0.0 110.859 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.93 130.56 80.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.04 -25.7 23.25 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.377 2.051 . . . . 0.0 112.538 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' CB ' ' CE2' ' A' ' 108' ' ' PHE . 9.7 ttt180 -86.61 -22.05 26.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.984 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -91.08 -40.29 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 110.31 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -64.17 -30.37 71.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.68 -50.96 15.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.6 -30.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.101 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -81.36 -53.14 6.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.867 0.842 . . . . 0.0 109.908 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.79 -49.34 65.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -54.97 -55.15 33.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.973 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 50.3 ttp85 -61.44 -13.44 20.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.544 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.95 -43.0 9.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.957 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -91.38 -25.33 19.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.418 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.36 -20.27 8.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.361 . . . . 0.0 111.057 -179.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.9 7.59 62.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.068 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.25 115.62 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.856 0.36 . . . . 0.0 110.383 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.64 -34.04 11.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.195 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 76.33 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.197 0.522 . . . . 0.0 111.051 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.51 129.07 13.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -116.33 147.63 41.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.02 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.2 t -77.03 119.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.325 0.583 . . . . 0.0 111.068 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.512 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -93.41 -26.05 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.837 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.59 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.518 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.43 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 29.2 tt0 -148.65 118.76 7.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.583 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.691 HG11 ' O ' ' A' ' 78' ' ' TYR . 8.1 t -58.21 123.95 68.07 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.61 -17.05 58.32 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.723 2.282 . . . . 0.0 113.312 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.691 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.77 -178.54 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.907 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -110.5 146.3 36.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.874 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 9.5 mt -112.73 117.61 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.064 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 2.7 p -109.76 132.35 54.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -129.08 161.58 29.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.624 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.9 158.37 29.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.383 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -104.26 150.85 38.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.444 2.096 . . . . 0.0 111.956 179.606 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.5 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.796 0.331 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -26.34 36.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.078 0.466 . . . . 0.0 110.396 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.61 -152.3 8.53 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.585 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -152.81 116.7 4.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.71 0.29 . . . . 0.0 111.084 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -85.62 105.62 16.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -117.65 161.34 19.81 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 105.08 12.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.388 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 74.1 m95 -75.69 136.41 40.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 112.259 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 26.9 m-85 -118.78 133.73 55.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.03 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.8 tp -79.57 135.28 36.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.097 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 38.3 m-85 -127.87 133.46 49.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.188 0.518 . . . . 0.0 112.187 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -96.02 119.44 34.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.507 177.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.56 122.89 19.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 110.761 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 p -124.54 37.55 4.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.27 -145.01 4.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.097 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.64 154.19 45.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.84 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -77.17 -17.98 58.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.2 -26.22 42.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 16.4 mt -72.51 98.68 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.341 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -113.89 95.79 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.4 mt -56.58 -21.15 24.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.457 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -59.67 -56.88 16.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.417 0.627 . . . . 0.0 109.867 179.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 136.85 -174.96 21.37 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.436 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -90.96 38.66 0.96 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.09 29.43 74.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.96 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -111.79 -64.8 1.24 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.0 111.38 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.46 165.11 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 146.05 94.68 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.4 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 47.4 Cg_exo -54.84 140.89 78.27 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.607 2.204 . . . . 0.0 112.381 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -110.65 -27.35 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 5.9 m-85 -118.74 159.44 23.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.588 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.5 -16.34 5.59 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.772 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.534 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 4.7 mp0 -152.24 174.27 13.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.734 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.4 p-90 -159.59 154.19 24.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.114 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.57 159.63 44.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.366 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 74.7 m95 -93.68 125.82 38.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.437 HG22 ' CA ' ' A' ' 142' ' ' LEU . 27.4 m -138.8 151.17 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 111.696 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.33 160.42 79.12 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 14.4 Cg_endo -57.0 -18.19 27.36 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 121.875 1.717 . . . . 0.0 111.929 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.27 -34.24 14.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.121 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -50.24 37.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.977 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.437 ' CA ' HG22 ' A' ' 137' ' ' VAL . 3.5 tp -54.49 -31.82 56.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.457 0.646 . . . . 0.0 109.75 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.415 ' CD1' ' CG ' ' A' ' 155' ' ' LYS . 6.0 mm -69.84 -27.81 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.622 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.71 -23.56 42.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.065 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 142' ' ' LEU . 10.3 mt -81.67 -39.8 23.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.86 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 m -55.73 165.2 0.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 150' ' ' LYS . 14.8 p -95.84 161.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.518 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.52 -27.0 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 23.1 p90 -90.9 10.11 27.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.512 ' HB2' HG11 ' A' ' 147' ' ' VAL . 18.4 mtmt -150.07 13.98 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 111.611 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.518 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.7 mtpp -69.07 -62.79 2.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.141 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.3 Cg_endo -51.49 -40.01 63.79 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 111.988 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.475 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 22.7 t -58.73 -25.03 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.88 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.26 -51.46 5.29 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.541 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.415 ' CG ' ' CD1' ' A' ' 143' ' ' ILE . 11.1 mtpt -50.31 -33.95 21.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.463 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 6.6 tp10 -64.9 -46.02 83.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.69 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.6 t -59.31 -48.43 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.22 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 162' ' ' ALA . 72.5 mt -64.19 -48.65 75.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.616 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.6 m -49.4 -47.38 47.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.8 -24.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.134 0.492 . . . . 0.0 110.459 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.6 m-30 -101.24 -0.77 35.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.116 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.627 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.32 -51.86 24.12 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.333 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -55.74 -22.82 38.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.372 2.048 . . . . 0.0 112.176 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.41 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 88.8 m-70 -93.45 -19.55 21.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.416 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 3.7 mp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.15 0.5 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 tpt85 -82.72 152.15 25.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -79.19 128.21 33.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 8.5 m120 -152.55 163.36 39.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.455 HG23 ' CB ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -128.95 135.0 63.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.077 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.84 142.14 15.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.385 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.461 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -119.03 101.17 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.2 t -89.8 103.85 16.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 42.6 tp -102.87 140.52 37.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 111.11 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -124.54 157.34 35.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.836 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.9 p-10 -101.21 169.5 8.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -54.85 -17.61 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.626 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.24 56.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 110.942 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt 76.68 25.8 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.529 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.7 mttp -96.28 171.65 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' CG2' HD21 ' A' ' 142' ' ' LEU . 4.0 mp -109.55 123.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.463 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 74.9 t80 -57.72 110.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.48 134.35 54.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.8 135.9 54.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.61 153.85 25.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 39' ' ' ALA . 1.1 mtp85 -70.73 157.12 38.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 111.402 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -5.71 52.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.56 -18.11 4.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.148 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.494 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 54.3 mt -119.65 107.96 39.95 Favored Pre-proline 0 N--CA 1.456 -0.144 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.911 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 24.8 Cg_exo -62.49 128.93 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.0 t0 80.65 2.7 1.79 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.83 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -89.31 97.46 11.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.422 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.413 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.3 m95 -104.97 156.78 17.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.0 -177.0 2.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.753 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.44 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 2.9 mpp? -106.49 158.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 139.98 40.85 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -154.02 162.23 41.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.788 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.58 18.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.1 137.4 29.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.645 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 4.9 mt -70.75 159.55 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.555 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.65 149.61 22.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.921 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.25 98.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.236 0.541 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.08 39.84 11.05 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.919 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' HB3' HG22 ' A' ' 47' ' ' ILE . 5.8 tp10 -112.24 147.39 36.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.153 0.501 . . . . 0.0 110.872 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.03 133.79 78.34 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.56 -55.13 4.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.06 . . . . 0.0 112.609 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HG3' ' CD2' ' A' ' 108' ' ' PHE . 1.2 ttt-85 -59.13 -22.76 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.11 -49.66 7.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.733 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -58.53 -28.45 65.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.599 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.33 -51.37 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.074 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 55.5 mt -55.71 -30.67 27.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.047 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -80.54 -53.23 6.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.825 0.821 . . . . 0.0 109.838 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -55.96 -33.36 64.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.632 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.05 -61.24 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.115 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.606 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.9 ptp180 -62.39 -9.17 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.506 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.43 ' OE1' ' CG ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.86 -47.66 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.71 -30.39 17.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.266 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.416 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -114.07 -22.76 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.576 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 71.07 8.85 65.69 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.957 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.35 118.11 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.791 0.329 . . . . 0.0 110.342 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.08 -35.18 11.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.17 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.78 6.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.37 128.9 13.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.901 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.66 148.96 42.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.688 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.4 t -77.74 128.03 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.454 0.645 . . . . 0.0 111.924 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -108.46 -19.86 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.381 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -158.66 164.05 36.33 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.084 0.469 . . . . 0.0 111.622 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -148.98 118.51 6.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.516 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG1' ' CD1' ' A' ' 78' ' ' TYR . 3.4 t -57.91 110.39 2.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.059 0.457 . . . . 0.0 110.045 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.77 -23.41 11.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.257 2.638 . . . . 0.0 113.332 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.504 ' CD1' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -112.67 -175.75 2.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.235 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.422 ' CE2' ' HE2' ' A' ' 106' ' ' LYS . 51.3 m95 -105.36 147.96 27.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.658 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 HG13 ' A' ' 76' ' ' VAL . 1.6 mm? -109.22 118.46 36.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.219 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.4 p -120.14 131.18 54.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.731 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -126.47 170.2 12.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.525 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.81 158.29 42.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.238 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.25 153.75 46.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.548 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 122.414 2.076 . . . . 0.0 112.056 179.71 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.2 m95 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -30.55 63.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.419 0.628 . . . . 0.0 109.962 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 103' ' ' GLN . . . -150.67 -158.84 8.46 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.752 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -151.25 112.52 4.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.756 0.313 . . . . 0.0 111.186 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.54 105.56 16.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.5 pt20 -124.34 152.18 43.44 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -101.72 101.19 11.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.01 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.449 ' CG ' HG21 ' A' ' 157' ' ' VAL . 31.0 m95 -71.33 138.53 49.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 0.0 111.689 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 62.8 m-85 -123.23 134.09 54.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.547 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 19.4 tp -79.69 132.03 36.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.392 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 44.8 m-85 -126.08 128.83 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.513 ' HB2' HG13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.12 121.23 33.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -66.09 125.27 24.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.027 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.6 p -127.54 37.68 4.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.638 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.64 -144.7 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.122 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.82 154.18 44.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.878 0.37 . . . . 0.0 110.064 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.95 -16.47 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.69 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -18.33 54.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.704 0.287 . . . . 0.0 111.245 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -79.52 -24.79 41.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.0 110.837 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.463 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 21.2 mt -75.71 104.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.112 0.482 . . . . 0.0 111.568 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.51 95.86 4.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.859 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.3 mt -53.48 -24.46 13.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.626 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.3 mt -62.45 -57.55 10.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 110.026 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.66 -178.16 21.27 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -91.11 38.97 0.98 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.8 66.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -121.21 -69.64 0.83 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -84.86 165.1 17.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.32 145.21 39.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.31 128.68 30.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.579 2.186 . . . . 0.0 112.634 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.89 -32.28 6.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.542 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 14.6 m-85 -110.3 159.67 17.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.2 -19.94 5.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.987 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -152.48 175.38 12.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.115 0.483 . . . . 0.0 110.746 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.2 p-90 -157.15 154.25 29.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.195 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.09 161.47 42.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.367 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 72.1 m95 -94.7 123.56 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 32.4 m -135.52 151.21 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.033 0.444 . . . . 0.0 111.578 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.16 162.4 69.54 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.634 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.06 -18.54 36.6 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.792 1.661 . . . . 0.0 111.914 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.07 -34.51 14.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.223 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.66 -50.6 34.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.023 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.6 tp -54.01 -32.16 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.522 0.677 . . . . 0.0 109.818 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.32 -28.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.746 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.64 -22.38 40.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 40' ' ' TRP . 10.6 mt -83.5 -39.54 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 154' ' ' TYR . 3.6 m -59.48 167.4 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.478 HG12 ' CZ ' ' A' ' 149' ' ' PHE . 7.2 p -101.26 159.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -51.84 -40.88 61.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 9.4 p90 -79.58 1.5 25.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.472 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 27.6 mttm -136.44 7.56 3.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.573 0.225 . . . . 0.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 14.1 mtpt -70.31 -62.39 2.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.105 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.6 Cg_endo -53.93 -43.14 60.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.379 2.053 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.452 ' O ' HD13 ' A' ' 80' ' ' LEU . 78.0 t -57.35 -25.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.698 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.428 ' CD2' HG23 ' A' ' 146' ' ' THR . 3.9 m-30 -90.69 -53.25 4.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.445 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -31.91 16.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.229 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.0 tp10 -65.21 -46.17 81.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.503 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.515 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 49.1 t -59.83 -48.41 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.226 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 162' ' ' ALA . 71.9 mt -64.27 -49.15 72.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.1 m -50.35 -44.28 54.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.757 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 97.3 t -72.42 -24.83 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 110.595 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.515 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.8 m-30 -102.93 8.48 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.097 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.71 -52.61 62.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.725 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.7 Cg_endo -52.82 -23.39 20.57 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.509 2.14 . . . . 0.0 112.375 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 98.5 m-70 -89.91 -23.34 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.734 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.856 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 101' ' ' LYS . 26.8 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -89.51 152.16 21.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.396 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -81.03 125.31 30.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.603 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.3 t-20 -152.58 157.7 41.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.428 HG22 ' CB ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -123.5 125.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.238 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.52 147.61 18.69 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.246 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 43' ' ' PRO . 2.0 mm -116.24 101.69 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 111.541 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 5.7 t -92.07 97.84 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.414 HD23 ' CD2' ' A' ' 29' ' ' PHE . 19.8 tp -102.52 151.61 22.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.178 0.513 . . . . 0.0 111.646 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.0 ptt? -134.37 157.4 46.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.397 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.48 170.16 8.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.557 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -18.85 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.539 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.74 1.73 54.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.328 . . . . 0.0 110.887 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 33.5 mtmt 72.9 26.88 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.664 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.1 mmtp -97.7 173.54 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.0 mp -109.16 123.58 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.033 0.444 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.45 ' CE2' HG22 ' A' ' 65' ' ' THR . 3.0 t80 -58.13 104.4 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.27 53.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.752 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.88 138.49 53.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.46 157.45 23.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.1 mtp85 -74.85 158.71 32.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.25 0.548 . . . . 0.0 111.29 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 -4.78 48.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.953 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -129.24 -17.29 3.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.176 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.463 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 69.4 mt -121.39 112.06 33.04 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.094 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.3 Cg_endo -65.65 132.1 29.76 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.79 1.66 . . . . 0.0 111.683 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.38 5.36 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -91.74 97.6 11.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.301 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.406 ' CZ3' ' OG ' ' A' ' 135' ' ' SER . 31.2 m95 -104.86 156.68 17.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.185 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.2 pm0 -168.76 -176.78 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.775 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.476 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 1.4 mtt -113.53 160.11 32.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.656 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 54.6 Cg_exo -52.01 128.88 28.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.629 2.219 . . . . 0.0 112.615 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.72 141.75 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.41 133.56 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.704 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.94 133.88 52.56 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 4.7 mt -65.16 159.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.611 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.453 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.29 149.62 22.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -51.78 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.195 0.521 . . . . 0.0 110.756 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.71 10.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.904 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HB3' HG22 ' A' ' 47' ' ' ILE . 14.5 tp10 -113.16 146.49 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 110.865 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.5 135.78 75.23 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.9 -55.24 4.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.434 2.089 . . . . 0.0 112.577 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 8.8 ttm180 -59.4 -25.83 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.396 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -84.12 -50.49 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.729 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.21 -31.56 63.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' CB ' ' CD1' ' A' ' 19' ' ' ILE . . . -72.45 -53.91 10.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.102 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.63 -28.49 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.238 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -83.19 -52.85 6.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -56.96 -37.51 71.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.861 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.14 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.599 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -58.8 -12.23 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.05 -41.04 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.359 . . . . 0.0 111.462 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -90.55 -31.08 16.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.996 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.45 HG22 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.13 -21.24 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.84 2.97 72.49 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.6 t -67.52 110.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -95.02 -29.53 14.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.13 76.45 6.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.309 0.576 . . . . 0.0 110.536 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 131.4 15.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -118.91 139.73 51.16 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.249 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 26.7 t -68.69 120.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.37 0.605 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -94.97 -25.12 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.934 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.49 171.32 16.07 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.825 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -149.11 123.39 9.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.484 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 78' ' ' TYR . 41.4 t -57.83 126.21 75.75 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.76 0.314 . . . . 0.0 110.317 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.47 -18.9 56.45 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.91 2.407 . . . . 0.0 113.123 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.605 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -123.17 -175.37 3.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 111.28 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.427 ' CE2' ' HE2' ' A' ' 106' ' ' LYS . 53.5 m95 -102.9 147.41 26.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.062 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 1.1 mm? -105.24 117.54 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.647 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.8 p -116.03 137.97 51.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.311 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -134.39 170.11 16.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.338 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.98 158.37 39.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.184 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -112.3 145.46 32.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--N 1.345 0.392 0 C-N-CA 122.471 2.114 . . . . 0.0 112.432 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.6 m95 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.98 0.419 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -75.64 -32.26 60.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.967 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.56 -133.31 1.88 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.374 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.9 mt-30 -158.09 114.38 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.78 105.85 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' NE2' ' CZ2' ' A' ' 107' ' ' TRP . 3.6 pt20 -121.64 157.85 29.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -105.97 98.71 8.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.817 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.476 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 40.5 m95 -69.54 130.2 41.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.734 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.432 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 68.0 m-85 -116.5 135.53 53.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.1 tp -79.57 137.46 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.066 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 40.1 m-85 -129.63 133.13 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.244 0.545 . . . . 0.0 111.925 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 34.1 tttm -96.25 119.99 35.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.489 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -68.41 123.22 20.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.99 0.424 . . . . 0.0 110.978 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.9 p -124.81 37.56 4.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.464 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.23 -145.16 4.9 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.69 154.06 47.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 109.998 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -49.87 -16.83 0.3 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.541 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -22.66 56.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.28 -25.61 58.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 119' ' ' ILE . 36.8 mt -67.99 104.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.468 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -120.92 95.43 4.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.49 -21.58 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.693 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.16 -60.03 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 110.056 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.84 -175.09 24.68 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.542 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -91.81 38.75 0.99 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.134 0.492 . . . . 0.0 109.89 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.65 73.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.104 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 t -115.58 -69.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.24 165.09 12.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.177 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 149.27 65.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.91 124.92 13.42 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.613 2.208 . . . . 0.0 112.57 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -106.27 -28.58 10.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.454 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 3.9 m-85 -110.91 159.18 17.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.87 -22.76 4.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.697 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.456 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.7 mm-40 -152.27 174.34 13.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 110.552 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p-90 -159.95 159.88 32.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.26 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.406 ' OG ' ' CZ3' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -160.26 167.6 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.429 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 68.8 m95 -97.02 121.58 39.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 35.3 m -132.49 150.53 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.717 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -70.76 160.05 83.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 14.1 Cg_endo -56.89 -18.14 26.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 121.855 1.703 . . . . 0.0 111.915 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -34.06 15.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.987 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -50.91 23.54 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.8 tp -54.87 -31.25 59.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.447 0.642 . . . . 0.0 109.845 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 9.1 mm -70.03 -27.29 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.62 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.24 -17.12 47.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.145 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 142' ' ' LEU . 13.4 mt -87.59 -38.98 15.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.6 m -57.58 163.16 2.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.03 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 149' ' ' PHE . 13.0 p -90.0 161.82 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.965 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.507 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -55.68 -31.3 62.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.759 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -92.6 7.39 43.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.456 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 4.5 mttm -133.27 -8.27 2.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.513 0.197 . . . . 0.0 111.505 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.6 mtpp -54.47 -59.43 10.31 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.264 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 16.8 Cg_endo -57.78 -42.63 57.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.3 2.0 . . . . 0.0 111.938 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.463 ' O ' HD11 ' A' ' 80' ' ' LEU . 85.9 t -57.5 -27.92 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.418 ' CD2' ' HE1' ' A' ' 42' ' ' MET . 3.3 m-85 -91.86 -53.91 4.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.382 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.64 -38.3 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.416 ' HB3' HD12 ' A' ' 80' ' ' LEU . 8.4 tp10 -60.68 -46.26 91.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.505 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 42.8 t -58.54 -49.49 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.331 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 162' ' ' ALA . 68.4 mt -62.35 -49.59 74.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.3 p -49.83 -42.45 47.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.772 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.4 t -73.44 -24.6 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.115 0.483 . . . . 0.0 110.343 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.516 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.3 m-30 -104.63 12.05 33.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.995 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.01 -55.53 32.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.386 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.0 Cg_endo -55.87 -22.37 37.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.494 2.129 . . . . 0.0 112.248 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.413 ' CB ' ' CD2' ' A' ' 109' ' ' LEU . 98.4 m-70 -89.92 -17.97 27.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.934 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.717 0.294 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.416 ' HG2' ' CD2' ' A' ' 100' ' ' TRP . 29.9 mmm-85 -77.73 148.18 35.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -67.4 130.66 43.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.139 0.495 . . . . 0.0 111.534 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.471 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 m120 -152.5 162.52 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.447 HG23 ' CB ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -134.93 126.26 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 0.0 111.25 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.09 138.84 14.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.273 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -114.65 101.52 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.343 . . . . 0.0 111.26 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.9 t -90.17 104.58 17.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 112' ' ' PHE . 27.5 tp -103.29 149.13 25.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.063 0.458 . . . . 0.0 111.143 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.9 ptt? -130.11 157.37 42.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.708 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.8 p-10 -100.73 171.0 7.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.468 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -57.65 -16.02 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.547 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.04 0.27 56.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp 76.9 27.48 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.656 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -98.83 171.21 8.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -109.91 121.23 62.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.967 0.413 . . . . 0.0 110.953 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.456 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 86.9 t80 -55.49 110.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.61 137.81 51.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.356 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -123.23 139.88 53.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.401 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.21 156.88 24.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.626 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -73.01 157.75 36.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 111.367 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mt -90.5 -5.88 55.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.124 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.88 -16.6 2.89 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 61.6 mt -119.07 106.03 43.96 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 31.0 Cg_exo -60.77 129.05 27.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.164 1.909 . . . . 0.0 111.888 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.2 t70 80.61 0.93 1.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.929 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.52 97.67 10.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.4 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -101.47 155.09 18.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.119 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -169.13 -176.86 2.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.699 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.456 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 4.2 mpp? -102.66 157.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 121.37 7.9 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.601 2.201 . . . . 0.0 112.498 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -123.23 161.64 24.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.61 138.7 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.435 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.39 129.08 19.53 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 4.9 mt -61.12 158.62 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.7 m-20 -90.21 150.41 21.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.47 99.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.156 0.503 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.26 37.93 9.48 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.779 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB3' HG23 ' A' ' 47' ' ' ILE . 49.1 tt0 -114.39 147.92 38.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.174 0.511 . . . . 0.0 110.701 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.11 142.52 72.31 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.508 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 49.0 Cg_exo -56.45 -57.88 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.504 2.136 . . . . 0.0 112.89 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.8 ttt-85 -58.38 -24.78 60.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.43 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -87.71 -42.76 12.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 110.252 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -62.39 -32.7 73.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.197 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.28 -52.49 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 51.4 mt -56.82 -29.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.999 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -81.2 -52.78 6.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.716 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 31.5 mm-40 -55.4 -44.83 76.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.638 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.17 -51.86 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.829 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.575 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 31.9 ttp180 -61.59 -13.68 23.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.577 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.02 -42.26 10.08 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -90.76 -27.05 19.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.42 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.45 -21.55 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 111.093 -179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.09 8.39 61.5 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.981 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -65.23 110.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.237 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.9 p -92.46 -34.95 13.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.239 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.37 76.6 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 111.055 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.44 129.34 13.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.605 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.4 pt-20 -119.14 140.28 50.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.323 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.3 t -69.28 121.65 19.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.353 0.597 . . . . 0.0 111.17 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -97.74 -22.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' A' ' 164' ' ' HIS . . . -163.37 165.65 23.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.504 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 10.6 pt-20 -149.06 121.17 8.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.608 ' CG1' ' CD1' ' A' ' 78' ' ' TYR . 32.4 t -56.94 126.01 71.28 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 -19.41 46.48 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.951 2.434 . . . . 0.0 113.242 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.608 ' CD1' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.13 -175.3 3.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 111.511 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -104.57 147.76 27.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.77 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -104.52 118.08 35.72 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.418 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.413 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -119.98 133.71 55.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.949 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -133.85 170.31 15.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.98 161.24 23.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.634 0.731 . . . . 0.0 111.42 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 10.8 m-85 -111.15 144.06 29.66 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 122.648 2.232 . . . . 0.0 112.565 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.416 ' CD2' ' HG2' ' A' ' 14' ' ' ARG . 90.9 m95 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.813 0.34 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -30.83 66.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -179.51 -133.85 2.06 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.937 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 14.1 pt20 -157.96 114.84 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.0 111.343 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.413 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -87.46 105.78 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.848 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.7 pt20 -123.19 144.87 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -95.66 98.68 10.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 178.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.456 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 22.2 m95 -66.14 143.57 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.193 0.52 . . . . 0.0 112.149 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.3 m-85 -129.21 136.98 50.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.246 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 23.6 tp -79.34 155.01 28.64 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.489 ' N ' ' O ' ' A' ' 20' ' ' CYS . 32.8 m-85 -146.1 132.73 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.252 0.549 . . . . 0.0 112.023 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 5.5 tptp -96.46 118.27 32.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.53 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.427 ' CD1' HD21 ' A' ' 21' ' ' LEU . 4.6 t80 -68.17 120.69 14.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 0.0 110.701 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.9 p -121.81 37.43 4.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.457 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.83 -144.38 4.7 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.086 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.29 154.29 45.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 110.004 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -49.73 -16.8 0.27 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -15.7 59.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.02 -25.47 37.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 14.9 mt -73.18 103.89 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.582 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.48 95.85 4.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.024 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 49.0 mt -56.02 -21.65 22.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.654 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.95 -58.84 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 109.984 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.69 -172.19 24.5 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.435 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -93.31 38.82 1.05 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.15 0.5 . . . . 0.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.45 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.302 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.8 m -114.28 -67.75 0.97 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.769 0.318 . . . . 0.0 111.25 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -98.38 165.1 12.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -76.37 147.54 79.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.69 136.18 49.81 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.613 2.209 . . . . 0.0 112.55 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -108.12 -28.39 9.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.653 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 19.0 m-85 -120.37 159.69 24.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.17 -18.11 6.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.85 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.4 mm-40 -152.45 174.94 13.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.193 0.52 . . . . 0.0 110.782 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.4 p-90 -159.45 152.38 21.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.964 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 m -148.08 157.26 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.541 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 86.9 m95 -92.81 125.11 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -136.73 151.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.118 0.485 . . . . 0.0 111.662 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.13 159.07 85.8 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.555 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.419 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.7 Cg_endo -55.82 -18.63 22.21 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.841 1.694 . . . . 0.0 112.016 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -34.17 15.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -50.45 30.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.9 tp -54.3 -29.8 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.32 0.581 . . . . 0.0 109.829 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.0 mm -69.83 -28.49 37.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.655 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -22.39 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.268 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.41 HD11 ' CD1' ' A' ' 142' ' ' LEU . 10.5 mt -82.97 -39.15 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.428 HG23 ' CG ' ' A' ' 154' ' ' TYR . 26.9 m -53.87 164.21 0.62 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.532 HG12 ' CZ ' ' A' ' 149' ' ' PHE . 10.3 p -97.24 162.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -51.51 -38.38 53.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.985 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.532 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 23.8 p90 -88.34 10.82 18.55 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.415 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 67.3 mttt -130.95 -5.12 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.419 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 12.2 mttt -55.97 -62.0 5.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.9 Cg_endo -59.01 -48.16 15.28 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.388 2.058 . . . . 0.0 112.233 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 80' ' ' LEU . 92.3 t -57.22 -27.1 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.24 0.543 . . . . 0.0 111.11 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.454 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.0 m-85 -90.91 -52.73 4.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.428 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -31.85 18.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.308 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.39 -46.13 81.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.445 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.502 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 57.7 t -59.57 -53.2 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.32 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' ALA . 59.1 mt -62.85 -50.01 72.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.9 t -51.66 -45.61 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.84 -25.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 110.297 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.502 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.9 m-30 -101.96 7.98 41.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.551 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.23 -56.23 21.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.623 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.9 Cg_endo -50.16 -24.67 11.65 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.567 2.178 . . . . 0.0 112.384 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.428 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 95.9 m-70 -95.39 -18.34 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.964 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.51 152.23 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -75.93 126.96 32.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.6 t-20 -152.5 157.07 40.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG23 ' CB ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -125.45 124.49 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.891 0.377 . . . . 0.0 111.202 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.55 140.96 15.44 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.197 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -121.23 101.83 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.441 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.3 t -89.76 107.3 19.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 tp -103.19 146.54 28.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.7 157.53 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.976 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.47 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.7 p-10 -100.59 170.93 8.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.06 -18.21 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.608 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 0.31 56.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.988 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp 76.83 25.63 0.85 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.558 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttp -94.4 172.44 8.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.8 mp -110.54 120.35 61.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.947 0.403 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.456 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 68.2 t80 -53.9 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.129 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.52 131.57 56.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.368 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -117.33 138.29 51.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.914 0.388 . . . . 0.0 111.178 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.29 155.87 24.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -70.41 159.16 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 111.599 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -92.84 -5.81 50.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.831 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.51 -19.49 4.19 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.477 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 66.8 mt -120.4 112.76 34.1 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.968 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.09 131.61 29.22 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.858 1.705 . . . . 0.0 111.911 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.32 2.66 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -86.94 97.36 10.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.301 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -102.34 155.41 18.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.176 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -168.62 169.15 10.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.416 ' HE2' ' CG ' ' A' ' 154' ' ' TYR . 76.2 mtm -89.92 155.22 47.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.16 149.37 22.16 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.697 2.265 . . . . 0.0 113.061 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -176.39 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.214 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 138.08 4.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.296 -0.955 . . . . 0.0 112.858 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.76 126.32 29.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 48' ' ' ASP . 5.6 mt -60.99 161.28 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.685 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -88.34 -176.38 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.2 98.62 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.23 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.79 47.39 9.8 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.749 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HB3' HG21 ' A' ' 47' ' ' ILE . 6.5 tt0 -115.62 146.75 41.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.55 134.86 84.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.588 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.43 -57.25 2.2 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.401 2.067 . . . . 0.0 112.659 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.424 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -56.84 -28.06 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.434 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -81.97 -49.7 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.718 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -57.16 -30.76 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.65 -52.0 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.9 mt -55.85 -28.71 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.244 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.5 ttp85 -83.62 -52.8 6.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.885 0.85 . . . . 0.0 109.89 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -56.36 -34.55 66.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.684 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.4 tp -57.13 -59.54 4.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.181 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.564 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 22.4 ptt85 -61.34 -10.71 7.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.793 0.33 . . . . 0.0 110.691 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -91.19 -45.12 8.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 0.0 111.561 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.46 -28.12 17.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -21.49 10.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.837 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.17 4.85 74.53 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.039 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.2 119.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.364 . . . . 0.0 110.566 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -99.25 -34.07 10.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.35 78.27 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.184 0.516 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.39 129.6 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.924 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -120.0 145.76 46.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.577 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.1 t -76.11 125.9 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.527 0.679 . . . . 0.0 111.967 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -107.62 -16.19 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.339 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB2' ' CD1' ' A' ' 161' ' ' PHE . . . -155.35 160.18 40.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 115.56 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.104 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 78' ' ' TYR . 7.2 t -57.33 127.47 77.0 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.951 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 -15.55 44.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.784 2.322 . . . . 0.0 113.585 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -128.34 174.63 9.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.493 0.663 . . . . 0.0 112.364 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.438 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 13.0 m95 -99.8 147.09 25.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 46.1 mt -114.34 117.56 31.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.763 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -113.56 130.57 56.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -131.91 160.14 36.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.46 158.38 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.182 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.11 150.17 37.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--N 1.344 0.299 0 C-N-CA 122.441 2.094 . . . . 0.0 112.027 179.616 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.3 m95 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 -30.14 55.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -166.04 -144.5 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.447 ' NE2' ' CD2' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -158.16 113.44 2.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 111.511 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.15 105.67 17.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.936 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.9 pt20 -126.08 153.7 44.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.5 mttt -107.81 95.76 5.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.522 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.428 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 61.4 m95 -63.42 140.2 58.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.336 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 66.9 m-85 -125.82 138.32 53.82 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.402 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 21.6 tp -79.56 154.77 28.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.487 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 34.2 m-85 -148.51 127.83 13.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 0.0 111.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.533 ' HB2' HG13 ' A' ' 73' ' ' ILE . 22.8 tttt -93.72 119.58 32.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.576 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -62.77 125.31 23.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.7 p -127.11 37.88 4.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.52 -144.84 4.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.071 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -127.2 154.26 45.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -49.83 -16.65 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.574 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -78.55 -18.1 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -80.3 -25.56 39.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.811 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 15.5 mt -74.15 102.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.369 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.49 96.09 5.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.115 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 53.0 mt -55.45 -22.73 21.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.436 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.24 -58.51 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.13 -179.26 20.8 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.595 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -90.0 38.65 0.93 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.151 0.501 . . . . 0.0 109.768 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.93 73.4 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.254 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -102.88 165.19 11.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -73.41 148.48 88.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -50.85 138.93 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.216 . . . . 0.0 112.624 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -112.07 -33.0 6.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.648 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 29.1 m-85 -116.83 159.38 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.522 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.93 -16.82 6.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.852 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.41 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.2 mm-40 -152.31 175.04 13.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.3 p-90 -159.11 151.54 21.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.134 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 m -147.62 161.05 41.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.492 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.47 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.4 m95 -95.09 125.03 39.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.436 HG21 ' CA ' ' A' ' 142' ' ' LEU . 27.5 m -137.55 150.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.7 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -70.15 159.62 83.78 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.533 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 12.3 Cg_endo -56.27 -18.3 23.68 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 121.826 1.684 . . . . 0.0 111.999 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.06 -34.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.029 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.25 -50.48 32.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.069 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.436 ' CA ' HG21 ' A' ' 137' ' ' VAL . 3.4 tp -53.62 -34.12 57.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.592 0.71 . . . . 0.0 109.885 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 139' ' ' PRO . 7.8 mm -66.99 -27.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.737 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.31 -22.07 38.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.969 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.7 mt -84.11 -39.41 19.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.827 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -58.35 167.51 1.35 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.115 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 150' ' ' LYS . 13.6 p -98.97 163.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.833 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -36.62 79.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 147' ' ' VAL . 8.5 p90 -79.38 -0.82 34.31 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.506 ' HB2' HG13 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -139.09 10.66 2.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.676 0.274 . . . . 0.0 111.278 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mtpt -69.45 -62.76 2.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.7 Cg_endo -53.99 -43.34 59.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.47 2.113 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.462 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.5 t -57.64 -24.59 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.416 ' CG ' ' HE2' ' A' ' 42' ' ' MET . 3.1 m-85 -91.02 -47.81 7.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.438 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -33.32 32.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 5.6 tp10 -67.15 -45.77 76.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 45.9 t -59.02 -47.09 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.056 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.6 mt -66.65 -48.69 68.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.781 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -52.07 -45.85 64.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.79 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.56 -24.84 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 110.679 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.0 m-30 -98.17 -7.86 28.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.16 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.528 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -50.19 -44.92 82.15 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.559 0.218 . . . . 0.0 111.371 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 162' ' ' ALA . 35.6 Cg_exo -60.5 -22.97 73.94 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.63 2.22 . . . . 0.0 112.679 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.419 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 73.5 m-70 -95.02 -44.48 7.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.793 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.405 ' HB3' ' CA ' ' A' ' 103' ' ' GLN . 5.5 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -78.96 152.62 30.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.5 128.16 35.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.254 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 1.5 t30 -152.77 159.03 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.449 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.435 HG12 HD12 ' A' ' 47' ' ' ILE . 4.5 m -136.23 125.33 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.994 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.39 154.8 20.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.925 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.497 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 5.2 mp -128.88 110.87 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' PHE . 43.0 t -90.57 103.97 16.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD23 ' CD2' ' A' ' 29' ' ' PHE . 25.1 tp -102.88 149.61 24.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.065 0.459 . . . . 0.0 111.239 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.96 158.25 38.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.967 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.465 ' HB3' ' CZ3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -108.55 167.32 10.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.65 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -49.08 -19.24 0.4 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.56 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 0.0 111.467 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 76.71 23.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.659 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.91 171.71 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.77 123.44 64.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.018 0.437 . . . . 0.0 110.758 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.418 ' CD2' HD23 ' A' ' 21' ' ' LEU . 9.3 t80 -52.43 116.84 2.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.14 132.29 54.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.024 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -121.69 139.8 53.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.981 0.419 . . . . 0.0 111.38 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.05 155.85 24.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.391 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.423 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -71.84 158.39 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.541 . . . . 0.0 111.634 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.46 -6.03 53.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.997 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -131.11 -17.68 3.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.494 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 54.6 mt -118.6 111.7 37.66 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.0 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 131.72 29.66 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.94 1.76 . . . . 0.0 111.811 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.49 3.07 3.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.793 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.22 97.41 11.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.7 m95 -102.39 155.73 18.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.252 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -169.13 -176.94 2.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.692 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.3 mpp? -103.29 158.26 32.15 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.57 146.61 80.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.463 2.109 . . . . 0.0 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.435 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -153.98 176.64 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.18 6.44 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.81 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.71 130.77 20.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.222 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.9 mt -58.59 159.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.3 m-20 -90.49 149.47 22.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.822 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.44 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 39.8 10.84 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.935 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HB3' HG21 ' A' ' 47' ' ' ILE . 5.9 tp10 -114.12 146.78 39.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.908 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.54 140.98 82.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.497 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.77 -37.8 95.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.357 2.038 . . . . 0.0 112.471 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.5 ttp180 -75.78 -23.34 55.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.67 -43.97 10.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.445 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.418 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -62.04 -30.84 71.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.32 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.4 -51.37 17.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.157 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.0 mt -56.82 -28.77 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.18 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 ttp85 -84.25 -52.8 5.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.792 0.806 . . . . 0.0 109.991 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -53.15 -42.54 66.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -55.83 -54.64 42.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.529 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.8 ttp180 -61.17 -13.92 21.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.299 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -92.01 -40.85 10.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.836 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.39 -26.26 18.96 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -20.55 8.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.48 4.09 73.7 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.098 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.02 118.58 15.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.616 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -98.62 -35.25 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.29 80.85 6.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.944 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.63 130.8 14.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.035 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 pt-20 -120.3 144.0 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.02 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.5 t -76.79 122.95 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.646 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.609 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.5 mm -107.08 -15.33 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.438 ' HB1' ' CB ' ' A' ' 109' ' ' LEU . . . -155.98 154.03 30.47 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.837 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -148.67 117.93 6.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 78' ' ' TYR . 7.5 t -57.53 127.03 77.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.926 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.58 -6.12 18.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.923 2.415 . . . . 0.0 114.117 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.597 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -136.53 138.97 41.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.431 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 24.9 m95 -64.28 145.32 56.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.279 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -103.92 138.73 40.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.4 p -139.18 130.7 27.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CE1' HG13 ' A' ' 153' ' ' VAL . 9.9 p90 -139.1 170.44 15.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.95 158.3 35.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.018 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -102.44 154.21 37.59 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.703 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 122.389 2.059 . . . . 0.0 112.145 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 71.9 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -25.43 41.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.44 . . . . 0.0 110.578 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -177.98 -137.82 2.9 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.826 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.405 ' CA ' ' HB3' ' A' ' 13' ' ' TYR . 3.6 pt20 -158.16 115.28 2.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.704 0.287 . . . . 0.0 111.436 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 80' ' ' LEU . . . -85.92 105.56 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.522 ' OE1' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -123.6 154.44 39.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -111.31 103.83 12.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.696 178.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.522 ' CD1' ' OE1' ' A' ' 105' ' ' GLN . 28.1 m95 -66.23 146.18 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.201 0.524 . . . . 0.0 112.085 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 50.8 m-85 -129.13 130.65 46.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.925 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.2 tp -78.72 151.81 31.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 45.1 m-85 -148.62 128.0 13.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.609 ' HB2' HG13 ' A' ' 73' ' ' ILE . 16.0 tptt -92.62 122.45 35.05 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -64.88 126.35 27.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.849 0.357 . . . . 0.0 111.226 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.415 ' CG2' ' HG2' ' A' ' 71' ' ' GLU . 3.2 p -125.45 37.34 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.37 -145.03 4.76 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.106 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -128.51 154.31 46.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.837 0.351 . . . . 0.0 110.147 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -49.33 -17.13 0.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.33 -20.38 57.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.802 0.334 . . . . 0.0 111.224 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.21 -26.28 52.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 119' ' ' ILE . 31.5 mt -68.68 104.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.474 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.1 95.87 4.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.159 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.0 mt -57.34 -21.04 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.522 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' CD1' ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -60.53 -57.66 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.95 -179.65 18.71 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.19 38.72 0.94 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.71 28.44 73.76 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.127 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -114.99 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.269 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -102.17 165.12 11.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -74.71 145.54 81.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.403 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 52.5 Cg_exo -53.82 137.98 68.32 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.577 2.184 . . . . 0.0 112.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.57 -28.22 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.43 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 13.9 m-85 -118.02 159.5 23.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.23 -19.66 5.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.723 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.402 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 32.3 mm-40 -152.25 174.51 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.078 0.465 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.9 p-90 -159.27 154.05 24.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.388 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.14 166.25 26.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.301 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.465 ' CZ3' ' HB3' ' A' ' 23' ' ' ASN . 54.1 m95 -99.54 125.67 45.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.2 m -139.28 151.44 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.469 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -69.76 162.48 67.56 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.466 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 19.3 Cg_endo -58.78 -16.72 32.63 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.762 1.642 . . . . 0.0 111.995 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -35.01 13.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.2 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.36 33.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.051 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.6 tp -54.57 -27.81 41.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.473 0.654 . . . . 0.0 110.014 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 139' ' ' PRO . 5.2 mm -73.52 -27.45 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.843 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.45 -23.79 42.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.085 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.409 HD22 ' CD1' ' A' ' 40' ' ' TRP . 8.8 mt -81.01 -40.18 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 109.922 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 m -57.89 169.3 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.872 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 149' ' ' PHE . 6.1 p -105.37 159.03 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.551 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 11.3 pt-20 -42.42 -51.87 4.81 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.487 ' CE2' HG12 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -71.11 -7.29 45.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.238 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.447 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 1.9 mttt -123.34 -1.59 8.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.586 0.232 . . . . 0.0 111.514 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 15.6 mtpt -68.63 -60.74 4.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.277 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 14.8 Cg_endo -57.3 -42.68 59.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.304 2.002 . . . . 0.0 111.538 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.516 ' O ' HD12 ' A' ' 80' ' ' LEU . 35.0 t -61.07 -24.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 3.4 m-85 -90.64 -50.19 6.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.253 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' CG ' ' CD1' ' A' ' 143' ' ' ILE . 7.9 mtpm? -51.38 -30.92 20.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.377 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.464 ' HB3' HD13 ' A' ' 80' ' ' LEU . 1.3 tp10 -67.54 -46.23 73.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.322 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.527 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 39.4 t -62.13 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.102 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 162' ' ' ALA . 73.7 mt -67.19 -49.07 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.6 t -51.13 -46.86 62.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.1 t -66.12 -24.03 33.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.192 0.52 . . . . 0.0 110.34 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.675 ' C ' ' HD2' ' A' ' 163' ' ' PRO . 10.5 m-30 -98.65 -6.67 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.786 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -44.69 -39.46 7.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.675 ' HD2' ' C ' ' A' ' 161' ' ' PHE . 20.5 Cg_endo -63.17 -23.84 72.88 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.135 1.89 . . . . 0.0 113.8 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.674 ' CD2' ' HB3' ' A' ' 161' ' ' PHE . 3.2 p80 -89.37 -25.41 21.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.754 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.641 ' HG ' ' CE1' ' A' ' 164' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.9 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.993 0.425 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 3.7 ttt85 -84.25 152.42 24.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -63.74 129.4 39.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 20.5 t-20 -152.65 150.82 29.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 53' ' ' PRO . 2.7 m -123.28 141.37 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.34 149.85 17.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.281 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.477 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -129.22 101.6 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.1 t -89.63 106.29 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 32.6 tp -102.68 143.0 32.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 111.195 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.3 ptt? -127.74 157.3 40.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 40.0 p-10 -103.3 170.21 8.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.302 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -55.74 -17.47 6.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.515 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.02 0.42 56.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.731 0.3 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 76.47 26.43 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' MET . 12.6 mttt -97.01 173.88 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 142' ' ' LEU . 4.8 mp -112.2 121.4 64.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.943 0.401 . . . . 0.0 110.884 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.458 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 12.6 t80 -54.73 108.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.384 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.79 134.49 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.376 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.27 141.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 111.319 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.29 158.31 23.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.614 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 5.0 mtp-105 -71.26 163.65 27.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.35 0.595 . . . . 0.0 111.676 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.2 mt -96.67 -7.33 34.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.564 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.13 -18.51 4.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.348 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.543 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 66.7 mt -120.73 112.76 33.61 Favored Pre-proline 0 N--CA 1.457 -0.109 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.171 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.44 132.1 30.18 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.955 1.77 . . . . 0.0 111.792 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.37 2.47 3.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.829 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.67 97.55 11.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.312 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -101.18 156.08 17.64 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.933 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -168.98 169.43 9.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 43.2 mtm -97.09 155.9 36.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 129.67 20.15 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.193 . . . . 0.0 113.038 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 141.74 19.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.57 160.84 28.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.863 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.9 126.84 7.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 11.7 mt -55.71 162.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.579 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 8.5 m-20 -73.48 -170.9 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.573 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.06 29.28 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.275 0.56 . . . . 0.0 111.145 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.53 52.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' HB3' HG22 ' A' ' 47' ' ' ILE . 2.7 tt0 -128.43 148.17 50.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.088 0.47 . . . . 0.0 111.076 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.13 128.19 81.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.87 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HA ' HG13 ' A' ' 17' ' ' VAL . 1.4 Cg_endo -45.93 -29.73 6.3 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.59 2.194 . . . . 0.0 113.11 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -29.57 62.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.775 0.322 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -86.67 -44.59 11.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.195 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.15 -31.69 67.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.92 -54.76 7.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.066 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.6 mt -56.05 -31.7 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -78.84 -53.4 7.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.832 0.825 . . . . 0.0 109.89 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 15.2 mm-40 -50.87 -38.97 52.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.45 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -58.15 -58.88 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.129 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.523 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 ptp180 -61.42 -11.84 12.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -91.62 -43.74 9.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 0.0 111.718 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.78 -25.4 19.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -115.43 -20.91 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.12 5.17 70.26 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.72 129.34 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 p -105.71 -34.63 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 81.64 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.54 14.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -119.63 147.48 44.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.17 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.534 ' CG2' ' CZ ' ' A' ' 110' ' ' PHE . 31.2 t -78.49 123.06 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.433 0.635 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.557 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -104.34 -22.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.274 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -152.11 159.75 43.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.18 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.5 pt-20 -148.31 111.7 4.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.171 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 ' CD1' ' A' ' 78' ' ' TYR . 3.8 t -57.62 125.73 73.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.219 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 4.8 Cg_exo -74.45 -8.14 20.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.845 2.363 . . . . 0.0 113.571 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.529 ' CD1' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.44 135.91 50.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 112.187 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD2' ' CG ' ' A' ' 106' ' ' LYS . 29.3 m95 -67.7 145.57 54.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.07 0.462 . . . . 0.0 110.109 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.409 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 55.7 mt -111.36 117.93 34.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.897 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.5 p -108.89 140.18 42.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.74 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -134.24 170.18 16.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.886 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.81 158.34 33.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -120.85 146.6 44.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.603 2.202 . . . . 0.0 112.241 179.974 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.427 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 36.7 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -30.76 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.64 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -161.6 -143.44 3.68 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.098 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.9 mm-40 -157.64 115.55 3.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.883 0.373 . . . . 0.0 111.435 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.48 105.61 17.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.3 pt20 -124.34 154.78 39.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' CG ' ' CD2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -107.51 105.38 15.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.485 178.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.465 ' CG ' HG21 ' A' ' 157' ' ' VAL . 26.6 m95 -72.92 144.88 47.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.222 0.534 . . . . 0.0 112.259 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.9 m-85 -127.58 132.79 49.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.361 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.7 tp -79.81 129.08 34.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.534 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 46.4 m-85 -123.73 127.87 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.557 ' HB2' HG13 ' A' ' 73' ' ' ILE . 2.2 tppp? -91.73 121.78 33.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -63.52 126.68 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.846 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 p -127.12 37.62 4.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.627 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.56 -145.17 4.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.066 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -129.64 154.16 47.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.882 0.372 . . . . 0.0 110.067 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -49.5 -16.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.602 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -76.9 -23.29 52.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.88 -25.17 52.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.822 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.03 104.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.393 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -121.2 95.91 4.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.914 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.8 mt -58.56 -21.05 51.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mt -61.46 -57.44 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.799 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.87 179.04 21.81 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.575 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -90.25 38.75 0.94 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.214 0.531 . . . . 0.0 109.724 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.56 26.95 73.28 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.063 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -117.42 -69.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -96.44 165.13 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.204 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -77.43 148.81 77.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -50.51 135.92 40.57 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.62 2.213 . . . . 0.0 112.597 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -111.91 -30.64 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.43 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 25.3 m-85 -118.34 159.51 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.7 -13.96 7.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.697 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.8 mp0 -152.17 174.18 14.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.085 0.469 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.3 p-90 -159.74 150.04 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 m -148.68 156.64 42.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.465 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -92.14 125.01 36.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.5 m -135.62 150.78 29.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.138 0.494 . . . . 0.0 111.579 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.8 159.67 83.08 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.583 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 12.9 Cg_endo -56.5 -17.97 23.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.917 1.745 . . . . 0.0 111.965 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.07 14.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.102 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.49 -50.63 29.58 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.3 tp -53.68 -33.43 55.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 109.819 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 139' ' ' PRO . 6.0 mm -67.34 -27.65 39.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.811 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.3 -24.37 42.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.057 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD13 ' CD1' ' A' ' 142' ' ' LEU . 8.6 mt -82.34 -39.58 22.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.857 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 m -54.25 168.59 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.272 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.481 HG12 ' CZ ' ' A' ' 149' ' ' PHE . 7.5 p -103.65 160.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -47.65 -40.61 20.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.349 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.481 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 21.7 p90 -86.22 8.3 21.7 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.434 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 15.1 mttt -130.9 -1.61 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.588 0.233 . . . . 0.0 111.457 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 31.6 mttt -63.81 -62.85 4.64 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.269 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 14.7 Cg_endo -57.16 -41.4 74.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.102 . . . . 0.0 112.004 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 82' ' ' TYR . 20.0 t -60.62 -26.78 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.15 0.5 . . . . 0.0 110.977 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.1 m-85 -91.09 -55.05 3.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.846 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.404 ' CG ' ' CD1' ' A' ' 143' ' ' ILE . 34.6 mttm -47.92 -33.49 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.709 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 7.4 tp10 -67.94 -44.5 76.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.519 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 58.6 t -61.5 -49.17 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.222 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 162' ' ' ALA . 73.9 mt -62.86 -48.4 79.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.658 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.9 m -49.58 -47.49 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.808 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.27 -24.98 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.664 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.519 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.6 m-30 -100.6 1.93 41.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.283 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.94 -54.47 40.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.355 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.29 -20.81 26.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.608 2.206 . . . . 0.0 112.379 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.416 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 19.9 m-70 -89.51 -21.19 23.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.677 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.895 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 121.148 0.499 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.44 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 14.9 ttt-85 -84.95 152.12 23.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.302 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 4.3 mmp_? -66.24 124.32 22.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 12.8 t-20 -152.65 159.9 43.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' A' ' 56' ' ' ALA . 3.7 m -133.96 146.79 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.52 150.47 17.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.467 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -127.89 101.98 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.277 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -89.45 104.93 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 36.5 tp -103.09 141.59 35.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.061 0.458 . . . . 0.0 111.277 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.84 157.58 37.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.8 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.43 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.5 p-10 -101.4 171.33 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.241 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.33 -16.76 9.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.535 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.15 56.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.729 0.299 . . . . 0.0 110.972 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? 77.05 27.04 0.71 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.484 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -99.81 171.67 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -110.32 124.3 66.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.879 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.457 ' CE2' ' CG2' ' A' ' 119' ' ' ILE . 33.7 t80 -58.52 108.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.82 129.88 56.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.398 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -113.96 141.27 47.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.133 0.492 . . . . 0.0 111.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.435 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 2.3 p -82.53 158.84 22.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.726 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.529 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -67.6 165.92 16.03 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 111.712 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -89.31 -8.86 52.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.161 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -148.07 -7.51 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.529 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 49.9 mt -114.35 109.77 48.43 Favored Pre-proline 0 CA--C 1.523 -0.083 0 CA-C-N 118.562 0.619 . . . . 0.0 110.918 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 27.2 Cg_endo -64.87 130.85 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.892 1.728 . . . . 0.0 111.616 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.7 t70 80.89 1.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.485 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' ' HB ' ' A' ' 36' ' ' ILE . . . -94.67 97.66 10.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.153 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 33.3 m95 -108.91 162.17 14.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.859 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -168.73 164.8 12.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.457 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 77.6 mtm -94.9 157.79 36.12 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.66 132.99 32.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.646 2.231 . . . . 0.0 113.006 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.29 154.34 33.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.244 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.47 151.31 21.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.829 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.18 141.93 43.86 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.454 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 20.3 mt -76.68 164.32 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.952 0.406 . . . . 0.0 110.716 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 3.2 m-20 -84.05 -175.8 5.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.671 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.63 100.01 6.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.324 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.65 49.77 17.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.615 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 3.1 tp10 -115.68 145.65 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -71.83 132.73 84.76 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.453 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HA ' HD11 ' A' ' 47' ' ' ILE . 55.9 Cg_exo -52.96 -44.91 44.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.492 2.128 . . . . 0.0 112.9 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -59.92 -27.16 66.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -86.75 -47.37 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.712 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.02 -29.69 68.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.73 -50.35 15.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.203 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.421 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 55.7 mt -57.78 -30.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.088 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 3.1 ttp-105 -81.05 -53.54 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 109.815 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -53.96 -33.82 57.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.39 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tp -55.06 -59.82 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 5.9 ptt180 -61.47 -11.94 12.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.81 -39.57 11.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 111.548 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -90.26 -32.75 16.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.099 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.88 -23.24 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.091 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.53 1.54 82.69 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' A' ' 112' ' ' PHE . 51.1 t -67.2 115.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -33.9 14.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.5 81.86 5.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.853 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.18 131.59 15.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.788 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.9 pt-20 -118.81 146.63 44.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.521 ' CG2' ' CZ ' ' A' ' 110' ' ' PHE . 25.6 t -78.86 122.34 33.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.618 . . . . 0.0 111.529 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -104.62 -21.43 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 161' ' ' PHE . . . -152.86 160.83 43.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.175 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.34 110.72 4.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 78' ' ' TYR . 3.4 t -57.63 123.56 63.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.65 -6.03 17.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.798 2.332 . . . . 0.0 113.745 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.526 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -130.06 135.08 47.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.241 0.543 . . . . 0.0 112.09 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.44 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 27.9 m95 -66.46 147.24 53.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 53.2 mt -116.51 117.63 30.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.657 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.414 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 2.6 p -111.84 131.51 55.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -132.05 161.31 33.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.62 158.45 26.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.241 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -112.8 154.36 44.87 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.701 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.531 2.154 . . . . 0.0 112.419 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 15.7 m95 . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -32.95 70.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.199 0.523 . . . . 0.0 109.998 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.23 -153.11 6.4 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.665 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -158.21 116.65 3.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.747 0.308 . . . . 0.0 111.217 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.414 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -85.88 105.65 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' NE2' ' CE1' ' A' ' 82' ' ' TYR . 0.9 OUTLIER -124.82 152.41 43.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -106.7 101.63 11.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.594 178.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.457 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 22.1 m95 -69.01 143.96 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 0.0 112.128 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 50.9 m-85 -124.83 135.74 53.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.277 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.6 tp -79.88 131.09 35.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.392 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.6 m-85 -125.39 127.35 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.673 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.516 ' HB2' HG13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.56 123.62 34.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.425 ' CD1' HG11 ' A' ' 67' ' ' VAL . 5.7 t80 -67.51 128.82 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 111.328 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 69' ' ' SER . 4.7 p -128.7 37.64 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.264 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.34 -144.45 4.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.156 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 153.86 47.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.968 0.413 . . . . 0.0 110.199 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.87 -14.35 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.589 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.62 -17.84 40.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.38 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -81.37 -24.58 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.457 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 32.1 mt -69.46 105.32 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 111.579 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -116.7 95.88 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.874 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.6 mt -52.22 -24.82 7.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.0 mt -63.21 -57.64 9.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.252 0.549 . . . . 0.0 109.974 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.32 -177.45 25.59 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.5 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.29 39.01 1.01 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.142 0.496 . . . . 0.0 109.709 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.18 71.5 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -121.83 -64.18 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.82 165.15 17.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 155.52 47.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.003 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.7 149.8 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.786 2.324 . . . . 0.0 112.773 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -144.21 -44.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.437 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 7.4 m-85 -111.6 159.74 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.35 -16.4 6.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.989 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 23.4 mm-40 -152.32 175.11 13.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 110.491 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.9 p-90 -159.09 150.96 20.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.178 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 m -148.55 162.24 40.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 73.8 m95 -95.67 125.33 40.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.657 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.8 m -137.63 150.96 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.097 0.475 . . . . 0.0 111.681 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.9 158.8 87.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.616 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 11.1 Cg_endo -54.89 -19.45 19.43 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 121.941 1.761 . . . . 0.0 112.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.19 -33.85 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.994 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -50.05 30.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.916 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.8 tp -54.18 -29.67 46.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.447 0.641 . . . . 0.0 109.785 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.1 mm -69.53 -28.41 37.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.71 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.5 -21.02 42.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.127 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.0 mt -84.37 -39.54 18.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.933 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -58.33 164.98 2.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.971 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 150' ' ' LYS . 15.0 p -95.57 160.85 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.504 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.9 OUTLIER -59.92 -27.07 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 24.8 p90 -91.1 10.9 24.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.511 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.1 mtmt -151.8 14.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.669 0.271 . . . . 0.0 111.584 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.504 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.8 mtpp -69.21 -62.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.25 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.1 Cg_endo -51.72 -41.98 59.18 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.533 2.155 . . . . 0.0 112.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.438 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 19.0 t -56.09 -27.24 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.439 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -90.59 -53.0 4.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.473 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -31.86 18.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.192 0.52 . . . . 0.0 110.445 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 3.3 tp10 -67.58 -44.85 77.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.696 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.501 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 43.6 t -61.31 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.06 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 162' ' ' ALA . 71.8 mt -65.0 -48.71 73.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.55 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 t -49.43 -47.5 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.689 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.93 -25.41 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 110.35 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.501 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.5 m-30 -102.53 8.57 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.068 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.537 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.99 -57.26 16.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.27 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 14.1 Cg_endo -57.2 -22.02 46.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.426 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 97.2 m-70 -89.91 -14.25 34.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.095 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.921 179.905 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.5 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.936 0.398 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.42 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 7.3 mtp85 -80.82 152.15 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -71.29 132.94 45.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.244 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 18.9 t-20 -152.83 157.16 40.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.868 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.426 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.5 m -129.02 134.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 111.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.64 157.11 15.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.098 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 43' ' ' PRO . 1.4 mm -120.77 101.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.691 0.246 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.7 t -89.59 97.28 11.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 23.4 tp -102.5 145.27 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 111.393 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.35 157.31 41.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.749 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.5 p-10 -102.06 170.33 8.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.348 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.48 -18.55 4.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.91 0.14 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 76.78 25.23 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.607 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' MET . 14.4 mttp -93.63 173.27 7.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.1 mp -111.44 120.07 61.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 110.868 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 19.8 t80 -53.88 110.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.53 129.93 56.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.46 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.52 138.95 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.059 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.04 155.56 25.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -71.77 157.37 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 111.546 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mt -91.86 -5.37 53.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.841 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.79 -21.44 4.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.024 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 57.9 mt -118.23 112.5 37.77 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.938 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.23 131.52 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.895 1.73 . . . . 0.0 111.765 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 77.43 3.25 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.89 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -87.94 97.45 10.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.414 ' CD1' HD21 ' A' ' 145' ' ' LEU . 24.4 m95 -101.06 156.92 17.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.292 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -168.38 -176.98 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.598 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.425 ' HE1' ' CZ3' ' A' ' 107' ' ' TRP . 1.3 mpp? -110.08 156.95 39.19 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.965 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.443 ' HB2' HG12 ' A' ' 19' ' ' ILE . 72.2 Cg_exo -48.65 143.25 16.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.775 2.317 . . . . 0.0 113.021 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 145.1 22.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.37 133.1 2.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.741 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -62.62 140.28 45.94 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.329 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 48' ' ' ASP . 4.3 mt -73.31 160.32 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.459 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -85.44 -177.18 6.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -77.9 99.22 5.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.35 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.45 9.69 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.729 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -116.57 144.78 43.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.02 137.31 82.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.591 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.39 -50.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.454 2.103 . . . . 0.0 112.457 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 19.2 ttp180 -62.38 -25.43 67.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -83.64 -51.4 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.695 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -57.14 -31.13 65.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.22 -53.65 10.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.4 mt -54.75 -27.92 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.192 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -83.82 -53.13 5.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.805 0.812 . . . . 0.0 109.626 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.57 -32.7 65.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.394 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tp -53.12 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.575 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.7 ptt180 -62.07 -10.87 11.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.448 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.81 -42.14 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.596 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -90.53 -32.42 16.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -21.91 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.995 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.46 4.8 70.75 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.956 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.75 117.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.792 0.296 . . . . 0.0 110.361 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -35.22 12.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.13 77.53 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.24 129.16 13.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.826 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.1 mm-40 -119.93 148.16 43.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.719 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.6 t -78.18 125.9 38.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 111.722 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -105.09 -20.42 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.318 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -156.06 163.19 39.98 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.231 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.425 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 1.3 pm0 -148.54 117.34 6.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 78' ' ' TYR . 6.7 t -57.03 125.43 70.03 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.063 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.28 -17.74 60.78 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.771 2.314 . . . . 0.0 113.362 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.655 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.9 -176.45 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.395 0.617 . . . . 0.0 112.125 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.427 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 15.2 m95 -109.15 147.29 32.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.924 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.473 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 2.0 mt -112.35 117.75 33.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.02 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.3 p -111.14 132.25 54.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.518 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -126.7 169.52 13.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.52 158.41 40.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.108 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -109.72 154.38 42.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.609 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 122.404 2.07 . . . . 0.0 112.34 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.42 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 55.3 m95 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.816 0.341 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -30.14 60.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.19 -139.62 2.87 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.005 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.11 115.7 2.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.789 0.328 . . . . 0.0 111.376 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.83 105.86 16.64 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -117.01 157.73 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -113.65 95.87 5.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.841 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.447 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 61.7 m95 -64.24 145.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 61.2 m-85 -129.31 134.19 47.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.267 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.0 tp -80.02 132.21 35.95 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.58 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 50.3 m-85 -127.16 128.49 46.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 111.278 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.536 ' HB2' HG13 ' A' ' 73' ' ' ILE . 21.3 tttm -92.8 122.76 35.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -65.8 126.12 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.874 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.7 p -128.42 37.91 4.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.549 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.19 -144.98 4.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.148 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.88 154.22 45.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -50.2 -16.26 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -79.72 -17.48 53.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.26 . . . . 0.0 111.356 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -24.93 37.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.5 mt -72.46 103.82 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.477 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.66 95.59 5.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.952 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.5 mt -54.54 -24.23 19.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.4 -56.96 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.273 0.558 . . . . 0.0 109.988 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.67 -178.5 23.37 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.465 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -90.64 38.73 0.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.067 0.461 . . . . 0.0 109.872 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.17 73.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.219 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -107.11 -65.16 1.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.778 0.323 . . . . 0.0 111.206 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -115.55 164.97 13.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.277 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 153.91 50.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.111 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.17 177.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.776 2.317 . . . . 0.0 112.672 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -150.07 -44.75 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 6.0 m-85 -112.06 159.91 18.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.411 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.68 -21.14 5.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.679 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.445 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.6 mm-40 -152.29 174.68 13.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 28.1 p-90 -159.12 154.74 26.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.332 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -151.71 158.73 43.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 80.1 m95 -92.58 125.81 37.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.3 m -137.4 150.69 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.729 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 4.1 p -68.91 159.18 83.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.576 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' CA ' HD11 ' A' ' 158' ' ' LEU . 13.0 Cg_endo -56.38 -18.91 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.873 1.715 . . . . 0.0 112.033 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -92.02 -33.88 14.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.117 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -71.08 -50.47 33.45 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.9 tp -53.16 -33.67 53.54 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.435 0.636 . . . . 0.0 109.876 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -64.88 -29.63 47.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.629 178.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.63 -31.49 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.8 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.414 HD21 ' CD1' ' A' ' 40' ' ' TRP . 9.4 mt -75.98 -40.46 53.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.033 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 m -55.45 164.15 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.259 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 149' ' ' PHE . 13.7 p -96.3 161.9 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -33.62 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.492 ' CD1' ' HG3' ' A' ' 150' ' ' LYS . 8.3 p90 -79.88 0.92 29.13 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.492 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 5.0 mtmt -147.51 17.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.665 0.269 . . . . 0.0 111.437 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.1 mtpt -69.21 -62.75 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.012 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 13.6 Cg_endo -56.5 -40.73 82.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.146 . . . . 0.0 111.935 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.473 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 20.0 t -54.39 -25.52 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.08 -51.88 5.11 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -32.06 15.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.471 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.07 -45.52 77.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.623 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 57.1 t -58.44 -47.47 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.927 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 162' ' ' ALA . 36.7 mt -63.05 -49.16 75.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.794 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.7 t -49.35 -45.68 46.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.71 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.1 -24.62 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.465 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.516 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.5 m-30 -103.82 8.55 37.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.088 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.629 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.68 -51.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.844 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.8 Cg_endo -52.67 -23.75 20.94 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.433 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 99.1 m-70 -90.4 -23.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.838 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.912 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.904 0.383 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -86.18 152.28 22.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.421 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 15' ' ' ARG . 3.1 mmp_? -60.7 129.62 42.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.4 m120 -152.73 160.21 43.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.432 ' CG1' HD11 ' A' ' 47' ' ' ILE . 1.2 m -135.39 148.4 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.033 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -118.28 150.11 18.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.289 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.9 mp -127.34 101.66 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.477 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.0 t -91.11 108.08 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.7 tp -103.45 148.96 25.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.455 . . . . 0.0 111.252 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.5 ptt? -131.26 157.54 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.674 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 30.8 p-10 -104.96 169.68 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.24 -18.29 5.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.77 2.88 52.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 19.5 mttm 73.23 26.85 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.565 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.27 172.51 8.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.0 mp -110.2 117.89 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 11.4 t80 -52.25 107.55 0.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.79 141.41 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.57 140.67 52.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.51 158.29 23.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.644 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.9 mtp-105 -71.69 163.55 27.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.438 0.637 . . . . 0.0 111.667 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -97.14 -6.8 34.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.498 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.72 -18.18 3.92 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.548 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 66.6 mt -121.15 112.59 33.1 Favored Pre-proline 0 N--CA 1.457 -0.088 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.243 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.7 Cg_endo -65.59 132.41 30.85 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.884 1.723 . . . . 0.0 111.532 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.1 2.59 2.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.33 97.49 11.23 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 145' ' ' LEU . 33.3 m95 -102.9 156.67 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.74 -176.9 2.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.666 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.445 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 64.1 mtm -108.14 155.45 40.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 134.42 29.4 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.19 159.35 41.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.52 166.76 36.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.26 135.35 14.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.409 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 8.6 mt -66.08 160.99 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.663 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.68 150.69 21.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.883 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.63 97.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.72 38.81 9.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.048 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HB3' HG23 ' A' ' 47' ' ' ILE . 2.8 tt0 -114.67 145.18 42.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.64 139.18 86.12 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.64 -55.51 2.96 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.443 2.096 . . . . 0.0 112.65 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 26.9 ttp180 -59.21 -23.58 62.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.89 -48.16 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.16 -31.53 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.408 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -73.32 -54.12 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.113 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mt -55.81 -29.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.231 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 ttp85 -82.8 -53.06 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.02 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.63 -45.59 57.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.374 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -56.55 -52.5 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 42.9 ttp180 -62.45 -12.54 22.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.568 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.61 -41.86 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 111.571 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -90.6 -28.43 18.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.985 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -121.93 -22.67 5.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.08 9.47 63.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.952 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.38 108.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 110.139 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.99 -35.54 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.422 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.28 74.25 7.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.225 0.536 . . . . 0.0 111.247 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.41 126.38 11.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.564 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.5 mm-40 -119.67 147.73 44.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.821 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 47.7 t -76.83 125.54 36.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.494 0.664 . . . . 0.0 111.704 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.578 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -108.55 -17.38 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.525 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 164' ' ' HIS . . . -154.49 162.16 41.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.006 0.432 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 46.5 tt0 -148.53 115.45 6.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.143 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 78' ' ' TYR . 3.8 t -57.58 128.15 79.09 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -11.76 30.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.902 2.401 . . . . 0.0 114.071 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.612 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -132.14 153.15 50.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.338 0.589 . . . . 0.0 112.36 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 20.0 m95 -80.02 143.49 34.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 153' ' ' VAL . 2.4 mt -111.34 118.09 34.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.93 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.416 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -113.5 130.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -132.98 160.62 36.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.619 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.9 158.38 29.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -102.43 155.51 36.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.608 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.448 2.099 . . . . 0.0 112.157 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 40.1 m95 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.813 0.34 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -31.15 64.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.3 -139.07 2.58 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.009 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -157.89 116.02 3.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.543 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.416 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -92.62 111.93 23.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.724 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -131.95 150.7 52.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.425 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -102.77 97.08 7.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.287 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.42 ' CH2' ' HB2' ' A' ' 42' ' ' MET . 43.2 m95 -65.34 139.22 58.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.427 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 44.0 m-85 -120.23 138.44 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.539 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 25.3 tp -79.72 154.97 28.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.512 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.2 m-85 -148.17 127.87 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.437 . . . . 0.0 111.782 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.578 ' HB2' HG13 ' A' ' 73' ' ' ILE . 24.6 tttm -93.0 120.46 33.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.594 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -67.11 122.08 17.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.726 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.0 p -123.0 37.37 4.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.553 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.91 -144.38 4.69 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.152 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.07 154.2 45.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.61 -16.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -76.77 -16.9 59.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.256 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -25.36 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.755 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 mt -73.51 99.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 65' ' ' THR . 11.6 t-20 -114.29 95.71 5.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.6 mt -54.97 -21.99 13.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.809 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.0 mt -63.94 -59.48 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.269 0.557 . . . . 0.0 109.956 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.72 -170.48 26.96 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.483 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -95.6 39.07 1.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.82 75.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.052 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.9 t -120.88 -70.26 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 111.154 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.1 165.08 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.213 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -84.36 148.97 54.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.994 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.15 130.76 29.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.649 2.232 . . . . 0.0 112.625 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.62 -30.33 7.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.439 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 34.5 m-85 -119.87 159.53 24.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.415 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.24 -16.16 6.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.716 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.67 174.0 14.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.223 0.535 . . . . 0.0 110.63 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.6 p-90 -159.85 155.17 25.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.066 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.1 m -153.87 159.44 41.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.405 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 81.1 m95 -92.76 124.06 36.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.63 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 29.0 m -135.28 150.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -70.4 160.54 80.85 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.479 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 16.2 Cg_endo -57.65 -17.89 30.69 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.765 1.643 . . . . 0.0 111.87 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -34.39 14.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.072 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -50.6 29.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.021 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.8 tp -54.08 -31.45 51.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 109.801 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.6 mm -68.25 -28.42 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.694 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.55 -20.7 42.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.226 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 40' ' ' TRP . 10.7 mt -85.05 -39.22 18.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.41 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 48.6 m -57.76 162.37 3.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.122 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 150' ' ' LYS . 9.4 p -96.0 160.66 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -50.17 -33.01 17.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.461 ' CG ' HG12 ' A' ' 147' ' ' VAL . 19.5 p90 -89.36 13.73 12.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.492 ' HB2' HG13 ' A' ' 147' ' ' VAL . 2.7 mtmp? -139.21 -2.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.586 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 19.2 mttt -55.18 -62.2 4.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.535 0.207 . . . . 0.0 111.352 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.2 Cg_endo -60.81 -42.35 38.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.059 . . . . 0.0 112.201 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.521 ' O ' HD13 ' A' ' 80' ' ' LEU . 10.3 t -57.8 -31.55 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.336 0.588 . . . . 0.0 110.874 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.445 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -90.57 -50.66 5.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.846 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -50.39 -34.23 23.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HB3' HD12 ' A' ' 80' ' ' LEU . 1.2 tp10 -67.92 -45.01 75.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.623 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.496 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 39.3 t -57.84 -44.42 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.113 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 162' ' ' ALA . 75.3 mt -68.81 -48.81 62.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.746 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -51.59 -45.87 63.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.59 -24.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.496 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.5 m-30 -101.47 -2.35 30.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.303 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -47.19 -52.95 31.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.473 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.3 Cg_endo -53.85 -22.08 22.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.511 2.141 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 67.7 m-70 -97.23 -16.97 20.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.686 0.279 . . . . 0.0 111.097 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.407 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 5.4 mp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.924 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.132 0.491 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.421 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 2.5 tmm_? -87.14 152.59 22.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.381 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 132.17 47.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.115 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.472 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 35.6 t30 -152.96 151.09 29.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.029 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -128.2 127.78 67.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.019 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.11 161.73 18.32 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.233 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 43' ' ' PRO . 1.6 mm -126.84 101.61 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.615 0.208 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 10.9 t -91.28 93.51 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 17.1 tp -102.36 148.77 25.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.326 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.2 ptt? -131.02 157.53 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.793 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.3 p-10 -100.51 171.23 7.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.399 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -55.51 -18.25 6.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 0.56 56.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.363 . . . . 0.0 110.849 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp 76.37 25.16 1.01 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.713 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.2 mtpp -92.95 173.25 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.2 mp -110.54 116.66 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 4.4 t80 -50.82 107.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.298 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.53 142.54 46.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.64 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -128.3 140.12 52.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.44 157.74 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -74.2 159.37 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.309 0.576 . . . . 0.0 111.455 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.64 -5.33 45.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.887 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -127.81 -17.52 4.46 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.128 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 67.4 mt -122.11 112.65 31.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.978 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.35 132.04 30.15 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.835 1.69 . . . . 0.0 111.771 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 76.79 4.49 3.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.794 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.474 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.98 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.35 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.431 ' CD1' HD22 ' A' ' 145' ' ' LEU . 32.3 m95 -102.37 155.92 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.197 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.7 -176.95 2.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.81 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.432 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.5 mpp? -107.08 156.82 36.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.469 ' HB2' HG12 ' A' ' 19' ' ' ILE . 75.1 Cg_exo -48.98 140.92 23.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.892 2.394 . . . . 0.0 113.088 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -141.66 142.92 33.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.056 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -153.95 118.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.57 120.87 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.305 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 48' ' ' ASP . 5.4 mt -53.9 160.42 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.0 -176.03 4.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.61 99.68 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 48.81 18.64 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.604 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' HB3' HG21 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -116.11 146.01 42.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 110.969 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.13 136.13 93.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.59 -60.96 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.566 2.177 . . . . 0.0 112.577 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -55.1 -23.39 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.4 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -87.06 -41.47 13.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.983 0.421 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.34 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.361 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.07 -53.88 9.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.098 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -55.33 -30.34 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.124 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.05 -52.82 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.811 0.815 . . . . 0.0 109.816 179.079 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.411 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 7.4 mm-40 -55.3 -36.42 66.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.459 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HB2' HG13 ' A' ' 19' ' ' ILE . 10.7 tp -61.06 -62.9 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.646 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 2.1 tmm_? -59.55 -12.91 7.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.09 -45.66 8.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.938 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.79 -27.73 18.69 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.38 -20.79 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.691 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 79.52 -7.5 53.37 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.079 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.98 117.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.981 0.39 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.0 p -101.88 -31.56 10.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.37 78.0 6.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.22 0.534 . . . . 0.0 110.848 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.45 130.37 14.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.707 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.1 pt-20 -119.66 140.56 50.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.3 t -69.64 116.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.302 0.572 . . . . 0.0 111.265 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.649 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.1 mt -91.1 -24.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.046 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.74 168.98 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.539 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.78 118.77 7.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.856 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 78' ' ' TYR . 4.8 t -57.16 129.82 79.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.957 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.95 -19.46 63.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 113.332 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.617 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.98 -177.71 3.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.29 0.567 . . . . 0.0 112.1 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.454 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 47.8 m95 -107.13 147.45 30.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.967 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 3.5 mt -111.55 117.74 33.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.09 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 p -109.19 137.34 47.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.417 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -128.11 170.26 13.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.55 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.99 158.23 38.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.64 148.85 51.57 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 122.54 2.16 . . . . 0.0 112.365 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.421 ' CG ' ' HB2' ' A' ' 14' ' ' ARG . 11.9 m95 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.26 62.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.99 -153.5 6.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.685 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -158.16 117.06 3.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.739 0.304 . . . . 0.0 111.438 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.72 105.35 16.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.1 pt20 -115.79 153.75 30.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -107.85 95.81 5.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.569 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.468 ' CG ' HG22 ' A' ' 157' ' ' VAL . 27.4 m95 -65.18 138.24 58.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 112.034 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 74.0 m-85 -122.25 132.72 54.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.4 tp -79.33 134.37 36.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.186 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.486 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 45.0 m-85 -126.89 132.9 50.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.299 0.571 . . . . 0.0 112.031 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.649 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 2.0 ttmt -95.14 120.2 34.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.411 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -68.59 121.9 17.38 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.755 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.7 p -122.73 37.32 4.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.6 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.77 -145.12 4.84 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.085 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -127.93 154.08 45.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 0.0 110.093 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.51 -15.25 0.4 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -84.1 -13.08 53.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 -25.33 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.962 0.411 . . . . 0.0 110.511 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.4 mt -73.45 107.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.642 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.21 95.72 5.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.009 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.5 mt -53.35 -23.31 9.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.761 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.0 mt -63.22 -59.07 5.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.228 0.537 . . . . 0.0 109.977 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.53 -175.42 22.92 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.457 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -91.53 38.79 0.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.108 0.48 . . . . 0.0 109.818 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.55 73.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.171 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.1 t -108.85 -66.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.119 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -108.32 165.12 11.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -68.75 148.31 97.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -50.86 145.16 24.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.526 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -113.79 -35.72 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -113.83 159.51 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.51 5.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.351 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.523 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.55 173.66 14.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.129 0.49 . . . . 0.0 110.5 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 33.6 p-90 -160.39 157.95 28.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.78 158.5 36.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.451 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.446 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 83.3 m95 -91.17 123.44 34.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.626 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 32.8 m -134.33 151.12 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.164 0.507 . . . . 0.0 111.726 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -69.49 160.85 77.64 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.478 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 19.6 Cg_endo -58.59 -16.85 32.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.669 1.58 . . . . 0.0 111.876 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.34 -34.03 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.103 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -51.59 23.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.107 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.443 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.2 tp -54.29 -32.43 56.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.473 0.654 . . . . 0.0 109.806 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 139' ' ' PRO . 6.2 mm -68.35 -27.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.781 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.1 -22.03 42.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.221 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.431 HD22 ' CD1' ' A' ' 40' ' ' TRP . 10.8 mt -83.99 -39.16 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.15 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.417 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 23.6 m -55.55 164.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.453 HG11 ' HB2' ' A' ' 150' ' ' LYS . 7.9 p -93.71 165.01 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.054 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -55.66 -35.48 66.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 9.7 p90 -88.58 9.96 22.14 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.453 ' HB2' HG11 ' A' ' 147' ' ' VAL . 20.0 mtmt -131.31 -3.46 3.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.523 0.202 . . . . 0.0 111.442 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.429 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttt -58.38 -63.27 4.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 15.5 Cg_endo -57.28 -41.49 72.62 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.176 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 34.1 t -59.18 -28.97 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 4.1 m-30 -91.37 -54.01 4.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.842 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -47.86 -34.34 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -66.99 -45.18 78.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.779 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.499 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 56.9 t -57.27 -50.13 77.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.348 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.2 mt -62.45 -48.64 78.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.749 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -49.77 -47.29 51.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.92 -24.52 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 110.46 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.499 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.6 m-30 -104.11 9.28 36.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.154 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.615 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.57 -51.7 70.72 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.715 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.98 -23.48 21.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.51 2.14 . . . . 0.0 112.289 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.414 ' CE1' HG21 ' A' ' 73' ' ' ILE . 98.2 m-70 -89.78 -24.99 21.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.599 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.85 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -80.18 147.41 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.452 ' N ' ' HG3' ' A' ' 14' ' ' ARG . 34.2 mtm180 -65.1 137.52 57.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 6.5 m120 -152.32 153.18 33.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.298 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.439 HG12 HD11 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -122.33 118.33 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.11 146.82 19.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.031 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -123.5 101.94 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.791 0.329 . . . . 0.0 111.259 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.06 100.54 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 39.4 tp -102.69 139.28 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.068 0.461 . . . . 0.0 111.225 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.62 157.28 37.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.82 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.449 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -103.61 169.85 8.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.287 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -50.88 -18.36 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 0.23 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.097 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 75.64 25.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.688 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.9 mmtp -97.65 172.65 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.6 mp -109.74 125.25 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 54.7 t80 -58.76 110.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.61 129.87 56.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.109 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -115.21 136.09 53.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 111.489 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.429 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.1 p -82.38 154.84 25.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.74 158.54 36.11 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.227 0.537 . . . . 0.0 111.517 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.94 -5.9 52.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.009 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -130.8 -17.43 3.18 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 55.1 mt -119.12 111.91 36.61 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.026 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.4 Cg_endo -65.28 131.4 28.22 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.873 1.715 . . . . 0.0 111.902 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.6 t70 77.73 2.69 2.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.78 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.94 97.22 11.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.429 ' CE3' ' N ' ' A' ' 32' ' ' SER . 50.5 m95 -104.68 157.88 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 0.7 OUTLIER -168.89 173.78 6.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 69.5 mtm -102.25 156.86 34.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.69 131.78 26.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.613 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.15 157.72 39.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.51 34.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.589 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -79.75 130.87 10.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.556 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.6 mt -59.44 160.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.51 148.06 22.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -48.16 99.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.6 18.41 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.798 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.6 tp10 -111.38 147.2 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.933 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.23 128.9 85.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.338 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 51.9 Cg_exo -52.8 -23.59 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.329 2.019 . . . . 0.0 112.676 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HD3' ' CE2' ' A' ' 108' ' ' PHE . 9.6 tpt180 -85.54 -22.03 28.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -91.06 -43.45 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.491 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.436 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.59 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.84 -52.86 15.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.17 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 64.1 mt -56.52 -27.83 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.316 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -84.88 -52.77 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.824 0.821 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -56.17 -34.24 66.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.592 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tp -57.41 -59.0 5.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.042 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.565 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 25.1 ptt180 -60.99 -11.84 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 110.504 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -91.69 -43.52 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.886 0.374 . . . . 0.0 111.544 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.3 -25.94 19.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.301 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.452 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.68 -22.01 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.961 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.21 4.55 73.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.972 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.46 124.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.785 0.326 . . . . 0.0 110.61 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -35.67 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.26 79.08 6.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.749 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 129.55 13.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.6 mm-40 -119.19 147.61 44.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.65 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 48.9 t -77.21 128.93 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.898 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CD1' ' CB ' ' A' ' 111' ' ' LYS . 2.0 mm -108.19 -18.63 7.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.378 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB1' ' CD2' ' A' ' 164' ' ' HIS . . . -159.27 162.25 36.07 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.423 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.9 pt-20 -148.83 118.77 7.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.721 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 78' ' ' TYR . 17.9 t -58.02 125.34 73.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.273 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.01 -19.8 69.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.739 2.293 . . . . 0.0 113.068 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.597 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.68 -176.74 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.031 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.417 ' CE2' ' HE2' ' A' ' 106' ' ' LYS . 20.4 m95 -108.75 147.1 32.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.023 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 4.4 mt -112.29 117.7 33.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.01 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.9 p -108.65 136.7 47.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.683 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -130.0 170.18 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.337 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.03 158.04 40.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.16 150.61 45.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 38.0 m95 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.757 0.313 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -29.47 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.713 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -163.86 -139.39 2.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.307 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 82' ' ' TYR . 32.9 mt-30 -157.53 115.07 3.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.28 112.11 23.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.688 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.2 pt20 -127.29 159.69 33.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -112.51 95.91 5.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.456 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 40.5 m95 -64.48 141.56 58.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.157 0.503 . . . . 0.0 112.271 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 54.8 m-85 -124.67 133.55 53.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.224 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.8 tp -79.63 131.37 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.553 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 45.0 m-85 -127.05 129.38 47.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 111.351 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.493 ' CB ' ' CD1' ' A' ' 73' ' ' ILE . 11.5 tttt -93.34 120.97 34.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -63.46 126.93 29.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 0.0 111.014 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.2 p -129.64 38.15 3.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.58 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.83 -145.05 4.71 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.992 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -128.08 154.14 46.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -50.35 -16.29 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.62 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -79.16 -19.64 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -79.77 -25.07 41.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.45 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 18.1 mt -70.81 102.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.374 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.88 96.19 5.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.935 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 34.9 mt -56.67 -24.18 47.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.488 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.94 -56.96 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.294 0.568 . . . . 0.0 109.996 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.91 178.84 23.42 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.483 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -90.79 38.93 0.97 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.51 26.92 70.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.123 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -120.62 -70.84 0.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.91 165.2 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -84.35 154.78 63.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.94 160.48 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.791 2.328 . . . . 0.0 112.722 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -150.19 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.471 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.452 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 1.5 m-85 -107.57 159.51 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.181 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -17.94 5.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.068 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -152.42 175.23 12.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.177 0.513 . . . . 0.0 110.659 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.4 p-90 -156.42 150.43 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.258 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.43 165.64 29.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.349 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.449 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 59.9 m95 -99.43 125.44 45.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.5 m -137.97 150.6 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 111.56 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -70.76 158.61 87.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.677 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.413 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.07 -19.1 19.16 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.914 1.743 . . . . 0.0 111.943 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.76 -34.21 15.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.106 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -50.48 27.35 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.954 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.1 tp -54.01 -29.76 44.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.42 0.629 . . . . 0.0 109.882 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.0 mm -69.01 -28.61 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.733 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.55 -20.93 42.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.21 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mt -84.4 -39.35 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.066 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.3 m -58.2 163.81 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.066 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 150' ' ' LYS . 13.6 p -92.59 161.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.5 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.06 -26.45 66.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.457 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 22.8 p90 -91.55 12.09 22.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.51 ' HB2' HG12 ' A' ' 147' ' ' VAL . 2.1 mtmp? -149.75 12.91 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.568 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.5 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.4 mtpm? -65.15 -62.48 4.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.166 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 11.9 Cg_endo -55.54 -40.86 83.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.478 2.118 . . . . 0.0 112.106 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.462 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -57.03 -28.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.492 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.5 m-85 -91.42 -52.65 4.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.64 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -33.56 17.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.586 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -45.58 81.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.553 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 43.3 t -58.28 -46.62 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.071 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 162' ' ' ALA . 73.4 mt -64.14 -48.89 74.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.787 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 -46.71 59.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.22 -23.13 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.518 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 11.2 m-30 -102.96 -1.8 28.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.432 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -49.84 -44.25 77.34 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 38.8 Cg_endo -71.16 -21.54 27.04 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.13 1.887 . . . . 0.0 112.817 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.45 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 81.1 m-70 -89.37 -41.91 11.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.699 0.285 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 161' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.27 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -86.71 152.5 22.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.265 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 1.9 mmp_? -62.19 128.42 36.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.214 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 11.6 t-20 -152.64 159.42 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.42 HG22 ' CB ' ' A' ' 56' ' ' ALA . 3.3 m -134.9 140.58 45.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.385 . . . . 0.0 111.222 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 149.54 16.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.49 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -128.38 103.78 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 0.0 111.58 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 20.5 t -89.71 106.33 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 HD21 ' CD2' ' A' ' 29' ' ' PHE . 28.7 tp -103.17 145.06 30.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 111.333 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.5 ptm -130.56 157.39 42.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.518 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.462 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.93 169.78 8.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.011 0.434 . . . . 0.0 111.466 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -51.16 -18.63 0.93 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.615 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.95 1.42 55.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.8 mtmm 73.38 26.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.649 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttt -99.01 175.14 6.02 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -110.93 126.37 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 111.007 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 12.1 t80 -58.43 109.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.26 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.02 129.67 56.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.433 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.77 137.89 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.089 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.401 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.2 155.99 24.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.782 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' ALA . 1.4 mtp85 -71.38 159.83 33.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.617 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.45 -5.64 48.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.916 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -19.29 4.01 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.218 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.461 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 59.7 mt -120.05 112.68 34.65 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.983 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.37 131.73 29.12 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.901 1.734 . . . . 0.0 111.713 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.35 3.3 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.777 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -88.47 97.21 10.95 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.243 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -102.47 156.73 17.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.238 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -168.62 169.22 10.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.792 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.3 mtm -92.92 156.17 40.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.33 124.35 11.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.556 2.171 . . . . 0.0 112.695 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -154.24 158.43 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.383 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.91 153.5 22.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.799 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.1 137.37 49.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 7.4 mt -64.57 161.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 110.405 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.3 m-20 -90.04 147.95 23.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.59 98.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.226 0.536 . . . . 0.0 110.807 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.01 36.03 8.63 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.024 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HB3' HG23 ' A' ' 47' ' ' ILE . 5.0 tt0 -116.34 142.31 47.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.48 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.54 142.88 84.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.674 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.44 -48.75 19.78 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.487 2.125 . . . . 0.0 112.566 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -26.04 67.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -84.65 -46.92 11.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.656 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.29 -31.62 67.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.57 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.26 -53.54 10.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.177 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.3 mt -55.9 -30.38 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.104 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -81.83 -53.23 6.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.735 0.779 . . . . 0.0 109.779 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -52.66 -39.04 61.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.451 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -55.59 -57.38 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.041 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.557 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 2.7 ptt-85 -61.44 -12.48 14.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.432 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.69 -42.5 10.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 111.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.41 -25.14 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.229 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.447 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.33 -21.61 8.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.758 0.314 . . . . 0.0 111.069 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.15 5.23 70.57 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.894 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.08 128.16 36.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 0.0 110.633 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -34.89 8.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 81.63 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.46 . . . . 0.0 110.974 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 130.69 14.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.84 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -119.77 148.21 43.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.983 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.5 t -79.14 122.83 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.339 0.59 . . . . 0.0 111.553 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.528 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -102.85 -20.79 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HB1' ' CD2' ' A' ' 164' ' ' HIS . . . -155.27 162.53 40.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.039 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.23 115.97 6.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.011 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 78' ' ' TYR . 3.5 t -57.21 128.46 78.23 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 -10.8 25.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.796 2.331 . . . . 0.0 113.942 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -131.16 160.8 33.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 112.294 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -88.71 147.11 24.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.867 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 95.9 mt -115.44 117.63 30.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.418 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -114.59 130.83 56.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.757 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -133.46 165.64 24.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -124.86 158.31 33.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.154 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -103.2 155.4 36.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 C--N 1.344 0.329 0 C-N-CA 122.406 2.071 . . . . 0.0 112.266 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 27.7 m95 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -29.89 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.124 0.487 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.74 -143.94 4.27 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.696 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -158.7 124.38 4.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.847 0.356 . . . . 0.0 111.315 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.73 106.48 17.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -115.9 149.22 39.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.406 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 2.1 mmtp -109.52 96.45 6.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.491 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 73.3 m95 -62.65 145.78 53.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 70.1 m-85 -130.95 133.56 45.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.936 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.2 tp -79.68 130.88 35.74 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.595 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 46.9 m-85 -125.33 127.59 46.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.017 0.437 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.528 ' HB2' HG13 ' A' ' 73' ' ' ILE . 62.8 tttm -92.56 120.75 33.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -62.9 126.21 26.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.5 p -127.06 37.96 4.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.584 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.59 -145.16 4.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.059 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -128.95 154.24 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 109.984 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.3 -17.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.569 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.85 -22.79 53.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.01 -25.62 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.9 mt -68.0 103.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.56 96.06 4.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.041 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 44.6 mt -58.72 -20.82 52.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.403 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -57.0 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.3 178.32 19.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.332 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -89.79 38.65 0.92 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.193 0.521 . . . . 0.0 109.714 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.11 29.76 76.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.233 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.0 m -109.34 -64.04 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 111.336 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -115.8 165.11 13.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 152.69 68.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.84 176.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 0.0 112.668 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -150.14 -44.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 18.6 m-85 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 -18.16 6.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.732 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.2 mm-40 -152.3 175.0 13.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.042 0.448 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.1 p-90 -159.23 152.07 21.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.15 163.39 38.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.362 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.462 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 64.9 m95 -95.98 123.58 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 33.0 m -133.14 151.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.559 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.1 158.22 87.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.525 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CB ' HD12 ' A' ' 158' ' ' LEU . 10.9 Cg_endo -54.44 -19.57 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.0 1.8 . . . . 0.0 112.097 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -92.13 -34.36 14.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.276 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -50.25 46.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.935 0.398 . . . . 0.0 110.152 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.2 tp -53.21 -34.02 55.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.479 0.657 . . . . 0.0 109.871 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.458 HG21 ' HD2' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -66.48 -28.61 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.673 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -77.39 -32.59 54.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.654 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.6 mt -74.64 -40.94 61.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.87 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.3 m -53.53 164.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.221 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.496 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 7.3 p -97.37 159.82 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 1.0 OUTLIER -47.24 -43.68 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.465 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.496 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 39.2 p90 -83.95 7.02 19.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HB2' ' CG1' ' A' ' 147' ' ' VAL . 25.3 mtmt -128.12 -6.31 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.59 0.234 . . . . 0.0 111.33 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.491 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.7 mtpm? -59.42 -60.63 9.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.592 0.235 . . . . 0.0 111.285 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.0 Cg_endo -61.54 -42.3 34.23 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.047 . . . . 0.0 112.15 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 82' ' ' TYR . 13.4 t -58.1 -26.69 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.5 -52.61 4.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.505 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.458 ' HD2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.75 -30.66 14.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.617 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.98 -44.99 75.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.484 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.509 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.6 t -59.99 -48.77 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' ALA . 59.2 mt -60.8 -48.95 79.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.971 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.0 m -48.89 -42.9 38.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.831 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 93.7 t -72.76 -24.78 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.03 0.443 . . . . 0.0 110.716 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.509 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.7 m-30 -100.97 -1.51 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.272 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.625 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.68 -51.84 27.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.539 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -54.69 -22.02 27.34 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.301 2.0 . . . . 0.0 112.358 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.434 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 90.4 m-70 -96.09 -17.42 20.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.124 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 3.8 mp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.884 0.374 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -81.48 152.3 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.017 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -66.75 136.31 55.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.523 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 m120 -152.54 156.21 38.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.449 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.449 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.6 m -129.79 121.83 53.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.853 0.359 . . . . 0.0 111.383 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.03 140.18 14.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.442 HG22 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -114.2 101.69 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.2 t -90.18 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.2 tp -103.09 147.13 27.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.56 157.14 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.821 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 43.7 p-10 -99.87 172.48 7.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.14 -17.8 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.313 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -0.11 57.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.815 0.341 . . . . 0.0 110.994 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttt 76.93 25.44 0.83 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.599 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.4 mmtp -93.53 175.58 6.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.1 mp -113.89 126.4 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 32.8 t80 -58.56 109.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.75 129.89 56.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.349 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.43 138.91 52.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.558 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.5 p -82.04 157.58 24.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -73.08 158.45 35.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 111.433 -179.478 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.77 -5.54 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.067 178.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -130.87 -17.76 3.11 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.473 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 65.9 mt -118.77 112.19 36.99 Favored Pre-proline 0 N--CA 1.455 -0.178 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.951 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.2 131.72 29.39 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.995 1.797 . . . . 0.0 111.889 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 t70 76.62 4.09 3.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.713 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.473 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -89.2 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.412 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -102.95 155.46 18.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -169.04 171.63 8.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.753 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.414 ' HE2' ' CZ3' ' A' ' 107' ' ' TRP . 1.9 mpp? -95.85 157.72 35.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.652 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.54 129.47 15.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.58 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.06 153.74 32.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.46 167.95 33.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -80.02 133.17 12.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.559 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.6 mt -60.12 160.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 2.0 m-20 -90.24 149.31 22.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.96 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.22 0.533 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.18 10.25 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.954 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 47' ' ' ILE . 16.0 tp10 -114.09 145.96 40.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.865 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.11 139.6 79.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.429 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.01 -55.07 3.78 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.387 2.058 . . . . 0.0 112.599 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -60.29 -27.53 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.214 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -82.48 -49.42 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.798 0.332 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -58.82 -30.68 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.482 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.85 -53.45 10.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.16 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.1 mt -55.78 -29.79 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.116 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -80.69 -53.51 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.786 0.803 . . . . 0.0 109.73 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.97 -33.29 62.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.568 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.1 tp -56.56 -58.4 8.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.123 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.569 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 9.2 ptt180 -62.12 -11.06 12.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 0.0 110.545 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -91.71 -44.34 9.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.47 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.87 -29.6 17.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.3 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.445 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -114.93 -21.33 10.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.33 6.69 70.53 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.885 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.92 130.84 35.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.327 . . . . 0.0 110.548 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -109.79 -33.01 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.37 78.78 6.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.164 0.507 . . . . 0.0 110.831 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.36 131.29 15.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.846 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -119.41 140.37 50.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.239 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.2 t -69.76 116.86 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.292 0.568 . . . . 0.0 111.387 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -90.91 -24.0 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.774 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.42 168.64 26.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.214 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -148.51 116.26 6.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.236 179.623 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.648 HG11 ' O ' ' A' ' 78' ' ' TYR . 6.2 t -57.33 130.29 80.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 -15.42 35.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.763 2.309 . . . . 0.0 113.626 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.648 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -128.04 170.35 13.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.459 0.647 . . . . 0.0 112.359 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.426 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 8.8 m95 -96.22 145.99 25.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.978 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 2.3 mt -110.24 117.91 34.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.171 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 p -107.7 136.23 47.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.49 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -127.88 170.11 13.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.466 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.33 158.29 38.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.89 152.09 47.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.798 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.344 0.3 0 C-N-CA 122.597 2.198 . . . . 0.0 112.288 -179.975 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.2 m95 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.794 0.33 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -29.35 60.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.24 -139.13 2.69 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.82 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -157.64 113.92 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.81 0.338 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.1 105.66 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.8 pt20 -120.24 150.57 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.5 mttp -102.77 95.71 6.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.388 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CZ2' ' NE2' ' A' ' 105' ' ' GLN . 43.7 m95 -64.33 143.5 57.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.236 -178.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.432 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 67.3 m-85 -128.0 137.69 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.15 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 22.1 tp -79.43 155.18 28.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 20' ' ' CYS . 33.1 m-85 -146.47 131.96 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 111.955 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.628 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -94.73 119.56 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 178.032 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.65 121.44 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.613 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.8 p -123.92 37.71 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.565 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.93 -145.31 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.129 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.5 154.24 47.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -49.47 -16.96 0.24 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.603 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -76.33 -21.06 56.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.102 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.56 -25.19 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.23 104.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.513 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -119.96 95.55 4.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.708 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 41.3 mt -58.82 -24.82 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 -179.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.1 -55.04 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.39 178.63 17.22 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.397 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -89.64 38.64 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.212 0.529 . . . . 0.0 109.687 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.93 29.63 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.226 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -107.02 -64.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.84 165.16 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -60.22 151.36 67.8 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.34 176.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.716 2.277 . . . . 0.0 112.602 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -150.13 -45.24 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.722 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 21.2 m-85 -112.72 159.39 18.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.96 -14.6 6.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.637 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.558 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 10.6 mp0 -152.15 174.22 14.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.019 0.438 . . . . 0.0 110.357 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.0 p-90 -159.65 152.06 21.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.333 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.62 153.93 35.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.306 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 87.8 m95 -89.95 126.13 35.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.439 HG21 ' CA ' ' A' ' 142' ' ' LEU . 30.9 m -137.46 150.63 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.666 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -68.23 159.33 80.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.574 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.417 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 13.4 Cg_endo -56.72 -18.98 28.79 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 121.816 1.677 . . . . 0.0 111.732 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.5 -34.15 15.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -50.84 25.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' CA ' HG21 ' A' ' 137' ' ' VAL . 3.4 tp -54.14 -30.66 49.83 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.434 0.635 . . . . 0.0 109.864 179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.4 mm -68.52 -28.78 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 178.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.39 -20.98 42.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.21 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.64 -39.24 18.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.072 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 m -58.05 164.27 2.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.113 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' A' ' 150' ' ' LYS . 12.7 p -93.01 162.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.787 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.497 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -59.03 -27.6 65.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -179.433 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.452 ' CE2' HG12 ' A' ' 147' ' ' VAL . 7.9 p90 -93.28 7.6 43.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.481 ' HB2' HG13 ' A' ' 147' ' ' VAL . 3.1 mtmp? -140.25 11.04 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.497 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.7 mtpp -70.54 -62.45 2.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.6 Cg_endo -52.99 -46.74 31.77 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.153 . . . . 0.0 112.121 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.47 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -56.46 -26.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.499 . . . . 0.0 110.959 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.33 -51.43 5.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.656 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -34.84 21.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -45.96 84.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.576 179.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.514 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.3 t -57.04 -49.52 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 162' ' ' ALA . 78.0 mt -62.92 -49.14 75.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.824 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.8 p -50.17 -46.67 54.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.74 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.3 -24.84 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.048 0.452 . . . . 0.0 110.475 179.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.514 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.3 m-30 -102.27 7.08 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.013 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.613 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.67 -53.07 54.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.801 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 8.1 Cg_endo -50.59 -24.83 13.41 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.562 2.175 . . . . 0.0 112.52 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.412 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 98.1 m-70 -92.88 -22.38 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.883 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.964 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.103 0.478 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -85.79 152.6 22.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -73.38 129.31 37.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.8 t-20 -153.26 156.85 39.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.675 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' A' ' 56' ' ' ALA . 4.5 m -127.38 138.04 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.006 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.83 155.13 16.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.464 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -128.52 101.77 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.701 0.286 . . . . 0.0 111.345 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.8 t -89.7 103.38 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.4 tp -103.02 145.09 30.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -131.42 157.05 44.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 27' ' ' LYS . 10.4 p-10 -97.43 175.1 6.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -14.2 39.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.243 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.2 0.48 56.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.77 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp 75.63 26.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.513 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 12.9 mttp -97.88 172.97 7.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.01 140.74 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 110.667 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 11.0 t80 -75.6 109.31 9.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.541 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.429 ' CB ' ' CD2' ' A' ' 142' ' ' LEU . . . -116.63 132.79 56.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.85 135.23 54.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.38 155.01 24.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -71.24 159.22 35.02 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 111.506 -179.386 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -93.44 -6.85 46.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.838 178.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.93 -18.92 4.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.09 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.492 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 52.6 mt -119.4 111.65 36.38 Favored Pre-proline 0 N--CA 1.455 -0.213 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.881 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.59 131.27 29.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.995 1.797 . . . . 0.0 111.977 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 77.35 2.37 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.824 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -85.59 97.22 9.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -101.7 154.84 18.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.323 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.31 173.27 6.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -99.26 161.15 25.65 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.03 133.9 24.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.498 2.132 . . . . 0.0 112.759 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 155.8 35.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.35 143.58 9.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.683 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.8 143.43 39.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.534 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.8 mt -76.87 160.72 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 5.0 m-20 -90.25 177.54 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.125 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.88 99.28 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.39 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.61 47.01 12.94 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.615 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -110.36 148.55 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.185 0.517 . . . . 0.0 110.949 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.83 126.11 88.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.366 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.3 -34.59 70.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.385 2.057 . . . . 0.0 112.569 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.73 -25.0 53.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -87.57 -45.53 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.428 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.458 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -59.27 -31.07 68.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.369 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.59 -52.55 13.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -56.34 -31.41 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.289 0.566 . . . . 0.0 109.905 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -78.58 -53.6 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.849 178.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -54.88 -36.08 64.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.602 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -56.15 -54.15 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.575 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -62.22 -11.7 16.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.718 179.121 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -91.52 -41.48 10.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 111.477 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -90.25 -31.17 17.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.923 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -119.62 -23.8 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.339 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 69.74 10.13 63.6 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.647 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 t -69.3 119.08 14.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.222 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.62 -34.02 12.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.105 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.2 78.49 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.179 0.514 . . . . 0.0 110.962 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.35 131.45 15.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.851 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -119.95 141.9 49.23 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.146 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.8 t -70.87 117.01 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.237 0.541 . . . . 0.0 111.437 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.656 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.1 mt -91.03 -26.11 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.41 169.31 24.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.282 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.6 pt-20 -148.44 112.06 5.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 78' ' ' TYR . 2.5 t -57.65 123.82 64.78 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.965 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.5 -3.96 14.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.801 2.334 . . . . 0.0 114.045 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.518 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -131.23 139.45 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.204 0.526 . . . . 0.0 112.131 -179.855 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.451 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 15.2 m95 -75.31 145.06 42.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 89.6 mt -111.2 117.58 33.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 p -108.52 131.74 54.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.751 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -129.84 166.26 20.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.3 158.34 29.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.098 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.35 153.18 45.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.738 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 0.0 112.384 -179.931 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.2 m95 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -26.99 44.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.447 . . . . 0.0 110.435 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.66 -138.5 2.47 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -158.05 113.76 2.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -88.22 105.82 17.79 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.73 150.27 52.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 2.7 mttt -97.77 156.5 16.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.47 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.457 ' CG ' HG23 ' A' ' 157' ' ' VAL . 45.2 m95 -120.81 140.32 51.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.02 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.4 m-85 -123.46 131.18 53.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.056 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.7 tp -79.26 135.84 36.88 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.146 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.494 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 39.4 m-85 -126.82 131.67 51.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 112.02 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.656 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 3.5 ttmt -93.76 120.18 33.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.374 178.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -68.97 122.43 18.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -123.96 37.8 4.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.508 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.46 -144.74 4.8 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.141 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.56 154.27 47.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -48.96 -17.45 0.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.523 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.23 -24.21 59.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.319 . . . . 0.0 111.027 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.19 -26.24 58.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 119' ' ' ILE . 29.8 mt -69.14 101.52 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 123' ' ' GLY . 13.2 p-10 -125.28 96.07 4.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.839 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 60.7 mt -55.27 -19.24 7.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.067 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.52 -58.62 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.383 0.611 . . . . 0.0 110.124 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.402 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . 138.64 179.41 17.22 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.311 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -89.61 38.84 0.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.1 28.3 72.68 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.224 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.95 -64.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.7 165.07 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -71.08 152.3 94.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.042 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.16 169.17 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.678 2.252 . . . . 0.0 112.519 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -150.07 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.781 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 12.6 m-85 -106.15 159.32 16.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.46 -18.67 5.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.78 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.42 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 9.3 mm-40 -152.17 175.31 12.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 110.398 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.08 154.53 25.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.33 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -151.56 162.5 40.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.301 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 86.8 m95 -98.97 129.37 45.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 28' ' ' ILE . 28.4 m -139.41 156.19 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.964 -179.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -73.63 152.98 89.57 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -49.19 -20.83 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.114 1.876 . . . . 0.0 112.132 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -90.42 -33.82 15.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.437 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.415 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -70.09 -50.8 37.28 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 110.22 179.496 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -51.94 -36.05 47.97 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.515 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.2 mm -63.08 -29.05 46.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.934 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 141' ' ' GLN . 0.5 OUTLIER -80.53 -22.01 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.116 179.028 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.13 -39.13 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 m -59.33 165.64 2.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.868 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 149' ' ' PHE . 8.3 p -97.35 159.72 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.05 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 19.1 mt-10 -52.14 -38.44 57.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 13.6 p90 -84.34 5.28 27.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 20.9 mtpp -140.09 9.26 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.512 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.6 mtpp -69.07 -62.77 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.8 Cg_endo -54.33 -39.66 86.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 111.87 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.449 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 14.1 t -58.13 -27.02 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 110.799 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.33 -50.66 5.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.375 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -51.01 -34.63 30.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 3.4 tp10 -63.91 -46.09 86.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.51 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.509 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.4 t -60.09 -47.28 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.249 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 162' ' ' ALA . 69.2 mt -63.36 -48.5 77.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.695 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.5 m -48.77 -47.88 41.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.731 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 74.6 t -67.52 -24.9 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.509 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.2 m-30 -102.25 7.32 40.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.027 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -50.75 -53.05 50.98 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.602 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.8 Cg_endo -50.66 -24.75 13.51 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.545 2.163 . . . . 0.0 112.316 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 73' ' ' ILE . 98.7 m-70 -89.77 -24.5 21.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.644 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.878 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.991 0.424 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 6.7 mtp-105 -76.07 152.39 36.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -75.22 133.38 41.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.1 m120 -152.22 161.9 41.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.496 HG13 HD12 ' A' ' 47' ' ' ILE . 1.9 m -132.24 125.63 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.235 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 138.79 14.13 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.219 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' ' 110' ' ' PHE . 4.5 mp -111.69 102.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' PHE . 7.6 t -89.68 102.12 14.81 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.09 146.39 28.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 0.0 110.933 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.24 157.2 41.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 12.4 t30 -93.65 173.42 7.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.044 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.97 -16.58 61.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.845 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.41 -0.71 57.69 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 81.77 24.6 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.632 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -93.83 170.48 9.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.3 mp -109.81 121.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.5 ' CE2' ' CG2' ' A' ' 65' ' ' THR . 1.7 t80 -54.04 107.56 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.259 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.85 137.72 52.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.746 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.96 141.95 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.17 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.33 158.32 23.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.968 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.8 mtp-105 -72.71 164.04 27.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 111.723 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 mt -97.93 -7.0 31.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.44 178.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.54 -18.21 3.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.55 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 62.9 mt -121.12 112.42 33.26 Favored Pre-proline 0 N--CA 1.457 -0.094 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.189 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.79 132.62 31.09 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.816 1.677 . . . . 0.0 111.475 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 77.86 3.8 2.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.683 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -90.85 97.55 11.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 145' ' ' LEU . 27.6 m95 -102.28 156.58 17.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.065 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.75 -176.68 2.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.703 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 76.3 mtm -107.31 156.59 37.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.12 132.35 27.68 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.56 2.173 . . . . 0.0 112.579 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 157.39 42.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.695 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.51 171.37 34.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.02 135.92 13.58 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.574 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.496 HD12 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -68.6 161.03 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.619 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -83.76 -174.85 5.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.767 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.91 99.57 6.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.281 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.43 50.73 19.72 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.597 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.47 155.23 25.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.096 -179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -77.87 130.34 73.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 52.0 Cg_exo -54.6 -21.66 25.48 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.389 2.059 . . . . 0.0 112.932 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HD2' ' CD2' ' A' ' 108' ' ' PHE . 3.1 tpt180 -84.39 -25.44 29.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -88.05 -43.29 11.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.578 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -63.36 -29.87 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.519 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.79 -51.83 13.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.3 mt -57.32 -29.07 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.237 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ttp-105 -81.85 -53.3 6.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.831 0.824 . . . . 0.0 109.698 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -54.48 -31.83 56.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 3.1 tp -58.43 -63.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.562 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 11.7 ptp180 -60.45 -12.14 8.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -92.08 -40.91 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.53 -32.08 16.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.5 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.86 -24.84 7.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.936 0.398 . . . . 0.0 110.899 -179.55 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 82.3 -0.65 88.72 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.063 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 37.5 t -66.82 121.73 16.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.986 0.393 . . . . 0.0 110.331 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 -33.8 10.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.03 77.48 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.41 129.16 13.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.919 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 7.0 mt-10 -120.39 146.44 46.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.627 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 55.8 t -76.46 125.69 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.49 0.662 . . . . 0.0 111.928 -179.06 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.56 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -107.44 -17.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.248 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -153.72 159.68 42.06 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.18 111.63 4.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 78' ' ' TYR . 4.5 t -57.58 125.32 71.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.05 -8.15 20.75 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.85 2.366 . . . . 0.0 113.785 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.583 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.54 146.67 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 112.05 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.434 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 16.4 m95 -79.69 145.21 33.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.012 0.434 . . . . 0.0 109.976 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 82.5 mt -111.11 117.55 33.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.733 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.442 HG21 ' CB ' ' A' ' 104' ' ' ALA . 19.3 p -111.74 130.03 55.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.812 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -130.56 163.58 26.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 0.0 110.707 179.539 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.68 158.27 35.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.189 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -101.98 155.93 35.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.496 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.309 2.006 . . . . 0.0 112.196 -179.924 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.439 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 56.7 m95 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.821 0.344 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -28.72 62.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.22 -139.18 2.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.092 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -157.63 117.12 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.326 . . . . 0.0 111.343 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.442 ' CB ' HG21 ' A' ' 81' ' ' THR . . . -86.65 110.58 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -130.85 150.19 52.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.717 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.434 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.1 mtmt -107.51 102.54 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.443 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.449 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 29.9 m95 -67.9 143.28 55.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.417 ' CD2' ' HD2' ' A' ' 54' ' ' ARG . 61.1 m-85 -125.48 137.77 53.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.035 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 21.5 tp -79.36 154.49 28.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 44.4 m-85 -148.0 127.54 13.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.564 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.56 ' HB2' HG13 ' A' ' 73' ' ' ILE . 4.7 tptp -92.48 121.65 34.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -65.32 123.46 19.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.955 0.407 . . . . 0.0 110.637 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 p -124.68 37.67 4.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.758 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.46 -144.88 4.72 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.034 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.29 154.27 47.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.09 -17.35 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.522 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -74.69 -22.18 58.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -26.24 56.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 119' ' ' ILE . 25.2 mt -69.97 94.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.325 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -117.92 95.98 5.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.931 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.0 mt -52.53 -20.04 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.175 -179.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.0 mt -57.9 -59.09 5.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.378 0.609 . . . . 0.0 109.966 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -178.56 18.53 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.453 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -89.52 38.77 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.58 26.27 71.87 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -103.23 -64.63 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.128 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.29 165.19 12.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -69.29 151.19 97.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -48.86 135.85 28.56 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.624 2.216 . . . . 0.0 112.572 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -113.24 -25.87 8.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 6.6 m-85 -123.17 159.25 29.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.711 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.56 -17.62 5.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.72 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.489 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.36 173.35 15.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 0.0 110.568 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.2 p-90 -160.41 160.56 32.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.426 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -159.3 154.68 25.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.345 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.468 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 87.3 m95 -88.62 127.18 35.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.729 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 26.9 m -138.52 150.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 111.857 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.3 p -68.5 160.86 74.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.647 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 19.7 Cg_endo -58.66 -17.12 33.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 121.773 1.649 . . . . 0.0 111.801 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.06 -34.18 14.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -51.08 23.86 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.039 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.2 tp -54.01 -31.73 51.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 109.823 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.0 mm -67.17 -28.75 43.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.654 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -80.68 -20.7 42.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.18 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 40' ' ' TRP . 11.1 mt -85.77 -39.0 17.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.401 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 24.2 m -56.48 163.95 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.237 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.1 p -93.01 160.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 1.1 mt-10 -49.66 -41.83 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.275 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 45.1 p90 -85.36 8.71 17.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.401 ' CB ' ' CG2' ' A' ' 146' ' ' THR . 19.0 mttt -129.06 -8.66 4.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.602 0.239 . . . . 0.0 111.31 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.485 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.8 mtpm? -57.7 -59.88 11.64 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.311 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.9 Cg_endo -61.09 -42.46 36.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.369 2.046 . . . . 0.0 112.174 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.432 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 16.4 t -60.07 -27.28 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.418 ' CE2' ' HE3' ' A' ' 42' ' ' MET . 3.2 m-85 -90.79 -51.4 5.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -32.27 18.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.418 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 6.0 tp10 -66.67 -45.73 77.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.529 179.175 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.493 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.6 t -58.84 -47.44 89.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.963 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 162' ' ' ALA . 76.4 mt -63.73 -48.6 76.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -50.09 -47.36 53.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.861 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.54 -25.71 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 110.404 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.493 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.5 m-30 -102.24 9.64 39.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.975 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.32 -57.92 16.22 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.318 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -58.26 -21.88 54.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.475 2.117 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 93.3 m-70 -89.96 -11.15 42.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.209 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.922 179.843 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -82.2 152.24 26.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -70.2 131.43 44.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.985 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.547 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.1 t30 -152.78 155.0 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' A' ' 47' ' ' ILE . 19.2 m -133.11 137.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.103 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.92 131.92 9.37 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.128 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.45 HG22 ' CE1' ' A' ' 110' ' ' PHE . 4.5 mp -97.43 113.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.811 0.338 . . . . 0.0 111.863 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 110' ' ' PHE . 8.6 t -96.16 103.17 15.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 112' ' ' PHE . 29.5 tp -103.37 149.37 24.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 111.132 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.07 157.27 45.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.672 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.9 p-10 -98.19 172.31 7.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.614 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -57.82 -17.72 17.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.522 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.81 0.34 56.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 mttm 77.06 25.46 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.515 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 7.4 mttp -93.77 174.41 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.597 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.75 138.51 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -179.807 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 5.2 t80 -76.68 103.7 6.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.494 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.34 139.86 49.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -124.01 137.86 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.52 154.43 25.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.646 179.878 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.403 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.2 mtp85 -71.23 157.66 37.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 111.628 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.45 -5.35 49.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.768 178.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.6 -19.42 4.57 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.985 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 56.9 mt -120.62 112.18 34.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.913 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.04 131.42 28.67 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.856 1.704 . . . . 0.0 111.878 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t70 77.15 3.7 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.773 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.4 10.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.349 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -102.41 157.32 17.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 -176.87 2.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.96 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 51.7 mtm -106.09 159.51 29.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.67 128.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.504 2.136 . . . . 0.0 112.787 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -150.48 167.42 27.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.37 59.39 0.11 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.864 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . 43.17 -165.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.091 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 4.5 mt -132.12 159.68 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 110.578 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 22.5 m-20 -90.38 149.81 22.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.09 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.99 39.6 11.46 Favored Glycine 0 C--N 1.32 -0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.945 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 9.2 tp10 -109.56 146.25 34.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.165 0.507 . . . . 0.0 110.965 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 128.38 81.91 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.318 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 76.0 Cg_exo -50.58 -25.82 15.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.358 2.039 . . . . 0.0 112.688 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.85 -24.0 31.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.94 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.91 -43.36 10.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.08 -32.1 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.175 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.71 -53.38 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.084 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.64 -28.58 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.442 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -84.21 -53.3 5.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 109.959 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -50.71 -42.91 57.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.326 -1.307 . . . . 0.0 111.223 -179.667 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -57.81 -51.9 67.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.584 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 12.8 ttm-85 -62.87 -13.45 34.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.448 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -38.73 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -87.59 -35.5 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.1 -22.78 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 111.164 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.48 6.48 76.31 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.86 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.411 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 19.2 t -56.71 108.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 110.178 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -34.04 16.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 76.13 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.172 0.511 . . . . 0.0 111.054 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.84 13.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.687 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.1 pt-20 -119.92 141.1 49.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.19 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.7 t -70.61 116.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 111.334 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.653 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -90.72 -25.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' HB1' ' CE1' ' A' ' 164' ' ' HIS . . . -156.85 169.6 24.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.268 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 11.2 pt-20 -148.59 117.22 6.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.012 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 78' ' ' TYR . 4.5 t -57.05 123.73 61.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.38 -13.45 39.34 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.885 2.39 . . . . 0.0 113.607 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.671 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.1 -179.04 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.349 0.595 . . . . 0.0 112.291 -179.417 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.411 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 21.3 m95 -107.89 147.5 30.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.052 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 3.1 mt -112.51 117.81 33.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.044 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.4 p -112.34 132.4 55.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.435 -179.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -127.05 170.15 12.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 158.27 29.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 11.5 m-85 -118.42 142.53 31.53 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 122.394 2.063 . . . . 0.0 112.234 179.87 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 36.3 m95 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.752 0.31 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -30.36 64.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -162.51 -142.85 3.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.975 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -157.01 112.86 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.805 0.336 . . . . 0.0 111.366 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.66 105.74 17.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.5 pt20 -120.05 161.97 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -116.14 105.15 12.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.217 178.638 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 60.2 m95 -78.35 144.43 36.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.0 m-85 -127.83 136.64 51.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.6 tp -79.67 155.04 28.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' CYS . 29.4 m-85 -145.92 132.44 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.198 0.523 . . . . 0.0 111.967 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.653 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -95.64 118.74 32.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.522 177.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 21' ' ' LEU . 3.9 t80 -68.73 119.74 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.3 p -120.84 37.32 4.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.497 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.72 -144.79 4.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.212 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.01 154.26 46.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -49.01 -17.47 0.2 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -74.0 -21.48 59.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.77 -24.77 56.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.14 105.66 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.443 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -122.93 95.56 4.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.021 179.219 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.6 mt -55.73 -21.65 19.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.698 -179.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.47 -58.44 6.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.278 0.561 . . . . 0.0 109.898 178.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.49 -170.41 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.393 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -93.7 38.8 1.06 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.87 75.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.135 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -116.38 -69.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.846 0.355 . . . . 0.0 111.212 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -89.88 165.12 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.69 148.18 54.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.27 126.62 17.88 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.65 2.233 . . . . 0.0 112.463 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.0 -28.25 9.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.745 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 11.2 m-85 -113.08 159.25 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.476 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.15 -20.79 5.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.711 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.448 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.0 mm-40 -152.27 174.63 13.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.076 0.465 . . . . 0.0 110.47 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 p-90 -159.2 157.55 30.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.165 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -157.59 160.73 38.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.493 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.1 m95 -92.87 127.37 38.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.47 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 28' ' ' ILE . 35.7 m -136.15 152.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -72.62 152.51 91.59 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -49.06 -23.26 6.04 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.105 1.87 . . . . 0.0 111.926 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.96 -33.71 19.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -50.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.041 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.8 tp -54.18 -29.3 45.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.488 0.661 . . . . 0.0 109.817 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.0 mm -70.52 -28.39 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.75 178.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.2 -21.84 42.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.14 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 142' ' ' LEU . 11.4 mt -82.48 -39.67 22.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.124 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.9 m -58.78 163.6 3.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.023 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 150' ' ' LYS . 12.6 p -92.58 161.42 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.32 -26.64 68.54 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.112 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CD2' HG22 ' A' ' 147' ' ' VAL . 24.6 p90 -91.11 10.88 25.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.505 ' HB2' HG13 ' A' ' 147' ' ' VAL . 5.7 mtmm -152.75 15.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.658 0.266 . . . . 0.0 111.698 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.512 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.1 mtpp -67.04 -62.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.228 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.1 Cg_endo -50.77 -40.43 56.71 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.536 2.158 . . . . 0.0 112.097 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 21.4 t -57.15 -27.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.26 0.552 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.449 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.22 -48.47 6.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.372 179.019 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -52.68 -32.28 41.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.581 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.89 -45.72 77.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.385 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.6 t -59.04 -46.78 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.983 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.1 mt -66.55 -48.69 68.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.647 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.9 t -50.24 -47.17 55.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.674 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.5 t -68.49 -24.56 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.073 0.463 . . . . 0.0 110.349 179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.51 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.3 m-30 -103.26 5.69 37.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.212 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.19 -55.36 31.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.609 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.72 -22.51 17.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.577 2.184 . . . . 0.0 112.351 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.441 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 16.3 m-70 -89.97 -22.2 22.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.717 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.914 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.859 0.361 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 5.6 ttm180 -83.36 152.24 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.131 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -65.21 131.66 47.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.49 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.5 m120 -152.52 159.27 43.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.894 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.424 HG22 ' CB ' ' A' ' 56' ' ' ALA . 1.5 m -132.29 127.68 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.254 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.12 144.38 17.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.162 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -120.95 102.11 11.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.8 t -89.71 107.65 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -103.08 144.8 30.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.014 0.435 . . . . 0.0 111.196 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.07 157.48 41.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.747 -179.973 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.9 p-10 -103.89 170.38 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.34 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -55.08 -18.13 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.94 4.48 47.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 179.705 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 4.8 mtpp 70.55 27.86 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mttt -96.73 172.38 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 65.9 t80 -57.19 109.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.183 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.62 132.44 56.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.254 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -115.57 138.03 51.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.468 . . . . 0.0 111.509 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.69 158.5 22.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.514 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 2.2 mtp-105 -71.26 164.21 26.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.41 0.624 . . . . 0.0 111.468 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -96.25 -6.06 38.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.69 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -136.17 -14.09 1.8 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 64.5 mt -120.67 111.77 34.36 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.358 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 32.8 Cg_endo -66.38 132.97 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.739 1.626 . . . . 0.0 111.306 179.123 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 79.12 3.18 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.465 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -94.95 97.74 10.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.152 179.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 23.7 m95 -108.78 160.21 16.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.085 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -168.86 170.81 8.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.859 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.453 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 71.0 mtm -97.91 156.71 35.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.67 137.81 39.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 0.0 112.917 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.27 157.02 38.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.378 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.93 153.02 23.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.754 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 132.17 17.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 6.4 mt -59.88 160.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.761 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 179.796 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.13 98.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.18 0.514 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.73 39.3 10.66 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.941 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 47' ' ' ILE . 15.5 tp10 -114.22 146.48 40.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 110.93 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.9 139.82 80.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.494 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.51 -52.55 7.91 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.46 2.107 . . . . 0.0 112.608 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -62.9 -25.48 68.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.328 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -84.66 -48.88 9.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.699 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.424 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -59.04 -28.31 66.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.54 -50.2 16.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.158 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -57.25 -29.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -82.69 -53.12 6.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.747 0.784 . . . . 0.0 109.956 179.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -52.65 -42.33 64.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.471 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -57.11 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.686 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 32.0 ttp180 -61.98 -13.54 26.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.331 178.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.02 -42.73 9.82 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -91.26 -25.66 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.447 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.8 -20.5 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.11 6.67 65.12 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.049 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.1 117.19 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.506 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -96.14 -35.73 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 78.56 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 111.141 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.53 129.43 13.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.931 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.76 148.96 42.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.06 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.8 t -79.56 123.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.422 0.629 . . . . 0.0 111.495 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.556 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -106.12 -20.17 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.398 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 161' ' ' PHE . . . -154.55 159.35 40.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.435 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.2 pt-20 -148.66 117.11 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.989 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.624 HG11 ' O ' ' A' ' 78' ' ' TYR . 11.0 t -57.26 126.76 75.13 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.065 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.94 -19.78 69.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.754 2.302 . . . . 0.0 113.228 -179.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.624 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.45 -177.98 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.049 -179.518 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.458 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.0 m95 -108.48 146.73 32.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.798 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 3.4 mt -111.71 117.61 33.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.014 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.403 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 4.0 p -111.57 131.89 54.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.946 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -133.75 163.88 28.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.68 179.824 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -122.23 158.25 29.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.65 150.41 42.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo . . . . . 0 C--N 1.345 0.353 0 C-N-CA 122.553 2.169 . . . . 0.0 112.443 179.98 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 69.2 m95 . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.791 0.329 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -31.15 67.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.32 -143.03 3.54 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.005 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -157.61 114.47 2.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.878 0.37 . . . . 0.0 111.498 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.403 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -94.51 105.78 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 7.6 pt20 -127.81 156.6 42.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.08 97.91 7.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 178.862 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 28.0 m95 -65.72 141.95 58.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 0.0 112.134 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 62.0 m-85 -125.6 137.24 53.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.316 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.3 tp -79.54 146.14 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 40.0 m-85 -139.11 127.88 23.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.008 0.432 . . . . 0.0 111.651 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.556 ' HB2' HG13 ' A' ' 73' ' ' ILE . 15.3 tttm -92.02 120.44 32.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.522 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -64.89 125.53 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.798 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 p -126.54 37.73 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.89 -144.86 4.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.236 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -127.15 154.27 44.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.917 0.389 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -49.75 -16.67 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.642 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.97 -18.16 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.266 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.06 -25.36 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 17.7 mt -74.2 103.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.49 -179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -117.61 95.89 5.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 47.2 mt -55.2 -23.32 21.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.64 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 29.0 mt -62.37 -57.4 11.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.285 0.564 . . . . 0.0 110.065 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.03 25.0 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.51 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.27 38.84 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 109.89 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.05 27.79 73.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.222 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.5 t -110.49 -65.97 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.837 0.351 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.57 165.06 11.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 149.9 97.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.0 177.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.732 2.288 . . . . 0.0 112.612 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -150.07 -45.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.552 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 18.9 m-85 -107.41 159.74 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.331 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.12 -16.9 6.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.803 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.552 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.47 174.7 13.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.12 0.486 . . . . 0.0 110.705 -179.816 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -159.51 153.67 23.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.08 179.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.06 161.62 42.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.41 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.443 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -94.95 123.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.433 HG21 ' CA ' ' A' ' 142' ' ' LEU . 27.3 m -135.39 151.05 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.071 0.463 . . . . 0.0 111.641 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.85 159.23 86.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.422 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.7 Cg_endo -55.51 -19.38 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.935 1.756 . . . . 0.0 111.873 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.26 -34.25 15.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.48 -50.48 25.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.989 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.433 ' CA ' HG21 ' A' ' 137' ' ' VAL . 4.3 tp -54.01 -29.95 45.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.489 0.661 . . . . 0.0 109.915 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.9 mm -68.15 -29.15 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.582 178.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.6 -22.15 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.41 -39.24 19.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.005 179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m -58.63 168.56 1.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 149' ' ' PHE . 6.3 p -104.64 159.92 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.047 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -45.44 -46.17 13.35 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CE2' HG12 ' A' ' 147' ' ' VAL . 1.5 p90 -76.8 -1.89 30.47 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.426 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mtmp? -125.73 1.57 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.579 0.228 . . . . 0.0 111.528 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.3 mttt -65.36 -62.55 4.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.342 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.03 -42.44 44.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.419 2.08 . . . . 0.0 112.239 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.458 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.4 t -59.16 -29.07 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.273 0.558 . . . . 0.0 110.966 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.78 -50.97 5.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.692 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -35.01 21.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.669 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -44.81 81.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.642 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.488 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 44.2 t -57.76 -46.51 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.084 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.3 mt -66.27 -48.87 69.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.9 m -50.02 -47.17 53.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.39 -25.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.067 0.46 . . . . 0.0 110.307 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.488 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.4 m-30 -104.8 12.0 33.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.981 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.498 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.98 -59.47 9.78 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.404 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -56.31 -21.53 37.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.586 2.191 . . . . 0.0 112.268 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.417 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 62.6 m-70 -89.95 -12.67 38.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.971 179.769 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.809 0.338 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HG3' ' CH2' ' A' ' 100' ' ' TRP . 2.1 ttp85 -92.48 152.38 19.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -62.12 132.55 53.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.425 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 19.1 t-20 -152.73 154.53 35.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.358 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.452 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.3 m -126.3 131.49 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 111.388 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.81 148.3 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.033 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -123.06 102.43 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.761 0.315 . . . . 0.0 111.397 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.2 t -89.48 104.69 17.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -102.59 145.3 29.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.0 0.429 . . . . 0.0 111.105 -178.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.2 ptm -127.65 157.26 40.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.2 p-10 -106.31 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -54.05 -18.33 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -88.86 3.94 49.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 179.803 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 20.7 mmtm 70.47 27.38 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.577 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 22' ' ' MET . 11.4 mmtm -96.38 175.32 6.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.1 mp -113.65 119.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.956 0.408 . . . . 0.0 110.809 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 18.8 t80 -52.46 110.29 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.74 133.6 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.412 179.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.89 139.1 52.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.9 p -82.3 155.78 24.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.685 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.448 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 1.3 mtt85 -72.01 158.09 36.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 mt -91.77 -5.66 53.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.019 178.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.79 -18.18 3.48 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 61.7 mt -118.78 111.84 37.24 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.7 131.24 28.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.981 1.787 . . . . 0.0 111.968 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 77.08 3.26 3.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.856 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.478 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -87.23 97.56 10.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.406 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -101.59 155.87 17.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.221 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.85 -176.92 2.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.651 179.724 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.4 mpp? -107.17 158.18 33.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 128.88 19.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.603 2.202 . . . . 0.0 112.417 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.03 157.09 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.76 139.24 5.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.571 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.31 137.48 49.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 9.2 mt -69.22 162.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.632 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -75.93 -172.16 1.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.613 179.614 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -90.14 27.45 1.63 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.24 0.543 . . . . 0.0 111.145 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.91 48.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 47' ' ' ILE . 5.4 tp10 -124.33 149.61 46.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 110.929 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -77.76 137.73 62.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.1 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.68 -55.18 4.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.363 2.042 . . . . 0.0 112.763 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' CG ' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -58.42 -31.55 67.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.316 -179.731 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -80.07 -49.73 11.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.733 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -56.69 -30.6 63.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.497 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.46 -52.59 13.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.099 179.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.2 mt -56.41 -29.85 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.23 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -81.67 -53.15 6.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.762 0.791 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -52.08 -45.71 64.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.597 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tp -56.0 -56.16 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.811 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.503 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 40.1 ttp180 -60.56 -14.48 20.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.298 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -92.07 -41.35 10.56 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.897 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -91.5 -25.04 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.31 -20.06 9.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.086 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.24 6.24 64.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.051 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -71.18 123.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.865 0.333 . . . . 0.0 110.469 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -34.12 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.24 76.77 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.987 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.26 129.01 13.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.873 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 12.0 mt-10 -120.39 148.5 43.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.765 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 38.9 t -78.15 125.39 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.456 0.646 . . . . 0.0 111.694 -179.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -106.28 -21.62 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.237 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 3.4 pt-20 -148.52 115.85 6.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.011 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 78' ' ' TYR . 4.8 t -57.31 130.17 80.36 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.066 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 -15.96 40.07 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.721 2.281 . . . . 0.0 113.6 -178.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.65 -176.05 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.417 0.627 . . . . 0.0 112.48 -179.369 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.435 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 25.6 m95 -106.27 147.48 29.09 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.279 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 5.5 mt -114.47 117.94 32.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.996 179.22 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.406 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -111.04 135.07 52.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.435 -179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -122.71 170.26 10.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.683 -179.355 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.21 158.23 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -117.63 152.51 49.79 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.309 179.96 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CH2' ' HG3' ' A' ' 14' ' ' ARG . 56.9 m95 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.519 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -85.72 -23.02 27.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -174.7 -137.58 2.51 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.048 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 90.0 mm-40 -157.3 113.85 2.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.886 0.374 . . . . 0.0 111.346 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -88.0 105.63 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.3 pt20 -121.64 157.06 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -112.15 95.72 5.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.198 178.569 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.451 ' CG ' HG21 ' A' ' 157' ' ' VAL . 24.2 m95 -64.12 150.5 45.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.308 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CE2' ' CG ' ' A' ' 54' ' ' ARG . 64.9 m-85 -133.15 133.29 42.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.284 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.6 tp -79.81 130.23 35.14 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.9 m-85 -124.49 129.13 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.505 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.544 ' HB2' HG13 ' A' ' 73' ' ' ILE . 5.1 tptt -92.38 123.06 35.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.2 124.48 23.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.694 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.6 p -126.73 37.87 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.747 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.2 -145.13 4.79 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.031 179.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -128.54 154.13 46.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.25 -16.25 0.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.67 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.71 -18.36 54.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.744 0.307 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.12 -25.0 40.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.09 103.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.501 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.5 95.61 5.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.69 -23.15 39.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.54 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 mt -61.85 -56.77 15.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.25 0.548 . . . . 0.0 109.997 179.233 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.38 -178.47 22.3 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.552 179.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -90.72 38.74 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.1 0.476 . . . . 0.0 109.843 179.208 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.23 73.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -112.76 -67.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 111.19 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -105.54 165.04 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.235 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.54 150.75 95.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.43 138.77 38.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.654 2.236 . . . . 0.0 112.506 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -112.4 -31.48 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.724 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.457 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 7.2 m-85 -118.02 159.56 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.03 -20.07 5.37 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.879 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.415 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.5 mm-40 -152.23 174.66 13.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.248 0.547 . . . . 0.0 110.599 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 p-90 -159.2 154.11 24.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.178 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.427 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -93.05 125.31 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 28.9 m -137.63 150.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.116 0.484 . . . . 0.0 111.619 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -69.54 159.83 82.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.472 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 14.0 Cg_endo -56.69 -18.89 28.21 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.796 1.664 . . . . 0.0 111.838 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.12 -34.2 15.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.054 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -50.9 22.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.112 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.1 tp -54.22 -30.28 49.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.393 0.616 . . . . 0.0 109.826 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.1 mm -68.97 -28.31 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.717 178.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 -17.53 47.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.367 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.53 -38.8 15.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.186 179.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.6 m -59.51 162.26 5.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 150' ' ' LYS . 10.1 p -91.62 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.66 -33.18 32.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.467 ' CG ' HG12 ' A' ' 147' ' ' VAL . 13.3 p90 -87.53 10.9 16.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.516 ' HB2' HG13 ' A' ' 147' ' ' VAL . 8.6 mtmm -136.74 -2.24 2.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 30.1 mttt -55.76 -61.81 5.67 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.201 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.3 Cg_endo -59.6 -45.84 23.66 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.377 2.051 . . . . 0.0 112.122 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 39.5 t -56.06 -27.79 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.227 0.537 . . . . 0.0 111.066 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.428 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.8 m-30 -91.55 -53.71 4.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -32.63 14.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 110.522 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -66.2 -45.56 80.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.498 179.148 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.511 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.4 t -57.9 -50.38 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.123 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.7 mt -61.68 -48.89 78.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.698 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 t -49.71 -47.53 50.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.664 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.0 t -67.84 -25.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.461 . . . . 0.0 110.31 179.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.511 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.6 m-30 -102.1 7.88 40.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.156 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.64 -57.0 17.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.258 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.4 Cg_endo -56.76 -22.39 44.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 91.5 m-70 -89.97 -14.37 34.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.025 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.894 179.829 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.008 0.432 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.46 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 2.1 ptm85 -73.79 143.52 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -67.02 133.17 49.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.399 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.503 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.3 t-20 -152.55 155.96 38.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -123.87 130.0 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.216 179.786 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.18 146.38 18.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.126 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.467 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.4 mp -124.56 102.03 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.9 t -89.57 101.82 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -103.03 143.3 32.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 0.0 111.229 -178.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.86 157.41 39.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.751 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 36.2 p-10 -100.71 170.05 8.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.232 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -56.27 -16.67 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.56 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.98 0.11 56.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.688 0.28 . . . . 0.0 110.973 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mttm 77.21 26.71 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.602 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -98.93 173.27 6.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -111.23 122.97 66.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 65' ' ' THR . 66.7 t80 -56.5 110.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.8 129.88 56.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.236 179.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.11 137.54 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.62 157.61 23.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.55 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.447 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.2 mtp85 -72.94 159.51 33.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.15 -5.65 49.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.996 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.49 -16.81 3.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 54.5 mt -119.65 111.97 35.75 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.24 131.82 29.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.904 1.736 . . . . 0.0 111.8 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 76.92 3.52 3.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.783 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -89.67 97.51 11.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.414 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CD1' HD23 ' A' ' 145' ' ' LEU . 37.7 m95 -104.62 156.65 17.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.044 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -168.8 169.56 9.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.451 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 45.9 mtm -94.15 155.83 39.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.45 134.11 37.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.512 2.142 . . . . 0.0 112.687 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 163.54 39.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.493 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.45 142.73 7.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.746 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.84 135.61 49.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.59 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.5 mt -66.84 160.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.55 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.469 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.17 149.35 22.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.824 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -50.73 99.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.219 0.533 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.57 39.83 11.76 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.851 -179.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB3' HG21 ' A' ' 47' ' ' ILE . 6.0 tp10 -113.76 145.18 41.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.91 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.43 125.56 89.7 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.236 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' HG12 ' A' ' 17' ' ' VAL . 6.6 Cg_endo -50.16 -47.97 21.77 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.46 2.106 . . . . 0.0 112.772 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -59.31 -27.73 66.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.725 0.298 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -88.01 -43.44 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -60.78 -32.18 71.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.174 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.11 -54.06 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.034 179.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -55.79 -29.53 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.278 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttp85 -82.69 -52.79 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.798 0.808 . . . . 0.0 109.981 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.92 -44.1 66.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.575 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -56.97 -55.39 35.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.676 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 33.7 ttp180 -62.28 -13.3 26.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.283 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.12 -43.25 9.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.827 -179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.18 -25.85 19.35 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.77 -20.35 9.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.451 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.88 4.69 67.58 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.103 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.86 116.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.834 0.35 . . . . 0.0 110.529 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.65 -34.5 11.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -179.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.38 78.4 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.48 129.04 13.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.871 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.68 149.02 42.12 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.56 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 30.6 t -80.06 122.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.4 0.619 . . . . 0.0 111.355 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -103.03 -20.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.414 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -155.94 161.0 40.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.68 117.48 6.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.877 179.652 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 78' ' ' TYR . 6.4 t -57.16 128.78 78.59 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.22 -18.18 55.54 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 113.337 -178.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -125.6 -179.16 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 112.111 -179.505 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 6.2 m95 -108.45 145.94 33.89 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 66.5 mt -110.66 117.3 33.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.106 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 17.4 p -101.63 137.49 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.762 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -131.85 169.78 15.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 -179.417 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.91 158.42 36.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -116.32 145.04 34.2 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 112.323 -179.954 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.46 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 19.0 m95 . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -29.23 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.634 -179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.96 -146.19 4.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.279 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -158.17 129.95 6.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.914 0.388 . . . . 0.0 111.777 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.71 106.84 15.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.889 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.3 pt20 -122.06 161.59 22.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.606 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -113.85 101.66 9.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.021 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.479 ' CG ' HG23 ' A' ' 157' ' ' VAL . 33.8 m95 -70.36 153.15 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 0.0 112.401 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 73.3 m-85 -137.08 134.12 36.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.199 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.7 tp -79.88 130.97 35.73 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.424 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 46.3 m-85 -125.55 128.43 47.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.581 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.518 ' HB2' HG13 ' A' ' 73' ' ' ILE . 1.9 tptt -92.25 121.18 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -64.86 124.88 23.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.984 0.421 . . . . 0.0 110.816 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.2 p -125.66 37.51 4.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.602 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.12 -145.18 4.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.13 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -128.09 154.24 45.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.829 0.347 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -50.03 -16.52 0.3 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.62 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -18.35 54.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.682 0.277 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.34 -25.29 39.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 16.1 mt -72.35 97.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.361 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -111.42 95.71 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.078 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -55.42 -23.06 22.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.667 -179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.75 -58.11 8.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.299 0.571 . . . . 0.0 110.001 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.51 -176.85 25.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.554 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.44 38.79 1.02 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 179.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.34 28.18 73.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.169 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -112.18 -65.98 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.04 165.13 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.241 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -66.78 151.87 96.2 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.42 176.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.04 -44.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.681 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 23.0 m-85 -109.44 159.53 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.392 179.644 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.83 -19.19 6.12 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -152.46 174.69 13.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.455 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 23.7 p-90 -158.38 151.72 23.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.145 179.064 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.2 m -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.386 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.444 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 73.7 m95 -93.32 123.47 36.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.666 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 31.6 m -134.05 151.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.111 0.482 . . . . 0.0 111.716 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.6 p -70.23 158.34 87.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.419 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.02 -19.1 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.978 1.786 . . . . 0.0 112.046 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.01 -33.46 14.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 179.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -50.05 35.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.107 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.1 tp -53.34 -31.93 46.7 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.35 -29.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.683 178.566 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -32.07 57.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 40' ' ' TRP . 8.1 mt -75.47 -40.47 57.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.008 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 m -55.4 165.07 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.141 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.3 p -98.9 160.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.221 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -47.34 -43.35 22.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.43 -179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.7 p90 -82.66 4.12 26.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.272 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.439 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 16.1 mttt -125.25 -3.29 7.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 111.368 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 35.5 mttt -59.95 -61.87 7.03 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.0 Cg_endo -61.08 -43.29 30.58 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.456 2.104 . . . . 0.0 112.403 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 82' ' ' TYR . 15.4 t -57.23 -29.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.08 -55.25 3.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.8 -32.59 6.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 3.1 tp10 -69.73 -44.19 70.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.785 179.407 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.521 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.5 t -59.57 -42.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.136 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 162' ' ' ALA . 51.3 mt -67.46 -48.1 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.619 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -50.58 -46.84 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.807 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.08 -24.54 30.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.123 0.487 . . . . 0.0 110.411 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.521 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.5 m-30 -102.61 6.05 39.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.117 -179.178 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.449 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -50.97 -49.9 77.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.532 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 162' ' ' ALA . 75.0 Cg_exo -49.73 -25.21 11.09 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.565 2.176 . . . . 0.0 112.559 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.427 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 96.7 m-70 -94.68 -26.71 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.96 0.41 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.422 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 4.1 ptm85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -67.32 130.33 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.472 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.8 m120 -152.68 159.63 43.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.448 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.5 m -133.61 131.32 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.257 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.34 144.7 16.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.298 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.3 mp -120.5 101.81 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.172 -179.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.2 t -89.54 107.21 18.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.228 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.9 tp -103.42 141.86 35.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.097 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.49 157.46 40.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.1 p-10 -101.02 171.04 7.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.331 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.13 -17.62 7.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.586 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.07 0.26 56.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.733 0.302 . . . . 0.0 110.971 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp 77.0 26.21 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.5 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.21 172.11 8.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.965 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.8 mp -110.91 121.32 63.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.367 . . . . 0.0 110.937 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 37.0 t80 -56.06 109.4 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.233 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.7 130.01 56.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.36 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.29 136.1 53.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.41 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -82.29 155.39 24.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.416 179.637 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.427 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -72.12 157.29 38.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.355 0.597 . . . . 0.0 111.732 -179.223 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.43 -6.44 49.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.828 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.53 -18.26 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.216 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 61.7 mt -119.6 110.92 36.64 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 28.5 Cg_endo -65.17 131.83 29.8 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.816 1.677 . . . . 0.0 111.73 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 t70 77.11 5.46 3.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.642 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -92.82 97.84 11.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.5 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.41 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 19.2 m95 -107.0 156.4 18.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -168.8 176.69 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 2.2 mpp? -101.3 160.44 26.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.34 136.95 24.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.571 2.181 . . . . 0.0 112.786 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 155.77 35.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.14 155.6 26.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.675 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.88 132.82 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.8 mt -60.23 161.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.644 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.25 149.33 22.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.91 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.44 98.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.194 0.521 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.51 10.0 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.947 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' HB3' HG23 ' A' ' 47' ' ' ILE . 6.1 tp10 -114.38 146.27 40.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.16 140.05 76.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.511 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.24 -52.43 8.74 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.383 2.055 . . . . 0.0 112.575 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -62.56 -25.62 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.156 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.64 -50.02 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.676 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -58.25 -31.97 67.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.504 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.24 -52.0 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.266 179.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 55.1 mt -57.24 -28.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.213 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -84.0 -53.18 5.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.749 0.785 . . . . 0.0 109.777 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.56 -32.7 58.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.29 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 tp -55.73 -54.79 40.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.595 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -61.67 -13.0 18.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.911 0.386 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.64 -37.92 12.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 0.0 111.395 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.7 -36.42 17.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.955 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.453 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.07 -23.46 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.1 3.05 84.48 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.81 -179.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.95 115.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.821 0.343 . . . . 0.0 110.461 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -91.83 -36.95 13.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.18 78.98 6.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 129.56 13.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.845 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -120.04 147.76 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.859 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.4 t -78.22 125.03 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.405 0.621 . . . . 0.0 111.858 -179.141 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.591 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -107.0 -19.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.362 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -152.03 158.26 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.327 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -148.56 116.75 6.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.995 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 78' ' ' TYR . 10.9 t -57.26 130.79 80.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.094 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -17.66 40.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.647 2.231 . . . . 0.0 113.316 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.35 177.08 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 112.15 -179.497 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 m95 -104.32 146.05 29.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.976 179.067 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 94.8 mt -113.19 117.56 32.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.4 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 2.5 p -111.19 131.9 54.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -132.69 162.81 30.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.616 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.22 158.38 24.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.47 154.44 47.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.493 2.129 . . . . 0.0 112.528 -179.97 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 51.8 m95 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -31.31 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -156.22 -144.66 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.991 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.09 114.95 2.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.347 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -92.74 105.97 18.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.874 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 8.2 pt20 -127.32 155.59 43.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 112.539 -178.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -109.26 96.34 6.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.633 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CG ' HG21 ' A' ' 157' ' ' VAL . 23.2 m95 -63.7 145.68 55.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.106 -178.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 59.2 m-85 -128.16 137.05 51.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.428 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 19.4 tp -79.71 146.95 32.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.523 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 45.4 m-85 -140.77 127.05 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.978 0.418 . . . . 0.0 111.545 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.591 ' HB2' HG13 ' A' ' 73' ' ' ILE . 14.5 tttm -90.47 121.06 32.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -65.41 125.17 24.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 -179.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.0 p -127.77 38.14 4.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.549 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.77 -145.47 4.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.153 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.23 154.05 45.33 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -50.5 -16.08 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.7 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -79.74 -19.11 49.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.767 0.318 . . . . 0.0 111.307 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -78.74 -25.28 44.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.464 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 16.5 mt -74.78 103.48 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.378 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -113.77 95.51 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.918 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.8 mt -49.82 -26.28 3.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.732 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 34.0 mt -63.5 -57.48 10.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 109.982 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.63 -173.49 25.98 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.42 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -93.44 38.86 1.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.19 0.519 . . . . 0.0 109.993 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.89 27.51 73.04 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.267 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -115.13 -68.17 0.94 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.09 165.01 13.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -78.84 153.88 77.99 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.956 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.18 162.52 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.836 2.358 . . . . 0.0 112.554 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -149.95 -44.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.47 159.12 16.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.389 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.94 -20.36 4.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.696 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -152.42 174.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.456 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.6 p-90 -159.17 156.19 28.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.151 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.96 164.2 38.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.401 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.44 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 69.0 m95 -94.44 124.95 38.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.672 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 29.7 m -138.21 151.49 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.057 0.456 . . . . 0.0 111.626 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -70.2 159.97 82.55 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 14.6 Cg_endo -57.15 -17.88 27.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.775 1.65 . . . . 0.0 111.786 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -34.43 15.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.154 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -50.78 25.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 109.97 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.5 tp -54.39 -28.96 47.07 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.387 0.613 . . . . 0.0 109.858 179.079 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.9 mm -69.45 -28.73 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.812 178.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.26 -20.04 45.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.271 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' A' ' 142' ' ' LEU . 10.0 mt -86.32 -39.07 16.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -62.22 166.09 5.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.104 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 150' ' ' LYS . 9.3 p -98.41 161.57 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.023 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 0.5 OUTLIER -52.21 -33.37 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.459 ' CG ' HG11 ' A' ' 147' ' ' VAL . 17.8 p90 -86.48 16.0 4.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.937 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.473 ' HB2' HG12 ' A' ' 147' ' ' VAL . 2.4 mtpm? -143.93 -26.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.064 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.9 mtpt -43.38 -61.61 1.77 Allowed Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.653 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.2 Cg_endo -59.42 -44.36 33.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.265 1.976 . . . . 0.0 111.822 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 17.1 t -60.01 -24.99 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.804 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.8 m-30 -90.85 -50.92 5.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.594 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -48.9 -36.63 17.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 5.0 tp10 -64.92 -45.4 86.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.451 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.514 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 37.8 t -58.81 -43.02 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.123 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 162' ' ' ALA . 53.4 mt -69.09 -49.22 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.623 178.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -50.35 -46.78 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.718 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.54 -24.87 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.426 179.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.514 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.1 m-30 -102.26 2.36 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.244 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.79 -56.07 24.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.406 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.9 -21.22 25.45 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.602 2.201 . . . . 0.0 112.391 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.426 ' CE1' ' HB1' ' A' ' 74' ' ' ALA . 12.0 m-70 -89.64 -20.02 24.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.748 0.309 . . . . 0.0 110.816 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.87 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.13 152.27 24.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -66.03 132.75 49.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.113 0.483 . . . . 0.0 111.502 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.8 t30 -152.49 158.49 42.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.1 m -132.2 133.34 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 111.68 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.15 153.61 17.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.938 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.446 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.1 mp -127.08 103.37 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.323 . . . . 0.0 111.488 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.6 t -89.7 104.07 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.0 tp -103.24 145.28 30.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.211 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.94 157.53 39.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.719 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.7 p-10 -101.55 170.57 8.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.06 -18.23 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.466 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.0 0.58 56.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.714 0.292 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt 76.03 26.12 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.485 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mttt -96.64 171.24 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.419 ' CG2' ' CD2' ' A' ' 142' ' ' LEU . 4.1 mp -108.16 124.14 64.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.948 0.404 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 67.6 t80 -58.53 110.16 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.143 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.29 53.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.423 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -118.73 136.25 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 111.317 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.66 153.74 25.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.563 179.778 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -70.8 158.3 36.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.532 -179.408 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -92.65 -6.63 48.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.92 178.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -128.75 -17.23 4.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.15 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.509 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 51.6 mt -119.76 107.79 39.92 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.898 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 25.9 Cg_exo -61.98 128.74 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.164 1.909 . . . . 0.0 111.899 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.2 t70 80.06 1.78 2.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.917 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -87.22 97.62 10.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 145' ' ' LEU . 49.0 m95 -103.55 157.24 17.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.995 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.79 -177.01 2.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.42 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 71.6 mtm -109.13 156.76 38.68 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.54 140.26 56.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.595 2.196 . . . . 0.0 112.79 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 158.79 40.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.1 147.06 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.559 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.05 136.41 32.73 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.429 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.3 mt -65.43 159.94 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.789 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.45 150.27 21.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.69 98.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.242 0.544 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.39 39.14 10.06 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.98 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HB3' HG21 ' A' ' 47' ' ' ILE . 14.2 tp10 -113.85 146.2 40.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 110.844 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.8 139.13 80.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.568 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.92 -52.08 8.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.416 2.077 . . . . 0.0 112.658 -179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 108' ' ' PHE . 5.8 ttp85 -62.73 -26.64 68.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.277 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -84.51 -48.77 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.55 -28.27 65.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.553 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.49 -50.03 16.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.185 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 mt -57.64 -29.63 34.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -82.13 -53.24 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.799 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -53.01 -41.14 64.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.4 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -56.13 -52.57 63.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.637 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.568 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 30.3 ttp180 -61.87 -13.82 28.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 178.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.19 -42.28 9.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.03 -26.17 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.418 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -120.6 -21.18 6.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.845 0.355 . . . . 0.0 111.081 -179.366 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 8.93 62.76 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.059 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.19 114.65 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -35.41 12.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.549 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 76.38 6.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.52 . . . . 0.0 111.107 -179.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 127.96 12.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.809 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 8.7 mt-10 -119.41 147.03 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.732 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.1 t -77.12 125.8 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.413 0.625 . . . . 0.0 111.817 -179.115 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -107.77 -16.65 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.366 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -155.57 158.39 38.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.41 115.36 6.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.195 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.625 HG11 ' O ' ' A' ' 78' ' ' TYR . 9.2 t -57.46 127.39 77.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.33 -18.06 59.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.748 2.299 . . . . 0.0 113.349 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.625 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.96 -179.28 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.401 0.619 . . . . 0.0 112.204 -179.471 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.44 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 7.9 m95 -106.78 147.15 30.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.738 178.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 50.7 mt -113.86 117.84 32.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.103 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.401 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -112.63 132.49 55.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.834 -179.363 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -130.0 164.01 25.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.651 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.48 158.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.216 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -114.98 154.77 47.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.595 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.516 2.144 . . . . 0.0 112.315 179.981 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.1 m95 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.772 0.32 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -30.7 61.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.09 -141.66 3.22 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.017 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -157.65 115.84 3.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.401 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -91.12 106.24 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.808 178.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 5.7 pt20 -124.56 153.25 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.377 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -105.84 95.93 6.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.339 178.526 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.416 ' CD2' HG23 ' A' ' 157' ' ' VAL . 35.5 m95 -62.95 142.43 58.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.339 -178.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 54' ' ' ARG . 65.9 m-85 -126.47 137.44 53.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.229 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 21.7 tp -79.56 154.57 28.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.51 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 43.9 m-85 -148.17 127.67 13.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.037 0.446 . . . . 0.0 111.786 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.571 ' HB2' HG13 ' A' ' 73' ' ' ILE . 12.1 tttp -92.71 119.5 32.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -65.01 123.89 20.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.948 0.404 . . . . 0.0 110.76 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.7 p -125.98 37.81 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.619 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.38 -144.85 4.72 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.101 179.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 154.19 45.93 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.82 -16.68 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.624 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.56 -19.14 56.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.725 0.298 . . . . 0.0 111.172 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.55 -25.17 41.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.452 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 17.7 mt -74.25 103.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.602 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.03 95.84 4.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.942 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 50.9 mt -54.79 -23.03 16.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.775 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.2 mt -63.42 -59.54 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.25 0.547 . . . . 0.0 110.014 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.23 -176.99 24.87 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.445 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.53 39.01 1.02 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.132 0.491 . . . . 0.0 109.697 179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.64 26.79 74.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.078 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -119.08 -69.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.179 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.33 165.1 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 153.56 65.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.13 162.1 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.74 2.293 . . . . 0.0 112.597 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -150.05 -46.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 12.7 m-85 -107.76 159.41 16.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.341 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.46 5.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.777 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -152.37 175.24 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.7 p-90 -156.68 152.5 27.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.09 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.6 m -147.93 163.63 36.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.409 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 69.7 m95 -98.12 122.48 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.661 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -134.91 150.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 111.58 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.93 162.33 72.74 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.699 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.94 -20.34 36.11 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.84 1.693 . . . . 0.0 111.826 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -35.88 15.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.269 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -69.96 -50.36 42.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.06 179.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.4 tp -53.96 -31.75 51.62 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.499 0.666 . . . . 0.0 109.81 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.85 -28.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 178.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.73 -20.98 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.254 179.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' A' ' 142' ' ' LEU . 10.2 mt -85.49 -38.95 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.096 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.403 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 29.8 m -56.14 163.43 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 150' ' ' LYS . 7.4 p -91.42 165.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.6 -32.1 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.774 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.2 p90 -92.89 13.62 19.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HB2' HG12 ' A' ' 147' ' ' VAL . 33.9 mttp -136.23 0.81 2.61 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.327 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 6.4 mttm -62.15 -62.83 5.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.0 -44.72 27.96 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.46 2.107 . . . . 0.0 112.172 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 14.9 t -58.47 -27.12 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 0.0 111.1 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.42 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -91.18 -52.08 5.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.48 -32.71 18.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 5.4 tp10 -66.29 -45.69 79.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.559 179.144 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.2 t -59.09 -46.39 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.934 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 162' ' ' ALA . 78.8 mt -66.31 -48.65 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.61 178.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.2 m -50.92 -46.52 60.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.37 -24.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.494 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.9 m-30 -101.08 -2.92 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.274 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.79 -53.56 25.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.599 0.238 . . . . 0.0 111.588 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.42 -21.88 25.26 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.466 2.111 . . . . 0.0 112.402 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 77.4 m-70 -96.19 -15.35 22.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.414 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 5.6 mp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.788 0.328 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -93.37 152.23 19.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -65.29 126.36 27.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.0 t-20 -152.62 156.37 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.424 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.7 m -129.29 136.88 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.44 157.31 15.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.163 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 43' ' ' PRO . 1.6 mm -121.4 102.34 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.795 -0.238 . . . . 0.0 111.335 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 7.8 t -89.73 94.93 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 29.9 tp -102.67 143.94 31.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.522 . . . . 0.0 111.509 -178.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.47 157.27 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.6 p-10 -98.41 170.92 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.516 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -57.72 -16.56 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 0.31 56.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.826 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 77.02 26.9 0.72 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -97.08 174.47 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.005 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -108.7 125.67 65.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.765 0.317 . . . . 0.0 110.783 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.465 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 44.4 t80 -63.42 108.82 1.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.592 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.443 ' CB ' ' CD2' ' A' ' 142' ' ' LEU . . . -116.35 131.27 56.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.672 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.71 133.77 55.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.6 p -82.35 154.61 25.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.457 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.43 157.35 37.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.268 0.556 . . . . 0.0 111.411 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -5.09 53.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.005 178.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -131.13 -16.72 3.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 66.3 mt -120.62 111.41 34.68 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.0 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.2 Cg_endo -65.25 131.9 29.9 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.868 1.712 . . . . 0.0 111.843 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.86 2.98 2.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.649 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -89.26 97.31 11.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.22 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.418 ' CD1' HD23 ' A' ' 145' ' ' LEU . 59.8 m95 -103.86 157.85 16.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.227 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -168.91 167.94 10.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.435 ' HE1' ' CH2' ' A' ' 107' ' ' TRP . 3.4 mpp? -101.84 145.1 29.88 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 4.0 Cg_exo -39.55 132.88 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.317 2.678 . . . . 0.0 112.967 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 154.62 33.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.549 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.6 144.21 8.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.624 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.52 138.83 43.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.368 179.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 48' ' ' ASP . 5.1 mt -68.42 159.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.334 . . . . 0.0 110.638 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -90.3 146.17 24.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.22 96.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.354 0.597 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 36.3 8.13 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.186 -179.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' HB3' HG21 ' A' ' 47' ' ' ILE . 4.9 tt0 -115.58 142.63 46.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 0.0 110.747 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.77 142.29 85.66 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.708 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.82 -57.15 2.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.511 2.14 . . . . 0.0 112.6 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 3.4 ttt180 -58.55 -26.79 63.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -83.0 -49.17 9.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -57.07 -32.46 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.98 -54.67 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.092 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.4 mt -53.82 -28.86 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.198 178.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -82.79 -53.12 6.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.759 0.79 . . . . 0.0 109.791 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -57.43 -33.19 67.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.8 tp -53.98 -59.66 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -179.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.576 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 4.7 ptt-85 -61.5 -10.94 8.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -91.44 -44.92 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.59 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -90.68 -31.41 16.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.192 -178.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.465 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -114.57 -21.93 10.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 0.0 110.961 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.85 8.87 64.91 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.825 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.91 120.55 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.393 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -34.96 10.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.28 76.86 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.213 0.53 . . . . 0.0 110.823 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 128.42 12.89 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.837 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 mt-10 -119.61 148.15 43.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.1 t -78.03 126.65 38.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -106.44 -19.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.387 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.29 162.36 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.327 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.7 117.52 6.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.022 179.686 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 78' ' ' TYR . 6.0 t -57.36 126.15 73.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.081 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.42 -18.34 62.72 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.771 2.314 . . . . 0.0 113.23 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.65 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.03 -177.21 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.243 0.544 . . . . 0.0 112.008 -179.583 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.428 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 20.8 m95 -107.8 147.27 31.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.127 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 3.2 mt -111.32 117.71 33.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 p -109.93 136.96 48.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.407 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -129.43 170.02 14.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.449 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 158.2 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -121.11 146.9 45.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.759 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo . . . . . 0 C--N 1.344 0.301 0 C-N-CA 122.368 2.045 . . . . 0.0 112.15 179.948 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.412 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 30.5 m95 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.845 0.355 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -35.88 73.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.36 0.6 . . . . 0.0 109.654 179.382 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.74 -133.29 1.53 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.738 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.408 ' O ' ' CE1' ' A' ' 82' ' ' TYR . 12.3 mm100 -156.31 113.85 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.42 105.84 17.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.701 178.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.2 pt20 -123.23 156.48 35.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.419 0.628 . . . . 0.0 112.69 -178.438 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.428 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.86 96.5 6.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.599 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.456 ' CG ' HG23 ' A' ' 157' ' ' VAL . 25.2 m95 -62.91 149.79 43.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.256 0.551 . . . . 0.0 112.35 -178.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.3 m-85 -132.92 133.44 43.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.0 tp -79.54 132.05 36.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.524 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 53.1 m-85 -126.45 129.44 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.322 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.541 ' HB2' HG13 ' A' ' 73' ' ' ILE . 36.6 tttm -93.68 120.28 33.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -63.91 125.42 24.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.797 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.7 p -127.86 37.86 4.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.22 -144.94 4.65 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.52 154.22 46.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.47 -16.92 0.23 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.577 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -22.57 53.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.764 0.316 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.51 -25.18 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.839 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.9 mt -71.23 97.31 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.78 95.73 5.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.958 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.2 mt -57.08 -21.87 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -179.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.85 -59.19 4.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.255 0.55 . . . . 0.0 109.862 179.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.17 178.48 22.5 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.4 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -90.71 38.85 0.96 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.95 26.3 69.32 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.084 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.78 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.101 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.36 165.16 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.196 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -86.46 147.9 45.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.808 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.05 125.8 17.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.544 2.163 . . . . 0.0 112.557 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -109.29 -29.25 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.413 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 3.7 m-85 -112.82 159.52 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.398 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.9 5.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.807 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.411 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm-40 -152.35 174.73 13.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.081 0.467 . . . . 0.0 110.419 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.1 p-90 -154.6 151.69 29.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.081 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -149.7 161.81 41.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.586 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.457 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 72.8 m95 -97.6 128.29 44.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.273 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 28' ' ' ILE . 28.0 m -138.79 155.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -74.84 151.44 86.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -47.89 -22.21 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.037 1.824 . . . . 0.0 112.064 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -34.66 17.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.469 179.24 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.403 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 mt-30 -69.14 -51.59 36.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -51.71 -36.5 47.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.707 0.765 . . . . 0.0 109.56 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.7 -28.88 45.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.038 178.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 141' ' ' GLN . 33.4 t70 -81.94 -19.85 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.161 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' A' ' 40' ' ' TRP . 9.9 mt -86.88 -38.49 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.408 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 28.3 m -56.55 163.47 1.77 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.079 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.474 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 8.1 p -93.74 161.34 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.86 -41.43 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.276 -179.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.474 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.3 p90 -84.23 5.87 24.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.317 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.439 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 14.6 mtmt -127.79 -3.98 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.534 0.206 . . . . 0.0 111.49 179.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 22.6 mttt -55.31 -62.43 4.39 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.548 0.213 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -60.61 -42.81 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 25.2 t -55.26 -29.4 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 111.245 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.423 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.2 m-30 -91.07 -53.31 4.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.7 -33.95 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -65.57 -45.46 83.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.589 179.177 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.506 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 60.3 t -58.06 -48.81 83.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 162' ' ' ALA . 66.8 mt -63.5 -48.66 76.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.721 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.6 m -49.81 -47.28 51.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.676 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.44 -24.6 27.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.106 0.479 . . . . 0.0 110.363 179.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.506 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.1 m-30 -105.77 13.93 28.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.931 -179.235 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -56.58 21.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.459 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.5 Cg_endo -52.46 -23.84 20.14 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.472 2.115 . . . . 0.0 112.197 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.424 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 97.6 m-70 -92.87 -20.68 20.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.878 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.1 mt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.895 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 148.96 66.42 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.497 2.132 . . . . 0.0 112.287 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 78.87 1.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.33 49.13 0.78 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.3 m -138.3 -160.73 1.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.025 0.441 . . . . 0.0 109.878 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mmt -174.88 111.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.66 14.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.926 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -177.61 137.5 0.39 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.403 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 22.7 Cg_endo -61.47 110.62 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.226 1.95 . . . . 0.0 112.081 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.72 -174.29 2.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.846 2.364 . . . . 0.0 112.047 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.97 150.39 24.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.768 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' CA ' ' CE ' ' A' ' 101' ' ' LYS . . . 95.63 -34.74 4.68 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.52 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -92.42 134.41 34.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.088 0.47 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 153.52 22.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 3.0 mmp_? -56.68 130.36 45.02 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.759 0.314 . . . . 0.0 110.617 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 1.1 t30 -152.83 153.25 32.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 53' ' ' PRO . 27.5 m -140.47 136.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.48 150.14 17.27 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 5.0 mp -122.5 103.71 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.685 0.279 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.7 t -89.43 106.76 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 33.1 tp -102.9 143.25 32.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 ptm -125.2 157.28 36.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.854 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.462 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 9.8 t30 -97.88 172.58 7.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.051 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -63.12 -17.17 62.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.858 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.45 -0.55 57.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.08 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mttm 80.99 24.86 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -95.15 170.97 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.411 ' CG2' ' CD2' ' A' ' 142' ' ' LEU . 4.7 mp -111.54 125.17 68.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 67.1 t80 -59.75 107.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.36 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.99 131.28 56.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.171 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.72 137.56 52.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.964 0.412 . . . . 0.0 111.371 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.38 155.52 24.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 2.9 mtp85 -73.35 157.27 37.29 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.0 111.411 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -4.95 52.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.897 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.97 -19.71 3.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.135 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.465 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.2 mt -119.15 112.4 36.18 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.2 131.47 28.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.951 1.768 . . . . 0.0 111.891 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.86 4.13 3.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.804 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.465 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.39 97.32 11.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.34 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 41.3 m95 -102.55 156.64 17.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.93 -176.88 2.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.981 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 20.0 mtm -111.74 155.23 43.44 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.594 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.44 131.7 30.83 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.565 2.177 . . . . 0.0 112.447 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' OE1' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.22 164.18 38.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.41 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -152.68 161.6 29.59 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.368 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.27 35.56 3.29 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.603 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.479 ' O ' ' O ' ' A' ' 46' ' ' GLY . 2.3 mt 51.95 159.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.287 0.565 . . . . 0.0 111.661 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.41 162.25 15.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.812 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.59 99.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.6 46.05 33.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.793 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.68 144.25 43.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.084 0.468 . . . . 0.0 111.115 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.55 143.11 71.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.806 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 88.8 Cg_exo -48.54 -62.93 0.36 Allowed 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.777 2.318 . . . . 0.0 113.689 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HD3' ' CE2' ' A' ' 108' ' ' PHE . 3.9 tpt180 -46.15 -33.72 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.81 -47.09 12.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -57.66 -35.0 69.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.05 -54.73 8.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.0 mt -57.65 -29.8 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -80.94 -53.56 6.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 34.7 mm-40 -50.38 -40.64 50.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.326 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -56.58 -53.86 52.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.59 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.3 ttp180 -63.81 -11.67 29.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.82 -40.14 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 111.596 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.07 -36.48 16.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.0 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.425 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.78 -24.32 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.056 0.455 . . . . 0.0 110.922 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.88 6.93 80.1 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.647 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 38.4 t -58.13 112.18 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.405 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 p -91.21 -33.77 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.08 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.25 75.19 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 110.946 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 133.69 17.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.853 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.9 mt-10 -126.69 148.73 49.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.666 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -77.63 126.66 38.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.83 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.1 mm -107.56 -19.71 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.446 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -157.63 160.96 38.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.566 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 5.0 pt-20 -149.53 118.62 6.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.879 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.605 ' CG1' ' CD1' ' A' ' 78' ' ' TYR . 36.7 t -56.99 124.47 65.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 -17.97 38.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.95 2.433 . . . . 0.0 113.352 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.605 ' CD1' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.37 -175.62 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.509 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.46 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 30.7 m95 -104.35 147.47 27.49 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.566 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -103.74 117.18 33.77 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.9 p -113.81 133.14 55.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.247 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -135.67 170.18 16.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.445 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.25 158.15 42.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -108.06 152.36 41.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 42.3 Cg_endo -68.06 170.9 13.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.468 2.112 . . . . 0.0 112.452 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.24 -14.94 41.34 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.981 2.454 . . . . 0.0 113.521 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -37.82 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.252 0.549 . . . . 0.0 110.045 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.493 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 58.1 t -77.17 -50.46 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.964 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.404 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 2.6 tpm_? -53.66 -60.41 3.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.123 0.963 . . . . 0.0 109.269 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -55.37 -27.88 50.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.059 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -81.99 -43.62 17.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' A' ' 96' ' ' TRP . 96.4 mt -61.81 -46.1 90.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.414 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -46.48 -34.02 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.638 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.75 -46.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.465 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -55.62 9.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.971 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.452 ' CD1' ' CD2' ' A' ' 92' ' ' LEU . 10.7 m0 -80.11 -31.78 39.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.867 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 75.78 36.51 42.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.503 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.3 147.76 52.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.89 75.45 0.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -129.76 149.99 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.668 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' CE ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -79.3 -28.78 42.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.88 -145.75 5.14 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.909 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -157.81 118.6 3.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.71 0.291 . . . . 0.0 111.455 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.6 112.72 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -124.93 141.16 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -97.79 95.89 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.64 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.486 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 72.6 m95 -62.95 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 112.149 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 71.2 m-85 -125.05 130.98 53.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.258 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.0 tp -79.64 131.12 35.89 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.685 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 49.3 m-85 -125.22 127.13 46.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.241 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.525 ' HB2' HG13 ' A' ' 73' ' ' ILE . 4.9 tptp -89.93 124.7 34.94 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -70.24 123.5 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 110.799 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.409 ' O ' ' HB3' ' A' ' 69' ' ' SER . 6.6 p -124.2 37.39 4.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.568 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.82 -144.23 4.86 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.104 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.17 154.14 46.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.838 0.352 . . . . 0.0 110.061 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -50.13 -16.51 0.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.64 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -77.41 -17.38 58.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.705 0.288 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.24 -25.23 42.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.422 HG22 ' CZ ' ' A' ' 29' ' ' PHE . 20.6 mt -70.45 104.83 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.492 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 65' ' ' THR . 56.3 t30 -122.26 95.78 4.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.14 -22.62 11.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.72 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.63 -59.28 4.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.271 0.558 . . . . 0.0 109.964 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.4 -172.13 23.99 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -92.88 38.74 1.03 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.082 0.468 . . . . 0.0 109.924 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.94 27.19 72.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.345 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.91 165.1 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 148.92 61.84 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -51.32 128.32 25.11 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.692 2.261 . . . . 0.0 112.55 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -108.45 -29.34 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.426 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 13.4 m-85 -111.67 159.46 18.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.38 -21.38 5.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.722 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 17.5 mm-40 -152.43 174.47 13.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.171 0.51 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.7 p-90 -159.13 156.57 29.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.042 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.76 161.92 40.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.473 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.462 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 73.3 m95 -93.9 124.89 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.697 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -136.6 150.89 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.151 0.501 . . . . 0.0 111.599 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 p -70.33 158.71 86.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.565 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.41 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.6 Cg_endo -55.36 -19.66 22.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.863 1.708 . . . . 0.0 111.885 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -34.34 16.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.075 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.35 -50.35 27.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.436 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.4 tp -54.39 -30.33 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.475 0.655 . . . . 0.0 109.891 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.3 mm -69.35 -28.47 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.724 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -80.19 -20.73 44.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.4 mt -84.07 -39.28 19.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.127 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.0 m -59.6 164.28 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.011 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.482 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 7.2 p -96.09 160.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -49.4 -41.7 40.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.482 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 9.2 p90 -81.3 2.85 26.31 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.454 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 4.2 mtpp -129.76 6.01 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.688 0.28 . . . . 0.0 111.197 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.2 mttt -64.02 -62.69 4.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 17.9 Cg_endo -58.1 -45.85 29.22 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.438 2.092 . . . . 0.0 112.061 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 157' ' ' VAL . 48.6 t -54.05 -29.63 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.941 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.96 -51.5 5.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.5 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -32.96 24.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.236 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' HB3' HD13 ' A' ' 80' ' ' LEU . 3.2 tp10 -64.31 -46.62 82.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.418 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.1 t -59.28 -50.97 77.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.29 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 162' ' ' ALA . 66.0 mt -62.89 -49.58 74.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.969 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -45.3 61.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.85 -25.01 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.352 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.517 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.1 m-30 -104.06 12.48 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.799 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.557 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.44 -55.26 36.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.604 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.7 Cg_endo -54.6 -22.25 27.66 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.481 2.121 . . . . 0.0 112.248 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 98.3 m-70 -91.61 -18.28 24.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.948 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.901 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.443 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.06 145.13 54.52 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.602 2.202 . . . . 0.0 112.354 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.2 tp -156.42 136.53 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.1 29.89 69.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.563 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.06 121.71 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.6 tpp -128.31 -33.6 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.752 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 74.38 24.47 1.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 p 174.64 130.73 0.13 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.646 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.14 110.56 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.413 2.075 . . . . 0.0 112.29 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.04 -176.94 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.031 2.487 . . . . 0.0 112.11 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.27 157.0 17.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -27.29 14.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.589 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -104.08 141.23 36.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.418 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -82.18 152.26 26.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.09 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 t30 -152.59 156.48 39.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.425 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 0.9 OUTLIER -127.59 130.93 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.17 154.2 20.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.052 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -131.94 102.82 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 111.411 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.5 t -89.7 103.81 16.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.0 146.22 28.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.904 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.45 157.3 41.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.005 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.46 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 13.1 t30 -94.37 173.99 7.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.1 -16.5 61.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.789 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -89.54 -0.78 57.75 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.089 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 25' ' ' ASP . 19.9 mtpt 81.74 24.77 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.594 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.3 173.05 7.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.8 mp -112.65 124.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 110.865 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 77.4 t80 -57.79 109.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.387 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.96 135.58 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.217 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -120.36 139.85 52.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 111.32 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.29 158.02 23.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.572 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.9 mtp-105 -72.22 162.61 29.22 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.376 0.608 . . . . 0.0 111.672 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -96.35 -6.47 37.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.552 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 -18.53 3.83 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.543 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 65.2 mt -120.94 112.95 33.19 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.26 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.8 Cg_endo -65.69 132.38 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.871 1.714 . . . . 0.0 111.643 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.15 1.83 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.811 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.68 97.51 11.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.181 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.403 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.9 m95 -102.65 157.03 17.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.74 -179.93 3.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.796 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -102.19 159.02 30.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.583 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.2 137.09 39.44 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.509 2.139 . . . . 0.0 112.817 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.403 ' OE1' ' CZ2' ' A' ' 107' ' ' TRP . 1.6 mm-40 -137.64 148.1 45.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.363 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.47 132.66 4.13 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.542 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.99 128.82 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 ' N ' ' A' ' 48' ' ' ASP . 4.8 mt -61.34 160.71 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.464 ' N ' HG21 ' A' ' 47' ' ' ILE . 27.1 m-20 -90.09 -176.66 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.069 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.48 98.53 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 110.22 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.07 46.01 8.57 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.661 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HB3' HG23 ' A' ' 47' ' ' ILE . 6.5 tp10 -115.51 147.29 40.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.807 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 136.03 78.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.71 -56.15 2.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.435 2.09 . . . . 0.0 112.682 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 6.1 ttp85 -58.68 -27.43 64.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.365 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.31 -48.85 9.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.575 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.17 -30.36 64.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.13 -50.38 19.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.153 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.1 mt -57.73 -29.48 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.171 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -83.2 -52.92 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.902 0.858 . . . . 0.0 109.856 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -53.77 -46.09 70.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tp -54.41 -56.06 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.504 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.3 ttp85 -60.06 -15.0 19.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.387 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.06 -42.06 10.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.47 -24.4 19.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.424 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.43 -19.66 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.21 4.48 63.83 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.175 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.65 114.08 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.23 -32.97 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.066 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.37 76.42 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.35 13.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.756 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.0 pt-20 -118.94 146.2 45.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 52.6 t -77.75 122.38 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.372 0.606 . . . . 0.0 111.535 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.2 mm -104.39 -15.95 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.621 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 164' ' ' HIS . . . -158.82 159.39 35.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.38 115.41 6.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.135 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 78' ' ' TYR . 12.2 t -57.44 126.54 75.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.21 -18.95 65.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.77 2.313 . . . . 0.0 113.237 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.613 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.3 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.38 0.61 . . . . 0.0 111.991 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.446 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.7 m95 -109.75 147.21 33.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.017 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 1.8 mt -112.45 117.59 32.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.956 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 p -112.93 131.67 55.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.606 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -130.7 163.34 27.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.07 158.36 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.119 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.4 153.86 45.54 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.771 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 28.4 Cg_endo -62.62 169.16 8.84 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.275 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.95 -16.62 50.88 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.108 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.04 -34.82 14.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.125 0.488 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 74.3 t -82.63 -48.22 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.222 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -45.43 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.566 0.698 . . . . 0.0 109.515 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.33 -28.02 65.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.611 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -46.95 25.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 96' ' ' TRP . 81.1 mt -57.41 -46.94 82.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.372 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -45.84 -31.41 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.33 -50.07 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.221 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -56.89 8.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.445 ' N ' ' O ' ' A' ' 92' ' ' LEU . 43.4 m0 -76.03 -34.94 59.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.693 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.83 33.65 33.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.419 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.92 147.29 49.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.742 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -109.75 64.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 57.9 m95 -121.69 150.11 42.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.664 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -30.35 58.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -162.08 -143.07 3.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.923 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -157.72 115.77 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 0.0 111.436 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.39 105.81 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.814 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.433 ' NE2' ' ND2' ' A' ' 16' ' ' ASN . 4.0 pt20 -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -104.29 98.07 7.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.519 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 31.3 m95 -65.32 137.12 57.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.278 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 68.5 m-85 -122.27 137.93 54.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.943 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.1 tp -79.21 154.14 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.821 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 39.6 m-85 -148.08 125.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.07 0.462 . . . . 0.0 111.738 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB2' HG13 ' A' ' 73' ' ' ILE . 39.5 tttp -91.4 122.55 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -68.23 123.9 22.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 p -124.02 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.13 -144.88 4.65 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.044 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.23 154.19 46.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.02 -16.61 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -77.73 -18.49 56.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 111.252 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -25.57 42.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.439 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 18.2 mt -73.77 103.9 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.517 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.36 95.87 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.027 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 50.6 mt -55.86 -22.55 25.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.543 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.26 -56.84 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.246 0.546 . . . . 0.0 109.95 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.39 -174.66 22.8 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.51 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -91.76 38.72 0.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.13 73.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.202 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.1 m -115.24 -67.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 111.267 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -101.28 165.16 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 146.8 86.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.11 139.74 51.9 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.583 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -109.83 -31.82 7.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 20.7 m-85 -116.88 159.61 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.415 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -15.72 6.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.814 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.53 174.59 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.522 . . . . 0.0 110.592 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.4 p-90 -159.61 153.1 22.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.056 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 m -151.74 156.9 41.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.484 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 76.7 m95 -91.35 124.83 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.841 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 29.6 m -134.71 150.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.724 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.5 p -69.54 158.5 86.77 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.573 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' CB ' HD13 ' A' ' 158' ' ' LEU . 11.2 Cg_endo -55.05 -19.37 19.94 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.99 1.793 . . . . 0.0 111.98 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -34.48 14.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.225 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.6 -50.28 46.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.424 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.0 tp -53.37 -33.26 52.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.416 0.626 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.406 HD12 ' CD1' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.88 -28.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.687 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.75 -32.84 52.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.676 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD22 ' CD1' ' A' ' 40' ' ' TRP . 7.1 mt -75.08 -40.62 59.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.88 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.407 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 28.3 m -54.92 163.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.21 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.482 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 10.6 p -98.49 160.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -49.39 -36.79 22.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.482 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 16.4 p90 -84.77 6.9 22.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.446 ' HB2' HG12 ' A' ' 147' ' ' VAL . 30.8 mttt -129.94 -4.67 4.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.1 mttt -56.53 -62.13 5.5 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.351 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.4 Cg_endo -60.9 -42.77 35.06 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.444 2.096 . . . . 0.0 112.131 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.451 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 11.4 t -60.65 -27.5 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.561 . . . . 0.0 110.953 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.8 m-30 -90.87 -53.15 4.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.68 -31.12 10.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -44.71 70.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.663 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 52.0 t -57.72 -48.26 83.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.098 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 162' ' ' ALA . 61.8 mt -64.5 -48.85 73.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.774 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.8 m -50.94 -46.18 60.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.887 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.31 -24.58 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 121.019 0.437 . . . . 0.0 110.766 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.518 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.2 m-30 -100.67 -2.02 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.647 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.2 -51.46 33.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 6.7 Cg_endo -49.29 -24.57 8.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.632 2.221 . . . . 0.0 112.567 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 97.2 m-70 -100.98 -15.99 17.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.302 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.409 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 4.4 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.445 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 144.83 54.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.596 2.197 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.25 38.66 19.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.99 -57.36 10.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.514 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.489 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 28.1 p -108.08 -155.59 0.56 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.07 -40.33 0.17 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.892 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 74.28 14.7 3.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.08 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 171.88 131.7 0.08 OUTLIER Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD3' ' NE1' ' A' ' 79' ' ' TRP . 91.7 Cg_endo -80.39 117.3 3.41 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.438 2.092 . . . . 0.0 112.415 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 3.4 Cg_endo -84.86 176.79 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.983 2.455 . . . . 0.0 111.499 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.16 17.37 8.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.993 0.425 . . . . 0.0 111.852 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 -2.61 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.481 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -129.44 153.12 48.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.51 152.15 25.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -74.36 125.2 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.168 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.4 m120 -152.41 159.03 43.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.452 HG23 ' CB ' ' A' ' 56' ' ' ALA . 1.8 m -129.74 135.68 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.128 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.93 17.42 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.303 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -126.21 101.63 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.7 t -89.84 102.94 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 23.5 tp -103.16 145.75 29.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.69 157.41 40.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.7 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.435 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 31.6 p-10 -102.39 169.98 8.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -55.37 -17.95 5.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.92 0.48 56.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt 76.46 25.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.678 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -95.62 171.95 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.4 mp -109.12 119.5 58.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.12 0.486 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 5.5 t80 -53.71 108.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.21 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 137.17 52.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.723 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.86 137.97 54.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.517 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.6 158.22 23.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.455 ' NH1' ' N7 ' ' A' ' 166' ' ' ATP . 1.3 mtp85 -75.39 159.11 31.78 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 111.302 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -94.2 -5.64 46.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.026 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.35 -16.94 3.85 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.229 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 64.9 mt -120.19 110.96 35.66 Favored Pre-proline 0 N--CA 1.454 -0.239 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.01 131.35 28.5 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.837 1.691 . . . . 0.0 111.845 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 77.58 5.22 3.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.685 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.7 97.62 11.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.354 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 31.3 m95 -103.72 156.12 18.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -168.8 -176.77 2.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.764 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 61.2 mtm -107.31 159.4 30.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.15 130.27 22.38 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.468 2.112 . . . . 0.0 112.549 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -154.1 160.23 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.12 169.34 38.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.612 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -83.92 130.88 10.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 48' ' ' ASP . 5.0 mt -60.07 160.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.713 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' N ' HG23 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.29 151.71 21.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.931 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.19 98.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.67 36.29 8.0 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.036 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HB3' HG22 ' A' ' 47' ' ' ILE . 5.0 tt0 -116.29 142.11 47.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.458 . . . . 0.0 110.861 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.46 143.15 82.18 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.04 -52.93 7.23 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.559 2.173 . . . . 0.0 112.604 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.429 ' HD3' ' CD2' ' A' ' 108' ' ' PHE . 4.4 tpp85 -59.03 -27.61 65.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -84.46 -48.44 9.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -58.98 -32.51 69.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.417 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.49 -53.57 11.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.7 mt -57.08 -29.34 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.081 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -81.7 -53.35 6.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 109.918 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.13 -45.16 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.309 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.425 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -55.74 -56.18 23.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.586 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.4 ttp180 -61.26 -12.19 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -91.6 -38.39 12.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.749 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.09 -35.37 15.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.921 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -119.02 -23.24 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.015 0.436 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.31 8.57 80.03 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.856 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 24.8 t -57.15 110.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.985 0.393 . . . . 0.0 110.313 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.0 p -89.84 -36.22 15.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.43 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.34 76.43 6.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.176 0.512 . . . . 0.0 111.086 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 128.53 12.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.78 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.6 pt-20 -119.38 147.78 43.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.098 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.6 t -78.41 123.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.344 0.593 . . . . 0.0 111.417 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -106.07 -19.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.753 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' CD2' ' A' ' 164' ' ' HIS . . . -156.85 162.94 39.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.135 0.493 . . . . 0.0 111.735 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.83 114.73 5.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.861 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.585 HG13 HD21 ' A' ' 80' ' ' LEU . 4.6 t -57.57 125.51 72.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.47 -11.6 31.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.872 2.381 . . . . 0.0 113.768 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.78 133.54 49.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.247 0.546 . . . . 0.0 111.917 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.42 ' CD2' ' HG2' ' A' ' 106' ' ' LYS . 49.2 m95 -59.79 147.09 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.226 0.536 . . . . 0.0 110.566 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.585 HD21 HG13 ' A' ' 76' ' ' VAL . 1.1 mm? -102.75 117.74 35.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.42 HG23 ' CB ' ' A' ' 104' ' ' ALA . 63.8 p -113.89 134.48 54.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -133.1 170.35 15.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.533 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.48 141.6 45.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.64 151.42 42.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.776 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 32.9 Cg_endo -63.6 170.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.518 2.145 . . . . 0.0 112.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.47 -16.95 57.86 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 0.0 113.275 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.65 -34.33 14.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.122 0.487 . . . . 0.0 110.132 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.489 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 74.4 t -83.19 -46.73 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.327 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -60.66 -46.3 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.487 0.66 . . . . 0.0 109.423 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.16 -27.37 67.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.58 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -47.05 16.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 96' ' ' TRP . 80.3 mt -59.26 -45.59 90.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 110.363 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.41 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.1 m-80 -46.02 -32.4 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.558 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.5 -49.28 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -56.12 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.462 ' N ' ' O ' ' A' ' 92' ' ' LEU . 18.4 m0 -78.39 -34.68 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.807 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 80.34 36.18 24.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.355 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.41 147.46 49.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.744 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -110.22 42.25 1.58 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.006 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -96.69 150.2 20.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -25.69 41.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.572 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -175.43 -138.23 2.74 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.036 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -157.72 116.79 3.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.823 0.344 . . . . 0.0 111.388 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.42 ' CB ' HG23 ' A' ' 81' ' ' THR . . . -86.41 105.8 17.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.835 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.1 pt20 -124.92 145.03 50.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 2.5 mmmp? -100.59 110.49 22.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.76 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 34.2 m95 -76.23 145.2 39.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.486 . . . . 0.0 112.145 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 59.5 m-85 -127.29 132.76 50.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.295 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.9 tp -79.5 132.93 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.359 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 50.0 m-85 -126.51 127.98 46.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.663 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.552 ' HB2' HG13 ' A' ' 73' ' ' ILE . 18.3 tttp -92.02 122.29 34.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -67.87 123.07 19.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 69' ' ' SER . 1.6 p -122.8 37.01 4.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.545 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.32 -144.49 4.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -128.06 154.37 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.97 -17.49 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.585 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -74.61 -19.28 60.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.12 -25.64 52.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 119' ' ' ILE . 25.5 mt -70.16 105.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 65' ' ' THR . 59.8 t30 -123.12 95.89 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.217 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 34.7 mt -55.73 -21.0 16.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.577 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -60.18 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.329 0.585 . . . . 0.0 109.774 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.25 23.39 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.324 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -93.92 38.83 1.07 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.159 0.504 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.59 28.0 70.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.2 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 m -102.24 -62.34 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.289 . . . . 0.0 111.255 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.27 165.24 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.146 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -57.95 146.06 69.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.031 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -51.69 -176.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.675 2.25 . . . . 0.0 112.517 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -150.1 -41.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.416 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 21.0 m-85 -106.32 159.37 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.69 5.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.377 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.4 mp0 -152.19 173.73 14.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.5 p-90 -160.25 160.31 32.48 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.242 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -158.73 160.76 36.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.508 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 81.3 m95 -93.12 124.61 37.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.623 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -137.27 151.16 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 111.773 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -68.88 161.35 72.58 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.517 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 18.7 Cg_endo -59.39 -16.73 36.58 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.716 1.61 . . . . 0.0 111.768 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.98 -34.1 14.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.069 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -51.5 21.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.13 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.6 tp -54.42 -31.4 55.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.459 0.647 . . . . 0.0 109.769 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.08 -27.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.775 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.73 -14.7 50.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.216 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 40' ' ' TRP . 12.6 mt -91.28 -38.32 12.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.392 0.615 . . . . 0.0 110.238 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.4 m -56.51 161.83 2.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.252 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.454 ' HB ' ' C6 ' ' A' ' 166' ' ' ATP . 14.0 p -87.98 162.31 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.3 -31.26 72.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 150' ' ' LYS . 11.2 p90 -82.17 2.57 30.95 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.476 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 3.3 mtmt -145.99 16.28 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 3.1 mttt -58.89 -61.96 6.73 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.073 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 22.3 Cg_endo -61.58 -42.5 32.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.462 ' O ' HD12 ' A' ' 80' ' ' LEU . 61.8 t -48.29 -29.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.248 0.547 . . . . 0.0 111.238 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -91.27 -55.0 3.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.249 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.52 -36.56 15.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.901 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' HB3' HD13 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -60.73 -46.74 89.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.475 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 44.6 t -61.29 -45.55 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.336 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' ALA . 56.3 mt -64.19 -49.04 73.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.965 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.2 t -50.63 -43.72 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 97.7 t -71.73 -25.19 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.326 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.529 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.8 m-30 -102.55 8.73 39.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.87 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.66 -56.04 26.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.5 Cg_endo -56.91 -22.78 47.71 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.374 2.049 . . . . 0.0 112.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 98.0 m-70 -91.31 -19.94 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.87 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.455 ' N7 ' ' NH1' ' A' ' 33' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.2 168.2 22.8 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.588 2.192 . . . . 0.0 112.303 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 60.18 -178.53 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.0 25.9 74.18 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.14 124.37 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.44 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.5 mmt -133.04 -38.31 0.97 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.745 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 75.4 19.15 2.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.727 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p 174.33 138.98 0.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 43.8 Cg_endo -68.86 109.69 2.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.32 2.014 . . . . 0.0 112.305 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.82 -175.64 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.012 2.475 . . . . 0.0 112.069 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -90.29 151.35 21.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -34.96 4.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -89.45 138.9 31.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 110.943 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.21 25.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -66.03 124.98 24.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 11.7 t-20 -152.53 160.66 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.997 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.422 ' CG1' HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -131.06 140.3 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -105.01 150.19 16.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.154 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -131.15 102.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.469 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -89.61 109.95 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -102.92 143.55 32.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.441 . . . . 0.0 111.171 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.6 ptm -128.93 157.29 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.421 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.5 p-10 -105.03 170.69 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.387 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -56.28 -17.5 7.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.644 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 0.61 56.56 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.775 0.322 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 mttm 76.35 26.39 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.566 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -97.91 172.27 7.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -111.15 123.19 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 73.9 t80 -56.45 109.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.57 129.97 56.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.448 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -114.81 136.09 53.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.412 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.4 p -82.46 154.86 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.748 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.7 OUTLIER -70.96 159.02 35.48 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.255 0.55 . . . . 0.0 111.397 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -93.33 -6.21 47.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.944 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -128.43 -18.1 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.201 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.1 mt -119.59 112.1 35.75 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.97 131.39 28.7 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.936 1.757 . . . . 0.0 111.95 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.74 3.51 3.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.851 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.54 11.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.412 ' CE3' ' N ' ' A' ' 32' ' ' SER . 42.1 m95 -104.56 156.71 17.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.02 8.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.429 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 70.1 mtm -97.91 156.67 35.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.83 139.22 42.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.536 2.157 . . . . 0.0 112.996 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.219 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.38 145.8 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.826 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.13 138.31 43.78 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.379 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.8 mt -69.17 161.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.57 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.2 150.09 22.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.6 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.14 8.48 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.109 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HB3' HG22 ' A' ' 47' ' ' ILE . 4.7 tt0 -115.08 143.48 45.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 0.0 110.887 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.68 139.68 80.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.604 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 63.5 Cg_exo -52.02 -53.51 6.85 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.448 2.098 . . . . 0.0 112.616 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -27.28 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -82.49 -51.26 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.694 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.408 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -56.84 -31.65 64.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.561 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.79 -51.91 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.271 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.4 mt -56.82 -27.94 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -84.96 -52.71 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.931 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.84 -47.37 67.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -53.99 -56.69 15.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 66.2 ttp85 -59.32 -15.2 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.414 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -92.13 -39.98 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.821 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.4 -25.08 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.89 -19.16 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.77 5.65 65.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.112 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.6 t -72.18 115.74 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.618 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -34.34 12.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.23 79.25 6.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.472 . . . . 0.0 110.997 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.29 131.33 15.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.897 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.2 pt-20 -120.72 147.2 45.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.5 t -78.03 123.01 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.382 0.611 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.551 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -105.4 -21.52 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -153.41 161.9 41.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.288 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 9.0 pt-20 -148.74 115.59 6.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.148 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG11 ' O ' ' A' ' 78' ' ' TYR . 4.6 t -57.24 125.78 71.97 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.917 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.2 -13.28 39.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.975 2.45 . . . . 0.0 114.177 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.661 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -129.4 157.2 42.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 112.028 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.425 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 32.4 m95 -77.4 145.66 37.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.123 0.487 . . . . 0.0 109.914 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -108.55 118.08 35.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.984 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 p -114.81 132.19 56.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.522 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -124.9 170.13 11.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.96 158.28 38.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -119.72 149.76 48.99 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.705 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.481 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 30.4 Cg_endo -63.06 170.38 7.67 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.539 2.16 . . . . 0.0 112.308 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.52 -17.42 59.9 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.819 2.346 . . . . 0.0 113.19 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -91.94 -34.64 14.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.173 0.511 . . . . 0.0 110.096 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.481 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 72.7 t -82.01 -47.56 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.292 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.8 93.66 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.57 0.7 . . . . 0.0 109.536 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -71.12 -27.56 63.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.772 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -46.96 24.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.631 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 96' ' ' TRP . 94.3 mt -59.56 -46.1 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.998 0.428 . . . . 0.0 110.391 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.404 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.3 m-80 -45.69 -32.43 2.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.41 -49.45 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.163 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -56.97 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.77 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.442 ' N ' ' O ' ' A' ' 92' ' ' LEU . 23.7 m0 -77.43 -36.2 53.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.639 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 82.29 34.8 22.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.362 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.05 147.15 49.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -109.75 65.23 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -122.83 150.18 43.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.86 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.583 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.13 -142.38 3.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.984 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -157.93 116.47 3.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.54 105.86 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.854 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.8 pt20 -124.28 144.61 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -98.81 95.82 7.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.697 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.421 ' CG ' HG23 ' A' ' 157' ' ' VAL . 53.8 m95 -62.91 148.72 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.449 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 68.6 m-85 -132.09 135.05 46.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.317 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.5 tp -79.9 129.46 34.5 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.512 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.6 m-85 -123.85 126.57 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.398 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' HB2' HG13 ' A' ' 73' ' ' ILE . 50.5 tttt -89.88 124.54 34.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.39 125.43 26.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.5 p -125.64 37.61 4.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.595 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.1 -144.91 4.76 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.129 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 154.2 45.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.85 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.611 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -20.39 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.17 -25.07 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.798 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 18.1 mt -73.46 102.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.549 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -119.35 95.63 4.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.924 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 68.6 mt -54.56 -23.78 18.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.651 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.5 mt -61.3 -55.23 34.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.099 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.9 -171.03 25.03 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.429 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.75 38.96 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.151 0.5 . . . . 0.0 109.84 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.17 28.56 73.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.985 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.36 -68.28 0.91 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 111.228 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.9 165.08 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.25 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -80.93 151.18 70.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.44 165.34 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.748 2.299 . . . . 0.0 112.623 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -150.05 -45.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.502 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 13.5 m-85 -107.48 159.62 16.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.19 -18.63 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -152.54 175.24 12.97 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.1 p-90 -156.14 150.9 26.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.113 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 162.32 40.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.34 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 71.4 m95 -96.28 124.31 40.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.2 m -136.42 150.78 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 111.511 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.1 p -71.1 158.11 88.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.572 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.0 Cg_endo -54.62 -20.49 21.54 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.907 1.738 . . . . 0.0 111.853 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 -34.3 17.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.118 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -72.69 -50.69 23.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.455 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.1 tp -54.14 -29.93 47.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.403 0.62 . . . . 0.0 109.881 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.7 mm -68.44 -28.88 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.674 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.27 -20.53 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 40' ' ' TRP . 10.3 mt -85.86 -39.14 17.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.402 HG22 ' CG ' ' A' ' 154' ' ' TYR . 5.7 m -60.2 156.19 15.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 150' ' ' LYS . 9.4 p -90.08 160.52 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -50.85 -35.71 33.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.458 ' CG ' HG12 ' A' ' 147' ' ' VAL . 13.9 p90 -84.8 9.97 12.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 147' ' ' VAL . 12.6 mttm -134.57 -25.3 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.264 . . . . 0.0 111.187 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.8 mtpt -44.5 -59.87 3.5 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.408 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.0 Cg_endo -59.06 -41.52 60.23 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.278 1.985 . . . . 0.0 111.912 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 82' ' ' TYR . 64.0 t -64.99 -25.78 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.429 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.46 -49.34 6.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.697 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.93 -35.1 22.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.681 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.4 tp10 -66.81 -44.96 79.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.7 t -58.64 -47.86 87.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.07 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 162' ' ' ALA . 66.6 mt -66.71 -49.26 66.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.703 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.2 m -50.6 -46.14 57.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.662 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.7 t -69.53 -24.68 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.516 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.5 m-30 -101.86 2.13 37.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.163 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.47 -55.21 31.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.15 -20.87 25.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.619 2.213 . . . . 0.0 112.34 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.423 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 17.9 m-70 -89.48 -21.06 23.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.729 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.933 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.43 ' O2A' ' CZ2' ' A' ' 96' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.26 152.84 66.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.527 2.151 . . . . 0.0 112.276 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.84 124.54 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.85 -8.83 76.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.794 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -179.57 125.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.279 . . . . 0.0 110.506 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.402 ' CE ' ' HG3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -150.89 -24.7 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 28.2 t0 77.57 43.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.936 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -177.85 121.54 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 122.42 8.81 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.375 2.05 . . . . 0.0 112.178 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 60.4 Cg_endo -88.85 -169.05 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 112.412 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 153.61 20.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.626 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 -35.34 4.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' CD2' ' HB ' ' A' ' 81' ' ' THR . 2.5 m-85 -102.96 136.99 41.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -86.11 152.23 23.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -64.02 132.56 50.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.371 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 21.1 t-20 -152.56 156.99 40.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.443 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 56' ' ' ALA . 3.3 m -127.81 129.49 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 111.281 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.2 147.03 18.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.177 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.458 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -122.34 103.35 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.699 0.285 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' PHE . 53.4 t -89.48 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.3 tp -103.19 144.56 31.16 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.319 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.8 ptt? -129.11 157.45 41.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.606 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.8 p-10 -98.35 172.51 7.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.349 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -60.45 -15.43 26.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 0.38 56.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp 77.57 27.16 0.63 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.536 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 136' ' ' TRP . 11.6 mmtm -99.11 175.67 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -107.62 147.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -82.67 104.94 13.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.73 129.89 56.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.31 137.13 52.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.417 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -82.03 152.81 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.764 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 5.0 mtp-105 -68.04 163.37 22.48 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.8 -7.66 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.384 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.1 -18.95 4.88 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.207 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.538 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 63.1 mt -121.02 112.41 33.41 Favored Pre-proline 0 N--CA 1.457 -0.083 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.43 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.939 1.759 . . . . 0.0 111.655 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t70 78.15 1.8 2.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.767 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.467 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.3 97.24 10.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.13 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' CE3' ' N ' ' A' ' 32' ' ' SER . 55.2 m95 -103.0 159.67 15.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.166 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -168.5 -178.01 3.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 36.3 mtm -109.4 156.58 39.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.77 128.43 18.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.584 2.189 . . . . 0.0 112.674 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' OE1' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.32 156.69 37.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 144.82 10.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.442 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.78 140.67 43.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 48' ' ' ASP . 4.4 mt -69.9 160.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' HG21 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.19 169.12 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.208 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.26 98.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.2 9.34 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.878 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 47' ' ' ILE . 10.7 tp10 -112.53 145.16 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.093 0.473 . . . . 0.0 110.846 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.64 133.82 73.24 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.422 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.48 -39.43 74.34 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.369 2.046 . . . . 0.0 112.569 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HD3' ' CE2' ' A' ' 108' ' ' PHE . 3.0 tpp85 -72.11 -27.84 62.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -85.12 -45.18 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -60.13 -32.62 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.368 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.22 -54.06 10.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.101 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -56.2 -29.1 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.291 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 ttp85 -82.58 -52.97 6.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.753 0.787 . . . . 0.0 109.872 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -51.78 -47.12 64.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.534 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tp -54.62 -56.3 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.886 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.51 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 6.6 ttp-105 -59.8 -15.14 18.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.293 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -92.06 -40.09 11.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.846 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.5 -25.29 19.34 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.57 -20.85 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.755 0.312 . . . . 0.0 111.063 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 76.72 1.39 71.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.015 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.0 t -69.42 116.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 110.615 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 -32.37 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.59 79.32 6.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.15 13.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.706 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.4 pt-20 -118.44 146.86 44.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.968 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.6 t -79.54 121.25 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 111.436 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -101.7 -20.79 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.391 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -153.14 160.24 42.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.07 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.8 pt-20 -148.43 116.02 6.28 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.169 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 78' ' ' TYR . 4.3 t -57.38 129.14 79.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.0 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 -16.32 46.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.744 2.296 . . . . 0.0 113.612 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.632 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -127.75 -179.43 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.458 0.647 . . . . 0.0 112.533 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 11.7 m95 -104.2 147.71 27.15 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.407 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 1.4 mt -113.08 117.52 32.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.719 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.425 ' HB ' ' CD2' ' A' ' 13' ' ' TYR . 16.5 p -111.4 131.14 55.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.723 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -125.72 170.24 11.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.368 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.86 156.5 44.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CZ ' ' O1A' ' A' ' 166' ' ' ATP . 4.8 m-85 -105.71 147.51 34.82 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.481 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 28.2 Cg_endo -63.04 169.94 8.32 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.68 -16.35 52.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.918 2.412 . . . . 0.0 113.338 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -34.41 13.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.113 0.482 . . . . 0.0 110.096 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.481 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 84.1 t -82.68 -47.17 18.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.259 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.4 92.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.486 0.66 . . . . 0.0 109.614 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -69.88 -27.22 64.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.737 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -46.64 17.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 96' ' ' TRP . 96.1 mt -60.56 -46.89 88.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.474 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -46.42 -33.46 3.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.733 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.59 -46.22 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.438 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -55.05 11.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.0 m0 -79.61 -34.01 41.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.845 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.92 35.92 33.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.374 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 147.37 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.742 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -108.34 73.82 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.406 ' CD1' ' HD2' ' A' ' 14' ' ' ARG . 52.5 m95 -135.11 150.4 50.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.743 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 2.1 mptp? -88.35 -21.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.68 -146.4 5.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.915 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -157.94 116.29 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -85.84 112.7 21.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -128.98 152.93 48.06 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.419 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.29 95.99 6.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 178.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.449 ' CD2' HG23 ' A' ' 157' ' ' VAL . 48.6 m95 -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 112.472 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.1 m-85 -133.05 134.82 44.87 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.09 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.6 tp -79.53 143.01 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.523 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 42.4 m-85 -136.97 127.5 26.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB2' HG13 ' A' ' 73' ' ' ILE . 25.8 tttp -91.71 121.24 33.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.8 127.0 30.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.204 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.1 p -126.27 37.31 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.76 -144.55 4.93 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.982 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 153.8 47.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.173 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD1' ' CH2' ' A' ' 134' ' ' TRP . 3.6 m-20 -52.12 -14.93 0.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.674 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -80.73 -20.36 42.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.254 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.54 -25.53 45.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.807 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.9 mt -67.08 104.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.459 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -122.06 95.8 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.119 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.6 mt -56.3 -21.89 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.8 -56.93 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 109.882 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.99 -175.59 22.56 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.487 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -91.98 38.97 1.0 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.76 72.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.958 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -121.15 -69.96 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.96 165.13 17.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.42 147.02 45.87 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 128.42 27.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.623 2.215 . . . . 0.0 112.53 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -111.54 -34.77 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.44 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 5.1 m-85 -108.02 159.61 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.334 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.9 -19.52 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.815 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 13.9 mm-40 -152.45 175.22 12.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.145 0.498 . . . . 0.0 110.592 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.8 p-90 -155.95 154.05 30.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.077 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.15 159.48 42.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.556 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 70.4 m95 -93.96 126.7 39.32 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.615 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 28' ' ' ILE . 35.7 m -135.88 152.84 31.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.41 . . . . 0.0 111.854 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 p -72.49 152.17 91.81 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.408 ' O ' HG12 ' A' ' 143' ' ' ILE . 5.3 Cg_endo -49.12 -22.13 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.25 -33.79 17.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -50.53 33.81 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.189 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.5 tp -53.35 -32.82 51.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.462 0.649 . . . . 0.0 109.828 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 139' ' ' PRO . 4.9 mm -67.2 -28.05 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.796 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -22.64 41.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.232 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.8 mt -83.09 -39.55 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.066 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.404 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 22.5 m -56.28 164.63 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.506 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -101.24 160.42 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -45.43 -46.09 13.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.359 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -75.29 -5.09 42.84 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 13.5 mtmt -121.73 -4.13 9.21 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mttt -57.76 -62.39 5.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.541 0.21 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.1 Cg_endo -61.14 -45.81 17.91 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.467 2.111 . . . . 0.0 112.241 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.469 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 23.0 t -56.84 -27.07 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.13 -52.32 4.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.74 -32.62 20.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.317 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.6 tp10 -64.88 -46.01 83.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.492 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.499 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.0 t -59.49 -52.36 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.191 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 162' ' ' ALA . 70.2 mt -59.97 -49.2 78.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.841 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 m -49.15 -46.43 45.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.639 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.1 t -69.61 -25.28 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.029 0.443 . . . . 0.0 110.366 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.4 m-30 -104.29 12.37 33.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.999 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.98 -58.28 14.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.0 Cg_endo -56.76 -21.81 41.7 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.433 2.088 . . . . 0.0 112.275 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.419 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 63.7 m-70 -90.01 -12.54 38.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.126 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.927 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.444 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -168.73 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.41 124.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.05 -27.74 8.1 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.591 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.467 ' CB ' ' CG ' ' A' ' 78' ' ' TYR . 27.4 p -124.13 -156.72 0.73 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.925 0.393 . . . . 0.0 110.09 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.408 ' HG3' HG23 ' A' ' 81' ' ' THR . 2.4 mmt -142.66 -33.65 0.46 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.938 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 52.6 27.07 4.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 0.0 111.27 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t 178.24 125.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.15 109.32 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.404 2.069 . . . . 0.0 112.264 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.55 -173.89 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.889 2.393 . . . . 0.0 112.082 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.98 147.38 23.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.834 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.33 35.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.04 136.25 44.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.943 0.402 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.8 OUTLIER -87.97 152.22 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -69.93 134.33 48.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.111 0.481 . . . . 0.0 111.441 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 19.8 t-20 -152.46 158.88 43.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 53' ' ' PRO . 1.4 m -128.18 130.0 69.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 111.584 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.98 139.31 14.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.132 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.434 HG22 ' CE1' ' A' ' 110' ' ' PHE . 4.2 mp -112.93 104.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.321 . . . . 0.0 111.417 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 110' ' ' PHE . 52.5 t -89.54 105.08 17.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.4 tp -103.36 141.84 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.983 0.42 . . . . 0.0 111.126 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.63 157.39 35.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.7 p-10 -100.84 170.53 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -57.13 -16.37 7.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.418 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -0.08 57.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 111.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 77.53 26.67 0.66 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.564 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mmtt -97.85 175.87 6.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' CG2' HD21 ' A' ' 142' ' ' LEU . 4.6 mp -115.31 126.88 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.455 ' CE1' ' CG2' ' A' ' 119' ' ' ILE . 66.3 t80 -59.47 110.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.379 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.86 130.0 56.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.02 136.74 52.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 0.0 111.472 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.43 155.16 24.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.646 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -71.98 156.98 38.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.284 0.564 . . . . 0.0 111.413 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.16 -5.36 52.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -127.52 -19.62 4.16 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.039 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 59.6 mt -119.54 112.44 35.58 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.904 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.46 131.66 28.74 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.905 1.737 . . . . 0.0 111.737 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 77.17 4.21 3.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.766 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -89.66 97.4 11.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.339 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -103.93 156.94 17.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.101 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -168.76 177.23 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.774 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.451 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 35.8 mtm -103.2 155.43 36.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.809 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.46 139.9 55.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.594 2.196 . . . . 0.0 112.67 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.19 158.18 39.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.74 140.37 6.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.586 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.74 139.87 48.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.451 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 6.7 mt -71.42 160.32 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.546 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.3 148.52 22.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.85 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -49.15 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.188 0.518 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.64 40.62 14.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.884 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB3' HG23 ' A' ' 47' ' ' ILE . 5.9 tp10 -113.3 145.74 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 110.938 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.87 124.05 90.28 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.156 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HA ' HG12 ' A' ' 17' ' ' VAL . 5.3 Cg_endo -48.97 -50.83 11.78 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.484 2.123 . . . . 0.0 112.818 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -57.44 -30.53 65.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.009 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -83.23 -47.12 11.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -58.38 -30.32 66.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.407 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.93 14.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.109 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 mt -57.02 -29.6 31.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.099 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -81.19 -53.15 6.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.877 0.846 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.98 -31.88 61.2 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.479 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.26 -62.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.5 ptt85 -61.22 -10.91 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.973 0.415 . . . . 0.0 110.456 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -91.5 -39.47 11.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.252 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.52 -33.66 15.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.158 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.93 -24.5 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 81.54 -0.21 88.28 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.668 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.6 t -63.68 118.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.311 . . . . 0.0 110.448 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -33.95 10.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.22 76.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.805 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.25 13.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.973 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -120.31 148.85 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 55.4 t -79.21 125.04 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.492 0.663 . . . . 0.0 111.901 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.559 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -104.93 -20.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.066 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 161' ' ' PHE . . . -152.2 161.21 42.96 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -148.16 113.25 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 78' ' ' TYR . 3.2 t -57.23 124.76 68.15 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.032 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.59 -5.72 17.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.802 2.335 . . . . 0.0 113.925 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -131.21 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 112.399 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -79.03 147.36 32.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.439 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 48.7 mt -115.97 117.74 30.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.842 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 6' ' ' MET . 10.2 p -114.78 131.67 56.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.585 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -127.56 170.07 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.52 158.44 39.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -110.55 153.54 43.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 34.3 Cg_endo -64.25 171.61 7.55 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.529 2.153 . . . . 0.0 112.328 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.39 -17.77 58.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.79 2.327 . . . . 0.0 113.215 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 -34.29 15.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.193 0.52 . . . . 0.0 110.16 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.484 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 78.9 t -82.33 -48.25 18.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -45.62 90.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.489 0.662 . . . . 0.0 109.547 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.55 -27.0 65.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.669 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -78.7 -46.51 18.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.597 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 96' ' ' TRP . 96.0 mt -59.11 -46.46 88.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -46.44 -32.73 3.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.605 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.56 -47.44 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.533 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -55.15 9.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.468 ' N ' ' O ' ' A' ' 92' ' ' LEU . 10.7 m0 -79.22 -30.72 43.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.952 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.28 37.37 48.34 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.417 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.19 147.57 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.685 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.92 48.23 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.928 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.42 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 57.1 m95 -111.46 150.18 30.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.695 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -27.81 44.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.48 -143.42 4.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.994 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -157.92 117.28 3.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.757 0.313 . . . . 0.0 111.365 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.74 107.61 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -123.16 151.93 41.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 96.84 6.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.43 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.448 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 52.1 m95 -62.7 147.86 48.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -130.99 135.14 47.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.2 tp -79.7 147.92 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.138 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' CYS . 27.3 m-85 -140.92 128.02 20.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.87 0.367 . . . . 0.0 111.567 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.559 ' HB2' HG13 ' A' ' 73' ' ' ILE . 31.3 tttt -91.79 119.96 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -64.87 125.14 23.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.7 p -126.86 37.62 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.25 -144.92 4.75 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.066 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -127.86 154.12 45.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -50.26 -16.23 0.31 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.657 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -79.03 -18.63 53.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.731 0.3 . . . . 0.0 111.232 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.33 -25.61 42.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.455 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 22.9 mt -79.01 105.84 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -124.78 96.7 4.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.08 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.6 mt -47.62 -21.8 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.232 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.5 -59.33 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.351 0.596 . . . . 0.0 109.99 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 133.08 -176.62 19.46 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.1 p30 -89.47 38.7 0.91 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.2 26.1 72.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.271 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -100.98 -64.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.708 0.289 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -112.52 165.14 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.1 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 144.8 91.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.05 135.88 59.94 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.581 2.188 . . . . 0.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.84 -29.55 7.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.73 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 9.7 m-85 -110.2 159.27 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.14 -19.78 5.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.795 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 25.5 mm-40 -152.43 175.08 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 110.438 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.07 155.46 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.2 m -153.84 158.71 41.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.348 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.458 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 79.5 m95 -90.98 123.72 34.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.836 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 29.5 m -134.34 149.88 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.503 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -68.65 158.65 84.93 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.581 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.418 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 12.0 Cg_endo -55.74 -19.17 23.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.875 1.717 . . . . 0.0 111.923 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -90.84 -34.21 15.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.078 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.68 -50.73 27.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.988 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.7 tp -54.1 -32.72 55.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 139' ' ' PRO . 5.6 mm -67.9 -28.16 40.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.09 -20.98 40.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.2 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' A' ' 142' ' ' LEU . 11.2 mt -84.75 -39.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.2 m -59.46 151.07 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.152 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 150' ' ' LYS . 8.7 p -80.78 160.09 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.0 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -51.75 -35.26 42.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.472 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -83.41 4.9 25.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.511 ' HB2' HG13 ' A' ' 147' ' ' VAL . 22.1 mttm -133.97 6.28 3.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.532 0.206 . . . . 0.0 111.304 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.5 mttt -62.32 -62.76 5.17 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.04 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.3 Cg_endo -58.74 -41.81 59.7 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.449 2.099 . . . . 0.0 112.051 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.439 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 17.3 t -58.34 -25.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.998 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.451 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -91.1 -50.2 5.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.609 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' CG ' ' CD1' ' A' ' 143' ' ' ILE . 39.3 mttp -51.39 -33.52 30.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 3.0 tp10 -65.59 -45.81 81.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.746 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.492 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.4 t -61.02 -51.62 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.203 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 162' ' ' ALA . 72.3 mt -62.59 -49.19 76.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.902 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -49.79 -47.15 51.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.677 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.72 -25.06 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.492 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.4 m-30 -104.07 10.79 35.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.001 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.52 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -57.99 13.9 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.9 Cg_endo -55.69 -21.76 33.3 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.464 2.109 . . . . 0.0 112.084 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.42 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 63.6 m-70 -92.53 -17.7 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.933 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.44 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.49 -168.49 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.647 2.231 . . . . 0.0 112.297 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.9 mt 60.1 -178.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.0 55.33 0.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.453 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -166.65 125.17 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.455 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 79' ' ' TRP . 10.7 tpp -126.84 105.35 8.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.19 24.43 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.597 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 174.94 121.71 0.12 Allowed Pre-proline 0 CA--C 1.529 0.15 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.47 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.65 111.13 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.224 1.95 . . . . 0.0 112.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.82 -169.37 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.786 2.324 . . . . 0.0 112.385 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.09 161.38 15.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.27 -31.2 7.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.28 134.81 53.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.0 ptt85 -79.15 152.86 30.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.133 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? -57.51 139.07 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.9 m120 -153.12 161.41 42.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.41 ' CG1' HD13 ' A' ' 47' ' ' ILE . 1.2 m -141.93 123.82 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.088 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 147.37 18.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.286 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.478 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -122.11 101.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 111.275 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.7 t -89.89 104.94 17.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 22.3 tp -102.97 148.16 26.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 ptt? -130.39 157.4 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.444 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 33.9 p-10 -104.32 169.35 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.269 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.72 -17.05 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.53 56.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.293 . . . . 0.0 111.006 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 76.42 26.71 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -98.1 172.53 7.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.1 mp -109.35 121.12 61.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.064 0.459 . . . . 0.0 111.06 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 5.0 t80 -55.28 107.82 0.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.267 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.81 141.8 47.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.758 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -126.37 139.4 53.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.345 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.71 158.29 22.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.621 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.1 mtp85 -75.12 159.69 31.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.527 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -94.49 -5.43 46.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.951 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.09 -16.99 3.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.482 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 57.7 mt -121.34 112.61 32.8 Favored Pre-proline 0 N--CA 1.454 -0.253 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.18 131.75 29.53 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.906 1.738 . . . . 0.0 111.788 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 t0 76.66 4.08 3.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.39 97.48 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.423 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -101.66 155.34 18.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -169.03 -176.61 2.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.419 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 4.3 mtm -113.71 154.4 45.75 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.73 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.46 142.35 78.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.599 2.199 . . . . 0.0 112.413 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -154.07 173.73 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.94 178.79 28.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.578 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' ILE . . . -112.92 23.91 13.76 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.689 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 46' ' ' GLY . 3.5 mt 51.26 157.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 0.0 111.643 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' N ' HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.77 176.64 6.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.71 98.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.221 0.534 . . . . 0.0 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.86 49.28 29.52 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.757 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' HG22 ' A' ' 47' ' ' ILE . 3.4 tt0 -112.65 148.14 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.254 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.14 -60.41 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.454 2.103 . . . . 0.0 112.864 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -55.57 -26.53 44.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -82.34 -49.01 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.697 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -57.79 -31.1 66.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.1 -53.11 11.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.119 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.3 mt -56.08 -29.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.186 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -83.79 -52.61 6.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.785 0.802 . . . . 0.0 109.945 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.44 -48.49 65.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.668 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tp -53.6 -55.51 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.982 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.578 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.8 ttp85 -58.7 -15.25 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -91.97 -37.64 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.715 0.293 . . . . 0.0 111.759 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -90.71 -28.73 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -121.92 -21.35 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.278 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.91 5.19 69.22 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.79 108.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.929 0.364 . . . . 0.0 110.306 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -34.4 15.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.25 75.02 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 127.24 11.85 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.853 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.88 148.83 43.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.678 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 43.6 t -77.94 127.1 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.853 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -106.95 -20.32 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.28 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.427 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.87 161.97 40.5 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.4 pt-20 -148.41 113.82 5.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.257 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 78' ' ' TYR . 3.6 t -57.55 125.36 71.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.185 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.27 -10.02 25.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.811 2.341 . . . . 0.0 113.617 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.496 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.45 133.6 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.582 . . . . 0.0 112.065 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' A' ' 6' ' ' MET . 24.8 m95 -65.39 147.21 53.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.693 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.467 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 43.9 mt -113.17 117.63 32.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.779 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.4 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 3.6 p -114.52 132.21 56.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -131.4 170.11 15.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.94 158.25 35.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -109.83 154.64 42.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 29.4 Cg_endo -62.96 170.93 6.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.484 2.123 . . . . 0.0 112.263 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.88 -17.24 59.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.834 2.356 . . . . 0.0 113.087 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -92.02 -33.62 14.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.181 0.515 . . . . 0.0 110.129 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 74.6 t -83.48 -48.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.338 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -45.18 91.57 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.512 0.672 . . . . 0.0 109.342 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.8 -27.72 66.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.6 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -47.2 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.418 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.5 mt -57.55 -46.56 83.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.453 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -46.0 -32.01 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.4 mt -96.39 -49.32 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.147 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -57.08 7.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.779 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LEU . 13.0 m0 -76.98 -34.35 57.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.87 34.89 29.48 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.412 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.58 147.2 49.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -109.63 48.6 0.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -105.71 149.98 25.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -30.33 63.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.723 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.47 -139.63 2.74 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.96 116.25 3.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 111.584 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -87.84 108.36 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.7 pt20 -120.16 150.85 39.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.3 mttt -107.91 95.88 5.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.19 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.46 ' CG ' HG21 ' A' ' 157' ' ' VAL . 49.4 m95 -62.97 138.96 58.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 112.259 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 54' ' ' ARG . 66.9 m-85 -124.85 132.44 53.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.937 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.2 tp -79.59 131.15 35.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.508 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.5 m-85 -125.49 129.57 50.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 111.498 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.531 ' HB2' HG13 ' A' ' 73' ' ' ILE . 28.1 tttt -93.53 121.08 34.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.2 123.32 19.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.1 p -124.66 37.51 4.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.613 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.47 -144.79 4.81 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.07 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -128.35 154.14 46.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -49.93 -16.72 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -20.24 57.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 111.131 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.61 -25.18 49.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 119' ' ' ILE . 20.7 mt -72.39 103.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.48 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' THR . 63.7 t30 -119.06 95.48 4.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.988 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.3 mt -54.78 -21.93 12.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.783 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.94 -59.23 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.64 -171.52 25.9 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.447 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -94.39 38.83 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.119 0.485 . . . . 0.0 109.936 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.2 27.13 72.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.4 t -106.0 -64.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.0 111.202 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -115.48 163.48 15.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.212 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.35 152.37 54.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.11 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.23 179.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.784 2.323 . . . . 0.0 112.581 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -148.39 -44.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.713 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 31.7 m-85 -110.59 159.59 17.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.421 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -113.72 -20.78 5.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.587 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.1 mm-40 -152.34 174.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.526 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.4 p-90 -159.54 157.45 29.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.073 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -154.51 160.49 41.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.455 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 82.5 m95 -93.63 123.43 36.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.54 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 30.2 m -134.88 150.43 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 111.777 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.455 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -69.59 160.64 78.72 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.598 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 16.6 Cg_endo -57.84 -17.62 30.77 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.832 1.688 . . . . 0.0 111.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.74 -34.07 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.07 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.01 -50.75 25.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.7 tp -54.24 -31.04 52.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.489 0.661 . . . . 0.0 109.83 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.8 mm -68.58 -28.44 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.621 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.78 -20.72 42.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.27 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 142' ' ' LEU . 11.7 mt -84.74 -39.11 18.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.119 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.421 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 26.0 m -56.74 163.63 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' A' ' 150' ' ' LYS . 7.5 p -91.66 164.96 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -55.23 -35.06 64.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.925 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.442 ' CE2' HG13 ' A' ' 147' ' ' VAL . 12.5 p90 -90.5 11.09 22.85 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HB2' HG11 ' A' ' 147' ' ' VAL . 2.1 mtmp? -133.23 -3.68 3.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.537 0.208 . . . . 0.0 111.513 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.43 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttm -58.98 -62.8 5.09 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.577 0.227 . . . . 0.0 111.192 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 17.3 Cg_endo -57.92 -41.61 67.1 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.467 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 20.8 t -59.75 -28.05 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.2 m-85 -91.16 -51.4 5.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.66 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -32.82 21.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -66.21 -45.65 79.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.565 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.3 t -58.97 -48.93 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.23 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 162' ' ' ALA . 77.3 mt -62.24 -48.68 78.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.723 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.9 m -49.67 -47.21 50.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.739 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.5 t -69.28 -25.43 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.494 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.6 m-30 -103.3 11.66 36.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.985 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.1 -57.69 16.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.486 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.8 Cg_endo -55.78 -22.04 35.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.511 2.141 . . . . 0.0 112.356 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 91.3 m-70 -90.33 -15.09 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.087 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.438 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.31 -167.52 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.626 2.217 . . . . 0.0 112.307 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.82 161.14 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.75 72.32 0.35 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.405 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.5 m -146.3 112.05 5.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.08 105.57 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.76 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -80.9 24.47 0.5 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.554 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 177.62 128.63 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.511 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.46 110.8 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.327 2.018 . . . . 0.0 112.165 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.62 -177.59 3.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.92 2.413 . . . . 0.0 112.071 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -90.36 151.21 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.832 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.05 -27.37 16.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.663 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -98.23 138.53 35.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.084 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.87 152.29 24.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -71.82 129.85 39.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 14.3 t-20 -152.84 161.89 41.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG11 HD13 ' A' ' 47' ' ' ILE . 1.7 m -131.54 135.53 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 111.458 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.434 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -103.8 150.62 17.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.101 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -126.7 101.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.822 0.344 . . . . 0.0 111.506 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 t -89.75 100.43 13.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.4 tp -102.79 143.65 32.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.044 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 2.8 ptt? -126.22 157.5 38.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 40.5 p-10 -98.98 170.95 8.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.76 -16.11 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.491 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -89.14 1.06 56.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 64.8 mttt 76.29 26.97 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.3 mttt -99.17 171.62 7.89 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.0 mp -109.94 122.76 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.902 0.382 . . . . 0.0 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 86.7 t80 -55.17 111.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.12 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.52 130.34 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.31 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.03 138.72 50.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.041 0.448 . . . . 0.0 111.193 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.534 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.25 158.07 23.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.632 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.3 mtp85 -73.35 159.72 32.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -93.36 -5.48 49.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.921 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.61 -17.76 3.62 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 69.6 mt -120.68 112.76 33.69 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.099 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.47 132.27 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.887 1.725 . . . . 0.0 111.684 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.76 4.82 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -90.36 97.56 11.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.41 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -103.36 155.58 18.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.126 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.72 170.95 9.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 68.1 mtm -90.04 153.87 47.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.689 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.29 139.14 41.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.156 . . . . 0.0 112.666 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.77 162.6 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.86 141.8 7.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.602 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -58.44 140.87 46.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.523 HD13 HG11 ' A' ' 17' ' ' VAL . 3.7 mt -72.66 159.29 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.496 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.58 148.66 22.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.09 99.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.225 0.536 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.23 40.42 13.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.913 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.3 tp10 -110.75 147.5 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.159 0.504 . . . . 0.0 110.859 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.93 130.56 80.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.04 -25.7 23.25 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.377 2.051 . . . . 0.0 112.538 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' CB ' ' CE2' ' A' ' 108' ' ' PHE . 9.7 ttt180 -86.61 -22.05 26.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.984 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -91.08 -40.29 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 110.31 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -64.17 -30.37 71.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.68 -50.96 15.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -57.6 -30.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.101 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -81.36 -53.14 6.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.867 0.842 . . . . 0.0 109.908 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.79 -49.34 65.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -54.97 -55.15 33.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.973 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.546 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 50.3 ttp85 -61.44 -13.44 20.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.544 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.95 -43.0 9.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.957 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -91.38 -25.33 19.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.418 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.36 -20.27 8.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.361 . . . . 0.0 111.057 -179.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.9 7.59 62.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.068 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.25 115.62 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.856 0.36 . . . . 0.0 110.383 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.64 -34.04 11.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.195 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 76.33 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.197 0.522 . . . . 0.0 111.051 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.51 129.07 13.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -116.33 147.63 41.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.02 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.2 t -77.03 119.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.325 0.583 . . . . 0.0 111.068 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.512 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -93.41 -26.05 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.837 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.59 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.518 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.43 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 29.2 tt0 -148.65 118.76 7.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.583 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.691 HG11 ' O ' ' A' ' 78' ' ' TYR . 8.1 t -58.21 123.95 68.07 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.61 -17.05 58.32 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.723 2.282 . . . . 0.0 113.312 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.691 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.77 -178.54 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.907 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -110.5 146.3 36.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.874 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.475 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 9.5 mt -112.73 117.61 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.064 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 2.7 p -109.76 132.35 54.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -129.08 161.58 29.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.624 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.9 158.37 29.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.383 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' CD2' HD12 ' A' ' 92' ' ' LEU . 1.5 m-85 -104.26 150.85 38.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.584 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.498 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 29.3 Cg_endo -62.28 168.42 9.48 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.444 2.096 . . . . 0.0 111.956 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.1 -16.2 48.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.781 2.321 . . . . 0.0 113.188 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -93.09 -39.18 11.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.239 0.542 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.498 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 82.0 t -78.51 -45.54 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.54 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -62.01 -47.13 86.16 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.526 0.679 . . . . 0.0 109.53 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -25.37 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.675 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -45.42 14.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 96' ' ' TRP . 42.8 mt -57.21 -41.7 79.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -45.62 -35.39 4.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.6 -47.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.29 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -65.93 -56.12 13.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 92' ' ' LEU . 17.2 m0 -81.51 -33.77 31.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.1 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 79.73 37.26 23.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.428 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.35 147.6 50.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 110.73 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.7 38.14 3.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -96.49 150.35 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.644 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -26.34 36.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.078 0.466 . . . . 0.0 110.396 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.61 -152.3 8.53 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.585 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -152.81 116.7 4.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.71 0.29 . . . . 0.0 111.084 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -85.62 105.62 16.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -117.65 161.34 19.81 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 105.08 12.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.388 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 74.1 m95 -75.69 136.41 40.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 112.259 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 26.9 m-85 -118.78 133.73 55.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.03 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.8 tp -79.57 135.28 36.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.097 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 38.3 m-85 -127.87 133.46 49.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.188 0.518 . . . . 0.0 112.187 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -96.02 119.44 34.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.507 177.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.56 122.89 19.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 110.761 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 p -124.54 37.55 4.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.27 -145.01 4.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.097 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.64 154.19 45.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.84 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -77.17 -17.98 58.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.2 -26.22 42.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 16.4 mt -72.51 98.68 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.341 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -113.89 95.79 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.4 mt -56.58 -21.15 24.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.457 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -59.67 -56.88 16.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.417 0.627 . . . . 0.0 109.867 179.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 136.85 -174.96 21.37 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.436 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -90.96 38.66 0.96 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.09 29.43 74.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.96 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -111.79 -64.8 1.24 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.0 111.38 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.46 165.11 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 146.05 94.68 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.4 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 47.4 Cg_exo -54.84 140.89 78.27 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.607 2.204 . . . . 0.0 112.381 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -110.65 -27.35 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 5.9 m-85 -118.74 159.44 23.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.588 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.5 -16.34 5.59 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.772 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.534 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 4.7 mp0 -152.24 174.27 13.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.734 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.4 p-90 -159.59 154.19 24.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.114 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.57 159.63 44.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.366 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 74.7 m95 -93.68 125.82 38.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.437 HG22 ' CA ' ' A' ' 142' ' ' LEU . 27.4 m -138.8 151.17 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 111.696 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.33 160.42 79.12 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 14.4 Cg_endo -57.0 -18.19 27.36 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 121.875 1.717 . . . . 0.0 111.929 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.27 -34.24 14.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.121 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -50.24 37.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.977 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.437 ' CA ' HG22 ' A' ' 137' ' ' VAL . 3.5 tp -54.49 -31.82 56.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.457 0.646 . . . . 0.0 109.75 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.415 ' CD1' ' CG ' ' A' ' 155' ' ' LYS . 6.0 mm -69.84 -27.81 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.622 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.71 -23.56 42.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.065 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 142' ' ' LEU . 10.3 mt -81.67 -39.8 23.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.86 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 m -55.73 165.2 0.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 150' ' ' LYS . 14.8 p -95.84 161.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.518 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.52 -27.0 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 23.1 p90 -90.9 10.11 27.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.512 ' HB2' HG11 ' A' ' 147' ' ' VAL . 18.4 mtmt -150.07 13.98 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 111.611 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.518 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.7 mtpp -69.07 -62.79 2.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.141 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.3 Cg_endo -51.49 -40.01 63.79 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 111.988 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.475 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 22.7 t -58.73 -25.03 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.88 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.26 -51.46 5.29 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.541 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.415 ' CG ' ' CD1' ' A' ' 143' ' ' ILE . 11.1 mtpt -50.31 -33.95 21.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.463 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 6.6 tp10 -64.9 -46.02 83.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.69 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.6 t -59.31 -48.43 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.22 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 162' ' ' ALA . 72.5 mt -64.19 -48.65 75.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.616 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.6 m -49.4 -47.38 47.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.8 -24.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.134 0.492 . . . . 0.0 110.459 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.6 m-30 -101.24 -0.77 35.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.116 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.627 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.32 -51.86 24.12 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.333 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -55.74 -22.82 38.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.372 2.048 . . . . 0.0 112.176 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.41 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 88.8 m-70 -93.45 -19.55 21.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.416 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 3.7 mp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.417 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.99 145.07 54.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.613 2.209 . . . . 0.0 112.297 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -176.55 145.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.76 -32.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.475 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -125.89 -154.84 0.65 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.894 0.378 . . . . 0.0 110.188 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -131.2 -44.33 1.03 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.662 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 1.9 t0 70.56 29.42 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.819 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 170.32 119.23 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.84 110.37 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.203 1.936 . . . . 0.0 111.962 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.16 -172.7 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.733 2.289 . . . . 0.0 111.87 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -89.87 144.38 25.99 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.141 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' HA3' ' HE2' ' A' ' 101' ' ' LYS . . . 92.42 -35.99 3.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -72.65 138.74 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 111.107 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 tpt85 -82.72 152.15 25.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -79.19 128.21 33.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 8.5 m120 -152.55 163.36 39.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.455 HG23 ' CB ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -128.95 135.0 63.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.077 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.84 142.14 15.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.385 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.461 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -119.03 101.17 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.2 t -89.8 103.85 16.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 42.6 tp -102.87 140.52 37.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 111.11 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -124.54 157.34 35.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.836 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.9 p-10 -101.21 169.5 8.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -54.85 -17.61 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.626 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.24 56.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 110.942 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt 76.68 25.8 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.529 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.7 mttp -96.28 171.65 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' CG2' HD21 ' A' ' 142' ' ' LEU . 4.0 mp -109.55 123.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.463 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 74.9 t80 -57.72 110.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.48 134.35 54.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.8 135.9 54.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.61 153.85 25.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 39' ' ' ALA . 1.1 mtp85 -70.73 157.12 38.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 111.402 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -5.71 52.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.56 -18.11 4.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.148 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.494 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 54.3 mt -119.65 107.96 39.95 Favored Pre-proline 0 N--CA 1.456 -0.144 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.911 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 24.8 Cg_exo -62.49 128.93 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.0 t0 80.65 2.7 1.79 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.83 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -89.31 97.46 11.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.422 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.413 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.3 m95 -104.97 156.78 17.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.0 -177.0 2.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.753 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.44 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 2.9 mpp? -106.49 158.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 139.98 40.85 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -154.02 162.23 41.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.788 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.58 18.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.1 137.4 29.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.645 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 4.9 mt -70.75 159.55 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.555 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.65 149.61 22.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.921 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.25 98.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.236 0.541 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.08 39.84 11.05 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.919 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' HB3' HG22 ' A' ' 47' ' ' ILE . 5.8 tp10 -112.24 147.39 36.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.153 0.501 . . . . 0.0 110.872 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.03 133.79 78.34 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.56 -55.13 4.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.06 . . . . 0.0 112.609 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HG3' ' CD2' ' A' ' 108' ' ' PHE . 1.2 ttt-85 -59.13 -22.76 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.11 -49.66 7.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.733 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -58.53 -28.45 65.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.599 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.33 -51.37 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.074 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 55.5 mt -55.71 -30.67 27.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.047 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -80.54 -53.23 6.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.825 0.821 . . . . 0.0 109.838 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -55.96 -33.36 64.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.632 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.05 -61.24 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.115 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.606 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.9 ptp180 -62.39 -9.17 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.506 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.43 ' OE1' ' CG ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.86 -47.66 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.71 -30.39 17.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.266 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.416 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -114.07 -22.76 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.576 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 71.07 8.85 65.69 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.957 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.35 118.11 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.791 0.329 . . . . 0.0 110.342 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.08 -35.18 11.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.17 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.78 6.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.37 128.9 13.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.901 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.66 148.96 42.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.688 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.4 t -77.74 128.03 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.454 0.645 . . . . 0.0 111.924 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -108.46 -19.86 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.381 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -158.66 164.05 36.33 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.084 0.469 . . . . 0.0 111.622 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -148.98 118.51 6.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.516 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG1' ' CD1' ' A' ' 78' ' ' TYR . 3.4 t -57.91 110.39 2.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.059 0.457 . . . . 0.0 110.045 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.77 -23.41 11.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.257 2.638 . . . . 0.0 113.332 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.504 ' CD1' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -112.67 -175.75 2.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.235 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.422 ' CE2' ' HE2' ' A' ' 106' ' ' LYS . 51.3 m95 -105.36 147.96 27.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.658 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD23 HG13 ' A' ' 76' ' ' VAL . 1.6 mm? -109.22 118.46 36.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.219 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.4 p -120.14 131.18 54.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.731 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -126.47 170.2 12.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.525 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.81 158.29 42.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.238 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.25 153.75 46.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.548 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 31.0 Cg_endo -63.38 171.99 5.93 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.414 2.076 . . . . 0.0 112.056 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.13 -17.35 58.65 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.794 2.329 . . . . 0.0 113.327 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -91.64 -36.43 13.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.143 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.484 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 75.8 t -79.45 -48.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.15 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -57.15 -49.49 75.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.728 . . . . 0.0 109.7 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.07 -25.16 66.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.898 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -43.73 18.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 96' ' ' TRP . 94.5 mt -61.86 -46.66 88.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.943 0.401 . . . . 0.0 110.428 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.57 -34.13 4.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.721 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.53 -45.51 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.513 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -56.07 7.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.768 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 92' ' ' LEU . 11.5 m0 -78.0 -32.24 51.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.722 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.03 36.57 40.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.324 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.81 147.23 46.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 110.718 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 0.5 OUTLIER -109.57 63.06 0.6 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.41 ' CE3' ' O ' ' A' ' 99' ' ' ASP . 9.2 m95 -132.51 132.73 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.153 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.41 ' HE2' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -73.48 -30.55 63.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.419 0.628 . . . . 0.0 109.962 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 103' ' ' GLN . . . -150.67 -158.84 8.46 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.752 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -151.25 112.52 4.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.756 0.313 . . . . 0.0 111.186 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.54 105.56 16.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.5 pt20 -124.34 152.18 43.44 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -101.72 101.19 11.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.01 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.449 ' CG ' HG21 ' A' ' 157' ' ' VAL . 31.0 m95 -71.33 138.53 49.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 0.0 111.689 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 62.8 m-85 -123.23 134.09 54.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.547 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 19.4 tp -79.69 132.03 36.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.392 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 44.8 m-85 -126.08 128.83 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.513 ' HB2' HG13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.12 121.23 33.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -66.09 125.27 24.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.027 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.6 p -127.54 37.68 4.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.638 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.64 -144.7 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.122 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.82 154.18 44.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.878 0.37 . . . . 0.0 110.064 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.95 -16.47 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.69 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -18.33 54.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.704 0.287 . . . . 0.0 111.245 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -79.52 -24.79 41.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.0 110.837 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.463 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 21.2 mt -75.71 104.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.112 0.482 . . . . 0.0 111.568 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.51 95.86 4.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.859 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.3 mt -53.48 -24.46 13.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.626 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.3 mt -62.45 -57.55 10.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 110.026 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.66 -178.16 21.27 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -91.11 38.97 0.98 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.8 66.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -121.21 -69.64 0.83 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -84.86 165.1 17.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.32 145.21 39.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.31 128.68 30.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.579 2.186 . . . . 0.0 112.634 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.89 -32.28 6.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.542 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 14.6 m-85 -110.3 159.67 17.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.2 -19.94 5.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.987 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -152.48 175.38 12.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.115 0.483 . . . . 0.0 110.746 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.2 p-90 -157.15 154.25 29.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.195 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.09 161.47 42.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.367 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 72.1 m95 -94.7 123.56 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 32.4 m -135.52 151.21 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.033 0.444 . . . . 0.0 111.578 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.16 162.4 69.54 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.634 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.06 -18.54 36.6 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.792 1.661 . . . . 0.0 111.914 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.07 -34.51 14.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.223 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.66 -50.6 34.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.023 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.6 tp -54.01 -32.16 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.522 0.677 . . . . 0.0 109.818 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.32 -28.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.746 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.64 -22.38 40.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 40' ' ' TRP . 10.6 mt -83.5 -39.54 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 154' ' ' TYR . 3.6 m -59.48 167.4 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.478 HG12 ' CZ ' ' A' ' 149' ' ' PHE . 7.2 p -101.26 159.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -51.84 -40.88 61.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 9.4 p90 -79.58 1.5 25.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.472 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 27.6 mttm -136.44 7.56 3.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.573 0.225 . . . . 0.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 14.1 mtpt -70.31 -62.39 2.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.105 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.6 Cg_endo -53.93 -43.14 60.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.379 2.053 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.452 ' O ' HD13 ' A' ' 80' ' ' LEU . 78.0 t -57.35 -25.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.698 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.428 ' CD2' HG23 ' A' ' 146' ' ' THR . 3.9 m-30 -90.69 -53.25 4.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.445 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -31.91 16.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.229 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.0 tp10 -65.21 -46.17 81.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.503 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.515 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 49.1 t -59.83 -48.41 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.226 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 162' ' ' ALA . 71.9 mt -64.27 -49.15 72.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.1 m -50.35 -44.28 54.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.757 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 97.3 t -72.42 -24.83 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 110.595 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.515 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.8 m-30 -102.93 8.48 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.097 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.71 -52.61 62.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.725 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.7 Cg_endo -52.82 -23.39 20.57 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.509 2.14 . . . . 0.0 112.375 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 98.5 m-70 -89.91 -23.34 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.734 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.856 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.436 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.61 175.69 7.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.63 2.22 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 mp 60.11 -177.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.24 53.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.543 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.485 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -137.91 -158.75 0.89 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.905 0.384 . . . . 0.0 110.122 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.0 mmt -148.11 -32.94 0.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.05 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 71.07 20.74 5.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.791 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 169.39 143.13 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.63 107.69 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.163 1.909 . . . . 0.0 112.178 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.814 ' O ' ' O ' ' A' ' 11' ' ' GLU . 18.2 Cg_exo -66.18 -155.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.09 2.527 . . . . 0.0 112.646 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.814 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -29.84 -145.67 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.657 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.97 33.72 2.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.794 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 10' ' ' PRO . 26.8 m-85 -67.12 153.65 43.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.197 0.499 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -89.51 152.16 21.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.396 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -81.03 125.31 30.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.603 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.3 t-20 -152.58 157.7 41.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.428 HG22 ' CB ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -123.5 125.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.238 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.52 147.61 18.69 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.246 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 43' ' ' PRO . 2.0 mm -116.24 101.69 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 111.541 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 5.7 t -92.07 97.84 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 HD23 ' CD2' ' A' ' 29' ' ' PHE . 19.8 tp -102.52 151.61 22.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.178 0.513 . . . . 0.0 111.646 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.0 ptt? -134.37 157.4 46.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.397 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.48 170.16 8.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.557 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -18.85 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.539 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.74 1.73 54.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.328 . . . . 0.0 110.887 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 33.5 mtmt 72.9 26.88 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.664 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.1 mmtp -97.7 173.54 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.0 mp -109.16 123.58 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.033 0.444 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.45 ' CE2' HG22 ' A' ' 65' ' ' THR . 3.0 t80 -58.13 104.4 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.27 53.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.752 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.88 138.49 53.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.46 157.45 23.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.1 mtp85 -74.85 158.71 32.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.25 0.548 . . . . 0.0 111.29 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 -4.78 48.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.953 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -129.24 -17.29 3.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.176 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.463 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 69.4 mt -121.39 112.06 33.04 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.094 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.3 Cg_endo -65.65 132.1 29.76 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.79 1.66 . . . . 0.0 111.683 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.38 5.36 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -91.74 97.6 11.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.301 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.406 ' CZ3' ' OG ' ' A' ' 135' ' ' SER . 31.2 m95 -104.86 156.68 17.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.185 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.2 pm0 -168.76 -176.78 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.775 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.476 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 1.4 mtt -113.53 160.11 32.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.656 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 54.6 Cg_exo -52.01 128.88 28.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.629 2.219 . . . . 0.0 112.615 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.72 141.75 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.41 133.56 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.704 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.94 133.88 52.56 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 4.7 mt -65.16 159.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.611 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.453 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.29 149.62 22.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -51.78 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.195 0.521 . . . . 0.0 110.756 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.71 10.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.904 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HB3' HG22 ' A' ' 47' ' ' ILE . 14.5 tp10 -113.16 146.49 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 110.865 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.5 135.78 75.23 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -51.9 -55.24 4.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.434 2.089 . . . . 0.0 112.577 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 8.8 ttm180 -59.4 -25.83 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.396 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -84.12 -50.49 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.729 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -56.21 -31.56 63.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' CB ' ' CD1' ' A' ' 19' ' ' ILE . . . -72.45 -53.91 10.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.102 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.63 -28.49 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.238 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -83.19 -52.85 6.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -56.96 -37.51 71.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.861 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.14 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.599 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -58.8 -12.23 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.05 -41.04 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.359 . . . . 0.0 111.462 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -90.55 -31.08 16.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.996 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.45 HG22 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.13 -21.24 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.84 2.97 72.49 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.6 t -67.52 110.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -95.02 -29.53 14.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.13 76.45 6.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.309 0.576 . . . . 0.0 110.536 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 131.4 15.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -118.91 139.73 51.16 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.249 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 26.7 t -68.69 120.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.37 0.605 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -94.97 -25.12 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.934 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.49 171.32 16.07 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.825 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -149.11 123.39 9.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.484 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 78' ' ' TYR . 41.4 t -57.83 126.21 75.75 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.76 0.314 . . . . 0.0 110.317 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.47 -18.9 56.45 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.91 2.407 . . . . 0.0 113.123 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.605 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -123.17 -175.37 3.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 111.28 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.427 ' CE2' ' HE2' ' A' ' 106' ' ' LYS . 53.5 m95 -102.9 147.41 26.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.062 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 1.1 mm? -105.24 117.54 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.647 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.8 p -116.03 137.97 51.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.311 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -134.39 170.11 16.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.338 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.98 158.37 39.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.184 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE1' ' O2A' ' A' ' 166' ' ' ATP . 8.6 m-85 -112.3 145.46 32.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 37.3 Cg_endo -66.47 171.33 10.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.471 2.114 . . . . 0.0 112.432 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.3 -16.31 46.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.912 2.408 . . . . 0.0 113.201 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -90.38 -38.23 13.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.523 . . . . 0.0 109.841 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.484 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 89.3 t -76.77 -49.83 22.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.946 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.54 -52.71 58.8 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.916 0.865 . . . . 0.0 109.639 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.52 -31.5 72.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.99 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -45.22 49.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 96' ' ' TRP . 93.7 mt -61.05 -47.45 86.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 110.516 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 46.7 m-20 -47.91 -30.27 4.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.67 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 mt -97.05 -47.94 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.416 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -55.37 8.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.945 0.403 . . . . 0.0 110.861 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 92' ' ' LEU . 17.4 m0 -80.43 -29.66 37.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.875 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 70.69 38.09 67.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.241 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.8 154.09 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.99 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.27 77.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.455 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.42 150.71 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.048 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -75.64 -32.26 60.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.967 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.56 -133.31 1.88 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.374 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.9 mt-30 -158.09 114.38 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.78 105.85 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' NE2' ' CZ2' ' A' ' 107' ' ' TRP . 3.6 pt20 -121.64 157.85 29.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -105.97 98.71 8.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.817 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.476 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 40.5 m95 -69.54 130.2 41.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.734 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.432 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 68.0 m-85 -116.5 135.53 53.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.1 tp -79.57 137.46 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.066 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 40.1 m-85 -129.63 133.13 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.244 0.545 . . . . 0.0 111.925 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 34.1 tttm -96.25 119.99 35.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.489 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -68.41 123.22 20.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.99 0.424 . . . . 0.0 110.978 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.9 p -124.81 37.56 4.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.464 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.23 -145.16 4.9 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.69 154.06 47.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 109.998 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -49.87 -16.83 0.3 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.541 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -22.66 56.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.28 -25.61 58.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 119' ' ' ILE . 36.8 mt -67.99 104.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.468 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -120.92 95.43 4.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.49 -21.58 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.693 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.16 -60.03 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 110.056 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.84 -175.09 24.68 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.542 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -91.81 38.75 0.99 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.134 0.492 . . . . 0.0 109.89 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.65 73.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.104 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 t -115.58 -69.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.24 165.09 12.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.177 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 149.27 65.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.91 124.92 13.42 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.613 2.208 . . . . 0.0 112.57 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -106.27 -28.58 10.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.454 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 3.9 m-85 -110.91 159.18 17.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.87 -22.76 4.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.697 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.456 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.7 mm-40 -152.27 174.34 13.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 110.552 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p-90 -159.95 159.88 32.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.26 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.406 ' OG ' ' CZ3' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -160.26 167.6 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.429 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 68.8 m95 -97.02 121.58 39.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 35.3 m -132.49 150.53 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.717 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -70.76 160.05 83.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 14.1 Cg_endo -56.89 -18.14 26.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 121.855 1.703 . . . . 0.0 111.915 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -34.06 15.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.987 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -50.91 23.54 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.8 tp -54.87 -31.25 59.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.447 0.642 . . . . 0.0 109.845 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 9.1 mm -70.03 -27.29 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.62 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.24 -17.12 47.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.145 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 142' ' ' LEU . 13.4 mt -87.59 -38.98 15.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.6 m -57.58 163.16 2.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.03 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 149' ' ' PHE . 13.0 p -90.0 161.82 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.965 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.507 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -55.68 -31.3 62.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.759 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -92.6 7.39 43.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.456 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 4.5 mttm -133.27 -8.27 2.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.513 0.197 . . . . 0.0 111.505 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.6 mtpp -54.47 -59.43 10.31 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.264 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 16.8 Cg_endo -57.78 -42.63 57.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.3 2.0 . . . . 0.0 111.938 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.463 ' O ' HD11 ' A' ' 80' ' ' LEU . 85.9 t -57.5 -27.92 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.418 ' CD2' ' HE1' ' A' ' 42' ' ' MET . 3.3 m-85 -91.86 -53.91 4.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.382 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.64 -38.3 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.416 ' HB3' HD12 ' A' ' 80' ' ' LEU . 8.4 tp10 -60.68 -46.26 91.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.505 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 42.8 t -58.54 -49.49 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.331 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 162' ' ' ALA . 68.4 mt -62.35 -49.59 74.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.3 p -49.83 -42.45 47.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.772 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.4 t -73.44 -24.6 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.115 0.483 . . . . 0.0 110.343 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.516 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.3 m-30 -104.63 12.05 33.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.995 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.01 -55.53 32.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.386 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.0 Cg_endo -55.87 -22.37 37.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.494 2.129 . . . . 0.0 112.248 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.413 ' CB ' ' CD2' ' A' ' 109' ' ' LEU . 98.4 m-70 -89.92 -17.97 27.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.934 179.895 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.441 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.08 -167.99 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.343 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -59.31 -170.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.43 55.69 5.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -137.98 -160.67 1.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.05 0.452 . . . . 0.0 109.938 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 178.94 111.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.98 15.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.899 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.09 132.45 0.41 Allowed Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.79 122.32 9.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.273 1.982 . . . . 0.0 112.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 30.4 Cg_endo -90.59 177.4 2.25 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.784 2.322 . . . . 0.0 111.735 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.78 10.33 26.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.445 . . . . 0.0 111.995 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.19 -13.99 37.41 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 12.9 m-85 -129.97 141.34 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.026 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.416 ' HG2' ' CD2' ' A' ' 100' ' ' TRP . 29.9 mmm-85 -77.73 148.18 35.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -67.4 130.66 43.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.139 0.495 . . . . 0.0 111.534 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.471 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 m120 -152.5 162.52 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.447 HG23 ' CB ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -134.93 126.26 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 0.0 111.25 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.09 138.84 14.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.273 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -114.65 101.52 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.343 . . . . 0.0 111.26 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.9 t -90.17 104.58 17.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 112' ' ' PHE . 27.5 tp -103.29 149.13 25.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.063 0.458 . . . . 0.0 111.143 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.9 ptt? -130.11 157.37 42.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.708 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.8 p-10 -100.73 171.0 7.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.468 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -57.65 -16.02 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.547 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.04 0.27 56.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp 76.9 27.48 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.656 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -98.83 171.21 8.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -109.91 121.23 62.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.967 0.413 . . . . 0.0 110.953 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.456 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 86.9 t80 -55.49 110.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.61 137.81 51.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.356 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -123.23 139.88 53.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.401 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.21 156.88 24.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.626 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -73.01 157.75 36.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 111.367 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mt -90.5 -5.88 55.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.124 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.88 -16.6 2.89 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 61.6 mt -119.07 106.03 43.96 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 31.0 Cg_exo -60.77 129.05 27.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.164 1.909 . . . . 0.0 111.888 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.2 t70 80.61 0.93 1.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.929 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.52 97.67 10.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.4 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -101.47 155.09 18.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.119 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -169.13 -176.86 2.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.699 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.456 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 4.2 mpp? -102.66 157.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 121.37 7.9 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.601 2.201 . . . . 0.0 112.498 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -123.23 161.64 24.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.401 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.61 138.7 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.435 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.39 129.08 19.53 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 4.9 mt -61.12 158.62 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.7 m-20 -90.21 150.41 21.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.47 99.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.156 0.503 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.26 37.93 9.48 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.779 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB3' HG23 ' A' ' 47' ' ' ILE . 49.1 tt0 -114.39 147.92 38.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.174 0.511 . . . . 0.0 110.701 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.11 142.52 72.31 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.508 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 49.0 Cg_exo -56.45 -57.88 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.504 2.136 . . . . 0.0 112.89 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.8 ttt-85 -58.38 -24.78 60.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.43 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -87.71 -42.76 12.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 110.252 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -62.39 -32.7 73.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.197 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.28 -52.49 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 51.4 mt -56.82 -29.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.999 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -81.2 -52.78 6.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.716 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 31.5 mm-40 -55.4 -44.83 76.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.638 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.17 -51.86 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.829 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.575 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 31.9 ttp180 -61.59 -13.68 23.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.577 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.02 -42.26 10.08 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -90.76 -27.05 19.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.42 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.45 -21.55 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 111.093 -179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.09 8.39 61.5 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.981 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -65.23 110.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.237 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.9 p -92.46 -34.95 13.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.239 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.37 76.6 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 111.055 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.44 129.34 13.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.605 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.4 pt-20 -119.14 140.28 50.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.323 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.3 t -69.28 121.65 19.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.353 0.597 . . . . 0.0 111.17 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -97.74 -22.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' A' ' 164' ' ' HIS . . . -163.37 165.65 23.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.504 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 10.6 pt-20 -149.06 121.17 8.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.608 ' CG1' ' CD1' ' A' ' 78' ' ' TYR . 32.4 t -56.94 126.01 71.28 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 -19.41 46.48 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.951 2.434 . . . . 0.0 113.242 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.608 ' CD1' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.13 -175.3 3.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 111.511 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -104.57 147.76 27.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.77 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -104.52 118.08 35.72 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.418 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.413 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -119.98 133.71 55.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.949 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -133.85 170.31 15.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.98 161.24 23.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.634 0.731 . . . . 0.0 111.42 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 10.8 m-85 -111.15 144.06 29.66 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.477 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 39.5 Cg_endo -66.92 171.48 11.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.648 2.232 . . . . 0.0 112.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.07 -16.49 46.08 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.013 2.475 . . . . 0.0 113.354 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -91.21 -35.98 14.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 110.085 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 84.5 t -78.42 -48.6 22.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.149 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -56.67 -52.27 65.54 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.763 0.792 . . . . 0.0 109.74 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.96 -27.03 68.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -44.76 14.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.957 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 96' ' ' TRP . 72.5 mt -62.6 -46.82 86.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 110.52 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 4.1 m-20 -47.35 -31.35 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.717 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.77 -47.42 12.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.919 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -58.16 4.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 110.761 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LEU . 22.3 m0 -77.25 -32.13 55.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.3 35.65 37.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.484 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.5 153.69 49.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.86 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -117.12 46.71 1.63 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.631 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.416 ' CD2' ' HG2' ' A' ' 14' ' ' ARG . 90.9 m95 -95.06 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -30.83 66.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -179.51 -133.85 2.06 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.937 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 14.1 pt20 -157.96 114.84 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.0 111.343 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.413 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -87.46 105.78 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.848 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.7 pt20 -123.19 144.87 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -95.66 98.68 10.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 178.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.456 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 22.2 m95 -66.14 143.57 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.193 0.52 . . . . 0.0 112.149 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.3 m-85 -129.21 136.98 50.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.246 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 23.6 tp -79.34 155.01 28.64 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.489 ' N ' ' O ' ' A' ' 20' ' ' CYS . 32.8 m-85 -146.1 132.73 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.252 0.549 . . . . 0.0 112.023 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 5.5 tptp -96.46 118.27 32.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.53 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.427 ' CD1' HD21 ' A' ' 21' ' ' LEU . 4.6 t80 -68.17 120.69 14.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 0.0 110.701 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.9 p -121.81 37.43 4.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.457 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.83 -144.38 4.7 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.086 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.29 154.29 45.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 110.004 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -49.73 -16.8 0.27 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -15.7 59.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.02 -25.47 37.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 14.9 mt -73.18 103.89 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.582 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.48 95.85 4.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.024 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 49.0 mt -56.02 -21.65 22.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.654 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.6 mt -62.95 -58.84 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 109.984 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.69 -172.19 24.5 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.435 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -93.31 38.82 1.05 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.15 0.5 . . . . 0.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.45 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.302 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.8 m -114.28 -67.75 0.97 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.769 0.318 . . . . 0.0 111.25 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -98.38 165.1 12.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -76.37 147.54 79.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.69 136.18 49.81 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.613 2.209 . . . . 0.0 112.55 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -108.12 -28.39 9.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.653 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 19.0 m-85 -120.37 159.69 24.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.17 -18.11 6.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.85 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.4 mm-40 -152.45 174.94 13.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.193 0.52 . . . . 0.0 110.782 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.4 p-90 -159.45 152.38 21.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.964 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 m -148.08 157.26 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.541 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 86.9 m95 -92.81 125.11 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -136.73 151.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.118 0.485 . . . . 0.0 111.662 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.13 159.07 85.8 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.555 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.419 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.7 Cg_endo -55.82 -18.63 22.21 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.841 1.694 . . . . 0.0 112.016 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -34.17 15.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -50.45 30.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.449 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.9 tp -54.3 -29.8 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.32 0.581 . . . . 0.0 109.829 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.0 mm -69.83 -28.49 37.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.655 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -22.39 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.268 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.41 HD11 ' CD1' ' A' ' 142' ' ' LEU . 10.5 mt -82.97 -39.15 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.428 HG23 ' CG ' ' A' ' 154' ' ' TYR . 26.9 m -53.87 164.21 0.62 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.532 HG12 ' CZ ' ' A' ' 149' ' ' PHE . 10.3 p -97.24 162.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -51.51 -38.38 53.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.985 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.532 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 23.8 p90 -88.34 10.82 18.55 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.415 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 67.3 mttt -130.95 -5.12 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.419 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 12.2 mttt -55.97 -62.0 5.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.9 Cg_endo -59.01 -48.16 15.28 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.388 2.058 . . . . 0.0 112.233 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 80' ' ' LEU . 92.3 t -57.22 -27.1 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.24 0.543 . . . . 0.0 111.11 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.454 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.0 m-85 -90.91 -52.73 4.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.428 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -31.85 18.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.308 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.39 -46.13 81.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.445 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.502 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 57.7 t -59.57 -53.2 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.32 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 162' ' ' ALA . 59.1 mt -62.85 -50.01 72.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.9 t -51.66 -45.61 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.84 -25.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 110.297 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.502 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.9 m-30 -101.96 7.98 41.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.551 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.23 -56.23 21.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.623 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.9 Cg_endo -50.16 -24.67 11.65 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.567 2.178 . . . . 0.0 112.384 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.428 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 95.9 m-70 -95.39 -18.34 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.964 179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.458 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.03 152.0 67.76 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.62 2.213 . . . . 0.0 112.278 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -57.48 178.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.72 40.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.14 125.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -123.49 -40.56 2.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.246 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 t0 71.35 24.93 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t 176.31 133.91 0.18 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.701 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.25 110.78 2.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.341 2.028 . . . . 0.0 112.324 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.27 -176.97 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.93 2.42 . . . . 0.0 112.151 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.49 151.84 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.34 -37.8 3.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.642 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -83.77 144.59 29.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.51 152.23 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -75.93 126.96 32.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.6 t-20 -152.5 157.07 40.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG23 ' CB ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -125.45 124.49 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.891 0.377 . . . . 0.0 111.202 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.55 140.96 15.44 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.197 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -121.23 101.83 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.441 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.3 t -89.76 107.3 19.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 tp -103.19 146.54 28.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.7 157.53 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.976 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.7 p-10 -100.59 170.93 8.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.06 -18.21 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.608 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 0.31 56.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.988 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp 76.83 25.63 0.85 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.558 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttp -94.4 172.44 8.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.8 mp -110.54 120.35 61.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.947 0.403 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.456 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 68.2 t80 -53.9 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.129 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.52 131.57 56.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.368 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -117.33 138.29 51.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.914 0.388 . . . . 0.0 111.178 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.29 155.87 24.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -70.41 159.16 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 111.599 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -92.84 -5.81 50.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.831 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.51 -19.49 4.19 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 66.8 mt -120.4 112.76 34.1 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.968 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.09 131.61 29.22 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.858 1.705 . . . . 0.0 111.911 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.32 2.66 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -86.94 97.36 10.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.301 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -102.34 155.41 18.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.176 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -168.62 169.15 10.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.416 ' HE2' ' CG ' ' A' ' 154' ' ' TYR . 76.2 mtm -89.92 155.22 47.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.16 149.37 22.16 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.697 2.265 . . . . 0.0 113.061 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -176.39 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.214 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 138.08 4.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.296 -0.955 . . . . 0.0 112.858 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.76 126.32 29.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 48' ' ' ASP . 5.6 mt -60.99 161.28 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.685 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -88.34 -176.38 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.2 98.62 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.23 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.79 47.39 9.8 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.749 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HB3' HG21 ' A' ' 47' ' ' ILE . 6.5 tt0 -115.62 146.75 41.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.55 134.86 84.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.588 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.43 -57.25 2.2 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.401 2.067 . . . . 0.0 112.659 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.424 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -56.84 -28.06 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.434 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -81.97 -49.7 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.718 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -57.16 -30.76 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.65 -52.0 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.9 mt -55.85 -28.71 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.244 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.5 ttp85 -83.62 -52.8 6.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.885 0.85 . . . . 0.0 109.89 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -56.36 -34.55 66.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.684 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.4 tp -57.13 -59.54 4.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.181 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.564 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 22.4 ptt85 -61.34 -10.71 7.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.793 0.33 . . . . 0.0 110.691 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -91.19 -45.12 8.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 0.0 111.561 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.46 -28.12 17.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -21.49 10.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.837 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.17 4.85 74.53 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.039 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.2 119.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.364 . . . . 0.0 110.566 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -99.25 -34.07 10.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.35 78.27 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.184 0.516 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.39 129.6 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.924 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -120.0 145.76 46.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.577 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.1 t -76.11 125.9 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.527 0.679 . . . . 0.0 111.967 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -107.62 -16.19 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.339 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB2' ' CD1' ' A' ' 161' ' ' PHE . . . -155.35 160.18 40.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 115.56 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.104 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 78' ' ' TYR . 7.2 t -57.33 127.47 77.0 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.951 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 -15.55 44.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.784 2.322 . . . . 0.0 113.585 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -128.34 174.63 9.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.493 0.663 . . . . 0.0 112.364 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.438 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 13.0 m95 -99.8 147.09 25.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 46.1 mt -114.34 117.56 31.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.763 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 p -113.56 130.57 56.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -131.91 160.14 36.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.46 158.38 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.182 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.11 150.17 37.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.483 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 30.6 Cg_endo -62.59 170.86 6.33 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.441 2.094 . . . . 0.0 112.027 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.6 -17.47 59.66 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.786 2.324 . . . . 0.0 113.298 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -93.32 -33.11 14.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.122 0.486 . . . . 0.0 110.216 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.483 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 74.4 t -84.26 -47.0 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -59.72 -45.66 91.48 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -27.73 67.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.524 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -46.6 19.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.8 mt -58.67 -46.56 86.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 0.0 110.525 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.401 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 12.3 m-80 -46.48 -32.27 3.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.696 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.66 -47.55 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -54.75 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' A' ' 92' ' ' LEU . 10.9 m95 -80.45 -29.94 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 75.8 34.75 47.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.548 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.73 147.18 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.586 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -118.43 64.28 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.019 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.3 m95 -119.5 150.04 40.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.74 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 -30.14 55.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -166.04 -144.5 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.447 ' NE2' ' CD2' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -158.16 113.44 2.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 111.511 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.15 105.67 17.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.936 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.9 pt20 -126.08 153.7 44.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.5 mttt -107.81 95.76 5.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.522 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.428 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 61.4 m95 -63.42 140.2 58.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.336 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 66.9 m-85 -125.82 138.32 53.82 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.402 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 21.6 tp -79.56 154.77 28.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.487 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 34.2 m-85 -148.51 127.83 13.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 0.0 111.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.533 ' HB2' HG13 ' A' ' 73' ' ' ILE . 22.8 tttt -93.72 119.58 32.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.576 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -62.77 125.31 23.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.7 p -127.11 37.88 4.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.52 -144.84 4.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.071 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -127.2 154.26 45.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -49.83 -16.65 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.574 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -78.55 -18.1 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -80.3 -25.56 39.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.811 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.456 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 15.5 mt -74.15 102.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.369 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.49 96.09 5.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.115 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 53.0 mt -55.45 -22.73 21.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.436 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.24 -58.51 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.13 -179.26 20.8 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.595 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -90.0 38.65 0.93 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.151 0.501 . . . . 0.0 109.768 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.93 73.4 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.254 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -102.88 165.19 11.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -73.41 148.48 88.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -50.85 138.93 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.216 . . . . 0.0 112.624 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -112.07 -33.0 6.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.648 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 29.1 m-85 -116.83 159.38 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.522 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.93 -16.82 6.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.852 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.41 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.2 mm-40 -152.31 175.04 13.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.3 p-90 -159.11 151.54 21.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.134 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 m -147.62 161.05 41.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.492 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.47 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.4 m95 -95.09 125.03 39.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.436 HG21 ' CA ' ' A' ' 142' ' ' LEU . 27.5 m -137.55 150.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.7 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -70.15 159.62 83.78 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.533 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 12.3 Cg_endo -56.27 -18.3 23.68 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 121.826 1.684 . . . . 0.0 111.999 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.06 -34.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.029 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.25 -50.48 32.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.069 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.436 ' CA ' HG21 ' A' ' 137' ' ' VAL . 3.4 tp -53.62 -34.12 57.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.592 0.71 . . . . 0.0 109.885 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 139' ' ' PRO . 7.8 mm -66.99 -27.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.737 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.31 -22.07 38.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.969 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.7 mt -84.11 -39.41 19.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.827 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -58.35 167.51 1.35 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.115 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 150' ' ' LYS . 13.6 p -98.97 163.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.833 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.99 -36.62 79.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 147' ' ' VAL . 8.5 p90 -79.38 -0.82 34.31 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.506 ' HB2' HG13 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -139.09 10.66 2.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.676 0.274 . . . . 0.0 111.278 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mtpt -69.45 -62.76 2.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.7 Cg_endo -53.99 -43.34 59.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.47 2.113 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.462 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.5 t -57.64 -24.59 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.416 ' CG ' ' HE2' ' A' ' 42' ' ' MET . 3.1 m-85 -91.02 -47.81 7.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.438 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -33.32 32.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 5.6 tp10 -67.15 -45.77 76.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 45.9 t -59.02 -47.09 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.056 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.6 mt -66.65 -48.69 68.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.781 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -52.07 -45.85 64.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.79 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.56 -24.84 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 110.679 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.0 m-30 -98.17 -7.86 28.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.16 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.528 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -50.19 -44.92 82.15 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.559 0.218 . . . . 0.0 111.371 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 162' ' ' ALA . 35.6 Cg_exo -60.5 -22.97 73.94 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.63 2.22 . . . . 0.0 112.679 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.419 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 73.5 m-70 -95.02 -44.48 7.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.793 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.427 ' O2B' ' CH2' ' A' ' 96' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.86 -167.63 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.598 2.199 . . . . 0.0 112.248 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.86 88.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.07 -30.67 4.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.54 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -140.59 -161.78 1.26 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 79' ' ' TRP . 4.5 tpp -168.24 108.46 0.53 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.757 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.45 12.55 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.057 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -158.46 123.83 2.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.517 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 52.2 Cg_endo -68.79 112.49 2.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.081 1.854 . . . . 0.0 112.337 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -89.01 -170.14 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.997 2.464 . . . . 0.0 112.326 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -88.72 163.75 15.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.83 -40.33 2.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.405 ' HB3' ' CA ' ' A' ' 103' ' ' GLN . 5.5 m-85 -100.94 134.2 44.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -78.96 152.62 30.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.517 ' NH1' ' HB3' ' A' ' 9' ' ' PRO . 4.8 mmp_? -66.5 128.16 35.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.254 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 1.5 t30 -152.77 159.03 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.449 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.435 HG12 HD12 ' A' ' 47' ' ' ILE . 4.5 m -136.23 125.33 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.994 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.39 154.8 20.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.925 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.497 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 5.2 mp -128.88 110.87 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' PHE . 43.0 t -90.57 103.97 16.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD23 ' CD2' ' A' ' 29' ' ' PHE . 25.1 tp -102.88 149.61 24.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.065 0.459 . . . . 0.0 111.239 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.96 158.25 38.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.967 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.465 ' HB3' ' CZ3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -108.55 167.32 10.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.65 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -49.08 -19.24 0.4 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.56 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 0.0 111.467 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 76.71 23.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.659 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.91 171.71 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.77 123.44 64.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.018 0.437 . . . . 0.0 110.758 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.418 ' CD2' HD23 ' A' ' 21' ' ' LEU . 9.3 t80 -52.43 116.84 2.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -122.14 132.29 54.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.024 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -121.69 139.8 53.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.981 0.419 . . . . 0.0 111.38 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.05 155.85 24.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.391 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.423 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -71.84 158.39 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.541 . . . . 0.0 111.634 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.46 -6.03 53.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.997 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -131.11 -17.68 3.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.494 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 54.6 mt -118.6 111.7 37.66 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.0 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 131.72 29.66 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.94 1.76 . . . . 0.0 111.811 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.49 3.07 3.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.793 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.494 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.22 97.41 11.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.7 m95 -102.39 155.73 18.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.252 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -169.13 -176.94 2.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.692 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.3 mpp? -103.29 158.26 32.15 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.57 146.61 80.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.463 2.109 . . . . 0.0 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.435 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -153.98 176.64 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.18 6.44 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.81 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.71 130.77 20.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.222 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.9 mt -58.59 159.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.3 m-20 -90.49 149.47 22.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.822 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.44 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 39.8 10.84 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.935 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HB3' HG21 ' A' ' 47' ' ' ILE . 5.9 tp10 -114.12 146.78 39.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.908 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.54 140.98 82.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.497 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.77 -37.8 95.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.357 2.038 . . . . 0.0 112.471 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.5 ttp180 -75.78 -23.34 55.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.67 -43.97 10.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.445 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.418 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -62.04 -30.84 71.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.32 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.4 -51.37 17.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.157 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.0 mt -56.82 -28.77 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.18 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 ttp85 -84.25 -52.8 5.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.792 0.806 . . . . 0.0 109.991 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -53.15 -42.54 66.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -55.83 -54.64 42.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.529 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.8 ttp180 -61.17 -13.92 21.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.299 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -92.01 -40.85 10.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.836 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.39 -26.26 18.96 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.02 -20.55 8.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.48 4.09 73.7 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.098 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.02 118.58 15.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.616 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -98.62 -35.25 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.29 80.85 6.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.944 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.63 130.8 14.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.035 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 pt-20 -120.3 144.0 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.02 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.5 t -76.79 122.95 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.646 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.609 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.5 mm -107.08 -15.33 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.438 ' HB1' ' CB ' ' A' ' 109' ' ' LEU . . . -155.98 154.03 30.47 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.837 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -148.67 117.93 6.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 78' ' ' TYR . 7.5 t -57.53 127.03 77.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.926 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.58 -6.12 18.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.923 2.415 . . . . 0.0 114.117 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.597 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -136.53 138.97 41.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' MET . 24.9 m95 -64.28 145.32 56.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.279 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -103.92 138.73 40.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.4 p -139.18 130.7 27.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CE1' HG13 ' A' ' 153' ' ' VAL . 9.9 p90 -139.1 170.44 15.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.95 158.3 35.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.018 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -102.44 154.21 37.59 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.703 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.453 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 25.6 Cg_endo -62.46 170.02 7.37 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.389 2.059 . . . . 0.0 112.145 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.88 -9.67 23.94 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.836 2.358 . . . . 0.0 113.131 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -97.03 -32.51 11.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.146 0.498 . . . . 0.0 110.024 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 98.5 t -84.11 -49.33 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -58.84 -49.39 77.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.27 -29.64 69.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.403 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -46.64 17.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 96' ' ' TRP . 93.8 mt -57.83 -46.95 84.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.642 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.408 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.9 m120 -45.74 -31.89 2.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.475 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.43 -49.6 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.278 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -56.28 10.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.793 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.456 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.5 m0 -77.62 -33.97 53.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.92 36.61 27.96 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.346 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.56 147.6 52.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -108.39 37.81 2.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.94 150.44 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -25.43 41.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.44 . . . . 0.0 110.578 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -177.98 -137.82 2.9 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.826 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.405 ' CA ' ' HB3' ' A' ' 13' ' ' TYR . 3.6 pt20 -158.16 115.28 2.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.704 0.287 . . . . 0.0 111.436 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 80' ' ' LEU . . . -85.92 105.56 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.522 ' OE1' ' CD1' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -123.6 154.44 39.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -111.31 103.83 12.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.696 178.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.522 ' CD1' ' OE1' ' A' ' 105' ' ' GLN . 28.1 m95 -66.23 146.18 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.201 0.524 . . . . 0.0 112.085 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 50.8 m-85 -129.13 130.65 46.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.925 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.2 tp -78.72 151.81 31.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 45.1 m-85 -148.62 128.0 13.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.609 ' HB2' HG13 ' A' ' 73' ' ' ILE . 16.0 tptt -92.62 122.45 35.05 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -64.88 126.35 27.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.849 0.357 . . . . 0.0 111.226 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.415 ' CG2' ' HG2' ' A' ' 71' ' ' GLU . 3.2 p -125.45 37.34 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.37 -145.03 4.76 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.106 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -128.51 154.31 46.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.837 0.351 . . . . 0.0 110.147 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -49.33 -17.13 0.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.33 -20.38 57.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.802 0.334 . . . . 0.0 111.224 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.21 -26.28 52.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 119' ' ' ILE . 31.5 mt -68.68 104.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.474 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.1 95.87 4.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.159 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.0 mt -57.34 -21.04 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.522 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' CD1' ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -60.53 -57.66 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.95 -179.65 18.71 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.19 38.72 0.94 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.71 28.44 73.76 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.127 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -114.99 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.269 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -102.17 165.12 11.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -74.71 145.54 81.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.403 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 52.5 Cg_exo -53.82 137.98 68.32 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.577 2.184 . . . . 0.0 112.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.57 -28.22 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.43 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 13.9 m-85 -118.02 159.5 23.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.23 -19.66 5.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.723 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.402 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 32.3 mm-40 -152.25 174.51 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.078 0.465 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.9 p-90 -159.27 154.05 24.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.388 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.14 166.25 26.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.301 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.465 ' CZ3' ' HB3' ' A' ' 23' ' ' ASN . 54.1 m95 -99.54 125.67 45.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.2 m -139.28 151.44 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.469 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -69.76 162.48 67.56 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.466 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 19.3 Cg_endo -58.78 -16.72 32.63 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.762 1.642 . . . . 0.0 111.995 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -35.01 13.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.2 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.36 33.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.051 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.6 tp -54.57 -27.81 41.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.473 0.654 . . . . 0.0 110.014 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 139' ' ' PRO . 5.2 mm -73.52 -27.45 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.843 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.45 -23.79 42.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.085 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.409 HD22 ' CD1' ' A' ' 40' ' ' TRP . 8.8 mt -81.01 -40.18 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 109.922 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.4 m -57.89 169.3 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.872 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 149' ' ' PHE . 6.1 p -105.37 159.03 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.551 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 11.3 pt-20 -42.42 -51.87 4.81 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.487 ' CE2' HG12 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -71.11 -7.29 45.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.238 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.447 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 1.9 mttt -123.34 -1.59 8.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.586 0.232 . . . . 0.0 111.514 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 15.6 mtpt -68.63 -60.74 4.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.277 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 14.8 Cg_endo -57.3 -42.68 59.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.304 2.002 . . . . 0.0 111.538 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.516 ' O ' HD12 ' A' ' 80' ' ' LEU . 35.0 t -61.07 -24.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 3.4 m-85 -90.64 -50.19 6.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.253 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' CG ' ' CD1' ' A' ' 143' ' ' ILE . 7.9 mtpm? -51.38 -30.92 20.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.377 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.464 ' HB3' HD13 ' A' ' 80' ' ' LEU . 1.3 tp10 -67.54 -46.23 73.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.322 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.527 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 39.4 t -62.13 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.102 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 162' ' ' ALA . 73.7 mt -67.19 -49.07 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.6 t -51.13 -46.86 62.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.1 t -66.12 -24.03 33.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.192 0.52 . . . . 0.0 110.34 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.675 ' C ' ' HD2' ' A' ' 163' ' ' PRO . 10.5 m-30 -98.65 -6.67 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.786 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -44.69 -39.46 7.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.675 ' HD2' ' C ' ' A' ' 161' ' ' PHE . 20.5 Cg_endo -63.17 -23.84 72.88 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.135 1.89 . . . . 0.0 113.8 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.674 ' CD2' ' HB3' ' A' ' 161' ' ' PHE . 3.2 p80 -89.37 -25.41 21.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.754 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.641 ' HG ' ' CE1' ' A' ' 164' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.9 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.415 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 175.72 8.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.32 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -175.0 159.44 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.82 84.98 1.41 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.444 ' HB3' ' CG ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER 64.08 125.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.626 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 tpt -112.0 -47.23 3.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.7 t70 66.07 23.08 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m 173.1 119.32 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.59 109.66 1.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.282 1.988 . . . . 0.0 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 -174.95 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.904 2.403 . . . . 0.0 112.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.29 153.57 20.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.834 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.01 -38.23 3.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.557 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -86.85 136.95 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 3.7 ttt85 -84.25 152.42 24.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -63.74 129.4 39.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 20.5 t-20 -152.65 150.82 29.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 53' ' ' PRO . 2.7 m -123.28 141.37 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.34 149.85 17.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.281 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.477 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -129.22 101.6 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.1 t -89.63 106.29 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 32.6 tp -102.68 143.0 32.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 111.195 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.3 ptt? -127.74 157.3 40.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 40.0 p-10 -103.3 170.21 8.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.302 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -55.74 -17.47 6.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.515 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.02 0.42 56.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.731 0.3 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 76.47 26.43 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' MET . 12.6 mttt -97.01 173.88 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 142' ' ' LEU . 4.8 mp -112.2 121.4 64.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.943 0.401 . . . . 0.0 110.884 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.458 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 12.6 t80 -54.73 108.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.384 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.79 134.49 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.376 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.27 141.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 111.319 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.29 158.31 23.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.614 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 5.0 mtp-105 -71.26 163.65 27.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.35 0.595 . . . . 0.0 111.676 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.2 mt -96.67 -7.33 34.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.564 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.13 -18.51 4.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.348 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.543 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 66.7 mt -120.73 112.76 33.61 Favored Pre-proline 0 N--CA 1.457 -0.109 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.171 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.44 132.1 30.18 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.955 1.77 . . . . 0.0 111.792 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.37 2.47 3.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.829 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.67 97.55 11.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.312 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -101.18 156.08 17.64 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.933 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -168.98 169.43 9.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 43.2 mtm -97.09 155.9 36.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 129.67 20.15 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.193 . . . . 0.0 113.038 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 141.74 19.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.57 160.84 28.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.863 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.9 126.84 7.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 11.7 mt -55.71 162.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.579 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 8.5 m-20 -73.48 -170.9 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.573 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.06 29.28 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.275 0.56 . . . . 0.0 111.145 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.53 52.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' HB3' HG22 ' A' ' 47' ' ' ILE . 2.7 tt0 -128.43 148.17 50.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.088 0.47 . . . . 0.0 111.076 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.13 128.19 81.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.87 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HA ' HG13 ' A' ' 17' ' ' VAL . 1.4 Cg_endo -45.93 -29.73 6.3 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.59 2.194 . . . . 0.0 113.11 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -29.57 62.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.775 0.322 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -86.67 -44.59 11.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.195 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.15 -31.69 67.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.92 -54.76 7.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.066 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.6 mt -56.05 -31.7 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -78.84 -53.4 7.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.832 0.825 . . . . 0.0 109.89 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 15.2 mm-40 -50.87 -38.97 52.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.45 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -58.15 -58.88 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.129 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.523 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 ptp180 -61.42 -11.84 12.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -91.62 -43.74 9.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 0.0 111.718 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.78 -25.4 19.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -115.43 -20.91 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.12 5.17 70.26 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.72 129.34 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 p -105.71 -34.63 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 81.64 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.54 14.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -119.63 147.48 44.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.17 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.534 ' CG2' ' CZ ' ' A' ' 110' ' ' PHE . 31.2 t -78.49 123.06 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.433 0.635 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.557 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -104.34 -22.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.274 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -152.11 159.75 43.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.18 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.5 pt-20 -148.31 111.7 4.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.171 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 ' CD1' ' A' ' 78' ' ' TYR . 3.8 t -57.62 125.73 73.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.219 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 4.8 Cg_exo -74.45 -8.14 20.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.845 2.363 . . . . 0.0 113.571 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.529 ' CD1' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.44 135.91 50.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 112.187 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD2' ' CG ' ' A' ' 106' ' ' LYS . 29.3 m95 -67.7 145.57 54.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.07 0.462 . . . . 0.0 110.109 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 55.7 mt -111.36 117.93 34.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.897 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.5 p -108.89 140.18 42.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.74 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -134.24 170.18 16.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.886 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.81 158.34 33.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -120.85 146.6 44.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.451 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 34.4 Cg_endo -64.52 172.28 6.95 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.603 2.202 . . . . 0.0 112.241 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.23 -9.59 25.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.844 2.363 . . . . 0.0 113.056 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -98.03 -35.24 10.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.146 0.498 . . . . 0.0 110.041 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.451 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 87.6 t -82.57 -45.34 19.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -60.74 -46.54 90.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 109.465 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.84 -28.22 68.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.586 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -47.63 16.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.627 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 96' ' ' TRP . 78.7 mt -58.44 -45.48 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 110.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.1 m-80 -46.14 -32.01 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.468 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.47 -49.36 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.39 -56.87 8.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.442 ' N ' ' O ' ' A' ' 92' ' ' LEU . 18.3 m0 -77.83 -34.46 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.785 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 80.74 34.66 27.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.577 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.43 147.07 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.56 49.66 0.91 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.427 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 36.7 m95 -105.24 150.15 25.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.744 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -30.76 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.64 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -161.6 -143.44 3.68 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.098 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.9 mm-40 -157.64 115.55 3.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.883 0.373 . . . . 0.0 111.435 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.48 105.61 17.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.3 pt20 -124.34 154.78 39.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' CG ' ' CD2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -107.51 105.38 15.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.485 178.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.465 ' CG ' HG21 ' A' ' 157' ' ' VAL . 26.6 m95 -72.92 144.88 47.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.222 0.534 . . . . 0.0 112.259 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.9 m-85 -127.58 132.79 49.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.361 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.7 tp -79.81 129.08 34.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.534 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 46.4 m-85 -123.73 127.87 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.557 ' HB2' HG13 ' A' ' 73' ' ' ILE . 2.2 tppp? -91.73 121.78 33.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -63.52 126.68 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.846 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 p -127.12 37.62 4.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.627 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.56 -145.17 4.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.066 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -129.64 154.16 47.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.882 0.372 . . . . 0.0 110.067 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -49.5 -16.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.602 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -76.9 -23.29 52.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.88 -25.17 52.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.822 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.03 104.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.393 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -121.2 95.91 4.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.914 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.8 mt -58.56 -21.05 51.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mt -61.46 -57.44 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.799 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.87 179.04 21.81 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.575 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -90.25 38.75 0.94 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.214 0.531 . . . . 0.0 109.724 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.56 26.95 73.28 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.063 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -117.42 -69.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -96.44 165.13 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.204 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -77.43 148.81 77.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -50.51 135.92 40.57 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.62 2.213 . . . . 0.0 112.597 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -111.91 -30.64 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.43 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 25.3 m-85 -118.34 159.51 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.7 -13.96 7.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.697 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.8 mp0 -152.17 174.18 14.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.085 0.469 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.3 p-90 -159.74 150.04 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 m -148.68 156.64 42.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.465 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.439 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -92.14 125.01 36.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.5 m -135.62 150.78 29.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.138 0.494 . . . . 0.0 111.579 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.8 159.67 83.08 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.583 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 12.9 Cg_endo -56.5 -17.97 23.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.917 1.745 . . . . 0.0 111.965 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.07 14.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.102 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.49 -50.63 29.58 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.3 tp -53.68 -33.43 55.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 109.819 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 139' ' ' PRO . 6.0 mm -67.34 -27.65 39.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.811 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.3 -24.37 42.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.057 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD13 ' CD1' ' A' ' 142' ' ' LEU . 8.6 mt -82.34 -39.58 22.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.857 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 m -54.25 168.59 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.272 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.481 HG12 ' CZ ' ' A' ' 149' ' ' PHE . 7.5 p -103.65 160.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -47.65 -40.61 20.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.349 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.481 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 21.7 p90 -86.22 8.3 21.7 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.434 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 15.1 mttt -130.9 -1.61 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.588 0.233 . . . . 0.0 111.457 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 31.6 mttt -63.81 -62.85 4.64 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.269 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 14.7 Cg_endo -57.16 -41.4 74.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.102 . . . . 0.0 112.004 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 82' ' ' TYR . 20.0 t -60.62 -26.78 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.15 0.5 . . . . 0.0 110.977 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.1 m-85 -91.09 -55.05 3.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.846 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.404 ' CG ' ' CD1' ' A' ' 143' ' ' ILE . 34.6 mttm -47.92 -33.49 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.709 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 7.4 tp10 -67.94 -44.5 76.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.519 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 58.6 t -61.5 -49.17 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.222 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 162' ' ' ALA . 73.9 mt -62.86 -48.4 79.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.658 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.9 m -49.58 -47.49 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.808 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.27 -24.98 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.664 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.519 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.6 m-30 -100.6 1.93 41.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.283 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.94 -54.47 40.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.355 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.29 -20.81 26.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.608 2.206 . . . . 0.0 112.379 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.416 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 19.9 m-70 -89.51 -21.19 23.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.677 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.895 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.458 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.89 145.03 55.21 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.522 2.148 . . . . 0.0 112.307 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 tp -133.52 -172.9 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.26 66.58 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.446 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 7.9 m -138.29 -159.82 1.0 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.975 0.417 . . . . 0.0 110.077 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.9 OUTLIER -159.88 100.15 1.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.864 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.28 12.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -156.81 120.27 2.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.8 112.37 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.208 1.939 . . . . 0.0 112.053 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 21.2 Cg_exo -65.47 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.611 2.208 . . . . 0.0 112.118 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.36 144.04 26.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.342 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' HA3' ' HE2' ' A' ' 101' ' ' LYS . . . 93.82 -40.56 2.75 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.731 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 10' ' ' PRO . 49.3 m-85 -68.62 136.76 53.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.148 0.499 . . . . 0.0 110.919 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 14.9 ttt-85 -84.95 152.12 23.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.302 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 4.3 mmp_? -66.24 124.32 22.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 12.8 t-20 -152.65 159.9 43.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' A' ' 56' ' ' ALA . 3.7 m -133.96 146.79 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.52 150.47 17.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.467 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -127.89 101.98 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.277 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -89.45 104.93 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 36.5 tp -103.09 141.59 35.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.061 0.458 . . . . 0.0 111.277 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.84 157.58 37.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.8 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.43 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.5 p-10 -101.4 171.33 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.241 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.33 -16.76 9.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.535 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.15 56.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.729 0.299 . . . . 0.0 110.972 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? 77.05 27.04 0.71 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.484 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -99.81 171.67 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -110.32 124.3 66.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.879 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.457 ' CE2' ' CG2' ' A' ' 119' ' ' ILE . 33.7 t80 -58.52 108.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.82 129.88 56.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.398 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -113.96 141.27 47.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.133 0.492 . . . . 0.0 111.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.435 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 2.3 p -82.53 158.84 22.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.726 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.529 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -67.6 165.92 16.03 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 111.712 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -89.31 -8.86 52.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.161 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -148.07 -7.51 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.529 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 49.9 mt -114.35 109.77 48.43 Favored Pre-proline 0 CA--C 1.523 -0.083 0 CA-C-N 118.562 0.619 . . . . 0.0 110.918 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 27.2 Cg_endo -64.87 130.85 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.892 1.728 . . . . 0.0 111.616 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.7 t70 80.89 1.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.485 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' ' HB ' ' A' ' 36' ' ' ILE . . . -94.67 97.66 10.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.153 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 33.3 m95 -108.91 162.17 14.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.859 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -168.73 164.8 12.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.457 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 77.6 mtm -94.9 157.79 36.12 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.66 132.99 32.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.646 2.231 . . . . 0.0 113.006 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.29 154.34 33.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.244 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.47 151.31 21.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.829 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.18 141.93 43.86 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.454 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 20.3 mt -76.68 164.32 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.952 0.406 . . . . 0.0 110.716 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 3.2 m-20 -84.05 -175.8 5.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.671 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.63 100.01 6.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.324 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.65 49.77 17.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.615 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 3.1 tp10 -115.68 145.65 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -71.83 132.73 84.76 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.453 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HA ' HD11 ' A' ' 47' ' ' ILE . 55.9 Cg_exo -52.96 -44.91 44.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.492 2.128 . . . . 0.0 112.9 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -59.92 -27.16 66.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -86.75 -47.37 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.712 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.02 -29.69 68.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.73 -50.35 15.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.203 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.421 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 55.7 mt -57.78 -30.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.088 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 3.1 ttp-105 -81.05 -53.54 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 109.815 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -53.96 -33.82 57.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.39 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tp -55.06 -59.82 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.601 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 5.9 ptt180 -61.47 -11.94 12.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.81 -39.57 11.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 111.548 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.402 ' OE2' ' PG ' ' A' ' 166' ' ' ATP . 5.0 mm-40 -90.26 -32.75 16.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.099 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.88 -23.24 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.091 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.53 1.54 82.69 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' A' ' 112' ' ' PHE . 51.1 t -67.2 115.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -33.9 14.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.5 81.86 5.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.853 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.18 131.59 15.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.788 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.9 pt-20 -118.81 146.63 44.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.521 ' CG2' ' CZ ' ' A' ' 110' ' ' PHE . 25.6 t -78.86 122.34 33.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.618 . . . . 0.0 111.529 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -104.62 -21.43 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 161' ' ' PHE . . . -152.86 160.83 43.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.175 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.34 110.72 4.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.526 HG13 ' CD1' ' A' ' 78' ' ' TYR . 3.4 t -57.63 123.56 63.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.65 -6.03 17.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.798 2.332 . . . . 0.0 113.745 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.526 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -130.06 135.08 47.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.241 0.543 . . . . 0.0 112.09 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' MET . 27.9 m95 -66.46 147.24 53.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 53.2 mt -116.51 117.63 30.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.657 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.414 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 2.6 p -111.84 131.51 55.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -132.05 161.31 33.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.62 158.45 26.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.241 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -112.8 154.36 44.87 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.701 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 29.4 Cg_endo -62.95 171.61 5.85 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.531 2.154 . . . . 0.0 112.419 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.08 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.84 2.36 . . . . 0.0 113.165 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -91.46 -34.45 14.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.17 0.51 . . . . 0.0 110.017 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.473 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 71.3 t -82.41 -48.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.169 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.72 -46.13 84.83 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 109.538 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.07 -28.29 67.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.6 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -46.93 22.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.661 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 96' ' ' TRP . 96.1 mt -58.51 -47.07 85.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.472 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -45.86 -31.67 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.549 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.53 -49.13 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -55.2 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.869 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.447 ' N ' ' O ' ' A' ' 92' ' ' LEU . 18.9 m0 -78.43 -34.9 47.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.655 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.46 36.16 30.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.3 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 147.28 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.866 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.405 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -108.36 71.99 0.82 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.806 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 15.7 m95 -135.29 136.81 41.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.086 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.419 ' HE2' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -70.53 -32.95 70.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.199 0.523 . . . . 0.0 109.998 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.23 -153.11 6.4 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.665 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -158.21 116.65 3.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.747 0.308 . . . . 0.0 111.217 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.414 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -85.88 105.65 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' NE2' ' CE1' ' A' ' 82' ' ' TYR . 0.9 OUTLIER -124.82 152.41 43.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -106.7 101.63 11.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.594 178.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.457 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 22.1 m95 -69.01 143.96 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 0.0 112.128 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 50.9 m-85 -124.83 135.74 53.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.277 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.6 tp -79.88 131.09 35.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.392 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.6 m-85 -125.39 127.35 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.673 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.516 ' HB2' HG13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.56 123.62 34.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.425 ' CD1' HG11 ' A' ' 67' ' ' VAL . 5.7 t80 -67.51 128.82 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 111.328 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 69' ' ' SER . 4.7 p -128.7 37.64 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.264 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.34 -144.45 4.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.156 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 153.86 47.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.968 0.413 . . . . 0.0 110.199 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.87 -14.35 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.589 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.62 -17.84 40.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.38 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -81.37 -24.58 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.457 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 32.1 mt -69.46 105.32 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 111.579 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -116.7 95.88 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.874 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.6 mt -52.22 -24.82 7.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.0 mt -63.21 -57.64 9.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.252 0.549 . . . . 0.0 109.974 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.32 -177.45 25.59 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.5 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.29 39.01 1.01 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.142 0.496 . . . . 0.0 109.709 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.18 71.5 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -121.83 -64.18 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.82 165.15 17.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 155.52 47.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.003 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.7 149.8 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.786 2.324 . . . . 0.0 112.773 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -144.21 -44.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.437 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 7.4 m-85 -111.6 159.74 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.35 -16.4 6.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.989 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 23.4 mm-40 -152.32 175.11 13.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 110.491 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.9 p-90 -159.09 150.96 20.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.178 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 m -148.55 162.24 40.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 73.8 m95 -95.67 125.33 40.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.657 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.8 m -137.63 150.96 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.097 0.475 . . . . 0.0 111.681 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.9 158.8 87.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.616 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 11.1 Cg_endo -54.89 -19.45 19.43 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 121.941 1.761 . . . . 0.0 112.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.19 -33.85 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.994 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -50.05 30.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.916 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.8 tp -54.18 -29.67 46.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.447 0.641 . . . . 0.0 109.785 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.1 mm -69.53 -28.41 37.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.71 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.5 -21.02 42.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.127 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.0 mt -84.37 -39.54 18.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.933 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -58.33 164.98 2.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.971 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 150' ' ' LYS . 15.0 p -95.57 160.85 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.504 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.9 OUTLIER -59.92 -27.07 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 24.8 p90 -91.1 10.9 24.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.511 ' HB2' HG12 ' A' ' 147' ' ' VAL . 10.1 mtmt -151.8 14.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.669 0.271 . . . . 0.0 111.584 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.504 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.8 mtpp -69.21 -62.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.25 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.1 Cg_endo -51.72 -41.98 59.18 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.533 2.155 . . . . 0.0 112.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.438 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 19.0 t -56.09 -27.24 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.439 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -90.59 -53.0 4.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.473 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -31.86 18.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.192 0.52 . . . . 0.0 110.445 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 3.3 tp10 -67.58 -44.85 77.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.696 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.501 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 43.6 t -61.31 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.06 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 162' ' ' ALA . 71.8 mt -65.0 -48.71 73.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.55 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 t -49.43 -47.5 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.689 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.93 -25.41 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 110.35 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.501 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.5 m-30 -102.53 8.57 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.068 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.537 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.99 -57.26 16.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.27 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 14.1 Cg_endo -57.2 -22.02 46.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.426 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 97.2 m-70 -89.91 -14.25 34.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.095 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.921 179.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.446 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 -177.93 2.18 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.577 2.184 . . . . 0.0 112.282 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -60.31 172.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.18 37.19 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.03 121.37 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.75 0.309 . . . . 0.0 110.552 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.83 -36.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.65 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 77.5 24.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 170.51 137.51 0.07 OUTLIER Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.517 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 36.2 Cg_endo -65.88 109.79 1.56 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.352 2.034 . . . . 0.0 112.187 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.95 -177.14 3.69 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.102 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.35 152.5 20.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.911 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 -27.24 17.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.5 m-85 -109.2 138.16 45.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.978 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 7.3 mtp85 -80.82 152.15 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -71.29 132.94 45.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.244 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 18.9 t-20 -152.83 157.16 40.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.868 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.426 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.5 m -129.02 134.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 111.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.64 157.11 15.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.098 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 43' ' ' PRO . 1.4 mm -120.77 101.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.691 0.246 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.7 t -89.59 97.28 11.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 23.4 tp -102.5 145.27 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 111.393 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.35 157.31 41.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.749 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.5 p-10 -102.06 170.33 8.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.348 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.48 -18.55 4.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.91 0.14 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 76.78 25.23 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.607 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' MET . 14.4 mttp -93.63 173.27 7.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.1 mp -111.44 120.07 61.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 110.868 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 19.8 t80 -53.88 110.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.53 129.93 56.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.46 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.52 138.95 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.059 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.04 155.56 25.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -71.77 157.37 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 111.546 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mt -91.86 -5.37 53.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.841 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.79 -21.44 4.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.024 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 57.9 mt -118.23 112.5 37.77 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.938 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.23 131.52 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.895 1.73 . . . . 0.0 111.765 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 77.43 3.25 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.89 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -87.94 97.45 10.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.414 ' CD1' HD21 ' A' ' 145' ' ' LEU . 24.4 m95 -101.06 156.92 17.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.292 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -168.38 -176.98 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.598 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.425 ' HE1' ' CZ3' ' A' ' 107' ' ' TRP . 1.3 mpp? -110.08 156.95 39.19 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.965 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.443 ' HB2' HG12 ' A' ' 19' ' ' ILE . 72.2 Cg_exo -48.65 143.25 16.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.775 2.317 . . . . 0.0 113.021 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 145.1 22.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.37 133.1 2.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.741 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -62.62 140.28 45.94 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.329 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 48' ' ' ASP . 4.3 mt -73.31 160.32 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.459 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -85.44 -177.18 6.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -77.9 99.22 5.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.35 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.45 9.69 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.729 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -116.57 144.78 43.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.02 137.31 82.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.591 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.39 -50.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.454 2.103 . . . . 0.0 112.457 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 19.2 ttp180 -62.38 -25.43 67.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -83.64 -51.4 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.695 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -57.14 -31.13 65.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.22 -53.65 10.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.4 mt -54.75 -27.92 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.192 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -83.82 -53.13 5.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.805 0.812 . . . . 0.0 109.626 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.57 -32.7 65.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.394 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tp -53.12 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.575 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.7 ptt180 -62.07 -10.87 11.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.448 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.81 -42.14 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.596 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -90.53 -32.42 16.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -21.91 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.995 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.46 4.8 70.75 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.956 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.3 t -69.75 117.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.792 0.296 . . . . 0.0 110.361 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -35.22 12.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.13 77.53 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.24 129.16 13.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.826 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.1 mm-40 -119.93 148.16 43.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.719 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.6 t -78.18 125.9 38.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 111.722 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -105.09 -20.42 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.318 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -156.06 163.19 39.98 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.231 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.425 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 1.3 pm0 -148.54 117.34 6.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 78' ' ' TYR . 6.7 t -57.03 125.43 70.03 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.063 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.28 -17.74 60.78 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.771 2.314 . . . . 0.0 113.362 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.655 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.9 -176.45 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.395 0.617 . . . . 0.0 112.125 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.427 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 15.2 m95 -109.15 147.29 32.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.924 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.473 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 2.0 mt -112.35 117.75 33.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.02 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.3 p -111.14 132.25 54.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.518 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -126.7 169.52 13.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.52 158.41 40.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.108 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -109.72 154.38 42.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.609 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.481 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 29.1 Cg_endo -63.0 171.52 6.02 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.404 2.07 . . . . 0.0 112.34 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.93 -17.26 59.13 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.819 2.346 . . . . 0.0 113.238 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -92.31 -34.01 14.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.195 0.521 . . . . 0.0 110.169 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.481 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 70.3 t -82.96 -47.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.303 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -45.66 91.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.481 0.657 . . . . 0.0 109.49 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -68.69 -26.72 65.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.648 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 -46.74 17.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 96' ' ' TRP . 88.7 mt -59.21 -45.84 90.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -45.98 -32.13 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.4 -49.6 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.201 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -67.27 -55.24 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.781 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 92' ' ' LEU . 16.0 m0 -77.38 -35.17 54.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.72 36.48 25.71 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.287 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.81 147.46 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.749 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -111.91 42.88 1.66 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.42 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 55.3 m95 -102.45 150.32 23.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.706 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -30.14 60.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -172.19 -139.62 2.87 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.005 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.11 115.7 2.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.789 0.328 . . . . 0.0 111.376 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.83 105.86 16.64 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -117.01 157.73 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -113.65 95.87 5.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.841 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.447 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 61.7 m95 -64.24 145.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 61.2 m-85 -129.31 134.19 47.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.267 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.0 tp -80.02 132.21 35.95 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.58 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 50.3 m-85 -127.16 128.49 46.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 111.278 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.536 ' HB2' HG13 ' A' ' 73' ' ' ILE . 21.3 tttm -92.8 122.76 35.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -65.8 126.12 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.874 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.7 p -128.42 37.91 4.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.549 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.19 -144.98 4.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.148 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.88 154.22 45.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -50.2 -16.26 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -79.72 -17.48 53.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.26 . . . . 0.0 111.356 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -24.93 37.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.5 mt -72.46 103.82 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.477 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.66 95.59 5.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.952 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 47.5 mt -54.54 -24.23 19.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.4 -56.96 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.273 0.558 . . . . 0.0 109.988 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.67 -178.5 23.37 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.465 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -90.64 38.73 0.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.067 0.461 . . . . 0.0 109.872 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.17 73.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.219 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -107.11 -65.16 1.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.778 0.323 . . . . 0.0 111.206 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -115.55 164.97 13.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.277 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 153.91 50.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.111 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.17 177.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.776 2.317 . . . . 0.0 112.672 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -150.07 -44.75 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.446 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 6.0 m-85 -112.06 159.91 18.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.411 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.68 -21.14 5.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.679 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.445 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.6 mm-40 -152.29 174.68 13.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 28.1 p-90 -159.12 154.74 26.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.332 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -151.71 158.73 43.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 80.1 m95 -92.58 125.81 37.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.3 m -137.4 150.69 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.729 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 4.1 p -68.91 159.18 83.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.576 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' CA ' HD11 ' A' ' 158' ' ' LEU . 13.0 Cg_endo -56.38 -18.91 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.873 1.715 . . . . 0.0 112.033 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -92.02 -33.88 14.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.117 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -71.08 -50.47 33.45 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.442 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.9 tp -53.16 -33.67 53.54 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.435 0.636 . . . . 0.0 109.876 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -64.88 -29.63 47.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.629 178.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.63 -31.49 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.8 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.414 HD21 ' CD1' ' A' ' 40' ' ' TRP . 9.4 mt -75.98 -40.46 53.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.033 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 m -55.45 164.15 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.259 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 149' ' ' PHE . 13.7 p -96.3 161.9 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -33.62 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.492 ' CD1' ' HG3' ' A' ' 150' ' ' LYS . 8.3 p90 -79.88 0.92 29.13 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.492 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 5.0 mtmt -147.51 17.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.665 0.269 . . . . 0.0 111.437 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.1 mtpt -69.21 -62.75 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.012 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 13.6 Cg_endo -56.5 -40.73 82.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.146 . . . . 0.0 111.935 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.473 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 20.0 t -54.39 -25.52 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.08 -51.88 5.11 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -32.06 15.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.471 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.07 -45.52 77.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.623 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 57.1 t -58.44 -47.47 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.927 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 162' ' ' ALA . 36.7 mt -63.05 -49.16 75.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.794 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.7 t -49.35 -45.68 46.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.71 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.1 -24.62 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.465 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.516 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.5 m-30 -103.82 8.55 37.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.088 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.629 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.68 -51.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.844 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.8 Cg_endo -52.67 -23.75 20.94 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.433 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 99.1 m-70 -90.4 -23.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.838 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.912 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.449 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.93 -173.16 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.567 2.178 . . . . 0.0 112.254 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 2.6 mm? -112.53 79.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.91 36.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.544 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.93 120.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mmt -125.19 -40.06 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.587 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 74.43 19.08 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p 171.3 136.21 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.456 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 40.9 Cg_endo -68.17 109.7 2.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.347 2.031 . . . . 0.0 112.314 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.05 -174.65 2.02 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.932 2.421 . . . . 0.0 112.073 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.14 154.55 19.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.906 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.16 -38.09 3.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -89.38 141.61 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -86.18 152.28 22.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.421 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 15' ' ' ARG . 3.1 mmp_? -60.7 129.62 42.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.4 m120 -152.73 160.21 43.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.432 ' CG1' HD11 ' A' ' 47' ' ' ILE . 1.2 m -135.39 148.4 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.033 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -118.28 150.11 18.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.289 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.9 mp -127.34 101.66 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.477 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.0 t -91.11 108.08 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.7 tp -103.45 148.96 25.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.455 . . . . 0.0 111.252 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.5 ptt? -131.26 157.54 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.674 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 30.8 p-10 -104.96 169.68 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.24 -18.29 5.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.77 2.88 52.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 19.5 mttm 73.23 26.85 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.565 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -95.27 172.51 8.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.0 mp -110.2 117.89 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 11.4 t80 -52.25 107.55 0.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.79 141.41 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.57 140.67 52.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.51 158.29 23.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.644 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.9 mtp-105 -71.69 163.55 27.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.438 0.637 . . . . 0.0 111.667 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -97.14 -6.8 34.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.498 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.72 -18.18 3.92 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.548 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 66.6 mt -121.15 112.59 33.1 Favored Pre-proline 0 N--CA 1.457 -0.088 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.243 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.7 Cg_endo -65.59 132.41 30.85 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.884 1.723 . . . . 0.0 111.532 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.1 2.59 2.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.33 97.49 11.23 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 145' ' ' LEU . 33.3 m95 -102.9 156.67 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.74 -176.9 2.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.666 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.445 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 64.1 mtm -108.14 155.45 40.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 134.42 29.4 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.19 159.35 41.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.52 166.76 36.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.26 135.35 14.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.409 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 8.6 mt -66.08 160.99 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.663 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.68 150.69 21.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.883 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.63 97.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.72 38.81 9.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.048 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HB3' HG23 ' A' ' 47' ' ' ILE . 2.8 tt0 -114.67 145.18 42.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.64 139.18 86.12 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.64 -55.51 2.96 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.443 2.096 . . . . 0.0 112.65 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 26.9 ttp180 -59.21 -23.58 62.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.89 -48.16 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.412 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.16 -31.53 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.408 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -73.32 -54.12 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.113 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mt -55.81 -29.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.231 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 ttp85 -82.8 -53.06 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.02 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.63 -45.59 57.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.374 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -56.55 -52.5 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 42.9 ttp180 -62.45 -12.54 22.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.568 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.61 -41.86 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 111.571 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -90.6 -28.43 18.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.985 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -121.93 -22.67 5.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.08 9.47 63.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.952 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.38 108.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 110.139 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.99 -35.54 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.422 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.28 74.25 7.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.225 0.536 . . . . 0.0 111.247 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.41 126.38 11.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.564 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.5 mm-40 -119.67 147.73 44.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.821 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 47.7 t -76.83 125.54 36.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.494 0.664 . . . . 0.0 111.704 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.578 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -108.55 -17.38 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.525 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 164' ' ' HIS . . . -154.49 162.16 41.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.006 0.432 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 46.5 tt0 -148.53 115.45 6.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.143 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 78' ' ' TYR . 3.8 t -57.58 128.15 79.09 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -11.76 30.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.902 2.401 . . . . 0.0 114.071 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.612 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -132.14 153.15 50.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.338 0.589 . . . . 0.0 112.36 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.424 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 20.0 m95 -80.02 143.49 34.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 153' ' ' VAL . 2.4 mt -111.34 118.09 34.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.93 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.416 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -113.5 130.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -132.98 160.62 36.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.619 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.9 158.38 29.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -102.43 155.51 36.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.608 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 28.1 Cg_endo -62.75 171.95 5.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.448 2.099 . . . . 0.0 112.157 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.13 -9.89 25.18 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.893 2.395 . . . . 0.0 113.032 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -98.36 -35.67 10.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 110.043 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.464 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 99.9 t -82.53 -44.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.247 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -46.2 90.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 0.0 109.509 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -67.73 -26.83 66.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.689 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -46.88 13.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.76 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' TRP . 88.8 mt -59.67 -45.27 92.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.423 . . . . 0.0 110.413 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.7 -34.03 3.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.49 -47.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.267 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.23 -56.99 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' LEU . 15.7 m0 -78.28 -34.97 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.86 35.36 22.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.522 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.04 147.1 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -114.73 41.0 2.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -103.74 150.12 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.659 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -31.15 64.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.3 -139.07 2.58 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.009 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -157.89 116.02 3.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.543 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.416 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -92.62 111.93 23.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.724 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -131.95 150.7 52.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.425 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -102.77 97.08 7.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.287 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.42 ' CH2' ' HB2' ' A' ' 42' ' ' MET . 43.2 m95 -65.34 139.22 58.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.427 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 44.0 m-85 -120.23 138.44 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.539 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 25.3 tp -79.72 154.97 28.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.512 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.2 m-85 -148.17 127.87 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.437 . . . . 0.0 111.782 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.578 ' HB2' HG13 ' A' ' 73' ' ' ILE . 24.6 tttm -93.0 120.46 33.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.594 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -67.11 122.08 17.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.726 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.0 p -123.0 37.37 4.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.553 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.91 -144.38 4.69 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.152 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.07 154.2 45.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.61 -16.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -76.77 -16.9 59.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.256 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -25.36 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.755 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 mt -73.51 99.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 65' ' ' THR . 11.6 t-20 -114.29 95.71 5.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.6 mt -54.97 -21.99 13.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.809 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.0 mt -63.94 -59.48 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.269 0.557 . . . . 0.0 109.956 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.72 -170.48 26.96 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.483 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -95.6 39.07 1.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.82 75.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.052 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.9 t -120.88 -70.26 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 111.154 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.1 165.08 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.213 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -84.36 148.97 54.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.994 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.15 130.76 29.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.649 2.232 . . . . 0.0 112.625 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.62 -30.33 7.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.439 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 34.5 m-85 -119.87 159.53 24.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.415 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.24 -16.16 6.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.716 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.67 174.0 14.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.223 0.535 . . . . 0.0 110.63 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.6 p-90 -159.85 155.17 25.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.066 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.1 m -153.87 159.44 41.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.405 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 81.1 m95 -92.76 124.06 36.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.63 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 29.0 m -135.28 150.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -70.4 160.54 80.85 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.479 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 16.2 Cg_endo -57.65 -17.89 30.69 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.765 1.643 . . . . 0.0 111.87 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -34.39 14.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.072 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -50.6 29.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.021 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.8 tp -54.08 -31.45 51.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 109.801 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.6 mm -68.25 -28.42 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.694 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.55 -20.7 42.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.226 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 40' ' ' TRP . 10.7 mt -85.05 -39.22 18.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.41 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 48.6 m -57.76 162.37 3.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.122 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' A' ' 150' ' ' LYS . 9.4 p -96.0 160.66 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -50.17 -33.01 17.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.461 ' CG ' HG12 ' A' ' 147' ' ' VAL . 19.5 p90 -89.36 13.73 12.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.492 ' HB2' HG13 ' A' ' 147' ' ' VAL . 2.7 mtmp? -139.21 -2.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.586 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 19.2 mttt -55.18 -62.2 4.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.535 0.207 . . . . 0.0 111.352 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.2 Cg_endo -60.81 -42.35 38.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.059 . . . . 0.0 112.201 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.521 ' O ' HD13 ' A' ' 80' ' ' LEU . 10.3 t -57.8 -31.55 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.336 0.588 . . . . 0.0 110.874 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.445 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -90.57 -50.66 5.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.846 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -50.39 -34.23 23.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HB3' HD12 ' A' ' 80' ' ' LEU . 1.2 tp10 -67.92 -45.01 75.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.623 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.496 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 39.3 t -57.84 -44.42 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.113 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 162' ' ' ALA . 75.3 mt -68.81 -48.81 62.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.746 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -51.59 -45.87 63.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.59 -24.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.496 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.5 m-30 -101.47 -2.35 30.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.303 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -47.19 -52.95 31.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.473 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.3 Cg_endo -53.85 -22.08 22.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.511 2.141 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 67.7 m-70 -97.23 -16.97 20.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.686 0.279 . . . . 0.0 111.097 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.407 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 5.4 mp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.924 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.436 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.12 145.33 54.77 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.526 2.151 . . . . 0.0 112.285 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mt -175.55 94.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.38 23.14 1.54 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.626 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.49 124.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.377 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.59 -31.87 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.892 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 69.57 22.26 6.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 176.33 140.5 0.22 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.333 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 55.7 Cg_endo -71.31 114.96 4.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.196 1.931 . . . . 0.0 112.786 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 7.2 Cg_exo -72.42 -172.03 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.581 2.187 . . . . 0.0 111.612 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -90.23 142.98 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.417 ' HA3' ' HE2' ' A' ' 101' ' ' LYS . . . 92.53 -36.83 3.54 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.232 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 10' ' ' PRO . 25.0 m-85 -77.12 135.9 38.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 111.205 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.421 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 2.5 tmm_? -87.14 152.59 22.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.381 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.485 ' NH2' ' HB3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -67.2 132.17 47.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.115 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.472 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 35.6 t30 -152.96 151.09 29.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.029 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -128.2 127.78 67.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.019 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.11 161.73 18.32 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.233 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 43' ' ' PRO . 1.6 mm -126.84 101.61 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.615 0.208 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 10.9 t -91.28 93.51 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 17.1 tp -102.36 148.77 25.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.326 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.2 ptt? -131.02 157.53 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.793 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.3 p-10 -100.51 171.23 7.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.399 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -55.51 -18.25 6.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 0.56 56.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.363 . . . . 0.0 110.849 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp 76.37 25.16 1.01 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.713 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.2 mtpp -92.95 173.25 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.2 mp -110.54 116.66 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 4.4 t80 -50.82 107.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.298 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.53 142.54 46.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.64 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -128.3 140.12 52.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.44 157.74 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -74.2 159.37 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.309 0.576 . . . . 0.0 111.455 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.64 -5.33 45.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.887 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -127.81 -17.52 4.46 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.128 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 67.4 mt -122.11 112.65 31.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.978 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.35 132.04 30.15 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.835 1.69 . . . . 0.0 111.771 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 76.79 4.49 3.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.794 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.474 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.98 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.35 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.431 ' CD1' HD22 ' A' ' 145' ' ' LEU . 32.3 m95 -102.37 155.92 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.197 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.7 -176.95 2.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.81 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.432 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.5 mpp? -107.08 156.82 36.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.469 ' HB2' HG12 ' A' ' 19' ' ' ILE . 75.1 Cg_exo -48.98 140.92 23.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.892 2.394 . . . . 0.0 113.088 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -141.66 142.92 33.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.056 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -153.95 118.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.57 120.87 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.305 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.469 HG22 ' N ' ' A' ' 48' ' ' ASP . 5.4 mt -53.9 160.42 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.0 -176.03 4.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.61 99.68 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 48.81 18.64 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.604 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' HB3' HG21 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -116.11 146.01 42.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 110.969 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.13 136.13 93.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.59 -60.96 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.566 2.177 . . . . 0.0 112.577 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -55.1 -23.39 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.4 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -87.06 -41.47 13.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.983 0.421 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.34 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.361 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.07 -53.88 9.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.098 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -55.33 -30.34 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.124 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.05 -52.82 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.811 0.815 . . . . 0.0 109.816 179.079 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 7.4 mm-40 -55.3 -36.42 66.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.459 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HB2' HG13 ' A' ' 19' ' ' ILE . 10.7 tp -61.06 -62.9 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.646 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 2.1 tmm_? -59.55 -12.91 7.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.09 -45.66 8.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.938 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.79 -27.73 18.69 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.38 -20.79 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.691 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 79.52 -7.5 53.37 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.079 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.98 117.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.981 0.39 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.0 p -101.88 -31.56 10.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.37 78.0 6.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.22 0.534 . . . . 0.0 110.848 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.45 130.37 14.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.707 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.1 pt-20 -119.66 140.56 50.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.3 t -69.64 116.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.302 0.572 . . . . 0.0 111.265 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.649 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.1 mt -91.1 -24.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.046 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.74 168.98 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.539 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.78 118.77 7.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.856 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 78' ' ' TYR . 4.8 t -57.16 129.82 79.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.957 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.95 -19.46 63.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 113.332 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.617 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.98 -177.71 3.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.29 0.567 . . . . 0.0 112.1 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.454 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 47.8 m95 -107.13 147.45 30.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.967 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 3.5 mt -111.55 117.74 33.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.09 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 p -109.19 137.34 47.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.417 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -128.11 170.26 13.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.55 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.99 158.23 38.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.64 148.85 51.57 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.469 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 29.2 Cg_endo -63.29 168.13 11.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.54 2.16 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.4 -16.5 47.64 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.863 2.375 . . . . 0.0 113.079 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -91.58 -34.1 14.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 110.114 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.469 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 77.0 t -82.93 -49.01 17.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.198 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -45.68 83.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 109.498 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.41 -29.96 68.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.517 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -47.46 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.554 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.8 mt -57.56 -48.05 80.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.515 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -46.08 -31.11 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.49 -48.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.353 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -55.08 12.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.91 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.453 ' N ' ' O ' ' A' ' 92' ' ' LEU . 21.8 m0 -79.04 -32.75 45.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 74.78 37.14 45.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.237 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.433 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -127.57 149.11 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.402 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 8.4 p-10 -105.98 69.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 98' ' ' SER . 11.9 m95 -135.27 136.3 41.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.952 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HE2' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.11 -31.26 62.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 110.023 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.99 -153.5 6.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.685 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -158.16 117.06 3.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.739 0.304 . . . . 0.0 111.438 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.72 105.35 16.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.1 pt20 -115.79 153.75 30.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -107.85 95.81 5.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.569 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.468 ' CG ' HG22 ' A' ' 157' ' ' VAL . 27.4 m95 -65.18 138.24 58.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 112.034 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 74.0 m-85 -122.25 132.72 54.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.4 tp -79.33 134.37 36.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.186 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.486 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 45.0 m-85 -126.89 132.9 50.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.299 0.571 . . . . 0.0 112.031 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.649 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 2.0 ttmt -95.14 120.2 34.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.411 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -68.59 121.9 17.38 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.755 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.7 p -122.73 37.32 4.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.6 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.77 -145.12 4.84 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.085 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -127.93 154.08 45.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 0.0 110.093 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.51 -15.25 0.4 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -84.1 -13.08 53.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 -25.33 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.962 0.411 . . . . 0.0 110.511 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 18.4 mt -73.45 107.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.642 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.21 95.72 5.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.009 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 49.5 mt -53.35 -23.31 9.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.761 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.0 mt -63.22 -59.07 5.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.228 0.537 . . . . 0.0 109.977 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.53 -175.42 22.92 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.457 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -91.53 38.79 0.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.108 0.48 . . . . 0.0 109.818 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.55 73.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.171 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.1 t -108.85 -66.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.119 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -108.32 165.12 11.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -68.75 148.31 97.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -50.86 145.16 24.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.526 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -113.79 -35.72 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -113.83 159.51 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.51 5.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.351 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.523 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.55 173.66 14.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.129 0.49 . . . . 0.0 110.5 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 33.6 p-90 -160.39 157.95 28.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.78 158.5 36.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.451 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.446 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 83.3 m95 -91.17 123.44 34.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.626 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 32.8 m -134.33 151.12 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.164 0.507 . . . . 0.0 111.726 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -69.49 160.85 77.64 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.478 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 19.6 Cg_endo -58.59 -16.85 32.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.669 1.58 . . . . 0.0 111.876 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.34 -34.03 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.103 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -51.59 23.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.107 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.443 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 2.2 tp -54.29 -32.43 56.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.473 0.654 . . . . 0.0 109.806 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 139' ' ' PRO . 6.2 mm -68.35 -27.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.781 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.1 -22.03 42.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.221 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.431 HD22 ' CD1' ' A' ' 40' ' ' TRP . 10.8 mt -83.99 -39.16 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.15 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.417 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 23.6 m -55.55 164.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.453 HG11 ' HB2' ' A' ' 150' ' ' LYS . 7.9 p -93.71 165.01 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.054 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -55.66 -35.48 66.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 9.7 p90 -88.58 9.96 22.14 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.453 ' HB2' HG11 ' A' ' 147' ' ' VAL . 20.0 mtmt -131.31 -3.46 3.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.523 0.202 . . . . 0.0 111.442 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.429 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttt -58.38 -63.27 4.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 15.5 Cg_endo -57.28 -41.49 72.62 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.176 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 34.1 t -59.18 -28.97 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 4.1 m-30 -91.37 -54.01 4.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.842 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -47.86 -34.34 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -66.99 -45.18 78.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.779 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.499 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 56.9 t -57.27 -50.13 77.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.348 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.2 mt -62.45 -48.64 78.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.749 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -49.77 -47.29 51.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.92 -24.52 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 110.46 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.6 m-30 -104.11 9.28 36.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.154 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.615 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.57 -51.7 70.72 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.715 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.98 -23.48 21.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.51 2.14 . . . . 0.0 112.289 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.414 ' CE1' HG21 ' A' ' 73' ' ' ILE . 98.2 m-70 -89.78 -24.99 21.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.599 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.85 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.441 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.87 164.95 31.54 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.607 2.205 . . . . 0.0 112.273 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 133.74 55.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.57 22.15 71.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.618 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.24 123.07 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.816 0.341 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.0 mmt -134.72 -31.94 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.848 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 72.73 22.58 3.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.672 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p 173.67 133.98 0.12 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 39.2 Cg_endo -67.85 111.1 2.3 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.301 2.001 . . . . 0.0 112.367 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.39 -174.73 1.92 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.776 2.317 . . . . 0.0 112.009 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.29 153.99 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.97 -38.08 3.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.583 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -96.42 134.58 39.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -80.18 147.41 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' N ' ' HG3' ' A' ' 14' ' ' ARG . 34.2 mtm180 -65.1 137.52 57.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 6.5 m120 -152.32 153.18 33.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.298 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.439 HG12 HD11 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -122.33 118.33 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.11 146.82 19.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.031 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -123.5 101.94 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.791 0.329 . . . . 0.0 111.259 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.06 100.54 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 39.4 tp -102.69 139.28 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.068 0.461 . . . . 0.0 111.225 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.62 157.28 37.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.82 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.449 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -103.61 169.85 8.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.287 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -50.88 -18.36 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 0.23 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.097 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 75.64 25.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.688 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.9 mmtp -97.65 172.65 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.6 mp -109.74 125.25 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 54.7 t80 -58.76 110.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.61 129.87 56.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.109 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -115.21 136.09 53.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 111.489 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.429 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.1 p -82.38 154.84 25.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.74 158.54 36.11 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.227 0.537 . . . . 0.0 111.517 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.94 -5.9 52.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.009 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -130.8 -17.43 3.18 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 55.1 mt -119.12 111.91 36.61 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.026 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.4 Cg_endo -65.28 131.4 28.22 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.873 1.715 . . . . 0.0 111.902 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.6 t70 77.73 2.69 2.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.78 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -88.94 97.22 11.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.429 ' CE3' ' N ' ' A' ' 32' ' ' SER . 50.5 m95 -104.68 157.88 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 0.7 OUTLIER -168.89 173.78 6.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 69.5 mtm -102.25 156.86 34.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.69 131.78 26.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.613 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' CG ' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.15 157.72 39.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.51 34.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.589 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -79.75 130.87 10.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.556 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.6 mt -59.44 160.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.51 148.06 22.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -48.16 99.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.6 18.41 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.798 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.6 tp10 -111.38 147.2 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.933 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.23 128.9 85.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.338 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 51.9 Cg_exo -52.8 -23.59 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.329 2.019 . . . . 0.0 112.676 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HD3' ' CE2' ' A' ' 108' ' ' PHE . 9.6 tpt180 -85.54 -22.03 28.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -91.06 -43.45 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.491 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.436 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.59 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.84 -52.86 15.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.17 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 64.1 mt -56.52 -27.83 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.316 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -84.88 -52.77 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.824 0.821 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -56.17 -34.24 66.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.592 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tp -57.41 -59.0 5.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.042 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.565 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 25.1 ptt180 -60.99 -11.84 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 110.504 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -91.69 -43.52 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.886 0.374 . . . . 0.0 111.544 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.3 -25.94 19.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.301 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.452 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.68 -22.01 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.961 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.21 4.55 73.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.972 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.46 124.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.785 0.326 . . . . 0.0 110.61 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -35.67 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.26 79.08 6.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.749 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 129.55 13.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.6 mm-40 -119.19 147.61 44.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.65 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 48.9 t -77.21 128.93 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.898 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CD1' ' CB ' ' A' ' 111' ' ' LYS . 2.0 mm -108.19 -18.63 7.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.378 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB1' ' CD2' ' A' ' 164' ' ' HIS . . . -159.27 162.25 36.07 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.423 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.9 pt-20 -148.83 118.77 7.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.721 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 78' ' ' TYR . 17.9 t -58.02 125.34 73.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.273 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.01 -19.8 69.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.739 2.293 . . . . 0.0 113.068 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.597 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.68 -176.74 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.031 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.43 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 20.4 m95 -108.75 147.1 32.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.023 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 4.4 mt -112.29 117.7 33.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.01 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.9 p -108.65 136.7 47.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.683 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -130.0 170.18 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.337 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.03 158.04 40.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.427 ' CZ ' ' O1A' ' A' ' 166' ' ' ATP . 15.0 m-85 -116.16 150.61 45.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.47 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 30.0 Cg_endo -63.08 171.91 5.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.39 -17.78 60.83 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.8 2.333 . . . . 0.0 113.19 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 ttmm -91.52 -34.25 14.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.47 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 71.0 t -82.63 -48.05 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.298 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -58.69 -45.71 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.488 0.661 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.18 -27.87 66.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.581 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -47.12 21.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.588 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 96' ' ' TRP . 94.6 mt -58.36 -46.75 85.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.408 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.5 m-80 -45.91 -31.93 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.616 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.4 -48.8 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.305 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -56.71 8.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.801 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 92' ' ' LEU . 18.8 m0 -78.33 -33.26 49.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.98 35.22 31.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.443 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.47 147.34 47.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.678 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -109.59 39.32 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -96.69 146.81 24.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.63 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -29.47 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.713 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -163.86 -139.39 2.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.307 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 82' ' ' TYR . 32.9 mt-30 -157.53 115.07 3.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.28 112.11 23.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.688 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.2 pt20 -127.29 159.69 33.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -112.51 95.91 5.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.456 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 40.5 m95 -64.48 141.56 58.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.157 0.503 . . . . 0.0 112.271 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 54.8 m-85 -124.67 133.55 53.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.224 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.8 tp -79.63 131.37 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.553 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 45.0 m-85 -127.05 129.38 47.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 111.351 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.493 ' CB ' ' CD1' ' A' ' 73' ' ' ILE . 11.5 tttt -93.34 120.97 34.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -63.46 126.93 29.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 0.0 111.014 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.2 p -129.64 38.15 3.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.58 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.83 -145.05 4.71 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.992 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -128.08 154.14 46.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -50.35 -16.29 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.62 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -79.16 -19.64 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -79.77 -25.07 41.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.45 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 18.1 mt -70.81 102.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.374 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.88 96.19 5.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.935 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 34.9 mt -56.67 -24.18 47.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.488 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.94 -56.96 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.294 0.568 . . . . 0.0 109.996 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.91 178.84 23.42 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.483 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -90.79 38.93 0.97 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.51 26.92 70.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.123 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -120.62 -70.84 0.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.91 165.2 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -84.35 154.78 63.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.94 160.48 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.791 2.328 . . . . 0.0 112.722 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -150.19 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.471 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.452 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 1.5 m-85 -107.57 159.51 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.181 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -17.94 5.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.068 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -152.42 175.23 12.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.177 0.513 . . . . 0.0 110.659 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.4 p-90 -156.42 150.43 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.258 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.43 165.64 29.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.349 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.449 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 59.9 m95 -99.43 125.44 45.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.5 m -137.97 150.6 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 111.56 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -70.76 158.61 87.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.677 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.413 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.07 -19.1 19.16 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.914 1.743 . . . . 0.0 111.943 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.76 -34.21 15.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.106 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -50.48 27.35 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.954 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.1 tp -54.01 -29.76 44.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.42 0.629 . . . . 0.0 109.882 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.0 mm -69.01 -28.61 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.733 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.55 -20.93 42.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.21 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mt -84.4 -39.35 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.066 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.3 m -58.2 163.81 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.066 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 150' ' ' LYS . 13.6 p -92.59 161.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.5 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.06 -26.45 66.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.457 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 22.8 p90 -91.55 12.09 22.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.51 ' HB2' HG12 ' A' ' 147' ' ' VAL . 2.1 mtmp? -149.75 12.91 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.568 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.5 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.4 mtpm? -65.15 -62.48 4.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.166 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 11.9 Cg_endo -55.54 -40.86 83.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.478 2.118 . . . . 0.0 112.106 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.462 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -57.03 -28.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.492 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.5 m-85 -91.42 -52.65 4.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.64 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -33.56 17.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.586 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -45.58 81.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.553 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 43.3 t -58.28 -46.62 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.071 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 162' ' ' ALA . 73.4 mt -64.14 -48.89 74.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.787 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 -46.71 59.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.22 -23.13 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.518 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 11.2 m-30 -102.96 -1.8 28.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.432 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -49.84 -44.25 77.34 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 38.8 Cg_endo -71.16 -21.54 27.04 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.13 1.887 . . . . 0.0 112.817 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.45 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 81.1 m-70 -89.37 -41.91 11.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.699 0.285 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 161' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.27 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.471 ' PG ' ' CG ' ' A' ' 44' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.09 179.91 3.53 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.564 2.176 . . . . 0.0 112.282 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.5 mt 61.13 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.38 45.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.479 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 3.0 t -130.96 -155.08 0.67 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.999 0.428 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mmt -124.6 -43.32 2.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.14 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t0 72.2 24.43 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 170.06 128.22 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.583 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.56 109.64 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.261 1.974 . . . . 0.0 112.234 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.25 -173.15 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.846 2.364 . . . . 0.0 112.009 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -90.1 148.02 23.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.28 -28.22 13.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.553 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -93.93 140.2 29.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -86.71 152.5 22.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.265 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 1.9 mmp_? -62.19 128.42 36.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.214 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 11.6 t-20 -152.64 159.42 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG22 ' CB ' ' A' ' 56' ' ' ALA . 3.3 m -134.9 140.58 45.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.385 . . . . 0.0 111.222 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 149.54 16.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.49 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -128.38 103.78 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 0.0 111.58 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 20.5 t -89.71 106.33 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 HD21 ' CD2' ' A' ' 29' ' ' PHE . 28.7 tp -103.17 145.06 30.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 111.333 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.5 ptm -130.56 157.39 42.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.518 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.462 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.93 169.78 8.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.011 0.434 . . . . 0.0 111.466 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -51.16 -18.63 0.93 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.615 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.95 1.42 55.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.8 mtmm 73.38 26.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.649 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttt -99.01 175.14 6.02 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -110.93 126.37 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 111.007 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 12.1 t80 -58.43 109.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.26 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -117.02 129.67 56.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.433 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.77 137.89 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.089 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.401 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.2 155.99 24.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.782 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' ALA . 1.4 mtp85 -71.38 159.83 33.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.617 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.45 -5.64 48.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.916 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -19.29 4.01 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.218 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.461 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 59.7 mt -120.05 112.68 34.65 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.983 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.37 131.73 29.12 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.901 1.734 . . . . 0.0 111.713 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.35 3.3 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.777 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -88.47 97.21 10.95 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.243 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -102.47 156.73 17.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.238 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -168.62 169.22 10.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.792 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.3 mtm -92.92 156.17 40.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.33 124.35 11.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.556 2.171 . . . . 0.0 112.695 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -154.24 158.43 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.383 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.91 153.5 22.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.799 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.1 137.37 49.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 7.4 mt -64.57 161.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 110.405 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.3 m-20 -90.04 147.95 23.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.59 98.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.226 0.536 . . . . 0.0 110.807 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.01 36.03 8.63 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.024 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' HB3' HG23 ' A' ' 47' ' ' ILE . 5.0 tt0 -116.34 142.31 47.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.48 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.54 142.88 84.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.674 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.44 -48.75 19.78 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.487 2.125 . . . . 0.0 112.566 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -26.04 67.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -84.65 -46.92 11.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.656 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.29 -31.62 67.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.57 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.26 -53.54 10.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.177 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.3 mt -55.9 -30.38 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.104 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -81.83 -53.23 6.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.735 0.779 . . . . 0.0 109.779 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -52.66 -39.04 61.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.451 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -55.59 -57.38 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.041 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.557 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 2.7 ptt-85 -61.44 -12.48 14.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.432 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.69 -42.5 10.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 111.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.41 -25.14 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.229 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.447 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.33 -21.61 8.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.758 0.314 . . . . 0.0 111.069 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.15 5.23 70.57 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.894 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.4 t -75.08 128.16 36.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 0.0 110.633 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -34.89 8.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 81.63 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.46 . . . . 0.0 110.974 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 130.69 14.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.84 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -119.77 148.21 43.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.983 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.5 t -79.14 122.83 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.339 0.59 . . . . 0.0 111.553 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.528 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -102.85 -20.79 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HB1' ' CD2' ' A' ' 164' ' ' HIS . . . -155.27 162.53 40.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.039 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.23 115.97 6.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.011 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 78' ' ' TYR . 3.5 t -57.21 128.46 78.23 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 -10.8 25.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.796 2.331 . . . . 0.0 113.942 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -131.16 160.8 33.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 112.294 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -88.71 147.11 24.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.867 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 95.9 mt -115.44 117.63 30.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.418 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -114.59 130.83 56.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.757 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -133.46 165.64 24.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -124.86 158.31 33.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.154 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -103.2 155.4 36.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.472 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 27.0 Cg_endo -62.35 171.57 5.22 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.406 2.071 . . . . 0.0 112.266 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.79 -16.99 58.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.777 2.318 . . . . 0.0 113.25 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.44 -33.57 14.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.183 0.516 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 77.2 t -83.43 -47.88 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.326 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.88 -46.43 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.587 0.708 . . . . 0.0 109.461 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.05 -27.73 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.512 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -46.61 19.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.543 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.6 mt -58.19 -46.56 85.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.471 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -46.13 -32.63 3.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.43 -48.07 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.399 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -56.18 8.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.464 ' N ' ' O ' ' A' ' 92' ' ' LEU . 17.1 m0 -78.0 -31.9 50.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.878 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.87 36.65 35.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.4 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.92 147.39 47.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.76 38.81 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.879 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -103.86 150.1 24.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -29.89 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.124 0.487 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.74 -143.94 4.27 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.696 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -158.7 124.38 4.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.847 0.356 . . . . 0.0 111.315 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.73 106.48 17.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -115.9 149.22 39.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.406 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 2.1 mmtp -109.52 96.45 6.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.491 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 73.3 m95 -62.65 145.78 53.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 70.1 m-85 -130.95 133.56 45.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.936 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.2 tp -79.68 130.88 35.74 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.595 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 46.9 m-85 -125.33 127.59 46.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.017 0.437 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.528 ' HB2' HG13 ' A' ' 73' ' ' ILE . 62.8 tttm -92.56 120.75 33.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -62.9 126.21 26.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.5 p -127.06 37.96 4.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.584 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.59 -145.16 4.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.059 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -128.95 154.24 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 109.984 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.3 -17.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.569 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.85 -22.79 53.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.01 -25.62 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.9 mt -68.0 103.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.56 96.06 4.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.041 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 44.6 mt -58.72 -20.82 52.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.403 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -57.0 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.3 178.32 19.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.332 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -89.79 38.65 0.92 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.193 0.521 . . . . 0.0 109.714 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.11 29.76 76.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.233 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.0 m -109.34 -64.04 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 111.336 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -115.8 165.11 13.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 152.69 68.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.84 176.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 0.0 112.668 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -150.14 -44.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 18.6 m-85 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 -18.16 6.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.732 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.2 mm-40 -152.3 175.0 13.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.042 0.448 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.1 p-90 -159.23 152.07 21.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.15 163.39 38.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.362 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.462 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 64.9 m95 -95.98 123.58 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 33.0 m -133.14 151.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.559 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.1 158.22 87.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.525 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CB ' HD12 ' A' ' 158' ' ' LEU . 10.9 Cg_endo -54.44 -19.57 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.0 1.8 . . . . 0.0 112.097 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -92.13 -34.36 14.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.276 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -50.25 46.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.935 0.398 . . . . 0.0 110.152 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.2 tp -53.21 -34.02 55.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.479 0.657 . . . . 0.0 109.871 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.458 HG21 ' HD2' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -66.48 -28.61 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.673 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -77.39 -32.59 54.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.654 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 8.6 mt -74.64 -40.94 61.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.87 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.3 m -53.53 164.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.221 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.496 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 7.3 p -97.37 159.82 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 1.0 OUTLIER -47.24 -43.68 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.465 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.496 ' CZ ' HG13 ' A' ' 147' ' ' VAL . 39.2 p90 -83.95 7.02 19.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HB2' ' CG1' ' A' ' 147' ' ' VAL . 25.3 mtmt -128.12 -6.31 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.59 0.234 . . . . 0.0 111.33 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.491 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.7 mtpm? -59.42 -60.63 9.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.592 0.235 . . . . 0.0 111.285 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.0 Cg_endo -61.54 -42.3 34.23 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.047 . . . . 0.0 112.15 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 82' ' ' TYR . 13.4 t -58.1 -26.69 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.5 -52.61 4.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.505 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.458 ' HD2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.75 -30.66 14.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.617 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.98 -44.99 75.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.484 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.509 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.6 t -59.99 -48.77 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' ALA . 59.2 mt -60.8 -48.95 79.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.971 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.0 m -48.89 -42.9 38.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.831 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 93.7 t -72.76 -24.78 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.03 0.443 . . . . 0.0 110.716 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.509 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 10.7 m-30 -100.97 -1.51 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.272 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.625 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.68 -51.84 27.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.539 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -54.69 -22.02 27.34 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.301 2.0 . . . . 0.0 112.358 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.434 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 90.4 m-70 -96.09 -17.42 20.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.124 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 3.8 mp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.22 159.31 53.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.543 2.162 . . . . 0.0 112.292 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -175.5 150.23 1.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.993 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.6 31.4 63.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.42 120.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.6 mmt -122.79 -38.63 2.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.529 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 t70 75.72 22.54 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 170.1 138.07 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 60.9 Cg_endo -73.41 114.57 4.07 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.328 2.019 . . . . 0.0 112.268 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -88.35 -170.06 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.837 2.358 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.67 155.67 19.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.46 -35.09 4.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -106.51 135.65 47.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.374 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -81.48 152.3 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.017 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -66.75 136.31 55.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.523 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 m120 -152.54 156.21 38.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.449 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.449 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.6 m -129.79 121.83 53.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.853 0.359 . . . . 0.0 111.383 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.03 140.18 14.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.442 HG22 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -114.2 101.69 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.2 t -90.18 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.2 tp -103.09 147.13 27.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.56 157.14 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.821 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 43.7 p-10 -99.87 172.48 7.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.14 -17.8 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.313 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -0.11 57.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.815 0.341 . . . . 0.0 110.994 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttt 76.93 25.44 0.83 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.599 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.4 mmtp -93.53 175.58 6.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.1 mp -113.89 126.4 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 32.8 t80 -58.56 109.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.75 129.89 56.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.349 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.43 138.91 52.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.558 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.5 p -82.04 157.58 24.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -73.08 158.45 35.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 111.433 -179.478 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.77 -5.54 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.067 178.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -130.87 -17.76 3.11 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.473 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 65.9 mt -118.77 112.19 36.99 Favored Pre-proline 0 N--CA 1.455 -0.178 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.951 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.2 131.72 29.39 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.995 1.797 . . . . 0.0 111.889 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 t70 76.62 4.09 3.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.713 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.473 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -89.2 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.412 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -102.95 155.46 18.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -169.04 171.63 8.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.753 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.414 ' HE2' ' CZ3' ' A' ' 107' ' ' TRP . 1.9 mpp? -95.85 157.72 35.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.652 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.54 129.47 15.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.58 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.06 153.74 32.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.46 167.95 33.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -80.02 133.17 12.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.559 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.6 mt -60.12 160.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 2.0 m-20 -90.24 149.31 22.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.96 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.22 0.533 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.18 10.25 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.954 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 47' ' ' ILE . 16.0 tp10 -114.09 145.96 40.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.865 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.11 139.6 79.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.429 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.01 -55.07 3.78 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.387 2.058 . . . . 0.0 112.599 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -60.29 -27.53 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.214 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -82.48 -49.42 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.798 0.332 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -58.82 -30.68 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.482 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.85 -53.45 10.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.16 179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.1 mt -55.78 -29.79 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.116 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -80.69 -53.51 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.786 0.803 . . . . 0.0 109.73 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.97 -33.29 62.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.568 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.1 tp -56.56 -58.4 8.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.123 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.569 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 9.2 ptt180 -62.12 -11.06 12.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 0.0 110.545 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -91.71 -44.34 9.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.47 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.87 -29.6 17.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.3 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.445 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -114.93 -21.33 10.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.33 6.69 70.53 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.885 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.92 130.84 35.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.327 . . . . 0.0 110.548 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -109.79 -33.01 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.37 78.78 6.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.164 0.507 . . . . 0.0 110.831 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.36 131.29 15.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.846 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -119.41 140.37 50.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.239 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.2 t -69.76 116.86 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.292 0.568 . . . . 0.0 111.387 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -90.91 -24.0 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.774 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.42 168.64 26.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.214 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -148.51 116.26 6.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.236 179.623 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.648 HG11 ' O ' ' A' ' 78' ' ' TYR . 6.2 t -57.33 130.29 80.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 -15.42 35.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.763 2.309 . . . . 0.0 113.626 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.648 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -128.04 170.35 13.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.459 0.647 . . . . 0.0 112.359 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.426 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 8.8 m95 -96.22 145.99 25.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.978 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 2.3 mt -110.24 117.91 34.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.171 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.0 p -107.7 136.23 47.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.49 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -127.88 170.11 13.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.466 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.33 158.29 38.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.89 152.09 47.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.798 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 34.2 Cg_endo -63.95 169.82 9.81 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.597 2.198 . . . . 0.0 112.288 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.62 -17.39 59.4 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 113.16 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -92.07 -34.04 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.187 0.518 . . . . 0.0 110.178 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.488 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 76.2 t -83.26 -47.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -45.36 91.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.76 -27.5 65.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.597 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -47.09 19.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.3 mt -58.89 -46.46 87.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.359 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -45.82 -31.84 2.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.568 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.37 -49.29 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.278 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -56.26 12.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.452 ' N ' ' O ' ' A' ' 92' ' ' LEU . 21.6 m0 -78.3 -35.0 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.81 34.94 26.26 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.47 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 147.25 47.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.26 41.93 1.76 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.935 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -99.16 150.31 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.726 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -29.35 60.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.24 -139.13 2.69 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.82 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -157.64 113.92 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.81 0.338 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.1 105.66 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.8 pt20 -120.24 150.57 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.5 mttp -102.77 95.71 6.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.388 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CZ2' ' NE2' ' A' ' 105' ' ' GLN . 43.7 m95 -64.33 143.5 57.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.236 -178.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.432 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 67.3 m-85 -128.0 137.69 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.15 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 22.1 tp -79.43 155.18 28.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 20' ' ' CYS . 33.1 m-85 -146.47 131.96 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 111.955 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.628 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -94.73 119.56 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 178.032 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.65 121.44 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.613 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.8 p -123.92 37.71 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.565 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.93 -145.31 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.129 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.5 154.24 47.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -49.47 -16.96 0.24 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.603 179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -76.33 -21.06 56.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.102 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.56 -25.19 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.7 mt -69.23 104.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.513 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -119.96 95.55 4.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.708 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 41.3 mt -58.82 -24.82 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 -179.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.1 -55.04 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.39 178.63 17.22 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.397 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -89.64 38.64 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.212 0.529 . . . . 0.0 109.687 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.93 29.63 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.226 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -107.02 -64.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.84 165.16 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -60.22 151.36 67.8 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.34 176.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.716 2.277 . . . . 0.0 112.602 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -150.13 -45.24 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.722 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 21.2 m-85 -112.72 159.39 18.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.96 -14.6 6.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.637 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.558 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 10.6 mp0 -152.15 174.22 14.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.019 0.438 . . . . 0.0 110.357 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.0 p-90 -159.65 152.06 21.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.333 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.62 153.93 35.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.306 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 87.8 m95 -89.95 126.13 35.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.439 HG21 ' CA ' ' A' ' 142' ' ' LEU . 30.9 m -137.46 150.63 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.666 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -68.23 159.33 80.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.574 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.417 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 13.4 Cg_endo -56.72 -18.98 28.79 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 121.816 1.677 . . . . 0.0 111.732 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.5 -34.15 15.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -50.84 25.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' CA ' HG21 ' A' ' 137' ' ' VAL . 3.4 tp -54.14 -30.66 49.83 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.434 0.635 . . . . 0.0 109.864 179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.4 mm -68.52 -28.78 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 178.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.39 -20.98 42.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.21 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.64 -39.24 18.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.072 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 m -58.05 164.27 2.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.113 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' A' ' 150' ' ' LYS . 12.7 p -93.01 162.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.787 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.497 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -59.03 -27.6 65.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -179.433 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.452 ' CE2' HG12 ' A' ' 147' ' ' VAL . 7.9 p90 -93.28 7.6 43.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.481 ' HB2' HG13 ' A' ' 147' ' ' VAL . 3.1 mtmp? -140.25 11.04 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.497 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.7 mtpp -70.54 -62.45 2.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.6 Cg_endo -52.99 -46.74 31.77 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.153 . . . . 0.0 112.121 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.47 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -56.46 -26.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.499 . . . . 0.0 110.959 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.33 -51.43 5.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.656 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -34.84 21.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -45.96 84.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.576 179.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.514 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.3 t -57.04 -49.52 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 162' ' ' ALA . 78.0 mt -62.92 -49.14 75.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.824 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.8 p -50.17 -46.67 54.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.74 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.3 -24.84 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.048 0.452 . . . . 0.0 110.475 179.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.514 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.3 m-30 -102.27 7.08 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.013 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.613 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.67 -53.07 54.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.801 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 8.1 Cg_endo -50.59 -24.83 13.41 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.562 2.175 . . . . 0.0 112.52 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.412 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 98.1 m-70 -92.88 -22.38 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.883 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.964 179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.434 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.21 167.66 24.38 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.685 2.256 . . . . 0.0 112.285 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 tp 59.97 99.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.73 -86.89 1.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 78' ' ' TYR . 1.3 m 63.77 125.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -137.27 101.54 4.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.884 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.79 12.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.123 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -154.96 128.37 4.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.52 0.2 . . . . 0.0 110.481 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 15' ' ' ARG . 56.0 Cg_endo -70.74 114.65 3.93 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.245 1.963 . . . . 0.0 112.62 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.12 -175.6 2.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.727 2.285 . . . . 0.0 111.748 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.33 150.02 22.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.951 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.27 -33.74 5.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -87.1 138.17 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.144 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -85.79 152.6 22.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 9' ' ' PRO . 1.3 mmp_? -73.38 129.31 37.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.8 t-20 -153.26 156.85 39.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.675 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' A' ' 56' ' ' ALA . 4.5 m -127.38 138.04 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.006 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.83 155.13 16.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.464 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -128.52 101.77 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.701 0.286 . . . . 0.0 111.345 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.8 t -89.7 103.38 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.4 tp -103.02 145.09 30.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -131.42 157.05 44.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 27' ' ' LYS . 10.4 p-10 -97.43 175.1 6.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -14.2 39.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.243 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.2 0.48 56.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.77 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp 75.63 26.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.513 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 12.9 mttp -97.88 172.97 7.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.01 140.74 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 110.667 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 11.0 t80 -75.6 109.31 9.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.541 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.429 ' CB ' ' CD2' ' A' ' 142' ' ' LEU . . . -116.63 132.79 56.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.85 135.23 54.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.38 155.01 24.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -71.24 159.22 35.02 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 111.506 -179.386 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -93.44 -6.85 46.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.838 178.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.93 -18.92 4.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.09 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.492 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 52.6 mt -119.4 111.65 36.38 Favored Pre-proline 0 N--CA 1.455 -0.213 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.881 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.59 131.27 29.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.995 1.797 . . . . 0.0 111.977 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 77.35 2.37 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.824 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -85.59 97.22 9.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -101.7 154.84 18.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.323 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.31 173.27 6.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -99.26 161.15 25.65 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.03 133.9 24.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.498 2.132 . . . . 0.0 112.759 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 155.8 35.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.35 143.58 9.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.683 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.8 143.43 39.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.534 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.8 mt -76.87 160.72 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 5.0 m-20 -90.25 177.54 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.125 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.88 99.28 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.39 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.61 47.01 12.94 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.615 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -110.36 148.55 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.185 0.517 . . . . 0.0 110.949 -179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.83 126.11 88.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.366 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.3 -34.59 70.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.385 2.057 . . . . 0.0 112.569 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.73 -25.0 53.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -87.57 -45.53 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.428 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.458 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -59.27 -31.07 68.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.369 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.59 -52.55 13.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -56.34 -31.41 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.289 0.566 . . . . 0.0 109.905 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -78.58 -53.6 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.849 178.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -54.88 -36.08 64.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.602 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -56.15 -54.15 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.575 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -62.22 -11.7 16.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.718 179.121 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -91.52 -41.48 10.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 111.477 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -90.25 -31.17 17.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.923 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -119.62 -23.8 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.339 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 69.74 10.13 63.6 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.647 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 t -69.3 119.08 14.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.222 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.62 -34.02 12.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.105 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.2 78.49 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.179 0.514 . . . . 0.0 110.962 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.35 131.45 15.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.851 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -119.95 141.9 49.23 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.146 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.8 t -70.87 117.01 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.237 0.541 . . . . 0.0 111.437 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.656 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.1 mt -91.03 -26.11 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -159.41 169.31 24.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.282 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.6 pt-20 -148.44 112.06 5.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 78' ' ' TYR . 2.5 t -57.65 123.82 64.78 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.965 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.5 -3.96 14.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.801 2.334 . . . . 0.0 114.045 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.518 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -131.23 139.45 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.204 0.526 . . . . 0.0 112.131 -179.855 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.456 ' N ' ' O ' ' A' ' 6' ' ' MET . 15.2 m95 -75.31 145.06 42.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 89.6 mt -111.2 117.58 33.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 p -108.52 131.74 54.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.751 -179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -129.84 166.26 20.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.3 158.34 29.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.098 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.35 153.18 45.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.738 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.471 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 29.9 Cg_endo -63.47 170.79 7.64 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 0.0 112.384 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.69 -17.34 59.53 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 113.147 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -91.35 -33.59 15.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.146 0.498 . . . . 0.0 110.143 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.471 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 78.2 t -82.75 -48.64 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.306 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -58.29 -46.28 86.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.481 0.658 . . . . 0.0 109.472 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -67.82 -27.53 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.584 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -46.58 20.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.564 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 96' ' ' TRP . 94.2 mt -58.56 -46.5 86.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -46.01 -31.93 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.6 mt -96.48 -49.29 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.227 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -56.35 9.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.82 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.457 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.6 m0 -77.32 -33.59 55.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.05 31.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.398 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.43 ' CB ' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -127.62 147.44 50.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.775 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.17 38.72 1.96 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.43 ' CD1' ' CB ' ' A' ' 98' ' ' SER . 34.2 m95 -93.23 150.44 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -26.99 44.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.447 . . . . 0.0 110.435 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.66 -138.5 2.47 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -158.05 113.76 2.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -88.22 105.82 17.79 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.73 150.27 52.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 2.7 mttt -97.77 156.5 16.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.47 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.457 ' CG ' HG23 ' A' ' 157' ' ' VAL . 45.2 m95 -120.81 140.32 51.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.02 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.4 m-85 -123.46 131.18 53.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.056 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.7 tp -79.26 135.84 36.88 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.146 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.494 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 39.4 m-85 -126.82 131.67 51.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 112.02 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.656 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 3.5 ttmt -93.76 120.18 33.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.374 178.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -68.97 122.43 18.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -123.96 37.8 4.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.508 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.46 -144.74 4.8 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.141 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.56 154.27 47.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -48.96 -17.45 0.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.523 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.23 -24.21 59.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.319 . . . . 0.0 111.027 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.19 -26.24 58.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 119' ' ' ILE . 29.8 mt -69.14 101.52 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 123' ' ' GLY . 13.2 p-10 -125.28 96.07 4.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.839 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 60.7 mt -55.27 -19.24 7.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.067 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.52 -58.62 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.383 0.611 . . . . 0.0 110.124 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.402 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . 138.64 179.41 17.22 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.311 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -89.61 38.84 0.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.1 28.3 72.68 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.224 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.95 -64.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.7 165.07 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -71.08 152.3 94.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.042 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.16 169.17 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.678 2.252 . . . . 0.0 112.519 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -150.07 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.781 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 12.6 m-85 -106.15 159.32 16.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.46 -18.67 5.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.78 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.42 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 9.3 mm-40 -152.17 175.31 12.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 110.398 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.08 154.53 25.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.33 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -151.56 162.5 40.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.301 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 86.8 m95 -98.97 129.37 45.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 28' ' ' ILE . 28.4 m -139.41 156.19 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.964 -179.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -73.63 152.98 89.57 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -49.19 -20.83 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.114 1.876 . . . . 0.0 112.132 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -90.42 -33.82 15.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.437 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.415 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -70.09 -50.8 37.28 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 110.22 179.496 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -51.94 -36.05 47.97 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.515 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.2 mm -63.08 -29.05 46.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.934 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 141' ' ' GLN . 0.5 OUTLIER -80.53 -22.01 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.116 179.028 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.6 mt -84.13 -39.13 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.2 m -59.33 165.64 2.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.868 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 149' ' ' PHE . 8.3 p -97.35 159.72 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.05 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 19.1 mt-10 -52.14 -38.44 57.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 147' ' ' VAL . 13.6 p90 -84.34 5.28 27.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 20.9 mtpp -140.09 9.26 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.512 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.6 mtpp -69.07 -62.77 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.8 Cg_endo -54.33 -39.66 86.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 111.87 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.449 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 14.1 t -58.13 -27.02 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 110.799 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.33 -50.66 5.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.375 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -51.01 -34.63 30.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 3.4 tp10 -63.91 -46.09 86.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.51 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.509 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.4 t -60.09 -47.28 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.249 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 162' ' ' ALA . 69.2 mt -63.36 -48.5 77.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.695 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.5 m -48.77 -47.88 41.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.731 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 74.6 t -67.52 -24.9 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.509 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.2 m-30 -102.25 7.32 40.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.027 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -50.75 -53.05 50.98 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.602 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.8 Cg_endo -50.66 -24.75 13.51 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.545 2.163 . . . . 0.0 112.316 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 73' ' ' ILE . 98.7 m-70 -89.77 -24.5 21.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.644 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.878 179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.437 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.04 170.5 16.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.596 2.198 . . . . 0.0 112.35 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 pp -96.46 138.43 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.18 46.19 1.27 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.576 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.413 ' OG ' ' CD2' ' A' ' 78' ' ' TYR . 4.6 t 164.9 139.83 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.022 0.439 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.409 ' HG3' HG22 ' A' ' 81' ' ' THR . 7.5 mmt -115.6 -30.15 6.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.256 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 61.7 16.29 7.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.545 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p 167.68 141.73 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.721 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 57.1 Cg_endo -71.76 111.83 3.24 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.281 1.987 . . . . 0.0 112.221 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.85 -175.18 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.84 2.36 . . . . 0.0 112.158 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.27 149.3 22.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.19 -19.8 51.31 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -109.66 135.57 50.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 110.996 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 6.7 mtp-105 -76.07 152.39 36.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -75.22 133.38 41.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.1 m120 -152.22 161.9 41.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.496 HG13 HD12 ' A' ' 47' ' ' ILE . 1.9 m -132.24 125.63 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.235 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 138.79 14.13 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.219 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' ' 110' ' ' PHE . 4.5 mp -111.69 102.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' PHE . 7.6 t -89.68 102.12 14.81 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.09 146.39 28.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 0.0 110.933 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.24 157.2 41.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 12.4 t30 -93.65 173.42 7.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.044 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.97 -16.58 61.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.845 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.41 -0.71 57.69 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 81.77 24.6 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.632 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -93.83 170.48 9.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.3 mp -109.81 121.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.5 ' CE2' ' CG2' ' A' ' 65' ' ' THR . 1.7 t80 -54.04 107.56 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.259 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.85 137.72 52.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.746 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.96 141.95 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.17 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.33 158.32 23.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.968 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.8 mtp-105 -72.71 164.04 27.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 111.723 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 mt -97.93 -7.0 31.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.44 178.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.54 -18.21 3.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.55 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 62.9 mt -121.12 112.42 33.26 Favored Pre-proline 0 N--CA 1.457 -0.094 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.189 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.79 132.62 31.09 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.816 1.677 . . . . 0.0 111.475 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 77.86 3.8 2.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.683 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -90.85 97.55 11.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 145' ' ' LEU . 27.6 m95 -102.28 156.58 17.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.065 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.75 -176.68 2.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.703 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 76.3 mtm -107.31 156.59 37.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.12 132.35 27.68 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.56 2.173 . . . . 0.0 112.579 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 157.39 42.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.695 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.51 171.37 34.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.02 135.92 13.58 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.574 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.496 HD12 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -68.6 161.03 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.619 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -83.76 -174.85 5.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.767 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.91 99.57 6.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.281 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.43 50.73 19.72 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.597 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.47 155.23 25.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.096 -179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -77.87 130.34 73.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.404 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 52.0 Cg_exo -54.6 -21.66 25.48 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.389 2.059 . . . . 0.0 112.932 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HD2' ' CD2' ' A' ' 108' ' ' PHE . 3.1 tpt180 -84.39 -25.44 29.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -88.05 -43.29 11.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.578 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -63.36 -29.87 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.519 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.79 -51.83 13.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.3 mt -57.32 -29.07 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.237 179.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ttp-105 -81.85 -53.3 6.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.831 0.824 . . . . 0.0 109.698 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -54.48 -31.83 56.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 3.1 tp -58.43 -63.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.562 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 11.7 ptp180 -60.45 -12.14 8.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -92.08 -40.91 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.53 -32.08 16.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.5 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.86 -24.84 7.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.936 0.398 . . . . 0.0 110.899 -179.55 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 82.3 -0.65 88.72 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.063 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 37.5 t -66.82 121.73 16.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.986 0.393 . . . . 0.0 110.331 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 -33.8 10.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.03 77.48 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.41 129.16 13.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.919 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 7.0 mt-10 -120.39 146.44 46.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.627 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 55.8 t -76.46 125.69 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.49 0.662 . . . . 0.0 111.928 -179.06 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.56 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -107.44 -17.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.248 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -153.72 159.68 42.06 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.18 111.63 4.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 78' ' ' TYR . 4.5 t -57.58 125.32 71.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.05 -8.15 20.75 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.85 2.366 . . . . 0.0 113.785 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.583 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.54 146.67 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 112.05 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.434 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 16.4 m95 -79.69 145.21 33.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.012 0.434 . . . . 0.0 109.976 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 82.5 mt -111.11 117.55 33.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.733 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.442 HG21 ' CB ' ' A' ' 104' ' ' ALA . 19.3 p -111.74 130.03 55.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.812 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -130.56 163.58 26.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 0.0 110.707 179.539 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.68 158.27 35.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.189 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -101.98 155.93 35.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.496 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 29.9 Cg_endo -63.25 166.95 13.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.309 2.006 . . . . 0.0 112.196 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.76 -16.1 41.82 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.799 2.333 . . . . 0.0 113.232 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -92.57 -31.57 15.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.107 0.48 . . . . 0.0 110.25 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 78.9 t -84.93 -49.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' NH1' ' ND2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -59.63 -45.68 91.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.25 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.06 -29.15 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.409 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -46.75 17.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.686 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.8 mt -57.3 -46.48 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' ND2' ' NH1' ' A' ' 89' ' ' ARG . 3.3 m-20 -44.86 -35.26 2.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.48 -46.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.421 179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -69.19 -55.68 9.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.946 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 92' ' ' LEU . 11.3 m0 -79.48 -31.3 42.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.47 39.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.325 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.15 146.62 49.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 110.638 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -110.28 44.8 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.439 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 56.7 m95 -107.98 144.46 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -28.72 62.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.22 -139.18 2.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.092 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -157.63 117.12 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.326 . . . . 0.0 111.343 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.442 ' CB ' HG21 ' A' ' 81' ' ' THR . . . -86.65 110.58 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -130.85 150.19 52.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.717 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.434 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.1 mtmt -107.51 102.54 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.443 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.449 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 29.9 m95 -67.9 143.28 55.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.417 ' CD2' ' HD2' ' A' ' 54' ' ' ARG . 61.1 m-85 -125.48 137.77 53.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.035 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 21.5 tp -79.36 154.49 28.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.52 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 44.4 m-85 -148.0 127.54 13.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.564 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.56 ' HB2' HG13 ' A' ' 73' ' ' ILE . 4.7 tptp -92.48 121.65 34.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -65.32 123.46 19.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.955 0.407 . . . . 0.0 110.637 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 p -124.68 37.67 4.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.758 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.46 -144.88 4.72 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.034 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.29 154.27 47.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.09 -17.35 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.522 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -74.69 -22.18 58.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -26.24 56.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 119' ' ' ILE . 25.2 mt -69.97 94.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.325 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -117.92 95.98 5.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.931 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.0 mt -52.53 -20.04 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.175 -179.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.0 mt -57.9 -59.09 5.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.378 0.609 . . . . 0.0 109.966 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -178.56 18.53 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.453 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -89.52 38.77 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.58 26.27 71.87 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -103.23 -64.63 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.128 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.29 165.19 12.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -69.29 151.19 97.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -48.86 135.85 28.56 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.624 2.216 . . . . 0.0 112.572 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -113.24 -25.87 8.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 6.6 m-85 -123.17 159.25 29.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.711 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.56 -17.62 5.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.72 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.489 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.36 173.35 15.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 0.0 110.568 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.2 p-90 -160.41 160.56 32.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.426 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -159.3 154.68 25.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.345 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.468 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 87.3 m95 -88.62 127.18 35.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.729 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 26.9 m -138.52 150.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 111.857 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.3 p -68.5 160.86 74.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.647 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 19.7 Cg_endo -58.66 -17.12 33.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 121.773 1.649 . . . . 0.0 111.801 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.06 -34.18 14.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -51.08 23.86 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.039 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.2 tp -54.01 -31.73 51.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 109.823 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.0 mm -67.17 -28.75 43.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.654 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -80.68 -20.7 42.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.18 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 40' ' ' TRP . 11.1 mt -85.77 -39.0 17.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.401 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 24.2 m -56.48 163.95 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.237 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.1 p -93.01 160.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 1.1 mt-10 -49.66 -41.83 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.275 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 45.1 p90 -85.36 8.71 17.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.401 ' CB ' ' CG2' ' A' ' 146' ' ' THR . 19.0 mttt -129.06 -8.66 4.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.602 0.239 . . . . 0.0 111.31 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.8 mtpm? -57.7 -59.88 11.64 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.311 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.9 Cg_endo -61.09 -42.46 36.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.369 2.046 . . . . 0.0 112.174 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.432 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 16.4 t -60.07 -27.28 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.418 ' CE2' ' HE3' ' A' ' 42' ' ' MET . 3.2 m-85 -90.79 -51.4 5.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -32.27 18.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.418 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 6.0 tp10 -66.67 -45.73 77.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.529 179.175 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.493 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.6 t -58.84 -47.44 89.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.963 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 162' ' ' ALA . 76.4 mt -63.73 -48.6 76.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -50.09 -47.36 53.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.861 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.54 -25.71 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 110.404 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.493 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.5 m-30 -102.24 9.64 39.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.975 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.32 -57.92 16.22 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.318 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -58.26 -21.88 54.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.475 2.117 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 93.3 m-70 -89.96 -11.15 42.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.209 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.922 179.843 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.445 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.18 -168.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.562 2.175 . . . . 0.0 112.312 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.57 84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.23 27.57 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.555 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.92 116.87 4.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.68 -39.55 4.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.179 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.3 t0 72.74 24.32 2.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.98 130.6 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.598 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.67 109.31 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.322 2.015 . . . . 0.0 112.28 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.19 -176.31 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.981 2.454 . . . . 0.0 112.1 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 153.92 20.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.934 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -37.45 3.4 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.724 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.91 137.97 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -82.2 152.24 26.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -70.2 131.43 44.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.985 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.547 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.1 t30 -152.78 155.0 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' A' ' 47' ' ' ILE . 19.2 m -133.11 137.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.103 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.92 131.92 9.37 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.128 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.45 HG22 ' CE1' ' A' ' 110' ' ' PHE . 4.5 mp -97.43 113.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.811 0.338 . . . . 0.0 111.863 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 110' ' ' PHE . 8.6 t -96.16 103.17 15.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 112' ' ' PHE . 29.5 tp -103.37 149.37 24.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 111.132 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.07 157.27 45.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.672 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.9 p-10 -98.19 172.31 7.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.614 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -57.82 -17.72 17.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.522 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.81 0.34 56.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 mttm 77.06 25.46 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.515 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 7.4 mttp -93.77 174.41 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.597 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.75 138.51 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -179.807 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 5.2 t80 -76.68 103.7 6.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.494 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.34 139.86 49.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -124.01 137.86 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.52 154.43 25.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.646 179.878 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.403 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.2 mtp85 -71.23 157.66 37.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 111.628 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.45 -5.35 49.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.768 178.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.6 -19.42 4.57 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.985 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 56.9 mt -120.62 112.18 34.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.913 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.04 131.42 28.67 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.856 1.704 . . . . 0.0 111.878 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t70 77.15 3.7 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.773 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.4 10.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.349 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -102.41 157.32 17.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.927 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 -176.87 2.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.96 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 51.7 mtm -106.09 159.51 29.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.67 128.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.504 2.136 . . . . 0.0 112.787 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -150.48 167.42 27.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.37 59.39 0.11 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.864 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . 43.17 -165.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.091 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 4.5 mt -132.12 159.68 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 110.578 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 22.5 m-20 -90.38 149.81 22.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.09 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.99 39.6 11.46 Favored Glycine 0 C--N 1.32 -0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.945 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 9.2 tp10 -109.56 146.25 34.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.165 0.507 . . . . 0.0 110.965 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 128.38 81.91 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.318 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.436 ' HA ' ' CG1' ' A' ' 17' ' ' VAL . 76.0 Cg_exo -50.58 -25.82 15.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.358 2.039 . . . . 0.0 112.688 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.85 -24.0 31.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.94 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.91 -43.36 10.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.08 -32.1 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.175 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.71 -53.38 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.084 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.64 -28.58 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.442 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -84.21 -53.3 5.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 109.959 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -50.71 -42.91 57.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.326 -1.307 . . . . 0.0 111.223 -179.667 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.411 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -57.81 -51.9 67.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.584 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 12.8 ttm-85 -62.87 -13.45 34.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.448 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -38.73 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -87.59 -35.5 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.1 -22.78 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 111.164 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.48 6.48 76.31 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.86 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.411 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 19.2 t -56.71 108.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 110.178 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -34.04 16.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 76.13 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.172 0.511 . . . . 0.0 111.054 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.84 13.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.687 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.1 pt-20 -119.92 141.1 49.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.19 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.7 t -70.61 116.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 111.334 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.653 ' CD1' ' HB2' ' A' ' 111' ' ' LYS . 1.2 mt -90.72 -25.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' HB1' ' CE1' ' A' ' 164' ' ' HIS . . . -156.85 169.6 24.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.268 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 11.2 pt-20 -148.59 117.22 6.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.012 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 78' ' ' TYR . 4.5 t -57.05 123.73 61.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.38 -13.45 39.34 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.885 2.39 . . . . 0.0 113.607 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.671 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.1 -179.04 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.349 0.595 . . . . 0.0 112.291 -179.417 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.411 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 21.3 m95 -107.89 147.5 30.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.052 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 3.1 mt -112.51 117.81 33.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.044 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.4 p -112.34 132.4 55.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.435 -179.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -127.05 170.15 12.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 158.27 29.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 11.5 m-85 -118.42 142.53 31.53 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 27.6 Cg_endo -62.48 171.69 5.24 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.394 2.063 . . . . 0.0 112.234 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.65 -16.77 56.68 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.773 2.315 . . . . 0.0 113.307 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.03 -34.55 13.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.159 0.504 . . . . 0.0 110.185 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.488 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 96.0 t -83.0 -46.96 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.277 179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -46.21 90.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.47 0.653 . . . . 0.0 109.494 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.78 -26.64 66.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.673 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.07 -46.04 15.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 96' ' ' TRP . 48.0 mt -56.43 -42.9 78.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.43 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.416 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -44.83 -34.17 2.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.749 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.25 -48.67 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -56.95 10.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.929 0.395 . . . . 0.0 110.768 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.441 ' N ' ' O ' ' A' ' 92' ' ' LEU . 38.6 m0 -78.83 -36.31 42.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 82.83 33.84 23.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.314 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.426 ' CB ' ' CD1' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -131.17 149.1 52.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 110.785 -179.812 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.53 38.7 2.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CD1' ' CB ' ' A' ' 98' ' ' SER . 36.3 m95 -89.24 150.31 22.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -30.36 64.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -162.51 -142.85 3.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.975 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -157.01 112.86 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.805 0.336 . . . . 0.0 111.366 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.66 105.74 17.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.5 pt20 -120.05 161.97 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -116.14 105.15 12.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.217 178.638 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 60.2 m95 -78.35 144.43 36.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.0 m-85 -127.83 136.64 51.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 20.6 tp -79.67 155.04 28.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 20' ' ' CYS . 29.4 m-85 -145.92 132.44 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.198 0.523 . . . . 0.0 111.967 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.653 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -95.64 118.74 32.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.522 177.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 21' ' ' LEU . 3.9 t80 -68.73 119.74 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.3 p -120.84 37.32 4.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.497 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.72 -144.79 4.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.212 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.01 154.26 46.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -49.01 -17.47 0.2 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -74.0 -21.48 59.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.77 -24.77 56.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.14 105.66 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.443 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -122.93 95.56 4.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.021 179.219 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.6 mt -55.73 -21.65 19.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.698 -179.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.47 -58.44 6.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.278 0.561 . . . . 0.0 109.898 178.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.49 -170.41 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.393 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -93.7 38.8 1.06 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.87 75.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.135 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -116.38 -69.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.846 0.355 . . . . 0.0 111.212 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -89.88 165.12 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.69 148.18 54.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.27 126.62 17.88 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.65 2.233 . . . . 0.0 112.463 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.0 -28.25 9.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.745 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 11.2 m-85 -113.08 159.25 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.476 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.15 -20.79 5.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.711 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.448 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.0 mm-40 -152.27 174.63 13.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.076 0.465 . . . . 0.0 110.47 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 p-90 -159.2 157.55 30.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.165 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -157.59 160.73 38.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.493 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.1 m95 -92.87 127.37 38.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.47 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 28' ' ' ILE . 35.7 m -136.15 152.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -72.62 152.51 91.59 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -49.06 -23.26 6.04 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.105 1.87 . . . . 0.0 111.926 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.96 -33.71 19.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -50.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.041 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.8 tp -54.18 -29.3 45.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.488 0.661 . . . . 0.0 109.817 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.0 mm -70.52 -28.39 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.75 178.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.2 -21.84 42.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.14 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 142' ' ' LEU . 11.4 mt -82.48 -39.67 22.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.124 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.9 m -58.78 163.6 3.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.023 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 150' ' ' LYS . 12.6 p -92.58 161.42 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.32 -26.64 68.54 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.112 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CD2' HG22 ' A' ' 147' ' ' VAL . 24.6 p90 -91.11 10.88 25.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.505 ' HB2' HG13 ' A' ' 147' ' ' VAL . 5.7 mtmm -152.75 15.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.658 0.266 . . . . 0.0 111.698 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.512 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.1 mtpp -67.04 -62.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.228 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.1 Cg_endo -50.77 -40.43 56.71 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.536 2.158 . . . . 0.0 112.097 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 21.4 t -57.15 -27.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.26 0.552 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.449 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.22 -48.47 6.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.372 179.019 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -52.68 -32.28 41.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.581 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -66.89 -45.72 77.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.385 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.6 t -59.04 -46.78 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.983 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.1 mt -66.55 -48.69 68.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.647 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.9 t -50.24 -47.17 55.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.674 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.5 t -68.49 -24.56 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.073 0.463 . . . . 0.0 110.349 179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.51 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.3 m-30 -103.26 5.69 37.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.212 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.19 -55.36 31.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.609 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.72 -22.51 17.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.577 2.184 . . . . 0.0 112.351 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.441 ' CE1' ' O ' ' A' ' 73' ' ' ILE . 16.3 m-70 -89.97 -22.2 22.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.717 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.914 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.446 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.53 -167.77 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.29 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.54 161.41 28.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.34 26.51 27.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.572 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.42 121.04 1.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.543 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.2 mmt -122.56 -35.42 3.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.65 21.08 6.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.806 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 172.91 130.6 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.463 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.38 109.41 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.317 2.011 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.23 -176.17 3.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.059 2.506 . . . . 0.0 112.091 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -90.26 153.92 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.75 -29.89 9.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -103.48 139.56 38.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 5.6 ttm180 -83.36 152.24 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.131 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -65.21 131.66 47.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.49 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.5 m120 -152.52 159.27 43.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.894 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.424 HG22 ' CB ' ' A' ' 56' ' ' ALA . 1.5 m -132.29 127.68 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.254 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.12 144.38 17.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.162 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -120.95 102.11 11.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.8 t -89.71 107.65 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -103.08 144.8 30.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.014 0.435 . . . . 0.0 111.196 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.07 157.48 41.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.747 -179.973 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.9 p-10 -103.89 170.38 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.34 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -55.08 -18.13 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.94 4.48 47.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 179.705 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 4.8 mtpp 70.55 27.86 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mttt -96.73 172.38 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 65.9 t80 -57.19 109.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.183 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.62 132.44 56.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.254 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -115.57 138.03 51.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.468 . . . . 0.0 111.509 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.69 158.5 22.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.514 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 2.2 mtp-105 -71.26 164.21 26.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.41 0.624 . . . . 0.0 111.468 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -96.25 -6.06 38.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.69 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -136.17 -14.09 1.8 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 64.5 mt -120.67 111.77 34.36 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.358 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 32.8 Cg_endo -66.38 132.97 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.739 1.626 . . . . 0.0 111.306 179.123 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 79.12 3.18 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.465 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -94.95 97.74 10.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.152 179.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 23.7 m95 -108.78 160.21 16.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.085 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -168.86 170.81 8.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.859 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.453 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 71.0 mtm -97.91 156.71 35.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.67 137.81 39.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 0.0 112.917 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.27 157.02 38.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.378 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.93 153.02 23.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.754 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 132.17 17.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 6.4 mt -59.88 160.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.761 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 179.796 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.13 98.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.18 0.514 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.73 39.3 10.66 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.941 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 47' ' ' ILE . 15.5 tp10 -114.22 146.48 40.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 110.93 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.9 139.82 80.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.494 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.51 -52.55 7.91 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.46 2.107 . . . . 0.0 112.608 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -62.9 -25.48 68.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.328 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -84.66 -48.88 9.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.699 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.424 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -59.04 -28.31 66.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.54 -50.2 16.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.158 179.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -57.25 -29.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -82.69 -53.12 6.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.747 0.784 . . . . 0.0 109.956 179.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -52.65 -42.33 64.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.471 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -57.11 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.686 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 32.0 ttp180 -61.98 -13.54 26.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.331 178.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.02 -42.73 9.82 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -91.26 -25.66 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.447 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.8 -20.5 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.11 6.67 65.12 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.049 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.1 117.19 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.506 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -96.14 -35.73 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 78.56 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 111.141 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.53 129.43 13.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.931 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.76 148.96 42.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.06 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.8 t -79.56 123.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.422 0.629 . . . . 0.0 111.495 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.556 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -106.12 -20.17 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.398 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 161' ' ' PHE . . . -154.55 159.35 40.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.435 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.2 pt-20 -148.66 117.11 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.989 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.624 HG11 ' O ' ' A' ' 78' ' ' TYR . 11.0 t -57.26 126.76 75.13 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.065 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.94 -19.78 69.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.754 2.302 . . . . 0.0 113.228 -179.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.624 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.45 -177.98 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.049 -179.518 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.458 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.0 m95 -108.48 146.73 32.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.798 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 3.4 mt -111.71 117.61 33.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.014 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.403 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 4.0 p -111.57 131.89 54.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.946 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -133.75 163.88 28.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.68 179.824 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -122.23 158.25 29.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.65 150.41 42.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.469 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 27.3 Cg_endo -62.41 170.49 6.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.553 2.169 . . . . 0.0 112.443 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.8 -16.77 51.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.89 2.393 . . . . 0.0 113.257 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.6 -39.28 11.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.197 0.523 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.469 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 94.8 t -78.46 -46.37 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.318 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -46.55 88.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.465 0.65 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.39 -29.11 69.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.574 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -47.22 19.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.676 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' TRP . 92.7 mt -58.04 -45.87 86.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.356 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.408 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.8 m-80 -45.58 -31.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.567 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.33 -50.2 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.239 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -56.33 12.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.839 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' LEU . 21.5 m0 -78.54 -34.73 46.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 81.06 34.45 26.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.552 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.81 147.17 47.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.707 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.8 39.29 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 69.2 m95 -97.41 150.13 21.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -31.15 67.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.32 -143.03 3.54 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.005 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -157.61 114.47 2.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.878 0.37 . . . . 0.0 111.498 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.403 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -94.51 105.78 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 7.6 pt20 -127.81 156.6 42.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.08 97.91 7.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 178.862 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 28.0 m95 -65.72 141.95 58.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 0.0 112.134 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 62.0 m-85 -125.6 137.24 53.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.316 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.3 tp -79.54 146.14 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 40.0 m-85 -139.11 127.88 23.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.008 0.432 . . . . 0.0 111.651 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.556 ' HB2' HG13 ' A' ' 73' ' ' ILE . 15.3 tttm -92.02 120.44 32.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.522 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -64.89 125.53 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.798 -179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.1 p -126.54 37.73 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.89 -144.86 4.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.236 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -127.15 154.27 44.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.917 0.389 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -49.75 -16.67 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.642 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.97 -18.16 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.266 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.06 -25.36 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 17.7 mt -74.2 103.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.49 -179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -117.61 95.89 5.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 47.2 mt -55.2 -23.32 21.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.64 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 29.0 mt -62.37 -57.4 11.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.285 0.564 . . . . 0.0 110.065 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.03 25.0 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.51 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.27 38.84 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 109.89 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.05 27.79 73.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.222 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.5 t -110.49 -65.97 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.837 0.351 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.57 165.06 11.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 149.9 97.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.0 177.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.732 2.288 . . . . 0.0 112.612 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -150.07 -45.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.552 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 18.9 m-85 -107.41 159.74 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.331 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.12 -16.9 6.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.803 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.552 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.47 174.7 13.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.12 0.486 . . . . 0.0 110.705 -179.816 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -159.51 153.67 23.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.08 179.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.06 161.62 42.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.41 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.443 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -94.95 123.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.433 HG21 ' CA ' ' A' ' 142' ' ' LEU . 27.3 m -135.39 151.05 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.071 0.463 . . . . 0.0 111.641 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.85 159.23 86.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.422 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.7 Cg_endo -55.51 -19.38 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.935 1.756 . . . . 0.0 111.873 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.26 -34.25 15.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.48 -50.48 25.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.989 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.433 ' CA ' HG21 ' A' ' 137' ' ' VAL . 4.3 tp -54.01 -29.95 45.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.489 0.661 . . . . 0.0 109.915 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 2.9 mm -68.15 -29.15 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.582 178.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.6 -22.15 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.41 -39.24 19.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.005 179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m -58.63 168.56 1.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 149' ' ' PHE . 6.3 p -104.64 159.92 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.047 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -45.44 -46.17 13.35 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CE2' HG12 ' A' ' 147' ' ' VAL . 1.5 p90 -76.8 -1.89 30.47 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.426 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mtmp? -125.73 1.57 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.579 0.228 . . . . 0.0 111.528 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.3 mttt -65.36 -62.55 4.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.342 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.03 -42.44 44.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.419 2.08 . . . . 0.0 112.239 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.458 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 13.4 t -59.16 -29.07 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.273 0.558 . . . . 0.0 110.966 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.78 -50.97 5.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.692 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -35.01 21.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.669 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 -44.81 81.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.642 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 44.2 t -57.76 -46.51 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.084 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.3 mt -66.27 -48.87 69.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.9 m -50.02 -47.17 53.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.39 -25.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.067 0.46 . . . . 0.0 110.307 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.488 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.4 m-30 -104.8 12.0 33.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.981 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.498 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.98 -59.47 9.78 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.404 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -56.31 -21.53 37.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.586 2.191 . . . . 0.0 112.268 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.417 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 62.6 m-70 -89.95 -12.67 38.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.971 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.477 ' PA ' " C3'" ' A' ' 166' ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.28 145.1 53.21 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.537 2.158 . . . . 0.0 112.32 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 26.1 tp -153.25 102.47 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.73 65.49 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.477 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER 178.59 127.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.595 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.1 ptp -140.32 -27.46 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.036 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.08 28.79 1.01 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.636 0.255 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 140.99 0.28 Allowed Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.64 120.35 4.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.214 179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -91.42 -171.13 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.936 2.424 . . . . 0.0 112.459 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -87.81 151.07 23.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.768 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.28 -28.95 11.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.428 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.0 m-85 -111.91 140.74 46.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.338 . . . . 0.0 110.725 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HG3' ' CH2' ' A' ' 100' ' ' TRP . 2.1 ttp85 -92.48 152.38 19.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -62.12 132.55 53.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.425 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 19.1 t-20 -152.73 154.53 35.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.358 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.452 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.3 m -126.3 131.49 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 111.388 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.81 148.3 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.033 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.485 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -123.06 102.43 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.761 0.315 . . . . 0.0 111.397 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.2 t -89.48 104.69 17.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -102.59 145.3 29.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.0 0.429 . . . . 0.0 111.105 -178.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.2 ptm -127.65 157.26 40.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.2 p-10 -106.31 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -54.05 -18.33 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -88.86 3.94 49.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 179.803 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 20.7 mmtm 70.47 27.38 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.577 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 22' ' ' MET . 11.4 mmtm -96.38 175.32 6.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 5.1 mp -113.65 119.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.956 0.408 . . . . 0.0 110.809 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 18.8 t80 -52.46 110.29 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.74 133.6 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.412 179.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.89 139.1 52.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.9 p -82.3 155.78 24.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.685 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.448 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 1.3 mtt85 -72.01 158.09 36.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 mt -91.77 -5.66 53.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.019 178.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.79 -18.18 3.48 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 61.7 mt -118.78 111.84 37.24 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.7 131.24 28.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.981 1.787 . . . . 0.0 111.968 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 77.08 3.26 3.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.856 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.478 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -87.23 97.56 10.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.406 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -101.59 155.87 17.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.221 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.85 -176.92 2.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.651 179.724 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.4 mpp? -107.17 158.18 33.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 128.88 19.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.603 2.202 . . . . 0.0 112.417 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.03 157.09 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.76 139.24 5.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.571 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.31 137.48 49.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 9.2 mt -69.22 162.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.632 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -75.93 -172.16 1.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.613 179.614 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -90.14 27.45 1.63 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.24 0.543 . . . . 0.0 111.145 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.91 48.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 47' ' ' ILE . 5.4 tp10 -124.33 149.61 46.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 110.929 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -77.76 137.73 62.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.1 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -50.68 -55.18 4.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.363 2.042 . . . . 0.0 112.763 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' CG ' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -58.42 -31.55 67.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.316 -179.731 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -80.07 -49.73 11.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.733 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' CB ' HG23 ' A' ' 17' ' ' VAL . . . -56.69 -30.6 63.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.497 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.46 -52.59 13.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.099 179.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.2 mt -56.41 -29.85 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.23 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -81.67 -53.15 6.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.762 0.791 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -52.08 -45.71 64.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.597 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tp -56.0 -56.16 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.811 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.503 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 40.1 ttp180 -60.56 -14.48 20.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.298 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -92.07 -41.35 10.56 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.897 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -91.5 -25.04 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.31 -20.06 9.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.086 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.24 6.24 64.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.051 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -71.18 123.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.865 0.333 . . . . 0.0 110.469 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -34.12 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.24 76.77 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.987 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.26 129.01 13.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.873 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 12.0 mt-10 -120.39 148.5 43.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.765 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 38.9 t -78.15 125.39 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.456 0.646 . . . . 0.0 111.694 -179.332 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.544 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -106.28 -21.62 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.237 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 3.4 pt-20 -148.52 115.85 6.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.011 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 78' ' ' TYR . 4.8 t -57.31 130.17 80.36 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.066 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 -15.96 40.07 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.721 2.281 . . . . 0.0 113.6 -178.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.65 -176.05 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.417 0.627 . . . . 0.0 112.48 -179.369 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.435 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 25.6 m95 -106.27 147.48 29.09 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.279 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 5.5 mt -114.47 117.94 32.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.996 179.22 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.406 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -111.04 135.07 52.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.435 -179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -122.71 170.26 10.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.683 -179.355 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.21 158.23 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -117.63 152.51 49.79 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.471 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 36.5 Cg_endo -64.96 165.41 21.53 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.98 -16.34 44.7 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.847 2.364 . . . . 0.0 113.066 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.66 -34.9 14.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.075 0.464 . . . . 0.0 110.13 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.471 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 64.9 t -81.9 -48.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -44.63 92.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.459 0.647 . . . . 0.0 109.576 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.78 -31.14 67.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.633 179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.39 -48.01 52.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.737 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 96' ' ' TRP . 96.8 mt -59.05 -47.69 84.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.599 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.423 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 3.0 m-80 -46.75 -31.4 2.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.636 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.1 mt -96.67 -48.08 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.355 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -52.83 28.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.473 ' N ' ' O ' ' A' ' 92' ' ' LEU . 22.5 m0 -80.89 -35.12 32.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.68 38.34 28.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.195 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.9 159.13 34.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.812 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -118.08 77.89 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CH2' ' HG3' ' A' ' 14' ' ' ARG . 56.9 m95 -135.3 150.24 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.573 179.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.519 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -85.72 -23.02 27.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -174.7 -137.58 2.51 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.048 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 90.0 mm-40 -157.3 113.85 2.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.886 0.374 . . . . 0.0 111.346 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -88.0 105.63 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.3 pt20 -121.64 157.06 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -112.15 95.72 5.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.198 178.569 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.451 ' CG ' HG21 ' A' ' 157' ' ' VAL . 24.2 m95 -64.12 150.5 45.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.308 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CE2' ' CG ' ' A' ' 54' ' ' ARG . 64.9 m-85 -133.15 133.29 42.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.284 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 17.6 tp -79.81 130.23 35.14 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 47.9 m-85 -124.49 129.13 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.505 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.544 ' HB2' HG13 ' A' ' 73' ' ' ILE . 5.1 tptt -92.38 123.06 35.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -67.2 124.48 23.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.694 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.6 p -126.73 37.87 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.747 179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.2 -145.13 4.79 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.031 179.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -128.54 154.13 46.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.25 -16.25 0.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.67 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.71 -18.36 54.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.744 0.307 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.12 -25.0 40.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.6 mt -72.09 103.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.501 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.5 95.61 5.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.69 -23.15 39.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.54 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 mt -61.85 -56.77 15.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.25 0.548 . . . . 0.0 109.997 179.233 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.38 -178.47 22.3 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.552 179.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -90.72 38.74 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.1 0.476 . . . . 0.0 109.843 179.208 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.23 73.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -112.76 -67.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 111.19 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -105.54 165.04 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.235 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.54 150.75 95.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -50.43 138.77 38.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.654 2.236 . . . . 0.0 112.506 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -112.4 -31.48 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.724 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.457 ' CE1' ' NE2' ' A' ' 41' ' ' GLN . 7.2 m-85 -118.02 159.56 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.03 -20.07 5.37 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.879 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.415 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.5 mm-40 -152.23 174.66 13.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.248 0.547 . . . . 0.0 110.599 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 p-90 -159.2 154.11 24.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.178 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.427 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -93.05 125.31 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 28.9 m -137.63 150.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.116 0.484 . . . . 0.0 111.619 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -69.54 159.83 82.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.472 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 14.0 Cg_endo -56.69 -18.89 28.21 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.796 1.664 . . . . 0.0 111.838 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.12 -34.2 15.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.054 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -50.9 22.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.112 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.1 tp -54.22 -30.28 49.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.393 0.616 . . . . 0.0 109.826 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 5.1 mm -68.97 -28.31 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.717 178.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 -17.53 47.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.367 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.53 -38.8 15.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.186 179.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.6 m -59.51 162.26 5.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 150' ' ' LYS . 10.1 p -91.62 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.66 -33.18 32.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.467 ' CG ' HG12 ' A' ' 147' ' ' VAL . 13.3 p90 -87.53 10.9 16.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.516 ' HB2' HG13 ' A' ' 147' ' ' VAL . 8.6 mtmm -136.74 -2.24 2.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 30.1 mttt -55.76 -61.81 5.67 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.201 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.3 Cg_endo -59.6 -45.84 23.66 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.377 2.051 . . . . 0.0 112.122 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 39.5 t -56.06 -27.79 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.227 0.537 . . . . 0.0 111.066 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.428 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.8 m-30 -91.55 -53.71 4.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.76 -32.63 14.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 110.522 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -66.2 -45.56 80.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.498 179.148 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.511 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.4 t -57.9 -50.38 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.123 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 162' ' ' ALA . 74.7 mt -61.68 -48.89 78.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.698 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 t -49.71 -47.53 50.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.664 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.0 t -67.84 -25.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.461 . . . . 0.0 110.31 179.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.511 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 8.6 m-30 -102.1 7.88 40.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.156 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.64 -57.0 17.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.258 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.4 Cg_endo -56.76 -22.39 44.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB1' ' A' ' 74' ' ' ALA . 91.5 m-70 -89.97 -14.37 34.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.025 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.894 179.829 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.437 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -178.51 2.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.588 2.192 . . . . 0.0 112.227 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 86.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.17 31.18 9.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.499 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.41 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.5 OUTLIER 173.62 128.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.343 . . . . 0.0 110.547 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.9 tpp -124.75 -32.14 3.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.779 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 74.61 19.36 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.87 142.4 0.17 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 41.7 Cg_endo -68.26 114.93 3.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.279 1.986 . . . . 0.0 112.183 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.13 -176.27 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.589 2.193 . . . . 0.0 111.87 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 151.27 21.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.327 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA3' ' NZ ' ' A' ' 101' ' ' LYS . . . 88.83 -37.15 3.34 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.877 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.68 131.95 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.008 0.432 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.46 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 2.1 ptm85 -73.79 143.52 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -67.02 133.17 49.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.399 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.503 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.3 t-20 -152.55 155.96 38.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -123.87 130.0 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.216 179.786 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.18 146.38 18.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.126 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.467 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.4 mp -124.56 102.03 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.9 t -89.57 101.82 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -103.03 143.3 32.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 0.0 111.229 -178.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.86 157.41 39.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.751 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 36.2 p-10 -100.71 170.05 8.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.232 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -56.27 -16.67 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.56 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.98 0.11 56.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.688 0.28 . . . . 0.0 110.973 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mttm 77.21 26.71 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.602 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -98.93 173.27 6.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.7 mp -111.23 122.97 66.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 65' ' ' THR . 66.7 t80 -56.5 110.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.8 129.88 56.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.236 179.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.11 137.54 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.62 157.61 23.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.55 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.447 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.2 mtp85 -72.94 159.51 33.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.15 -5.65 49.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.996 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.49 -16.81 3.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 54.5 mt -119.65 111.97 35.75 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.24 131.82 29.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.904 1.736 . . . . 0.0 111.8 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 76.92 3.52 3.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.783 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -89.67 97.51 11.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.414 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CD1' HD23 ' A' ' 145' ' ' LEU . 37.7 m95 -104.62 156.65 17.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.044 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -168.8 169.56 9.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.451 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 45.9 mtm -94.15 155.83 39.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.45 134.11 37.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.512 2.142 . . . . 0.0 112.687 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 163.54 39.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.493 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.45 142.73 7.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.746 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.84 135.61 49.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.59 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.5 mt -66.84 160.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.55 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.469 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.17 149.35 22.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.824 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -50.73 99.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.219 0.533 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.57 39.83 11.76 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.851 -179.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB3' HG21 ' A' ' 47' ' ' ILE . 6.0 tp10 -113.76 145.18 41.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.91 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.43 125.56 89.7 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.236 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' HG12 ' A' ' 17' ' ' VAL . 6.6 Cg_endo -50.16 -47.97 21.77 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.46 2.106 . . . . 0.0 112.772 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -59.31 -27.73 66.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.725 0.298 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -88.01 -43.44 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -60.78 -32.18 71.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.174 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.11 -54.06 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.034 179.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.42 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -55.79 -29.53 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.278 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttp85 -82.69 -52.79 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.798 0.808 . . . . 0.0 109.981 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.92 -44.1 66.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.575 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 tp -56.97 -55.39 35.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.676 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 33.7 ttp180 -62.28 -13.3 26.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.283 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.12 -43.25 9.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.827 -179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.18 -25.85 19.35 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.77 -20.35 9.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.451 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.88 4.69 67.58 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.103 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.86 116.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.834 0.35 . . . . 0.0 110.529 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.65 -34.5 11.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -179.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.38 78.4 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.48 129.04 13.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.871 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.68 149.02 42.12 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.56 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 30.6 t -80.06 122.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.4 0.619 . . . . 0.0 111.355 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -103.03 -20.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.414 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -155.94 161.0 40.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.68 117.48 6.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.877 179.652 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 78' ' ' TYR . 6.4 t -57.16 128.78 78.59 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.22 -18.18 55.54 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 113.337 -178.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -125.6 -179.16 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 112.111 -179.505 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.436 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 6.2 m95 -108.45 145.94 33.89 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 66.5 mt -110.66 117.3 33.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.106 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 17.4 p -101.63 137.49 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.762 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -131.85 169.78 15.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 -179.417 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.91 158.42 36.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -116.32 145.04 34.2 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 24.4 Cg_endo -62.23 169.56 7.68 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 112.323 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.87 -16.48 44.93 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.868 2.379 . . . . 0.0 113.233 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -90.73 -42.85 10.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.274 0.559 . . . . 0.0 109.829 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 96.4 t -74.11 -46.45 45.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.448 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -46.17 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.515 0.674 . . . . 0.0 109.731 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.35 -21.58 62.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.888 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 -44.87 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.638 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 96' ' ' TRP . 84.4 mt -60.83 -45.06 95.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.462 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.412 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.4 m-80 -46.92 -33.13 4.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 94' ' ' ILE . 1.9 mp -96.72 -47.64 12.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -68.43 -54.87 14.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.358 . . . . 0.0 111.002 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.456 ' N ' ' O ' ' A' ' 92' ' ' LEU . 27.1 m0 -79.76 -33.34 40.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 76.36 38.51 33.48 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.196 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.414 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -125.27 147.52 49.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.382 . . . . 0.0 110.893 -179.823 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.63 74.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.828 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.46 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 19.0 m95 -135.19 149.42 49.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.964 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.422 ' NZ ' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -81.72 -29.23 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.634 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -155.96 -146.19 4.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.279 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -158.17 129.95 6.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.914 0.388 . . . . 0.0 111.777 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.71 106.84 15.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.889 178.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.3 pt20 -122.06 161.59 22.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.606 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -113.85 101.66 9.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.021 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.479 ' CG ' HG23 ' A' ' 157' ' ' VAL . 33.8 m95 -70.36 153.15 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 0.0 112.401 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 73.3 m-85 -137.08 134.12 36.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.199 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.7 tp -79.88 130.97 35.73 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.424 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 46.3 m-85 -125.55 128.43 47.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.581 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.518 ' HB2' HG13 ' A' ' 73' ' ' ILE . 1.9 tptt -92.25 121.18 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -64.86 124.88 23.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.984 0.421 . . . . 0.0 110.816 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.2 p -125.66 37.51 4.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.602 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.12 -145.18 4.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.13 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -128.09 154.24 45.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.829 0.347 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -50.03 -16.52 0.3 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.62 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -18.35 54.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.682 0.277 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.34 -25.29 39.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 16.1 mt -72.35 97.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.361 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -111.42 95.71 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.078 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -55.42 -23.06 22.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.667 -179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.75 -58.11 8.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.299 0.571 . . . . 0.0 110.001 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.51 -176.85 25.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.554 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.44 38.79 1.02 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 179.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.34 28.18 73.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.169 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -112.18 -65.98 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.04 165.13 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.241 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -66.78 151.87 96.2 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.42 176.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.04 -44.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.681 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 23.0 m-85 -109.44 159.53 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.392 179.644 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.83 -19.19 6.12 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -152.46 174.69 13.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.455 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 23.7 p-90 -158.38 151.72 23.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.145 179.064 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.2 m -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.386 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.444 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 73.7 m95 -93.32 123.47 36.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.666 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 31.6 m -134.05 151.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.111 0.482 . . . . 0.0 111.716 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.6 p -70.23 158.34 87.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.419 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.02 -19.1 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.978 1.786 . . . . 0.0 112.046 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.01 -33.46 14.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 179.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -50.05 35.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.107 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 4.1 tp -53.34 -31.93 46.7 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.413 HD13 ' CD1' ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.35 -29.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.683 178.566 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -32.07 57.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 40' ' ' TRP . 8.1 mt -75.47 -40.47 57.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.008 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 16.8 m -55.4 165.07 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.141 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.3 p -98.9 160.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.221 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -47.34 -43.35 22.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.43 -179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.467 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.7 p90 -82.66 4.12 26.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.272 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.439 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 16.1 mttt -125.25 -3.29 7.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 111.368 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 35.5 mttt -59.95 -61.87 7.03 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.0 Cg_endo -61.08 -43.29 30.58 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.456 2.104 . . . . 0.0 112.403 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 82' ' ' TYR . 15.4 t -57.23 -29.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.08 -55.25 3.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.8 -32.59 6.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 3.1 tp10 -69.73 -44.19 70.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.785 179.407 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.521 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.5 t -59.57 -42.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.136 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 162' ' ' ALA . 51.3 mt -67.46 -48.1 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.619 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -50.58 -46.84 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.807 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.08 -24.54 30.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.123 0.487 . . . . 0.0 110.411 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.521 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.5 m-30 -102.61 6.05 39.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.117 -179.178 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.449 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -50.97 -49.9 77.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.532 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 162' ' ' ALA . 75.0 Cg_exo -49.73 -25.21 11.09 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.565 2.176 . . . . 0.0 112.559 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.427 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 96.7 m-70 -94.68 -26.71 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.448 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.09 173.65 10.94 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.677 2.251 . . . . 0.0 112.312 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 tp -175.63 87.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.7 33.86 2.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.79 129.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 110.518 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mmt -121.69 -38.17 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.409 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 68.46 18.66 8.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.856 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t 172.86 132.97 0.1 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.23 109.56 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.337 2.024 . . . . 0.0 112.297 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.76 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.065 2.51 . . . . 0.0 112.047 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.3 151.7 21.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.64 -25.24 28.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.56 138.13 43.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.41 . . . . 0.0 110.966 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.422 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 4.1 ptm85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -67.32 130.33 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.472 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.8 m120 -152.68 159.63 43.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.448 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.5 m -133.61 131.32 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.257 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.34 144.7 16.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.298 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.449 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.3 mp -120.5 101.81 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.172 -179.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.2 t -89.54 107.21 18.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.228 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.9 tp -103.42 141.86 35.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.097 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.49 157.46 40.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.1 p-10 -101.02 171.04 7.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.331 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.13 -17.62 7.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.586 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.07 0.26 56.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.733 0.302 . . . . 0.0 110.971 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp 77.0 26.21 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.5 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.21 172.11 8.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.965 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 139' ' ' PRO . 4.8 mp -110.91 121.32 63.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.367 . . . . 0.0 110.937 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 37.0 t80 -56.06 109.4 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.233 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.7 130.01 56.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.36 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.29 136.1 53.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.41 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -82.29 155.39 24.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.416 179.637 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.427 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -72.12 157.29 38.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.355 0.597 . . . . 0.0 111.732 -179.223 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.43 -6.44 49.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.828 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.53 -18.26 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.216 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 39' ' ' ALA . 61.7 mt -119.6 110.92 36.64 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 28.5 Cg_endo -65.17 131.83 29.8 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.816 1.677 . . . . 0.0 111.73 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 t70 77.11 5.46 3.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.642 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . . . -92.82 97.84 11.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.5 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.41 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 19.2 m95 -107.0 156.4 18.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -168.8 176.69 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 2.2 mpp? -101.3 160.44 26.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.34 136.95 24.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.571 2.181 . . . . 0.0 112.786 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 155.77 35.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.14 155.6 26.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.675 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.88 132.82 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.8 mt -60.23 161.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.644 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.25 149.33 22.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.91 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.44 98.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.194 0.521 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.51 10.0 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.947 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' HB3' HG23 ' A' ' 47' ' ' ILE . 6.1 tp10 -114.38 146.27 40.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.16 140.05 76.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.511 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.24 -52.43 8.74 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.383 2.055 . . . . 0.0 112.575 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -62.56 -25.62 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.156 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.64 -50.02 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.676 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -58.25 -31.97 67.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.504 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.24 -52.0 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.266 179.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 55.1 mt -57.24 -28.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.213 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -84.0 -53.18 5.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.749 0.785 . . . . 0.0 109.777 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.56 -32.7 58.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.29 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 tp -55.73 -54.79 40.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.595 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -61.67 -13.0 18.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.911 0.386 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.64 -37.92 12.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 0.0 111.395 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.7 -36.42 17.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.955 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.453 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.07 -23.46 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.1 3.05 84.48 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.81 -179.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.95 115.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.821 0.343 . . . . 0.0 110.461 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -91.83 -36.95 13.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.18 78.98 6.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 110.979 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 129.56 13.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.845 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -120.04 147.76 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.859 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.4 t -78.22 125.03 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.405 0.621 . . . . 0.0 111.858 -179.141 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.591 HG13 ' HB2' ' A' ' 111' ' ' LYS . 1.9 mm -107.0 -19.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.362 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . . . -152.03 158.26 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.327 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -148.56 116.75 6.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.995 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 78' ' ' TYR . 10.9 t -57.26 130.79 80.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.094 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -17.66 40.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.647 2.231 . . . . 0.0 113.316 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.643 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.35 177.08 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 112.15 -179.497 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 m95 -104.32 146.05 29.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.976 179.067 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 94.8 mt -113.19 117.56 32.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.4 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 2.5 p -111.19 131.9 54.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -132.69 162.81 30.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.616 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.22 158.38 24.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.47 154.44 47.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.467 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 30.6 Cg_endo -63.87 172.0 6.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.493 2.129 . . . . 0.0 112.528 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.879 2.386 . . . . 0.0 113.256 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -90.17 -35.08 15.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 109.979 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.467 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 73.3 t -80.41 -49.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.187 179.252 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -47.4 80.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.515 0.674 . . . . 0.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -27.51 67.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.92 179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.89 -46.56 18.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.2 mt -60.44 -45.72 92.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 110.263 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.1 m-80 -45.2 -30.69 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.639 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.08 -50.66 11.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -51.76 64.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.74 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.429 ' CZ2' ' O1A' ' A' ' 166' ' ' ATP . 33.9 m0 -81.96 -40.77 21.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.837 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 86.85 34.48 11.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.42 156.19 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.76 67.52 0.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 51.8 m95 -124.47 150.24 45.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -31.31 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -156.22 -144.66 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.991 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.09 114.95 2.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.347 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -92.74 105.97 18.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.874 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 8.2 pt20 -127.32 155.59 43.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 112.539 -178.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -109.26 96.34 6.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.633 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CG ' HG21 ' A' ' 157' ' ' VAL . 23.2 m95 -63.7 145.68 55.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.106 -178.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 59.2 m-85 -128.16 137.05 51.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.428 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 19.4 tp -79.71 146.95 32.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.523 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 45.4 m-85 -140.77 127.05 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.978 0.418 . . . . 0.0 111.545 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.591 ' HB2' HG13 ' A' ' 73' ' ' ILE . 14.5 tttm -90.47 121.06 32.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -65.41 125.17 24.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 -179.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.0 p -127.77 38.14 4.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.549 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.77 -145.47 4.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.153 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.23 154.05 45.33 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -50.5 -16.08 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.7 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -79.74 -19.11 49.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.767 0.318 . . . . 0.0 111.307 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -78.74 -25.28 44.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.464 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 16.5 mt -74.78 103.48 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.378 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -113.77 95.51 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.918 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.8 mt -49.82 -26.28 3.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.732 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 34.0 mt -63.5 -57.48 10.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 109.982 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.63 -173.49 25.98 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.42 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -93.44 38.86 1.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.19 0.519 . . . . 0.0 109.993 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.89 27.51 73.04 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.267 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -115.13 -68.17 0.94 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.09 165.01 13.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -78.84 153.88 77.99 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.956 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -46.18 162.52 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.836 2.358 . . . . 0.0 112.554 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -149.95 -44.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.47 159.12 16.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.389 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.94 -20.36 4.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.696 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -152.42 174.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.456 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.6 p-90 -159.17 156.19 28.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.151 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.96 164.2 38.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.401 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.44 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 69.0 m95 -94.44 124.95 38.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.672 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 29.7 m -138.21 151.49 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.057 0.456 . . . . 0.0 111.626 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -70.2 159.97 82.55 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 14.6 Cg_endo -57.15 -17.88 27.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.775 1.65 . . . . 0.0 111.786 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -34.43 15.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.154 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -50.78 25.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 109.97 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.5 tp -54.39 -28.96 47.07 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.387 0.613 . . . . 0.0 109.858 179.079 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.9 mm -69.45 -28.73 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.812 178.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.26 -20.04 45.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.271 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' A' ' 142' ' ' LEU . 10.0 mt -86.32 -39.07 16.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -62.22 166.09 5.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.104 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 150' ' ' LYS . 9.3 p -98.41 161.57 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.023 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 0.5 OUTLIER -52.21 -33.37 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.459 ' CG ' HG11 ' A' ' 147' ' ' VAL . 17.8 p90 -86.48 16.0 4.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.937 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.473 ' HB2' HG12 ' A' ' 147' ' ' VAL . 2.4 mtpm? -143.93 -26.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.064 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.9 mtpt -43.38 -61.61 1.77 Allowed Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.653 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.2 Cg_endo -59.42 -44.36 33.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.265 1.976 . . . . 0.0 111.822 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 17.1 t -60.01 -24.99 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.804 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.8 m-30 -90.85 -50.92 5.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.594 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -48.9 -36.63 17.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 5.0 tp10 -64.92 -45.4 86.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.451 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.514 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 37.8 t -58.81 -43.02 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.123 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 162' ' ' ALA . 53.4 mt -69.09 -49.22 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.623 178.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -50.35 -46.78 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.718 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.54 -24.87 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.426 179.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.514 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.1 m-30 -102.26 2.36 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.244 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.79 -56.07 24.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.406 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.9 -21.22 25.45 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.602 2.201 . . . . 0.0 112.391 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.426 ' CE1' ' HB1' ' A' ' 74' ' ' ALA . 12.0 m-70 -89.64 -20.02 24.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.748 0.309 . . . . 0.0 110.816 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.87 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.429 ' O1A' ' CZ2' ' A' ' 96' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.16 -178.39 2.47 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.545 2.164 . . . . 0.0 112.294 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.66 114.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.78 21.74 5.6 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.62 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.52 129.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.624 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.43 -35.52 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.49 14.26 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.156 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.62 139.77 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 57.3 Cg_endo -71.9 112.79 3.48 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.357 2.038 . . . . 0.0 112.293 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -92.15 -172.37 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.137 2.558 . . . . 0.0 112.369 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.25 159.84 20.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.36 -35.85 4.09 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -110.4 138.78 46.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.13 152.27 24.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -66.03 132.75 49.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.113 0.483 . . . . 0.0 111.502 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.8 t30 -152.49 158.49 42.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.1 m -132.2 133.34 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 111.68 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.15 153.61 17.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.938 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.446 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 4.1 mp -127.08 103.37 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.323 . . . . 0.0 111.488 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.6 t -89.7 104.07 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.0 tp -103.24 145.28 30.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.211 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.94 157.53 39.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.719 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.7 p-10 -101.55 170.57 8.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.06 -18.23 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.466 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.0 0.58 56.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.714 0.292 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt 76.03 26.12 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.485 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mttt -96.64 171.24 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 ' CG2' ' CD2' ' A' ' 142' ' ' LEU . 4.1 mp -108.16 124.14 64.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.948 0.404 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CZ ' ' CG2' ' A' ' 119' ' ' ILE . 67.6 t80 -58.53 110.16 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.143 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.29 53.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.423 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -118.73 136.25 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 111.317 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.66 153.74 25.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.563 179.778 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 39' ' ' ALA . 0.5 OUTLIER -70.8 158.3 36.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.532 -179.408 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -92.65 -6.63 48.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.92 178.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -128.75 -17.23 4.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.15 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.509 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 51.6 mt -119.76 107.79 39.92 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.898 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 25.9 Cg_exo -61.98 128.74 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.164 1.909 . . . . 0.0 111.899 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.2 t70 80.06 1.78 2.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.917 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -87.22 97.62 10.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 145' ' ' LEU . 49.0 m95 -103.55 157.24 17.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.995 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.79 -177.01 2.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.42 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 71.6 mtm -109.13 156.76 38.68 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.54 140.26 56.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.595 2.196 . . . . 0.0 112.79 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 158.79 40.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.1 147.06 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.559 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.05 136.41 32.73 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.429 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 48' ' ' ASP . 5.3 mt -65.43 159.94 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.789 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.45 150.27 21.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.69 98.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.242 0.544 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.39 39.14 10.06 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.98 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HB3' HG21 ' A' ' 47' ' ' ILE . 14.2 tp10 -113.85 146.2 40.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 110.844 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.8 139.13 80.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.568 179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.92 -52.08 8.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.416 2.077 . . . . 0.0 112.658 -179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 108' ' ' PHE . 5.8 ttp85 -62.73 -26.64 68.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.277 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -84.51 -48.77 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.55 -28.27 65.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.553 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.49 -50.03 16.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.185 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 mt -57.64 -29.63 34.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -82.13 -53.24 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.799 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -53.01 -41.14 64.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.4 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tp -56.13 -52.57 63.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.637 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.568 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 30.3 ttp180 -61.87 -13.82 28.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 178.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.19 -42.28 9.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.03 -26.17 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.418 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -120.6 -21.18 6.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.845 0.355 . . . . 0.0 111.081 -179.366 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 8.93 62.76 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.059 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.19 114.65 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -35.41 12.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.549 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.27 76.38 6.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.52 . . . . 0.0 111.107 -179.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 127.96 12.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.809 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 8.7 mt-10 -119.41 147.03 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.732 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.1 t -77.12 125.8 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.413 0.625 . . . . 0.0 111.817 -179.115 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -107.77 -16.65 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.366 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 161' ' ' PHE . . . -155.57 158.39 38.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.41 115.36 6.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.195 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.625 HG11 ' O ' ' A' ' 78' ' ' TYR . 9.2 t -57.46 127.39 77.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.33 -18.06 59.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.748 2.299 . . . . 0.0 113.349 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.625 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.96 -179.28 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.401 0.619 . . . . 0.0 112.204 -179.471 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.44 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 7.9 m95 -106.78 147.15 30.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.738 178.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 50.7 mt -113.86 117.84 32.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.103 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.401 ' CG2' ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -112.63 132.49 55.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.834 -179.363 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -130.0 164.01 25.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.651 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.48 158.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.216 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -114.98 154.77 47.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.595 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 30.7 Cg_endo -63.48 166.72 14.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.516 2.144 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.92 -16.42 44.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.881 2.387 . . . . 0.0 113.197 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.8 -34.29 15.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.194 0.521 . . . . 0.0 110.053 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 74.7 t -81.72 -51.21 15.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.222 179.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.4 ' NH1' ' ND2' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -55.09 -49.87 70.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 109.567 178.781 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.69 -29.06 70.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.547 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -76.16 -46.52 28.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 96' ' ' TRP . 92.4 mt -58.74 -47.4 84.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 110.262 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.1 m-80 -44.96 -30.83 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.672 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mt -96.11 -49.73 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.221 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -54.05 37.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.445 ' N ' ' O ' ' A' ' 92' ' ' LEU . 25.7 m0 -79.86 -38.45 32.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.849 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 85.15 33.97 16.05 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.469 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.3 147.57 52.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.56 72.34 0.78 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -124.6 149.95 46.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.742 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -30.7 61.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.09 -141.66 3.22 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.017 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -157.65 115.84 3.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.401 ' CB ' ' CG2' ' A' ' 81' ' ' THR . . . -91.12 106.24 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.808 178.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 5.7 pt20 -124.56 153.25 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.377 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -105.84 95.93 6.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.339 178.526 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.416 ' CD2' HG23 ' A' ' 157' ' ' VAL . 35.5 m95 -62.95 142.43 58.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.339 -178.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 54' ' ' ARG . 65.9 m-85 -126.47 137.44 53.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.229 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 21.7 tp -79.56 154.57 28.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.51 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 43.9 m-85 -148.17 127.67 13.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.037 0.446 . . . . 0.0 111.786 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.571 ' HB2' HG13 ' A' ' 73' ' ' ILE . 12.1 tttp -92.71 119.5 32.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -65.01 123.89 20.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.948 0.404 . . . . 0.0 110.76 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.7 p -125.98 37.81 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.619 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.38 -144.85 4.72 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.101 179.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 154.19 45.93 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.82 -16.68 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.624 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.56 -19.14 56.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.725 0.298 . . . . 0.0 111.172 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.55 -25.17 41.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.452 ' CG2' ' CZ ' ' A' ' 29' ' ' PHE . 17.7 mt -74.25 103.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.602 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.03 95.84 4.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.942 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 131' ' ' PHE . 50.9 mt -54.79 -23.03 16.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.775 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.2 mt -63.42 -59.54 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.25 0.547 . . . . 0.0 110.014 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.23 -176.99 24.87 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.445 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.53 39.01 1.02 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.132 0.491 . . . . 0.0 109.697 179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.64 26.79 74.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.078 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -119.08 -69.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.179 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.33 165.1 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 153.56 65.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.13 162.1 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.74 2.293 . . . . 0.0 112.597 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -150.05 -46.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 12.7 m-85 -107.76 159.41 16.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.341 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.46 5.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.777 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -152.37 175.24 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.7 p-90 -156.68 152.5 27.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.09 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.6 m -147.93 163.63 36.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.409 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 69.7 m95 -98.12 122.48 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.661 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -134.91 150.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 111.58 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.93 162.33 72.74 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.699 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.94 -20.34 36.11 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.84 1.693 . . . . 0.0 111.826 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -35.88 15.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.269 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -69.96 -50.36 42.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.06 179.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 3.4 tp -53.96 -31.75 51.62 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.499 0.666 . . . . 0.0 109.81 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.9 mm -67.85 -28.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 178.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.73 -20.98 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.254 179.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' A' ' 142' ' ' LEU . 10.2 mt -85.49 -38.95 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.096 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.403 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 29.8 m -56.14 163.43 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 150' ' ' LYS . 7.4 p -91.42 165.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.6 -32.1 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.774 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.449 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.2 p90 -92.89 13.62 19.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HB2' HG12 ' A' ' 147' ' ' VAL . 33.9 mttp -136.23 0.81 2.61 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.327 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 6.4 mttm -62.15 -62.83 5.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.0 -44.72 27.96 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.46 2.107 . . . . 0.0 112.172 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 14.9 t -58.47 -27.12 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 0.0 111.1 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.42 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -91.18 -52.08 5.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.48 -32.71 18.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 5.4 tp10 -66.29 -45.69 79.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.559 179.144 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.2 t -59.09 -46.39 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.934 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 162' ' ' ALA . 78.8 mt -66.31 -48.65 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.61 178.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.2 m -50.92 -46.52 60.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.37 -24.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.494 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.9 m-30 -101.08 -2.92 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.274 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.79 -53.56 25.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.599 0.238 . . . . 0.0 111.588 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.42 -21.88 25.26 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.466 2.111 . . . . 0.0 112.402 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 77.4 m-70 -96.19 -15.35 22.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.414 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 5.6 mp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.44 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -168.78 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.584 2.189 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.46 42.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.57 25.86 22.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.07 114.62 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.492 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.9 mmt -116.67 -36.03 4.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 t0 68.42 20.86 8.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p 174.45 136.87 0.15 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.27 109.73 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.349 2.032 . . . . 0.0 112.318 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 7.9 Cg_exo -72.24 -172.91 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.901 2.4 . . . . 0.0 112.202 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -90.18 146.61 24.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.046 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' HA3' ' HG3' ' A' ' 101' ' ' LYS . . . 92.55 -39.69 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.567 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 23.9 m-85 -77.18 141.71 39.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.761 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -93.37 152.23 19.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -65.29 126.36 27.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.0 t-20 -152.62 156.37 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.424 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.7 m -129.29 136.88 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.44 157.31 15.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.163 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 43' ' ' PRO . 1.6 mm -121.4 102.34 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.795 -0.238 . . . . 0.0 111.335 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 7.8 t -89.73 94.93 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 29.9 tp -102.67 143.94 31.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.522 . . . . 0.0 111.509 -178.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.47 157.27 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.6 p-10 -98.41 170.92 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.516 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -57.72 -16.56 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 0.31 56.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.826 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 77.02 26.9 0.72 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -97.08 174.47 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.005 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -108.7 125.67 65.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.765 0.317 . . . . 0.0 110.783 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.465 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 44.4 t80 -63.42 108.82 1.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.592 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.443 ' CB ' ' CD2' ' A' ' 142' ' ' LEU . . . -116.35 131.27 56.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.672 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.71 133.77 55.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.6 p -82.35 154.61 25.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.457 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.43 157.35 37.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.268 0.556 . . . . 0.0 111.411 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -5.09 53.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.005 178.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -131.13 -16.72 3.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' CG2' ' HB1' ' A' ' 39' ' ' ALA . 66.3 mt -120.62 111.41 34.68 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.0 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.2 Cg_endo -65.25 131.9 29.9 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.868 1.712 . . . . 0.0 111.843 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.86 2.98 2.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.649 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' A' ' 36' ' ' ILE . . . -89.26 97.31 11.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.22 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.418 ' CD1' HD23 ' A' ' 145' ' ' LEU . 59.8 m95 -103.86 157.85 16.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.227 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -168.91 167.94 10.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.435 ' HE1' ' CH2' ' A' ' 107' ' ' TRP . 3.4 mpp? -101.84 145.1 29.88 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 4.0 Cg_exo -39.55 132.88 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.317 2.678 . . . . 0.0 112.967 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 154.62 33.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.549 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.6 144.21 8.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.624 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.52 138.83 43.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.368 179.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 48' ' ' ASP . 5.1 mt -68.42 159.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.334 . . . . 0.0 110.638 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -90.3 146.17 24.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.22 96.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.354 0.597 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 36.3 8.13 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.186 -179.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' HB3' HG21 ' A' ' 47' ' ' ILE . 4.9 tt0 -115.58 142.63 46.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 0.0 110.747 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.77 142.29 85.66 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.708 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.82 -57.15 2.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.511 2.14 . . . . 0.0 112.6 -179.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 3.4 ttt180 -58.55 -26.79 63.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -83.0 -49.17 9.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -57.07 -32.46 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.98 -54.67 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.092 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.4 mt -53.82 -28.86 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.198 178.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -82.79 -53.12 6.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.759 0.79 . . . . 0.0 109.791 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -57.43 -33.19 67.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.8 tp -53.98 -59.66 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -179.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.576 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 4.7 ptt-85 -61.5 -10.94 8.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -91.44 -44.92 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.59 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -90.68 -31.41 16.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.192 -178.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.465 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -114.57 -21.93 10.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 0.0 110.961 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.85 8.87 64.91 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.825 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.7 t -73.91 120.55 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.393 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -34.96 10.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.28 76.86 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.213 0.53 . . . . 0.0 110.823 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 128.42 12.89 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.837 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 mt-10 -119.61 148.15 43.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.1 t -78.03 126.65 38.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 111' ' ' LYS . 2.0 mm -106.44 -19.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.387 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.29 162.36 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.327 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.7 117.52 6.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.022 179.686 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 78' ' ' TYR . 6.0 t -57.36 126.15 73.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.081 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.42 -18.34 62.72 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.771 2.314 . . . . 0.0 113.23 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.65 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.03 -177.21 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.243 0.544 . . . . 0.0 112.008 -179.583 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.428 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 20.8 m95 -107.8 147.27 31.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.127 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.453 ' CD1' ' O ' ' A' ' 153' ' ' VAL . 3.2 mt -111.32 117.71 33.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 p -109.93 136.96 48.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.407 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -129.43 170.02 14.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.449 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 158.2 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.412 ' CE1' H5'1 ' A' ' 166' ' ' ATP . 29.6 m-85 -121.11 146.9 45.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' HG2' ' CG2' ' A' ' 88' ' ' VAL . 22.1 Cg_endo -61.74 167.55 9.99 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.368 2.045 . . . . 0.0 112.15 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -15.17 37.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.874 2.383 . . . . 0.0 113.227 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -30.67 15.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.061 0.457 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' A' ' 85' ' ' PRO . 71.8 t -85.1 -51.33 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.468 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -57.04 -47.0 81.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.565 0.697 . . . . 0.0 109.393 179.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -65.05 -29.15 70.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.395 179.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -47.38 24.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.424 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 96' ' ' TRP . 92.7 mt -56.78 -47.88 79.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.462 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.416 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.2 m-80 -45.89 -30.66 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.636 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.34 -49.61 12.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -56.83 8.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.695 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.491 ' CZ2' ' PG ' ' A' ' 166' ' ' ATP . 22.7 m0 -76.3 -34.59 59.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.613 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.82 33.89 36.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.38 153.25 49.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.919 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.52 77.03 1.03 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.625 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.412 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 30.5 m95 -121.24 150.36 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.462 ' HG3' ' HA3' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -70.37 -35.88 73.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.36 0.6 . . . . 0.0 109.654 179.382 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.74 -133.29 1.53 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.738 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.408 ' O ' ' CE1' ' A' ' 82' ' ' TYR . 12.3 mm100 -156.31 113.85 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.42 105.84 17.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.701 178.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.2 pt20 -123.23 156.48 35.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.419 0.628 . . . . 0.0 112.69 -178.438 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.86 96.5 6.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.599 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.456 ' CG ' HG23 ' A' ' 157' ' ' VAL . 25.2 m95 -62.91 149.79 43.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.256 0.551 . . . . 0.0 112.35 -178.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.3 m-85 -132.92 133.44 43.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 18.0 tp -79.54 132.05 36.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.524 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CZ ' ' CG2' ' A' ' 72' ' ' VAL . 53.1 m-85 -126.45 129.44 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.322 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.541 ' HB2' HG13 ' A' ' 73' ' ' ILE . 36.6 tttm -93.68 120.28 33.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -63.91 125.42 24.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.797 -179.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.7 p -127.86 37.86 4.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.22 -144.94 4.65 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.52 154.22 46.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.47 -16.92 0.23 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.577 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -22.57 53.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.764 0.316 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.51 -25.18 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.839 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.9 mt -71.23 97.31 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.78 95.73 5.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.958 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.2 mt -57.08 -21.87 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -179.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.85 -59.19 4.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.255 0.55 . . . . 0.0 109.862 179.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.17 178.48 22.5 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.4 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -90.71 38.85 0.96 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.95 26.3 69.32 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.084 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.78 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.101 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.36 165.16 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.196 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -86.46 147.9 45.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.808 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.05 125.8 17.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.544 2.163 . . . . 0.0 112.557 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -109.29 -29.25 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.413 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 3.7 m-85 -112.82 159.52 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.398 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.9 5.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.807 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.411 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm-40 -152.35 174.73 13.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.081 0.467 . . . . 0.0 110.419 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.1 p-90 -154.6 151.69 29.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.081 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -149.7 161.81 41.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.586 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.457 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 72.8 m95 -97.6 128.29 44.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.273 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 28' ' ' ILE . 28.0 m -138.79 155.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -74.84 151.44 86.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -47.89 -22.21 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.037 1.824 . . . . 0.0 112.064 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -34.66 17.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.469 179.24 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.403 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 mt-30 -69.14 -51.59 36.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.445 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -51.71 -36.5 47.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.707 0.765 . . . . 0.0 109.56 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.7 -28.88 45.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.038 178.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 141' ' ' GLN . 33.4 t70 -81.94 -19.85 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.161 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' A' ' 40' ' ' TRP . 9.9 mt -86.88 -38.49 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.408 ' CG2' ' CB ' ' A' ' 150' ' ' LYS . 28.3 m -56.55 163.47 1.77 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.079 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.474 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 8.1 p -93.74 161.34 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.86 -41.43 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.276 -179.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.474 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.3 p90 -84.23 5.87 24.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.317 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.439 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 14.6 mtmt -127.79 -3.98 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.534 0.206 . . . . 0.0 111.49 179.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 22.6 mttt -55.31 -62.43 4.39 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.548 0.213 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -60.61 -42.81 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.453 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 25.2 t -55.26 -29.4 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 111.245 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.423 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.2 m-30 -91.07 -53.31 4.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.7 -33.95 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -65.57 -45.46 83.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.589 179.177 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.506 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 60.3 t -58.06 -48.81 83.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 162' ' ' ALA . 66.8 mt -63.5 -48.66 76.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.721 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.6 m -49.81 -47.28 51.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.676 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.44 -24.6 27.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.106 0.479 . . . . 0.0 110.363 179.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.506 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 9.1 m-30 -105.77 13.93 28.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.931 -179.235 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.552 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -56.58 21.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.459 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.5 Cg_endo -52.46 -23.84 20.14 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.472 2.115 . . . . 0.0 112.197 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.424 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 97.6 m-70 -92.87 -20.68 20.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.878 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.1 mt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.895 179.996 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' ATP . . . . . 0.491 ' PG ' ' CZ2' ' A' ' 96' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 121.088 0.47 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 153.52 22.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 3.0 mmp_? -56.68 130.36 45.02 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.759 0.314 . . . . 0.0 110.617 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.5 t-20 -152.83 153.25 32.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 53' ' ' PRO . 27.5 m -140.47 136.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.48 150.14 17.27 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.92 HG23 ' CD1' ' A' ' 110' ' ' PHE . 5.0 mp -122.5 103.71 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.685 0.279 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 32.7 t -89.43 106.76 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 110' ' ' PHE . 33.1 tp -102.9 143.25 32.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 ptm -125.2 157.28 36.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.854 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 9.8 t30 -97.88 172.58 7.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.051 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -63.12 -17.17 62.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.858 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.45 -0.55 57.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.08 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mttm 80.99 24.86 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -95.15 170.97 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.592 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.54 125.17 68.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.745 ' HE1' HD13 ' A' ' 119' ' ' ILE . 67.1 t80 -59.75 107.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.36 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.99 131.28 56.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.171 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.72 137.56 52.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.964 0.412 . . . . 0.0 111.371 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.38 155.52 24.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.557 ' CD ' HD12 ' A' ' 36' ' ' ILE . 2.9 mtp85 -73.35 157.27 37.29 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.0 111.411 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -4.95 52.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.897 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.97 -19.71 3.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.135 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.621 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.2 mt -119.15 112.4 36.18 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.2 131.47 28.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.951 1.768 . . . . 0.0 111.891 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.86 4.13 3.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.804 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.39 97.32 11.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.34 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HD22 ' A' ' 145' ' ' LEU . 41.3 m95 -102.55 156.64 17.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.93 -176.88 2.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.981 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 20.0 mtm -111.74 155.23 43.44 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.594 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.44 131.7 30.83 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.565 2.177 . . . . 0.0 112.447 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.22 164.18 38.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -152.68 161.6 29.59 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.368 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.27 35.56 3.29 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.603 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.732 ' CG1' HG13 ' A' ' 17' ' ' VAL . 2.3 mt 51.95 159.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.287 0.565 . . . . 0.0 111.661 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.41 162.25 15.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.812 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.59 99.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.6 46.05 33.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.793 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 1.6 tt0 -114.68 144.25 43.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.084 0.468 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.55 143.11 71.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.806 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.812 ' HA ' HG11 ' A' ' 17' ' ' VAL . 88.8 Cg_exo -48.54 -62.93 0.36 Allowed 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.777 2.318 . . . . 0.0 113.689 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.9 tpt180 -46.15 -33.72 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.81 -47.09 12.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -57.66 -35.0 69.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.05 -54.73 8.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.0 mt -57.65 -29.8 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -80.94 -53.56 6.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 34.7 mm-40 -50.38 -40.64 50.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.326 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.861 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -56.58 -53.86 52.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.3 ttp180 -63.81 -11.67 29.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.82 -40.14 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 111.596 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.07 -36.48 16.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.0 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.78 -24.32 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.056 0.455 . . . . 0.0 110.922 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.88 6.93 80.1 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.647 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' A' ' 61' ' ' LEU . 38.4 t -58.13 112.18 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.405 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 p -91.21 -33.77 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.08 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.25 75.19 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 110.946 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 133.69 17.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.853 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.9 mt-10 -126.69 148.73 49.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.666 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -77.63 126.66 38.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.83 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.1 mm -107.56 -19.71 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.446 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.63 160.96 38.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.566 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 5.0 pt-20 -149.53 118.62 6.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.879 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HA ' HG11 ' A' ' 160' ' ' VAL . 36.7 t -56.99 124.47 65.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 -17.97 38.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.95 2.433 . . . . 0.0 113.352 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.657 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.37 -175.62 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.509 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.48 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 30.7 m95 -104.35 147.47 27.49 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.566 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.906 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -103.74 117.18 33.77 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.767 HG22 ' HB2' ' A' ' 104' ' ' ALA . 42.9 p -113.81 133.14 55.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.247 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.883 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -135.67 170.18 16.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.445 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.25 158.15 42.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -108.06 152.36 41.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.345 0.345 0 C-N-CA 122.468 2.112 . . . . 0.0 112.452 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.3 m95 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -28.78 42.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.88 -145.75 5.14 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.909 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -157.81 118.6 3.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.71 0.291 . . . . 0.0 111.455 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.767 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -85.6 112.72 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -124.93 141.16 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -97.79 95.89 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.64 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.486 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 72.6 m95 -62.95 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 112.149 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.447 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 71.2 m-85 -125.05 130.98 53.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.258 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -79.64 131.12 35.89 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.685 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.92 ' CD1' HG23 ' A' ' 19' ' ' ILE . 49.3 m-85 -125.22 127.13 46.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.241 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.87 ' HB3' HD11 ' A' ' 73' ' ' ILE . 4.9 tptp -89.93 124.7 34.94 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.695 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.3 t80 -70.24 123.5 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 110.799 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' SER . 6.6 p -124.2 37.39 4.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.568 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -135.82 -144.23 4.86 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.104 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.17 154.14 46.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.838 0.352 . . . . 0.0 110.061 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -50.13 -16.51 0.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.64 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -77.41 -17.38 58.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.705 0.288 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.24 -25.23 42.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.745 HD13 ' HE1' ' A' ' 29' ' ' PHE . 20.6 mt -70.45 104.83 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.492 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 65' ' ' THR . 56.3 t30 -122.26 95.78 4.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 131' ' ' PHE . 38.2 mt -54.14 -22.62 11.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.72 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.602 HD22 ' HG3' ' A' ' 129' ' ' PRO . 15.7 mt -63.63 -59.28 4.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.271 0.558 . . . . 0.0 109.964 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.4 -172.13 23.99 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -92.88 38.74 1.03 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.082 0.468 . . . . 0.0 109.924 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.94 27.19 72.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.345 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.91 165.1 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 148.92 61.84 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.602 ' HG3' HD22 ' A' ' 122' ' ' LEU . 54.6 Cg_exo -51.32 128.32 25.11 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.692 2.261 . . . . 0.0 112.55 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -108.45 -29.34 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.4 m-85 -111.67 159.46 18.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.38 -21.38 5.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.722 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.455 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 17.5 mm-40 -152.43 174.47 13.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.171 0.51 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.7 p-90 -159.13 156.57 29.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.042 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.76 161.92 40.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.473 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.467 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 73.3 m95 -93.9 124.89 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.697 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -136.6 150.89 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.151 0.501 . . . . 0.0 111.599 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.8 p -70.33 158.71 86.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.565 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.592 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.6 Cg_endo -55.36 -19.66 22.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.863 1.708 . . . . 0.0 111.885 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -34.34 16.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.075 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.35 -50.35 27.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.916 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.4 tp -54.39 -30.33 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.475 0.655 . . . . 0.0 109.891 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.516 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.3 mm -69.35 -28.47 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.724 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -80.19 -20.73 44.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.4 mt -84.07 -39.28 19.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.127 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 150' ' ' LYS . 27.0 m -59.6 164.28 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.011 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.2 p -96.09 160.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 147' ' ' VAL . 17.7 mm-40 -49.4 -41.7 40.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.2 p90 -81.3 2.85 26.31 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.545 ' O ' HG21 ' A' ' 146' ' ' THR . 4.2 mtpp -129.76 6.01 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.688 0.28 . . . . 0.0 111.197 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.2 mttt -64.02 -62.69 4.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 17.9 Cg_endo -58.1 -45.85 29.22 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.438 2.092 . . . . 0.0 112.061 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.906 HG13 ' HB3' ' A' ' 80' ' ' LEU . 48.6 t -54.05 -29.63 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.941 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.96 -51.5 5.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.5 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -51.09 -32.96 24.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.236 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.818 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.2 tp10 -64.31 -46.62 82.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.418 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.1 t -59.28 -50.97 77.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.29 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.557 HD13 ' CA ' ' A' ' 139' ' ' PRO . 66.0 mt -62.89 -49.58 74.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.969 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -45.3 61.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 156' ' ' GLU . 65.3 t -70.85 -25.01 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.352 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.877 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -104.06 12.48 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.799 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.571 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.44 -55.26 36.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.604 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.7 Cg_endo -54.6 -22.25 27.66 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.481 2.121 . . . . 0.0 112.248 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.641 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.3 m-70 -91.61 -18.28 24.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.948 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.901 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.946 0.403 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -82.18 152.26 26.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.09 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.488 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 22.2 t-20 -152.59 156.48 39.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.742 HG13 HD11 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -127.59 130.93 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.17 154.2 20.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.052 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.941 HG21 HD22 ' A' ' 61' ' ' LEU . 4.7 mp -131.94 102.82 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 111.411 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.5 t -89.7 103.81 16.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.0 146.22 28.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.904 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.45 157.3 41.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.005 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 13.1 t30 -94.37 173.99 7.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.1 -16.5 61.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.789 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -89.54 -0.78 57.75 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.089 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 25' ' ' ASP . 19.9 mtpt 81.74 24.77 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.594 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.3 173.05 7.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.532 HG21 HD23 ' A' ' 142' ' ' LEU . 4.8 mp -112.65 124.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 110.865 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 119' ' ' ILE . 77.4 t80 -57.79 109.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.387 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.96 135.58 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.217 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -120.36 139.85 52.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 111.32 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.29 158.02 23.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.572 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.9 mtp-105 -72.22 162.61 29.22 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.376 0.608 . . . . 0.0 111.672 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.4 mt -96.35 -6.47 37.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.552 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 -18.53 3.83 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.574 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 65.2 mt -120.94 112.95 33.19 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.26 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.8 Cg_endo -65.69 132.38 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.871 1.714 . . . . 0.0 111.643 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.15 1.83 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.811 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.68 97.51 11.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.181 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.414 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.9 m95 -102.65 157.03 17.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.74 -179.93 3.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.796 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -102.19 159.02 30.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.583 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.2 137.09 39.44 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.509 2.139 . . . . 0.0 112.817 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.403 ' OE1' ' CZ2' ' A' ' 107' ' ' TRP . 1.6 mm-40 -137.64 148.1 45.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.363 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.47 132.66 4.13 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.542 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.99 128.82 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.742 HD11 HG13 ' A' ' 17' ' ' VAL . 4.8 mt -61.34 160.71 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.519 ' N ' HG22 ' A' ' 47' ' ' ILE . 27.1 m-20 -90.09 -176.66 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.069 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.48 98.53 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 110.22 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.07 46.01 8.57 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.661 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -115.51 147.29 40.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.807 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 136.03 78.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.648 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.0 Cg_exo -53.71 -56.15 2.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.435 2.09 . . . . 0.0 112.682 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 58' ' ' ILE . 6.1 ttp85 -58.68 -27.43 64.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.365 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.31 -48.85 9.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.575 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -57.17 -30.36 64.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.742 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -74.13 -50.38 19.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.153 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ARG . 40.1 mt -57.73 -29.48 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.171 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -83.2 -52.92 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.902 0.858 . . . . 0.0 109.856 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -53.77 -46.09 70.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.941 HD22 HG21 ' A' ' 19' ' ' ILE . 3.4 tp -54.41 -56.06 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.3 ttp85 -60.06 -15.0 19.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.387 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.06 -42.06 10.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.47 -24.4 19.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.801 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.43 -19.66 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.21 4.48 63.83 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.175 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.635 HG13 ' HE1' ' A' ' 112' ' ' PHE . 40.2 t -70.65 114.08 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.23 -32.97 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.066 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 76.42 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.35 13.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.756 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.0 pt-20 -118.94 146.2 45.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 52.6 t -77.75 122.38 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.372 0.606 . . . . 0.0 111.535 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.911 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.2 mm -104.39 -15.95 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.621 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.82 159.39 35.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.38 115.41 6.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.135 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.858 ' HA ' HG11 ' A' ' 160' ' ' VAL . 12.2 t -57.44 126.54 75.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.21 -18.95 65.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.77 2.313 . . . . 0.0 113.237 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.582 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.3 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.38 0.61 . . . . 0.0 111.991 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.786 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.7 m95 -109.75 147.21 33.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.017 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.786 HD23 ' C ' ' A' ' 79' ' ' TRP . 1.8 mt -112.45 117.59 32.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.956 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.797 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.9 p -112.93 131.67 55.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.867 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.7 163.34 27.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.07 158.36 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.119 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.4 153.86 45.54 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.771 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.275 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 57.9 m95 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.816 0.341 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -30.35 58.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -162.08 -143.07 3.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.923 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -157.72 115.77 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 0.0 111.436 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.797 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -93.39 105.81 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.814 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -104.29 98.07 7.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.519 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.484 ' CD2' HG21 ' A' ' 157' ' ' VAL . 31.3 m95 -65.32 137.12 57.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.278 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 54' ' ' ARG . 68.5 m-85 -122.27 137.93 54.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.943 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.821 HD23 ' HB ' ' A' ' 73' ' ' ILE . 20.1 tp -79.21 154.14 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.821 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 19' ' ' ILE . 39.6 m-85 -148.08 125.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.07 0.462 . . . . 0.0 111.738 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.911 ' HB3' HD11 ' A' ' 73' ' ' ILE . 39.5 tttp -91.4 122.55 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.635 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.2 t80 -68.23 123.9 22.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.9 p -124.02 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.13 -144.88 4.65 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.044 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.23 154.19 46.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.02 -16.61 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -77.73 -18.49 56.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 111.252 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -25.57 42.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.732 HG21 ' CE1' ' A' ' 29' ' ' PHE . 18.2 mt -73.77 103.9 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.517 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -119.36 95.87 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.027 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.6 mt -55.86 -22.55 25.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.543 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.588 HD23 ' CG ' ' A' ' 129' ' ' PRO . 1.7 mt -61.26 -56.84 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.246 0.546 . . . . 0.0 109.95 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.39 -174.66 22.8 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.51 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -91.76 38.72 0.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.13 73.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.202 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.1 m -115.24 -67.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 111.267 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -101.28 165.16 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 146.8 86.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.588 ' CG ' HD23 ' A' ' 122' ' ' LEU . 52.6 Cg_exo -52.11 139.74 51.9 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.583 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -109.83 -31.82 7.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.824 ' HB2' HD13 ' A' ' 121' ' ' LEU . 20.7 m-85 -116.88 159.61 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.415 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -15.72 6.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.814 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.566 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.53 174.59 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.522 . . . . 0.0 110.592 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.4 p-90 -159.61 153.1 22.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.056 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 m -151.74 156.9 41.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.484 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.469 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 76.7 m95 -91.35 124.83 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.841 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.902 HG11 HD11 ' A' ' 145' ' ' LEU . 29.6 m -134.71 150.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.724 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.5 p -69.54 158.5 86.77 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.573 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.517 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.05 -19.37 19.94 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.99 1.793 . . . . 0.0 111.98 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -34.48 14.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.225 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.6 -50.28 46.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.925 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.0 tp -53.37 -33.26 52.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.416 0.626 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.88 -28.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.687 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.75 -32.84 52.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.676 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 142' ' ' LEU . 7.1 mt -75.08 -40.62 59.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.88 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 147' ' ' VAL . 28.3 m -54.92 163.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.21 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.797 HG11 ' CE2' ' A' ' 149' ' ' PHE . 10.6 p -98.49 160.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.1 mm-40 -49.39 -36.79 22.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.797 ' CE2' HG11 ' A' ' 147' ' ' VAL . 16.4 p90 -84.77 6.9 22.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.453 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 30.8 mttt -129.94 -4.67 4.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.1 mttt -56.53 -62.13 5.5 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.351 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.4 Cg_endo -60.9 -42.77 35.06 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.444 2.096 . . . . 0.0 112.131 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.867 HG11 ' CD1' ' A' ' 82' ' ' TYR . 11.4 t -60.65 -27.5 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.561 . . . . 0.0 110.953 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.8 m-30 -90.87 -53.15 4.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.68 -31.12 10.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -69.48 -44.71 70.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.663 179.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 153' ' ' VAL . 52.0 t -57.72 -48.26 83.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.098 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 162' ' ' ALA . 61.8 mt -64.5 -48.85 73.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.774 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.8 m -50.94 -46.18 60.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.887 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.1 t -70.31 -24.58 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 121.019 0.437 . . . . 0.0 110.766 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.786 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.2 m-30 -100.67 -2.02 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.66 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.2 -51.46 33.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 6.7 Cg_endo -49.29 -24.57 8.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.632 2.221 . . . . 0.0 112.567 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.664 ' ND1' HG22 ' A' ' 73' ' ' ILE . 97.2 m-70 -100.98 -15.99 17.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.302 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 161' ' ' PHE . 4.4 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.51 152.15 25.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -74.36 125.2 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.168 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.4 m120 -152.41 159.03 43.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.72 HG13 HD11 ' A' ' 47' ' ' ILE . 1.8 m -129.74 135.68 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.128 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.93 17.42 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.303 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.907 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -126.21 101.63 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.7 t -89.84 102.94 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.5 tp -103.16 145.75 29.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.69 157.41 40.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.7 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 31.6 p-10 -102.39 169.98 8.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -55.37 -17.95 5.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.92 0.48 56.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt 76.46 25.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.678 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -95.62 171.95 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.551 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.4 mp -109.12 119.5 58.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.12 0.486 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.787 ' CE2' HG21 ' A' ' 65' ' ' THR . 5.5 t80 -53.71 108.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.21 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 137.17 52.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.723 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.86 137.97 54.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.6 158.22 23.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.795 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtp85 -75.39 159.11 31.78 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 111.302 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -94.2 -5.64 46.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.026 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.35 -16.94 3.85 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.229 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.795 HD12 ' CD ' ' A' ' 33' ' ' ARG . 64.9 mt -120.19 110.96 35.66 Favored Pre-proline 0 N--CA 1.454 -0.239 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.01 131.35 28.5 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.837 1.691 . . . . 0.0 111.845 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 77.58 5.22 3.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.685 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.607 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.7 97.62 11.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.354 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.3 m95 -103.72 156.12 18.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -168.8 -176.77 2.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.764 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 61.2 mtm -107.31 159.4 30.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.15 130.27 22.38 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.468 2.112 . . . . 0.0 112.549 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.1 160.23 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.12 169.34 38.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.612 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -83.92 130.88 10.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 17' ' ' VAL . 5.0 mt -60.07 160.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.713 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.29 151.71 21.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.931 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.19 98.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.67 36.29 8.0 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.036 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.0 tt0 -116.29 142.11 47.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.458 . . . . 0.0 110.861 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.46 143.15 82.18 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HA ' HG11 ' A' ' 17' ' ' VAL . 50.4 Cg_exo -54.04 -52.93 7.23 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.559 2.173 . . . . 0.0 112.604 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.586 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 4.4 tpp85 -59.03 -27.61 65.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -84.46 -48.44 9.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.553 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.98 -32.51 69.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.417 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.49 -53.57 11.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 54' ' ' ARG . 53.7 mt -57.08 -29.34 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.081 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -81.7 -53.35 6.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 109.918 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.13 -45.16 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.309 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.856 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -55.74 -56.18 23.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.596 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.4 ttp180 -61.26 -12.19 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -91.6 -38.39 12.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.749 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.09 -35.37 15.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.921 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.787 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -119.02 -23.24 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.015 0.436 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.31 8.57 80.03 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.856 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.856 ' HB ' HD11 ' A' ' 61' ' ' LEU . 24.8 t -57.15 110.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.985 0.393 . . . . 0.0 110.313 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.0 p -89.84 -36.22 15.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.43 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.34 76.43 6.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.176 0.512 . . . . 0.0 111.086 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.43 128.53 12.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.78 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.6 pt-20 -119.38 147.78 43.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.098 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.606 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.6 t -78.41 123.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.344 0.593 . . . . 0.0 111.417 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.899 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -106.07 -19.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.753 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -156.85 162.94 39.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.135 0.493 . . . . 0.0 111.735 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.83 114.73 5.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.861 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.71 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.6 t -57.57 125.51 72.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.47 -11.6 31.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.872 2.381 . . . . 0.0 113.768 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.538 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.78 133.54 49.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.247 0.546 . . . . 0.0 111.917 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.447 ' CD2' ' HG2' ' A' ' 106' ' ' LYS . 49.2 m95 -59.79 147.09 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.226 0.536 . . . . 0.0 110.566 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.894 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.1 mm? -102.75 117.74 35.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.497 HG22 ' HB2' ' A' ' 104' ' ' ALA . 63.8 p -113.89 134.48 54.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.873 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -133.1 170.35 15.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.533 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.48 141.6 45.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.64 151.42 42.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.776 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--N 1.343 0.281 0 C-N-CA 122.518 2.145 . . . . 0.0 112.372 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.774 0.321 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -25.69 41.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.572 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.43 -138.23 2.74 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.036 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -157.72 116.79 3.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.823 0.344 . . . . 0.0 111.388 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -86.41 105.8 17.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.835 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.799 HE21 ' HE1' ' A' ' 107' ' ' TRP . 5.8 pt20 -124.92 145.03 50.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 2.5 mmmp? -100.59 110.49 22.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.76 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.799 ' HE1' HE21 ' A' ' 105' ' ' GLN . 34.2 m95 -76.23 145.2 39.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.486 . . . . 0.0 112.145 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 59.5 m-85 -127.29 132.76 50.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.295 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.87 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.9 tp -79.5 132.93 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.359 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.907 ' CD1' HG23 ' A' ' 19' ' ' ILE . 50.0 m-85 -126.51 127.98 46.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.663 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.899 ' HB3' HD11 ' A' ' 73' ' ' ILE . 18.3 tttp -92.02 122.29 34.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.658 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.8 t80 -67.87 123.07 19.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' SER . 1.6 p -122.8 37.01 4.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.545 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.32 -144.49 4.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -128.06 154.37 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.97 -17.49 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.585 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -74.61 -19.28 60.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.12 -25.64 52.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 25.5 mt -70.16 105.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 65' ' ' THR . 59.8 t30 -123.12 95.89 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.217 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' A' ' 131' ' ' PHE . 34.7 mt -55.73 -21.0 16.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.577 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.894 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -62.94 -60.18 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.329 0.585 . . . . 0.0 109.774 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.25 23.39 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.324 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -93.92 38.83 1.07 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.159 0.504 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.59 28.0 70.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.2 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 m -102.24 -62.34 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.289 . . . . 0.0 111.255 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.27 165.24 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.146 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -57.95 146.06 69.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.031 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.894 ' HG3' HD13 ' A' ' 122' ' ' LEU . 63.7 Cg_exo -51.69 -176.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.675 2.25 . . . . 0.0 112.517 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 34' ' ' LEU . 4.4 mm-40 -150.1 -41.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.583 ' HB2' HD13 ' A' ' 121' ' ' LEU . 21.0 m-85 -106.32 159.37 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.69 5.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.377 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.4 mp0 -152.19 173.73 14.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.5 p-90 -160.25 160.31 32.48 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.242 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -158.73 160.76 36.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.508 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 81.3 m95 -93.12 124.61 37.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.623 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -137.27 151.16 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 111.773 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -68.88 161.35 72.58 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.517 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.551 ' HD3' HD11 ' A' ' 28' ' ' ILE . 18.7 Cg_endo -59.39 -16.73 36.58 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.716 1.61 . . . . 0.0 111.768 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.98 -34.1 14.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.069 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -51.5 21.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.13 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.871 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.42 -31.4 55.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.459 0.647 . . . . 0.0 109.769 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.571 HD11 ' CA ' ' A' ' 155' ' ' LYS . 8.2 mm -68.08 -27.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.775 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.73 -14.7 50.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.216 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.871 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.6 mt -91.28 -38.32 12.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.392 0.615 . . . . 0.0 110.238 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 147' ' ' VAL . 59.4 m -56.51 161.83 2.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.252 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.875 HG11 ' CE2' ' A' ' 149' ' ' PHE . 14.0 p -87.98 162.31 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -63.3 -31.26 72.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.875 ' CE2' HG11 ' A' ' 147' ' ' VAL . 11.2 p90 -82.17 2.57 30.95 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.481 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 3.3 mtmt -145.99 16.28 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 3.1 mttt -58.89 -61.96 6.73 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.073 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.3 Cg_endo -61.58 -42.5 32.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.894 HG13 ' HB3' ' A' ' 80' ' ' LEU . 61.8 t -48.29 -29.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.248 0.547 . . . . 0.0 111.238 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.27 -55.0 3.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.249 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.571 ' CA ' HD11 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -48.52 -36.56 15.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.901 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.827 ' HB3' HD11 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -60.73 -46.74 89.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.475 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.601 HG21 ' CD2' ' A' ' 107' ' ' TRP . 44.6 t -61.29 -45.55 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.336 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.507 HD13 ' CA ' ' A' ' 139' ' ' PRO . 56.3 mt -64.19 -49.04 73.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.965 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.2 t -50.63 -43.72 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.7 t -71.73 -25.19 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.326 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.87 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.8 m-30 -102.55 8.73 39.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.87 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.554 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.66 -56.04 26.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.5 Cg_endo -56.91 -22.78 47.71 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.374 2.049 . . . . 0.0 112.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.0 m-70 -91.31 -19.94 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.87 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.21 25.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -66.03 124.98 24.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 11.7 t-20 -152.53 160.66 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.997 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.772 HG13 HD11 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -131.06 140.3 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -105.01 150.19 16.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.154 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.952 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -131.15 102.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.469 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -89.61 109.95 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 110' ' ' PHE . 42.7 tp -102.92 143.55 32.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.441 . . . . 0.0 111.171 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.6 ptm -128.93 157.29 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.5 p-10 -105.03 170.69 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.387 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -56.28 -17.5 7.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.644 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 0.61 56.56 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.775 0.322 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 mttm 76.35 26.39 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.566 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -97.91 172.27 7.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.15 123.19 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.748 ' CE1' HG21 ' A' ' 119' ' ' ILE . 73.9 t80 -56.45 109.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.57 129.97 56.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.448 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.81 136.09 53.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.412 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.4 p -82.46 154.86 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.748 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.578 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -70.96 159.02 35.48 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.255 0.55 . . . . 0.0 111.397 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -93.33 -6.21 47.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.944 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -128.43 -18.1 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.201 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.1 mt -119.59 112.1 35.75 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.97 131.39 28.7 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.936 1.757 . . . . 0.0 111.95 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.74 3.51 3.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.851 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.54 11.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.719 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.1 m95 -104.56 156.71 17.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.02 8.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.505 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 70.1 mtm -97.91 156.67 35.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.83 139.22 42.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.536 2.157 . . . . 0.0 112.996 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.219 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.38 145.8 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.826 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.13 138.31 43.78 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.379 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.772 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -69.17 161.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.57 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.494 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.2 150.09 22.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.6 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.14 8.48 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.109 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 4.7 tt0 -115.08 143.48 45.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 0.0 110.887 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.68 139.68 80.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.604 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.639 ' O ' HG11 ' A' ' 17' ' ' VAL . 63.5 Cg_exo -52.02 -53.51 6.85 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.448 2.098 . . . . 0.0 112.616 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -60.01 -27.28 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -82.49 -51.26 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.694 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.542 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -56.84 -31.65 64.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.561 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.79 -51.91 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.271 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 54' ' ' ARG . 50.4 mt -56.82 -27.94 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -84.96 -52.71 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.931 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.84 -47.37 67.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -53.99 -56.69 15.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 66.2 ttp85 -59.32 -15.2 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.414 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -92.13 -39.98 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.821 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.4 -25.08 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.829 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.89 -19.16 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.238 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.77 5.65 65.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.112 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.681 HG13 ' HE1' ' A' ' 112' ' ' PHE . 49.6 t -72.18 115.74 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -34.34 12.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.23 79.25 6.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.472 . . . . 0.0 110.997 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.29 131.33 15.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.897 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.2 pt-20 -120.72 147.2 45.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.5 t -78.03 123.01 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.382 0.611 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.932 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -105.4 -21.52 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.753 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -153.41 161.9 41.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.288 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 9.0 pt-20 -148.74 115.59 6.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.148 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.819 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.6 t -57.24 125.78 71.97 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.917 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.2 -13.28 39.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.975 2.45 . . . . 0.0 114.177 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.619 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -129.4 157.2 42.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 112.028 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.528 ' C ' HD23 ' A' ' 80' ' ' LEU . 32.4 m95 -77.4 145.66 37.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.123 0.487 . . . . 0.0 109.914 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.895 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -108.55 118.08 35.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.984 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.859 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.8 p -114.81 132.19 56.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.522 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.875 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -124.9 170.13 11.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.96 158.28 38.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -119.72 149.76 48.99 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.705 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.539 2.16 . . . . 0.0 112.308 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.8 m95 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.86 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.583 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -167.13 -142.38 3.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.984 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -157.93 116.47 3.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.859 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.54 105.86 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.854 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.8 pt20 -124.28 144.61 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -98.81 95.82 7.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.697 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.432 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.8 m95 -62.91 148.72 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.449 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 68.6 m-85 -132.09 135.05 46.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.317 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.796 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.5 tp -79.9 129.46 34.5 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.952 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.6 m-85 -123.85 126.57 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.398 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.932 ' HB3' HD11 ' A' ' 73' ' ' ILE . 50.5 tttt -89.88 124.54 34.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.681 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -68.39 125.43 26.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.5 p -125.64 37.61 4.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.595 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.1 -144.91 4.76 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.129 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 154.2 45.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.85 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.611 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -20.39 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.17 -25.07 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.798 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.748 HG21 ' CE1' ' A' ' 29' ' ' PHE . 18.1 mt -73.46 102.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.549 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -119.35 95.63 4.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.924 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 131' ' ' PHE . 68.6 mt -54.56 -23.78 18.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.651 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 129' ' ' PRO . 59.5 mt -61.3 -55.23 34.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.099 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.9 -171.03 25.03 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.429 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.75 38.96 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.151 0.5 . . . . 0.0 109.84 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.17 28.56 73.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.985 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.36 -68.28 0.91 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 111.228 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.9 165.08 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.25 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -80.93 151.18 70.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.449 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.0 Cg_exo -48.44 165.34 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.748 2.299 . . . . 0.0 112.623 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.412 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.6 mt-10 -150.05 -45.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.502 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.828 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.5 m-85 -107.48 159.62 16.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.19 -18.63 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.409 ' O ' HD11 ' A' ' 121' ' ' LEU . 24.1 mm-40 -152.54 175.24 12.97 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.1 p-90 -156.14 150.9 26.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.113 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 162.32 40.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.34 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 71.4 m95 -96.28 124.31 40.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 145' ' ' LEU . 27.2 m -136.42 150.78 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 111.511 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -71.1 158.11 88.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.572 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.615 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.0 Cg_endo -54.62 -20.49 21.54 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.907 1.738 . . . . 0.0 111.853 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 -34.3 17.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.118 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -72.69 -50.69 23.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.931 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -54.14 -29.93 47.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.403 0.62 . . . . 0.0 109.881 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.569 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.7 mm -68.44 -28.88 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.674 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.27 -20.53 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.3 mt -85.86 -39.14 17.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 150' ' ' LYS . 5.7 m -60.2 156.19 15.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.955 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.4 p -90.08 160.52 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.85 -35.71 33.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.955 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.9 p90 -84.8 9.97 12.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.611 ' HB2' HG22 ' A' ' 146' ' ' THR . 12.6 mttm -134.57 -25.3 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.264 . . . . 0.0 111.187 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.8 mtpt -44.5 -59.87 3.5 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.408 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.0 Cg_endo -59.06 -41.52 60.23 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.278 1.985 . . . . 0.0 111.912 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 80' ' ' LEU . 64.0 t -64.99 -25.78 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.3 m-85 -90.46 -49.34 6.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.697 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.93 -35.1 22.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.681 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.724 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.4 tp10 -66.81 -44.96 79.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.7 t -58.64 -47.86 87.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.07 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.615 HD13 ' CA ' ' A' ' 139' ' ' PRO . 66.6 mt -66.71 -49.26 66.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.703 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.2 m -50.6 -46.14 57.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.662 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 76' ' ' VAL . 85.7 t -69.53 -24.68 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.796 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -101.86 2.13 37.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.163 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.47 -55.21 31.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.15 -20.87 25.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.619 2.213 . . . . 0.0 112.34 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.753 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 17.9 m-70 -89.48 -21.06 23.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.729 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.933 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.428 ' HD2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -86.11 152.23 23.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -64.02 132.56 50.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.371 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 21.1 t-20 -152.56 156.99 40.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.443 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.802 HG13 HD11 ' A' ' 47' ' ' ILE . 3.3 m -127.81 129.49 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 111.281 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.2 147.03 18.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.177 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.882 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -122.34 103.35 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.699 0.285 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' PHE . 53.4 t -89.48 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 33.3 tp -103.19 144.56 31.16 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.319 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.8 ptt? -129.11 157.45 41.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.606 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.8 p-10 -98.35 172.51 7.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.349 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -60.45 -15.43 26.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 0.38 56.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp 77.57 27.16 0.63 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.536 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.783 ' C ' HD13 ' A' ' 28' ' ' ILE . 11.6 mmtm -99.11 175.67 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.861 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -107.62 147.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.573 ' HE2' HD13 ' A' ' 119' ' ' ILE . 10.8 t80 -82.67 104.94 13.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.73 129.89 56.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.31 137.13 52.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.03 152.81 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.764 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 5.0 mtp-105 -68.04 163.37 22.48 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.1 mt -97.8 -7.66 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.384 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.1 -18.95 4.88 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.207 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.594 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 63.1 mt -121.02 112.41 33.41 Favored Pre-proline 0 N--CA 1.457 -0.083 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.43 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.939 1.759 . . . . 0.0 111.655 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t70 78.15 1.8 2.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.767 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.3 97.24 10.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.13 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD1' HD22 ' A' ' 145' ' ' LEU . 55.2 m95 -103.0 159.67 15.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.166 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -168.5 -178.01 3.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 36.3 mtm -109.4 156.58 39.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.77 128.43 18.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.584 2.189 . . . . 0.0 112.674 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.32 156.69 37.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.688 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 144.82 10.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.442 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.78 140.67 43.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.802 HD11 HG13 ' A' ' 17' ' ' VAL . 4.4 mt -69.9 160.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.19 169.12 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.208 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.26 98.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.2 9.34 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.878 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 10.7 tp10 -112.53 145.16 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.093 0.473 . . . . 0.0 110.846 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.64 133.82 73.24 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.422 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HA ' HG11 ' A' ' 17' ' ' VAL . 53.3 Cg_exo -52.48 -39.43 74.34 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.369 2.046 . . . . 0.0 112.569 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.0 tpp85 -72.11 -27.84 62.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -85.12 -45.18 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.541 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.13 -32.62 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.368 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.22 -54.06 10.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.101 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' ARG . 48.9 mt -56.2 -29.1 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.291 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 ttp85 -82.58 -52.97 6.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.753 0.787 . . . . 0.0 109.872 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -51.78 -47.12 64.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.534 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -54.62 -56.3 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.886 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 6.6 ttp-105 -59.8 -15.14 18.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.293 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -92.06 -40.09 11.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.846 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.5 -25.29 19.34 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.827 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.57 -20.85 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.755 0.312 . . . . 0.0 111.063 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 76.72 1.39 71.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.015 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.683 HG13 ' HE1' ' A' ' 112' ' ' PHE . 46.0 t -69.42 116.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 110.615 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 -32.37 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.59 79.32 6.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.15 13.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.706 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.4 pt-20 -118.44 146.86 44.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.968 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.6 t -79.54 121.25 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 111.436 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.929 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -101.7 -20.79 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.391 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -153.14 160.24 42.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.07 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.8 pt-20 -148.43 116.02 6.28 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.169 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.844 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.3 t -57.38 129.14 79.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.0 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 -16.32 46.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.744 2.296 . . . . 0.0 113.612 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.607 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -127.75 -179.43 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.458 0.647 . . . . 0.0 112.533 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.807 ' C ' HD23 ' A' ' 80' ' ' LEU . 11.7 m95 -104.2 147.71 27.15 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.407 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.807 HD23 ' C ' ' A' ' 79' ' ' TRP . 1.4 mt -113.08 117.52 32.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.719 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.847 HG22 ' CB ' ' A' ' 104' ' ' ALA . 16.5 p -111.4 131.14 55.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.723 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.873 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -125.72 170.24 11.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.368 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.86 156.5 44.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -105.71 147.51 34.82 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.428 ' CD1' ' HD2' ' A' ' 14' ' ' ARG . 52.5 m95 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.868 0.366 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 2.1 mptp? -88.35 -21.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.68 -146.4 5.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.915 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -157.94 116.29 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.847 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.84 112.7 21.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -128.98 152.93 48.06 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.29 95.99 6.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 178.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.557 ' CD2' HG21 ' A' ' 157' ' ' VAL . 48.6 m95 -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 112.472 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.1 m-85 -133.05 134.82 44.87 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.09 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 16.6 tp -79.53 143.01 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.882 ' CD1' HG23 ' A' ' 19' ' ' ILE . 42.4 m-85 -136.97 127.5 26.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.929 ' HB3' HD11 ' A' ' 73' ' ' ILE . 25.8 tttp -91.71 121.24 33.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.683 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.9 t80 -65.8 127.0 30.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.204 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.1 p -126.27 37.31 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.76 -144.55 4.93 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.982 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 153.8 47.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.173 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD1' ' CH2' ' A' ' 134' ' ' TRP . 3.6 m-20 -52.12 -14.93 0.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.674 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.73 -20.36 42.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.254 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.54 -25.53 45.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.807 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.573 HD13 ' HE2' ' A' ' 29' ' ' PHE . 25.9 mt -67.08 104.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.459 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.515 HD22 HD12 ' A' ' 122' ' ' LEU . 4.6 t-20 -122.06 95.8 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.119 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 131' ' ' PHE . 36.6 mt -56.3 -21.89 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.515 HD12 HD22 ' A' ' 120' ' ' ASN . 8.3 mt -60.8 -56.93 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 109.882 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.99 -175.59 22.56 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.487 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -91.98 38.97 1.0 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.76 72.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.958 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -121.15 -69.96 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.96 165.13 17.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.42 147.02 45.87 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 128.42 27.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.623 2.215 . . . . 0.0 112.53 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.408 ' C ' HD12 ' A' ' 34' ' ' LEU . 23.4 mp0 -111.54 -34.77 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.81 ' HB2' HD13 ' A' ' 121' ' ' LEU . 5.1 m-85 -108.02 159.61 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.334 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.9 -19.52 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.815 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.423 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 13.9 mm-40 -152.45 175.22 12.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.145 0.498 . . . . 0.0 110.592 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.8 p-90 -155.95 154.05 30.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.077 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.15 159.48 42.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.556 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 70.4 m95 -93.96 126.7 39.32 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.615 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.768 HG11 HD11 ' A' ' 145' ' ' LEU . 35.7 m -135.88 152.84 31.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.41 . . . . 0.0 111.854 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 p -72.49 152.17 91.81 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.811 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.3 Cg_endo -49.12 -22.13 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.25 -33.79 17.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -50.53 33.81 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.189 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.963 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.5 tp -53.35 -32.82 51.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.462 0.649 . . . . 0.0 109.828 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.689 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.9 mm -67.2 -28.05 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.796 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -22.64 41.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.232 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.963 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.8 mt -83.09 -39.55 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.066 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 150' ' ' LYS . 22.5 m -56.28 164.63 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -101.24 160.42 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 147' ' ' VAL . 24.4 mt-10 -45.43 -46.09 13.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.359 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -75.29 -5.09 42.84 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.459 ' O ' HG21 ' A' ' 146' ' ' THR . 13.5 mtmt -121.73 -4.13 9.21 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mttt -57.76 -62.39 5.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.541 0.21 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.1 Cg_endo -61.14 -45.81 17.91 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.467 2.111 . . . . 0.0 112.241 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.873 HG21 ' HB3' ' A' ' 82' ' ' TYR . 23.0 t -56.84 -27.07 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.13 -52.32 4.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -50.74 -32.62 20.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.317 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.6 tp10 -64.88 -46.01 83.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.492 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.0 t -59.49 -52.36 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.191 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 139' ' ' PRO . 70.2 mt -59.97 -49.2 78.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.841 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 m -49.15 -46.43 45.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.639 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.1 t -69.61 -25.28 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.029 0.443 . . . . 0.0 110.366 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.29 12.37 33.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.999 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.98 -58.28 14.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.0 Cg_endo -56.76 -21.81 41.7 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.433 2.088 . . . . 0.0 112.275 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.412 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 63.7 m-70 -90.01 -12.54 38.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.126 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.927 179.844 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.943 0.402 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.8 OUTLIER -87.97 152.22 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -69.93 134.33 48.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.111 0.481 . . . . 0.0 111.441 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.8 t-20 -152.46 158.88 43.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.779 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.4 m -128.18 130.0 69.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 111.584 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.98 139.31 14.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.132 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.797 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -112.93 104.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.321 . . . . 0.0 111.417 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 110' ' ' PHE . 52.5 t -89.54 105.08 17.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 110' ' ' PHE . 40.4 tp -103.36 141.84 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.983 0.42 . . . . 0.0 111.126 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.63 157.39 35.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.7 p-10 -100.84 170.53 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -57.13 -16.37 7.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.418 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -0.08 57.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 111.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 77.53 26.67 0.66 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.564 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mmtt -97.85 175.87 6.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.565 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.6 mp -115.31 126.88 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.891 ' CE1' HG21 ' A' ' 119' ' ' ILE . 66.3 t80 -59.47 110.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.379 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.602 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.86 130.0 56.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.02 136.74 52.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 0.0 111.472 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.43 155.16 24.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.646 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.542 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -71.98 156.98 38.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.284 0.564 . . . . 0.0 111.413 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.16 -5.36 52.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -127.52 -19.62 4.16 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.039 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 59.6 mt -119.54 112.44 35.58 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.904 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.46 131.66 28.74 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.905 1.737 . . . . 0.0 111.737 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 77.17 4.21 3.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.766 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.66 97.4 11.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.339 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.514 ' CD1' HD22 ' A' ' 145' ' ' LEU . 34.8 m95 -103.93 156.94 17.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.101 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -168.76 177.23 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.774 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.46 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 35.8 mtm -103.2 155.43 36.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.809 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.46 139.9 55.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.594 2.196 . . . . 0.0 112.67 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.19 158.18 39.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.74 140.37 6.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.586 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.74 139.87 48.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.451 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 17' ' ' VAL . 6.7 mt -71.42 160.32 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.546 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.3 148.52 22.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.85 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -49.15 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.188 0.518 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.64 40.62 14.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.884 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.9 tp10 -113.3 145.74 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 110.938 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -72.87 124.05 90.28 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.156 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.677 ' O ' HG11 ' A' ' 17' ' ' VAL . 5.3 Cg_endo -48.97 -50.83 11.78 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.484 2.123 . . . . 0.0 112.818 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 58' ' ' ILE . 33.1 ttt180 -57.44 -30.53 65.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -83.23 -47.12 11.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.38 -30.32 66.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.407 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.779 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.86 -51.93 14.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.109 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 54' ' ' ARG . 28.4 mt -57.02 -29.6 31.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.099 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -81.19 -53.15 6.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.877 0.846 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.98 -31.88 61.2 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.479 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.863 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.3 tp -57.26 -62.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.604 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.5 ptt85 -61.22 -10.91 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.973 0.415 . . . . 0.0 110.456 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -91.5 -39.47 11.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.252 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.52 -33.66 15.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.158 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.93 -24.5 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 81.54 -0.21 88.28 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.668 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.863 ' HB ' HD11 ' A' ' 61' ' ' LEU . 46.6 t -63.68 118.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.311 . . . . 0.0 110.448 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -33.95 10.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.404 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.22 76.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.805 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.25 13.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.973 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -120.31 148.85 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 110' ' ' PHE . 55.4 t -79.21 125.04 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.492 0.663 . . . . 0.0 111.901 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.884 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -104.93 -20.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.066 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -152.2 161.21 42.96 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -148.16 113.25 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.816 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.2 t -57.23 124.76 68.15 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.032 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.59 -5.72 17.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.802 2.335 . . . . 0.0 113.925 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.569 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -131.21 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 112.399 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -79.03 147.36 32.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 153' ' ' VAL . 48.7 mt -115.97 117.74 30.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.842 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.839 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -114.78 131.67 56.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.585 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.789 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -127.56 170.07 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.52 158.44 39.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -110.55 153.54 43.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 C--N 1.345 0.346 0 C-N-CA 122.529 2.153 . . . . 0.0 112.328 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 57.1 m95 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.821 0.344 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -27.81 44.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.48 -143.42 4.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.994 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -157.92 117.28 3.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.757 0.313 . . . . 0.0 111.365 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.839 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.74 107.61 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -123.16 151.93 41.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.302 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 96.84 6.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.43 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.492 ' CD2' HG21 ' A' ' 157' ' ' VAL . 52.1 m95 -62.7 147.86 48.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -130.99 135.14 47.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.825 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.2 tp -79.7 147.92 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.138 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.841 ' O ' HD12 ' A' ' 21' ' ' LEU . 27.3 m-85 -140.92 128.02 20.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.87 0.367 . . . . 0.0 111.567 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.884 ' HB3' HD11 ' A' ' 73' ' ' ILE . 31.3 tttt -91.79 119.96 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.674 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.9 t80 -64.87 125.14 23.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 111' ' ' LYS . 10.7 p -126.86 37.62 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.25 -144.92 4.75 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.066 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -127.86 154.12 45.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -50.26 -16.23 0.31 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.657 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -79.03 -18.63 53.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.731 0.3 . . . . 0.0 111.232 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.33 -25.61 42.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.891 HG21 ' CE1' ' A' ' 29' ' ' PHE . 22.9 mt -79.01 105.84 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -124.78 96.7 4.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.08 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.815 HD13 ' HB2' ' A' ' 131' ' ' PHE . 36.6 mt -47.62 -21.8 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.232 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD22 ' HG3' ' A' ' 129' ' ' PRO . 88.1 mt -57.5 -59.33 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.351 0.596 . . . . 0.0 109.99 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 133.08 -176.62 19.46 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.1 p30 -89.47 38.7 0.91 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.2 26.1 72.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.271 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -100.98 -64.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.708 0.289 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -112.52 165.14 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.1 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 144.8 91.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HG3' HD22 ' A' ' 122' ' ' LEU . 50.6 Cg_exo -53.05 135.88 59.94 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.581 2.188 . . . . 0.0 112.474 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.84 -29.55 7.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.73 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.815 ' HB2' HD13 ' A' ' 121' ' ' LEU . 9.7 m-85 -110.2 159.27 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.14 -19.78 5.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.795 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.469 ' C ' HD11 ' A' ' 121' ' ' LEU . 25.5 mm-40 -152.43 175.08 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 110.438 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.07 155.46 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.2 m -153.84 158.71 41.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.348 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.475 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 79.5 m95 -90.98 123.72 34.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.836 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 145' ' ' LEU . 29.5 m -134.34 149.88 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.503 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -68.65 158.65 84.93 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.581 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' CA ' HD13 ' A' ' 158' ' ' LEU . 12.0 Cg_endo -55.74 -19.17 23.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.875 1.717 . . . . 0.0 111.923 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -90.84 -34.21 15.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.078 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.68 -50.73 27.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.988 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.894 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.7 tp -54.1 -32.72 55.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.566 HD12 ' HG3' ' A' ' 155' ' ' LYS . 5.6 mm -67.9 -28.16 40.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.09 -20.98 40.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.2 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.894 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.2 mt -84.75 -39.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 150' ' ' LYS . 58.2 m -59.46 151.07 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.836 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.7 p -80.78 160.09 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.0 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 147' ' ' VAL . 4.6 mt-10 -51.75 -35.26 42.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.836 ' CE2' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -83.41 4.9 25.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.509 ' O ' HG21 ' A' ' 146' ' ' THR . 22.1 mttm -133.97 6.28 3.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.532 0.206 . . . . 0.0 111.304 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.5 mttt -62.32 -62.76 5.17 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.04 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.3 Cg_endo -58.74 -41.81 59.7 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.449 2.099 . . . . 0.0 112.051 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' A' ' 80' ' ' LEU . 17.3 t -58.34 -25.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.998 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.46 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.3 m-85 -91.1 -50.2 5.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.609 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.566 ' HG3' HD12 ' A' ' 143' ' ' ILE . 39.3 mttp -51.39 -33.52 30.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.819 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.0 tp10 -65.59 -45.81 81.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.746 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -61.02 -51.62 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.203 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.586 HD13 ' CA ' ' A' ' 139' ' ' PRO . 72.3 mt -62.59 -49.19 76.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.902 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -49.79 -47.15 51.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.677 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.816 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.1 t -68.72 -25.06 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.825 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.07 10.79 35.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.001 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -57.99 13.9 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.9 Cg_endo -55.69 -21.76 33.3 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.464 2.109 . . . . 0.0 112.084 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 63.6 m-70 -92.53 -17.7 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.933 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.0 ptt85 -79.15 152.86 30.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.133 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? -57.51 139.07 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.9 m120 -153.12 161.41 42.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.86 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.2 m -141.93 123.82 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.088 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 147.37 18.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.286 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.925 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -122.11 101.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 111.275 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.7 t -89.89 104.94 17.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 110' ' ' PHE . 22.3 tp -102.97 148.16 26.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 ptt? -130.39 157.4 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 33.9 p-10 -104.32 169.35 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.269 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.72 -17.05 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.53 56.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.293 . . . . 0.0 111.006 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 76.42 26.71 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -98.1 172.53 7.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -109.35 121.12 61.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.064 0.459 . . . . 0.0 111.06 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.796 ' CD2' HD23 ' A' ' 21' ' ' LEU . 5.0 t80 -55.28 107.82 0.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.267 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.81 141.8 47.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.758 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -126.37 139.4 53.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.345 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.483 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.71 158.29 22.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.621 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -75.12 159.69 31.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.527 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -94.49 -5.43 46.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.951 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.09 -16.99 3.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.619 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.7 mt -121.34 112.61 32.8 Favored Pre-proline 0 N--CA 1.454 -0.253 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.18 131.75 29.53 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.906 1.738 . . . . 0.0 111.788 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 t0 76.66 4.08 3.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.619 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.39 97.48 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.423 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.658 ' CD1' HD22 ' A' ' 145' ' ' LEU . 38.8 m95 -101.66 155.34 18.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -169.03 -176.61 2.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 4.3 mtm -113.71 154.4 45.75 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.73 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.46 142.35 78.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.599 2.199 . . . . 0.0 112.413 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -154.07 173.73 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.94 178.79 28.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.578 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' ILE . . . -112.92 23.91 13.76 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.689 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.738 HD11 HG13 ' A' ' 17' ' ' VAL . 3.5 mt 51.26 157.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 0.0 111.643 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.77 176.64 6.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.71 98.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.221 0.534 . . . . 0.0 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.86 49.28 29.52 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.757 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 3.4 tt0 -112.65 148.14 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.254 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.742 ' O ' HG11 ' A' ' 17' ' ' VAL . 76.7 Cg_exo -51.14 -60.41 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.454 2.103 . . . . 0.0 112.864 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -55.57 -26.53 44.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -82.34 -49.01 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.697 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -57.79 -31.1 66.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.86 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.1 -53.11 11.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.119 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -56.08 -29.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.186 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -83.79 -52.61 6.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.785 0.802 . . . . 0.0 109.945 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.44 -48.49 65.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.668 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -53.6 -55.51 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.582 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.8 ttp85 -58.7 -15.25 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -91.97 -37.64 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.715 0.293 . . . . 0.0 111.759 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -90.71 -28.73 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.734 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.92 -21.35 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.278 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.91 5.19 69.22 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG13 ' HE1' ' A' ' 112' ' ' PHE . 24.5 t -61.79 108.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.929 0.364 . . . . 0.0 110.306 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -34.4 15.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.413 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.02 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.34 127.24 11.85 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.853 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.88 148.83 43.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.678 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 43.6 t -77.94 127.1 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.853 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.95 -20.32 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.28 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.87 161.97 40.5 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.4 pt-20 -148.41 113.82 5.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.257 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.74 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.6 t -57.55 125.36 71.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.185 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.27 -10.02 25.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.811 2.341 . . . . 0.0 113.617 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.53 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.45 133.6 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.582 . . . . 0.0 112.065 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.447 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 24.8 m95 -65.39 147.21 53.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.693 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.717 ' HB3' HG13 ' A' ' 153' ' ' VAL . 43.9 mt -113.17 117.63 32.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.779 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.841 HG22 ' CB ' ' A' ' 104' ' ' ALA . 3.6 p -114.52 132.21 56.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.747 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -131.4 170.11 15.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.94 158.25 35.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -109.83 154.64 42.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.345 0.345 0 C-N-CA 122.484 2.123 . . . . 0.0 112.263 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 73.3 m95 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.759 0.314 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -30.33 63.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.723 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.47 -139.63 2.74 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.96 116.25 3.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 111.584 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.841 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.84 108.36 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.793 HE21 ' HE1' ' A' ' 107' ' ' TRP . 6.4 pt20 -120.16 150.85 39.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.3 mttt -107.91 95.88 5.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.19 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.793 ' HE1' HE21 ' A' ' 105' ' ' GLN . 49.4 m95 -62.97 138.96 58.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 112.259 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -124.85 132.44 53.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.937 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.2 tp -79.59 131.15 35.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.925 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.5 m-85 -125.49 129.57 50.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 111.498 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 28.1 tttt -93.53 121.08 34.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.5 t80 -66.2 123.32 19.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 69' ' ' SER . 11.1 p -124.66 37.51 4.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.613 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -137.47 -144.79 4.81 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.07 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -128.35 154.14 46.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -49.93 -16.72 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -76.52 -20.24 57.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 111.131 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.61 -25.18 49.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.39 103.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' THR . 63.7 t30 -119.06 95.48 4.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.988 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 131' ' ' PHE . 52.3 mt -54.78 -21.93 12.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.783 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.94 -59.23 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.64 -171.52 25.9 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.447 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -94.39 38.83 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.119 0.485 . . . . 0.0 109.936 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.2 27.13 72.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.4 t -106.0 -64.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.0 111.202 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -115.48 163.48 15.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.212 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.35 152.37 54.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.11 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.23 179.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.784 2.323 . . . . 0.0 112.581 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -148.39 -44.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.713 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 121' ' ' LEU . 31.7 m-85 -110.59 159.59 17.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.421 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -113.72 -20.78 5.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.587 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.483 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.1 mm-40 -152.34 174.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.526 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.4 p-90 -159.54 157.45 29.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.073 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -154.51 160.49 41.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.455 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 82.5 m95 -93.63 123.43 36.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.54 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.731 HG11 HD11 ' A' ' 145' ' ' LEU . 30.2 m -134.88 150.43 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 111.777 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.509 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -69.59 160.64 78.72 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.598 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.597 ' CB ' HD13 ' A' ' 158' ' ' LEU . 16.6 Cg_endo -57.84 -17.62 30.77 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.832 1.688 . . . . 0.0 111.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.74 -34.07 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.07 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.01 -50.75 25.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.933 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.7 tp -54.24 -31.04 52.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.489 0.661 . . . . 0.0 109.83 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.54 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.8 mm -68.58 -28.44 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.621 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.78 -20.72 42.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.27 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.7 mt -84.74 -39.11 18.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.119 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 150' ' ' LYS . 26.0 m -56.74 163.63 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.73 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.5 p -91.66 164.96 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.5 ' N ' HG22 ' A' ' 147' ' ' VAL . 8.6 mt-10 -55.23 -35.06 64.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.925 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.73 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.5 p90 -90.5 11.09 22.85 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.608 ' HB2' HG12 ' A' ' 147' ' ' VAL . 2.1 mtmp? -133.23 -3.68 3.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.537 0.208 . . . . 0.0 111.513 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.43 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttm -58.98 -62.8 5.09 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.577 0.227 . . . . 0.0 111.192 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 17.3 Cg_endo -57.92 -41.61 67.1 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.8 t -59.75 -28.05 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.2 m-85 -91.16 -51.4 5.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.66 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.54 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.78 -32.82 21.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.5 tp10 -66.21 -45.65 79.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.565 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.585 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.3 t -58.97 -48.93 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.23 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.597 HD13 ' CB ' ' A' ' 139' ' ' PRO . 77.3 mt -62.24 -48.68 78.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.723 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.9 m -49.67 -47.21 50.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.739 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.5 t -69.28 -25.43 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.85 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.6 m-30 -103.3 11.66 36.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.985 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.1 -57.69 16.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.486 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.8 Cg_endo -55.78 -22.04 35.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.511 2.141 . . . . 0.0 112.356 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.532 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 91.3 m-70 -90.33 -15.09 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.087 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.952 0.406 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.87 152.29 24.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -71.82 129.85 39.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 14.3 t-20 -152.84 161.89 41.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.787 HG13 HD11 ' A' ' 47' ' ' ILE . 1.7 m -131.54 135.53 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 111.458 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -103.8 150.62 17.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.101 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.911 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -126.7 101.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.822 0.344 . . . . 0.0 111.506 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 t -89.75 100.43 13.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.4 tp -102.79 143.65 32.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.044 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 2.8 ptt? -126.22 157.5 38.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 40.5 p-10 -98.98 170.95 8.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.76 -16.11 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.491 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -89.14 1.06 56.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 64.8 mttt 76.29 26.97 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.3 mttt -99.17 171.62 7.89 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -109.94 122.76 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.902 0.382 . . . . 0.0 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.761 ' CE1' HG21 ' A' ' 119' ' ' ILE . 86.7 t80 -55.17 111.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.12 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.52 130.34 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.31 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.03 138.72 50.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.041 0.448 . . . . 0.0 111.193 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.25 158.07 23.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.632 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.704 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtp85 -73.35 159.72 32.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.0 mt -93.36 -5.48 49.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.921 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.61 -17.76 3.62 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.704 HD12 ' CD ' ' A' ' 33' ' ' ARG . 69.6 mt -120.68 112.76 33.69 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.099 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.47 132.27 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.887 1.725 . . . . 0.0 111.684 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.76 4.82 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.617 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.36 97.56 11.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.41 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CD1' HD22 ' A' ' 145' ' ' LEU . 19.2 m95 -103.36 155.58 18.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.126 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.72 170.95 9.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 68.1 mtm -90.04 153.87 47.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.689 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.29 139.14 41.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.156 . . . . 0.0 112.666 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.77 162.6 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.86 141.8 7.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.602 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -58.44 140.87 46.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.787 HD11 HG13 ' A' ' 17' ' ' VAL . 3.7 mt -72.66 159.29 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.496 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.58 148.66 22.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.09 99.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.225 0.536 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.23 40.42 13.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.913 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.3 tp10 -110.75 147.5 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.159 0.504 . . . . 0.0 110.859 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.93 130.56 80.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.571 ' HA ' HG11 ' A' ' 17' ' ' VAL . 55.0 Cg_exo -52.04 -25.7 23.25 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.377 2.051 . . . . 0.0 112.538 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' CB ' ' CE2' ' A' ' 108' ' ' PHE . 9.7 ttt180 -86.61 -22.05 26.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.984 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -91.08 -40.29 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 110.31 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.461 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -64.17 -30.37 71.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.666 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -74.68 -50.96 15.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 54' ' ' ARG . 59.1 mt -57.6 -30.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.101 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -81.36 -53.14 6.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.867 0.842 . . . . 0.0 109.908 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.79 -49.34 65.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.91 HD22 HG21 ' A' ' 19' ' ' ILE . 3.3 tp -54.97 -55.15 33.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.973 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 50.3 ttp85 -61.44 -13.44 20.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.544 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.95 -43.0 9.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.957 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -91.38 -25.33 19.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.788 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.36 -20.27 8.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.361 . . . . 0.0 111.057 -179.333 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.9 7.59 62.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.068 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.656 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.2 t -67.25 115.62 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.856 0.36 . . . . 0.0 110.383 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.64 -34.04 11.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.195 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 76.33 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.197 0.522 . . . . 0.0 111.051 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.51 129.07 13.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -116.33 147.63 41.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.02 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.2 t -77.03 119.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.325 0.583 . . . . 0.0 111.068 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.919 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -93.41 -26.05 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.837 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.59 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.518 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.425 ' CG ' ' CE2' ' A' ' 108' ' ' PHE . 29.2 tt0 -148.65 118.76 7.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.583 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.747 ' HA ' HG11 ' A' ' 160' ' ' VAL . 8.1 t -58.21 123.95 68.07 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.61 -17.05 58.32 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.723 2.282 . . . . 0.0 113.312 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.77 -178.54 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.907 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.454 ' C ' HD23 ' A' ' 80' ' ' LEU . 13.0 m95 -110.5 146.3 36.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.874 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.596 ' HB3' HG13 ' A' ' 153' ' ' VAL . 9.5 mt -112.73 117.61 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.064 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.833 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.7 p -109.76 132.35 54.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.821 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -129.08 161.58 29.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.624 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.9 158.37 29.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.383 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -104.26 150.85 38.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.444 2.096 . . . . 0.0 111.956 179.606 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.5 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.796 0.331 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -26.34 36.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.078 0.466 . . . . 0.0 110.396 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.61 -152.3 8.53 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.585 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -152.81 116.7 4.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.71 0.29 . . . . 0.0 111.084 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.833 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.62 105.62 16.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -117.65 161.34 19.81 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 105.08 12.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.388 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 74.1 m95 -75.69 136.41 40.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 112.259 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CE2' ' CG ' ' A' ' 75' ' ' GLU . 26.9 m-85 -118.78 133.73 55.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.03 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.919 HD23 ' HB ' ' A' ' 73' ' ' ILE . 17.8 tp -79.57 135.28 36.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.097 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.911 ' CD1' HG23 ' A' ' 19' ' ' ILE . 38.3 m-85 -127.87 133.46 49.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.188 0.518 . . . . 0.0 112.187 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.557 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -96.02 119.44 34.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.507 177.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.619 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -68.56 122.89 19.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 110.761 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 p -124.54 37.55 4.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.27 -145.01 4.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.097 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.64 154.19 45.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.84 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -77.17 -17.98 58.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.2 -26.22 42.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.761 HG21 ' CE1' ' A' ' 29' ' ' PHE . 16.4 mt -72.51 98.68 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.341 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -113.89 95.79 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.4 mt -56.58 -21.15 24.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.457 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.866 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -59.67 -56.88 16.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.417 0.627 . . . . 0.0 109.867 179.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 136.85 -174.96 21.37 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.436 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -90.96 38.66 0.96 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.09 29.43 74.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.96 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -111.79 -64.8 1.24 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.0 111.38 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.46 165.11 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 146.05 94.68 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.866 ' HG3' HD13 ' A' ' 122' ' ' LEU . 47.4 Cg_exo -54.84 140.89 78.27 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.607 2.204 . . . . 0.0 112.381 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -110.65 -27.35 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.462 ' HB2' HD13 ' A' ' 121' ' ' LEU . 5.9 m-85 -118.74 159.44 23.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.588 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.5 -16.34 5.59 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.772 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.556 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 4.7 mp0 -152.24 174.27 13.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.734 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.4 p-90 -159.59 154.19 24.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.114 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.57 159.63 44.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.366 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 74.7 m95 -93.68 125.82 38.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 145' ' ' LEU . 27.4 m -138.8 151.17 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 111.696 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.33 160.42 79.12 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.588 ' HD3' HD11 ' A' ' 28' ' ' ILE . 14.4 Cg_endo -57.0 -18.19 27.36 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 121.875 1.717 . . . . 0.0 111.929 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.27 -34.24 14.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.121 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -50.24 37.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.977 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.942 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.5 tp -54.49 -31.82 56.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.457 0.646 . . . . 0.0 109.75 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.49 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.0 mm -69.84 -27.81 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.622 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.71 -23.56 42.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.065 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.3 mt -81.67 -39.8 23.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.86 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 147' ' ' VAL . 8.8 m -55.73 165.2 0.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.866 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 14.8 p -95.84 161.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.53 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.52 -27.0 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.866 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 23.1 p90 -90.9 10.11 27.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' A' ' 82' ' ' TYR . 18.4 mtmt -150.07 13.98 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 111.611 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.7 mtpp -69.07 -62.79 2.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.141 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.3 Cg_endo -51.49 -40.01 63.79 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 111.988 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.821 HG21 ' HB3' ' A' ' 82' ' ' TYR . 22.7 t -58.73 -25.03 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.88 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.26 -51.46 5.29 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.541 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HG3' HD12 ' A' ' 143' ' ' ILE . 11.1 mtpt -50.31 -33.95 21.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.463 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 6.6 tp10 -64.9 -46.02 83.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.69 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.6 t -59.31 -48.43 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.22 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.517 HD13 ' CB ' ' A' ' 139' ' ' PRO . 72.5 mt -64.19 -48.65 75.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.616 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.6 m -49.4 -47.38 47.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.747 HG11 ' HA ' ' A' ' 76' ' ' VAL . 72.1 t -66.8 -24.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.134 0.492 . . . . 0.0 110.459 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.881 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.6 m-30 -101.24 -0.77 35.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.116 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.32 -51.86 24.12 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.333 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -55.74 -22.82 38.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.372 2.048 . . . . 0.0 112.176 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.618 ' ND1' HG22 ' A' ' 73' ' ' ILE . 88.8 m-70 -93.45 -19.55 21.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.7 mp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.443 ' N ' ' HZ1' ' A' ' 101' ' ' LYS . 79.5 m-85 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.15 0.5 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 30.2 tpt85 -82.72 152.15 25.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.07 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -79.19 128.21 33.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 8.5 m120 -152.55 163.36 39.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.816 HG13 HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -128.95 135.0 63.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.077 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.84 142.14 15.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.385 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.887 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -119.03 101.17 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.2 t -89.8 103.85 16.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 110' ' ' PHE . 42.6 tp -102.87 140.52 37.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 111.11 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -124.54 157.34 35.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.836 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.9 p-10 -101.21 169.5 8.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -54.85 -17.61 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.626 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.24 56.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 110.942 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt 76.68 25.8 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.529 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.7 mttp -96.28 171.65 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 28' ' ' ILE . 4.0 mp -109.55 123.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.812 ' CE1' HG21 ' A' ' 119' ' ' ILE . 74.9 t80 -57.72 110.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.48 134.35 54.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.8 135.9 54.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.61 153.85 25.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.572 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -70.73 157.12 38.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 111.402 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -5.71 52.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.56 -18.11 4.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.148 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.3 mt -119.65 107.96 39.95 Favored Pre-proline 0 N--CA 1.456 -0.144 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.911 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 24.8 Cg_exo -62.49 128.93 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.0 t0 80.65 2.7 1.79 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.83 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.31 97.46 11.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.422 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.3 m95 -104.97 156.78 17.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.0 -177.0 2.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.753 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.44 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 2.9 mpp? -106.49 158.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 139.98 40.85 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -154.02 162.23 41.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.788 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.58 18.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.1 137.4 29.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.645 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.816 HD11 HG13 ' A' ' 17' ' ' VAL . 4.9 mt -70.75 159.55 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.555 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.65 149.61 22.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.921 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.25 98.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.236 0.541 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.08 39.84 11.05 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.919 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.8 tp10 -112.24 147.39 36.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.153 0.501 . . . . 0.0 110.872 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.03 133.79 78.34 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.595 ' O ' HG11 ' A' ' 17' ' ' VAL . 53.1 Cg_exo -52.56 -55.13 4.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.06 . . . . 0.0 112.609 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 58' ' ' ILE . 1.2 ttt-85 -59.13 -22.76 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.11 -49.66 7.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.733 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.456 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.53 -28.45 65.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.599 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -75.33 -51.37 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.074 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.5 mt -55.71 -30.67 27.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.047 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -80.54 -53.23 6.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.825 0.821 . . . . 0.0 109.838 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -55.96 -33.36 64.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.632 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.776 HD11 ' HB ' ' A' ' 67' ' ' VAL . 8.5 tp -58.05 -61.24 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.115 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.612 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.9 ptp180 -62.39 -9.17 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.506 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.86 -47.66 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.71 -30.39 17.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.266 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.742 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.07 -22.76 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.576 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 71.07 8.85 65.69 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.957 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.776 ' HB ' HD11 ' A' ' 61' ' ' LEU . 39.7 t -70.35 118.11 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.791 0.329 . . . . 0.0 110.342 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.08 -35.18 11.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.17 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.424 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.78 6.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.37 128.9 13.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.901 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.66 148.96 42.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.688 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.4 t -77.74 128.03 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.454 0.645 . . . . 0.0 111.924 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.46 -19.86 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.381 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.66 164.05 36.33 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.084 0.469 . . . . 0.0 111.622 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -148.98 118.51 6.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.516 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.883 HG11 HD21 ' A' ' 80' ' ' LEU . 3.4 t -57.91 110.39 2.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.059 0.457 . . . . 0.0 110.045 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.77 -23.41 11.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.257 2.638 . . . . 0.0 113.332 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.707 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -112.67 -175.75 2.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.235 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.534 ' C ' HD22 ' A' ' 80' ' ' LEU . 51.3 m95 -105.36 147.96 27.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.658 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.905 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.6 mm? -109.22 118.46 36.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.219 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.768 HG22 ' CB ' ' A' ' 104' ' ' ALA . 8.4 p -120.14 131.18 54.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.864 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -126.47 170.2 12.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.525 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.81 158.29 42.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.238 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.25 153.75 46.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.548 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 122.414 2.076 . . . . 0.0 112.056 179.71 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.403 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 9.2 m95 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.443 ' HZ1' ' N ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -73.48 -30.55 63.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.419 0.628 . . . . 0.0 109.962 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 103' ' ' GLN . . . -150.67 -158.84 8.46 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.752 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 10.1 mp0 -151.25 112.52 4.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.756 0.313 . . . . 0.0 111.186 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.768 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -86.54 105.56 16.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.504 ' NE2' ' OH ' ' A' ' 82' ' ' TYR . 7.0 pt20 -124.34 152.18 43.44 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.428 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -101.72 101.19 11.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.01 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.614 ' CD2' HG21 ' A' ' 157' ' ' VAL . 31.0 m95 -71.33 138.53 49.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 0.0 111.689 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 62.8 m-85 -123.23 134.09 54.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.547 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.858 HD13 ' CD2' ' A' ' 161' ' ' PHE . 19.4 tp -79.69 132.03 36.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.392 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.887 ' CD1' HG23 ' A' ' 19' ' ' ILE . 44.8 m-85 -126.08 128.83 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.12 121.23 33.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.645 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -66.09 125.27 24.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.027 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 69' ' ' SER . 11.6 p -127.54 37.68 4.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.638 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.64 -144.7 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.122 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.82 154.18 44.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.878 0.37 . . . . 0.0 110.064 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.95 -16.47 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.69 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -18.33 54.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.704 0.287 . . . . 0.0 111.245 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -79.52 -24.79 41.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.0 110.837 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.812 HG21 ' CE1' ' A' ' 29' ' ' PHE . 21.2 mt -75.71 104.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.112 0.482 . . . . 0.0 111.568 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.51 95.86 4.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.859 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.822 HD13 ' HB2' ' A' ' 131' ' ' PHE . 61.3 mt -53.48 -24.46 13.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.626 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.431 HD22 ' CG ' ' A' ' 129' ' ' PRO . 18.3 mt -62.45 -57.55 10.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 110.026 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.66 -178.16 21.27 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -91.11 38.97 0.98 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.8 66.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -121.21 -69.64 0.83 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -84.86 165.1 17.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.32 145.21 39.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.431 ' CG ' HD22 ' A' ' 122' ' ' LEU . 50.7 Cg_exo -53.31 128.68 30.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.579 2.186 . . . . 0.0 112.634 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.89 -32.28 6.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.542 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.822 ' HB2' HD13 ' A' ' 121' ' ' LEU . 14.6 m-85 -110.3 159.67 17.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.2 -19.94 5.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.987 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.4 mm-40 -152.48 175.38 12.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.115 0.483 . . . . 0.0 110.746 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.2 p-90 -157.15 154.25 29.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.195 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.09 161.47 42.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.367 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.454 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 72.1 m95 -94.7 123.56 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 145' ' ' LEU . 32.4 m -135.52 151.21 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.033 0.444 . . . . 0.0 111.578 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.16 162.4 69.54 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.634 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.64 ' CA ' HD13 ' A' ' 158' ' ' LEU . 37.8 Cg_exo -58.06 -18.54 36.6 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.792 1.661 . . . . 0.0 111.914 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.07 -34.51 14.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.223 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.66 -50.6 34.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.023 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.909 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.01 -32.16 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.522 0.677 . . . . 0.0 109.818 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.564 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.2 mm -68.32 -28.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.746 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.64 -22.38 40.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.6 mt -83.5 -39.54 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 150' ' ' LYS . 3.6 m -59.48 167.4 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.512 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.2 p -101.26 159.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -51.84 -40.88 61.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.512 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.4 p90 -79.58 1.5 25.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.472 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 27.6 mttm -136.44 7.56 3.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.573 0.225 . . . . 0.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 14.1 mtpt -70.31 -62.39 2.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.105 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.6 Cg_endo -53.93 -43.14 60.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.379 2.053 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.905 HG13 ' HB3' ' A' ' 80' ' ' LEU . 78.0 t -57.35 -25.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.698 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -90.69 -53.25 4.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.445 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.564 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.52 -31.91 16.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.229 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.84 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.0 tp10 -65.21 -46.17 81.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.503 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 107' ' ' TRP . 49.1 t -59.83 -48.41 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.226 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.64 HD13 ' CA ' ' A' ' 139' ' ' PRO . 71.9 mt -64.27 -49.15 72.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.1 m -50.35 -44.28 54.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.757 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.3 t -72.42 -24.83 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 110.595 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.858 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.8 m-30 -102.93 8.48 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.097 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.71 -52.61 62.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.725 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.7 Cg_endo -52.82 -23.39 20.57 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.509 2.14 . . . . 0.0 112.375 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.641 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.5 m-70 -89.91 -23.34 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.734 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.696 ' OXT' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.856 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 101' ' ' LYS . 26.8 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -89.51 152.16 21.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.396 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -81.03 125.31 30.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.603 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.3 t-20 -152.58 157.7 41.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -123.5 125.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.238 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -95.52 147.61 18.69 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.246 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.747 ' CD1' ' HB1' ' A' ' 57' ' ' ALA . 2.0 mm -116.24 101.69 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 111.541 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 5.7 t -92.07 97.84 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.889 HD12 ' O ' ' A' ' 110' ' ' PHE . 19.8 tp -102.52 151.61 22.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.178 0.513 . . . . 0.0 111.646 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.0 ptt? -134.37 157.4 46.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.397 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.509 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.48 170.16 8.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.557 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -18.85 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.539 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.41 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.74 1.73 54.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.328 . . . . 0.0 110.887 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 33.5 mtmt 72.9 26.88 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.664 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.1 mmtp -97.7 173.54 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.568 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -109.16 123.58 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.033 0.444 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CD2' HD23 ' A' ' 21' ' ' LEU . 3.0 t80 -58.13 104.4 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.66 135.27 53.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.752 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.88 138.49 53.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.46 157.45 23.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.759 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -74.85 158.71 32.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.25 0.548 . . . . 0.0 111.29 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 -4.78 48.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.953 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -129.24 -17.29 3.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.176 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.759 HD12 ' CD ' ' A' ' 33' ' ' ARG . 69.4 mt -121.39 112.06 33.04 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.094 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.3 Cg_endo -65.65 132.1 29.76 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.79 1.66 . . . . 0.0 111.683 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.38 5.36 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -91.74 97.6 11.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.301 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.733 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.2 m95 -104.86 156.68 17.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.185 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -168.76 -176.78 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.775 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.476 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 1.4 mtt -113.53 160.11 32.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.656 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 54.6 Cg_exo -52.01 128.88 28.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.629 2.219 . . . . 0.0 112.615 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.72 141.75 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.41 133.56 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.704 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.94 133.88 52.56 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.748 HD11 HG13 ' A' ' 17' ' ' VAL . 4.7 mt -65.16 159.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.611 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.2 m-20 -90.29 149.62 22.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -51.78 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.195 0.521 . . . . 0.0 110.756 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.71 10.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.904 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 14.5 tp10 -113.16 146.49 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 110.865 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.5 135.78 75.23 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.663 ' O ' HG11 ' A' ' 17' ' ' VAL . 58.8 Cg_exo -51.9 -55.24 4.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.434 2.089 . . . . 0.0 112.577 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 58' ' ' ILE . 8.8 ttm180 -59.4 -25.83 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.396 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -84.12 -50.49 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.729 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -56.21 -31.56 63.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.747 ' HB1' ' CD1' ' A' ' 19' ' ' ILE . . . -72.45 -53.91 10.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.102 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.0 mt -54.63 -28.49 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.238 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -83.19 -52.85 6.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -56.96 -37.51 71.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.861 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.835 HD11 ' HB ' ' A' ' 67' ' ' VAL . 9.2 tp -54.14 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.61 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -58.8 -12.23 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.05 -41.04 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.359 . . . . 0.0 111.462 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -90.55 -31.08 16.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.996 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.725 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.13 -21.24 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.84 2.97 72.49 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.835 ' HB ' HD11 ' A' ' 61' ' ' LEU . 24.6 t -67.52 110.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -95.02 -29.53 14.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.13 76.45 6.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.309 0.576 . . . . 0.0 110.536 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 131.4 15.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.545 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -118.91 139.73 51.16 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.249 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 26.7 t -68.69 120.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.37 0.605 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.869 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -94.97 -25.12 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.934 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -163.49 171.32 16.07 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.825 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -149.11 123.39 9.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.484 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.685 HG11 HD21 ' A' ' 80' ' ' LEU . 41.4 t -57.83 126.21 75.75 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.76 0.314 . . . . 0.0 110.317 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.47 -18.9 56.45 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.91 2.407 . . . . 0.0 113.123 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.676 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -123.17 -175.37 3.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 111.28 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.462 ' C ' HD22 ' A' ' 80' ' ' LEU . 53.5 m95 -102.9 147.41 26.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.062 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.928 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.1 mm? -105.24 117.54 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.647 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.767 HG22 ' CB ' ' A' ' 104' ' ' ALA . 51.8 p -116.03 137.97 51.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.311 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.878 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -134.39 170.11 16.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.338 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.98 158.37 39.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.184 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -112.3 145.46 32.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--N 1.345 0.392 0 C-N-CA 122.471 2.114 . . . . 0.0 112.432 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.6 m95 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.98 0.419 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -75.64 -32.26 60.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.967 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.56 -133.31 1.88 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.374 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.9 mt-30 -158.09 114.38 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -93.78 105.85 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 1.1 pt20 -121.64 157.85 29.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.437 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -105.97 98.71 8.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.817 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.569 ' CD2' HG21 ' A' ' 157' ' ' VAL . 40.5 m95 -69.54 130.2 41.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.734 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 68.0 m-85 -116.5 135.53 53.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.881 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.1 tp -79.57 137.46 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.066 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.889 ' O ' HD12 ' A' ' 21' ' ' LEU . 40.1 m-85 -129.63 133.13 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.244 0.545 . . . . 0.0 111.925 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 34.1 tttm -96.25 119.99 35.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.489 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.672 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.9 t80 -68.41 123.22 20.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.99 0.424 . . . . 0.0 110.978 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.477 HG21 ' OE1' ' A' ' 71' ' ' GLU . 8.9 p -124.81 37.56 4.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.464 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.23 -145.16 4.9 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.69 154.06 47.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 109.998 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -49.87 -16.83 0.3 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.541 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -22.66 56.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.28 -25.61 58.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.403 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 36.8 mt -67.99 104.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.468 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' THR . 1.2 t-20 -120.92 95.43 4.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 131' ' ' PHE . 32.0 mt -55.49 -21.58 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.693 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.588 HD22 ' HG3' ' A' ' 129' ' ' PRO . 16.7 mt -65.16 -60.03 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.84 -175.09 24.68 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.542 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -91.81 38.75 0.99 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.134 0.492 . . . . 0.0 109.89 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.65 73.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.104 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 t -115.58 -69.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.24 165.09 12.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.177 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 149.27 65.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.588 ' HG3' HD22 ' A' ' 122' ' ' LEU . 73.8 Cg_exo -49.91 124.92 13.42 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.613 2.208 . . . . 0.0 112.57 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -106.27 -28.58 10.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.587 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.9 m-85 -110.91 159.18 17.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.87 -22.76 4.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.697 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.7 mm-40 -152.27 174.34 13.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 110.552 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p-90 -159.95 159.88 32.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.26 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.26 167.6 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.509 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 68.8 m95 -97.02 121.58 39.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.687 HG23 ' HB2' ' A' ' 142' ' ' LEU . 35.3 m -132.49 150.53 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.717 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -70.76 160.05 83.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.64 ' CA ' HD13 ' A' ' 158' ' ' LEU . 14.1 Cg_endo -56.89 -18.14 26.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 121.855 1.703 . . . . 0.0 111.915 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -34.06 15.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.987 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -50.91 23.54 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.87 -31.25 59.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.447 0.642 . . . . 0.0 109.845 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.597 HD11 ' CA ' ' A' ' 155' ' ' LYS . 9.1 mm -70.03 -27.29 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.62 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.24 -17.12 47.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.145 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 142' ' ' LEU . 13.4 mt -87.59 -38.98 15.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 147' ' ' VAL . 25.6 m -57.58 163.16 2.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.03 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.683 HG12 ' HB2' ' A' ' 150' ' ' LYS . 13.0 p -90.0 161.82 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.965 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.517 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -55.68 -31.3 62.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.759 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.646 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -92.6 7.39 43.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.683 ' HB2' HG12 ' A' ' 147' ' ' VAL . 4.5 mttm -133.27 -8.27 2.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.513 0.197 . . . . 0.0 111.505 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.517 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.6 mtpp -54.47 -59.43 10.31 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.264 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 16.8 Cg_endo -57.78 -42.63 57.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.3 2.0 . . . . 0.0 111.938 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.928 HG13 ' HB3' ' A' ' 80' ' ' LEU . 85.9 t -57.5 -27.92 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.86 -53.91 4.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.382 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.597 ' CA ' HD11 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -47.64 -38.3 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.868 ' HB3' HD11 ' A' ' 80' ' ' LEU . 8.4 tp10 -60.68 -46.26 91.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.505 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 107' ' ' TRP . 42.8 t -58.54 -49.49 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.331 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.64 HD13 ' CA ' ' A' ' 139' ' ' PRO . 68.4 mt -62.35 -49.59 74.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.3 p -49.83 -42.45 47.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.772 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.4 t -73.44 -24.6 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.115 0.483 . . . . 0.0 110.343 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.881 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.3 m-30 -104.63 12.05 33.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.995 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.559 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.01 -55.53 32.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.386 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.0 Cg_endo -55.87 -22.37 37.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.494 2.129 . . . . 0.0 112.248 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.473 ' ND1' HG22 ' A' ' 73' ' ' ILE . 98.4 m-70 -89.92 -17.97 27.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.484 HD23 ' SD ' ' A' ' 22' ' ' MET . 1.8 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.934 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.717 0.294 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.433 ' HG2' ' CD2' ' A' ' 100' ' ' TRP . 29.9 mmm-85 -77.73 148.18 35.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -67.4 130.66 43.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.139 0.495 . . . . 0.0 111.534 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.494 ' ND2' ' HA2' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -152.5 162.52 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.289 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.72 HG13 HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.93 126.26 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 0.0 111.25 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.09 138.84 14.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.273 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.929 HG21 HD22 ' A' ' 61' ' ' LEU . 4.8 mp -114.65 101.52 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.343 . . . . 0.0 111.26 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.9 t -90.17 104.58 17.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.5 tp -103.29 149.13 25.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.063 0.458 . . . . 0.0 111.143 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.564 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.9 ptt? -130.11 157.37 42.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.708 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.452 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.8 p-10 -100.73 171.0 7.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.468 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -57.65 -16.02 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.547 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.04 0.27 56.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp 76.9 27.48 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.656 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -98.83 171.21 8.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.524 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -109.91 121.23 62.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.967 0.413 . . . . 0.0 110.953 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.708 ' CE1' HG21 ' A' ' 119' ' ' ILE . 86.9 t80 -55.49 110.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.61 137.81 51.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.356 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -123.23 139.88 53.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.21 156.88 24.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.626 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.775 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -73.01 157.75 36.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 111.367 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.1 mt -90.5 -5.88 55.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.124 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.88 -16.6 2.89 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.775 HD12 ' CD ' ' A' ' 33' ' ' ARG . 61.6 mt -119.07 106.03 43.96 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 31.0 Cg_exo -60.77 129.05 27.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.164 1.909 . . . . 0.0 111.888 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.2 t70 80.61 0.93 1.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.929 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.52 97.67 10.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.4 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD1' HD22 ' A' ' 145' ' ' LEU . 49.5 m95 -101.47 155.09 18.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.119 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -169.13 -176.86 2.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.699 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.456 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 4.2 mpp? -102.66 157.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 121.37 7.9 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.601 2.201 . . . . 0.0 112.498 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -123.23 161.64 24.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.61 138.7 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.435 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' HA2' ' ND2' ' A' ' 16' ' ' ASN . . . -70.39 129.08 19.53 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 17' ' ' VAL . 4.9 mt -61.12 158.62 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -90.21 150.41 21.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.47 99.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.156 0.503 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.26 37.93 9.48 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.779 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 49.1 tt0 -114.39 147.92 38.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.174 0.511 . . . . 0.0 110.701 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.11 142.52 72.31 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.508 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HA ' HG11 ' A' ' 17' ' ' VAL . 49.0 Cg_exo -56.45 -57.88 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.504 2.136 . . . . 0.0 112.89 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 58' ' ' ILE . 4.8 ttt-85 -58.38 -24.78 60.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.43 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -87.71 -42.76 12.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 110.252 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.39 -32.7 73.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.197 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.28 -52.49 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 54' ' ' ARG . 51.4 mt -56.82 -29.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.999 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -81.2 -52.78 6.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.716 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 31.5 mm-40 -55.4 -44.83 76.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.638 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.929 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -55.17 -51.86 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.829 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.583 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 31.9 ttp180 -61.59 -13.68 23.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.577 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.02 -42.26 10.08 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -90.76 -27.05 19.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.72 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.45 -21.55 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 111.093 -179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.09 8.39 61.5 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.981 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.817 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.2 t -65.23 110.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.237 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.9 p -92.46 -34.95 13.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.239 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 76.6 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 111.055 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.44 129.34 13.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.605 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.526 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.4 pt-20 -119.14 140.28 50.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.323 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.3 t -69.28 121.65 19.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.353 0.597 . . . . 0.0 111.17 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.897 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -97.74 -22.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -163.37 165.65 23.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.504 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 10.6 pt-20 -149.06 121.17 8.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.809 ' HA ' HG11 ' A' ' 160' ' ' VAL . 32.4 t -56.94 126.01 71.28 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 -19.41 46.48 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.951 2.434 . . . . 0.0 113.242 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.65 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.13 -175.3 3.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 111.511 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.461 ' C ' HD22 ' A' ' 80' ' ' LEU . 17.1 m95 -104.57 147.76 27.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.77 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.889 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -104.52 118.08 35.72 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.418 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.869 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -119.98 133.71 55.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.949 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.886 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -133.85 170.31 15.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.98 161.24 23.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.634 0.731 . . . . 0.0 111.42 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 10.8 m-85 -111.15 144.06 29.66 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 122.648 2.232 . . . . 0.0 112.565 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.433 ' CD2' ' HG2' ' A' ' 14' ' ' ARG . 90.9 m95 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.813 0.34 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -30.83 66.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -179.51 -133.85 2.06 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.937 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 14.1 pt20 -157.96 114.84 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.0 111.343 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.869 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.46 105.78 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.848 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.519 ' NE2' ' OH ' ' A' ' 82' ' ' TYR . 10.1 pt20 -123.19 144.87 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -95.66 98.68 10.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 178.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.621 ' CD2' HG21 ' A' ' 157' ' ' VAL . 22.2 m95 -66.14 143.57 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.193 0.52 . . . . 0.0 112.149 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.3 m-85 -129.21 136.98 50.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.246 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.897 HD23 ' HB ' ' A' ' 73' ' ' ILE . 23.6 tp -79.34 155.01 28.64 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.869 ' O ' HD12 ' A' ' 21' ' ' LEU . 32.8 m-85 -146.1 132.73 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.252 0.549 . . . . 0.0 112.023 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 5.5 tptp -96.46 118.27 32.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.53 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.643 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -68.17 120.69 14.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 0.0 110.701 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.42 HG21 ' OE1' ' A' ' 71' ' ' GLU . 5.9 p -121.81 37.43 4.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.457 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.83 -144.38 4.7 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.086 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.29 154.29 45.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 110.004 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -49.73 -16.8 0.27 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -15.7 59.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.02 -25.47 37.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.708 HG21 ' CE1' ' A' ' 29' ' ' PHE . 14.9 mt -73.18 103.89 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.582 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.48 95.85 4.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.024 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.0 mt -56.02 -21.65 22.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.654 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 129' ' ' PRO . 14.6 mt -62.95 -58.84 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 109.984 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.69 -172.19 24.5 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.435 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -93.31 38.82 1.05 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.15 0.5 . . . . 0.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.45 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.302 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.8 m -114.28 -67.75 0.97 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.769 0.318 . . . . 0.0 111.25 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -98.38 165.1 12.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -76.37 147.54 79.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.489 ' HB2' HD11 ' A' ' 34' ' ' LEU . 53.1 Cg_exo -51.69 136.18 49.81 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.613 2.209 . . . . 0.0 112.55 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -108.12 -28.39 9.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.653 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 19.0 m-85 -120.37 159.69 24.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.17 -18.11 6.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.85 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.419 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.4 mm-40 -152.45 174.94 13.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.193 0.52 . . . . 0.0 110.782 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.4 p-90 -159.45 152.38 21.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.964 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 m -148.08 157.26 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.541 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.452 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 86.9 m95 -92.81 125.11 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.745 HG11 HD11 ' A' ' 145' ' ' LEU . 27.0 m -136.73 151.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.118 0.485 . . . . 0.0 111.662 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.13 159.07 85.8 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.555 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.574 ' O ' HD13 ' A' ' 158' ' ' LEU . 11.7 Cg_endo -55.82 -18.63 22.21 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.841 1.694 . . . . 0.0 112.016 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -34.17 15.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -50.45 30.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.944 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.9 tp -54.3 -29.8 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.32 0.581 . . . . 0.0 109.829 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.548 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -69.83 -28.49 37.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.655 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -22.39 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.268 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.944 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.5 mt -82.97 -39.15 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 147' ' ' VAL . 26.9 m -53.87 164.21 0.62 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 150' ' ' LYS . 10.3 p -97.24 162.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.528 ' N ' HG22 ' A' ' 147' ' ' VAL . 15.8 mt-10 -51.51 -38.38 53.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.985 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 23.8 p90 -88.34 10.82 18.55 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.571 ' HB2' HG12 ' A' ' 147' ' ' VAL . 67.3 mttt -130.95 -5.12 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.419 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 12.2 mttt -55.97 -62.0 5.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.9 Cg_endo -59.01 -48.16 15.28 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.388 2.058 . . . . 0.0 112.233 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.889 HG13 ' HB3' ' A' ' 80' ' ' LEU . 92.3 t -57.22 -27.1 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.24 0.543 . . . . 0.0 111.11 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.454 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.0 m-85 -90.91 -52.73 4.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.428 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.548 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.88 -31.85 18.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.308 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.804 ' HB3' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -65.39 -46.13 81.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.445 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.621 HG21 ' CD2' ' A' ' 107' ' ' TRP . 57.7 t -59.57 -53.2 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.32 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 139' ' ' PRO . 59.1 mt -62.85 -50.01 72.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.9 t -51.66 -45.61 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.0 t -69.84 -25.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 110.297 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.838 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.9 m-30 -101.96 7.98 41.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.23 -56.23 21.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.623 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.9 Cg_endo -50.16 -24.67 11.65 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.567 2.178 . . . . 0.0 112.384 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 95.9 m-70 -95.39 -18.34 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.564 HD23 ' SD ' ' A' ' 22' ' ' MET . 1.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.964 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.51 152.23 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -75.93 126.96 32.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.6 t-20 -152.5 157.07 40.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.786 HG13 HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -125.45 124.49 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.891 0.377 . . . . 0.0 111.202 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.55 140.96 15.44 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.197 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.824 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -121.23 101.83 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.441 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.3 t -89.76 107.3 19.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.2 tp -103.19 146.54 28.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.7 157.53 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.976 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.7 p-10 -100.59 170.93 8.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.06 -18.21 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.608 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 0.31 56.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.988 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp 76.83 25.63 0.85 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.558 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttp -94.4 172.44 8.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.566 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -110.54 120.35 61.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.947 0.403 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' HG21 ' A' ' 119' ' ' ILE . 68.2 t80 -53.9 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.129 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.52 131.57 56.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.368 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.33 138.29 51.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.914 0.388 . . . . 0.0 111.178 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.29 155.87 24.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.4 mtp85 -70.41 159.16 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 111.599 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.9 mt -92.84 -5.81 50.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.831 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.51 -19.49 4.19 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 66.8 mt -120.4 112.76 34.1 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.968 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.09 131.61 29.22 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.858 1.705 . . . . 0.0 111.911 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.32 2.66 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.94 97.36 10.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.301 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CD1' HD22 ' A' ' 145' ' ' LEU . 26.2 m95 -102.34 155.41 18.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -168.62 169.15 10.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.477 ' HE1' ' CG ' ' A' ' 154' ' ' TYR . 76.2 mtm -89.92 155.22 47.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.16 149.37 22.16 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.697 2.265 . . . . 0.0 113.061 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -176.39 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.214 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 138.08 4.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.296 -0.955 . . . . 0.0 112.858 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.76 126.32 29.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.786 HD11 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -60.99 161.28 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.685 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -88.34 -176.38 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.2 98.62 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.23 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.79 47.39 9.8 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.749 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 6.5 tt0 -115.62 146.75 41.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.55 134.86 84.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.588 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.677 ' O ' HG11 ' A' ' 17' ' ' VAL . 55.2 Cg_exo -52.43 -57.25 2.2 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.401 2.067 . . . . 0.0 112.659 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -56.84 -28.06 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.434 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -81.97 -49.7 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.718 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.16 -30.76 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.824 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.65 -52.0 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 54' ' ' ARG . 43.9 mt -55.85 -28.71 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.244 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG3' ' NH2' ' A' ' 62' ' ' ARG . 36.5 ttp85 -83.62 -52.8 6.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.885 0.85 . . . . 0.0 109.89 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -56.36 -34.55 66.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.684 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.81 HD12 ' OG1' ' A' ' 65' ' ' THR . 5.4 tp -57.13 -59.54 4.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.181 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.566 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 22.4 ptt85 -61.34 -10.71 7.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.793 0.33 . . . . 0.0 110.691 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -91.19 -45.12 8.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 0.0 111.561 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.46 -28.12 17.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.81 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -113.56 -21.49 10.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.837 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.17 4.85 74.53 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.039 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.699 ' HB ' HD11 ' A' ' 61' ' ' LEU . 55.8 t -75.2 119.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.364 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -99.25 -34.07 10.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.35 78.27 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.184 0.516 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.39 129.6 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.924 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -120.0 145.76 46.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.577 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.556 HG22 ' CE1' ' A' ' 110' ' ' PHE . 53.1 t -76.11 125.9 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.527 0.679 . . . . 0.0 111.967 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.933 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.62 -16.19 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.339 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.586 ' HB2' ' ND1' ' A' ' 164' ' ' HIS . . . -155.35 160.18 40.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 115.56 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.104 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.87 ' HA ' HG11 ' A' ' 160' ' ' VAL . 7.2 t -57.33 127.47 77.0 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.951 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 -15.55 44.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.784 2.322 . . . . 0.0 113.585 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -128.34 174.63 9.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.493 0.663 . . . . 0.0 112.364 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.454 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 13.0 m95 -99.8 147.09 25.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.876 ' HB3' HG13 ' A' ' 153' ' ' VAL . 46.1 mt -114.34 117.56 31.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.763 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.728 HG22 ' CB ' ' A' ' 104' ' ' ALA . 3.0 p -113.56 130.57 56.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.865 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -131.91 160.14 36.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.46 158.38 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.182 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.11 150.17 37.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--N 1.344 0.299 0 C-N-CA 122.441 2.094 . . . . 0.0 112.027 179.616 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.3 m95 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 -30.14 55.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -166.04 -144.5 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -158.16 113.44 2.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 111.511 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.728 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.15 105.67 17.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.936 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.08 153.7 44.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.5 mttt -107.81 95.76 5.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.522 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.437 ' CD2' HG21 ' A' ' 157' ' ' VAL . 61.4 m95 -63.42 140.2 58.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.336 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 66.9 m-85 -125.82 138.32 53.82 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.402 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.786 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.6 tp -79.56 154.77 28.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.824 ' CD1' HG23 ' A' ' 19' ' ' ILE . 34.2 m-85 -148.51 127.83 13.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 0.0 111.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.933 ' HB3' HD11 ' A' ' 73' ' ' ILE . 22.8 tttt -93.72 119.58 32.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.576 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.655 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.9 t80 -62.77 125.31 23.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 71' ' ' GLU . 7.7 p -127.11 37.88 4.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.52 -144.84 4.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.071 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -127.2 154.26 45.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -49.83 -16.65 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.574 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -78.55 -18.1 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -80.3 -25.56 39.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.811 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.784 HG21 ' CE1' ' A' ' 29' ' ' PHE . 15.5 mt -74.15 102.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.369 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.49 96.09 5.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.115 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.748 HD13 ' HB2' ' A' ' 131' ' ' PHE . 53.0 mt -55.45 -22.73 21.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.436 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.448 HD22 ' HG3' ' A' ' 129' ' ' PRO . 19.5 mt -62.24 -58.51 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.13 -179.26 20.8 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.595 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -90.0 38.65 0.93 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.151 0.501 . . . . 0.0 109.768 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.93 73.4 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.254 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -102.88 165.19 11.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -73.41 148.48 88.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.448 ' HG3' HD22 ' A' ' 122' ' ' LEU . 59.5 Cg_exo -50.85 138.93 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.216 . . . . 0.0 112.624 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -112.07 -33.0 6.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.648 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.748 ' HB2' HD13 ' A' ' 121' ' ' LEU . 29.1 m-85 -116.83 159.38 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.522 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.93 -16.82 6.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.852 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 121' ' ' LEU . 20.2 mm-40 -152.31 175.04 13.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.3 p-90 -159.11 151.54 21.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.134 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 m -147.62 161.05 41.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.492 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.488 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.4 m95 -95.09 125.03 39.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.833 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -137.55 150.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.7 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -70.15 159.62 83.78 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.533 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.566 ' HD3' HD11 ' A' ' 28' ' ' ILE . 12.3 Cg_endo -56.27 -18.3 23.68 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 121.826 1.684 . . . . 0.0 111.999 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.06 -34.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.029 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.25 -50.48 32.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.069 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.907 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -53.62 -34.12 57.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.592 0.71 . . . . 0.0 109.885 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.55 HD12 ' CD ' ' A' ' 155' ' ' LYS . 7.8 mm -66.99 -27.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.737 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.31 -22.07 38.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.969 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.7 mt -84.11 -39.41 19.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.827 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -58.35 167.51 1.35 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.115 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.847 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 13.6 p -98.97 163.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.833 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.53 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -60.99 -36.62 79.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.847 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 8.5 p90 -79.38 -0.82 34.31 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.456 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -139.09 10.66 2.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.676 0.274 . . . . 0.0 111.278 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.437 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mtpt -69.45 -62.76 2.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.7 Cg_endo -53.99 -43.34 59.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.47 2.113 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.876 HG13 ' HB3' ' A' ' 80' ' ' LEU . 13.5 t -57.64 -24.59 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.477 ' CG ' ' HE1' ' A' ' 42' ' ' MET . 3.1 m-85 -91.02 -47.81 7.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.438 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.55 ' CD ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -51.57 -33.32 32.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.612 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.6 tp10 -67.15 -45.77 76.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 45.9 t -59.02 -47.09 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.056 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 139' ' ' PRO . 74.6 mt -66.65 -48.69 68.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.781 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -52.07 -45.85 64.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.79 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.87 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.3 t -69.56 -24.84 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 110.679 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.786 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.0 m-30 -98.17 -7.86 28.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.16 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -50.19 -44.92 82.15 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.559 0.218 . . . . 0.0 111.371 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 35.6 Cg_exo -60.5 -22.97 73.94 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.63 2.22 . . . . 0.0 112.679 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' A' ' 74' ' ' ALA . 58.7 m80 -95.02 -44.48 7.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.793 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.641 HD12 HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB3' ' CA ' ' A' ' 103' ' ' GLN . 5.5 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -78.96 152.62 30.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.412 HH12 ' HB3' ' A' ' 104' ' ' ALA . 4.8 mmp_? -66.5 128.16 35.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.254 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 1.8 t-20 -152.77 159.03 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.449 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.761 HG13 ' CG1' ' A' ' 47' ' ' ILE . 4.5 m -136.23 125.33 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.994 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.39 154.8 20.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.925 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.944 HG23 ' CD1' ' A' ' 110' ' ' PHE . 5.2 mp -128.88 110.87 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' PHE . 43.0 t -90.57 103.97 16.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 110' ' ' PHE . 25.1 tp -102.88 149.61 24.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.065 0.459 . . . . 0.0 111.239 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.563 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -127.96 158.25 38.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.967 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' HB3' ' CZ3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -108.55 167.32 10.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.65 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -49.08 -19.24 0.4 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.56 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 0.0 111.467 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 76.71 23.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.659 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.91 171.71 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.598 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.59 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -108.77 123.44 64.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.018 0.437 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.537 ' HE2' HD13 ' A' ' 119' ' ' ILE . 9.3 t80 -52.43 116.84 2.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -122.14 132.29 54.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.024 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -121.69 139.8 53.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.981 0.419 . . . . 0.0 111.38 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.05 155.85 24.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.391 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.595 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -71.84 158.39 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.541 . . . . 0.0 111.634 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.3 mt -91.46 -6.03 53.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.997 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -131.11 -17.68 3.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.6 mt -118.6 111.7 37.66 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.0 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 131.72 29.66 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.94 1.76 . . . . 0.0 111.811 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.49 3.07 3.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.793 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.22 97.41 11.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.475 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.7 m95 -102.39 155.73 18.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.252 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -169.13 -176.94 2.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.692 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.3 mpp? -103.29 158.26 32.15 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.57 146.61 80.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.463 2.109 . . . . 0.0 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.456 ' HB2' HE21 ' A' ' 44' ' ' GLN . 0.0 OUTLIER -153.98 176.64 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.18 6.44 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.81 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.71 130.77 20.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.222 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.761 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.9 mt -58.59 159.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.485 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.3 m-20 -90.49 149.47 22.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.822 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.44 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 39.8 10.84 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.935 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.9 tp10 -114.12 146.78 39.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.908 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -72.54 140.98 82.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.497 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HA ' HG11 ' A' ' 17' ' ' VAL . 33.1 Cg_exo -57.77 -37.8 95.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.357 2.038 . . . . 0.0 112.471 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 58' ' ' ILE . 4.5 ttp180 -75.78 -23.34 55.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.67 -43.97 10.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.445 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.04 -30.84 71.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.32 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.4 -51.37 17.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 54' ' ' ARG . 58.0 mt -56.82 -28.77 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.18 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 ttp85 -84.25 -52.8 5.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.792 0.806 . . . . 0.0 109.991 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -53.15 -42.54 66.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.827 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -55.83 -54.64 42.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.531 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.8 ttp180 -61.17 -13.92 21.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.299 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -92.01 -40.85 10.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.836 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.39 -26.26 18.96 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.808 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.02 -20.55 8.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.35 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.48 4.09 73.7 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.098 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.653 HG13 ' HE1' ' A' ' 112' ' ' PHE . 55.8 t -71.02 118.58 15.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.616 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -98.62 -35.25 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.29 80.85 6.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.944 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.63 130.8 14.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.035 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 pt-20 -120.3 144.0 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.02 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.5 t -76.79 122.95 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.646 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.887 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.5 mm -107.08 -15.33 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 109' ' ' LEU . . . -155.98 154.03 30.47 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.837 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -148.67 117.93 6.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.81 ' HA ' HG11 ' A' ' 160' ' ' VAL . 7.5 t -57.53 127.03 77.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.926 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.58 -6.12 18.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.923 2.415 . . . . 0.0 114.117 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.531 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -136.53 138.97 41.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.443 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 24.9 m95 -64.28 145.32 56.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.279 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.851 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -103.92 138.73 40.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.643 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.4 p -139.18 130.7 27.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.844 ' CD1' HG11 ' A' ' 153' ' ' VAL . 9.9 p90 -139.1 170.44 15.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.95 158.3 35.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.018 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -102.44 154.21 37.59 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.703 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 122.389 2.059 . . . . 0.0 112.145 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 71.9 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -25.43 41.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.44 . . . . 0.0 110.578 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -177.98 -137.82 2.9 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.826 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.42 ' CA ' ' HB3' ' A' ' 13' ' ' TYR . 3.6 pt20 -158.16 115.28 2.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.704 0.287 . . . . 0.0 111.436 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.643 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.92 105.56 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -123.6 154.44 39.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -111.31 103.83 12.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.696 178.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.672 ' CD2' HG21 ' A' ' 157' ' ' VAL . 28.1 m95 -66.23 146.18 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.201 0.524 . . . . 0.0 112.085 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 50.8 m-85 -129.13 130.65 46.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.925 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.656 HD23 ' HB ' ' A' ' 73' ' ' ILE . 20.2 tp -78.72 151.81 31.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.944 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.1 m-85 -148.62 128.0 13.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.887 ' HB3' HD11 ' A' ' 73' ' ' ILE . 16.0 tptt -92.62 122.45 35.05 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -64.88 126.35 27.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.849 0.357 . . . . 0.0 111.226 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.2 p -125.45 37.34 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.37 -145.03 4.76 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.106 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -128.51 154.31 46.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.837 0.351 . . . . 0.0 110.147 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -49.33 -17.13 0.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -20.38 57.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.802 0.334 . . . . 0.0 111.224 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.21 -26.28 52.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.537 HD13 ' HE2' ' A' ' 29' ' ' PHE . 31.5 mt -68.68 104.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.474 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.1 95.87 4.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.159 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 131' ' ' PHE . 61.0 mt -57.34 -21.04 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.522 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.859 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -60.53 -57.66 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.95 -179.65 18.71 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.19 38.72 0.94 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.71 28.44 73.76 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.127 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -114.99 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.269 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -102.17 165.12 11.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -74.71 145.54 81.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.859 ' HG3' HD13 ' A' ' 122' ' ' LEU . 52.5 Cg_exo -53.82 137.98 68.32 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.577 2.184 . . . . 0.0 112.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.57 -28.22 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.573 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.9 m-85 -118.02 159.5 23.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.23 -19.66 5.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.723 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 32.3 mm-40 -152.25 174.51 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.078 0.465 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.9 p-90 -159.27 154.05 24.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.388 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.14 166.25 26.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.301 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.483 ' CZ3' ' HB3' ' A' ' 23' ' ' ASN . 54.1 m95 -99.54 125.67 45.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.2 m -139.28 151.44 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -69.76 162.48 67.56 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.466 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.596 ' O ' HD13 ' A' ' 158' ' ' LEU . 19.3 Cg_endo -58.78 -16.72 32.63 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.762 1.642 . . . . 0.0 111.995 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -35.01 13.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.2 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.36 33.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.051 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.943 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.57 -27.81 41.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.473 0.654 . . . . 0.0 110.014 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.619 HD12 ' HG3' ' A' ' 155' ' ' LYS . 5.2 mm -73.52 -27.45 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.843 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.45 -23.79 42.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.085 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.8 mt -81.01 -40.18 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 109.922 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 150' ' ' LYS . 4.4 m -57.89 169.3 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.872 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.1 p -105.37 159.03 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.551 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 147' ' ' VAL . 11.3 pt-20 -42.42 -51.87 4.81 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.514 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -71.11 -7.29 45.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.238 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.493 ' O ' HG21 ' A' ' 146' ' ' THR . 1.9 mttt -123.34 -1.59 8.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.586 0.232 . . . . 0.0 111.514 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 15.6 mtpt -68.63 -60.74 4.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.277 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 14.8 Cg_endo -57.3 -42.68 59.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.304 2.002 . . . . 0.0 111.538 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 80' ' ' LEU . 35.0 t -61.07 -24.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 3.4 m-85 -90.64 -50.19 6.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.253 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.619 ' HG3' HD12 ' A' ' 143' ' ' ILE . 7.9 mtpm? -51.38 -30.92 20.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.377 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.781 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.3 tp10 -67.54 -46.23 73.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.322 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.672 HG21 ' CD2' ' A' ' 107' ' ' TRP . 39.4 t -62.13 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.102 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 139' ' ' PRO . 73.7 mt -67.19 -49.07 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.6 t -51.13 -46.86 62.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 76' ' ' VAL . 87.1 t -66.12 -24.03 33.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.192 0.52 . . . . 0.0 110.34 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.719 ' O ' HD12 ' A' ' 165' ' ' LEU . 10.5 m-30 -98.65 -6.67 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.786 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.67 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -44.69 -39.46 7.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.689 ' HD2' ' C ' ' A' ' 161' ' ' PHE . 20.5 Cg_endo -63.17 -23.84 72.88 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.135 1.89 . . . . 0.0 113.8 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 161' ' ' PHE . 3.2 p80 -89.37 -25.41 21.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.754 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.9 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.993 0.425 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 3.7 ttt85 -84.25 152.42 24.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -63.74 129.4 39.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.527 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 20.5 t-20 -152.65 150.82 29.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 53' ' ' PRO . 2.7 m -123.28 141.37 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.34 149.85 17.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.281 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.936 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -129.22 101.6 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.1 t -89.63 106.29 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 110' ' ' PHE . 32.6 tp -102.68 143.0 32.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 111.195 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.3 ptt? -127.74 157.3 40.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 40.0 p-10 -103.3 170.21 8.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.302 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -55.74 -17.47 6.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.515 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.02 0.42 56.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.731 0.3 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 76.47 26.43 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 22' ' ' MET . 12.6 mttt -97.01 173.88 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.544 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -112.2 121.4 64.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.943 0.401 . . . . 0.0 110.884 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.458 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 12.6 t80 -54.73 108.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.384 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.79 134.49 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.27 141.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 111.319 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.29 158.31 23.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.614 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.667 ' CD ' HD12 ' A' ' 36' ' ' ILE . 5.0 mtp-105 -71.26 163.65 27.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.35 0.595 . . . . 0.0 111.676 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.2 mt -96.67 -7.33 34.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.564 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.13 -18.51 4.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.348 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.667 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.7 mt -120.73 112.76 33.61 Favored Pre-proline 0 N--CA 1.457 -0.109 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.171 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.44 132.1 30.18 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.955 1.77 . . . . 0.0 111.792 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.37 2.47 3.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.829 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.67 97.55 11.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.312 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.552 ' CD1' HD22 ' A' ' 145' ' ' LEU . 38.0 m95 -101.18 156.08 17.64 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.933 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -168.98 169.43 9.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 43.2 mtm -97.09 155.9 36.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 129.67 20.15 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.193 . . . . 0.0 113.038 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 141.74 19.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.57 160.84 28.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.863 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.9 126.84 7.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.629 HD11 HG13 ' A' ' 17' ' ' VAL . 11.7 mt -55.71 162.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.579 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 47' ' ' ILE . 8.5 m-20 -73.48 -170.9 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.573 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.06 29.28 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.275 0.56 . . . . 0.0 111.145 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.53 52.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 2.7 tt0 -128.43 148.17 50.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.088 0.47 . . . . 0.0 111.076 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.13 128.19 81.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.87 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.66 ' HA ' HG11 ' A' ' 17' ' ' VAL . 1.4 Cg_endo -45.93 -29.73 6.3 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.59 2.194 . . . . 0.0 113.11 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.551 HH12 HG11 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -73.48 -29.57 62.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.775 0.322 . . . . 0.0 110.917 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -86.67 -44.59 11.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.195 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -58.15 -31.69 67.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.92 -54.76 7.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.066 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ARG . 31.6 mt -56.05 -31.7 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -78.84 -53.4 7.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.832 0.825 . . . . 0.0 109.89 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -50.87 -38.97 52.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.45 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.1 tp -58.15 -58.88 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.129 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.526 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 ptp180 -61.42 -11.84 12.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -91.62 -43.74 9.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 0.0 111.718 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.78 -25.4 19.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.72 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -115.43 -20.91 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.12 5.17 70.26 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG13 ' HE1' ' A' ' 112' ' ' PHE . 53.2 t -74.72 129.34 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 p -105.71 -34.63 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.27 81.64 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.912 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.54 14.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.653 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.2 OUTLIER -119.63 147.48 44.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.17 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.578 HG23 ' CE2' ' A' ' 110' ' ' PHE . 31.2 t -78.49 123.06 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.433 0.635 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.907 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -104.34 -22.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.274 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -152.11 159.75 43.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.18 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.5 pt-20 -148.31 111.7 4.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.171 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.67 HG22 HG21 ' A' ' 160' ' ' VAL . 3.8 t -57.62 125.73 73.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.219 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 4.8 Cg_exo -74.45 -8.14 20.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.845 2.363 . . . . 0.0 113.571 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.576 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.44 135.91 50.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 112.187 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD2' ' CG ' ' A' ' 106' ' ' LYS . 29.3 m95 -67.7 145.57 54.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.07 0.462 . . . . 0.0 110.109 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.633 ' HB3' HG13 ' A' ' 153' ' ' VAL . 55.7 mt -111.36 117.93 34.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.897 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.882 HG22 ' CB ' ' A' ' 104' ' ' ALA . 9.5 p -108.89 140.18 42.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.74 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.766 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -134.24 170.18 16.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.886 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.81 158.34 33.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -120.85 146.6 44.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.603 2.202 . . . . 0.0 112.241 179.974 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 36.7 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -30.76 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.64 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -161.6 -143.44 3.68 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.098 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.9 mm-40 -157.64 115.55 3.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.883 0.373 . . . . 0.0 111.435 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.882 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -95.48 105.61 17.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 6.7 pt20 -124.34 154.78 39.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' CG ' ' CD2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -107.51 105.38 15.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.485 178.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' HG21 ' A' ' 157' ' ' VAL . 26.6 m95 -72.92 144.88 47.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.222 0.534 . . . . 0.0 112.259 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.9 m-85 -127.58 132.79 49.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.361 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.803 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.81 129.08 34.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.936 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.4 m-85 -123.73 127.87 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.907 ' HB3' HD11 ' A' ' 73' ' ' ILE . 2.2 tppp? -91.73 121.78 33.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.652 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.0 t80 -63.52 126.68 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.846 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.653 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.9 p -127.12 37.62 4.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.56 -145.17 4.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.066 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -129.64 154.16 47.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.882 0.372 . . . . 0.0 110.067 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.482 ' HA ' HD12 ' A' ' 119' ' ' ILE . 20.2 m-20 -49.5 -16.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.602 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -76.9 -23.29 52.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.88 -25.17 52.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.822 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 116' ' ' ASP . 23.2 mt -68.03 104.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.393 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.47 ' OD1' HD12 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -121.2 95.91 4.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.914 179.198 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 131' ' ' PHE . 44.8 mt -58.56 -21.05 51.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.499 HD23 ' CG ' ' A' ' 129' ' ' PRO . 2.3 mt -61.46 -57.44 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.799 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.87 179.04 21.81 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.575 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -90.25 38.75 0.94 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.214 0.531 . . . . 0.0 109.724 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.56 26.95 73.28 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.063 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -117.42 -69.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -96.44 165.13 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.204 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -77.43 148.81 77.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.499 ' CG ' HD23 ' A' ' 122' ' ' LEU . 64.2 Cg_exo -50.51 135.92 40.57 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.62 2.213 . . . . 0.0 112.597 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -111.91 -30.64 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.781 ' HB2' HD13 ' A' ' 121' ' ' LEU . 25.3 m-85 -118.34 159.51 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.7 -13.96 7.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.697 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.563 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.8 mp0 -152.17 174.18 14.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.085 0.469 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.3 p-90 -159.74 150.04 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 m -148.68 156.64 42.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.465 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -92.14 125.01 36.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.72 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -135.62 150.78 29.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.138 0.494 . . . . 0.0 111.579 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.8 159.67 83.08 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.583 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.582 ' CA ' HD13 ' A' ' 158' ' ' LEU . 12.9 Cg_endo -56.5 -17.97 23.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.917 1.745 . . . . 0.0 111.965 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.07 14.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.102 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.49 -50.63 29.58 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.959 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.3 tp -53.68 -33.43 55.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 109.819 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.55 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.0 mm -67.34 -27.65 39.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.811 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.3 -24.37 42.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.057 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.959 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.6 mt -82.34 -39.58 22.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.857 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 150' ' ' LYS . 3.3 m -54.25 168.59 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.272 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.5 p -103.65 160.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 147' ' ' VAL . 5.4 mt-10 -47.65 -40.61 20.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.349 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 21.7 p90 -86.22 8.3 21.7 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' HG21 ' A' ' 146' ' ' THR . 15.1 mttt -130.9 -1.61 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.588 0.233 . . . . 0.0 111.457 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 31.6 mttt -63.81 -62.85 4.64 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.269 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 14.7 Cg_endo -57.16 -41.4 74.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.102 . . . . 0.0 112.004 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.0 t -60.62 -26.78 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.15 0.5 . . . . 0.0 110.977 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.1 m-85 -91.09 -55.05 3.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.846 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HG3' HD12 ' A' ' 143' ' ' ILE . 34.6 mttm -47.92 -33.49 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.709 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.596 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.4 tp10 -67.94 -44.5 76.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.615 HG21 ' CD2' ' A' ' 107' ' ' TRP . 58.6 t -61.5 -49.17 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.222 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.582 HD13 ' CA ' ' A' ' 139' ' ' PRO . 73.9 mt -62.86 -48.4 79.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.658 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.9 m -49.58 -47.49 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.808 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.67 HG21 HG22 ' A' ' 76' ' ' VAL . 89.3 t -69.27 -24.98 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.664 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.803 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.6 m-30 -100.6 1.93 41.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.283 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.94 -54.47 40.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.355 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.29 -20.81 26.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.608 2.206 . . . . 0.0 112.379 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 19.5 m80 -89.51 -21.19 23.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.677 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.41 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.895 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' N ' ' HZ1' ' A' ' 101' ' ' LYS . 49.3 m-85 . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 121.148 0.499 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 14.9 ttt-85 -84.95 152.12 23.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.302 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.698 HH22 ' HB3' ' A' ' 104' ' ' ALA . 4.3 mmp_? -66.24 124.32 22.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 12.8 t-20 -152.65 159.9 43.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD11 ' A' ' 47' ' ' ILE . 3.7 m -133.96 146.79 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.52 150.47 17.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.891 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -127.89 101.98 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.277 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -89.45 104.93 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 110' ' ' PHE . 36.5 tp -103.09 141.59 35.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.061 0.458 . . . . 0.0 111.277 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.84 157.58 37.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.8 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.5 p-10 -101.4 171.33 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.241 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.33 -16.76 9.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.535 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.15 56.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.729 0.299 . . . . 0.0 110.972 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? 77.05 27.04 0.71 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.484 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -99.81 171.67 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.603 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -110.32 124.3 66.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.879 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.828 ' CE2' HG21 ' A' ' 119' ' ' ILE . 33.7 t80 -58.52 108.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.626 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.82 129.88 56.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.398 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -113.96 141.27 47.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.133 0.492 . . . . 0.0 111.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.53 158.84 22.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.726 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.568 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -67.6 165.92 16.03 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 111.712 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -89.31 -8.86 52.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.161 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.404 ' OD1' HG13 ' A' ' 36' ' ' ILE . 1.3 p30 -148.07 -7.51 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 49.9 mt -114.35 109.77 48.43 Favored Pre-proline 0 CA--C 1.523 -0.083 0 CA-C-N 118.562 0.619 . . . . 0.0 110.918 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 27.2 Cg_endo -64.87 130.85 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.892 1.728 . . . . 0.0 111.616 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.7 t70 80.89 1.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.485 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -94.67 97.66 10.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.153 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 33.3 m95 -108.91 162.17 14.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.859 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -168.73 164.8 12.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.457 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 77.6 mtm -94.9 157.79 36.12 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.66 132.99 32.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.646 2.231 . . . . 0.0 113.006 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.29 154.34 33.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.244 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.47 151.31 21.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.829 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.18 141.93 43.86 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.454 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.969 HD11 HG13 ' A' ' 17' ' ' VAL . 20.3 mt -76.68 164.32 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.952 0.406 . . . . 0.0 110.716 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.57 ' N ' HG22 ' A' ' 47' ' ' ILE . 3.2 m-20 -84.05 -175.8 5.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.671 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.63 100.01 6.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.324 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.65 49.77 17.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.615 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 3.1 tp10 -115.68 145.65 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -71.83 132.73 84.76 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.453 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.686 ' HA ' HG11 ' A' ' 17' ' ' VAL . 55.9 Cg_exo -52.96 -44.91 44.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.492 2.128 . . . . 0.0 112.9 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -59.92 -27.16 66.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -86.75 -47.37 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.712 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.02 -29.69 68.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -75.73 -50.35 15.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.7 mt -57.78 -30.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.088 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 3.1 ttp-105 -81.05 -53.54 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 109.815 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -53.96 -33.82 57.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.39 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.847 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -55.06 -59.82 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.609 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 5.9 ptt180 -61.47 -11.94 12.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.81 -39.57 11.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 111.548 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -90.26 -32.75 16.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.099 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.88 -23.24 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.091 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.53 1.54 82.69 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.847 ' HB ' HD11 ' A' ' 61' ' ' LEU . 51.1 t -67.2 115.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -33.9 14.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.478 ' HG ' ' CD ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -90.5 81.86 5.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.853 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.18 131.59 15.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.788 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.9 pt-20 -118.81 146.63 44.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.589 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.6 t -78.86 122.34 33.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.618 . . . . 0.0 111.529 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -104.62 -21.43 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.614 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -152.86 160.83 43.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.175 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.34 110.72 4.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.714 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.4 t -57.63 123.56 63.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.65 -6.03 17.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.798 2.332 . . . . 0.0 113.745 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.572 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -130.06 135.08 47.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.241 0.543 . . . . 0.0 112.09 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 27.9 m95 -66.46 147.24 53.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.848 ' HB3' HG13 ' A' ' 153' ' ' VAL . 53.2 mt -116.51 117.63 30.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.657 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.847 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.6 p -111.84 131.51 55.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.87 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -132.05 161.31 33.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.62 158.45 26.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.241 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -112.8 154.36 44.87 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.701 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.531 2.154 . . . . 0.0 112.419 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.456 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 15.7 m95 . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' H ' ' HE3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -70.53 -32.95 70.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.199 0.523 . . . . 0.0 109.998 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -155.23 -153.11 6.4 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.665 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -158.21 116.65 3.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.747 0.308 . . . . 0.0 111.217 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.847 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.88 105.65 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -124.82 152.41 43.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -106.7 101.63 11.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.594 178.771 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.457 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 22.1 m95 -69.01 143.96 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 0.0 112.128 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 50.9 m-85 -124.83 135.74 53.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.277 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.816 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.6 tp -79.88 131.09 35.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.392 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.891 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.6 m-85 -125.39 127.35 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.673 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.56 123.62 34.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.691 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.7 t80 -67.51 128.82 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 111.328 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' SER . 4.7 p -128.7 37.64 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.264 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -136.34 -144.45 4.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.156 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 153.86 47.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.968 0.413 . . . . 0.0 110.199 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.87 -14.35 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.589 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.62 -17.84 40.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.38 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.478 ' CD ' ' HG ' ' A' ' 69' ' ' SER . 6.3 tt0 -81.37 -24.58 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.828 HG21 ' CE2' ' A' ' 29' ' ' PHE . 32.1 mt -69.46 105.32 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 111.579 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.556 HD22 ' HB2' ' A' ' 122' ' ' LEU . 47.3 t30 -116.7 95.88 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.874 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 51.6 mt -52.22 -24.82 7.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.669 HD22 ' HG3' ' A' ' 129' ' ' PRO . 54.0 mt -63.21 -57.64 9.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.252 0.549 . . . . 0.0 109.974 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.32 -177.45 25.59 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.5 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.29 39.01 1.01 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.142 0.496 . . . . 0.0 109.709 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.18 71.5 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -121.83 -64.18 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.82 165.15 17.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 155.52 47.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.003 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.669 ' HG3' HD22 ' A' ' 122' ' ' LEU . 83.8 Cg_exo -44.7 149.8 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.786 2.324 . . . . 0.0 112.773 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -144.21 -44.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 7.4 m-85 -111.6 159.74 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.35 -16.4 6.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.989 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.451 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 23.4 mm-40 -152.32 175.11 13.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 110.491 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.9 p-90 -159.09 150.96 20.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.178 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 m -148.55 162.24 40.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 73.8 m95 -95.67 125.33 40.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.657 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.853 HG11 HD11 ' A' ' 145' ' ' LEU . 27.8 m -137.63 150.96 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.097 0.475 . . . . 0.0 111.681 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.9 158.8 87.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.616 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.649 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.1 Cg_endo -54.89 -19.45 19.43 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 121.941 1.761 . . . . 0.0 112.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.19 -33.85 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.994 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -50.05 30.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.916 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.94 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.18 -29.67 46.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.447 0.641 . . . . 0.0 109.785 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.458 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.1 mm -69.53 -28.41 37.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.71 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.5 -21.02 42.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.127 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.94 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.0 mt -84.37 -39.54 18.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.933 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -58.33 164.98 2.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.971 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.846 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 15.0 p -95.57 160.85 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.516 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.9 OUTLIER -59.92 -27.07 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.846 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 24.8 p90 -91.1 10.9 24.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.435 ' HD3' ' CE2' ' A' ' 82' ' ' TYR . 10.1 mtmt -151.8 14.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.669 0.271 . . . . 0.0 111.584 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.516 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.8 mtpp -69.21 -62.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.25 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.1 Cg_endo -51.72 -41.98 59.18 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.533 2.155 . . . . 0.0 112.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.87 HG11 ' CD1' ' A' ' 82' ' ' TYR . 19.0 t -56.09 -27.24 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.439 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -90.59 -53.0 4.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.473 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.458 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.8 -31.86 18.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.192 0.52 . . . . 0.0 110.445 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.687 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.3 tp10 -67.58 -44.85 77.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.696 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 153' ' ' VAL . 43.6 t -61.31 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.06 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.649 HD13 ' CA ' ' A' ' 139' ' ' PRO . 71.8 mt -65.0 -48.71 73.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.55 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 t -49.43 -47.5 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.689 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.714 HG11 ' HA ' ' A' ' 76' ' ' VAL . 71.3 t -67.93 -25.41 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 110.35 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.816 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.5 m-30 -102.53 8.57 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.068 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.99 -57.26 16.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.27 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 14.1 Cg_endo -57.2 -22.02 46.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.512 ' ND1' ' HB2' ' A' ' 74' ' ' ALA . 69.1 m80 -89.91 -14.25 34.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.095 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.921 179.905 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.5 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.936 0.398 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HD3' ' CD1' ' A' ' 100' ' ' TRP . 7.3 mtp85 -80.82 152.15 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 39.8 mtm180 -71.29 132.94 45.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.244 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.9 t-20 -152.83 157.16 40.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.868 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 47' ' ' ILE . 2.5 m -129.02 134.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 111.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.793 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -106.64 157.11 15.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.098 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.793 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.4 mm -120.77 101.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.691 0.246 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.7 t -89.59 97.28 11.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.4 tp -102.5 145.27 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 111.393 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.35 157.31 41.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.749 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.5 p-10 -102.06 170.33 8.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.348 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.48 -18.55 4.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.91 0.14 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 76.78 25.23 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.607 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' MET . 14.4 mttp -93.63 173.27 7.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.54 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -111.44 120.07 61.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 110.868 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 119' ' ' ILE . 19.8 t80 -53.88 110.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.422 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.53 129.93 56.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.52 138.95 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.059 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.04 155.56 25.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -71.77 157.37 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 111.546 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mt -91.86 -5.37 53.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.841 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.79 -21.44 4.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.024 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.9 mt -118.23 112.5 37.77 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.938 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.23 131.52 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.895 1.73 . . . . 0.0 111.765 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 77.43 3.25 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.89 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.94 97.45 10.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.563 ' CD1' HD22 ' A' ' 145' ' ' LEU . 24.4 m95 -101.06 156.92 17.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.292 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -168.38 -176.98 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.598 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -110.08 156.95 39.19 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HB2' HG12 ' A' ' 19' ' ' ILE . 72.2 Cg_exo -48.65 143.25 16.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.775 2.317 . . . . 0.0 113.021 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 145.1 22.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.37 133.1 2.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.741 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -62.62 140.28 45.94 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.329 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.747 HD11 HG13 ' A' ' 17' ' ' VAL . 4.3 mt -73.31 160.32 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -85.44 -177.18 6.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -77.9 99.22 5.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.35 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.45 9.69 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.729 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.1 tt0 -116.57 144.78 43.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.02 137.31 82.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.591 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.622 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.3 Cg_exo -53.39 -50.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.454 2.103 . . . . 0.0 112.457 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 58' ' ' ILE . 19.2 ttp180 -62.38 -25.43 67.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -83.64 -51.4 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.695 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.14 -31.13 65.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.22 -53.65 10.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 54' ' ' ARG . 54.4 mt -54.75 -27.92 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.192 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -83.82 -53.13 5.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.805 0.812 . . . . 0.0 109.626 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.57 -32.7 65.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.394 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -53.12 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.584 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.7 ptt180 -62.07 -10.87 11.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.448 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.81 -42.14 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.596 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -90.53 -32.42 16.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -21.91 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.995 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.46 4.8 70.75 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.956 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 61' ' ' LEU . 44.3 t -69.75 117.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.792 0.296 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -35.22 12.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.13 77.53 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.24 129.16 13.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.826 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.1 mm-40 -119.93 148.16 43.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.719 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.592 HG23 ' CE2' ' A' ' 110' ' ' PHE . 41.6 t -78.18 125.9 38.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 111.722 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.898 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -105.09 -20.42 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.318 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.709 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -156.06 163.19 39.98 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.231 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 1.3 pm0 -148.54 117.34 6.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.846 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.7 t -57.03 125.43 70.03 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.063 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.28 -17.74 60.78 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.771 2.314 . . . . 0.0 113.362 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.9 -176.45 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.395 0.617 . . . . 0.0 112.125 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.784 ' C ' HD23 ' A' ' 80' ' ' LEU . 15.2 m95 -109.15 147.29 32.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.924 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.784 HD23 ' C ' ' A' ' 79' ' ' TRP . 2.0 mt -112.35 117.75 33.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.02 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.839 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.3 p -111.14 132.25 54.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.518 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.867 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -126.7 169.52 13.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.52 158.41 40.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.108 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' CZ ' ' NE2' ' A' ' 103' ' ' GLN . 49.5 m-85 -109.72 154.38 42.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.609 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 122.404 2.07 . . . . 0.0 112.34 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.424 ' CD1' ' HD3' ' A' ' 14' ' ' ARG . 55.3 m95 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.816 0.341 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -30.14 60.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.19 -139.62 2.87 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.005 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.53 ' NE2' ' CZ ' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -158.11 115.7 2.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.789 0.328 . . . . 0.0 111.376 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.839 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.83 105.86 16.64 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -117.01 157.73 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -113.65 95.87 5.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.841 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD2' HG21 ' A' ' 157' ' ' VAL . 61.7 m95 -64.24 145.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 61.2 m-85 -129.31 134.19 47.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.267 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.861 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -80.02 132.21 35.95 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.58 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HD12 ' A' ' 21' ' ' LEU . 50.3 m-85 -127.16 128.49 46.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 111.278 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.898 ' HB3' HD11 ' A' ' 73' ' ' ILE . 21.3 tttm -92.8 122.76 35.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.668 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -65.8 126.12 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.874 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.7 p -128.42 37.91 4.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.549 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -139.19 -144.98 4.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.148 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.88 154.22 45.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.563 ' HA ' HD12 ' A' ' 119' ' ' ILE . 12.8 m-20 -50.2 -16.26 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -79.72 -17.48 53.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.26 . . . . 0.0 111.356 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -24.93 37.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.593 HG21 ' CE2' ' A' ' 29' ' ' PHE . 7.5 mt -72.46 103.82 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.66 95.59 5.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.952 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' A' ' 131' ' ' PHE . 47.5 mt -54.54 -24.23 19.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.453 HD22 ' HG3' ' A' ' 129' ' ' PRO . 15.5 mt -63.4 -56.96 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.273 0.558 . . . . 0.0 109.988 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.67 -178.5 23.37 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.465 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -90.64 38.73 0.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.067 0.461 . . . . 0.0 109.872 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.17 73.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.219 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -107.11 -65.16 1.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.778 0.323 . . . . 0.0 111.206 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -115.55 164.97 13.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.277 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 153.91 50.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.111 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HG3' HD22 ' A' ' 122' ' ' LEU . 74.6 Cg_exo -48.17 177.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.776 2.317 . . . . 0.0 112.672 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -150.07 -44.75 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.0 m-85 -112.06 159.91 18.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.411 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.68 -21.14 5.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.679 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.6 mm-40 -152.29 174.68 13.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 28.1 p-90 -159.12 154.74 26.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.332 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -151.71 158.73 43.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.458 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 80.1 m95 -92.58 125.81 37.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.901 HG11 HD11 ' A' ' 145' ' ' LEU . 27.3 m -137.4 150.69 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.729 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 4.1 p -68.91 159.18 83.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.576 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.54 ' HD3' HD11 ' A' ' 28' ' ' ILE . 13.0 Cg_endo -56.38 -18.91 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.873 1.715 . . . . 0.0 112.033 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -92.02 -33.88 14.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.117 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -71.08 -50.47 33.45 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.895 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.9 tp -53.16 -33.67 53.54 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.435 0.636 . . . . 0.0 109.876 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -64.88 -29.63 47.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.629 178.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.63 -31.49 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.8 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.901 HD11 HG11 ' A' ' 137' ' ' VAL . 9.4 mt -75.98 -40.46 53.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.033 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 147' ' ' VAL . 13.8 m -55.45 164.15 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.259 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.86 HG11 ' CE2' ' A' ' 149' ' ' PHE . 13.7 p -96.3 161.9 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.483 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -63.12 -33.62 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.86 ' CE2' HG11 ' A' ' 147' ' ' VAL . 8.3 p90 -79.88 0.92 29.13 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.497 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 5.0 mtmt -147.51 17.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.665 0.269 . . . . 0.0 111.437 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.1 mtpt -69.21 -62.75 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.012 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 13.6 Cg_endo -56.5 -40.73 82.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.146 . . . . 0.0 111.935 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.0 t -54.39 -25.52 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.08 -51.88 5.11 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -32.06 15.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.471 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -67.07 -45.52 77.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.623 179.226 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 57.1 t -58.44 -47.47 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.927 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 143' ' ' ILE . 36.7 mt -63.05 -49.16 75.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.794 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.7 t -49.35 -45.68 46.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.71 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.846 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.2 t -70.1 -24.62 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.465 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.861 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -103.82 8.55 37.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.088 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.642 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.68 -51.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.844 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.8 Cg_endo -52.67 -23.75 20.94 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.433 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.709 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 99.1 m-70 -90.4 -23.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.838 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.912 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.904 0.383 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -86.18 152.28 22.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.421 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.464 HH22 ' HB3' ' A' ' 104' ' ' ALA . 3.1 mmp_? -60.7 129.62 42.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.0 m-80 -152.73 160.21 43.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.682 HG13 HD11 ' A' ' 47' ' ' ILE . 1.2 m -135.39 148.4 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.033 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -118.28 150.11 18.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.289 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.892 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.9 mp -127.34 101.66 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.477 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.0 t -91.11 108.08 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.7 tp -103.45 148.96 25.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.455 . . . . 0.0 111.252 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.559 ' SD ' HD21 ' A' ' 109' ' ' LEU . 1.5 ptt? -131.26 157.54 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.674 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.456 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 30.8 p-10 -104.96 169.68 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.24 -18.29 5.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.77 2.88 52.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 19.5 mttm 73.23 26.85 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.565 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' HG22 ' A' ' 138' ' ' THR . 0.0 OUTLIER -95.27 172.51 8.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.549 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -110.2 117.89 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.812 ' HE2' HG21 ' A' ' 65' ' ' THR . 11.4 t80 -52.25 107.55 0.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.79 141.41 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.57 140.67 52.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.51 158.29 23.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.644 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.606 ' CD ' HD12 ' A' ' 36' ' ' ILE . 4.9 mtp-105 -71.69 163.55 27.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.438 0.637 . . . . 0.0 111.667 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.0 mt -97.14 -6.8 34.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.498 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.72 -18.18 3.92 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.606 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.6 mt -121.15 112.59 33.1 Favored Pre-proline 0 N--CA 1.457 -0.088 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.243 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.7 Cg_endo -65.59 132.41 30.85 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.884 1.723 . . . . 0.0 111.532 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.1 2.59 2.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.585 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.33 97.49 11.23 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.683 ' CD1' HD22 ' A' ' 145' ' ' LEU . 33.3 m95 -102.9 156.67 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.74 -176.9 2.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.666 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.479 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 64.1 mtm -108.14 155.45 40.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 134.42 29.4 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.19 159.35 41.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.52 166.76 36.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.26 135.35 14.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.409 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HG13 ' A' ' 17' ' ' VAL . 8.6 mt -66.08 160.99 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.663 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.68 150.69 21.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.883 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.63 97.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.72 38.81 9.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.048 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HB3' HG23 ' A' ' 47' ' ' ILE . 2.8 tt0 -114.67 145.18 42.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 -70.64 139.18 86.12 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.676 ' O ' HG11 ' A' ' 17' ' ' VAL . 49.1 Cg_exo -55.64 -55.51 2.96 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.443 2.096 . . . . 0.0 112.65 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.46 ' O ' HD12 ' A' ' 58' ' ' ILE . 26.9 ttp180 -59.21 -23.58 62.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.89 -48.16 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.16 -31.53 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.812 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.32 -54.12 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.113 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 54' ' ' ARG . 50.9 mt -55.81 -29.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.231 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 ttp85 -82.8 -53.06 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.02 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.63 -45.59 57.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.374 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -56.55 -52.5 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.61 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 42.9 ttp180 -62.45 -12.54 22.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.568 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.61 -41.86 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 111.571 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -90.6 -28.43 18.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.985 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.812 HG21 ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.93 -22.67 5.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.08 9.47 63.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.952 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HB ' HD11 ' A' ' 61' ' ' LEU . 21.3 t -60.38 108.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 110.139 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.99 -35.54 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.422 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.28 74.25 7.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.225 0.536 . . . . 0.0 111.247 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.41 126.38 11.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.564 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.5 mm-40 -119.67 147.73 44.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.821 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 47.7 t -76.83 125.54 36.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.494 0.664 . . . . 0.0 111.704 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.55 -17.38 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.525 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -154.49 162.16 41.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.006 0.432 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 46.5 tt0 -148.53 115.45 6.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.143 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.923 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.8 t -57.58 128.15 79.09 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -11.76 30.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.902 2.401 . . . . 0.0 114.071 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -132.14 153.15 50.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.338 0.589 . . . . 0.0 112.36 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.714 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.0 m95 -80.02 143.49 34.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 79' ' ' TRP . 2.4 mt -111.34 118.09 34.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.93 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.845 HG22 ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -113.5 130.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.792 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -132.98 160.62 36.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.619 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.9 158.38 29.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -102.43 155.51 36.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.608 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.448 2.099 . . . . 0.0 112.157 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 40.1 m95 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.813 0.34 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -31.15 64.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -167.3 -139.07 2.58 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.009 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -157.89 116.02 3.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.543 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.845 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -92.62 111.93 23.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.724 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.95 150.7 52.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -102.77 97.08 7.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.287 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 42' ' ' MET . 43.2 m95 -65.34 139.22 58.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 44.0 m-85 -120.23 138.44 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.539 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.852 HD13 ' CD2' ' A' ' 161' ' ' PHE . 25.3 tp -79.72 154.97 28.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.892 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.2 m-85 -148.17 127.87 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.437 . . . . 0.0 111.782 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 24.6 tttm -93.0 120.46 33.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.594 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.634 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.1 t80 -67.11 122.08 17.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.726 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' SER . 10.0 p -123.0 37.37 4.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.553 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -137.91 -144.38 4.69 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.152 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.07 154.2 45.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.61 -16.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -76.77 -16.9 59.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.256 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -25.36 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.755 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 mt -73.51 99.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -114.29 95.71 5.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 131' ' ' PHE . 46.6 mt -54.97 -21.99 13.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.809 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.552 HD22 ' HG3' ' A' ' 129' ' ' PRO . 24.0 mt -63.94 -59.48 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.269 0.557 . . . . 0.0 109.956 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.72 -170.48 26.96 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.483 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -95.6 39.07 1.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.82 75.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.052 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.9 t -120.88 -70.26 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 111.154 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.1 165.08 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.213 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -84.36 148.97 54.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.994 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.552 ' HG3' HD22 ' A' ' 122' ' ' LEU . 70.8 Cg_exo -50.15 130.76 29.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.649 2.232 . . . . 0.0 112.625 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.62 -30.33 7.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.508 ' HB2' HD13 ' A' ' 121' ' ' LEU . 34.5 m-85 -119.87 159.53 24.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.415 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.24 -16.16 6.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.716 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.67 174.0 14.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.223 0.535 . . . . 0.0 110.63 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.6 p-90 -159.85 155.17 25.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.066 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.1 m -153.87 159.44 41.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.405 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 81.1 m95 -92.76 124.06 36.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.63 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.724 HG11 HD11 ' A' ' 145' ' ' LEU . 29.0 m -135.28 150.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.494 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 1.5 p -70.4 160.54 80.85 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.479 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.603 ' CA ' HD13 ' A' ' 158' ' ' LEU . 16.2 Cg_endo -57.65 -17.89 30.69 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.765 1.643 . . . . 0.0 111.87 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -34.39 14.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.072 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -50.6 29.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.021 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.942 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.08 -31.45 51.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 109.801 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.529 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.6 mm -68.25 -28.42 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.694 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.55 -20.7 42.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.226 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.7 mt -85.05 -39.22 18.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 147' ' ' VAL . 48.6 m -57.76 162.37 3.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.122 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.954 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.4 p -96.0 160.66 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' N ' HG22 ' A' ' 147' ' ' VAL . 7.9 mt-10 -50.17 -33.01 17.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.954 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 19.5 p90 -89.36 13.73 12.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 2.7 mtmp? -139.21 -2.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.586 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 19.2 mttt -55.18 -62.2 4.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.535 0.207 . . . . 0.0 111.352 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.2 Cg_endo -60.81 -42.35 38.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.059 . . . . 0.0 112.201 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.792 HG11 ' CD1' ' A' ' 82' ' ' TYR . 10.3 t -57.8 -31.55 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.336 0.588 . . . . 0.0 110.874 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.479 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -90.57 -50.66 5.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.846 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.529 ' HD2' HD12 ' A' ' 143' ' ' ILE . 5.2 tttt -50.39 -34.23 23.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.2 tp10 -67.92 -45.01 75.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.623 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 153' ' ' VAL . 39.3 t -57.84 -44.42 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.113 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.603 HD13 ' CA ' ' A' ' 139' ' ' PRO . 75.3 mt -68.81 -48.81 62.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.746 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -51.59 -45.87 63.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.923 HG11 ' HA ' ' A' ' 76' ' ' VAL . 84.0 t -69.59 -24.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.852 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.5 m-30 -101.47 -2.35 30.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.303 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -47.19 -52.95 31.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.473 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.3 Cg_endo -53.85 -22.08 22.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.511 2.141 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 49.9 m80 -97.23 -16.97 20.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.686 0.279 . . . . 0.0 111.097 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 161' ' ' PHE . 5.4 mp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.924 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.132 0.491 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 2.5 tmm_? -87.14 152.59 22.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.381 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' A' ' 15' ' ' ARG . 0.3 OUTLIER -67.2 132.17 47.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.115 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 35.6 t30 -152.96 151.09 29.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.029 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -128.2 127.78 67.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.019 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.767 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -101.11 161.73 18.32 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.233 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.6 mm -126.84 101.61 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.615 0.208 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 10.9 t -91.28 93.51 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.897 HD12 ' O ' ' A' ' 110' ' ' PHE . 17.1 tp -102.36 148.77 25.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.326 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.724 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.2 ptt? -131.02 157.53 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.793 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.3 p-10 -100.51 171.23 7.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.399 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -55.51 -18.25 6.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 0.56 56.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.363 . . . . 0.0 110.849 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp 76.37 25.16 1.01 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.713 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.2 mtpp -92.95 173.25 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.536 HG21 HD23 ' A' ' 142' ' ' LEU . 5.2 mp -110.54 116.66 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CD2' HD23 ' A' ' 21' ' ' LEU . 4.4 t80 -50.82 107.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.298 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.53 142.54 46.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.64 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -128.3 140.12 52.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.44 157.74 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.616 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -74.2 159.37 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.309 0.576 . . . . 0.0 111.455 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.0 mt -94.64 -5.33 45.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.887 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -127.81 -17.52 4.46 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.128 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.616 HD12 ' CD ' ' A' ' 33' ' ' ARG . 67.4 mt -122.11 112.65 31.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.978 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.35 132.04 30.15 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.835 1.69 . . . . 0.0 111.771 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 76.79 4.49 3.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.794 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.607 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.98 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.35 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.639 ' CD1' HD22 ' A' ' 145' ' ' LEU . 32.3 m95 -102.37 155.92 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.197 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.7 -176.95 2.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.81 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.432 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.5 mpp? -107.08 156.82 36.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HB2' HG12 ' A' ' 19' ' ' ILE . 75.1 Cg_exo -48.98 140.92 23.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.892 2.394 . . . . 0.0 113.088 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 43' ' ' PRO . 0.4 OUTLIER -141.66 142.92 33.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.056 179.22 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -153.95 118.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.57 120.87 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.305 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.633 HD11 HG13 ' A' ' 17' ' ' VAL . 5.4 mt -53.9 160.42 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.53 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.0 -176.03 4.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.61 99.68 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 48.81 18.64 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.604 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.11 146.01 42.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 110.969 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.13 136.13 93.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' HG11 ' A' ' 17' ' ' VAL . 32.5 Cg_exo -59.59 -60.96 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.566 2.177 . . . . 0.0 112.577 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -55.1 -23.39 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.4 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -87.06 -41.47 13.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.983 0.421 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -62.34 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.361 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -73.07 -53.88 9.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.098 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' ARG . 46.0 mt -55.33 -30.34 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.124 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.05 -52.82 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.811 0.815 . . . . 0.0 109.816 179.079 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 7.4 mm-40 -55.3 -36.42 66.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.459 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD12 ' OG1' ' A' ' 65' ' ' THR . 10.7 tp -61.06 -62.9 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.646 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.682 ' HG3' HG22 ' A' ' 68' ' ' THR . 2.1 tmm_? -59.55 -12.91 7.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.09 -45.66 8.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.938 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.79 -27.73 18.69 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.749 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -115.38 -20.79 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.691 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 79.52 -7.5 53.37 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.079 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.72 ' HB ' HD11 ' A' ' 61' ' ' LEU . 47.1 t -59.98 117.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.981 0.39 . . . . 0.0 110.571 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.682 HG22 ' HG3' ' A' ' 62' ' ' ARG . 21.0 p -101.88 -31.56 10.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.044 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 78.0 6.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.22 0.534 . . . . 0.0 110.848 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.45 130.37 14.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.707 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.1 pt-20 -119.66 140.56 50.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.3 t -69.64 116.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.302 0.572 . . . . 0.0 111.265 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.882 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.1 mt -91.1 -24.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.046 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -161.74 168.98 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.539 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.78 118.77 7.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.856 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.805 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.8 t -57.16 129.82 79.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.957 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.95 -19.46 63.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 113.332 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.593 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.98 -177.71 3.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.29 0.567 . . . . 0.0 112.1 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.731 ' C ' HD23 ' A' ' 80' ' ' LEU . 47.8 m95 -107.13 147.45 30.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.967 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 79' ' ' TRP . 3.5 mt -111.55 117.74 33.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.09 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.853 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.9 p -109.19 137.34 47.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.417 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.845 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -128.11 170.26 13.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.55 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.99 158.23 38.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.64 148.85 51.57 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 122.54 2.16 . . . . 0.0 112.365 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.429 ' CG ' ' HB2' ' A' ' 14' ' ' ARG . 11.9 m95 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.26 62.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -153.99 -153.5 6.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -158.16 117.06 3.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.739 0.304 . . . . 0.0 111.438 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.853 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.72 105.35 16.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.445 ' HG3' ' CD1' ' A' ' 107' ' ' TRP . 5.1 pt20 -115.79 153.75 30.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -107.85 95.81 5.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.569 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.638 ' CD2' HG21 ' A' ' 157' ' ' VAL . 27.4 m95 -65.18 138.24 58.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 112.034 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 74.0 m-85 -122.25 132.72 54.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.882 HD23 ' HB ' ' A' ' 73' ' ' ILE . 18.4 tp -79.33 134.37 36.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.186 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.897 ' O ' HD12 ' A' ' 21' ' ' LEU . 45.0 m-85 -126.89 132.9 50.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.299 0.571 . . . . 0.0 112.031 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.662 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 2.0 ttmt -95.14 120.2 34.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.411 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.642 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.1 t80 -68.59 121.9 17.38 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.755 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.547 HG21 ' OE1' ' A' ' 71' ' ' GLU . 7.7 p -122.73 37.32 4.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.6 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.77 -145.12 4.84 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.085 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -127.93 154.08 45.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 0.0 110.093 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.51 -15.25 0.4 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -84.1 -13.08 53.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 -25.33 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.962 0.411 . . . . 0.0 110.511 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 67' ' ' VAL . 18.4 mt -73.45 107.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.642 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -118.21 95.72 5.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.009 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.5 mt -53.35 -23.31 9.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.761 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.0 mt -63.22 -59.07 5.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.228 0.537 . . . . 0.0 109.977 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.53 -175.42 22.92 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.457 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -91.53 38.79 0.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.108 0.48 . . . . 0.0 109.818 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.55 73.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.171 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.1 t -108.85 -66.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.119 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -108.32 165.12 11.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -68.75 148.31 97.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 34' ' ' LEU . 61.9 Cg_exo -50.86 145.16 24.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.526 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -113.79 -35.72 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.615 ' HB2' HD13 ' A' ' 121' ' ' LEU . 11.2 m-85 -113.83 159.51 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.567 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.51 5.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.351 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.55 173.66 14.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.129 0.49 . . . . 0.0 110.5 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 33.6 p-90 -160.39 157.95 28.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.78 158.5 36.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.451 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.459 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.3 m95 -91.17 123.44 34.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.626 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 142' ' ' LEU . 32.8 m -134.33 151.12 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.164 0.507 . . . . 0.0 111.726 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -69.49 160.85 77.64 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.478 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.694 ' CB ' HD13 ' A' ' 158' ' ' LEU . 19.6 Cg_endo -58.59 -16.85 32.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.669 1.58 . . . . 0.0 111.876 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.34 -34.03 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.103 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -51.59 23.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.107 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.926 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.2 tp -54.29 -32.43 56.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.473 0.654 . . . . 0.0 109.806 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.598 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.2 mm -68.35 -27.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.781 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.1 -22.03 42.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.221 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.8 mt -83.99 -39.16 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.15 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 147' ' ' VAL . 23.6 m -55.55 164.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.759 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.9 p -93.71 165.01 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.054 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.9 mm-40 -55.66 -35.48 66.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.759 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.7 p90 -88.58 9.96 22.14 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 147' ' ' VAL . 20.0 mtmt -131.31 -3.46 3.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.523 0.202 . . . . 0.0 111.442 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.429 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttt -58.38 -63.27 4.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 15.5 Cg_endo -57.28 -41.49 72.62 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.176 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 82' ' ' TYR . 34.1 t -59.18 -28.97 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 4.1 m-30 -91.37 -54.01 4.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.842 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HG3' HD12 ' A' ' 143' ' ' ILE . 21.3 mttt -47.86 -34.34 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.2 tp10 -66.99 -45.18 78.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.779 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.638 HG21 ' CD2' ' A' ' 107' ' ' TRP . 56.9 t -57.27 -50.13 77.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.348 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.694 HD13 ' CB ' ' A' ' 139' ' ' PRO . 74.2 mt -62.45 -48.64 78.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.749 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -49.77 -47.29 51.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.805 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.5 t -68.92 -24.52 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 110.46 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.867 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.6 m-30 -104.11 9.28 36.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.154 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.625 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.57 -51.7 70.72 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.715 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.98 -23.48 21.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.51 2.14 . . . . 0.0 112.289 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.696 ' CE1' HG22 ' A' ' 73' ' ' ILE . 98.2 m-70 -89.78 -24.99 21.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.599 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.724 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.85 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -80.18 147.41 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.448 ' N ' ' HG3' ' A' ' 14' ' ' ARG . 34.2 mtm180 -65.1 137.52 57.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 6.5 m120 -152.32 153.18 33.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.298 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.722 HG13 ' CG1' ' A' ' 47' ' ' ILE . 1.0 OUTLIER -122.33 118.33 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.11 146.82 19.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.031 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.91 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -123.5 101.94 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.791 0.329 . . . . 0.0 111.259 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.06 100.54 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 110' ' ' PHE . 39.4 tp -102.69 139.28 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.068 0.461 . . . . 0.0 111.225 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.62 157.28 37.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.82 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -103.61 169.85 8.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.287 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -50.88 -18.36 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -88.99 0.23 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.097 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 75.64 25.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.688 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.9 mmtp -97.65 172.65 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.6 mp -109.74 125.25 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.77 ' CE2' HG21 ' A' ' 119' ' ' ILE . 54.7 t80 -58.76 110.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.61 129.87 56.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.109 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -115.21 136.09 53.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 111.489 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.429 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.1 p -82.38 154.84 25.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.535 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.74 158.54 36.11 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.227 0.537 . . . . 0.0 111.517 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.2 mt -91.94 -5.9 52.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.009 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -130.8 -17.43 3.18 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.625 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 55.1 mt -119.12 111.91 36.61 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.026 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.4 Cg_endo -65.28 131.4 28.22 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.873 1.715 . . . . 0.0 111.902 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.6 t70 77.73 2.69 2.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.78 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.625 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.94 97.22 11.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 50.5 m95 -104.68 157.88 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -168.89 173.78 6.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 69.5 mtm -102.25 156.86 34.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.69 131.78 26.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.613 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.418 ' CB ' HE22 ' A' ' 105' ' ' GLN . 0.0 OUTLIER -154.15 157.72 39.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.51 34.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.589 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -79.75 130.87 10.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.556 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.722 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.6 mt -59.44 160.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.51 148.06 22.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -48.16 99.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.6 18.41 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.798 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.6 tp10 -111.38 147.2 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.933 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.23 128.9 85.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.338 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.57 ' HA ' HG11 ' A' ' 17' ' ' VAL . 51.9 Cg_exo -52.8 -23.59 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.329 2.019 . . . . 0.0 112.676 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' O ' HD12 ' A' ' 58' ' ' ILE . 9.6 tpt180 -85.54 -22.03 28.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -91.06 -43.45 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.491 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.459 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.59 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.547 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -71.84 -52.86 15.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.17 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 54' ' ' ARG . 64.1 mt -56.52 -27.83 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.316 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -84.88 -52.77 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.824 0.821 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -56.17 -34.24 66.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.592 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.787 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.4 tp -57.41 -59.0 5.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.042 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.569 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 25.1 ptt180 -60.99 -11.84 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 110.504 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -91.69 -43.52 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.886 0.374 . . . . 0.0 111.544 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.3 -25.94 19.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.301 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.787 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.68 -22.01 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.961 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.21 4.55 73.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.972 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.769 ' HB ' HD11 ' A' ' 61' ' ' LEU . 53.2 t -74.46 124.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.785 0.326 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -35.67 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.26 79.08 6.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.749 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 129.55 13.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.6 mm-40 -119.19 147.61 44.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.65 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 48.9 t -77.21 128.93 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.898 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.19 -18.63 7.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.378 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -159.27 162.25 36.07 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.423 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.9 pt-20 -148.83 118.77 7.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.721 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HA ' HG11 ' A' ' 160' ' ' VAL . 17.9 t -58.02 125.34 73.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.273 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.01 -19.8 69.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.739 2.293 . . . . 0.0 113.068 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.587 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.68 -176.74 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.031 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.691 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.4 m95 -108.75 147.1 32.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.023 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.691 HD23 ' C ' ' A' ' 79' ' ' TRP . 4.4 mt -112.29 117.7 33.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.01 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.866 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.9 p -108.65 136.7 47.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.683 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.824 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.0 170.18 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.337 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.03 158.04 40.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.16 150.61 45.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 38.0 m95 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.757 0.313 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -29.47 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.713 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -163.86 -139.39 2.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.307 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 82' ' ' TYR . 77.1 mt-30 -157.53 115.07 3.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.866 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -96.28 112.11 23.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.688 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.2 pt20 -127.29 159.69 33.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -112.51 95.91 5.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.456 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CD2' HG21 ' A' ' 157' ' ' VAL . 40.5 m95 -64.48 141.56 58.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.157 0.503 . . . . 0.0 112.271 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 54.8 m-85 -124.67 133.55 53.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.224 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.8 tp -79.63 131.37 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.553 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.91 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.0 m-85 -127.05 129.38 47.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 111.351 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.897 ' HB3' HD11 ' A' ' 73' ' ' ILE . 11.5 tttt -93.34 120.97 34.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.657 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.7 t80 -63.46 126.93 29.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 0.0 111.014 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 111' ' ' LYS . 18.2 p -129.64 38.15 3.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.58 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.83 -145.05 4.71 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.992 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -128.08 154.14 46.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -50.35 -16.29 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.62 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -79.16 -19.64 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -79.77 -25.07 41.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.77 HG21 ' CE2' ' A' ' 29' ' ' PHE . 18.1 mt -70.81 102.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.374 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.88 96.19 5.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.935 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.802 HD13 ' HB2' ' A' ' 131' ' ' PHE . 34.9 mt -56.67 -24.18 47.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.488 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 129' ' ' PRO . 58.4 mt -61.94 -56.96 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.294 0.568 . . . . 0.0 109.996 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.91 178.84 23.42 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.483 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -90.79 38.93 0.97 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.51 26.92 70.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.123 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -120.62 -70.84 0.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.91 165.2 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -84.35 154.78 63.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.579 ' HG3' HD22 ' A' ' 122' ' ' LEU . 87.9 Cg_exo -45.94 160.48 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.791 2.328 . . . . 0.0 112.722 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.0 mt-10 -150.19 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.802 ' HB2' HD13 ' A' ' 121' ' ' LEU . 1.5 m-85 -107.57 159.51 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.181 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -17.94 5.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.068 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -152.42 175.23 12.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.177 0.513 . . . . 0.0 110.659 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.4 p-90 -156.42 150.43 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.258 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.43 165.64 29.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.349 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 59.9 m95 -99.43 125.44 45.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.784 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -137.97 150.6 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 111.56 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -70.76 158.61 87.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.677 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.647 ' CB ' HD13 ' A' ' 158' ' ' LEU . 11.2 Cg_endo -55.07 -19.1 19.16 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.914 1.743 . . . . 0.0 111.943 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.76 -34.21 15.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.106 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -50.48 27.35 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.954 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -54.01 -29.76 44.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.42 0.629 . . . . 0.0 109.882 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.475 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -69.01 -28.61 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.733 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.55 -20.93 42.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.21 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.8 mt -84.4 -39.35 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.066 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 147' ' ' VAL . 20.3 m -58.2 163.81 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.066 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.906 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 13.6 p -92.59 161.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.06 -26.45 66.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.906 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 22.8 p90 -91.55 12.09 22.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -149.75 12.91 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.568 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.515 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.4 mtpm? -65.15 -62.48 4.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.166 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 11.9 Cg_endo -55.54 -40.86 83.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.478 2.118 . . . . 0.0 112.106 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.824 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.7 t -57.03 -28.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.492 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.5 m-85 -91.42 -52.65 4.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.64 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.475 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.88 -33.56 17.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.586 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.01 -45.58 81.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.553 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 107' ' ' TRP . 43.3 t -58.28 -46.62 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.071 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 139' ' ' PRO . 73.4 mt -64.14 -48.89 74.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.787 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 -46.71 59.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.683 HG11 ' HA ' ' A' ' 76' ' ' VAL . 90.0 t -67.22 -23.13 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 11.2 m-30 -102.96 -1.8 28.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.432 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -49.84 -44.25 77.34 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 38.8 Cg_endo -71.16 -21.54 27.04 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.13 1.887 . . . . 0.0 112.817 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -89.37 -41.91 11.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.699 0.285 . . . . 0.0 110.463 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 161' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.27 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 26.3 m-85 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -86.71 152.5 22.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.265 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.647 HH22 ' HB3' ' A' ' 104' ' ' ALA . 1.9 mmp_? -62.19 128.42 36.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.214 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 11.6 t-20 -152.64 159.42 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.688 HG13 HD11 ' A' ' 47' ' ' ILE . 3.3 m -134.9 140.58 45.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.385 . . . . 0.0 111.222 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 149.54 16.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.932 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -128.38 103.78 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 0.0 111.58 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 20.5 t -89.71 106.33 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.7 tp -103.17 145.06 30.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 111.333 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.5 ptm -130.56 157.39 42.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.518 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.489 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.93 169.78 8.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.011 0.434 . . . . 0.0 111.466 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -51.16 -18.63 0.93 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.615 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.417 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.95 1.42 55.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm 73.38 26.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.649 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttt -99.01 175.14 6.02 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -110.93 126.37 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 111.007 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' HE2' HD13 ' A' ' 119' ' ' ILE . 12.1 t80 -58.43 109.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.26 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -117.02 129.67 56.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.433 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.77 137.89 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.089 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.2 155.99 24.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.782 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.4 mtp85 -71.38 159.83 33.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.617 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.45 -5.64 48.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.916 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -19.29 4.01 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.218 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.623 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 59.7 mt -120.05 112.68 34.65 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.983 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.37 131.73 29.12 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.901 1.734 . . . . 0.0 111.713 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.35 3.3 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.777 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.47 97.21 10.95 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.243 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.622 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.5 m95 -102.47 156.73 17.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.238 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -168.62 169.22 10.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.792 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.3 mtm -92.92 156.17 40.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.33 124.35 11.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.556 2.171 . . . . 0.0 112.695 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.4 ' NE2' ' OH ' ' A' ' 82' ' ' TYR . 1.9 pt20 -154.24 158.43 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.383 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.91 153.5 22.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.799 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.1 137.37 49.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.688 HD11 HG13 ' A' ' 17' ' ' VAL . 7.4 mt -64.57 161.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 110.405 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.3 m-20 -90.04 147.95 23.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.59 98.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.226 0.536 . . . . 0.0 110.807 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.01 36.03 8.63 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.024 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.0 tt0 -116.34 142.31 47.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.48 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.54 142.88 84.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.674 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.57 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.6 Cg_exo -54.44 -48.75 19.78 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.487 2.125 . . . . 0.0 112.566 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -65.55 -26.04 67.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -84.65 -46.92 11.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.656 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -58.29 -31.62 67.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.57 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.678 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.26 -53.54 10.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.177 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 54' ' ' ARG . 47.3 mt -55.9 -30.38 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.104 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -81.83 -53.23 6.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.735 0.779 . . . . 0.0 109.779 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -52.66 -39.04 61.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.451 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.809 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.3 tp -55.59 -57.38 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.041 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.559 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 2.7 ptt-85 -61.44 -12.48 14.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.432 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.69 -42.5 10.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 111.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.41 -25.14 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.229 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.809 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.33 -21.61 8.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.758 0.314 . . . . 0.0 111.069 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.15 5.23 70.57 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.894 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG13 ' HE1' ' A' ' 112' ' ' PHE . 53.4 t -75.08 128.16 36.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 0.0 110.633 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -34.89 8.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.3 81.63 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.46 . . . . 0.0 110.974 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 130.69 14.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.84 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.688 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -119.77 148.21 43.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.983 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.5 t -79.14 122.83 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.339 0.59 . . . . 0.0 111.553 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.866 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -102.85 -20.79 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.27 162.53 40.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.039 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.23 115.97 6.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.011 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.826 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.5 t -57.21 128.46 78.23 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 -10.8 25.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.796 2.331 . . . . 0.0 113.942 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.608 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -131.16 160.8 33.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 112.294 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -88.71 147.11 24.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.867 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.783 ' HB3' HG13 ' A' ' 153' ' ' VAL . 95.9 mt -115.44 117.63 30.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.815 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -114.59 130.83 56.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.757 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.833 ' CE1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -133.46 165.64 24.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -124.86 158.31 33.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.154 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -103.2 155.4 36.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 C--N 1.344 0.329 0 C-N-CA 122.406 2.071 . . . . 0.0 112.266 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 27.7 m95 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -29.89 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.124 0.487 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.74 -143.94 4.27 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.696 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -158.7 124.38 4.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.847 0.356 . . . . 0.0 111.315 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.815 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.73 106.48 17.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -115.9 149.22 39.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.406 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 2.1 mmtp -109.52 96.45 6.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.542 ' CG ' HG21 ' A' ' 157' ' ' VAL . 73.3 m95 -62.65 145.78 53.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 70.1 m-85 -130.95 133.56 45.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.936 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.818 HD13 ' CD2' ' A' ' 161' ' ' PHE . 16.2 tp -79.68 130.88 35.74 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.595 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.932 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.9 m-85 -125.33 127.59 46.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.017 0.437 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.866 ' HB3' HD11 ' A' ' 73' ' ' ILE . 62.8 tttm -92.56 120.75 33.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.7 t80 -62.9 126.21 26.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.688 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.5 p -127.06 37.96 4.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.584 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.59 -145.16 4.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.059 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -128.95 154.24 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 109.984 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.3 -17.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.569 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.85 -22.79 53.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.01 -25.62 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.603 HD13 ' HE2' ' A' ' 29' ' ' PHE . 30.9 mt -68.0 103.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.56 96.06 4.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.041 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 131' ' ' PHE . 44.6 mt -58.72 -20.82 52.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.403 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.928 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -60.25 -57.0 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 179.184 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.3 178.32 19.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.332 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -89.79 38.65 0.92 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.193 0.521 . . . . 0.0 109.714 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.11 29.76 76.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.233 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.0 m -109.34 -64.04 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 111.336 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -115.8 165.11 13.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 152.69 68.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.928 ' HG3' HD13 ' A' ' 122' ' ' LEU . 77.0 Cg_exo -48.84 176.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 0.0 112.668 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -150.14 -44.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.767 ' HB2' HD13 ' A' ' 121' ' ' LEU . 18.6 m-85 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 -18.16 6.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.732 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.2 mm-40 -152.3 175.0 13.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.042 0.448 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.1 p-90 -159.23 152.07 21.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.15 163.39 38.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.362 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.489 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 64.9 m95 -95.98 123.58 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.856 HG11 HD11 ' A' ' 145' ' ' LEU . 33.0 m -133.14 151.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.559 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.1 158.22 87.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.525 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.541 ' HD3' HD11 ' A' ' 28' ' ' ILE . 10.9 Cg_endo -54.44 -19.57 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.0 1.8 . . . . 0.0 112.097 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -92.13 -34.36 14.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.276 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -50.25 46.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.935 0.398 . . . . 0.0 110.152 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.928 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.2 tp -53.21 -34.02 55.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.479 0.657 . . . . 0.0 109.871 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.524 HG21 ' NZ ' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -66.48 -28.61 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.673 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -77.39 -32.59 54.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.654 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.928 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.6 mt -74.64 -40.94 61.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.87 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 150' ' ' LYS . 18.3 m -53.53 164.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.221 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' A' ' 149' ' ' PHE . 7.3 p -97.37 159.82 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -47.24 -43.68 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.465 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 147' ' ' VAL . 39.2 p90 -83.95 7.02 19.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.454 ' O ' HG21 ' A' ' 146' ' ' THR . 25.3 mtmt -128.12 -6.31 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.59 0.234 . . . . 0.0 111.33 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.506 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.7 mtpm? -59.42 -60.63 9.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.592 0.235 . . . . 0.0 111.285 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.0 Cg_endo -61.54 -42.3 34.23 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.047 . . . . 0.0 112.15 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.833 HG11 ' CE1' ' A' ' 82' ' ' TYR . 13.4 t -58.1 -26.69 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.5 -52.61 4.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.505 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.524 ' NZ ' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.75 -30.66 14.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.617 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.7 tp10 -67.98 -44.99 75.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.484 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.542 HG21 ' CG ' ' A' ' 107' ' ' TRP . 48.6 t -59.99 -48.77 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' ALA . 59.2 mt -60.8 -48.95 79.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.971 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.0 m -48.89 -42.9 38.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.831 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.826 HG11 ' HA ' ' A' ' 76' ' ' VAL . 93.7 t -72.76 -24.78 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.03 0.443 . . . . 0.0 110.716 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.818 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.7 m-30 -100.97 -1.51 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.272 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.68 -51.84 27.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.539 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -54.69 -22.02 27.34 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.301 2.0 . . . . 0.0 112.358 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.596 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 90.4 m-70 -96.09 -17.42 20.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.124 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.8 mp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.884 0.374 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -81.48 152.3 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.017 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -66.75 136.31 55.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.523 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 m120 -152.54 156.21 38.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.449 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 m -129.79 121.83 53.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.853 0.359 . . . . 0.0 111.383 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.03 140.18 14.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.814 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -114.2 101.69 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.2 t -90.18 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.2 tp -103.09 147.13 27.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.56 157.14 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.821 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 43.7 p-10 -99.87 172.48 7.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.14 -17.8 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.313 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -0.11 57.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.815 0.341 . . . . 0.0 110.994 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttt 76.93 25.44 0.83 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.599 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.4 mmtp -93.53 175.58 6.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.589 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -113.89 126.4 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 32.8 t80 -58.56 109.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.75 129.89 56.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.349 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.43 138.91 52.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.578 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.5 p -82.04 157.58 24.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.767 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -73.08 158.45 35.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 111.433 -179.478 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.77 -5.54 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.067 178.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -130.87 -17.76 3.11 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.767 HD12 ' CD ' ' A' ' 33' ' ' ARG . 65.9 mt -118.77 112.19 36.99 Favored Pre-proline 0 N--CA 1.455 -0.178 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.951 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.2 131.72 29.39 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.995 1.797 . . . . 0.0 111.889 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 t70 76.62 4.09 3.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.713 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.2 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.412 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 36.9 m95 -102.95 155.46 18.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -169.04 171.63 8.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.753 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.414 ' SD ' HD21 ' A' ' 142' ' ' LEU . 1.9 mpp? -95.85 157.72 35.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.652 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.54 129.47 15.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.58 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.06 153.74 32.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.46 167.95 33.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -80.02 133.17 12.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.559 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.646 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.6 mt -60.12 160.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.487 ' N ' HG22 ' A' ' 47' ' ' ILE . 2.0 m-20 -90.24 149.31 22.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.96 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.22 0.533 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.18 10.25 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.954 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 16.0 tp10 -114.09 145.96 40.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.865 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.11 139.6 79.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.429 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.6 Cg_exo -54.01 -55.07 3.78 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.387 2.058 . . . . 0.0 112.599 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.29 -27.53 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.214 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -82.48 -49.42 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.798 0.332 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.542 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.82 -30.68 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.482 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.788 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.85 -53.45 10.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.16 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 54' ' ' ARG . 53.1 mt -55.78 -29.79 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.116 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -80.69 -53.51 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.786 0.803 . . . . 0.0 109.73 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.97 -33.29 62.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.568 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.769 HD12 ' OG1' ' A' ' 65' ' ' THR . 6.1 tp -56.56 -58.4 8.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.123 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.573 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 9.2 ptt180 -62.12 -11.06 12.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 0.0 110.545 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -91.71 -44.34 9.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.47 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.87 -29.6 17.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.3 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.769 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.93 -21.33 10.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.33 6.69 70.53 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.885 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.747 ' HB ' HD11 ' A' ' 61' ' ' LEU . 52.8 t -75.92 130.84 35.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.327 . . . . 0.0 110.548 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -109.79 -33.01 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 78.78 6.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.164 0.507 . . . . 0.0 110.831 -179.924 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.36 131.29 15.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.846 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.0 pt-20 -119.41 140.37 50.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.239 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.2 t -69.76 116.86 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.292 0.568 . . . . 0.0 111.387 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.797 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -90.91 -24.0 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.774 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.42 168.64 26.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.214 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -148.51 116.26 6.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.236 179.623 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.801 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.2 t -57.33 130.29 80.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 -15.42 35.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.763 2.309 . . . . 0.0 113.626 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.626 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -128.04 170.35 13.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.459 0.647 . . . . 0.0 112.359 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.75 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.8 m95 -96.22 145.99 25.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.978 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 79' ' ' TRP . 2.3 mt -110.24 117.91 34.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.171 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.846 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.0 p -107.7 136.23 47.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.49 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.867 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -127.88 170.11 13.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.466 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.33 158.29 38.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.89 152.09 47.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.798 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.344 0.3 0 C-N-CA 122.597 2.198 . . . . 0.0 112.288 -179.975 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.2 m95 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.794 0.33 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -29.35 60.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.24 -139.13 2.69 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.82 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -157.64 113.92 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.81 0.338 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.846 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.1 105.66 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' NE2' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 pt20 -120.24 150.57 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.329 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.5 mttp -102.77 95.71 6.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.388 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.544 ' CD2' HG21 ' A' ' 157' ' ' VAL . 43.7 m95 -64.33 143.5 57.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.236 -178.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.3 m-85 -128.0 137.69 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.15 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.849 HD13 ' CD2' ' A' ' 161' ' ' PHE . 22.1 tp -79.43 155.18 28.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 21' ' ' LEU . 33.1 m-85 -146.47 131.96 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 111.955 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.637 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -94.73 119.56 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 178.032 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.576 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -67.65 121.44 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.613 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.606 HG21 ' OE1' ' A' ' 71' ' ' GLU . 7.8 p -123.92 37.71 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.565 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.93 -145.31 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.129 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.5 154.24 47.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.49 ' HA ' HD12 ' A' ' 119' ' ' ILE . 6.5 m-20 -49.47 -16.96 0.24 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.603 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -76.33 -21.06 56.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.102 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.56 -25.19 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 116' ' ' ASP . 15.7 mt -69.23 104.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.513 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.671 HD21 HD12 ' A' ' 122' ' ' LEU . 29.4 t-20 -119.96 95.55 4.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.708 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.799 HD13 ' HB2' ' A' ' 131' ' ' PHE . 41.3 mt -58.82 -24.82 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 -179.013 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.671 HD12 HD21 ' A' ' 120' ' ' ASN . 6.4 mt -60.1 -55.04 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.39 178.63 17.22 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.397 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -89.64 38.64 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.212 0.529 . . . . 0.0 109.687 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.93 29.63 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.226 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -107.02 -64.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.84 165.16 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -60.22 151.36 67.8 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.554 ' HG3' HD23 ' A' ' 122' ' ' LEU . 77.6 Cg_exo -49.34 176.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.716 2.277 . . . . 0.0 112.602 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -150.13 -45.24 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.722 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.799 ' HB2' HD13 ' A' ' 121' ' ' LEU . 21.2 m-85 -112.72 159.39 18.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.96 -14.6 6.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.637 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.578 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 10.6 mp0 -152.15 174.22 14.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.019 0.438 . . . . 0.0 110.357 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.0 p-90 -159.65 152.06 21.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.333 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.62 153.93 35.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.306 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.466 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 87.8 m95 -89.95 126.13 35.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.72 HG11 HD11 ' A' ' 145' ' ' LEU . 30.9 m -137.46 150.63 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.666 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -68.23 159.33 80.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.574 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.686 ' CA ' HD13 ' A' ' 158' ' ' LEU . 13.4 Cg_endo -56.72 -18.98 28.79 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 121.816 1.677 . . . . 0.0 111.732 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.5 -34.15 15.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -50.84 25.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.907 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -54.14 -30.66 49.83 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.434 0.635 . . . . 0.0 109.864 179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.552 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.4 mm -68.52 -28.78 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 178.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.39 -20.98 42.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.21 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.2 mt -84.64 -39.24 18.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.072 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 150' ' ' LYS . 11.8 m -58.05 164.27 2.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.715 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 12.7 p -93.01 162.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.787 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.03 -27.6 65.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -179.433 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.715 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 7.9 p90 -93.28 7.6 43.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.605 ' HB2' HG12 ' A' ' 147' ' ' VAL . 3.1 mtmp? -140.25 11.04 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.509 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.7 mtpp -70.54 -62.45 2.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.6 Cg_endo -52.99 -46.74 31.77 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.153 . . . . 0.0 112.121 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.7 t -56.46 -26.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.499 . . . . 0.0 110.959 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.33 -51.43 5.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.656 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.84 -34.84 21.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -64.62 -45.96 84.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.576 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.3 t -57.04 -49.52 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.686 HD13 ' CA ' ' A' ' 139' ' ' PRO . 78.0 mt -62.92 -49.14 75.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.824 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.8 p -50.17 -46.67 54.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.74 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.801 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -69.3 -24.84 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.048 0.452 . . . . 0.0 110.475 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.849 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.3 m-30 -102.27 7.08 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.013 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.67 -53.07 54.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.801 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 8.1 Cg_endo -50.59 -24.83 13.41 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.562 2.175 . . . . 0.0 112.52 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.632 ' ND1' HG22 ' A' ' 73' ' ' ILE . 98.1 m-70 -92.88 -22.38 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.883 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.964 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.103 0.478 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -85.79 152.6 22.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.418 HH21 ' HB3' ' A' ' 104' ' ' ALA . 1.3 mmp_? -73.38 129.31 37.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.8 t-20 -153.26 156.85 39.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.675 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.79 HG13 HD11 ' A' ' 47' ' ' ILE . 4.5 m -127.38 138.04 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.006 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.83 155.13 16.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.877 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -128.52 101.77 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.701 0.286 . . . . 0.0 111.345 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' PHE . 18.8 t -89.7 103.38 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 110' ' ' PHE . 31.4 tp -103.02 145.09 30.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.76 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.8 ptt? -131.42 157.05 44.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.69 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 27' ' ' LYS . 10.4 p-10 -97.43 175.1 6.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -14.2 39.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.243 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.2 0.48 56.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.77 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp 75.63 26.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.513 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.756 ' C ' HD13 ' A' ' 28' ' ' ILE . 12.9 mttp -97.88 172.97 7.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.856 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.01 140.74 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 110.667 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HE2' HD13 ' A' ' 119' ' ' ILE . 11.0 t80 -75.6 109.31 9.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.541 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . . . -116.63 132.79 56.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.85 135.23 54.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.38 155.01 24.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -71.24 159.22 35.02 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 111.506 -179.386 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -93.44 -6.85 46.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.838 178.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.93 -18.92 4.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.09 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.61 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 52.6 mt -119.4 111.65 36.38 Favored Pre-proline 0 N--CA 1.455 -0.213 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.881 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.59 131.27 29.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.995 1.797 . . . . 0.0 111.977 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 77.35 2.37 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.824 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.61 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -85.59 97.22 9.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.654 ' CD1' HD22 ' A' ' 145' ' ' LEU . 51.7 m95 -101.7 154.84 18.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.323 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.31 173.27 6.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -99.26 161.15 25.65 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.03 133.9 24.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.498 2.132 . . . . 0.0 112.759 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 155.8 35.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.35 143.58 9.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.683 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.8 143.43 39.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.534 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.79 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -76.87 160.72 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 47' ' ' ILE . 5.0 m-20 -90.25 177.54 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.125 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.88 99.28 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.39 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.61 47.01 12.94 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.615 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' CG ' ' HB2' ' A' ' 56' ' ' ALA . 5.6 tp10 -110.36 148.55 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.185 0.517 . . . . 0.0 110.949 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.83 126.11 88.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.366 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.622 ' HA ' HG11 ' A' ' 17' ' ' VAL . 53.7 Cg_exo -53.3 -34.59 70.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.385 2.057 . . . . 0.0 112.569 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' O ' HD12 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -76.73 -25.0 53.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.936 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -87.57 -45.53 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.428 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.502 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -59.27 -31.07 68.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.369 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.59 -52.55 13.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.2 mt -56.34 -31.41 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.289 0.566 . . . . 0.0 109.905 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -78.58 -53.6 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.849 178.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -54.88 -36.08 64.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.602 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.774 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.3 tp -56.15 -54.15 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.586 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -62.22 -11.7 16.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.718 179.121 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -91.52 -41.48 10.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 111.477 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -90.25 -31.17 17.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.923 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.693 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -119.62 -23.8 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.339 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 69.74 10.13 63.6 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.647 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.774 ' HB ' HD11 ' A' ' 61' ' ' LEU . 25.5 t -69.3 119.08 14.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.222 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.62 -34.02 12.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.105 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.2 78.49 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.179 0.514 . . . . 0.0 110.962 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.35 131.45 15.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.851 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -119.95 141.9 49.23 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.146 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.8 t -70.87 117.01 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.237 0.541 . . . . 0.0 111.437 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.778 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.1 mt -91.03 -26.11 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.572 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -159.41 169.31 24.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.282 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.6 pt-20 -148.44 112.06 5.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 160' ' ' VAL . 2.5 t -57.65 123.82 64.78 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.965 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.5 -3.96 14.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.801 2.334 . . . . 0.0 114.045 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -131.23 139.45 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.204 0.526 . . . . 0.0 112.131 -179.855 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.458 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 15.2 m95 -75.31 145.06 42.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.693 ' HB3' HG13 ' A' ' 153' ' ' VAL . 89.6 mt -111.2 117.58 33.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.666 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.1 p -108.52 131.74 54.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.751 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.785 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -129.84 166.26 20.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.3 158.34 29.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.098 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.35 153.18 45.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.738 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 0.0 112.384 -179.931 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.2 m95 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -26.99 44.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.447 . . . . 0.0 110.435 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.66 -138.5 2.47 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -158.05 113.76 2.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.666 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -88.22 105.82 17.79 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.73 150.27 52.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 2.7 mttt -97.77 156.5 16.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.47 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.566 ' CD2' HG21 ' A' ' 157' ' ' VAL . 45.2 m95 -120.81 140.32 51.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.02 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.4 m-85 -123.46 131.18 53.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.056 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.875 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.26 135.84 36.88 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.146 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.877 ' CD1' HG23 ' A' ' 19' ' ' ILE . 39.4 m-85 -126.82 131.67 51.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 112.02 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.67 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 3.5 ttmt -93.76 120.18 33.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.374 178.055 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.669 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -68.97 122.43 18.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 69' ' ' SER . 7.4 p -123.96 37.8 4.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.46 -144.74 4.8 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.141 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.56 154.27 47.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -48.96 -17.45 0.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.523 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.23 -24.21 59.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.319 . . . . 0.0 111.027 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.19 -26.24 58.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.488 HD13 ' HE2' ' A' ' 29' ' ' PHE . 29.8 mt -69.14 101.52 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 123' ' ' GLY . 13.2 p-10 -125.28 96.07 4.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.839 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 60.7 mt -55.27 -19.24 7.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.067 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.52 -58.62 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.383 0.611 . . . . 0.0 110.124 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.402 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . 138.64 179.41 17.22 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.311 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -89.61 38.84 0.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.1 28.3 72.68 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.224 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.95 -64.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.7 165.07 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -71.08 152.3 94.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.042 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.16 169.17 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.678 2.252 . . . . 0.0 112.519 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' C ' HD12 ' A' ' 34' ' ' LEU . 20.7 mm-40 -150.07 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.781 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 12.6 m-85 -106.15 159.32 16.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.46 -18.67 5.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.78 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.439 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 9.3 mm-40 -152.17 175.31 12.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 110.398 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.08 154.53 25.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.33 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -151.56 162.5 40.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.301 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 86.8 m95 -98.97 129.37 45.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 145' ' ' LEU . 28.4 m -139.41 156.19 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.964 -179.121 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -73.63 152.98 89.57 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.833 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.2 Cg_endo -49.19 -20.83 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.114 1.876 . . . . 0.0 112.132 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -90.42 -33.82 15.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.437 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -70.09 -50.8 37.28 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 110.22 179.496 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.932 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -51.94 -36.05 47.97 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.515 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.591 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.2 mm -63.08 -29.05 46.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.934 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.53 -22.01 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.116 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.6 mt -84.13 -39.13 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.243 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 150' ' ' LYS . 9.2 m -59.33 165.64 2.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 8.3 p -97.35 159.72 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.05 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.528 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 19.1 mt-10 -52.14 -38.44 57.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.6 p90 -84.34 5.28 27.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 146' ' ' THR . 20.9 mtpp -140.09 9.26 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.528 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.6 mtpp -69.07 -62.77 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.8 Cg_endo -54.33 -39.66 86.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 111.87 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.785 HG11 ' CD1' ' A' ' 82' ' ' TYR . 14.1 t -58.13 -27.02 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 110.799 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.33 -50.66 5.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.375 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.591 ' HD2' HD12 ' A' ' 143' ' ' ILE . 3.6 tttt -51.01 -34.63 30.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.625 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.4 tp10 -63.91 -46.09 86.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.51 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -60.09 -47.28 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.249 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.583 HD13 ' CA ' ' A' ' 139' ' ' PRO . 69.2 mt -63.36 -48.5 77.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.695 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.5 m -48.77 -47.88 41.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.731 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.811 HG21 HG22 ' A' ' 76' ' ' VAL . 74.6 t -67.52 -24.9 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.875 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.2 m-30 -102.25 7.32 40.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.027 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -50.75 -53.05 50.98 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.602 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.8 Cg_endo -50.66 -24.75 13.51 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.545 2.163 . . . . 0.0 112.316 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.677 ' CE1' HG22 ' A' ' 73' ' ' ILE . 98.7 m-70 -89.77 -24.5 21.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.644 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.76 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.878 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.991 0.424 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 6.7 mtp-105 -76.07 152.39 36.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -75.22 133.38 41.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.46 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.1 m120 -152.22 161.9 41.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.801 HG13 HD11 ' A' ' 47' ' ' ILE . 1.9 m -132.24 125.63 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.235 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 138.79 14.13 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.219 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.821 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -111.69 102.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' PHE . 7.6 t -89.68 102.12 14.81 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.09 146.39 28.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 0.0 110.933 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.24 157.2 41.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 12.4 t30 -93.65 173.42 7.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.044 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.97 -16.58 61.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.845 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.41 -0.71 57.69 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 81.77 24.6 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.632 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -93.83 170.48 9.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.3 mp -109.81 121.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.73 ' CD2' HD23 ' A' ' 21' ' ' LEU . 1.7 t80 -54.04 107.56 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.259 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.85 137.72 52.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.746 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.96 141.95 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.17 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.33 158.32 23.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.968 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.584 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.8 mtp-105 -72.71 164.04 27.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 111.723 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.5 mt -97.93 -7.0 31.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.44 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.54 -18.21 3.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.587 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 62.9 mt -121.12 112.42 33.26 Favored Pre-proline 0 N--CA 1.457 -0.094 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.189 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.79 132.62 31.09 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.816 1.677 . . . . 0.0 111.475 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 77.86 3.8 2.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.683 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.587 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.85 97.55 11.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.522 ' CD1' HD22 ' A' ' 145' ' ' LEU . 27.6 m95 -102.28 156.58 17.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.065 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -168.75 -176.68 2.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.703 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 76.3 mtm -107.31 156.59 37.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.12 132.35 27.68 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.56 2.173 . . . . 0.0 112.579 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 157.39 42.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.695 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.51 171.37 34.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.02 135.92 13.58 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.574 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.801 HD11 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -68.6 161.03 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.619 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -83.76 -174.85 5.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.767 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.91 99.57 6.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.281 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.43 50.73 19.72 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.597 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.47 155.23 25.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.096 -179.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -77.87 130.34 73.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.588 ' HA ' HG11 ' A' ' 17' ' ' VAL . 52.0 Cg_exo -54.6 -21.66 25.48 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.389 2.059 . . . . 0.0 112.932 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.1 tpt180 -84.39 -25.44 29.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -88.05 -43.29 11.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.578 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -63.36 -29.87 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.519 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.584 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -74.79 -51.83 13.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 54' ' ' ARG . 61.3 mt -57.32 -29.07 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.237 179.291 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 3.2 ttp-105 -81.85 -53.3 6.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.831 0.824 . . . . 0.0 109.698 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -54.48 -31.83 56.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.84 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.1 tp -58.43 -63.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.565 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 11.7 ptp180 -60.45 -12.14 8.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -92.08 -40.91 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.53 -32.08 16.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.658 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.86 -24.84 7.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.936 0.398 . . . . 0.0 110.899 -179.55 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 82.3 -0.65 88.72 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.063 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.5 t -66.82 121.73 16.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.986 0.393 . . . . 0.0 110.331 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 -33.8 10.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.03 77.48 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.41 129.16 13.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.919 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 7.0 mt-10 -120.39 146.44 46.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.627 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 55.8 t -76.46 125.69 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.49 0.662 . . . . 0.0 111.928 -179.06 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.885 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.44 -17.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.248 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -153.72 159.68 42.06 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.18 111.63 4.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.753 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.5 t -57.58 125.32 71.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.05 -8.15 20.75 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.85 2.366 . . . . 0.0 113.785 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.555 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.54 146.67 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 112.05 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.444 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 16.4 m95 -79.69 145.21 33.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.012 0.434 . . . . 0.0 109.976 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.815 ' HB3' HG13 ' A' ' 153' ' ' VAL . 82.5 mt -111.11 117.55 33.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.733 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.724 HG22 ' CB ' ' A' ' 104' ' ' ALA . 19.3 p -111.74 130.03 55.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.812 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.825 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.56 163.58 26.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 0.0 110.707 179.539 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.68 158.27 35.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.189 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -101.98 155.93 35.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.496 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.309 2.006 . . . . 0.0 112.196 -179.924 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.458 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 56.7 m95 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.821 0.344 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -28.72 62.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.22 -139.18 2.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.092 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -157.63 117.12 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.326 . . . . 0.0 111.343 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.724 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -86.65 110.58 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -130.85 150.19 52.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.717 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.1 mtmt -107.51 102.54 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.443 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CD2' HG21 ' A' ' 157' ' ' VAL . 29.9 m95 -67.9 143.28 55.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.442 ' CD2' ' HD2' ' A' ' 54' ' ' ARG . 61.1 m-85 -125.48 137.77 53.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.035 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.808 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.5 tp -79.36 154.49 28.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.83 ' O ' HD12 ' A' ' 21' ' ' LEU . 44.4 m-85 -148.0 127.54 13.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.564 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.885 ' HB3' HD11 ' A' ' 73' ' ' ILE . 4.7 tptp -92.48 121.65 34.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -65.32 123.46 19.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.955 0.407 . . . . 0.0 110.637 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 111' ' ' LYS . 4.8 p -124.68 37.67 4.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.758 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.4 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.46 -144.88 4.72 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.034 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.29 154.27 47.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.09 -17.35 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.522 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -74.69 -22.18 58.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -26.24 56.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.497 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 25.2 mt -69.97 94.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.325 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -117.92 95.98 5.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.931 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 131' ' ' PHE . 46.0 mt -52.53 -20.04 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.175 -179.124 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.424 HD22 ' HG3' ' A' ' 129' ' ' PRO . 98.0 mt -57.9 -59.09 5.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.378 0.609 . . . . 0.0 109.966 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -178.56 18.53 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.453 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -89.52 38.77 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.58 26.27 71.87 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -103.23 -64.63 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.128 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.29 165.19 12.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -69.29 151.19 97.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.5 ' HB2' HD11 ' A' ' 34' ' ' LEU . 75.5 Cg_exo -48.86 135.85 28.56 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.624 2.216 . . . . 0.0 112.572 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -113.24 -25.87 8.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.6 m-85 -123.17 159.25 29.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.711 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.56 -17.62 5.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.72 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.511 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.36 173.35 15.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 0.0 110.568 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.2 p-90 -160.41 160.56 32.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.426 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -159.3 154.68 25.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.345 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.475 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 87.3 m95 -88.62 127.18 35.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.729 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.691 HG11 HD11 ' A' ' 145' ' ' LEU . 26.9 m -138.52 150.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 111.857 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.3 p -68.5 160.86 74.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.647 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.608 ' CB ' HD13 ' A' ' 158' ' ' LEU . 19.7 Cg_endo -58.66 -17.12 33.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 121.773 1.649 . . . . 0.0 111.801 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.06 -34.18 14.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -51.08 23.86 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.039 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.88 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.2 tp -54.01 -31.73 51.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 109.823 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.64 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -67.17 -28.75 43.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.654 178.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -80.68 -20.7 42.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.18 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.88 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.1 mt -85.77 -39.0 17.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 150' ' ' LYS . 24.2 m -56.48 163.95 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.237 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.672 HG21 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -93.01 160.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.1 mt-10 -49.66 -41.83 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.275 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 147' ' ' VAL . 45.1 p90 -85.36 8.71 17.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.484 ' HB2' HG12 ' A' ' 147' ' ' VAL . 19.0 mttt -129.06 -8.66 4.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.602 0.239 . . . . 0.0 111.31 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.499 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.8 mtpm? -57.7 -59.88 11.64 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.311 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.9 Cg_endo -61.09 -42.46 36.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.369 2.046 . . . . 0.0 112.174 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.825 HG11 ' CD1' ' A' ' 82' ' ' TYR . 16.4 t -60.07 -27.28 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.79 -51.4 5.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.64 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -50.65 -32.27 18.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.418 179.663 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.738 ' HB3' HD11 ' A' ' 80' ' ' LEU . 6.0 tp10 -66.67 -45.73 77.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.529 179.175 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.6 t -58.84 -47.44 89.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.963 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 139' ' ' PRO . 76.4 mt -63.73 -48.6 76.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -50.09 -47.36 53.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.861 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 76' ' ' VAL . 76.0 t -69.54 -25.71 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 110.404 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.808 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.5 m-30 -102.24 9.64 39.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.975 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.32 -57.92 16.22 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.318 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -58.26 -21.88 54.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.475 2.117 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.526 ' ND1' ' HB2' ' A' ' 74' ' ' ALA . 69.2 m80 -89.96 -11.15 42.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.209 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.922 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -82.2 152.24 26.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -70.2 131.43 44.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.985 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.554 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.1 t30 -152.78 155.0 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.797 HG13 HD11 ' A' ' 47' ' ' ILE . 19.2 m -133.11 137.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.103 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.92 131.92 9.37 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.128 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.893 HG21 HD22 ' A' ' 61' ' ' LEU . 4.5 mp -97.43 113.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.811 0.338 . . . . 0.0 111.863 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 110' ' ' PHE . 8.6 t -96.16 103.17 15.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.009 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.5 tp -103.37 149.37 24.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 111.132 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.439 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -133.07 157.27 45.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.672 179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.9 p-10 -98.19 172.31 7.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.614 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -57.82 -17.72 17.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.522 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.81 0.34 56.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 mttm 77.06 25.46 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.515 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.786 ' C ' HD13 ' A' ' 28' ' ' ILE . 7.4 mttp -93.77 174.41 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.867 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.75 138.51 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -179.807 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.813 ' CE2' HG21 ' A' ' 65' ' ' THR . 5.2 t80 -76.68 103.7 6.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.494 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.34 139.86 49.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -124.01 137.86 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.52 154.43 25.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.646 179.878 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.507 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -71.23 157.66 37.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 111.628 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.45 -5.35 49.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.768 178.265 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.6 -19.42 4.57 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.985 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.622 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 56.9 mt -120.62 112.18 34.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.913 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.04 131.42 28.67 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.856 1.704 . . . . 0.0 111.878 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t70 77.15 3.7 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.773 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.622 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.4 10.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.349 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.698 ' CD1' HD22 ' A' ' 145' ' ' LEU . 41.9 m95 -102.41 157.32 17.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.927 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 -176.87 2.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.96 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.569 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 51.7 mtm -106.09 159.51 29.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.67 128.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.504 2.136 . . . . 0.0 112.787 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -150.48 167.42 27.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.37 59.39 0.11 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.864 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . 43.17 -165.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.091 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.797 HD11 HG13 ' A' ' 17' ' ' VAL . 4.5 mt -132.12 159.68 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 110.578 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 47' ' ' ILE . 22.5 m-20 -90.38 149.81 22.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.09 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.99 39.6 11.46 Favored Glycine 0 C--N 1.32 -0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.945 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 9.2 tp10 -109.56 146.25 34.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.165 0.507 . . . . 0.0 110.965 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 128.38 81.91 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.318 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.645 ' HA ' HG11 ' A' ' 17' ' ' VAL . 76.0 Cg_exo -50.58 -25.82 15.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.358 2.039 . . . . 0.0 112.688 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -83.85 -24.0 31.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.91 -43.36 10.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -61.08 -32.1 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.175 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -71.71 -53.38 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.084 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.8 mt -56.64 -28.58 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.442 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -84.21 -53.3 5.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 109.959 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -50.71 -42.91 57.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.326 -1.307 . . . . 0.0 111.223 -179.667 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 19' ' ' ILE . 2.8 tp -57.81 -51.9 67.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.598 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 12.8 ttm-85 -62.87 -13.45 34.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.448 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -38.73 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -87.59 -35.5 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.813 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.1 -22.78 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 111.164 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.48 6.48 76.31 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.86 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.857 ' HB ' HD11 ' A' ' 61' ' ' LEU . 19.2 t -56.71 108.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 110.178 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -34.04 16.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.27 76.13 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.172 0.511 . . . . 0.0 111.054 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.84 13.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.687 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.611 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.1 pt-20 -119.92 141.1 49.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.19 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.7 t -70.61 116.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 111.334 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.732 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -90.72 -25.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.847 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -156.85 169.6 24.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.268 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 11.2 pt-20 -148.59 117.22 6.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.012 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.857 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.5 t -57.05 123.73 61.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.38 -13.45 39.34 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.885 2.39 . . . . 0.0 113.607 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.1 -179.04 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.349 0.595 . . . . 0.0 112.291 -179.417 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.724 ' C ' HD23 ' A' ' 80' ' ' LEU . 21.3 m95 -107.89 147.5 30.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.052 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 79' ' ' TRP . 3.1 mt -112.51 117.81 33.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.044 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.84 HG22 ' CB ' ' A' ' 104' ' ' ALA . 6.4 p -112.34 132.4 55.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.435 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.826 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -127.05 170.15 12.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 158.27 29.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 11.5 m-85 -118.42 142.53 31.53 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 122.394 2.063 . . . . 0.0 112.234 179.87 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 36.3 m95 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.752 0.31 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -30.36 64.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -162.51 -142.85 3.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.975 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -157.01 112.86 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.805 0.336 . . . . 0.0 111.366 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.84 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.66 105.74 17.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.517 ' NE2' ' OH ' ' A' ' 82' ' ' TYR . 21.0 pt20 -120.05 161.97 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -116.14 105.15 12.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.217 178.638 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.47 ' CD2' HG21 ' A' ' 157' ' ' VAL . 60.2 m95 -78.35 144.43 36.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.169 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.0 m-85 -127.83 136.64 51.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.6 tp -79.67 155.04 28.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HD12 ' A' ' 21' ' ' LEU . 29.4 m-85 -145.92 132.44 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.198 0.523 . . . . 0.0 111.967 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.667 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -95.64 118.74 32.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.522 177.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.646 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.9 t80 -68.73 119.74 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.611 HG21 ' OE1' ' A' ' 71' ' ' GLU . 6.3 p -120.84 37.32 4.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.497 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.72 -144.79 4.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.212 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.01 154.26 46.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -49.01 -17.47 0.2 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -74.0 -21.48 59.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.77 -24.77 56.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.414 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 34.1 mt -70.14 105.66 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.443 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -122.93 95.56 4.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.021 179.219 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 131' ' ' PHE . 37.6 mt -55.73 -21.65 19.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.698 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.631 HD22 ' HG3' ' A' ' 129' ' ' PRO . 17.6 mt -64.47 -58.44 6.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.278 0.561 . . . . 0.0 109.898 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.49 -170.41 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.393 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -93.7 38.8 1.06 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.87 75.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.135 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -116.38 -69.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.846 0.355 . . . . 0.0 111.212 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -89.88 165.12 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.69 148.18 54.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.631 ' HG3' HD22 ' A' ' 122' ' ' LEU . 74.2 Cg_exo -50.27 126.62 17.88 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.65 2.233 . . . . 0.0 112.463 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.0 -28.25 9.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.745 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.561 ' HB2' HD13 ' A' ' 121' ' ' LEU . 11.2 m-85 -113.08 159.25 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.476 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.15 -20.79 5.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.711 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.469 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.0 mm-40 -152.27 174.63 13.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.076 0.465 . . . . 0.0 110.47 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 p-90 -159.2 157.55 30.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.165 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -157.59 160.73 38.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.493 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.1 m95 -92.87 127.37 38.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.47 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.738 HG11 HD11 ' A' ' 145' ' ' LEU . 35.7 m -136.15 152.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -72.62 152.51 91.59 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.2 Cg_endo -49.06 -23.26 6.04 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.105 1.87 . . . . 0.0 111.926 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.96 -33.71 19.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -71.5 -50.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.041 179.298 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.933 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.8 tp -54.18 -29.3 45.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.488 0.661 . . . . 0.0 109.817 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.592 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -70.52 -28.39 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.75 178.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.2 -21.84 42.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.14 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.4 mt -82.48 -39.67 22.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.124 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 147' ' ' VAL . 24.9 m -58.78 163.6 3.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.023 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.824 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 12.6 p -92.58 161.42 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.52 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.32 -26.64 68.54 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.112 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.824 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 24.6 p90 -91.11 10.88 25.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 5.7 mtmm -152.75 15.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.658 0.266 . . . . 0.0 111.698 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.52 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.1 mtpp -67.04 -62.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.228 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.1 Cg_endo -50.77 -40.43 56.71 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.536 2.158 . . . . 0.0 112.097 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.826 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.4 t -57.15 -27.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.26 0.552 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.569 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -91.22 -48.47 6.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.372 179.019 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HD2' HD12 ' A' ' 143' ' ' ILE . 3.5 tttt -52.68 -32.28 41.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.581 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 160' ' ' VAL . 2.4 tp10 -66.89 -45.72 77.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.385 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.6 t -59.04 -46.78 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.983 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.546 HD13 ' CA ' ' A' ' 139' ' ' PRO . 74.1 mt -66.55 -48.69 68.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.647 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.9 t -50.24 -47.17 55.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.674 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.857 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.5 t -68.49 -24.56 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.073 0.463 . . . . 0.0 110.349 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.862 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.3 m-30 -103.26 5.69 37.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.212 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.19 -55.36 31.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.609 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.72 -22.51 17.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.577 2.184 . . . . 0.0 112.351 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.847 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 16.3 m-70 -89.97 -22.2 22.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.717 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.694 ' OXT' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.914 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.859 0.361 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 5.6 ttm180 -83.36 152.24 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.131 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -65.21 131.66 47.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.5 m120 -152.52 159.27 43.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.894 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.5 m -132.29 127.68 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.254 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.12 144.38 17.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.162 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.886 HG21 HD22 ' A' ' 61' ' ' LEU . 4.8 mp -120.95 102.11 11.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.8 t -89.71 107.65 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.011 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 110' ' ' PHE . 37.6 tp -103.08 144.8 30.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.014 0.435 . . . . 0.0 111.196 -179.025 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.07 157.48 41.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.747 -179.973 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.9 p-10 -103.89 170.38 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.34 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -55.08 -18.13 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.94 4.48 47.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 179.705 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 4.8 mtpp 70.55 27.86 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mttt -96.73 172.38 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 119' ' ' ILE . 65.9 t80 -57.19 109.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.183 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.62 132.44 56.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.254 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -115.57 138.03 51.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.468 . . . . 0.0 111.509 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.575 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.69 158.5 22.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.543 ' CD ' HD12 ' A' ' 36' ' ' ILE . 2.2 mtp-105 -71.26 164.21 26.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.41 0.624 . . . . 0.0 111.468 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -96.25 -6.06 38.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.69 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -136.17 -14.09 1.8 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 64.5 mt -120.67 111.77 34.36 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.358 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 32.8 Cg_endo -66.38 132.97 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.739 1.626 . . . . 0.0 111.306 179.123 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 79.12 3.18 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.465 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -94.95 97.74 10.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.152 179.281 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.427 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 23.7 m95 -108.78 160.21 16.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.085 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -168.86 170.81 8.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.859 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.453 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 71.0 mtm -97.91 156.71 35.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.67 137.81 39.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 0.0 112.917 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.27 157.02 38.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.378 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.93 153.02 23.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.754 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 132.17 17.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.626 HD11 HG13 ' A' ' 17' ' ' VAL . 6.4 mt -59.88 160.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.761 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 179.796 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.13 98.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.18 0.514 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.73 39.3 10.66 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.941 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HB3' HG23 ' A' ' 47' ' ' ILE . 15.5 tp10 -114.22 146.48 40.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 110.93 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.9 139.82 80.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.494 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.64 ' O ' HG11 ' A' ' 17' ' ' VAL . 52.2 Cg_exo -54.51 -52.55 7.91 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.46 2.107 . . . . 0.0 112.608 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' HD12 ' A' ' 58' ' ' ILE . 7.0 ttt180 -62.9 -25.48 68.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.328 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -84.66 -48.88 9.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.699 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -59.04 -28.31 66.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.772 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -75.54 -50.2 16.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.158 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.418 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.1 mt -57.25 -29.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -82.69 -53.12 6.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.747 0.784 . . . . 0.0 109.956 179.036 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -52.65 -42.33 64.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.471 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -57.11 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.686 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 32.0 ttp180 -61.98 -13.54 26.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.331 178.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.02 -42.73 9.82 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -91.26 -25.66 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.811 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.8 -20.5 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.11 6.67 65.12 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.049 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.657 HG13 ' HE1' ' A' ' 112' ' ' PHE . 46.9 t -71.1 117.19 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.506 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -96.14 -35.73 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.3 78.56 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 111.141 -179.698 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.53 129.43 13.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.931 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.61 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.76 148.96 42.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.06 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.8 t -79.56 123.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.422 0.629 . . . . 0.0 111.495 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.872 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -106.12 -20.17 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.398 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -154.55 159.35 40.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.435 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.2 pt-20 -148.66 117.11 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.989 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.842 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.0 t -57.26 126.76 75.13 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.065 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.94 -19.78 69.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.754 2.302 . . . . 0.0 113.228 -179.092 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.598 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.45 -177.98 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.049 -179.518 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.699 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.0 m95 -108.48 146.73 32.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.798 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.699 HD23 ' C ' ' A' ' 79' ' ' TRP . 3.4 mt -111.71 117.61 33.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.014 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.832 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.0 p -111.57 131.89 54.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.946 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.835 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -133.75 163.88 28.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.68 179.824 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -122.23 158.25 29.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.65 150.41 42.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo . . . . . 0 C--N 1.345 0.353 0 C-N-CA 122.553 2.169 . . . . 0.0 112.443 179.98 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 69.2 m95 . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.791 0.329 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -31.15 67.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -160.32 -143.03 3.54 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.005 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -157.61 114.47 2.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.878 0.37 . . . . 0.0 111.498 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.832 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -94.51 105.78 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -127.81 156.6 42.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.08 97.91 7.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 178.862 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 28.0 m95 -65.72 141.95 58.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 0.0 112.134 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 62.0 m-85 -125.6 137.24 53.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.316 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.3 tp -79.54 146.14 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.88 ' CD1' HG23 ' A' ' 19' ' ' ILE . 40.0 m-85 -139.11 127.88 23.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.008 0.432 . . . . 0.0 111.651 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.872 ' HB3' HD11 ' A' ' 73' ' ' ILE . 15.3 tttm -92.02 120.44 32.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.522 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.657 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.5 t80 -64.89 125.53 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.798 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.1 p -126.54 37.73 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -139.89 -144.86 4.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.236 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -127.15 154.27 44.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.917 0.389 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -49.75 -16.67 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.642 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.97 -18.16 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.266 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.06 -25.36 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 29' ' ' PHE . 17.7 mt -74.2 103.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.49 -179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -117.61 95.89 5.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 131' ' ' PHE . 47.2 mt -55.2 -23.32 21.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.64 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.417 HD22 ' HG3' ' A' ' 129' ' ' PRO . 29.0 mt -62.37 -57.4 11.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.285 0.564 . . . . 0.0 110.065 179.3 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.03 25.0 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.51 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.27 38.84 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 109.89 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.05 27.79 73.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.222 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.5 t -110.49 -65.97 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.837 0.351 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.57 165.06 11.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 149.9 97.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HG3' HD22 ' A' ' 122' ' ' LEU . 69.3 Cg_exo -50.0 177.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.732 2.288 . . . . 0.0 112.612 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -150.07 -45.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.552 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.819 ' HB2' HD13 ' A' ' 121' ' ' LEU . 18.9 m-85 -107.41 159.74 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.331 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.12 -16.9 6.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.803 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.575 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.47 174.7 13.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.12 0.486 . . . . 0.0 110.705 -179.816 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.5 p-90 -159.51 153.67 23.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.08 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.06 161.62 42.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.41 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -94.95 123.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.766 HG11 HD11 ' A' ' 145' ' ' LEU . 27.3 m -135.39 151.05 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.071 0.463 . . . . 0.0 111.641 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.85 159.23 86.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.687 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.7 Cg_endo -55.51 -19.38 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.935 1.756 . . . . 0.0 111.873 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.26 -34.25 15.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.48 -50.48 25.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.989 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.924 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.3 tp -54.01 -29.95 45.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.489 0.661 . . . . 0.0 109.915 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.601 HD12 ' HD2' ' A' ' 155' ' ' LYS . 2.9 mm -68.15 -29.15 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.582 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.6 -22.15 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.6 mt -84.41 -39.24 19.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.005 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 150' ' ' LYS . 4.8 m -58.63 168.56 1.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.3 p -104.64 159.92 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.047 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 147' ' ' VAL . 2.7 mm-40 -45.44 -46.17 13.35 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 147' ' ' VAL . 1.5 p90 -76.8 -1.89 30.47 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.507 ' O ' HG21 ' A' ' 146' ' ' THR . 1.8 mtmp? -125.73 1.57 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.579 0.228 . . . . 0.0 111.528 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.3 mttt -65.36 -62.55 4.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.342 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.03 -42.44 44.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.419 2.08 . . . . 0.0 112.239 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.835 HG11 ' CD1' ' A' ' 82' ' ' TYR . 13.4 t -59.16 -29.07 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.273 0.558 . . . . 0.0 110.966 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.78 -50.97 5.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.692 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -49.78 -35.01 21.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.669 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -66.58 -44.81 81.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.642 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 153' ' ' VAL . 44.2 t -57.76 -46.51 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.084 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.687 HD13 ' CA ' ' A' ' 139' ' ' PRO . 74.3 mt -66.27 -48.87 69.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.9 m -50.02 -47.17 53.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.1 t -68.39 -25.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.067 0.46 . . . . 0.0 110.307 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.8 12.0 33.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.981 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' A' ' 163' ' ' PRO . . . -53.98 -59.47 9.78 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.404 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -56.31 -21.53 37.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.586 2.191 . . . . 0.0 112.268 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.419 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 62.6 m-70 -89.95 -12.67 38.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.971 179.769 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.809 0.338 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HD3' ' CE2' ' A' ' 100' ' ' TRP . 2.1 ttp85 -92.48 152.38 19.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -62.12 132.55 53.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.425 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 19.1 t-20 -152.73 154.53 35.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.358 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.818 HG13 HD11 ' A' ' 47' ' ' ILE . 2.3 m -126.3 131.49 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 111.388 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.81 148.3 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.033 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.927 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -123.06 102.43 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.761 0.315 . . . . 0.0 111.397 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.2 t -89.48 104.69 17.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.859 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -102.59 145.3 29.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.0 0.429 . . . . 0.0 111.105 -178.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.2 ptm -127.65 157.26 40.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.2 p-10 -106.31 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -54.05 -18.33 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -88.86 3.94 49.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 179.803 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 20.7 mmtm 70.47 27.38 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.577 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' MET . 11.4 mmtm -96.38 175.32 6.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.594 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -113.65 119.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.956 0.408 . . . . 0.0 110.809 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 119' ' ' ILE . 18.8 t80 -52.46 110.29 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.74 133.6 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.412 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.89 139.1 52.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.9 p -82.3 155.78 24.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.685 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.737 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtt85 -72.01 158.09 36.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.5 mt -91.77 -5.66 53.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.019 178.547 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.79 -18.18 3.48 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.737 HD12 ' CD ' ' A' ' 33' ' ' ARG . 61.7 mt -118.78 111.84 37.24 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.7 131.24 28.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.981 1.787 . . . . 0.0 111.968 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 77.08 3.26 3.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.856 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.23 97.56 10.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.406 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.671 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.6 m95 -101.59 155.87 17.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.221 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -168.85 -176.92 2.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.651 179.724 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.467 ' SD ' HD21 ' A' ' 142' ' ' LEU . 3.4 mpp? -107.17 158.18 33.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 128.88 19.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.603 2.202 . . . . 0.0 112.417 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -154.03 157.09 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.76 139.24 5.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.571 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.31 137.48 49.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.818 HD11 HG13 ' A' ' 17' ' ' VAL . 9.2 mt -69.22 162.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.632 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -75.93 -172.16 1.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.613 179.614 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -90.14 27.45 1.63 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.24 0.543 . . . . 0.0 111.145 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.91 48.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 56' ' ' ALA . 5.4 tp10 -124.33 149.61 46.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 110.929 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -77.76 137.73 62.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.1 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.698 ' O ' HG11 ' A' ' 17' ' ' VAL . 77.5 Cg_exo -50.68 -55.18 4.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.363 2.042 . . . . 0.0 112.763 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.56 ' HD3' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.42 -31.55 67.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.316 -179.731 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -80.07 -49.73 11.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.733 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.577 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -56.69 -30.6 63.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.497 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.746 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.46 -52.59 13.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.56 HD11 ' HD3' ' A' ' 54' ' ' ARG . 41.2 mt -56.41 -29.85 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.23 179.079 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -81.67 -53.15 6.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.762 0.791 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -52.08 -45.71 64.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.597 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.915 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -56.0 -56.16 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.811 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 40.1 ttp180 -60.56 -14.48 20.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.298 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -92.07 -41.35 10.56 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.897 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -91.5 -25.04 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.5 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.837 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.31 -20.06 9.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.086 -179.31 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.24 6.24 64.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.051 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.629 HG13 ' HE1' ' A' ' 112' ' ' PHE . 48.4 t -71.18 123.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.865 0.333 . . . . 0.0 110.469 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -34.12 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.24 76.77 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.987 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.26 129.01 13.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.873 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 12.0 mt-10 -120.39 148.5 43.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.765 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 110' ' ' PHE . 38.9 t -78.15 125.39 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.456 0.646 . . . . 0.0 111.694 -179.332 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.28 -21.62 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.237 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 3.4 pt-20 -148.52 115.85 6.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.011 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.828 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.8 t -57.31 130.17 80.36 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.066 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 -15.96 40.07 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.721 2.281 . . . . 0.0 113.6 -178.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.553 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.65 -176.05 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.417 0.627 . . . . 0.0 112.48 -179.369 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.69 ' C ' HD23 ' A' ' 80' ' ' LEU . 25.6 m95 -106.27 147.48 29.09 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.279 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.69 HD23 ' C ' ' A' ' 79' ' ' TRP . 5.5 mt -114.47 117.94 32.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.996 179.22 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.86 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -111.04 135.07 52.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.435 -179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.899 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -122.71 170.26 10.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.683 -179.355 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.21 158.23 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -117.63 152.51 49.79 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.309 179.96 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.429 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 56.9 m95 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.519 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -85.72 -23.02 27.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -174.7 -137.58 2.51 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.048 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 90.0 mm-40 -157.3 113.85 2.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.886 0.374 . . . . 0.0 111.346 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.86 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -88.0 105.63 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.3 pt20 -121.64 157.06 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -112.15 95.72 5.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.198 178.569 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.644 ' CD2' HG21 ' A' ' 157' ' ' VAL . 24.2 m95 -64.12 150.5 45.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.308 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CE2' ' CG ' ' A' ' 54' ' ' ARG . 64.9 m-85 -133.15 133.29 42.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.284 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.834 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.6 tp -79.81 130.23 35.14 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.927 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.9 m-85 -124.49 129.13 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.505 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.844 ' HB3' HD11 ' A' ' 73' ' ' ILE . 5.1 tptt -92.38 123.06 35.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -67.2 124.48 23.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.694 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' SER . 17.6 p -126.73 37.87 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.747 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.2 -145.13 4.79 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.031 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -128.54 154.13 46.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.55 ' HA ' HD12 ' A' ' 119' ' ' ILE . 10.6 m-20 -50.25 -16.25 0.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.67 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -18.36 54.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.744 0.307 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.12 -25.0 40.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 116' ' ' ASP . 8.6 mt -72.09 103.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.501 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.5 95.61 5.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 131' ' ' PHE . 43.8 mt -56.69 -23.15 39.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.54 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 mt -61.85 -56.77 15.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.25 0.548 . . . . 0.0 109.997 179.233 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.38 -178.47 22.3 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.552 179.719 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -90.72 38.74 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.1 0.476 . . . . 0.0 109.843 179.208 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.23 73.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -112.76 -67.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 111.19 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -105.54 165.04 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.235 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.54 150.75 95.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' LEU . 59.9 Cg_exo -50.43 138.77 38.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.654 2.236 . . . . 0.0 112.506 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -112.4 -31.48 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.724 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.539 ' HB2' HD13 ' A' ' 121' ' ' LEU . 7.2 m-85 -118.02 159.56 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.03 -20.07 5.37 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.879 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.435 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.5 mm-40 -152.23 174.66 13.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.248 0.547 . . . . 0.0 110.599 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 p-90 -159.2 154.11 24.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.178 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -93.05 125.31 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 142' ' ' LEU . 28.9 m -137.63 150.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.116 0.484 . . . . 0.0 111.619 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -69.54 159.83 82.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.472 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.641 ' CB ' HD13 ' A' ' 158' ' ' LEU . 14.0 Cg_endo -56.69 -18.89 28.21 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.796 1.664 . . . . 0.0 111.838 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.12 -34.2 15.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.054 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -50.9 22.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.112 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.1 tp -54.22 -30.28 49.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.393 0.616 . . . . 0.0 109.826 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 143' ' ' ILE . 5.1 mm -68.97 -28.31 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.717 178.703 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 -17.53 47.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.367 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.0 mt -87.53 -38.8 15.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.186 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 147' ' ' VAL . 67.6 m -59.51 162.26 5.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.046 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.962 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 10.1 p -91.62 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.8 mt-10 -51.66 -33.18 32.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.039 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.962 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.3 p90 -87.53 10.9 16.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 8.6 mtmm -136.74 -2.24 2.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 30.1 mttt -55.76 -61.81 5.67 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.201 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.3 Cg_endo -59.6 -45.84 23.66 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.377 2.051 . . . . 0.0 112.122 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.899 HG21 ' HB3' ' A' ' 82' ' ' TYR . 39.5 t -56.06 -27.79 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.227 0.537 . . . . 0.0 111.066 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.8 m-30 -91.55 -53.71 4.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.4 ' CD ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.76 -32.63 14.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 110.522 179.87 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.2 -45.56 80.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.498 179.148 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -57.9 -50.38 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.123 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.641 HD13 ' CB ' ' A' ' 139' ' ' PRO . 74.7 mt -61.68 -48.89 78.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.698 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 t -49.71 -47.53 50.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.664 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.0 t -67.84 -25.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.461 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.834 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.6 m-30 -102.1 7.88 40.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.156 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.64 -57.0 17.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.258 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.4 Cg_endo -56.76 -22.39 44.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.503 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 71.6 m80 -89.97 -14.37 34.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.025 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.894 179.829 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.008 0.432 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.468 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 2.1 ptm85 -73.79 143.52 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.401 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 38.5 mtm180 -67.02 133.17 49.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.399 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.3 t-20 -152.55 155.96 38.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.738 HG13 HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -123.87 130.0 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.216 179.786 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.18 146.38 18.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.126 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.906 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.4 mp -124.56 102.03 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.9 t -89.57 101.82 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -103.03 143.3 32.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 0.0 111.229 -178.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.86 157.41 39.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.751 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.2 p-10 -100.71 170.05 8.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.232 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -56.27 -16.67 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.56 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.98 0.11 56.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.688 0.28 . . . . 0.0 110.973 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mttm 77.21 26.71 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.602 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -98.93 173.27 6.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.916 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.537 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.23 122.97 66.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.746 ' CE1' HG21 ' A' ' 119' ' ' ILE . 66.7 t80 -56.5 110.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.8 129.88 56.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.236 179.348 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.11 137.54 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.62 157.61 23.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.55 179.761 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.56 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -72.94 159.51 33.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.15 -5.65 49.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.996 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.49 -16.81 3.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.621 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.5 mt -119.65 111.97 35.75 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.24 131.82 29.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.904 1.736 . . . . 0.0 111.8 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 76.92 3.52 3.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.783 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.67 97.51 11.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.414 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.424 ' CD1' HD22 ' A' ' 145' ' ' LEU . 37.7 m95 -104.62 156.65 17.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.044 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -168.8 169.56 9.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.451 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 45.9 mtm -94.15 155.83 39.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.45 134.11 37.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.512 2.142 . . . . 0.0 112.687 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 163.54 39.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.493 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.45 142.73 7.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.746 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.84 135.61 49.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.59 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.738 HD11 HG13 ' A' ' 17' ' ' VAL . 5.5 mt -66.84 160.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.55 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.494 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.17 149.35 22.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.824 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -50.73 99.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.219 0.533 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.57 39.83 11.76 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.851 -179.513 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 6.0 tp10 -113.76 145.18 41.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.91 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 m-20 -74.43 125.56 89.7 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.236 179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.591 ' O ' HG11 ' A' ' 17' ' ' VAL . 6.6 Cg_endo -50.16 -47.97 21.77 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.46 2.106 . . . . 0.0 112.772 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.634 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -59.31 -27.73 66.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.725 0.298 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -88.01 -43.44 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.78 -32.18 71.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.174 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.11 -54.06 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.034 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -55.79 -29.53 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.278 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttp85 -82.69 -52.79 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.798 0.808 . . . . 0.0 109.981 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.92 -44.1 66.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.575 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.787 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.3 tp -56.97 -55.39 35.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.676 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 33.7 ttp180 -62.28 -13.3 26.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.283 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.12 -43.25 9.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.827 -179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.18 -25.85 19.35 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.787 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -116.77 -20.35 9.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.451 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.88 4.69 67.58 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.103 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.672 HG13 ' HE1' ' A' ' 112' ' ' PHE . 47.4 t -69.86 116.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.834 0.35 . . . . 0.0 110.529 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.65 -34.5 11.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -179.773 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.38 78.4 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.48 129.04 13.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.871 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.613 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.68 149.02 42.12 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.56 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.634 HG11 ' CZ ' ' A' ' 54' ' ' ARG . 30.6 t -80.06 122.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.4 0.619 . . . . 0.0 111.355 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.901 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -103.03 -20.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.414 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.94 161.0 40.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.68 117.48 6.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.877 179.652 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.864 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.4 t -57.16 128.78 78.59 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.22 -18.18 55.54 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 113.337 -178.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.641 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -125.6 -179.16 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 112.111 -179.505 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.431 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 6.2 m95 -108.45 145.94 33.89 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.706 HD21 ' HG2' ' A' ' 156' ' ' GLU . 66.5 mt -110.66 117.3 33.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.106 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.864 HG22 ' CB ' ' A' ' 104' ' ' ALA . 17.4 p -101.63 137.49 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.762 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.724 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -131.85 169.78 15.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 -179.417 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.91 158.42 36.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -116.32 145.04 34.2 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 112.323 -179.954 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.468 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 19.0 m95 . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' H ' ' HE3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -81.72 -29.23 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.634 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -155.96 -146.19 4.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.279 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -158.17 129.95 6.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.914 0.388 . . . . 0.0 111.777 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.864 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -111.71 106.84 15.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.889 178.503 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.461 ' NE2' ' OD1' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -122.06 161.59 22.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.606 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -113.85 101.66 9.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.021 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.54 ' CD2' HG21 ' A' ' 157' ' ' VAL . 33.8 m95 -70.36 153.15 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 0.0 112.401 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 73.3 m-85 -137.08 134.12 36.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.199 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.826 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.88 130.97 35.73 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.424 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.906 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.3 m-85 -125.55 128.43 47.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.581 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.901 ' HB3' HD11 ' A' ' 73' ' ' ILE . 1.9 tptt -92.25 121.18 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.783 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.672 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -64.86 124.88 23.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.984 0.421 . . . . 0.0 110.816 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.613 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.2 p -125.66 37.51 4.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.602 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -139.12 -145.18 4.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.13 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -128.09 154.24 45.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.829 0.347 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -50.03 -16.52 0.3 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.62 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -18.35 54.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.682 0.277 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.34 -25.29 39.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.746 HG21 ' CE1' ' A' ' 29' ' ' PHE . 16.1 mt -72.35 97.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.361 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -111.42 95.71 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.078 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 131' ' ' PHE . 66.8 mt -55.42 -23.06 22.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.667 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.75 -58.11 8.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.299 0.571 . . . . 0.0 110.001 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.51 -176.85 25.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.554 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.44 38.79 1.02 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 179.153 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.34 28.18 73.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.169 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -112.18 -65.98 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.04 165.13 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.241 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -66.78 151.87 96.2 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.42 176.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.04 -44.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.681 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 121' ' ' LEU . 23.0 m-85 -109.44 159.53 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.392 179.644 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.83 -19.19 6.12 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 21.3 mm-40 -152.46 174.69 13.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.455 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 23.7 p-90 -158.38 151.72 23.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.145 179.064 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.2 m -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.386 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -93.32 123.47 36.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.666 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 145' ' ' LEU . 31.6 m -134.05 151.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.111 0.482 . . . . 0.0 111.716 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.6 p -70.23 158.34 87.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.537 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.02 -19.1 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.978 1.786 . . . . 0.0 112.046 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.01 -33.46 14.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 179.207 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -50.05 35.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.107 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.896 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -53.34 -31.93 46.7 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.437 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.35 -29.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.683 178.566 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -32.07 57.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.1 mt -75.47 -40.47 57.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.008 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 150' ' ' LYS . 16.8 m -55.4 165.07 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.141 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.3 p -98.9 160.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.221 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.4 mm-40 -47.34 -43.35 22.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.43 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 12.7 p90 -82.66 4.12 26.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.272 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 16.1 mttt -125.25 -3.29 7.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 111.368 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 35.5 mttt -59.95 -61.87 7.03 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.0 Cg_endo -61.08 -43.29 30.58 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.456 2.104 . . . . 0.0 112.403 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.724 HG21 ' HB3' ' A' ' 82' ' ' TYR . 15.4 t -57.23 -29.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.08 -55.25 3.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.8 -32.59 6.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.706 ' HG2' HD21 ' A' ' 80' ' ' LEU . 3.1 tp10 -69.73 -44.19 70.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.785 179.407 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.5 t -59.57 -42.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.136 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 162' ' ' ALA . 51.3 mt -67.46 -48.1 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.619 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -50.58 -46.84 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.807 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.864 HG11 ' HA ' ' A' ' 76' ' ' VAL . 87.7 t -68.08 -24.54 30.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.123 0.487 . . . . 0.0 110.411 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.826 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -102.61 6.05 39.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.117 -179.178 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -50.97 -49.9 77.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.532 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 75.0 Cg_exo -49.73 -25.21 11.09 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.565 2.176 . . . . 0.0 112.559 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.726 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 96.7 m-70 -94.68 -26.71 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.96 0.41 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 4.1 ptm85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -67.32 130.33 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.47 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.8 m120 -152.68 159.63 43.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.731 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.5 m -133.61 131.32 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.257 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.34 144.7 16.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.298 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.866 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.3 mp -120.5 101.81 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.172 -179.809 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.2 t -89.54 107.21 18.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.228 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 110' ' ' PHE . 45.9 tp -103.42 141.86 35.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.097 -179.073 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.49 157.46 40.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.1 p-10 -101.02 171.04 7.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.331 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.13 -17.62 7.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.586 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.07 0.26 56.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.733 0.302 . . . . 0.0 110.971 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp 77.0 26.21 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.5 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.21 172.11 8.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.965 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.589 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -110.91 121.32 63.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.367 . . . . 0.0 110.937 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CE2' HG21 ' A' ' 119' ' ' ILE . 37.0 t80 -56.06 109.4 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.233 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.7 130.01 56.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.36 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.29 136.1 53.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.414 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -82.29 155.39 24.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.416 179.637 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.624 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -72.12 157.29 38.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.355 0.597 . . . . 0.0 111.732 -179.223 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.43 -6.44 49.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.828 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.53 -18.26 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.216 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 61.7 mt -119.6 110.92 36.64 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 28.5 Cg_endo -65.17 131.83 29.8 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.816 1.677 . . . . 0.0 111.73 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 t70 77.11 5.46 3.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.642 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -92.82 97.84 11.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.5 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.53 ' CD1' HD22 ' A' ' 145' ' ' LEU . 19.2 m95 -107.0 156.4 18.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -168.8 176.69 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.498 ' HE2' ' CZ3' ' A' ' 107' ' ' TRP . 2.2 mpp? -101.3 160.44 26.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.34 136.95 24.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.571 2.181 . . . . 0.0 112.786 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 155.77 35.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.14 155.6 26.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.675 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.88 132.82 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.635 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -60.23 161.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.644 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.485 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.25 149.33 22.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.91 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.44 98.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.194 0.521 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.51 10.0 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.947 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 6.1 tp10 -114.38 146.27 40.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.16 140.05 76.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.511 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.578 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.2 Cg_exo -53.24 -52.43 8.74 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.383 2.055 . . . . 0.0 112.575 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' O ' HD12 ' A' ' 58' ' ' ILE . 2.2 tmm_? -62.56 -25.62 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.156 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.64 -50.02 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.676 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.53 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.25 -31.97 67.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.504 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.24 -52.0 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.1 mt -57.24 -28.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.213 179.22 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -84.0 -53.18 5.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.749 0.785 . . . . 0.0 109.777 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.56 -32.7 58.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.29 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.874 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.0 tp -55.73 -54.79 40.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.605 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -61.67 -13.0 18.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.911 0.386 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.64 -37.92 12.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 0.0 111.395 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.7 -36.42 17.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.955 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.506 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.07 -23.46 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.1 3.05 84.48 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.81 -179.579 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.874 ' HB ' HD11 ' A' ' 61' ' ' LEU . 39.0 t -61.95 115.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.821 0.343 . . . . 0.0 110.461 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -91.83 -36.95 13.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.18 78.98 6.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 110.979 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 129.56 13.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.845 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -120.04 147.76 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.859 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.4 t -78.22 125.03 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.405 0.621 . . . . 0.0 111.858 -179.141 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.895 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -107.0 -19.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.362 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.722 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -152.03 158.26 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.327 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -148.56 116.75 6.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.995 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.888 ' HA ' HG11 ' A' ' 160' ' ' VAL . 10.9 t -57.26 130.79 80.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.094 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -17.66 40.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.647 2.231 . . . . 0.0 113.316 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.624 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.35 177.08 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 112.15 -179.497 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.463 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 m95 -104.32 146.05 29.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.976 179.067 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.914 ' HB3' HG13 ' A' ' 153' ' ' VAL . 94.8 mt -113.19 117.56 32.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.798 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.5 p -111.19 131.9 54.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.864 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -132.69 162.81 30.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.616 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.22 158.38 24.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.47 154.44 47.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.493 2.129 . . . . 0.0 112.528 -179.97 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 51.8 m95 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -31.31 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -156.22 -144.66 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.991 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.09 114.95 2.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.347 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.798 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -92.74 105.97 18.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.874 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -127.32 155.59 43.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 112.539 -178.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -109.26 96.34 6.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.633 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.498 ' CZ3' ' HE2' ' A' ' 42' ' ' MET . 23.2 m95 -63.7 145.68 55.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.106 -178.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 59.2 m-85 -128.16 137.05 51.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.428 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.79 HD13 ' CD2' ' A' ' 161' ' ' PHE . 19.4 tp -79.71 146.95 32.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.4 m-85 -140.77 127.05 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.978 0.418 . . . . 0.0 111.545 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.895 ' HB3' HD11 ' A' ' 73' ' ' ILE . 14.5 tttm -90.47 121.06 32.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -65.41 125.17 24.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 111' ' ' LYS . 10.0 p -127.77 38.14 4.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.549 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -137.77 -145.47 4.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.153 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.23 154.05 45.33 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -50.5 -16.08 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.7 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -79.74 -19.11 49.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.767 0.318 . . . . 0.0 111.307 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -78.74 -25.28 44.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.824 HG21 ' CE2' ' A' ' 29' ' ' PHE . 16.5 mt -74.78 103.48 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.378 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -113.77 95.51 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.918 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 131' ' ' PHE . 31.8 mt -49.82 -26.28 3.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.732 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.539 HD22 ' HG3' ' A' ' 129' ' ' PRO . 34.0 mt -63.5 -57.48 10.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 109.982 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.63 -173.49 25.98 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.42 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -93.44 38.86 1.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.19 0.519 . . . . 0.0 109.993 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.89 27.51 73.04 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.267 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -115.13 -68.17 0.94 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.09 165.01 13.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -78.84 153.88 77.99 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.956 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.539 ' HG3' HD22 ' A' ' 122' ' ' LEU . 87.5 Cg_exo -46.18 162.52 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.836 2.358 . . . . 0.0 112.554 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -149.95 -44.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HB2' HD13 ' A' ' 121' ' ' LEU . 20.7 m-85 -106.47 159.12 16.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.94 -20.36 4.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.696 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.413 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.3 mm-40 -152.42 174.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.456 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.6 p-90 -159.17 156.19 28.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.151 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.96 164.2 38.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.401 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 69.0 m95 -94.44 124.95 38.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.672 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 142' ' ' LEU . 29.7 m -138.21 151.49 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.057 0.456 . . . . 0.0 111.626 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -70.2 159.97 82.55 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.677 ' CA ' HD13 ' A' ' 158' ' ' LEU . 14.6 Cg_endo -57.15 -17.88 27.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.775 1.65 . . . . 0.0 111.786 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -34.43 15.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.154 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -50.78 25.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 109.97 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.5 tp -54.39 -28.96 47.07 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.387 0.613 . . . . 0.0 109.858 179.079 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.574 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm -69.45 -28.73 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.812 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.26 -20.04 45.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.271 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.0 mt -86.32 -39.07 16.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -62.22 166.09 5.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.104 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.978 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.3 p -98.41 161.57 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.023 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -52.21 -33.37 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.98 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.978 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.8 p90 -86.48 16.0 4.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.937 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 149' ' ' PHE . 2.4 mtpm? -143.93 -26.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.064 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.9 mtpt -43.38 -61.61 1.77 Allowed Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.653 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.2 Cg_endo -59.42 -44.36 33.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.265 1.976 . . . . 0.0 111.822 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.914 HG13 ' HB3' ' A' ' 80' ' ' LEU . 17.1 t -60.01 -24.99 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.804 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.8 m-30 -90.85 -50.92 5.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.594 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.574 ' HD2' HD12 ' A' ' 143' ' ' ILE . 2.7 tttt -48.9 -36.63 17.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.726 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.0 tp10 -64.92 -45.4 86.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.451 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 153' ' ' VAL . 37.8 t -58.81 -43.02 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.123 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.677 HD13 ' CA ' ' A' ' 139' ' ' PRO . 53.4 mt -69.09 -49.22 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.623 178.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -50.35 -46.78 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.718 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.888 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.9 t -67.54 -24.87 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.426 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.79 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -102.26 2.36 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.244 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.567 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.79 -56.07 24.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.406 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.9 -21.22 25.45 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.602 2.201 . . . . 0.0 112.391 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.722 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 9.4 m80 -89.64 -20.02 24.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.748 0.309 . . . . 0.0 110.816 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.87 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.13 152.27 24.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -66.03 132.75 49.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.113 0.483 . . . . 0.0 111.502 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.8 t30 -152.49 158.49 42.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.744 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.1 m -132.2 133.34 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 111.68 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.15 153.61 17.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.938 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.9 HG21 HD22 ' A' ' 61' ' ' LEU . 4.1 mp -127.08 103.37 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.323 . . . . 0.0 111.488 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.6 t -89.7 104.07 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.0 tp -103.24 145.28 30.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.211 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.94 157.53 39.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.719 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.7 p-10 -101.55 170.57 8.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.06 -18.23 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.466 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.0 0.58 56.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.714 0.292 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt 76.03 26.12 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.485 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mttt -96.64 171.24 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.514 HD12 ' O ' ' A' ' 137' ' ' VAL . 4.1 mp -108.16 124.14 64.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.948 0.404 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CE1' HG21 ' A' ' 119' ' ' ILE . 67.6 t80 -58.53 110.16 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.143 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.66 135.29 53.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.73 136.25 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 111.317 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.66 153.74 25.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.563 179.778 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.591 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -70.8 158.3 36.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.532 -179.408 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -92.65 -6.63 48.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.92 178.444 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -128.75 -17.23 4.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.15 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 51.6 mt -119.76 107.79 39.92 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.898 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 25.9 Cg_exo -61.98 128.74 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.164 1.909 . . . . 0.0 111.899 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.2 t70 80.06 1.78 2.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.917 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.22 97.62 10.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.576 ' CD1' HD22 ' A' ' 145' ' ' LEU . 49.0 m95 -103.55 157.24 17.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.995 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.79 -177.01 2.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 71.6 mtm -109.13 156.76 38.68 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.54 140.26 56.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.595 2.196 . . . . 0.0 112.79 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 158.79 40.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.1 147.06 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.559 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.05 136.41 32.73 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.429 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 17' ' ' VAL . 5.3 mt -65.43 159.94 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.789 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.474 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.2 m-20 -90.45 150.27 21.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.69 98.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.242 0.544 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.39 39.14 10.06 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.98 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 14.2 tp10 -113.85 146.2 40.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 110.844 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 -72.8 139.13 80.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.568 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.613 ' O ' HG11 ' A' ' 17' ' ' VAL . 52.5 Cg_exo -54.92 -52.08 8.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.416 2.077 . . . . 0.0 112.658 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 108' ' ' PHE . 5.8 ttp85 -62.73 -26.64 68.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.277 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -84.51 -48.77 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.55 -28.27 65.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.553 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -75.49 -50.03 16.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.185 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 54' ' ' ARG . 45.2 mt -57.64 -29.63 34.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -82.13 -53.24 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.799 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -53.01 -41.14 64.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.4 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -56.13 -52.57 63.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.637 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 30.3 ttp180 -61.87 -13.82 28.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 178.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.19 -42.28 9.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.03 -26.17 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.739 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -120.6 -21.18 6.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.845 0.355 . . . . 0.0 111.081 -179.366 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 8.93 62.76 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.059 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.697 ' HB ' HD11 ' A' ' 61' ' ' LEU . 38.9 t -70.19 114.65 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -35.41 12.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.549 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.27 76.38 6.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.52 . . . . 0.0 111.107 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 127.96 12.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.809 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.66 ' OE1' HG21 ' A' ' 113' ' ' THR . 8.7 mt-10 -119.41 147.03 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.732 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.1 t -77.12 125.8 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.413 0.625 . . . . 0.0 111.817 -179.115 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.77 -16.65 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.366 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -155.57 158.39 38.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.41 115.36 6.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.195 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.835 ' HA ' HG11 ' A' ' 160' ' ' VAL . 9.2 t -57.46 127.39 77.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.33 -18.06 59.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.748 2.299 . . . . 0.0 113.349 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.59 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.96 -179.28 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.401 0.619 . . . . 0.0 112.204 -179.471 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 7.9 m95 -106.78 147.15 30.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.738 178.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.82 ' HB3' HG13 ' A' ' 153' ' ' VAL . 50.7 mt -113.86 117.84 32.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.103 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.781 HG22 ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -112.63 132.49 55.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.834 -179.363 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.871 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.0 164.01 25.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.651 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.48 158.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.216 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -114.98 154.77 47.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.595 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.516 2.144 . . . . 0.0 112.315 179.981 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.1 m95 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.772 0.32 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -30.7 61.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.09 -141.66 3.22 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.017 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -157.65 115.84 3.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.12 106.24 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.808 178.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 5.7 pt20 -124.56 153.25 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.377 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -105.84 95.93 6.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.339 178.526 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.563 ' CD2' HG21 ' A' ' 157' ' ' VAL . 35.5 m95 -62.95 142.43 58.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.339 -178.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CD2' ' HG3' ' A' ' 54' ' ' ARG . 65.9 m-85 -126.47 137.44 53.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.229 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.7 tp -79.56 154.57 28.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 21' ' ' LEU . 43.9 m-85 -148.17 127.67 13.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.037 0.446 . . . . 0.0 111.786 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.897 ' HB3' HD11 ' A' ' 73' ' ' ILE . 12.1 tttp -92.71 119.5 32.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.8 t80 -65.01 123.89 20.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.948 0.404 . . . . 0.0 110.76 -179.519 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.66 HG21 ' OE1' ' A' ' 71' ' ' GLU . 16.7 p -125.98 37.81 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.619 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.38 -144.85 4.72 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.101 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 154.19 45.93 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.82 -16.68 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.624 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.56 -19.14 56.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.725 0.298 . . . . 0.0 111.172 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.55 -25.17 41.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.759 HG21 ' CE1' ' A' ' 29' ' ' PHE . 17.7 mt -74.25 103.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.602 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.03 95.84 4.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.942 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.9 mt -54.79 -23.03 16.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.775 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 129' ' ' PRO . 70.2 mt -63.42 -59.54 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.25 0.547 . . . . 0.0 110.014 179.328 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.23 -176.99 24.87 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.445 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.53 39.01 1.02 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.132 0.491 . . . . 0.0 109.697 179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.64 26.79 74.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.078 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -119.08 -69.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.179 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.33 165.1 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 153.56 65.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 122' ' ' LEU . 77.0 Cg_exo -47.13 162.1 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.74 2.293 . . . . 0.0 112.597 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' C ' HD12 ' A' ' 34' ' ' LEU . 63.5 mm-40 -150.05 -46.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.809 ' HB2' HD13 ' A' ' 121' ' ' LEU . 12.7 m-85 -107.76 159.41 16.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.341 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.46 5.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.777 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.415 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 11.1 mm-40 -152.37 175.24 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.7 p-90 -156.68 152.5 27.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.09 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.6 m -147.93 163.63 36.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.409 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.462 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 69.7 m95 -98.12 122.48 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.661 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.87 HG11 HD11 ' A' ' 145' ' ' LEU . 27.0 m -134.91 150.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 111.58 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.93 162.33 72.74 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.699 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.584 ' CA ' HD13 ' A' ' 158' ' ' LEU . 31.5 Cg_exo -56.94 -20.34 36.11 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.84 1.693 . . . . 0.0 111.826 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -35.88 15.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.269 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -69.96 -50.36 42.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.06 179.186 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.903 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -53.96 -31.75 51.62 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.499 0.666 . . . . 0.0 109.81 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.568 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm -67.85 -28.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 178.687 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.73 -20.98 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.254 179.057 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.903 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.2 mt -85.49 -38.95 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.096 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 150' ' ' LYS . 29.8 m -56.14 163.43 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.4 p -91.42 165.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -57.6 -32.1 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.774 -179.653 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.2 p90 -92.89 13.62 19.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.686 ' HB2' HG12 ' A' ' 147' ' ' VAL . 33.9 mttp -136.23 0.81 2.61 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.327 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 6.4 mttm -62.15 -62.83 5.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.0 -44.72 27.96 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.46 2.107 . . . . 0.0 112.172 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.871 HG11 ' CD1' ' A' ' 82' ' ' TYR . 14.9 t -58.47 -27.12 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 0.0 111.1 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.18 -52.08 5.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.568 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -50.48 -32.71 18.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.825 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.552 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.4 tp10 -66.29 -45.69 79.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.559 179.144 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.2 t -59.09 -46.39 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.934 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.584 HD13 ' CA ' ' A' ' 139' ' ' PRO . 78.8 mt -66.31 -48.65 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.61 178.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.2 m -50.92 -46.52 60.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 76' ' ' VAL . 90.2 t -69.37 -24.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.9 m-30 -101.08 -2.92 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.274 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.617 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.79 -53.56 25.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.599 0.238 . . . . 0.0 111.588 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.42 -21.88 25.26 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.466 2.111 . . . . 0.0 112.402 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.46 ' ND1' ' HB2' ' A' ' 74' ' ' ALA . 58.7 m80 -96.19 -15.35 22.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 161' ' ' PHE . 5.6 mp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.788 0.328 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -93.37 152.23 19.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -65.29 126.36 27.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.471 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.0 t-20 -152.62 156.37 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.7 m -129.29 136.88 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.71 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -106.44 157.31 15.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.163 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.71 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.6 mm -121.4 102.34 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.795 -0.238 . . . . 0.0 111.335 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 7.8 t -89.73 94.93 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.571 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.9 tp -102.67 143.94 31.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.522 . . . . 0.0 111.509 -178.281 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.47 157.27 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.6 p-10 -98.41 170.92 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.516 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -57.72 -16.56 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 0.31 56.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.826 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 77.02 26.9 0.72 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.811 ' C ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -97.08 174.47 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.005 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.837 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -108.7 125.67 65.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.765 0.317 . . . . 0.0 110.783 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.733 ' HE2' HD13 ' A' ' 119' ' ' ILE . 44.4 t80 -63.42 108.82 1.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.592 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . . . -116.35 131.27 56.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.672 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.71 133.77 55.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.6 p -82.35 154.61 25.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.782 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.43 157.35 37.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.268 0.556 . . . . 0.0 111.411 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -5.09 53.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.005 178.493 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -131.13 -16.72 3.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.782 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.3 mt -120.62 111.41 34.68 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.0 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.2 Cg_endo -65.25 131.9 29.9 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.868 1.712 . . . . 0.0 111.843 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.86 2.98 2.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.649 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.26 97.31 11.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.22 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.539 ' CD1' HD22 ' A' ' 145' ' ' LEU . 59.8 m95 -103.86 157.85 16.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.227 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -168.91 167.94 10.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.443 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 3.4 mpp? -101.84 145.1 29.88 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 4.0 Cg_exo -39.55 132.88 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.317 2.678 . . . . 0.0 112.967 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 154.62 33.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.549 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.6 144.21 8.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.624 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.52 138.83 43.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.368 179.823 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.655 HD11 HG13 ' A' ' 17' ' ' VAL . 5.1 mt -68.42 159.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.334 . . . . 0.0 110.638 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -90.3 146.17 24.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.22 96.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.354 0.597 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 36.3 8.13 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.186 -179.801 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 4.9 tt0 -115.58 142.63 46.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 0.0 110.747 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.77 142.29 85.66 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.708 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.622 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.8 Cg_exo -53.82 -57.15 2.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.511 2.14 . . . . 0.0 112.6 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 3.4 ttt180 -58.55 -26.79 63.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.636 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -83.0 -49.17 9.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.07 -32.46 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -71.98 -54.67 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.092 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 54' ' ' ARG . 48.4 mt -53.82 -28.86 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.198 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -82.79 -53.12 6.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.759 0.79 . . . . 0.0 109.791 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -57.43 -33.19 67.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD11 ' HB ' ' A' ' 67' ' ' VAL . 8.8 tp -53.98 -59.66 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.582 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 4.7 ptt-85 -61.5 -10.94 8.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -91.44 -44.92 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.59 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -90.68 -31.41 16.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.192 -178.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.758 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.57 -21.93 10.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 0.0 110.961 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.85 8.87 64.91 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.825 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.818 ' HB ' HD11 ' A' ' 61' ' ' LEU . 42.7 t -73.91 120.55 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.393 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -34.96 10.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.28 76.86 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.213 0.53 . . . . 0.0 110.823 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 128.42 12.89 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.837 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 mt-10 -119.61 148.15 43.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.596 HG23 ' CE2' ' A' ' 110' ' ' PHE . 41.1 t -78.03 126.65 38.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.882 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.44 -19.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.387 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.29 162.36 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.327 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.7 117.52 6.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.022 179.686 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.833 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.0 t -57.36 126.15 73.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.081 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.42 -18.34 62.72 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.771 2.314 . . . . 0.0 113.23 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.621 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.03 -177.21 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.243 0.544 . . . . 0.0 112.008 -179.583 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.74 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.8 m95 -107.8 147.27 31.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.127 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.74 HD23 ' C ' ' A' ' 79' ' ' TRP . 3.2 mt -111.32 117.71 33.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.862 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.4 p -109.93 136.96 48.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.407 -179.504 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.839 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -129.43 170.02 14.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.449 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 158.2 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -121.11 146.9 45.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.759 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo . . . . . 0 C--N 1.344 0.301 0 C-N-CA 122.368 2.045 . . . . 0.0 112.15 179.948 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.407 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 30.5 m95 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.845 0.355 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -70.37 -35.88 73.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.36 0.6 . . . . 0.0 109.654 179.382 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.74 -133.29 1.53 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.738 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 12.3 mm100 -156.31 113.85 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.862 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -96.42 105.84 17.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.701 178.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -123.23 156.48 35.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.419 0.628 . . . . 0.0 112.69 -178.438 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.86 96.5 6.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.599 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.658 ' CD2' HG21 ' A' ' 157' ' ' VAL . 25.2 m95 -62.91 149.79 43.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.256 0.551 . . . . 0.0 112.35 -178.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.3 m-85 -132.92 133.44 43.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.88 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -79.54 132.05 36.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.524 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HD12 ' A' ' 21' ' ' LEU . 53.1 m-85 -126.45 129.44 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.322 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.882 ' HB3' HD11 ' A' ' 73' ' ' ILE . 36.6 tttm -93.68 120.28 33.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.802 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.658 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.4 t80 -63.91 125.42 24.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.797 -179.415 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.476 HG21 ' HG3' ' A' ' 71' ' ' GLU . 3.7 p -127.86 37.86 4.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -139.22 -144.94 4.65 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.52 154.22 46.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.47 -16.92 0.23 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.577 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -22.57 53.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.764 0.316 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.51 -25.18 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.839 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.733 HD13 ' HE2' ' A' ' 29' ' ' PHE . 28.9 mt -71.23 97.31 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.78 95.73 5.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.958 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 131' ' ' PHE . 68.2 mt -57.08 -21.87 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -179.256 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 ' HG3' ' A' ' 129' ' ' PRO . 22.3 mt -63.85 -59.19 4.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.255 0.55 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.17 178.48 22.5 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.4 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -90.71 38.85 0.96 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.95 26.3 69.32 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.084 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.78 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.101 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.36 165.16 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.196 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -86.46 147.9 45.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.808 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.467 ' HG3' HD22 ' A' ' 122' ' ' LEU . 64.4 Cg_exo -51.05 125.8 17.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.544 2.163 . . . . 0.0 112.557 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -109.29 -29.25 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.592 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.7 m-85 -112.82 159.52 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.398 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.9 5.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.807 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm-40 -152.35 174.73 13.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.081 0.467 . . . . 0.0 110.419 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.1 p-90 -154.6 151.69 29.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.081 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -149.7 161.81 41.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.586 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 72.8 m95 -97.6 128.29 44.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.273 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 145' ' ' LEU . 28.0 m -138.79 155.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -74.84 151.44 86.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.59 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HD3' HD11 ' A' ' 28' ' ' ILE . 3.4 Cg_endo -47.89 -22.21 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.037 1.824 . . . . 0.0 112.064 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -34.66 17.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.469 179.24 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.414 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 mt-30 -69.14 -51.59 36.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.935 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -51.71 -36.5 47.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.707 0.765 . . . . 0.0 109.56 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.676 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.8 mm -62.7 -28.88 45.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.038 178.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 141' ' ' GLN . 33.4 t70 -81.94 -19.85 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.161 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.9 mt -86.88 -38.49 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 150' ' ' LYS . 28.3 m -56.55 163.47 1.77 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.079 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 150' ' ' LYS . 8.1 p -93.74 161.34 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.86 -41.43 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.276 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 12.3 p90 -84.23 5.87 24.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.317 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 147' ' ' VAL . 14.6 mtmt -127.79 -3.98 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.534 0.206 . . . . 0.0 111.49 179.33 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 22.6 mttt -55.31 -62.43 4.39 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.548 0.213 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -60.61 -42.81 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 82' ' ' TYR . 25.2 t -55.26 -29.4 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 111.245 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.437 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.2 m-30 -91.07 -53.31 4.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -49.7 -33.95 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 179.958 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 tp10 -65.57 -45.46 83.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.589 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 107' ' ' TRP . 60.3 t -58.06 -48.81 83.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 139' ' ' PRO . 66.8 mt -63.5 -48.66 76.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.721 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.6 m -49.81 -47.28 51.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.676 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.833 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.1 t -69.44 -24.6 27.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.106 0.479 . . . . 0.0 110.363 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.88 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -105.77 13.93 28.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.931 -179.235 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -56.58 21.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.459 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.5 Cg_endo -52.46 -23.84 20.14 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.472 2.115 . . . . 0.0 112.197 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.621 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 97.6 m-70 -92.87 -20.68 20.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.878 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.526 HD22 HD12 ' A' ' 28' ' ' ILE . 4.1 mt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 148.96 66.42 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.497 2.132 . . . . 0.0 112.287 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 78.87 1.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.33 49.13 0.78 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.3 m -138.3 -160.73 1.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.025 0.441 . . . . 0.0 109.878 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mmt -174.88 111.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.66 14.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.926 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -177.61 137.5 0.39 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 22.7 Cg_endo -61.47 110.62 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.226 1.95 . . . . 0.0 112.081 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.9 Cg_exo -76.72 -174.29 2.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.846 2.364 . . . . 0.0 112.047 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.97 150.39 24.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.768 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' CA ' ' CE ' ' A' ' 101' ' ' LYS . . . 95.63 -34.74 4.68 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.52 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -92.42 134.41 34.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.088 0.47 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 153.52 22.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' NH1' ' HB3' ' A' ' 9' ' ' PRO . 3.0 mmp_? -56.68 130.36 45.02 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.759 0.314 . . . . 0.0 110.617 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.5 t-20 -152.83 153.25 32.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 53' ' ' PRO . 27.5 m -140.47 136.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.48 150.14 17.27 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.92 HG23 ' CD1' ' A' ' 110' ' ' PHE . 5.0 mp -122.5 103.71 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.685 0.279 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 32.7 t -89.43 106.76 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 110' ' ' PHE . 33.1 tp -102.9 143.25 32.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 ptm -125.2 157.28 36.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.854 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 9.8 t30 -97.88 172.58 7.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.051 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -63.12 -17.17 62.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.858 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.45 -0.55 57.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.08 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mttm 80.99 24.86 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -95.15 170.97 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.592 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.54 125.17 68.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.745 ' HE1' HD13 ' A' ' 119' ' ' ILE . 67.1 t80 -59.75 107.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.36 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.99 131.28 56.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.171 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.72 137.56 52.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.964 0.412 . . . . 0.0 111.371 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.38 155.52 24.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.557 ' CD ' HD12 ' A' ' 36' ' ' ILE . 2.9 mtp85 -73.35 157.27 37.29 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.0 111.411 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -4.95 52.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.897 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.97 -19.71 3.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.135 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.621 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.2 mt -119.15 112.4 36.18 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.2 131.47 28.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.951 1.768 . . . . 0.0 111.891 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.86 4.13 3.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.804 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.39 97.32 11.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.34 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HD22 ' A' ' 145' ' ' LEU . 41.3 m95 -102.55 156.64 17.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.93 -176.88 2.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.981 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 20.0 mtm -111.74 155.23 43.44 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.594 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.44 131.7 30.83 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.565 2.177 . . . . 0.0 112.447 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' OE1' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.22 164.18 38.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -152.68 161.6 29.59 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.368 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.27 35.56 3.29 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.603 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.732 ' CG1' HG13 ' A' ' 17' ' ' VAL . 2.3 mt 51.95 159.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.287 0.565 . . . . 0.0 111.661 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.41 162.25 15.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.812 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.59 99.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.6 46.05 33.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.793 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 1.6 tt0 -114.68 144.25 43.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.084 0.468 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.55 143.11 71.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.806 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.812 ' HA ' HG11 ' A' ' 17' ' ' VAL . 88.8 Cg_exo -48.54 -62.93 0.36 Allowed 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.777 2.318 . . . . 0.0 113.689 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.9 tpt180 -46.15 -33.72 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.81 -47.09 12.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -57.66 -35.0 69.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.05 -54.73 8.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.0 mt -57.65 -29.8 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -80.94 -53.56 6.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 34.7 mm-40 -50.38 -40.64 50.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.326 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.861 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -56.58 -53.86 52.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.3 ttp180 -63.81 -11.67 29.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.82 -40.14 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 111.596 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.07 -36.48 16.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.0 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.78 -24.32 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.056 0.455 . . . . 0.0 110.922 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.88 6.93 80.1 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.647 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' A' ' 61' ' ' LEU . 38.4 t -58.13 112.18 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.405 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 p -91.21 -33.77 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.08 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.25 75.19 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 110.946 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 133.69 17.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.853 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.9 mt-10 -126.69 148.73 49.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.666 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -77.63 126.66 38.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.83 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.1 mm -107.56 -19.71 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.446 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.63 160.96 38.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.566 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 5.0 pt-20 -149.53 118.62 6.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.879 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HA ' HG11 ' A' ' 160' ' ' VAL . 36.7 t -56.99 124.47 65.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 -17.97 38.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.95 2.433 . . . . 0.0 113.352 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.657 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.37 -175.62 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.509 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.48 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 30.7 m95 -104.35 147.47 27.49 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.566 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.906 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -103.74 117.18 33.77 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.767 HG22 ' HB2' ' A' ' 104' ' ' ALA . 42.9 p -113.81 133.14 55.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.247 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.883 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -135.67 170.18 16.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.445 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.25 158.15 42.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 9.9 m-85 -108.06 152.36 41.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.784 ' HG2' HG23 ' A' ' 88' ' ' VAL . 42.3 Cg_endo -68.06 170.9 13.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.468 2.112 . . . . 0.0 112.452 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.24 -14.94 41.34 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.981 2.454 . . . . 0.0 113.521 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -37.82 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.252 0.549 . . . . 0.0 110.045 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.784 HG23 ' HG2' ' A' ' 85' ' ' PRO . 58.1 t -77.17 -50.46 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.964 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.44 HH21 HD12 ' A' ' 92' ' ' LEU . 2.6 tpm_? -53.66 -60.41 3.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.123 0.963 . . . . 0.0 109.269 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.677 ' O ' HD12 ' A' ' 94' ' ' ILE . 12.6 tt0 -55.37 -27.88 50.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -81.99 -43.62 17.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.485 HD22 ' CG ' ' A' ' 96' ' ' TRP . 96.4 mt -61.81 -46.1 90.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.415 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -46.48 -34.02 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.638 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.677 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.75 -46.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.465 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -55.62 9.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.971 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.485 ' CG ' HD22 ' A' ' 92' ' ' LEU . 10.7 m0 -80.11 -31.78 39.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.867 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 75.78 36.51 42.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.503 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.3 147.76 52.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.89 75.45 0.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -129.76 149.99 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.668 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' CE ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -79.3 -28.78 42.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.88 -145.75 5.14 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.909 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -157.81 118.6 3.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.71 0.291 . . . . 0.0 111.455 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.767 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -85.6 112.72 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -124.93 141.16 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -97.79 95.89 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.64 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.486 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 72.6 m95 -62.95 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 112.149 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.447 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 71.2 m-85 -125.05 130.98 53.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.258 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -79.64 131.12 35.89 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.685 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.92 ' CD1' HG23 ' A' ' 19' ' ' ILE . 49.3 m-85 -125.22 127.13 46.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.241 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.87 ' HB3' HD11 ' A' ' 73' ' ' ILE . 4.9 tptp -89.93 124.7 34.94 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.695 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.3 t80 -70.24 123.5 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 110.799 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' SER . 6.6 p -124.2 37.39 4.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.568 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -135.82 -144.23 4.86 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.104 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.17 154.14 46.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.838 0.352 . . . . 0.0 110.061 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -50.13 -16.51 0.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.64 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -77.41 -17.38 58.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.705 0.288 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.24 -25.23 42.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.745 HD13 ' HE1' ' A' ' 29' ' ' PHE . 20.6 mt -70.45 104.83 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.492 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 65' ' ' THR . 56.3 t30 -122.26 95.78 4.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 131' ' ' PHE . 38.2 mt -54.14 -22.62 11.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.72 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.602 HD22 ' HG3' ' A' ' 129' ' ' PRO . 15.7 mt -63.63 -59.28 4.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.271 0.558 . . . . 0.0 109.964 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.4 -172.13 23.99 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -92.88 38.74 1.03 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.082 0.468 . . . . 0.0 109.924 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.94 27.19 72.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.345 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.91 165.1 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 148.92 61.84 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.602 ' HG3' HD22 ' A' ' 122' ' ' LEU . 54.6 Cg_exo -51.32 128.32 25.11 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.692 2.261 . . . . 0.0 112.55 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -108.45 -29.34 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.4 m-85 -111.67 159.46 18.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.38 -21.38 5.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.722 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.455 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 17.5 mm-40 -152.43 174.47 13.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.171 0.51 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.7 p-90 -159.13 156.57 29.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.042 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.76 161.92 40.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.473 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.467 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 73.3 m95 -93.9 124.89 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.697 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -136.6 150.89 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.151 0.501 . . . . 0.0 111.599 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.8 p -70.33 158.71 86.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.565 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.592 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.6 Cg_endo -55.36 -19.66 22.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.863 1.708 . . . . 0.0 111.885 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -34.34 16.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.075 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.35 -50.35 27.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.916 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.4 tp -54.39 -30.33 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.475 0.655 . . . . 0.0 109.891 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.516 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.3 mm -69.35 -28.47 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.724 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -80.19 -20.73 44.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.4 mt -84.07 -39.28 19.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.127 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 150' ' ' LYS . 27.0 m -59.6 164.28 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.011 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.2 p -96.09 160.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 147' ' ' VAL . 17.7 mm-40 -49.4 -41.7 40.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.2 p90 -81.3 2.85 26.31 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.545 ' O ' HG21 ' A' ' 146' ' ' THR . 4.2 mtpp -129.76 6.01 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.688 0.28 . . . . 0.0 111.197 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.2 mttt -64.02 -62.69 4.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 17.9 Cg_endo -58.1 -45.85 29.22 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.438 2.092 . . . . 0.0 112.061 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.906 HG13 ' HB3' ' A' ' 80' ' ' LEU . 48.6 t -54.05 -29.63 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.941 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.96 -51.5 5.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.5 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -51.09 -32.96 24.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.236 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.818 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.2 tp10 -64.31 -46.62 82.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.418 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.1 t -59.28 -50.97 77.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.29 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.557 HD13 ' CA ' ' A' ' 139' ' ' PRO . 66.0 mt -62.89 -49.58 74.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.969 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -45.3 61.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 156' ' ' GLU . 65.3 t -70.85 -25.01 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.352 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.877 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -104.06 12.48 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.799 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.571 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.44 -55.26 36.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.604 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.7 Cg_endo -54.6 -22.25 27.66 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.481 2.121 . . . . 0.0 112.248 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.641 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.3 m-70 -91.61 -18.28 24.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.948 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.901 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.451 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.06 145.13 54.52 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.602 2.202 . . . . 0.0 112.354 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.2 tp -156.42 136.53 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.851 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 60.1 29.89 69.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.563 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.06 121.71 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.6 tpp -128.31 -33.6 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.752 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 74.38 24.47 1.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 p 174.64 130.73 0.13 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.646 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 34.1 Cg_endo -65.14 110.56 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.413 2.075 . . . . 0.0 112.29 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 5.9 Cg_exo -79.04 -176.94 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.031 2.487 . . . . 0.0 112.11 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.27 157.0 17.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -27.29 14.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.589 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -104.08 141.23 36.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -82.18 152.26 26.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.09 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.488 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 22.2 t-20 -152.59 156.48 39.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.742 HG13 HD11 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -127.59 130.93 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.17 154.2 20.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.052 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.941 HG21 HD22 ' A' ' 61' ' ' LEU . 4.7 mp -131.94 102.82 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 111.411 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.5 t -89.7 103.81 16.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.0 146.22 28.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.904 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.45 157.3 41.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.005 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 13.1 t30 -94.37 173.99 7.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.1 -16.5 61.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.789 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -89.54 -0.78 57.75 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.089 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 25' ' ' ASP . 19.9 mtpt 81.74 24.77 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.594 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.3 173.05 7.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.532 HG21 HD23 ' A' ' 142' ' ' LEU . 4.8 mp -112.65 124.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 110.865 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 119' ' ' ILE . 77.4 t80 -57.79 109.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.387 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.96 135.58 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.217 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -120.36 139.85 52.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 111.32 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.29 158.02 23.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.572 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.9 mtp-105 -72.22 162.61 29.22 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.376 0.608 . . . . 0.0 111.672 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.4 mt -96.35 -6.47 37.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.552 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 -18.53 3.83 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.574 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 65.2 mt -120.94 112.95 33.19 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.26 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.8 Cg_endo -65.69 132.38 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.871 1.714 . . . . 0.0 111.643 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.15 1.83 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.811 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.68 97.51 11.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.181 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.414 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.9 m95 -102.65 157.03 17.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -168.74 -179.93 3.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.796 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -102.19 159.02 30.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.583 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.2 137.09 39.44 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.509 2.139 . . . . 0.0 112.817 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.403 ' OE1' ' CZ2' ' A' ' 107' ' ' TRP . 1.6 mm-40 -137.64 148.1 45.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.363 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.47 132.66 4.13 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.542 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.99 128.82 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.742 HD11 HG13 ' A' ' 17' ' ' VAL . 4.8 mt -61.34 160.71 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.519 ' N ' HG22 ' A' ' 47' ' ' ILE . 27.1 m-20 -90.09 -176.66 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.069 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.48 98.53 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 110.22 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.07 46.01 8.57 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.661 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -115.51 147.29 40.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.807 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 136.03 78.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.648 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.0 Cg_exo -53.71 -56.15 2.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.435 2.09 . . . . 0.0 112.682 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 58' ' ' ILE . 6.1 ttp85 -58.68 -27.43 64.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.365 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.31 -48.85 9.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.575 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -57.17 -30.36 64.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.742 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -74.13 -50.38 19.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.153 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ARG . 40.1 mt -57.73 -29.48 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.171 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -83.2 -52.92 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.902 0.858 . . . . 0.0 109.856 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -53.77 -46.09 70.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.941 HD22 HG21 ' A' ' 19' ' ' ILE . 3.4 tp -54.41 -56.06 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.3 ttp85 -60.06 -15.0 19.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.387 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.06 -42.06 10.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.47 -24.4 19.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.801 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.43 -19.66 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.21 4.48 63.83 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.175 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.635 HG13 ' HE1' ' A' ' 112' ' ' PHE . 40.2 t -70.65 114.08 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.23 -32.97 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.066 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 76.42 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.35 13.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.756 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.0 pt-20 -118.94 146.2 45.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 52.6 t -77.75 122.38 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.372 0.606 . . . . 0.0 111.535 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.911 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.2 mm -104.39 -15.95 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.621 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.82 159.39 35.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.38 115.41 6.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.135 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.858 ' HA ' HG11 ' A' ' 160' ' ' VAL . 12.2 t -57.44 126.54 75.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.21 -18.95 65.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.77 2.313 . . . . 0.0 113.237 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.582 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.3 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.38 0.61 . . . . 0.0 111.991 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.786 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.7 m95 -109.75 147.21 33.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.017 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 4' ' ' GLY . 1.8 mt -112.45 117.59 32.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.956 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.797 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.9 p -112.93 131.67 55.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.867 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.7 163.34 27.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.07 158.36 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.119 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.4 153.86 45.54 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.771 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.613 ' HG2' HG23 ' A' ' 88' ' ' VAL . 28.4 Cg_endo -62.62 169.16 8.84 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.275 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.95 -16.62 50.88 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.108 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.04 -34.82 14.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.125 0.488 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.3 t -82.63 -48.22 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.222 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -45.43 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.566 0.698 . . . . 0.0 109.515 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.5 tp10 -69.33 -28.02 65.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.611 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -46.95 25.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.824 HD22 ' CD2' ' A' ' 96' ' ' TRP . 81.1 mt -57.41 -46.94 82.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.372 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -45.84 -31.41 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.33 -50.07 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.221 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -56.89 8.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.824 ' CD2' HD22 ' A' ' 92' ' ' LEU . 43.4 m0 -76.03 -34.94 59.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.693 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.83 33.65 33.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.419 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.92 147.29 49.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.742 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -109.75 64.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 57.9 m95 -121.69 150.11 42.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.664 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -30.35 58.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -162.08 -143.07 3.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.923 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -157.72 115.77 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 0.0 111.436 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.797 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -93.39 105.81 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.814 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -104.29 98.07 7.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.519 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.484 ' CD2' HG21 ' A' ' 157' ' ' VAL . 31.3 m95 -65.32 137.12 57.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.278 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 54' ' ' ARG . 68.5 m-85 -122.27 137.93 54.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.943 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.821 HD23 ' HB ' ' A' ' 73' ' ' ILE . 20.1 tp -79.21 154.14 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.821 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 19' ' ' ILE . 39.6 m-85 -148.08 125.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.07 0.462 . . . . 0.0 111.738 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.911 ' HB3' HD11 ' A' ' 73' ' ' ILE . 39.5 tttp -91.4 122.55 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.635 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.2 t80 -68.23 123.9 22.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.9 p -124.02 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.13 -144.88 4.65 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.044 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.23 154.19 46.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.02 -16.61 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -77.73 -18.49 56.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 111.252 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -25.57 42.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.732 HG21 ' CE1' ' A' ' 29' ' ' PHE . 18.2 mt -73.77 103.9 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.517 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -119.36 95.87 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.027 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.6 mt -55.86 -22.55 25.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.543 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.588 HD23 ' CG ' ' A' ' 129' ' ' PRO . 1.7 mt -61.26 -56.84 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.246 0.546 . . . . 0.0 109.95 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.39 -174.66 22.8 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.51 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -91.76 38.72 0.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.13 73.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.202 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.1 m -115.24 -67.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 111.267 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -101.28 165.16 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 146.8 86.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.588 ' CG ' HD23 ' A' ' 122' ' ' LEU . 52.6 Cg_exo -52.11 139.74 51.9 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.583 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -109.83 -31.82 7.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.824 ' HB2' HD13 ' A' ' 121' ' ' LEU . 20.7 m-85 -116.88 159.61 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.415 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -15.72 6.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.814 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.566 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.53 174.59 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.522 . . . . 0.0 110.592 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.4 p-90 -159.61 153.1 22.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.056 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 m -151.74 156.9 41.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.484 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.469 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 76.7 m95 -91.35 124.83 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.841 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.902 HG11 HD11 ' A' ' 145' ' ' LEU . 29.6 m -134.71 150.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.724 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.5 p -69.54 158.5 86.77 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.573 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.517 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.05 -19.37 19.94 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.99 1.793 . . . . 0.0 111.98 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -34.48 14.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.225 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.6 -50.28 46.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.925 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.0 tp -53.37 -33.26 52.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.416 0.626 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.88 -28.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.687 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.75 -32.84 52.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.676 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 142' ' ' LEU . 7.1 mt -75.08 -40.62 59.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.88 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 147' ' ' VAL . 28.3 m -54.92 163.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.21 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.797 HG11 ' CE2' ' A' ' 149' ' ' PHE . 10.6 p -98.49 160.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.1 mm-40 -49.39 -36.79 22.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.797 ' CE2' HG11 ' A' ' 147' ' ' VAL . 16.4 p90 -84.77 6.9 22.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.453 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 30.8 mttt -129.94 -4.67 4.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.1 mttt -56.53 -62.13 5.5 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.351 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.4 Cg_endo -60.9 -42.77 35.06 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.444 2.096 . . . . 0.0 112.131 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.867 HG11 ' CD1' ' A' ' 82' ' ' TYR . 11.4 t -60.65 -27.5 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.561 . . . . 0.0 110.953 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.8 m-30 -90.87 -53.15 4.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.68 -31.12 10.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -69.48 -44.71 70.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.663 179.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 153' ' ' VAL . 52.0 t -57.72 -48.26 83.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.098 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 162' ' ' ALA . 61.8 mt -64.5 -48.85 73.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.774 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.8 m -50.94 -46.18 60.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.887 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.1 t -70.31 -24.58 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 121.019 0.437 . . . . 0.0 110.766 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.786 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.2 m-30 -100.67 -2.02 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.66 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.2 -51.46 33.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 6.7 Cg_endo -49.29 -24.57 8.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.632 2.221 . . . . 0.0 112.567 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.664 ' ND1' HG22 ' A' ' 73' ' ' ILE . 97.2 m-70 -100.98 -15.99 17.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.302 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 161' ' ' PHE . 4.4 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.454 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 144.83 54.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.596 2.197 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.25 38.66 19.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.99 -57.36 10.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.514 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.489 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 28.1 p -108.08 -155.59 0.56 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.436 ' HE2' ' HA ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -148.07 -40.33 0.17 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.892 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 74.28 14.7 3.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.08 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 171.88 131.7 0.08 OUTLIER Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 91.7 Cg_endo -80.39 117.3 3.41 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.438 2.092 . . . . 0.0 112.415 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 3.4 Cg_endo -84.86 176.79 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.983 2.455 . . . . 0.0 111.499 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.16 17.37 8.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.993 0.425 . . . . 0.0 111.852 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 -2.61 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.481 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -129.44 153.12 48.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.51 152.15 25.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -74.36 125.2 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.168 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.4 m120 -152.41 159.03 43.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.72 HG13 HD11 ' A' ' 47' ' ' ILE . 1.8 m -129.74 135.68 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.128 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.93 17.42 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.303 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.907 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -126.21 101.63 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.7 t -89.84 102.94 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.5 tp -103.16 145.75 29.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.69 157.41 40.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.7 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 31.6 p-10 -102.39 169.98 8.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -55.37 -17.95 5.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.92 0.48 56.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt 76.46 25.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.678 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -95.62 171.95 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.551 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.4 mp -109.12 119.5 58.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.12 0.486 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.787 ' CE2' HG21 ' A' ' 65' ' ' THR . 5.5 t80 -53.71 108.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.21 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 137.17 52.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.723 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.86 137.97 54.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.6 158.22 23.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.795 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtp85 -75.39 159.11 31.78 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 111.302 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -94.2 -5.64 46.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.026 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.35 -16.94 3.85 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.229 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.795 HD12 ' CD ' ' A' ' 33' ' ' ARG . 64.9 mt -120.19 110.96 35.66 Favored Pre-proline 0 N--CA 1.454 -0.239 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.01 131.35 28.5 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.837 1.691 . . . . 0.0 111.845 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 77.58 5.22 3.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.685 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.607 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.7 97.62 11.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.354 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.3 m95 -103.72 156.12 18.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -168.8 -176.77 2.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.764 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 61.2 mtm -107.31 159.4 30.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.15 130.27 22.38 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.468 2.112 . . . . 0.0 112.549 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.1 160.23 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.12 169.34 38.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.612 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -83.92 130.88 10.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 17' ' ' VAL . 5.0 mt -60.07 160.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.713 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.29 151.71 21.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.931 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.19 98.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.67 36.29 8.0 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.036 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.0 tt0 -116.29 142.11 47.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.458 . . . . 0.0 110.861 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.46 143.15 82.18 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HA ' HG11 ' A' ' 17' ' ' VAL . 50.4 Cg_exo -54.04 -52.93 7.23 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.559 2.173 . . . . 0.0 112.604 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.586 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 4.4 tpp85 -59.03 -27.61 65.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -84.46 -48.44 9.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.553 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.98 -32.51 69.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.417 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.49 -53.57 11.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 54' ' ' ARG . 53.7 mt -57.08 -29.34 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.081 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -81.7 -53.35 6.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 109.918 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.13 -45.16 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.309 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.856 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -55.74 -56.18 23.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.596 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.4 ttp180 -61.26 -12.19 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -91.6 -38.39 12.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.749 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.09 -35.37 15.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.921 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.787 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -119.02 -23.24 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.015 0.436 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.31 8.57 80.03 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.856 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.856 ' HB ' HD11 ' A' ' 61' ' ' LEU . 24.8 t -57.15 110.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.985 0.393 . . . . 0.0 110.313 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.0 p -89.84 -36.22 15.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.43 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.34 76.43 6.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.176 0.512 . . . . 0.0 111.086 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.43 128.53 12.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.78 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.6 pt-20 -119.38 147.78 43.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.098 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.606 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.6 t -78.41 123.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.344 0.593 . . . . 0.0 111.417 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.899 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -106.07 -19.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.753 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -156.85 162.94 39.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.135 0.493 . . . . 0.0 111.735 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.83 114.73 5.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.861 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.71 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.6 t -57.57 125.51 72.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.47 -11.6 31.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.872 2.381 . . . . 0.0 113.768 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.538 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.78 133.54 49.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.247 0.546 . . . . 0.0 111.917 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.447 ' CD2' ' HG2' ' A' ' 106' ' ' LYS . 49.2 m95 -59.79 147.09 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.226 0.536 . . . . 0.0 110.566 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.894 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.1 mm? -102.75 117.74 35.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.497 HG22 ' HB2' ' A' ' 104' ' ' ALA . 63.8 p -113.89 134.48 54.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.873 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -133.1 170.35 15.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.533 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.48 141.6 45.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.64 151.42 42.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.776 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.562 ' HG2' HG23 ' A' ' 88' ' ' VAL . 32.9 Cg_endo -63.6 170.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.518 2.145 . . . . 0.0 112.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.47 -16.95 57.86 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 0.0 113.275 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.65 -34.33 14.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.122 0.487 . . . . 0.0 110.132 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.4 t -83.19 -46.73 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.327 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -60.66 -46.3 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.487 0.66 . . . . 0.0 109.423 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -67.16 -27.37 67.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.58 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -47.05 16.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 96' ' ' TRP . 80.3 mt -59.26 -45.59 90.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 110.363 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.1 m-80 -46.02 -32.4 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.558 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.5 -49.28 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -56.12 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.462 ' N ' ' O ' ' A' ' 92' ' ' LEU . 18.4 m0 -78.39 -34.68 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.807 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 80.34 36.18 24.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.355 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.41 147.46 49.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.744 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -110.22 42.25 1.58 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.006 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -96.69 150.2 20.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -25.69 41.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.572 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.43 -138.23 2.74 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.036 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -157.72 116.79 3.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.823 0.344 . . . . 0.0 111.388 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -86.41 105.8 17.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.835 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.799 HE21 ' HE1' ' A' ' 107' ' ' TRP . 5.8 pt20 -124.92 145.03 50.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 2.5 mmmp? -100.59 110.49 22.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.76 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.799 ' HE1' HE21 ' A' ' 105' ' ' GLN . 34.2 m95 -76.23 145.2 39.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.486 . . . . 0.0 112.145 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 59.5 m-85 -127.29 132.76 50.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.295 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.87 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.9 tp -79.5 132.93 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.359 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.907 ' CD1' HG23 ' A' ' 19' ' ' ILE . 50.0 m-85 -126.51 127.98 46.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.663 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.899 ' HB3' HD11 ' A' ' 73' ' ' ILE . 18.3 tttp -92.02 122.29 34.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.658 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.8 t80 -67.87 123.07 19.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' SER . 1.6 p -122.8 37.01 4.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.545 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.32 -144.49 4.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -128.06 154.37 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.97 -17.49 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.585 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -74.61 -19.28 60.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.12 -25.64 52.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 25.5 mt -70.16 105.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 65' ' ' THR . 59.8 t30 -123.12 95.89 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.217 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' A' ' 131' ' ' PHE . 34.7 mt -55.73 -21.0 16.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.577 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.894 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -62.94 -60.18 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.329 0.585 . . . . 0.0 109.774 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.25 23.39 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.324 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -93.92 38.83 1.07 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.159 0.504 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.59 28.0 70.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.2 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 m -102.24 -62.34 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.289 . . . . 0.0 111.255 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.27 165.24 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.146 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -57.95 146.06 69.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.031 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.894 ' HG3' HD13 ' A' ' 122' ' ' LEU . 63.7 Cg_exo -51.69 -176.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.675 2.25 . . . . 0.0 112.517 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 34' ' ' LEU . 4.4 mm-40 -150.1 -41.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.583 ' HB2' HD13 ' A' ' 121' ' ' LEU . 21.0 m-85 -106.32 159.37 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.69 5.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.377 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.4 mp0 -152.19 173.73 14.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.5 p-90 -160.25 160.31 32.48 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.242 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -158.73 160.76 36.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.508 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 81.3 m95 -93.12 124.61 37.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.623 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -137.27 151.16 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 111.773 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -68.88 161.35 72.58 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.517 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.551 ' HD3' HD11 ' A' ' 28' ' ' ILE . 18.7 Cg_endo -59.39 -16.73 36.58 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.716 1.61 . . . . 0.0 111.768 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.98 -34.1 14.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.069 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -51.5 21.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.13 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.871 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.42 -31.4 55.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.459 0.647 . . . . 0.0 109.769 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.571 HD11 ' CA ' ' A' ' 155' ' ' LYS . 8.2 mm -68.08 -27.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.775 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.73 -14.7 50.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.216 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.871 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.6 mt -91.28 -38.32 12.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.392 0.615 . . . . 0.0 110.238 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 147' ' ' VAL . 59.4 m -56.51 161.83 2.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.252 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.875 HG11 ' CE2' ' A' ' 149' ' ' PHE . 14.0 p -87.98 162.31 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -63.3 -31.26 72.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.875 ' CE2' HG11 ' A' ' 147' ' ' VAL . 11.2 p90 -82.17 2.57 30.95 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.481 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 3.3 mtmt -145.99 16.28 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 3.1 mttt -58.89 -61.96 6.73 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.073 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.3 Cg_endo -61.58 -42.5 32.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.894 HG13 ' HB3' ' A' ' 80' ' ' LEU . 61.8 t -48.29 -29.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.248 0.547 . . . . 0.0 111.238 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.27 -55.0 3.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.249 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.571 ' CA ' HD11 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -48.52 -36.56 15.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.901 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.827 ' HB3' HD11 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -60.73 -46.74 89.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.475 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.601 HG21 ' CD2' ' A' ' 107' ' ' TRP . 44.6 t -61.29 -45.55 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.336 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.507 HD13 ' CA ' ' A' ' 139' ' ' PRO . 56.3 mt -64.19 -49.04 73.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.965 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.2 t -50.63 -43.72 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.7 t -71.73 -25.19 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.326 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.87 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.8 m-30 -102.55 8.73 39.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.87 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.554 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.66 -56.04 26.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.5 Cg_endo -56.91 -22.78 47.71 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.374 2.049 . . . . 0.0 112.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.0 m-70 -91.31 -19.94 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.87 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.466 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.2 168.2 22.8 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.588 2.192 . . . . 0.0 112.303 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 3' ' ' LEU . 4.2 mm? 60.18 -178.53 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.0 25.9 74.18 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.14 124.37 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.44 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.5 mmt -133.04 -38.31 0.97 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.745 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 75.4 19.15 2.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.727 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p 174.33 138.98 0.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 43.8 Cg_endo -68.86 109.69 2.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.32 2.014 . . . . 0.0 112.305 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.82 -175.64 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.012 2.475 . . . . 0.0 112.069 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -90.29 151.35 21.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -34.96 4.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -89.45 138.9 31.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 110.943 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.21 25.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -66.03 124.98 24.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 11.7 t-20 -152.53 160.66 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.997 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.772 HG13 HD11 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -131.06 140.3 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -105.01 150.19 16.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.154 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.952 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -131.15 102.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.469 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -89.61 109.95 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 110' ' ' PHE . 42.7 tp -102.92 143.55 32.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.441 . . . . 0.0 111.171 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.6 ptm -128.93 157.29 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.5 p-10 -105.03 170.69 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.387 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -56.28 -17.5 7.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.644 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 0.61 56.56 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.775 0.322 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 mttm 76.35 26.39 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.566 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -97.91 172.27 7.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.15 123.19 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.748 ' CE1' HG21 ' A' ' 119' ' ' ILE . 73.9 t80 -56.45 109.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.57 129.97 56.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.448 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.81 136.09 53.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.412 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.4 p -82.46 154.86 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.748 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.578 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -70.96 159.02 35.48 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.255 0.55 . . . . 0.0 111.397 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -93.33 -6.21 47.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.944 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -128.43 -18.1 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.201 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.1 mt -119.59 112.1 35.75 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.97 131.39 28.7 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.936 1.757 . . . . 0.0 111.95 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.74 3.51 3.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.851 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.54 11.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.719 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.1 m95 -104.56 156.71 17.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.02 8.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.505 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 70.1 mtm -97.91 156.67 35.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.83 139.22 42.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.536 2.157 . . . . 0.0 112.996 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.219 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.38 145.8 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.826 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.13 138.31 43.78 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.379 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.772 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -69.17 161.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.57 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.494 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.2 150.09 22.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.6 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.14 8.48 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.109 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 4.7 tt0 -115.08 143.48 45.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 0.0 110.887 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.68 139.68 80.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.604 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.639 ' O ' HG11 ' A' ' 17' ' ' VAL . 63.5 Cg_exo -52.02 -53.51 6.85 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.448 2.098 . . . . 0.0 112.616 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -60.01 -27.28 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -82.49 -51.26 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.694 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.542 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -56.84 -31.65 64.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.561 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.79 -51.91 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.271 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 54' ' ' ARG . 50.4 mt -56.82 -27.94 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -84.96 -52.71 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.931 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.84 -47.37 67.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -53.99 -56.69 15.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 66.2 ttp85 -59.32 -15.2 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.414 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -92.13 -39.98 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.821 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.4 -25.08 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.829 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.89 -19.16 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.238 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.77 5.65 65.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.112 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.681 HG13 ' HE1' ' A' ' 112' ' ' PHE . 49.6 t -72.18 115.74 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -34.34 12.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.23 79.25 6.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.472 . . . . 0.0 110.997 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.29 131.33 15.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.897 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.2 pt-20 -120.72 147.2 45.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.5 t -78.03 123.01 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.382 0.611 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.932 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -105.4 -21.52 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.753 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -153.41 161.9 41.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.288 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 9.0 pt-20 -148.74 115.59 6.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.148 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.819 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.6 t -57.24 125.78 71.97 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.917 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.2 -13.28 39.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.975 2.45 . . . . 0.0 114.177 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.619 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -129.4 157.2 42.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 112.028 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.528 ' C ' HD23 ' A' ' 80' ' ' LEU . 32.4 m95 -77.4 145.66 37.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.123 0.487 . . . . 0.0 109.914 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.895 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -108.55 118.08 35.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.984 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.859 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.8 p -114.81 132.19 56.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.522 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.875 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -124.9 170.13 11.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.96 158.28 38.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -119.72 149.76 48.99 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.705 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.568 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.4 Cg_endo -63.06 170.38 7.67 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.539 2.16 . . . . 0.0 112.308 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.52 -17.42 59.9 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.819 2.346 . . . . 0.0 113.19 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -91.94 -34.64 14.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.173 0.511 . . . . 0.0 110.096 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG23 ' HG2' ' A' ' 85' ' ' PRO . 72.7 t -82.01 -47.56 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.292 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.8 93.66 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.57 0.7 . . . . 0.0 109.536 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.61 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.7 tp10 -71.12 -27.56 63.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.772 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -46.96 24.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.631 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.65 HD21 H5'2 ' A' ' 166' ' ' ATP . 94.3 mt -59.56 -46.1 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.998 0.428 . . . . 0.0 110.391 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.3 m-80 -45.69 -32.43 2.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.41 -49.45 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.163 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -56.97 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.77 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.442 ' N ' ' O ' ' A' ' 92' ' ' LEU . 23.7 m0 -77.43 -36.2 53.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.639 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 82.29 34.8 22.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.362 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.05 147.15 49.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -109.75 65.23 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -122.83 150.18 43.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.86 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.583 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -167.13 -142.38 3.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.984 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -157.93 116.47 3.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.859 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.54 105.86 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.854 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.8 pt20 -124.28 144.61 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -98.81 95.82 7.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.697 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.432 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.8 m95 -62.91 148.72 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.449 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 68.6 m-85 -132.09 135.05 46.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.317 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.796 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.5 tp -79.9 129.46 34.5 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.952 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.6 m-85 -123.85 126.57 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.398 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.932 ' HB3' HD11 ' A' ' 73' ' ' ILE . 50.5 tttt -89.88 124.54 34.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.681 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -68.39 125.43 26.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.5 p -125.64 37.61 4.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.595 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.1 -144.91 4.76 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.129 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 154.2 45.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.85 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.611 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -20.39 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.17 -25.07 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.798 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.748 HG21 ' CE1' ' A' ' 29' ' ' PHE . 18.1 mt -73.46 102.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.549 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -119.35 95.63 4.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.924 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 131' ' ' PHE . 68.6 mt -54.56 -23.78 18.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.651 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 129' ' ' PRO . 59.5 mt -61.3 -55.23 34.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.099 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.9 -171.03 25.03 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.429 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.75 38.96 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.151 0.5 . . . . 0.0 109.84 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.17 28.56 73.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.985 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.36 -68.28 0.91 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 111.228 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.9 165.08 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.25 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -80.93 151.18 70.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.449 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.0 Cg_exo -48.44 165.34 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.748 2.299 . . . . 0.0 112.623 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.412 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.6 mt-10 -150.05 -45.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.502 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.828 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.5 m-85 -107.48 159.62 16.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.19 -18.63 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' O ' HD11 ' A' ' 121' ' ' LEU . 24.1 mm-40 -152.54 175.24 12.97 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.1 p-90 -156.14 150.9 26.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.113 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 162.32 40.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.34 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 71.4 m95 -96.28 124.31 40.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 145' ' ' LEU . 27.2 m -136.42 150.78 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 111.511 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -71.1 158.11 88.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.572 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.615 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.0 Cg_endo -54.62 -20.49 21.54 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.907 1.738 . . . . 0.0 111.853 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 -34.3 17.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.118 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -72.69 -50.69 23.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.931 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -54.14 -29.93 47.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.403 0.62 . . . . 0.0 109.881 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.569 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.7 mm -68.44 -28.88 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.674 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.27 -20.53 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.3 mt -85.86 -39.14 17.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 150' ' ' LYS . 5.7 m -60.2 156.19 15.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.955 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.4 p -90.08 160.52 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.85 -35.71 33.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.955 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.9 p90 -84.8 9.97 12.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.611 ' HB2' HG22 ' A' ' 146' ' ' THR . 12.6 mttm -134.57 -25.3 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.264 . . . . 0.0 111.187 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.8 mtpt -44.5 -59.87 3.5 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.408 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.0 Cg_endo -59.06 -41.52 60.23 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.278 1.985 . . . . 0.0 111.912 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 80' ' ' LEU . 64.0 t -64.99 -25.78 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.3 m-85 -90.46 -49.34 6.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.697 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.93 -35.1 22.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.681 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.724 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.4 tp10 -66.81 -44.96 79.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.7 t -58.64 -47.86 87.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.07 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.615 HD13 ' CA ' ' A' ' 139' ' ' PRO . 66.6 mt -66.71 -49.26 66.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.703 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.2 m -50.6 -46.14 57.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.662 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 76' ' ' VAL . 85.7 t -69.53 -24.68 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.796 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -101.86 2.13 37.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.163 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.47 -55.21 31.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.15 -20.87 25.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.619 2.213 . . . . 0.0 112.34 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.753 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 17.9 m-70 -89.48 -21.06 23.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.729 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.933 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.65 H5'2 HD21 ' A' ' 92' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' C ' HD23 ' A' ' 3' ' ' LEU . 55.6 Cg_endo -70.26 152.84 66.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.527 2.151 . . . . 0.0 112.276 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.631 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -147.84 124.54 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.563 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 87.85 -8.83 76.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.794 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.475 ' HB3' ' CD1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -179.57 125.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.279 . . . . 0.0 110.506 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -150.89 -24.7 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 28.2 t0 77.57 43.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.936 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -177.85 121.54 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 122.42 8.81 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.375 2.05 . . . . 0.0 112.178 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 60.4 Cg_endo -88.85 -169.05 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 112.412 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 153.61 20.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.626 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 -35.34 4.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 2.5 m-85 -102.96 136.99 41.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.428 ' HD2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -86.11 152.23 23.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -64.02 132.56 50.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.371 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 21.1 t-20 -152.56 156.99 40.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.443 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.802 HG13 HD11 ' A' ' 47' ' ' ILE . 3.3 m -127.81 129.49 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 111.281 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.2 147.03 18.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.177 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.882 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -122.34 103.35 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.699 0.285 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' PHE . 53.4 t -89.48 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 33.3 tp -103.19 144.56 31.16 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.319 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.8 ptt? -129.11 157.45 41.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.606 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.8 p-10 -98.35 172.51 7.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.349 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -60.45 -15.43 26.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 0.38 56.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp 77.57 27.16 0.63 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.536 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.783 ' C ' HD13 ' A' ' 28' ' ' ILE . 11.6 mmtm -99.11 175.67 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.861 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -107.62 147.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' HE2' HD13 ' A' ' 119' ' ' ILE . 10.8 t80 -82.67 104.94 13.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.73 129.89 56.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.31 137.13 52.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.03 152.81 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.764 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 5.0 mtp-105 -68.04 163.37 22.48 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.1 mt -97.8 -7.66 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.384 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.1 -18.95 4.88 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.207 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.594 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 63.1 mt -121.02 112.41 33.41 Favored Pre-proline 0 N--CA 1.457 -0.083 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.43 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.939 1.759 . . . . 0.0 111.655 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t70 78.15 1.8 2.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.767 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.3 97.24 10.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.13 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD1' HD22 ' A' ' 145' ' ' LEU . 55.2 m95 -103.0 159.67 15.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.166 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -168.5 -178.01 3.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 36.3 mtm -109.4 156.58 39.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.77 128.43 18.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.584 2.189 . . . . 0.0 112.674 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' OE1' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.32 156.69 37.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 144.82 10.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.442 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.78 140.67 43.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.802 HD11 HG13 ' A' ' 17' ' ' VAL . 4.4 mt -69.9 160.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.19 169.12 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.208 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.26 98.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.2 9.34 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.878 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 10.7 tp10 -112.53 145.16 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.093 0.473 . . . . 0.0 110.846 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.64 133.82 73.24 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.422 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HA ' HG11 ' A' ' 17' ' ' VAL . 53.3 Cg_exo -52.48 -39.43 74.34 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.369 2.046 . . . . 0.0 112.569 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.0 tpp85 -72.11 -27.84 62.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -85.12 -45.18 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.541 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.13 -32.62 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.368 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.22 -54.06 10.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.101 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' ARG . 48.9 mt -56.2 -29.1 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.291 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 ttp85 -82.58 -52.97 6.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.753 0.787 . . . . 0.0 109.872 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -51.78 -47.12 64.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.534 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -54.62 -56.3 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.886 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 6.6 ttp-105 -59.8 -15.14 18.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.293 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -92.06 -40.09 11.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.846 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.5 -25.29 19.34 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.827 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.57 -20.85 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.755 0.312 . . . . 0.0 111.063 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 76.72 1.39 71.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.015 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.683 HG13 ' HE1' ' A' ' 112' ' ' PHE . 46.0 t -69.42 116.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 110.615 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 -32.37 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.59 79.32 6.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.15 13.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.706 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.4 pt-20 -118.44 146.86 44.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.968 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.6 t -79.54 121.25 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 111.436 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.929 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -101.7 -20.79 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.391 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -153.14 160.24 42.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.07 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.8 pt-20 -148.43 116.02 6.28 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.169 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.844 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.3 t -57.38 129.14 79.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.0 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 -16.32 46.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.744 2.296 . . . . 0.0 113.612 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.607 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -127.75 -179.43 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.458 0.647 . . . . 0.0 112.533 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.807 ' C ' HD23 ' A' ' 80' ' ' LEU . 11.7 m95 -104.2 147.71 27.15 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.407 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.807 HD23 ' C ' ' A' ' 79' ' ' TRP . 1.4 mt -113.08 117.52 32.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.719 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.847 HG22 ' CB ' ' A' ' 104' ' ' ALA . 16.5 p -111.4 131.14 55.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.723 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.873 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -125.72 170.24 11.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.368 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.86 156.5 44.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CZ ' ' O1A' ' A' ' 166' ' ' ATP . 4.8 m-85 -105.71 147.51 34.82 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.612 ' HG2' HG23 ' A' ' 88' ' ' VAL . 28.2 Cg_endo -63.04 169.94 8.32 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.68 -16.35 52.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.918 2.412 . . . . 0.0 113.338 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -34.41 13.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.113 0.482 . . . . 0.0 110.096 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.612 HG23 ' HG2' ' A' ' 85' ' ' PRO . 84.1 t -82.68 -47.17 18.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.259 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.4 92.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.486 0.66 . . . . 0.0 109.614 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.753 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.2 tp10 -69.88 -27.22 64.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.737 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -46.64 17.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.542 HD13 ' O2A' ' A' ' 166' ' ' ATP . 96.1 mt -60.56 -46.89 88.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.474 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -46.42 -33.46 3.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.733 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.753 HD12 ' O ' ' A' ' 90' ' ' GLU . 4.2 mt -96.59 -46.22 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.438 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -55.05 11.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.0 m0 -79.61 -34.01 41.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.845 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.92 35.92 33.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.374 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 147.37 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.742 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -108.34 73.82 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.428 ' CD1' ' HD2' ' A' ' 14' ' ' ARG . 52.5 m95 -135.11 150.4 50.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.743 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 2.1 mptp? -88.35 -21.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.68 -146.4 5.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.915 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -157.94 116.29 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.847 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.84 112.7 21.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -128.98 152.93 48.06 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.29 95.99 6.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 178.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.557 ' CD2' HG21 ' A' ' 157' ' ' VAL . 48.6 m95 -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 112.472 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.1 m-85 -133.05 134.82 44.87 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.09 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 16.6 tp -79.53 143.01 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.882 ' CD1' HG23 ' A' ' 19' ' ' ILE . 42.4 m-85 -136.97 127.5 26.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.929 ' HB3' HD11 ' A' ' 73' ' ' ILE . 25.8 tttp -91.71 121.24 33.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.683 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.9 t80 -65.8 127.0 30.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.204 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.1 p -126.27 37.31 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.76 -144.55 4.93 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.982 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 153.8 47.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.173 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD1' ' CH2' ' A' ' 134' ' ' TRP . 3.6 m-20 -52.12 -14.93 0.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.674 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.73 -20.36 42.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.254 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.54 -25.53 45.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.807 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.573 HD13 ' HE2' ' A' ' 29' ' ' PHE . 25.9 mt -67.08 104.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.459 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.515 HD22 HD12 ' A' ' 122' ' ' LEU . 4.6 t-20 -122.06 95.8 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.119 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 131' ' ' PHE . 36.6 mt -56.3 -21.89 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.515 HD12 HD22 ' A' ' 120' ' ' ASN . 8.3 mt -60.8 -56.93 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 109.882 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.99 -175.59 22.56 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.487 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -91.98 38.97 1.0 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.76 72.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.958 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -121.15 -69.96 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.96 165.13 17.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.42 147.02 45.87 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 128.42 27.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.623 2.215 . . . . 0.0 112.53 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.408 ' C ' HD12 ' A' ' 34' ' ' LEU . 23.4 mp0 -111.54 -34.77 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.81 ' HB2' HD13 ' A' ' 121' ' ' LEU . 5.1 m-85 -108.02 159.61 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.334 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.9 -19.52 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.815 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.423 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 13.9 mm-40 -152.45 175.22 12.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.145 0.498 . . . . 0.0 110.592 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.8 p-90 -155.95 154.05 30.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.077 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.15 159.48 42.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.556 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 70.4 m95 -93.96 126.7 39.32 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.615 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.768 HG11 HD11 ' A' ' 145' ' ' LEU . 35.7 m -135.88 152.84 31.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.41 . . . . 0.0 111.854 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 p -72.49 152.17 91.81 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.811 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.3 Cg_endo -49.12 -22.13 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.25 -33.79 17.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -50.53 33.81 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.189 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.963 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.5 tp -53.35 -32.82 51.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.462 0.649 . . . . 0.0 109.828 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.689 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.9 mm -67.2 -28.05 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.796 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -22.64 41.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.232 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.963 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.8 mt -83.09 -39.55 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.066 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 150' ' ' LYS . 22.5 m -56.28 164.63 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -101.24 160.42 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 147' ' ' VAL . 24.4 mt-10 -45.43 -46.09 13.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.359 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -75.29 -5.09 42.84 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.459 ' O ' HG21 ' A' ' 146' ' ' THR . 13.5 mtmt -121.73 -4.13 9.21 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mttt -57.76 -62.39 5.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.541 0.21 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.1 Cg_endo -61.14 -45.81 17.91 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.467 2.111 . . . . 0.0 112.241 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.873 HG21 ' HB3' ' A' ' 82' ' ' TYR . 23.0 t -56.84 -27.07 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.13 -52.32 4.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -50.74 -32.62 20.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.317 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.6 tp10 -64.88 -46.01 83.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.492 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.0 t -59.49 -52.36 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.191 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 139' ' ' PRO . 70.2 mt -59.97 -49.2 78.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.841 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 m -49.15 -46.43 45.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.639 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.1 t -69.61 -25.28 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.029 0.443 . . . . 0.0 110.366 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.29 12.37 33.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.999 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.98 -58.28 14.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.0 Cg_endo -56.76 -21.81 41.7 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.433 2.088 . . . . 0.0 112.275 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.412 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 63.7 m-70 -90.01 -12.54 38.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.126 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.927 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.542 ' O2A' HD13 ' A' ' 92' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -168.73 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 5' ' ' SER . 0.1 OUTLIER 63.41 124.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.05 -27.74 8.1 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.591 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.814 ' O ' HD12 ' A' ' 3' ' ' LEU . 27.4 p -124.13 -156.72 0.73 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.925 0.393 . . . . 0.0 110.09 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.4 mmt -142.66 -33.65 0.46 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.938 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 52.6 27.07 4.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 0.0 111.27 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t 178.24 125.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 37.8 Cg_endo -67.15 109.32 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.404 2.069 . . . . 0.0 112.264 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 2.8 Cg_exo -75.55 -173.89 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.889 2.393 . . . . 0.0 112.082 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.98 147.38 23.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.834 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.33 35.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.04 136.25 44.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.943 0.402 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.8 OUTLIER -87.97 152.22 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -69.93 134.33 48.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.111 0.481 . . . . 0.0 111.441 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.8 t-20 -152.46 158.88 43.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.779 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.4 m -128.18 130.0 69.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 111.584 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.98 139.31 14.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.132 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.797 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -112.93 104.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.321 . . . . 0.0 111.417 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 110' ' ' PHE . 52.5 t -89.54 105.08 17.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 110' ' ' PHE . 40.4 tp -103.36 141.84 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.983 0.42 . . . . 0.0 111.126 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.63 157.39 35.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.7 p-10 -100.84 170.53 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -57.13 -16.37 7.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.418 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -0.08 57.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 111.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 77.53 26.67 0.66 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.564 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mmtt -97.85 175.87 6.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.565 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.6 mp -115.31 126.88 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.891 ' CE1' HG21 ' A' ' 119' ' ' ILE . 66.3 t80 -59.47 110.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.379 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.602 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.86 130.0 56.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.02 136.74 52.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 0.0 111.472 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.43 155.16 24.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.646 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.542 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -71.98 156.98 38.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.284 0.564 . . . . 0.0 111.413 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.16 -5.36 52.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -127.52 -19.62 4.16 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.039 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 59.6 mt -119.54 112.44 35.58 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.904 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.46 131.66 28.74 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.905 1.737 . . . . 0.0 111.737 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 77.17 4.21 3.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.766 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.66 97.4 11.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.339 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.514 ' CD1' HD22 ' A' ' 145' ' ' LEU . 34.8 m95 -103.93 156.94 17.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.101 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -168.76 177.23 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.774 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.46 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 35.8 mtm -103.2 155.43 36.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.809 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.46 139.9 55.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.594 2.196 . . . . 0.0 112.67 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.19 158.18 39.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.74 140.37 6.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.586 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.74 139.87 48.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.451 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 17' ' ' VAL . 6.7 mt -71.42 160.32 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.546 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.3 148.52 22.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.85 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -49.15 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.188 0.518 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.64 40.62 14.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.884 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.9 tp10 -113.3 145.74 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 110.938 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -72.87 124.05 90.28 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.156 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.677 ' O ' HG11 ' A' ' 17' ' ' VAL . 5.3 Cg_endo -48.97 -50.83 11.78 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.484 2.123 . . . . 0.0 112.818 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 58' ' ' ILE . 33.1 ttt180 -57.44 -30.53 65.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -83.23 -47.12 11.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.38 -30.32 66.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.407 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.779 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.86 -51.93 14.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.109 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 54' ' ' ARG . 28.4 mt -57.02 -29.6 31.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.099 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -81.19 -53.15 6.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.877 0.846 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.98 -31.88 61.2 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.479 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.863 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.3 tp -57.26 -62.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.604 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.5 ptt85 -61.22 -10.91 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.973 0.415 . . . . 0.0 110.456 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -91.5 -39.47 11.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.252 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.52 -33.66 15.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.158 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.93 -24.5 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 81.54 -0.21 88.28 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.668 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.863 ' HB ' HD11 ' A' ' 61' ' ' LEU . 46.6 t -63.68 118.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.311 . . . . 0.0 110.448 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -33.95 10.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.404 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.22 76.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.805 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.25 13.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.973 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -120.31 148.85 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 110' ' ' PHE . 55.4 t -79.21 125.04 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.492 0.663 . . . . 0.0 111.901 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.884 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -104.93 -20.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.066 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -152.2 161.21 42.96 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -148.16 113.25 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.816 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.2 t -57.23 124.76 68.15 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.032 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.59 -5.72 17.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.802 2.335 . . . . 0.0 113.925 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.569 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -131.21 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 112.399 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -79.03 147.36 32.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 153' ' ' VAL . 48.7 mt -115.97 117.74 30.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.842 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.839 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -114.78 131.67 56.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.585 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.789 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -127.56 170.07 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.52 158.44 39.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -110.55 153.54 43.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.578 ' HG2' HG23 ' A' ' 88' ' ' VAL . 34.3 Cg_endo -64.25 171.61 7.55 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.529 2.153 . . . . 0.0 112.328 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.39 -17.77 58.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.79 2.327 . . . . 0.0 113.215 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 -34.29 15.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.193 0.52 . . . . 0.0 110.16 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.578 HG23 ' HG2' ' A' ' 85' ' ' PRO . 78.9 t -82.33 -48.25 18.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -45.62 90.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.489 0.662 . . . . 0.0 109.547 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.636 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.9 tt0 -68.55 -27.0 65.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.669 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -78.7 -46.51 18.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.597 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' A' ' 96' ' ' TRP . 96.0 mt -59.11 -46.46 88.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -46.44 -32.73 3.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.605 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.56 -47.44 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.533 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -55.15 9.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.5 ' CG ' HD22 ' A' ' 92' ' ' LEU . 10.7 m0 -79.22 -30.72 43.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.952 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.28 37.37 48.34 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.417 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.19 147.57 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.685 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.92 48.23 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.928 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 57.1 m95 -111.46 150.18 30.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.695 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -27.81 44.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.48 -143.42 4.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.994 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.443 ' NE2' ' O3G' ' A' ' 166' ' ' ATP . 43.4 mt-30 -157.92 117.28 3.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.757 0.313 . . . . 0.0 111.365 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.839 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.74 107.61 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -123.16 151.93 41.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.302 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 96.84 6.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.43 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.492 ' CD2' HG21 ' A' ' 157' ' ' VAL . 52.1 m95 -62.7 147.86 48.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -130.99 135.14 47.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.825 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.2 tp -79.7 147.92 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.138 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.841 ' O ' HD12 ' A' ' 21' ' ' LEU . 27.3 m-85 -140.92 128.02 20.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.87 0.367 . . . . 0.0 111.567 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.884 ' HB3' HD11 ' A' ' 73' ' ' ILE . 31.3 tttt -91.79 119.96 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.674 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.9 t80 -64.87 125.14 23.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 111' ' ' LYS . 10.7 p -126.86 37.62 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.25 -144.92 4.75 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.066 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -127.86 154.12 45.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -50.26 -16.23 0.31 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.657 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -79.03 -18.63 53.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.731 0.3 . . . . 0.0 111.232 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.33 -25.61 42.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.891 HG21 ' CE1' ' A' ' 29' ' ' PHE . 22.9 mt -79.01 105.84 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -124.78 96.7 4.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.08 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.815 HD13 ' HB2' ' A' ' 131' ' ' PHE . 36.6 mt -47.62 -21.8 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.232 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD22 ' HG3' ' A' ' 129' ' ' PRO . 88.1 mt -57.5 -59.33 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.351 0.596 . . . . 0.0 109.99 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 133.08 -176.62 19.46 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.1 p30 -89.47 38.7 0.91 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.2 26.1 72.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.271 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -100.98 -64.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.708 0.289 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -112.52 165.14 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.1 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 144.8 91.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HG3' HD22 ' A' ' 122' ' ' LEU . 50.6 Cg_exo -53.05 135.88 59.94 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.581 2.188 . . . . 0.0 112.474 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.84 -29.55 7.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.73 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.815 ' HB2' HD13 ' A' ' 121' ' ' LEU . 9.7 m-85 -110.2 159.27 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.14 -19.78 5.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.795 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.469 ' C ' HD11 ' A' ' 121' ' ' LEU . 25.5 mm-40 -152.43 175.08 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 110.438 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.07 155.46 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.2 m -153.84 158.71 41.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.348 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.475 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 79.5 m95 -90.98 123.72 34.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.836 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 145' ' ' LEU . 29.5 m -134.34 149.88 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.503 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -68.65 158.65 84.93 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.581 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' CA ' HD13 ' A' ' 158' ' ' LEU . 12.0 Cg_endo -55.74 -19.17 23.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.875 1.717 . . . . 0.0 111.923 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -90.84 -34.21 15.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.078 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.68 -50.73 27.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.988 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.894 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.7 tp -54.1 -32.72 55.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.566 HD12 ' HG3' ' A' ' 155' ' ' LYS . 5.6 mm -67.9 -28.16 40.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.09 -20.98 40.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.2 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.894 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.2 mt -84.75 -39.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 150' ' ' LYS . 58.2 m -59.46 151.07 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.836 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.7 p -80.78 160.09 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.0 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 147' ' ' VAL . 4.6 mt-10 -51.75 -35.26 42.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.836 ' CE2' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -83.41 4.9 25.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.509 ' O ' HG21 ' A' ' 146' ' ' THR . 22.1 mttm -133.97 6.28 3.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.532 0.206 . . . . 0.0 111.304 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.5 mttt -62.32 -62.76 5.17 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.04 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.3 Cg_endo -58.74 -41.81 59.7 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.449 2.099 . . . . 0.0 112.051 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' A' ' 80' ' ' LEU . 17.3 t -58.34 -25.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.998 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.46 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.3 m-85 -91.1 -50.2 5.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.609 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.566 ' HG3' HD12 ' A' ' 143' ' ' ILE . 39.3 mttp -51.39 -33.52 30.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.819 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.0 tp10 -65.59 -45.81 81.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.746 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -61.02 -51.62 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.203 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.586 HD13 ' CA ' ' A' ' 139' ' ' PRO . 72.3 mt -62.59 -49.19 76.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.902 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -49.79 -47.15 51.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.677 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.816 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.1 t -68.72 -25.06 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.825 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.07 10.79 35.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.001 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -57.99 13.9 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.9 Cg_endo -55.69 -21.76 33.3 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.464 2.109 . . . . 0.0 112.084 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 63.6 m-70 -92.53 -17.7 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.933 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.45 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.49 -168.49 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.647 2.231 . . . . 0.0 112.297 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.9 mt 60.1 -178.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.0 55.33 0.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.453 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -166.65 125.17 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.455 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 79' ' ' TRP . 10.7 tpp -126.84 105.35 8.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.19 24.43 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.597 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 174.94 121.71 0.12 Allowed Pre-proline 0 CA--C 1.529 0.15 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.47 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.65 111.13 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.224 1.95 . . . . 0.0 112.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.82 -169.37 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.786 2.324 . . . . 0.0 112.385 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.09 161.38 15.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.27 -31.2 7.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.28 134.81 53.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.0 ptt85 -79.15 152.86 30.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.133 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? -57.51 139.07 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.9 m120 -153.12 161.41 42.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.86 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.2 m -141.93 123.82 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.088 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 147.37 18.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.286 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.925 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -122.11 101.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 111.275 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.7 t -89.89 104.94 17.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 110' ' ' PHE . 22.3 tp -102.97 148.16 26.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 ptt? -130.39 157.4 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 33.9 p-10 -104.32 169.35 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.269 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.72 -17.05 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.53 56.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.293 . . . . 0.0 111.006 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 76.42 26.71 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -98.1 172.53 7.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -109.35 121.12 61.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.064 0.459 . . . . 0.0 111.06 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.796 ' CD2' HD23 ' A' ' 21' ' ' LEU . 5.0 t80 -55.28 107.82 0.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.267 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.81 141.8 47.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.758 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -126.37 139.4 53.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.345 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.483 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.71 158.29 22.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.621 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -75.12 159.69 31.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.527 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -94.49 -5.43 46.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.951 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.09 -16.99 3.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.619 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.7 mt -121.34 112.61 32.8 Favored Pre-proline 0 N--CA 1.454 -0.253 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.18 131.75 29.53 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.906 1.738 . . . . 0.0 111.788 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 t0 76.66 4.08 3.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.619 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.39 97.48 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.423 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.658 ' CD1' HD22 ' A' ' 145' ' ' LEU . 38.8 m95 -101.66 155.34 18.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -169.03 -176.61 2.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 4.3 mtm -113.71 154.4 45.75 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.73 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.46 142.35 78.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.599 2.199 . . . . 0.0 112.413 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -154.07 173.73 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.94 178.79 28.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.578 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' ILE . . . -112.92 23.91 13.76 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.689 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.738 HD11 HG13 ' A' ' 17' ' ' VAL . 3.5 mt 51.26 157.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 0.0 111.643 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.77 176.64 6.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.71 98.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.221 0.534 . . . . 0.0 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.86 49.28 29.52 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.757 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 3.4 tt0 -112.65 148.14 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.254 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.742 ' O ' HG11 ' A' ' 17' ' ' VAL . 76.7 Cg_exo -51.14 -60.41 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.454 2.103 . . . . 0.0 112.864 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -55.57 -26.53 44.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -82.34 -49.01 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.697 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -57.79 -31.1 66.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.86 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.1 -53.11 11.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.119 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -56.08 -29.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.186 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -83.79 -52.61 6.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.785 0.802 . . . . 0.0 109.945 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.44 -48.49 65.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.668 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -53.6 -55.51 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.582 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.8 ttp85 -58.7 -15.25 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -91.97 -37.64 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.715 0.293 . . . . 0.0 111.759 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -90.71 -28.73 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.734 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.92 -21.35 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.278 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.91 5.19 69.22 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG13 ' HE1' ' A' ' 112' ' ' PHE . 24.5 t -61.79 108.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.929 0.364 . . . . 0.0 110.306 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -34.4 15.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.413 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.02 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.34 127.24 11.85 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.853 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.88 148.83 43.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.678 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 43.6 t -77.94 127.1 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.853 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.95 -20.32 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.28 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.87 161.97 40.5 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.4 pt-20 -148.41 113.82 5.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.257 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.74 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.6 t -57.55 125.36 71.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.185 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.27 -10.02 25.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.811 2.341 . . . . 0.0 113.617 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.53 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.45 133.6 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.582 . . . . 0.0 112.065 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' A' ' 6' ' ' MET . 24.8 m95 -65.39 147.21 53.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.693 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.717 ' HB3' HG13 ' A' ' 153' ' ' VAL . 43.9 mt -113.17 117.63 32.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.779 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.841 HG22 ' CB ' ' A' ' 104' ' ' ALA . 3.6 p -114.52 132.21 56.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.747 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -131.4 170.11 15.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.94 158.25 35.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -109.83 154.64 42.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.58 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.4 Cg_endo -62.96 170.93 6.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.484 2.123 . . . . 0.0 112.263 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.88 -17.24 59.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.834 2.356 . . . . 0.0 113.087 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -92.02 -33.62 14.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.181 0.515 . . . . 0.0 110.129 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.58 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.6 t -83.48 -48.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.338 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -45.18 91.57 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.512 0.672 . . . . 0.0 109.342 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -68.8 -27.72 66.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.6 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -47.2 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.418 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 96' ' ' TRP . 95.5 mt -57.55 -46.56 83.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.453 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -46.0 -32.01 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.4 mt -96.39 -49.32 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.147 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -57.08 7.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.779 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.463 ' CD1' HD22 ' A' ' 92' ' ' LEU . 13.0 m0 -76.98 -34.35 57.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.87 34.89 29.48 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.412 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.58 147.2 49.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -109.63 48.6 0.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -105.71 149.98 25.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -30.33 63.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.723 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.47 -139.63 2.74 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.96 116.25 3.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 111.584 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.841 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.84 108.36 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.793 HE21 ' HE1' ' A' ' 107' ' ' TRP . 6.4 pt20 -120.16 150.85 39.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.3 mttt -107.91 95.88 5.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.19 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.793 ' HE1' HE21 ' A' ' 105' ' ' GLN . 49.4 m95 -62.97 138.96 58.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 112.259 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -124.85 132.44 53.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.937 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.2 tp -79.59 131.15 35.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.925 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.5 m-85 -125.49 129.57 50.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 111.498 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 28.1 tttt -93.53 121.08 34.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.5 t80 -66.2 123.32 19.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 69' ' ' SER . 11.1 p -124.66 37.51 4.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.613 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -137.47 -144.79 4.81 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.07 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -128.35 154.14 46.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -49.93 -16.72 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -76.52 -20.24 57.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 111.131 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.61 -25.18 49.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.39 103.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' THR . 63.7 t30 -119.06 95.48 4.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.988 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 131' ' ' PHE . 52.3 mt -54.78 -21.93 12.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.783 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.94 -59.23 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.64 -171.52 25.9 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.447 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -94.39 38.83 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.119 0.485 . . . . 0.0 109.936 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.2 27.13 72.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.4 t -106.0 -64.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.0 111.202 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -115.48 163.48 15.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.212 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.35 152.37 54.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.11 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.23 179.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.784 2.323 . . . . 0.0 112.581 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -148.39 -44.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.713 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 121' ' ' LEU . 31.7 m-85 -110.59 159.59 17.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.421 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -113.72 -20.78 5.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.587 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.483 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.1 mm-40 -152.34 174.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.526 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.4 p-90 -159.54 157.45 29.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.073 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -154.51 160.49 41.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.455 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 82.5 m95 -93.63 123.43 36.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.54 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.731 HG11 HD11 ' A' ' 145' ' ' LEU . 30.2 m -134.88 150.43 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 111.777 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.509 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -69.59 160.64 78.72 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.598 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.597 ' CB ' HD13 ' A' ' 158' ' ' LEU . 16.6 Cg_endo -57.84 -17.62 30.77 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.832 1.688 . . . . 0.0 111.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.74 -34.07 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.07 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.01 -50.75 25.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.933 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.7 tp -54.24 -31.04 52.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.489 0.661 . . . . 0.0 109.83 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.54 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.8 mm -68.58 -28.44 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.621 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.78 -20.72 42.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.27 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.7 mt -84.74 -39.11 18.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.119 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 150' ' ' LYS . 26.0 m -56.74 163.63 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.73 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.5 p -91.66 164.96 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.5 ' N ' HG22 ' A' ' 147' ' ' VAL . 8.6 mt-10 -55.23 -35.06 64.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.925 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.73 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.5 p90 -90.5 11.09 22.85 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.608 ' HB2' HG12 ' A' ' 147' ' ' VAL . 2.1 mtmp? -133.23 -3.68 3.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.537 0.208 . . . . 0.0 111.513 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.43 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttm -58.98 -62.8 5.09 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.577 0.227 . . . . 0.0 111.192 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 17.3 Cg_endo -57.92 -41.61 67.1 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.8 t -59.75 -28.05 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.2 m-85 -91.16 -51.4 5.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.66 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.54 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.78 -32.82 21.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.5 tp10 -66.21 -45.65 79.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.565 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.585 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.3 t -58.97 -48.93 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.23 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.597 HD13 ' CB ' ' A' ' 139' ' ' PRO . 77.3 mt -62.24 -48.68 78.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.723 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.9 m -49.67 -47.21 50.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.739 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.5 t -69.28 -25.43 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.85 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.6 m-30 -103.3 11.66 36.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.985 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.1 -57.69 16.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.486 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.8 Cg_endo -55.78 -22.04 35.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.511 2.141 . . . . 0.0 112.356 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.532 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 91.3 m-70 -90.33 -15.09 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.087 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.448 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.31 -167.52 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.626 2.217 . . . . 0.0 112.307 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.82 161.14 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.75 72.32 0.35 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.405 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.5 m -146.3 112.05 5.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.08 105.57 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.76 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -80.9 24.47 0.5 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.554 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 177.62 128.63 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.511 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 19.4 Cg_endo -60.46 110.8 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.327 2.018 . . . . 0.0 112.165 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.2 Cg_exo -79.62 -177.59 3.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.92 2.413 . . . . 0.0 112.071 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -90.36 151.21 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.832 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.05 -27.37 16.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.663 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -98.23 138.53 35.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.084 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.87 152.29 24.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -71.82 129.85 39.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 14.3 t-20 -152.84 161.89 41.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.787 HG13 HD11 ' A' ' 47' ' ' ILE . 1.7 m -131.54 135.53 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 111.458 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -103.8 150.62 17.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.101 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.911 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -126.7 101.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.822 0.344 . . . . 0.0 111.506 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 t -89.75 100.43 13.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.4 tp -102.79 143.65 32.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.044 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 2.8 ptt? -126.22 157.5 38.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 40.5 p-10 -98.98 170.95 8.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.76 -16.11 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.491 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -89.14 1.06 56.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 64.8 mttt 76.29 26.97 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.3 mttt -99.17 171.62 7.89 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -109.94 122.76 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.902 0.382 . . . . 0.0 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.761 ' CE1' HG21 ' A' ' 119' ' ' ILE . 86.7 t80 -55.17 111.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.12 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.52 130.34 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.31 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.03 138.72 50.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.041 0.448 . . . . 0.0 111.193 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.25 158.07 23.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.632 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.704 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtp85 -73.35 159.72 32.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.0 mt -93.36 -5.48 49.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.921 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.61 -17.76 3.62 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.704 HD12 ' CD ' ' A' ' 33' ' ' ARG . 69.6 mt -120.68 112.76 33.69 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.099 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.47 132.27 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.887 1.725 . . . . 0.0 111.684 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.76 4.82 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.617 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.36 97.56 11.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.41 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CD1' HD22 ' A' ' 145' ' ' LEU . 19.2 m95 -103.36 155.58 18.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.126 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.72 170.95 9.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 68.1 mtm -90.04 153.87 47.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.689 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.29 139.14 41.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.156 . . . . 0.0 112.666 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.77 162.6 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.86 141.8 7.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.602 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -58.44 140.87 46.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.787 HD11 HG13 ' A' ' 17' ' ' VAL . 3.7 mt -72.66 159.29 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.496 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.58 148.66 22.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.09 99.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.225 0.536 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.23 40.42 13.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.913 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.3 tp10 -110.75 147.5 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.159 0.504 . . . . 0.0 110.859 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.93 130.56 80.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.571 ' HA ' HG11 ' A' ' 17' ' ' VAL . 55.0 Cg_exo -52.04 -25.7 23.25 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.377 2.051 . . . . 0.0 112.538 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' CB ' ' CE2' ' A' ' 108' ' ' PHE . 9.7 ttt180 -86.61 -22.05 26.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.984 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -91.08 -40.29 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 110.31 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.461 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -64.17 -30.37 71.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.666 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -74.68 -50.96 15.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 54' ' ' ARG . 59.1 mt -57.6 -30.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.101 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -81.36 -53.14 6.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.867 0.842 . . . . 0.0 109.908 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.79 -49.34 65.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.91 HD22 HG21 ' A' ' 19' ' ' ILE . 3.3 tp -54.97 -55.15 33.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.973 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 50.3 ttp85 -61.44 -13.44 20.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.544 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.95 -43.0 9.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.957 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -91.38 -25.33 19.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.788 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.36 -20.27 8.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.361 . . . . 0.0 111.057 -179.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.9 7.59 62.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.068 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.656 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.2 t -67.25 115.62 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.856 0.36 . . . . 0.0 110.383 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.64 -34.04 11.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.195 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 76.33 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.197 0.522 . . . . 0.0 111.051 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.51 129.07 13.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -116.33 147.63 41.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.02 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.2 t -77.03 119.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.325 0.583 . . . . 0.0 111.068 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.919 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -93.41 -26.05 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.837 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.59 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.518 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.425 ' CG ' ' CE2' ' A' ' 108' ' ' PHE . 29.2 tt0 -148.65 118.76 7.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.583 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.747 ' HA ' HG11 ' A' ' 160' ' ' VAL . 8.1 t -58.21 123.95 68.07 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.61 -17.05 58.32 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.723 2.282 . . . . 0.0 113.312 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.77 -178.54 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.907 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.454 ' C ' HD23 ' A' ' 80' ' ' LEU . 13.0 m95 -110.5 146.3 36.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.874 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.596 ' HB3' HG13 ' A' ' 153' ' ' VAL . 9.5 mt -112.73 117.61 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.064 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.833 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.7 p -109.76 132.35 54.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.821 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -129.08 161.58 29.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.624 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.9 158.37 29.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.383 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' CD2' HD12 ' A' ' 92' ' ' LEU . 1.5 m-85 -104.26 150.85 38.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.584 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.583 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.3 Cg_endo -62.28 168.42 9.48 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.444 2.096 . . . . 0.0 111.956 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.1 -16.2 48.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.781 2.321 . . . . 0.0 113.188 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -93.09 -39.18 11.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.239 0.542 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.583 HG23 ' HG2' ' A' ' 85' ' ' PRO . 82.0 t -78.51 -45.54 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.54 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -62.01 -47.13 86.16 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.526 0.679 . . . . 0.0 109.53 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -25.37 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.675 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -45.42 14.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.647 HD22 ' CG ' ' A' ' 96' ' ' TRP . 42.8 mt -57.21 -41.7 79.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -45.62 -35.39 4.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 94' ' ' ILE . 3.3 mp -96.6 -47.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.29 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -65.93 -56.12 13.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.647 ' CG ' HD22 ' A' ' 92' ' ' LEU . 17.2 m0 -81.51 -33.77 31.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.1 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 79.73 37.26 23.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.428 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.35 147.6 50.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 110.73 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.7 38.14 3.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -96.49 150.35 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.644 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -26.34 36.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.078 0.466 . . . . 0.0 110.396 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.61 -152.3 8.53 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.585 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -152.81 116.7 4.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.71 0.29 . . . . 0.0 111.084 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.833 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.62 105.62 16.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -117.65 161.34 19.81 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 105.08 12.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.388 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 74.1 m95 -75.69 136.41 40.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 112.259 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CE2' ' CG ' ' A' ' 75' ' ' GLU . 26.9 m-85 -118.78 133.73 55.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.03 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.919 HD23 ' HB ' ' A' ' 73' ' ' ILE . 17.8 tp -79.57 135.28 36.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.097 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.911 ' CD1' HG23 ' A' ' 19' ' ' ILE . 38.3 m-85 -127.87 133.46 49.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.188 0.518 . . . . 0.0 112.187 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.557 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -96.02 119.44 34.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.507 177.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.619 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -68.56 122.89 19.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 110.761 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 p -124.54 37.55 4.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.27 -145.01 4.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.097 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.64 154.19 45.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.84 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -77.17 -17.98 58.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.2 -26.22 42.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.761 HG21 ' CE1' ' A' ' 29' ' ' PHE . 16.4 mt -72.51 98.68 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.341 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -113.89 95.79 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.4 mt -56.58 -21.15 24.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.457 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.866 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -59.67 -56.88 16.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.417 0.627 . . . . 0.0 109.867 179.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 136.85 -174.96 21.37 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.436 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -90.96 38.66 0.96 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.09 29.43 74.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.96 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -111.79 -64.8 1.24 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.0 111.38 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.46 165.11 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 146.05 94.68 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.866 ' HG3' HD13 ' A' ' 122' ' ' LEU . 47.4 Cg_exo -54.84 140.89 78.27 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.607 2.204 . . . . 0.0 112.381 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -110.65 -27.35 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.462 ' HB2' HD13 ' A' ' 121' ' ' LEU . 5.9 m-85 -118.74 159.44 23.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.588 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.5 -16.34 5.59 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.772 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.556 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 4.7 mp0 -152.24 174.27 13.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.734 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.4 p-90 -159.59 154.19 24.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.114 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.57 159.63 44.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.366 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 74.7 m95 -93.68 125.82 38.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 145' ' ' LEU . 27.4 m -138.8 151.17 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 111.696 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.33 160.42 79.12 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.588 ' HD3' HD11 ' A' ' 28' ' ' ILE . 14.4 Cg_endo -57.0 -18.19 27.36 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 121.875 1.717 . . . . 0.0 111.929 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.27 -34.24 14.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.121 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -50.24 37.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.977 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.942 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.5 tp -54.49 -31.82 56.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.457 0.646 . . . . 0.0 109.75 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.49 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.0 mm -69.84 -27.81 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.622 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.71 -23.56 42.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.065 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.3 mt -81.67 -39.8 23.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.86 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 147' ' ' VAL . 8.8 m -55.73 165.2 0.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.866 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 14.8 p -95.84 161.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.53 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.52 -27.0 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.866 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 23.1 p90 -90.9 10.11 27.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' A' ' 82' ' ' TYR . 18.4 mtmt -150.07 13.98 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 111.611 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.7 mtpp -69.07 -62.79 2.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.141 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.3 Cg_endo -51.49 -40.01 63.79 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 111.988 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.821 HG21 ' HB3' ' A' ' 82' ' ' TYR . 22.7 t -58.73 -25.03 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.88 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.26 -51.46 5.29 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.541 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HG3' HD12 ' A' ' 143' ' ' ILE . 11.1 mtpt -50.31 -33.95 21.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.463 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 6.6 tp10 -64.9 -46.02 83.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.69 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.6 t -59.31 -48.43 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.22 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.517 HD13 ' CB ' ' A' ' 139' ' ' PRO . 72.5 mt -64.19 -48.65 75.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.616 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.6 m -49.4 -47.38 47.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.747 HG11 ' HA ' ' A' ' 76' ' ' VAL . 72.1 t -66.8 -24.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.134 0.492 . . . . 0.0 110.459 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.881 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.6 m-30 -101.24 -0.77 35.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.116 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.32 -51.86 24.12 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.333 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -55.74 -22.82 38.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.372 2.048 . . . . 0.0 112.176 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.618 ' ND1' HG22 ' A' ' 73' ' ' ILE . 88.8 m-70 -93.45 -19.55 21.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.7 mp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.479 " H2'" HD11 ' A' ' 36' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.99 145.07 54.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.613 2.209 . . . . 0.0 112.297 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 3' ' ' LEU . 4.2 pp -176.55 145.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.76 -32.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.478 ' C ' ' HE2' ' A' ' 6' ' ' MET . 0.3 OUTLIER -125.89 -154.84 0.65 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.894 0.378 . . . . 0.0 110.188 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.537 ' HE3' HG23 ' A' ' 81' ' ' THR . 1.0 OUTLIER -131.2 -44.33 1.03 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.662 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 1.9 t0 70.56 29.42 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.819 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 170.32 119.23 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HD3' ' NE1' ' A' ' 79' ' ' TRP . 21.0 Cg_endo -61.84 110.37 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.203 1.936 . . . . 0.0 111.962 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 6.3 Cg_exo -73.16 -172.7 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.733 2.289 . . . . 0.0 111.87 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -89.87 144.38 25.99 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.141 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' HZ3' ' A' ' 101' ' ' LYS . . . 92.42 -35.99 3.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -72.65 138.74 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 111.107 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 30.2 tpt85 -82.72 152.15 25.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.07 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -79.19 128.21 33.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 8.5 m120 -152.55 163.36 39.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.816 HG13 HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -128.95 135.0 63.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.077 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.84 142.14 15.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.385 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.887 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -119.03 101.17 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.2 t -89.8 103.85 16.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 110' ' ' PHE . 42.6 tp -102.87 140.52 37.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 111.11 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -124.54 157.34 35.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.836 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.9 p-10 -101.21 169.5 8.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -54.85 -17.61 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.626 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.24 56.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 110.942 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt 76.68 25.8 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.529 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.7 mttp -96.28 171.65 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 28' ' ' ILE . 4.0 mp -109.55 123.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.812 ' CE1' HG21 ' A' ' 119' ' ' ILE . 74.9 t80 -57.72 110.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.48 134.35 54.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.8 135.9 54.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.61 153.85 25.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.572 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -70.73 157.12 38.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 111.402 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -5.71 52.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.56 -18.11 4.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.148 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.3 mt -119.65 107.96 39.95 Favored Pre-proline 0 N--CA 1.456 -0.144 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.911 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 24.8 Cg_exo -62.49 128.93 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.0 t0 80.65 2.7 1.79 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.83 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.31 97.46 11.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.422 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.3 m95 -104.97 156.78 17.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.0 -177.0 2.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.753 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.44 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 2.9 mpp? -106.49 158.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 139.98 40.85 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -154.02 162.23 41.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.788 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.58 18.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.1 137.4 29.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.645 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.816 HD11 HG13 ' A' ' 17' ' ' VAL . 4.9 mt -70.75 159.55 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.555 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.65 149.61 22.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.921 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.25 98.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.236 0.541 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.08 39.84 11.05 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.919 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.8 tp10 -112.24 147.39 36.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.153 0.501 . . . . 0.0 110.872 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.03 133.79 78.34 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.595 ' O ' HG11 ' A' ' 17' ' ' VAL . 53.1 Cg_exo -52.56 -55.13 4.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.06 . . . . 0.0 112.609 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 58' ' ' ILE . 1.2 ttt-85 -59.13 -22.76 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.11 -49.66 7.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.733 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.456 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.53 -28.45 65.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.599 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -75.33 -51.37 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.074 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.5 mt -55.71 -30.67 27.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.047 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -80.54 -53.23 6.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.825 0.821 . . . . 0.0 109.838 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -55.96 -33.36 64.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.632 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.776 HD11 ' HB ' ' A' ' 67' ' ' VAL . 8.5 tp -58.05 -61.24 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.115 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.612 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.9 ptp180 -62.39 -9.17 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.506 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.86 -47.66 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.71 -30.39 17.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.266 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.742 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.07 -22.76 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.576 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 71.07 8.85 65.69 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.957 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.776 ' HB ' HD11 ' A' ' 61' ' ' LEU . 39.7 t -70.35 118.11 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.791 0.329 . . . . 0.0 110.342 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.08 -35.18 11.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.17 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.424 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.78 6.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.37 128.9 13.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.901 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.66 148.96 42.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.688 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.4 t -77.74 128.03 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.454 0.645 . . . . 0.0 111.924 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.46 -19.86 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.381 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.66 164.05 36.33 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.084 0.469 . . . . 0.0 111.622 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -148.98 118.51 6.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.516 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.883 HG11 HD21 ' A' ' 80' ' ' LEU . 3.4 t -57.91 110.39 2.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.059 0.457 . . . . 0.0 110.045 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.77 -23.41 11.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.257 2.638 . . . . 0.0 113.332 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.707 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -112.67 -175.75 2.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.235 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.534 ' C ' HD22 ' A' ' 80' ' ' LEU . 51.3 m95 -105.36 147.96 27.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.658 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.905 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.6 mm? -109.22 118.46 36.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.219 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.768 HG22 ' CB ' ' A' ' 104' ' ' ALA . 8.4 p -120.14 131.18 54.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.864 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -126.47 170.2 12.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.525 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.81 158.29 42.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.238 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.25 153.75 46.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.548 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HG2' HG23 ' A' ' 88' ' ' VAL . 31.0 Cg_endo -63.38 171.99 5.93 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.414 2.076 . . . . 0.0 112.056 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.13 -17.35 58.65 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.794 2.329 . . . . 0.0 113.327 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -91.64 -36.43 13.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.143 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' A' ' 85' ' ' PRO . 75.8 t -79.45 -48.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.15 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -57.15 -49.49 75.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.728 . . . . 0.0 109.7 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.1 tm-20 -67.07 -25.16 66.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.898 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -43.73 18.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 96' ' ' TRP . 94.5 mt -61.86 -46.66 88.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.943 0.401 . . . . 0.0 110.428 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.57 -34.13 4.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.721 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.718 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.8 mt -96.53 -45.51 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.513 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -56.07 7.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.768 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.468 ' CD2' HD22 ' A' ' 92' ' ' LEU . 11.5 m0 -78.0 -32.24 51.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.722 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.03 36.57 40.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.324 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.81 147.23 46.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 110.718 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 0.5 OUTLIER -109.57 63.06 0.6 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.41 ' CE3' ' O ' ' A' ' 99' ' ' ASP . 9.2 m95 -132.51 132.73 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.153 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HZ3' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -73.48 -30.55 63.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.419 0.628 . . . . 0.0 109.962 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 103' ' ' GLN . . . -150.67 -158.84 8.46 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.752 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 10.1 mp0 -151.25 112.52 4.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.756 0.313 . . . . 0.0 111.186 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.768 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -86.54 105.56 16.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.504 ' NE2' ' OH ' ' A' ' 82' ' ' TYR . 7.0 pt20 -124.34 152.18 43.44 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -101.72 101.19 11.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.01 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.614 ' CD2' HG21 ' A' ' 157' ' ' VAL . 31.0 m95 -71.33 138.53 49.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 0.0 111.689 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 62.8 m-85 -123.23 134.09 54.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.547 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.858 HD13 ' CD2' ' A' ' 161' ' ' PHE . 19.4 tp -79.69 132.03 36.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.392 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.887 ' CD1' HG23 ' A' ' 19' ' ' ILE . 44.8 m-85 -126.08 128.83 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.12 121.23 33.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.645 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -66.09 125.27 24.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.027 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 69' ' ' SER . 11.6 p -127.54 37.68 4.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.638 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.64 -144.7 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.122 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.82 154.18 44.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.878 0.37 . . . . 0.0 110.064 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.95 -16.47 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.69 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -18.33 54.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.704 0.287 . . . . 0.0 111.245 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -79.52 -24.79 41.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.0 110.837 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.812 HG21 ' CE1' ' A' ' 29' ' ' PHE . 21.2 mt -75.71 104.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.112 0.482 . . . . 0.0 111.568 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.51 95.86 4.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.859 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.822 HD13 ' HB2' ' A' ' 131' ' ' PHE . 61.3 mt -53.48 -24.46 13.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.626 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.431 HD22 ' CG ' ' A' ' 129' ' ' PRO . 18.3 mt -62.45 -57.55 10.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 110.026 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.66 -178.16 21.27 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -91.11 38.97 0.98 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.8 66.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -121.21 -69.64 0.83 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -84.86 165.1 17.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.32 145.21 39.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.431 ' CG ' HD22 ' A' ' 122' ' ' LEU . 50.7 Cg_exo -53.31 128.68 30.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.579 2.186 . . . . 0.0 112.634 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.89 -32.28 6.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.542 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.822 ' HB2' HD13 ' A' ' 121' ' ' LEU . 14.6 m-85 -110.3 159.67 17.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.2 -19.94 5.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.987 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.4 mm-40 -152.48 175.38 12.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.115 0.483 . . . . 0.0 110.746 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.2 p-90 -157.15 154.25 29.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.195 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.09 161.47 42.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.367 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.454 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 72.1 m95 -94.7 123.56 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 145' ' ' LEU . 32.4 m -135.52 151.21 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.033 0.444 . . . . 0.0 111.578 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.16 162.4 69.54 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.634 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.64 ' CA ' HD13 ' A' ' 158' ' ' LEU . 37.8 Cg_exo -58.06 -18.54 36.6 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.792 1.661 . . . . 0.0 111.914 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.07 -34.51 14.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.223 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.66 -50.6 34.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.023 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.909 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.01 -32.16 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.522 0.677 . . . . 0.0 109.818 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.564 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.2 mm -68.32 -28.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.746 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.64 -22.38 40.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.6 mt -83.5 -39.54 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 150' ' ' LYS . 3.6 m -59.48 167.4 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.512 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.2 p -101.26 159.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -51.84 -40.88 61.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.512 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.4 p90 -79.58 1.5 25.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.472 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 27.6 mttm -136.44 7.56 3.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.573 0.225 . . . . 0.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 14.1 mtpt -70.31 -62.39 2.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.105 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.6 Cg_endo -53.93 -43.14 60.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.379 2.053 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.905 HG13 ' HB3' ' A' ' 80' ' ' LEU . 78.0 t -57.35 -25.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.698 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -90.69 -53.25 4.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.445 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.564 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.52 -31.91 16.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.229 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.84 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.0 tp10 -65.21 -46.17 81.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.503 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 107' ' ' TRP . 49.1 t -59.83 -48.41 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.226 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.64 HD13 ' CA ' ' A' ' 139' ' ' PRO . 71.9 mt -64.27 -49.15 72.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.1 m -50.35 -44.28 54.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.757 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.3 t -72.42 -24.83 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 110.595 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.858 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.8 m-30 -102.93 8.48 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.097 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.71 -52.61 62.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.725 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.7 Cg_endo -52.82 -23.39 20.57 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.509 2.14 . . . . 0.0 112.375 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.641 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.5 m-70 -89.91 -23.34 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.734 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.696 ' OXT' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.856 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.481 ' O2B' ' NE2' ' A' ' 103' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.61 175.69 7.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.63 2.22 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 mp 60.11 -177.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.24 53.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.543 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.485 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -137.91 -158.75 0.89 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.905 0.384 . . . . 0.0 110.122 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.0 mmt -148.11 -32.94 0.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.05 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 1.2 m-20 71.07 20.74 5.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.791 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 169.39 143.13 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.63 107.69 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.163 1.909 . . . . 0.0 112.178 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.884 ' HG2' HG21 ' A' ' 81' ' ' THR . 18.2 Cg_exo -66.18 -155.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.09 2.527 . . . . 0.0 112.646 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.814 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -29.84 -145.67 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.657 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.97 33.72 2.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.794 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 26.8 m-85 -67.12 153.65 43.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.197 0.499 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -89.51 152.16 21.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.396 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -81.03 125.31 30.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.603 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.3 t-20 -152.58 157.7 41.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -123.5 125.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.238 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -95.52 147.61 18.69 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.246 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.747 ' CD1' ' HB1' ' A' ' 57' ' ' ALA . 2.0 mm -116.24 101.69 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 111.541 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 5.7 t -92.07 97.84 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.889 HD12 ' O ' ' A' ' 110' ' ' PHE . 19.8 tp -102.52 151.61 22.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.178 0.513 . . . . 0.0 111.646 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.0 ptt? -134.37 157.4 46.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.397 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.509 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.48 170.16 8.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.557 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -18.85 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.539 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.74 1.73 54.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.328 . . . . 0.0 110.887 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 33.5 mtmt 72.9 26.88 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.664 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.1 mmtp -97.7 173.54 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.568 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -109.16 123.58 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.033 0.444 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CD2' HD23 ' A' ' 21' ' ' LEU . 3.0 t80 -58.13 104.4 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.66 135.27 53.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.752 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.88 138.49 53.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.46 157.45 23.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.759 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -74.85 158.71 32.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.25 0.548 . . . . 0.0 111.29 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 -4.78 48.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.953 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -129.24 -17.29 3.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.176 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.759 HD12 ' CD ' ' A' ' 33' ' ' ARG . 69.4 mt -121.39 112.06 33.04 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.094 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.3 Cg_endo -65.65 132.1 29.76 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.79 1.66 . . . . 0.0 111.683 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.38 5.36 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -91.74 97.6 11.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.301 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.733 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.2 m95 -104.86 156.68 17.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.185 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -168.76 -176.78 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.775 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.476 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 1.4 mtt -113.53 160.11 32.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.656 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 54.6 Cg_exo -52.01 128.88 28.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.629 2.219 . . . . 0.0 112.615 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -141.72 141.75 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.41 133.56 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.704 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.94 133.88 52.56 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.748 HD11 HG13 ' A' ' 17' ' ' VAL . 4.7 mt -65.16 159.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.611 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.2 m-20 -90.29 149.62 22.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -51.78 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.195 0.521 . . . . 0.0 110.756 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.71 10.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.904 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 14.5 tp10 -113.16 146.49 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 110.865 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.5 135.78 75.23 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.663 ' O ' HG11 ' A' ' 17' ' ' VAL . 58.8 Cg_exo -51.9 -55.24 4.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.434 2.089 . . . . 0.0 112.577 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 58' ' ' ILE . 8.8 ttm180 -59.4 -25.83 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.396 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -84.12 -50.49 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.729 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -56.21 -31.56 63.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.747 ' HB1' ' CD1' ' A' ' 19' ' ' ILE . . . -72.45 -53.91 10.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.102 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.0 mt -54.63 -28.49 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.238 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -83.19 -52.85 6.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -56.96 -37.51 71.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.861 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.835 HD11 ' HB ' ' A' ' 67' ' ' VAL . 9.2 tp -54.14 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.61 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -58.8 -12.23 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.05 -41.04 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.359 . . . . 0.0 111.462 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -90.55 -31.08 16.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.996 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.725 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.13 -21.24 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.84 2.97 72.49 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.835 ' HB ' HD11 ' A' ' 61' ' ' LEU . 24.6 t -67.52 110.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -95.02 -29.53 14.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.13 76.45 6.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.309 0.576 . . . . 0.0 110.536 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 131.4 15.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.545 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -118.91 139.73 51.16 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.249 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 26.7 t -68.69 120.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.37 0.605 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.869 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -94.97 -25.12 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.934 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -163.49 171.32 16.07 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.825 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -149.11 123.39 9.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.484 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.685 HG11 HD21 ' A' ' 80' ' ' LEU . 41.4 t -57.83 126.21 75.75 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.76 0.314 . . . . 0.0 110.317 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.47 -18.9 56.45 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.91 2.407 . . . . 0.0 113.123 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.676 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -123.17 -175.37 3.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 111.28 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.462 ' C ' HD22 ' A' ' 80' ' ' LEU . 53.5 m95 -102.9 147.41 26.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.062 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.928 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.1 mm? -105.24 117.54 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.647 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.884 HG21 ' HG2' ' A' ' 10' ' ' PRO . 51.8 p -116.03 137.97 51.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.311 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.878 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -134.39 170.11 16.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.338 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.98 158.37 39.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.184 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE1' ' O2A' ' A' ' 166' ' ' ATP . 8.6 m-85 -112.3 145.46 32.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.751 ' HG2' HG23 ' A' ' 88' ' ' VAL . 37.3 Cg_endo -66.47 171.33 10.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.471 2.114 . . . . 0.0 112.432 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.3 -16.31 46.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.912 2.408 . . . . 0.0 113.201 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -90.38 -38.23 13.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.523 . . . . 0.0 109.841 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.751 HG23 ' HG2' ' A' ' 85' ' ' PRO . 89.3 t -76.77 -49.83 22.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.946 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.54 -52.71 58.8 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.916 0.865 . . . . 0.0 109.639 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.743 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.7 OUTLIER -64.52 -31.5 72.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.99 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -45.22 49.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 96' ' ' TRP . 93.7 mt -61.05 -47.45 86.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 110.516 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.492 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 46.7 m-20 -47.91 -30.27 4.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.67 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.743 HD12 ' O ' ' A' ' 90' ' ' GLU . 4.5 mt -97.05 -47.94 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.416 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -55.37 8.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.945 0.403 . . . . 0.0 110.861 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.493 ' CD2' HD22 ' A' ' 92' ' ' LEU . 17.4 m0 -80.43 -29.66 37.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.875 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 70.69 38.09 67.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.241 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.8 154.09 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.99 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.27 77.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.455 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.42 150.71 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.048 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -75.64 -32.26 60.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.967 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.56 -133.31 1.88 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.374 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.9 mt-30 -158.09 114.38 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -93.78 105.85 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 1.1 pt20 -121.64 157.85 29.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.437 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -105.97 98.71 8.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.817 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.569 ' CD2' HG21 ' A' ' 157' ' ' VAL . 40.5 m95 -69.54 130.2 41.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.734 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 68.0 m-85 -116.5 135.53 53.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.881 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.1 tp -79.57 137.46 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.066 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.889 ' O ' HD12 ' A' ' 21' ' ' LEU . 40.1 m-85 -129.63 133.13 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.244 0.545 . . . . 0.0 111.925 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 34.1 tttm -96.25 119.99 35.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.489 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.672 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.9 t80 -68.41 123.22 20.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.99 0.424 . . . . 0.0 110.978 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.477 HG21 ' OE1' ' A' ' 71' ' ' GLU . 8.9 p -124.81 37.56 4.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.464 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.23 -145.16 4.9 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.69 154.06 47.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 109.998 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -49.87 -16.83 0.3 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.541 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -22.66 56.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.28 -25.61 58.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.403 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 36.8 mt -67.99 104.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.468 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' THR . 1.2 t-20 -120.92 95.43 4.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 131' ' ' PHE . 32.0 mt -55.49 -21.58 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.693 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.588 HD22 ' HG3' ' A' ' 129' ' ' PRO . 16.7 mt -65.16 -60.03 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.84 -175.09 24.68 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.542 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -91.81 38.75 0.99 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.134 0.492 . . . . 0.0 109.89 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.65 73.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.104 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 t -115.58 -69.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.24 165.09 12.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.177 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 149.27 65.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.588 ' HG3' HD22 ' A' ' 122' ' ' LEU . 73.8 Cg_exo -49.91 124.92 13.42 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.613 2.208 . . . . 0.0 112.57 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -106.27 -28.58 10.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.587 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.9 m-85 -110.91 159.18 17.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.87 -22.76 4.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.697 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.7 mm-40 -152.27 174.34 13.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 110.552 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p-90 -159.95 159.88 32.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.26 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.26 167.6 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.509 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 68.8 m95 -97.02 121.58 39.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.687 HG23 ' HB2' ' A' ' 142' ' ' LEU . 35.3 m -132.49 150.53 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.717 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -70.76 160.05 83.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.64 ' CA ' HD13 ' A' ' 158' ' ' LEU . 14.1 Cg_endo -56.89 -18.14 26.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 121.855 1.703 . . . . 0.0 111.915 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -34.06 15.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.987 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -50.91 23.54 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.87 -31.25 59.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.447 0.642 . . . . 0.0 109.845 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.597 HD11 ' CA ' ' A' ' 155' ' ' LYS . 9.1 mm -70.03 -27.29 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.62 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.24 -17.12 47.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.145 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 142' ' ' LEU . 13.4 mt -87.59 -38.98 15.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 147' ' ' VAL . 25.6 m -57.58 163.16 2.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.03 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.683 HG12 ' HB2' ' A' ' 150' ' ' LYS . 13.0 p -90.0 161.82 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.965 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.517 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -55.68 -31.3 62.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.759 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.646 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -92.6 7.39 43.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.683 ' HB2' HG12 ' A' ' 147' ' ' VAL . 4.5 mttm -133.27 -8.27 2.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.513 0.197 . . . . 0.0 111.505 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.517 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.6 mtpp -54.47 -59.43 10.31 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.264 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 16.8 Cg_endo -57.78 -42.63 57.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.3 2.0 . . . . 0.0 111.938 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.928 HG13 ' HB3' ' A' ' 80' ' ' LEU . 85.9 t -57.5 -27.92 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.86 -53.91 4.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.382 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.597 ' CA ' HD11 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -47.64 -38.3 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.868 ' HB3' HD11 ' A' ' 80' ' ' LEU . 8.4 tp10 -60.68 -46.26 91.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.505 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 107' ' ' TRP . 42.8 t -58.54 -49.49 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.331 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.64 HD13 ' CA ' ' A' ' 139' ' ' PRO . 68.4 mt -62.35 -49.59 74.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.3 p -49.83 -42.45 47.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.772 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.4 t -73.44 -24.6 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.115 0.483 . . . . 0.0 110.343 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.881 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.3 m-30 -104.63 12.05 33.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.995 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.559 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.01 -55.53 32.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.386 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.0 Cg_endo -55.87 -22.37 37.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.494 2.129 . . . . 0.0 112.248 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.473 ' ND1' HG22 ' A' ' 73' ' ' ILE . 98.4 m-70 -89.92 -17.97 27.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.484 HD23 ' SD ' ' A' ' 22' ' ' MET . 1.8 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.934 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.45 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.08 -167.99 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.343 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.4 pt? -59.31 -170.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.43 55.69 5.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -137.98 -160.67 1.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.05 0.452 . . . . 0.0 109.938 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 178.94 111.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.98 15.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.899 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.09 132.45 0.41 Allowed Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.79 122.32 9.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.273 1.982 . . . . 0.0 112.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 30.4 Cg_endo -90.59 177.4 2.25 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.784 2.322 . . . . 0.0 111.735 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.78 10.33 26.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.445 . . . . 0.0 111.995 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.19 -13.99 37.41 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.452 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 12.9 m-85 -129.97 141.34 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.026 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.433 ' HG2' ' CD2' ' A' ' 100' ' ' TRP . 29.9 mmm-85 -77.73 148.18 35.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -67.4 130.66 43.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.139 0.495 . . . . 0.0 111.534 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' ND2' ' HA2' ' A' ' 46' ' ' GLY . 1.0 OUTLIER -152.5 162.52 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.289 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.72 HG13 HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.93 126.26 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 0.0 111.25 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.09 138.84 14.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.273 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.929 HG21 HD22 ' A' ' 61' ' ' LEU . 4.8 mp -114.65 101.52 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.343 . . . . 0.0 111.26 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.9 t -90.17 104.58 17.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.5 tp -103.29 149.13 25.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.063 0.458 . . . . 0.0 111.143 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.564 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.9 ptt? -130.11 157.37 42.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.708 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.452 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.8 p-10 -100.73 171.0 7.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.468 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -57.65 -16.02 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.547 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.04 0.27 56.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp 76.9 27.48 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.656 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -98.83 171.21 8.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.524 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -109.91 121.23 62.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.967 0.413 . . . . 0.0 110.953 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.708 ' CE1' HG21 ' A' ' 119' ' ' ILE . 86.9 t80 -55.49 110.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.61 137.81 51.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.356 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -123.23 139.88 53.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.21 156.88 24.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.626 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.775 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -73.01 157.75 36.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 111.367 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.1 mt -90.5 -5.88 55.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.124 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.88 -16.6 2.89 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.775 HD12 ' CD ' ' A' ' 33' ' ' ARG . 61.6 mt -119.07 106.03 43.96 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 31.0 Cg_exo -60.77 129.05 27.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.164 1.909 . . . . 0.0 111.888 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.2 t70 80.61 0.93 1.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.929 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.52 97.67 10.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.4 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD1' HD22 ' A' ' 145' ' ' LEU . 49.5 m95 -101.47 155.09 18.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.119 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -169.13 -176.86 2.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.699 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.456 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 4.2 mpp? -102.66 157.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 121.37 7.9 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.601 2.201 . . . . 0.0 112.498 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -123.23 161.64 24.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.61 138.7 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.435 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' HA2' ' ND2' ' A' ' 16' ' ' ASN . . . -70.39 129.08 19.53 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 17' ' ' VAL . 4.9 mt -61.12 158.62 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -90.21 150.41 21.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.47 99.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.156 0.503 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.26 37.93 9.48 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.779 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 49.1 tt0 -114.39 147.92 38.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.174 0.511 . . . . 0.0 110.701 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.11 142.52 72.31 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.508 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HA ' HG11 ' A' ' 17' ' ' VAL . 49.0 Cg_exo -56.45 -57.88 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.504 2.136 . . . . 0.0 112.89 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 58' ' ' ILE . 4.8 ttt-85 -58.38 -24.78 60.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.43 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -87.71 -42.76 12.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 110.252 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.39 -32.7 73.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.197 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.28 -52.49 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 54' ' ' ARG . 51.4 mt -56.82 -29.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.999 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -81.2 -52.78 6.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.716 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 31.5 mm-40 -55.4 -44.83 76.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.638 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.929 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -55.17 -51.86 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.829 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.583 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 31.9 ttp180 -61.59 -13.68 23.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.577 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.02 -42.26 10.08 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -90.76 -27.05 19.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.72 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.45 -21.55 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 111.093 -179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.09 8.39 61.5 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.981 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.817 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.2 t -65.23 110.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.237 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.9 p -92.46 -34.95 13.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.239 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 76.6 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 111.055 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.44 129.34 13.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.605 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.526 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.4 pt-20 -119.14 140.28 50.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.323 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.3 t -69.28 121.65 19.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.353 0.597 . . . . 0.0 111.17 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.897 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -97.74 -22.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -163.37 165.65 23.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.504 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 10.6 pt-20 -149.06 121.17 8.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.809 ' HA ' HG11 ' A' ' 160' ' ' VAL . 32.4 t -56.94 126.01 71.28 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 -19.41 46.48 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.951 2.434 . . . . 0.0 113.242 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.65 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.13 -175.3 3.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 111.511 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.461 ' C ' HD22 ' A' ' 80' ' ' LEU . 17.1 m95 -104.57 147.76 27.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.77 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.889 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -104.52 118.08 35.72 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.418 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.869 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -119.98 133.71 55.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.949 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.886 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -133.85 170.31 15.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.98 161.24 23.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.634 0.731 . . . . 0.0 111.42 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 10.8 m-85 -111.15 144.06 29.66 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.775 ' HG2' HG23 ' A' ' 88' ' ' VAL . 39.5 Cg_endo -66.92 171.48 11.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.648 2.232 . . . . 0.0 112.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.07 -16.49 46.08 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.013 2.475 . . . . 0.0 113.354 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -91.21 -35.98 14.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 110.085 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.775 HG23 ' HG2' ' A' ' 85' ' ' PRO . 84.5 t -78.42 -48.6 22.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.149 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -56.67 -52.27 65.54 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.763 0.792 . . . . 0.0 109.74 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.604 ' O ' HD13 ' A' ' 94' ' ' ILE . 3.9 tt0 -61.96 -27.03 68.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -44.76 14.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.957 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 96' ' ' TRP . 72.5 mt -62.6 -46.82 86.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 110.52 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.432 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 4.1 m-20 -47.35 -31.35 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.717 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 90' ' ' GLU . 3.5 mp -96.77 -47.42 12.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.919 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -58.16 4.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 110.761 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LEU . 22.3 m0 -77.25 -32.13 55.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.3 35.65 37.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.484 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.5 153.69 49.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.86 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -117.12 46.71 1.63 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.631 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.433 ' CD2' ' HG2' ' A' ' 14' ' ' ARG . 90.9 m95 -95.06 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -30.83 66.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -179.51 -133.85 2.06 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.937 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 14.1 pt20 -157.96 114.84 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.0 111.343 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.869 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.46 105.78 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.848 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.519 ' NE2' ' OH ' ' A' ' 82' ' ' TYR . 10.1 pt20 -123.19 144.87 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -95.66 98.68 10.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 178.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.621 ' CD2' HG21 ' A' ' 157' ' ' VAL . 22.2 m95 -66.14 143.57 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.193 0.52 . . . . 0.0 112.149 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.3 m-85 -129.21 136.98 50.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.246 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.897 HD23 ' HB ' ' A' ' 73' ' ' ILE . 23.6 tp -79.34 155.01 28.64 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.869 ' O ' HD12 ' A' ' 21' ' ' LEU . 32.8 m-85 -146.1 132.73 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.252 0.549 . . . . 0.0 112.023 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 5.5 tptp -96.46 118.27 32.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.53 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.643 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -68.17 120.69 14.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 0.0 110.701 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.42 HG21 ' OE1' ' A' ' 71' ' ' GLU . 5.9 p -121.81 37.43 4.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.457 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.83 -144.38 4.7 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.086 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.29 154.29 45.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 110.004 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -49.73 -16.8 0.27 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -15.7 59.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.02 -25.47 37.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.708 HG21 ' CE1' ' A' ' 29' ' ' PHE . 14.9 mt -73.18 103.89 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.582 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.48 95.85 4.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.024 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.0 mt -56.02 -21.65 22.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.654 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 129' ' ' PRO . 14.6 mt -62.95 -58.84 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 109.984 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.69 -172.19 24.5 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.435 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -93.31 38.82 1.05 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.15 0.5 . . . . 0.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.45 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.302 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.8 m -114.28 -67.75 0.97 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.769 0.318 . . . . 0.0 111.25 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -98.38 165.1 12.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -76.37 147.54 79.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.489 ' HB2' HD11 ' A' ' 34' ' ' LEU . 53.1 Cg_exo -51.69 136.18 49.81 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.613 2.209 . . . . 0.0 112.55 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -108.12 -28.39 9.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.653 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 19.0 m-85 -120.37 159.69 24.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.17 -18.11 6.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.85 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.419 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.4 mm-40 -152.45 174.94 13.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.193 0.52 . . . . 0.0 110.782 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.4 p-90 -159.45 152.38 21.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.964 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 m -148.08 157.26 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.541 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.452 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 86.9 m95 -92.81 125.11 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.745 HG11 HD11 ' A' ' 145' ' ' LEU . 27.0 m -136.73 151.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.118 0.485 . . . . 0.0 111.662 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.13 159.07 85.8 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.555 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.574 ' O ' HD13 ' A' ' 158' ' ' LEU . 11.7 Cg_endo -55.82 -18.63 22.21 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.841 1.694 . . . . 0.0 112.016 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -34.17 15.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -50.45 30.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.944 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.9 tp -54.3 -29.8 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.32 0.581 . . . . 0.0 109.829 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.548 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -69.83 -28.49 37.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.655 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -22.39 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.268 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.944 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.5 mt -82.97 -39.15 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 147' ' ' VAL . 26.9 m -53.87 164.21 0.62 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 150' ' ' LYS . 10.3 p -97.24 162.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.528 ' N ' HG22 ' A' ' 147' ' ' VAL . 15.8 mt-10 -51.51 -38.38 53.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.985 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 23.8 p90 -88.34 10.82 18.55 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.571 ' HB2' HG12 ' A' ' 147' ' ' VAL . 67.3 mttt -130.95 -5.12 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.419 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 12.2 mttt -55.97 -62.0 5.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.9 Cg_endo -59.01 -48.16 15.28 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.388 2.058 . . . . 0.0 112.233 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.889 HG13 ' HB3' ' A' ' 80' ' ' LEU . 92.3 t -57.22 -27.1 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.24 0.543 . . . . 0.0 111.11 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.454 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.0 m-85 -90.91 -52.73 4.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.428 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.548 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.88 -31.85 18.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.308 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.804 ' HB3' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -65.39 -46.13 81.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.445 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.621 HG21 ' CD2' ' A' ' 107' ' ' TRP . 57.7 t -59.57 -53.2 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.32 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 139' ' ' PRO . 59.1 mt -62.85 -50.01 72.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.9 t -51.66 -45.61 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.0 t -69.84 -25.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 110.297 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.838 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.9 m-30 -101.96 7.98 41.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.23 -56.23 21.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.623 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.9 Cg_endo -50.16 -24.67 11.65 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.567 2.178 . . . . 0.0 112.384 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 95.9 m-70 -95.39 -18.34 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.564 HD23 ' SD ' ' A' ' 22' ' ' MET . 1.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.964 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.535 " H4'" HG13 ' A' ' 88' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.03 152.0 67.76 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.62 2.213 . . . . 0.0 112.278 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -57.48 178.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.712 ' N ' HD22 ' A' ' 3' ' ' LEU . . . 124.72 40.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.14 125.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -123.49 -40.56 2.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.246 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 t0 71.35 24.93 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t 176.31 133.91 0.18 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.701 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 41.9 Cg_endo -68.25 110.78 2.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.341 2.028 . . . . 0.0 112.324 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 5.5 Cg_exo -79.27 -176.97 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.93 2.42 . . . . 0.0 112.151 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.49 151.84 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.34 -37.8 3.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.642 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -83.77 144.59 29.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.51 152.23 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -75.93 126.96 32.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.6 t-20 -152.5 157.07 40.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.786 HG13 HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -125.45 124.49 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.891 0.377 . . . . 0.0 111.202 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.55 140.96 15.44 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.197 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.824 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -121.23 101.83 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.441 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.3 t -89.76 107.3 19.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.2 tp -103.19 146.54 28.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.7 157.53 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.976 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.7 p-10 -100.59 170.93 8.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.06 -18.21 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.608 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 0.31 56.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.988 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp 76.83 25.63 0.85 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.558 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttp -94.4 172.44 8.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.566 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -110.54 120.35 61.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.947 0.403 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' HG21 ' A' ' 119' ' ' ILE . 68.2 t80 -53.9 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.129 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.52 131.57 56.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.368 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.33 138.29 51.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.914 0.388 . . . . 0.0 111.178 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.29 155.87 24.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.4 mtp85 -70.41 159.16 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 111.599 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.9 mt -92.84 -5.81 50.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.831 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.51 -19.49 4.19 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 66.8 mt -120.4 112.76 34.1 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.968 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.09 131.61 29.22 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.858 1.705 . . . . 0.0 111.911 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.32 2.66 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.94 97.36 10.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.301 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CD1' HD22 ' A' ' 145' ' ' LEU . 26.2 m95 -102.34 155.41 18.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -168.62 169.15 10.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.477 ' HE1' ' CG ' ' A' ' 154' ' ' TYR . 76.2 mtm -89.92 155.22 47.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.16 149.37 22.16 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.697 2.265 . . . . 0.0 113.061 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -176.39 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.214 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 138.08 4.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.296 -0.955 . . . . 0.0 112.858 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.76 126.32 29.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.786 HD11 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -60.99 161.28 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.685 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -88.34 -176.38 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.2 98.62 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.23 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.79 47.39 9.8 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.749 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 6.5 tt0 -115.62 146.75 41.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.55 134.86 84.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.588 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.677 ' O ' HG11 ' A' ' 17' ' ' VAL . 55.2 Cg_exo -52.43 -57.25 2.2 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.401 2.067 . . . . 0.0 112.659 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -56.84 -28.06 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.434 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -81.97 -49.7 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.718 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.16 -30.76 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.824 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.65 -52.0 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 54' ' ' ARG . 43.9 mt -55.85 -28.71 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.244 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG3' ' NH2' ' A' ' 62' ' ' ARG . 36.5 ttp85 -83.62 -52.8 6.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.885 0.85 . . . . 0.0 109.89 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -56.36 -34.55 66.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.684 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.81 HD12 ' OG1' ' A' ' 65' ' ' THR . 5.4 tp -57.13 -59.54 4.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.181 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.566 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 22.4 ptt85 -61.34 -10.71 7.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.793 0.33 . . . . 0.0 110.691 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -91.19 -45.12 8.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 0.0 111.561 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.46 -28.12 17.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.81 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -113.56 -21.49 10.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.837 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.17 4.85 74.53 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.039 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.699 ' HB ' HD11 ' A' ' 61' ' ' LEU . 55.8 t -75.2 119.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.364 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -99.25 -34.07 10.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.35 78.27 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.184 0.516 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.39 129.6 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.924 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -120.0 145.76 46.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.577 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.556 HG22 ' CE1' ' A' ' 110' ' ' PHE . 53.1 t -76.11 125.9 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.527 0.679 . . . . 0.0 111.967 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.933 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.62 -16.19 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.339 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.586 ' HB2' ' ND1' ' A' ' 164' ' ' HIS . . . -155.35 160.18 40.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 115.56 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.104 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.87 ' HA ' HG11 ' A' ' 160' ' ' VAL . 7.2 t -57.33 127.47 77.0 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.951 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 -15.55 44.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.784 2.322 . . . . 0.0 113.585 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -128.34 174.63 9.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.493 0.663 . . . . 0.0 112.364 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.454 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 13.0 m95 -99.8 147.09 25.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.876 ' HB3' HG13 ' A' ' 153' ' ' VAL . 46.1 mt -114.34 117.56 31.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.763 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.728 HG22 ' CB ' ' A' ' 104' ' ' ALA . 3.0 p -113.56 130.57 56.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.865 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -131.91 160.14 36.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.46 158.38 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.182 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.11 150.17 37.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.537 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.6 Cg_endo -62.59 170.86 6.33 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.441 2.094 . . . . 0.0 112.027 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.6 -17.47 59.66 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.786 2.324 . . . . 0.0 113.298 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -93.32 -33.11 14.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.122 0.486 . . . . 0.0 110.216 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.537 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.4 t -84.26 -47.0 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -59.72 -45.66 91.48 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.635 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -67.66 -27.73 67.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.524 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -46.6 19.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.482 HD22 ' CD1' ' A' ' 96' ' ' TRP . 95.8 mt -58.67 -46.56 86.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 0.0 110.525 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -46.48 -32.27 3.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.696 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.66 -47.55 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -54.75 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.482 ' CD1' HD22 ' A' ' 92' ' ' LEU . 10.9 m95 -80.45 -29.94 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.8 34.75 47.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.548 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.73 147.18 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.586 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -118.43 64.28 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.019 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.3 m95 -119.5 150.04 40.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.74 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 -30.14 55.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -166.04 -144.5 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -158.16 113.44 2.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 111.511 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.728 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.15 105.67 17.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.936 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.08 153.7 44.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.5 mttt -107.81 95.76 5.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.522 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.437 ' CD2' HG21 ' A' ' 157' ' ' VAL . 61.4 m95 -63.42 140.2 58.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.336 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 66.9 m-85 -125.82 138.32 53.82 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.402 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.786 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.6 tp -79.56 154.77 28.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.824 ' CD1' HG23 ' A' ' 19' ' ' ILE . 34.2 m-85 -148.51 127.83 13.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 0.0 111.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.933 ' HB3' HD11 ' A' ' 73' ' ' ILE . 22.8 tttt -93.72 119.58 32.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.576 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.655 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.9 t80 -62.77 125.31 23.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 71' ' ' GLU . 7.7 p -127.11 37.88 4.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.52 -144.84 4.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.071 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -127.2 154.26 45.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -49.83 -16.65 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.574 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -78.55 -18.1 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -80.3 -25.56 39.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.811 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.784 HG21 ' CE1' ' A' ' 29' ' ' PHE . 15.5 mt -74.15 102.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.369 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.49 96.09 5.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.115 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.748 HD13 ' HB2' ' A' ' 131' ' ' PHE . 53.0 mt -55.45 -22.73 21.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.436 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.448 HD22 ' HG3' ' A' ' 129' ' ' PRO . 19.5 mt -62.24 -58.51 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.13 -179.26 20.8 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.595 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -90.0 38.65 0.93 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.151 0.501 . . . . 0.0 109.768 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.93 73.4 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.254 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -102.88 165.19 11.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -73.41 148.48 88.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.448 ' HG3' HD22 ' A' ' 122' ' ' LEU . 59.5 Cg_exo -50.85 138.93 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.216 . . . . 0.0 112.624 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -112.07 -33.0 6.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.648 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.748 ' HB2' HD13 ' A' ' 121' ' ' LEU . 29.1 m-85 -116.83 159.38 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.522 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.93 -16.82 6.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.852 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 121' ' ' LEU . 20.2 mm-40 -152.31 175.04 13.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.3 p-90 -159.11 151.54 21.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.134 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 m -147.62 161.05 41.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.492 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.488 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.4 m95 -95.09 125.03 39.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.833 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -137.55 150.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.7 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -70.15 159.62 83.78 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.533 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.566 ' HD3' HD11 ' A' ' 28' ' ' ILE . 12.3 Cg_endo -56.27 -18.3 23.68 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 121.826 1.684 . . . . 0.0 111.999 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.06 -34.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.029 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.25 -50.48 32.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.069 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.907 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -53.62 -34.12 57.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.592 0.71 . . . . 0.0 109.885 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.55 HD12 ' CD ' ' A' ' 155' ' ' LYS . 7.8 mm -66.99 -27.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.737 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.31 -22.07 38.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.969 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.7 mt -84.11 -39.41 19.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.827 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -58.35 167.51 1.35 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.115 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.847 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 13.6 p -98.97 163.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.833 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.53 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -60.99 -36.62 79.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.847 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 8.5 p90 -79.38 -0.82 34.31 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.456 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -139.09 10.66 2.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.676 0.274 . . . . 0.0 111.278 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.437 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mtpt -69.45 -62.76 2.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.7 Cg_endo -53.99 -43.34 59.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.47 2.113 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.876 HG13 ' HB3' ' A' ' 80' ' ' LEU . 13.5 t -57.64 -24.59 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.477 ' CG ' ' HE1' ' A' ' 42' ' ' MET . 3.1 m-85 -91.02 -47.81 7.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.438 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.55 ' CD ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -51.57 -33.32 32.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.612 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.6 tp10 -67.15 -45.77 76.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 45.9 t -59.02 -47.09 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.056 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 139' ' ' PRO . 74.6 mt -66.65 -48.69 68.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.781 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -52.07 -45.85 64.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.79 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.87 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.3 t -69.56 -24.84 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 110.679 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.786 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.0 m-30 -98.17 -7.86 28.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.16 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -50.19 -44.92 82.15 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.559 0.218 . . . . 0.0 111.371 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 35.6 Cg_exo -60.5 -22.97 73.94 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.63 2.22 . . . . 0.0 112.679 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' A' ' 74' ' ' ALA . 58.7 m80 -95.02 -44.48 7.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.793 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.641 HD12 HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.427 ' O2B' ' CH2' ' A' ' 96' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.86 -167.63 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.598 2.199 . . . . 0.0 112.248 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.458 ' C ' HD13 ' A' ' 3' ' ' LEU . 1.9 tm? -58.86 88.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.07 -30.67 4.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.54 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -140.59 -161.78 1.26 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 79' ' ' TRP . 4.5 tpp -168.24 108.46 0.53 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.757 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.45 12.55 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.057 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -158.46 123.83 2.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 52.2 Cg_endo -68.79 112.49 2.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.081 1.854 . . . . 0.0 112.337 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -89.01 -170.14 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.997 2.464 . . . . 0.0 112.326 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -88.72 163.75 15.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.83 -40.33 2.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB3' ' CA ' ' A' ' 103' ' ' GLN . 5.5 m-85 -100.94 134.2 44.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -78.96 152.62 30.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.548 ' NH1' ' HB3' ' A' ' 9' ' ' PRO . 4.8 mmp_? -66.5 128.16 35.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.254 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 1.8 t-20 -152.77 159.03 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.449 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.761 HG13 ' CG1' ' A' ' 47' ' ' ILE . 4.5 m -136.23 125.33 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.994 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.39 154.8 20.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.925 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.944 HG23 ' CD1' ' A' ' 110' ' ' PHE . 5.2 mp -128.88 110.87 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' PHE . 43.0 t -90.57 103.97 16.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 110' ' ' PHE . 25.1 tp -102.88 149.61 24.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.065 0.459 . . . . 0.0 111.239 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.563 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -127.96 158.25 38.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.967 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' HB3' ' CZ3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -108.55 167.32 10.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.65 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -49.08 -19.24 0.4 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.56 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 0.0 111.467 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 76.71 23.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.659 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.91 171.71 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.598 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.59 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -108.77 123.44 64.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.018 0.437 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' HE2' HD13 ' A' ' 119' ' ' ILE . 9.3 t80 -52.43 116.84 2.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -122.14 132.29 54.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.024 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -121.69 139.8 53.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.981 0.419 . . . . 0.0 111.38 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.05 155.85 24.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.391 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.595 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -71.84 158.39 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.541 . . . . 0.0 111.634 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.3 mt -91.46 -6.03 53.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.997 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -131.11 -17.68 3.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.6 mt -118.6 111.7 37.66 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.0 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 131.72 29.66 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.94 1.76 . . . . 0.0 111.811 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.49 3.07 3.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.793 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.22 97.41 11.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.475 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.7 m95 -102.39 155.73 18.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.252 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -169.13 -176.94 2.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.692 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.3 mpp? -103.29 158.26 32.15 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.57 146.61 80.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.463 2.109 . . . . 0.0 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.456 ' HB2' HE21 ' A' ' 44' ' ' GLN . 0.0 OUTLIER -153.98 176.64 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.18 6.44 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.81 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.71 130.77 20.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.222 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.761 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.9 mt -58.59 159.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.3 m-20 -90.49 149.47 22.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.822 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.44 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 39.8 10.84 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.935 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.9 tp10 -114.12 146.78 39.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.908 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -72.54 140.98 82.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.497 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HA ' HG11 ' A' ' 17' ' ' VAL . 33.1 Cg_exo -57.77 -37.8 95.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.357 2.038 . . . . 0.0 112.471 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 58' ' ' ILE . 4.5 ttp180 -75.78 -23.34 55.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.67 -43.97 10.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.445 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.04 -30.84 71.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.32 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.4 -51.37 17.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 54' ' ' ARG . 58.0 mt -56.82 -28.77 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.18 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 ttp85 -84.25 -52.8 5.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.792 0.806 . . . . 0.0 109.991 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -53.15 -42.54 66.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.827 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -55.83 -54.64 42.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.531 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.8 ttp180 -61.17 -13.92 21.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.299 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -92.01 -40.85 10.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.836 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.39 -26.26 18.96 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.808 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.02 -20.55 8.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.35 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.48 4.09 73.7 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.098 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.653 HG13 ' HE1' ' A' ' 112' ' ' PHE . 55.8 t -71.02 118.58 15.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.616 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -98.62 -35.25 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.29 80.85 6.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.944 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.63 130.8 14.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.035 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 pt-20 -120.3 144.0 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.02 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.5 t -76.79 122.95 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.646 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.887 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.5 mm -107.08 -15.33 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 109' ' ' LEU . . . -155.98 154.03 30.47 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.837 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -148.67 117.93 6.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.81 ' HA ' HG11 ' A' ' 160' ' ' VAL . 7.5 t -57.53 127.03 77.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.926 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.58 -6.12 18.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.923 2.415 . . . . 0.0 114.117 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.531 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -136.53 138.97 41.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' MET . 24.9 m95 -64.28 145.32 56.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.279 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.851 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -103.92 138.73 40.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.643 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.4 p -139.18 130.7 27.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.844 ' CD1' HG11 ' A' ' 153' ' ' VAL . 9.9 p90 -139.1 170.44 15.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.95 158.3 35.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.018 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -102.44 154.21 37.59 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.703 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.669 ' HG2' HG23 ' A' ' 88' ' ' VAL . 25.6 Cg_endo -62.46 170.02 7.37 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.389 2.059 . . . . 0.0 112.145 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.88 -9.67 23.94 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.836 2.358 . . . . 0.0 113.131 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -97.03 -32.51 11.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.146 0.498 . . . . 0.0 110.024 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.669 HG23 ' HG2' ' A' ' 85' ' ' PRO . 98.5 t -84.11 -49.33 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -58.84 -49.39 77.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.597 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.5 tt0 -61.27 -29.64 69.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.403 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -46.64 17.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 96' ' ' TRP . 93.8 mt -57.83 -46.95 84.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.642 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.408 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.9 m120 -45.74 -31.89 2.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.475 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.43 -49.6 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.278 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -56.28 10.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.793 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.5 m0 -77.62 -33.97 53.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.92 36.61 27.96 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.346 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.56 147.6 52.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -108.39 37.81 2.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.94 150.44 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -25.43 41.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.44 . . . . 0.0 110.578 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -177.98 -137.82 2.9 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.826 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.42 ' CA ' ' HB3' ' A' ' 13' ' ' TYR . 3.6 pt20 -158.16 115.28 2.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.704 0.287 . . . . 0.0 111.436 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.643 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.92 105.56 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -123.6 154.44 39.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -111.31 103.83 12.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.696 178.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.672 ' CD2' HG21 ' A' ' 157' ' ' VAL . 28.1 m95 -66.23 146.18 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.201 0.524 . . . . 0.0 112.085 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 50.8 m-85 -129.13 130.65 46.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.925 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.656 HD23 ' HB ' ' A' ' 73' ' ' ILE . 20.2 tp -78.72 151.81 31.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.944 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.1 m-85 -148.62 128.0 13.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.887 ' HB3' HD11 ' A' ' 73' ' ' ILE . 16.0 tptt -92.62 122.45 35.05 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -64.88 126.35 27.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.849 0.357 . . . . 0.0 111.226 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.2 p -125.45 37.34 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.37 -145.03 4.76 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.106 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -128.51 154.31 46.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.837 0.351 . . . . 0.0 110.147 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -49.33 -17.13 0.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.33 -20.38 57.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.802 0.334 . . . . 0.0 111.224 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.21 -26.28 52.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.537 HD13 ' HE2' ' A' ' 29' ' ' PHE . 31.5 mt -68.68 104.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.474 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.1 95.87 4.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.159 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 131' ' ' PHE . 61.0 mt -57.34 -21.04 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.522 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.859 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -60.53 -57.66 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.95 -179.65 18.71 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.19 38.72 0.94 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.71 28.44 73.76 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.127 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -114.99 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.269 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -102.17 165.12 11.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -74.71 145.54 81.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.859 ' HG3' HD13 ' A' ' 122' ' ' LEU . 52.5 Cg_exo -53.82 137.98 68.32 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.577 2.184 . . . . 0.0 112.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.57 -28.22 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.573 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.9 m-85 -118.02 159.5 23.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.23 -19.66 5.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.723 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 32.3 mm-40 -152.25 174.51 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.078 0.465 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.9 p-90 -159.27 154.05 24.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.388 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.14 166.25 26.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.301 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.483 ' CZ3' ' HB3' ' A' ' 23' ' ' ASN . 54.1 m95 -99.54 125.67 45.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.2 m -139.28 151.44 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -69.76 162.48 67.56 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.466 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.596 ' O ' HD13 ' A' ' 158' ' ' LEU . 19.3 Cg_endo -58.78 -16.72 32.63 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.762 1.642 . . . . 0.0 111.995 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -35.01 13.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.2 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.36 33.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.051 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.943 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.57 -27.81 41.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.473 0.654 . . . . 0.0 110.014 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.619 HD12 ' HG3' ' A' ' 155' ' ' LYS . 5.2 mm -73.52 -27.45 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.843 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.45 -23.79 42.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.085 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.8 mt -81.01 -40.18 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 109.922 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 150' ' ' LYS . 4.4 m -57.89 169.3 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.872 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.1 p -105.37 159.03 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.551 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 147' ' ' VAL . 11.3 pt-20 -42.42 -51.87 4.81 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.514 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -71.11 -7.29 45.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.238 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.493 ' O ' HG21 ' A' ' 146' ' ' THR . 1.9 mttt -123.34 -1.59 8.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.586 0.232 . . . . 0.0 111.514 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 15.6 mtpt -68.63 -60.74 4.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.277 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 14.8 Cg_endo -57.3 -42.68 59.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.304 2.002 . . . . 0.0 111.538 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 80' ' ' LEU . 35.0 t -61.07 -24.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 3.4 m-85 -90.64 -50.19 6.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.253 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.619 ' HG3' HD12 ' A' ' 143' ' ' ILE . 7.9 mtpm? -51.38 -30.92 20.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.377 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.781 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.3 tp10 -67.54 -46.23 73.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.322 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.672 HG21 ' CD2' ' A' ' 107' ' ' TRP . 39.4 t -62.13 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.102 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 139' ' ' PRO . 73.7 mt -67.19 -49.07 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.6 t -51.13 -46.86 62.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 76' ' ' VAL . 87.1 t -66.12 -24.03 33.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.192 0.52 . . . . 0.0 110.34 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.719 ' O ' HD12 ' A' ' 165' ' ' LEU . 10.5 m-30 -98.65 -6.67 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.786 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.67 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -44.69 -39.46 7.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.689 ' HD2' ' C ' ' A' ' 161' ' ' PHE . 20.5 Cg_endo -63.17 -23.84 72.88 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.135 1.89 . . . . 0.0 113.8 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 161' ' ' PHE . 3.2 p80 -89.37 -25.41 21.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.754 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.9 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.42 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 175.72 8.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.32 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 3' ' ' LEU . 2.1 pt? -175.0 159.44 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.82 84.98 1.41 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.457 ' HB3' ' CG ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER 64.08 125.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.626 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 tpt -112.0 -47.23 3.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.7 t70 66.07 23.08 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m 173.1 119.32 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.59 109.66 1.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.282 1.988 . . . . 0.0 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 -174.95 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.904 2.403 . . . . 0.0 112.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.29 153.57 20.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.834 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.01 -38.23 3.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.557 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -86.85 136.95 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 3.7 ttt85 -84.25 152.42 24.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -63.74 129.4 39.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.527 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 20.5 t-20 -152.65 150.82 29.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 53' ' ' PRO . 2.7 m -123.28 141.37 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.34 149.85 17.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.281 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.936 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -129.22 101.6 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.1 t -89.63 106.29 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 110' ' ' PHE . 32.6 tp -102.68 143.0 32.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 111.195 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.3 ptt? -127.74 157.3 40.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 40.0 p-10 -103.3 170.21 8.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.302 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -55.74 -17.47 6.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.515 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.02 0.42 56.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.731 0.3 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 76.47 26.43 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 22' ' ' MET . 12.6 mttt -97.01 173.88 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.544 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -112.2 121.4 64.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.943 0.401 . . . . 0.0 110.884 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.458 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 12.6 t80 -54.73 108.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.384 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.79 134.49 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.27 141.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 111.319 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.29 158.31 23.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.614 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.667 ' CD ' HD12 ' A' ' 36' ' ' ILE . 5.0 mtp-105 -71.26 163.65 27.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.35 0.595 . . . . 0.0 111.676 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.2 mt -96.67 -7.33 34.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.564 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.13 -18.51 4.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.348 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.667 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.7 mt -120.73 112.76 33.61 Favored Pre-proline 0 N--CA 1.457 -0.109 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.171 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.44 132.1 30.18 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.955 1.77 . . . . 0.0 111.792 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.37 2.47 3.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.829 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.67 97.55 11.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.312 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.552 ' CD1' HD22 ' A' ' 145' ' ' LEU . 38.0 m95 -101.18 156.08 17.64 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.933 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -168.98 169.43 9.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 43.2 mtm -97.09 155.9 36.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 129.67 20.15 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.193 . . . . 0.0 113.038 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 141.74 19.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.57 160.84 28.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.863 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.9 126.84 7.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.629 HD11 HG13 ' A' ' 17' ' ' VAL . 11.7 mt -55.71 162.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.579 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 47' ' ' ILE . 8.5 m-20 -73.48 -170.9 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.573 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.06 29.28 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.275 0.56 . . . . 0.0 111.145 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.53 52.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 2.7 tt0 -128.43 148.17 50.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.088 0.47 . . . . 0.0 111.076 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.13 128.19 81.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.87 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.66 ' HA ' HG11 ' A' ' 17' ' ' VAL . 1.4 Cg_endo -45.93 -29.73 6.3 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.59 2.194 . . . . 0.0 113.11 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.551 HH12 HG11 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -73.48 -29.57 62.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.775 0.322 . . . . 0.0 110.917 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -86.67 -44.59 11.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.195 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -58.15 -31.69 67.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.92 -54.76 7.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.066 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ARG . 31.6 mt -56.05 -31.7 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -78.84 -53.4 7.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.832 0.825 . . . . 0.0 109.89 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -50.87 -38.97 52.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.45 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.1 tp -58.15 -58.88 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.129 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.526 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 ptp180 -61.42 -11.84 12.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -91.62 -43.74 9.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 0.0 111.718 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.78 -25.4 19.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.72 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -115.43 -20.91 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.12 5.17 70.26 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG13 ' HE1' ' A' ' 112' ' ' PHE . 53.2 t -74.72 129.34 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 p -105.71 -34.63 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.27 81.64 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.912 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.54 14.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.653 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.2 OUTLIER -119.63 147.48 44.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.17 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.578 HG23 ' CE2' ' A' ' 110' ' ' PHE . 31.2 t -78.49 123.06 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.433 0.635 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.907 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -104.34 -22.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.274 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -152.11 159.75 43.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.18 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.5 pt-20 -148.31 111.7 4.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.171 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.67 HG22 HG21 ' A' ' 160' ' ' VAL . 3.8 t -57.62 125.73 73.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.219 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 4.8 Cg_exo -74.45 -8.14 20.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.845 2.363 . . . . 0.0 113.571 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.44 135.91 50.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 112.187 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD2' ' CG ' ' A' ' 106' ' ' LYS . 29.3 m95 -67.7 145.57 54.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.07 0.462 . . . . 0.0 110.109 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.633 ' HB3' HG13 ' A' ' 153' ' ' VAL . 55.7 mt -111.36 117.93 34.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.897 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.882 HG22 ' CB ' ' A' ' 104' ' ' ALA . 9.5 p -108.89 140.18 42.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.74 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.766 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -134.24 170.18 16.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.886 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.81 158.34 33.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -120.85 146.6 44.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.655 ' HG2' HG23 ' A' ' 88' ' ' VAL . 34.4 Cg_endo -64.52 172.28 6.95 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.603 2.202 . . . . 0.0 112.241 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.23 -9.59 25.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.844 2.363 . . . . 0.0 113.056 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -98.03 -35.24 10.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.146 0.498 . . . . 0.0 110.041 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.655 HG23 ' HG2' ' A' ' 85' ' ' PRO . 87.6 t -82.57 -45.34 19.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -60.74 -46.54 90.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 109.465 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.4 tm-20 -66.84 -28.22 68.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.586 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -47.63 16.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.627 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.44 HD22 ' CG ' ' A' ' 96' ' ' TRP . 78.7 mt -58.44 -45.48 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 110.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.1 m-80 -46.14 -32.01 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.468 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.47 -49.36 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.39 -56.87 8.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.44 ' CG ' HD22 ' A' ' 92' ' ' LEU . 18.3 m0 -77.83 -34.46 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.785 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 80.74 34.66 27.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.577 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.43 147.07 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.56 49.66 0.91 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 36.7 m95 -105.24 150.15 25.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.744 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -30.76 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.64 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -161.6 -143.44 3.68 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.098 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.9 mm-40 -157.64 115.55 3.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.883 0.373 . . . . 0.0 111.435 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.882 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -95.48 105.61 17.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 6.7 pt20 -124.34 154.78 39.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' CG ' ' CD2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -107.51 105.38 15.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.485 178.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' HG21 ' A' ' 157' ' ' VAL . 26.6 m95 -72.92 144.88 47.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.222 0.534 . . . . 0.0 112.259 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.9 m-85 -127.58 132.79 49.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.361 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.803 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.81 129.08 34.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.936 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.4 m-85 -123.73 127.87 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.907 ' HB3' HD11 ' A' ' 73' ' ' ILE . 2.2 tppp? -91.73 121.78 33.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.652 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.0 t80 -63.52 126.68 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.846 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.653 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.9 p -127.12 37.62 4.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.56 -145.17 4.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.066 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -129.64 154.16 47.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.882 0.372 . . . . 0.0 110.067 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.482 ' HA ' HD12 ' A' ' 119' ' ' ILE . 20.2 m-20 -49.5 -16.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.602 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -76.9 -23.29 52.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.88 -25.17 52.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.822 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 116' ' ' ASP . 23.2 mt -68.03 104.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.393 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' OD1' HD12 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -121.2 95.91 4.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.914 179.198 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 131' ' ' PHE . 44.8 mt -58.56 -21.05 51.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.499 HD23 ' CG ' ' A' ' 129' ' ' PRO . 2.3 mt -61.46 -57.44 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.799 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.87 179.04 21.81 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.575 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -90.25 38.75 0.94 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.214 0.531 . . . . 0.0 109.724 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.56 26.95 73.28 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.063 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -117.42 -69.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -96.44 165.13 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.204 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -77.43 148.81 77.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.499 ' CG ' HD23 ' A' ' 122' ' ' LEU . 64.2 Cg_exo -50.51 135.92 40.57 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.62 2.213 . . . . 0.0 112.597 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -111.91 -30.64 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.781 ' HB2' HD13 ' A' ' 121' ' ' LEU . 25.3 m-85 -118.34 159.51 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.7 -13.96 7.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.697 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.563 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.8 mp0 -152.17 174.18 14.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.085 0.469 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.3 p-90 -159.74 150.04 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 m -148.68 156.64 42.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.465 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -92.14 125.01 36.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.72 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -135.62 150.78 29.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.138 0.494 . . . . 0.0 111.579 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.8 159.67 83.08 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.583 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.582 ' CA ' HD13 ' A' ' 158' ' ' LEU . 12.9 Cg_endo -56.5 -17.97 23.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.917 1.745 . . . . 0.0 111.965 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.07 14.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.102 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.49 -50.63 29.58 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.959 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.3 tp -53.68 -33.43 55.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 109.819 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.55 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.0 mm -67.34 -27.65 39.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.811 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.3 -24.37 42.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.057 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.959 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.6 mt -82.34 -39.58 22.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.857 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 150' ' ' LYS . 3.3 m -54.25 168.59 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.272 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.5 p -103.65 160.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 147' ' ' VAL . 5.4 mt-10 -47.65 -40.61 20.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.349 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 21.7 p90 -86.22 8.3 21.7 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' HG21 ' A' ' 146' ' ' THR . 15.1 mttt -130.9 -1.61 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.588 0.233 . . . . 0.0 111.457 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 31.6 mttt -63.81 -62.85 4.64 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.269 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 14.7 Cg_endo -57.16 -41.4 74.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.102 . . . . 0.0 112.004 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.0 t -60.62 -26.78 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.15 0.5 . . . . 0.0 110.977 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.1 m-85 -91.09 -55.05 3.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.846 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HG3' HD12 ' A' ' 143' ' ' ILE . 34.6 mttm -47.92 -33.49 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.709 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.596 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.4 tp10 -67.94 -44.5 76.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.615 HG21 ' CD2' ' A' ' 107' ' ' TRP . 58.6 t -61.5 -49.17 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.222 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.582 HD13 ' CA ' ' A' ' 139' ' ' PRO . 73.9 mt -62.86 -48.4 79.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.658 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.9 m -49.58 -47.49 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.808 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.67 HG21 HG22 ' A' ' 76' ' ' VAL . 89.3 t -69.27 -24.98 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.664 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.803 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.6 m-30 -100.6 1.93 41.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.283 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.94 -54.47 40.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.355 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.29 -20.81 26.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.608 2.206 . . . . 0.0 112.379 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.601 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 19.5 m80 -89.51 -21.19 23.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.677 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.41 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.895 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.467 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.89 145.03 55.21 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.522 2.148 . . . . 0.0 112.307 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 3' ' ' LEU . 3.5 tp -133.52 -172.9 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.26 66.58 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.446 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 7.9 m -138.29 -159.82 1.0 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.975 0.417 . . . . 0.0 110.077 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.9 OUTLIER -159.88 100.15 1.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.864 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.28 12.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -156.81 120.27 2.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 19.5 Cg_endo -58.8 112.37 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.208 1.939 . . . . 0.0 112.053 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 21.2 Cg_exo -65.47 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.611 2.208 . . . . 0.0 112.118 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.36 144.04 26.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.342 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' C ' ' HE2' ' A' ' 101' ' ' LYS . . . 93.82 -40.56 2.75 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.731 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 49.3 m-85 -68.62 136.76 53.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.148 0.499 . . . . 0.0 110.919 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 14.9 ttt-85 -84.95 152.12 23.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.302 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.698 HH22 ' HB3' ' A' ' 104' ' ' ALA . 4.3 mmp_? -66.24 124.32 22.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 12.8 t-20 -152.65 159.9 43.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD11 ' A' ' 47' ' ' ILE . 3.7 m -133.96 146.79 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.52 150.47 17.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.891 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -127.89 101.98 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.277 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -89.45 104.93 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 110' ' ' PHE . 36.5 tp -103.09 141.59 35.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.061 0.458 . . . . 0.0 111.277 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.84 157.58 37.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.8 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.5 p-10 -101.4 171.33 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.241 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.33 -16.76 9.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.535 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.15 56.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.729 0.299 . . . . 0.0 110.972 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? 77.05 27.04 0.71 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.484 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -99.81 171.67 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.603 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -110.32 124.3 66.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.879 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.828 ' CE2' HG21 ' A' ' 119' ' ' ILE . 33.7 t80 -58.52 108.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.626 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.82 129.88 56.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.398 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -113.96 141.27 47.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.133 0.492 . . . . 0.0 111.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.53 158.84 22.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.726 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.568 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -67.6 165.92 16.03 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 111.712 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -89.31 -8.86 52.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.161 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' OD1' HG13 ' A' ' 36' ' ' ILE . 1.3 p30 -148.07 -7.51 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 49.9 mt -114.35 109.77 48.43 Favored Pre-proline 0 CA--C 1.523 -0.083 0 CA-C-N 118.562 0.619 . . . . 0.0 110.918 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 27.2 Cg_endo -64.87 130.85 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.892 1.728 . . . . 0.0 111.616 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.7 t70 80.89 1.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.485 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -94.67 97.66 10.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.153 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 33.3 m95 -108.91 162.17 14.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.859 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -168.73 164.8 12.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.457 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 77.6 mtm -94.9 157.79 36.12 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.66 132.99 32.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.646 2.231 . . . . 0.0 113.006 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.29 154.34 33.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.244 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.47 151.31 21.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.829 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.18 141.93 43.86 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.454 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.969 HD11 HG13 ' A' ' 17' ' ' VAL . 20.3 mt -76.68 164.32 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.952 0.406 . . . . 0.0 110.716 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.57 ' N ' HG22 ' A' ' 47' ' ' ILE . 3.2 m-20 -84.05 -175.8 5.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.671 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.63 100.01 6.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.324 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.65 49.77 17.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.615 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 3.1 tp10 -115.68 145.65 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -71.83 132.73 84.76 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.453 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.686 ' HA ' HG11 ' A' ' 17' ' ' VAL . 55.9 Cg_exo -52.96 -44.91 44.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.492 2.128 . . . . 0.0 112.9 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -59.92 -27.16 66.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -86.75 -47.37 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.712 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.02 -29.69 68.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -75.73 -50.35 15.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.7 mt -57.78 -30.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.088 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 3.1 ttp-105 -81.05 -53.54 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 109.815 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -53.96 -33.82 57.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.39 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.847 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -55.06 -59.82 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.609 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 5.9 ptt180 -61.47 -11.94 12.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.81 -39.57 11.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 111.548 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.402 ' OE2' ' PG ' ' A' ' 166' ' ' ATP . 5.0 mm-40 -90.26 -32.75 16.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.099 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.88 -23.24 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.091 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.53 1.54 82.69 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.847 ' HB ' HD11 ' A' ' 61' ' ' LEU . 51.1 t -67.2 115.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -33.9 14.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.478 ' HG ' ' CD ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -90.5 81.86 5.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.853 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.18 131.59 15.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.788 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.9 pt-20 -118.81 146.63 44.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.589 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.6 t -78.86 122.34 33.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.618 . . . . 0.0 111.529 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -104.62 -21.43 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.614 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -152.86 160.83 43.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.175 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.34 110.72 4.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.714 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.4 t -57.63 123.56 63.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.65 -6.03 17.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.798 2.332 . . . . 0.0 113.745 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.572 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -130.06 135.08 47.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.241 0.543 . . . . 0.0 112.09 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' MET . 27.9 m95 -66.46 147.24 53.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.848 ' HB3' HG13 ' A' ' 153' ' ' VAL . 53.2 mt -116.51 117.63 30.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.657 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.847 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.6 p -111.84 131.51 55.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.87 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -132.05 161.31 33.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.62 158.45 26.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.241 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -112.8 154.36 44.87 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.701 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.608 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.4 Cg_endo -62.95 171.61 5.85 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.531 2.154 . . . . 0.0 112.419 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.08 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.84 2.36 . . . . 0.0 113.165 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -91.46 -34.45 14.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.17 0.51 . . . . 0.0 110.017 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.608 HG23 ' HG2' ' A' ' 85' ' ' PRO . 71.3 t -82.41 -48.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.169 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.72 -46.13 84.83 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 109.538 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.611 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.6 tt0 -68.07 -28.29 67.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.6 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -46.93 22.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.661 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 96' ' ' TRP . 96.1 mt -58.51 -47.07 85.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.472 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.1 m120 -45.86 -31.67 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.549 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.7 mt -96.53 -49.13 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -55.2 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.869 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.477 ' CE2' HD22 ' A' ' 92' ' ' LEU . 18.9 m0 -78.43 -34.9 47.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.655 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.46 36.16 30.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.3 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 147.28 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.866 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.405 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -108.36 71.99 0.82 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.806 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.456 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 15.7 m95 -135.29 136.81 41.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.086 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' H ' ' HE3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -70.53 -32.95 70.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.199 0.523 . . . . 0.0 109.998 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -155.23 -153.11 6.4 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.665 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -158.21 116.65 3.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.747 0.308 . . . . 0.0 111.217 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.847 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.88 105.65 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -124.82 152.41 43.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -106.7 101.63 11.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.594 178.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.457 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 22.1 m95 -69.01 143.96 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 0.0 112.128 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 50.9 m-85 -124.83 135.74 53.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.277 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.816 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.6 tp -79.88 131.09 35.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.392 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.891 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.6 m-85 -125.39 127.35 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.673 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.56 123.62 34.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.691 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.7 t80 -67.51 128.82 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 111.328 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' SER . 4.7 p -128.7 37.64 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.264 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -136.34 -144.45 4.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.156 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 153.86 47.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.968 0.413 . . . . 0.0 110.199 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.87 -14.35 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.589 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.62 -17.84 40.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.38 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.478 ' CD ' ' HG ' ' A' ' 69' ' ' SER . 6.3 tt0 -81.37 -24.58 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.828 HG21 ' CE2' ' A' ' 29' ' ' PHE . 32.1 mt -69.46 105.32 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 111.579 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.556 HD22 ' HB2' ' A' ' 122' ' ' LEU . 47.3 t30 -116.7 95.88 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.874 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 51.6 mt -52.22 -24.82 7.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.669 HD22 ' HG3' ' A' ' 129' ' ' PRO . 54.0 mt -63.21 -57.64 9.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.252 0.549 . . . . 0.0 109.974 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.32 -177.45 25.59 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.5 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.29 39.01 1.01 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.142 0.496 . . . . 0.0 109.709 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.18 71.5 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -121.83 -64.18 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.82 165.15 17.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 155.52 47.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.003 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.669 ' HG3' HD22 ' A' ' 122' ' ' LEU . 83.8 Cg_exo -44.7 149.8 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.786 2.324 . . . . 0.0 112.773 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -144.21 -44.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 7.4 m-85 -111.6 159.74 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.35 -16.4 6.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.989 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.451 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 23.4 mm-40 -152.32 175.11 13.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 110.491 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.9 p-90 -159.09 150.96 20.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.178 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 m -148.55 162.24 40.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 73.8 m95 -95.67 125.33 40.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.657 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.853 HG11 HD11 ' A' ' 145' ' ' LEU . 27.8 m -137.63 150.96 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.097 0.475 . . . . 0.0 111.681 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.9 158.8 87.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.616 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.649 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.1 Cg_endo -54.89 -19.45 19.43 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 121.941 1.761 . . . . 0.0 112.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.19 -33.85 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.994 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -50.05 30.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.916 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.94 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.18 -29.67 46.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.447 0.641 . . . . 0.0 109.785 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.458 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.1 mm -69.53 -28.41 37.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.71 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.5 -21.02 42.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.127 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.94 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.0 mt -84.37 -39.54 18.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.933 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -58.33 164.98 2.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.971 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.846 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 15.0 p -95.57 160.85 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.516 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.9 OUTLIER -59.92 -27.07 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.846 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 24.8 p90 -91.1 10.9 24.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.435 ' HD3' ' CE2' ' A' ' 82' ' ' TYR . 10.1 mtmt -151.8 14.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.669 0.271 . . . . 0.0 111.584 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.516 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.8 mtpp -69.21 -62.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.25 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.1 Cg_endo -51.72 -41.98 59.18 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.533 2.155 . . . . 0.0 112.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.87 HG11 ' CD1' ' A' ' 82' ' ' TYR . 19.0 t -56.09 -27.24 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.439 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -90.59 -53.0 4.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.473 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.458 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.8 -31.86 18.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.192 0.52 . . . . 0.0 110.445 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.687 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.3 tp10 -67.58 -44.85 77.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.696 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 153' ' ' VAL . 43.6 t -61.31 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.06 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.649 HD13 ' CA ' ' A' ' 139' ' ' PRO . 71.8 mt -65.0 -48.71 73.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.55 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 t -49.43 -47.5 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.689 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.714 HG11 ' HA ' ' A' ' 76' ' ' VAL . 71.3 t -67.93 -25.41 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 110.35 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.816 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.5 m-30 -102.53 8.57 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.068 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.99 -57.26 16.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.27 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 14.1 Cg_endo -57.2 -22.02 46.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.512 ' ND1' ' HB2' ' A' ' 74' ' ' ALA . 69.1 m80 -89.91 -14.25 34.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.095 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.921 179.905 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.456 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 -177.93 2.18 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.577 2.184 . . . . 0.0 112.282 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.1 pt? -60.31 172.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.798 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 118.18 37.19 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.03 121.37 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.75 0.309 . . . . 0.0 110.552 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.83 -36.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.65 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 77.5 24.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 170.51 137.51 0.07 OUTLIER Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.517 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 36.2 Cg_endo -65.88 109.79 1.56 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.352 2.034 . . . . 0.0 112.187 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 6.1 Cg_exo -78.95 -177.14 3.69 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.102 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.35 152.5 20.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.911 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 -27.24 17.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.5 m-85 -109.2 138.16 45.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.978 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HD3' ' CD1' ' A' ' 100' ' ' TRP . 7.3 mtp85 -80.82 152.15 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 39.8 mtm180 -71.29 132.94 45.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.244 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.9 t-20 -152.83 157.16 40.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.868 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 47' ' ' ILE . 2.5 m -129.02 134.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 111.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.793 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -106.64 157.11 15.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.098 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.793 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.4 mm -120.77 101.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.691 0.246 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.7 t -89.59 97.28 11.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.4 tp -102.5 145.27 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 111.393 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.35 157.31 41.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.749 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.5 p-10 -102.06 170.33 8.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.348 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.48 -18.55 4.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.91 0.14 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 76.78 25.23 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.607 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' MET . 14.4 mttp -93.63 173.27 7.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.54 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -111.44 120.07 61.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 110.868 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 119' ' ' ILE . 19.8 t80 -53.88 110.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.422 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.53 129.93 56.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.52 138.95 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.059 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.04 155.56 25.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -71.77 157.37 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 111.546 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mt -91.86 -5.37 53.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.841 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.79 -21.44 4.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.024 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.9 mt -118.23 112.5 37.77 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.938 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.23 131.52 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.895 1.73 . . . . 0.0 111.765 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 77.43 3.25 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.89 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.94 97.45 10.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.563 ' CD1' HD22 ' A' ' 145' ' ' LEU . 24.4 m95 -101.06 156.92 17.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.292 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -168.38 -176.98 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.598 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -110.08 156.95 39.19 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HB2' HG12 ' A' ' 19' ' ' ILE . 72.2 Cg_exo -48.65 143.25 16.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.775 2.317 . . . . 0.0 113.021 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 145.1 22.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.37 133.1 2.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.741 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -62.62 140.28 45.94 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.329 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.747 HD11 HG13 ' A' ' 17' ' ' VAL . 4.3 mt -73.31 160.32 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -85.44 -177.18 6.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -77.9 99.22 5.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.35 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.45 9.69 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.729 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.1 tt0 -116.57 144.78 43.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.02 137.31 82.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.591 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.622 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.3 Cg_exo -53.39 -50.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.454 2.103 . . . . 0.0 112.457 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 58' ' ' ILE . 19.2 ttp180 -62.38 -25.43 67.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -83.64 -51.4 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.695 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.14 -31.13 65.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.22 -53.65 10.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 54' ' ' ARG . 54.4 mt -54.75 -27.92 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.192 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -83.82 -53.13 5.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.805 0.812 . . . . 0.0 109.626 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.57 -32.7 65.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.394 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -53.12 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.584 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.7 ptt180 -62.07 -10.87 11.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.448 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.81 -42.14 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.596 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -90.53 -32.42 16.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -21.91 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.995 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.46 4.8 70.75 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.956 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 61' ' ' LEU . 44.3 t -69.75 117.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.792 0.296 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -35.22 12.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.13 77.53 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.24 129.16 13.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.826 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.1 mm-40 -119.93 148.16 43.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.719 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.592 HG23 ' CE2' ' A' ' 110' ' ' PHE . 41.6 t -78.18 125.9 38.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 111.722 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.898 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -105.09 -20.42 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.318 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.709 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -156.06 163.19 39.98 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.231 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 1.3 pm0 -148.54 117.34 6.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.846 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.7 t -57.03 125.43 70.03 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.063 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.28 -17.74 60.78 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.771 2.314 . . . . 0.0 113.362 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.9 -176.45 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.395 0.617 . . . . 0.0 112.125 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.784 ' C ' HD23 ' A' ' 80' ' ' LEU . 15.2 m95 -109.15 147.29 32.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.924 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 4' ' ' GLY . 2.0 mt -112.35 117.75 33.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.02 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.839 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.3 p -111.14 132.25 54.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.518 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.867 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -126.7 169.52 13.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.52 158.41 40.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.108 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' CZ ' ' NE2' ' A' ' 103' ' ' GLN . 49.5 m-85 -109.72 154.38 42.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.609 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.1 Cg_endo -63.0 171.52 6.02 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.404 2.07 . . . . 0.0 112.34 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.93 -17.26 59.13 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.819 2.346 . . . . 0.0 113.238 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -92.31 -34.01 14.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.195 0.521 . . . . 0.0 110.169 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' A' ' 85' ' ' PRO . 70.3 t -82.96 -47.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.303 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -45.66 91.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.481 0.657 . . . . 0.0 109.49 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 94' ' ' ILE . 31.5 tt0 -68.69 -26.72 65.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.648 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 -46.74 17.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 96' ' ' TRP . 88.7 mt -59.21 -45.84 90.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -45.98 -32.13 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.4 -49.6 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.201 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -67.27 -55.24 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.781 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 92' ' ' LEU . 16.0 m0 -77.38 -35.17 54.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.72 36.48 25.71 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.287 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.81 147.46 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.749 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -111.91 42.88 1.66 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.424 ' CD1' ' HD3' ' A' ' 14' ' ' ARG . 55.3 m95 -102.45 150.32 23.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.706 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -30.14 60.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.19 -139.62 2.87 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.005 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.53 ' NE2' ' CZ ' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -158.11 115.7 2.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.789 0.328 . . . . 0.0 111.376 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.839 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.83 105.86 16.64 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -117.01 157.73 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -113.65 95.87 5.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.841 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD2' HG21 ' A' ' 157' ' ' VAL . 61.7 m95 -64.24 145.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 61.2 m-85 -129.31 134.19 47.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.267 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.861 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -80.02 132.21 35.95 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.58 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HD12 ' A' ' 21' ' ' LEU . 50.3 m-85 -127.16 128.49 46.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 111.278 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.898 ' HB3' HD11 ' A' ' 73' ' ' ILE . 21.3 tttm -92.8 122.76 35.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.668 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -65.8 126.12 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.874 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.7 p -128.42 37.91 4.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.549 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -139.19 -144.98 4.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.148 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.88 154.22 45.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.563 ' HA ' HD12 ' A' ' 119' ' ' ILE . 12.8 m-20 -50.2 -16.26 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -79.72 -17.48 53.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.26 . . . . 0.0 111.356 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -24.93 37.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.593 HG21 ' CE2' ' A' ' 29' ' ' PHE . 7.5 mt -72.46 103.82 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.66 95.59 5.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.952 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' A' ' 131' ' ' PHE . 47.5 mt -54.54 -24.23 19.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.453 HD22 ' HG3' ' A' ' 129' ' ' PRO . 15.5 mt -63.4 -56.96 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.273 0.558 . . . . 0.0 109.988 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.67 -178.5 23.37 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.465 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -90.64 38.73 0.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.067 0.461 . . . . 0.0 109.872 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.17 73.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.219 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -107.11 -65.16 1.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.778 0.323 . . . . 0.0 111.206 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -115.55 164.97 13.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.277 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 153.91 50.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.111 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HG3' HD22 ' A' ' 122' ' ' LEU . 74.6 Cg_exo -48.17 177.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.776 2.317 . . . . 0.0 112.672 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -150.07 -44.75 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.0 m-85 -112.06 159.91 18.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.411 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.68 -21.14 5.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.679 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.6 mm-40 -152.29 174.68 13.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 28.1 p-90 -159.12 154.74 26.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.332 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -151.71 158.73 43.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.458 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 80.1 m95 -92.58 125.81 37.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.901 HG11 HD11 ' A' ' 145' ' ' LEU . 27.3 m -137.4 150.69 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.729 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 4.1 p -68.91 159.18 83.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.576 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.54 ' HD3' HD11 ' A' ' 28' ' ' ILE . 13.0 Cg_endo -56.38 -18.91 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.873 1.715 . . . . 0.0 112.033 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -92.02 -33.88 14.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.117 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -71.08 -50.47 33.45 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.895 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.9 tp -53.16 -33.67 53.54 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.435 0.636 . . . . 0.0 109.876 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -64.88 -29.63 47.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.629 178.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.63 -31.49 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.8 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.901 HD11 HG11 ' A' ' 137' ' ' VAL . 9.4 mt -75.98 -40.46 53.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.033 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 147' ' ' VAL . 13.8 m -55.45 164.15 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.259 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.86 HG11 ' CE2' ' A' ' 149' ' ' PHE . 13.7 p -96.3 161.9 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -63.12 -33.62 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.86 ' CE2' HG11 ' A' ' 147' ' ' VAL . 8.3 p90 -79.88 0.92 29.13 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.497 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 5.0 mtmt -147.51 17.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.665 0.269 . . . . 0.0 111.437 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.1 mtpt -69.21 -62.75 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.012 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 13.6 Cg_endo -56.5 -40.73 82.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.146 . . . . 0.0 111.935 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.0 t -54.39 -25.52 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.08 -51.88 5.11 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -32.06 15.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.471 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -67.07 -45.52 77.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.623 179.226 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 57.1 t -58.44 -47.47 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.927 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 143' ' ' ILE . 36.7 mt -63.05 -49.16 75.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.794 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.7 t -49.35 -45.68 46.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.71 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.846 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.2 t -70.1 -24.62 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.465 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.861 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -103.82 8.55 37.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.088 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.642 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.68 -51.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.844 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.8 Cg_endo -52.67 -23.75 20.94 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.433 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.709 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 99.1 m-70 -90.4 -23.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.838 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.912 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.496 " H2'" HD11 ' A' ' 36' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.447 ' C ' HD22 ' A' ' 3' ' ' LEU . 54.2 Cg_endo -69.93 -173.16 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.567 2.178 . . . . 0.0 112.254 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.616 HD22 ' N ' ' A' ' 3' ' ' LEU . 2.6 mm? -112.53 79.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.678 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -170.91 36.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.544 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.93 120.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mmt -125.19 -40.06 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.587 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 74.43 19.08 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p 171.3 136.21 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.456 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 40.9 Cg_endo -68.17 109.7 2.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.347 2.031 . . . . 0.0 112.314 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 3.7 Cg_exo -75.05 -174.65 2.02 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.932 2.421 . . . . 0.0 112.073 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.14 154.55 19.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.906 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.16 -38.09 3.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -89.38 141.61 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -86.18 152.28 22.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.421 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.464 HH22 ' HB3' ' A' ' 104' ' ' ALA . 3.1 mmp_? -60.7 129.62 42.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.0 m-80 -152.73 160.21 43.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.682 HG13 HD11 ' A' ' 47' ' ' ILE . 1.2 m -135.39 148.4 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.033 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -118.28 150.11 18.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.289 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.892 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.9 mp -127.34 101.66 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.477 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.0 t -91.11 108.08 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.7 tp -103.45 148.96 25.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.455 . . . . 0.0 111.252 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.559 ' SD ' HD21 ' A' ' 109' ' ' LEU . 1.5 ptt? -131.26 157.54 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.674 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.456 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 30.8 p-10 -104.96 169.68 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.24 -18.29 5.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.77 2.88 52.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 19.5 mttm 73.23 26.85 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.565 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' HG22 ' A' ' 138' ' ' THR . 0.0 OUTLIER -95.27 172.51 8.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.549 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -110.2 117.89 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.812 ' HE2' HG21 ' A' ' 65' ' ' THR . 11.4 t80 -52.25 107.55 0.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.79 141.41 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.57 140.67 52.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.51 158.29 23.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.644 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.606 ' CD ' HD12 ' A' ' 36' ' ' ILE . 4.9 mtp-105 -71.69 163.55 27.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.438 0.637 . . . . 0.0 111.667 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.0 mt -97.14 -6.8 34.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.498 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.72 -18.18 3.92 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.606 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.6 mt -121.15 112.59 33.1 Favored Pre-proline 0 N--CA 1.457 -0.088 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.243 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.7 Cg_endo -65.59 132.41 30.85 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.884 1.723 . . . . 0.0 111.532 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.1 2.59 2.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.585 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.33 97.49 11.23 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.683 ' CD1' HD22 ' A' ' 145' ' ' LEU . 33.3 m95 -102.9 156.67 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.74 -176.9 2.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.666 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.479 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 64.1 mtm -108.14 155.45 40.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 134.42 29.4 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.19 159.35 41.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.52 166.76 36.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.26 135.35 14.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.409 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HG13 ' A' ' 17' ' ' VAL . 8.6 mt -66.08 160.99 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.663 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.68 150.69 21.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.883 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.63 97.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.72 38.81 9.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.048 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HB3' HG23 ' A' ' 47' ' ' ILE . 2.8 tt0 -114.67 145.18 42.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 -70.64 139.18 86.12 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.676 ' O ' HG11 ' A' ' 17' ' ' VAL . 49.1 Cg_exo -55.64 -55.51 2.96 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.443 2.096 . . . . 0.0 112.65 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.46 ' O ' HD12 ' A' ' 58' ' ' ILE . 26.9 ttp180 -59.21 -23.58 62.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.89 -48.16 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.16 -31.53 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.812 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.32 -54.12 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.113 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 54' ' ' ARG . 50.9 mt -55.81 -29.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.231 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 ttp85 -82.8 -53.06 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.02 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.63 -45.59 57.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.374 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -56.55 -52.5 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.61 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 42.9 ttp180 -62.45 -12.54 22.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.568 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.61 -41.86 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 111.571 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -90.6 -28.43 18.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.985 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.812 HG21 ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.93 -22.67 5.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.08 9.47 63.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.952 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HB ' HD11 ' A' ' 61' ' ' LEU . 21.3 t -60.38 108.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 110.139 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.99 -35.54 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.422 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.28 74.25 7.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.225 0.536 . . . . 0.0 111.247 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.41 126.38 11.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.564 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.5 mm-40 -119.67 147.73 44.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.821 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 47.7 t -76.83 125.54 36.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.494 0.664 . . . . 0.0 111.704 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.55 -17.38 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.525 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.519 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -154.49 162.16 41.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.006 0.432 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 46.5 tt0 -148.53 115.45 6.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.143 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.923 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.8 t -57.58 128.15 79.09 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -11.76 30.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.902 2.401 . . . . 0.0 114.071 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -132.14 153.15 50.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.338 0.589 . . . . 0.0 112.36 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.714 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.0 m95 -80.02 143.49 34.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 79' ' ' TRP . 2.4 mt -111.34 118.09 34.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.93 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.845 HG22 ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -113.5 130.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.792 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -132.98 160.62 36.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.619 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.9 158.38 29.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -102.43 155.51 36.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.608 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.644 ' HG2' HG23 ' A' ' 88' ' ' VAL . 28.1 Cg_endo -62.75 171.95 5.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.448 2.099 . . . . 0.0 112.157 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.13 -9.89 25.18 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.893 2.395 . . . . 0.0 113.032 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -98.36 -35.67 10.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 110.043 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.644 HG23 ' HG2' ' A' ' 85' ' ' PRO . 99.9 t -82.53 -44.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.247 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -46.2 90.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 0.0 109.509 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.634 ' O ' HD12 ' A' ' 94' ' ' ILE . 45.0 tt0 -67.73 -26.83 66.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.689 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -46.88 13.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.76 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' TRP . 88.8 mt -59.67 -45.27 92.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.423 . . . . 0.0 110.413 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.7 -34.03 3.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.49 -47.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.267 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.23 -56.99 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' LEU . 15.7 m0 -78.28 -34.97 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.86 35.36 22.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.522 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.04 147.1 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -114.73 41.0 2.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -103.74 150.12 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.659 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -31.15 64.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -167.3 -139.07 2.58 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.009 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -157.89 116.02 3.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.543 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.845 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -92.62 111.93 23.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.724 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.95 150.7 52.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -102.77 97.08 7.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.287 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 42' ' ' MET . 43.2 m95 -65.34 139.22 58.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 44.0 m-85 -120.23 138.44 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.539 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.852 HD13 ' CD2' ' A' ' 161' ' ' PHE . 25.3 tp -79.72 154.97 28.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.892 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.2 m-85 -148.17 127.87 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.437 . . . . 0.0 111.782 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 24.6 tttm -93.0 120.46 33.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.594 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.634 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.1 t80 -67.11 122.08 17.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.726 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' SER . 10.0 p -123.0 37.37 4.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.553 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -137.91 -144.38 4.69 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.152 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.07 154.2 45.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.61 -16.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -76.77 -16.9 59.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.256 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -25.36 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.755 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 mt -73.51 99.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -114.29 95.71 5.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 131' ' ' PHE . 46.6 mt -54.97 -21.99 13.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.809 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.552 HD22 ' HG3' ' A' ' 129' ' ' PRO . 24.0 mt -63.94 -59.48 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.269 0.557 . . . . 0.0 109.956 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.72 -170.48 26.96 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.483 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -95.6 39.07 1.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.82 75.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.052 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.9 t -120.88 -70.26 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 111.154 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.1 165.08 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.213 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -84.36 148.97 54.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.994 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.552 ' HG3' HD22 ' A' ' 122' ' ' LEU . 70.8 Cg_exo -50.15 130.76 29.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.649 2.232 . . . . 0.0 112.625 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.62 -30.33 7.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.508 ' HB2' HD13 ' A' ' 121' ' ' LEU . 34.5 m-85 -119.87 159.53 24.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.415 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.24 -16.16 6.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.716 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.67 174.0 14.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.223 0.535 . . . . 0.0 110.63 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.6 p-90 -159.85 155.17 25.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.066 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.1 m -153.87 159.44 41.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.405 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 81.1 m95 -92.76 124.06 36.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.63 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.724 HG11 HD11 ' A' ' 145' ' ' LEU . 29.0 m -135.28 150.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.494 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 1.5 p -70.4 160.54 80.85 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.479 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.603 ' CA ' HD13 ' A' ' 158' ' ' LEU . 16.2 Cg_endo -57.65 -17.89 30.69 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.765 1.643 . . . . 0.0 111.87 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -34.39 14.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.072 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -50.6 29.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.021 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.942 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.08 -31.45 51.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 109.801 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.529 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.6 mm -68.25 -28.42 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.694 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.55 -20.7 42.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.226 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.7 mt -85.05 -39.22 18.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 147' ' ' VAL . 48.6 m -57.76 162.37 3.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.122 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.954 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.4 p -96.0 160.66 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' N ' HG22 ' A' ' 147' ' ' VAL . 7.9 mt-10 -50.17 -33.01 17.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.954 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 19.5 p90 -89.36 13.73 12.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 2.7 mtmp? -139.21 -2.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.586 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 19.2 mttt -55.18 -62.2 4.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.535 0.207 . . . . 0.0 111.352 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.2 Cg_endo -60.81 -42.35 38.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.059 . . . . 0.0 112.201 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.792 HG11 ' CD1' ' A' ' 82' ' ' TYR . 10.3 t -57.8 -31.55 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.336 0.588 . . . . 0.0 110.874 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.479 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -90.57 -50.66 5.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.846 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.529 ' HD2' HD12 ' A' ' 143' ' ' ILE . 5.2 tttt -50.39 -34.23 23.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.2 tp10 -67.92 -45.01 75.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.623 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 153' ' ' VAL . 39.3 t -57.84 -44.42 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.113 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.603 HD13 ' CA ' ' A' ' 139' ' ' PRO . 75.3 mt -68.81 -48.81 62.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.746 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -51.59 -45.87 63.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.923 HG11 ' HA ' ' A' ' 76' ' ' VAL . 84.0 t -69.59 -24.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.852 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.5 m-30 -101.47 -2.35 30.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.303 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -47.19 -52.95 31.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.473 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.3 Cg_endo -53.85 -22.08 22.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.511 2.141 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 49.9 m80 -97.23 -16.97 20.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.686 0.279 . . . . 0.0 111.097 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 161' ' ' PHE . 5.4 mp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.924 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.445 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.12 145.33 54.77 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.526 2.151 . . . . 0.0 112.285 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 3' ' ' LEU . 3.0 mt -175.55 94.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.772 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -147.38 23.14 1.54 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.626 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.49 124.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.377 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.59 -31.87 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.892 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 69.57 22.26 6.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 176.33 140.5 0.22 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.333 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.498 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 55.7 Cg_endo -71.31 114.96 4.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.196 1.931 . . . . 0.0 112.786 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 7.2 Cg_exo -72.42 -172.03 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.581 2.187 . . . . 0.0 111.612 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -90.23 142.98 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA3' ' HZ3' ' A' ' 101' ' ' LYS . . . 92.53 -36.83 3.54 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.232 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 25.0 m-85 -77.12 135.9 38.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 111.205 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 2.5 tmm_? -87.14 152.59 22.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.381 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -67.2 132.17 47.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.115 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 35.6 t30 -152.96 151.09 29.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.029 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -128.2 127.78 67.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.019 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.767 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -101.11 161.73 18.32 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.233 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.6 mm -126.84 101.61 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.615 0.208 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 10.9 t -91.28 93.51 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.897 HD12 ' O ' ' A' ' 110' ' ' PHE . 17.1 tp -102.36 148.77 25.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.326 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.724 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.2 ptt? -131.02 157.53 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.793 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.3 p-10 -100.51 171.23 7.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.399 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -55.51 -18.25 6.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 0.56 56.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.363 . . . . 0.0 110.849 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp 76.37 25.16 1.01 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.713 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.2 mtpp -92.95 173.25 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.536 HG21 HD23 ' A' ' 142' ' ' LEU . 5.2 mp -110.54 116.66 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CD2' HD23 ' A' ' 21' ' ' LEU . 4.4 t80 -50.82 107.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.298 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.53 142.54 46.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.64 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -128.3 140.12 52.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.44 157.74 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.616 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -74.2 159.37 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.309 0.576 . . . . 0.0 111.455 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.0 mt -94.64 -5.33 45.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.887 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -127.81 -17.52 4.46 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.128 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.616 HD12 ' CD ' ' A' ' 33' ' ' ARG . 67.4 mt -122.11 112.65 31.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.978 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.35 132.04 30.15 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.835 1.69 . . . . 0.0 111.771 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 76.79 4.49 3.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.794 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.607 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.98 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.35 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.639 ' CD1' HD22 ' A' ' 145' ' ' LEU . 32.3 m95 -102.37 155.92 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.197 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.7 -176.95 2.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.81 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.432 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.5 mpp? -107.08 156.82 36.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HB2' HG12 ' A' ' 19' ' ' ILE . 75.1 Cg_exo -48.98 140.92 23.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.892 2.394 . . . . 0.0 113.088 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 43' ' ' PRO . 0.4 OUTLIER -141.66 142.92 33.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.056 179.22 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -153.95 118.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.57 120.87 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.305 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.633 HD11 HG13 ' A' ' 17' ' ' VAL . 5.4 mt -53.9 160.42 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.53 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.0 -176.03 4.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.61 99.68 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 48.81 18.64 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.604 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.11 146.01 42.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 110.969 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.13 136.13 93.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' HG11 ' A' ' 17' ' ' VAL . 32.5 Cg_exo -59.59 -60.96 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.566 2.177 . . . . 0.0 112.577 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -55.1 -23.39 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.4 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -87.06 -41.47 13.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.983 0.421 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -62.34 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.361 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -73.07 -53.88 9.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.098 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' ARG . 46.0 mt -55.33 -30.34 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.124 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.05 -52.82 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.811 0.815 . . . . 0.0 109.816 179.079 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 7.4 mm-40 -55.3 -36.42 66.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.459 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD12 ' OG1' ' A' ' 65' ' ' THR . 10.7 tp -61.06 -62.9 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.646 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.682 ' HG3' HG22 ' A' ' 68' ' ' THR . 2.1 tmm_? -59.55 -12.91 7.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.09 -45.66 8.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.938 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.79 -27.73 18.69 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.749 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -115.38 -20.79 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.691 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 79.52 -7.5 53.37 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.079 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.72 ' HB ' HD11 ' A' ' 61' ' ' LEU . 47.1 t -59.98 117.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.981 0.39 . . . . 0.0 110.571 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.682 HG22 ' HG3' ' A' ' 62' ' ' ARG . 21.0 p -101.88 -31.56 10.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.044 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 78.0 6.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.22 0.534 . . . . 0.0 110.848 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.45 130.37 14.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.707 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.1 pt-20 -119.66 140.56 50.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.3 t -69.64 116.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.302 0.572 . . . . 0.0 111.265 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.882 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.1 mt -91.1 -24.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.046 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -161.74 168.98 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.539 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.78 118.77 7.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.856 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.805 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.8 t -57.16 129.82 79.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.957 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.95 -19.46 63.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 113.332 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.593 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.98 -177.71 3.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.29 0.567 . . . . 0.0 112.1 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.731 ' C ' HD23 ' A' ' 80' ' ' LEU . 47.8 m95 -107.13 147.45 30.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.967 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 4' ' ' GLY . 3.5 mt -111.55 117.74 33.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.09 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.853 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.9 p -109.19 137.34 47.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.417 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.845 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -128.11 170.26 13.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.55 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.99 158.23 38.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.64 148.85 51.57 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.599 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.2 Cg_endo -63.29 168.13 11.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.54 2.16 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.4 -16.5 47.64 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.863 2.375 . . . . 0.0 113.079 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -91.58 -34.1 14.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 110.114 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.599 HG23 ' HG2' ' A' ' 85' ' ' PRO . 77.0 t -82.93 -49.01 17.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.198 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -45.68 83.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 109.498 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.632 ' O ' HD12 ' A' ' 94' ' ' ILE . 29.5 tt0 -68.41 -29.96 68.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.517 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -47.46 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.554 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.479 HD22 ' CD2' ' A' ' 96' ' ' TRP . 95.8 mt -57.56 -48.05 80.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.515 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -46.08 -31.11 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.7 mt -96.49 -48.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.353 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -55.08 12.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.91 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.479 ' CD2' HD22 ' A' ' 92' ' ' LEU . 21.8 m0 -79.04 -32.75 45.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 74.78 37.14 45.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.237 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -127.57 149.11 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.402 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 8.4 p-10 -105.98 69.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' SER . 11.9 m95 -135.27 136.3 41.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.952 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HZ3' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.11 -31.26 62.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 110.023 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -153.99 -153.5 6.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -158.16 117.06 3.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.739 0.304 . . . . 0.0 111.438 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.853 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.72 105.35 16.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.445 ' HG3' ' CD1' ' A' ' 107' ' ' TRP . 5.1 pt20 -115.79 153.75 30.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -107.85 95.81 5.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.569 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.638 ' CD2' HG21 ' A' ' 157' ' ' VAL . 27.4 m95 -65.18 138.24 58.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 112.034 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 74.0 m-85 -122.25 132.72 54.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.882 HD23 ' HB ' ' A' ' 73' ' ' ILE . 18.4 tp -79.33 134.37 36.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.186 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.897 ' O ' HD12 ' A' ' 21' ' ' LEU . 45.0 m-85 -126.89 132.9 50.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.299 0.571 . . . . 0.0 112.031 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.662 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 2.0 ttmt -95.14 120.2 34.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.411 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.642 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.1 t80 -68.59 121.9 17.38 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.755 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.547 HG21 ' OE1' ' A' ' 71' ' ' GLU . 7.7 p -122.73 37.32 4.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.6 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.77 -145.12 4.84 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.085 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -127.93 154.08 45.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 0.0 110.093 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.51 -15.25 0.4 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -84.1 -13.08 53.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 -25.33 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.962 0.411 . . . . 0.0 110.511 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 67' ' ' VAL . 18.4 mt -73.45 107.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.642 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -118.21 95.72 5.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.009 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.5 mt -53.35 -23.31 9.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.761 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.0 mt -63.22 -59.07 5.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.228 0.537 . . . . 0.0 109.977 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.53 -175.42 22.92 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.457 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -91.53 38.79 0.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.108 0.48 . . . . 0.0 109.818 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.55 73.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.171 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.1 t -108.85 -66.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.119 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -108.32 165.12 11.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -68.75 148.31 97.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 34' ' ' LEU . 61.9 Cg_exo -50.86 145.16 24.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.526 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -113.79 -35.72 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.615 ' HB2' HD13 ' A' ' 121' ' ' LEU . 11.2 m-85 -113.83 159.51 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.567 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.51 5.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.351 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.55 173.66 14.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.129 0.49 . . . . 0.0 110.5 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 33.6 p-90 -160.39 157.95 28.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.78 158.5 36.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.451 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.459 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.3 m95 -91.17 123.44 34.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.626 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 142' ' ' LEU . 32.8 m -134.33 151.12 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.164 0.507 . . . . 0.0 111.726 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -69.49 160.85 77.64 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.478 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.694 ' CB ' HD13 ' A' ' 158' ' ' LEU . 19.6 Cg_endo -58.59 -16.85 32.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.669 1.58 . . . . 0.0 111.876 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.34 -34.03 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.103 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -51.59 23.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.107 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.926 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.2 tp -54.29 -32.43 56.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.473 0.654 . . . . 0.0 109.806 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.598 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.2 mm -68.35 -27.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.781 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.1 -22.03 42.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.221 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.8 mt -83.99 -39.16 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.15 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 147' ' ' VAL . 23.6 m -55.55 164.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.759 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.9 p -93.71 165.01 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.054 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.9 mm-40 -55.66 -35.48 66.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.759 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.7 p90 -88.58 9.96 22.14 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 147' ' ' VAL . 20.0 mtmt -131.31 -3.46 3.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.523 0.202 . . . . 0.0 111.442 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.429 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttt -58.38 -63.27 4.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 15.5 Cg_endo -57.28 -41.49 72.62 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.176 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 82' ' ' TYR . 34.1 t -59.18 -28.97 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 4.1 m-30 -91.37 -54.01 4.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.842 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HG3' HD12 ' A' ' 143' ' ' ILE . 21.3 mttt -47.86 -34.34 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.2 tp10 -66.99 -45.18 78.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.779 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.638 HG21 ' CD2' ' A' ' 107' ' ' TRP . 56.9 t -57.27 -50.13 77.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.348 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.694 HD13 ' CB ' ' A' ' 139' ' ' PRO . 74.2 mt -62.45 -48.64 78.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.749 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -49.77 -47.29 51.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.805 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.5 t -68.92 -24.52 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 110.46 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.867 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.6 m-30 -104.11 9.28 36.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.154 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.625 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.57 -51.7 70.72 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.715 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.98 -23.48 21.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.51 2.14 . . . . 0.0 112.289 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.696 ' CE1' HG22 ' A' ' 73' ' ' ILE . 98.2 m-70 -89.78 -24.99 21.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.599 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.724 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.85 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.451 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.87 164.95 31.54 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.607 2.205 . . . . 0.0 112.273 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 133.74 55.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.79 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 66.57 22.15 71.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.618 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.24 123.07 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.816 0.341 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.0 mmt -134.72 -31.94 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.848 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 72.73 22.58 3.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.672 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p 173.67 133.98 0.12 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 39.2 Cg_endo -67.85 111.1 2.3 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.301 2.001 . . . . 0.0 112.367 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.39 -174.73 1.92 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.776 2.317 . . . . 0.0 112.009 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.29 153.99 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.97 -38.08 3.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.583 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -96.42 134.58 39.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -80.18 147.41 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' N ' ' HG3' ' A' ' 14' ' ' ARG . 34.2 mtm180 -65.1 137.52 57.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 6.5 m120 -152.32 153.18 33.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.298 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.722 HG13 ' CG1' ' A' ' 47' ' ' ILE . 1.0 OUTLIER -122.33 118.33 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.11 146.82 19.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.031 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.91 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -123.5 101.94 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.791 0.329 . . . . 0.0 111.259 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.06 100.54 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 110' ' ' PHE . 39.4 tp -102.69 139.28 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.068 0.461 . . . . 0.0 111.225 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.62 157.28 37.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.82 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -103.61 169.85 8.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.287 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -50.88 -18.36 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -88.99 0.23 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.097 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 75.64 25.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.688 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.9 mmtp -97.65 172.65 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.6 mp -109.74 125.25 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.77 ' CE2' HG21 ' A' ' 119' ' ' ILE . 54.7 t80 -58.76 110.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.61 129.87 56.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.109 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -115.21 136.09 53.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 111.489 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.429 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.1 p -82.38 154.84 25.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.535 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.74 158.54 36.11 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.227 0.537 . . . . 0.0 111.517 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.2 mt -91.94 -5.9 52.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.009 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -130.8 -17.43 3.18 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.625 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 55.1 mt -119.12 111.91 36.61 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.026 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.4 Cg_endo -65.28 131.4 28.22 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.873 1.715 . . . . 0.0 111.902 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.6 t70 77.73 2.69 2.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.78 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.625 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.94 97.22 11.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 50.5 m95 -104.68 157.88 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -168.89 173.78 6.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 69.5 mtm -102.25 156.86 34.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.69 131.78 26.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.613 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' CG ' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.15 157.72 39.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.51 34.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.589 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -79.75 130.87 10.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.556 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.722 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.6 mt -59.44 160.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.51 148.06 22.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -48.16 99.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.6 18.41 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.798 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.6 tp10 -111.38 147.2 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.933 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.23 128.9 85.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.338 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.57 ' HA ' HG11 ' A' ' 17' ' ' VAL . 51.9 Cg_exo -52.8 -23.59 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.329 2.019 . . . . 0.0 112.676 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' O ' HD12 ' A' ' 58' ' ' ILE . 9.6 tpt180 -85.54 -22.03 28.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -91.06 -43.45 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.491 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.459 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.59 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.547 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -71.84 -52.86 15.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.17 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 54' ' ' ARG . 64.1 mt -56.52 -27.83 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.316 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -84.88 -52.77 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.824 0.821 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -56.17 -34.24 66.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.592 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.787 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.4 tp -57.41 -59.0 5.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.042 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.569 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 25.1 ptt180 -60.99 -11.84 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 110.504 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -91.69 -43.52 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.886 0.374 . . . . 0.0 111.544 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.3 -25.94 19.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.301 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.787 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.68 -22.01 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.961 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.21 4.55 73.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.972 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.769 ' HB ' HD11 ' A' ' 61' ' ' LEU . 53.2 t -74.46 124.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.785 0.326 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -35.67 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.26 79.08 6.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.749 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 129.55 13.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.6 mm-40 -119.19 147.61 44.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.65 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 48.9 t -77.21 128.93 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.898 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.19 -18.63 7.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.378 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -159.27 162.25 36.07 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.423 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.9 pt-20 -148.83 118.77 7.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.721 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HA ' HG11 ' A' ' 160' ' ' VAL . 17.9 t -58.02 125.34 73.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.273 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.01 -19.8 69.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.739 2.293 . . . . 0.0 113.068 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.587 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.68 -176.74 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.031 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.691 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.4 m95 -108.75 147.1 32.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.023 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 4' ' ' GLY . 4.4 mt -112.29 117.7 33.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.01 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.866 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.9 p -108.65 136.7 47.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.683 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.824 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.0 170.18 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.337 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.03 158.04 40.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.427 ' CZ ' ' O1A' ' A' ' 166' ' ' ATP . 15.0 m-85 -116.16 150.61 45.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.578 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.0 Cg_endo -63.08 171.91 5.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.39 -17.78 60.83 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.8 2.333 . . . . 0.0 113.19 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 ttmm -91.52 -34.25 14.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.578 HG23 ' HG2' ' A' ' 85' ' ' PRO . 71.0 t -82.63 -48.05 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.298 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -58.69 -45.71 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.488 0.661 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.618 ' O ' HD12 ' A' ' 94' ' ' ILE . 28.4 tt0 -68.18 -27.87 66.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.581 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -47.12 21.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.588 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 96' ' ' TRP . 94.6 mt -58.36 -46.75 85.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.407 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.5 m-80 -45.91 -31.93 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.616 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.4 -48.8 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.305 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -56.71 8.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.801 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 92' ' ' LEU . 18.8 m0 -78.33 -33.26 49.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.98 35.22 31.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.443 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.47 147.34 47.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.678 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -109.59 39.32 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -96.69 146.81 24.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.63 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -29.47 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.713 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -163.86 -139.39 2.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.307 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 82' ' ' TYR . 77.1 mt-30 -157.53 115.07 3.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.866 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -96.28 112.11 23.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.688 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.2 pt20 -127.29 159.69 33.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -112.51 95.91 5.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.456 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CD2' HG21 ' A' ' 157' ' ' VAL . 40.5 m95 -64.48 141.56 58.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.157 0.503 . . . . 0.0 112.271 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 54.8 m-85 -124.67 133.55 53.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.224 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.8 tp -79.63 131.37 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.553 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.91 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.0 m-85 -127.05 129.38 47.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 111.351 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.897 ' HB3' HD11 ' A' ' 73' ' ' ILE . 11.5 tttt -93.34 120.97 34.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.657 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.7 t80 -63.46 126.93 29.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 0.0 111.014 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 111' ' ' LYS . 18.2 p -129.64 38.15 3.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.58 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.83 -145.05 4.71 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.992 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -128.08 154.14 46.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -50.35 -16.29 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.62 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -79.16 -19.64 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -79.77 -25.07 41.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.77 HG21 ' CE2' ' A' ' 29' ' ' PHE . 18.1 mt -70.81 102.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.374 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.88 96.19 5.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.935 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.802 HD13 ' HB2' ' A' ' 131' ' ' PHE . 34.9 mt -56.67 -24.18 47.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.488 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 129' ' ' PRO . 58.4 mt -61.94 -56.96 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.294 0.568 . . . . 0.0 109.996 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.91 178.84 23.42 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.483 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -90.79 38.93 0.97 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.51 26.92 70.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.123 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -120.62 -70.84 0.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.91 165.2 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -84.35 154.78 63.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.579 ' HG3' HD22 ' A' ' 122' ' ' LEU . 87.9 Cg_exo -45.94 160.48 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.791 2.328 . . . . 0.0 112.722 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.0 mt-10 -150.19 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.802 ' HB2' HD13 ' A' ' 121' ' ' LEU . 1.5 m-85 -107.57 159.51 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.181 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -17.94 5.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.068 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -152.42 175.23 12.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.177 0.513 . . . . 0.0 110.659 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.4 p-90 -156.42 150.43 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.258 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.43 165.64 29.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.349 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 59.9 m95 -99.43 125.44 45.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.784 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -137.97 150.6 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 111.56 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -70.76 158.61 87.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.677 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.647 ' CB ' HD13 ' A' ' 158' ' ' LEU . 11.2 Cg_endo -55.07 -19.1 19.16 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.914 1.743 . . . . 0.0 111.943 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.76 -34.21 15.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.106 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -50.48 27.35 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.954 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -54.01 -29.76 44.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.42 0.629 . . . . 0.0 109.882 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.475 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -69.01 -28.61 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.733 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.55 -20.93 42.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.21 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.8 mt -84.4 -39.35 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.066 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 147' ' ' VAL . 20.3 m -58.2 163.81 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.066 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.906 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 13.6 p -92.59 161.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.06 -26.45 66.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.906 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 22.8 p90 -91.55 12.09 22.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HE2' ' PB ' ' A' ' 166' ' ' ATP . 2.1 mtmp? -149.75 12.91 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.568 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.515 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.4 mtpm? -65.15 -62.48 4.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.166 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 11.9 Cg_endo -55.54 -40.86 83.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.478 2.118 . . . . 0.0 112.106 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.824 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.7 t -57.03 -28.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.492 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.5 m-85 -91.42 -52.65 4.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.64 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.475 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.88 -33.56 17.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.586 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.01 -45.58 81.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.553 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 107' ' ' TRP . 43.3 t -58.28 -46.62 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.071 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 139' ' ' PRO . 73.4 mt -64.14 -48.89 74.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.787 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 -46.71 59.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.683 HG11 ' HA ' ' A' ' 76' ' ' VAL . 90.0 t -67.22 -23.13 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 11.2 m-30 -102.96 -1.8 28.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.432 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -49.84 -44.25 77.34 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 38.8 Cg_endo -71.16 -21.54 27.04 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.13 1.887 . . . . 0.0 112.817 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -89.37 -41.91 11.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.699 0.285 . . . . 0.0 110.463 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 161' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.27 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.471 ' PG ' ' CG ' ' A' ' 44' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.09 179.91 3.53 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.564 2.176 . . . . 0.0 112.282 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.5 mt 61.13 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.38 45.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.587 ' OG ' HD23 ' A' ' 80' ' ' LEU . 3.0 t -130.96 -155.08 0.67 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.999 0.428 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.567 ' HG3' HG23 ' A' ' 81' ' ' THR . 1.4 mmt -124.6 -43.32 2.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.14 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t0 72.2 24.43 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 170.06 128.22 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.583 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.3 Cg_endo -64.56 109.64 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.261 1.974 . . . . 0.0 112.234 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' CD ' HG21 ' A' ' 81' ' ' THR . 8.4 Cg_exo -72.25 -173.15 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.846 2.364 . . . . 0.0 112.009 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -90.1 148.02 23.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.28 -28.22 13.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.553 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 26.3 m-85 -93.93 140.2 29.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -86.71 152.5 22.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.265 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.647 HH22 ' HB3' ' A' ' 104' ' ' ALA . 1.9 mmp_? -62.19 128.42 36.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.214 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 11.6 t-20 -152.64 159.42 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.688 HG13 HD11 ' A' ' 47' ' ' ILE . 3.3 m -134.9 140.58 45.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.385 . . . . 0.0 111.222 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 149.54 16.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.932 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -128.38 103.78 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 0.0 111.58 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 20.5 t -89.71 106.33 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.7 tp -103.17 145.06 30.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 111.333 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.5 ptm -130.56 157.39 42.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.518 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.489 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.93 169.78 8.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.011 0.434 . . . . 0.0 111.466 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -51.16 -18.63 0.93 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.615 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.417 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.95 1.42 55.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm 73.38 26.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.649 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttt -99.01 175.14 6.02 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -110.93 126.37 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 111.007 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' HE2' HD13 ' A' ' 119' ' ' ILE . 12.1 t80 -58.43 109.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.26 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -117.02 129.67 56.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.433 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.77 137.89 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.089 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.2 155.99 24.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.782 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.4 mtp85 -71.38 159.83 33.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.617 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.45 -5.64 48.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.916 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -19.29 4.01 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.218 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.623 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 59.7 mt -120.05 112.68 34.65 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.983 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.37 131.73 29.12 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.901 1.734 . . . . 0.0 111.713 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.35 3.3 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.777 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.47 97.21 10.95 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.243 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.622 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.5 m95 -102.47 156.73 17.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.238 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -168.62 169.22 10.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.792 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.3 mtm -92.92 156.17 40.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.33 124.35 11.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.556 2.171 . . . . 0.0 112.695 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.4 ' NE2' ' OH ' ' A' ' 82' ' ' TYR . 1.9 pt20 -154.24 158.43 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.383 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.91 153.5 22.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.799 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.1 137.37 49.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.688 HD11 HG13 ' A' ' 17' ' ' VAL . 7.4 mt -64.57 161.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 110.405 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.3 m-20 -90.04 147.95 23.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.59 98.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.226 0.536 . . . . 0.0 110.807 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.01 36.03 8.63 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.024 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.0 tt0 -116.34 142.31 47.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.48 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.54 142.88 84.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.674 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.57 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.6 Cg_exo -54.44 -48.75 19.78 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.487 2.125 . . . . 0.0 112.566 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -65.55 -26.04 67.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -84.65 -46.92 11.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.656 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -58.29 -31.62 67.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.57 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.678 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.26 -53.54 10.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.177 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 54' ' ' ARG . 47.3 mt -55.9 -30.38 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.104 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -81.83 -53.23 6.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.735 0.779 . . . . 0.0 109.779 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -52.66 -39.04 61.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.451 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.809 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.3 tp -55.59 -57.38 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.041 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.559 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 2.7 ptt-85 -61.44 -12.48 14.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.432 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.69 -42.5 10.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 111.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.41 -25.14 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.229 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.809 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.33 -21.61 8.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.758 0.314 . . . . 0.0 111.069 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.15 5.23 70.57 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.894 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG13 ' HE1' ' A' ' 112' ' ' PHE . 53.4 t -75.08 128.16 36.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 0.0 110.633 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -34.89 8.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.3 81.63 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.46 . . . . 0.0 110.974 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 130.69 14.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.84 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.688 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -119.77 148.21 43.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.983 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.5 t -79.14 122.83 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.339 0.59 . . . . 0.0 111.553 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.866 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -102.85 -20.79 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.27 162.53 40.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.039 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.23 115.97 6.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.011 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.826 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.5 t -57.21 128.46 78.23 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 -10.8 25.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.796 2.331 . . . . 0.0 113.942 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.608 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -131.16 160.8 33.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 112.294 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.406 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 30.9 m95 -88.71 147.11 24.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.867 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.783 ' HB3' HG13 ' A' ' 153' ' ' VAL . 95.9 mt -115.44 117.63 30.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.815 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -114.59 130.83 56.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.757 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.833 ' CE1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -133.46 165.64 24.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -124.86 158.31 33.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.154 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -103.2 155.4 36.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.598 ' HG2' HG23 ' A' ' 88' ' ' VAL . 27.0 Cg_endo -62.35 171.57 5.22 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.406 2.071 . . . . 0.0 112.266 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.79 -16.99 58.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.777 2.318 . . . . 0.0 113.25 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.44 -33.57 14.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.183 0.516 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.598 HG23 ' HG2' ' A' ' 85' ' ' PRO . 77.2 t -83.43 -47.88 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.326 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.88 -46.43 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.587 0.708 . . . . 0.0 109.461 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.5 tt0 -67.05 -27.73 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.512 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -46.61 19.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.543 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.538 HD22 ' CD2' ' A' ' 96' ' ' TRP . 95.6 mt -58.19 -46.56 85.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.471 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -46.13 -32.63 3.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.43 -48.07 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.399 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -56.18 8.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.538 ' CD2' HD22 ' A' ' 92' ' ' LEU . 17.1 m0 -78.0 -31.9 50.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.878 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.87 36.65 35.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.4 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.92 147.39 47.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.76 38.81 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.879 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -103.86 150.1 24.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -29.89 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.124 0.487 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.74 -143.94 4.27 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.696 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -158.7 124.38 4.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.847 0.356 . . . . 0.0 111.315 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.815 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.73 106.48 17.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -115.9 149.22 39.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.406 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 2.1 mmtp -109.52 96.45 6.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.542 ' CG ' HG21 ' A' ' 157' ' ' VAL . 73.3 m95 -62.65 145.78 53.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 70.1 m-85 -130.95 133.56 45.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.936 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.818 HD13 ' CD2' ' A' ' 161' ' ' PHE . 16.2 tp -79.68 130.88 35.74 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.595 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.932 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.9 m-85 -125.33 127.59 46.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.017 0.437 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.866 ' HB3' HD11 ' A' ' 73' ' ' ILE . 62.8 tttm -92.56 120.75 33.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.7 t80 -62.9 126.21 26.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.688 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.5 p -127.06 37.96 4.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.584 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.59 -145.16 4.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.059 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -128.95 154.24 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 109.984 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.3 -17.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.569 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.85 -22.79 53.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.01 -25.62 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.603 HD13 ' HE2' ' A' ' 29' ' ' PHE . 30.9 mt -68.0 103.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.56 96.06 4.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.041 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 131' ' ' PHE . 44.6 mt -58.72 -20.82 52.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.403 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.928 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -60.25 -57.0 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 179.184 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.3 178.32 19.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.332 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -89.79 38.65 0.92 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.193 0.521 . . . . 0.0 109.714 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.11 29.76 76.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.233 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.0 m -109.34 -64.04 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 111.336 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -115.8 165.11 13.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 152.69 68.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.928 ' HG3' HD13 ' A' ' 122' ' ' LEU . 77.0 Cg_exo -48.84 176.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 0.0 112.668 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -150.14 -44.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.767 ' HB2' HD13 ' A' ' 121' ' ' LEU . 18.6 m-85 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 -18.16 6.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.732 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.2 mm-40 -152.3 175.0 13.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.042 0.448 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.1 p-90 -159.23 152.07 21.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.15 163.39 38.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.362 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.489 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 64.9 m95 -95.98 123.58 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.856 HG11 HD11 ' A' ' 145' ' ' LEU . 33.0 m -133.14 151.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.559 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.1 158.22 87.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.525 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.541 ' HD3' HD11 ' A' ' 28' ' ' ILE . 10.9 Cg_endo -54.44 -19.57 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.0 1.8 . . . . 0.0 112.097 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -92.13 -34.36 14.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.276 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -50.25 46.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.935 0.398 . . . . 0.0 110.152 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.928 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.2 tp -53.21 -34.02 55.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.479 0.657 . . . . 0.0 109.871 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.524 HG21 ' NZ ' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -66.48 -28.61 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.673 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -77.39 -32.59 54.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.654 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.928 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.6 mt -74.64 -40.94 61.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.87 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 150' ' ' LYS . 18.3 m -53.53 164.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.221 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' A' ' 149' ' ' PHE . 7.3 p -97.37 159.82 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -47.24 -43.68 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.465 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 147' ' ' VAL . 39.2 p90 -83.95 7.02 19.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.454 ' O ' HG21 ' A' ' 146' ' ' THR . 25.3 mtmt -128.12 -6.31 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.59 0.234 . . . . 0.0 111.33 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.506 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.7 mtpm? -59.42 -60.63 9.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.592 0.235 . . . . 0.0 111.285 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.0 Cg_endo -61.54 -42.3 34.23 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.047 . . . . 0.0 112.15 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.833 HG11 ' CE1' ' A' ' 82' ' ' TYR . 13.4 t -58.1 -26.69 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.5 -52.61 4.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.505 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.524 ' NZ ' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.75 -30.66 14.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.617 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.7 tp10 -67.98 -44.99 75.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.484 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.542 HG21 ' CG ' ' A' ' 107' ' ' TRP . 48.6 t -59.99 -48.77 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' ALA . 59.2 mt -60.8 -48.95 79.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.971 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.0 m -48.89 -42.9 38.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.831 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.826 HG11 ' HA ' ' A' ' 76' ' ' VAL . 93.7 t -72.76 -24.78 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.03 0.443 . . . . 0.0 110.716 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.818 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.7 m-30 -100.97 -1.51 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.272 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.68 -51.84 27.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.539 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -54.69 -22.02 27.34 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.301 2.0 . . . . 0.0 112.358 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.596 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 90.4 m-70 -96.09 -17.42 20.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.124 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.8 mp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.22 159.31 53.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.543 2.162 . . . . 0.0 112.292 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.612 HD22 ' C ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -175.5 150.23 1.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.993 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.79 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 57.6 31.4 63.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.42 120.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.6 mmt -122.79 -38.63 2.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.529 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 t70 75.72 22.54 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 170.1 138.07 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 60.9 Cg_endo -73.41 114.57 4.07 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.328 2.019 . . . . 0.0 112.268 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -88.35 -170.06 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.837 2.358 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.67 155.67 19.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.46 -35.09 4.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -106.51 135.65 47.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.374 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -81.48 152.3 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.017 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -66.75 136.31 55.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.523 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 m120 -152.54 156.21 38.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.449 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 m -129.79 121.83 53.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.853 0.359 . . . . 0.0 111.383 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.03 140.18 14.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.814 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -114.2 101.69 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.2 t -90.18 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.2 tp -103.09 147.13 27.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.56 157.14 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.821 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 43.7 p-10 -99.87 172.48 7.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.14 -17.8 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.313 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -0.11 57.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.815 0.341 . . . . 0.0 110.994 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttt 76.93 25.44 0.83 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.599 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.4 mmtp -93.53 175.58 6.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.589 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -113.89 126.4 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 32.8 t80 -58.56 109.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.75 129.89 56.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.349 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.43 138.91 52.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.578 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.5 p -82.04 157.58 24.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.767 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -73.08 158.45 35.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 111.433 -179.478 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.77 -5.54 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.067 178.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -130.87 -17.76 3.11 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.767 HD12 ' CD ' ' A' ' 33' ' ' ARG . 65.9 mt -118.77 112.19 36.99 Favored Pre-proline 0 N--CA 1.455 -0.178 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.951 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.2 131.72 29.39 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.995 1.797 . . . . 0.0 111.889 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 t70 76.62 4.09 3.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.713 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.2 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.412 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 36.9 m95 -102.95 155.46 18.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -169.04 171.63 8.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.753 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.414 ' SD ' HD21 ' A' ' 142' ' ' LEU . 1.9 mpp? -95.85 157.72 35.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.652 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.54 129.47 15.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.58 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.06 153.74 32.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.46 167.95 33.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -80.02 133.17 12.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.559 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.646 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.6 mt -60.12 160.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.487 ' N ' HG22 ' A' ' 47' ' ' ILE . 2.0 m-20 -90.24 149.31 22.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.96 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.22 0.533 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.18 10.25 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.954 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 16.0 tp10 -114.09 145.96 40.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.865 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.11 139.6 79.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.429 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.6 Cg_exo -54.01 -55.07 3.78 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.387 2.058 . . . . 0.0 112.599 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.29 -27.53 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.214 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -82.48 -49.42 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.798 0.332 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.542 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.82 -30.68 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.482 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.788 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.85 -53.45 10.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.16 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 54' ' ' ARG . 53.1 mt -55.78 -29.79 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.116 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -80.69 -53.51 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.786 0.803 . . . . 0.0 109.73 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.97 -33.29 62.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.568 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.769 HD12 ' OG1' ' A' ' 65' ' ' THR . 6.1 tp -56.56 -58.4 8.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.123 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.573 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 9.2 ptt180 -62.12 -11.06 12.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 0.0 110.545 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -91.71 -44.34 9.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.47 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.87 -29.6 17.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.3 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.769 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.93 -21.33 10.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.33 6.69 70.53 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.885 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.747 ' HB ' HD11 ' A' ' 61' ' ' LEU . 52.8 t -75.92 130.84 35.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.327 . . . . 0.0 110.548 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -109.79 -33.01 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 78.78 6.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.164 0.507 . . . . 0.0 110.831 -179.924 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.36 131.29 15.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.846 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.0 pt-20 -119.41 140.37 50.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.239 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.2 t -69.76 116.86 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.292 0.568 . . . . 0.0 111.387 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.797 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -90.91 -24.0 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.774 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.42 168.64 26.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.214 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -148.51 116.26 6.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.236 179.623 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.801 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.2 t -57.33 130.29 80.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 -15.42 35.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.763 2.309 . . . . 0.0 113.626 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.626 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -128.04 170.35 13.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.459 0.647 . . . . 0.0 112.359 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.75 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.8 m95 -96.22 145.99 25.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.978 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 4' ' ' GLY . 2.3 mt -110.24 117.91 34.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.171 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.846 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.0 p -107.7 136.23 47.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.49 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.867 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -127.88 170.11 13.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.466 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.33 158.29 38.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.89 152.09 47.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.798 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.539 ' HG2' HG23 ' A' ' 88' ' ' VAL . 34.2 Cg_endo -63.95 169.82 9.81 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.597 2.198 . . . . 0.0 112.288 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.62 -17.39 59.4 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 113.16 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -92.07 -34.04 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.187 0.518 . . . . 0.0 110.178 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.539 HG23 ' HG2' ' A' ' 85' ' ' PRO . 76.2 t -83.26 -47.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -45.36 91.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.616 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.4 tp10 -68.76 -27.5 65.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.597 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -47.09 19.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.3 mt -58.89 -46.46 87.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.359 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.1 m120 -45.82 -31.84 2.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.568 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.37 -49.29 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.278 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -56.26 12.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 92' ' ' LEU . 21.6 m0 -78.3 -35.0 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 80.81 34.94 26.26 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.47 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 147.25 47.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.26 41.93 1.76 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.935 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -99.16 150.31 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.726 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -29.35 60.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.24 -139.13 2.69 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.82 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -157.64 113.92 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.81 0.338 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.846 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.1 105.66 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' NE2' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 pt20 -120.24 150.57 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.5 mttp -102.77 95.71 6.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.388 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.544 ' CD2' HG21 ' A' ' 157' ' ' VAL . 43.7 m95 -64.33 143.5 57.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.236 -178.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.3 m-85 -128.0 137.69 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.15 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.849 HD13 ' CD2' ' A' ' 161' ' ' PHE . 22.1 tp -79.43 155.18 28.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 21' ' ' LEU . 33.1 m-85 -146.47 131.96 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 111.955 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.637 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -94.73 119.56 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 178.032 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.576 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -67.65 121.44 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.613 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.606 HG21 ' OE1' ' A' ' 71' ' ' GLU . 7.8 p -123.92 37.71 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.565 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.93 -145.31 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.129 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.5 154.24 47.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.49 ' HA ' HD12 ' A' ' 119' ' ' ILE . 6.5 m-20 -49.47 -16.96 0.24 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.603 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -76.33 -21.06 56.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.102 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.56 -25.19 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 116' ' ' ASP . 15.7 mt -69.23 104.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.513 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.671 HD21 HD12 ' A' ' 122' ' ' LEU . 29.4 t-20 -119.96 95.55 4.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.708 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.799 HD13 ' HB2' ' A' ' 131' ' ' PHE . 41.3 mt -58.82 -24.82 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 -179.013 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.671 HD12 HD21 ' A' ' 120' ' ' ASN . 6.4 mt -60.1 -55.04 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.39 178.63 17.22 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.397 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -89.64 38.64 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.212 0.529 . . . . 0.0 109.687 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.93 29.63 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.226 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -107.02 -64.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.84 165.16 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -60.22 151.36 67.8 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.554 ' HG3' HD23 ' A' ' 122' ' ' LEU . 77.6 Cg_exo -49.34 176.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.716 2.277 . . . . 0.0 112.602 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -150.13 -45.24 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.722 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.799 ' HB2' HD13 ' A' ' 121' ' ' LEU . 21.2 m-85 -112.72 159.39 18.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.96 -14.6 6.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.637 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.578 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 10.6 mp0 -152.15 174.22 14.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.019 0.438 . . . . 0.0 110.357 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.0 p-90 -159.65 152.06 21.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.333 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.62 153.93 35.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.306 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.466 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 87.8 m95 -89.95 126.13 35.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.72 HG11 HD11 ' A' ' 145' ' ' LEU . 30.9 m -137.46 150.63 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.666 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -68.23 159.33 80.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.574 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.686 ' CA ' HD13 ' A' ' 158' ' ' LEU . 13.4 Cg_endo -56.72 -18.98 28.79 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 121.816 1.677 . . . . 0.0 111.732 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.5 -34.15 15.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -50.84 25.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.907 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -54.14 -30.66 49.83 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.434 0.635 . . . . 0.0 109.864 179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.552 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.4 mm -68.52 -28.78 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 178.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.39 -20.98 42.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.21 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.2 mt -84.64 -39.24 18.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.072 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 150' ' ' LYS . 11.8 m -58.05 164.27 2.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.715 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 12.7 p -93.01 162.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.787 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.03 -27.6 65.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -179.433 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.715 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 7.9 p90 -93.28 7.6 43.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.605 ' HB2' HG12 ' A' ' 147' ' ' VAL . 3.1 mtmp? -140.25 11.04 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.509 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.7 mtpp -70.54 -62.45 2.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.586 ' CB ' HD23 ' A' ' 3' ' ' LEU . 9.6 Cg_endo -52.99 -46.74 31.77 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.153 . . . . 0.0 112.121 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.7 t -56.46 -26.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.499 . . . . 0.0 110.959 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.33 -51.43 5.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.656 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.84 -34.84 21.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -64.62 -45.96 84.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.576 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.3 t -57.04 -49.52 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.686 HD13 ' CA ' ' A' ' 139' ' ' PRO . 78.0 mt -62.92 -49.14 75.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.824 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.8 p -50.17 -46.67 54.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.74 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.801 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -69.3 -24.84 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.048 0.452 . . . . 0.0 110.475 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.849 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.3 m-30 -102.27 7.08 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.013 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.67 -53.07 54.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.801 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 8.1 Cg_endo -50.59 -24.83 13.41 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.562 2.175 . . . . 0.0 112.52 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.632 ' ND1' HG22 ' A' ' 73' ' ' ILE . 98.1 m-70 -92.88 -22.38 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.883 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.964 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.444 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.21 167.66 24.38 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.685 2.256 . . . . 0.0 112.285 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 tp 59.97 99.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.73 -86.89 1.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.436 ' HB3' ' CG ' ' A' ' 78' ' ' TYR . 1.3 m 63.77 125.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -137.27 101.54 4.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.884 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.79 12.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.123 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -154.96 128.37 4.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.52 0.2 . . . . 0.0 110.481 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 15' ' ' ARG . 56.0 Cg_endo -70.74 114.65 3.93 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.245 1.963 . . . . 0.0 112.62 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 2.9 Cg_exo -75.12 -175.6 2.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.727 2.285 . . . . 0.0 111.748 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.33 150.02 22.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.951 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.27 -33.74 5.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -87.1 138.17 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.144 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -85.79 152.6 22.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 9' ' ' PRO . 1.3 mmp_? -73.38 129.31 37.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.8 t-20 -153.26 156.85 39.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.675 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.79 HG13 HD11 ' A' ' 47' ' ' ILE . 4.5 m -127.38 138.04 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.006 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.83 155.13 16.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.877 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -128.52 101.77 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.701 0.286 . . . . 0.0 111.345 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' PHE . 18.8 t -89.7 103.38 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 110' ' ' PHE . 31.4 tp -103.02 145.09 30.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.76 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.8 ptt? -131.42 157.05 44.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.69 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 27' ' ' LYS . 10.4 p-10 -97.43 175.1 6.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -14.2 39.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.243 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.2 0.48 56.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.77 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp 75.63 26.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.513 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.756 ' C ' HD13 ' A' ' 28' ' ' ILE . 12.9 mttp -97.88 172.97 7.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.856 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.01 140.74 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 110.667 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HE2' HD13 ' A' ' 119' ' ' ILE . 11.0 t80 -75.6 109.31 9.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.541 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . . . -116.63 132.79 56.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.85 135.23 54.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.38 155.01 24.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -71.24 159.22 35.02 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 111.506 -179.386 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -93.44 -6.85 46.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.838 178.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.93 -18.92 4.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.09 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.61 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 52.6 mt -119.4 111.65 36.38 Favored Pre-proline 0 N--CA 1.455 -0.213 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.881 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.59 131.27 29.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.995 1.797 . . . . 0.0 111.977 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 77.35 2.37 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.824 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.61 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -85.59 97.22 9.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.654 ' CD1' HD22 ' A' ' 145' ' ' LEU . 51.7 m95 -101.7 154.84 18.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.323 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.31 173.27 6.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -99.26 161.15 25.65 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.03 133.9 24.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.498 2.132 . . . . 0.0 112.759 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 155.8 35.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.35 143.58 9.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.683 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.8 143.43 39.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.534 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.79 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -76.87 160.72 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 47' ' ' ILE . 5.0 m-20 -90.25 177.54 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.125 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.88 99.28 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.39 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.61 47.01 12.94 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.615 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' CG ' ' HB2' ' A' ' 56' ' ' ALA . 5.6 tp10 -110.36 148.55 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.185 0.517 . . . . 0.0 110.949 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.83 126.11 88.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.366 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.622 ' HA ' HG11 ' A' ' 17' ' ' VAL . 53.7 Cg_exo -53.3 -34.59 70.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.385 2.057 . . . . 0.0 112.569 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' O ' HD12 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -76.73 -25.0 53.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.936 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -87.57 -45.53 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.428 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.502 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -59.27 -31.07 68.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.369 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.59 -52.55 13.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.2 mt -56.34 -31.41 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.289 0.566 . . . . 0.0 109.905 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -78.58 -53.6 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.849 178.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -54.88 -36.08 64.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.602 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.774 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.3 tp -56.15 -54.15 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.586 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -62.22 -11.7 16.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.718 179.121 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -91.52 -41.48 10.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 111.477 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -90.25 -31.17 17.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.923 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.693 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -119.62 -23.8 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.339 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 69.74 10.13 63.6 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.647 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.774 ' HB ' HD11 ' A' ' 61' ' ' LEU . 25.5 t -69.3 119.08 14.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.222 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.62 -34.02 12.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.105 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.2 78.49 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.179 0.514 . . . . 0.0 110.962 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.35 131.45 15.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.851 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -119.95 141.9 49.23 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.146 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.8 t -70.87 117.01 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.237 0.541 . . . . 0.0 111.437 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.778 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.1 mt -91.03 -26.11 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.572 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -159.41 169.31 24.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.282 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.6 pt-20 -148.44 112.06 5.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 160' ' ' VAL . 2.5 t -57.65 123.82 64.78 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.965 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.5 -3.96 14.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.801 2.334 . . . . 0.0 114.045 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -131.23 139.45 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.204 0.526 . . . . 0.0 112.131 -179.855 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.458 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 15.2 m95 -75.31 145.06 42.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.693 ' HB3' HG13 ' A' ' 153' ' ' VAL . 89.6 mt -111.2 117.58 33.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.666 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.1 p -108.52 131.74 54.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.751 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.785 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -129.84 166.26 20.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.3 158.34 29.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.098 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.35 153.18 45.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.738 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.9 Cg_endo -63.47 170.79 7.64 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 0.0 112.384 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.69 -17.34 59.53 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 113.147 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -91.35 -33.59 15.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.146 0.498 . . . . 0.0 110.143 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.587 HG23 ' HG2' ' A' ' 85' ' ' PRO . 78.2 t -82.75 -48.64 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.306 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -58.29 -46.28 86.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.481 0.658 . . . . 0.0 109.472 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.611 ' O ' HD12 ' A' ' 94' ' ' ILE . 46.4 tt0 -67.82 -27.53 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.584 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -46.58 20.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.564 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 96' ' ' TRP . 94.2 mt -58.56 -46.5 86.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -46.01 -31.93 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.48 -49.29 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.227 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -56.35 9.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.82 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.457 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.6 m0 -77.32 -33.59 55.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.05 31.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.398 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -127.62 147.44 50.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.775 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.17 38.72 1.96 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 98' ' ' SER . 34.2 m95 -93.23 150.44 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -26.99 44.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.447 . . . . 0.0 110.435 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.66 -138.5 2.47 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -158.05 113.76 2.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.666 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -88.22 105.82 17.79 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.73 150.27 52.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 2.7 mttt -97.77 156.5 16.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.47 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.566 ' CD2' HG21 ' A' ' 157' ' ' VAL . 45.2 m95 -120.81 140.32 51.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.02 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.4 m-85 -123.46 131.18 53.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.056 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.875 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.26 135.84 36.88 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.146 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.877 ' CD1' HG23 ' A' ' 19' ' ' ILE . 39.4 m-85 -126.82 131.67 51.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 112.02 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.67 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 3.5 ttmt -93.76 120.18 33.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.374 178.055 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.669 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -68.97 122.43 18.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 69' ' ' SER . 7.4 p -123.96 37.8 4.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.46 -144.74 4.8 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.141 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.56 154.27 47.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -48.96 -17.45 0.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.523 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.23 -24.21 59.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.319 . . . . 0.0 111.027 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.19 -26.24 58.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.488 HD13 ' HE2' ' A' ' 29' ' ' PHE . 29.8 mt -69.14 101.52 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 123' ' ' GLY . 13.2 p-10 -125.28 96.07 4.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.839 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 60.7 mt -55.27 -19.24 7.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.067 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.52 -58.62 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.383 0.611 . . . . 0.0 110.124 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.402 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . 138.64 179.41 17.22 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.311 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -89.61 38.84 0.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.1 28.3 72.68 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.224 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.95 -64.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.7 165.07 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -71.08 152.3 94.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.042 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.16 169.17 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.678 2.252 . . . . 0.0 112.519 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' C ' HD12 ' A' ' 34' ' ' LEU . 20.7 mm-40 -150.07 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.781 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 12.6 m-85 -106.15 159.32 16.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.46 -18.67 5.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.78 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.439 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 9.3 mm-40 -152.17 175.31 12.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 110.398 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.08 154.53 25.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.33 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -151.56 162.5 40.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.301 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 86.8 m95 -98.97 129.37 45.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 145' ' ' LEU . 28.4 m -139.41 156.19 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.964 -179.121 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -73.63 152.98 89.57 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.833 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.2 Cg_endo -49.19 -20.83 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.114 1.876 . . . . 0.0 112.132 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -90.42 -33.82 15.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.437 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -70.09 -50.8 37.28 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 110.22 179.496 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.932 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -51.94 -36.05 47.97 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.515 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.591 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.2 mm -63.08 -29.05 46.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.934 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.53 -22.01 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.116 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.6 mt -84.13 -39.13 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.243 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 150' ' ' LYS . 9.2 m -59.33 165.64 2.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 8.3 p -97.35 159.72 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.05 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.528 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 19.1 mt-10 -52.14 -38.44 57.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.6 p90 -84.34 5.28 27.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 146' ' ' THR . 20.9 mtpp -140.09 9.26 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.528 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.6 mtpp -69.07 -62.77 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.8 Cg_endo -54.33 -39.66 86.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 111.87 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.785 HG11 ' CD1' ' A' ' 82' ' ' TYR . 14.1 t -58.13 -27.02 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 110.799 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.33 -50.66 5.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.375 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.591 ' HD2' HD12 ' A' ' 143' ' ' ILE . 3.6 tttt -51.01 -34.63 30.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.625 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.4 tp10 -63.91 -46.09 86.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.51 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -60.09 -47.28 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.249 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.583 HD13 ' CA ' ' A' ' 139' ' ' PRO . 69.2 mt -63.36 -48.5 77.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.695 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.5 m -48.77 -47.88 41.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.731 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.811 HG21 HG22 ' A' ' 76' ' ' VAL . 74.6 t -67.52 -24.9 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.875 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.2 m-30 -102.25 7.32 40.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.027 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -50.75 -53.05 50.98 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.602 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.8 Cg_endo -50.66 -24.75 13.51 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.545 2.163 . . . . 0.0 112.316 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.677 ' CE1' HG22 ' A' ' 73' ' ' ILE . 98.7 m-70 -89.77 -24.5 21.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.644 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.76 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.878 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.444 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.04 170.5 16.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.596 2.198 . . . . 0.0 112.35 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 3' ' ' LEU . 4.0 pp -96.46 138.43 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.18 46.19 1.27 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.576 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 78' ' ' TYR . 4.6 t 164.9 139.83 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.022 0.439 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.888 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.5 mmt -115.6 -30.15 6.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.256 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 6.0 m-20 61.7 16.29 7.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.545 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p 167.68 141.73 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.721 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 57.1 Cg_endo -71.76 111.83 3.24 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.281 1.987 . . . . 0.0 112.221 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 104' ' ' ALA . 6.8 Cg_exo -73.85 -175.18 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.84 2.36 . . . . 0.0 112.158 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.27 149.3 22.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.19 -19.8 51.31 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -109.66 135.57 50.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 110.996 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 6.7 mtp-105 -76.07 152.39 36.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -75.22 133.38 41.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.46 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.1 m120 -152.22 161.9 41.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.801 HG13 HD11 ' A' ' 47' ' ' ILE . 1.9 m -132.24 125.63 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.235 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 138.79 14.13 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.219 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.821 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -111.69 102.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' PHE . 7.6 t -89.68 102.12 14.81 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.09 146.39 28.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 0.0 110.933 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.24 157.2 41.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 12.4 t30 -93.65 173.42 7.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.044 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.97 -16.58 61.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.845 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.41 -0.71 57.69 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 81.77 24.6 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.632 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -93.83 170.48 9.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.3 mp -109.81 121.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.73 ' CD2' HD23 ' A' ' 21' ' ' LEU . 1.7 t80 -54.04 107.56 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.259 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.85 137.72 52.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.746 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.96 141.95 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.17 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.33 158.32 23.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.968 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.584 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.8 mtp-105 -72.71 164.04 27.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 111.723 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.5 mt -97.93 -7.0 31.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.44 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.54 -18.21 3.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.587 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 62.9 mt -121.12 112.42 33.26 Favored Pre-proline 0 N--CA 1.457 -0.094 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.189 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.79 132.62 31.09 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.816 1.677 . . . . 0.0 111.475 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 77.86 3.8 2.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.683 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.587 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.85 97.55 11.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.522 ' CD1' HD22 ' A' ' 145' ' ' LEU . 27.6 m95 -102.28 156.58 17.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.065 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -168.75 -176.68 2.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.703 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 76.3 mtm -107.31 156.59 37.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.12 132.35 27.68 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.56 2.173 . . . . 0.0 112.579 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 157.39 42.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.695 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.51 171.37 34.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.02 135.92 13.58 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.574 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.801 HD11 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -68.6 161.03 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.619 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -83.76 -174.85 5.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.767 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.91 99.57 6.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.281 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.43 50.73 19.72 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.597 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.47 155.23 25.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.096 -179.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -77.87 130.34 73.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.588 ' HA ' HG11 ' A' ' 17' ' ' VAL . 52.0 Cg_exo -54.6 -21.66 25.48 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.389 2.059 . . . . 0.0 112.932 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.1 tpt180 -84.39 -25.44 29.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -88.05 -43.29 11.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.578 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -63.36 -29.87 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.519 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.584 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -74.79 -51.83 13.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 54' ' ' ARG . 61.3 mt -57.32 -29.07 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.237 179.291 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 3.2 ttp-105 -81.85 -53.3 6.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.831 0.824 . . . . 0.0 109.698 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -54.48 -31.83 56.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.84 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.1 tp -58.43 -63.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.565 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 11.7 ptp180 -60.45 -12.14 8.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -92.08 -40.91 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.53 -32.08 16.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.658 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.86 -24.84 7.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.936 0.398 . . . . 0.0 110.899 -179.55 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 82.3 -0.65 88.72 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.063 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.5 t -66.82 121.73 16.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.986 0.393 . . . . 0.0 110.331 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 -33.8 10.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.03 77.48 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.41 129.16 13.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.919 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 7.0 mt-10 -120.39 146.44 46.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.627 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 55.8 t -76.46 125.69 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.49 0.662 . . . . 0.0 111.928 -179.06 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.885 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.44 -17.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.248 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -153.72 159.68 42.06 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.18 111.63 4.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.753 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.5 t -57.58 125.32 71.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.05 -8.15 20.75 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.85 2.366 . . . . 0.0 113.785 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.555 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.54 146.67 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 112.05 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.444 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 16.4 m95 -79.69 145.21 33.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.012 0.434 . . . . 0.0 109.976 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.815 ' HB3' HG13 ' A' ' 153' ' ' VAL . 82.5 mt -111.11 117.55 33.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.733 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.888 HG23 ' HG3' ' A' ' 6' ' ' MET . 19.3 p -111.74 130.03 55.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.812 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.825 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.56 163.58 26.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 0.0 110.707 179.539 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.68 158.27 35.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.189 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -101.98 155.93 35.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.496 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.594 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.9 Cg_endo -63.25 166.95 13.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.309 2.006 . . . . 0.0 112.196 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.76 -16.1 41.82 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.799 2.333 . . . . 0.0 113.232 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -92.57 -31.57 15.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.107 0.48 . . . . 0.0 110.25 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.594 HG23 ' HG2' ' A' ' 85' ' ' PRO . 78.9 t -84.93 -49.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' NH1' ' ND2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -59.63 -45.68 91.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.25 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.9 tp10 -65.06 -29.15 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.409 179.469 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -46.75 17.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.686 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.494 HD22 ' CG ' ' A' ' 96' ' ' TRP . 95.8 mt -57.3 -46.48 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' ND2' ' NH1' ' A' ' 89' ' ' ARG . 3.3 m-20 -44.86 -35.26 2.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.48 -46.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.421 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -69.19 -55.68 9.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.946 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.494 ' CG ' HD22 ' A' ' 92' ' ' LEU . 11.3 m0 -79.48 -31.3 42.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.47 39.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.325 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.15 146.62 49.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 110.638 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -110.28 44.8 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.458 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 56.7 m95 -107.98 144.46 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -28.72 62.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.22 -139.18 2.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.092 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -157.63 117.12 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.326 . . . . 0.0 111.343 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.724 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -86.65 110.58 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -130.85 150.19 52.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.717 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.1 mtmt -107.51 102.54 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.443 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CD2' HG21 ' A' ' 157' ' ' VAL . 29.9 m95 -67.9 143.28 55.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.442 ' CD2' ' HD2' ' A' ' 54' ' ' ARG . 61.1 m-85 -125.48 137.77 53.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.035 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.808 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.5 tp -79.36 154.49 28.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.83 ' O ' HD12 ' A' ' 21' ' ' LEU . 44.4 m-85 -148.0 127.54 13.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.564 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.885 ' HB3' HD11 ' A' ' 73' ' ' ILE . 4.7 tptp -92.48 121.65 34.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -65.32 123.46 19.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.955 0.407 . . . . 0.0 110.637 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 111' ' ' LYS . 4.8 p -124.68 37.67 4.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.758 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.4 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.46 -144.88 4.72 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.034 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.29 154.27 47.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.09 -17.35 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.522 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -74.69 -22.18 58.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -26.24 56.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.497 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 25.2 mt -69.97 94.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.325 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -117.92 95.98 5.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.931 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 131' ' ' PHE . 46.0 mt -52.53 -20.04 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.175 -179.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.424 HD22 ' HG3' ' A' ' 129' ' ' PRO . 98.0 mt -57.9 -59.09 5.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.378 0.609 . . . . 0.0 109.966 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -178.56 18.53 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.453 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -89.52 38.77 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.58 26.27 71.87 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -103.23 -64.63 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.128 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.29 165.19 12.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -69.29 151.19 97.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.5 ' HB2' HD11 ' A' ' 34' ' ' LEU . 75.5 Cg_exo -48.86 135.85 28.56 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.624 2.216 . . . . 0.0 112.572 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -113.24 -25.87 8.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.6 m-85 -123.17 159.25 29.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.711 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.56 -17.62 5.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.72 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.511 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.36 173.35 15.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 0.0 110.568 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.2 p-90 -160.41 160.56 32.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.426 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -159.3 154.68 25.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.345 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.475 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 87.3 m95 -88.62 127.18 35.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.729 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.691 HG11 HD11 ' A' ' 145' ' ' LEU . 26.9 m -138.52 150.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 111.857 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.3 p -68.5 160.86 74.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.647 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.608 ' CB ' HD13 ' A' ' 158' ' ' LEU . 19.7 Cg_endo -58.66 -17.12 33.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 121.773 1.649 . . . . 0.0 111.801 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.06 -34.18 14.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -51.08 23.86 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.039 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.88 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.2 tp -54.01 -31.73 51.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 109.823 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.64 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -67.17 -28.75 43.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.654 178.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -80.68 -20.7 42.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.18 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.88 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.1 mt -85.77 -39.0 17.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 150' ' ' LYS . 24.2 m -56.48 163.95 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.237 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.672 HG21 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -93.01 160.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.1 mt-10 -49.66 -41.83 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.275 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 147' ' ' VAL . 45.1 p90 -85.36 8.71 17.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.484 ' HB2' HG12 ' A' ' 147' ' ' VAL . 19.0 mttt -129.06 -8.66 4.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.602 0.239 . . . . 0.0 111.31 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.499 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.8 mtpm? -57.7 -59.88 11.64 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.311 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.9 Cg_endo -61.09 -42.46 36.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.369 2.046 . . . . 0.0 112.174 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.825 HG11 ' CD1' ' A' ' 82' ' ' TYR . 16.4 t -60.07 -27.28 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.79 -51.4 5.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.64 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -50.65 -32.27 18.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.418 179.663 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.738 ' HB3' HD11 ' A' ' 80' ' ' LEU . 6.0 tp10 -66.67 -45.73 77.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.529 179.175 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.6 t -58.84 -47.44 89.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.963 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 139' ' ' PRO . 76.4 mt -63.73 -48.6 76.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -50.09 -47.36 53.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.861 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 76' ' ' VAL . 76.0 t -69.54 -25.71 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 110.404 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.808 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.5 m-30 -102.24 9.64 39.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.975 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.32 -57.92 16.22 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.318 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -58.26 -21.88 54.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.475 2.117 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.526 ' ND1' ' HB2' ' A' ' 74' ' ' ALA . 69.2 m80 -89.96 -11.15 42.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.209 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.922 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.454 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.18 -168.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.562 2.175 . . . . 0.0 112.312 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.57 84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.748 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -160.23 27.57 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.555 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.92 116.87 4.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.68 -39.55 4.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.179 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 6.3 t0 72.74 24.32 2.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.98 130.6 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.598 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 37.4 Cg_endo -66.67 109.31 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.322 2.015 . . . . 0.0 112.28 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.2 Cg_exo -77.19 -176.31 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.981 2.454 . . . . 0.0 112.1 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 153.92 20.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.934 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -37.45 3.4 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.724 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.91 137.97 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -82.2 152.24 26.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -70.2 131.43 44.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.985 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.554 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.1 t30 -152.78 155.0 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.797 HG13 HD11 ' A' ' 47' ' ' ILE . 19.2 m -133.11 137.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.103 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.92 131.92 9.37 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.128 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.893 HG21 HD22 ' A' ' 61' ' ' LEU . 4.5 mp -97.43 113.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.811 0.338 . . . . 0.0 111.863 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 110' ' ' PHE . 8.6 t -96.16 103.17 15.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.009 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.5 tp -103.37 149.37 24.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 111.132 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.439 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -133.07 157.27 45.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.672 179.93 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.9 p-10 -98.19 172.31 7.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.614 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -57.82 -17.72 17.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.522 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.81 0.34 56.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 mttm 77.06 25.46 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.515 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.786 ' C ' HD13 ' A' ' 28' ' ' ILE . 7.4 mttp -93.77 174.41 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.867 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.75 138.51 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -179.807 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.813 ' CE2' HG21 ' A' ' 65' ' ' THR . 5.2 t80 -76.68 103.7 6.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.494 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.34 139.86 49.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -124.01 137.86 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.52 154.43 25.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.646 179.878 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.507 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -71.23 157.66 37.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 111.628 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.45 -5.35 49.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.768 178.265 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.6 -19.42 4.57 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.985 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.622 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 56.9 mt -120.62 112.18 34.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.913 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.04 131.42 28.67 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.856 1.704 . . . . 0.0 111.878 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t70 77.15 3.7 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.773 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.622 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.4 10.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.349 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.698 ' CD1' HD22 ' A' ' 145' ' ' LEU . 41.9 m95 -102.41 157.32 17.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.927 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 -176.87 2.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.96 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.569 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 51.7 mtm -106.09 159.51 29.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.67 128.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.504 2.136 . . . . 0.0 112.787 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -150.48 167.42 27.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.37 59.39 0.11 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.864 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . 43.17 -165.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.091 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.797 HD11 HG13 ' A' ' 17' ' ' VAL . 4.5 mt -132.12 159.68 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 110.578 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 47' ' ' ILE . 22.5 m-20 -90.38 149.81 22.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.09 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.99 39.6 11.46 Favored Glycine 0 C--N 1.32 -0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.945 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 9.2 tp10 -109.56 146.25 34.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.165 0.507 . . . . 0.0 110.965 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 128.38 81.91 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.318 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.645 ' HA ' HG11 ' A' ' 17' ' ' VAL . 76.0 Cg_exo -50.58 -25.82 15.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.358 2.039 . . . . 0.0 112.688 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -83.85 -24.0 31.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.91 -43.36 10.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -61.08 -32.1 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.175 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -71.71 -53.38 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.084 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.8 mt -56.64 -28.58 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.442 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -84.21 -53.3 5.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 109.959 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -50.71 -42.91 57.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.326 -1.307 . . . . 0.0 111.223 -179.667 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 19' ' ' ILE . 2.8 tp -57.81 -51.9 67.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.598 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 12.8 ttm-85 -62.87 -13.45 34.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.448 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -38.73 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -87.59 -35.5 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.813 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.1 -22.78 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 111.164 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.48 6.48 76.31 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.86 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.857 ' HB ' HD11 ' A' ' 61' ' ' LEU . 19.2 t -56.71 108.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 110.178 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -34.04 16.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.27 76.13 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.172 0.511 . . . . 0.0 111.054 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.84 13.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.687 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.611 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.1 pt-20 -119.92 141.1 49.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.19 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.7 t -70.61 116.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 111.334 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.732 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -90.72 -25.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.847 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -156.85 169.6 24.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.268 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 11.2 pt-20 -148.59 117.22 6.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.012 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.857 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.5 t -57.05 123.73 61.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.38 -13.45 39.34 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.885 2.39 . . . . 0.0 113.607 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.1 -179.04 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.349 0.595 . . . . 0.0 112.291 -179.417 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.724 ' C ' HD23 ' A' ' 80' ' ' LEU . 21.3 m95 -107.89 147.5 30.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.052 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.748 HD22 ' O ' ' A' ' 4' ' ' GLY . 3.1 mt -112.51 117.81 33.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.044 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.84 HG22 ' CB ' ' A' ' 104' ' ' ALA . 6.4 p -112.34 132.4 55.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.435 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.826 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -127.05 170.15 12.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 158.27 29.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 11.5 m-85 -118.42 142.53 31.53 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.631 ' HG2' HG23 ' A' ' 88' ' ' VAL . 27.6 Cg_endo -62.48 171.69 5.24 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.394 2.063 . . . . 0.0 112.234 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.65 -16.77 56.68 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.773 2.315 . . . . 0.0 113.307 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.03 -34.55 13.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.159 0.504 . . . . 0.0 110.185 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.631 HG23 ' HG2' ' A' ' 85' ' ' PRO . 96.0 t -83.0 -46.96 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.277 179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -46.21 90.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.47 0.653 . . . . 0.0 109.494 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.78 -26.64 66.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.673 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.07 -46.04 15.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.732 HD22 ' CD2' ' A' ' 96' ' ' TRP . 48.0 mt -56.43 -42.9 78.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.43 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -44.83 -34.17 2.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.749 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 94' ' ' ILE . 3.3 mp -96.25 -48.67 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -56.95 10.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.929 0.395 . . . . 0.0 110.768 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.732 ' CD2' HD22 ' A' ' 92' ' ' LEU . 38.6 m0 -78.83 -36.31 42.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 82.83 33.84 23.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.314 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.426 ' CB ' ' CD1' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -131.17 149.1 52.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 110.785 -179.812 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.53 38.7 2.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CD1' ' CB ' ' A' ' 98' ' ' SER . 36.3 m95 -89.24 150.31 22.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -30.36 64.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -162.51 -142.85 3.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.975 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -157.01 112.86 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.805 0.336 . . . . 0.0 111.366 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.84 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.66 105.74 17.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.517 ' NE2' ' OH ' ' A' ' 82' ' ' TYR . 21.0 pt20 -120.05 161.97 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -116.14 105.15 12.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.217 178.638 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.47 ' CD2' HG21 ' A' ' 157' ' ' VAL . 60.2 m95 -78.35 144.43 36.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.169 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.0 m-85 -127.83 136.64 51.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.6 tp -79.67 155.04 28.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HD12 ' A' ' 21' ' ' LEU . 29.4 m-85 -145.92 132.44 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.198 0.523 . . . . 0.0 111.967 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.667 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -95.64 118.74 32.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.522 177.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.646 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.9 t80 -68.73 119.74 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.611 HG21 ' OE1' ' A' ' 71' ' ' GLU . 6.3 p -120.84 37.32 4.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.497 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.72 -144.79 4.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.212 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.01 154.26 46.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -49.01 -17.47 0.2 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -74.0 -21.48 59.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.77 -24.77 56.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.414 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 34.1 mt -70.14 105.66 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.443 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -122.93 95.56 4.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.021 179.219 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 131' ' ' PHE . 37.6 mt -55.73 -21.65 19.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.698 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.631 HD22 ' HG3' ' A' ' 129' ' ' PRO . 17.6 mt -64.47 -58.44 6.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.278 0.561 . . . . 0.0 109.898 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.49 -170.41 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.393 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -93.7 38.8 1.06 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.87 75.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.135 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -116.38 -69.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.846 0.355 . . . . 0.0 111.212 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -89.88 165.12 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.69 148.18 54.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.631 ' HG3' HD22 ' A' ' 122' ' ' LEU . 74.2 Cg_exo -50.27 126.62 17.88 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.65 2.233 . . . . 0.0 112.463 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.0 -28.25 9.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.745 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.561 ' HB2' HD13 ' A' ' 121' ' ' LEU . 11.2 m-85 -113.08 159.25 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.476 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.15 -20.79 5.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.711 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.469 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.0 mm-40 -152.27 174.63 13.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.076 0.465 . . . . 0.0 110.47 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 p-90 -159.2 157.55 30.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.165 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -157.59 160.73 38.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.493 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.1 m95 -92.87 127.37 38.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.47 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.738 HG11 HD11 ' A' ' 145' ' ' LEU . 35.7 m -136.15 152.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -72.62 152.51 91.59 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.2 Cg_endo -49.06 -23.26 6.04 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.105 1.87 . . . . 0.0 111.926 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.96 -33.71 19.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -71.5 -50.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.041 179.298 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.933 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.8 tp -54.18 -29.3 45.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.488 0.661 . . . . 0.0 109.817 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.592 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -70.52 -28.39 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.75 178.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.2 -21.84 42.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.14 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.4 mt -82.48 -39.67 22.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.124 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 147' ' ' VAL . 24.9 m -58.78 163.6 3.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.023 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.824 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 12.6 p -92.58 161.42 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.52 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.32 -26.64 68.54 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.112 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.824 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 24.6 p90 -91.11 10.88 25.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 5.7 mtmm -152.75 15.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.658 0.266 . . . . 0.0 111.698 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.52 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.1 mtpp -67.04 -62.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.228 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.1 Cg_endo -50.77 -40.43 56.71 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.536 2.158 . . . . 0.0 112.097 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.826 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.4 t -57.15 -27.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.26 0.552 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.569 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -91.22 -48.47 6.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.372 179.019 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HD2' HD12 ' A' ' 143' ' ' ILE . 3.5 tttt -52.68 -32.28 41.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.581 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 160' ' ' VAL . 2.4 tp10 -66.89 -45.72 77.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.385 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.6 t -59.04 -46.78 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.983 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.546 HD13 ' CA ' ' A' ' 139' ' ' PRO . 74.1 mt -66.55 -48.69 68.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.647 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.9 t -50.24 -47.17 55.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.674 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.857 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.5 t -68.49 -24.56 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.073 0.463 . . . . 0.0 110.349 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.862 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.3 m-30 -103.26 5.69 37.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.212 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.19 -55.36 31.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.609 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.72 -22.51 17.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.577 2.184 . . . . 0.0 112.351 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.847 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 16.3 m-70 -89.97 -22.2 22.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.717 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.694 ' OXT' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.914 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.455 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.53 -167.77 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.29 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.54 161.41 28.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.814 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 88.34 26.51 27.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.572 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.42 121.04 1.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.543 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.2 mmt -122.56 -35.42 3.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 3.1 m-20 69.65 21.08 6.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.806 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 172.91 130.6 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.463 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.1 Cg_endo -64.38 109.41 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.317 2.011 . . . . 0.0 112.346 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 6.0 Cg_exo -78.23 -176.17 3.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.059 2.506 . . . . 0.0 112.091 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -90.26 153.92 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.75 -29.89 9.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -103.48 139.56 38.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 5.6 ttm180 -83.36 152.24 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.131 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -65.21 131.66 47.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.5 m120 -152.52 159.27 43.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.894 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.5 m -132.29 127.68 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.254 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.12 144.38 17.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.162 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.886 HG21 HD22 ' A' ' 61' ' ' LEU . 4.8 mp -120.95 102.11 11.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.8 t -89.71 107.65 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.011 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 110' ' ' PHE . 37.6 tp -103.08 144.8 30.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.014 0.435 . . . . 0.0 111.196 -179.025 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.07 157.48 41.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.747 -179.973 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.9 p-10 -103.89 170.38 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.34 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -55.08 -18.13 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.94 4.48 47.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 179.705 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 4.8 mtpp 70.55 27.86 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mttt -96.73 172.38 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 119' ' ' ILE . 65.9 t80 -57.19 109.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.183 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.62 132.44 56.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.254 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -115.57 138.03 51.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.468 . . . . 0.0 111.509 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.575 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.69 158.5 22.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.543 ' CD ' HD12 ' A' ' 36' ' ' ILE . 2.2 mtp-105 -71.26 164.21 26.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.41 0.624 . . . . 0.0 111.468 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -96.25 -6.06 38.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.69 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -136.17 -14.09 1.8 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 64.5 mt -120.67 111.77 34.36 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.358 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 32.8 Cg_endo -66.38 132.97 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.739 1.626 . . . . 0.0 111.306 179.123 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 79.12 3.18 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.465 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -94.95 97.74 10.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.152 179.281 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.427 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 23.7 m95 -108.78 160.21 16.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.085 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -168.86 170.81 8.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.859 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.453 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 71.0 mtm -97.91 156.71 35.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.67 137.81 39.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 0.0 112.917 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.27 157.02 38.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.378 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.93 153.02 23.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.754 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 132.17 17.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.626 HD11 HG13 ' A' ' 17' ' ' VAL . 6.4 mt -59.88 160.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.761 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 179.796 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.13 98.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.18 0.514 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.73 39.3 10.66 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.941 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HB3' HG23 ' A' ' 47' ' ' ILE . 15.5 tp10 -114.22 146.48 40.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 110.93 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.9 139.82 80.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.494 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.64 ' O ' HG11 ' A' ' 17' ' ' VAL . 52.2 Cg_exo -54.51 -52.55 7.91 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.46 2.107 . . . . 0.0 112.608 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' HD12 ' A' ' 58' ' ' ILE . 7.0 ttt180 -62.9 -25.48 68.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.328 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -84.66 -48.88 9.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.699 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -59.04 -28.31 66.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.772 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -75.54 -50.2 16.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.158 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.418 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.1 mt -57.25 -29.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -82.69 -53.12 6.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.747 0.784 . . . . 0.0 109.956 179.036 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -52.65 -42.33 64.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.471 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -57.11 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.686 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 32.0 ttp180 -61.98 -13.54 26.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.331 178.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.02 -42.73 9.82 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -91.26 -25.66 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.811 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.8 -20.5 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.11 6.67 65.12 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.049 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.657 HG13 ' HE1' ' A' ' 112' ' ' PHE . 46.9 t -71.1 117.19 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.506 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -96.14 -35.73 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.3 78.56 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 111.141 -179.698 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.53 129.43 13.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.931 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.61 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.76 148.96 42.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.06 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.8 t -79.56 123.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.422 0.629 . . . . 0.0 111.495 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.872 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -106.12 -20.17 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.398 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -154.55 159.35 40.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.435 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.2 pt-20 -148.66 117.11 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.989 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.842 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.0 t -57.26 126.76 75.13 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.065 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.94 -19.78 69.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.754 2.302 . . . . 0.0 113.228 -179.092 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.598 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.45 -177.98 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.049 -179.518 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.699 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.0 m95 -108.48 146.73 32.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.798 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.814 HD22 ' O ' ' A' ' 4' ' ' GLY . 3.4 mt -111.71 117.61 33.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.014 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.832 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.0 p -111.57 131.89 54.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.946 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.835 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -133.75 163.88 28.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.68 179.824 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -122.23 158.25 29.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.65 150.41 42.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.625 ' HG2' HG23 ' A' ' 88' ' ' VAL . 27.3 Cg_endo -62.41 170.49 6.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.553 2.169 . . . . 0.0 112.443 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.8 -16.77 51.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.89 2.393 . . . . 0.0 113.257 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.6 -39.28 11.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.197 0.523 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.625 HG23 ' HG2' ' A' ' 85' ' ' PRO . 94.8 t -78.46 -46.37 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.318 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -46.55 88.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.465 0.65 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.525 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.7 tt0 -66.39 -29.11 69.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.574 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -47.22 19.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.676 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' TRP . 92.7 mt -58.04 -45.87 86.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.356 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.8 m-80 -45.58 -31.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.567 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.33 -50.2 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.239 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -56.33 12.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.839 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' LEU . 21.5 m0 -78.54 -34.73 46.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 81.06 34.45 26.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.552 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.81 147.17 47.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.707 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.8 39.29 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 69.2 m95 -97.41 150.13 21.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -31.15 67.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -160.32 -143.03 3.54 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.005 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -157.61 114.47 2.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.878 0.37 . . . . 0.0 111.498 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.832 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -94.51 105.78 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -127.81 156.6 42.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.08 97.91 7.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 178.862 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 28.0 m95 -65.72 141.95 58.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 0.0 112.134 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 62.0 m-85 -125.6 137.24 53.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.316 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.3 tp -79.54 146.14 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.88 ' CD1' HG23 ' A' ' 19' ' ' ILE . 40.0 m-85 -139.11 127.88 23.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.008 0.432 . . . . 0.0 111.651 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.872 ' HB3' HD11 ' A' ' 73' ' ' ILE . 15.3 tttm -92.02 120.44 32.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.522 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.657 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.5 t80 -64.89 125.53 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.798 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.1 p -126.54 37.73 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -139.89 -144.86 4.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.236 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -127.15 154.27 44.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.917 0.389 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -49.75 -16.67 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.642 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.97 -18.16 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.266 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.06 -25.36 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 29' ' ' PHE . 17.7 mt -74.2 103.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.49 -179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -117.61 95.89 5.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 131' ' ' PHE . 47.2 mt -55.2 -23.32 21.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.64 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.417 HD22 ' HG3' ' A' ' 129' ' ' PRO . 29.0 mt -62.37 -57.4 11.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.285 0.564 . . . . 0.0 110.065 179.3 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.03 25.0 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.51 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.27 38.84 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 109.89 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.05 27.79 73.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.222 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.5 t -110.49 -65.97 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.837 0.351 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.57 165.06 11.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 149.9 97.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HG3' HD22 ' A' ' 122' ' ' LEU . 69.3 Cg_exo -50.0 177.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.732 2.288 . . . . 0.0 112.612 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -150.07 -45.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.552 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.819 ' HB2' HD13 ' A' ' 121' ' ' LEU . 18.9 m-85 -107.41 159.74 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.331 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.12 -16.9 6.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.803 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.575 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.47 174.7 13.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.12 0.486 . . . . 0.0 110.705 -179.816 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.5 p-90 -159.51 153.67 23.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.08 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.06 161.62 42.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.41 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -94.95 123.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.766 HG11 HD11 ' A' ' 145' ' ' LEU . 27.3 m -135.39 151.05 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.071 0.463 . . . . 0.0 111.641 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.85 159.23 86.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.687 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.7 Cg_endo -55.51 -19.38 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.935 1.756 . . . . 0.0 111.873 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.26 -34.25 15.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.48 -50.48 25.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.989 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.924 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.3 tp -54.01 -29.95 45.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.489 0.661 . . . . 0.0 109.915 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.601 HD12 ' HD2' ' A' ' 155' ' ' LYS . 2.9 mm -68.15 -29.15 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.582 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.6 -22.15 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.6 mt -84.41 -39.24 19.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.005 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 150' ' ' LYS . 4.8 m -58.63 168.56 1.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.3 p -104.64 159.92 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.047 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 147' ' ' VAL . 2.7 mm-40 -45.44 -46.17 13.35 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 147' ' ' VAL . 1.5 p90 -76.8 -1.89 30.47 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.507 ' O ' HG21 ' A' ' 146' ' ' THR . 1.8 mtmp? -125.73 1.57 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.579 0.228 . . . . 0.0 111.528 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.3 mttt -65.36 -62.55 4.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.342 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.03 -42.44 44.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.419 2.08 . . . . 0.0 112.239 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.835 HG11 ' CD1' ' A' ' 82' ' ' TYR . 13.4 t -59.16 -29.07 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.273 0.558 . . . . 0.0 110.966 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.78 -50.97 5.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.692 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -49.78 -35.01 21.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.669 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -66.58 -44.81 81.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.642 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 153' ' ' VAL . 44.2 t -57.76 -46.51 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.084 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.687 HD13 ' CA ' ' A' ' 139' ' ' PRO . 74.3 mt -66.27 -48.87 69.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.9 m -50.02 -47.17 53.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.1 t -68.39 -25.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.067 0.46 . . . . 0.0 110.307 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.8 12.0 33.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.981 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' A' ' 163' ' ' PRO . . . -53.98 -59.47 9.78 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.404 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -56.31 -21.53 37.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.586 2.191 . . . . 0.0 112.268 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.419 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 62.6 m-70 -89.95 -12.67 38.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.971 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.477 ' PA ' " C3'" ' A' ' 166' ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.28 145.1 53.21 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.537 2.158 . . . . 0.0 112.32 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.437 HD23 ' HG3' ' A' ' 152' ' ' PRO . 26.1 tp -153.25 102.47 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.691 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 118.73 65.49 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.477 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.453 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER 178.59 127.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.595 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.1 ptp -140.32 -27.46 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.036 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.08 28.79 1.01 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.636 0.255 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 140.99 0.28 Allowed Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.64 120.35 4.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.214 179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -91.42 -171.13 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.936 2.424 . . . . 0.0 112.459 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -87.81 151.07 23.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.768 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.28 -28.95 11.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.428 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.0 m-85 -111.91 140.74 46.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.338 . . . . 0.0 110.725 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HD3' ' CE2' ' A' ' 100' ' ' TRP . 2.1 ttp85 -92.48 152.38 19.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -62.12 132.55 53.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.425 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 19.1 t-20 -152.73 154.53 35.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.358 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.818 HG13 HD11 ' A' ' 47' ' ' ILE . 2.3 m -126.3 131.49 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 111.388 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.81 148.3 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.033 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.927 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -123.06 102.43 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.761 0.315 . . . . 0.0 111.397 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.2 t -89.48 104.69 17.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.859 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -102.59 145.3 29.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.0 0.429 . . . . 0.0 111.105 -178.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.2 ptm -127.65 157.26 40.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.2 p-10 -106.31 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -54.05 -18.33 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -88.86 3.94 49.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 179.803 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 20.7 mmtm 70.47 27.38 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.577 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' MET . 11.4 mmtm -96.38 175.32 6.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.594 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -113.65 119.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.956 0.408 . . . . 0.0 110.809 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 119' ' ' ILE . 18.8 t80 -52.46 110.29 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.74 133.6 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.412 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.89 139.1 52.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.9 p -82.3 155.78 24.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.685 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.737 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtt85 -72.01 158.09 36.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.5 mt -91.77 -5.66 53.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.019 178.547 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.79 -18.18 3.48 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.737 HD12 ' CD ' ' A' ' 33' ' ' ARG . 61.7 mt -118.78 111.84 37.24 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.7 131.24 28.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.981 1.787 . . . . 0.0 111.968 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 77.08 3.26 3.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.856 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.23 97.56 10.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.406 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.671 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.6 m95 -101.59 155.87 17.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.221 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -168.85 -176.92 2.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.651 179.724 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.467 ' SD ' HD21 ' A' ' 142' ' ' LEU . 3.4 mpp? -107.17 158.18 33.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 128.88 19.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.603 2.202 . . . . 0.0 112.417 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -154.03 157.09 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.76 139.24 5.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.571 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.31 137.48 49.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.818 HD11 HG13 ' A' ' 17' ' ' VAL . 9.2 mt -69.22 162.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.632 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -75.93 -172.16 1.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.613 179.614 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -90.14 27.45 1.63 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.24 0.543 . . . . 0.0 111.145 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.91 48.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 56' ' ' ALA . 5.4 tp10 -124.33 149.61 46.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 110.929 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -77.76 137.73 62.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.1 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.698 ' O ' HG11 ' A' ' 17' ' ' VAL . 77.5 Cg_exo -50.68 -55.18 4.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.363 2.042 . . . . 0.0 112.763 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.56 ' HD3' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.42 -31.55 67.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.316 -179.731 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -80.07 -49.73 11.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.733 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.577 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -56.69 -30.6 63.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.497 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.746 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.46 -52.59 13.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.56 HD11 ' HD3' ' A' ' 54' ' ' ARG . 41.2 mt -56.41 -29.85 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.23 179.079 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -81.67 -53.15 6.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.762 0.791 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -52.08 -45.71 64.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.597 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.915 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -56.0 -56.16 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.811 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 40.1 ttp180 -60.56 -14.48 20.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.298 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -92.07 -41.35 10.56 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.897 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -91.5 -25.04 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.5 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.837 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.31 -20.06 9.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.086 -179.31 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.24 6.24 64.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.051 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.629 HG13 ' HE1' ' A' ' 112' ' ' PHE . 48.4 t -71.18 123.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.865 0.333 . . . . 0.0 110.469 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -34.12 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.24 76.77 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.987 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.26 129.01 13.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.873 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 12.0 mt-10 -120.39 148.5 43.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.765 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 110' ' ' PHE . 38.9 t -78.15 125.39 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.456 0.646 . . . . 0.0 111.694 -179.332 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.28 -21.62 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.237 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 3.4 pt-20 -148.52 115.85 6.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.011 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.828 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.8 t -57.31 130.17 80.36 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.066 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 -15.96 40.07 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.721 2.281 . . . . 0.0 113.6 -178.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.553 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.65 -176.05 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.417 0.627 . . . . 0.0 112.48 -179.369 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.69 ' C ' HD23 ' A' ' 80' ' ' LEU . 25.6 m95 -106.27 147.48 29.09 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.279 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.691 HD22 ' O ' ' A' ' 4' ' ' GLY . 5.5 mt -114.47 117.94 32.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.996 179.22 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.86 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -111.04 135.07 52.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.435 -179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.899 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -122.71 170.26 10.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.683 -179.355 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.21 158.23 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -117.63 152.51 49.79 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HG2' HG23 ' A' ' 88' ' ' VAL . 36.5 Cg_endo -64.96 165.41 21.53 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.98 -16.34 44.7 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.847 2.364 . . . . 0.0 113.066 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.66 -34.9 14.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.075 0.464 . . . . 0.0 110.13 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.566 HG23 ' HG2' ' A' ' 85' ' ' PRO . 64.9 t -81.9 -48.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -44.63 92.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.459 0.647 . . . . 0.0 109.576 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 94' ' ' ILE . 9.1 tt0 -70.78 -31.14 67.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.633 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.39 -48.01 52.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.737 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 96' ' ' TRP . 96.8 mt -59.05 -47.69 84.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.599 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.421 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 3.0 m-80 -46.75 -31.4 2.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.636 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 90' ' ' GLU . 4.1 mt -96.67 -48.08 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.355 179.458 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -52.83 28.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.473 ' N ' ' O ' ' A' ' 92' ' ' LEU . 22.5 m0 -80.89 -35.12 32.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.68 38.34 28.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.195 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.9 159.13 34.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.812 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -118.08 77.89 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.429 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 56.9 m95 -135.3 150.24 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.573 179.826 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.519 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -85.72 -23.02 27.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -174.7 -137.58 2.51 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.048 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 90.0 mm-40 -157.3 113.85 2.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.886 0.374 . . . . 0.0 111.346 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.86 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -88.0 105.63 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.3 pt20 -121.64 157.06 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -112.15 95.72 5.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.198 178.569 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.644 ' CD2' HG21 ' A' ' 157' ' ' VAL . 24.2 m95 -64.12 150.5 45.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.308 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CE2' ' CG ' ' A' ' 54' ' ' ARG . 64.9 m-85 -133.15 133.29 42.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.284 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.834 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.6 tp -79.81 130.23 35.14 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.927 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.9 m-85 -124.49 129.13 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.505 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.844 ' HB3' HD11 ' A' ' 73' ' ' ILE . 5.1 tptt -92.38 123.06 35.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -67.2 124.48 23.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.694 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' SER . 17.6 p -126.73 37.87 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.747 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.2 -145.13 4.79 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.031 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -128.54 154.13 46.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.55 ' HA ' HD12 ' A' ' 119' ' ' ILE . 10.6 m-20 -50.25 -16.25 0.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.67 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -18.36 54.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.744 0.307 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.12 -25.0 40.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 116' ' ' ASP . 8.6 mt -72.09 103.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.501 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.5 95.61 5.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 131' ' ' PHE . 43.8 mt -56.69 -23.15 39.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.54 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 mt -61.85 -56.77 15.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.25 0.548 . . . . 0.0 109.997 179.233 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.38 -178.47 22.3 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.552 179.719 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -90.72 38.74 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.1 0.476 . . . . 0.0 109.843 179.208 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.23 73.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -112.76 -67.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 111.19 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -105.54 165.04 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.235 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.54 150.75 95.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' LEU . 59.9 Cg_exo -50.43 138.77 38.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.654 2.236 . . . . 0.0 112.506 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -112.4 -31.48 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.724 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.539 ' HB2' HD13 ' A' ' 121' ' ' LEU . 7.2 m-85 -118.02 159.56 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.03 -20.07 5.37 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.879 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.435 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.5 mm-40 -152.23 174.66 13.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.248 0.547 . . . . 0.0 110.599 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 p-90 -159.2 154.11 24.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.178 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -93.05 125.31 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 142' ' ' LEU . 28.9 m -137.63 150.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.116 0.484 . . . . 0.0 111.619 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -69.54 159.83 82.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.472 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.641 ' CB ' HD13 ' A' ' 158' ' ' LEU . 14.0 Cg_endo -56.69 -18.89 28.21 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.796 1.664 . . . . 0.0 111.838 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.12 -34.2 15.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.054 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -50.9 22.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.112 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.1 tp -54.22 -30.28 49.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.393 0.616 . . . . 0.0 109.826 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 143' ' ' ILE . 5.1 mm -68.97 -28.31 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.717 178.703 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 -17.53 47.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.367 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.0 mt -87.53 -38.8 15.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.186 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 147' ' ' VAL . 67.6 m -59.51 162.26 5.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.046 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.962 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 10.1 p -91.62 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.8 mt-10 -51.66 -33.18 32.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.039 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.962 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.3 p90 -87.53 10.9 16.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 8.6 mtmm -136.74 -2.24 2.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 30.1 mttt -55.76 -61.81 5.67 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.201 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.437 ' HG3' HD23 ' A' ' 3' ' ' LEU . 18.3 Cg_endo -59.6 -45.84 23.66 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.377 2.051 . . . . 0.0 112.122 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.899 HG21 ' HB3' ' A' ' 82' ' ' TYR . 39.5 t -56.06 -27.79 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.227 0.537 . . . . 0.0 111.066 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.8 m-30 -91.55 -53.71 4.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' CD ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.76 -32.63 14.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 110.522 179.87 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.2 -45.56 80.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.498 179.148 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -57.9 -50.38 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.123 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.641 HD13 ' CB ' ' A' ' 139' ' ' PRO . 74.7 mt -61.68 -48.89 78.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.698 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 t -49.71 -47.53 50.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.664 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.0 t -67.84 -25.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.461 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.834 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.6 m-30 -102.1 7.88 40.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.156 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.64 -57.0 17.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.258 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.4 Cg_endo -56.76 -22.39 44.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.503 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 71.6 m80 -89.97 -14.37 34.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.025 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.894 179.829 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.446 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -178.51 2.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.588 2.192 . . . . 0.0 112.227 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.442 ' CD1' ' HE2' ' A' ' 6' ' ' MET . 0.2 OUTLIER -63.75 86.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 -179.973 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.17 31.18 9.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.499 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.5 OUTLIER 173.62 128.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.343 . . . . 0.0 110.547 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.442 ' HE2' ' CD1' ' A' ' 3' ' ' LEU . 10.9 tpp -124.75 -32.14 3.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.779 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 5.7 m-20 74.61 19.36 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.87 142.4 0.17 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 41.7 Cg_endo -68.26 114.93 3.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.279 1.986 . . . . 0.0 112.183 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.695 ' HG2' HG21 ' A' ' 81' ' ' THR . 11.6 Cg_exo -71.13 -176.27 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.589 2.193 . . . . 0.0 111.87 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 151.27 21.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.327 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.559 ' HA3' ' HZ3' ' A' ' 101' ' ' LYS . . . 88.83 -37.15 3.34 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.877 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.68 131.95 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.008 0.432 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.468 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 2.1 ptm85 -73.79 143.52 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.401 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 38.5 mtm180 -67.02 133.17 49.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.399 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.3 t-20 -152.55 155.96 38.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.738 HG13 HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -123.87 130.0 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.216 179.786 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.18 146.38 18.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.126 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.906 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.4 mp -124.56 102.03 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.9 t -89.57 101.82 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -103.03 143.3 32.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 0.0 111.229 -178.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.86 157.41 39.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.751 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.2 p-10 -100.71 170.05 8.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.232 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -56.27 -16.67 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.56 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.98 0.11 56.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.688 0.28 . . . . 0.0 110.973 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mttm 77.21 26.71 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.602 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -98.93 173.27 6.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.916 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.537 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.23 122.97 66.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.746 ' CE1' HG21 ' A' ' 119' ' ' ILE . 66.7 t80 -56.5 110.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.8 129.88 56.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.236 179.348 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.11 137.54 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.62 157.61 23.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.55 179.761 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.56 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -72.94 159.51 33.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.15 -5.65 49.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.996 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.49 -16.81 3.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.621 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.5 mt -119.65 111.97 35.75 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.24 131.82 29.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.904 1.736 . . . . 0.0 111.8 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 76.92 3.52 3.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.783 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.67 97.51 11.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.414 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.424 ' CD1' HD22 ' A' ' 145' ' ' LEU . 37.7 m95 -104.62 156.65 17.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.044 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -168.8 169.56 9.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.815 179.986 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.451 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 45.9 mtm -94.15 155.83 39.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.45 134.11 37.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.512 2.142 . . . . 0.0 112.687 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 163.54 39.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.493 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.45 142.73 7.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.746 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.84 135.61 49.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.59 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.738 HD11 HG13 ' A' ' 17' ' ' VAL . 5.5 mt -66.84 160.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.55 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.494 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.17 149.35 22.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.824 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -50.73 99.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.219 0.533 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.57 39.83 11.76 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.851 -179.513 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 6.0 tp10 -113.76 145.18 41.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.91 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 m-20 -74.43 125.56 89.7 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.236 179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.591 ' O ' HG11 ' A' ' 17' ' ' VAL . 6.6 Cg_endo -50.16 -47.97 21.77 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.46 2.106 . . . . 0.0 112.772 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.634 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -59.31 -27.73 66.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.725 0.298 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -88.01 -43.44 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.78 -32.18 71.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.174 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.11 -54.06 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.034 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -55.79 -29.53 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.278 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttp85 -82.69 -52.79 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.798 0.808 . . . . 0.0 109.981 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.92 -44.1 66.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.575 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.787 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.3 tp -56.97 -55.39 35.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.676 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 33.7 ttp180 -62.28 -13.3 26.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.283 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.12 -43.25 9.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.827 -179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.18 -25.85 19.35 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.787 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -116.77 -20.35 9.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.451 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.88 4.69 67.58 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.103 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.672 HG13 ' HE1' ' A' ' 112' ' ' PHE . 47.4 t -69.86 116.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.834 0.35 . . . . 0.0 110.529 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.65 -34.5 11.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -179.773 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.38 78.4 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.48 129.04 13.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.871 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.613 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.68 149.02 42.12 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.56 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.634 HG11 ' CZ ' ' A' ' 54' ' ' ARG . 30.6 t -80.06 122.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.4 0.619 . . . . 0.0 111.355 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.901 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -103.03 -20.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.414 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.94 161.0 40.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.68 117.48 6.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.877 179.652 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.864 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.4 t -57.16 128.78 78.59 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.22 -18.18 55.54 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 113.337 -178.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.641 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -125.6 -179.16 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 112.111 -179.505 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.437 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 6.2 m95 -108.45 145.94 33.89 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.706 HD21 ' HG2' ' A' ' 156' ' ' GLU . 66.5 mt -110.66 117.3 33.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.106 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.864 HG22 ' CB ' ' A' ' 104' ' ' ALA . 17.4 p -101.63 137.49 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.762 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.724 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -131.85 169.78 15.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 -179.417 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.91 158.42 36.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -116.32 145.04 34.2 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.639 ' HG2' HG23 ' A' ' 88' ' ' VAL . 24.4 Cg_endo -62.23 169.56 7.68 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 112.323 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.87 -16.48 44.93 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.868 2.379 . . . . 0.0 113.233 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -90.73 -42.85 10.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.274 0.559 . . . . 0.0 109.829 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.639 HG23 ' HG2' ' A' ' 85' ' ' PRO . 96.4 t -74.11 -46.45 45.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.448 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -46.17 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.515 0.674 . . . . 0.0 109.731 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.634 ' O ' HD13 ' A' ' 94' ' ' ILE . 39.4 tt0 -71.35 -21.58 62.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.888 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 -44.87 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.638 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.762 HD22 ' CD2' ' A' ' 96' ' ' TRP . 84.4 mt -60.83 -45.06 95.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.462 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.0 m120 -46.92 -33.13 4.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.634 HD13 ' O ' ' A' ' 90' ' ' GLU . 1.9 mp -96.72 -47.64 12.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -68.43 -54.87 14.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.358 . . . . 0.0 111.002 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.762 ' CD2' HD22 ' A' ' 92' ' ' LEU . 27.1 m0 -79.76 -33.34 40.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 76.36 38.51 33.48 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.196 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -125.27 147.52 49.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.382 . . . . 0.0 110.893 -179.823 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.63 74.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.828 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.468 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 19.0 m95 -135.19 149.42 49.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.964 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.559 ' HZ3' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -81.72 -29.23 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.634 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -155.96 -146.19 4.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.279 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -158.17 129.95 6.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.914 0.388 . . . . 0.0 111.777 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.864 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -111.71 106.84 15.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.889 178.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.461 ' NE2' ' OD1' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -122.06 161.59 22.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.606 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -113.85 101.66 9.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.021 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.54 ' CD2' HG21 ' A' ' 157' ' ' VAL . 33.8 m95 -70.36 153.15 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 0.0 112.401 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 73.3 m-85 -137.08 134.12 36.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.199 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.826 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.88 130.97 35.73 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.424 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.906 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.3 m-85 -125.55 128.43 47.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.581 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.901 ' HB3' HD11 ' A' ' 73' ' ' ILE . 1.9 tptt -92.25 121.18 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.783 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.672 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -64.86 124.88 23.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.984 0.421 . . . . 0.0 110.816 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.613 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.2 p -125.66 37.51 4.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.602 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -139.12 -145.18 4.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.13 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -128.09 154.24 45.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.829 0.347 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -50.03 -16.52 0.3 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.62 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -18.35 54.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.682 0.277 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.34 -25.29 39.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.746 HG21 ' CE1' ' A' ' 29' ' ' PHE . 16.1 mt -72.35 97.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.361 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -111.42 95.71 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.078 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 131' ' ' PHE . 66.8 mt -55.42 -23.06 22.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.667 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.75 -58.11 8.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.299 0.571 . . . . 0.0 110.001 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.51 -176.85 25.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.554 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.44 38.79 1.02 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 179.153 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.34 28.18 73.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.169 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -112.18 -65.98 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.04 165.13 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.241 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -66.78 151.87 96.2 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.42 176.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.04 -44.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.681 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 121' ' ' LEU . 23.0 m-85 -109.44 159.53 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.392 179.644 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.83 -19.19 6.12 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 21.3 mm-40 -152.46 174.69 13.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.455 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 23.7 p-90 -158.38 151.72 23.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.145 179.064 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.2 m -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.386 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -93.32 123.47 36.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.666 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 145' ' ' LEU . 31.6 m -134.05 151.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.111 0.482 . . . . 0.0 111.716 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.6 p -70.23 158.34 87.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.537 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.02 -19.1 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.978 1.786 . . . . 0.0 112.046 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.01 -33.46 14.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 179.207 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -50.05 35.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.107 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.896 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -53.34 -31.93 46.7 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.437 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.35 -29.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.683 178.566 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -32.07 57.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.1 mt -75.47 -40.47 57.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.008 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 150' ' ' LYS . 16.8 m -55.4 165.07 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.141 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.3 p -98.9 160.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.221 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.4 mm-40 -47.34 -43.35 22.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.43 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 12.7 p90 -82.66 4.12 26.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.272 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 16.1 mttt -125.25 -3.29 7.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 111.368 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 35.5 mttt -59.95 -61.87 7.03 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.0 Cg_endo -61.08 -43.29 30.58 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.456 2.104 . . . . 0.0 112.403 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.724 HG21 ' HB3' ' A' ' 82' ' ' TYR . 15.4 t -57.23 -29.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.08 -55.25 3.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.8 -32.59 6.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.706 ' HG2' HD21 ' A' ' 80' ' ' LEU . 3.1 tp10 -69.73 -44.19 70.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.785 179.407 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.5 t -59.57 -42.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.136 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 162' ' ' ALA . 51.3 mt -67.46 -48.1 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.619 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -50.58 -46.84 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.807 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.864 HG11 ' HA ' ' A' ' 76' ' ' VAL . 87.7 t -68.08 -24.54 30.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.123 0.487 . . . . 0.0 110.411 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.826 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -102.61 6.05 39.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.117 -179.178 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -50.97 -49.9 77.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.532 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 75.0 Cg_exo -49.73 -25.21 11.09 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.565 2.176 . . . . 0.0 112.559 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.726 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 96.7 m-70 -94.68 -26.71 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.455 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.09 173.65 10.94 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.677 2.251 . . . . 0.0 112.312 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 81' ' ' THR . 4.4 tp -175.63 87.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.7 33.86 2.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.79 129.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 110.518 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mmt -121.69 -38.17 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.409 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 68.46 18.66 8.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.856 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t 172.86 132.97 0.1 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 33.3 Cg_endo -65.23 109.56 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.337 2.024 . . . . 0.0 112.297 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 5.0 Cg_exo -79.76 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.065 2.51 . . . . 0.0 112.047 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.3 151.7 21.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.64 -25.24 28.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.56 138.13 43.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.41 . . . . 0.0 110.966 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 4.1 ptm85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -67.32 130.33 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.47 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.8 m120 -152.68 159.63 43.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.731 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.5 m -133.61 131.32 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.257 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.34 144.7 16.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.298 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.866 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.3 mp -120.5 101.81 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.172 -179.809 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.2 t -89.54 107.21 18.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.228 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 110' ' ' PHE . 45.9 tp -103.42 141.86 35.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.097 -179.073 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.49 157.46 40.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.1 p-10 -101.02 171.04 7.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.331 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.13 -17.62 7.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.586 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.07 0.26 56.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.733 0.302 . . . . 0.0 110.971 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp 77.0 26.21 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.5 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.21 172.11 8.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.965 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.589 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -110.91 121.32 63.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.367 . . . . 0.0 110.937 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CE2' HG21 ' A' ' 119' ' ' ILE . 37.0 t80 -56.06 109.4 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.233 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.7 130.01 56.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.36 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.29 136.1 53.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.414 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -82.29 155.39 24.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.416 179.637 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.624 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -72.12 157.29 38.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.355 0.597 . . . . 0.0 111.732 -179.223 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.43 -6.44 49.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.828 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.53 -18.26 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.216 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 61.7 mt -119.6 110.92 36.64 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 28.5 Cg_endo -65.17 131.83 29.8 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.816 1.677 . . . . 0.0 111.73 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 t70 77.11 5.46 3.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.642 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -92.82 97.84 11.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.5 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.53 ' CD1' HD22 ' A' ' 145' ' ' LEU . 19.2 m95 -107.0 156.4 18.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -168.8 176.69 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.498 ' HE2' ' CZ3' ' A' ' 107' ' ' TRP . 2.2 mpp? -101.3 160.44 26.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.34 136.95 24.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.571 2.181 . . . . 0.0 112.786 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 155.77 35.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.14 155.6 26.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.675 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.88 132.82 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.635 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -60.23 161.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.644 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.25 149.33 22.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.91 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.44 98.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.194 0.521 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.51 10.0 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.947 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 6.1 tp10 -114.38 146.27 40.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.16 140.05 76.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.511 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.578 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.2 Cg_exo -53.24 -52.43 8.74 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.383 2.055 . . . . 0.0 112.575 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' O ' HD12 ' A' ' 58' ' ' ILE . 2.2 tmm_? -62.56 -25.62 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.156 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.64 -50.02 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.676 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.53 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.25 -31.97 67.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.504 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.24 -52.0 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.1 mt -57.24 -28.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.213 179.22 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -84.0 -53.18 5.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.749 0.785 . . . . 0.0 109.777 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.56 -32.7 58.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.29 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.874 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.0 tp -55.73 -54.79 40.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.605 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -61.67 -13.0 18.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.911 0.386 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.64 -37.92 12.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 0.0 111.395 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.7 -36.42 17.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.955 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.506 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.07 -23.46 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.1 3.05 84.48 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.81 -179.579 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.874 ' HB ' HD11 ' A' ' 61' ' ' LEU . 39.0 t -61.95 115.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.821 0.343 . . . . 0.0 110.461 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -91.83 -36.95 13.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.18 78.98 6.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 110.979 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 129.56 13.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.845 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -120.04 147.76 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.859 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.4 t -78.22 125.03 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.405 0.621 . . . . 0.0 111.858 -179.141 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.895 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -107.0 -19.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.362 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.722 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -152.03 158.26 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.327 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -148.56 116.75 6.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.995 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.888 ' HA ' HG11 ' A' ' 160' ' ' VAL . 10.9 t -57.26 130.79 80.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.094 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -17.66 40.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.647 2.231 . . . . 0.0 113.316 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.624 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.35 177.08 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 112.15 -179.497 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.463 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 m95 -104.32 146.05 29.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.976 179.067 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.914 ' HB3' HG13 ' A' ' 153' ' ' VAL . 94.8 mt -113.19 117.56 32.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.798 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.5 p -111.19 131.9 54.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.864 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -132.69 162.81 30.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.616 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.22 158.38 24.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.47 154.44 47.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.634 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.6 Cg_endo -63.87 172.0 6.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.493 2.129 . . . . 0.0 112.528 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.879 2.386 . . . . 0.0 113.256 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -90.17 -35.08 15.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 109.979 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 85' ' ' PRO . 73.3 t -80.41 -49.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.187 179.252 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -47.4 80.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.515 0.674 . . . . 0.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.585 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -67.54 -27.51 67.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.92 179.801 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.89 -46.56 18.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.551 HD21 H5'2 ' A' ' 166' ' ' ATP . 95.2 mt -60.44 -45.72 92.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 110.263 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.425 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.0 m120 -45.2 -30.69 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.639 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.7 mt -96.08 -50.66 11.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 179.409 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -51.76 64.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.74 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.429 ' CZ2' ' O1A' ' A' ' 166' ' ' ATP . 33.9 m0 -81.96 -40.77 21.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.837 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 86.85 34.48 11.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.42 156.19 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.76 67.52 0.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 51.8 m95 -124.47 150.24 45.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -31.31 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -156.22 -144.66 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.991 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.09 114.95 2.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.347 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.798 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -92.74 105.97 18.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.874 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -127.32 155.59 43.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 112.539 -178.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -109.26 96.34 6.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.633 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.498 ' CZ3' ' HE2' ' A' ' 42' ' ' MET . 23.2 m95 -63.7 145.68 55.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.106 -178.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 59.2 m-85 -128.16 137.05 51.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.428 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.79 HD13 ' CD2' ' A' ' 161' ' ' PHE . 19.4 tp -79.71 146.95 32.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.4 m-85 -140.77 127.05 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.978 0.418 . . . . 0.0 111.545 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.895 ' HB3' HD11 ' A' ' 73' ' ' ILE . 14.5 tttm -90.47 121.06 32.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -65.41 125.17 24.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 111' ' ' LYS . 10.0 p -127.77 38.14 4.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.549 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -137.77 -145.47 4.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.153 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.23 154.05 45.33 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -50.5 -16.08 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.7 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -79.74 -19.11 49.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.767 0.318 . . . . 0.0 111.307 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -78.74 -25.28 44.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.824 HG21 ' CE2' ' A' ' 29' ' ' PHE . 16.5 mt -74.78 103.48 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.378 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -113.77 95.51 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.918 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 131' ' ' PHE . 31.8 mt -49.82 -26.28 3.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.732 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.539 HD22 ' HG3' ' A' ' 129' ' ' PRO . 34.0 mt -63.5 -57.48 10.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 109.982 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.63 -173.49 25.98 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.42 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -93.44 38.86 1.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.19 0.519 . . . . 0.0 109.993 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.89 27.51 73.04 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.267 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -115.13 -68.17 0.94 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.09 165.01 13.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -78.84 153.88 77.99 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.956 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.539 ' HG3' HD22 ' A' ' 122' ' ' LEU . 87.5 Cg_exo -46.18 162.52 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.836 2.358 . . . . 0.0 112.554 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -149.95 -44.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HB2' HD13 ' A' ' 121' ' ' LEU . 20.7 m-85 -106.47 159.12 16.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.94 -20.36 4.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.696 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.413 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.3 mm-40 -152.42 174.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.456 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.6 p-90 -159.17 156.19 28.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.151 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.96 164.2 38.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.401 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 69.0 m95 -94.44 124.95 38.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.672 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 142' ' ' LEU . 29.7 m -138.21 151.49 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.057 0.456 . . . . 0.0 111.626 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -70.2 159.97 82.55 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.677 ' CA ' HD13 ' A' ' 158' ' ' LEU . 14.6 Cg_endo -57.15 -17.88 27.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.775 1.65 . . . . 0.0 111.786 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -34.43 15.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.154 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -50.78 25.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 109.97 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.5 tp -54.39 -28.96 47.07 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.387 0.613 . . . . 0.0 109.858 179.079 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.574 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm -69.45 -28.73 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.812 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.26 -20.04 45.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.271 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.0 mt -86.32 -39.07 16.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -62.22 166.09 5.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.104 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.978 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.3 p -98.41 161.57 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.023 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -52.21 -33.37 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.98 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.978 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.8 p90 -86.48 16.0 4.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.937 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 149' ' ' PHE . 2.4 mtpm? -143.93 -26.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.064 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.9 mtpt -43.38 -61.61 1.77 Allowed Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.653 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.2 Cg_endo -59.42 -44.36 33.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.265 1.976 . . . . 0.0 111.822 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.914 HG13 ' HB3' ' A' ' 80' ' ' LEU . 17.1 t -60.01 -24.99 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.804 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.8 m-30 -90.85 -50.92 5.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.594 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.574 ' HD2' HD12 ' A' ' 143' ' ' ILE . 2.7 tttt -48.9 -36.63 17.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.726 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.0 tp10 -64.92 -45.4 86.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.451 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 153' ' ' VAL . 37.8 t -58.81 -43.02 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.123 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.677 HD13 ' CA ' ' A' ' 139' ' ' PRO . 53.4 mt -69.09 -49.22 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.623 178.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -50.35 -46.78 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.718 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.888 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.9 t -67.54 -24.87 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.426 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.79 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -102.26 2.36 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.244 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.567 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.79 -56.07 24.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.406 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.9 -21.22 25.45 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.602 2.201 . . . . 0.0 112.391 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.722 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 9.4 m80 -89.64 -20.02 24.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.748 0.309 . . . . 0.0 110.816 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.87 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.551 H5'2 HD21 ' A' ' 92' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.16 -178.39 2.47 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.545 2.164 . . . . 0.0 112.294 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.66 114.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.78 21.74 5.6 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.62 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.52 129.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.624 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.43 -35.52 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.49 14.26 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.156 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.62 139.77 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 57.3 Cg_endo -71.9 112.79 3.48 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.357 2.038 . . . . 0.0 112.293 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -92.15 -172.37 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.137 2.558 . . . . 0.0 112.369 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.25 159.84 20.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.36 -35.85 4.09 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -110.4 138.78 46.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.13 152.27 24.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -66.03 132.75 49.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.113 0.483 . . . . 0.0 111.502 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.8 t30 -152.49 158.49 42.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.744 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.1 m -132.2 133.34 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 111.68 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.15 153.61 17.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.938 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.9 HG21 HD22 ' A' ' 61' ' ' LEU . 4.1 mp -127.08 103.37 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.323 . . . . 0.0 111.488 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.6 t -89.7 104.07 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.0 tp -103.24 145.28 30.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.211 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.94 157.53 39.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.719 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.7 p-10 -101.55 170.57 8.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.06 -18.23 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.466 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.0 0.58 56.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.714 0.292 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt 76.03 26.12 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.485 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mttt -96.64 171.24 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.514 HD12 ' O ' ' A' ' 137' ' ' VAL . 4.1 mp -108.16 124.14 64.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.948 0.404 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CE1' HG21 ' A' ' 119' ' ' ILE . 67.6 t80 -58.53 110.16 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.143 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.66 135.29 53.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.73 136.25 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 111.317 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.66 153.74 25.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.563 179.778 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.591 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -70.8 158.3 36.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.532 -179.408 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -92.65 -6.63 48.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.92 178.444 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -128.75 -17.23 4.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.15 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 51.6 mt -119.76 107.79 39.92 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.898 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 25.9 Cg_exo -61.98 128.74 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.164 1.909 . . . . 0.0 111.899 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.2 t70 80.06 1.78 2.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.917 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.22 97.62 10.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.576 ' CD1' HD22 ' A' ' 145' ' ' LEU . 49.0 m95 -103.55 157.24 17.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.995 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.79 -177.01 2.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 71.6 mtm -109.13 156.76 38.68 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.54 140.26 56.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.595 2.196 . . . . 0.0 112.79 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 158.79 40.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.1 147.06 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.559 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.05 136.41 32.73 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.429 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 17' ' ' VAL . 5.3 mt -65.43 159.94 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.789 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.474 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.2 m-20 -90.45 150.27 21.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.69 98.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.242 0.544 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.39 39.14 10.06 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.98 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 14.2 tp10 -113.85 146.2 40.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 110.844 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 -72.8 139.13 80.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.568 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.613 ' O ' HG11 ' A' ' 17' ' ' VAL . 52.5 Cg_exo -54.92 -52.08 8.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.416 2.077 . . . . 0.0 112.658 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 108' ' ' PHE . 5.8 ttp85 -62.73 -26.64 68.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.277 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -84.51 -48.77 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.55 -28.27 65.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.553 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -75.49 -50.03 16.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.185 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 54' ' ' ARG . 45.2 mt -57.64 -29.63 34.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -82.13 -53.24 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.799 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -53.01 -41.14 64.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.4 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -56.13 -52.57 63.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.637 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 30.3 ttp180 -61.87 -13.82 28.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 178.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.19 -42.28 9.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.03 -26.17 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.739 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -120.6 -21.18 6.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.845 0.355 . . . . 0.0 111.081 -179.366 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 8.93 62.76 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.059 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.697 ' HB ' HD11 ' A' ' 61' ' ' LEU . 38.9 t -70.19 114.65 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -35.41 12.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.549 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.27 76.38 6.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.52 . . . . 0.0 111.107 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 127.96 12.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.809 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.66 ' OE1' HG21 ' A' ' 113' ' ' THR . 8.7 mt-10 -119.41 147.03 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.732 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.1 t -77.12 125.8 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.413 0.625 . . . . 0.0 111.817 -179.115 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.77 -16.65 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.366 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -155.57 158.39 38.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.41 115.36 6.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.195 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.835 ' HA ' HG11 ' A' ' 160' ' ' VAL . 9.2 t -57.46 127.39 77.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.33 -18.06 59.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.748 2.299 . . . . 0.0 113.349 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.59 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.96 -179.28 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.401 0.619 . . . . 0.0 112.204 -179.471 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 7.9 m95 -106.78 147.15 30.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.738 178.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.82 ' HB3' HG13 ' A' ' 153' ' ' VAL . 50.7 mt -113.86 117.84 32.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.103 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.781 HG22 ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -112.63 132.49 55.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.834 -179.363 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.871 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.0 164.01 25.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.651 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.48 158.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.216 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -114.98 154.77 47.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.595 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.7 Cg_endo -63.48 166.72 14.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.516 2.144 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.92 -16.42 44.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.881 2.387 . . . . 0.0 113.197 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.8 -34.29 15.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.194 0.521 . . . . 0.0 110.053 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.7 t -81.72 -51.21 15.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.222 179.264 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.09 -49.87 70.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 109.567 178.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.573 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.7 tt0 -63.69 -29.06 70.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.547 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -76.16 -46.52 28.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.664 HD21 H5'2 ' A' ' 166' ' ' ATP . 92.4 mt -58.74 -47.4 84.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 110.262 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.41 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.7 m120 -44.96 -30.83 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.672 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.573 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.11 -49.73 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.221 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -54.05 37.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.438 ' CE2' ' O2A' ' A' ' 166' ' ' ATP . 25.7 m0 -79.86 -38.45 32.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.849 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 85.15 33.97 16.05 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.469 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.3 147.57 52.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.56 72.34 0.78 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -124.6 149.95 46.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.742 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -30.7 61.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.09 -141.66 3.22 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.017 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -157.65 115.84 3.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.12 106.24 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.808 178.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 5.7 pt20 -124.56 153.25 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.377 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -105.84 95.93 6.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.339 178.526 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.563 ' CD2' HG21 ' A' ' 157' ' ' VAL . 35.5 m95 -62.95 142.43 58.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.339 -178.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CD2' ' HG3' ' A' ' 54' ' ' ARG . 65.9 m-85 -126.47 137.44 53.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.229 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.7 tp -79.56 154.57 28.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 21' ' ' LEU . 43.9 m-85 -148.17 127.67 13.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.037 0.446 . . . . 0.0 111.786 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.897 ' HB3' HD11 ' A' ' 73' ' ' ILE . 12.1 tttp -92.71 119.5 32.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.8 t80 -65.01 123.89 20.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.948 0.404 . . . . 0.0 110.76 -179.519 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.66 HG21 ' OE1' ' A' ' 71' ' ' GLU . 16.7 p -125.98 37.81 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.619 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.38 -144.85 4.72 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.101 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 154.19 45.93 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.82 -16.68 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.624 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.56 -19.14 56.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.725 0.298 . . . . 0.0 111.172 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.55 -25.17 41.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.759 HG21 ' CE1' ' A' ' 29' ' ' PHE . 17.7 mt -74.25 103.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.602 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.03 95.84 4.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.942 178.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.9 mt -54.79 -23.03 16.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.775 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 129' ' ' PRO . 70.2 mt -63.42 -59.54 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.25 0.547 . . . . 0.0 110.014 179.328 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.23 -176.99 24.87 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.445 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.53 39.01 1.02 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.132 0.491 . . . . 0.0 109.697 179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.64 26.79 74.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.078 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -119.08 -69.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.179 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.33 165.1 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 153.56 65.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 122' ' ' LEU . 77.0 Cg_exo -47.13 162.1 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.74 2.293 . . . . 0.0 112.597 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' C ' HD12 ' A' ' 34' ' ' LEU . 63.5 mm-40 -150.05 -46.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.809 ' HB2' HD13 ' A' ' 121' ' ' LEU . 12.7 m-85 -107.76 159.41 16.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.341 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.46 5.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.777 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.415 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 11.1 mm-40 -152.37 175.24 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.7 p-90 -156.68 152.5 27.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.09 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.6 m -147.93 163.63 36.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.409 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.462 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 69.7 m95 -98.12 122.48 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.661 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.87 HG11 HD11 ' A' ' 145' ' ' LEU . 27.0 m -134.91 150.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 111.58 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.93 162.33 72.74 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.699 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.584 ' CA ' HD13 ' A' ' 158' ' ' LEU . 31.5 Cg_exo -56.94 -20.34 36.11 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.84 1.693 . . . . 0.0 111.826 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -35.88 15.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.269 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -69.96 -50.36 42.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.06 179.186 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.903 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -53.96 -31.75 51.62 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.499 0.666 . . . . 0.0 109.81 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.568 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm -67.85 -28.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 178.687 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.73 -20.98 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.254 179.057 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.903 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.2 mt -85.49 -38.95 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.096 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 150' ' ' LYS . 29.8 m -56.14 163.43 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.4 p -91.42 165.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -57.6 -32.1 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.774 -179.653 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.2 p90 -92.89 13.62 19.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.686 ' HB2' HG12 ' A' ' 147' ' ' VAL . 33.9 mttp -136.23 0.81 2.61 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.327 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 6.4 mttm -62.15 -62.83 5.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.0 -44.72 27.96 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.46 2.107 . . . . 0.0 112.172 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.871 HG11 ' CD1' ' A' ' 82' ' ' TYR . 14.9 t -58.47 -27.12 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 0.0 111.1 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.18 -52.08 5.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.568 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -50.48 -32.71 18.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.825 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.552 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.4 tp10 -66.29 -45.69 79.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.559 179.144 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.2 t -59.09 -46.39 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.934 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.584 HD13 ' CA ' ' A' ' 139' ' ' PRO . 78.8 mt -66.31 -48.65 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.61 178.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.2 m -50.92 -46.52 60.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 76' ' ' VAL . 90.2 t -69.37 -24.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.9 m-30 -101.08 -2.92 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.274 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.617 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.79 -53.56 25.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.599 0.238 . . . . 0.0 111.588 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.42 -21.88 25.26 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.466 2.111 . . . . 0.0 112.402 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.46 ' ND1' ' HB2' ' A' ' 74' ' ' ALA . 58.7 m80 -96.19 -15.35 22.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 161' ' ' PHE . 5.6 mp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.664 H5'2 HD21 ' A' ' 92' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -168.78 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.584 2.189 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.46 42.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.776 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -95.57 25.86 22.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.07 114.62 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.492 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.9 mmt -116.67 -36.03 4.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.434 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 1.5 t0 68.42 20.86 8.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p 174.45 136.87 0.15 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 15' ' ' ARG . 37.2 Cg_endo -66.27 109.73 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.349 2.032 . . . . 0.0 112.318 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HG2' HG21 ' A' ' 81' ' ' THR . 7.9 Cg_exo -72.24 -172.91 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.901 2.4 . . . . 0.0 112.202 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -90.18 146.61 24.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.046 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.5 ' HA3' ' HG3' ' A' ' 101' ' ' LYS . . . 92.55 -39.69 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.567 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 23.9 m-85 -77.18 141.71 39.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.761 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -93.37 152.23 19.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 12.6 mmp_? -65.29 126.36 27.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.471 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.0 t-20 -152.62 156.37 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.7 m -129.29 136.88 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.71 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -106.44 157.31 15.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.163 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.71 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.6 mm -121.4 102.34 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.795 -0.238 . . . . 0.0 111.335 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 7.8 t -89.73 94.93 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.571 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.9 tp -102.67 143.94 31.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.522 . . . . 0.0 111.509 -178.281 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.47 157.27 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.6 p-10 -98.41 170.92 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.516 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -57.72 -16.56 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 0.31 56.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.826 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 77.02 26.9 0.72 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.811 ' C ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -97.08 174.47 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.005 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.837 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -108.7 125.67 65.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.765 0.317 . . . . 0.0 110.783 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.733 ' HE2' HD13 ' A' ' 119' ' ' ILE . 44.4 t80 -63.42 108.82 1.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.592 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . . . -116.35 131.27 56.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.672 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.71 133.77 55.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.6 p -82.35 154.61 25.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.782 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.43 157.35 37.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.268 0.556 . . . . 0.0 111.411 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -5.09 53.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.005 178.493 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -131.13 -16.72 3.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.782 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.3 mt -120.62 111.41 34.68 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.0 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.2 Cg_endo -65.25 131.9 29.9 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.868 1.712 . . . . 0.0 111.843 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.86 2.98 2.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.649 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.26 97.31 11.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.22 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.539 ' CD1' HD22 ' A' ' 145' ' ' LEU . 59.8 m95 -103.86 157.85 16.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.227 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -168.91 167.94 10.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.443 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 3.4 mpp? -101.84 145.1 29.88 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 4.0 Cg_exo -39.55 132.88 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.317 2.678 . . . . 0.0 112.967 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 154.62 33.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.549 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.6 144.21 8.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.624 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.52 138.83 43.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.368 179.823 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.655 HD11 HG13 ' A' ' 17' ' ' VAL . 5.1 mt -68.42 159.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.334 . . . . 0.0 110.638 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -90.3 146.17 24.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.22 96.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.354 0.597 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 36.3 8.13 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.186 -179.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 4.9 tt0 -115.58 142.63 46.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 0.0 110.747 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.77 142.29 85.66 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.708 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.622 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.8 Cg_exo -53.82 -57.15 2.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.511 2.14 . . . . 0.0 112.6 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 3.4 ttt180 -58.55 -26.79 63.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.636 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -83.0 -49.17 9.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.07 -32.46 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -71.98 -54.67 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.092 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 54' ' ' ARG . 48.4 mt -53.82 -28.86 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.198 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -82.79 -53.12 6.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.759 0.79 . . . . 0.0 109.791 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -57.43 -33.19 67.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD11 ' HB ' ' A' ' 67' ' ' VAL . 8.8 tp -53.98 -59.66 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.582 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 4.7 ptt-85 -61.5 -10.94 8.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -91.44 -44.92 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.59 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -90.68 -31.41 16.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.192 -178.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.758 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.57 -21.93 10.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 0.0 110.961 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.85 8.87 64.91 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.825 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.818 ' HB ' HD11 ' A' ' 61' ' ' LEU . 42.7 t -73.91 120.55 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.393 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -34.96 10.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.28 76.86 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.213 0.53 . . . . 0.0 110.823 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 128.42 12.89 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.837 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 mt-10 -119.61 148.15 43.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.596 HG23 ' CE2' ' A' ' 110' ' ' PHE . 41.1 t -78.03 126.65 38.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.882 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.44 -19.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.387 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.29 162.36 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.327 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.7 117.52 6.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.022 179.686 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.833 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.0 t -57.36 126.15 73.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.081 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.42 -18.34 62.72 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.771 2.314 . . . . 0.0 113.23 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.621 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.03 -177.21 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.243 0.544 . . . . 0.0 112.008 -179.583 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.74 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.8 m95 -107.8 147.27 31.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.127 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 4' ' ' GLY . 3.2 mt -111.32 117.71 33.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.862 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.4 p -109.93 136.96 48.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.407 -179.504 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.839 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -129.43 170.02 14.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.449 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 158.2 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE1' H5'1 ' A' ' 166' ' ' ATP . 29.6 m-85 -121.11 146.9 45.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.644 ' HG2' HG23 ' A' ' 88' ' ' VAL . 22.1 Cg_endo -61.74 167.55 9.99 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.368 2.045 . . . . 0.0 112.15 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -15.17 37.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.874 2.383 . . . . 0.0 113.227 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -30.67 15.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.061 0.457 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.644 HG23 ' HG2' ' A' ' 85' ' ' PRO . 71.8 t -85.1 -51.33 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.468 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -57.04 -47.0 81.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.565 0.697 . . . . 0.0 109.393 179.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.6 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.8 tt0 -65.05 -29.15 70.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.395 179.317 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -47.38 24.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.424 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.589 HD22 ' CE2' ' A' ' 96' ' ' TRP . 92.7 mt -56.78 -47.88 79.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.462 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.416 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.8 m120 -45.89 -30.66 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.636 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.7 mt -96.34 -49.61 12.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.492 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -56.83 8.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.695 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.589 ' CE2' HD22 ' A' ' 92' ' ' LEU . 22.7 m0 -76.3 -34.59 59.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.613 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.82 33.89 36.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.4 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.4 OUTLIER -131.38 153.25 49.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.52 77.03 1.03 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.625 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.407 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 30.5 m95 -121.24 150.36 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.5 ' HG3' ' HA3' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -70.37 -35.88 73.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.36 0.6 . . . . 0.0 109.654 179.382 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.74 -133.29 1.53 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.738 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 12.3 mm100 -156.31 113.85 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.862 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -96.42 105.84 17.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.701 178.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -123.23 156.48 35.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.419 0.628 . . . . 0.0 112.69 -178.438 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.86 96.5 6.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.599 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.658 ' CD2' HG21 ' A' ' 157' ' ' VAL . 25.2 m95 -62.91 149.79 43.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.256 0.551 . . . . 0.0 112.35 -178.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.3 m-85 -132.92 133.44 43.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.88 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -79.54 132.05 36.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.524 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HD12 ' A' ' 21' ' ' LEU . 53.1 m-85 -126.45 129.44 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.322 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.882 ' HB3' HD11 ' A' ' 73' ' ' ILE . 36.6 tttm -93.68 120.28 33.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.802 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.658 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.4 t80 -63.91 125.42 24.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.797 -179.415 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.476 HG21 ' HG3' ' A' ' 71' ' ' GLU . 3.7 p -127.86 37.86 4.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -139.22 -144.94 4.65 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.52 154.22 46.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.47 -16.92 0.23 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.577 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -22.57 53.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.764 0.316 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.51 -25.18 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.839 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.733 HD13 ' HE2' ' A' ' 29' ' ' PHE . 28.9 mt -71.23 97.31 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.78 95.73 5.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.958 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 131' ' ' PHE . 68.2 mt -57.08 -21.87 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -179.256 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 ' HG3' ' A' ' 129' ' ' PRO . 22.3 mt -63.85 -59.19 4.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.255 0.55 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.17 178.48 22.5 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.4 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -90.71 38.85 0.96 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.95 26.3 69.32 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.084 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.78 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.101 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.36 165.16 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.196 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -86.46 147.9 45.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.808 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.467 ' HG3' HD22 ' A' ' 122' ' ' LEU . 64.4 Cg_exo -51.05 125.8 17.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.544 2.163 . . . . 0.0 112.557 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -109.29 -29.25 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.592 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.7 m-85 -112.82 159.52 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.398 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.9 5.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.807 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm-40 -152.35 174.73 13.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.081 0.467 . . . . 0.0 110.419 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.1 p-90 -154.6 151.69 29.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.081 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -149.7 161.81 41.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.586 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 72.8 m95 -97.6 128.29 44.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.273 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 145' ' ' LEU . 28.0 m -138.79 155.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -74.84 151.44 86.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HD3' HD11 ' A' ' 28' ' ' ILE . 3.4 Cg_endo -47.89 -22.21 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.037 1.824 . . . . 0.0 112.064 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -34.66 17.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.469 179.24 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.414 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 mt-30 -69.14 -51.59 36.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.935 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -51.71 -36.5 47.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.707 0.765 . . . . 0.0 109.56 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.676 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.8 mm -62.7 -28.88 45.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.038 178.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 141' ' ' GLN . 33.4 t70 -81.94 -19.85 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.161 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.9 mt -86.88 -38.49 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 150' ' ' LYS . 28.3 m -56.55 163.47 1.77 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.079 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 150' ' ' LYS . 8.1 p -93.74 161.34 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.86 -41.43 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.276 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 12.3 p90 -84.23 5.87 24.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.317 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 147' ' ' VAL . 14.6 mtmt -127.79 -3.98 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.534 0.206 . . . . 0.0 111.49 179.33 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 22.6 mttt -55.31 -62.43 4.39 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.548 0.213 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -60.61 -42.81 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 82' ' ' TYR . 25.2 t -55.26 -29.4 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 111.245 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.437 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.2 m-30 -91.07 -53.31 4.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -49.7 -33.95 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 179.958 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 tp10 -65.57 -45.46 83.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.589 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 107' ' ' TRP . 60.3 t -58.06 -48.81 83.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 139' ' ' PRO . 66.8 mt -63.5 -48.66 76.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.721 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.6 m -49.81 -47.28 51.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.676 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.833 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.1 t -69.44 -24.6 27.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.106 0.479 . . . . 0.0 110.363 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.88 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -105.77 13.93 28.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.931 -179.235 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -56.58 21.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.459 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.5 Cg_endo -52.46 -23.84 20.14 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.472 2.115 . . . . 0.0 112.197 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.621 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 97.6 m-70 -92.87 -20.68 20.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.878 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.526 HD22 HD12 ' A' ' 28' ' ' ILE . 4.1 mt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' ATP . . . . . 0.491 ' PG ' ' CZ2' ' A' ' 96' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 121.088 0.47 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 153.52 22.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 3.0 mmp_? -56.68 130.36 45.02 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.759 0.314 . . . . 0.0 110.617 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 1.1 t30 -152.83 153.25 32.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 53' ' ' PRO . 27.5 m -140.47 136.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.48 150.14 17.27 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.92 HG23 ' CD1' ' A' ' 110' ' ' PHE . 5.0 mp -122.5 103.71 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.685 0.279 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 32.7 t -89.43 106.76 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 110' ' ' PHE . 33.1 tp -102.9 143.25 32.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 ptm -125.2 157.28 36.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.854 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 9.8 t30 -97.88 172.58 7.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.051 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -63.12 -17.17 62.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.858 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.45 -0.55 57.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.08 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mttm 80.99 24.86 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -95.15 170.97 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.592 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.54 125.17 68.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.745 ' HE1' HD13 ' A' ' 119' ' ' ILE . 67.1 t80 -59.75 107.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.36 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.99 131.28 56.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.171 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.72 137.56 52.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.964 0.412 . . . . 0.0 111.371 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.38 155.52 24.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.557 ' CD ' HD12 ' A' ' 36' ' ' ILE . 2.9 mtp85 -73.35 157.27 37.29 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.0 111.411 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -4.95 52.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.897 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.97 -19.71 3.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.135 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.621 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.2 mt -119.15 112.4 36.18 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.2 131.47 28.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.951 1.768 . . . . 0.0 111.891 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.86 4.13 3.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.804 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.39 97.32 11.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.34 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HD22 ' A' ' 145' ' ' LEU . 41.3 m95 -102.55 156.64 17.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.93 -176.88 2.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.981 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 20.0 mtm -111.74 155.23 43.44 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.594 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.44 131.7 30.83 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.565 2.177 . . . . 0.0 112.447 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.22 164.18 38.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -152.68 161.6 29.59 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.368 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.27 35.56 3.29 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.603 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.732 ' CG1' HG13 ' A' ' 17' ' ' VAL . 2.3 mt 51.95 159.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.287 0.565 . . . . 0.0 111.661 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.41 162.25 15.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.812 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.59 99.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.6 46.05 33.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.793 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 1.6 tt0 -114.68 144.25 43.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.084 0.468 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.55 143.11 71.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.806 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.812 ' HA ' HG11 ' A' ' 17' ' ' VAL . 88.8 Cg_exo -48.54 -62.93 0.36 Allowed 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.777 2.318 . . . . 0.0 113.689 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.9 tpt180 -46.15 -33.72 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.81 -47.09 12.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -57.66 -35.0 69.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.05 -54.73 8.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.0 mt -57.65 -29.8 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -80.94 -53.56 6.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 34.7 mm-40 -50.38 -40.64 50.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.326 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.861 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -56.58 -53.86 52.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.3 ttp180 -63.81 -11.67 29.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.82 -40.14 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 111.596 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.07 -36.48 16.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.0 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.78 -24.32 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.056 0.455 . . . . 0.0 110.922 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.88 6.93 80.1 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.647 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' A' ' 61' ' ' LEU . 38.4 t -58.13 112.18 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.405 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 p -91.21 -33.77 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.08 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.25 75.19 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 110.946 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 133.69 17.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.853 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.9 mt-10 -126.69 148.73 49.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.666 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -77.63 126.66 38.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.83 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.1 mm -107.56 -19.71 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.446 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.63 160.96 38.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.566 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 5.0 pt-20 -149.53 118.62 6.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.879 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HA ' HG11 ' A' ' 160' ' ' VAL . 36.7 t -56.99 124.47 65.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 -17.97 38.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.95 2.433 . . . . 0.0 113.352 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.657 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.37 -175.62 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.509 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.48 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 30.7 m95 -104.35 147.47 27.49 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.566 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.906 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -103.74 117.18 33.77 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.767 HG22 ' HB2' ' A' ' 104' ' ' ALA . 42.9 p -113.81 133.14 55.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.247 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.883 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -135.67 170.18 16.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.445 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.25 158.15 42.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -108.06 152.36 41.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--N 1.345 0.345 0 C-N-CA 122.468 2.112 . . . . 0.0 112.452 -179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.3 m95 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.789 0.328 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -28.78 42.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.88 -145.75 5.14 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.909 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -157.81 118.6 3.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.71 0.291 . . . . 0.0 111.455 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.767 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -85.6 112.72 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -124.93 141.16 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -97.79 95.89 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.64 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.486 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 72.6 m95 -62.95 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 112.149 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.447 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 71.2 m-85 -125.05 130.98 53.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.258 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -79.64 131.12 35.89 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.685 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.92 ' CD1' HG23 ' A' ' 19' ' ' ILE . 49.3 m-85 -125.22 127.13 46.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.241 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.87 ' HB3' HD11 ' A' ' 73' ' ' ILE . 4.9 tptp -89.93 124.7 34.94 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.695 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.3 t80 -70.24 123.5 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 110.799 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' SER . 6.6 p -124.2 37.39 4.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.568 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -135.82 -144.23 4.86 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.104 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.17 154.14 46.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.838 0.352 . . . . 0.0 110.061 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -50.13 -16.51 0.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.64 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -77.41 -17.38 58.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.705 0.288 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.24 -25.23 42.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.745 HD13 ' HE1' ' A' ' 29' ' ' PHE . 20.6 mt -70.45 104.83 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.492 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 65' ' ' THR . 56.3 t30 -122.26 95.78 4.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 131' ' ' PHE . 38.2 mt -54.14 -22.62 11.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.72 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.602 HD22 ' HG3' ' A' ' 129' ' ' PRO . 15.7 mt -63.63 -59.28 4.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.271 0.558 . . . . 0.0 109.964 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.4 -172.13 23.99 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -92.88 38.74 1.03 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.082 0.468 . . . . 0.0 109.924 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.94 27.19 72.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.345 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.91 165.1 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 148.92 61.84 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.602 ' HG3' HD22 ' A' ' 122' ' ' LEU . 54.6 Cg_exo -51.32 128.32 25.11 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.692 2.261 . . . . 0.0 112.55 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -108.45 -29.34 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.4 m-85 -111.67 159.46 18.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.38 -21.38 5.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.722 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.455 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 17.5 mm-40 -152.43 174.47 13.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.171 0.51 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.7 p-90 -159.13 156.57 29.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.042 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.76 161.92 40.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.473 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.467 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 73.3 m95 -93.9 124.89 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.697 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -136.6 150.89 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.151 0.501 . . . . 0.0 111.599 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.8 p -70.33 158.71 86.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.565 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.592 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.6 Cg_endo -55.36 -19.66 22.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.863 1.708 . . . . 0.0 111.885 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -34.34 16.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.075 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.35 -50.35 27.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.916 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.4 tp -54.39 -30.33 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.475 0.655 . . . . 0.0 109.891 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.516 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.3 mm -69.35 -28.47 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.724 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -80.19 -20.73 44.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.4 mt -84.07 -39.28 19.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.127 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 150' ' ' LYS . 27.0 m -59.6 164.28 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.011 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.2 p -96.09 160.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 147' ' ' VAL . 17.7 mm-40 -49.4 -41.7 40.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.2 p90 -81.3 2.85 26.31 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.545 ' O ' HG21 ' A' ' 146' ' ' THR . 4.2 mtpp -129.76 6.01 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.688 0.28 . . . . 0.0 111.197 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.2 mttt -64.02 -62.69 4.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 17.9 Cg_endo -58.1 -45.85 29.22 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.438 2.092 . . . . 0.0 112.061 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.906 HG13 ' HB3' ' A' ' 80' ' ' LEU . 48.6 t -54.05 -29.63 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.941 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.96 -51.5 5.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.5 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -51.09 -32.96 24.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.236 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.818 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.2 tp10 -64.31 -46.62 82.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.418 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.1 t -59.28 -50.97 77.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.29 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.557 HD13 ' CA ' ' A' ' 139' ' ' PRO . 66.0 mt -62.89 -49.58 74.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.969 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -45.3 61.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 156' ' ' GLU . 65.3 t -70.85 -25.01 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.352 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.877 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -104.06 12.48 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.799 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.571 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.44 -55.26 36.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.604 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.7 Cg_endo -54.6 -22.25 27.66 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.481 2.121 . . . . 0.0 112.248 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.641 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.3 m-70 -91.61 -18.28 24.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.948 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.901 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.946 0.403 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -82.18 152.26 26.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.09 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.488 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 t30 -152.59 156.48 39.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -127.59 130.93 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.17 154.2 20.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.052 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.941 HG21 HD22 ' A' ' 61' ' ' LEU . 4.7 mp -131.94 102.82 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 111.411 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.5 t -89.7 103.81 16.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.0 146.22 28.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.904 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.45 157.3 41.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.005 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 13.1 t30 -94.37 173.99 7.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.1 -16.5 61.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.789 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -89.54 -0.78 57.75 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.089 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 25' ' ' ASP . 19.9 mtpt 81.74 24.77 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.594 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.3 173.05 7.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.532 HG21 HD23 ' A' ' 142' ' ' LEU . 4.8 mp -112.65 124.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 110.865 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 119' ' ' ILE . 77.4 t80 -57.79 109.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.387 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.96 135.58 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.217 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -120.36 139.85 52.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 111.32 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.29 158.02 23.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.572 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.9 mtp-105 -72.22 162.61 29.22 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.376 0.608 . . . . 0.0 111.672 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.4 mt -96.35 -6.47 37.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.552 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 -18.53 3.83 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.574 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 65.2 mt -120.94 112.95 33.19 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.26 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.8 Cg_endo -65.69 132.38 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.871 1.714 . . . . 0.0 111.643 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.15 1.83 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.811 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.68 97.51 11.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.181 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.414 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.9 m95 -102.65 157.03 17.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.74 -179.93 3.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.796 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -102.19 159.02 30.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.583 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.2 137.09 39.44 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.509 2.139 . . . . 0.0 112.817 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.403 ' OE1' ' CZ2' ' A' ' 107' ' ' TRP . 1.6 mm-40 -137.64 148.1 45.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.363 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.47 132.66 4.13 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.542 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.99 128.82 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.742 HD11 HG13 ' A' ' 17' ' ' VAL . 4.8 mt -61.34 160.71 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.519 ' N ' HG22 ' A' ' 47' ' ' ILE . 27.1 m-20 -90.09 -176.66 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.069 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.48 98.53 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 110.22 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.07 46.01 8.57 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.661 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -115.51 147.29 40.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.807 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 136.03 78.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.648 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.0 Cg_exo -53.71 -56.15 2.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.435 2.09 . . . . 0.0 112.682 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 58' ' ' ILE . 6.1 ttp85 -58.68 -27.43 64.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.365 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.31 -48.85 9.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.575 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -57.17 -30.36 64.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.742 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -74.13 -50.38 19.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.153 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ARG . 40.1 mt -57.73 -29.48 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.171 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -83.2 -52.92 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.902 0.858 . . . . 0.0 109.856 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -53.77 -46.09 70.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.941 HD22 HG21 ' A' ' 19' ' ' ILE . 3.4 tp -54.41 -56.06 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.3 ttp85 -60.06 -15.0 19.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.387 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.06 -42.06 10.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.47 -24.4 19.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.801 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.43 -19.66 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.21 4.48 63.83 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.175 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.635 HG13 ' HE1' ' A' ' 112' ' ' PHE . 40.2 t -70.65 114.08 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.23 -32.97 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.066 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 76.42 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.35 13.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.756 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.0 pt-20 -118.94 146.2 45.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 52.6 t -77.75 122.38 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.372 0.606 . . . . 0.0 111.535 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.911 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.2 mm -104.39 -15.95 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.621 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.82 159.39 35.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.38 115.41 6.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.135 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.858 ' HA ' HG11 ' A' ' 160' ' ' VAL . 12.2 t -57.44 126.54 75.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.21 -18.95 65.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.77 2.313 . . . . 0.0 113.237 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.582 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.3 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.38 0.61 . . . . 0.0 111.991 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.786 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.7 m95 -109.75 147.21 33.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.017 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.786 HD23 ' C ' ' A' ' 79' ' ' TRP . 1.8 mt -112.45 117.59 32.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.956 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.797 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.9 p -112.93 131.67 55.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.867 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.7 163.34 27.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.07 158.36 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.119 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.4 153.86 45.54 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.771 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.275 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 57.9 m95 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.816 0.341 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -30.35 58.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -162.08 -143.07 3.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.923 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -157.72 115.77 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 0.0 111.436 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.797 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -93.39 105.81 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.814 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.433 ' NE2' ' ND2' ' A' ' 16' ' ' ASN . 4.0 pt20 -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -104.29 98.07 7.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.519 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.484 ' CD2' HG21 ' A' ' 157' ' ' VAL . 31.3 m95 -65.32 137.12 57.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.278 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 54' ' ' ARG . 68.5 m-85 -122.27 137.93 54.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.943 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.821 HD23 ' HB ' ' A' ' 73' ' ' ILE . 20.1 tp -79.21 154.14 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.821 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 19' ' ' ILE . 39.6 m-85 -148.08 125.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.07 0.462 . . . . 0.0 111.738 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.911 ' HB3' HD11 ' A' ' 73' ' ' ILE . 39.5 tttp -91.4 122.55 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.635 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.2 t80 -68.23 123.9 22.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.9 p -124.02 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.13 -144.88 4.65 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.044 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.23 154.19 46.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.02 -16.61 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -77.73 -18.49 56.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 111.252 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -25.57 42.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.732 HG21 ' CE1' ' A' ' 29' ' ' PHE . 18.2 mt -73.77 103.9 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.517 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.636 ' ND2' HD12 ' A' ' 122' ' ' LEU . 0.9 OUTLIER -119.36 95.87 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.027 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.6 mt -55.86 -22.55 25.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.543 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.636 HD12 ' ND2' ' A' ' 120' ' ' ASN . 1.7 mt -61.26 -56.84 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.246 0.546 . . . . 0.0 109.95 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.39 -174.66 22.8 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.51 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -91.76 38.72 0.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.13 73.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.202 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.1 m -115.24 -67.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 111.267 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -101.28 165.16 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 146.8 86.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.588 ' CG ' HD23 ' A' ' 122' ' ' LEU . 52.6 Cg_exo -52.11 139.74 51.9 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.583 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -109.83 -31.82 7.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.824 ' HB2' HD13 ' A' ' 121' ' ' LEU . 20.7 m-85 -116.88 159.61 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.415 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -15.72 6.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.814 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.566 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.53 174.59 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.522 . . . . 0.0 110.592 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.4 p-90 -159.61 153.1 22.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.056 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 m -151.74 156.9 41.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.484 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.469 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 76.7 m95 -91.35 124.83 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.841 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.902 HG11 HD11 ' A' ' 145' ' ' LEU . 29.6 m -134.71 150.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.724 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.5 p -69.54 158.5 86.77 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.573 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.517 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.05 -19.37 19.94 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.99 1.793 . . . . 0.0 111.98 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -34.48 14.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.225 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.6 -50.28 46.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.925 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.0 tp -53.37 -33.26 52.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.416 0.626 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.88 -28.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.687 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.75 -32.84 52.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.676 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 142' ' ' LEU . 7.1 mt -75.08 -40.62 59.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.88 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 147' ' ' VAL . 28.3 m -54.92 163.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.21 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.797 HG11 ' CE2' ' A' ' 149' ' ' PHE . 10.6 p -98.49 160.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.1 mm-40 -49.39 -36.79 22.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.797 ' CE2' HG11 ' A' ' 147' ' ' VAL . 16.4 p90 -84.77 6.9 22.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.453 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 30.8 mttt -129.94 -4.67 4.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.1 mttt -56.53 -62.13 5.5 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.351 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.4 Cg_endo -60.9 -42.77 35.06 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.444 2.096 . . . . 0.0 112.131 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.867 HG11 ' CD1' ' A' ' 82' ' ' TYR . 11.4 t -60.65 -27.5 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.561 . . . . 0.0 110.953 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.8 m-30 -90.87 -53.15 4.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.68 -31.12 10.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -69.48 -44.71 70.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.663 179.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 153' ' ' VAL . 52.0 t -57.72 -48.26 83.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.098 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 162' ' ' ALA . 61.8 mt -64.5 -48.85 73.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.774 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.8 m -50.94 -46.18 60.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.887 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.1 t -70.31 -24.58 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 121.019 0.437 . . . . 0.0 110.766 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.786 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.2 m-30 -100.67 -2.02 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.66 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.2 -51.46 33.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 6.7 Cg_endo -49.29 -24.57 8.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.632 2.221 . . . . 0.0 112.567 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.664 ' ND1' HG22 ' A' ' 73' ' ' ILE . 97.2 m-70 -100.98 -15.99 17.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.302 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 161' ' ' PHE . 4.4 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.51 152.15 25.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -74.36 125.2 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.168 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.4 m120 -152.41 159.03 43.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.72 HG13 HD11 ' A' ' 47' ' ' ILE . 1.8 m -129.74 135.68 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.128 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.93 17.42 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.303 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.907 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -126.21 101.63 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.7 t -89.84 102.94 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.5 tp -103.16 145.75 29.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.69 157.41 40.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.7 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 31.6 p-10 -102.39 169.98 8.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -55.37 -17.95 5.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.92 0.48 56.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt 76.46 25.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.678 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -95.62 171.95 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.551 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.4 mp -109.12 119.5 58.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.12 0.486 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.787 ' CE2' HG21 ' A' ' 65' ' ' THR . 5.5 t80 -53.71 108.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.21 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 137.17 52.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.723 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.86 137.97 54.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.6 158.22 23.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.795 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtp85 -75.39 159.11 31.78 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 111.302 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -94.2 -5.64 46.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.026 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.35 -16.94 3.85 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.229 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.795 HD12 ' CD ' ' A' ' 33' ' ' ARG . 64.9 mt -120.19 110.96 35.66 Favored Pre-proline 0 N--CA 1.454 -0.239 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.01 131.35 28.5 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.837 1.691 . . . . 0.0 111.845 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 77.58 5.22 3.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.685 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.607 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.7 97.62 11.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.354 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.3 m95 -103.72 156.12 18.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -168.8 -176.77 2.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.764 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 61.2 mtm -107.31 159.4 30.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.15 130.27 22.38 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.468 2.112 . . . . 0.0 112.549 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -154.1 160.23 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.12 169.34 38.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.612 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -83.92 130.88 10.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 17' ' ' VAL . 5.0 mt -60.07 160.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.713 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.29 151.71 21.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.931 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.19 98.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.67 36.29 8.0 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.036 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.0 tt0 -116.29 142.11 47.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.458 . . . . 0.0 110.861 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.46 143.15 82.18 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HA ' HG11 ' A' ' 17' ' ' VAL . 50.4 Cg_exo -54.04 -52.93 7.23 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.559 2.173 . . . . 0.0 112.604 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.586 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 4.4 tpp85 -59.03 -27.61 65.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -84.46 -48.44 9.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.553 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.98 -32.51 69.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.417 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.49 -53.57 11.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 54' ' ' ARG . 53.7 mt -57.08 -29.34 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.081 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -81.7 -53.35 6.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 109.918 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.13 -45.16 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.309 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.856 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -55.74 -56.18 23.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.596 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.4 ttp180 -61.26 -12.19 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -91.6 -38.39 12.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.749 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.09 -35.37 15.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.921 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.787 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -119.02 -23.24 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.015 0.436 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.31 8.57 80.03 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.856 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.856 ' HB ' HD11 ' A' ' 61' ' ' LEU . 24.8 t -57.15 110.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.985 0.393 . . . . 0.0 110.313 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.0 p -89.84 -36.22 15.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.43 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.34 76.43 6.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.176 0.512 . . . . 0.0 111.086 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.43 128.53 12.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.78 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.6 pt-20 -119.38 147.78 43.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.098 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.606 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.6 t -78.41 123.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.344 0.593 . . . . 0.0 111.417 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.899 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -106.07 -19.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.753 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -156.85 162.94 39.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.135 0.493 . . . . 0.0 111.735 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.83 114.73 5.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.861 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.71 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.6 t -57.57 125.51 72.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.47 -11.6 31.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.872 2.381 . . . . 0.0 113.768 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.538 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.78 133.54 49.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.247 0.546 . . . . 0.0 111.917 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.447 ' CD2' ' HG2' ' A' ' 106' ' ' LYS . 49.2 m95 -59.79 147.09 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.226 0.536 . . . . 0.0 110.566 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.894 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.1 mm? -102.75 117.74 35.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.497 HG22 ' HB2' ' A' ' 104' ' ' ALA . 63.8 p -113.89 134.48 54.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.873 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -133.1 170.35 15.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.533 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.48 141.6 45.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.64 151.42 42.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.776 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--N 1.343 0.281 0 C-N-CA 122.518 2.145 . . . . 0.0 112.372 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.774 0.321 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -25.69 41.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.572 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.43 -138.23 2.74 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.036 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -157.72 116.79 3.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.823 0.344 . . . . 0.0 111.388 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -86.41 105.8 17.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.835 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.1 pt20 -124.92 145.03 50.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 2.5 mmmp? -100.59 110.49 22.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.76 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.601 ' CD2' HG21 ' A' ' 157' ' ' VAL . 34.2 m95 -76.23 145.2 39.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.486 . . . . 0.0 112.145 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 59.5 m-85 -127.29 132.76 50.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.295 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.87 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.9 tp -79.5 132.93 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.359 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.907 ' CD1' HG23 ' A' ' 19' ' ' ILE . 50.0 m-85 -126.51 127.98 46.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.663 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.899 ' HB3' HD11 ' A' ' 73' ' ' ILE . 18.3 tttp -92.02 122.29 34.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.658 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.8 t80 -67.87 123.07 19.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' SER . 1.6 p -122.8 37.01 4.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.545 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.32 -144.49 4.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -128.06 154.37 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.97 -17.49 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.585 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -74.61 -19.28 60.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.12 -25.64 52.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 25.5 mt -70.16 105.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 65' ' ' THR . 59.8 t30 -123.12 95.89 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.217 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' A' ' 131' ' ' PHE . 34.7 mt -55.73 -21.0 16.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.577 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.894 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -62.94 -60.18 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.329 0.585 . . . . 0.0 109.774 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.25 23.39 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.324 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -93.92 38.83 1.07 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.159 0.504 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.59 28.0 70.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.2 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 m -102.24 -62.34 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.289 . . . . 0.0 111.255 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.27 165.24 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.146 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -57.95 146.06 69.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.031 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.894 ' HG3' HD13 ' A' ' 122' ' ' LEU . 63.7 Cg_exo -51.69 -176.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.675 2.25 . . . . 0.0 112.517 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 34' ' ' LEU . 4.4 mm-40 -150.1 -41.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.583 ' HB2' HD13 ' A' ' 121' ' ' LEU . 21.0 m-85 -106.32 159.37 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.69 5.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.377 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.4 mp0 -152.19 173.73 14.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.5 p-90 -160.25 160.31 32.48 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.242 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -158.73 160.76 36.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.508 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 81.3 m95 -93.12 124.61 37.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.623 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -137.27 151.16 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 111.773 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -68.88 161.35 72.58 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.517 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.551 ' HD3' HD11 ' A' ' 28' ' ' ILE . 18.7 Cg_endo -59.39 -16.73 36.58 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.716 1.61 . . . . 0.0 111.768 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.98 -34.1 14.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.069 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -51.5 21.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.13 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.871 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.42 -31.4 55.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.459 0.647 . . . . 0.0 109.769 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.571 HD11 ' CA ' ' A' ' 155' ' ' LYS . 8.2 mm -68.08 -27.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.775 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.73 -14.7 50.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.216 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.871 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.6 mt -91.28 -38.32 12.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.392 0.615 . . . . 0.0 110.238 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 147' ' ' VAL . 59.4 m -56.51 161.83 2.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.252 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.875 HG11 ' CE2' ' A' ' 149' ' ' PHE . 14.0 p -87.98 162.31 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -63.3 -31.26 72.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.875 ' CE2' HG11 ' A' ' 147' ' ' VAL . 11.2 p90 -82.17 2.57 30.95 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.481 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 3.3 mtmt -145.99 16.28 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 3.1 mttt -58.89 -61.96 6.73 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.073 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.3 Cg_endo -61.58 -42.5 32.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.894 HG13 ' HB3' ' A' ' 80' ' ' LEU . 61.8 t -48.29 -29.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.248 0.547 . . . . 0.0 111.238 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.27 -55.0 3.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.249 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.571 ' CA ' HD11 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -48.52 -36.56 15.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.901 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.827 ' HB3' HD11 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -60.73 -46.74 89.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.475 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.601 HG21 ' CD2' ' A' ' 107' ' ' TRP . 44.6 t -61.29 -45.55 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.336 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.507 HD13 ' CA ' ' A' ' 139' ' ' PRO . 56.3 mt -64.19 -49.04 73.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.965 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.2 t -50.63 -43.72 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.7 t -71.73 -25.19 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.326 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.87 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.8 m-30 -102.55 8.73 39.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.87 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.554 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.66 -56.04 26.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.5 Cg_endo -56.91 -22.78 47.71 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.374 2.049 . . . . 0.0 112.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.0 m-70 -91.31 -19.94 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.87 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.892 0.377 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.21 25.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -66.03 124.98 24.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 11.7 t-20 -152.53 160.66 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.997 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.772 HG13 HD11 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -131.06 140.3 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -105.01 150.19 16.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.154 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.952 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -131.15 102.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.469 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -89.61 109.95 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 110' ' ' PHE . 42.7 tp -102.92 143.55 32.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.441 . . . . 0.0 111.171 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.6 ptm -128.93 157.29 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.5 p-10 -105.03 170.69 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.387 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -56.28 -17.5 7.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.644 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 0.61 56.56 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.775 0.322 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 mttm 76.35 26.39 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.566 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -97.91 172.27 7.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.15 123.19 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.748 ' CE1' HG21 ' A' ' 119' ' ' ILE . 73.9 t80 -56.45 109.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.57 129.97 56.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.448 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.81 136.09 53.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.412 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.4 p -82.46 154.86 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.748 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.578 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -70.96 159.02 35.48 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.255 0.55 . . . . 0.0 111.397 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -93.33 -6.21 47.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.944 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -128.43 -18.1 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.201 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.1 mt -119.59 112.1 35.75 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.97 131.39 28.7 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.936 1.757 . . . . 0.0 111.95 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.74 3.51 3.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.851 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.54 11.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.719 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.1 m95 -104.56 156.71 17.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.02 8.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.505 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 70.1 mtm -97.91 156.67 35.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.83 139.22 42.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.536 2.157 . . . . 0.0 112.996 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.219 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.38 145.8 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.826 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.13 138.31 43.78 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.379 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.772 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -69.17 161.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.57 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.494 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.2 150.09 22.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.6 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.14 8.48 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.109 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 4.7 tt0 -115.08 143.48 45.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 0.0 110.887 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.68 139.68 80.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.604 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.639 ' O ' HG11 ' A' ' 17' ' ' VAL . 63.5 Cg_exo -52.02 -53.51 6.85 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.448 2.098 . . . . 0.0 112.616 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -60.01 -27.28 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -82.49 -51.26 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.694 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.542 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -56.84 -31.65 64.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.561 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.79 -51.91 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.271 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 54' ' ' ARG . 50.4 mt -56.82 -27.94 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -84.96 -52.71 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.931 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.84 -47.37 67.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -53.99 -56.69 15.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 66.2 ttp85 -59.32 -15.2 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.414 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -92.13 -39.98 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.821 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.4 -25.08 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.829 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.89 -19.16 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.77 5.65 65.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.112 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.681 HG13 ' HE1' ' A' ' 112' ' ' PHE . 49.6 t -72.18 115.74 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -34.34 12.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.23 79.25 6.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.472 . . . . 0.0 110.997 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.29 131.33 15.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.897 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.2 pt-20 -120.72 147.2 45.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.5 t -78.03 123.01 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.382 0.611 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.932 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -105.4 -21.52 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.753 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -153.41 161.9 41.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.288 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 9.0 pt-20 -148.74 115.59 6.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.148 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.819 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.6 t -57.24 125.78 71.97 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.917 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.2 -13.28 39.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.975 2.45 . . . . 0.0 114.177 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.619 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -129.4 157.2 42.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 112.028 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.528 ' C ' HD23 ' A' ' 80' ' ' LEU . 32.4 m95 -77.4 145.66 37.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.123 0.487 . . . . 0.0 109.914 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.895 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -108.55 118.08 35.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.984 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.859 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.8 p -114.81 132.19 56.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.522 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.875 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -124.9 170.13 11.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.96 158.28 38.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -119.72 149.76 48.99 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.705 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.539 2.16 . . . . 0.0 112.308 179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.8 m95 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.725 0.298 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.86 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.583 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -167.13 -142.38 3.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.984 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -157.93 116.47 3.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.859 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.54 105.86 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.854 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.8 pt20 -124.28 144.61 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -98.81 95.82 7.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.697 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.432 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.8 m95 -62.91 148.72 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.449 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 68.6 m-85 -132.09 135.05 46.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.317 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.796 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.5 tp -79.9 129.46 34.5 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.952 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.6 m-85 -123.85 126.57 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.398 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.932 ' HB3' HD11 ' A' ' 73' ' ' ILE . 50.5 tttt -89.88 124.54 34.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.681 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -68.39 125.43 26.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.5 p -125.64 37.61 4.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.595 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.1 -144.91 4.76 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.129 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 154.2 45.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.85 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.611 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -20.39 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.17 -25.07 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.798 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.748 HG21 ' CE1' ' A' ' 29' ' ' PHE . 18.1 mt -73.46 102.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.549 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -119.35 95.63 4.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.924 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 131' ' ' PHE . 68.6 mt -54.56 -23.78 18.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.651 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 129' ' ' PRO . 59.5 mt -61.3 -55.23 34.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.099 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.9 -171.03 25.03 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.429 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.75 38.96 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.151 0.5 . . . . 0.0 109.84 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.17 28.56 73.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.985 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.36 -68.28 0.91 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 111.228 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.9 165.08 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.25 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -80.93 151.18 70.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.449 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.0 Cg_exo -48.44 165.34 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.748 2.299 . . . . 0.0 112.623 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.412 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.6 mt-10 -150.05 -45.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.502 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.828 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.5 m-85 -107.48 159.62 16.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.19 -18.63 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.409 ' O ' HD11 ' A' ' 121' ' ' LEU . 24.1 mm-40 -152.54 175.24 12.97 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.1 p-90 -156.14 150.9 26.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.113 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 162.32 40.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.34 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 71.4 m95 -96.28 124.31 40.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 145' ' ' LEU . 27.2 m -136.42 150.78 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 111.511 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -71.1 158.11 88.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.572 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.615 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.0 Cg_endo -54.62 -20.49 21.54 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.907 1.738 . . . . 0.0 111.853 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 -34.3 17.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.118 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -72.69 -50.69 23.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.931 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -54.14 -29.93 47.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.403 0.62 . . . . 0.0 109.881 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.569 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.7 mm -68.44 -28.88 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.674 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.27 -20.53 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.3 mt -85.86 -39.14 17.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 150' ' ' LYS . 5.7 m -60.2 156.19 15.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.955 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.4 p -90.08 160.52 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.85 -35.71 33.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.955 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.9 p90 -84.8 9.97 12.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.611 ' HB2' HG22 ' A' ' 146' ' ' THR . 12.6 mttm -134.57 -25.3 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.264 . . . . 0.0 111.187 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.8 mtpt -44.5 -59.87 3.5 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.408 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.0 Cg_endo -59.06 -41.52 60.23 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.278 1.985 . . . . 0.0 111.912 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 80' ' ' LEU . 64.0 t -64.99 -25.78 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.3 m-85 -90.46 -49.34 6.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.697 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.93 -35.1 22.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.681 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.724 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.4 tp10 -66.81 -44.96 79.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.7 t -58.64 -47.86 87.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.07 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.615 HD13 ' CA ' ' A' ' 139' ' ' PRO . 66.6 mt -66.71 -49.26 66.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.703 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.2 m -50.6 -46.14 57.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.662 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 76' ' ' VAL . 85.7 t -69.53 -24.68 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.796 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -101.86 2.13 37.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.163 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.47 -55.21 31.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.15 -20.87 25.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.619 2.213 . . . . 0.0 112.34 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.753 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 17.9 m-70 -89.48 -21.06 23.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.729 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.933 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.428 ' HD2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -86.11 152.23 23.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -64.02 132.56 50.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.371 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 21.1 t-20 -152.56 156.99 40.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.443 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.802 HG13 HD11 ' A' ' 47' ' ' ILE . 3.3 m -127.81 129.49 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 111.281 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.2 147.03 18.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.177 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.882 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -122.34 103.35 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.699 0.285 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' PHE . 53.4 t -89.48 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 33.3 tp -103.19 144.56 31.16 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.319 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.8 ptt? -129.11 157.45 41.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.606 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.8 p-10 -98.35 172.51 7.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.349 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -60.45 -15.43 26.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 0.38 56.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp 77.57 27.16 0.63 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.536 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.783 ' C ' HD13 ' A' ' 28' ' ' ILE . 11.6 mmtm -99.11 175.67 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.861 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -107.62 147.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.573 ' HE2' HD13 ' A' ' 119' ' ' ILE . 10.8 t80 -82.67 104.94 13.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.73 129.89 56.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.31 137.13 52.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.03 152.81 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.764 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 5.0 mtp-105 -68.04 163.37 22.48 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.1 mt -97.8 -7.66 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.384 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.1 -18.95 4.88 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.207 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.594 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 63.1 mt -121.02 112.41 33.41 Favored Pre-proline 0 N--CA 1.457 -0.083 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.43 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.939 1.759 . . . . 0.0 111.655 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t70 78.15 1.8 2.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.767 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.3 97.24 10.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.13 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD1' HD22 ' A' ' 145' ' ' LEU . 55.2 m95 -103.0 159.67 15.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.166 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -168.5 -178.01 3.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 36.3 mtm -109.4 156.58 39.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.77 128.43 18.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.584 2.189 . . . . 0.0 112.674 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.32 156.69 37.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.688 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 144.82 10.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.442 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.78 140.67 43.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.802 HD11 HG13 ' A' ' 17' ' ' VAL . 4.4 mt -69.9 160.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.19 169.12 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.208 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.26 98.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.2 9.34 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.878 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 10.7 tp10 -112.53 145.16 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.093 0.473 . . . . 0.0 110.846 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.64 133.82 73.24 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.422 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HA ' HG11 ' A' ' 17' ' ' VAL . 53.3 Cg_exo -52.48 -39.43 74.34 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.369 2.046 . . . . 0.0 112.569 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.0 tpp85 -72.11 -27.84 62.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -85.12 -45.18 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.541 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.13 -32.62 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.368 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.22 -54.06 10.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.101 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' ARG . 48.9 mt -56.2 -29.1 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.291 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 ttp85 -82.58 -52.97 6.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.753 0.787 . . . . 0.0 109.872 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -51.78 -47.12 64.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.534 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -54.62 -56.3 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.886 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 6.6 ttp-105 -59.8 -15.14 18.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.293 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -92.06 -40.09 11.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.846 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.5 -25.29 19.34 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.827 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.57 -20.85 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.755 0.312 . . . . 0.0 111.063 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 76.72 1.39 71.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.015 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.683 HG13 ' HE1' ' A' ' 112' ' ' PHE . 46.0 t -69.42 116.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 110.615 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 -32.37 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.59 79.32 6.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.15 13.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.706 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.4 pt-20 -118.44 146.86 44.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.968 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.6 t -79.54 121.25 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 111.436 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.929 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -101.7 -20.79 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.391 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -153.14 160.24 42.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.07 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.8 pt-20 -148.43 116.02 6.28 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.169 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.844 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.3 t -57.38 129.14 79.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.0 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 -16.32 46.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.744 2.296 . . . . 0.0 113.612 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.607 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -127.75 -179.43 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.458 0.647 . . . . 0.0 112.533 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.807 ' C ' HD23 ' A' ' 80' ' ' LEU . 11.7 m95 -104.2 147.71 27.15 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.407 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.807 HD23 ' C ' ' A' ' 79' ' ' TRP . 1.4 mt -113.08 117.52 32.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.719 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.847 HG22 ' CB ' ' A' ' 104' ' ' ALA . 16.5 p -111.4 131.14 55.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.723 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.873 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -125.72 170.24 11.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.368 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.86 156.5 44.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -105.71 147.51 34.82 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.428 ' CD1' ' HD2' ' A' ' 14' ' ' ARG . 52.5 m95 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.868 0.366 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 2.1 mptp? -88.35 -21.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.68 -146.4 5.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.915 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -157.94 116.29 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.847 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.84 112.7 21.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -128.98 152.93 48.06 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.29 95.99 6.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 178.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.557 ' CD2' HG21 ' A' ' 157' ' ' VAL . 48.6 m95 -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 112.472 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.1 m-85 -133.05 134.82 44.87 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.09 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 16.6 tp -79.53 143.01 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.882 ' CD1' HG23 ' A' ' 19' ' ' ILE . 42.4 m-85 -136.97 127.5 26.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.929 ' HB3' HD11 ' A' ' 73' ' ' ILE . 25.8 tttp -91.71 121.24 33.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.683 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.9 t80 -65.8 127.0 30.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.204 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.1 p -126.27 37.31 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.76 -144.55 4.93 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.982 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 153.8 47.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.173 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD1' ' CH2' ' A' ' 134' ' ' TRP . 3.6 m-20 -52.12 -14.93 0.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.674 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -80.73 -20.36 42.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.254 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.54 -25.53 45.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.807 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.573 HD13 ' HE2' ' A' ' 29' ' ' PHE . 25.9 mt -67.08 104.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.459 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.553 HD21 HD12 ' A' ' 122' ' ' LEU . 29.4 t30 -122.06 95.8 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.119 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 131' ' ' PHE . 36.6 mt -56.3 -21.89 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.553 HD12 HD21 ' A' ' 120' ' ' ASN . 8.3 mt -60.8 -56.93 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 109.882 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.99 -175.59 22.56 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.487 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -91.98 38.97 1.0 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.76 72.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.958 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -121.15 -69.96 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.96 165.13 17.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.42 147.02 45.87 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 128.42 27.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.623 2.215 . . . . 0.0 112.53 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.408 ' C ' HD12 ' A' ' 34' ' ' LEU . 23.4 mp0 -111.54 -34.77 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.81 ' HB2' HD13 ' A' ' 121' ' ' LEU . 5.1 m-85 -108.02 159.61 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.334 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.9 -19.52 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.815 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.423 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 13.9 mm-40 -152.45 175.22 12.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.145 0.498 . . . . 0.0 110.592 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.8 p-90 -155.95 154.05 30.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.077 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.15 159.48 42.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.556 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 70.4 m95 -93.96 126.7 39.32 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.615 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.768 HG11 HD11 ' A' ' 145' ' ' LEU . 35.7 m -135.88 152.84 31.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.41 . . . . 0.0 111.854 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 p -72.49 152.17 91.81 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.811 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.3 Cg_endo -49.12 -22.13 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.25 -33.79 17.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -50.53 33.81 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.189 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.963 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.5 tp -53.35 -32.82 51.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.462 0.649 . . . . 0.0 109.828 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.689 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.9 mm -67.2 -28.05 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.796 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -22.64 41.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.232 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.963 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.8 mt -83.09 -39.55 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.066 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 150' ' ' LYS . 22.5 m -56.28 164.63 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -101.24 160.42 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 147' ' ' VAL . 24.4 mt-10 -45.43 -46.09 13.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.359 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -75.29 -5.09 42.84 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.459 ' O ' HG21 ' A' ' 146' ' ' THR . 13.5 mtmt -121.73 -4.13 9.21 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mttt -57.76 -62.39 5.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.541 0.21 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.1 Cg_endo -61.14 -45.81 17.91 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.467 2.111 . . . . 0.0 112.241 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.873 HG21 ' HB3' ' A' ' 82' ' ' TYR . 23.0 t -56.84 -27.07 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.13 -52.32 4.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -50.74 -32.62 20.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.317 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.6 tp10 -64.88 -46.01 83.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.492 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.0 t -59.49 -52.36 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.191 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 139' ' ' PRO . 70.2 mt -59.97 -49.2 78.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.841 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 m -49.15 -46.43 45.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.639 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.1 t -69.61 -25.28 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.029 0.443 . . . . 0.0 110.366 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.29 12.37 33.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.999 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.98 -58.28 14.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.0 Cg_endo -56.76 -21.81 41.7 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.433 2.088 . . . . 0.0 112.275 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.412 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 63.7 m-70 -90.01 -12.54 38.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.126 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.927 179.844 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.943 0.402 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.8 OUTLIER -87.97 152.22 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -69.93 134.33 48.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.111 0.481 . . . . 0.0 111.441 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.8 t-20 -152.46 158.88 43.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.779 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.4 m -128.18 130.0 69.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 111.584 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.98 139.31 14.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.132 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.797 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -112.93 104.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.321 . . . . 0.0 111.417 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 110' ' ' PHE . 52.5 t -89.54 105.08 17.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 110' ' ' PHE . 40.4 tp -103.36 141.84 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.983 0.42 . . . . 0.0 111.126 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.63 157.39 35.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.7 p-10 -100.84 170.53 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -57.13 -16.37 7.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.418 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -0.08 57.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 111.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 77.53 26.67 0.66 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.564 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mmtt -97.85 175.87 6.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.565 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.6 mp -115.31 126.88 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.891 ' CE1' HG21 ' A' ' 119' ' ' ILE . 66.3 t80 -59.47 110.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.379 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.602 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.86 130.0 56.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.02 136.74 52.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 0.0 111.472 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.43 155.16 24.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.646 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.542 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -71.98 156.98 38.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.284 0.564 . . . . 0.0 111.413 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.16 -5.36 52.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -127.52 -19.62 4.16 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.039 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 59.6 mt -119.54 112.44 35.58 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.904 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.46 131.66 28.74 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.905 1.737 . . . . 0.0 111.737 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 77.17 4.21 3.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.766 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.66 97.4 11.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.339 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.514 ' CD1' HD22 ' A' ' 145' ' ' LEU . 34.8 m95 -103.93 156.94 17.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.101 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -168.76 177.23 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.774 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.46 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 35.8 mtm -103.2 155.43 36.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.809 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.46 139.9 55.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.594 2.196 . . . . 0.0 112.67 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.19 158.18 39.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.74 140.37 6.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.586 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.74 139.87 48.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.451 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 17' ' ' VAL . 6.7 mt -71.42 160.32 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.546 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.3 148.52 22.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.85 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -49.15 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.188 0.518 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.64 40.62 14.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.884 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.9 tp10 -113.3 145.74 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 110.938 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -72.87 124.05 90.28 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.156 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.677 ' O ' HG11 ' A' ' 17' ' ' VAL . 5.3 Cg_endo -48.97 -50.83 11.78 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.484 2.123 . . . . 0.0 112.818 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 58' ' ' ILE . 33.1 ttt180 -57.44 -30.53 65.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -83.23 -47.12 11.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.38 -30.32 66.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.407 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.779 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.86 -51.93 14.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.109 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 54' ' ' ARG . 28.4 mt -57.02 -29.6 31.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.099 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -81.19 -53.15 6.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.877 0.846 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.98 -31.88 61.2 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.479 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.863 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.3 tp -57.26 -62.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.604 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.5 ptt85 -61.22 -10.91 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.973 0.415 . . . . 0.0 110.456 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -91.5 -39.47 11.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.252 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.52 -33.66 15.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.158 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.93 -24.5 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 81.54 -0.21 88.28 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.668 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.863 ' HB ' HD11 ' A' ' 61' ' ' LEU . 46.6 t -63.68 118.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.311 . . . . 0.0 110.448 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -33.95 10.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.404 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.22 76.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.805 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.25 13.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.973 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -120.31 148.85 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 110' ' ' PHE . 55.4 t -79.21 125.04 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.492 0.663 . . . . 0.0 111.901 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.884 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -104.93 -20.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.066 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -152.2 161.21 42.96 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -148.16 113.25 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.816 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.2 t -57.23 124.76 68.15 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.032 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.59 -5.72 17.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.802 2.335 . . . . 0.0 113.925 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.569 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -131.21 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 112.399 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -79.03 147.36 32.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 153' ' ' VAL . 48.7 mt -115.97 117.74 30.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.842 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.839 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -114.78 131.67 56.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.585 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.789 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -127.56 170.07 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.52 158.44 39.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -110.55 153.54 43.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 C--N 1.345 0.346 0 C-N-CA 122.529 2.153 . . . . 0.0 112.328 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 57.1 m95 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.821 0.344 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -27.81 44.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.48 -143.42 4.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.994 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -157.92 117.28 3.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.757 0.313 . . . . 0.0 111.365 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.839 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.74 107.61 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -123.16 151.93 41.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 96.84 6.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.43 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.492 ' CD2' HG21 ' A' ' 157' ' ' VAL . 52.1 m95 -62.7 147.86 48.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -130.99 135.14 47.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.825 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.2 tp -79.7 147.92 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.138 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.841 ' O ' HD12 ' A' ' 21' ' ' LEU . 27.3 m-85 -140.92 128.02 20.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.87 0.367 . . . . 0.0 111.567 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.884 ' HB3' HD11 ' A' ' 73' ' ' ILE . 31.3 tttt -91.79 119.96 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.674 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.9 t80 -64.87 125.14 23.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 111' ' ' LYS . 10.7 p -126.86 37.62 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.25 -144.92 4.75 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.066 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -127.86 154.12 45.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -50.26 -16.23 0.31 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.657 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -79.03 -18.63 53.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.731 0.3 . . . . 0.0 111.232 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.33 -25.61 42.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.891 HG21 ' CE1' ' A' ' 29' ' ' PHE . 22.9 mt -79.01 105.84 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -124.78 96.7 4.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.08 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.815 HD13 ' HB2' ' A' ' 131' ' ' PHE . 36.6 mt -47.62 -21.8 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.232 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD22 ' HG3' ' A' ' 129' ' ' PRO . 88.1 mt -57.5 -59.33 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.351 0.596 . . . . 0.0 109.99 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 133.08 -176.62 19.46 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.1 p30 -89.47 38.7 0.91 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.2 26.1 72.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.271 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -100.98 -64.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.708 0.289 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -112.52 165.14 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.1 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 144.8 91.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HG3' HD22 ' A' ' 122' ' ' LEU . 50.6 Cg_exo -53.05 135.88 59.94 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.581 2.188 . . . . 0.0 112.474 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.84 -29.55 7.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.73 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.815 ' HB2' HD13 ' A' ' 121' ' ' LEU . 9.7 m-85 -110.2 159.27 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.14 -19.78 5.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.795 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.469 ' C ' HD11 ' A' ' 121' ' ' LEU . 25.5 mm-40 -152.43 175.08 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 110.438 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.07 155.46 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.2 m -153.84 158.71 41.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.348 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.475 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 79.5 m95 -90.98 123.72 34.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.836 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 145' ' ' LEU . 29.5 m -134.34 149.88 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.503 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -68.65 158.65 84.93 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.581 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' CA ' HD13 ' A' ' 158' ' ' LEU . 12.0 Cg_endo -55.74 -19.17 23.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.875 1.717 . . . . 0.0 111.923 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -90.84 -34.21 15.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.078 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.68 -50.73 27.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.988 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.894 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.7 tp -54.1 -32.72 55.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.566 HD12 ' HG3' ' A' ' 155' ' ' LYS . 5.6 mm -67.9 -28.16 40.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.09 -20.98 40.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.2 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.894 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.2 mt -84.75 -39.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 150' ' ' LYS . 58.2 m -59.46 151.07 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.836 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.7 p -80.78 160.09 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.0 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 147' ' ' VAL . 4.6 mt-10 -51.75 -35.26 42.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.836 ' CE2' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -83.41 4.9 25.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.509 ' O ' HG21 ' A' ' 146' ' ' THR . 22.1 mttm -133.97 6.28 3.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.532 0.206 . . . . 0.0 111.304 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.5 mttt -62.32 -62.76 5.17 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.04 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.3 Cg_endo -58.74 -41.81 59.7 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.449 2.099 . . . . 0.0 112.051 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' A' ' 80' ' ' LEU . 17.3 t -58.34 -25.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.998 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.46 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.3 m-85 -91.1 -50.2 5.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.609 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.566 ' HG3' HD12 ' A' ' 143' ' ' ILE . 39.3 mttp -51.39 -33.52 30.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.819 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.0 tp10 -65.59 -45.81 81.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.746 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.492 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.4 t -61.02 -51.62 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.203 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.586 HD13 ' CA ' ' A' ' 139' ' ' PRO . 72.3 mt -62.59 -49.19 76.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.902 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -49.79 -47.15 51.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.677 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.816 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.1 t -68.72 -25.06 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.825 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.07 10.79 35.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.001 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -57.99 13.9 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.9 Cg_endo -55.69 -21.76 33.3 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.464 2.109 . . . . 0.0 112.084 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 63.6 m-70 -92.53 -17.7 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.933 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.0 ptt85 -79.15 152.86 30.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.133 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? -57.51 139.07 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.9 m120 -153.12 161.41 42.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.86 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.2 m -141.93 123.82 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.088 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 147.37 18.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.286 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.925 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -122.11 101.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 111.275 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.7 t -89.89 104.94 17.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 110' ' ' PHE . 22.3 tp -102.97 148.16 26.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 ptt? -130.39 157.4 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 33.9 p-10 -104.32 169.35 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.269 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.72 -17.05 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.53 56.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.293 . . . . 0.0 111.006 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 76.42 26.71 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -98.1 172.53 7.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -109.35 121.12 61.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.064 0.459 . . . . 0.0 111.06 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.796 ' CD2' HD23 ' A' ' 21' ' ' LEU . 5.0 t80 -55.28 107.82 0.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.267 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.81 141.8 47.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.758 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -126.37 139.4 53.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.345 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.483 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.71 158.29 22.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.621 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -75.12 159.69 31.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.527 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -94.49 -5.43 46.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.951 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.09 -16.99 3.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.619 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.7 mt -121.34 112.61 32.8 Favored Pre-proline 0 N--CA 1.454 -0.253 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.18 131.75 29.53 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.906 1.738 . . . . 0.0 111.788 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 t0 76.66 4.08 3.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.619 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.39 97.48 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.423 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.658 ' CD1' HD22 ' A' ' 145' ' ' LEU . 38.8 m95 -101.66 155.34 18.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -169.03 -176.61 2.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 4.3 mtm -113.71 154.4 45.75 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.73 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.46 142.35 78.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.599 2.199 . . . . 0.0 112.413 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -154.07 173.73 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.94 178.79 28.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.578 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' ILE . . . -112.92 23.91 13.76 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.689 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.738 HD11 HG13 ' A' ' 17' ' ' VAL . 3.5 mt 51.26 157.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 0.0 111.643 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.77 176.64 6.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.71 98.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.221 0.534 . . . . 0.0 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.86 49.28 29.52 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.757 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 3.4 tt0 -112.65 148.14 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.254 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.742 ' O ' HG11 ' A' ' 17' ' ' VAL . 76.7 Cg_exo -51.14 -60.41 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.454 2.103 . . . . 0.0 112.864 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -55.57 -26.53 44.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -82.34 -49.01 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.697 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -57.79 -31.1 66.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.86 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.1 -53.11 11.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.119 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -56.08 -29.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.186 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -83.79 -52.61 6.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.785 0.802 . . . . 0.0 109.945 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.44 -48.49 65.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.668 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -53.6 -55.51 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.582 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.8 ttp85 -58.7 -15.25 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -91.97 -37.64 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.715 0.293 . . . . 0.0 111.759 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -90.71 -28.73 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.734 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.92 -21.35 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.278 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.91 5.19 69.22 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG13 ' HE1' ' A' ' 112' ' ' PHE . 24.5 t -61.79 108.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.929 0.364 . . . . 0.0 110.306 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -34.4 15.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.413 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.02 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.34 127.24 11.85 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.853 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.88 148.83 43.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.678 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 43.6 t -77.94 127.1 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.853 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.95 -20.32 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.28 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.87 161.97 40.5 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.4 pt-20 -148.41 113.82 5.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.257 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.74 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.6 t -57.55 125.36 71.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.185 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.27 -10.02 25.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.811 2.341 . . . . 0.0 113.617 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.53 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.45 133.6 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.582 . . . . 0.0 112.065 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.447 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 24.8 m95 -65.39 147.21 53.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.693 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.717 ' HB3' HG13 ' A' ' 153' ' ' VAL . 43.9 mt -113.17 117.63 32.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.779 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.841 HG22 ' CB ' ' A' ' 104' ' ' ALA . 3.6 p -114.52 132.21 56.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.747 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -131.4 170.11 15.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.94 158.25 35.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -109.83 154.64 42.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.345 0.345 0 C-N-CA 122.484 2.123 . . . . 0.0 112.263 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 73.3 m95 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.759 0.314 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -30.33 63.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.723 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.47 -139.63 2.74 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.96 116.25 3.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 111.584 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.841 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.84 108.36 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.7 pt20 -120.16 150.85 39.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.3 mttt -107.91 95.88 5.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.19 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.585 ' CD2' HG21 ' A' ' 157' ' ' VAL . 49.4 m95 -62.97 138.96 58.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 112.259 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -124.85 132.44 53.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.937 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.2 tp -79.59 131.15 35.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.925 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.5 m-85 -125.49 129.57 50.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 111.498 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 28.1 tttt -93.53 121.08 34.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.5 t80 -66.2 123.32 19.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 69' ' ' SER . 11.1 p -124.66 37.51 4.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.613 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -137.47 -144.79 4.81 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.07 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -128.35 154.14 46.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -49.93 -16.72 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -20.24 57.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 111.131 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.61 -25.18 49.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.39 103.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' THR . 63.7 t30 -119.06 95.48 4.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.988 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 131' ' ' PHE . 52.3 mt -54.78 -21.93 12.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.783 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.94 -59.23 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.64 -171.52 25.9 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.447 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -94.39 38.83 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.119 0.485 . . . . 0.0 109.936 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.2 27.13 72.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.4 t -106.0 -64.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.0 111.202 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -115.48 163.48 15.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.212 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.35 152.37 54.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.11 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.23 179.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.784 2.323 . . . . 0.0 112.581 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -148.39 -44.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.713 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 121' ' ' LEU . 31.7 m-85 -110.59 159.59 17.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.421 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -113.72 -20.78 5.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.587 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.483 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.1 mm-40 -152.34 174.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.526 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.4 p-90 -159.54 157.45 29.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.073 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -154.51 160.49 41.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.455 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 82.5 m95 -93.63 123.43 36.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.54 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.731 HG11 HD11 ' A' ' 145' ' ' LEU . 30.2 m -134.88 150.43 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 111.777 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.509 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -69.59 160.64 78.72 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.598 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.597 ' CB ' HD13 ' A' ' 158' ' ' LEU . 16.6 Cg_endo -57.84 -17.62 30.77 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.832 1.688 . . . . 0.0 111.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.74 -34.07 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.07 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.01 -50.75 25.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.933 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.7 tp -54.24 -31.04 52.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.489 0.661 . . . . 0.0 109.83 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.54 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.8 mm -68.58 -28.44 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.621 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.78 -20.72 42.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.27 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.7 mt -84.74 -39.11 18.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.119 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 150' ' ' LYS . 26.0 m -56.74 163.63 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.73 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.5 p -91.66 164.96 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.5 ' N ' HG22 ' A' ' 147' ' ' VAL . 8.6 mt-10 -55.23 -35.06 64.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.925 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.73 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.5 p90 -90.5 11.09 22.85 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.608 ' HB2' HG12 ' A' ' 147' ' ' VAL . 2.1 mtmp? -133.23 -3.68 3.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.537 0.208 . . . . 0.0 111.513 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.43 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttm -58.98 -62.8 5.09 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.577 0.227 . . . . 0.0 111.192 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 17.3 Cg_endo -57.92 -41.61 67.1 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.8 t -59.75 -28.05 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.2 m-85 -91.16 -51.4 5.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.66 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.54 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.78 -32.82 21.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.5 tp10 -66.21 -45.65 79.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.565 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.585 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.3 t -58.97 -48.93 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.23 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.597 HD13 ' CB ' ' A' ' 139' ' ' PRO . 77.3 mt -62.24 -48.68 78.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.723 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.9 m -49.67 -47.21 50.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.739 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.5 t -69.28 -25.43 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.85 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.6 m-30 -103.3 11.66 36.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.985 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.1 -57.69 16.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.486 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.8 Cg_endo -55.78 -22.04 35.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.511 2.141 . . . . 0.0 112.356 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.532 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 91.3 m-70 -90.33 -15.09 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.087 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.952 0.406 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.87 152.29 24.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -71.82 129.85 39.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 14.3 t-20 -152.84 161.89 41.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.787 HG13 HD11 ' A' ' 47' ' ' ILE . 1.7 m -131.54 135.53 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 111.458 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -103.8 150.62 17.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.101 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.911 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -126.7 101.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.822 0.344 . . . . 0.0 111.506 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 t -89.75 100.43 13.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.4 tp -102.79 143.65 32.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.044 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 2.8 ptt? -126.22 157.5 38.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 40.5 p-10 -98.98 170.95 8.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.76 -16.11 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.491 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -89.14 1.06 56.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 64.8 mttt 76.29 26.97 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.3 mttt -99.17 171.62 7.89 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -109.94 122.76 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.902 0.382 . . . . 0.0 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.761 ' CE1' HG21 ' A' ' 119' ' ' ILE . 86.7 t80 -55.17 111.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.12 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.52 130.34 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.31 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.03 138.72 50.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.041 0.448 . . . . 0.0 111.193 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.25 158.07 23.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.632 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.704 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtp85 -73.35 159.72 32.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.0 mt -93.36 -5.48 49.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.921 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.61 -17.76 3.62 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.704 HD12 ' CD ' ' A' ' 33' ' ' ARG . 69.6 mt -120.68 112.76 33.69 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.099 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.47 132.27 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.887 1.725 . . . . 0.0 111.684 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.76 4.82 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.617 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.36 97.56 11.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.41 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CD1' HD22 ' A' ' 145' ' ' LEU . 19.2 m95 -103.36 155.58 18.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.126 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.72 170.95 9.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 68.1 mtm -90.04 153.87 47.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.689 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.29 139.14 41.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.156 . . . . 0.0 112.666 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.77 162.6 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.86 141.8 7.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.602 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -58.44 140.87 46.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.787 HD11 HG13 ' A' ' 17' ' ' VAL . 3.7 mt -72.66 159.29 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.496 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.58 148.66 22.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.09 99.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.225 0.536 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.23 40.42 13.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.913 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.3 tp10 -110.75 147.5 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.159 0.504 . . . . 0.0 110.859 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.93 130.56 80.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.571 ' HA ' HG11 ' A' ' 17' ' ' VAL . 55.0 Cg_exo -52.04 -25.7 23.25 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.377 2.051 . . . . 0.0 112.538 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' CB ' ' CE2' ' A' ' 108' ' ' PHE . 9.7 ttt180 -86.61 -22.05 26.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.984 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -91.08 -40.29 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 110.31 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.461 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -64.17 -30.37 71.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.666 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -74.68 -50.96 15.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 54' ' ' ARG . 59.1 mt -57.6 -30.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.101 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -81.36 -53.14 6.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.867 0.842 . . . . 0.0 109.908 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.79 -49.34 65.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.91 HD22 HG21 ' A' ' 19' ' ' ILE . 3.3 tp -54.97 -55.15 33.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.973 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 50.3 ttp85 -61.44 -13.44 20.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.544 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.95 -43.0 9.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.957 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -91.38 -25.33 19.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.788 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.36 -20.27 8.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.361 . . . . 0.0 111.057 -179.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.9 7.59 62.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.068 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.656 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.2 t -67.25 115.62 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.856 0.36 . . . . 0.0 110.383 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.64 -34.04 11.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.195 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 76.33 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.197 0.522 . . . . 0.0 111.051 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.51 129.07 13.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -116.33 147.63 41.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.02 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.2 t -77.03 119.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.325 0.583 . . . . 0.0 111.068 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.919 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -93.41 -26.05 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.837 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.59 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.518 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.425 ' CG ' ' CE2' ' A' ' 108' ' ' PHE . 29.2 tt0 -148.65 118.76 7.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.583 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.747 ' HA ' HG11 ' A' ' 160' ' ' VAL . 8.1 t -58.21 123.95 68.07 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.61 -17.05 58.32 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.723 2.282 . . . . 0.0 113.312 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.77 -178.54 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.907 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.454 ' C ' HD23 ' A' ' 80' ' ' LEU . 13.0 m95 -110.5 146.3 36.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.874 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.596 ' HB3' HG13 ' A' ' 153' ' ' VAL . 9.5 mt -112.73 117.61 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.064 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.833 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.7 p -109.76 132.35 54.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.821 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -129.08 161.58 29.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.624 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.9 158.37 29.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.383 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -104.26 150.85 38.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.584 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo . . . . . 0 C--N 1.343 0.252 0 C-N-CA 122.444 2.096 . . . . 0.0 111.956 179.606 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.5 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.796 0.331 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -26.34 36.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.078 0.466 . . . . 0.0 110.396 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.61 -152.3 8.53 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.585 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -152.81 116.7 4.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.71 0.29 . . . . 0.0 111.084 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.833 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.62 105.62 16.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -117.65 161.34 19.81 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 105.08 12.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.388 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 74.1 m95 -75.69 136.41 40.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 112.259 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CE2' ' CG ' ' A' ' 75' ' ' GLU . 26.9 m-85 -118.78 133.73 55.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.03 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.919 HD23 ' HB ' ' A' ' 73' ' ' ILE . 17.8 tp -79.57 135.28 36.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.097 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.911 ' CD1' HG23 ' A' ' 19' ' ' ILE . 38.3 m-85 -127.87 133.46 49.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.188 0.518 . . . . 0.0 112.187 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.557 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -96.02 119.44 34.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.507 177.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.619 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -68.56 122.89 19.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 110.761 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 p -124.54 37.55 4.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.27 -145.01 4.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.097 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.64 154.19 45.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.84 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -77.17 -17.98 58.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.2 -26.22 42.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.761 HG21 ' CE1' ' A' ' 29' ' ' PHE . 16.4 mt -72.51 98.68 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.341 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -113.89 95.79 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.4 mt -56.58 -21.15 24.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.457 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.866 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -59.67 -56.88 16.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.417 0.627 . . . . 0.0 109.867 179.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 136.85 -174.96 21.37 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.436 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -90.96 38.66 0.96 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.09 29.43 74.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.96 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -111.79 -64.8 1.24 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.0 111.38 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.46 165.11 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 146.05 94.68 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.866 ' HG3' HD13 ' A' ' 122' ' ' LEU . 47.4 Cg_exo -54.84 140.89 78.27 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.607 2.204 . . . . 0.0 112.381 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -110.65 -27.35 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.462 ' HB2' HD13 ' A' ' 121' ' ' LEU . 5.9 m-85 -118.74 159.44 23.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.588 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.5 -16.34 5.59 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.772 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.556 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 4.7 mp0 -152.24 174.27 13.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.734 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.4 p-90 -159.59 154.19 24.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.114 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.57 159.63 44.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.366 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 74.7 m95 -93.68 125.82 38.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 145' ' ' LEU . 27.4 m -138.8 151.17 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 111.696 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.33 160.42 79.12 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.588 ' HD3' HD11 ' A' ' 28' ' ' ILE . 14.4 Cg_endo -57.0 -18.19 27.36 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 121.875 1.717 . . . . 0.0 111.929 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.27 -34.24 14.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.121 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -50.24 37.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.977 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.942 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.5 tp -54.49 -31.82 56.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.457 0.646 . . . . 0.0 109.75 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.49 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.0 mm -69.84 -27.81 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.622 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.71 -23.56 42.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.065 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.3 mt -81.67 -39.8 23.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.86 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 147' ' ' VAL . 8.8 m -55.73 165.2 0.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.866 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 14.8 p -95.84 161.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.53 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.52 -27.0 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.866 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 23.1 p90 -90.9 10.11 27.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' A' ' 82' ' ' TYR . 18.4 mtmt -150.07 13.98 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 111.611 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.7 mtpp -69.07 -62.79 2.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.141 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.3 Cg_endo -51.49 -40.01 63.79 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 111.988 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.821 HG21 ' HB3' ' A' ' 82' ' ' TYR . 22.7 t -58.73 -25.03 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.88 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.26 -51.46 5.29 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.541 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HG3' HD12 ' A' ' 143' ' ' ILE . 11.1 mtpt -50.31 -33.95 21.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.463 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 6.6 tp10 -64.9 -46.02 83.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.69 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.6 t -59.31 -48.43 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.22 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.517 HD13 ' CB ' ' A' ' 139' ' ' PRO . 72.5 mt -64.19 -48.65 75.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.616 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.6 m -49.4 -47.38 47.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.747 HG11 ' HA ' ' A' ' 76' ' ' VAL . 72.1 t -66.8 -24.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.134 0.492 . . . . 0.0 110.459 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.881 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.6 m-30 -101.24 -0.77 35.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.116 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.32 -51.86 24.12 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.333 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -55.74 -22.82 38.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.372 2.048 . . . . 0.0 112.176 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.618 ' ND1' HG22 ' A' ' 73' ' ' ILE . 88.8 m-70 -93.45 -19.55 21.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.7 mp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.443 ' N ' ' HZ1' ' A' ' 101' ' ' LYS . 79.5 m-85 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.15 0.5 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 30.2 tpt85 -82.72 152.15 25.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.07 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -79.19 128.21 33.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 8.5 m120 -152.55 163.36 39.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.816 HG13 HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -128.95 135.0 63.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.077 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.84 142.14 15.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.385 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.887 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -119.03 101.17 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.2 t -89.8 103.85 16.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 110' ' ' PHE . 42.6 tp -102.87 140.52 37.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 111.11 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -124.54 157.34 35.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.836 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.9 p-10 -101.21 169.5 8.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -54.85 -17.61 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.626 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.24 56.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 110.942 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt 76.68 25.8 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.529 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.7 mttp -96.28 171.65 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 28' ' ' ILE . 4.0 mp -109.55 123.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.812 ' CE1' HG21 ' A' ' 119' ' ' ILE . 74.9 t80 -57.72 110.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.48 134.35 54.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.8 135.9 54.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.61 153.85 25.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.572 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -70.73 157.12 38.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 111.402 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -5.71 52.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.56 -18.11 4.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.148 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.3 mt -119.65 107.96 39.95 Favored Pre-proline 0 N--CA 1.456 -0.144 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.911 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 24.8 Cg_exo -62.49 128.93 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.0 t0 80.65 2.7 1.79 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.83 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.31 97.46 11.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.422 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.3 m95 -104.97 156.78 17.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.0 -177.0 2.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.753 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.44 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 2.9 mpp? -106.49 158.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 139.98 40.85 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -154.02 162.23 41.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.788 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.58 18.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.1 137.4 29.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.645 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.816 HD11 HG13 ' A' ' 17' ' ' VAL . 4.9 mt -70.75 159.55 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.555 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.65 149.61 22.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.921 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.25 98.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.236 0.541 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.08 39.84 11.05 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.919 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.8 tp10 -112.24 147.39 36.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.153 0.501 . . . . 0.0 110.872 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.03 133.79 78.34 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.595 ' O ' HG11 ' A' ' 17' ' ' VAL . 53.1 Cg_exo -52.56 -55.13 4.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.06 . . . . 0.0 112.609 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 58' ' ' ILE . 1.2 ttt-85 -59.13 -22.76 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.11 -49.66 7.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.733 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.456 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.53 -28.45 65.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.599 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -75.33 -51.37 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.074 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.5 mt -55.71 -30.67 27.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.047 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -80.54 -53.23 6.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.825 0.821 . . . . 0.0 109.838 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -55.96 -33.36 64.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.632 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.776 HD11 ' HB ' ' A' ' 67' ' ' VAL . 8.5 tp -58.05 -61.24 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.115 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.612 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.9 ptp180 -62.39 -9.17 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.506 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.86 -47.66 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.71 -30.39 17.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.266 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.742 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.07 -22.76 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.576 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 71.07 8.85 65.69 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.957 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.776 ' HB ' HD11 ' A' ' 61' ' ' LEU . 39.7 t -70.35 118.11 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.791 0.329 . . . . 0.0 110.342 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.08 -35.18 11.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.17 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.424 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.78 6.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.37 128.9 13.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.901 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.66 148.96 42.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.688 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.4 t -77.74 128.03 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.454 0.645 . . . . 0.0 111.924 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.46 -19.86 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.381 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.66 164.05 36.33 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.084 0.469 . . . . 0.0 111.622 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -148.98 118.51 6.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.516 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.883 HG11 HD21 ' A' ' 80' ' ' LEU . 3.4 t -57.91 110.39 2.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.059 0.457 . . . . 0.0 110.045 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.77 -23.41 11.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.257 2.638 . . . . 0.0 113.332 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.707 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -112.67 -175.75 2.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.235 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.534 ' C ' HD22 ' A' ' 80' ' ' LEU . 51.3 m95 -105.36 147.96 27.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.658 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.905 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.6 mm? -109.22 118.46 36.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.219 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.768 HG22 ' CB ' ' A' ' 104' ' ' ALA . 8.4 p -120.14 131.18 54.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.864 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -126.47 170.2 12.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.525 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.81 158.29 42.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.238 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.25 153.75 46.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.548 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 122.414 2.076 . . . . 0.0 112.056 179.71 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.403 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 9.2 m95 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.443 ' HZ1' ' N ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -73.48 -30.55 63.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.419 0.628 . . . . 0.0 109.962 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 103' ' ' GLN . . . -150.67 -158.84 8.46 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.752 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -151.25 112.52 4.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.756 0.313 . . . . 0.0 111.186 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.768 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -86.54 105.56 16.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.5 pt20 -124.34 152.18 43.44 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.428 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -101.72 101.19 11.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.01 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.614 ' CD2' HG21 ' A' ' 157' ' ' VAL . 31.0 m95 -71.33 138.53 49.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 0.0 111.689 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 62.8 m-85 -123.23 134.09 54.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.547 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.858 HD13 ' CD2' ' A' ' 161' ' ' PHE . 19.4 tp -79.69 132.03 36.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.392 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.887 ' CD1' HG23 ' A' ' 19' ' ' ILE . 44.8 m-85 -126.08 128.83 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.12 121.23 33.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.645 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -66.09 125.27 24.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.027 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 69' ' ' SER . 11.6 p -127.54 37.68 4.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.638 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.64 -144.7 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.122 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.82 154.18 44.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.878 0.37 . . . . 0.0 110.064 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.95 -16.47 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.69 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -18.33 54.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.704 0.287 . . . . 0.0 111.245 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -79.52 -24.79 41.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.0 110.837 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.812 HG21 ' CE1' ' A' ' 29' ' ' PHE . 21.2 mt -75.71 104.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.112 0.482 . . . . 0.0 111.568 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.51 95.86 4.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.859 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.822 HD13 ' HB2' ' A' ' 131' ' ' PHE . 61.3 mt -53.48 -24.46 13.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.626 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.431 HD22 ' CG ' ' A' ' 129' ' ' PRO . 18.3 mt -62.45 -57.55 10.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 110.026 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.66 -178.16 21.27 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -91.11 38.97 0.98 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.8 66.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -121.21 -69.64 0.83 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -84.86 165.1 17.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.32 145.21 39.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.431 ' CG ' HD22 ' A' ' 122' ' ' LEU . 50.7 Cg_exo -53.31 128.68 30.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.579 2.186 . . . . 0.0 112.634 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.89 -32.28 6.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.542 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.822 ' HB2' HD13 ' A' ' 121' ' ' LEU . 14.6 m-85 -110.3 159.67 17.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.2 -19.94 5.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.987 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.4 mm-40 -152.48 175.38 12.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.115 0.483 . . . . 0.0 110.746 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.2 p-90 -157.15 154.25 29.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.195 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.09 161.47 42.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.367 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.454 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 72.1 m95 -94.7 123.56 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 145' ' ' LEU . 32.4 m -135.52 151.21 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.033 0.444 . . . . 0.0 111.578 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.16 162.4 69.54 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.634 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.64 ' CA ' HD13 ' A' ' 158' ' ' LEU . 37.8 Cg_exo -58.06 -18.54 36.6 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.792 1.661 . . . . 0.0 111.914 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.07 -34.51 14.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.223 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.66 -50.6 34.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.023 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.909 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.01 -32.16 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.522 0.677 . . . . 0.0 109.818 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.564 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.2 mm -68.32 -28.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.746 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.64 -22.38 40.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.6 mt -83.5 -39.54 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 150' ' ' LYS . 3.6 m -59.48 167.4 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.512 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.2 p -101.26 159.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -51.84 -40.88 61.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.512 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.4 p90 -79.58 1.5 25.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.472 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 27.6 mttm -136.44 7.56 3.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.573 0.225 . . . . 0.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 14.1 mtpt -70.31 -62.39 2.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.105 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.6 Cg_endo -53.93 -43.14 60.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.379 2.053 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.905 HG13 ' HB3' ' A' ' 80' ' ' LEU . 78.0 t -57.35 -25.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.698 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -90.69 -53.25 4.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.445 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.564 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.52 -31.91 16.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.229 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.84 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.0 tp10 -65.21 -46.17 81.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.503 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 107' ' ' TRP . 49.1 t -59.83 -48.41 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.226 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.64 HD13 ' CA ' ' A' ' 139' ' ' PRO . 71.9 mt -64.27 -49.15 72.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.1 m -50.35 -44.28 54.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.757 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.3 t -72.42 -24.83 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 110.595 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.858 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.8 m-30 -102.93 8.48 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.097 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.71 -52.61 62.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.725 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.7 Cg_endo -52.82 -23.39 20.57 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.509 2.14 . . . . 0.0 112.375 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.641 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.5 m-70 -89.91 -23.34 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.734 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.696 HD12 ' OXT' ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.856 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 101' ' ' LYS . 26.8 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -89.51 152.16 21.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.396 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -81.03 125.31 30.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.603 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.3 t-20 -152.58 157.7 41.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -123.5 125.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.238 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -95.52 147.61 18.69 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.246 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.747 ' CD1' ' HB1' ' A' ' 57' ' ' ALA . 2.0 mm -116.24 101.69 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 111.541 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 5.7 t -92.07 97.84 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.889 HD12 ' O ' ' A' ' 110' ' ' PHE . 19.8 tp -102.52 151.61 22.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.178 0.513 . . . . 0.0 111.646 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.0 ptt? -134.37 157.4 46.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.397 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.509 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.48 170.16 8.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.557 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -18.85 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.539 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.41 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.74 1.73 54.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.328 . . . . 0.0 110.887 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 33.5 mtmt 72.9 26.88 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.664 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.1 mmtp -97.7 173.54 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.568 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -109.16 123.58 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.033 0.444 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CD2' HD23 ' A' ' 21' ' ' LEU . 3.0 t80 -58.13 104.4 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.66 135.27 53.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.752 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.88 138.49 53.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.46 157.45 23.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.759 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -74.85 158.71 32.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.25 0.548 . . . . 0.0 111.29 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 -4.78 48.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.953 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -129.24 -17.29 3.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.176 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.759 HD12 ' CD ' ' A' ' 33' ' ' ARG . 69.4 mt -121.39 112.06 33.04 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.094 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.3 Cg_endo -65.65 132.1 29.76 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.79 1.66 . . . . 0.0 111.683 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.38 5.36 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -91.74 97.6 11.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.301 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.733 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.2 m95 -104.86 156.68 17.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.185 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.2 pm0 -168.76 -176.78 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.775 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.476 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 1.4 mtt -113.53 160.11 32.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.656 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 54.6 Cg_exo -52.01 128.88 28.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.629 2.219 . . . . 0.0 112.615 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.72 141.75 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.41 133.56 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.704 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.94 133.88 52.56 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.748 HD11 HG13 ' A' ' 17' ' ' VAL . 4.7 mt -65.16 159.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.611 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.2 m-20 -90.29 149.62 22.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -51.78 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.195 0.521 . . . . 0.0 110.756 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.71 10.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.904 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 14.5 tp10 -113.16 146.49 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 110.865 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.5 135.78 75.23 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.663 ' O ' HG11 ' A' ' 17' ' ' VAL . 58.8 Cg_exo -51.9 -55.24 4.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.434 2.089 . . . . 0.0 112.577 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 58' ' ' ILE . 8.8 ttm180 -59.4 -25.83 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.396 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -84.12 -50.49 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.729 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -56.21 -31.56 63.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.747 ' HB1' ' CD1' ' A' ' 19' ' ' ILE . . . -72.45 -53.91 10.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.102 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.0 mt -54.63 -28.49 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.238 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -83.19 -52.85 6.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -56.96 -37.51 71.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.861 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.835 HD11 ' HB ' ' A' ' 67' ' ' VAL . 9.2 tp -54.14 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.61 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -58.8 -12.23 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.05 -41.04 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.359 . . . . 0.0 111.462 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -90.55 -31.08 16.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.996 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.725 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.13 -21.24 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.84 2.97 72.49 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.835 ' HB ' HD11 ' A' ' 61' ' ' LEU . 24.6 t -67.52 110.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -95.02 -29.53 14.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.13 76.45 6.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.309 0.576 . . . . 0.0 110.536 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 131.4 15.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.545 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -118.91 139.73 51.16 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.249 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 26.7 t -68.69 120.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.37 0.605 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.869 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -94.97 -25.12 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.934 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -163.49 171.32 16.07 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.825 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -149.11 123.39 9.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.484 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.685 HG11 HD21 ' A' ' 80' ' ' LEU . 41.4 t -57.83 126.21 75.75 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.76 0.314 . . . . 0.0 110.317 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.47 -18.9 56.45 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.91 2.407 . . . . 0.0 113.123 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.676 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -123.17 -175.37 3.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 111.28 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.462 ' C ' HD22 ' A' ' 80' ' ' LEU . 53.5 m95 -102.9 147.41 26.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.062 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.928 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.1 mm? -105.24 117.54 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.647 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.767 HG22 ' CB ' ' A' ' 104' ' ' ALA . 51.8 p -116.03 137.97 51.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.311 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.878 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -134.39 170.11 16.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.338 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.98 158.37 39.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.184 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -112.3 145.46 32.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--N 1.345 0.392 0 C-N-CA 122.471 2.114 . . . . 0.0 112.432 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.6 m95 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.98 0.419 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -75.64 -32.26 60.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.967 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.56 -133.31 1.88 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.374 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.9 mt-30 -158.09 114.38 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -93.78 105.85 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' NE2' ' CZ2' ' A' ' 107' ' ' TRP . 3.6 pt20 -121.64 157.85 29.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.437 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -105.97 98.71 8.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.817 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.569 ' CD2' HG21 ' A' ' 157' ' ' VAL . 40.5 m95 -69.54 130.2 41.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.734 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 68.0 m-85 -116.5 135.53 53.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.881 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.1 tp -79.57 137.46 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.066 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.889 ' O ' HD12 ' A' ' 21' ' ' LEU . 40.1 m-85 -129.63 133.13 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.244 0.545 . . . . 0.0 111.925 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 34.1 tttm -96.25 119.99 35.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.489 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.672 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.9 t80 -68.41 123.22 20.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.99 0.424 . . . . 0.0 110.978 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.477 HG21 ' OE1' ' A' ' 71' ' ' GLU . 8.9 p -124.81 37.56 4.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.464 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.23 -145.16 4.9 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.69 154.06 47.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 109.998 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -49.87 -16.83 0.3 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.541 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -22.66 56.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.28 -25.61 58.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.403 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 36.8 mt -67.99 104.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.468 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -120.92 95.43 4.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 131' ' ' PHE . 32.0 mt -55.49 -21.58 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.693 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.588 HD22 ' HG3' ' A' ' 129' ' ' PRO . 16.7 mt -65.16 -60.03 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.84 -175.09 24.68 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.542 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -91.81 38.75 0.99 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.134 0.492 . . . . 0.0 109.89 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.65 73.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.104 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 t -115.58 -69.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.24 165.09 12.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.177 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 149.27 65.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.588 ' HG3' HD22 ' A' ' 122' ' ' LEU . 73.8 Cg_exo -49.91 124.92 13.42 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.613 2.208 . . . . 0.0 112.57 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -106.27 -28.58 10.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.587 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.9 m-85 -110.91 159.18 17.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.87 -22.76 4.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.697 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.7 mm-40 -152.27 174.34 13.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 110.552 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p-90 -159.95 159.88 32.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.26 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.26 167.6 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.509 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 68.8 m95 -97.02 121.58 39.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.687 HG23 ' HB2' ' A' ' 142' ' ' LEU . 35.3 m -132.49 150.53 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.717 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -70.76 160.05 83.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.64 ' CA ' HD13 ' A' ' 158' ' ' LEU . 14.1 Cg_endo -56.89 -18.14 26.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 121.855 1.703 . . . . 0.0 111.915 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -34.06 15.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.987 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -50.91 23.54 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.87 -31.25 59.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.447 0.642 . . . . 0.0 109.845 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.597 HD11 ' CA ' ' A' ' 155' ' ' LYS . 9.1 mm -70.03 -27.29 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.62 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.24 -17.12 47.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.145 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 142' ' ' LEU . 13.4 mt -87.59 -38.98 15.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 147' ' ' VAL . 25.6 m -57.58 163.16 2.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.03 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.683 HG12 ' HB2' ' A' ' 150' ' ' LYS . 13.0 p -90.0 161.82 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.965 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.517 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -55.68 -31.3 62.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.759 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.646 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -92.6 7.39 43.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.683 ' HB2' HG12 ' A' ' 147' ' ' VAL . 4.5 mttm -133.27 -8.27 2.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.513 0.197 . . . . 0.0 111.505 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.517 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.6 mtpp -54.47 -59.43 10.31 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.264 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 16.8 Cg_endo -57.78 -42.63 57.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.3 2.0 . . . . 0.0 111.938 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.928 HG13 ' HB3' ' A' ' 80' ' ' LEU . 85.9 t -57.5 -27.92 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.86 -53.91 4.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.382 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.597 ' CA ' HD11 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -47.64 -38.3 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.868 ' HB3' HD11 ' A' ' 80' ' ' LEU . 8.4 tp10 -60.68 -46.26 91.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.505 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 107' ' ' TRP . 42.8 t -58.54 -49.49 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.331 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.64 HD13 ' CA ' ' A' ' 139' ' ' PRO . 68.4 mt -62.35 -49.59 74.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.3 p -49.83 -42.45 47.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.772 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.4 t -73.44 -24.6 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.115 0.483 . . . . 0.0 110.343 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.881 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.3 m-30 -104.63 12.05 33.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.995 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.559 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.01 -55.53 32.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.386 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.0 Cg_endo -55.87 -22.37 37.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.494 2.129 . . . . 0.0 112.248 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.473 ' ND1' HG22 ' A' ' 73' ' ' ILE . 98.4 m-70 -89.92 -17.97 27.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.484 HD23 ' SD ' ' A' ' 22' ' ' MET . 1.8 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.934 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.717 0.294 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.433 ' HG2' ' CD2' ' A' ' 100' ' ' TRP . 29.9 mmm-85 -77.73 148.18 35.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -67.4 130.66 43.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.139 0.495 . . . . 0.0 111.534 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.486 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 m120 -152.5 162.52 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.72 HG13 HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.93 126.26 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 0.0 111.25 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' HA3' ' NE2' ' A' ' 105' ' ' GLN . . . -98.09 138.84 14.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.273 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.929 HG21 HD22 ' A' ' 61' ' ' LEU . 4.8 mp -114.65 101.52 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.343 . . . . 0.0 111.26 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.9 t -90.17 104.58 17.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.5 tp -103.29 149.13 25.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.063 0.458 . . . . 0.0 111.143 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.564 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.9 ptt? -130.11 157.37 42.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.708 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.452 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.8 p-10 -100.73 171.0 7.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.468 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -57.65 -16.02 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.547 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.04 0.27 56.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp 76.9 27.48 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.656 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -98.83 171.21 8.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.524 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -109.91 121.23 62.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.967 0.413 . . . . 0.0 110.953 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.708 ' CE1' HG21 ' A' ' 119' ' ' ILE . 86.9 t80 -55.49 110.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.61 137.81 51.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.356 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -123.23 139.88 53.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.21 156.88 24.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.626 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.775 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -73.01 157.75 36.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 111.367 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.1 mt -90.5 -5.88 55.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.124 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.88 -16.6 2.89 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.775 HD12 ' CD ' ' A' ' 33' ' ' ARG . 61.6 mt -119.07 106.03 43.96 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 31.0 Cg_exo -60.77 129.05 27.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.164 1.909 . . . . 0.0 111.888 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.2 t70 80.61 0.93 1.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.929 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.52 97.67 10.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.4 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD1' HD22 ' A' ' 145' ' ' LEU . 49.5 m95 -101.47 155.09 18.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.119 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -169.13 -176.86 2.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.699 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.456 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 4.2 mpp? -102.66 157.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 121.37 7.9 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.601 2.201 . . . . 0.0 112.498 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -123.23 161.64 24.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.61 138.7 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.435 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.39 129.08 19.53 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 17' ' ' VAL . 4.9 mt -61.12 158.62 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -90.21 150.41 21.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.47 99.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.156 0.503 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.26 37.93 9.48 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.779 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 49.1 tt0 -114.39 147.92 38.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.174 0.511 . . . . 0.0 110.701 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.11 142.52 72.31 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.508 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HA ' HG11 ' A' ' 17' ' ' VAL . 49.0 Cg_exo -56.45 -57.88 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.504 2.136 . . . . 0.0 112.89 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 58' ' ' ILE . 4.8 ttt-85 -58.38 -24.78 60.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.43 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -87.71 -42.76 12.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 110.252 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.39 -32.7 73.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.197 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.28 -52.49 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 54' ' ' ARG . 51.4 mt -56.82 -29.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.999 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -81.2 -52.78 6.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.716 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 31.5 mm-40 -55.4 -44.83 76.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.638 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.929 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -55.17 -51.86 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.829 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.583 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 31.9 ttp180 -61.59 -13.68 23.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.577 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.02 -42.26 10.08 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -90.76 -27.05 19.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.72 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.45 -21.55 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 111.093 -179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.09 8.39 61.5 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.981 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.817 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.2 t -65.23 110.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.237 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.9 p -92.46 -34.95 13.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.239 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 76.6 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 111.055 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.44 129.34 13.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.605 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.526 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.4 pt-20 -119.14 140.28 50.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.323 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.3 t -69.28 121.65 19.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.353 0.597 . . . . 0.0 111.17 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.897 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -97.74 -22.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -163.37 165.65 23.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.504 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 10.6 pt-20 -149.06 121.17 8.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.809 ' HA ' HG11 ' A' ' 160' ' ' VAL . 32.4 t -56.94 126.01 71.28 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 -19.41 46.48 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.951 2.434 . . . . 0.0 113.242 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.65 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.13 -175.3 3.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 111.511 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.461 ' C ' HD22 ' A' ' 80' ' ' LEU . 17.1 m95 -104.57 147.76 27.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.77 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.889 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -104.52 118.08 35.72 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.418 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.869 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -119.98 133.71 55.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.949 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.886 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -133.85 170.31 15.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.98 161.24 23.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.634 0.731 . . . . 0.0 111.42 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 10.8 m-85 -111.15 144.06 29.66 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 122.648 2.232 . . . . 0.0 112.565 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.433 ' CD2' ' HG2' ' A' ' 14' ' ' ARG . 90.9 m95 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.813 0.34 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -30.83 66.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -179.51 -133.85 2.06 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.937 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 14.1 pt20 -157.96 114.84 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.0 111.343 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.869 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.46 105.78 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.848 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.7 pt20 -123.19 144.87 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -95.66 98.68 10.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 178.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.621 ' CD2' HG21 ' A' ' 157' ' ' VAL . 22.2 m95 -66.14 143.57 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.193 0.52 . . . . 0.0 112.149 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.3 m-85 -129.21 136.98 50.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.246 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.897 HD23 ' HB ' ' A' ' 73' ' ' ILE . 23.6 tp -79.34 155.01 28.64 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.869 ' O ' HD12 ' A' ' 21' ' ' LEU . 32.8 m-85 -146.1 132.73 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.252 0.549 . . . . 0.0 112.023 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 5.5 tptp -96.46 118.27 32.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.53 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.643 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -68.17 120.69 14.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 0.0 110.701 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.42 HG21 ' OE1' ' A' ' 71' ' ' GLU . 5.9 p -121.81 37.43 4.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.457 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.83 -144.38 4.7 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.086 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.29 154.29 45.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 110.004 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -49.73 -16.8 0.27 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -15.7 59.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.02 -25.47 37.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.708 HG21 ' CE1' ' A' ' 29' ' ' PHE . 14.9 mt -73.18 103.89 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.582 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.48 95.85 4.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.024 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.0 mt -56.02 -21.65 22.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.654 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 129' ' ' PRO . 14.6 mt -62.95 -58.84 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 109.984 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.69 -172.19 24.5 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.435 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -93.31 38.82 1.05 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.15 0.5 . . . . 0.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.45 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.302 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.8 m -114.28 -67.75 0.97 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.769 0.318 . . . . 0.0 111.25 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -98.38 165.1 12.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -76.37 147.54 79.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.489 ' HB2' HD11 ' A' ' 34' ' ' LEU . 53.1 Cg_exo -51.69 136.18 49.81 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.613 2.209 . . . . 0.0 112.55 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -108.12 -28.39 9.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.653 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 19.0 m-85 -120.37 159.69 24.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.17 -18.11 6.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.85 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.419 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.4 mm-40 -152.45 174.94 13.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.193 0.52 . . . . 0.0 110.782 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.4 p-90 -159.45 152.38 21.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.964 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 m -148.08 157.26 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.541 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.452 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 86.9 m95 -92.81 125.11 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.745 HG11 HD11 ' A' ' 145' ' ' LEU . 27.0 m -136.73 151.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.118 0.485 . . . . 0.0 111.662 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.13 159.07 85.8 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.555 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.574 ' O ' HD13 ' A' ' 158' ' ' LEU . 11.7 Cg_endo -55.82 -18.63 22.21 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.841 1.694 . . . . 0.0 112.016 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -34.17 15.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -50.45 30.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.944 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.9 tp -54.3 -29.8 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.32 0.581 . . . . 0.0 109.829 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.548 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -69.83 -28.49 37.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.655 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -22.39 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.268 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.944 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.5 mt -82.97 -39.15 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 147' ' ' VAL . 26.9 m -53.87 164.21 0.62 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 150' ' ' LYS . 10.3 p -97.24 162.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.528 ' N ' HG22 ' A' ' 147' ' ' VAL . 15.8 mt-10 -51.51 -38.38 53.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.985 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 23.8 p90 -88.34 10.82 18.55 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.571 ' HB2' HG12 ' A' ' 147' ' ' VAL . 67.3 mttt -130.95 -5.12 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.419 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 12.2 mttt -55.97 -62.0 5.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.9 Cg_endo -59.01 -48.16 15.28 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.388 2.058 . . . . 0.0 112.233 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.889 HG13 ' HB3' ' A' ' 80' ' ' LEU . 92.3 t -57.22 -27.1 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.24 0.543 . . . . 0.0 111.11 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.454 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.0 m-85 -90.91 -52.73 4.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.428 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.548 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.88 -31.85 18.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.308 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.804 ' HB3' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -65.39 -46.13 81.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.445 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.621 HG21 ' CD2' ' A' ' 107' ' ' TRP . 57.7 t -59.57 -53.2 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.32 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 139' ' ' PRO . 59.1 mt -62.85 -50.01 72.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.9 t -51.66 -45.61 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.0 t -69.84 -25.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 110.297 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.838 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.9 m-30 -101.96 7.98 41.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.23 -56.23 21.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.623 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.9 Cg_endo -50.16 -24.67 11.65 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.567 2.178 . . . . 0.0 112.384 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 95.9 m-70 -95.39 -18.34 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.564 HD23 ' SD ' ' A' ' 22' ' ' MET . 1.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.964 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.51 152.23 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -75.93 126.96 32.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.6 t-20 -152.5 157.07 40.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.786 HG13 HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -125.45 124.49 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.891 0.377 . . . . 0.0 111.202 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.55 140.96 15.44 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.197 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.824 HG13 ' HB1' ' A' ' 57' ' ' ALA . 4.5 mp -121.23 101.83 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.441 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.3 t -89.76 107.3 19.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.2 tp -103.19 146.54 28.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.7 157.53 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.976 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.7 p-10 -100.59 170.93 8.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.06 -18.21 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.608 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 0.31 56.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.988 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp 76.83 25.63 0.85 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.558 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttp -94.4 172.44 8.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.566 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -110.54 120.35 61.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.947 0.403 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' HG21 ' A' ' 119' ' ' ILE . 68.2 t80 -53.9 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.129 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.52 131.57 56.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.368 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.33 138.29 51.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.914 0.388 . . . . 0.0 111.178 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.29 155.87 24.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.4 mtp85 -70.41 159.16 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 111.599 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.9 mt -92.84 -5.81 50.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.831 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.51 -19.49 4.19 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 66.8 mt -120.4 112.76 34.1 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.968 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.09 131.61 29.22 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.858 1.705 . . . . 0.0 111.911 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.32 2.66 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.94 97.36 10.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.301 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CD1' HD22 ' A' ' 145' ' ' LEU . 26.2 m95 -102.34 155.41 18.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -168.62 169.15 10.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.477 ' HE1' ' CG ' ' A' ' 154' ' ' TYR . 76.2 mtm -89.92 155.22 47.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.16 149.37 22.16 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.697 2.265 . . . . 0.0 113.061 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -176.39 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.214 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 138.08 4.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.296 -0.955 . . . . 0.0 112.858 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.76 126.32 29.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.786 HD11 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -60.99 161.28 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.685 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -88.34 -176.38 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.2 98.62 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.23 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.79 47.39 9.8 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.749 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 6.5 tt0 -115.62 146.75 41.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.55 134.86 84.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.588 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.677 ' O ' HG11 ' A' ' 17' ' ' VAL . 55.2 Cg_exo -52.43 -57.25 2.2 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.401 2.067 . . . . 0.0 112.659 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -56.84 -28.06 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.434 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -81.97 -49.7 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.718 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.16 -30.76 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.824 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.65 -52.0 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 54' ' ' ARG . 43.9 mt -55.85 -28.71 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.244 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG3' ' NH2' ' A' ' 62' ' ' ARG . 36.5 ttp85 -83.62 -52.8 6.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.885 0.85 . . . . 0.0 109.89 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -56.36 -34.55 66.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.684 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.81 HD12 ' OG1' ' A' ' 65' ' ' THR . 5.4 tp -57.13 -59.54 4.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.181 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.566 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 22.4 ptt85 -61.34 -10.71 7.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.793 0.33 . . . . 0.0 110.691 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -91.19 -45.12 8.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 0.0 111.561 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.46 -28.12 17.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.81 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -113.56 -21.49 10.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.837 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.17 4.85 74.53 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.039 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.699 ' HB ' HD11 ' A' ' 61' ' ' LEU . 55.8 t -75.2 119.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.364 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -99.25 -34.07 10.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.35 78.27 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.184 0.516 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.39 129.6 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.924 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -120.0 145.76 46.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.577 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.556 HG22 ' CE1' ' A' ' 110' ' ' PHE . 53.1 t -76.11 125.9 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.527 0.679 . . . . 0.0 111.967 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.933 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.62 -16.19 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.339 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.786 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.35 160.18 40.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 115.56 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.104 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.87 ' HA ' HG11 ' A' ' 160' ' ' VAL . 7.2 t -57.33 127.47 77.0 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.951 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 -15.55 44.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.784 2.322 . . . . 0.0 113.585 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -128.34 174.63 9.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.493 0.663 . . . . 0.0 112.364 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.454 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 13.0 m95 -99.8 147.09 25.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.876 ' HB3' HG13 ' A' ' 153' ' ' VAL . 46.1 mt -114.34 117.56 31.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.763 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.728 HG22 ' CB ' ' A' ' 104' ' ' ALA . 3.0 p -113.56 130.57 56.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.865 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -131.91 160.14 36.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.46 158.38 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.182 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.11 150.17 37.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--N 1.344 0.299 0 C-N-CA 122.441 2.094 . . . . 0.0 112.027 179.616 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.3 m95 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.768 0.318 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 -30.14 55.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -166.04 -144.5 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.447 ' NE2' ' CD2' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -158.16 113.44 2.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 111.511 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.728 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.15 105.67 17.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.936 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.08 153.7 44.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.5 mttt -107.81 95.76 5.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.522 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.437 ' CD2' HG21 ' A' ' 157' ' ' VAL . 61.4 m95 -63.42 140.2 58.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.336 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 66.9 m-85 -125.82 138.32 53.82 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.402 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.786 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.6 tp -79.56 154.77 28.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.824 ' CD1' HG23 ' A' ' 19' ' ' ILE . 34.2 m-85 -148.51 127.83 13.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 0.0 111.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.933 ' HB3' HD11 ' A' ' 73' ' ' ILE . 22.8 tttt -93.72 119.58 32.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.576 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.655 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.9 t80 -62.77 125.31 23.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 71' ' ' GLU . 7.7 p -127.11 37.88 4.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.52 -144.84 4.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.071 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -127.2 154.26 45.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -49.83 -16.65 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.574 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -78.55 -18.1 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -80.3 -25.56 39.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.811 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.784 HG21 ' CE1' ' A' ' 29' ' ' PHE . 15.5 mt -74.15 102.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.369 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.49 96.09 5.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.115 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.748 HD13 ' HB2' ' A' ' 131' ' ' PHE . 53.0 mt -55.45 -22.73 21.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.436 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.448 HD22 ' HG3' ' A' ' 129' ' ' PRO . 19.5 mt -62.24 -58.51 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.13 -179.26 20.8 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.595 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -90.0 38.65 0.93 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.151 0.501 . . . . 0.0 109.768 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.93 73.4 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.254 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -102.88 165.19 11.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -73.41 148.48 88.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.448 ' HG3' HD22 ' A' ' 122' ' ' LEU . 59.5 Cg_exo -50.85 138.93 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.216 . . . . 0.0 112.624 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -112.07 -33.0 6.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.648 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.748 ' HB2' HD13 ' A' ' 121' ' ' LEU . 29.1 m-85 -116.83 159.38 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.522 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.93 -16.82 6.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.852 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 121' ' ' LEU . 20.2 mm-40 -152.31 175.04 13.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.3 p-90 -159.11 151.54 21.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.134 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 m -147.62 161.05 41.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.492 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.488 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.4 m95 -95.09 125.03 39.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.833 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -137.55 150.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.7 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -70.15 159.62 83.78 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.533 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.566 ' HD3' HD11 ' A' ' 28' ' ' ILE . 12.3 Cg_endo -56.27 -18.3 23.68 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 121.826 1.684 . . . . 0.0 111.999 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.06 -34.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.029 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.25 -50.48 32.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.069 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.907 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -53.62 -34.12 57.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.592 0.71 . . . . 0.0 109.885 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.55 HD12 ' CD ' ' A' ' 155' ' ' LYS . 7.8 mm -66.99 -27.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.737 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.31 -22.07 38.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.969 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.7 mt -84.11 -39.41 19.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.827 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -58.35 167.51 1.35 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.115 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.847 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 13.6 p -98.97 163.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.833 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.53 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -60.99 -36.62 79.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.847 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 8.5 p90 -79.38 -0.82 34.31 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.456 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -139.09 10.66 2.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.676 0.274 . . . . 0.0 111.278 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.437 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mtpt -69.45 -62.76 2.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.7 Cg_endo -53.99 -43.34 59.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.47 2.113 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.876 HG13 ' HB3' ' A' ' 80' ' ' LEU . 13.5 t -57.64 -24.59 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.477 ' CG ' ' HE1' ' A' ' 42' ' ' MET . 3.1 m-85 -91.02 -47.81 7.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.438 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.55 ' CD ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -51.57 -33.32 32.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.612 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.6 tp10 -67.15 -45.77 76.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 45.9 t -59.02 -47.09 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.056 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 139' ' ' PRO . 74.6 mt -66.65 -48.69 68.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.781 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -52.07 -45.85 64.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.79 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.87 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.3 t -69.56 -24.84 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 110.679 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.786 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.0 m-30 -98.17 -7.86 28.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.16 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -50.19 -44.92 82.15 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.559 0.218 . . . . 0.0 111.371 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 35.6 Cg_exo -60.5 -22.97 73.94 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.63 2.22 . . . . 0.0 112.679 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.786 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 73.5 m-70 -95.02 -44.48 7.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.793 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.641 HD12 HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB3' ' CA ' ' A' ' 103' ' ' GLN . 5.5 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -78.96 152.62 30.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.412 HH12 ' HB3' ' A' ' 104' ' ' ALA . 4.8 mmp_? -66.5 128.16 35.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.254 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 1.5 t30 -152.77 159.03 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.449 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.761 HG13 ' CG1' ' A' ' 47' ' ' ILE . 4.5 m -136.23 125.33 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.994 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.39 154.8 20.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.925 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.944 HG23 ' CD1' ' A' ' 110' ' ' PHE . 5.2 mp -128.88 110.87 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' PHE . 43.0 t -90.57 103.97 16.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 110' ' ' PHE . 25.1 tp -102.88 149.61 24.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.065 0.459 . . . . 0.0 111.239 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.563 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -127.96 158.25 38.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.967 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' HB3' ' CZ3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -108.55 167.32 10.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.65 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -49.08 -19.24 0.4 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.56 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 0.0 111.467 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 76.71 23.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.659 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.91 171.71 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.59 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -108.77 123.44 64.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.018 0.437 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.537 ' HE2' HD13 ' A' ' 119' ' ' ILE . 9.3 t80 -52.43 116.84 2.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -122.14 132.29 54.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.024 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -121.69 139.8 53.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.981 0.419 . . . . 0.0 111.38 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.05 155.85 24.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.391 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.595 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -71.84 158.39 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.541 . . . . 0.0 111.634 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.3 mt -91.46 -6.03 53.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.997 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -131.11 -17.68 3.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.6 mt -118.6 111.7 37.66 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.0 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 131.72 29.66 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.94 1.76 . . . . 0.0 111.811 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.49 3.07 3.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.793 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.22 97.41 11.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.475 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.7 m95 -102.39 155.73 18.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.252 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -169.13 -176.94 2.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.692 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.3 mpp? -103.29 158.26 32.15 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.57 146.61 80.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.463 2.109 . . . . 0.0 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -153.98 176.64 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.18 6.44 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.81 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.71 130.77 20.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.222 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.761 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.9 mt -58.59 159.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.485 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.3 m-20 -90.49 149.47 22.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.822 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.44 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 39.8 10.84 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.935 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.9 tp10 -114.12 146.78 39.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.908 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -72.54 140.98 82.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.497 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HA ' HG11 ' A' ' 17' ' ' VAL . 33.1 Cg_exo -57.77 -37.8 95.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.357 2.038 . . . . 0.0 112.471 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 58' ' ' ILE . 4.5 ttp180 -75.78 -23.34 55.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.67 -43.97 10.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.445 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.04 -30.84 71.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.32 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.4 -51.37 17.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 54' ' ' ARG . 58.0 mt -56.82 -28.77 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.18 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 ttp85 -84.25 -52.8 5.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.792 0.806 . . . . 0.0 109.991 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -53.15 -42.54 66.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.827 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -55.83 -54.64 42.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.531 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.8 ttp180 -61.17 -13.92 21.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.299 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -92.01 -40.85 10.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.836 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.39 -26.26 18.96 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.808 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.02 -20.55 8.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.48 4.09 73.7 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.098 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.653 HG13 ' HE1' ' A' ' 112' ' ' PHE . 55.8 t -71.02 118.58 15.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.616 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -98.62 -35.25 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.29 80.85 6.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.944 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.63 130.8 14.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.035 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 pt-20 -120.3 144.0 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.02 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.5 t -76.79 122.95 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.646 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.887 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.5 mm -107.08 -15.33 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 109' ' ' LEU . . . -155.98 154.03 30.47 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.837 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -148.67 117.93 6.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.81 ' HA ' HG11 ' A' ' 160' ' ' VAL . 7.5 t -57.53 127.03 77.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.926 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.58 -6.12 18.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.923 2.415 . . . . 0.0 114.117 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.531 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -136.53 138.97 41.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.443 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 24.9 m95 -64.28 145.32 56.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.279 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.851 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -103.92 138.73 40.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.643 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.4 p -139.18 130.7 27.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.844 ' CD1' HG11 ' A' ' 153' ' ' VAL . 9.9 p90 -139.1 170.44 15.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.95 158.3 35.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.018 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -102.44 154.21 37.59 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.703 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 122.389 2.059 . . . . 0.0 112.145 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 71.9 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -25.43 41.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.44 . . . . 0.0 110.578 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -177.98 -137.82 2.9 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.826 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.42 ' CA ' ' HB3' ' A' ' 13' ' ' TYR . 3.6 pt20 -158.16 115.28 2.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.704 0.287 . . . . 0.0 111.436 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.643 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.92 105.56 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -123.6 154.44 39.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -111.31 103.83 12.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.696 178.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.672 ' CD2' HG21 ' A' ' 157' ' ' VAL . 28.1 m95 -66.23 146.18 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.201 0.524 . . . . 0.0 112.085 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 50.8 m-85 -129.13 130.65 46.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.925 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.656 HD23 ' HB ' ' A' ' 73' ' ' ILE . 20.2 tp -78.72 151.81 31.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.944 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.1 m-85 -148.62 128.0 13.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.887 ' HB3' HD11 ' A' ' 73' ' ' ILE . 16.0 tptt -92.62 122.45 35.05 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -64.88 126.35 27.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.849 0.357 . . . . 0.0 111.226 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.2 p -125.45 37.34 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.37 -145.03 4.76 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.106 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -128.51 154.31 46.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.837 0.351 . . . . 0.0 110.147 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -49.33 -17.13 0.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.33 -20.38 57.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.802 0.334 . . . . 0.0 111.224 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.21 -26.28 52.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.537 HD13 ' HE2' ' A' ' 29' ' ' PHE . 31.5 mt -68.68 104.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.474 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.1 95.87 4.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.159 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 131' ' ' PHE . 61.0 mt -57.34 -21.04 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.522 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.859 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -60.53 -57.66 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.95 -179.65 18.71 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.19 38.72 0.94 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.71 28.44 73.76 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.127 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -114.99 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.269 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -102.17 165.12 11.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -74.71 145.54 81.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.859 ' HG3' HD13 ' A' ' 122' ' ' LEU . 52.5 Cg_exo -53.82 137.98 68.32 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.577 2.184 . . . . 0.0 112.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.57 -28.22 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.573 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.9 m-85 -118.02 159.5 23.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.23 -19.66 5.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.723 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 32.3 mm-40 -152.25 174.51 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.078 0.465 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.9 p-90 -159.27 154.05 24.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.388 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.14 166.25 26.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.301 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.483 ' CZ3' ' HB3' ' A' ' 23' ' ' ASN . 54.1 m95 -99.54 125.67 45.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.2 m -139.28 151.44 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -69.76 162.48 67.56 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.466 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.596 ' O ' HD13 ' A' ' 158' ' ' LEU . 19.3 Cg_endo -58.78 -16.72 32.63 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.762 1.642 . . . . 0.0 111.995 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -35.01 13.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.2 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.36 33.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.051 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.943 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.57 -27.81 41.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.473 0.654 . . . . 0.0 110.014 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.619 HD12 ' HG3' ' A' ' 155' ' ' LYS . 5.2 mm -73.52 -27.45 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.843 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.45 -23.79 42.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.085 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.8 mt -81.01 -40.18 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 109.922 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 150' ' ' LYS . 4.4 m -57.89 169.3 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.872 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.1 p -105.37 159.03 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.551 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 147' ' ' VAL . 11.3 pt-20 -42.42 -51.87 4.81 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.514 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -71.11 -7.29 45.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.238 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.493 ' O ' HG21 ' A' ' 146' ' ' THR . 1.9 mttt -123.34 -1.59 8.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.586 0.232 . . . . 0.0 111.514 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 15.6 mtpt -68.63 -60.74 4.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.277 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 14.8 Cg_endo -57.3 -42.68 59.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.304 2.002 . . . . 0.0 111.538 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 80' ' ' LEU . 35.0 t -61.07 -24.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 3.4 m-85 -90.64 -50.19 6.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.253 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.619 ' HG3' HD12 ' A' ' 143' ' ' ILE . 7.9 mtpm? -51.38 -30.92 20.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.377 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.781 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.3 tp10 -67.54 -46.23 73.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.322 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.672 HG21 ' CD2' ' A' ' 107' ' ' TRP . 39.4 t -62.13 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.102 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 139' ' ' PRO . 73.7 mt -67.19 -49.07 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.6 t -51.13 -46.86 62.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 76' ' ' VAL . 87.1 t -66.12 -24.03 33.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.192 0.52 . . . . 0.0 110.34 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.719 ' O ' HD12 ' A' ' 165' ' ' LEU . 10.5 m-30 -98.65 -6.67 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.786 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.67 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -44.69 -39.46 7.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.689 ' HD2' ' C ' ' A' ' 161' ' ' PHE . 20.5 Cg_endo -63.17 -23.84 72.88 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.135 1.89 . . . . 0.0 113.8 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 161' ' ' PHE . 3.2 p80 -89.37 -25.41 21.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.754 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.9 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.993 0.425 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 3.7 ttt85 -84.25 152.42 24.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -63.74 129.4 39.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.527 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 20.5 t-20 -152.65 150.82 29.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 53' ' ' PRO . 2.7 m -123.28 141.37 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' ' NE2' ' A' ' 105' ' ' GLN . . . -109.34 149.85 17.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.281 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.936 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -129.22 101.6 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.1 t -89.63 106.29 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 110' ' ' PHE . 32.6 tp -102.68 143.0 32.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 111.195 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.3 ptt? -127.74 157.3 40.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 40.0 p-10 -103.3 170.21 8.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.302 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -55.74 -17.47 6.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.515 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.02 0.42 56.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.731 0.3 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 76.47 26.43 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 22' ' ' MET . 12.6 mttt -97.01 173.88 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.544 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -112.2 121.4 64.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.943 0.401 . . . . 0.0 110.884 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.458 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 12.6 t80 -54.73 108.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.384 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.79 134.49 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.27 141.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 111.319 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.29 158.31 23.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.614 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.667 ' CD ' HD12 ' A' ' 36' ' ' ILE . 5.0 mtp-105 -71.26 163.65 27.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.35 0.595 . . . . 0.0 111.676 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.2 mt -96.67 -7.33 34.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.564 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.13 -18.51 4.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.348 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.667 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.7 mt -120.73 112.76 33.61 Favored Pre-proline 0 N--CA 1.457 -0.109 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.171 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.44 132.1 30.18 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.955 1.77 . . . . 0.0 111.792 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.37 2.47 3.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.829 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.67 97.55 11.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.312 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.552 ' CD1' HD22 ' A' ' 145' ' ' LEU . 38.0 m95 -101.18 156.08 17.64 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.933 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -168.98 169.43 9.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 43.2 mtm -97.09 155.9 36.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 129.67 20.15 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.193 . . . . 0.0 113.038 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 141.74 19.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.57 160.84 28.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.863 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.9 126.84 7.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.629 HD11 HG13 ' A' ' 17' ' ' VAL . 11.7 mt -55.71 162.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.579 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 47' ' ' ILE . 8.5 m-20 -73.48 -170.9 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.573 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.06 29.28 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.275 0.56 . . . . 0.0 111.145 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.53 52.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 2.7 tt0 -128.43 148.17 50.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.088 0.47 . . . . 0.0 111.076 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.13 128.19 81.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.87 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.66 ' HA ' HG11 ' A' ' 17' ' ' VAL . 1.4 Cg_endo -45.93 -29.73 6.3 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.59 2.194 . . . . 0.0 113.11 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.551 HH12 HG11 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -73.48 -29.57 62.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.775 0.322 . . . . 0.0 110.917 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -86.67 -44.59 11.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.195 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -58.15 -31.69 67.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.92 -54.76 7.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.066 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ARG . 31.6 mt -56.05 -31.7 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -78.84 -53.4 7.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.832 0.825 . . . . 0.0 109.89 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -50.87 -38.97 52.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.45 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.1 tp -58.15 -58.88 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.129 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.526 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 ptp180 -61.42 -11.84 12.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -91.62 -43.74 9.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 0.0 111.718 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.78 -25.4 19.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.72 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -115.43 -20.91 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.12 5.17 70.26 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG13 ' HE1' ' A' ' 112' ' ' PHE . 53.2 t -74.72 129.34 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 p -105.71 -34.63 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.27 81.64 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.912 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.54 14.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.653 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.2 OUTLIER -119.63 147.48 44.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.17 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.578 HG23 ' CE2' ' A' ' 110' ' ' PHE . 31.2 t -78.49 123.06 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.433 0.635 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.907 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -104.34 -22.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.274 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.76 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -152.11 159.75 43.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.18 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.5 pt-20 -148.31 111.7 4.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.171 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.67 HG22 HG21 ' A' ' 160' ' ' VAL . 3.8 t -57.62 125.73 73.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.219 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 4.8 Cg_exo -74.45 -8.14 20.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.845 2.363 . . . . 0.0 113.571 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.576 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.44 135.91 50.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 112.187 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD2' ' CG ' ' A' ' 106' ' ' LYS . 29.3 m95 -67.7 145.57 54.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.07 0.462 . . . . 0.0 110.109 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.633 ' HB3' HG13 ' A' ' 153' ' ' VAL . 55.7 mt -111.36 117.93 34.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.897 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.882 HG22 ' CB ' ' A' ' 104' ' ' ALA . 9.5 p -108.89 140.18 42.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.74 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.766 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -134.24 170.18 16.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.886 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.81 158.34 33.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -120.85 146.6 44.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--N 1.346 0.396 0 C-N-CA 122.603 2.202 . . . . 0.0 112.241 179.974 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 36.7 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.833 0.349 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -30.76 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.64 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -161.6 -143.44 3.68 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.098 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.9 mm-40 -157.64 115.55 3.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.883 0.373 . . . . 0.0 111.435 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.882 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -95.48 105.61 17.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.3 pt20 -124.34 154.78 39.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' CG ' ' CD2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -107.51 105.38 15.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.485 178.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' HG21 ' A' ' 157' ' ' VAL . 26.6 m95 -72.92 144.88 47.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.222 0.534 . . . . 0.0 112.259 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.9 m-85 -127.58 132.79 49.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.361 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.803 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.81 129.08 34.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.936 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.4 m-85 -123.73 127.87 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.907 ' HB3' HD11 ' A' ' 73' ' ' ILE . 2.2 tppp? -91.73 121.78 33.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.652 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.0 t80 -63.52 126.68 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.846 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.653 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.9 p -127.12 37.62 4.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.56 -145.17 4.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.066 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -129.64 154.16 47.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.882 0.372 . . . . 0.0 110.067 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.482 ' HA ' HD12 ' A' ' 119' ' ' ILE . 20.2 m-20 -49.5 -16.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.602 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -76.9 -23.29 52.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.88 -25.17 52.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.822 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 116' ' ' ASP . 23.2 mt -68.03 104.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.393 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.62 ' ND2' HD12 ' A' ' 122' ' ' LEU . 1.1 m120 -121.2 95.91 4.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.914 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 131' ' ' PHE . 44.8 mt -58.56 -21.05 51.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.62 HD12 ' ND2' ' A' ' 120' ' ' ASN . 2.3 mt -61.46 -57.44 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.799 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.87 179.04 21.81 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.575 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -90.25 38.75 0.94 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.214 0.531 . . . . 0.0 109.724 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.56 26.95 73.28 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.063 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -117.42 -69.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -96.44 165.13 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.204 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -77.43 148.81 77.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.499 ' CG ' HD23 ' A' ' 122' ' ' LEU . 64.2 Cg_exo -50.51 135.92 40.57 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.62 2.213 . . . . 0.0 112.597 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -111.91 -30.64 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.781 ' HB2' HD13 ' A' ' 121' ' ' LEU . 25.3 m-85 -118.34 159.51 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.7 -13.96 7.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.697 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.563 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.8 mp0 -152.17 174.18 14.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.085 0.469 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.3 p-90 -159.74 150.04 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 m -148.68 156.64 42.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.465 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -92.14 125.01 36.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.72 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -135.62 150.78 29.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.138 0.494 . . . . 0.0 111.579 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.8 159.67 83.08 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.583 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.582 ' CA ' HD13 ' A' ' 158' ' ' LEU . 12.9 Cg_endo -56.5 -17.97 23.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.917 1.745 . . . . 0.0 111.965 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.07 14.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.102 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.49 -50.63 29.58 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.959 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.3 tp -53.68 -33.43 55.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 109.819 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.55 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.0 mm -67.34 -27.65 39.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.811 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.3 -24.37 42.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.057 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.959 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.6 mt -82.34 -39.58 22.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.857 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 150' ' ' LYS . 3.3 m -54.25 168.59 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.272 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.5 p -103.65 160.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 147' ' ' VAL . 5.4 mt-10 -47.65 -40.61 20.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.349 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 21.7 p90 -86.22 8.3 21.7 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' HG21 ' A' ' 146' ' ' THR . 15.1 mttt -130.9 -1.61 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.588 0.233 . . . . 0.0 111.457 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 31.6 mttt -63.81 -62.85 4.64 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.269 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 14.7 Cg_endo -57.16 -41.4 74.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.102 . . . . 0.0 112.004 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.0 t -60.62 -26.78 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.15 0.5 . . . . 0.0 110.977 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.1 m-85 -91.09 -55.05 3.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.846 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HG3' HD12 ' A' ' 143' ' ' ILE . 34.6 mttm -47.92 -33.49 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.709 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.596 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.4 tp10 -67.94 -44.5 76.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.615 HG21 ' CD2' ' A' ' 107' ' ' TRP . 58.6 t -61.5 -49.17 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.222 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.582 HD13 ' CA ' ' A' ' 139' ' ' PRO . 73.9 mt -62.86 -48.4 79.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.658 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.9 m -49.58 -47.49 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.808 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.67 HG21 HG22 ' A' ' 76' ' ' VAL . 89.3 t -69.27 -24.98 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.664 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.803 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.6 m-30 -100.6 1.93 41.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.283 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.94 -54.47 40.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.355 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.29 -20.81 26.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.608 2.206 . . . . 0.0 112.379 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.76 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 19.9 m-70 -89.51 -21.19 23.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.677 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.41 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.895 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' N ' ' HZ1' ' A' ' 101' ' ' LYS . 49.3 m-85 . . . . . 0 CA--C 1.522 -0.118 0 CA-C-O 121.148 0.499 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 14.9 ttt-85 -84.95 152.12 23.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.302 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.698 HH22 ' HB3' ' A' ' 104' ' ' ALA . 4.3 mmp_? -66.24 124.32 22.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 12.8 t-20 -152.65 159.9 43.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD11 ' A' ' 47' ' ' ILE . 3.7 m -133.96 146.79 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.52 150.47 17.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.891 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -127.89 101.98 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.277 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -89.45 104.93 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 110' ' ' PHE . 36.5 tp -103.09 141.59 35.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.061 0.458 . . . . 0.0 111.277 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.84 157.58 37.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.8 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.5 p-10 -101.4 171.33 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.241 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.33 -16.76 9.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.535 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.15 56.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.729 0.299 . . . . 0.0 110.972 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? 77.05 27.04 0.71 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.484 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -99.81 171.67 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.603 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -110.32 124.3 66.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.879 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.828 ' CE2' HG21 ' A' ' 119' ' ' ILE . 33.7 t80 -58.52 108.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.626 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.82 129.88 56.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.398 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -113.96 141.27 47.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.133 0.492 . . . . 0.0 111.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.53 158.84 22.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.726 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.568 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -67.6 165.92 16.03 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 111.712 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -89.31 -8.86 52.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.161 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.404 ' OD1' HG13 ' A' ' 36' ' ' ILE . 1.3 p30 -148.07 -7.51 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 49.9 mt -114.35 109.77 48.43 Favored Pre-proline 0 CA--C 1.523 -0.083 0 CA-C-N 118.562 0.619 . . . . 0.0 110.918 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 27.2 Cg_endo -64.87 130.85 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.892 1.728 . . . . 0.0 111.616 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.7 t70 80.89 1.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.485 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -94.67 97.66 10.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.153 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 33.3 m95 -108.91 162.17 14.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.859 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -168.73 164.8 12.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.457 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 77.6 mtm -94.9 157.79 36.12 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.66 132.99 32.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.646 2.231 . . . . 0.0 113.006 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.29 154.34 33.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.244 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.47 151.31 21.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.829 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.18 141.93 43.86 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.454 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.969 HD11 HG13 ' A' ' 17' ' ' VAL . 20.3 mt -76.68 164.32 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.952 0.406 . . . . 0.0 110.716 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.57 ' N ' HG22 ' A' ' 47' ' ' ILE . 3.2 m-20 -84.05 -175.8 5.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.671 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.63 100.01 6.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.324 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.65 49.77 17.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.615 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 3.1 tp10 -115.68 145.65 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -71.83 132.73 84.76 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.453 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.686 ' HA ' HG11 ' A' ' 17' ' ' VAL . 55.9 Cg_exo -52.96 -44.91 44.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.492 2.128 . . . . 0.0 112.9 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -59.92 -27.16 66.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -86.75 -47.37 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.712 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.02 -29.69 68.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -75.73 -50.35 15.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.7 mt -57.78 -30.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.088 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 59' ' ' ARG . 3.1 ttp-105 -81.05 -53.54 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 109.815 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -53.96 -33.82 57.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.39 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.847 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -55.06 -59.82 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.609 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 5.9 ptt180 -61.47 -11.94 12.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.81 -39.57 11.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 111.548 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -90.26 -32.75 16.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.099 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.88 -23.24 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.091 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.53 1.54 82.69 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.847 ' HB ' HD11 ' A' ' 61' ' ' LEU . 51.1 t -67.2 115.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -33.9 14.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.478 ' HG ' ' CD ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -90.5 81.86 5.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.853 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.18 131.59 15.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.788 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.9 pt-20 -118.81 146.63 44.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.589 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.6 t -78.86 122.34 33.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.618 . . . . 0.0 111.529 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -104.62 -21.43 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.712 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -152.86 160.83 43.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.175 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.34 110.72 4.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.714 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.4 t -57.63 123.56 63.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.65 -6.03 17.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.798 2.332 . . . . 0.0 113.745 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.572 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -130.06 135.08 47.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.241 0.543 . . . . 0.0 112.09 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 27.9 m95 -66.46 147.24 53.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.848 ' HB3' HG13 ' A' ' 153' ' ' VAL . 53.2 mt -116.51 117.63 30.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.657 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.847 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.6 p -111.84 131.51 55.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.87 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -132.05 161.31 33.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.62 158.45 26.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.241 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -112.8 154.36 44.87 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.701 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.531 2.154 . . . . 0.0 112.419 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.456 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 15.7 m95 . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.866 0.365 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' H ' ' HE3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -70.53 -32.95 70.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.199 0.523 . . . . 0.0 109.998 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -155.23 -153.11 6.4 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.665 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -158.21 116.65 3.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.747 0.308 . . . . 0.0 111.217 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.847 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.88 105.65 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' NE2' ' CE1' ' A' ' 82' ' ' TYR . 0.9 OUTLIER -124.82 152.41 43.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -106.7 101.63 11.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.594 178.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.457 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 22.1 m95 -69.01 143.96 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 0.0 112.128 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 50.9 m-85 -124.83 135.74 53.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.277 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.816 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.6 tp -79.88 131.09 35.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.392 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.891 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.6 m-85 -125.39 127.35 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.673 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.56 123.62 34.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.691 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.7 t80 -67.51 128.82 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 111.328 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' SER . 4.7 p -128.7 37.64 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.264 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -136.34 -144.45 4.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.156 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 153.86 47.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.968 0.413 . . . . 0.0 110.199 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.87 -14.35 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.589 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.62 -17.84 40.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.38 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.478 ' CD ' ' HG ' ' A' ' 69' ' ' SER . 6.3 tt0 -81.37 -24.58 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.828 HG21 ' CE2' ' A' ' 29' ' ' PHE . 32.1 mt -69.46 105.32 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 111.579 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.535 HD21 HD12 ' A' ' 122' ' ' LEU . 10.1 t-20 -116.7 95.88 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.874 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 51.6 mt -52.22 -24.82 7.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.669 HD22 ' HG3' ' A' ' 129' ' ' PRO . 54.0 mt -63.21 -57.64 9.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.252 0.549 . . . . 0.0 109.974 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.32 -177.45 25.59 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.5 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.29 39.01 1.01 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.142 0.496 . . . . 0.0 109.709 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.18 71.5 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -121.83 -64.18 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.82 165.15 17.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 155.52 47.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.003 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.669 ' HG3' HD22 ' A' ' 122' ' ' LEU . 83.8 Cg_exo -44.7 149.8 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.786 2.324 . . . . 0.0 112.773 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -144.21 -44.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 7.4 m-85 -111.6 159.74 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.35 -16.4 6.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.989 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.451 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 23.4 mm-40 -152.32 175.11 13.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 110.491 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.9 p-90 -159.09 150.96 20.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.178 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 m -148.55 162.24 40.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 73.8 m95 -95.67 125.33 40.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.657 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.853 HG11 HD11 ' A' ' 145' ' ' LEU . 27.8 m -137.63 150.96 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.097 0.475 . . . . 0.0 111.681 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.9 158.8 87.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.616 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.649 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.1 Cg_endo -54.89 -19.45 19.43 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 121.941 1.761 . . . . 0.0 112.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.19 -33.85 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.994 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -50.05 30.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.916 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.94 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.18 -29.67 46.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.447 0.641 . . . . 0.0 109.785 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.458 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.1 mm -69.53 -28.41 37.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.71 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.5 -21.02 42.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.127 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.94 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.0 mt -84.37 -39.54 18.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.933 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -58.33 164.98 2.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.971 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.846 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 15.0 p -95.57 160.85 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.516 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.9 OUTLIER -59.92 -27.07 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.846 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 24.8 p90 -91.1 10.9 24.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.435 ' HD3' ' CE2' ' A' ' 82' ' ' TYR . 10.1 mtmt -151.8 14.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.669 0.271 . . . . 0.0 111.584 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.516 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.8 mtpp -69.21 -62.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.25 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.1 Cg_endo -51.72 -41.98 59.18 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.533 2.155 . . . . 0.0 112.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.87 HG11 ' CD1' ' A' ' 82' ' ' TYR . 19.0 t -56.09 -27.24 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.439 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -90.59 -53.0 4.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.473 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.458 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.8 -31.86 18.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.192 0.52 . . . . 0.0 110.445 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.687 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.3 tp10 -67.58 -44.85 77.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.696 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 153' ' ' VAL . 43.6 t -61.31 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.06 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.649 HD13 ' CA ' ' A' ' 139' ' ' PRO . 71.8 mt -65.0 -48.71 73.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.55 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 t -49.43 -47.5 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.689 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.714 HG11 ' HA ' ' A' ' 76' ' ' VAL . 71.3 t -67.93 -25.41 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 110.35 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.816 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.5 m-30 -102.53 8.57 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.068 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.99 -57.26 16.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.27 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 14.1 Cg_endo -57.2 -22.02 46.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.712 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 97.2 m-70 -89.91 -14.25 34.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.095 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.921 179.905 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.5 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.936 0.398 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HD3' ' CD1' ' A' ' 100' ' ' TRP . 7.3 mtp85 -80.82 152.15 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 39.8 mtm180 -71.29 132.94 45.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.244 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.9 t-20 -152.83 157.16 40.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.868 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 47' ' ' ILE . 2.5 m -129.02 134.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 111.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.793 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -106.64 157.11 15.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.098 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.793 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.4 mm -120.77 101.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.691 0.246 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.7 t -89.59 97.28 11.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.4 tp -102.5 145.27 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 111.393 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.35 157.31 41.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.749 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.5 p-10 -102.06 170.33 8.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.348 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.48 -18.55 4.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.91 0.14 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 76.78 25.23 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.607 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' MET . 14.4 mttp -93.63 173.27 7.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.54 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -111.44 120.07 61.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 110.868 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 119' ' ' ILE . 19.8 t80 -53.88 110.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.422 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.53 129.93 56.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.52 138.95 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.059 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.04 155.56 25.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -71.77 157.37 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 111.546 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mt -91.86 -5.37 53.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.841 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.79 -21.44 4.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.024 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.9 mt -118.23 112.5 37.77 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.938 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.23 131.52 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.895 1.73 . . . . 0.0 111.765 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 77.43 3.25 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.89 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.94 97.45 10.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.563 ' CD1' HD22 ' A' ' 145' ' ' LEU . 24.4 m95 -101.06 156.92 17.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.292 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -168.38 -176.98 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.598 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -110.08 156.95 39.19 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HB2' HG12 ' A' ' 19' ' ' ILE . 72.2 Cg_exo -48.65 143.25 16.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.775 2.317 . . . . 0.0 113.021 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 145.1 22.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.37 133.1 2.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.741 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -62.62 140.28 45.94 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.329 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.747 HD11 HG13 ' A' ' 17' ' ' VAL . 4.3 mt -73.31 160.32 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -85.44 -177.18 6.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -77.9 99.22 5.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.35 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.45 9.69 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.729 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.1 tt0 -116.57 144.78 43.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.02 137.31 82.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.591 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.622 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.3 Cg_exo -53.39 -50.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.454 2.103 . . . . 0.0 112.457 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 58' ' ' ILE . 19.2 ttp180 -62.38 -25.43 67.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -83.64 -51.4 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.695 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.14 -31.13 65.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.22 -53.65 10.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 54' ' ' ARG . 54.4 mt -54.75 -27.92 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.192 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -83.82 -53.13 5.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.805 0.812 . . . . 0.0 109.626 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.57 -32.7 65.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.394 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -53.12 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.584 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.7 ptt180 -62.07 -10.87 11.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.448 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.81 -42.14 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.596 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -90.53 -32.42 16.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -21.91 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.995 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.46 4.8 70.75 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.956 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 61' ' ' LEU . 44.3 t -69.75 117.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.792 0.296 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -35.22 12.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.13 77.53 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.24 129.16 13.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.826 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.1 mm-40 -119.93 148.16 43.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.719 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.592 HG23 ' CE2' ' A' ' 110' ' ' PHE . 41.6 t -78.18 125.9 38.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 111.722 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.898 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -105.09 -20.42 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.318 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.709 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -156.06 163.19 39.98 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.231 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 1.3 pm0 -148.54 117.34 6.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.846 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.7 t -57.03 125.43 70.03 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.063 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.28 -17.74 60.78 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.771 2.314 . . . . 0.0 113.362 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.9 -176.45 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.395 0.617 . . . . 0.0 112.125 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.784 ' C ' HD23 ' A' ' 80' ' ' LEU . 15.2 m95 -109.15 147.29 32.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.924 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.784 HD23 ' C ' ' A' ' 79' ' ' TRP . 2.0 mt -112.35 117.75 33.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.02 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.839 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.3 p -111.14 132.25 54.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.518 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.867 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -126.7 169.52 13.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.52 158.41 40.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.108 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -109.72 154.38 42.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.609 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 122.404 2.07 . . . . 0.0 112.34 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.424 ' CD1' ' HD3' ' A' ' 14' ' ' ARG . 55.3 m95 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.816 0.341 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -30.14 60.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.19 -139.62 2.87 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.005 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.11 115.7 2.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.789 0.328 . . . . 0.0 111.376 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.839 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.83 105.86 16.64 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -117.01 157.73 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -113.65 95.87 5.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.841 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD2' HG21 ' A' ' 157' ' ' VAL . 61.7 m95 -64.24 145.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 61.2 m-85 -129.31 134.19 47.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.267 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.861 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -80.02 132.21 35.95 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.58 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HD12 ' A' ' 21' ' ' LEU . 50.3 m-85 -127.16 128.49 46.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 111.278 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.898 ' HB3' HD11 ' A' ' 73' ' ' ILE . 21.3 tttm -92.8 122.76 35.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.668 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -65.8 126.12 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.874 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.7 p -128.42 37.91 4.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.549 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -139.19 -144.98 4.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.148 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.88 154.22 45.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.563 ' HA ' HD12 ' A' ' 119' ' ' ILE . 12.8 m-20 -50.2 -16.26 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -79.72 -17.48 53.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.26 . . . . 0.0 111.356 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -24.93 37.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.593 HG21 ' CE2' ' A' ' 29' ' ' PHE . 7.5 mt -72.46 103.82 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.66 95.59 5.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.952 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' A' ' 131' ' ' PHE . 47.5 mt -54.54 -24.23 19.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.453 HD22 ' HG3' ' A' ' 129' ' ' PRO . 15.5 mt -63.4 -56.96 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.273 0.558 . . . . 0.0 109.988 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.67 -178.5 23.37 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.465 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -90.64 38.73 0.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.067 0.461 . . . . 0.0 109.872 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.17 73.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.219 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -107.11 -65.16 1.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.778 0.323 . . . . 0.0 111.206 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -115.55 164.97 13.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.277 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 153.91 50.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.111 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HG3' HD22 ' A' ' 122' ' ' LEU . 74.6 Cg_exo -48.17 177.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.776 2.317 . . . . 0.0 112.672 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -150.07 -44.75 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.0 m-85 -112.06 159.91 18.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.411 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.68 -21.14 5.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.679 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.6 mm-40 -152.29 174.68 13.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 28.1 p-90 -159.12 154.74 26.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.332 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -151.71 158.73 43.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.458 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 80.1 m95 -92.58 125.81 37.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.901 HG11 HD11 ' A' ' 145' ' ' LEU . 27.3 m -137.4 150.69 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.729 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 4.1 p -68.91 159.18 83.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.576 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.54 ' HD3' HD11 ' A' ' 28' ' ' ILE . 13.0 Cg_endo -56.38 -18.91 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.873 1.715 . . . . 0.0 112.033 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -92.02 -33.88 14.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.117 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -71.08 -50.47 33.45 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.895 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.9 tp -53.16 -33.67 53.54 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.435 0.636 . . . . 0.0 109.876 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -64.88 -29.63 47.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.629 178.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.63 -31.49 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.8 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.901 HD11 HG11 ' A' ' 137' ' ' VAL . 9.4 mt -75.98 -40.46 53.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.033 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 147' ' ' VAL . 13.8 m -55.45 164.15 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.259 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.86 HG11 ' CE2' ' A' ' 149' ' ' PHE . 13.7 p -96.3 161.9 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.483 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -63.12 -33.62 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.86 ' CE2' HG11 ' A' ' 147' ' ' VAL . 8.3 p90 -79.88 0.92 29.13 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.497 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 5.0 mtmt -147.51 17.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.665 0.269 . . . . 0.0 111.437 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.1 mtpt -69.21 -62.75 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.012 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 13.6 Cg_endo -56.5 -40.73 82.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.146 . . . . 0.0 111.935 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.0 t -54.39 -25.52 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.08 -51.88 5.11 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -32.06 15.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.471 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -67.07 -45.52 77.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.623 179.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 57.1 t -58.44 -47.47 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.927 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 143' ' ' ILE . 36.7 mt -63.05 -49.16 75.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.794 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.7 t -49.35 -45.68 46.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.71 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.846 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.2 t -70.1 -24.62 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.465 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.861 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -103.82 8.55 37.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.088 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.642 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.68 -51.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.844 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.8 Cg_endo -52.67 -23.75 20.94 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.433 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.709 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 99.1 m-70 -90.4 -23.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.838 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.912 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.904 0.383 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -86.18 152.28 22.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.421 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.464 HH22 ' HB3' ' A' ' 104' ' ' ALA . 3.1 mmp_? -60.7 129.62 42.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.4 m120 -152.73 160.21 43.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.682 HG13 HD11 ' A' ' 47' ' ' ILE . 1.2 m -135.39 148.4 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.033 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -118.28 150.11 18.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.289 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.892 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.9 mp -127.34 101.66 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.477 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.0 t -91.11 108.08 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.7 tp -103.45 148.96 25.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.455 . . . . 0.0 111.252 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.559 ' SD ' HD21 ' A' ' 109' ' ' LEU . 1.5 ptt? -131.26 157.54 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.674 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.456 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 30.8 p-10 -104.96 169.68 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.24 -18.29 5.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.77 2.88 52.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 19.5 mttm 73.23 26.85 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.565 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' HG22 ' A' ' 138' ' ' THR . 0.0 OUTLIER -95.27 172.51 8.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.549 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -110.2 117.89 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.812 ' HE2' HG21 ' A' ' 65' ' ' THR . 11.4 t80 -52.25 107.55 0.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.79 141.41 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.57 140.67 52.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.51 158.29 23.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.644 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.606 ' CD ' HD12 ' A' ' 36' ' ' ILE . 4.9 mtp-105 -71.69 163.55 27.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.438 0.637 . . . . 0.0 111.667 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.0 mt -97.14 -6.8 34.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.498 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.72 -18.18 3.92 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.606 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.6 mt -121.15 112.59 33.1 Favored Pre-proline 0 N--CA 1.457 -0.088 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.243 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.7 Cg_endo -65.59 132.41 30.85 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.884 1.723 . . . . 0.0 111.532 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.1 2.59 2.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.585 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.33 97.49 11.23 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.683 ' CD1' HD22 ' A' ' 145' ' ' LEU . 33.3 m95 -102.9 156.67 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.74 -176.9 2.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.666 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.479 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 64.1 mtm -108.14 155.45 40.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 134.42 29.4 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.19 159.35 41.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.52 166.76 36.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.26 135.35 14.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.409 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HG13 ' A' ' 17' ' ' VAL . 8.6 mt -66.08 160.99 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.663 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.68 150.69 21.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.883 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.63 97.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.72 38.81 9.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.048 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HB3' HG23 ' A' ' 47' ' ' ILE . 2.8 tt0 -114.67 145.18 42.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 -70.64 139.18 86.12 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.676 ' O ' HG11 ' A' ' 17' ' ' VAL . 49.1 Cg_exo -55.64 -55.51 2.96 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.443 2.096 . . . . 0.0 112.65 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.46 ' O ' HD12 ' A' ' 58' ' ' ILE . 26.9 ttp180 -59.21 -23.58 62.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.89 -48.16 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.16 -31.53 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.812 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.32 -54.12 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.113 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 54' ' ' ARG . 50.9 mt -55.81 -29.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.231 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 ttp85 -82.8 -53.06 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.02 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.63 -45.59 57.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.374 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -56.55 -52.5 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.61 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 42.9 ttp180 -62.45 -12.54 22.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.568 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.61 -41.86 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 111.571 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -90.6 -28.43 18.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.985 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.812 HG21 ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.93 -22.67 5.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.08 9.47 63.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.952 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HB ' HD11 ' A' ' 61' ' ' LEU . 21.3 t -60.38 108.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 110.139 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.99 -35.54 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.422 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.28 74.25 7.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.225 0.536 . . . . 0.0 111.247 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.41 126.38 11.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.564 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.5 mm-40 -119.67 147.73 44.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.821 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 47.7 t -76.83 125.54 36.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.494 0.664 . . . . 0.0 111.704 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.55 -17.38 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.525 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -154.49 162.16 41.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.006 0.432 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 46.5 tt0 -148.53 115.45 6.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.143 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.923 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.8 t -57.58 128.15 79.09 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -11.76 30.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.902 2.401 . . . . 0.0 114.071 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -132.14 153.15 50.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.338 0.589 . . . . 0.0 112.36 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.714 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.0 m95 -80.02 143.49 34.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 79' ' ' TRP . 2.4 mt -111.34 118.09 34.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.93 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.845 HG22 ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -113.5 130.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.792 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -132.98 160.62 36.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.619 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.9 158.38 29.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -102.43 155.51 36.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.608 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.448 2.099 . . . . 0.0 112.157 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 40.1 m95 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.813 0.34 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -31.15 64.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -167.3 -139.07 2.58 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.009 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -157.89 116.02 3.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.543 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.845 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -92.62 111.93 23.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.724 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -131.95 150.7 52.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -102.77 97.08 7.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.287 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 42' ' ' MET . 43.2 m95 -65.34 139.22 58.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 44.0 m-85 -120.23 138.44 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.539 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.852 HD13 ' CD2' ' A' ' 161' ' ' PHE . 25.3 tp -79.72 154.97 28.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.892 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.2 m-85 -148.17 127.87 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.437 . . . . 0.0 111.782 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 24.6 tttm -93.0 120.46 33.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.594 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.634 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.1 t80 -67.11 122.08 17.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.726 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' SER . 10.0 p -123.0 37.37 4.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.553 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -137.91 -144.38 4.69 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.152 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.07 154.2 45.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.61 -16.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -76.77 -16.9 59.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.256 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -25.36 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.755 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 mt -73.51 99.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -114.29 95.71 5.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 131' ' ' PHE . 46.6 mt -54.97 -21.99 13.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.809 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.552 HD22 ' HG3' ' A' ' 129' ' ' PRO . 24.0 mt -63.94 -59.48 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.269 0.557 . . . . 0.0 109.956 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.72 -170.48 26.96 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.483 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -95.6 39.07 1.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.82 75.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.052 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.9 t -120.88 -70.26 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 111.154 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.1 165.08 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.213 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -84.36 148.97 54.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.994 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.552 ' HG3' HD22 ' A' ' 122' ' ' LEU . 70.8 Cg_exo -50.15 130.76 29.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.649 2.232 . . . . 0.0 112.625 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.62 -30.33 7.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.508 ' HB2' HD13 ' A' ' 121' ' ' LEU . 34.5 m-85 -119.87 159.53 24.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.415 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.24 -16.16 6.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.716 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.67 174.0 14.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.223 0.535 . . . . 0.0 110.63 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.6 p-90 -159.85 155.17 25.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.066 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.1 m -153.87 159.44 41.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.405 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 81.1 m95 -92.76 124.06 36.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.63 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.724 HG11 HD11 ' A' ' 145' ' ' LEU . 29.0 m -135.28 150.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.494 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 1.5 p -70.4 160.54 80.85 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.479 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.603 ' CA ' HD13 ' A' ' 158' ' ' LEU . 16.2 Cg_endo -57.65 -17.89 30.69 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.765 1.643 . . . . 0.0 111.87 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -34.39 14.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.072 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -50.6 29.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.021 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.942 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.08 -31.45 51.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 109.801 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.529 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.6 mm -68.25 -28.42 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.694 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.55 -20.7 42.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.226 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.7 mt -85.05 -39.22 18.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 147' ' ' VAL . 48.6 m -57.76 162.37 3.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.122 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.954 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.4 p -96.0 160.66 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.501 ' N ' HG22 ' A' ' 147' ' ' VAL . 7.9 mt-10 -50.17 -33.01 17.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.954 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 19.5 p90 -89.36 13.73 12.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 2.7 mtmp? -139.21 -2.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.586 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 19.2 mttt -55.18 -62.2 4.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.535 0.207 . . . . 0.0 111.352 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.2 Cg_endo -60.81 -42.35 38.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.059 . . . . 0.0 112.201 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.792 HG11 ' CD1' ' A' ' 82' ' ' TYR . 10.3 t -57.8 -31.55 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.336 0.588 . . . . 0.0 110.874 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.479 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -90.57 -50.66 5.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.846 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.529 ' HD2' HD12 ' A' ' 143' ' ' ILE . 5.2 tttt -50.39 -34.23 23.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.2 tp10 -67.92 -45.01 75.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.623 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 153' ' ' VAL . 39.3 t -57.84 -44.42 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.113 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.603 HD13 ' CA ' ' A' ' 139' ' ' PRO . 75.3 mt -68.81 -48.81 62.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.746 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -51.59 -45.87 63.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.923 HG11 ' HA ' ' A' ' 76' ' ' VAL . 84.0 t -69.59 -24.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.852 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.5 m-30 -101.47 -2.35 30.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.303 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -47.19 -52.95 31.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.473 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.3 Cg_endo -53.85 -22.08 22.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.511 2.141 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 67.7 m-70 -97.23 -16.97 20.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.686 0.279 . . . . 0.0 111.097 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 161' ' ' PHE . 5.4 mp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.924 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.132 0.491 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 2.5 tmm_? -87.14 152.59 22.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.381 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' A' ' 15' ' ' ARG . 0.3 OUTLIER -67.2 132.17 47.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.115 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 35.6 t30 -152.96 151.09 29.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.029 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -128.2 127.78 67.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.019 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.767 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -101.11 161.73 18.32 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.233 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.6 mm -126.84 101.61 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.615 0.208 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 10.9 t -91.28 93.51 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.897 HD12 ' O ' ' A' ' 110' ' ' PHE . 17.1 tp -102.36 148.77 25.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.326 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.724 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.2 ptt? -131.02 157.53 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.793 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.3 p-10 -100.51 171.23 7.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.399 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -55.51 -18.25 6.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 0.56 56.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.363 . . . . 0.0 110.849 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp 76.37 25.16 1.01 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.713 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.2 mtpp -92.95 173.25 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.536 HG21 HD23 ' A' ' 142' ' ' LEU . 5.2 mp -110.54 116.66 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CD2' HD23 ' A' ' 21' ' ' LEU . 4.4 t80 -50.82 107.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.298 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.53 142.54 46.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.64 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -128.3 140.12 52.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.44 157.74 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.616 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -74.2 159.37 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.309 0.576 . . . . 0.0 111.455 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.0 mt -94.64 -5.33 45.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.887 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -127.81 -17.52 4.46 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.128 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.616 HD12 ' CD ' ' A' ' 33' ' ' ARG . 67.4 mt -122.11 112.65 31.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.978 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.35 132.04 30.15 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.835 1.69 . . . . 0.0 111.771 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 76.79 4.49 3.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.794 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.607 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.98 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.35 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.639 ' CD1' HD22 ' A' ' 145' ' ' LEU . 32.3 m95 -102.37 155.92 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.197 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.7 -176.95 2.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.81 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.432 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.5 mpp? -107.08 156.82 36.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HB2' HG12 ' A' ' 19' ' ' ILE . 75.1 Cg_exo -48.98 140.92 23.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.892 2.394 . . . . 0.0 113.088 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 42' ' ' MET . 2.9 mm-40 -141.66 142.92 33.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.056 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -153.95 118.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.57 120.87 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.305 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.633 HD11 HG13 ' A' ' 17' ' ' VAL . 5.4 mt -53.9 160.42 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.53 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.0 -176.03 4.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.61 99.68 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 48.81 18.64 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.604 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.11 146.01 42.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 110.969 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.13 136.13 93.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' HG11 ' A' ' 17' ' ' VAL . 32.5 Cg_exo -59.59 -60.96 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.566 2.177 . . . . 0.0 112.577 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -55.1 -23.39 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.4 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -87.06 -41.47 13.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.983 0.421 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -62.34 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.361 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -73.07 -53.88 9.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.098 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' ARG . 46.0 mt -55.33 -30.34 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.124 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.05 -52.82 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.811 0.815 . . . . 0.0 109.816 179.079 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 7.4 mm-40 -55.3 -36.42 66.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.459 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD12 ' OG1' ' A' ' 65' ' ' THR . 10.7 tp -61.06 -62.9 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.646 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.682 ' HG3' HG22 ' A' ' 68' ' ' THR . 2.1 tmm_? -59.55 -12.91 7.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.09 -45.66 8.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.938 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.79 -27.73 18.69 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.749 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -115.38 -20.79 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.691 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 79.52 -7.5 53.37 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.079 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.72 ' HB ' HD11 ' A' ' 61' ' ' LEU . 47.1 t -59.98 117.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.981 0.39 . . . . 0.0 110.571 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.682 HG22 ' HG3' ' A' ' 62' ' ' ARG . 21.0 p -101.88 -31.56 10.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.044 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 78.0 6.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.22 0.534 . . . . 0.0 110.848 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.45 130.37 14.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.707 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.1 pt-20 -119.66 140.56 50.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.3 t -69.64 116.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.302 0.572 . . . . 0.0 111.265 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.882 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.1 mt -91.1 -24.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.046 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -161.74 168.98 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.539 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.78 118.77 7.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.856 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.805 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.8 t -57.16 129.82 79.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.957 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.95 -19.46 63.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 113.332 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.593 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.98 -177.71 3.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.29 0.567 . . . . 0.0 112.1 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.731 ' C ' HD23 ' A' ' 80' ' ' LEU . 47.8 m95 -107.13 147.45 30.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.967 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 79' ' ' TRP . 3.5 mt -111.55 117.74 33.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.09 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.853 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.9 p -109.19 137.34 47.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.417 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.845 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -128.11 170.26 13.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.55 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.99 158.23 38.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.64 148.85 51.57 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 122.54 2.16 . . . . 0.0 112.365 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.429 ' CG ' ' HB2' ' A' ' 14' ' ' ARG . 11.9 m95 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.26 62.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 110.023 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -153.99 -153.5 6.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -158.16 117.06 3.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.739 0.304 . . . . 0.0 111.438 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.853 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.72 105.35 16.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.445 ' HG3' ' CD1' ' A' ' 107' ' ' TRP . 5.1 pt20 -115.79 153.75 30.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -107.85 95.81 5.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.569 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.638 ' CD2' HG21 ' A' ' 157' ' ' VAL . 27.4 m95 -65.18 138.24 58.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 112.034 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 74.0 m-85 -122.25 132.72 54.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.882 HD23 ' HB ' ' A' ' 73' ' ' ILE . 18.4 tp -79.33 134.37 36.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.186 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.897 ' O ' HD12 ' A' ' 21' ' ' LEU . 45.0 m-85 -126.89 132.9 50.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.299 0.571 . . . . 0.0 112.031 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.662 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 2.0 ttmt -95.14 120.2 34.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.411 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.642 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.1 t80 -68.59 121.9 17.38 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.755 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.547 HG21 ' OE1' ' A' ' 71' ' ' GLU . 7.7 p -122.73 37.32 4.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.6 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.77 -145.12 4.84 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.085 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -127.93 154.08 45.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 0.0 110.093 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.51 -15.25 0.4 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -84.1 -13.08 53.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 -25.33 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.962 0.411 . . . . 0.0 110.511 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 67' ' ' VAL . 18.4 mt -73.45 107.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.642 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.21 95.72 5.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.009 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.5 mt -53.35 -23.31 9.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.761 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.0 mt -63.22 -59.07 5.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.228 0.537 . . . . 0.0 109.977 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.53 -175.42 22.92 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.457 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -91.53 38.79 0.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.108 0.48 . . . . 0.0 109.818 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.55 73.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.171 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.1 t -108.85 -66.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.119 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -108.32 165.12 11.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -68.75 148.31 97.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 34' ' ' LEU . 61.9 Cg_exo -50.86 145.16 24.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.526 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -113.79 -35.72 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.615 ' HB2' HD13 ' A' ' 121' ' ' LEU . 11.2 m-85 -113.83 159.51 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.567 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.51 5.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.351 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.55 173.66 14.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.129 0.49 . . . . 0.0 110.5 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 33.6 p-90 -160.39 157.95 28.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.78 158.5 36.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.451 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.459 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.3 m95 -91.17 123.44 34.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.626 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 142' ' ' LEU . 32.8 m -134.33 151.12 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.164 0.507 . . . . 0.0 111.726 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -69.49 160.85 77.64 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.478 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.694 ' CB ' HD13 ' A' ' 158' ' ' LEU . 19.6 Cg_endo -58.59 -16.85 32.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.669 1.58 . . . . 0.0 111.876 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.34 -34.03 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.103 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -51.59 23.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.107 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.926 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.2 tp -54.29 -32.43 56.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.473 0.654 . . . . 0.0 109.806 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.598 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.2 mm -68.35 -27.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.781 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.1 -22.03 42.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.221 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.8 mt -83.99 -39.16 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.15 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 147' ' ' VAL . 23.6 m -55.55 164.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.759 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.9 p -93.71 165.01 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.054 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.9 mm-40 -55.66 -35.48 66.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.759 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.7 p90 -88.58 9.96 22.14 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 147' ' ' VAL . 20.0 mtmt -131.31 -3.46 3.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.523 0.202 . . . . 0.0 111.442 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.429 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttt -58.38 -63.27 4.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 15.5 Cg_endo -57.28 -41.49 72.62 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.176 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 82' ' ' TYR . 34.1 t -59.18 -28.97 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 4.1 m-30 -91.37 -54.01 4.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.842 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HG3' HD12 ' A' ' 143' ' ' ILE . 21.3 mttt -47.86 -34.34 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.2 tp10 -66.99 -45.18 78.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.779 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.638 HG21 ' CD2' ' A' ' 107' ' ' TRP . 56.9 t -57.27 -50.13 77.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.348 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.694 HD13 ' CB ' ' A' ' 139' ' ' PRO . 74.2 mt -62.45 -48.64 78.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.749 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -49.77 -47.29 51.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.805 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.5 t -68.92 -24.52 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 110.46 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.867 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.6 m-30 -104.11 9.28 36.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.154 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.625 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.57 -51.7 70.72 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.715 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.98 -23.48 21.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.51 2.14 . . . . 0.0 112.289 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.696 ' CE1' HG22 ' A' ' 73' ' ' ILE . 98.2 m-70 -89.78 -24.99 21.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.599 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.724 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.85 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -80.18 147.41 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.448 ' N ' ' HG3' ' A' ' 14' ' ' ARG . 34.2 mtm180 -65.1 137.52 57.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 6.5 m120 -152.32 153.18 33.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.298 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.722 HG13 ' CG1' ' A' ' 47' ' ' ILE . 1.0 OUTLIER -122.33 118.33 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.11 146.82 19.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.031 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.91 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -123.5 101.94 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.791 0.329 . . . . 0.0 111.259 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.06 100.54 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 110' ' ' PHE . 39.4 tp -102.69 139.28 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.068 0.461 . . . . 0.0 111.225 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.62 157.28 37.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.82 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -103.61 169.85 8.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.287 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -50.88 -18.36 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -88.99 0.23 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.097 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 75.64 25.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.688 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.9 mmtp -97.65 172.65 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.6 mp -109.74 125.25 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.77 ' CE2' HG21 ' A' ' 119' ' ' ILE . 54.7 t80 -58.76 110.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.61 129.87 56.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.109 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' HE22 ' A' ' 41' ' ' GLN . . . -115.21 136.09 53.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 111.489 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.429 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.1 p -82.38 154.84 25.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.535 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.74 158.54 36.11 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.227 0.537 . . . . 0.0 111.517 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.2 mt -91.94 -5.9 52.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.009 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -130.8 -17.43 3.18 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.625 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 55.1 mt -119.12 111.91 36.61 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.026 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.4 Cg_endo -65.28 131.4 28.22 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.873 1.715 . . . . 0.0 111.902 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.6 t70 77.73 2.69 2.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.78 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.625 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.94 97.22 11.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 50.5 m95 -104.68 157.88 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.547 HE22 ' HB3' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -168.89 173.78 6.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 69.5 mtm -102.25 156.86 34.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.69 131.78 26.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.613 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.15 157.72 39.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.51 34.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.589 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -79.75 130.87 10.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.556 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.722 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.6 mt -59.44 160.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.51 148.06 22.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -48.16 99.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.6 18.41 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.798 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.6 tp10 -111.38 147.2 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.933 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.23 128.9 85.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.338 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.57 ' HA ' HG11 ' A' ' 17' ' ' VAL . 51.9 Cg_exo -52.8 -23.59 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.329 2.019 . . . . 0.0 112.676 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' O ' HD12 ' A' ' 58' ' ' ILE . 9.6 tpt180 -85.54 -22.03 28.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -91.06 -43.45 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.491 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.459 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.59 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.547 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -71.84 -52.86 15.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.17 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 54' ' ' ARG . 64.1 mt -56.52 -27.83 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.316 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -84.88 -52.77 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.824 0.821 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -56.17 -34.24 66.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.592 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.787 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.4 tp -57.41 -59.0 5.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.042 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.569 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 25.1 ptt180 -60.99 -11.84 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 110.504 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -91.69 -43.52 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.886 0.374 . . . . 0.0 111.544 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.3 -25.94 19.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.301 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.787 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.68 -22.01 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.961 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.21 4.55 73.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.972 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.769 ' HB ' HD11 ' A' ' 61' ' ' LEU . 53.2 t -74.46 124.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.785 0.326 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -35.67 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.26 79.08 6.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.749 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 129.55 13.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.6 mm-40 -119.19 147.61 44.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.65 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 48.9 t -77.21 128.93 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.898 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.19 -18.63 7.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.378 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -159.27 162.25 36.07 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.423 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.9 pt-20 -148.83 118.77 7.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.721 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HA ' HG11 ' A' ' 160' ' ' VAL . 17.9 t -58.02 125.34 73.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.273 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.01 -19.8 69.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.739 2.293 . . . . 0.0 113.068 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.587 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.68 -176.74 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.031 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.691 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.4 m95 -108.75 147.1 32.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.023 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.691 HD23 ' C ' ' A' ' 79' ' ' TRP . 4.4 mt -112.29 117.7 33.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.01 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.866 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.9 p -108.65 136.7 47.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.683 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.824 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.0 170.18 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.337 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.03 158.04 40.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.16 150.61 45.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 38.0 m95 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.757 0.313 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -29.47 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.713 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -163.86 -139.39 2.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.307 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 82' ' ' TYR . 32.9 mt-30 -157.53 115.07 3.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.866 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -96.28 112.11 23.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.688 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.2 pt20 -127.29 159.69 33.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -112.51 95.91 5.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.456 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CD2' HG21 ' A' ' 157' ' ' VAL . 40.5 m95 -64.48 141.56 58.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.157 0.503 . . . . 0.0 112.271 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 54.8 m-85 -124.67 133.55 53.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.224 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.8 tp -79.63 131.37 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.553 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.91 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.0 m-85 -127.05 129.38 47.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 111.351 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.897 ' HB3' HD11 ' A' ' 73' ' ' ILE . 11.5 tttt -93.34 120.97 34.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.657 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.7 t80 -63.46 126.93 29.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 0.0 111.014 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 111' ' ' LYS . 18.2 p -129.64 38.15 3.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.58 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.83 -145.05 4.71 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.992 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -128.08 154.14 46.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -50.35 -16.29 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.62 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -79.16 -19.64 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -79.77 -25.07 41.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.77 HG21 ' CE2' ' A' ' 29' ' ' PHE . 18.1 mt -70.81 102.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.374 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.88 96.19 5.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.935 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.802 HD13 ' HB2' ' A' ' 131' ' ' PHE . 34.9 mt -56.67 -24.18 47.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.488 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 129' ' ' PRO . 58.4 mt -61.94 -56.96 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.294 0.568 . . . . 0.0 109.996 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.91 178.84 23.42 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.483 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -90.79 38.93 0.97 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.51 26.92 70.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.123 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -120.62 -70.84 0.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.91 165.2 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -84.35 154.78 63.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.579 ' HG3' HD22 ' A' ' 122' ' ' LEU . 87.9 Cg_exo -45.94 160.48 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.791 2.328 . . . . 0.0 112.722 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.0 mt-10 -150.19 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.802 ' HB2' HD13 ' A' ' 121' ' ' LEU . 1.5 m-85 -107.57 159.51 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.181 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -17.94 5.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.068 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -152.42 175.23 12.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.177 0.513 . . . . 0.0 110.659 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.4 p-90 -156.42 150.43 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.258 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.43 165.64 29.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.349 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 59.9 m95 -99.43 125.44 45.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.784 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -137.97 150.6 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 111.56 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -70.76 158.61 87.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.677 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.647 ' CB ' HD13 ' A' ' 158' ' ' LEU . 11.2 Cg_endo -55.07 -19.1 19.16 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.914 1.743 . . . . 0.0 111.943 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.76 -34.21 15.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.106 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -50.48 27.35 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.954 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -54.01 -29.76 44.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.42 0.629 . . . . 0.0 109.882 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.475 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -69.01 -28.61 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.733 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.55 -20.93 42.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.21 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.8 mt -84.4 -39.35 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.066 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 147' ' ' VAL . 20.3 m -58.2 163.81 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.066 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.906 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 13.6 p -92.59 161.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.06 -26.45 66.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.906 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 22.8 p90 -91.55 12.09 22.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -149.75 12.91 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.568 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.515 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.4 mtpm? -65.15 -62.48 4.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.166 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 11.9 Cg_endo -55.54 -40.86 83.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.478 2.118 . . . . 0.0 112.106 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.824 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.7 t -57.03 -28.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.492 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.5 m-85 -91.42 -52.65 4.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.64 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.475 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.88 -33.56 17.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.586 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.01 -45.58 81.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.553 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 107' ' ' TRP . 43.3 t -58.28 -46.62 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.071 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 139' ' ' PRO . 73.4 mt -64.14 -48.89 74.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.787 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 -46.71 59.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.683 HG11 ' HA ' ' A' ' 76' ' ' VAL . 90.0 t -67.22 -23.13 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 11.2 m-30 -102.96 -1.8 28.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.432 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -49.84 -44.25 77.34 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 38.8 Cg_endo -71.16 -21.54 27.04 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.13 1.887 . . . . 0.0 112.817 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.433 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 81.1 m-70 -89.37 -41.91 11.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.699 0.285 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 161' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.27 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 26.3 m-85 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -86.71 152.5 22.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.265 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.647 HH22 ' HB3' ' A' ' 104' ' ' ALA . 1.9 mmp_? -62.19 128.42 36.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.214 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 11.6 t-20 -152.64 159.42 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.688 HG13 HD11 ' A' ' 47' ' ' ILE . 3.3 m -134.9 140.58 45.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.385 . . . . 0.0 111.222 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 149.54 16.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.932 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -128.38 103.78 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 0.0 111.58 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 20.5 t -89.71 106.33 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.7 tp -103.17 145.06 30.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 111.333 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.5 ptm -130.56 157.39 42.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.518 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.489 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.93 169.78 8.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.011 0.434 . . . . 0.0 111.466 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -51.16 -18.63 0.93 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.615 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.417 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.95 1.42 55.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm 73.38 26.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.649 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttt -99.01 175.14 6.02 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -110.93 126.37 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 111.007 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' HE2' HD13 ' A' ' 119' ' ' ILE . 12.1 t80 -58.43 109.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.26 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -117.02 129.67 56.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.433 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.77 137.89 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.089 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.2 155.99 24.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.782 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.4 mtp85 -71.38 159.83 33.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.617 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.45 -5.64 48.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.916 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -19.29 4.01 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.218 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.623 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 59.7 mt -120.05 112.68 34.65 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.983 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.37 131.73 29.12 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.901 1.734 . . . . 0.0 111.713 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.35 3.3 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.777 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.47 97.21 10.95 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.243 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.622 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.5 m95 -102.47 156.73 17.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.238 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -168.62 169.22 10.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.792 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.3 mtm -92.92 156.17 40.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.33 124.35 11.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.556 2.171 . . . . 0.0 112.695 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -154.24 158.43 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.383 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.91 153.5 22.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.799 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.1 137.37 49.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.688 HD11 HG13 ' A' ' 17' ' ' VAL . 7.4 mt -64.57 161.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 110.405 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.3 m-20 -90.04 147.95 23.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.59 98.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.226 0.536 . . . . 0.0 110.807 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.01 36.03 8.63 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.024 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.0 tt0 -116.34 142.31 47.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.48 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.54 142.88 84.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.674 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.57 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.6 Cg_exo -54.44 -48.75 19.78 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.487 2.125 . . . . 0.0 112.566 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -65.55 -26.04 67.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -84.65 -46.92 11.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.656 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -58.29 -31.62 67.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.57 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.678 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.26 -53.54 10.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.177 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 54' ' ' ARG . 47.3 mt -55.9 -30.38 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.104 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -81.83 -53.23 6.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.735 0.779 . . . . 0.0 109.779 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -52.66 -39.04 61.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.451 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.809 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.3 tp -55.59 -57.38 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.041 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.559 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 2.7 ptt-85 -61.44 -12.48 14.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.432 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.69 -42.5 10.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 111.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.41 -25.14 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.229 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.809 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.33 -21.61 8.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.758 0.314 . . . . 0.0 111.069 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.15 5.23 70.57 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.894 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG13 ' HE1' ' A' ' 112' ' ' PHE . 53.4 t -75.08 128.16 36.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 0.0 110.633 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -34.89 8.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.3 81.63 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.46 . . . . 0.0 110.974 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 130.69 14.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.84 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.688 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -119.77 148.21 43.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.983 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.5 t -79.14 122.83 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.339 0.59 . . . . 0.0 111.553 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.866 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -102.85 -20.79 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.27 162.53 40.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.039 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.23 115.97 6.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.011 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.826 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.5 t -57.21 128.46 78.23 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 -10.8 25.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.796 2.331 . . . . 0.0 113.942 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.608 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -131.16 160.8 33.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 112.294 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -88.71 147.11 24.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.867 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.783 ' HB3' HG13 ' A' ' 153' ' ' VAL . 95.9 mt -115.44 117.63 30.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.815 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -114.59 130.83 56.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.757 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.833 ' CE1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -133.46 165.64 24.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -124.86 158.31 33.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.154 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -103.2 155.4 36.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo . . . . . 0 C--N 1.344 0.329 0 C-N-CA 122.406 2.071 . . . . 0.0 112.266 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 27.7 m95 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.746 0.308 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -29.89 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.124 0.487 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.74 -143.94 4.27 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.696 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -158.7 124.38 4.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.847 0.356 . . . . 0.0 111.315 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.815 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.73 106.48 17.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -115.9 149.22 39.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.406 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 2.1 mmtp -109.52 96.45 6.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.542 ' CG ' HG21 ' A' ' 157' ' ' VAL . 73.3 m95 -62.65 145.78 53.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 70.1 m-85 -130.95 133.56 45.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.936 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.818 HD13 ' CD2' ' A' ' 161' ' ' PHE . 16.2 tp -79.68 130.88 35.74 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.595 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.932 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.9 m-85 -125.33 127.59 46.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.017 0.437 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.866 ' HB3' HD11 ' A' ' 73' ' ' ILE . 62.8 tttm -92.56 120.75 33.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.7 t80 -62.9 126.21 26.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.688 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.5 p -127.06 37.96 4.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.584 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.59 -145.16 4.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.059 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -128.95 154.24 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 109.984 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.3 -17.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.569 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.85 -22.79 53.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.01 -25.62 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.603 HD13 ' HE2' ' A' ' 29' ' ' PHE . 30.9 mt -68.0 103.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.56 96.06 4.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.041 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 131' ' ' PHE . 44.6 mt -58.72 -20.82 52.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.403 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.928 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -60.25 -57.0 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 179.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.3 178.32 19.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.332 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -89.79 38.65 0.92 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.193 0.521 . . . . 0.0 109.714 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.11 29.76 76.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.233 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.0 m -109.34 -64.04 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 111.336 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -115.8 165.11 13.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 152.69 68.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.928 ' HG3' HD13 ' A' ' 122' ' ' LEU . 77.0 Cg_exo -48.84 176.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 0.0 112.668 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -150.14 -44.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.767 ' HB2' HD13 ' A' ' 121' ' ' LEU . 18.6 m-85 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 -18.16 6.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.732 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.2 mm-40 -152.3 175.0 13.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.042 0.448 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.1 p-90 -159.23 152.07 21.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.15 163.39 38.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.362 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.489 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 64.9 m95 -95.98 123.58 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.856 HG11 HD11 ' A' ' 145' ' ' LEU . 33.0 m -133.14 151.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.559 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.1 158.22 87.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.525 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.541 ' HD3' HD11 ' A' ' 28' ' ' ILE . 10.9 Cg_endo -54.44 -19.57 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.0 1.8 . . . . 0.0 112.097 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -92.13 -34.36 14.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.276 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -50.25 46.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.935 0.398 . . . . 0.0 110.152 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.928 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.2 tp -53.21 -34.02 55.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.479 0.657 . . . . 0.0 109.871 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.524 HG21 ' NZ ' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -66.48 -28.61 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.673 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -77.39 -32.59 54.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.654 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.928 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.6 mt -74.64 -40.94 61.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.87 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 150' ' ' LYS . 18.3 m -53.53 164.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.221 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' A' ' 149' ' ' PHE . 7.3 p -97.37 159.82 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 1.0 OUTLIER -47.24 -43.68 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.465 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 147' ' ' VAL . 39.2 p90 -83.95 7.02 19.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.454 ' O ' HG21 ' A' ' 146' ' ' THR . 25.3 mtmt -128.12 -6.31 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.59 0.234 . . . . 0.0 111.33 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.506 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.7 mtpm? -59.42 -60.63 9.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.592 0.235 . . . . 0.0 111.285 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.0 Cg_endo -61.54 -42.3 34.23 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.047 . . . . 0.0 112.15 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.833 HG11 ' CE1' ' A' ' 82' ' ' TYR . 13.4 t -58.1 -26.69 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.5 -52.61 4.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.505 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.524 ' NZ ' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.75 -30.66 14.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.617 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.7 tp10 -67.98 -44.99 75.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.484 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.542 HG21 ' CG ' ' A' ' 107' ' ' TRP . 48.6 t -59.99 -48.77 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' ALA . 59.2 mt -60.8 -48.95 79.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.971 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.0 m -48.89 -42.9 38.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.831 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.826 HG11 ' HA ' ' A' ' 76' ' ' VAL . 93.7 t -72.76 -24.78 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.03 0.443 . . . . 0.0 110.716 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.818 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.7 m-30 -100.97 -1.51 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.272 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.68 -51.84 27.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.539 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -54.69 -22.02 27.34 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.301 2.0 . . . . 0.0 112.358 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.596 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 90.4 m-70 -96.09 -17.42 20.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.124 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.8 mp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.884 0.374 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -81.48 152.3 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.017 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -66.75 136.31 55.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.523 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 m120 -152.54 156.21 38.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.449 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 m -129.79 121.83 53.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.853 0.359 . . . . 0.0 111.383 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.03 140.18 14.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.814 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -114.2 101.69 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.2 t -90.18 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.2 tp -103.09 147.13 27.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.56 157.14 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.821 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 43.7 p-10 -99.87 172.48 7.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.14 -17.8 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.313 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -0.11 57.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.815 0.341 . . . . 0.0 110.994 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttt 76.93 25.44 0.83 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.599 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.4 mmtp -93.53 175.58 6.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.589 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -113.89 126.4 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 32.8 t80 -58.56 109.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.75 129.89 56.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.349 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.43 138.91 52.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.578 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.5 p -82.04 157.58 24.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.767 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -73.08 158.45 35.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 111.433 -179.478 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.77 -5.54 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.067 178.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -130.87 -17.76 3.11 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.767 HD12 ' CD ' ' A' ' 33' ' ' ARG . 65.9 mt -118.77 112.19 36.99 Favored Pre-proline 0 N--CA 1.455 -0.178 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.951 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.2 131.72 29.39 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.995 1.797 . . . . 0.0 111.889 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 t70 76.62 4.09 3.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.713 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.2 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.412 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 36.9 m95 -102.95 155.46 18.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -169.04 171.63 8.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.753 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.414 ' SD ' HD21 ' A' ' 142' ' ' LEU . 1.9 mpp? -95.85 157.72 35.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.652 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.54 129.47 15.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.58 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.06 153.74 32.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.46 167.95 33.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -80.02 133.17 12.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.559 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.646 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.6 mt -60.12 160.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.487 ' N ' HG22 ' A' ' 47' ' ' ILE . 2.0 m-20 -90.24 149.31 22.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.96 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.22 0.533 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.18 10.25 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.954 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 16.0 tp10 -114.09 145.96 40.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.865 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.11 139.6 79.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.429 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.6 Cg_exo -54.01 -55.07 3.78 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.387 2.058 . . . . 0.0 112.599 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.29 -27.53 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.214 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -82.48 -49.42 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.798 0.332 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.542 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.82 -30.68 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.482 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.788 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.85 -53.45 10.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.16 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 54' ' ' ARG . 53.1 mt -55.78 -29.79 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.116 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -80.69 -53.51 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.786 0.803 . . . . 0.0 109.73 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.97 -33.29 62.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.568 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.769 HD12 ' OG1' ' A' ' 65' ' ' THR . 6.1 tp -56.56 -58.4 8.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.123 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.573 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 9.2 ptt180 -62.12 -11.06 12.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 0.0 110.545 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -91.71 -44.34 9.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.47 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.87 -29.6 17.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.3 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.769 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.93 -21.33 10.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.33 6.69 70.53 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.885 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.747 ' HB ' HD11 ' A' ' 61' ' ' LEU . 52.8 t -75.92 130.84 35.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.327 . . . . 0.0 110.548 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -109.79 -33.01 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 78.78 6.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.164 0.507 . . . . 0.0 110.831 -179.924 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.36 131.29 15.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.846 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.0 pt-20 -119.41 140.37 50.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.239 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.2 t -69.76 116.86 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.292 0.568 . . . . 0.0 111.387 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.797 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -90.91 -24.0 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.774 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.42 168.64 26.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.214 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -148.51 116.26 6.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.236 179.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.801 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.2 t -57.33 130.29 80.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 -15.42 35.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.763 2.309 . . . . 0.0 113.626 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.626 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -128.04 170.35 13.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.459 0.647 . . . . 0.0 112.359 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.75 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.8 m95 -96.22 145.99 25.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.978 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 79' ' ' TRP . 2.3 mt -110.24 117.91 34.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.171 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.846 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.0 p -107.7 136.23 47.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.49 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.867 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -127.88 170.11 13.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.466 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.33 158.29 38.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.89 152.09 47.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.798 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.344 0.3 0 C-N-CA 122.597 2.198 . . . . 0.0 112.288 -179.975 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.2 m95 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.794 0.33 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -29.35 60.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.24 -139.13 2.69 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.82 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -157.64 113.92 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.81 0.338 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.846 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.1 105.66 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' NE2' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 pt20 -120.24 150.57 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.5 mttp -102.77 95.71 6.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.388 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.544 ' CD2' HG21 ' A' ' 157' ' ' VAL . 43.7 m95 -64.33 143.5 57.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.236 -178.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.3 m-85 -128.0 137.69 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.15 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.849 HD13 ' CD2' ' A' ' 161' ' ' PHE . 22.1 tp -79.43 155.18 28.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 21' ' ' LEU . 33.1 m-85 -146.47 131.96 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 111.955 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.637 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -94.73 119.56 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 178.032 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.576 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -67.65 121.44 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.613 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.606 HG21 ' OE1' ' A' ' 71' ' ' GLU . 7.8 p -123.92 37.71 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.565 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.93 -145.31 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.129 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.5 154.24 47.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.49 ' HA ' HD12 ' A' ' 119' ' ' ILE . 6.5 m-20 -49.47 -16.96 0.24 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.603 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -76.33 -21.06 56.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.102 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.56 -25.19 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 116' ' ' ASP . 15.7 mt -69.23 104.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.513 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.671 HD21 HD12 ' A' ' 122' ' ' LEU . 29.4 t-20 -119.96 95.55 4.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.708 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.799 HD13 ' HB2' ' A' ' 131' ' ' PHE . 41.3 mt -58.82 -24.82 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 -179.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.671 HD12 HD21 ' A' ' 120' ' ' ASN . 6.4 mt -60.1 -55.04 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.39 178.63 17.22 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.397 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -89.64 38.64 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.212 0.529 . . . . 0.0 109.687 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.93 29.63 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.226 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -107.02 -64.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.84 165.16 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -60.22 151.36 67.8 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.554 ' HG3' HD23 ' A' ' 122' ' ' LEU . 77.6 Cg_exo -49.34 176.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.716 2.277 . . . . 0.0 112.602 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -150.13 -45.24 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.722 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.799 ' HB2' HD13 ' A' ' 121' ' ' LEU . 21.2 m-85 -112.72 159.39 18.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.96 -14.6 6.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.637 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.578 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 10.6 mp0 -152.15 174.22 14.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.019 0.438 . . . . 0.0 110.357 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.0 p-90 -159.65 152.06 21.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.333 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.62 153.93 35.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.306 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.466 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 87.8 m95 -89.95 126.13 35.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.72 HG11 HD11 ' A' ' 145' ' ' LEU . 30.9 m -137.46 150.63 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.666 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -68.23 159.33 80.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.574 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.686 ' CA ' HD13 ' A' ' 158' ' ' LEU . 13.4 Cg_endo -56.72 -18.98 28.79 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 121.816 1.677 . . . . 0.0 111.732 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.5 -34.15 15.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -50.84 25.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.907 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -54.14 -30.66 49.83 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.434 0.635 . . . . 0.0 109.864 179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.552 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.4 mm -68.52 -28.78 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 178.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.39 -20.98 42.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.21 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.2 mt -84.64 -39.24 18.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.072 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 150' ' ' LYS . 11.8 m -58.05 164.27 2.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.715 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 12.7 p -93.01 162.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.787 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.03 -27.6 65.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -179.433 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.715 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 7.9 p90 -93.28 7.6 43.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.605 ' HB2' HG12 ' A' ' 147' ' ' VAL . 3.1 mtmp? -140.25 11.04 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.509 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.7 mtpp -70.54 -62.45 2.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.6 Cg_endo -52.99 -46.74 31.77 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.153 . . . . 0.0 112.121 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.7 t -56.46 -26.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.499 . . . . 0.0 110.959 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.33 -51.43 5.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.656 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.84 -34.84 21.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -64.62 -45.96 84.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.576 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.3 t -57.04 -49.52 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.686 HD13 ' CA ' ' A' ' 139' ' ' PRO . 78.0 mt -62.92 -49.14 75.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.824 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.8 p -50.17 -46.67 54.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.74 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.801 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -69.3 -24.84 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.048 0.452 . . . . 0.0 110.475 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.849 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.3 m-30 -102.27 7.08 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.013 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.67 -53.07 54.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.801 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 8.1 Cg_endo -50.59 -24.83 13.41 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.562 2.175 . . . . 0.0 112.52 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.632 ' ND1' HG22 ' A' ' 73' ' ' ILE . 98.1 m-70 -92.88 -22.38 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.883 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.964 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.103 0.478 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -85.79 152.6 22.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.418 HH21 ' HB3' ' A' ' 104' ' ' ALA . 1.3 mmp_? -73.38 129.31 37.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.8 t-20 -153.26 156.85 39.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.675 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.79 HG13 HD11 ' A' ' 47' ' ' ILE . 4.5 m -127.38 138.04 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.006 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.83 155.13 16.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.877 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -128.52 101.77 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.701 0.286 . . . . 0.0 111.345 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' PHE . 18.8 t -89.7 103.38 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 110' ' ' PHE . 31.4 tp -103.02 145.09 30.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.76 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.8 ptt? -131.42 157.05 44.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.69 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 27' ' ' LYS . 10.4 p-10 -97.43 175.1 6.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -14.2 39.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.243 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.2 0.48 56.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.77 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp 75.63 26.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.513 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.756 ' C ' HD13 ' A' ' 28' ' ' ILE . 12.9 mttp -97.88 172.97 7.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.856 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.01 140.74 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 110.667 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HE2' HD13 ' A' ' 119' ' ' ILE . 11.0 t80 -75.6 109.31 9.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.541 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . . . -116.63 132.79 56.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.85 135.23 54.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.38 155.01 24.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -71.24 159.22 35.02 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 111.506 -179.386 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -93.44 -6.85 46.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.838 178.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.93 -18.92 4.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.09 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.61 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 52.6 mt -119.4 111.65 36.38 Favored Pre-proline 0 N--CA 1.455 -0.213 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.881 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.59 131.27 29.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.995 1.797 . . . . 0.0 111.977 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 77.35 2.37 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.824 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.61 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -85.59 97.22 9.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.654 ' CD1' HD22 ' A' ' 145' ' ' LEU . 51.7 m95 -101.7 154.84 18.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.323 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.31 173.27 6.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -99.26 161.15 25.65 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.03 133.9 24.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.498 2.132 . . . . 0.0 112.759 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 155.8 35.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.35 143.58 9.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.683 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.8 143.43 39.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.534 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.79 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -76.87 160.72 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 47' ' ' ILE . 5.0 m-20 -90.25 177.54 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.125 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.88 99.28 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.39 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.61 47.01 12.94 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.615 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' CG ' ' HB2' ' A' ' 56' ' ' ALA . 5.6 tp10 -110.36 148.55 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.185 0.517 . . . . 0.0 110.949 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.83 126.11 88.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.366 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.622 ' HA ' HG11 ' A' ' 17' ' ' VAL . 53.7 Cg_exo -53.3 -34.59 70.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.385 2.057 . . . . 0.0 112.569 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' O ' HD12 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -76.73 -25.0 53.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.936 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -87.57 -45.53 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.428 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.502 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -59.27 -31.07 68.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.369 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.59 -52.55 13.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.2 mt -56.34 -31.41 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.289 0.566 . . . . 0.0 109.905 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -78.58 -53.6 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.849 178.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -54.88 -36.08 64.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.602 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.774 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.3 tp -56.15 -54.15 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.586 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -62.22 -11.7 16.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.718 179.121 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -91.52 -41.48 10.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 111.477 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -90.25 -31.17 17.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.923 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.693 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -119.62 -23.8 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.339 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 69.74 10.13 63.6 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.647 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.774 ' HB ' HD11 ' A' ' 61' ' ' LEU . 25.5 t -69.3 119.08 14.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.222 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.62 -34.02 12.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.105 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.2 78.49 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.179 0.514 . . . . 0.0 110.962 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.35 131.45 15.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.851 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -119.95 141.9 49.23 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.146 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.8 t -70.87 117.01 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.237 0.541 . . . . 0.0 111.437 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.778 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.1 mt -91.03 -26.11 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.572 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -159.41 169.31 24.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.282 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.6 pt-20 -148.44 112.06 5.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 160' ' ' VAL . 2.5 t -57.65 123.82 64.78 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.965 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.5 -3.96 14.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.801 2.334 . . . . 0.0 114.045 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -131.23 139.45 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.204 0.526 . . . . 0.0 112.131 -179.855 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.458 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 15.2 m95 -75.31 145.06 42.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.693 ' HB3' HG13 ' A' ' 153' ' ' VAL . 89.6 mt -111.2 117.58 33.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.666 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.1 p -108.52 131.74 54.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.751 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.785 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -129.84 166.26 20.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.3 158.34 29.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.098 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.35 153.18 45.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.738 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 0.0 112.384 -179.931 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.2 m95 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -26.99 44.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.447 . . . . 0.0 110.435 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.66 -138.5 2.47 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -158.05 113.76 2.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.666 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -88.22 105.82 17.79 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.73 150.27 52.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 2.7 mttt -97.77 156.5 16.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.47 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.566 ' CD2' HG21 ' A' ' 157' ' ' VAL . 45.2 m95 -120.81 140.32 51.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.02 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.4 m-85 -123.46 131.18 53.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.056 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.875 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.26 135.84 36.88 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.146 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.877 ' CD1' HG23 ' A' ' 19' ' ' ILE . 39.4 m-85 -126.82 131.67 51.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 112.02 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.67 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 3.5 ttmt -93.76 120.18 33.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.374 178.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.669 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -68.97 122.43 18.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 69' ' ' SER . 7.4 p -123.96 37.8 4.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.46 -144.74 4.8 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.141 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.56 154.27 47.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -48.96 -17.45 0.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.523 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.23 -24.21 59.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.319 . . . . 0.0 111.027 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.19 -26.24 58.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.488 HD13 ' HE2' ' A' ' 29' ' ' PHE . 29.8 mt -69.14 101.52 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 123' ' ' GLY . 13.2 p-10 -125.28 96.07 4.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.839 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 60.7 mt -55.27 -19.24 7.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.067 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.52 -58.62 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.383 0.611 . . . . 0.0 110.124 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.402 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . 138.64 179.41 17.22 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.311 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -89.61 38.84 0.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.1 28.3 72.68 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.224 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.95 -64.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.7 165.07 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -71.08 152.3 94.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.042 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.16 169.17 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.678 2.252 . . . . 0.0 112.519 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' C ' HD12 ' A' ' 34' ' ' LEU . 20.7 mm-40 -150.07 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.781 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 12.6 m-85 -106.15 159.32 16.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.46 -18.67 5.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.78 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.439 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 9.3 mm-40 -152.17 175.31 12.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 110.398 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.08 154.53 25.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.33 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -151.56 162.5 40.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.301 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 86.8 m95 -98.97 129.37 45.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 145' ' ' LEU . 28.4 m -139.41 156.19 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.964 -179.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -73.63 152.98 89.57 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.833 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.2 Cg_endo -49.19 -20.83 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.114 1.876 . . . . 0.0 112.132 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -90.42 -33.82 15.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.437 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -70.09 -50.8 37.28 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 110.22 179.496 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.932 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -51.94 -36.05 47.97 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.515 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.591 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.2 mm -63.08 -29.05 46.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.934 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.53 -22.01 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.116 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.6 mt -84.13 -39.13 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 150' ' ' LYS . 9.2 m -59.33 165.64 2.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 8.3 p -97.35 159.72 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.05 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.528 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 19.1 mt-10 -52.14 -38.44 57.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.6 p90 -84.34 5.28 27.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 146' ' ' THR . 20.9 mtpp -140.09 9.26 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.528 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.6 mtpp -69.07 -62.77 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.8 Cg_endo -54.33 -39.66 86.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 111.87 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.785 HG11 ' CD1' ' A' ' 82' ' ' TYR . 14.1 t -58.13 -27.02 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 110.799 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.33 -50.66 5.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.375 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.591 ' HD2' HD12 ' A' ' 143' ' ' ILE . 3.6 tttt -51.01 -34.63 30.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.625 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.4 tp10 -63.91 -46.09 86.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.51 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -60.09 -47.28 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.249 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.583 HD13 ' CA ' ' A' ' 139' ' ' PRO . 69.2 mt -63.36 -48.5 77.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.695 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.5 m -48.77 -47.88 41.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.731 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.811 HG21 HG22 ' A' ' 76' ' ' VAL . 74.6 t -67.52 -24.9 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.875 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.2 m-30 -102.25 7.32 40.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.027 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -50.75 -53.05 50.98 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.602 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.8 Cg_endo -50.66 -24.75 13.51 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.545 2.163 . . . . 0.0 112.316 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.677 ' CE1' HG22 ' A' ' 73' ' ' ILE . 98.7 m-70 -89.77 -24.5 21.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.644 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.76 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.878 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.991 0.424 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 6.7 mtp-105 -76.07 152.39 36.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -75.22 133.38 41.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.46 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.1 m120 -152.22 161.9 41.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.801 HG13 HD11 ' A' ' 47' ' ' ILE . 1.9 m -132.24 125.63 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.235 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 138.79 14.13 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.219 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.821 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -111.69 102.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' PHE . 7.6 t -89.68 102.12 14.81 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.09 146.39 28.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 0.0 110.933 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.24 157.2 41.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 12.4 t30 -93.65 173.42 7.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.044 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.97 -16.58 61.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.845 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.41 -0.71 57.69 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 81.77 24.6 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.632 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -93.83 170.48 9.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.3 mp -109.81 121.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.73 ' CD2' HD23 ' A' ' 21' ' ' LEU . 1.7 t80 -54.04 107.56 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.259 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.85 137.72 52.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.746 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.96 141.95 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.17 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.33 158.32 23.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.584 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.8 mtp-105 -72.71 164.04 27.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 111.723 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.5 mt -97.93 -7.0 31.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.44 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.54 -18.21 3.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.587 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 62.9 mt -121.12 112.42 33.26 Favored Pre-proline 0 N--CA 1.457 -0.094 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.189 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.79 132.62 31.09 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.816 1.677 . . . . 0.0 111.475 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 77.86 3.8 2.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.683 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.587 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.85 97.55 11.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.522 ' CD1' HD22 ' A' ' 145' ' ' LEU . 27.6 m95 -102.28 156.58 17.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.065 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.75 -176.68 2.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.703 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 76.3 mtm -107.31 156.59 37.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.12 132.35 27.68 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.56 2.173 . . . . 0.0 112.579 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 157.39 42.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.695 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.51 171.37 34.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.02 135.92 13.58 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.574 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.801 HD11 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -68.6 161.03 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.619 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -83.76 -174.85 5.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.767 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.91 99.57 6.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.281 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.43 50.73 19.72 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.597 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.47 155.23 25.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.096 -179.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -77.87 130.34 73.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.588 ' HA ' HG11 ' A' ' 17' ' ' VAL . 52.0 Cg_exo -54.6 -21.66 25.48 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.389 2.059 . . . . 0.0 112.932 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.1 tpt180 -84.39 -25.44 29.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -88.05 -43.29 11.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.578 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -63.36 -29.87 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.519 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.584 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -74.79 -51.83 13.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 54' ' ' ARG . 61.3 mt -57.32 -29.07 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.237 179.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 3.2 ttp-105 -81.85 -53.3 6.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.831 0.824 . . . . 0.0 109.698 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -54.48 -31.83 56.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.84 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.1 tp -58.43 -63.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.565 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 11.7 ptp180 -60.45 -12.14 8.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -92.08 -40.91 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.53 -32.08 16.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.658 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.86 -24.84 7.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.936 0.398 . . . . 0.0 110.899 -179.55 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 82.3 -0.65 88.72 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.063 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.5 t -66.82 121.73 16.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.986 0.393 . . . . 0.0 110.331 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 -33.8 10.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.03 77.48 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.41 129.16 13.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.919 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 7.0 mt-10 -120.39 146.44 46.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.627 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 55.8 t -76.46 125.69 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.49 0.662 . . . . 0.0 111.928 -179.06 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.885 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.44 -17.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.248 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.737 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -153.72 159.68 42.06 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.18 111.63 4.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.753 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.5 t -57.58 125.32 71.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.05 -8.15 20.75 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.85 2.366 . . . . 0.0 113.785 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.555 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.54 146.67 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 112.05 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.444 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 16.4 m95 -79.69 145.21 33.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.012 0.434 . . . . 0.0 109.976 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.815 ' HB3' HG13 ' A' ' 153' ' ' VAL . 82.5 mt -111.11 117.55 33.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.733 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.724 HG22 ' CB ' ' A' ' 104' ' ' ALA . 19.3 p -111.74 130.03 55.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.812 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.825 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.56 163.58 26.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 0.0 110.707 179.539 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.68 158.27 35.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.189 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -101.98 155.93 35.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.496 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.309 2.006 . . . . 0.0 112.196 -179.924 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.458 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 56.7 m95 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.821 0.344 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -28.72 62.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.22 -139.18 2.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.092 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -157.63 117.12 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.326 . . . . 0.0 111.343 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.724 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -86.65 110.58 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -130.85 150.19 52.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.717 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.1 mtmt -107.51 102.54 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.443 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CD2' HG21 ' A' ' 157' ' ' VAL . 29.9 m95 -67.9 143.28 55.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.442 ' CD2' ' HD2' ' A' ' 54' ' ' ARG . 61.1 m-85 -125.48 137.77 53.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.035 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.808 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.5 tp -79.36 154.49 28.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.83 ' O ' HD12 ' A' ' 21' ' ' LEU . 44.4 m-85 -148.0 127.54 13.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.564 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.885 ' HB3' HD11 ' A' ' 73' ' ' ILE . 4.7 tptp -92.48 121.65 34.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -65.32 123.46 19.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.955 0.407 . . . . 0.0 110.637 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 111' ' ' LYS . 4.8 p -124.68 37.67 4.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.758 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.4 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.46 -144.88 4.72 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.034 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.29 154.27 47.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.09 -17.35 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.522 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -74.69 -22.18 58.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -26.24 56.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.497 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 25.2 mt -69.97 94.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.325 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -117.92 95.98 5.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.931 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 131' ' ' PHE . 46.0 mt -52.53 -20.04 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.175 -179.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.424 HD22 ' HG3' ' A' ' 129' ' ' PRO . 98.0 mt -57.9 -59.09 5.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.378 0.609 . . . . 0.0 109.966 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -178.56 18.53 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.453 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -89.52 38.77 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.58 26.27 71.87 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -103.23 -64.63 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.128 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.29 165.19 12.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -69.29 151.19 97.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.5 ' HB2' HD11 ' A' ' 34' ' ' LEU . 75.5 Cg_exo -48.86 135.85 28.56 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.624 2.216 . . . . 0.0 112.572 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -113.24 -25.87 8.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.6 m-85 -123.17 159.25 29.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.711 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.56 -17.62 5.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.72 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.511 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.36 173.35 15.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 0.0 110.568 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.2 p-90 -160.41 160.56 32.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.426 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -159.3 154.68 25.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.345 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.475 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 87.3 m95 -88.62 127.18 35.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.729 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.691 HG11 HD11 ' A' ' 145' ' ' LEU . 26.9 m -138.52 150.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 111.857 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.3 p -68.5 160.86 74.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.647 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.608 ' CB ' HD13 ' A' ' 158' ' ' LEU . 19.7 Cg_endo -58.66 -17.12 33.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 121.773 1.649 . . . . 0.0 111.801 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.06 -34.18 14.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -51.08 23.86 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.039 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.88 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.2 tp -54.01 -31.73 51.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 109.823 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.64 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -67.17 -28.75 43.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.654 178.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -80.68 -20.7 42.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.18 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.88 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.1 mt -85.77 -39.0 17.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 150' ' ' LYS . 24.2 m -56.48 163.95 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.237 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.672 HG21 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -93.01 160.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.499 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 1.1 mt-10 -49.66 -41.83 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.275 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 147' ' ' VAL . 45.1 p90 -85.36 8.71 17.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.484 ' HB2' HG12 ' A' ' 147' ' ' VAL . 19.0 mttt -129.06 -8.66 4.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.602 0.239 . . . . 0.0 111.31 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.499 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.8 mtpm? -57.7 -59.88 11.64 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.311 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.9 Cg_endo -61.09 -42.46 36.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.369 2.046 . . . . 0.0 112.174 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.825 HG11 ' CD1' ' A' ' 82' ' ' TYR . 16.4 t -60.07 -27.28 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.79 -51.4 5.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.64 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -50.65 -32.27 18.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.418 179.663 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.738 ' HB3' HD11 ' A' ' 80' ' ' LEU . 6.0 tp10 -66.67 -45.73 77.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.529 179.175 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.6 t -58.84 -47.44 89.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.963 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 139' ' ' PRO . 76.4 mt -63.73 -48.6 76.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -50.09 -47.36 53.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.861 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 76' ' ' VAL . 76.0 t -69.54 -25.71 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 110.404 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.808 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.5 m-30 -102.24 9.64 39.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.975 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.32 -57.92 16.22 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.318 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -58.26 -21.88 54.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.475 2.117 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.737 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 93.3 m-70 -89.96 -11.15 42.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.209 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.922 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -82.2 152.24 26.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -70.2 131.43 44.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.985 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.554 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.1 t30 -152.78 155.0 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.797 HG13 HD11 ' A' ' 47' ' ' ILE . 19.2 m -133.11 137.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.103 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.92 131.92 9.37 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.128 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.893 HG21 HD22 ' A' ' 61' ' ' LEU . 4.5 mp -97.43 113.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.811 0.338 . . . . 0.0 111.863 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 110' ' ' PHE . 8.6 t -96.16 103.17 15.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.5 tp -103.37 149.37 24.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 111.132 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.439 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -133.07 157.27 45.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.672 179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.9 p-10 -98.19 172.31 7.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.614 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -57.82 -17.72 17.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.522 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.81 0.34 56.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 mttm 77.06 25.46 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.515 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.786 ' C ' HD13 ' A' ' 28' ' ' ILE . 7.4 mttp -93.77 174.41 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.867 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.75 138.51 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -179.807 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.813 ' CE2' HG21 ' A' ' 65' ' ' THR . 5.2 t80 -76.68 103.7 6.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.494 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.34 139.86 49.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -124.01 137.86 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.52 154.43 25.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.646 179.878 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.507 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -71.23 157.66 37.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 111.628 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.45 -5.35 49.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.768 178.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.6 -19.42 4.57 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.985 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.622 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 56.9 mt -120.62 112.18 34.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.913 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.04 131.42 28.67 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.856 1.704 . . . . 0.0 111.878 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t70 77.15 3.7 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.773 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.622 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.4 10.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.349 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.698 ' CD1' HD22 ' A' ' 145' ' ' LEU . 41.9 m95 -102.41 157.32 17.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.927 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 -176.87 2.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.96 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.569 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 51.7 mtm -106.09 159.51 29.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.67 128.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.504 2.136 . . . . 0.0 112.787 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -150.48 167.42 27.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.37 59.39 0.11 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.864 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . 43.17 -165.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.091 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.797 HD11 HG13 ' A' ' 17' ' ' VAL . 4.5 mt -132.12 159.68 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 110.578 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 47' ' ' ILE . 22.5 m-20 -90.38 149.81 22.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.09 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.99 39.6 11.46 Favored Glycine 0 C--N 1.32 -0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.945 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 9.2 tp10 -109.56 146.25 34.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.165 0.507 . . . . 0.0 110.965 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 128.38 81.91 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.318 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.645 ' HA ' HG11 ' A' ' 17' ' ' VAL . 76.0 Cg_exo -50.58 -25.82 15.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.358 2.039 . . . . 0.0 112.688 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -83.85 -24.0 31.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.91 -43.36 10.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -61.08 -32.1 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.175 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -71.71 -53.38 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.084 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.8 mt -56.64 -28.58 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.442 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -84.21 -53.3 5.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 109.959 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -50.71 -42.91 57.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.326 -1.307 . . . . 0.0 111.223 -179.667 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 19' ' ' ILE . 2.8 tp -57.81 -51.9 67.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.598 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 12.8 ttm-85 -62.87 -13.45 34.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.448 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -38.73 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -87.59 -35.5 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.813 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.1 -22.78 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 111.164 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.48 6.48 76.31 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.86 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.857 ' HB ' HD11 ' A' ' 61' ' ' LEU . 19.2 t -56.71 108.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 110.178 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -34.04 16.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.27 76.13 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.172 0.511 . . . . 0.0 111.054 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.84 13.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.687 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.611 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.1 pt-20 -119.92 141.1 49.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.19 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.7 t -70.61 116.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 111.334 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.732 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -90.72 -25.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.847 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -156.85 169.6 24.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.268 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 11.2 pt-20 -148.59 117.22 6.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.012 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.857 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.5 t -57.05 123.73 61.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.38 -13.45 39.34 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.885 2.39 . . . . 0.0 113.607 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.1 -179.04 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.349 0.595 . . . . 0.0 112.291 -179.417 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.724 ' C ' HD23 ' A' ' 80' ' ' LEU . 21.3 m95 -107.89 147.5 30.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.052 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 79' ' ' TRP . 3.1 mt -112.51 117.81 33.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.044 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.84 HG22 ' CB ' ' A' ' 104' ' ' ALA . 6.4 p -112.34 132.4 55.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.435 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.826 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -127.05 170.15 12.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 158.27 29.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 11.5 m-85 -118.42 142.53 31.53 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 122.394 2.063 . . . . 0.0 112.234 179.87 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 36.3 m95 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.752 0.31 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -30.36 64.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -162.51 -142.85 3.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.975 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -157.01 112.86 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.805 0.336 . . . . 0.0 111.366 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.84 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.66 105.74 17.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.454 ' NE2' ' CE2' ' A' ' 107' ' ' TRP . 5.5 pt20 -120.05 161.97 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -116.14 105.15 12.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.217 178.638 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.47 ' CD2' HG21 ' A' ' 157' ' ' VAL . 60.2 m95 -78.35 144.43 36.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.0 m-85 -127.83 136.64 51.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.6 tp -79.67 155.04 28.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HD12 ' A' ' 21' ' ' LEU . 29.4 m-85 -145.92 132.44 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.198 0.523 . . . . 0.0 111.967 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.667 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -95.64 118.74 32.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.522 177.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.646 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.9 t80 -68.73 119.74 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.611 HG21 ' OE1' ' A' ' 71' ' ' GLU . 6.3 p -120.84 37.32 4.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.497 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.72 -144.79 4.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.212 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.01 154.26 46.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -49.01 -17.47 0.2 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -74.0 -21.48 59.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.77 -24.77 56.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.414 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 34.1 mt -70.14 105.66 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.443 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -122.93 95.56 4.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.021 179.219 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 131' ' ' PHE . 37.6 mt -55.73 -21.65 19.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.698 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.631 HD22 ' HG3' ' A' ' 129' ' ' PRO . 17.6 mt -64.47 -58.44 6.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.278 0.561 . . . . 0.0 109.898 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.49 -170.41 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.393 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -93.7 38.8 1.06 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.87 75.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.135 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -116.38 -69.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.846 0.355 . . . . 0.0 111.212 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -89.88 165.12 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.69 148.18 54.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.631 ' HG3' HD22 ' A' ' 122' ' ' LEU . 74.2 Cg_exo -50.27 126.62 17.88 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.65 2.233 . . . . 0.0 112.463 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.0 -28.25 9.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.745 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.561 ' HB2' HD13 ' A' ' 121' ' ' LEU . 11.2 m-85 -113.08 159.25 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.476 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.15 -20.79 5.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.711 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.469 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.0 mm-40 -152.27 174.63 13.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.076 0.465 . . . . 0.0 110.47 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 p-90 -159.2 157.55 30.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.165 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -157.59 160.73 38.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.493 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.1 m95 -92.87 127.37 38.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.47 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.738 HG11 HD11 ' A' ' 145' ' ' LEU . 35.7 m -136.15 152.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -72.62 152.51 91.59 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.2 Cg_endo -49.06 -23.26 6.04 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.105 1.87 . . . . 0.0 111.926 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.96 -33.71 19.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -71.5 -50.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.041 179.298 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.933 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.8 tp -54.18 -29.3 45.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.488 0.661 . . . . 0.0 109.817 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.592 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -70.52 -28.39 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.75 178.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.2 -21.84 42.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.14 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.4 mt -82.48 -39.67 22.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.124 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 147' ' ' VAL . 24.9 m -58.78 163.6 3.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.023 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.824 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 12.6 p -92.58 161.42 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.52 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.32 -26.64 68.54 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.112 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.824 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 24.6 p90 -91.11 10.88 25.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 5.7 mtmm -152.75 15.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.658 0.266 . . . . 0.0 111.698 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.52 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.1 mtpp -67.04 -62.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.228 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.1 Cg_endo -50.77 -40.43 56.71 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.536 2.158 . . . . 0.0 112.097 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.826 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.4 t -57.15 -27.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.26 0.552 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.569 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -91.22 -48.47 6.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.372 179.019 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HD2' HD12 ' A' ' 143' ' ' ILE . 3.5 tttt -52.68 -32.28 41.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.581 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 160' ' ' VAL . 2.4 tp10 -66.89 -45.72 77.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.385 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.6 t -59.04 -46.78 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.983 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.546 HD13 ' CA ' ' A' ' 139' ' ' PRO . 74.1 mt -66.55 -48.69 68.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.647 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.9 t -50.24 -47.17 55.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.674 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.857 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.5 t -68.49 -24.56 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.073 0.463 . . . . 0.0 110.349 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.862 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.3 m-30 -103.26 5.69 37.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.212 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.19 -55.36 31.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.609 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.72 -22.51 17.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.577 2.184 . . . . 0.0 112.351 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.847 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 16.3 m-70 -89.97 -22.2 22.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.717 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.694 HD12 ' OXT' ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.914 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.859 0.361 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 5.6 ttm180 -83.36 152.24 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.131 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -65.21 131.66 47.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.5 m120 -152.52 159.27 43.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.894 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.5 m -132.29 127.68 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.254 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.12 144.38 17.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.162 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.886 HG21 HD22 ' A' ' 61' ' ' LEU . 4.8 mp -120.95 102.11 11.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.8 t -89.71 107.65 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 110' ' ' PHE . 37.6 tp -103.08 144.8 30.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.014 0.435 . . . . 0.0 111.196 -179.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.07 157.48 41.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.747 -179.973 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.9 p-10 -103.89 170.38 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.34 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -55.08 -18.13 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.94 4.48 47.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 179.705 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 4.8 mtpp 70.55 27.86 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mttt -96.73 172.38 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 119' ' ' ILE . 65.9 t80 -57.19 109.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.183 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.62 132.44 56.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.254 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -115.57 138.03 51.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.468 . . . . 0.0 111.509 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.575 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.69 158.5 22.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.543 ' CD ' HD12 ' A' ' 36' ' ' ILE . 2.2 mtp-105 -71.26 164.21 26.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.41 0.624 . . . . 0.0 111.468 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -96.25 -6.06 38.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.69 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -136.17 -14.09 1.8 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 64.5 mt -120.67 111.77 34.36 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.358 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 32.8 Cg_endo -66.38 132.97 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.739 1.626 . . . . 0.0 111.306 179.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 79.12 3.18 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.465 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -94.95 97.74 10.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.152 179.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.427 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 23.7 m95 -108.78 160.21 16.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.085 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -168.86 170.81 8.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.859 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.453 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 71.0 mtm -97.91 156.71 35.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.67 137.81 39.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 0.0 112.917 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.27 157.02 38.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.378 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.93 153.02 23.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.754 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 132.17 17.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.626 HD11 HG13 ' A' ' 17' ' ' VAL . 6.4 mt -59.88 160.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.761 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 179.796 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.13 98.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.18 0.514 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.73 39.3 10.66 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.941 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HB3' HG23 ' A' ' 47' ' ' ILE . 15.5 tp10 -114.22 146.48 40.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 110.93 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.9 139.82 80.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.494 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.64 ' O ' HG11 ' A' ' 17' ' ' VAL . 52.2 Cg_exo -54.51 -52.55 7.91 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.46 2.107 . . . . 0.0 112.608 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' HD12 ' A' ' 58' ' ' ILE . 7.0 ttt180 -62.9 -25.48 68.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.328 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -84.66 -48.88 9.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.699 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -59.04 -28.31 66.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.772 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -75.54 -50.2 16.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.158 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.418 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.1 mt -57.25 -29.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -82.69 -53.12 6.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.747 0.784 . . . . 0.0 109.956 179.036 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -52.65 -42.33 64.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.471 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -57.11 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.686 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 32.0 ttp180 -61.98 -13.54 26.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.331 178.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.02 -42.73 9.82 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -91.26 -25.66 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.811 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.8 -20.5 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.11 6.67 65.12 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.049 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.657 HG13 ' HE1' ' A' ' 112' ' ' PHE . 46.9 t -71.1 117.19 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.506 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -96.14 -35.73 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.3 78.56 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 111.141 -179.698 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.53 129.43 13.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.931 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.61 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.76 148.96 42.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.06 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.8 t -79.56 123.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.422 0.629 . . . . 0.0 111.495 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.872 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -106.12 -20.17 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.398 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -154.55 159.35 40.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.435 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.2 pt-20 -148.66 117.11 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.989 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.842 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.0 t -57.26 126.76 75.13 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.065 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.94 -19.78 69.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.754 2.302 . . . . 0.0 113.228 -179.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.598 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.45 -177.98 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.049 -179.518 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.699 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.0 m95 -108.48 146.73 32.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.798 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.699 HD23 ' C ' ' A' ' 79' ' ' TRP . 3.4 mt -111.71 117.61 33.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.014 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.832 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.0 p -111.57 131.89 54.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.946 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.835 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -133.75 163.88 28.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.68 179.824 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -122.23 158.25 29.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.65 150.41 42.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo . . . . . 0 C--N 1.345 0.353 0 C-N-CA 122.553 2.169 . . . . 0.0 112.443 179.98 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 69.2 m95 . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.791 0.329 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -31.15 67.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -160.32 -143.03 3.54 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.005 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -157.61 114.47 2.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.878 0.37 . . . . 0.0 111.498 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.832 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -94.51 105.78 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -127.81 156.6 42.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.08 97.91 7.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 178.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 28.0 m95 -65.72 141.95 58.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 0.0 112.134 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 62.0 m-85 -125.6 137.24 53.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.316 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.3 tp -79.54 146.14 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.88 ' CD1' HG23 ' A' ' 19' ' ' ILE . 40.0 m-85 -139.11 127.88 23.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.008 0.432 . . . . 0.0 111.651 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.872 ' HB3' HD11 ' A' ' 73' ' ' ILE . 15.3 tttm -92.02 120.44 32.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.522 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.657 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.5 t80 -64.89 125.53 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.798 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.1 p -126.54 37.73 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -139.89 -144.86 4.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.236 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -127.15 154.27 44.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.917 0.389 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -49.75 -16.67 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.642 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.97 -18.16 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.266 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.06 -25.36 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 29' ' ' PHE . 17.7 mt -74.2 103.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.49 -179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -117.61 95.89 5.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 131' ' ' PHE . 47.2 mt -55.2 -23.32 21.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.64 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.417 HD22 ' HG3' ' A' ' 129' ' ' PRO . 29.0 mt -62.37 -57.4 11.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.285 0.564 . . . . 0.0 110.065 179.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.03 25.0 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.51 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.27 38.84 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 109.89 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.05 27.79 73.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.222 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.5 t -110.49 -65.97 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.837 0.351 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.57 165.06 11.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 149.9 97.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HG3' HD22 ' A' ' 122' ' ' LEU . 69.3 Cg_exo -50.0 177.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.732 2.288 . . . . 0.0 112.612 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -150.07 -45.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.552 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.819 ' HB2' HD13 ' A' ' 121' ' ' LEU . 18.9 m-85 -107.41 159.74 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.331 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.12 -16.9 6.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.803 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.575 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.47 174.7 13.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.12 0.486 . . . . 0.0 110.705 -179.816 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.5 p-90 -159.51 153.67 23.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.08 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.06 161.62 42.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.41 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -94.95 123.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.766 HG11 HD11 ' A' ' 145' ' ' LEU . 27.3 m -135.39 151.05 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.071 0.463 . . . . 0.0 111.641 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.85 159.23 86.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.687 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.7 Cg_endo -55.51 -19.38 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.935 1.756 . . . . 0.0 111.873 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.26 -34.25 15.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.48 -50.48 25.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.989 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.924 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.3 tp -54.01 -29.95 45.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.489 0.661 . . . . 0.0 109.915 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.601 HD12 ' HD2' ' A' ' 155' ' ' LYS . 2.9 mm -68.15 -29.15 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.582 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.6 -22.15 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.6 mt -84.41 -39.24 19.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.005 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 150' ' ' LYS . 4.8 m -58.63 168.56 1.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.3 p -104.64 159.92 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.047 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 147' ' ' VAL . 2.7 mm-40 -45.44 -46.17 13.35 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 147' ' ' VAL . 1.5 p90 -76.8 -1.89 30.47 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.507 ' O ' HG21 ' A' ' 146' ' ' THR . 1.8 mtmp? -125.73 1.57 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.579 0.228 . . . . 0.0 111.528 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.3 mttt -65.36 -62.55 4.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.342 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.03 -42.44 44.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.419 2.08 . . . . 0.0 112.239 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.835 HG11 ' CD1' ' A' ' 82' ' ' TYR . 13.4 t -59.16 -29.07 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.273 0.558 . . . . 0.0 110.966 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.78 -50.97 5.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.692 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -49.78 -35.01 21.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.669 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -66.58 -44.81 81.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.642 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 153' ' ' VAL . 44.2 t -57.76 -46.51 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.084 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.687 HD13 ' CA ' ' A' ' 139' ' ' PRO . 74.3 mt -66.27 -48.87 69.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.9 m -50.02 -47.17 53.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.1 t -68.39 -25.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.067 0.46 . . . . 0.0 110.307 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.8 12.0 33.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.981 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' A' ' 163' ' ' PRO . . . -53.98 -59.47 9.78 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.404 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -56.31 -21.53 37.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.586 2.191 . . . . 0.0 112.268 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.419 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 62.6 m-70 -89.95 -12.67 38.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.971 179.769 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.809 0.338 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HD3' ' CE2' ' A' ' 100' ' ' TRP . 2.1 ttp85 -92.48 152.38 19.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -62.12 132.55 53.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.425 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 19.1 t-20 -152.73 154.53 35.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.358 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.818 HG13 HD11 ' A' ' 47' ' ' ILE . 2.3 m -126.3 131.49 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 111.388 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.81 148.3 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.033 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.927 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -123.06 102.43 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.761 0.315 . . . . 0.0 111.397 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.2 t -89.48 104.69 17.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.859 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -102.59 145.3 29.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.0 0.429 . . . . 0.0 111.105 -178.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.2 ptm -127.65 157.26 40.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.2 p-10 -106.31 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -54.05 -18.33 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -88.86 3.94 49.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 179.803 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 20.7 mmtm 70.47 27.38 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.577 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' MET . 11.4 mmtm -96.38 175.32 6.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.594 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -113.65 119.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.956 0.408 . . . . 0.0 110.809 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 119' ' ' ILE . 18.8 t80 -52.46 110.29 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.74 133.6 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.412 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.89 139.1 52.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.9 p -82.3 155.78 24.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.685 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.737 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtt85 -72.01 158.09 36.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.5 mt -91.77 -5.66 53.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.019 178.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.79 -18.18 3.48 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.737 HD12 ' CD ' ' A' ' 33' ' ' ARG . 61.7 mt -118.78 111.84 37.24 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.7 131.24 28.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.981 1.787 . . . . 0.0 111.968 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 77.08 3.26 3.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.856 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.23 97.56 10.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.406 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.671 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.6 m95 -101.59 155.87 17.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.221 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.85 -176.92 2.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.651 179.724 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.467 ' SD ' HD21 ' A' ' 142' ' ' LEU . 3.4 mpp? -107.17 158.18 33.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 128.88 19.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.603 2.202 . . . . 0.0 112.417 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.03 157.09 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.76 139.24 5.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.571 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.31 137.48 49.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.818 HD11 HG13 ' A' ' 17' ' ' VAL . 9.2 mt -69.22 162.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.632 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -75.93 -172.16 1.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.613 179.614 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -90.14 27.45 1.63 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.24 0.543 . . . . 0.0 111.145 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.91 48.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 56' ' ' ALA . 5.4 tp10 -124.33 149.61 46.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 110.929 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -77.76 137.73 62.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.1 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.698 ' O ' HG11 ' A' ' 17' ' ' VAL . 77.5 Cg_exo -50.68 -55.18 4.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.363 2.042 . . . . 0.0 112.763 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.56 ' HD3' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.42 -31.55 67.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.316 -179.731 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -80.07 -49.73 11.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.733 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.577 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -56.69 -30.6 63.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.497 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.746 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.46 -52.59 13.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.56 HD11 ' HD3' ' A' ' 54' ' ' ARG . 41.2 mt -56.41 -29.85 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.23 179.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -81.67 -53.15 6.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.762 0.791 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -52.08 -45.71 64.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.597 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.915 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -56.0 -56.16 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.811 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 40.1 ttp180 -60.56 -14.48 20.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.298 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -92.07 -41.35 10.56 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.897 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -91.5 -25.04 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.837 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.31 -20.06 9.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.086 -179.31 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.24 6.24 64.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.051 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.629 HG13 ' HE1' ' A' ' 112' ' ' PHE . 48.4 t -71.18 123.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.865 0.333 . . . . 0.0 110.469 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -34.12 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.24 76.77 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.987 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.26 129.01 13.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.873 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 12.0 mt-10 -120.39 148.5 43.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.765 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 110' ' ' PHE . 38.9 t -78.15 125.39 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.456 0.646 . . . . 0.0 111.694 -179.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.28 -21.62 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.237 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.672 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 3.4 pt-20 -148.52 115.85 6.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.011 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.828 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.8 t -57.31 130.17 80.36 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.066 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 -15.96 40.07 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.721 2.281 . . . . 0.0 113.6 -178.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.553 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.65 -176.05 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.417 0.627 . . . . 0.0 112.48 -179.369 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.69 ' C ' HD23 ' A' ' 80' ' ' LEU . 25.6 m95 -106.27 147.48 29.09 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.279 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.69 HD23 ' C ' ' A' ' 79' ' ' TRP . 5.5 mt -114.47 117.94 32.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.996 179.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.86 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -111.04 135.07 52.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.435 -179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.899 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -122.71 170.26 10.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.683 -179.355 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.21 158.23 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -117.63 152.51 49.79 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.309 179.96 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.429 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 56.9 m95 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.519 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -85.72 -23.02 27.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -174.7 -137.58 2.51 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.048 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 90.0 mm-40 -157.3 113.85 2.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.886 0.374 . . . . 0.0 111.346 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.86 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -88.0 105.63 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.3 pt20 -121.64 157.06 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -112.15 95.72 5.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.198 178.569 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.644 ' CD2' HG21 ' A' ' 157' ' ' VAL . 24.2 m95 -64.12 150.5 45.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.308 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CE2' ' CG ' ' A' ' 54' ' ' ARG . 64.9 m-85 -133.15 133.29 42.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.284 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.834 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.6 tp -79.81 130.23 35.14 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.927 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.9 m-85 -124.49 129.13 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.505 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.844 ' HB3' HD11 ' A' ' 73' ' ' ILE . 5.1 tptt -92.38 123.06 35.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -67.2 124.48 23.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.694 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' SER . 17.6 p -126.73 37.87 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.747 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.2 -145.13 4.79 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.031 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -128.54 154.13 46.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.55 ' HA ' HD12 ' A' ' 119' ' ' ILE . 10.6 m-20 -50.25 -16.25 0.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.67 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.71 -18.36 54.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.744 0.307 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.12 -25.0 40.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 116' ' ' ASP . 8.6 mt -72.09 103.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.501 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.5 95.61 5.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 131' ' ' PHE . 43.8 mt -56.69 -23.15 39.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.54 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 mt -61.85 -56.77 15.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.25 0.548 . . . . 0.0 109.997 179.233 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.38 -178.47 22.3 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.552 179.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -90.72 38.74 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.1 0.476 . . . . 0.0 109.843 179.208 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.23 73.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -112.76 -67.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 111.19 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -105.54 165.04 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.235 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.54 150.75 95.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' LEU . 59.9 Cg_exo -50.43 138.77 38.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.654 2.236 . . . . 0.0 112.506 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -112.4 -31.48 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.724 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.539 ' HB2' HD13 ' A' ' 121' ' ' LEU . 7.2 m-85 -118.02 159.56 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.03 -20.07 5.37 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.879 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.435 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.5 mm-40 -152.23 174.66 13.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.248 0.547 . . . . 0.0 110.599 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 p-90 -159.2 154.11 24.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.178 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -93.05 125.31 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 142' ' ' LEU . 28.9 m -137.63 150.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.116 0.484 . . . . 0.0 111.619 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -69.54 159.83 82.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.472 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.641 ' CB ' HD13 ' A' ' 158' ' ' LEU . 14.0 Cg_endo -56.69 -18.89 28.21 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.796 1.664 . . . . 0.0 111.838 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.12 -34.2 15.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.054 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -50.9 22.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.112 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.1 tp -54.22 -30.28 49.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.393 0.616 . . . . 0.0 109.826 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 143' ' ' ILE . 5.1 mm -68.97 -28.31 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.717 178.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 -17.53 47.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.367 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.0 mt -87.53 -38.8 15.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.186 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 147' ' ' VAL . 67.6 m -59.51 162.26 5.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.046 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.962 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 10.1 p -91.62 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.8 mt-10 -51.66 -33.18 32.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.962 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.3 p90 -87.53 10.9 16.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 8.6 mtmm -136.74 -2.24 2.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 30.1 mttt -55.76 -61.81 5.67 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.201 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.3 Cg_endo -59.6 -45.84 23.66 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.377 2.051 . . . . 0.0 112.122 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.899 HG21 ' HB3' ' A' ' 82' ' ' TYR . 39.5 t -56.06 -27.79 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.227 0.537 . . . . 0.0 111.066 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.8 m-30 -91.55 -53.71 4.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.4 ' CD ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.76 -32.63 14.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 110.522 179.87 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.2 -45.56 80.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.498 179.148 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -57.9 -50.38 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.123 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.641 HD13 ' CB ' ' A' ' 139' ' ' PRO . 74.7 mt -61.68 -48.89 78.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.698 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 t -49.71 -47.53 50.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.664 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.0 t -67.84 -25.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.461 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.834 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.6 m-30 -102.1 7.88 40.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.156 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.64 -57.0 17.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.258 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.4 Cg_endo -56.76 -22.39 44.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.672 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 91.5 m-70 -89.97 -14.37 34.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.025 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.894 179.829 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.008 0.432 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.468 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 2.1 ptm85 -73.79 143.52 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.401 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 38.5 mtm180 -67.02 133.17 49.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.399 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.3 t-20 -152.55 155.96 38.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.738 HG13 HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -123.87 130.0 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.216 179.786 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.18 146.38 18.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.126 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.906 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.4 mp -124.56 102.03 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.9 t -89.57 101.82 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -103.03 143.3 32.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 0.0 111.229 -178.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.86 157.41 39.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.751 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.2 p-10 -100.71 170.05 8.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.232 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -56.27 -16.67 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.56 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.98 0.11 56.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.688 0.28 . . . . 0.0 110.973 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mttm 77.21 26.71 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.602 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -98.93 173.27 6.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.537 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.23 122.97 66.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.746 ' CE1' HG21 ' A' ' 119' ' ' ILE . 66.7 t80 -56.5 110.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.8 129.88 56.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.236 179.348 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.11 137.54 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.62 157.61 23.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.55 179.761 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.56 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -72.94 159.51 33.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.15 -5.65 49.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.996 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.49 -16.81 3.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.621 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.5 mt -119.65 111.97 35.75 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.24 131.82 29.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.904 1.736 . . . . 0.0 111.8 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 76.92 3.52 3.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.783 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.67 97.51 11.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.414 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.424 ' CD1' HD22 ' A' ' 145' ' ' LEU . 37.7 m95 -104.62 156.65 17.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.044 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -168.8 169.56 9.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.451 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 45.9 mtm -94.15 155.83 39.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.45 134.11 37.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.512 2.142 . . . . 0.0 112.687 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 163.54 39.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.493 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.45 142.73 7.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.746 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.84 135.61 49.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.59 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.738 HD11 HG13 ' A' ' 17' ' ' VAL . 5.5 mt -66.84 160.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.55 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.494 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.17 149.35 22.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.824 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -50.73 99.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.219 0.533 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.57 39.83 11.76 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.851 -179.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 6.0 tp10 -113.76 145.18 41.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.91 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 m-20 -74.43 125.56 89.7 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.236 179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.591 ' O ' HG11 ' A' ' 17' ' ' VAL . 6.6 Cg_endo -50.16 -47.97 21.77 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.46 2.106 . . . . 0.0 112.772 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.634 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -59.31 -27.73 66.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.725 0.298 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -88.01 -43.44 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.78 -32.18 71.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.174 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.11 -54.06 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.034 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -55.79 -29.53 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.278 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttp85 -82.69 -52.79 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.798 0.808 . . . . 0.0 109.981 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.92 -44.1 66.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.575 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.787 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.3 tp -56.97 -55.39 35.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.676 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 33.7 ttp180 -62.28 -13.3 26.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.283 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.12 -43.25 9.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.827 -179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.18 -25.85 19.35 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.787 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -116.77 -20.35 9.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.451 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.88 4.69 67.58 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.103 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.672 HG13 ' HE1' ' A' ' 112' ' ' PHE . 47.4 t -69.86 116.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.834 0.35 . . . . 0.0 110.529 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.65 -34.5 11.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -179.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.38 78.4 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.48 129.04 13.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.871 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.613 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.68 149.02 42.12 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.56 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.634 HG11 ' CZ ' ' A' ' 54' ' ' ARG . 30.6 t -80.06 122.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.4 0.619 . . . . 0.0 111.355 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.901 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -103.03 -20.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.414 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.94 161.0 40.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.68 117.48 6.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.877 179.652 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.864 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.4 t -57.16 128.78 78.59 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.22 -18.18 55.54 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 113.337 -178.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.641 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -125.6 -179.16 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 112.111 -179.505 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.431 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 6.2 m95 -108.45 145.94 33.89 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.706 HD21 ' HG2' ' A' ' 156' ' ' GLU . 66.5 mt -110.66 117.3 33.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.864 HG22 ' CB ' ' A' ' 104' ' ' ALA . 17.4 p -101.63 137.49 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.762 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.724 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -131.85 169.78 15.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 -179.417 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.91 158.42 36.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -116.32 145.04 34.2 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 112.323 -179.954 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.468 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 19.0 m95 . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' H ' ' HE3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -81.72 -29.23 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.634 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -155.96 -146.19 4.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.279 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -158.17 129.95 6.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.914 0.388 . . . . 0.0 111.777 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.864 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -111.71 106.84 15.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.889 178.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.406 ' CB ' ' O ' ' A' ' 16' ' ' ASN . 3.3 pt20 -122.06 161.59 22.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.606 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -113.85 101.66 9.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.021 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.54 ' CD2' HG21 ' A' ' 157' ' ' VAL . 33.8 m95 -70.36 153.15 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 0.0 112.401 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 73.3 m-85 -137.08 134.12 36.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.199 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.826 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.88 130.97 35.73 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.424 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.906 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.3 m-85 -125.55 128.43 47.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.581 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.901 ' HB3' HD11 ' A' ' 73' ' ' ILE . 1.9 tptt -92.25 121.18 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.672 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -64.86 124.88 23.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.984 0.421 . . . . 0.0 110.816 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.613 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.2 p -125.66 37.51 4.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.602 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -139.12 -145.18 4.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.13 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -128.09 154.24 45.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.829 0.347 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -50.03 -16.52 0.3 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.62 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -18.35 54.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.682 0.277 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.34 -25.29 39.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.746 HG21 ' CE1' ' A' ' 29' ' ' PHE . 16.1 mt -72.35 97.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.361 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -111.42 95.71 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.078 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 131' ' ' PHE . 66.8 mt -55.42 -23.06 22.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.667 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.75 -58.11 8.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.299 0.571 . . . . 0.0 110.001 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.51 -176.85 25.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.554 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.44 38.79 1.02 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 179.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.34 28.18 73.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.169 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -112.18 -65.98 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.04 165.13 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.241 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -66.78 151.87 96.2 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.42 176.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.04 -44.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.681 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 121' ' ' LEU . 23.0 m-85 -109.44 159.53 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.392 179.644 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.83 -19.19 6.12 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 21.3 mm-40 -152.46 174.69 13.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.455 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 23.7 p-90 -158.38 151.72 23.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.145 179.064 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.2 m -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.386 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -93.32 123.47 36.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.666 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 145' ' ' LEU . 31.6 m -134.05 151.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.111 0.482 . . . . 0.0 111.716 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.6 p -70.23 158.34 87.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.537 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.02 -19.1 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.978 1.786 . . . . 0.0 112.046 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.01 -33.46 14.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 179.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -50.05 35.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.107 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.896 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -53.34 -31.93 46.7 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.437 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.35 -29.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.683 178.566 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -32.07 57.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.1 mt -75.47 -40.47 57.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.008 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 150' ' ' LYS . 16.8 m -55.4 165.07 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.141 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.3 p -98.9 160.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.221 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.4 mm-40 -47.34 -43.35 22.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.43 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 12.7 p90 -82.66 4.12 26.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.272 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 16.1 mttt -125.25 -3.29 7.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 111.368 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 35.5 mttt -59.95 -61.87 7.03 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.0 Cg_endo -61.08 -43.29 30.58 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.456 2.104 . . . . 0.0 112.403 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.724 HG21 ' HB3' ' A' ' 82' ' ' TYR . 15.4 t -57.23 -29.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.08 -55.25 3.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.8 -32.59 6.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.706 ' HG2' HD21 ' A' ' 80' ' ' LEU . 3.1 tp10 -69.73 -44.19 70.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.785 179.407 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.5 t -59.57 -42.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.136 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 162' ' ' ALA . 51.3 mt -67.46 -48.1 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.619 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -50.58 -46.84 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.807 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.864 HG11 ' HA ' ' A' ' 76' ' ' VAL . 87.7 t -68.08 -24.54 30.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.123 0.487 . . . . 0.0 110.411 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.826 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -102.61 6.05 39.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.117 -179.178 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -50.97 -49.9 77.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.532 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 75.0 Cg_exo -49.73 -25.21 11.09 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.565 2.176 . . . . 0.0 112.559 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.726 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 96.7 m-70 -94.68 -26.71 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.96 0.41 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 4.1 ptm85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -67.32 130.33 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.47 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.8 m120 -152.68 159.63 43.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.731 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.5 m -133.61 131.32 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.257 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.34 144.7 16.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.298 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.866 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.3 mp -120.5 101.81 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.172 -179.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.2 t -89.54 107.21 18.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.228 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 110' ' ' PHE . 45.9 tp -103.42 141.86 35.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.097 -179.073 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.49 157.46 40.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.1 p-10 -101.02 171.04 7.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.331 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.13 -17.62 7.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.586 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.07 0.26 56.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.733 0.302 . . . . 0.0 110.971 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp 77.0 26.21 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.5 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.21 172.11 8.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.965 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.589 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -110.91 121.32 63.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.367 . . . . 0.0 110.937 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CE2' HG21 ' A' ' 119' ' ' ILE . 37.0 t80 -56.06 109.4 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.233 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.7 130.01 56.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.36 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.29 136.1 53.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.414 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -82.29 155.39 24.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.416 179.637 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.624 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -72.12 157.29 38.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.355 0.597 . . . . 0.0 111.732 -179.223 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.43 -6.44 49.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.828 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.53 -18.26 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.216 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.629 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 61.7 mt -119.6 110.92 36.64 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 28.5 Cg_endo -65.17 131.83 29.8 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.816 1.677 . . . . 0.0 111.73 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 t70 77.11 5.46 3.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.642 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -92.82 97.84 11.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.5 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.53 ' CD1' HD22 ' A' ' 145' ' ' LEU . 19.2 m95 -107.0 156.4 18.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -168.8 176.69 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.498 ' HE2' ' CZ3' ' A' ' 107' ' ' TRP . 2.2 mpp? -101.3 160.44 26.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.34 136.95 24.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.571 2.181 . . . . 0.0 112.786 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 155.77 35.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.14 155.6 26.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.675 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.88 132.82 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.635 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -60.23 161.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.644 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.485 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.25 149.33 22.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.91 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.44 98.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.194 0.521 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.51 10.0 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.947 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 6.1 tp10 -114.38 146.27 40.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.16 140.05 76.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.511 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.578 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.2 Cg_exo -53.24 -52.43 8.74 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.383 2.055 . . . . 0.0 112.575 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' O ' HD12 ' A' ' 58' ' ' ILE . 2.2 tmm_? -62.56 -25.62 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.156 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.64 -50.02 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.676 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.53 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.25 -31.97 67.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.504 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.24 -52.0 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.1 mt -57.24 -28.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.213 179.22 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -84.0 -53.18 5.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.749 0.785 . . . . 0.0 109.777 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.56 -32.7 58.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.29 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.874 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.0 tp -55.73 -54.79 40.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.605 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -61.67 -13.0 18.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.911 0.386 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.64 -37.92 12.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 0.0 111.395 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.7 -36.42 17.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.955 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.506 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.07 -23.46 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.1 3.05 84.48 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.81 -179.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.874 ' HB ' HD11 ' A' ' 61' ' ' LEU . 39.0 t -61.95 115.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.821 0.343 . . . . 0.0 110.461 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -91.83 -36.95 13.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.18 78.98 6.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 110.979 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 129.56 13.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.845 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -120.04 147.76 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.859 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.4 t -78.22 125.03 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.405 0.621 . . . . 0.0 111.858 -179.141 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.895 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -107.0 -19.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.362 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.769 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -152.03 158.26 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.327 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -148.56 116.75 6.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.995 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.888 ' HA ' HG11 ' A' ' 160' ' ' VAL . 10.9 t -57.26 130.79 80.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.094 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -17.66 40.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.647 2.231 . . . . 0.0 113.316 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.624 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.35 177.08 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 112.15 -179.497 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.463 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 m95 -104.32 146.05 29.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.976 179.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.914 ' HB3' HG13 ' A' ' 153' ' ' VAL . 94.8 mt -113.19 117.56 32.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.798 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.5 p -111.19 131.9 54.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.864 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -132.69 162.81 30.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.616 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.22 158.38 24.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.47 154.44 47.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.493 2.129 . . . . 0.0 112.528 -179.97 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 51.8 m95 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.809 0.338 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -31.31 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -156.22 -144.66 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.991 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.09 114.95 2.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.347 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.798 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -92.74 105.97 18.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.874 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -127.32 155.59 43.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 112.539 -178.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -109.26 96.34 6.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.633 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.498 ' CZ3' ' HE2' ' A' ' 42' ' ' MET . 23.2 m95 -63.7 145.68 55.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.106 -178.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 59.2 m-85 -128.16 137.05 51.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.428 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.79 HD13 ' CD2' ' A' ' 161' ' ' PHE . 19.4 tp -79.71 146.95 32.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.4 m-85 -140.77 127.05 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.978 0.418 . . . . 0.0 111.545 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.895 ' HB3' HD11 ' A' ' 73' ' ' ILE . 14.5 tttm -90.47 121.06 32.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -65.41 125.17 24.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 111' ' ' LYS . 10.0 p -127.77 38.14 4.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.549 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -137.77 -145.47 4.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.153 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.23 154.05 45.33 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -50.5 -16.08 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.7 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -79.74 -19.11 49.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.767 0.318 . . . . 0.0 111.307 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -78.74 -25.28 44.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.824 HG21 ' CE2' ' A' ' 29' ' ' PHE . 16.5 mt -74.78 103.48 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.378 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -113.77 95.51 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.918 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 131' ' ' PHE . 31.8 mt -49.82 -26.28 3.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.732 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.539 HD22 ' HG3' ' A' ' 129' ' ' PRO . 34.0 mt -63.5 -57.48 10.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 109.982 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.63 -173.49 25.98 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.42 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -93.44 38.86 1.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.19 0.519 . . . . 0.0 109.993 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.89 27.51 73.04 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.267 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -115.13 -68.17 0.94 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.09 165.01 13.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -78.84 153.88 77.99 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.956 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.539 ' HG3' HD22 ' A' ' 122' ' ' LEU . 87.5 Cg_exo -46.18 162.52 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.836 2.358 . . . . 0.0 112.554 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -149.95 -44.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HB2' HD13 ' A' ' 121' ' ' LEU . 20.7 m-85 -106.47 159.12 16.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.94 -20.36 4.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.696 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.413 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.3 mm-40 -152.42 174.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.456 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.6 p-90 -159.17 156.19 28.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.151 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.96 164.2 38.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.401 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 69.0 m95 -94.44 124.95 38.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.672 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 142' ' ' LEU . 29.7 m -138.21 151.49 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.057 0.456 . . . . 0.0 111.626 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -70.2 159.97 82.55 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.677 ' CA ' HD13 ' A' ' 158' ' ' LEU . 14.6 Cg_endo -57.15 -17.88 27.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.775 1.65 . . . . 0.0 111.786 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -34.43 15.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.154 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -50.78 25.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 109.97 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.5 tp -54.39 -28.96 47.07 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.387 0.613 . . . . 0.0 109.858 179.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.574 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm -69.45 -28.73 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.812 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.26 -20.04 45.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.271 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.0 mt -86.32 -39.07 16.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -62.22 166.09 5.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.104 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.978 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.3 p -98.41 161.57 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.023 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -52.21 -33.37 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.978 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.8 p90 -86.48 16.0 4.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.937 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 149' ' ' PHE . 2.4 mtpm? -143.93 -26.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.064 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.9 mtpt -43.38 -61.61 1.77 Allowed Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.653 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.2 Cg_endo -59.42 -44.36 33.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.265 1.976 . . . . 0.0 111.822 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.914 HG13 ' HB3' ' A' ' 80' ' ' LEU . 17.1 t -60.01 -24.99 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.804 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.8 m-30 -90.85 -50.92 5.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.594 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.574 ' HD2' HD12 ' A' ' 143' ' ' ILE . 2.7 tttt -48.9 -36.63 17.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.726 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.0 tp10 -64.92 -45.4 86.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.451 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 153' ' ' VAL . 37.8 t -58.81 -43.02 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.123 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.677 HD13 ' CA ' ' A' ' 139' ' ' PRO . 53.4 mt -69.09 -49.22 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.623 178.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -50.35 -46.78 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.718 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.888 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.9 t -67.54 -24.87 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.426 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.79 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -102.26 2.36 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.244 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.567 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.79 -56.07 24.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.406 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.9 -21.22 25.45 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.602 2.201 . . . . 0.0 112.391 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.769 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 12.0 m-70 -89.64 -20.02 24.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.748 0.309 . . . . 0.0 110.816 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.87 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.13 152.27 24.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -66.03 132.75 49.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.113 0.483 . . . . 0.0 111.502 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.8 t30 -152.49 158.49 42.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.744 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.1 m -132.2 133.34 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 111.68 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.15 153.61 17.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.938 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.9 HG21 HD22 ' A' ' 61' ' ' LEU . 4.1 mp -127.08 103.37 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.323 . . . . 0.0 111.488 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.6 t -89.7 104.07 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.0 tp -103.24 145.28 30.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.211 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.94 157.53 39.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.719 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.7 p-10 -101.55 170.57 8.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.06 -18.23 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.466 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.0 0.58 56.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.714 0.292 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt 76.03 26.12 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.485 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mttt -96.64 171.24 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.514 HD12 ' O ' ' A' ' 137' ' ' VAL . 4.1 mp -108.16 124.14 64.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.948 0.404 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CE1' HG21 ' A' ' 119' ' ' ILE . 67.6 t80 -58.53 110.16 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.143 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.66 135.29 53.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.73 136.25 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 111.317 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.66 153.74 25.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.563 179.778 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.591 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -70.8 158.3 36.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.532 -179.408 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -92.65 -6.63 48.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.92 178.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -128.75 -17.23 4.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.15 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 51.6 mt -119.76 107.79 39.92 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.898 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 25.9 Cg_exo -61.98 128.74 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.164 1.909 . . . . 0.0 111.899 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.2 t70 80.06 1.78 2.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.917 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.22 97.62 10.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.576 ' CD1' HD22 ' A' ' 145' ' ' LEU . 49.0 m95 -103.55 157.24 17.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.995 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.79 -177.01 2.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 71.6 mtm -109.13 156.76 38.68 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.54 140.26 56.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.595 2.196 . . . . 0.0 112.79 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 158.79 40.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.1 147.06 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.559 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.05 136.41 32.73 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.429 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 17' ' ' VAL . 5.3 mt -65.43 159.94 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.789 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.474 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.2 m-20 -90.45 150.27 21.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.69 98.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.242 0.544 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.39 39.14 10.06 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.98 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 14.2 tp10 -113.85 146.2 40.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 110.844 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 -72.8 139.13 80.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.568 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.613 ' O ' HG11 ' A' ' 17' ' ' VAL . 52.5 Cg_exo -54.92 -52.08 8.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.416 2.077 . . . . 0.0 112.658 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 108' ' ' PHE . 5.8 ttp85 -62.73 -26.64 68.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.277 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -84.51 -48.77 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.55 -28.27 65.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.553 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -75.49 -50.03 16.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.185 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 54' ' ' ARG . 45.2 mt -57.64 -29.63 34.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -82.13 -53.24 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.799 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -53.01 -41.14 64.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.4 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -56.13 -52.57 63.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.637 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 30.3 ttp180 -61.87 -13.82 28.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 178.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.19 -42.28 9.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.03 -26.17 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.739 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -120.6 -21.18 6.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.845 0.355 . . . . 0.0 111.081 -179.366 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 8.93 62.76 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.059 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.697 ' HB ' HD11 ' A' ' 61' ' ' LEU . 38.9 t -70.19 114.65 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -35.41 12.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.549 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.27 76.38 6.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.52 . . . . 0.0 111.107 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 127.96 12.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.809 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.66 ' OE1' HG21 ' A' ' 113' ' ' THR . 8.7 mt-10 -119.41 147.03 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.732 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.1 t -77.12 125.8 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.413 0.625 . . . . 0.0 111.817 -179.115 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.77 -16.65 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.366 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.57 158.39 38.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.41 115.36 6.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.195 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.835 ' HA ' HG11 ' A' ' 160' ' ' VAL . 9.2 t -57.46 127.39 77.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.33 -18.06 59.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.748 2.299 . . . . 0.0 113.349 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.59 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.96 -179.28 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.401 0.619 . . . . 0.0 112.204 -179.471 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 7.9 m95 -106.78 147.15 30.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.738 178.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.82 ' HB3' HG13 ' A' ' 153' ' ' VAL . 50.7 mt -113.86 117.84 32.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.103 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.781 HG22 ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -112.63 132.49 55.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.834 -179.363 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.871 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.0 164.01 25.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.651 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.48 158.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.216 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -114.98 154.77 47.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.595 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 C--N 1.344 0.293 0 C-N-CA 122.516 2.144 . . . . 0.0 112.315 179.981 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.1 m95 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.772 0.32 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -30.7 61.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.09 -141.66 3.22 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.017 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -157.65 115.84 3.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.12 106.24 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.808 178.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 5.7 pt20 -124.56 153.25 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.377 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -105.84 95.93 6.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.339 178.526 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.563 ' CD2' HG21 ' A' ' 157' ' ' VAL . 35.5 m95 -62.95 142.43 58.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.339 -178.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 65.9 m-85 -126.47 137.44 53.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.229 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.7 tp -79.56 154.57 28.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 21' ' ' LEU . 43.9 m-85 -148.17 127.67 13.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.037 0.446 . . . . 0.0 111.786 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.897 ' HB3' HD11 ' A' ' 73' ' ' ILE . 12.1 tttp -92.71 119.5 32.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.8 t80 -65.01 123.89 20.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.948 0.404 . . . . 0.0 110.76 -179.519 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.66 HG21 ' OE1' ' A' ' 71' ' ' GLU . 16.7 p -125.98 37.81 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.619 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.38 -144.85 4.72 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.101 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 154.19 45.93 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.82 -16.68 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.624 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.56 -19.14 56.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.725 0.298 . . . . 0.0 111.172 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.55 -25.17 41.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.759 HG21 ' CE1' ' A' ' 29' ' ' PHE . 17.7 mt -74.25 103.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.602 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.467 HD21 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -119.03 95.84 4.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.942 178.949 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.9 mt -54.79 -23.03 16.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.775 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 129' ' ' PRO . 70.2 mt -63.42 -59.54 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.25 0.547 . . . . 0.0 110.014 179.328 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.23 -176.99 24.87 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.445 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.53 39.01 1.02 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.132 0.491 . . . . 0.0 109.697 179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.64 26.79 74.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.078 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -119.08 -69.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.179 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.33 165.1 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 153.56 65.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 122' ' ' LEU . 77.0 Cg_exo -47.13 162.1 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.74 2.293 . . . . 0.0 112.597 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' C ' HD12 ' A' ' 34' ' ' LEU . 63.5 mm-40 -150.05 -46.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.809 ' HB2' HD13 ' A' ' 121' ' ' LEU . 12.7 m-85 -107.76 159.41 16.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.341 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.46 5.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.777 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.415 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 11.1 mm-40 -152.37 175.24 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.7 p-90 -156.68 152.5 27.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.09 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.6 m -147.93 163.63 36.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.409 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.462 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 69.7 m95 -98.12 122.48 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.661 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.87 HG11 HD11 ' A' ' 145' ' ' LEU . 27.0 m -134.91 150.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 111.58 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.93 162.33 72.74 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.699 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.584 ' CA ' HD13 ' A' ' 158' ' ' LEU . 31.5 Cg_exo -56.94 -20.34 36.11 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.84 1.693 . . . . 0.0 111.826 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -35.88 15.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.269 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -69.96 -50.36 42.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.06 179.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.903 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -53.96 -31.75 51.62 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.499 0.666 . . . . 0.0 109.81 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.568 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm -67.85 -28.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 178.687 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.73 -20.98 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.254 179.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.903 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.2 mt -85.49 -38.95 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.096 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 150' ' ' LYS . 29.8 m -56.14 163.43 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.4 p -91.42 165.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -57.6 -32.1 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.774 -179.653 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.2 p90 -92.89 13.62 19.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.686 ' HB2' HG12 ' A' ' 147' ' ' VAL . 33.9 mttp -136.23 0.81 2.61 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.327 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 6.4 mttm -62.15 -62.83 5.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.0 -44.72 27.96 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.46 2.107 . . . . 0.0 112.172 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.871 HG11 ' CD1' ' A' ' 82' ' ' TYR . 14.9 t -58.47 -27.12 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 0.0 111.1 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.18 -52.08 5.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.568 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -50.48 -32.71 18.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.825 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.552 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.4 tp10 -66.29 -45.69 79.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.559 179.144 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.2 t -59.09 -46.39 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.934 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.584 HD13 ' CA ' ' A' ' 139' ' ' PRO . 78.8 mt -66.31 -48.65 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.61 178.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.2 m -50.92 -46.52 60.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 76' ' ' VAL . 90.2 t -69.37 -24.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.9 m-30 -101.08 -2.92 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.274 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.617 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.79 -53.56 25.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.599 0.238 . . . . 0.0 111.588 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.42 -21.88 25.26 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.466 2.111 . . . . 0.0 112.402 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.66 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 77.4 m-70 -96.19 -15.35 22.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 161' ' ' PHE . 5.6 mp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.788 0.328 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -93.37 152.23 19.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -65.29 126.36 27.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.471 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.0 t-20 -152.62 156.37 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.7 m -129.29 136.88 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.71 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -106.44 157.31 15.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.163 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.71 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.6 mm -121.4 102.34 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.795 -0.238 . . . . 0.0 111.335 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 7.8 t -89.73 94.93 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.9 tp -102.67 143.94 31.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.522 . . . . 0.0 111.509 -178.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.47 157.27 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.6 p-10 -98.41 170.92 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.516 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -57.72 -16.56 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 0.31 56.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.826 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 77.02 26.9 0.72 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.811 ' C ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -97.08 174.47 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.005 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.837 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -108.7 125.67 65.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.765 0.317 . . . . 0.0 110.783 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.733 ' HE2' HD13 ' A' ' 119' ' ' ILE . 44.4 t80 -63.42 108.82 1.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.592 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . . . -116.35 131.27 56.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.672 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.71 133.77 55.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.6 p -82.35 154.61 25.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.782 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.43 157.35 37.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.268 0.556 . . . . 0.0 111.411 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -5.09 53.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.005 178.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -131.13 -16.72 3.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.782 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.3 mt -120.62 111.41 34.68 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.0 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.2 Cg_endo -65.25 131.9 29.9 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.868 1.712 . . . . 0.0 111.843 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.86 2.98 2.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.649 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.26 97.31 11.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.22 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.539 ' CD1' HD22 ' A' ' 145' ' ' LEU . 59.8 m95 -103.86 157.85 16.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.227 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -168.91 167.94 10.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.443 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 3.4 mpp? -101.84 145.1 29.88 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 4.0 Cg_exo -39.55 132.88 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.317 2.678 . . . . 0.0 112.967 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 154.62 33.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.549 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.6 144.21 8.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.624 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.52 138.83 43.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.368 179.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.655 HD11 HG13 ' A' ' 17' ' ' VAL . 5.1 mt -68.42 159.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.334 . . . . 0.0 110.638 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -90.3 146.17 24.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.22 96.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.354 0.597 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 36.3 8.13 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.186 -179.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 4.9 tt0 -115.58 142.63 46.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 0.0 110.747 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.77 142.29 85.66 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.708 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.622 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.8 Cg_exo -53.82 -57.15 2.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.511 2.14 . . . . 0.0 112.6 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 3.4 ttt180 -58.55 -26.79 63.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -83.0 -49.17 9.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.07 -32.46 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -71.98 -54.67 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.092 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 54' ' ' ARG . 48.4 mt -53.82 -28.86 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.198 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -82.79 -53.12 6.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.759 0.79 . . . . 0.0 109.791 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -57.43 -33.19 67.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD11 ' HB ' ' A' ' 67' ' ' VAL . 8.8 tp -53.98 -59.66 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.582 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 4.7 ptt-85 -61.5 -10.94 8.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -91.44 -44.92 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.59 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -90.68 -31.41 16.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.192 -178.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.758 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.57 -21.93 10.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 0.0 110.961 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.85 8.87 64.91 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.825 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.818 ' HB ' HD11 ' A' ' 61' ' ' LEU . 42.7 t -73.91 120.55 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.393 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -34.96 10.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.28 76.86 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.213 0.53 . . . . 0.0 110.823 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 128.42 12.89 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.837 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 mt-10 -119.61 148.15 43.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.596 HG23 ' CE2' ' A' ' 110' ' ' PHE . 41.1 t -78.03 126.65 38.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.882 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.44 -19.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.387 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.29 162.36 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.327 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.7 117.52 6.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.022 179.686 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.833 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.0 t -57.36 126.15 73.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.081 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.42 -18.34 62.72 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.771 2.314 . . . . 0.0 113.23 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.621 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.03 -177.21 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.243 0.544 . . . . 0.0 112.008 -179.583 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.74 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.8 m95 -107.8 147.27 31.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.127 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.74 HD23 ' C ' ' A' ' 79' ' ' TRP . 3.2 mt -111.32 117.71 33.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.862 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.4 p -109.93 136.96 48.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.407 -179.504 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.839 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -129.43 170.02 14.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.449 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 158.2 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -121.11 146.9 45.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.759 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo . . . . . 0 C--N 1.344 0.301 0 C-N-CA 122.368 2.045 . . . . 0.0 112.15 179.948 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.407 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 30.5 m95 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.845 0.355 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -70.37 -35.88 73.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.36 0.6 . . . . 0.0 109.654 179.382 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.74 -133.29 1.53 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.738 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 12.3 mm100 -156.31 113.85 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.862 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -96.42 105.84 17.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.701 178.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -123.23 156.48 35.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.419 0.628 . . . . 0.0 112.69 -178.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.86 96.5 6.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.599 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.658 ' CD2' HG21 ' A' ' 157' ' ' VAL . 25.2 m95 -62.91 149.79 43.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.256 0.551 . . . . 0.0 112.35 -178.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.3 m-85 -132.92 133.44 43.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.88 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -79.54 132.05 36.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.524 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HD12 ' A' ' 21' ' ' LEU . 53.1 m-85 -126.45 129.44 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.322 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.882 ' HB3' HD11 ' A' ' 73' ' ' ILE . 36.6 tttm -93.68 120.28 33.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.658 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.4 t80 -63.91 125.42 24.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.797 -179.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.476 HG21 ' HG3' ' A' ' 71' ' ' GLU . 3.7 p -127.86 37.86 4.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -139.22 -144.94 4.65 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.52 154.22 46.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.47 -16.92 0.23 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.577 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -22.57 53.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.764 0.316 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.51 -25.18 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.839 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.733 HD13 ' HE2' ' A' ' 29' ' ' PHE . 28.9 mt -71.23 97.31 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.78 95.73 5.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.958 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 131' ' ' PHE . 68.2 mt -57.08 -21.87 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -179.256 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 ' HG3' ' A' ' 129' ' ' PRO . 22.3 mt -63.85 -59.19 4.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.255 0.55 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.17 178.48 22.5 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.4 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -90.71 38.85 0.96 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.95 26.3 69.32 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.084 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.78 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.101 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.36 165.16 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.196 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -86.46 147.9 45.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.808 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.467 ' HG3' HD22 ' A' ' 122' ' ' LEU . 64.4 Cg_exo -51.05 125.8 17.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.544 2.163 . . . . 0.0 112.557 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -109.29 -29.25 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.592 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.7 m-85 -112.82 159.52 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.398 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.9 5.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.807 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm-40 -152.35 174.73 13.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.081 0.467 . . . . 0.0 110.419 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.1 p-90 -154.6 151.69 29.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.081 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -149.7 161.81 41.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.586 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 72.8 m95 -97.6 128.29 44.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.273 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 145' ' ' LEU . 28.0 m -138.79 155.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -74.84 151.44 86.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HD3' HD11 ' A' ' 28' ' ' ILE . 3.4 Cg_endo -47.89 -22.21 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.037 1.824 . . . . 0.0 112.064 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -34.66 17.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.469 179.24 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.414 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 mt-30 -69.14 -51.59 36.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.935 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -51.71 -36.5 47.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.707 0.765 . . . . 0.0 109.56 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.676 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.8 mm -62.7 -28.88 45.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.038 178.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 141' ' ' GLN . 33.4 t70 -81.94 -19.85 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.161 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.9 mt -86.88 -38.49 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 150' ' ' LYS . 28.3 m -56.55 163.47 1.77 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.079 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 150' ' ' LYS . 8.1 p -93.74 161.34 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.86 -41.43 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.276 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 12.3 p90 -84.23 5.87 24.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.317 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 147' ' ' VAL . 14.6 mtmt -127.79 -3.98 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.534 0.206 . . . . 0.0 111.49 179.33 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 22.6 mttt -55.31 -62.43 4.39 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.548 0.213 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -60.61 -42.81 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 82' ' ' TYR . 25.2 t -55.26 -29.4 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 111.245 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.437 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.2 m-30 -91.07 -53.31 4.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -49.7 -33.95 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 179.958 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 tp10 -65.57 -45.46 83.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.589 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 107' ' ' TRP . 60.3 t -58.06 -48.81 83.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 139' ' ' PRO . 66.8 mt -63.5 -48.66 76.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.721 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.6 m -49.81 -47.28 51.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.676 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.833 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.1 t -69.44 -24.6 27.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.106 0.479 . . . . 0.0 110.363 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.88 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -105.77 13.93 28.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.931 -179.235 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -56.58 21.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.459 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.5 Cg_endo -52.46 -23.84 20.14 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.472 2.115 . . . . 0.0 112.197 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.621 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 97.6 m-70 -92.87 -20.68 20.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.878 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.526 HD22 HD12 ' A' ' 28' ' ' ILE . 4.1 mt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.73 148.96 66.42 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.497 2.132 . . . . 0.0 112.287 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 78.87 1.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.33 49.13 0.78 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.3 m -138.3 -160.73 1.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.025 0.441 . . . . 0.0 109.878 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 mmt -174.88 111.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.66 14.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.926 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.5 p -177.61 137.5 0.39 Allowed Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 22.7 Cg_endo -61.47 110.62 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.226 1.95 . . . . 0.0 112.081 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.9 Cg_exo -76.72 -174.29 2.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.846 2.364 . . . . 0.0 112.047 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -86.97 150.39 24.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.768 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' CA ' ' CE ' ' A' ' 101' ' ' LYS . . . 95.63 -34.74 4.68 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.52 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -92.42 134.41 34.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.088 0.47 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.69 153.52 22.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' NH1' ' HB3' ' A' ' 9' ' ' PRO . 3.0 mmp_? -56.68 130.36 45.02 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.759 0.314 . . . . 0.0 110.617 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 1.1 t30 -152.83 153.25 32.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.931 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.812 HG11 ' HA ' ' A' ' 53' ' ' PRO . 27.5 m -140.47 136.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.833 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.48 150.14 17.27 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.654 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.92 HG23 ' CD1' ' A' ' 110' ' ' PHE . 5.0 mp -122.5 103.71 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.685 0.279 . . . . 0.0 110.954 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 32.7 t -89.43 106.76 18.66 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.845 HD12 ' O ' ' A' ' 110' ' ' PHE . 33.1 tp -102.9 143.25 32.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.957 0.408 . . . . 0.0 111.045 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.7 ptm -125.2 157.28 36.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.854 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 9.8 t30 -97.88 172.58 7.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.051 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -63.12 -17.17 62.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.858 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.45 -0.55 57.57 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.08 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mttm 80.99 24.86 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.642 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.3 OUTLIER -95.15 170.97 9.02 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.592 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.54 125.17 68.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.745 ' HE1' HD13 ' A' ' 119' ' ' ILE . 67.1 t80 -59.75 107.97 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.36 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.99 131.28 56.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.171 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.72 137.56 52.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.964 0.412 . . . . 0.0 111.371 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.38 155.52 24.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.557 ' CD ' HD12 ' A' ' 36' ' ' ILE . 2.9 mtp85 -73.35 157.27 37.29 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.0 111.411 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -4.95 52.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.897 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.97 -19.71 3.96 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.135 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.621 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.2 mt -119.15 112.4 36.18 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.2 131.47 28.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.951 1.768 . . . . 0.0 111.891 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 76.86 4.13 3.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.804 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.39 97.32 11.13 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.34 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HD22 ' A' ' 145' ' ' LEU . 41.3 m95 -102.55 156.64 17.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.136 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -168.93 -176.88 2.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.981 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 20.0 mtm -111.74 155.23 43.44 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.594 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.44 131.7 30.83 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.565 2.177 . . . . 0.0 112.447 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' OE1' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.22 164.18 38.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.161 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -152.68 161.6 29.59 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.368 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.27 35.56 3.29 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.603 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.732 ' CG1' HG13 ' A' ' 17' ' ' VAL . 2.3 mt 51.95 159.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.287 0.565 . . . . 0.0 111.661 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.41 162.25 15.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.812 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.59 99.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.145 0.498 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.6 46.05 33.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.793 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 1.6 tt0 -114.68 144.25 43.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.084 0.468 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -76.55 143.11 71.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.806 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.812 ' HA ' HG11 ' A' ' 17' ' ' VAL . 88.8 Cg_exo -48.54 -62.93 0.36 Allowed 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.777 2.318 . . . . 0.0 113.689 -178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.9 tpt180 -46.15 -33.72 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.81 -47.09 12.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -57.66 -35.0 69.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.05 -54.73 8.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.0 mt -57.65 -29.8 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.128 0.49 . . . . 0.0 110.308 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -80.94 -53.56 6.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.768 0.794 . . . . 0.0 109.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 34.7 mm-40 -50.38 -40.64 50.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.326 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.861 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -56.58 -53.86 52.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.656 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.6 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.3 ttp180 -63.81 -11.67 29.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.294 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -91.82 -40.14 11.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 111.596 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -88.07 -36.48 16.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.0 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.591 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -117.78 -24.32 7.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.056 0.455 . . . . 0.0 110.922 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.88 6.93 80.1 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.647 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.861 ' HB ' HD11 ' A' ' 61' ' ' LEU . 38.4 t -58.13 112.18 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.405 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 p -91.21 -33.77 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.08 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.25 75.19 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 110.946 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 133.69 17.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.853 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.9 mt-10 -126.69 148.73 49.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.666 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -77.63 126.66 38.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.461 0.648 . . . . 0.0 111.83 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.1 mm -107.56 -19.71 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.446 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.63 160.96 38.6 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.063 0.459 . . . . 0.0 111.566 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 5.0 pt-20 -149.53 118.62 6.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.879 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HA ' HG11 ' A' ' 160' ' ' VAL . 36.7 t -56.99 124.47 65.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.69 -17.97 38.37 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.95 2.433 . . . . 0.0 113.352 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.657 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.37 -175.62 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.139 0.495 . . . . 0.0 111.509 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.48 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 30.7 m95 -104.35 147.47 27.49 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.566 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.906 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -103.74 117.18 33.77 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.767 HG22 ' HB2' ' A' ' 104' ' ' ALA . 42.9 p -113.81 133.14 55.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.247 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.883 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -135.67 170.18 16.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.445 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.25 158.15 42.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 9.9 m-85 -108.06 152.36 41.73 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.752 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.784 ' HG2' HG23 ' A' ' 88' ' ' VAL . 42.3 Cg_endo -68.06 170.9 13.43 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.468 2.112 . . . . 0.0 112.452 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.24 -14.94 41.34 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.981 2.454 . . . . 0.0 113.521 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.25 -37.82 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.252 0.549 . . . . 0.0 110.045 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.784 HG23 ' HG2' ' A' ' 85' ' ' PRO . 58.1 t -77.17 -50.46 20.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.964 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.44 HH21 HD12 ' A' ' 92' ' ' LEU . 2.6 tpm_? -53.66 -60.41 3.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.123 0.963 . . . . 0.0 109.269 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.677 ' O ' HD12 ' A' ' 94' ' ' ILE . 12.6 tt0 -55.37 -27.88 50.34 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.582 -1.645 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -81.99 -43.62 17.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.683 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.485 HD22 ' CG ' ' A' ' 96' ' ' TRP . 96.4 mt -61.81 -46.1 90.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.415 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -46.48 -34.02 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.638 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.677 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.75 -46.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.465 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -55.62 9.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 110.971 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.485 ' CG ' HD22 ' A' ' 92' ' ' LEU . 10.7 m0 -80.11 -31.78 39.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.867 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 75.78 36.51 42.2 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.503 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.3 147.76 52.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.67 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.89 75.45 0.92 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.949 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -129.76 149.99 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.668 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' CE ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -79.3 -28.78 42.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.88 -145.75 5.14 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.909 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -157.81 118.6 3.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.71 0.291 . . . . 0.0 111.455 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.767 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -85.6 112.72 21.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -124.93 141.16 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -97.79 95.89 7.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.64 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.486 ' CG ' ' CG2' ' A' ' 157' ' ' VAL . 72.6 m95 -62.95 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 112.149 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.447 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 71.2 m-85 -125.05 130.98 53.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.258 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.877 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -79.64 131.12 35.89 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.685 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.92 ' CD1' HG23 ' A' ' 19' ' ' ILE . 49.3 m-85 -125.22 127.13 46.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 111.241 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.87 ' HB3' HD11 ' A' ' 73' ' ' ILE . 4.9 tptp -89.93 124.7 34.94 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.695 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.3 t80 -70.24 123.5 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.015 0.436 . . . . 0.0 110.799 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' SER . 6.6 p -124.2 37.39 4.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.568 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -135.82 -144.23 4.86 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.104 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.17 154.14 46.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.838 0.352 . . . . 0.0 110.061 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -50.13 -16.51 0.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.64 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -77.41 -17.38 58.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.705 0.288 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.24 -25.23 42.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.745 HD13 ' HE1' ' A' ' 29' ' ' PHE . 20.6 mt -70.45 104.83 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.492 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 65' ' ' THR . 56.3 t30 -122.26 95.78 4.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 131' ' ' PHE . 38.2 mt -54.14 -22.62 11.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.72 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.602 HD22 ' HG3' ' A' ' 129' ' ' PRO . 15.7 mt -63.63 -59.28 4.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.271 0.558 . . . . 0.0 109.964 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.4 -172.13 23.99 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -92.88 38.74 1.03 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.082 0.468 . . . . 0.0 109.924 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.94 27.19 72.62 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.345 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -68.92 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 0.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -93.91 165.1 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.99 148.92 61.84 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.602 ' HG3' HD22 ' A' ' 122' ' ' LEU . 54.6 Cg_exo -51.32 128.32 25.11 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.692 2.261 . . . . 0.0 112.55 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -108.45 -29.34 8.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.4 m-85 -111.67 159.46 18.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.38 -21.38 5.18 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.722 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.455 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 17.5 mm-40 -152.43 174.47 13.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.171 0.51 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.7 p-90 -159.13 156.57 29.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.042 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.76 161.92 40.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.473 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.467 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 73.3 m95 -93.9 124.89 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.697 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.702 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -136.6 150.89 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.151 0.501 . . . . 0.0 111.599 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.8 p -70.33 158.71 86.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.565 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.592 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.6 Cg_endo -55.36 -19.66 22.95 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.863 1.708 . . . . 0.0 111.885 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -34.34 16.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.075 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.35 -50.35 27.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.916 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.4 tp -54.39 -30.33 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.475 0.655 . . . . 0.0 109.891 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.516 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.3 mm -69.35 -28.47 38.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.724 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -80.19 -20.73 44.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.4 mt -84.07 -39.28 19.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.127 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 150' ' ' LYS . 27.0 m -59.6 164.28 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.011 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.2 p -96.09 160.48 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.122 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.517 ' N ' HG22 ' A' ' 147' ' ' VAL . 17.7 mm-40 -49.4 -41.7 40.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.2 p90 -81.3 2.85 26.31 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.545 ' O ' HG21 ' A' ' 146' ' ' THR . 4.2 mtpp -129.76 6.01 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.688 0.28 . . . . 0.0 111.197 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.2 mttt -64.02 -62.69 4.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 17.9 Cg_endo -58.1 -45.85 29.22 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.438 2.092 . . . . 0.0 112.061 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.906 HG13 ' HB3' ' A' ' 80' ' ' LEU . 48.6 t -54.05 -29.63 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.941 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.96 -51.5 5.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.5 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -51.09 -32.96 24.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.236 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.818 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.2 tp10 -64.31 -46.62 82.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.418 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.1 t -59.28 -50.97 77.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.29 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.557 HD13 ' CA ' ' A' ' 139' ' ' PRO . 66.0 mt -62.89 -49.58 74.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.969 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -45.3 61.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.631 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 156' ' ' GLU . 65.3 t -70.85 -25.01 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.352 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.877 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -104.06 12.48 34.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.799 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.571 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.44 -55.26 36.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.604 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.7 Cg_endo -54.6 -22.25 27.66 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.481 2.121 . . . . 0.0 112.248 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.641 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.3 m-70 -91.61 -18.28 24.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.948 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.901 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.451 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.06 145.13 54.52 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.602 2.202 . . . . 0.0 112.354 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.2 tp -156.42 136.53 12.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.851 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 60.1 29.89 69.27 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.563 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.06 121.71 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.594 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.6 tpp -128.31 -33.6 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.752 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 74.38 24.47 1.82 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 p 174.64 130.73 0.13 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.646 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 34.1 Cg_endo -65.14 110.56 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.413 2.075 . . . . 0.0 112.29 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 5.9 Cg_exo -79.04 -176.94 3.55 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.031 2.487 . . . . 0.0 112.11 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.27 157.0 17.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.54 -27.29 14.35 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.589 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -104.08 141.23 36.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -82.18 152.26 26.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.09 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.488 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 t30 -152.59 156.48 39.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.837 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.742 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -127.59 130.93 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.17 154.2 20.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.052 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.941 HG21 HD22 ' A' ' 61' ' ' LEU . 4.7 mp -131.94 102.82 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 111.411 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.5 t -89.7 103.81 16.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.0 146.22 28.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.875 0.369 . . . . 0.0 110.904 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.45 157.3 41.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.005 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 13.1 t30 -94.37 173.99 7.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -64.1 -16.5 61.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.789 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -89.54 -0.78 57.75 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.089 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 25' ' ' ASP . 19.9 mtpt 81.74 24.77 0.23 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.594 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.3 173.05 7.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.532 HG21 HD23 ' A' ' 142' ' ' LEU . 4.8 mp -112.65 124.31 69.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 110.865 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 119' ' ' ILE . 77.4 t80 -57.79 109.58 0.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.387 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.96 135.58 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.217 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -120.36 139.85 52.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 111.32 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.29 158.02 23.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.572 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.9 mtp-105 -72.22 162.61 29.22 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.376 0.608 . . . . 0.0 111.672 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.4 mt -96.35 -6.47 37.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.552 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.76 -18.53 3.83 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.574 ' HB ' ' HD3' ' A' ' 33' ' ' ARG . 65.2 mt -120.94 112.95 33.19 Favored Pre-proline 0 N--CA 1.457 -0.085 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.26 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.8 Cg_endo -65.69 132.38 30.56 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.871 1.714 . . . . 0.0 111.643 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.15 1.83 2.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.811 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.68 97.51 11.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.181 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.414 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.9 m95 -102.65 157.03 17.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.74 -179.93 3.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.796 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -102.19 159.02 30.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.583 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.2 137.09 39.44 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.509 2.139 . . . . 0.0 112.817 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.403 ' OE1' ' CZ2' ' A' ' 107' ' ' TRP . 1.6 mm-40 -137.64 148.1 45.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.363 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.47 132.66 4.13 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.542 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.99 128.82 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.742 HD11 HG13 ' A' ' 17' ' ' VAL . 4.8 mt -61.34 160.71 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.519 ' N ' HG22 ' A' ' 47' ' ' ILE . 27.1 m-20 -90.09 -176.66 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.069 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.48 98.53 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 110.22 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.07 46.01 8.57 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.661 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -115.51 147.29 40.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.807 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.35 136.03 78.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.648 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.0 Cg_exo -53.71 -56.15 2.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.435 2.09 . . . . 0.0 112.682 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' O ' HD12 ' A' ' 58' ' ' ILE . 6.1 ttp85 -58.68 -27.43 64.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.365 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -83.31 -48.85 9.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.575 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -57.17 -30.36 64.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.742 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -74.13 -50.38 19.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.153 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ARG . 40.1 mt -57.73 -29.48 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.171 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -83.2 -52.92 6.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.902 0.858 . . . . 0.0 109.856 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -53.77 -46.09 70.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.616 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.941 HD22 HG21 ' A' ' 19' ' ' ILE . 3.4 tp -54.41 -56.06 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.3 ttp85 -60.06 -15.0 19.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.387 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.06 -42.06 10.17 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.47 -24.4 19.69 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.801 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.43 -19.66 8.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 -179.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.21 4.48 63.83 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.175 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.635 HG13 ' HE1' ' A' ' 112' ' ' PHE . 40.2 t -70.65 114.08 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.502 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.23 -32.97 11.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.066 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 76.42 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.213 0.53 . . . . 0.0 111.128 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.35 13.53 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.756 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.0 pt-20 -118.94 146.2 45.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.904 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 52.6 t -77.75 122.38 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.372 0.606 . . . . 0.0 111.535 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.911 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.2 mm -104.39 -15.95 8.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.621 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.82 159.39 35.03 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.124 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.38 115.41 6.11 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.135 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.858 ' HA ' HG11 ' A' ' 160' ' ' VAL . 12.2 t -57.44 126.54 75.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.217 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.21 -18.95 65.23 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.77 2.313 . . . . 0.0 113.237 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.582 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.3 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.38 0.61 . . . . 0.0 111.991 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.786 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.7 m95 -109.75 147.21 33.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.017 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.851 HD22 ' O ' ' A' ' 4' ' ' GLY . 1.8 mt -112.45 117.59 32.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.956 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.797 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.9 p -112.93 131.67 55.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.867 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.7 163.34 27.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.796 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.07 158.36 28.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.119 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -113.4 153.86 45.54 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.771 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.613 ' HG2' HG23 ' A' ' 88' ' ' VAL . 28.4 Cg_endo -62.62 169.16 8.84 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.275 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.95 -16.62 50.88 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.108 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.04 -34.82 14.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.125 0.488 . . . . 0.0 110.086 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.3 t -82.63 -48.22 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.222 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -45.43 85.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.566 0.698 . . . . 0.0 109.515 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.5 tp10 -69.33 -28.02 65.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.611 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -46.95 25.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.824 HD22 ' CD2' ' A' ' 96' ' ' TRP . 81.1 mt -57.41 -46.94 82.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.372 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -45.84 -31.41 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.33 -50.07 11.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.221 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -56.89 8.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.824 ' CD2' HD22 ' A' ' 92' ' ' LEU . 43.4 m0 -76.03 -34.94 59.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.693 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.83 33.65 33.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.419 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.92 147.29 49.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.014 0.435 . . . . 0.0 110.742 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -109.75 64.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 57.9 m95 -121.69 150.11 42.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.664 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -30.35 58.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -162.08 -143.07 3.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.923 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -157.72 115.77 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 0.0 111.436 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.797 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -93.39 105.81 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.814 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.433 ' NE2' ' ND2' ' A' ' 16' ' ' ASN . 4.0 pt20 -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -104.29 98.07 7.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.519 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.484 ' CD2' HG21 ' A' ' 157' ' ' VAL . 31.3 m95 -65.32 137.12 57.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.278 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 54' ' ' ARG . 68.5 m-85 -122.27 137.93 54.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.943 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.821 HD23 ' HB ' ' A' ' 73' ' ' ILE . 20.1 tp -79.21 154.14 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.821 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 19' ' ' ILE . 39.6 m-85 -148.08 125.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.07 0.462 . . . . 0.0 111.738 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.911 ' HB3' HD11 ' A' ' 73' ' ' ILE . 39.5 tttp -91.4 122.55 34.1 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.635 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.2 t80 -68.23 123.9 22.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.869 0.366 . . . . 0.0 110.904 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.9 p -124.02 37.29 4.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.13 -144.88 4.65 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.044 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.23 154.19 46.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.02 -16.61 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.559 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -77.73 -18.49 56.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 111.252 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -25.57 42.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.373 . . . . 0.0 110.844 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.732 HG21 ' CE1' ' A' ' 29' ' ' PHE . 18.2 mt -73.77 103.9 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.517 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.636 ' ND2' HD12 ' A' ' 122' ' ' LEU . 0.9 OUTLIER -119.36 95.87 4.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.027 179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.824 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.6 mt -55.86 -22.55 25.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.543 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.636 HD12 ' ND2' ' A' ' 120' ' ' ASN . 1.7 mt -61.26 -56.84 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.246 0.546 . . . . 0.0 109.95 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.39 -174.66 22.8 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.51 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -91.76 38.72 0.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 68.33 29.13 73.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.202 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.1 m -115.24 -67.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 111.267 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -101.28 165.16 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.239 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.59 146.8 86.43 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.588 ' CG ' HD23 ' A' ' 122' ' ' LEU . 52.6 Cg_exo -52.11 139.74 51.9 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.647 2.232 . . . . 0.0 112.583 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -109.83 -31.82 7.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.598 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.824 ' HB2' HD13 ' A' ' 121' ' ' LEU . 20.7 m-85 -116.88 159.61 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.415 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -15.72 6.81 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.814 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.566 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.53 174.59 13.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.522 . . . . 0.0 110.592 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.4 p-90 -159.61 153.1 22.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.056 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.3 m -151.74 156.9 41.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.484 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.469 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 76.7 m95 -91.35 124.83 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.841 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.902 HG11 HD11 ' A' ' 145' ' ' LEU . 29.6 m -134.71 150.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.724 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.5 p -69.54 158.5 86.77 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.573 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.517 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.05 -19.37 19.94 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 121.99 1.793 . . . . 0.0 111.98 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -34.48 14.4 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.225 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.6 -50.28 46.05 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.925 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.0 tp -53.37 -33.26 52.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.416 0.626 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.88 -28.73 43.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.687 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.75 -32.84 52.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.676 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 142' ' ' LEU . 7.1 mt -75.08 -40.62 59.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.88 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 147' ' ' VAL . 28.3 m -54.92 163.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.21 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.797 HG11 ' CE2' ' A' ' 149' ' ' PHE . 10.6 p -98.49 160.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.183 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.1 mm-40 -49.39 -36.79 22.92 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.797 ' CE2' HG11 ' A' ' 147' ' ' VAL . 16.4 p90 -84.77 6.9 22.56 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.453 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 30.8 mttt -129.94 -4.67 4.53 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.1 mttt -56.53 -62.13 5.5 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.351 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.4 Cg_endo -60.9 -42.77 35.06 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.444 2.096 . . . . 0.0 112.131 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.867 HG11 ' CD1' ' A' ' 82' ' ' TYR . 11.4 t -60.65 -27.5 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.277 0.561 . . . . 0.0 110.953 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.8 m-30 -90.87 -53.15 4.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.697 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.68 -31.12 10.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -69.48 -44.71 70.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.663 179.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 153' ' ' VAL . 52.0 t -57.72 -48.26 83.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.098 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 162' ' ' ALA . 61.8 mt -64.5 -48.85 73.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.774 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.8 m -50.94 -46.18 60.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.887 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.1 t -70.31 -24.58 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 121.019 0.437 . . . . 0.0 110.766 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.786 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.2 m-30 -100.67 -2.02 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.16 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.66 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.2 -51.46 33.24 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 6.7 Cg_endo -49.29 -24.57 8.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.632 2.221 . . . . 0.0 112.567 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.664 ' ND1' HG22 ' A' ' 73' ' ' ILE . 97.2 m-70 -100.98 -15.99 17.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.302 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 161' ' ' PHE . 4.4 mp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.886 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.454 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 144.83 54.94 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.596 2.197 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.25 38.66 19.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.99 -57.36 10.92 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.514 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.489 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 28.1 p -108.08 -155.59 0.56 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.436 ' HA ' ' HE2' ' A' ' 6' ' ' MET . 0.1 OUTLIER -148.07 -40.33 0.17 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.892 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 74.28 14.7 3.68 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.08 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 171.88 131.7 0.08 OUTLIER Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.561 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 91.7 Cg_endo -80.39 117.3 3.41 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.438 2.092 . . . . 0.0 112.415 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 3.4 Cg_endo -84.86 176.79 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.983 2.455 . . . . 0.0 111.499 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -91.16 17.37 8.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.993 0.425 . . . . 0.0 111.852 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 -2.61 35.0 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.481 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -129.44 153.12 48.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.51 152.15 25.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.74 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -74.36 125.2 27.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.168 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.4 m120 -152.41 159.03 43.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.72 HG13 HD11 ' A' ' 47' ' ' ILE . 1.8 m -129.74 135.68 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.128 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.93 17.42 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.303 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.907 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -126.21 101.63 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.767 0.317 . . . . 0.0 111.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.7 t -89.84 102.94 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.5 tp -103.16 145.75 29.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.946 0.403 . . . . 0.0 111.304 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.69 157.41 40.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.7 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 31.6 p-10 -102.39 169.98 8.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.375 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -55.37 -17.95 5.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.678 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.92 0.48 56.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.821 0.343 . . . . 0.0 110.983 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt 76.46 25.83 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.678 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -95.62 171.95 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.551 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.4 mp -109.12 119.5 58.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.12 0.486 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.787 ' CE2' HG21 ' A' ' 65' ' ' THR . 5.5 t80 -53.71 108.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.21 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.77 137.17 52.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.723 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.86 137.97 54.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.6 158.22 23.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.795 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtp85 -75.39 159.11 31.78 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 111.302 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -94.2 -5.64 46.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.026 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.35 -16.94 3.85 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.229 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.795 HD12 ' CD ' ' A' ' 33' ' ' ARG . 64.9 mt -120.19 110.96 35.66 Favored Pre-proline 0 N--CA 1.454 -0.239 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.01 131.35 28.5 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.837 1.691 . . . . 0.0 111.845 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 77.58 5.22 3.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.685 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.607 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.7 97.62 11.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.354 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.3 m95 -103.72 156.12 18.05 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -168.8 -176.77 2.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.764 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.464 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 61.2 mtm -107.31 159.4 30.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.15 130.27 22.38 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.468 2.112 . . . . 0.0 112.549 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -154.1 160.23 41.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.492 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.12 169.34 38.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.612 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -83.92 130.88 10.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.449 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 17' ' ' VAL . 5.0 mt -60.07 160.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 110.713 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.29 151.71 21.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.931 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.19 98.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.224 0.535 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.67 36.29 8.0 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.036 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.0 tt0 -116.29 142.11 47.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.061 0.458 . . . . 0.0 110.861 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.46 143.15 82.18 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HA ' HG11 ' A' ' 17' ' ' VAL . 50.4 Cg_exo -54.04 -52.93 7.23 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.559 2.173 . . . . 0.0 112.604 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.586 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 4.4 tpp85 -59.03 -27.61 65.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.219 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -84.46 -48.44 9.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.839 0.352 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.553 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.98 -32.51 69.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.417 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.49 -53.57 11.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.247 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.498 HD12 ' O ' ' A' ' 54' ' ' ARG . 53.7 mt -57.08 -29.34 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.081 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -81.7 -53.35 6.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.788 0.804 . . . . 0.0 109.918 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -50.13 -45.16 52.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.309 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.856 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.9 tp -55.74 -56.18 23.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.783 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.596 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.4 ttp180 -61.26 -12.19 12.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.563 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -91.6 -38.39 12.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.749 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.09 -35.37 15.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.921 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.787 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -119.02 -23.24 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.015 0.436 . . . . 0.0 110.999 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.31 8.57 80.03 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.856 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.856 ' HB ' HD11 ' A' ' 61' ' ' LEU . 24.8 t -57.15 110.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 116.985 0.393 . . . . 0.0 110.313 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.0 p -89.84 -36.22 15.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.43 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.34 76.43 6.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.176 0.512 . . . . 0.0 111.086 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.43 128.53 12.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.78 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.6 pt-20 -119.38 147.78 43.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.098 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.606 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.6 t -78.41 123.54 35.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.344 0.593 . . . . 0.0 111.417 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.899 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -106.07 -19.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.753 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -156.85 162.94 39.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.135 0.493 . . . . 0.0 111.735 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.83 114.73 5.72 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.861 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.71 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.6 t -57.57 125.51 72.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.182 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.47 -11.6 31.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.872 2.381 . . . . 0.0 113.768 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.538 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.78 133.54 49.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.247 0.546 . . . . 0.0 111.917 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.447 ' CD2' ' HG2' ' A' ' 106' ' ' LYS . 49.2 m95 -59.79 147.09 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.226 0.536 . . . . 0.0 110.566 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.894 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.1 mm? -102.75 117.74 35.3 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.835 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.497 HG22 ' HB2' ' A' ' 104' ' ' ALA . 63.8 p -113.89 134.48 54.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.873 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -133.1 170.35 15.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.533 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.48 141.6 45.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.64 151.42 42.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.776 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.562 ' HG2' HG23 ' A' ' 88' ' ' VAL . 32.9 Cg_endo -63.6 170.58 8.14 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.518 2.145 . . . . 0.0 112.372 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.47 -16.95 57.86 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.783 2.322 . . . . 0.0 113.275 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.65 -34.33 14.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.122 0.487 . . . . 0.0 110.132 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.4 t -83.19 -46.73 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.327 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -60.66 -46.3 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.487 0.66 . . . . 0.0 109.423 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -67.16 -27.37 67.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.58 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -47.05 16.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.624 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 96' ' ' TRP . 80.3 mt -59.26 -45.59 90.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.422 . . . . 0.0 110.363 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.1 m-80 -46.02 -32.4 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.558 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.5 -49.28 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.158 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -56.12 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.462 ' N ' ' O ' ' A' ' 92' ' ' LEU . 18.4 m0 -78.39 -34.68 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.807 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 80.34 36.18 24.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.355 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.41 147.46 49.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.744 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -110.22 42.25 1.58 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.006 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -96.69 150.2 20.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -25.69 41.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.572 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.43 -138.23 2.74 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.036 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -157.72 116.79 3.23 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.823 0.344 . . . . 0.0 111.388 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -86.41 105.8 17.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.835 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.1 pt20 -124.92 145.03 50.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 2.5 mmmp? -100.59 110.49 22.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.76 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.601 ' CD2' HG21 ' A' ' 157' ' ' VAL . 34.2 m95 -76.23 145.2 39.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.486 . . . . 0.0 112.145 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 75' ' ' GLU . 59.5 m-85 -127.29 132.76 50.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.295 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.87 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.9 tp -79.5 132.93 36.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.359 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.907 ' CD1' HG23 ' A' ' 19' ' ' ILE . 50.0 m-85 -126.51 127.98 46.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.04 0.448 . . . . 0.0 111.663 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.899 ' HB3' HD11 ' A' ' 73' ' ' ILE . 18.3 tttp -92.02 122.29 34.39 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.658 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.8 t80 -67.87 123.07 19.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.953 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' SER . 1.6 p -122.8 37.01 4.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.545 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.32 -144.49 4.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.153 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -128.06 154.37 45.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.97 -17.49 0.2 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.585 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -74.61 -19.28 60.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.12 -25.64 52.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 25.5 mt -70.16 105.29 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.311 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.407 ' O ' ' O ' ' A' ' 65' ' ' THR . 59.8 t30 -123.12 95.89 4.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.217 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' A' ' 131' ' ' PHE . 34.7 mt -55.73 -21.0 16.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.577 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.894 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -62.94 -60.18 3.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.329 0.585 . . . . 0.0 109.774 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.25 23.39 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.324 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -93.92 38.83 1.07 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.159 0.504 . . . . 0.0 109.758 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.59 28.0 70.66 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.2 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 m -102.24 -62.34 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.289 . . . . 0.0 111.255 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.27 165.24 17.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.146 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -57.95 146.06 69.65 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.031 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.894 ' HG3' HD13 ' A' ' 122' ' ' LEU . 63.7 Cg_exo -51.69 -176.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.675 2.25 . . . . 0.0 112.517 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 34' ' ' LEU . 4.4 mm-40 -150.1 -41.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.583 ' HB2' HD13 ' A' ' 121' ' ' LEU . 21.0 m-85 -106.32 159.37 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.69 5.31 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.377 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.4 mp0 -152.19 173.73 14.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.5 p-90 -160.25 160.31 32.48 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.242 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -158.73 160.76 36.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.508 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 81.3 m95 -93.12 124.61 37.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.623 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.0 m -137.27 151.16 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.087 0.47 . . . . 0.0 111.773 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -68.88 161.35 72.58 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.517 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.551 ' HD3' HD11 ' A' ' 28' ' ' ILE . 18.7 Cg_endo -59.39 -16.73 36.58 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.716 1.61 . . . . 0.0 111.768 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.98 -34.1 14.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.069 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -51.5 21.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.13 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.871 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.42 -31.4 55.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.459 0.647 . . . . 0.0 109.769 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.571 HD11 ' CA ' ' A' ' 155' ' ' LYS . 8.2 mm -68.08 -27.7 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.775 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.73 -14.7 50.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.216 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.871 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.6 mt -91.28 -38.32 12.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.392 0.615 . . . . 0.0 110.238 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 147' ' ' VAL . 59.4 m -56.51 161.83 2.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.252 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.875 HG11 ' CE2' ' A' ' 149' ' ' PHE . 14.0 p -87.98 162.31 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.992 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -63.3 -31.26 72.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.875 ' CE2' HG11 ' A' ' 147' ' ' VAL . 11.2 p90 -82.17 2.57 30.95 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.481 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 3.3 mtmt -145.99 16.28 1.38 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.426 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 3.1 mttt -58.89 -61.96 6.73 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.073 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.3 Cg_endo -61.58 -42.5 32.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.518 2.145 . . . . 0.0 112.271 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.894 HG13 ' HB3' ' A' ' 80' ' ' LEU . 61.8 t -48.29 -29.2 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.248 0.547 . . . . 0.0 111.238 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.27 -55.0 3.69 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.249 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.571 ' CA ' HD11 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -48.52 -36.56 15.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.901 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.827 ' HB3' HD11 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -60.73 -46.74 89.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.475 178.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.601 HG21 ' CD2' ' A' ' 107' ' ' TRP . 44.6 t -61.29 -45.55 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.336 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.507 HD13 ' CA ' ' A' ' 139' ' ' PRO . 56.3 mt -64.19 -49.04 73.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.965 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.2 t -50.63 -43.72 57.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.811 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.7 t -71.73 -25.19 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.326 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.87 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.8 m-30 -102.55 8.73 39.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.87 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.554 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.66 -56.04 26.77 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.333 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.5 Cg_endo -56.91 -22.78 47.71 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.374 2.049 . . . . 0.0 112.178 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.0 m-70 -91.31 -19.94 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.87 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.466 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.2 168.2 22.8 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.588 2.192 . . . . 0.0 112.303 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 3' ' ' LEU . 4.2 mm? 60.18 -178.53 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.0 25.9 74.18 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.14 124.37 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.44 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.5 mmt -133.04 -38.31 0.97 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.745 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 75.4 19.15 2.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.727 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p 174.33 138.98 0.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.403 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 43.8 Cg_endo -68.86 109.69 2.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.32 2.014 . . . . 0.0 112.305 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.82 -175.64 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.012 2.475 . . . . 0.0 112.069 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -90.29 151.35 21.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -34.96 4.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -89.45 138.9 31.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 110.943 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.0 152.21 25.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -66.03 124.98 24.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 11.7 t-20 -152.53 160.66 43.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.997 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.772 HG13 HD11 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -131.06 140.3 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.236 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -105.01 150.19 16.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.154 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.952 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -131.15 102.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.469 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -89.61 109.95 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 110' ' ' PHE . 42.7 tp -102.92 143.55 32.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.025 0.441 . . . . 0.0 111.171 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.6 ptm -128.93 157.29 42.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.889 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.5 p-10 -105.03 170.69 7.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.387 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -56.28 -17.5 7.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.644 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 0.61 56.56 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.775 0.322 . . . . 0.0 111.078 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 mttm 76.35 26.39 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.566 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -97.91 172.27 7.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.15 123.19 66.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.928 0.394 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.748 ' CE1' HG21 ' A' ' 119' ' ' ILE . 73.9 t80 -56.45 109.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.57 129.97 56.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.448 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.81 136.09 53.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 111.234 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.412 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.4 p -82.46 154.86 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.748 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.578 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -70.96 159.02 35.48 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.255 0.55 . . . . 0.0 111.397 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -93.33 -6.21 47.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.944 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -128.43 -18.1 4.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.201 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.1 mt -119.59 112.1 35.75 Favored Pre-proline 0 N--CA 1.454 -0.236 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.97 131.39 28.7 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.936 1.757 . . . . 0.0 111.95 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.74 3.51 3.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.851 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.54 11.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.401 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.719 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.1 m95 -104.56 156.71 17.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.02 8.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.835 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.505 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 70.1 mtm -97.91 156.67 35.72 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.765 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.83 139.22 42.99 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.536 2.157 . . . . 0.0 112.996 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 158.33 40.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.219 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.38 145.8 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.258 -0.972 . . . . 0.0 112.826 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.13 138.31 43.78 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.379 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.772 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -69.17 161.0 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.57 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.494 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.2 150.09 22.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.6 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.14 8.48 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.109 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 4.7 tt0 -115.08 143.48 45.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 0.0 110.887 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.68 139.68 80.85 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.604 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.639 ' O ' HG11 ' A' ' 17' ' ' VAL . 63.5 Cg_exo -52.02 -53.51 6.85 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.448 2.098 . . . . 0.0 112.616 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -60.01 -27.28 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -82.49 -51.26 7.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.694 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.542 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -56.84 -31.65 64.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.561 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.79 -51.91 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.271 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 54' ' ' ARG . 50.4 mt -56.82 -27.94 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -84.96 -52.71 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.807 0.813 . . . . 0.0 109.931 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -52.84 -47.37 67.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -53.99 -56.69 15.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.867 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 66.2 ttp85 -59.32 -15.2 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.414 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -92.13 -39.98 11.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.821 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.4 -25.08 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.829 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.89 -19.16 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 -179.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.77 5.65 65.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.112 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.681 HG13 ' HE1' ' A' ' 112' ' ' PHE . 49.6 t -72.18 115.74 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.797 0.332 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.61 -34.34 12.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.954 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.23 79.25 6.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.472 . . . . 0.0 110.997 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.29 131.33 15.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.897 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.2 pt-20 -120.72 147.2 45.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.043 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.5 t -78.03 123.01 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.382 0.611 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.932 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -105.4 -21.52 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.392 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.753 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -153.41 161.9 41.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.288 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 9.0 pt-20 -148.74 115.59 6.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.148 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.819 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.6 t -57.24 125.78 71.97 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.917 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.2 -13.28 39.06 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.975 2.45 . . . . 0.0 114.177 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.619 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -129.4 157.2 42.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 112.028 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.528 ' C ' HD23 ' A' ' 80' ' ' LEU . 32.4 m95 -77.4 145.66 37.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.123 0.487 . . . . 0.0 109.914 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.895 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -108.55 118.08 35.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.984 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.859 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.8 p -114.81 132.19 56.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.522 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.875 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -124.9 170.13 11.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.96 158.28 38.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -119.72 149.76 48.99 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.705 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.568 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.4 Cg_endo -63.06 170.38 7.67 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.539 2.16 . . . . 0.0 112.308 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.52 -17.42 59.9 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.819 2.346 . . . . 0.0 113.19 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -91.94 -34.64 14.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.173 0.511 . . . . 0.0 110.096 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG23 ' HG2' ' A' ' 85' ' ' PRO . 72.7 t -82.01 -47.56 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.292 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -44.8 93.66 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.57 0.7 . . . . 0.0 109.536 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.61 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.7 tp10 -71.12 -27.56 63.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.772 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 -46.96 24.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.631 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.65 HD21 H5'2 ' A' ' 166' ' ' ATP . 94.3 mt -59.56 -46.1 89.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.998 0.428 . . . . 0.0 110.391 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.3 m-80 -45.69 -32.43 2.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.41 -49.45 12.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.163 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -56.97 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.77 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.442 ' N ' ' O ' ' A' ' 92' ' ' LEU . 23.7 m0 -77.43 -36.2 53.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.639 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 82.29 34.8 22.37 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.362 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.05 147.15 49.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -109.75 65.23 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -122.83 150.18 43.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.679 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -28.86 46.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.583 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -167.13 -142.38 3.43 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.984 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -157.93 116.47 3.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.848 0.356 . . . . 0.0 111.387 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.859 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.54 105.86 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.854 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.8 pt20 -124.28 144.61 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HG2' ' CD2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -98.81 95.82 7.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.697 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.432 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.8 m95 -62.91 148.72 46.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.449 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 68.6 m-85 -132.09 135.05 46.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.317 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.796 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.5 tp -79.9 129.46 34.5 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.423 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.952 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.6 m-85 -123.85 126.57 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.398 . . . . 0.0 111.643 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.932 ' HB3' HD11 ' A' ' 73' ' ' ILE . 50.5 tttt -89.88 124.54 34.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.681 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -68.39 125.43 26.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.5 p -125.64 37.61 4.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.595 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.1 -144.91 4.76 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.129 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 154.2 45.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.85 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.611 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -20.39 52.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 111.168 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.17 -25.07 42.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.798 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.748 HG21 ' CE1' ' A' ' 29' ' ' PHE . 18.1 mt -73.46 102.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.549 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -119.35 95.63 4.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.924 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 131' ' ' PHE . 68.6 mt -54.56 -23.78 18.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.651 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 129' ' ' PRO . 59.5 mt -61.3 -55.23 34.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.099 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.9 -171.03 25.03 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.429 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -93.75 38.96 1.06 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.151 0.5 . . . . 0.0 109.84 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.17 28.56 73.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.985 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.36 -68.28 0.91 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 111.228 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.9 165.08 17.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.25 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -80.93 151.18 70.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.952 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.449 ' HG3' HD22 ' A' ' 122' ' ' LEU . 72.0 Cg_exo -48.44 165.34 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.748 2.299 . . . . 0.0 112.623 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.412 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.6 mt-10 -150.05 -45.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.502 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.828 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.5 m-85 -107.48 159.62 16.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.243 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.19 -18.63 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' O ' HD11 ' A' ' 121' ' ' LEU . 24.1 mm-40 -152.54 175.24 12.97 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.178 0.513 . . . . 0.0 110.664 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.1 p-90 -156.14 150.9 26.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.113 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 162.32 40.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.34 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.441 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 71.4 m95 -96.28 124.31 40.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 145' ' ' LEU . 27.2 m -136.42 150.78 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.08 0.467 . . . . 0.0 111.511 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -71.1 158.11 88.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.572 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.615 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.0 Cg_endo -54.62 -20.49 21.54 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.907 1.738 . . . . 0.0 111.853 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 -34.3 17.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.118 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -72.69 -50.69 23.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.931 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -54.14 -29.93 47.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.403 0.62 . . . . 0.0 109.881 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.569 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.7 mm -68.44 -28.88 42.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.674 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.27 -20.53 44.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.317 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.3 mt -85.86 -39.14 17.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 150' ' ' LYS . 5.7 m -60.2 156.19 15.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.955 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.4 p -90.08 160.52 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.898 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.85 -35.71 33.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.955 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.9 p90 -84.8 9.97 12.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.611 ' HB2' HG22 ' A' ' 146' ' ' THR . 12.6 mttm -134.57 -25.3 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.264 . . . . 0.0 111.187 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.8 mtpt -44.5 -59.87 3.5 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.408 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.0 Cg_endo -59.06 -41.52 60.23 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.278 1.985 . . . . 0.0 111.912 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' A' ' 80' ' ' LEU . 64.0 t -64.99 -25.78 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.3 m-85 -90.46 -49.34 6.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.697 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.93 -35.1 22.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.681 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.724 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.4 tp10 -66.81 -44.96 79.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.501 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.7 t -58.64 -47.86 87.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.07 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.615 HD13 ' CA ' ' A' ' 139' ' ' PRO . 66.6 mt -66.71 -49.26 66.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.703 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 43.2 m -50.6 -46.14 57.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.662 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.819 HG11 ' HA ' ' A' ' 76' ' ' VAL . 85.7 t -69.53 -24.68 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.545 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.796 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -101.86 2.13 37.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.163 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.47 -55.21 31.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.33 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.15 -20.87 25.73 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.619 2.213 . . . . 0.0 112.34 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.753 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 17.9 m-70 -89.48 -21.06 23.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.729 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.933 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.65 H5'2 HD21 ' A' ' 92' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' C ' HD23 ' A' ' 3' ' ' LEU . 55.6 Cg_endo -70.26 152.84 66.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.527 2.151 . . . . 0.0 112.276 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.631 HD23 ' N ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -147.84 124.54 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.563 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 87.85 -8.83 76.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.794 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.475 ' HB3' ' CD1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -179.57 125.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.279 . . . . 0.0 110.506 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -150.89 -24.7 0.22 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 28.2 t0 77.57 43.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.936 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 m -177.85 121.54 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.83 122.42 8.81 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.375 2.05 . . . . 0.0 112.178 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 60.4 Cg_endo -88.85 -169.05 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.858 2.372 . . . . 0.0 112.412 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -90.05 153.61 20.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.626 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 -35.34 4.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.444 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 2.5 m-85 -102.96 136.99 41.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.428 ' HD2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -86.11 152.23 23.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.096 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -64.02 132.56 50.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.371 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 21.1 t-20 -152.56 156.99 40.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.443 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.802 HG13 HD11 ' A' ' 47' ' ' ILE . 3.3 m -127.81 129.49 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 111.281 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.2 147.03 18.3 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.177 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.882 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -122.34 103.35 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.699 0.285 . . . . 0.0 111.324 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 110' ' ' PHE . 53.4 t -89.48 103.82 16.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 33.3 tp -103.19 144.56 31.16 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.035 0.445 . . . . 0.0 111.319 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.8 ptt? -129.11 157.45 41.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.606 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.8 p-10 -98.35 172.51 7.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.349 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -60.45 -15.43 26.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 0.38 56.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mtpp 77.57 27.16 0.63 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.536 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.783 ' C ' HD13 ' A' ' 28' ' ' ILE . 11.6 mmtm -99.11 175.67 5.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.861 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -107.62 147.28 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.861 0.362 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' HE2' HD13 ' A' ' 119' ' ' ILE . 10.8 t80 -82.67 104.94 13.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.758 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.73 129.89 56.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.31 137.13 52.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.03 152.81 26.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.764 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 5.0 mtp-105 -68.04 163.37 22.48 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.397 0.617 . . . . 0.0 111.728 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.1 mt -97.8 -7.66 30.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.384 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.1 -18.95 4.88 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.207 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.594 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 63.1 mt -121.02 112.41 33.41 Favored Pre-proline 0 N--CA 1.457 -0.083 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.149 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.43 132.03 29.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.939 1.759 . . . . 0.0 111.655 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t70 78.15 1.8 2.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.767 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.3 97.24 10.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.13 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD1' HD22 ' A' ' 145' ' ' LEU . 55.2 m95 -103.0 159.67 15.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.166 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -168.5 -178.01 3.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 36.3 mtm -109.4 156.58 39.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.77 128.43 18.9 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.584 2.189 . . . . 0.0 112.674 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' OE1' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.32 156.69 37.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 144.82 10.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.442 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.78 140.67 43.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.802 HD11 HG13 ' A' ' 17' ' ' VAL . 4.4 mt -69.9 160.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.19 169.12 11.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.208 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.26 98.74 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.207 0.527 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.2 9.34 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.878 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 10.7 tp10 -112.53 145.16 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.093 0.473 . . . . 0.0 110.846 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.64 133.82 73.24 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.422 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HA ' HG11 ' A' ' 17' ' ' VAL . 53.3 Cg_exo -52.48 -39.43 74.34 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.369 2.046 . . . . 0.0 112.569 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.0 tpp85 -72.11 -27.84 62.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -85.12 -45.18 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.541 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.13 -32.62 71.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.368 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.22 -54.06 10.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.101 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' ARG . 48.9 mt -56.2 -29.1 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.291 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 ttp85 -82.58 -52.97 6.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.753 0.787 . . . . 0.0 109.872 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -51.78 -47.12 64.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.534 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -54.62 -56.3 20.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.886 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 6.6 ttp-105 -59.8 -15.14 18.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.293 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -92.06 -40.09 11.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.846 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -91.5 -25.29 19.34 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.827 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.57 -20.85 8.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.755 0.312 . . . . 0.0 111.063 -179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 76.72 1.39 71.79 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.015 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.683 HG13 ' HE1' ' A' ' 112' ' ' PHE . 46.0 t -69.42 116.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.809 0.338 . . . . 0.0 110.615 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 -32.37 11.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.827 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.59 79.32 6.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.3 129.15 13.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.706 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 3.4 pt-20 -118.44 146.86 44.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.968 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.6 t -79.54 121.25 32.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 111.436 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.929 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -101.7 -20.79 5.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.391 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -153.14 160.24 42.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.07 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.8 pt-20 -148.43 116.02 6.28 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.169 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.844 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.3 t -57.38 129.14 79.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.0 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.61 -16.32 46.6 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.744 2.296 . . . . 0.0 113.612 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.607 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -127.75 -179.43 4.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.458 0.647 . . . . 0.0 112.533 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.807 ' C ' HD23 ' A' ' 80' ' ' LEU . 11.7 m95 -104.2 147.71 27.15 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.407 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.807 HD23 ' C ' ' A' ' 79' ' ' TRP . 1.4 mt -113.08 117.52 32.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.719 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.847 HG22 ' CB ' ' A' ' 104' ' ' ALA . 16.5 p -111.4 131.14 55.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.723 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.873 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -125.72 170.24 11.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.368 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -130.86 156.5 44.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.744 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CZ ' ' O1A' ' A' ' 166' ' ' ATP . 4.8 m-85 -105.71 147.51 34.82 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.612 ' HG2' HG23 ' A' ' 88' ' ' VAL . 28.2 Cg_endo -63.04 169.94 8.32 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.416 2.077 . . . . 0.0 112.29 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.68 -16.35 52.35 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.918 2.412 . . . . 0.0 113.338 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -34.41 13.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.113 0.482 . . . . 0.0 110.096 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.612 HG23 ' HG2' ' A' ' 85' ' ' PRO . 84.1 t -82.68 -47.17 18.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.259 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -45.4 92.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.486 0.66 . . . . 0.0 109.614 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.753 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.2 tp10 -69.88 -27.22 64.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.737 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -46.64 17.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.542 HD13 ' O2A' ' A' ' 166' ' ' ATP . 96.1 mt -60.56 -46.89 88.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.963 0.411 . . . . 0.0 110.474 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.6 OUTLIER -46.42 -33.46 3.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.733 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.753 HD12 ' O ' ' A' ' 90' ' ' GLU . 4.2 mt -96.59 -46.22 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.438 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -55.05 11.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.0 m0 -79.61 -34.01 41.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.845 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.92 35.92 33.78 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.374 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 147.37 47.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.742 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -108.34 73.82 0.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.428 ' CD1' ' HD2' ' A' ' 14' ' ' ARG . 52.5 m95 -135.11 150.4 50.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.743 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 2.1 mptp? -88.35 -21.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -175.68 -146.4 5.87 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.915 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -157.94 116.29 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.847 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.84 112.7 21.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -128.98 152.93 48.06 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.29 95.99 6.05 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 178.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.557 ' CD2' HG21 ' A' ' 157' ' ' VAL . 48.6 m95 -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.3 0.571 . . . . 0.0 112.472 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.1 m-85 -133.05 134.82 44.87 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.09 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 16.6 tp -79.53 143.01 35.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.882 ' CD1' HG23 ' A' ' 19' ' ' ILE . 42.4 m-85 -136.97 127.5 26.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.929 ' HB3' HD11 ' A' ' 73' ' ' ILE . 25.8 tttp -91.71 121.24 33.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.683 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.9 t80 -65.8 127.0 30.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.204 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 69' ' ' SER . 2.1 p -126.27 37.31 4.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.434 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.76 -144.55 4.93 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.982 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 153.8 47.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.173 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD1' ' CH2' ' A' ' 134' ' ' TRP . 3.6 m-20 -52.12 -14.93 0.48 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.674 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -80.73 -20.36 42.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.254 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.54 -25.53 45.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 110.807 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.573 HD13 ' HE2' ' A' ' 29' ' ' PHE . 25.9 mt -67.08 104.58 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.459 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.553 HD21 HD12 ' A' ' 122' ' ' LEU . 29.4 t30 -122.06 95.8 4.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.119 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 131' ' ' PHE . 36.6 mt -56.3 -21.89 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.553 HD12 HD21 ' A' ' 120' ' ' ASN . 8.3 mt -60.8 -56.93 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 109.882 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.99 -175.59 22.56 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.487 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -91.98 38.97 1.0 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.76 72.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.958 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -121.15 -69.96 0.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.96 165.13 17.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.42 147.02 45.87 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 128.42 27.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.623 2.215 . . . . 0.0 112.53 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.408 ' C ' HD12 ' A' ' 34' ' ' LEU . 23.4 mp0 -111.54 -34.77 5.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.81 ' HB2' HD13 ' A' ' 121' ' ' LEU . 5.1 m-85 -108.02 159.61 16.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.334 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.9 -19.52 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.815 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.423 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 13.9 mm-40 -152.45 175.22 12.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.145 0.498 . . . . 0.0 110.592 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.8 p-90 -155.95 154.05 30.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.077 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.15 159.48 42.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.556 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 70.4 m95 -93.96 126.7 39.32 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.615 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.768 HG11 HD11 ' A' ' 145' ' ' LEU . 35.7 m -135.88 152.84 31.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.96 0.41 . . . . 0.0 111.854 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 p -72.49 152.17 91.81 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.811 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.3 Cg_endo -49.12 -22.13 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -88.25 -33.79 17.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -50.53 33.81 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.189 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.963 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.5 tp -53.35 -32.82 51.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.462 0.649 . . . . 0.0 109.828 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.689 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.9 mm -67.2 -28.05 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.796 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.38 -22.64 41.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.232 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.963 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.8 mt -83.09 -39.55 21.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.066 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 150' ' ' LYS . 22.5 m -56.28 164.63 1.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.563 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -101.24 160.42 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.003 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 147' ' ' VAL . 24.4 mt-10 -45.43 -46.09 13.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.359 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.563 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -75.29 -5.09 42.84 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.459 ' O ' HG21 ' A' ' 146' ' ' THR . 13.5 mtmt -121.73 -4.13 9.21 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mttt -57.76 -62.39 5.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.541 0.21 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.1 Cg_endo -61.14 -45.81 17.91 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.467 2.111 . . . . 0.0 112.241 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.873 HG21 ' HB3' ' A' ' 82' ' ' TYR . 23.0 t -56.84 -27.07 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.13 -52.32 4.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -50.74 -32.62 20.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.317 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.6 tp10 -64.88 -46.01 83.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.492 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.0 t -59.49 -52.36 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.191 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 139' ' ' PRO . 70.2 mt -59.97 -49.2 78.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.841 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 m -49.15 -46.43 45.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.639 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.1 t -69.61 -25.28 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.029 0.443 . . . . 0.0 110.366 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.29 12.37 33.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.999 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.98 -58.28 14.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.0 Cg_endo -56.76 -21.81 41.7 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.433 2.088 . . . . 0.0 112.275 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.412 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 63.7 m-70 -90.01 -12.54 38.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.126 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.314 -0.85 . . . . 0.0 110.927 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.542 ' O2A' HD13 ' A' ' 92' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.89 -168.73 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.662 2.241 . . . . 0.0 112.266 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 5' ' ' SER . 0.1 OUTLIER 63.41 124.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.05 -27.74 8.1 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.591 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.814 ' O ' HD12 ' A' ' 3' ' ' LEU . 27.4 p -124.13 -156.72 0.73 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.925 0.393 . . . . 0.0 110.09 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.4 mmt -142.66 -33.65 0.46 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.938 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 52.6 27.07 4.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.826 0.346 . . . . 0.0 111.27 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t 178.24 125.64 0.2 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 37.8 Cg_endo -67.15 109.32 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.404 2.069 . . . . 0.0 112.264 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 2.8 Cg_exo -75.55 -173.89 1.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.889 2.393 . . . . 0.0 112.082 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.98 147.38 23.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.834 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.36 -22.33 35.68 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -105.04 136.25 44.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.943 0.402 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.8 OUTLIER -87.97 152.22 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -69.93 134.33 48.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.111 0.481 . . . . 0.0 111.441 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.8 t-20 -152.46 158.88 43.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.779 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.4 m -128.18 130.0 69.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.969 0.414 . . . . 0.0 111.584 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.98 139.31 14.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.132 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.797 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -112.93 104.43 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.321 . . . . 0.0 111.417 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 110' ' ' PHE . 52.5 t -89.54 105.08 17.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 110' ' ' PHE . 40.4 tp -103.36 141.84 35.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.983 0.42 . . . . 0.0 111.126 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.63 157.39 35.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.7 p-10 -100.84 170.53 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.267 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -57.13 -16.37 7.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.418 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.17 -0.08 57.16 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.702 0.287 . . . . 0.0 111.045 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttt 77.53 26.67 0.66 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.564 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mmtt -97.85 175.87 6.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.565 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.6 mp -115.31 126.88 73.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.932 0.396 . . . . 0.0 110.889 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.891 ' CE1' HG21 ' A' ' 119' ' ' ILE . 66.3 t80 -59.47 110.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.379 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.602 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.86 130.0 56.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.2 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.02 136.74 52.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.971 0.415 . . . . 0.0 111.472 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.43 155.16 24.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.646 179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.542 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -71.98 156.98 38.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.284 0.564 . . . . 0.0 111.413 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.16 -5.36 52.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -127.52 -19.62 4.16 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.039 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 59.6 mt -119.54 112.44 35.58 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.904 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.46 131.66 28.74 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.905 1.737 . . . . 0.0 111.737 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t70 77.17 4.21 3.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.766 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.66 97.4 11.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.339 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.514 ' CD1' HD22 ' A' ' 145' ' ' LEU . 34.8 m95 -103.93 156.94 17.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.101 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -168.76 177.23 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.774 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.46 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 35.8 mtm -103.2 155.43 36.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.809 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.46 139.9 55.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.594 2.196 . . . . 0.0 112.67 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.19 158.18 39.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.74 140.37 6.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.586 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.74 139.87 48.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.451 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 17' ' ' VAL . 6.7 mt -71.42 160.32 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 0.0 110.546 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.3 148.52 22.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.85 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -49.15 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.188 0.518 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.64 40.62 14.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.884 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.9 tp10 -113.3 145.74 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.13 0.491 . . . . 0.0 110.938 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -72.87 124.05 90.28 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.156 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.677 ' O ' HG11 ' A' ' 17' ' ' VAL . 5.3 Cg_endo -48.97 -50.83 11.78 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.484 2.123 . . . . 0.0 112.818 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 58' ' ' ILE . 33.1 ttt180 -57.44 -30.53 65.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 111.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -83.23 -47.12 11.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.345 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.38 -30.32 66.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.407 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.779 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.86 -51.93 14.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.109 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 54' ' ' ARG . 28.4 mt -57.02 -29.6 31.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.099 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -81.19 -53.15 6.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.877 0.846 . . . . 0.0 109.739 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -54.98 -31.88 61.2 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.479 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.863 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.3 tp -57.26 -62.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.604 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.5 ptt85 -61.22 -10.91 7.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.973 0.415 . . . . 0.0 110.456 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -91.5 -39.47 11.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.252 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.52 -33.66 15.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.158 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.93 -24.5 7.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 81.54 -0.21 88.28 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.668 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.863 ' HB ' HD11 ' A' ' 61' ' ' LEU . 46.6 t -63.68 118.99 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.311 . . . . 0.0 110.448 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -33.95 10.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.404 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.22 76.43 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.245 0.545 . . . . 0.0 110.805 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.25 13.41 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.973 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -120.31 148.85 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 110' ' ' PHE . 55.4 t -79.21 125.04 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.492 0.663 . . . . 0.0 111.901 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.884 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -104.93 -20.56 5.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.066 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -152.2 161.21 42.96 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -148.16 113.25 5.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.816 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.2 t -57.23 124.76 68.15 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.032 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.59 -5.72 17.26 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.802 2.335 . . . . 0.0 113.925 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.569 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -131.21 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 112.399 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -79.03 147.36 32.88 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 153' ' ' VAL . 48.7 mt -115.97 117.74 30.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.842 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.839 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -114.78 131.67 56.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.585 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.789 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -127.56 170.07 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.52 158.44 39.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.912 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -110.55 153.54 43.49 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.751 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.578 ' HG2' HG23 ' A' ' 88' ' ' VAL . 34.3 Cg_endo -64.25 171.61 7.55 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.529 2.153 . . . . 0.0 112.328 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.39 -17.77 58.59 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.79 2.327 . . . . 0.0 113.215 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 -34.29 15.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.193 0.52 . . . . 0.0 110.16 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.578 HG23 ' HG2' ' A' ' 85' ' ' PRO . 78.9 t -82.33 -48.25 18.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -45.62 90.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.489 0.662 . . . . 0.0 109.547 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.636 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.9 tt0 -68.55 -27.0 65.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.669 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -78.7 -46.51 18.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.597 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' A' ' 96' ' ' TRP . 96.0 mt -59.11 -46.46 88.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -46.44 -32.73 3.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.605 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.636 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.56 -47.44 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.533 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -55.15 9.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.5 ' CG ' HD22 ' A' ' 92' ' ' LEU . 10.7 m0 -79.22 -30.72 43.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.952 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.28 37.37 48.34 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.417 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.19 147.57 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.685 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.92 48.23 1.04 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.928 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 57.1 m95 -111.46 150.18 30.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.695 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -27.81 44.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.617 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.48 -143.42 4.03 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.994 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -157.92 117.28 3.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.757 0.313 . . . . 0.0 111.365 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.839 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.74 107.61 17.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -123.16 151.93 41.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 96.84 6.49 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.43 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.492 ' CD2' HG21 ' A' ' 157' ' ' VAL . 52.1 m95 -62.7 147.86 48.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -130.99 135.14 47.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.825 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.2 tp -79.7 147.92 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.138 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.841 ' O ' HD12 ' A' ' 21' ' ' LEU . 27.3 m-85 -140.92 128.02 20.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.87 0.367 . . . . 0.0 111.567 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.884 ' HB3' HD11 ' A' ' 73' ' ' ILE . 31.3 tttt -91.79 119.96 32.08 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.674 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.9 t80 -64.87 125.14 23.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 111' ' ' LYS . 10.7 p -126.86 37.62 4.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.658 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.404 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.25 -144.92 4.75 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.066 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -127.86 154.12 45.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -50.26 -16.23 0.31 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.657 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -79.03 -18.63 53.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.731 0.3 . . . . 0.0 111.232 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.33 -25.61 42.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.891 HG21 ' CE1' ' A' ' 29' ' ' PHE . 22.9 mt -79.01 105.84 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.502 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -124.78 96.7 4.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.08 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.815 HD13 ' HB2' ' A' ' 131' ' ' PHE . 36.6 mt -47.62 -21.8 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.232 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD22 ' HG3' ' A' ' 129' ' ' PRO . 88.1 mt -57.5 -59.33 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.351 0.596 . . . . 0.0 109.99 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 133.08 -176.62 19.46 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.1 p30 -89.47 38.7 0.91 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.2 26.1 72.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.271 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -100.98 -64.12 1.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.708 0.289 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -112.52 165.14 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.1 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 144.8 91.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.863 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HG3' HD22 ' A' ' 122' ' ' LEU . 50.6 Cg_exo -53.05 135.88 59.94 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.581 2.188 . . . . 0.0 112.474 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -110.84 -29.55 7.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.73 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.815 ' HB2' HD13 ' A' ' 121' ' ' LEU . 9.7 m-85 -110.2 159.27 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.14 -19.78 5.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.795 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.469 ' C ' HD11 ' A' ' 121' ' ' LEU . 25.5 mm-40 -152.43 175.08 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 110.438 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.487 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.07 155.46 27.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.2 m -153.84 158.71 41.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.348 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.475 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 79.5 m95 -90.98 123.72 34.68 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.836 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 145' ' ' LEU . 29.5 m -134.34 149.88 30.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.503 . . . . 0.0 111.497 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -68.65 158.65 84.93 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.581 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' CA ' HD13 ' A' ' 158' ' ' LEU . 12.0 Cg_endo -55.74 -19.17 23.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.875 1.717 . . . . 0.0 111.923 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -90.84 -34.21 15.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.078 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.68 -50.73 27.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.988 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.894 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.7 tp -54.1 -32.72 55.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.431 0.634 . . . . 0.0 109.79 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.566 HD12 ' HG3' ' A' ' 155' ' ' LYS . 5.6 mm -67.9 -28.16 40.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.09 -20.98 40.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.2 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.894 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.2 mt -84.75 -39.28 18.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.121 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 150' ' ' LYS . 58.2 m -59.46 151.07 24.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.152 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.836 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.7 p -80.78 160.09 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.0 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 147' ' ' VAL . 4.6 mt-10 -51.75 -35.26 42.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.836 ' CE2' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -83.41 4.9 25.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.509 ' O ' HG21 ' A' ' 146' ' ' THR . 22.1 mttm -133.97 6.28 3.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.532 0.206 . . . . 0.0 111.304 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.5 mttt -62.32 -62.76 5.17 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.04 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 19.3 Cg_endo -58.74 -41.81 59.7 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.449 2.099 . . . . 0.0 112.051 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' A' ' 80' ' ' LEU . 17.3 t -58.34 -25.99 28.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.998 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.46 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.3 m-85 -91.1 -50.2 5.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.609 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.566 ' HG3' HD12 ' A' ' 143' ' ' ILE . 39.3 mttp -51.39 -33.52 30.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.819 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.0 tp10 -65.59 -45.81 81.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.746 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.492 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 48.4 t -61.02 -51.62 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.203 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.586 HD13 ' CA ' ' A' ' 139' ' ' PRO . 72.3 mt -62.59 -49.19 76.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.902 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.7 t -49.79 -47.15 51.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.677 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.816 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.1 t -68.72 -25.06 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.825 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.07 10.79 35.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.001 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -57.99 13.9 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.293 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.9 Cg_endo -55.69 -21.76 33.3 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.464 2.109 . . . . 0.0 112.084 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.425 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 63.6 m-70 -92.53 -17.7 24.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.933 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.45 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.115 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.49 -168.49 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.647 2.231 . . . . 0.0 112.297 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.9 mt 60.1 -178.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.0 55.33 0.73 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.453 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -166.65 125.17 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.455 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 79' ' ' TRP . 10.7 tpp -126.84 105.35 8.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.19 24.43 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.597 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 174.94 121.71 0.12 Allowed Pre-proline 0 CA--C 1.529 0.15 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.47 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.65 111.13 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.224 1.95 . . . . 0.0 112.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.82 -169.37 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.786 2.324 . . . . 0.0 112.385 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.09 161.38 15.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.27 -31.2 7.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.28 134.81 53.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.0 ptt85 -79.15 152.86 30.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.133 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 mmp_? -57.51 139.07 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.9 m120 -153.12 161.41 42.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.86 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.2 m -141.93 123.82 13.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.088 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 147.37 18.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.286 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.925 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -122.11 101.62 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.729 0.299 . . . . 0.0 111.275 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.7 t -89.89 104.94 17.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 110' ' ' PHE . 22.3 tp -102.97 148.16 26.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.1 ptt? -130.39 157.4 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.67 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 33.9 p-10 -104.32 169.35 8.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.269 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.72 -17.05 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.53 56.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.714 0.293 . . . . 0.0 111.006 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 76.42 26.71 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -98.1 172.53 7.55 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -109.35 121.12 61.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.064 0.459 . . . . 0.0 111.06 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.796 ' CD2' HD23 ' A' ' 21' ' ' LEU . 5.0 t80 -55.28 107.82 0.35 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.267 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.81 141.8 47.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.758 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -126.37 139.4 53.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.345 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.483 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.71 158.29 22.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.621 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -75.12 159.69 31.35 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.31 0.576 . . . . 0.0 111.527 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -94.49 -5.43 46.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.951 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.09 -16.99 3.95 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.619 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.7 mt -121.34 112.61 32.8 Favored Pre-proline 0 N--CA 1.454 -0.253 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.18 131.75 29.53 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.906 1.738 . . . . 0.0 111.788 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 t0 76.66 4.08 3.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.619 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.39 97.48 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.423 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.658 ' CD1' HD22 ' A' ' 145' ' ' LEU . 38.8 m95 -101.66 155.34 18.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.141 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -169.03 -176.61 2.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.787 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 4.3 mtm -113.71 154.4 45.75 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.73 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.46 142.35 78.01 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.599 2.199 . . . . 0.0 112.413 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -154.07 173.73 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -151.94 178.79 28.99 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.578 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 47' ' ' ILE . . . -112.92 23.91 13.76 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.689 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.738 HD11 HG13 ' A' ' 17' ' ' VAL . 3.5 mt 51.26 157.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 0.0 111.643 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.77 176.64 6.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -65.71 98.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.221 0.534 . . . . 0.0 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.86 49.28 29.52 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.757 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 3.4 tt0 -112.65 148.14 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.094 0.473 . . . . 0.0 110.996 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -69.08 135.1 89.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.254 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.742 ' O ' HG11 ' A' ' 17' ' ' VAL . 76.7 Cg_exo -51.14 -60.41 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.454 2.103 . . . . 0.0 112.864 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -55.57 -26.53 44.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -82.34 -49.01 10.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.697 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -57.79 -31.1 66.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.86 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.1 -53.11 11.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.119 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -56.08 -29.04 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.186 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -83.79 -52.61 6.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.785 0.802 . . . . 0.0 109.945 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.44 -48.49 65.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.668 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -53.6 -55.51 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.582 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 62.8 ttp85 -58.7 -15.25 11.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -91.97 -37.64 12.72 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.715 0.293 . . . . 0.0 111.759 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -90.71 -28.73 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.734 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.92 -21.35 6.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.915 0.388 . . . . 0.0 111.278 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.91 5.19 69.22 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.141 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG13 ' HE1' ' A' ' 112' ' ' PHE . 24.5 t -61.79 108.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.929 0.364 . . . . 0.0 110.306 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.74 -34.4 15.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.322 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.413 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.02 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.203 0.525 . . . . 0.0 110.997 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.34 127.24 11.85 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.853 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.88 148.83 43.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.678 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 43.6 t -77.94 127.1 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.853 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.95 -20.32 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.28 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.87 161.97 40.5 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.232 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.4 pt-20 -148.41 113.82 5.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.257 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.74 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.6 t -57.55 125.36 71.91 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.185 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.27 -10.02 25.12 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.811 2.341 . . . . 0.0 113.617 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.53 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.45 133.6 48.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.321 0.582 . . . . 0.0 112.065 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' A' ' 6' ' ' MET . 24.8 m95 -65.39 147.21 53.82 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.693 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.717 ' HB3' HG13 ' A' ' 153' ' ' VAL . 43.9 mt -113.17 117.63 32.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.779 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.841 HG22 ' CB ' ' A' ' 104' ' ' ALA . 3.6 p -114.52 132.21 56.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.914 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.747 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -131.4 170.11 15.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -125.94 158.25 35.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.091 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -109.83 154.64 42.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.58 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.4 Cg_endo -62.96 170.93 6.71 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.484 2.123 . . . . 0.0 112.263 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.88 -17.24 59.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.834 2.356 . . . . 0.0 113.087 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -92.02 -33.62 14.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.181 0.515 . . . . 0.0 110.129 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.58 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.6 t -83.48 -48.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.338 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -45.18 91.57 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.512 0.672 . . . . 0.0 109.342 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.577 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -68.8 -27.72 66.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.6 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -47.2 21.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.418 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.463 HD22 ' CD1' ' A' ' 96' ' ' TRP . 95.5 mt -57.55 -46.56 83.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.453 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -46.0 -32.01 2.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.522 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.4 mt -96.39 -49.32 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.147 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -57.08 7.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.779 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.463 ' CD1' HD22 ' A' ' 92' ' ' LEU . 13.0 m0 -76.98 -34.35 57.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.87 34.89 29.48 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.412 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.58 147.2 49.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.028 0.442 . . . . 0.0 110.729 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -109.63 48.6 0.87 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -105.71 149.98 25.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.757 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -30.33 63.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.723 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -168.47 -139.63 2.74 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.071 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.96 116.25 3.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 111.584 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.841 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.84 108.36 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.7 pt20 -120.16 150.85 39.98 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.3 mttt -107.91 95.88 5.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.19 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.585 ' CD2' HG21 ' A' ' 157' ' ' VAL . 49.4 m95 -62.97 138.96 58.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 112.259 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.9 m-85 -124.85 132.44 53.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.937 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.85 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.2 tp -79.59 131.15 35.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.925 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.5 m-85 -125.49 129.57 50.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 111.498 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 28.1 tttt -93.53 121.08 34.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.5 t80 -66.2 123.32 19.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.86 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 69' ' ' SER . 11.1 p -124.66 37.51 4.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.613 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -137.47 -144.79 4.81 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.07 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -128.35 154.14 46.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -49.93 -16.72 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -20.24 57.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.286 . . . . 0.0 111.131 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.61 -25.18 49.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.39 103.49 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 65' ' ' THR . 63.7 t30 -119.06 95.48 4.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.988 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 131' ' ' PHE . 52.3 mt -54.78 -21.93 12.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.783 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.94 -59.23 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.218 0.533 . . . . 0.0 109.943 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.64 -171.52 25.9 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.447 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -94.39 38.83 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.119 0.485 . . . . 0.0 109.936 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.2 27.13 72.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.209 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.4 t -106.0 -64.28 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.0 111.202 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -115.48 163.48 15.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.212 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.35 152.37 54.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.11 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.23 179.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.784 2.323 . . . . 0.0 112.581 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -148.39 -44.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.713 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 121' ' ' LEU . 31.7 m-85 -110.59 159.59 17.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.421 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -113.72 -20.78 5.97 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.587 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.483 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.1 mm-40 -152.34 174.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.172 0.51 . . . . 0.0 110.526 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.4 p-90 -159.54 157.45 29.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.073 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.1 p -154.51 160.49 41.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.455 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 82.5 m95 -93.63 123.43 36.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.54 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.731 HG11 HD11 ' A' ' 145' ' ' LEU . 30.2 m -134.88 150.43 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 111.777 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.509 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -69.59 160.64 78.72 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.598 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.597 ' CB ' HD13 ' A' ' 158' ' ' LEU . 16.6 Cg_endo -57.84 -17.62 30.77 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.832 1.688 . . . . 0.0 111.885 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -91.74 -34.07 14.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.07 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.01 -50.75 25.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.027 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.933 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.7 tp -54.24 -31.04 52.36 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.489 0.661 . . . . 0.0 109.83 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.54 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.8 mm -68.58 -28.44 40.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.621 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.78 -20.72 42.0 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.27 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.7 mt -84.74 -39.11 18.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.119 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 150' ' ' LYS . 26.0 m -56.74 163.63 1.81 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.73 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.5 p -91.66 164.96 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.096 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.5 ' N ' HG22 ' A' ' 147' ' ' VAL . 8.6 mt-10 -55.23 -35.06 64.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.925 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.73 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.5 p90 -90.5 11.09 22.85 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.608 ' HB2' HG12 ' A' ' 147' ' ' VAL . 2.1 mtmp? -133.23 -3.68 3.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.537 0.208 . . . . 0.0 111.513 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.43 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttm -58.98 -62.8 5.09 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.577 0.227 . . . . 0.0 111.192 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 17.3 Cg_endo -57.92 -41.61 67.1 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.8 t -59.75 -28.05 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.935 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.2 m-85 -91.16 -51.4 5.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.66 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.54 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.78 -32.82 21.04 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.5 tp10 -66.21 -45.65 79.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.565 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.585 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.3 t -58.97 -48.93 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.23 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.597 HD13 ' CB ' ' A' ' 139' ' ' PRO . 77.3 mt -62.24 -48.68 78.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.723 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.9 m -49.67 -47.21 50.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.739 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.5 t -69.28 -25.43 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.85 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.6 m-30 -103.3 11.66 36.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.985 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.1 -57.69 16.95 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.486 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.8 Cg_endo -55.78 -22.04 35.28 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.511 2.141 . . . . 0.0 112.356 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.532 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 91.3 m-70 -90.33 -15.09 31.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.087 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.866 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.448 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.31 -167.52 0.25 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.626 2.217 . . . . 0.0 112.307 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 61.82 161.14 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.75 72.32 0.35 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.405 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.5 m -146.3 112.05 5.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.95 0.405 . . . . 0.0 110.764 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.08 105.57 15.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.76 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -80.9 24.47 0.5 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.554 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 177.62 128.63 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.511 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 19.4 Cg_endo -60.46 110.8 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.327 2.018 . . . . 0.0 112.165 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.2 Cg_exo -79.62 -177.59 3.96 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.92 2.413 . . . . 0.0 112.071 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -90.36 151.21 21.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.832 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.05 -27.37 16.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.663 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -98.23 138.53 35.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.952 0.406 . . . . 0.0 111.084 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.87 152.29 24.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -71.82 129.85 39.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 14.3 t-20 -152.84 161.89 41.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.87 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.787 HG13 HD11 ' A' ' 47' ' ' ILE . 1.7 m -131.54 135.53 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 111.458 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -103.8 150.62 17.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.101 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.911 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -126.7 101.89 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.822 0.344 . . . . 0.0 111.506 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 t -89.75 100.43 13.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.4 tp -102.79 143.65 32.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.044 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 2.8 ptt? -126.22 157.5 38.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.934 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 40.5 p-10 -98.98 170.95 8.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.76 -16.11 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.491 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -89.14 1.06 56.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 64.8 mttt 76.29 26.97 0.89 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' MET . 8.3 mttt -99.17 171.62 7.89 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -109.94 122.76 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.902 0.382 . . . . 0.0 110.966 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.761 ' CE1' HG21 ' A' ' 119' ' ' ILE . 86.7 t80 -55.17 111.25 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.12 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.52 130.34 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.31 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.03 138.72 50.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.041 0.448 . . . . 0.0 111.193 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.25 158.07 23.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.632 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.704 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtp85 -73.35 159.72 32.9 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.317 0.58 . . . . 0.0 111.51 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.0 mt -93.36 -5.48 49.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.921 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.61 -17.76 3.62 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.704 HD12 ' CD ' ' A' ' 33' ' ' ARG . 69.6 mt -120.68 112.76 33.69 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.099 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.47 132.27 30.68 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.887 1.725 . . . . 0.0 111.684 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t70 76.76 4.82 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.726 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.617 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.36 97.56 11.26 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.41 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CD1' HD22 ' A' ' 145' ' ' LEU . 19.2 m95 -103.36 155.58 18.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.126 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.72 170.95 9.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.448 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 68.1 mtm -90.04 153.87 47.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.689 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.29 139.14 41.1 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.156 . . . . 0.0 112.666 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.77 162.6 40.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.669 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.86 141.8 7.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.602 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -58.44 140.87 46.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.542 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.787 HD11 HG13 ' A' ' 17' ' ' VAL . 3.7 mt -72.66 159.29 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.496 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -90.58 148.66 22.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.09 99.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.225 0.536 . . . . 0.0 110.955 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.23 40.42 13.66 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.913 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.3 tp10 -110.75 147.5 34.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.159 0.504 . . . . 0.0 110.859 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.93 130.56 80.78 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.412 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.571 ' HA ' HG11 ' A' ' 17' ' ' VAL . 55.0 Cg_exo -52.04 -25.7 23.25 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.377 2.051 . . . . 0.0 112.538 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' CB ' ' CE2' ' A' ' 108' ' ' PHE . 9.7 ttt180 -86.61 -22.05 26.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.984 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -91.08 -40.29 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 110.31 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.461 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -64.17 -30.37 71.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.283 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.666 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -74.68 -50.96 15.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 54' ' ' ARG . 59.1 mt -57.6 -30.14 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.101 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -81.36 -53.14 6.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.867 0.842 . . . . 0.0 109.908 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.79 -49.34 65.78 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.91 HD22 HG21 ' A' ' 19' ' ' ILE . 3.3 tp -54.97 -55.15 33.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.973 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 50.3 ttp85 -61.44 -13.44 20.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.544 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -91.95 -43.0 9.7 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.957 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -91.38 -25.33 19.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.788 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.36 -20.27 8.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.361 . . . . 0.0 111.057 -179.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.9 7.59 62.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.068 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.656 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.2 t -67.25 115.62 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.856 0.36 . . . . 0.0 110.383 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.64 -34.04 11.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.195 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.3 76.33 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.197 0.522 . . . . 0.0 111.051 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.51 129.07 13.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -116.33 147.63 41.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.02 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.2 t -77.03 119.12 24.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.325 0.583 . . . . 0.0 111.068 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.919 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -93.41 -26.05 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.837 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.59 171.37 20.25 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.518 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.425 ' CG ' ' CE2' ' A' ' 108' ' ' PHE . 29.2 tt0 -148.65 118.76 7.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.583 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.747 ' HA ' HG11 ' A' ' 160' ' ' VAL . 8.1 t -58.21 123.95 68.07 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.61 -17.05 58.32 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.723 2.282 . . . . 0.0 113.312 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.67 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.77 -178.54 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.907 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.454 ' C ' HD23 ' A' ' 80' ' ' LEU . 13.0 m95 -110.5 146.3 36.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.874 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.596 ' HB3' HG13 ' A' ' 153' ' ' VAL . 9.5 mt -112.73 117.61 32.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.064 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.833 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.7 p -109.76 132.35 54.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.699 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.821 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -129.08 161.58 29.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.624 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.9 158.37 29.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.383 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' CD2' HD12 ' A' ' 92' ' ' LEU . 1.5 m-85 -104.26 150.85 38.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.584 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.583 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.3 Cg_endo -62.28 168.42 9.48 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.444 2.096 . . . . 0.0 111.956 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.1 -16.2 48.79 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.781 2.321 . . . . 0.0 113.188 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -93.09 -39.18 11.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.239 0.542 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.583 HG23 ' HG2' ' A' ' 85' ' ' PRO . 82.0 t -78.51 -45.54 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.54 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -62.01 -47.13 86.16 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.526 0.679 . . . . 0.0 109.53 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -25.37 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.675 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -45.42 14.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.596 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.647 HD22 ' CG ' ' A' ' 96' ' ' TRP . 42.8 mt -57.21 -41.7 79.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.469 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -45.62 -35.39 4.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.64 ' N ' HD12 ' A' ' 94' ' ' ILE . 3.3 mp -96.6 -47.22 12.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.29 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -65.93 -56.12 13.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.963 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.647 ' CG ' HD22 ' A' ' 92' ' ' LEU . 17.2 m0 -81.51 -33.77 31.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.1 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 79.73 37.26 23.56 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.428 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.35 147.6 50.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 110.73 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.7 38.14 3.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -96.49 150.35 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.644 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -26.34 36.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.078 0.466 . . . . 0.0 110.396 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.61 -152.3 8.53 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.585 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -152.81 116.7 4.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.71 0.29 . . . . 0.0 111.084 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.833 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.62 105.62 16.32 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -117.65 161.34 19.81 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.13 105.08 12.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.388 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.444 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 74.1 m95 -75.69 136.41 40.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 112.259 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CE2' ' CG ' ' A' ' 75' ' ' GLU . 26.9 m-85 -118.78 133.73 55.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.03 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.919 HD23 ' HB ' ' A' ' 73' ' ' ILE . 17.8 tp -79.57 135.28 36.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.097 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.911 ' CD1' HG23 ' A' ' 19' ' ' ILE . 38.3 m-85 -127.87 133.46 49.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.188 0.518 . . . . 0.0 112.187 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.557 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 0.1 OUTLIER -96.02 119.44 34.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.507 177.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.619 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -68.56 122.89 19.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 110.761 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.4 p -124.54 37.55 4.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.554 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.27 -145.01 4.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.097 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.64 154.19 45.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.84 -16.69 0.28 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.572 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -77.17 -17.98 58.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.714 0.292 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.2 -26.22 42.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 110.645 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.761 HG21 ' CE1' ' A' ' 29' ' ' PHE . 16.4 mt -72.51 98.68 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.341 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -113.89 95.79 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.4 mt -56.58 -21.15 24.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.457 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.866 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -59.67 -56.88 16.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.417 0.627 . . . . 0.0 109.867 179.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 136.85 -174.96 21.37 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.436 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -90.96 38.66 0.96 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.09 29.43 74.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.96 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.8 t -111.79 -64.8 1.24 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.794 0.331 . . . . 0.0 111.38 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.46 165.11 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 146.05 94.68 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.104 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.866 ' HG3' HD13 ' A' ' 122' ' ' LEU . 47.4 Cg_exo -54.84 140.89 78.27 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.607 2.204 . . . . 0.0 112.381 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -110.65 -27.35 8.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.804 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.462 ' HB2' HD13 ' A' ' 121' ' ' LEU . 5.9 m-85 -118.74 159.44 23.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.588 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.5 -16.34 5.59 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.772 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.556 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 4.7 mp0 -152.24 174.27 13.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.161 0.505 . . . . 0.0 110.734 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.4 p-90 -159.59 154.19 24.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.114 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.57 159.63 44.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.366 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 74.7 m95 -93.68 125.82 38.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.567 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 145' ' ' LEU . 27.4 m -138.8 151.17 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.095 0.474 . . . . 0.0 111.696 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.33 160.42 79.12 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.588 ' HD3' HD11 ' A' ' 28' ' ' ILE . 14.4 Cg_endo -57.0 -18.19 27.36 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 121.875 1.717 . . . . 0.0 111.929 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.27 -34.24 14.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.121 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -50.24 37.16 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.977 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.942 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.5 tp -54.49 -31.82 56.67 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.457 0.646 . . . . 0.0 109.75 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.49 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.0 mm -69.84 -27.81 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.622 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.71 -23.56 42.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.065 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.3 mt -81.67 -39.8 23.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.86 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 147' ' ' VAL . 8.8 m -55.73 165.2 0.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.866 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 14.8 p -95.84 161.14 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.931 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.53 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.52 -27.0 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.866 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 23.1 p90 -90.9 10.11 27.68 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' A' ' 82' ' ' TYR . 18.4 mtmt -150.07 13.98 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 111.611 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.53 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.7 mtpp -69.07 -62.79 2.48 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.141 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.3 Cg_endo -51.49 -40.01 63.79 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.513 2.142 . . . . 0.0 111.988 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.821 HG21 ' HB3' ' A' ' 82' ' ' TYR . 22.7 t -58.73 -25.03 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.88 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -91.26 -51.46 5.29 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.541 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HG3' HD12 ' A' ' 143' ' ' ILE . 11.1 mtpt -50.31 -33.95 21.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.463 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 80' ' ' LEU . 6.6 tp10 -64.9 -46.02 83.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.69 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 51.6 t -59.31 -48.43 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.22 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.517 HD13 ' CB ' ' A' ' 139' ' ' PRO . 72.5 mt -64.19 -48.65 75.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.616 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.6 m -49.4 -47.38 47.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.747 HG11 ' HA ' ' A' ' 76' ' ' VAL . 72.1 t -66.8 -24.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.134 0.492 . . . . 0.0 110.459 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.881 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.6 m-30 -101.24 -0.77 35.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.116 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.32 -51.86 24.12 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.333 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -55.74 -22.82 38.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.372 2.048 . . . . 0.0 112.176 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.618 ' ND1' HG22 ' A' ' 73' ' ' ILE . 88.8 m-70 -93.45 -19.55 21.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.656 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.7 mp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.857 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.479 " H2'" HD11 ' A' ' 36' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.99 145.07 54.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.613 2.209 . . . . 0.0 112.297 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 3' ' ' LEU . 4.2 pp -176.55 145.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.76 -32.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.478 ' C ' ' HE2' ' A' ' 6' ' ' MET . 0.3 OUTLIER -125.89 -154.84 0.65 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.894 0.378 . . . . 0.0 110.188 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.537 ' HE3' HG23 ' A' ' 81' ' ' THR . 1.0 OUTLIER -131.2 -44.33 1.03 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.662 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 1.9 t0 70.56 29.42 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.819 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 170.32 119.23 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HD3' ' NE1' ' A' ' 79' ' ' TRP . 21.0 Cg_endo -61.84 110.37 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.203 1.936 . . . . 0.0 111.962 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 6.3 Cg_exo -73.16 -172.7 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.733 2.289 . . . . 0.0 111.87 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -89.87 144.38 25.99 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.141 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' HZ3' ' A' ' 101' ' ' LYS . . . 92.42 -35.99 3.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -72.65 138.74 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.15 0.5 . . . . 0.0 111.107 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 30.2 tpt85 -82.72 152.15 25.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.07 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -79.19 128.21 33.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 8.5 m120 -152.55 163.36 39.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.816 HG13 HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -128.95 135.0 63.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.077 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.84 142.14 15.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.385 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.887 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -119.03 101.17 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.783 0.325 . . . . 0.0 110.954 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.2 t -89.8 103.85 16.47 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 110' ' ' PHE . 42.6 tp -102.87 140.52 37.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 111.11 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -124.54 157.34 35.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.836 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.9 p-10 -101.21 169.5 8.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -54.85 -17.61 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.626 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 0.24 56.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.72 0.295 . . . . 0.0 110.942 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt 76.68 25.8 0.87 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.529 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.7 mttp -96.28 171.65 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 28' ' ' ILE . 4.0 mp -109.55 123.21 65.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.812 ' CE1' HG21 ' A' ' 119' ' ' ILE . 74.9 t80 -57.72 110.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.48 134.35 54.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.303 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.8 135.9 54.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.61 153.85 25.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.625 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.572 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -70.73 157.12 38.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.284 0.564 . . . . 0.0 111.402 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.19 -5.71 52.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -128.56 -18.11 4.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.148 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.3 mt -119.65 107.96 39.95 Favored Pre-proline 0 N--CA 1.456 -0.144 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.911 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 24.8 Cg_exo -62.49 128.93 24.93 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.661 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.0 t0 80.65 2.7 1.79 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.83 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.31 97.46 11.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.422 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.3 m95 -104.97 156.78 17.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -169.0 -177.0 2.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.753 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.44 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 2.9 mpp? -106.49 158.56 32.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 139.98 40.85 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.41 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -154.02 162.23 41.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.788 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.58 18.0 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -69.1 137.4 29.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.645 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.816 HD11 HG13 ' A' ' 17' ' ' VAL . 4.9 mt -70.75 159.55 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.555 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.65 149.61 22.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.921 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.25 98.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.236 0.541 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.08 39.84 11.05 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.919 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.8 tp10 -112.24 147.39 36.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.153 0.501 . . . . 0.0 110.872 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.03 133.79 78.34 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.546 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.595 ' O ' HG11 ' A' ' 17' ' ' VAL . 53.1 Cg_exo -52.56 -55.13 4.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.391 2.06 . . . . 0.0 112.609 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.449 ' O ' HD12 ' A' ' 58' ' ' ILE . 1.2 ttt-85 -59.13 -22.76 61.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.11 -49.66 7.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 0.0 110.733 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.456 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.53 -28.45 65.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.599 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.661 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -75.33 -51.37 13.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.074 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.5 mt -55.71 -30.67 27.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.047 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ttp85 -80.54 -53.23 6.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.825 0.821 . . . . 0.0 109.838 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -55.96 -33.36 64.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.632 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.776 HD11 ' HB ' ' A' ' 67' ' ' VAL . 8.5 tp -58.05 -61.24 2.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.115 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.612 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.9 ptp180 -62.39 -9.17 7.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.981 0.42 . . . . 0.0 110.506 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -89.86 -47.66 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.71 -30.39 17.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.266 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.742 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.07 -22.76 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.576 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 71.07 8.85 65.69 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.957 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.776 ' HB ' HD11 ' A' ' 61' ' ' LEU . 39.7 t -70.35 118.11 14.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.791 0.329 . . . . 0.0 110.342 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.08 -35.18 11.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.17 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.424 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.25 75.78 6.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.37 128.9 13.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.901 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 1.1 mt-10 -119.66 148.96 42.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.688 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.4 t -77.74 128.03 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.454 0.645 . . . . 0.0 111.924 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.46 -19.86 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.381 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.66 164.05 36.33 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.084 0.469 . . . . 0.0 111.622 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -148.98 118.51 6.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.516 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.883 HG11 HD21 ' A' ' 80' ' ' LEU . 3.4 t -57.91 110.39 2.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.059 0.457 . . . . 0.0 110.045 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.77 -23.41 11.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.257 2.638 . . . . 0.0 113.332 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.707 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -112.67 -175.75 2.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.235 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.534 ' C ' HD22 ' A' ' 80' ' ' LEU . 51.3 m95 -105.36 147.96 27.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.658 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.905 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.6 mm? -109.22 118.46 36.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.219 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.768 HG22 ' CB ' ' A' ' 104' ' ' ALA . 8.4 p -120.14 131.18 54.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.731 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.864 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -126.47 170.2 12.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.525 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.81 158.29 42.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.238 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -114.25 153.75 46.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.548 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HG2' HG23 ' A' ' 88' ' ' VAL . 31.0 Cg_endo -63.38 171.99 5.93 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.414 2.076 . . . . 0.0 112.056 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.13 -17.35 58.65 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.794 2.329 . . . . 0.0 113.327 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -91.64 -36.43 13.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.143 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' A' ' 85' ' ' PRO . 75.8 t -79.45 -48.45 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.15 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -57.15 -49.49 75.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.728 . . . . 0.0 109.7 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.718 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.1 tm-20 -67.07 -25.16 66.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.898 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -43.73 18.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 96' ' ' TRP . 94.5 mt -61.86 -46.66 88.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.943 0.401 . . . . 0.0 110.428 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.57 -34.13 4.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.721 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.718 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.8 mt -96.53 -45.51 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.513 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -56.07 7.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.768 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.468 ' CD2' HD22 ' A' ' 92' ' ' LEU . 11.5 m0 -78.0 -32.24 51.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.722 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.03 36.57 40.64 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.324 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.81 147.23 46.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 110.718 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 0.5 OUTLIER -109.57 63.06 0.6 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.41 ' CE3' ' O ' ' A' ' 99' ' ' ASP . 9.2 m95 -132.51 132.73 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.153 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HZ3' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -73.48 -30.55 63.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.419 0.628 . . . . 0.0 109.962 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 103' ' ' GLN . . . -150.67 -158.84 8.46 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.752 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -151.25 112.52 4.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.756 0.313 . . . . 0.0 111.186 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.768 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -86.54 105.56 16.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.5 pt20 -124.34 152.18 43.44 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -101.72 101.19 11.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.01 178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.614 ' CD2' HG21 ' A' ' 157' ' ' VAL . 31.0 m95 -71.33 138.53 49.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 0.0 111.689 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 62.8 m-85 -123.23 134.09 54.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.547 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.858 HD13 ' CD2' ' A' ' 161' ' ' PHE . 19.4 tp -79.69 132.03 36.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.392 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.887 ' CD1' HG23 ' A' ' 19' ' ' ILE . 44.8 m-85 -126.08 128.83 47.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 111.37 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.859 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.12 121.23 33.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.645 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -66.09 125.27 24.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.027 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 69' ' ' SER . 11.6 p -127.54 37.68 4.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.638 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.64 -144.7 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.122 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.82 154.18 44.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.878 0.37 . . . . 0.0 110.064 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.95 -16.47 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.69 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -18.33 54.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.704 0.287 . . . . 0.0 111.245 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -79.52 -24.79 41.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.0 110.837 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.812 HG21 ' CE1' ' A' ' 29' ' ' PHE . 21.2 mt -75.71 104.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.112 0.482 . . . . 0.0 111.568 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.51 95.86 4.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.859 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.822 HD13 ' HB2' ' A' ' 131' ' ' PHE . 61.3 mt -53.48 -24.46 13.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.626 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.431 HD22 ' CG ' ' A' ' 129' ' ' PRO . 18.3 mt -62.45 -57.55 10.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 110.026 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.66 -178.16 21.27 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.251 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -91.11 38.97 0.98 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.8 66.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.095 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -121.21 -69.64 0.83 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -84.86 165.1 17.99 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.32 145.21 39.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.431 ' CG ' HD22 ' A' ' 122' ' ' LEU . 50.7 Cg_exo -53.31 128.68 30.17 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.579 2.186 . . . . 0.0 112.634 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -111.89 -32.28 6.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.542 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.822 ' HB2' HD13 ' A' ' 121' ' ' LEU . 14.6 m-85 -110.3 159.67 17.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.2 -19.94 5.35 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.987 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.4 mm-40 -152.48 175.38 12.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.115 0.483 . . . . 0.0 110.746 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.2 p-90 -157.15 154.25 29.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.195 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.09 161.47 42.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.367 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.454 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 72.1 m95 -94.7 123.56 38.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.757 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 145' ' ' LEU . 32.4 m -135.52 151.21 29.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.033 0.444 . . . . 0.0 111.578 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.16 162.4 69.54 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.634 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.64 ' CA ' HD13 ' A' ' 158' ' ' LEU . 37.8 Cg_exo -58.06 -18.54 36.6 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.792 1.661 . . . . 0.0 111.914 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.07 -34.51 14.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.223 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -70.66 -50.6 34.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.023 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.909 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.01 -32.16 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.522 0.677 . . . . 0.0 109.818 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.564 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.2 mm -68.32 -28.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.746 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.64 -22.38 40.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.059 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.6 mt -83.5 -39.54 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.893 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 150' ' ' LYS . 3.6 m -59.48 167.4 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.512 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.2 p -101.26 159.59 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.75 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -51.84 -40.88 61.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.512 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.4 p90 -79.58 1.5 25.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.472 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 27.6 mttm -136.44 7.56 3.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.573 0.225 . . . . 0.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 14.1 mtpt -70.31 -62.39 2.22 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.105 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.6 Cg_endo -53.93 -43.14 60.83 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.379 2.053 . . . . 0.0 111.796 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.905 HG13 ' HB3' ' A' ' 80' ' ' LEU . 78.0 t -57.35 -25.68 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.698 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -90.69 -53.25 4.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.445 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.564 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.52 -31.91 16.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.229 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.84 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.0 tp10 -65.21 -46.17 81.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.503 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.614 HG21 ' CD2' ' A' ' 107' ' ' TRP . 49.1 t -59.83 -48.41 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.226 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.64 HD13 ' CA ' ' A' ' 139' ' ' PRO . 71.9 mt -64.27 -49.15 72.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.767 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.1 m -50.35 -44.28 54.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.757 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.3 t -72.42 -24.83 22.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 110.595 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.858 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.8 m-30 -102.93 8.48 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.097 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.71 -52.61 62.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.725 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.7 Cg_endo -52.82 -23.39 20.57 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.509 2.14 . . . . 0.0 112.375 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.641 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 98.5 m-70 -89.91 -23.34 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.734 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.696 HD12 ' OXT' ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.856 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.443 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.61 175.69 7.65 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.63 2.22 . . . . 0.0 112.321 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 mp 60.11 -177.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.24 53.74 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.543 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.485 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -137.91 -158.75 0.89 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.905 0.384 . . . . 0.0 110.122 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 15.0 mmt -148.11 -32.94 0.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.05 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 1.2 m-20 71.07 20.74 5.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.791 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 169.39 143.13 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.048 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.63 107.69 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.163 1.909 . . . . 0.0 112.178 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.884 ' HG2' HG21 ' A' ' 81' ' ' THR . 18.2 Cg_exo -66.18 -155.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.09 2.527 . . . . 0.0 112.646 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.814 ' O ' ' O ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -29.84 -145.67 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.795 -1.093 . . . . 0.0 113.657 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.97 33.72 2.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.794 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 26.8 m-85 -67.12 153.65 43.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.197 0.499 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -89.51 152.16 21.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.396 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -81.03 125.31 30.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.603 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.3 t-20 -152.58 157.7 41.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -123.5 125.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.238 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -95.52 147.61 18.69 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.246 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.747 ' CD1' ' HB1' ' A' ' 57' ' ' ALA . 2.0 mm -116.24 101.69 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.663 0.268 . . . . 0.0 111.541 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 5.7 t -92.07 97.84 11.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.889 HD12 ' O ' ' A' ' 110' ' ' PHE . 19.8 tp -102.52 151.61 22.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.178 0.513 . . . . 0.0 111.646 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.0 ptt? -134.37 157.4 46.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.397 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.509 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.48 170.16 8.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.557 -179.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -18.85 1.04 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.539 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.74 1.73 54.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.79 0.328 . . . . 0.0 110.887 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 33.5 mtmt 72.9 26.88 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.664 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.1 mmtp -97.7 173.54 7.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.568 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -109.16 123.58 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.033 0.444 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.822 ' CD2' HD23 ' A' ' 21' ' ' LEU . 3.0 t80 -58.13 104.4 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.989 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.418 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.66 135.27 53.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.752 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.88 138.49 53.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.46 157.45 23.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.759 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.1 mtp85 -74.85 158.71 32.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.25 0.548 . . . . 0.0 111.29 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 -4.78 48.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.953 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -129.24 -17.29 3.84 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.176 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.759 HD12 ' CD ' ' A' ' 33' ' ' ARG . 69.4 mt -121.39 112.06 33.04 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.094 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.3 Cg_endo -65.65 132.1 29.76 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.79 1.66 . . . . 0.0 111.683 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.38 5.36 3.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -91.74 97.6 11.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.301 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.733 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.2 m95 -104.86 156.68 17.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.185 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.2 pm0 -168.76 -176.78 2.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.775 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.476 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 1.4 mtt -113.53 160.11 32.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.656 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 54.6 Cg_exo -52.01 128.88 28.5 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.629 2.219 . . . . 0.0 112.615 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.72 141.75 33.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.41 133.56 3.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.704 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.94 133.88 52.56 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.748 HD11 HG13 ' A' ' 17' ' ' VAL . 4.7 mt -65.16 159.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 110.611 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.2 m-20 -90.29 149.62 22.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -51.78 99.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.195 0.521 . . . . 0.0 110.756 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 38.71 10.35 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.904 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 14.5 tp10 -113.16 146.49 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.117 0.484 . . . . 0.0 110.865 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.5 135.78 75.23 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.663 ' O ' HG11 ' A' ' 17' ' ' VAL . 58.8 Cg_exo -51.9 -55.24 4.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.434 2.089 . . . . 0.0 112.577 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 58' ' ' ILE . 8.8 ttm180 -59.4 -25.83 64.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.396 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -84.12 -50.49 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.729 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -56.21 -31.56 63.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.575 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.747 ' HB1' ' CD1' ' A' ' 19' ' ' ILE . . . -72.45 -53.91 10.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.102 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.0 mt -54.63 -28.49 19.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.238 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -83.19 -52.85 6.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.915 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -56.96 -37.51 71.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.861 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.835 HD11 ' HB ' ' A' ' 67' ' ' VAL . 9.2 tp -54.14 -61.27 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.61 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -58.8 -12.23 4.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.83 0.348 . . . . 0.0 110.763 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.05 -41.04 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.359 . . . . 0.0 111.462 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -90.55 -31.08 16.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.996 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.725 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.13 -21.24 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.84 2.97 72.49 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.835 ' HB ' HD11 ' A' ' 61' ' ' LEU . 24.6 t -67.52 110.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -95.02 -29.53 14.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.13 76.45 6.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.309 0.576 . . . . 0.0 110.536 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 131.4 15.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.545 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -118.91 139.73 51.16 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.249 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 26.7 t -68.69 120.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.37 0.605 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.869 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -94.97 -25.12 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.934 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -163.49 171.32 16.07 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.825 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -149.11 123.39 9.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.484 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.685 HG11 HD21 ' A' ' 80' ' ' LEU . 41.4 t -57.83 126.21 75.75 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.76 0.314 . . . . 0.0 110.317 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.47 -18.9 56.45 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.91 2.407 . . . . 0.0 113.123 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.676 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -123.17 -175.37 3.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 111.28 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.462 ' C ' HD22 ' A' ' 80' ' ' LEU . 53.5 m95 -102.9 147.41 26.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.062 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.928 ' HB3' HG13 ' A' ' 153' ' ' VAL . 1.1 mm? -105.24 117.54 34.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.647 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.884 HG21 ' HG2' ' A' ' 10' ' ' PRO . 51.8 p -116.03 137.97 51.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.311 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.878 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -134.39 170.11 16.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.338 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.98 158.37 39.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.184 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE1' ' O2A' ' A' ' 166' ' ' ATP . 8.6 m-85 -112.3 145.46 32.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.751 ' HG2' HG23 ' A' ' 88' ' ' VAL . 37.3 Cg_endo -66.47 171.33 10.77 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.471 2.114 . . . . 0.0 112.432 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.3 -16.31 46.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.912 2.408 . . . . 0.0 113.201 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -90.38 -38.23 13.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.199 0.523 . . . . 0.0 109.841 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.751 HG23 ' HG2' ' A' ' 85' ' ' PRO . 89.3 t -76.77 -49.83 22.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.946 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.54 -52.71 58.8 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.916 0.865 . . . . 0.0 109.639 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.743 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.7 OUTLIER -64.52 -31.5 72.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.99 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -45.22 49.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 96' ' ' TRP . 93.7 mt -61.05 -47.45 86.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 110.516 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.492 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 46.7 m-20 -47.91 -30.27 4.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.67 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.743 HD12 ' O ' ' A' ' 90' ' ' GLU . 4.5 mt -97.05 -47.94 12.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.416 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -55.37 8.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.945 0.403 . . . . 0.0 110.861 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.493 ' CD2' HD22 ' A' ' 92' ' ' LEU . 17.4 m0 -80.43 -29.66 37.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.875 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 70.69 38.09 67.25 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.241 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.8 154.09 49.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.06 0.457 . . . . 0.0 110.99 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.27 77.57 1.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.455 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -119.42 150.71 39.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.048 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -75.64 -32.26 60.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.967 179.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.56 -133.31 1.88 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.374 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 73.9 mt-30 -158.09 114.38 2.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -93.78 105.85 17.85 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' NE2' ' CZ2' ' A' ' 107' ' ' TRP . 3.6 pt20 -121.64 157.85 29.92 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.437 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -105.97 98.71 8.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.817 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.569 ' CD2' HG21 ' A' ' 157' ' ' VAL . 40.5 m95 -69.54 130.2 41.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.734 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 68.0 m-85 -116.5 135.53 53.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.881 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.1 tp -79.57 137.46 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.066 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.889 ' O ' HD12 ' A' ' 21' ' ' LEU . 40.1 m-85 -129.63 133.13 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.244 0.545 . . . . 0.0 111.925 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 34.1 tttm -96.25 119.99 35.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.489 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.672 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.9 t80 -68.41 123.22 20.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.99 0.424 . . . . 0.0 110.978 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.477 HG21 ' OE1' ' A' ' 71' ' ' GLU . 8.9 p -124.81 37.56 4.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.464 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.23 -145.16 4.9 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.69 154.06 47.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 109.998 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -49.87 -16.83 0.3 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.541 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -22.66 56.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.28 -25.61 58.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.403 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 36.8 mt -67.99 104.58 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.468 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -120.92 95.43 4.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.036 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 131' ' ' PHE . 32.0 mt -55.49 -21.58 17.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.693 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.588 HD22 ' HG3' ' A' ' 129' ' ' PRO . 16.7 mt -65.16 -60.03 3.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.247 0.546 . . . . 0.0 110.056 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.84 -175.09 24.68 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.542 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -91.81 38.75 0.99 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.134 0.492 . . . . 0.0 109.89 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.65 73.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.104 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.3 t -115.58 -69.5 0.85 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.24 165.09 12.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.177 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.16 149.27 65.78 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.588 ' HG3' HD22 ' A' ' 122' ' ' LEU . 73.8 Cg_exo -49.91 124.92 13.42 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.613 2.208 . . . . 0.0 112.57 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -106.27 -28.58 10.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.657 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.587 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.9 m-85 -110.91 159.18 17.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.255 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.87 -22.76 4.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.697 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.7 mm-40 -152.27 174.34 13.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.152 0.501 . . . . 0.0 110.552 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 30.3 p-90 -159.95 159.88 32.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.26 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.26 167.6 27.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.509 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 68.8 m95 -97.02 121.58 39.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.704 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.687 HG23 ' HB2' ' A' ' 142' ' ' LEU . 35.3 m -132.49 150.53 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.479 . . . . 0.0 111.717 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -70.76 160.05 83.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.568 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.64 ' CA ' HD13 ' A' ' 158' ' ' LEU . 14.1 Cg_endo -56.89 -18.14 26.56 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 121.855 1.703 . . . . 0.0 111.915 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.05 -34.06 15.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.987 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.27 -50.91 23.54 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.87 -31.25 59.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.447 0.642 . . . . 0.0 109.845 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.597 HD11 ' CA ' ' A' ' 155' ' ' LYS . 9.1 mm -70.03 -27.29 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.62 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.24 -17.12 47.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.145 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 142' ' ' LEU . 13.4 mt -87.59 -38.98 15.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.331 0.586 . . . . 0.0 109.946 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 147' ' ' VAL . 25.6 m -57.58 163.16 2.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.03 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.683 HG12 ' HB2' ' A' ' 150' ' ' LYS . 13.0 p -90.0 161.82 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.965 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.517 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -55.68 -31.3 62.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.759 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.646 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 12.6 p90 -92.6 7.39 43.54 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.683 ' HB2' HG12 ' A' ' 147' ' ' VAL . 4.5 mttm -133.27 -8.27 2.96 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.513 0.197 . . . . 0.0 111.505 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.517 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.6 mtpp -54.47 -59.43 10.31 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.797 -0.183 . . . . 0.0 111.264 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 16.8 Cg_endo -57.78 -42.63 57.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.3 2.0 . . . . 0.0 111.938 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.928 HG13 ' HB3' ' A' ' 80' ' ' LEU . 85.9 t -57.5 -27.92 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.84 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.86 -53.91 4.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.382 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.597 ' CA ' HD11 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -47.64 -38.3 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.868 ' HB3' HD11 ' A' ' 80' ' ' LEU . 8.4 tp10 -60.68 -46.26 91.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.505 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 107' ' ' TRP . 42.8 t -58.54 -49.49 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.331 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.64 HD13 ' CA ' ' A' ' 139' ' ' PRO . 68.4 mt -62.35 -49.59 74.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.3 p -49.83 -42.45 47.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.772 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.4 t -73.44 -24.6 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.115 0.483 . . . . 0.0 110.343 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.881 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.3 m-30 -104.63 12.05 33.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.995 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.559 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -53.01 -55.53 32.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.386 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 12.0 Cg_endo -55.87 -22.37 37.43 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.494 2.129 . . . . 0.0 112.248 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.473 ' ND1' HG22 ' A' ' 73' ' ' ILE . 98.4 m-70 -89.92 -17.97 27.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.911 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.484 HD23 ' SD ' ' A' ' 22' ' ' MET . 1.8 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.934 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.45 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.08 -167.99 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.604 2.203 . . . . 0.0 112.343 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.4 pt? -59.31 -170.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.924 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.43 55.69 5.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 m -137.98 -160.67 1.08 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.05 0.452 . . . . 0.0 109.938 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 178.94 111.66 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.98 15.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.899 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.09 132.45 0.41 Allowed Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.79 122.32 9.68 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.273 1.982 . . . . 0.0 112.101 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 30.4 Cg_endo -90.59 177.4 2.25 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.784 2.322 . . . . 0.0 111.735 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -90.78 10.33 26.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.445 . . . . 0.0 111.995 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.19 -13.99 37.41 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.452 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 12.9 m-85 -129.97 141.34 50.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.026 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.433 ' HG2' ' CD2' ' A' ' 100' ' ' TRP . 29.9 mmm-85 -77.73 148.18 35.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -67.4 130.66 43.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.139 0.495 . . . . 0.0 111.534 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.486 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.6 m120 -152.5 162.52 41.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.72 HG13 HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.93 126.26 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.884 0.373 . . . . 0.0 111.25 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' HA3' ' NE2' ' A' ' 105' ' ' GLN . . . -98.09 138.84 14.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.273 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.929 HG21 HD22 ' A' ' 61' ' ' LEU . 4.8 mp -114.65 101.52 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.819 0.343 . . . . 0.0 111.26 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.9 t -90.17 104.58 17.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.5 tp -103.29 149.13 25.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.063 0.458 . . . . 0.0 111.143 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.564 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.9 ptt? -130.11 157.37 42.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.708 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.452 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.8 p-10 -100.73 171.0 7.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.468 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -57.65 -16.02 9.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.547 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.04 0.27 56.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp 76.9 27.48 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.656 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -98.83 171.21 8.22 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.524 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -109.91 121.23 62.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.967 0.413 . . . . 0.0 110.953 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.708 ' CE1' HG21 ' A' ' 119' ' ' ILE . 86.9 t80 -55.49 110.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.192 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.61 137.81 51.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.356 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -123.23 139.88 53.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.948 0.404 . . . . 0.0 111.292 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.21 156.88 24.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.626 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.775 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -73.01 157.75 36.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 111.367 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.1 mt -90.5 -5.88 55.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.124 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -131.88 -16.6 2.89 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.775 HD12 ' CD ' ' A' ' 33' ' ' ARG . 61.6 mt -119.07 106.03 43.96 Favored Pre-proline 0 N--CA 1.455 -0.214 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 31.0 Cg_exo -60.77 129.05 27.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.164 1.909 . . . . 0.0 111.888 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.2 t70 80.61 0.93 1.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.929 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.52 97.67 10.63 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.4 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD1' HD22 ' A' ' 145' ' ' LEU . 49.5 m95 -101.47 155.09 18.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.119 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' OE1' ' CZ ' ' A' ' 131' ' ' PHE . 0.0 OUTLIER -169.13 -176.86 2.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.699 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.456 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 4.2 mpp? -102.66 157.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 121.37 7.9 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.601 2.201 . . . . 0.0 112.498 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -123.23 161.64 24.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.639 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.402 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.61 138.7 5.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.435 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.39 129.08 19.53 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.631 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 17' ' ' VAL . 4.9 mt -61.12 158.62 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.787 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -90.21 150.41 21.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -52.47 99.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.156 0.503 . . . . 0.0 110.723 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.26 37.93 9.48 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.779 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 49.1 tt0 -114.39 147.92 38.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.174 0.511 . . . . 0.0 110.701 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.11 142.52 72.31 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.508 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HA ' HG11 ' A' ' 17' ' ' VAL . 49.0 Cg_exo -56.45 -57.88 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.504 2.136 . . . . 0.0 112.89 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 58' ' ' ILE . 4.8 ttt-85 -58.38 -24.78 60.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.43 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -87.71 -42.76 12.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 110.252 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.39 -32.7 73.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.197 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.28 -52.49 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.476 HD12 ' O ' ' A' ' 54' ' ' ARG . 51.4 mt -56.82 -29.71 31.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.999 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -81.2 -52.78 6.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.716 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 31.5 mm-40 -55.4 -44.83 76.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.638 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.929 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -55.17 -51.86 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.829 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.583 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 31.9 ttp180 -61.59 -13.68 23.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.577 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -92.02 -42.26 10.08 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -90.76 -27.05 19.17 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.72 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.45 -21.55 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.414 . . . . 0.0 111.093 -179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.583 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.09 8.39 61.5 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.981 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.817 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.2 t -65.23 110.53 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 0.0 110.237 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.9 p -92.46 -34.95 13.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.239 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 76.6 6.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.162 0.506 . . . . 0.0 111.055 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.44 129.34 13.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.605 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.526 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.4 pt-20 -119.14 140.28 50.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.323 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.3 t -69.28 121.65 19.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.353 0.597 . . . . 0.0 111.17 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.897 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -97.74 -22.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.847 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -163.37 165.65 23.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.504 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 10.6 pt-20 -149.06 121.17 8.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.809 ' HA ' HG11 ' A' ' 160' ' ' VAL . 32.4 t -56.94 126.01 71.28 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 -19.41 46.48 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.951 2.434 . . . . 0.0 113.242 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.65 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.13 -175.3 3.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 111.511 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.461 ' C ' HD22 ' A' ' 80' ' ' LEU . 17.1 m95 -104.57 147.76 27.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.77 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.889 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -104.52 118.08 35.72 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.418 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.869 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.2 p -119.98 133.71 55.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.949 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.886 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -133.85 170.31 15.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.771 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.98 161.24 23.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.634 0.731 . . . . 0.0 111.42 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 10.8 m-85 -111.15 144.06 29.66 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.95 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.775 ' HG2' HG23 ' A' ' 88' ' ' VAL . 39.5 Cg_endo -66.92 171.48 11.08 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.648 2.232 . . . . 0.0 112.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.07 -16.49 46.08 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.013 2.475 . . . . 0.0 113.354 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -91.21 -35.98 14.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 110.085 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.775 HG23 ' HG2' ' A' ' 85' ' ' PRO . 84.5 t -78.42 -48.6 22.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.149 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -56.67 -52.27 65.54 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.763 0.792 . . . . 0.0 109.74 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.604 ' O ' HD13 ' A' ' 94' ' ' ILE . 3.9 tt0 -61.96 -27.03 68.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.82 -44.76 14.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.957 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 96' ' ' TRP . 72.5 mt -62.6 -46.82 86.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 110.52 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.432 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 4.1 m-20 -47.35 -31.35 3.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.717 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 90' ' ' GLU . 3.5 mp -96.77 -47.42 12.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.919 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -58.16 4.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 0.0 110.761 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' LEU . 22.3 m0 -77.25 -32.13 55.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.792 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.3 35.65 37.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.484 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.5 153.69 49.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.994 0.426 . . . . 0.0 110.86 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -117.12 46.71 1.63 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.631 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.433 ' CD2' ' HG2' ' A' ' 14' ' ' ARG . 90.9 m95 -95.06 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -30.83 66.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -179.51 -133.85 2.06 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.937 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.432 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 14.1 pt20 -157.96 114.84 2.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.908 0.385 . . . . 0.0 111.343 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.869 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.46 105.78 17.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.848 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.7 pt20 -123.19 144.87 49.08 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -95.66 98.68 10.67 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.637 178.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.621 ' CD2' HG21 ' A' ' 157' ' ' VAL . 22.2 m95 -66.14 143.57 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.193 0.52 . . . . 0.0 112.149 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 66.3 m-85 -129.21 136.98 50.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.246 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.897 HD23 ' HB ' ' A' ' 73' ' ' ILE . 23.6 tp -79.34 155.01 28.64 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.869 ' O ' HD12 ' A' ' 21' ' ' LEU . 32.8 m-85 -146.1 132.73 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.252 0.549 . . . . 0.0 112.023 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 5.5 tptp -96.46 118.27 32.62 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.53 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.643 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -68.17 120.69 14.75 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.964 0.411 . . . . 0.0 110.701 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.42 HG21 ' OE1' ' A' ' 71' ' ' GLU . 5.9 p -121.81 37.43 4.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.457 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.83 -144.38 4.7 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.086 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.29 154.29 45.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.885 0.374 . . . . 0.0 110.004 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -49.73 -16.8 0.27 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.557 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -15.7 59.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.207 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -81.02 -25.47 37.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.708 HG21 ' CE1' ' A' ' 29' ' ' PHE . 14.9 mt -73.18 103.89 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.582 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.48 95.85 4.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.024 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.0 mt -56.02 -21.65 22.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.654 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' HG3' ' A' ' 129' ' ' PRO . 14.6 mt -62.95 -58.84 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.247 0.546 . . . . 0.0 109.984 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.69 -172.19 24.5 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.435 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -93.31 38.82 1.05 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.15 0.5 . . . . 0.0 109.909 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.45 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.302 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.8 m -114.28 -67.75 0.97 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.769 0.318 . . . . 0.0 111.25 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -98.38 165.1 12.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -76.37 147.54 79.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.91 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.489 ' HB2' HD11 ' A' ' 34' ' ' LEU . 53.1 Cg_exo -51.69 136.18 49.81 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.613 2.209 . . . . 0.0 112.55 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -108.12 -28.39 9.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.653 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 19.0 m-85 -120.37 159.69 24.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.337 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.17 -18.11 6.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.85 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.419 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.4 mm-40 -152.45 174.94 13.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.193 0.52 . . . . 0.0 110.782 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.4 p-90 -159.45 152.38 21.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.964 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.7 m -148.08 157.26 43.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.541 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.452 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 86.9 m95 -92.81 125.11 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.745 HG11 HD11 ' A' ' 145' ' ' LEU . 27.0 m -136.73 151.19 27.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.118 0.485 . . . . 0.0 111.662 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.13 159.07 85.8 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.555 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.574 ' O ' HD13 ' A' ' 158' ' ' LEU . 11.7 Cg_endo -55.82 -18.63 22.21 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.841 1.694 . . . . 0.0 112.016 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -34.17 15.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.078 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -50.45 30.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.944 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.9 tp -54.3 -29.8 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.32 0.581 . . . . 0.0 109.829 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.548 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -69.83 -28.49 37.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.655 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -22.39 42.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.268 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.944 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.5 mt -82.97 -39.15 21.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.016 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 147' ' ' VAL . 26.9 m -53.87 164.21 0.62 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.238 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.571 HG12 ' HB2' ' A' ' 150' ' ' LYS . 10.3 p -97.24 162.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.12 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.528 ' N ' HG22 ' A' ' 147' ' ' VAL . 15.8 mt-10 -51.51 -38.38 53.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.985 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 23.8 p90 -88.34 10.82 18.55 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.571 ' HB2' HG12 ' A' ' 147' ' ' VAL . 67.3 mttt -130.95 -5.12 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.419 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 12.2 mttt -55.97 -62.0 5.45 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.9 Cg_endo -59.01 -48.16 15.28 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.388 2.058 . . . . 0.0 112.233 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.889 HG13 ' HB3' ' A' ' 80' ' ' LEU . 92.3 t -57.22 -27.1 27.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.24 0.543 . . . . 0.0 111.11 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.454 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.0 m-85 -90.91 -52.73 4.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.428 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.548 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.88 -31.85 18.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.308 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.804 ' HB3' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -65.39 -46.13 81.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.445 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.621 HG21 ' CD2' ' A' ' 107' ' ' TRP . 57.7 t -59.57 -53.2 51.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.32 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 139' ' ' PRO . 59.1 mt -62.85 -50.01 72.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.119 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.9 t -51.66 -45.61 63.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.0 t -69.84 -25.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.033 0.444 . . . . 0.0 110.297 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.838 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.9 m-30 -101.96 7.98 41.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.827 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.23 -56.23 21.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.623 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.9 Cg_endo -50.16 -24.67 11.65 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.567 2.178 . . . . 0.0 112.384 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 95.9 m-70 -95.39 -18.34 20.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.564 HD23 ' SD ' ' A' ' 22' ' ' MET . 1.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.964 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.535 " H4'" HG13 ' A' ' 88' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.141 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.03 152.0 67.76 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.62 2.213 . . . . 0.0 112.278 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -57.48 178.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.016 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.712 ' N ' HD22 ' A' ' 3' ' ' LEU . . . 124.72 40.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.467 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.14 125.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.9 tpp -123.49 -40.56 2.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.246 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 t0 71.35 24.93 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t 176.31 133.91 0.18 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.701 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 41.9 Cg_endo -68.25 110.78 2.31 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.341 2.028 . . . . 0.0 112.324 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 5.5 Cg_exo -79.27 -176.97 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.93 2.42 . . . . 0.0 112.151 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -90.49 151.84 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.34 -37.8 3.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.642 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -83.77 144.59 29.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 0.0 110.976 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.51 152.23 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.084 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -75.93 126.96 32.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 19.6 t-20 -152.5 157.07 40.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.857 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.786 HG13 HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -125.45 124.49 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.891 0.377 . . . . 0.0 111.202 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.55 140.96 15.44 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.197 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.824 HG13 ' HB1' ' A' ' 57' ' ' ALA . 4.5 mp -121.23 101.83 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 0.0 111.441 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.3 t -89.76 107.3 19.02 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.2 tp -103.19 146.54 28.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.944 0.402 . . . . 0.0 111.114 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.7 157.53 41.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.976 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.7 p-10 -100.59 170.93 8.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.315 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -55.06 -18.21 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.608 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.95 0.31 56.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.749 0.309 . . . . 0.0 110.988 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp 76.83 25.63 0.85 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.558 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttp -94.4 172.44 8.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.566 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -110.54 120.35 61.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.947 0.403 . . . . 0.0 110.919 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.784 ' CE1' HG21 ' A' ' 119' ' ' ILE . 68.2 t80 -53.9 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.129 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.52 131.57 56.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.368 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.33 138.29 51.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.914 0.388 . . . . 0.0 111.178 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.29 155.87 24.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.579 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.4 mtp85 -70.41 159.16 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.295 0.569 . . . . 0.0 111.599 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.9 mt -92.84 -5.81 50.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.831 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.51 -19.49 4.19 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 66.8 mt -120.4 112.76 34.1 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.968 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.09 131.61 29.22 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 121.858 1.705 . . . . 0.0 111.911 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.32 2.66 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.82 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -86.94 97.36 10.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.301 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CD1' HD22 ' A' ' 145' ' ' LEU . 26.2 m95 -102.34 155.41 18.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.176 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -168.62 169.15 10.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.477 ' HE1' ' CG ' ' A' ' 154' ' ' TYR . 76.2 mtm -89.92 155.22 47.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.812 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.16 149.37 22.16 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.697 2.265 . . . . 0.0 113.061 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -176.39 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.214 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.44 138.08 4.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.296 -0.955 . . . . 0.0 112.858 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.76 126.32 29.46 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.786 HD11 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -60.99 161.28 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.685 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.7 m-20 -88.34 -176.38 5.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.944 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.2 98.62 5.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.127 0.489 . . . . 0.0 110.23 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.79 47.39 9.8 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.749 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 6.5 tt0 -115.62 146.75 41.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 110.808 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.55 134.86 84.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.588 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.677 ' O ' HG11 ' A' ' 17' ' ' VAL . 55.2 Cg_exo -52.43 -57.25 2.2 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.401 2.067 . . . . 0.0 112.659 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -56.84 -28.06 61.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.434 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -81.97 -49.7 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.718 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.16 -30.76 64.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.824 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.65 -52.0 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.126 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 54' ' ' ARG . 43.9 mt -55.85 -28.71 24.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.244 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG3' ' NH2' ' A' ' 62' ' ' ARG . 36.5 ttp85 -83.62 -52.8 6.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.885 0.85 . . . . 0.0 109.89 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -56.36 -34.55 66.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.684 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.81 HD12 ' OG1' ' A' ' 65' ' ' THR . 5.4 tp -57.13 -59.54 4.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.181 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.566 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 22.4 ptt85 -61.34 -10.71 7.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.793 0.33 . . . . 0.0 110.691 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -91.19 -45.12 8.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 0.0 111.561 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.46 -28.12 17.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.81 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -113.56 -21.49 10.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.837 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.17 4.85 74.53 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.039 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.699 ' HB ' HD11 ' A' ' 61' ' ' LEU . 55.8 t -75.2 119.0 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.364 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.1 p -99.25 -34.07 10.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.35 78.27 6.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.184 0.516 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.39 129.6 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.924 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -120.0 145.76 46.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.577 179.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.556 HG22 ' CE1' ' A' ' 110' ' ' PHE . 53.1 t -76.11 125.9 36.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.527 0.679 . . . . 0.0 111.967 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.933 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.62 -16.19 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.339 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.786 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.35 160.18 40.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 115.56 6.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.104 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.87 ' HA ' HG11 ' A' ' 160' ' ' VAL . 7.2 t -57.33 127.47 77.0 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.951 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.79 -15.55 44.36 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.784 2.322 . . . . 0.0 113.585 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.656 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -128.34 174.63 9.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.493 0.663 . . . . 0.0 112.364 -179.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.454 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 13.0 m95 -99.8 147.09 25.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.003 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.876 ' HB3' HG13 ' A' ' 153' ' ' VAL . 46.1 mt -114.34 117.56 31.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.763 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.728 HG22 ' CB ' ' A' ' 104' ' ' ALA . 3.0 p -113.56 130.57 56.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.865 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -131.91 160.14 36.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.61 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.46 158.38 26.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.182 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.11 150.17 37.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.588 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.537 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.6 Cg_endo -62.59 170.86 6.33 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.441 2.094 . . . . 0.0 112.027 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.6 -17.47 59.66 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.786 2.324 . . . . 0.0 113.298 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -93.32 -33.11 14.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.122 0.486 . . . . 0.0 110.216 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.537 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.4 t -84.26 -47.0 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.339 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -59.72 -45.66 91.48 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.635 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -67.66 -27.73 67.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.524 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -46.6 19.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.482 HD22 ' CD1' ' A' ' 96' ' ' TRP . 95.8 mt -58.67 -46.56 86.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 0.0 110.525 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -46.48 -32.27 3.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.696 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.635 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.66 -47.55 12.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -54.75 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.482 ' CD1' HD22 ' A' ' 92' ' ' LEU . 10.9 m95 -80.45 -29.94 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.925 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.8 34.75 47.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.548 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.73 147.18 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.586 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -118.43 64.28 0.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.019 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 53.3 m95 -119.5 150.04 40.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.74 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.04 -30.14 55.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.995 0.426 . . . . 0.0 110.616 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -166.04 -144.5 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.933 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.447 ' NE2' ' CD2' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -158.16 113.44 2.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.842 0.353 . . . . 0.0 111.511 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.728 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.15 105.67 17.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.936 178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.08 153.7 44.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 5.5 mttt -107.81 95.76 5.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.522 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.437 ' CD2' HG21 ' A' ' 157' ' ' VAL . 61.4 m95 -63.42 140.2 58.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.336 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 66.9 m-85 -125.82 138.32 53.82 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.402 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.786 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.6 tp -79.56 154.77 28.54 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.824 ' CD1' HG23 ' A' ' 19' ' ' ILE . 34.2 m-85 -148.51 127.83 13.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 0.0 111.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.933 ' HB3' HD11 ' A' ' 73' ' ' ILE . 22.8 tttt -93.72 119.58 32.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.576 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.655 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.9 t80 -62.77 125.31 23.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.398 . . . . 0.0 110.769 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 71' ' ' GLU . 7.7 p -127.11 37.88 4.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.52 -144.84 4.61 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.071 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -127.2 154.26 45.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -49.83 -16.65 0.28 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.574 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -78.55 -18.1 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.206 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -80.3 -25.56 39.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.811 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.784 HG21 ' CE1' ' A' ' 29' ' ' PHE . 15.5 mt -74.15 102.64 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.369 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.49 96.09 5.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.115 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.748 HD13 ' HB2' ' A' ' 131' ' ' PHE . 53.0 mt -55.45 -22.73 21.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.436 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.448 HD22 ' HG3' ' A' ' 129' ' ' PRO . 19.5 mt -62.24 -58.51 7.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 0.0 109.89 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.13 -179.26 20.8 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.595 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -90.0 38.65 0.93 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.151 0.501 . . . . 0.0 109.768 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.45 26.93 73.4 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.254 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 111.215 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -102.88 165.19 11.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -73.41 148.48 88.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.448 ' HG3' HD22 ' A' ' 122' ' ' LEU . 59.5 Cg_exo -50.85 138.93 41.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.216 . . . . 0.0 112.624 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -112.07 -33.0 6.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.648 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.748 ' HB2' HD13 ' A' ' 121' ' ' LEU . 29.1 m-85 -116.83 159.38 22.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.522 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.93 -16.82 6.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.852 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 121' ' ' LEU . 20.2 mm-40 -152.31 175.04 13.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.474 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 21.3 p-90 -159.11 151.54 21.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.134 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.2 m -147.62 161.05 41.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.492 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.488 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.4 m95 -95.09 125.03 39.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.833 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -137.55 150.81 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.085 0.469 . . . . 0.0 111.7 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.8 p -70.15 159.62 83.78 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.533 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.566 ' HD3' HD11 ' A' ' 28' ' ' ILE . 12.3 Cg_endo -56.27 -18.3 23.68 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 121.826 1.684 . . . . 0.0 111.999 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.06 -34.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.029 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -71.25 -50.48 32.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.069 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.907 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -53.62 -34.12 57.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.592 0.71 . . . . 0.0 109.885 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.55 HD12 ' CD ' ' A' ' 155' ' ' LYS . 7.8 mm -66.99 -27.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.737 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -81.31 -22.07 38.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.969 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.7 mt -84.11 -39.41 19.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.827 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -58.35 167.51 1.35 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.115 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.847 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 13.6 p -98.97 163.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.833 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.53 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -60.99 -36.62 79.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.847 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 8.5 p90 -79.38 -0.82 34.31 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.456 ' HB2' HG12 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -139.09 10.66 2.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.676 0.274 . . . . 0.0 111.278 179.012 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.437 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 15.3 mtpt -69.45 -62.76 2.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.173 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.7 Cg_endo -53.99 -43.34 59.07 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.47 2.113 . . . . 0.0 111.981 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.876 HG13 ' HB3' ' A' ' 80' ' ' LEU . 13.5 t -57.64 -24.59 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.849 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.477 ' CG ' ' HE1' ' A' ' 42' ' ' MET . 3.1 m-85 -91.02 -47.81 7.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.438 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.55 ' CD ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -51.57 -33.32 32.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.612 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.6 tp10 -67.15 -45.77 76.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.605 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 45.9 t -59.02 -47.09 91.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.056 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 139' ' ' PRO . 74.6 mt -66.65 -48.69 68.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.781 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -52.07 -45.85 64.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.79 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.87 HG11 ' HA ' ' A' ' 76' ' ' VAL . 86.3 t -69.56 -24.84 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.07 0.462 . . . . 0.0 110.679 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.786 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.0 m-30 -98.17 -7.86 28.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.16 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -50.19 -44.92 82.15 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.559 0.218 . . . . 0.0 111.371 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 35.6 Cg_exo -60.5 -22.97 73.94 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.63 2.22 . . . . 0.0 112.679 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.786 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 73.5 m-70 -95.02 -44.48 7.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.793 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.641 HD12 HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.111 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.427 ' O2B' ' CH2' ' A' ' 96' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.86 -167.63 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.598 2.199 . . . . 0.0 112.248 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.458 ' C ' HD13 ' A' ' 3' ' ' LEU . 1.9 tm? -58.86 88.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.07 -30.67 4.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.54 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.4 m -140.59 -161.78 1.26 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 79' ' ' TRP . 4.5 tpp -168.24 108.46 0.53 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.757 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.45 12.55 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.057 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -158.46 123.83 2.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 52.2 Cg_endo -68.79 112.49 2.91 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.081 1.854 . . . . 0.0 112.337 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -89.01 -170.14 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.997 2.464 . . . . 0.0 112.326 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -88.72 163.75 15.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.792 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.83 -40.33 2.59 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.38 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB3' ' CA ' ' A' ' 103' ' ' GLN . 5.5 m-85 -100.94 134.2 44.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 111.03 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -78.96 152.62 30.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.548 ' NH1' ' HB3' ' A' ' 9' ' ' PRO . 4.8 mmp_? -66.5 128.16 35.15 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.254 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 1.5 t30 -152.77 159.03 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.449 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.761 HG13 ' CG1' ' A' ' 47' ' ' ILE . 4.5 m -136.23 125.33 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.994 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.39 154.8 20.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.925 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.944 HG23 ' CD1' ' A' ' 110' ' ' PHE . 5.2 mp -128.88 110.87 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' PHE . 43.0 t -90.57 103.97 16.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 110' ' ' PHE . 25.1 tp -102.88 149.61 24.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.065 0.459 . . . . 0.0 111.239 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.563 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -127.96 158.25 38.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.967 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' HB3' ' CZ3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -108.55 167.32 10.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.65 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -49.08 -19.24 0.4 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.56 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 0.0 111.467 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 76.71 23.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.659 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -94.91 171.71 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.59 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -108.77 123.44 64.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.018 0.437 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' HE2' HD13 ' A' ' 119' ' ' ILE . 9.3 t80 -52.43 116.84 2.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -122.14 132.29 54.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.024 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -121.69 139.8 53.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.981 0.419 . . . . 0.0 111.38 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.05 155.85 24.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.391 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.595 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -71.84 158.39 36.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.541 . . . . 0.0 111.634 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.3 mt -91.46 -6.03 53.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.997 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -131.11 -17.68 3.04 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.611 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.6 mt -118.6 111.7 37.66 Favored Pre-proline 0 N--CA 1.455 -0.175 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.0 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.05 131.72 29.66 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.94 1.76 . . . . 0.0 111.811 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.49 3.07 3.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.793 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.22 97.41 11.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.357 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.475 ' CD1' HD22 ' A' ' 145' ' ' LEU . 42.7 m95 -102.39 155.73 18.06 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.252 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -169.13 -176.94 2.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.692 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.442 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.3 mpp? -103.29 158.26 32.15 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.57 146.61 80.09 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.463 2.109 . . . . 0.0 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HG2' ' ND2' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -153.98 176.64 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.18 6.44 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.81 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -70.71 130.77 20.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.222 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.761 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.9 mt -58.59 159.81 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.725 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.3 m-20 -90.49 149.47 22.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.822 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.44 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.238 0.542 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.28 39.8 10.84 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.935 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 5.9 tp10 -114.12 146.78 39.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.908 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -72.54 140.98 82.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.497 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HA ' HG11 ' A' ' 17' ' ' VAL . 33.1 Cg_exo -57.77 -37.8 95.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.357 2.038 . . . . 0.0 112.471 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' O ' HD12 ' A' ' 58' ' ' ILE . 4.5 ttp180 -75.78 -23.34 55.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.67 -43.97 10.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.445 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.04 -30.84 71.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.32 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.608 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.4 -51.37 17.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.157 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 54' ' ' ARG . 58.0 mt -56.82 -28.77 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.18 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 ttp85 -84.25 -52.8 5.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.792 0.806 . . . . 0.0 109.991 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -53.15 -42.54 66.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.47 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.827 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -55.83 -54.64 42.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.616 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.531 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 35.8 ttp180 -61.17 -13.92 21.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.299 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -92.01 -40.85 10.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.836 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -91.39 -26.26 18.96 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.808 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -118.02 -20.55 8.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.48 4.09 73.7 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.098 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.653 HG13 ' HE1' ' A' ' 112' ' ' PHE . 55.8 t -71.02 118.58 15.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.616 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -98.62 -35.25 10.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.092 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.29 80.85 6.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.944 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.63 130.8 14.51 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.035 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 pt-20 -120.3 144.0 48.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.02 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.5 t -76.79 122.95 32.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.646 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.887 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.5 mm -107.08 -15.33 8.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.572 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 109' ' ' LEU . . . -155.98 154.03 30.47 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.837 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -148.67 117.93 6.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.81 ' HA ' HG11 ' A' ' 160' ' ' VAL . 7.5 t -57.53 127.03 77.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.926 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.58 -6.12 18.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.923 2.415 . . . . 0.0 114.117 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.531 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -136.53 138.97 41.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.932 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' MET . 24.9 m95 -64.28 145.32 56.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.279 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.851 ' HB3' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -103.92 138.73 40.07 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.643 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.4 p -139.18 130.7 27.16 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.844 ' CD1' HG11 ' A' ' 153' ' ' VAL . 9.9 p90 -139.1 170.44 15.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.95 158.3 35.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.018 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -102.44 154.21 37.59 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.703 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.669 ' HG2' HG23 ' A' ' 88' ' ' VAL . 25.6 Cg_endo -62.46 170.02 7.37 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.389 2.059 . . . . 0.0 112.145 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.88 -9.67 23.94 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.836 2.358 . . . . 0.0 113.131 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -97.03 -32.51 11.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.146 0.498 . . . . 0.0 110.024 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.669 HG23 ' HG2' ' A' ' 85' ' ' PRO . 98.5 t -84.11 -49.33 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -58.84 -49.39 77.91 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.597 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.5 tt0 -61.27 -29.64 69.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.403 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -46.64 17.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 96' ' ' TRP . 93.8 mt -57.83 -46.95 84.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.642 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.408 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 10.9 m120 -45.74 -31.89 2.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.475 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.43 -49.6 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.278 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.08 -56.28 10.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.793 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.5 m0 -77.62 -33.97 53.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.697 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.92 36.61 27.96 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.346 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.56 147.6 52.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.768 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -108.39 37.81 2.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -88.94 150.44 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.8 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -25.43 41.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.44 . . . . 0.0 110.578 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -177.98 -137.82 2.9 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.826 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.42 ' CA ' ' HB3' ' A' ' 13' ' ' TYR . 3.6 pt20 -158.16 115.28 2.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.704 0.287 . . . . 0.0 111.436 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.643 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.92 105.56 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -123.6 154.44 39.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -111.31 103.83 12.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.696 178.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.672 ' CD2' HG21 ' A' ' 157' ' ' VAL . 28.1 m95 -66.23 146.18 54.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.201 0.524 . . . . 0.0 112.085 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 50.8 m-85 -129.13 130.65 46.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.925 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.656 HD23 ' HB ' ' A' ' 73' ' ' ILE . 20.2 tp -78.72 151.81 31.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.944 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.1 m-85 -148.62 128.0 13.05 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.887 ' HB3' HD11 ' A' ' 73' ' ' ILE . 16.0 tptt -92.62 122.45 35.05 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -64.88 126.35 27.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.849 0.357 . . . . 0.0 111.226 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 69' ' ' SER . 3.2 p -125.45 37.34 4.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.37 -145.03 4.76 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.106 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -128.51 154.31 46.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.837 0.351 . . . . 0.0 110.147 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -49.33 -17.13 0.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.33 -20.38 57.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.802 0.334 . . . . 0.0 111.224 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.21 -26.28 52.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.859 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.537 HD13 ' HE2' ' A' ' 29' ' ' PHE . 31.5 mt -68.68 104.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.474 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.1 95.87 4.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.159 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 131' ' ' PHE . 61.0 mt -57.34 -21.04 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.522 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.859 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -60.53 -57.66 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.95 -179.65 18.71 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.19 38.72 0.94 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.71 28.44 73.76 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.127 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -114.99 -66.71 1.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.319 . . . . 0.0 111.269 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -102.17 165.12 11.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -74.71 145.54 81.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.859 ' HG3' HD13 ' A' ' 122' ' ' LEU . 52.5 Cg_exo -53.82 137.98 68.32 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.577 2.184 . . . . 0.0 112.437 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -111.57 -28.22 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.801 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.573 ' HB2' HD13 ' A' ' 121' ' ' LEU . 13.9 m-85 -118.02 159.5 23.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.23 -19.66 5.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.723 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 32.3 mm-40 -152.25 174.51 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.078 0.465 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.9 p-90 -159.27 154.05 24.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.388 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.14 166.25 26.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.301 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.483 ' CZ3' ' HB3' ' A' ' 23' ' ' ASN . 54.1 m95 -99.54 125.67 45.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.714 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 142' ' ' LEU . 27.2 m -139.28 151.44 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -69.76 162.48 67.56 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.466 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.596 ' O ' HD13 ' A' ' 158' ' ' LEU . 19.3 Cg_endo -58.78 -16.72 32.63 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.762 1.642 . . . . 0.0 111.995 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 -35.01 13.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.2 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -50.36 33.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.927 0.394 . . . . 0.0 110.051 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.943 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.6 tp -54.57 -27.81 41.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.473 0.654 . . . . 0.0 110.014 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.619 HD12 ' HG3' ' A' ' 155' ' ' LYS . 5.2 mm -73.52 -27.45 23.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.843 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.45 -23.79 42.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.085 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.943 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.8 mt -81.01 -40.18 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 109.922 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 150' ' ' LYS . 4.4 m -57.89 169.3 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.872 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.1 p -105.37 159.03 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.551 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 147' ' ' VAL . 11.3 pt-20 -42.42 -51.87 4.81 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.514 ' CE2' HG11 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -71.11 -7.29 45.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.238 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.493 ' O ' HG21 ' A' ' 146' ' ' THR . 1.9 mttt -123.34 -1.59 8.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.586 0.232 . . . . 0.0 111.514 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 15.6 mtpt -68.63 -60.74 4.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.277 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 14.8 Cg_endo -57.3 -42.68 59.88 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.304 2.002 . . . . 0.0 111.538 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 80' ' ' LEU . 35.0 t -61.07 -24.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 3.4 m-85 -90.64 -50.19 6.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.253 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.619 ' HG3' HD12 ' A' ' 143' ' ' ILE . 7.9 mtpm? -51.38 -30.92 20.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.377 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.781 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.3 tp10 -67.54 -46.23 73.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.322 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.672 HG21 ' CD2' ' A' ' 107' ' ' TRP . 39.4 t -62.13 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.102 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 139' ' ' PRO . 73.7 mt -67.19 -49.07 65.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.6 t -51.13 -46.86 62.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 76' ' ' VAL . 87.1 t -66.12 -24.03 33.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.192 0.52 . . . . 0.0 110.34 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.719 ' O ' HD12 ' A' ' 165' ' ' LEU . 10.5 m-30 -98.65 -6.67 29.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.786 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.67 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -44.69 -39.46 7.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.689 ' HD2' ' C ' ' A' ' 161' ' ' PHE . 20.5 Cg_endo -63.17 -23.84 72.88 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.135 1.89 . . . . 0.0 113.8 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 161' ' ' PHE . 3.2 p80 -89.37 -25.41 21.59 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.754 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.9 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.42 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 175.72 8.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.32 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 3' ' ' LEU . 2.1 pt? -175.0 159.44 2.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.82 84.98 1.41 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.462 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.457 ' HB3' ' CG ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER 64.08 125.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.626 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 tpt -112.0 -47.23 3.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.396 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.7 t70 66.07 23.08 11.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.869 0.366 . . . . 0.0 110.979 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m 173.1 119.32 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.59 109.66 1.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.282 1.988 . . . . 0.0 112.357 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.32 -174.95 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.904 2.403 . . . . 0.0 112.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.29 153.57 20.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.834 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.01 -38.23 3.2 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.557 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -86.85 136.95 32.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 3.7 ttt85 -84.25 152.42 24.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.212 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mmp_? -63.74 129.4 39.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.527 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 20.5 t-20 -152.65 150.82 29.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.861 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 53' ' ' PRO . 2.7 m -123.28 141.37 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.898 0.38 . . . . 0.0 111.432 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' ' NE2' ' A' ' 105' ' ' GLN . . . -109.34 149.85 17.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.281 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.936 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -129.22 101.6 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 111.276 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.1 t -89.63 106.29 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 110' ' ' PHE . 32.6 tp -102.68 143.0 32.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 111.195 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.529 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.3 ptt? -127.74 157.3 40.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.826 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 40.0 p-10 -103.3 170.21 8.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.302 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -55.74 -17.47 6.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.515 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.02 0.42 56.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.731 0.3 . . . . 0.0 110.977 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 76.47 26.43 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.63 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 22' ' ' MET . 12.6 mttt -97.01 173.88 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.544 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -112.2 121.4 64.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.943 0.401 . . . . 0.0 110.884 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.458 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 12.6 t80 -54.73 108.36 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.384 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.79 134.49 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.376 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -122.27 141.73 51.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 111.319 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -82.29 158.31 23.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.614 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.667 ' CD ' HD12 ' A' ' 36' ' ' ILE . 5.0 mtp-105 -71.26 163.65 27.24 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.35 0.595 . . . . 0.0 111.676 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 129' ' ' PRO . 3.2 mt -96.67 -7.33 34.4 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.564 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -128.13 -18.51 4.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.348 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.667 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.7 mt -120.73 112.76 33.61 Favored Pre-proline 0 N--CA 1.457 -0.109 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.171 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.44 132.1 30.18 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.955 1.77 . . . . 0.0 111.792 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.37 2.47 3.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.829 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.67 97.55 11.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.312 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.552 ' CD1' HD22 ' A' ' 145' ' ' LEU . 38.0 m95 -101.18 156.08 17.64 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.933 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -168.98 169.43 9.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.897 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 43.2 mtm -97.09 155.9 36.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.582 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 129.67 20.15 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.193 . . . . 0.0 113.038 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 141.74 19.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.57 160.84 28.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.863 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.9 126.84 7.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.629 HD11 HG13 ' A' ' 17' ' ' VAL . 11.7 mt -55.71 162.67 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.579 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 47' ' ' ILE . 8.5 m-20 -73.48 -170.9 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.573 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.06 29.28 1.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.275 0.56 . . . . 0.0 111.145 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.53 52.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 2.7 tt0 -128.43 148.17 50.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.088 0.47 . . . . 0.0 111.076 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.13 128.19 81.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.87 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.66 ' HA ' HG11 ' A' ' 17' ' ' VAL . 1.4 Cg_endo -45.93 -29.73 6.3 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.59 2.194 . . . . 0.0 113.11 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.551 HH12 HG11 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -73.48 -29.57 62.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.775 0.322 . . . . 0.0 110.917 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -86.67 -44.59 11.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.195 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -58.15 -31.69 67.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -72.92 -54.76 7.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.066 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 54' ' ' ARG . 31.6 mt -56.05 -31.7 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.213 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -78.84 -53.4 7.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.832 0.825 . . . . 0.0 109.89 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -50.87 -38.97 52.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.45 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.72 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.1 tp -58.15 -58.88 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.129 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.526 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 1.1 ptp180 -61.42 -11.84 12.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -91.62 -43.74 9.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.833 0.349 . . . . 0.0 111.718 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -91.78 -25.4 19.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.72 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -115.43 -20.91 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.913 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.12 5.17 70.26 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG13 ' HE1' ' A' ' 112' ' ' PHE . 53.2 t -74.72 129.34 36.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.829 0.347 . . . . 0.0 110.603 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 p -105.71 -34.63 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.27 81.64 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.057 0.456 . . . . 0.0 110.912 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.38 130.54 14.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.804 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.653 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.2 OUTLIER -119.63 147.48 44.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.17 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.578 HG23 ' CE2' ' A' ' 110' ' ' PHE . 31.2 t -78.49 123.06 34.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.433 0.635 . . . . 0.0 111.487 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.907 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -104.34 -22.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.274 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.76 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -152.11 159.75 43.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.18 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 1.5 pt-20 -148.31 111.7 4.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.171 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.67 HG22 HG21 ' A' ' 160' ' ' VAL . 3.8 t -57.62 125.73 73.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.219 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 4.8 Cg_exo -74.45 -8.14 20.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.845 2.363 . . . . 0.0 113.571 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.44 135.91 50.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.247 0.546 . . . . 0.0 112.187 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD2' ' CG ' ' A' ' 106' ' ' LYS . 29.3 m95 -67.7 145.57 54.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.07 0.462 . . . . 0.0 110.109 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.633 ' HB3' HG13 ' A' ' 153' ' ' VAL . 55.7 mt -111.36 117.93 34.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.897 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.882 HG22 ' CB ' ' A' ' 104' ' ' ALA . 9.5 p -108.89 140.18 42.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.74 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.766 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -134.24 170.18 16.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.886 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.81 158.34 33.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -120.85 146.6 44.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.655 ' HG2' HG23 ' A' ' 88' ' ' VAL . 34.4 Cg_endo -64.52 172.28 6.95 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.603 2.202 . . . . 0.0 112.241 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.23 -9.59 25.69 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.844 2.363 . . . . 0.0 113.056 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -98.03 -35.24 10.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.146 0.498 . . . . 0.0 110.041 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.655 HG23 ' HG2' ' A' ' 85' ' ' PRO . 87.6 t -82.57 -45.34 19.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -60.74 -46.54 90.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.439 0.638 . . . . 0.0 109.465 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.4 tm-20 -66.84 -28.22 68.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.586 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -47.63 16.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.627 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.44 HD22 ' CG ' ' A' ' 96' ' ' TRP . 78.7 mt -58.44 -45.48 88.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 110.442 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.1 m-80 -46.14 -32.01 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.468 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.47 -49.36 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.39 -56.87 8.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.44 ' CG ' HD22 ' A' ' 92' ' ' LEU . 18.3 m0 -77.83 -34.46 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.785 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 80.74 34.66 27.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.577 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.43 147.07 49.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.56 49.66 0.91 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 36.7 m95 -105.24 150.15 25.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.744 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -30.76 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.64 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -161.6 -143.44 3.68 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.098 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 72.9 mm-40 -157.64 115.55 3.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.883 0.373 . . . . 0.0 111.435 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.882 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -95.48 105.61 17.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.3 pt20 -124.34 154.78 39.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' CG ' ' CD2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -107.51 105.38 15.26 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.485 178.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' HG21 ' A' ' 157' ' ' VAL . 26.6 m95 -72.92 144.88 47.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.222 0.534 . . . . 0.0 112.259 -178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.9 m-85 -127.58 132.79 49.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.361 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.803 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.81 129.08 34.19 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.936 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.4 m-85 -123.73 127.87 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.907 ' HB3' HD11 ' A' ' 73' ' ' ILE . 2.2 tppp? -91.73 121.78 33.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.652 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.0 t80 -63.52 126.68 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.846 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.653 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.9 p -127.12 37.62 4.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.627 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.56 -145.17 4.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.066 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -129.64 154.16 47.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.882 0.372 . . . . 0.0 110.067 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.482 ' HA ' HD12 ' A' ' 119' ' ' ILE . 20.2 m-20 -49.5 -16.92 0.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.602 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -76.9 -23.29 52.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.768 0.318 . . . . 0.0 111.041 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.88 -25.17 52.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.822 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 116' ' ' ASP . 23.2 mt -68.03 104.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.393 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.62 ' ND2' HD12 ' A' ' 122' ' ' LEU . 1.1 m120 -121.2 95.91 4.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.914 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 131' ' ' PHE . 44.8 mt -58.56 -21.05 51.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.41 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.62 HD12 ' ND2' ' A' ' 120' ' ' ASN . 2.3 mt -61.46 -57.44 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.261 0.553 . . . . 0.0 109.799 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.87 179.04 21.81 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.575 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -90.25 38.75 0.94 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.214 0.531 . . . . 0.0 109.724 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.56 26.95 73.28 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.063 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -117.42 -69.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.805 0.336 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -96.44 165.13 12.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.204 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -77.43 148.81 77.8 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.499 ' CG ' HD23 ' A' ' 122' ' ' LEU . 64.2 Cg_exo -50.51 135.92 40.57 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.62 2.213 . . . . 0.0 112.597 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -111.91 -30.64 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.781 ' HB2' HD13 ' A' ' 121' ' ' LEU . 25.3 m-85 -118.34 159.51 23.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.7 -13.96 7.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.697 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.563 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.8 mp0 -152.17 174.18 14.06 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.085 0.469 . . . . 0.0 110.479 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.3 p-90 -159.74 150.04 18.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.239 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.6 m -148.68 156.64 42.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.465 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -92.14 125.01 36.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.69 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.72 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -135.62 150.78 29.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.138 0.494 . . . . 0.0 111.579 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -69.8 159.67 83.08 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.583 179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.582 ' CA ' HD13 ' A' ' 158' ' ' LEU . 12.9 Cg_endo -56.5 -17.97 23.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.917 1.745 . . . . 0.0 111.965 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.07 14.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.102 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.49 -50.63 29.58 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.959 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.3 tp -53.68 -33.43 55.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.524 0.678 . . . . 0.0 109.819 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.55 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.0 mm -67.34 -27.65 39.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.811 178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.3 -24.37 42.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.057 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.959 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.6 mt -82.34 -39.58 22.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.857 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 150' ' ' LYS . 3.3 m -54.25 168.59 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.272 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.5 p -103.65 160.83 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.52 ' N ' HG22 ' A' ' 147' ' ' VAL . 5.4 mt-10 -47.65 -40.61 20.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.349 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 21.7 p90 -86.22 8.3 21.7 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' HG21 ' A' ' 146' ' ' THR . 15.1 mttt -130.9 -1.61 4.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.588 0.233 . . . . 0.0 111.457 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 31.6 mttt -63.81 -62.85 4.64 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.269 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 14.7 Cg_endo -57.16 -41.4 74.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.454 2.102 . . . . 0.0 112.004 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.766 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.0 t -60.62 -26.78 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.15 0.5 . . . . 0.0 110.977 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 42' ' ' MET . 3.1 m-85 -91.09 -55.05 3.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.846 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HG3' HD12 ' A' ' 143' ' ' ILE . 34.6 mttm -47.92 -33.49 7.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.709 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.596 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.4 tp10 -67.94 -44.5 76.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.615 HG21 ' CD2' ' A' ' 107' ' ' TRP . 58.6 t -61.5 -49.17 85.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.222 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.582 HD13 ' CA ' ' A' ' 139' ' ' PRO . 73.9 mt -62.86 -48.4 79.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.658 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.9 m -49.58 -47.49 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.808 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.67 HG21 HG22 ' A' ' 76' ' ' VAL . 89.3 t -69.27 -24.98 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.664 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.803 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.6 m-30 -100.6 1.93 41.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.283 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.591 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.94 -54.47 40.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.355 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -55.29 -20.81 26.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.608 2.206 . . . . 0.0 112.379 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.76 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 19.9 m-70 -89.51 -21.19 23.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.677 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.41 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.895 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.467 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.89 145.03 55.21 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.522 2.148 . . . . 0.0 112.307 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 3' ' ' LEU . 3.5 tp -133.52 -172.9 3.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.26 66.58 0.23 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.466 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.446 ' CB ' ' CD1' ' A' ' 78' ' ' TYR . 7.9 m -138.29 -159.82 1.0 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.975 0.417 . . . . 0.0 110.077 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.497 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.9 OUTLIER -159.88 100.15 1.41 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.864 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.28 12.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -156.81 120.27 2.26 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB3' ' NH1' ' A' ' 15' ' ' ARG . 19.5 Cg_endo -58.8 112.37 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.208 1.939 . . . . 0.0 112.053 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 21.2 Cg_exo -65.47 -171.11 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.611 2.208 . . . . 0.0 112.118 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.36 144.04 26.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.342 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' C ' ' HE2' ' A' ' 101' ' ' LYS . . . 93.82 -40.56 2.75 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.731 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 49.3 m-85 -68.62 136.76 53.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.148 0.499 . . . . 0.0 110.919 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 14.9 ttt-85 -84.95 152.12 23.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.302 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.698 HH22 ' HB3' ' A' ' 104' ' ' ALA . 4.3 mmp_? -66.24 124.32 22.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.872 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 12.8 t-20 -152.65 159.9 43.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD11 ' A' ' 47' ' ' ILE . 3.7 m -133.96 146.79 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.52 150.47 17.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.388 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.891 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.7 mp -127.89 101.98 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.683 0.277 . . . . 0.0 111.224 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -89.45 104.93 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 110' ' ' PHE . 36.5 tp -103.09 141.59 35.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.061 0.458 . . . . 0.0 111.277 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.84 157.58 37.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.8 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.5 p-10 -101.4 171.33 7.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.241 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -57.33 -16.76 9.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.535 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.22 0.15 56.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.729 0.299 . . . . 0.0 110.972 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? 77.05 27.04 0.71 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.484 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -99.81 171.67 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.603 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -110.32 124.3 66.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.879 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.828 ' CE2' HG21 ' A' ' 119' ' ' ILE . 33.7 t80 -58.52 108.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.22 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.626 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.82 129.88 56.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.398 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -113.96 141.27 47.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.133 0.492 . . . . 0.0 111.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 2.3 p -82.53 158.84 22.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.726 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.568 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -67.6 165.92 16.03 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 111.712 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -89.31 -8.86 52.46 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.161 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' OD1' HG13 ' A' ' 36' ' ' ILE . 1.3 p30 -148.07 -7.51 0.42 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 49.9 mt -114.35 109.77 48.43 Favored Pre-proline 0 CA--C 1.523 -0.083 0 CA-C-N 118.562 0.619 . . . . 0.0 110.918 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 27.2 Cg_endo -64.87 130.85 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.892 1.728 . . . . 0.0 111.616 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.7 t70 80.89 1.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.485 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -94.67 97.66 10.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.153 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 33.3 m95 -108.91 162.17 14.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.859 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -168.73 164.8 12.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.457 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 77.6 mtm -94.9 157.79 36.12 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.66 132.99 32.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.646 2.231 . . . . 0.0 113.006 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.29 154.34 33.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.244 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.47 151.31 21.82 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.829 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -65.18 141.93 43.86 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.454 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.969 HD11 HG13 ' A' ' 17' ' ' VAL . 20.3 mt -76.68 164.32 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.952 0.406 . . . . 0.0 110.716 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.57 ' N ' HG22 ' A' ' 47' ' ' ILE . 3.2 m-20 -84.05 -175.8 5.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.671 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -78.63 100.01 6.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 110.324 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.65 49.77 17.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.615 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 3.1 tp10 -115.68 145.65 42.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 111.047 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -71.83 132.73 84.76 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.453 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.686 ' HA ' HG11 ' A' ' 17' ' ' VAL . 55.9 Cg_exo -52.96 -44.91 44.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.492 2.128 . . . . 0.0 112.9 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -59.92 -27.16 66.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -86.75 -47.37 9.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 110.712 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.02 -29.69 68.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.628 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -75.73 -50.35 15.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.7 mt -57.78 -30.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.088 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 59' ' ' ARG . 3.1 ttp-105 -81.05 -53.54 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.707 0.765 . . . . 0.0 109.815 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -53.96 -33.82 57.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.39 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.847 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -55.06 -59.82 4.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.609 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 5.9 ptt180 -61.47 -11.94 12.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.81 -39.57 11.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.782 0.325 . . . . 0.0 111.548 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.402 ' OE2' ' PG ' ' A' ' 166' ' ' ATP . 5.0 mm-40 -90.26 -32.75 16.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.099 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.88 -23.24 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.091 -179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.53 1.54 82.69 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.799 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.847 ' HB ' HD11 ' A' ' 61' ' ' LEU . 51.1 t -67.2 115.73 5.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -33.9 14.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.985 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.478 ' HG ' ' CD ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -90.5 81.86 5.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.106 0.479 . . . . 0.0 110.853 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.18 131.59 15.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.788 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.9 pt-20 -118.81 146.63 44.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.954 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.589 HG23 ' CE2' ' A' ' 110' ' ' PHE . 25.6 t -78.86 122.34 33.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.399 0.618 . . . . 0.0 111.529 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -104.62 -21.43 5.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.341 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.712 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -152.86 160.83 43.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.175 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.34 110.72 4.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.714 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.4 t -57.63 123.56 63.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.65 -6.03 17.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.798 2.332 . . . . 0.0 113.745 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.572 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -130.06 135.08 47.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.241 0.543 . . . . 0.0 112.09 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' MET . 27.9 m95 -66.46 147.24 53.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.848 ' HB3' HG13 ' A' ' 153' ' ' VAL . 53.2 mt -116.51 117.63 30.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.657 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.847 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.6 p -111.84 131.51 55.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.056 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.87 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -132.05 161.31 33.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.797 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.62 158.45 26.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.241 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -112.8 154.36 44.87 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.701 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.608 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.4 Cg_endo -62.95 171.61 5.85 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.531 2.154 . . . . 0.0 112.419 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.08 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.84 2.36 . . . . 0.0 113.165 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -91.46 -34.45 14.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.17 0.51 . . . . 0.0 110.017 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.608 HG23 ' HG2' ' A' ' 85' ' ' PRO . 71.3 t -82.41 -48.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.169 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.72 -46.13 84.83 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.538 0.685 . . . . 0.0 109.538 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.611 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.6 tt0 -68.07 -28.29 67.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.6 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 -46.93 22.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.661 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 96' ' ' TRP . 96.1 mt -58.51 -47.07 85.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.472 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -45.86 -31.67 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.549 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.7 mt -96.53 -49.13 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -55.2 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.869 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.477 ' CE2' HD22 ' A' ' 92' ' ' LEU . 18.9 m0 -78.43 -34.9 47.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.655 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.46 36.16 30.97 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.3 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.33 147.28 50.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.065 0.46 . . . . 0.0 110.866 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.405 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -108.36 71.99 0.82 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.806 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.456 ' CD1' ' HB2' ' A' ' 14' ' ' ARG . 15.7 m95 -135.29 136.81 41.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.086 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' H ' ' HE3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -70.53 -32.95 70.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.199 0.523 . . . . 0.0 109.998 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -155.23 -153.11 6.4 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.665 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -158.21 116.65 3.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.747 0.308 . . . . 0.0 111.217 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.847 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.88 105.65 16.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' NE2' ' CE1' ' A' ' 82' ' ' TYR . 0.9 OUTLIER -124.82 152.41 43.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 0.2 OUTLIER -106.7 101.63 11.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.594 178.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.457 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 22.1 m95 -69.01 143.96 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.197 0.522 . . . . 0.0 112.128 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 50.9 m-85 -124.83 135.74 53.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.277 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.816 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.6 tp -79.88 131.09 35.78 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.392 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.891 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.6 m-85 -125.39 127.35 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.673 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.56 123.62 34.36 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.691 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.7 t80 -67.51 128.82 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 111.328 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 69' ' ' SER . 4.7 p -128.7 37.64 4.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.264 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -136.34 -144.45 4.85 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.156 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 153.86 47.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.968 0.413 . . . . 0.0 110.199 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.87 -14.35 0.55 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.589 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.62 -17.84 40.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.38 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.478 ' CD ' ' HG ' ' A' ' 69' ' ' SER . 6.3 tt0 -81.37 -24.58 36.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.794 0.33 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.828 HG21 ' CE2' ' A' ' 29' ' ' PHE . 32.1 mt -69.46 105.32 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.118 0.485 . . . . 0.0 111.579 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.535 HD21 HD12 ' A' ' 122' ' ' LEU . 10.1 t-20 -116.7 95.88 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.874 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 51.6 mt -52.22 -24.82 7.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.669 HD22 ' HG3' ' A' ' 129' ' ' PRO . 54.0 mt -63.21 -57.64 9.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.252 0.549 . . . . 0.0 109.974 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.32 -177.45 25.59 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.5 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.29 39.01 1.01 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.142 0.496 . . . . 0.0 109.709 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.18 71.5 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -121.83 -64.18 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 111.145 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.82 165.15 17.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.085 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 155.52 47.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.003 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.669 ' HG3' HD22 ' A' ' 122' ' ' LEU . 83.8 Cg_exo -44.7 149.8 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.786 2.324 . . . . 0.0 112.773 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -144.21 -44.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.745 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 7.4 m-85 -111.6 159.74 17.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.415 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.35 -16.4 6.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.989 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.451 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 23.4 mm-40 -152.32 175.11 13.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.105 0.479 . . . . 0.0 110.491 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 25.9 p-90 -159.09 150.96 20.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.178 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 m -148.55 162.24 40.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 73.8 m95 -95.67 125.33 40.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.657 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.853 HG11 HD11 ' A' ' 145' ' ' LEU . 27.8 m -137.63 150.96 25.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.097 0.475 . . . . 0.0 111.681 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.9 158.8 87.29 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.616 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.649 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.1 Cg_endo -54.89 -19.45 19.43 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 121.941 1.761 . . . . 0.0 112.096 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.19 -33.85 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.994 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -50.05 30.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.916 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.94 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.18 -29.67 46.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.447 0.641 . . . . 0.0 109.785 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.458 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.1 mm -69.53 -28.41 37.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.71 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.5 -21.02 42.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.127 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.94 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.0 mt -84.37 -39.54 18.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.933 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 m -58.33 164.98 2.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.971 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.846 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 15.0 p -95.57 160.85 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.899 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.516 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.9 OUTLIER -59.92 -27.07 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.846 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 24.8 p90 -91.1 10.9 24.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.435 ' HD3' ' CE2' ' A' ' 82' ' ' TYR . 10.1 mtmt -151.8 14.35 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.669 0.271 . . . . 0.0 111.584 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.516 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.8 mtpp -69.21 -62.59 2.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.25 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.1 Cg_endo -51.72 -41.98 59.18 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.533 2.155 . . . . 0.0 112.183 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.87 HG11 ' CD1' ' A' ' 82' ' ' TYR . 19.0 t -56.09 -27.24 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 110.936 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.439 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.2 m-85 -90.59 -53.0 4.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.473 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.458 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.8 -31.86 18.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.192 0.52 . . . . 0.0 110.445 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.687 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.3 tp10 -67.58 -44.85 77.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.696 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 153' ' ' VAL . 43.6 t -61.31 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.06 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.649 HD13 ' CA ' ' A' ' 139' ' ' PRO . 71.8 mt -65.0 -48.71 73.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.55 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 t -49.43 -47.5 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.689 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.714 HG11 ' HA ' ' A' ' 76' ' ' VAL . 71.3 t -67.93 -25.41 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.081 0.467 . . . . 0.0 110.35 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.816 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.5 m-30 -102.53 8.57 39.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.068 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.547 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.99 -57.26 16.99 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.27 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 14.1 Cg_endo -57.2 -22.02 46.32 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.435 2.09 . . . . 0.0 112.298 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.712 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 97.2 m-70 -89.91 -14.25 34.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.095 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.921 179.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.456 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 -177.93 2.18 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.577 2.184 . . . . 0.0 112.282 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.1 pt? -60.31 172.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.798 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 118.18 37.19 0.89 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.477 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.03 121.37 0.77 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.75 0.309 . . . . 0.0 110.552 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.7 mmt -130.83 -36.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.65 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 77.5 24.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 170.51 137.51 0.07 OUTLIER Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.517 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 36.2 Cg_endo -65.88 109.79 1.56 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.352 2.034 . . . . 0.0 112.187 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 6.1 Cg_exo -78.95 -177.14 3.69 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.102 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.35 152.5 20.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.911 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 -27.24 17.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.636 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.5 m-85 -109.2 138.16 45.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.978 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HD3' ' CD1' ' A' ' 100' ' ' TRP . 7.3 mtp85 -80.82 152.15 28.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 39.8 mtm180 -71.29 132.94 45.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.244 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 18.9 t-20 -152.83 157.16 40.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.868 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 47' ' ' ILE . 2.5 m -129.02 134.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 111.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.793 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -106.64 157.11 15.9 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.098 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.793 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.4 mm -120.77 101.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.691 0.246 . . . . 0.0 111.441 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 13.7 t -89.59 97.28 11.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.4 tp -102.5 145.27 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 111.393 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.35 157.31 41.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.749 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 36.5 p-10 -102.06 170.33 8.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.348 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -54.48 -18.55 4.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.595 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.91 0.14 56.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp 76.78 25.23 0.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.607 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' MET . 14.4 mttp -93.63 173.27 7.77 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.54 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -111.44 120.07 61.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.029 0.442 . . . . 0.0 110.868 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 119' ' ' ILE . 19.8 t80 -53.88 110.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.134 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.422 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.53 129.93 56.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.46 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.52 138.95 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.059 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.8 p -82.04 155.56 25.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -71.77 157.37 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 111.546 -179.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mt -91.86 -5.37 53.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.841 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.79 -21.44 4.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.024 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 57.9 mt -118.23 112.5 37.77 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.938 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.23 131.52 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 121.895 1.73 . . . . 0.0 111.765 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t70 77.43 3.25 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.89 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.94 97.45 10.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.563 ' CD1' HD22 ' A' ' 145' ' ' LEU . 24.4 m95 -101.06 156.92 17.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.292 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -168.38 -176.98 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.598 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -110.08 156.95 39.19 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.965 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HB2' HG12 ' A' ' 19' ' ' ILE . 72.2 Cg_exo -48.65 143.25 16.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.775 2.317 . . . . 0.0 113.021 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 145.1 22.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.37 133.1 2.99 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.741 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -62.62 140.28 45.94 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.329 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.747 HD11 HG13 ' A' ' 17' ' ' VAL . 4.3 mt -73.31 160.32 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.372 . . . . 0.0 110.696 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -85.44 -177.18 6.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -77.9 99.22 5.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.146 0.498 . . . . 0.0 110.35 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.7 46.45 9.69 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.729 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.1 tt0 -116.57 144.78 43.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.06 0.457 . . . . 0.0 110.879 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.02 137.31 82.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.591 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.622 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.3 Cg_exo -53.39 -50.45 13.88 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.454 2.103 . . . . 0.0 112.457 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 58' ' ' ILE . 19.2 ttp180 -62.38 -25.43 67.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -83.64 -51.4 7.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.695 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.14 -31.13 65.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.597 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.22 -53.65 10.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.465 HD12 ' O ' ' A' ' 54' ' ' ARG . 54.4 mt -54.75 -27.92 19.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.192 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.5 ttp85 -83.82 -53.13 5.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.805 0.812 . . . . 0.0 109.626 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -56.57 -32.7 65.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.394 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 67' ' ' VAL . 2.8 tp -53.12 -61.58 2.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.046 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.584 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 7.7 ptt180 -62.07 -10.87 11.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.448 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.81 -42.14 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.596 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -90.53 -32.42 16.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -21.91 8.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.9 0.381 . . . . 0.0 110.995 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.46 4.8 70.75 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.956 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 61' ' ' LEU . 44.3 t -69.75 117.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.792 0.296 . . . . 0.0 110.361 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -35.22 12.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.146 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.13 77.53 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.098 0.475 . . . . 0.0 110.848 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.24 129.16 13.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.826 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.1 mm-40 -119.93 148.16 43.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.719 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.592 HG23 ' CE2' ' A' ' 110' ' ' PHE . 41.6 t -78.18 125.9 38.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.438 0.637 . . . . 0.0 111.722 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.898 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -105.09 -20.42 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.318 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.709 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -156.06 163.19 39.98 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.231 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 1.3 pm0 -148.54 117.34 6.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.846 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.7 t -57.03 125.43 70.03 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.063 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.28 -17.74 60.78 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.771 2.314 . . . . 0.0 113.362 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.633 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -124.9 -176.45 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.395 0.617 . . . . 0.0 112.125 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.784 ' C ' HD23 ' A' ' 80' ' ' LEU . 15.2 m95 -109.15 147.29 32.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.924 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.798 HD22 ' O ' ' A' ' 4' ' ' GLY . 2.0 mt -112.35 117.75 33.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.02 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.839 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.3 p -111.14 132.25 54.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.518 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.867 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -126.7 169.52 13.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.544 -179.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.52 158.41 40.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.108 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -109.72 154.38 42.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.609 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.1 Cg_endo -63.0 171.52 6.02 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.404 2.07 . . . . 0.0 112.34 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.93 -17.26 59.13 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.819 2.346 . . . . 0.0 113.238 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -92.31 -34.01 14.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.195 0.521 . . . . 0.0 110.169 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' A' ' 85' ' ' PRO . 70.3 t -82.96 -47.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.303 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -45.66 91.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.481 0.657 . . . . 0.0 109.49 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 94' ' ' ILE . 31.5 tt0 -68.69 -26.72 65.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.648 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 -46.74 17.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 96' ' ' TRP . 88.7 mt -59.21 -45.84 90.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -45.98 -32.13 2.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.4 -49.6 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.201 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -67.27 -55.24 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.781 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.465 ' N ' ' O ' ' A' ' 92' ' ' LEU . 16.0 m0 -77.38 -35.17 54.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.61 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.72 36.48 25.71 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.287 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.81 147.46 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.999 0.428 . . . . 0.0 110.749 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -111.91 42.88 1.66 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.424 ' CD1' ' HD3' ' A' ' 14' ' ' ARG . 55.3 m95 -102.45 150.32 23.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.706 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -30.14 60.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.394 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -172.19 -139.62 2.87 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.005 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.11 115.7 2.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.789 0.328 . . . . 0.0 111.376 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.839 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.83 105.86 16.64 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.5 OUTLIER -117.01 157.73 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -113.65 95.87 5.57 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.841 179.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.49 ' CD2' HG21 ' A' ' 157' ' ' VAL . 61.7 m95 -64.24 145.63 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 75' ' ' GLU . 61.2 m-85 -129.31 134.19 47.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.267 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.861 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -80.02 132.21 35.95 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.58 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.858 ' O ' HD12 ' A' ' 21' ' ' LEU . 50.3 m-85 -127.16 128.49 46.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 111.278 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.898 ' HB3' HD11 ' A' ' 73' ' ' ILE . 21.3 tttm -92.8 122.76 35.52 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.668 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.5 t80 -65.8 126.12 27.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.007 0.432 . . . . 0.0 110.874 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.7 p -128.42 37.91 4.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.549 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -139.19 -144.98 4.66 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.148 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.88 154.22 45.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.563 ' HA ' HD12 ' A' ' 119' ' ' ILE . 12.8 m-20 -50.2 -16.26 0.3 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.708 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -79.72 -17.48 53.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.645 0.26 . . . . 0.0 111.356 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -24.93 37.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.94 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.593 HG21 ' CE2' ' A' ' 29' ' ' PHE . 7.5 mt -72.46 103.82 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.477 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -114.66 95.59 5.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.952 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' A' ' 131' ' ' PHE . 47.5 mt -54.54 -24.23 19.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.453 HD22 ' HG3' ' A' ' 129' ' ' PRO . 15.5 mt -63.4 -56.96 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.273 0.558 . . . . 0.0 109.988 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.67 -178.5 23.37 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.465 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -90.64 38.73 0.95 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.067 0.461 . . . . 0.0 109.872 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.17 73.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.219 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -107.11 -65.16 1.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.778 0.323 . . . . 0.0 111.206 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -115.55 164.97 13.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.277 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 153.91 50.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.111 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HG3' HD22 ' A' ' 122' ' ' LEU . 74.6 Cg_exo -48.17 177.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.776 2.317 . . . . 0.0 112.672 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -150.07 -44.75 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.0 m-85 -112.06 159.91 18.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.411 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.68 -21.14 5.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.679 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.6 mm-40 -152.29 174.68 13.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 110.453 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 28.1 p-90 -159.12 154.74 26.03 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.332 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -151.71 158.73 43.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.458 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 80.1 m95 -92.58 125.81 37.38 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.704 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.901 HG11 HD11 ' A' ' 145' ' ' LEU . 27.3 m -137.4 150.69 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.729 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 4.1 p -68.91 159.18 83.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.576 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.54 ' HD3' HD11 ' A' ' 28' ' ' ILE . 13.0 Cg_endo -56.38 -18.91 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.873 1.715 . . . . 0.0 112.033 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -92.02 -33.88 14.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.117 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -71.08 -50.47 33.45 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.895 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.9 tp -53.16 -33.67 53.54 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.435 0.636 . . . . 0.0 109.876 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -64.88 -29.63 47.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.629 178.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.63 -31.49 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.8 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.901 HD11 HG11 ' A' ' 137' ' ' VAL . 9.4 mt -75.98 -40.46 53.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.033 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 147' ' ' VAL . 13.8 m -55.45 164.15 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.259 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.86 HG11 ' CE2' ' A' ' 149' ' ' PHE . 13.7 p -96.3 161.9 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.881 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -63.12 -33.62 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.86 ' CE2' HG11 ' A' ' 147' ' ' VAL . 8.3 p90 -79.88 0.92 29.13 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.497 ' HG3' ' CD1' ' A' ' 149' ' ' PHE . 5.0 mtmt -147.51 17.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.665 0.269 . . . . 0.0 111.437 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.1 mtpt -69.21 -62.75 2.46 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.012 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 13.6 Cg_endo -56.5 -40.73 82.58 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.146 . . . . 0.0 111.935 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.0 t -54.39 -25.52 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.003 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -91.08 -51.88 5.11 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.354 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.18 -32.06 15.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.471 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -67.07 -45.52 77.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.623 179.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.516 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 57.1 t -58.44 -47.47 88.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.927 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 143' ' ' ILE . 36.7 mt -63.05 -49.16 75.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.794 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.7 t -49.35 -45.68 46.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.71 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.846 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.2 t -70.1 -24.62 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.072 0.463 . . . . 0.0 110.465 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.861 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -103.82 8.55 37.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.088 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.642 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.68 -51.36 74.36 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.844 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.8 Cg_endo -52.67 -23.75 20.94 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.419 2.079 . . . . 0.0 112.433 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.709 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 99.1 m-70 -90.4 -23.61 21.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.838 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.685 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.912 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.496 " H2'" HD11 ' A' ' 36' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.447 ' C ' HD22 ' A' ' 3' ' ' LEU . 54.2 Cg_endo -69.93 -173.16 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.567 2.178 . . . . 0.0 112.254 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.616 ' N ' HD22 ' A' ' 3' ' ' LEU . 2.6 mm? -112.53 79.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.678 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -170.91 36.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.544 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.93 120.31 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 0.0 110.445 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mmt -125.19 -40.06 2.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.587 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 74.43 19.08 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.923 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p 171.3 136.21 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.456 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 40.9 Cg_endo -68.17 109.7 2.04 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.347 2.031 . . . . 0.0 112.314 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 3.7 Cg_exo -75.05 -174.65 2.02 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.932 2.421 . . . . 0.0 112.073 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -90.14 154.55 19.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.906 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.16 -38.09 3.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -89.38 141.61 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -86.18 152.28 22.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.421 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.464 HH22 ' HB3' ' A' ' 104' ' ' ALA . 3.1 mmp_? -60.7 129.62 42.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.4 m120 -152.73 160.21 43.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.682 HG13 HD11 ' A' ' 47' ' ' ILE . 1.2 m -135.39 148.4 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.033 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -118.28 150.11 18.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.289 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.892 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.9 mp -127.34 101.66 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 0.0 111.477 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' PHE . 5.0 t -91.11 108.08 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.7 tp -103.45 148.96 25.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.054 0.455 . . . . 0.0 111.252 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.559 ' SD ' HD21 ' A' ' 109' ' ' LEU . 1.5 ptt? -131.26 157.54 42.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.674 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.456 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 30.8 p-10 -104.96 169.68 8.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -55.24 -18.29 5.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.77 2.88 52.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 0.0 110.899 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 19.5 mttm 73.23 26.85 2.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.565 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' NZ ' HG22 ' A' ' 138' ' ' THR . 0.0 OUTLIER -95.27 172.51 8.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.549 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.0 mp -110.2 117.89 55.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.812 ' HE2' HG21 ' A' ' 65' ' ' THR . 11.4 t80 -52.25 107.55 0.22 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.79 141.41 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.695 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.57 140.67 52.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.547 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.51 158.29 23.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.644 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.606 ' CD ' HD12 ' A' ' 36' ' ' ILE . 4.9 mtp-105 -71.69 163.55 27.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.438 0.637 . . . . 0.0 111.667 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.0 mt -97.14 -6.8 34.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.498 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.72 -18.18 3.92 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.606 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.6 mt -121.15 112.59 33.1 Favored Pre-proline 0 N--CA 1.457 -0.088 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.243 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 30.7 Cg_endo -65.59 132.41 30.85 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.884 1.723 . . . . 0.0 111.532 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 78.1 2.59 2.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.649 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.585 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.33 97.49 11.23 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.217 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.683 ' CD1' HD22 ' A' ' 145' ' ' LEU . 33.3 m95 -102.9 156.67 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.74 -176.9 2.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.666 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.479 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 64.1 mtm -108.14 155.45 40.13 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.71 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 134.42 29.4 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.19 159.35 41.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.52 166.76 36.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.722 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.26 135.35 14.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.409 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HG13 ' A' ' 17' ' ' VAL . 8.6 mt -66.08 160.99 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 110.663 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 1.2 m-20 -90.68 150.69 21.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.883 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.63 97.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.25 0.548 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.72 38.81 9.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.048 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HB3' HG23 ' A' ' 47' ' ' ILE . 2.8 tt0 -114.67 145.18 42.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.082 0.468 . . . . 0.0 110.879 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.1 t70 -70.64 139.18 86.12 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.676 ' O ' HG11 ' A' ' 17' ' ' VAL . 49.1 Cg_exo -55.64 -55.51 2.96 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.443 2.096 . . . . 0.0 112.65 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.46 ' O ' HD12 ' A' ' 58' ' ' ILE . 26.9 ttp180 -59.21 -23.58 62.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -84.89 -48.16 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.16 -31.53 67.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.812 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.32 -54.12 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.113 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 54' ' ' ARG . 50.9 mt -55.81 -29.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.231 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.1 ttp85 -82.8 -53.06 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.02 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.63 -45.59 57.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.374 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -56.55 -52.5 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.61 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 42.9 ttp180 -62.45 -12.54 22.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.568 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -91.61 -41.86 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 111.571 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -90.6 -28.43 18.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.985 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.812 HG21 ' HE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.93 -22.67 5.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.039 -179.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.08 9.47 63.52 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.952 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HB ' HD11 ' A' ' 61' ' ' LEU . 21.3 t -60.38 108.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 110.139 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.99 -35.54 15.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.422 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.28 74.25 7.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.225 0.536 . . . . 0.0 111.247 -179.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . . . -149.41 126.38 11.23 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.564 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.5 mm-40 -119.67 147.73 44.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.821 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 47.7 t -76.83 125.54 36.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.494 0.664 . . . . 0.0 111.704 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.894 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.55 -17.38 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.525 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -154.49 162.16 41.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.006 0.432 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 46.5 tt0 -148.53 115.45 6.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.143 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.923 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.8 t -57.58 128.15 79.09 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -11.76 30.18 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.902 2.401 . . . . 0.0 114.071 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -132.14 153.15 50.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.338 0.589 . . . . 0.0 112.36 -179.345 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.714 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.0 m95 -80.02 143.49 34.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 79' ' ' TRP . 2.4 mt -111.34 118.09 34.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.93 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.845 HG22 ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -113.5 130.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.849 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.792 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -132.98 160.62 36.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.619 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.9 158.38 29.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -102.43 155.51 36.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.608 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.644 ' HG2' HG23 ' A' ' 88' ' ' VAL . 28.1 Cg_endo -62.75 171.95 5.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.448 2.099 . . . . 0.0 112.157 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -66.13 -9.89 25.18 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.893 2.395 . . . . 0.0 113.032 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -98.36 -35.67 10.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.081 0.467 . . . . 0.0 110.043 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.644 HG23 ' HG2' ' A' ' 85' ' ' PRO . 99.9 t -82.53 -44.7 19.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.247 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -46.2 90.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 0.0 109.509 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.634 ' O ' HD12 ' A' ' 94' ' ' ILE . 45.0 tt0 -67.73 -26.83 66.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.689 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -46.88 13.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.76 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 96' ' ' TRP . 88.8 mt -59.67 -45.27 92.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.987 0.423 . . . . 0.0 110.413 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -45.7 -34.03 3.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.49 -47.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.267 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.23 -56.99 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.444 ' N ' ' O ' ' A' ' 92' ' ' LEU . 15.7 m0 -78.28 -34.97 48.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.75 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.86 35.36 22.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.522 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.04 147.1 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -114.73 41.0 2.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.886 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -103.74 150.12 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.659 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.14 -31.15 64.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.557 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -167.3 -139.07 2.58 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.009 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -157.89 116.02 3.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.543 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.845 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -92.62 111.93 23.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.724 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -131.95 150.7 52.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -102.77 97.08 7.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.287 178.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 42' ' ' MET . 43.2 m95 -65.34 139.22 58.56 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 44.0 m-85 -120.23 138.44 53.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.539 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.852 HD13 ' CD2' ' A' ' 161' ' ' PHE . 25.3 tp -79.72 154.97 28.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.892 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.2 m-85 -148.17 127.87 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.437 . . . . 0.0 111.782 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.894 ' HB3' HD11 ' A' ' 73' ' ' ILE . 24.6 tttm -93.0 120.46 33.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.594 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.634 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.1 t80 -67.11 122.08 17.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 110.726 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' SER . 10.0 p -123.0 37.37 4.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.553 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -137.91 -144.38 4.69 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.152 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.07 154.2 45.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -49.61 -16.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.597 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -76.77 -16.9 59.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.256 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -25.36 38.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.755 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 mt -73.51 99.46 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.48 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -114.29 95.71 5.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 131' ' ' PHE . 46.6 mt -54.97 -21.99 13.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.809 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.552 HD22 ' HG3' ' A' ' 129' ' ' PRO . 24.0 mt -63.94 -59.48 4.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.269 0.557 . . . . 0.0 109.956 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.72 -170.48 26.96 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.483 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -95.6 39.07 1.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.82 75.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.052 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.9 t -120.88 -70.26 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.857 0.361 . . . . 0.0 111.154 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -85.1 165.08 17.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.213 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -84.36 148.97 54.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.994 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.552 ' HG3' HD22 ' A' ' 122' ' ' LEU . 70.8 Cg_exo -50.15 130.76 29.14 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.649 2.232 . . . . 0.0 112.625 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.62 -30.33 7.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.508 ' HB2' HD13 ' A' ' 121' ' ' LEU . 34.5 m-85 -119.87 159.53 24.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.415 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.24 -16.16 6.25 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.716 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.67 174.0 14.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.223 0.535 . . . . 0.0 110.63 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.6 p-90 -159.85 155.17 25.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.066 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.1 m -153.87 159.44 41.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.405 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.464 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 81.1 m95 -92.76 124.06 36.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.63 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.724 HG11 HD11 ' A' ' 145' ' ' LEU . 29.0 m -135.28 150.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.099 0.476 . . . . 0.0 111.772 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.494 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 1.5 p -70.4 160.54 80.85 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.479 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.603 ' CA ' HD13 ' A' ' 158' ' ' LEU . 16.2 Cg_endo -57.65 -17.89 30.69 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.765 1.643 . . . . 0.0 111.87 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -34.39 14.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.072 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -50.6 29.3 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.021 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.942 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.8 tp -54.08 -31.45 51.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 109.801 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.529 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.6 mm -68.25 -28.42 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.694 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.55 -20.7 42.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.226 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.942 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.7 mt -85.05 -39.22 18.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.174 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 147' ' ' VAL . 48.6 m -57.76 162.37 3.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.122 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.954 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.4 p -96.0 160.66 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.069 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' N ' HG22 ' A' ' 147' ' ' VAL . 7.9 mt-10 -50.17 -33.01 17.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.954 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 19.5 p90 -89.36 13.73 12.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 2.7 mtmp? -139.21 -2.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.586 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 19.2 mttt -55.18 -62.2 4.72 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.535 0.207 . . . . 0.0 111.352 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.2 Cg_endo -60.81 -42.35 38.88 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.389 2.059 . . . . 0.0 112.201 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.792 HG11 ' CD1' ' A' ' 82' ' ' TYR . 10.3 t -57.8 -31.55 40.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.336 0.588 . . . . 0.0 110.874 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.479 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -90.57 -50.66 5.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.846 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.529 ' HD2' HD12 ' A' ' 143' ' ' ILE . 5.2 tttt -50.39 -34.23 23.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' A' ' 80' ' ' LEU . 1.2 tp10 -67.92 -45.01 75.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.623 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 153' ' ' VAL . 39.3 t -57.84 -44.42 86.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.113 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.603 HD13 ' CA ' ' A' ' 139' ' ' PRO . 75.3 mt -68.81 -48.81 62.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.746 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -51.59 -45.87 63.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.923 HG11 ' HA ' ' A' ' 76' ' ' VAL . 84.0 t -69.59 -24.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.653 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.852 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.5 m-30 -101.47 -2.35 30.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.303 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -47.19 -52.95 31.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.473 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.3 Cg_endo -53.85 -22.08 22.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.511 2.141 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.595 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 67.7 m-70 -97.23 -16.97 20.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.686 0.279 . . . . 0.0 111.097 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 161' ' ' PHE . 5.4 mp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.924 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.445 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.12 145.33 54.77 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.526 2.151 . . . . 0.0 112.285 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 3' ' ' LEU . 3.0 mt -175.55 94.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.772 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -147.38 23.14 1.54 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.626 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.49 124.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.377 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.59 -31.87 1.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.892 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 69.57 22.26 6.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 176.33 140.5 0.22 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.333 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.498 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 55.7 Cg_endo -71.31 114.96 4.09 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.196 1.931 . . . . 0.0 112.786 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 7.2 Cg_exo -72.42 -172.03 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.581 2.187 . . . . 0.0 111.612 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -90.23 142.98 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA3' ' HZ3' ' A' ' 101' ' ' LYS . . . 92.53 -36.83 3.54 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.232 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 25.0 m-85 -77.12 135.9 38.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.132 0.491 . . . . 0.0 111.205 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 2.5 tmm_? -87.14 152.59 22.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.381 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -67.2 132.17 47.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.115 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 35.6 t30 -152.96 151.09 29.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.029 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -128.2 127.78 67.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 111.019 179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.767 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -101.11 161.73 18.32 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.233 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.6 mm -126.84 101.61 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.615 0.208 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 10.9 t -91.28 93.51 9.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.897 HD12 ' O ' ' A' ' 110' ' ' PHE . 17.1 tp -102.36 148.77 25.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.326 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.724 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.2 ptt? -131.02 157.53 42.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.793 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 34.3 p-10 -100.51 171.23 7.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.399 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -55.51 -18.25 6.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.616 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.93 0.56 56.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.363 . . . . 0.0 110.849 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp 76.37 25.16 1.01 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.713 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.2 mtpp -92.95 173.25 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.536 HG21 HD23 ' A' ' 142' ' ' LEU . 5.2 mp -110.54 116.66 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 110.97 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.655 ' CD2' HD23 ' A' ' 21' ' ' LEU . 4.4 t80 -50.82 107.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.298 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.53 142.54 46.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.64 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -128.3 140.12 52.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.1 p -82.44 157.74 23.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.533 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.616 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -74.2 159.37 32.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.309 0.576 . . . . 0.0 111.455 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.0 mt -94.64 -5.33 45.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.887 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -127.81 -17.52 4.46 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.128 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.616 HD12 ' CD ' ' A' ' 33' ' ' ARG . 67.4 mt -122.11 112.65 31.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.978 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.35 132.04 30.15 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.835 1.69 . . . . 0.0 111.771 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 76.79 4.49 3.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.794 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.607 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.98 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.35 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.639 ' CD1' HD22 ' A' ' 145' ' ' LEU . 32.3 m95 -102.37 155.92 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.197 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.7 -176.95 2.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.81 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.432 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 3.5 mpp? -107.08 156.82 36.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HB2' HG12 ' A' ' 19' ' ' ILE . 75.1 Cg_exo -48.98 140.92 23.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.892 2.394 . . . . 0.0 113.088 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 42' ' ' MET . 2.9 mm-40 -141.66 142.92 33.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.056 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -153.95 118.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.57 120.87 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.305 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.633 HD11 HG13 ' A' ' 17' ' ' VAL . 5.4 mt -53.9 160.42 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.392 . . . . 0.0 111.142 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.53 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.0 -176.03 4.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.61 99.68 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.06 48.81 18.64 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.604 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.11 146.01 42.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 110.969 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -67.13 136.13 93.92 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.505 ' O ' HG11 ' A' ' 17' ' ' VAL . 32.5 Cg_exo -59.59 -60.96 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.566 2.177 . . . . 0.0 112.577 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -55.1 -23.39 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.4 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -87.06 -41.47 13.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.983 0.421 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -62.34 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.361 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -73.07 -53.88 9.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.098 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 54' ' ' ARG . 46.0 mt -55.33 -30.34 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.124 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -82.05 -52.82 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.811 0.815 . . . . 0.0 109.816 179.079 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 7.4 mm-40 -55.3 -36.42 66.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.459 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD12 ' OG1' ' A' ' 65' ' ' THR . 10.7 tp -61.06 -62.9 1.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.646 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.682 ' HG3' HG22 ' A' ' 68' ' ' THR . 2.1 tmm_? -59.55 -12.91 7.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.401 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.09 -45.66 8.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 111.938 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -90.79 -27.73 18.69 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.749 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -115.38 -20.79 10.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.691 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.529 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 79.52 -7.5 53.37 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.079 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.72 ' HB ' HD11 ' A' ' 61' ' ' LEU . 47.1 t -59.98 117.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.981 0.39 . . . . 0.0 110.571 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.682 HG22 ' HG3' ' A' ' 62' ' ' ARG . 21.0 p -101.88 -31.56 10.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.044 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 78.0 6.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.22 0.534 . . . . 0.0 110.848 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.45 130.37 14.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.707 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.1 pt-20 -119.66 140.56 50.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.337 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 36.3 t -69.64 116.93 11.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.302 0.572 . . . . 0.0 111.265 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.882 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.1 mt -91.1 -24.33 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.046 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -161.74 168.98 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.539 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.78 118.77 7.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.856 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.805 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.8 t -57.16 129.82 79.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.957 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.95 -19.46 63.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.687 2.258 . . . . 0.0 113.332 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.593 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.98 -177.71 3.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.29 0.567 . . . . 0.0 112.1 -179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.731 ' C ' HD23 ' A' ' 80' ' ' LEU . 47.8 m95 -107.13 147.45 30.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.967 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.772 HD22 ' O ' ' A' ' 4' ' ' GLY . 3.5 mt -111.55 117.74 33.8 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.09 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.853 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.9 p -109.19 137.34 47.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.417 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.845 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -128.11 170.26 13.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.55 -179.316 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.99 158.23 38.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.64 148.85 51.57 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.599 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.2 Cg_endo -63.29 168.13 11.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.54 2.16 . . . . 0.0 112.365 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.4 -16.5 47.64 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.863 2.375 . . . . 0.0 113.079 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -91.58 -34.1 14.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.16 0.505 . . . . 0.0 110.114 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.599 HG23 ' HG2' ' A' ' 85' ' ' PRO . 77.0 t -82.93 -49.01 17.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.198 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -45.68 83.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 0.0 109.498 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.632 ' O ' HD12 ' A' ' 94' ' ' ILE . 29.5 tt0 -68.41 -29.96 68.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.517 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -47.46 39.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.554 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.479 HD22 ' CD2' ' A' ' 96' ' ' TRP . 95.8 mt -57.56 -48.05 80.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.515 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -46.08 -31.11 2.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.632 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.7 mt -96.49 -48.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.353 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -55.08 12.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.91 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.479 ' CD2' HD22 ' A' ' 92' ' ' LEU . 21.8 m0 -79.04 -32.75 45.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.726 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 74.78 37.14 45.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.237 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -127.57 149.11 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.402 ' O ' ' CE3' ' A' ' 100' ' ' TRP . 8.4 p-10 -105.98 69.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.457 ' CD1' ' HB2' ' A' ' 98' ' ' SER . 11.9 m95 -135.27 136.3 41.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.952 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HZ3' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.11 -31.26 62.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.323 0.582 . . . . 0.0 110.023 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -153.99 -153.5 6.44 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.685 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -158.16 117.06 3.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.739 0.304 . . . . 0.0 111.438 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.853 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.72 105.35 16.19 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.445 ' HG3' ' CD1' ' A' ' 107' ' ' TRP . 5.1 pt20 -115.79 153.75 30.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -107.85 95.81 5.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.569 178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.638 ' CD2' HG21 ' A' ' 157' ' ' VAL . 27.4 m95 -65.18 138.24 58.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 112.034 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 74.0 m-85 -122.25 132.72 54.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.882 HD23 ' HB ' ' A' ' 73' ' ' ILE . 18.4 tp -79.33 134.37 36.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.186 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.897 ' O ' HD12 ' A' ' 21' ' ' LEU . 45.0 m-85 -126.89 132.9 50.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.299 0.571 . . . . 0.0 112.031 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.662 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 2.0 ttmt -95.14 120.2 34.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.411 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.642 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.1 t80 -68.59 121.9 17.38 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.755 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.547 HG21 ' OE1' ' A' ' 71' ' ' GLU . 7.7 p -122.73 37.32 4.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.6 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.77 -145.12 4.84 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.085 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -127.93 154.08 45.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.858 0.361 . . . . 0.0 110.093 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -51.51 -15.25 0.4 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.715 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -84.1 -13.08 53.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 -25.33 36.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.962 0.411 . . . . 0.0 110.511 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 67' ' ' VAL . 18.4 mt -73.45 107.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.642 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.21 95.72 5.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.009 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' A' ' 131' ' ' PHE . 49.5 mt -53.35 -23.31 9.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.761 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.0 mt -63.22 -59.07 5.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.228 0.537 . . . . 0.0 109.977 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.53 -175.42 22.92 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.457 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -91.53 38.79 0.99 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.108 0.48 . . . . 0.0 109.818 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.55 73.32 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.171 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.1 t -108.85 -66.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 111.119 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -108.32 165.12 11.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -68.75 148.31 97.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 34' ' ' LEU . 61.9 Cg_exo -50.86 145.16 24.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.526 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -113.79 -35.72 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.615 ' HB2' HD13 ' A' ' 121' ' ' LEU . 11.2 m-85 -113.83 159.51 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.567 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.51 5.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.351 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.55 173.66 14.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.129 0.49 . . . . 0.0 110.5 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 33.6 p-90 -160.39 157.95 28.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.78 158.5 36.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.451 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.459 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.3 m95 -91.17 123.44 34.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.626 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 142' ' ' LEU . 32.8 m -134.33 151.12 31.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.164 0.507 . . . . 0.0 111.726 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.1 p -69.49 160.85 77.64 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.478 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.694 ' CB ' HD13 ' A' ' 158' ' ' LEU . 19.6 Cg_endo -58.59 -16.85 32.08 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.669 1.58 . . . . 0.0 111.876 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.34 -34.03 14.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.103 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -51.59 23.69 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.107 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.926 ' HA ' HD12 ' A' ' 145' ' ' LEU . 2.2 tp -54.29 -32.43 56.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.473 0.654 . . . . 0.0 109.806 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.598 HD12 ' HG3' ' A' ' 155' ' ' LYS . 6.2 mm -68.35 -27.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.781 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.1 -22.03 42.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.221 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.8 mt -83.99 -39.16 20.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.15 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 147' ' ' VAL . 23.6 m -55.55 164.3 1.08 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.759 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.9 p -93.71 165.01 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.054 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.9 mm-40 -55.66 -35.48 66.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.868 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.759 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 9.7 p90 -88.58 9.96 22.14 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 147' ' ' VAL . 20.0 mtmt -131.31 -3.46 3.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.523 0.202 . . . . 0.0 111.442 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.429 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 14.3 mttt -58.38 -63.27 4.19 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.238 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 15.5 Cg_endo -57.28 -41.49 72.62 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.176 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 82' ' ' TYR . 34.1 t -59.18 -28.97 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.977 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 4.1 m-30 -91.37 -54.01 4.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.842 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HG3' HD12 ' A' ' 143' ' ' ILE . 21.3 mttt -47.86 -34.34 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.2 tp10 -66.99 -45.18 78.4 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.779 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.638 HG21 ' CD2' ' A' ' 107' ' ' TRP . 56.9 t -57.27 -50.13 77.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.348 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.694 HD13 ' CB ' ' A' ' 139' ' ' PRO . 74.2 mt -62.45 -48.64 78.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.749 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -49.77 -47.29 51.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.805 HG11 ' HA ' ' A' ' 76' ' ' VAL . 97.5 t -68.92 -24.52 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.018 0.437 . . . . 0.0 110.46 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.867 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.6 m-30 -104.11 9.28 36.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.154 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.625 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.57 -51.7 70.72 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.715 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.98 -23.48 21.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.51 2.14 . . . . 0.0 112.289 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.696 ' CE1' HG22 ' A' ' 73' ' ' ILE . 98.2 m-70 -89.78 -24.99 21.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.599 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.724 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.85 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.451 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.87 164.95 31.54 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.607 2.205 . . . . 0.0 112.273 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 133.74 55.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.79 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 66.57 22.15 71.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.618 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.24 123.07 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.816 0.341 . . . . 0.0 110.541 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 11.0 mmt -134.72 -31.94 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.848 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 72.73 22.58 3.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.672 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p 173.67 133.98 0.12 Allowed Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 39.2 Cg_endo -67.85 111.1 2.3 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.301 2.001 . . . . 0.0 112.367 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.39 -174.73 1.92 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.776 2.317 . . . . 0.0 112.009 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.29 153.99 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.97 -38.08 3.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.583 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -96.42 134.58 39.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -80.18 147.41 31.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' N ' ' HG3' ' A' ' 14' ' ' ARG . 34.2 mtm180 -65.1 137.52 57.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.298 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 6.5 m120 -152.32 153.18 33.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.298 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.722 HG13 ' CG1' ' A' ' 47' ' ' ILE . 1.0 OUTLIER -122.33 118.33 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -88.11 146.82 19.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.031 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.91 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.2 mp -123.5 101.94 10.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.791 0.329 . . . . 0.0 111.259 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.06 100.54 13.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 110' ' ' PHE . 39.4 tp -102.69 139.28 38.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.068 0.461 . . . . 0.0 111.225 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -125.62 157.28 37.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.82 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -103.61 169.85 8.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.287 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -50.88 -18.36 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -88.99 0.23 56.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.682 0.277 . . . . 0.0 111.097 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 75.64 25.89 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.688 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.9 mmtp -97.65 172.65 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.6 mp -109.74 125.25 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.77 ' CE2' HG21 ' A' ' 119' ' ' ILE . 54.7 t80 -58.76 110.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.207 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.61 129.87 56.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.109 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' HE22 ' A' ' 41' ' ' GLN . . . -115.21 136.09 53.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 111.489 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.429 ' N ' ' CE3' ' A' ' 40' ' ' TRP . 1.1 p -82.38 154.84 25.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.662 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.535 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.74 158.54 36.11 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.227 0.537 . . . . 0.0 111.517 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.2 mt -91.94 -5.9 52.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.009 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -130.8 -17.43 3.18 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.625 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 55.1 mt -119.12 111.91 36.61 Favored Pre-proline 0 N--CA 1.455 -0.206 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.026 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.4 Cg_endo -65.28 131.4 28.22 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.873 1.715 . . . . 0.0 111.902 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 1.6 t70 77.73 2.69 2.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.78 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.625 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.94 97.22 11.06 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.269 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 50.5 m95 -104.68 157.88 16.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.547 HE22 ' HB3' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -168.89 173.78 6.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' A' ' 154' ' ' TYR . 69.5 mtm -102.25 156.86 34.72 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.69 131.78 26.9 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.613 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' CG ' ' PG ' ' A' ' 166' ' ' ATP . 0.0 OUTLIER -154.15 157.72 39.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.51 34.45 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.589 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -79.75 130.87 10.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.556 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.722 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.6 mt -59.44 160.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.51 148.06 22.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -48.16 99.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.9 41.6 18.41 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.798 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 11.6 tp10 -111.38 147.2 35.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.933 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.23 128.9 85.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.338 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.57 ' HA ' HG11 ' A' ' 17' ' ' VAL . 51.9 Cg_exo -52.8 -23.59 21.1 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.329 2.019 . . . . 0.0 112.676 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' O ' HD12 ' A' ' 58' ' ' ILE . 9.6 tpt180 -85.54 -22.03 28.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -91.06 -43.45 9.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.491 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.459 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -62.59 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.215 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.547 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -71.84 -52.86 15.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.17 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.484 HD12 ' O ' ' A' ' 54' ' ' ARG . 64.1 mt -56.52 -27.83 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.316 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -84.88 -52.77 5.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.824 0.821 . . . . 0.0 109.883 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -56.17 -34.24 66.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.592 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.787 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.4 tp -57.41 -59.0 5.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.042 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.569 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 25.1 ptt180 -60.99 -11.84 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.784 0.326 . . . . 0.0 110.504 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -91.69 -43.52 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.886 0.374 . . . . 0.0 111.544 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.3 -25.94 19.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.301 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.787 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.68 -22.01 8.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.961 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 75.21 4.55 73.7 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.972 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.769 ' HB ' HD11 ' A' ' 61' ' ' LEU . 53.2 t -74.46 124.95 33.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.785 0.326 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.48 -35.67 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.26 79.08 6.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.749 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 129.55 13.83 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.919 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 5.6 mm-40 -119.19 147.61 44.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.65 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 48.9 t -77.21 128.93 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.898 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -108.19 -18.63 7.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.378 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -159.27 162.25 36.07 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.423 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 4.9 pt-20 -148.83 118.77 7.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.721 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HA ' HG11 ' A' ' 160' ' ' VAL . 17.9 t -58.02 125.34 73.8 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.273 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.01 -19.8 69.98 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.739 2.293 . . . . 0.0 113.068 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.587 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.68 -176.74 3.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.031 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.691 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.4 m95 -108.75 147.1 32.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.023 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 4' ' ' GLY . 4.4 mt -112.29 117.7 33.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.01 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.866 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.9 p -108.65 136.7 47.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.683 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.824 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.0 170.18 14.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.337 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.03 158.04 40.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.427 ' CZ ' ' O1A' ' A' ' 166' ' ' ATP . 15.0 m-85 -116.16 150.61 45.51 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.578 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.0 Cg_endo -63.08 171.91 5.65 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.39 -17.78 60.83 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.8 2.333 . . . . 0.0 113.19 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.7 ttmm -91.52 -34.25 14.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.578 HG23 ' HG2' ' A' ' 85' ' ' PRO . 71.0 t -82.63 -48.05 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.298 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -58.69 -45.71 88.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.488 0.661 . . . . 0.0 109.496 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.618 ' O ' HD12 ' A' ' 94' ' ' ILE . 28.4 tt0 -68.18 -27.87 66.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.581 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -47.12 21.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.588 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 96' ' ' TRP . 94.6 mt -58.36 -46.75 85.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.407 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.5 m-80 -45.91 -31.93 2.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.616 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.4 -48.8 12.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.305 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -56.71 8.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.801 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 92' ' ' LEU . 18.8 m0 -78.33 -33.26 49.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.98 35.22 31.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.443 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.47 147.34 47.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.678 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -109.59 39.32 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -96.69 146.81 24.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.63 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -29.47 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.713 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -163.86 -139.39 2.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.307 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 82' ' ' TYR . 32.9 mt-30 -157.53 115.07 3.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 111.542 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.866 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -96.28 112.11 23.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.688 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 4.2 pt20 -127.29 159.69 33.61 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -112.51 95.91 5.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.456 178.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CD2' HG21 ' A' ' 157' ' ' VAL . 40.5 m95 -64.48 141.56 58.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.157 0.503 . . . . 0.0 112.271 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 54.8 m-85 -124.67 133.55 53.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.224 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.8 tp -79.63 131.37 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.553 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.91 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.0 m-85 -127.05 129.38 47.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.913 0.387 . . . . 0.0 111.351 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.897 ' HB3' HD11 ' A' ' 73' ' ' ILE . 11.5 tttt -93.34 120.97 34.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.657 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.7 t80 -63.46 126.93 29.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.933 0.397 . . . . 0.0 111.014 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 111' ' ' LYS . 18.2 p -129.64 38.15 3.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.58 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.83 -145.05 4.71 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.992 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -128.08 154.14 46.03 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -50.35 -16.29 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.62 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -79.16 -19.64 50.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -79.77 -25.07 41.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.828 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.77 HG21 ' CE2' ' A' ' 29' ' ' PHE . 18.1 mt -70.81 102.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.374 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.88 96.19 5.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.935 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.802 HD13 ' HB2' ' A' ' 131' ' ' PHE . 34.9 mt -56.67 -24.18 47.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.488 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 129' ' ' PRO . 58.4 mt -61.94 -56.96 13.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.294 0.568 . . . . 0.0 109.996 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.91 178.84 23.42 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.483 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -90.79 38.93 0.97 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.51 26.92 70.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.123 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -120.62 -70.84 0.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.829 0.347 . . . . 0.0 111.222 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.91 165.2 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -84.35 154.78 63.11 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.897 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.579 ' HG3' HD22 ' A' ' 122' ' ' LEU . 87.9 Cg_exo -45.94 160.48 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.791 2.328 . . . . 0.0 112.722 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.0 mt-10 -150.19 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.802 ' HB2' HD13 ' A' ' 121' ' ' LEU . 1.5 m-85 -107.57 159.51 16.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.181 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.56 -17.94 5.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.068 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -152.42 175.23 12.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.177 0.513 . . . . 0.0 110.659 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.4 p-90 -156.42 150.43 25.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.258 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.43 165.64 29.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.349 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 59.9 m95 -99.43 125.44 45.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.811 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.784 HG11 HD11 ' A' ' 145' ' ' LEU . 27.5 m -137.97 150.6 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.994 0.426 . . . . 0.0 111.56 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -70.76 158.61 87.58 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.677 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.647 ' CB ' HD13 ' A' ' 158' ' ' LEU . 11.2 Cg_endo -55.07 -19.1 19.16 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.914 1.743 . . . . 0.0 111.943 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.76 -34.21 15.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.106 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -50.48 27.35 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.954 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -54.01 -29.76 44.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.42 0.629 . . . . 0.0 109.882 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.475 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -69.01 -28.61 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.733 178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.55 -20.93 42.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.21 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.8 mt -84.4 -39.35 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.066 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 147' ' ' VAL . 20.3 m -58.2 163.81 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.066 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.906 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 13.6 p -92.59 161.56 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -60.06 -26.45 66.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.906 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 22.8 p90 -91.55 12.09 22.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HE2' ' PB ' ' A' ' 166' ' ' ATP . 2.1 mtmp? -149.75 12.91 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.568 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.515 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.4 mtpm? -65.15 -62.48 4.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.166 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 11.9 Cg_endo -55.54 -40.86 83.02 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.478 2.118 . . . . 0.0 112.106 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.824 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.7 t -57.03 -28.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.492 . . . . 0.0 110.95 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.45 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.5 m-85 -91.42 -52.65 4.69 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.64 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.475 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.88 -33.56 17.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.586 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.01 -45.58 81.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.553 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.59 HG21 ' CD2' ' A' ' 107' ' ' TRP . 43.3 t -58.28 -46.62 88.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.071 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 139' ' ' PRO . 73.4 mt -64.14 -48.89 74.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.787 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.4 p -50.72 -46.71 59.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.683 HG11 ' HA ' ' A' ' 76' ' ' VAL . 90.0 t -67.22 -23.13 29.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 11.2 m-30 -102.96 -1.8 28.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.432 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -49.84 -44.25 77.34 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 38.8 Cg_endo -71.16 -21.54 27.04 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.13 1.887 . . . . 0.0 112.817 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.433 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 81.1 m-70 -89.37 -41.91 11.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.699 0.285 . . . . 0.0 110.463 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 161' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.411 -0.804 . . . . 0.0 111.27 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.471 ' PG ' ' CG ' ' A' ' 44' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.09 179.91 3.53 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.564 2.176 . . . . 0.0 112.282 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.5 mt 61.13 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.38 45.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.454 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.587 ' OG ' HD23 ' A' ' 80' ' ' LEU . 3.0 t -130.96 -155.08 0.67 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.999 0.428 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.567 ' HG3' HG23 ' A' ' 81' ' ' THR . 1.4 mmt -124.6 -43.32 2.03 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.14 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t0 72.2 24.43 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 170.06 128.22 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.583 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.3 Cg_endo -64.56 109.64 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.261 1.974 . . . . 0.0 112.234 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' CD ' HG21 ' A' ' 81' ' ' THR . 8.4 Cg_exo -72.25 -173.15 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.846 2.364 . . . . 0.0 112.009 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -90.1 148.02 23.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.28 -28.22 13.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.553 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 26.3 m-85 -93.93 140.2 29.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -86.71 152.5 22.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.265 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.647 HH22 ' HB3' ' A' ' 104' ' ' ALA . 1.9 mmp_? -62.19 128.42 36.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.214 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 11.6 t-20 -152.64 159.42 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.84 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.688 HG13 HD11 ' A' ' 47' ' ' ILE . 3.3 m -134.9 140.58 45.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.91 0.385 . . . . 0.0 111.222 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.48 149.54 16.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.157 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.932 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.8 mp -128.38 103.78 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.776 0.322 . . . . 0.0 111.58 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 20.5 t -89.71 106.33 18.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.7 tp -103.17 145.06 30.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 111.333 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 3.5 ptm -130.56 157.39 42.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.518 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.489 ' HB3' ' CH2' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -109.93 169.78 8.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.011 0.434 . . . . 0.0 111.466 -179.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -51.16 -18.63 0.93 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.615 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.417 ' H ' ' CG ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -88.95 1.42 55.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 110.964 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm 73.38 26.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.649 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.9 mttt -99.01 175.14 6.02 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -110.93 126.37 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 0.0 111.007 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' HE2' HD13 ' A' ' 119' ' ' ILE . 12.1 t80 -58.43 109.62 0.81 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.26 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -117.02 129.67 56.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.433 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.77 137.89 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.089 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.2 155.99 24.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.782 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.4 mtp85 -71.38 159.83 33.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.296 0.569 . . . . 0.0 111.617 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.45 -5.64 48.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.916 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -19.29 4.01 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.218 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.623 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 59.7 mt -120.05 112.68 34.65 Favored Pre-proline 0 N--CA 1.456 -0.167 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.983 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.37 131.73 29.12 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.901 1.734 . . . . 0.0 111.713 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t70 77.35 3.3 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.777 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.47 97.21 10.95 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.243 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.622 ' CD1' HD22 ' A' ' 145' ' ' LEU . 31.5 m95 -102.47 156.73 17.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.238 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -168.62 169.22 10.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.792 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.3 mtm -92.92 156.17 40.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.33 124.35 11.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.556 2.171 . . . . 0.0 112.695 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -154.24 158.43 40.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.383 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.91 153.5 22.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.799 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.1 137.37 49.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.359 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.688 HD11 HG13 ' A' ' 17' ' ' VAL . 7.4 mt -64.57 161.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 0.0 110.405 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.507 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.3 m-20 -90.04 147.95 23.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.956 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.59 98.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.226 0.536 . . . . 0.0 110.807 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.01 36.03 8.63 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.024 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 5.0 tt0 -116.34 142.31 47.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.107 0.48 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.54 142.88 84.47 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.674 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.57 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.6 Cg_exo -54.44 -48.75 19.78 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.487 2.125 . . . . 0.0 112.566 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -65.55 -26.04 67.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -84.65 -46.92 11.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.656 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -58.29 -31.62 67.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.57 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.678 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.26 -53.54 10.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.177 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 54' ' ' ARG . 47.3 mt -55.9 -30.38 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.104 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -81.83 -53.23 6.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.735 0.779 . . . . 0.0 109.779 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -52.66 -39.04 61.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.451 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.809 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.3 tp -55.59 -57.38 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.041 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.559 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 2.7 ptt-85 -61.44 -12.48 14.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.432 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -91.69 -42.5 10.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.829 0.347 . . . . 0.0 111.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -91.41 -25.14 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.229 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.809 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.33 -21.61 8.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.758 0.314 . . . . 0.0 111.069 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.15 5.23 70.57 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.894 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG13 ' HE1' ' A' ' 112' ' ' PHE . 53.4 t -75.08 128.16 36.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.857 0.36 . . . . 0.0 110.633 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.81 -34.89 8.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.3 81.63 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.067 0.46 . . . . 0.0 110.974 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 130.69 14.6 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.84 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.688 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -119.77 148.21 43.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.983 179.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.5 t -79.14 122.83 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.339 0.59 . . . . 0.0 111.553 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.866 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -102.85 -20.79 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.596 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.27 162.53 40.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.039 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.23 115.97 6.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.011 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.826 ' HA ' HG11 ' A' ' 160' ' ' VAL . 3.5 t -57.21 128.46 78.23 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 -10.8 25.5 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.796 2.331 . . . . 0.0 113.942 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.608 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -131.16 160.8 33.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 112.294 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.406 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 30.9 m95 -88.71 147.11 24.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.117 0.484 . . . . 0.0 110.867 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.783 ' HB3' HG13 ' A' ' 153' ' ' VAL . 95.9 mt -115.44 117.63 30.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.571 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.815 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -114.59 130.83 56.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.757 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.833 ' CE1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -133.46 165.64 24.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -124.86 158.31 33.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.154 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -103.2 155.4 36.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.699 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.598 ' HG2' HG23 ' A' ' 88' ' ' VAL . 27.0 Cg_endo -62.35 171.57 5.22 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.406 2.071 . . . . 0.0 112.266 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.79 -16.99 58.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.777 2.318 . . . . 0.0 113.25 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.44 -33.57 14.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.183 0.516 . . . . 0.0 110.209 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.598 HG23 ' HG2' ' A' ' 85' ' ' PRO . 77.2 t -83.43 -47.88 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.326 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.88 -46.43 87.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.587 0.708 . . . . 0.0 109.461 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.5 tt0 -67.05 -27.73 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.512 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -46.61 19.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.543 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.538 HD22 ' CD2' ' A' ' 96' ' ' TRP . 95.6 mt -58.19 -46.56 85.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.471 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -46.13 -32.63 3.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.43 -48.07 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.399 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -56.18 8.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.899 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.538 ' CD2' HD22 ' A' ' 92' ' ' LEU . 17.1 m0 -78.0 -31.9 50.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.878 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.87 36.65 35.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.4 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.92 147.39 47.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -110.76 38.81 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.879 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -103.86 150.1 24.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.736 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -29.89 59.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.124 0.487 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.74 -143.94 4.27 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.696 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.425 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -158.7 124.38 4.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.847 0.356 . . . . 0.0 111.315 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.815 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -85.73 106.48 17.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -115.9 149.22 39.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.406 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 2.1 mmtp -109.52 96.45 6.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.542 ' CG ' HG21 ' A' ' 157' ' ' VAL . 73.3 m95 -62.65 145.78 53.72 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 70.1 m-85 -130.95 133.56 45.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.936 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.818 HD13 ' CD2' ' A' ' 161' ' ' PHE . 16.2 tp -79.68 130.88 35.74 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.595 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.932 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.9 m-85 -125.33 127.59 46.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.017 0.437 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.866 ' HB3' HD11 ' A' ' 73' ' ' ILE . 62.8 tttm -92.56 120.75 33.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.7 t80 -62.9 126.21 26.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.688 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.5 p -127.06 37.96 4.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.584 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.59 -145.16 4.76 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.059 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -128.95 154.24 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 109.984 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -49.3 -17.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.569 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.85 -22.79 53.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -77.01 -25.62 52.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.759 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.603 HD13 ' HE2' ' A' ' 29' ' ' PHE . 30.9 mt -68.0 103.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.56 96.06 4.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.041 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 131' ' ' PHE . 44.6 mt -58.72 -20.82 52.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.403 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.928 HD13 ' HG3' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -60.25 -57.0 14.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 179.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 143.3 178.32 19.02 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.332 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -89.79 38.65 0.92 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.193 0.521 . . . . 0.0 109.714 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.11 29.76 76.18 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.233 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.0 m -109.34 -64.04 1.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.742 0.306 . . . . 0.0 111.336 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -115.8 165.11 13.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.901 0.381 . . . . 0.0 111.333 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 152.69 68.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.047 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.928 ' HG3' HD13 ' A' ' 122' ' ' LEU . 77.0 Cg_exo -48.84 176.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 0.0 112.668 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -150.14 -44.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.767 ' HB2' HD13 ' A' ' 121' ' ' LEU . 18.6 m-85 -111.19 159.52 17.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.493 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.09 -18.16 6.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.732 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 20.2 mm-40 -152.3 175.0 13.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.042 0.448 . . . . 0.0 110.405 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 24.1 p-90 -159.23 152.07 21.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.287 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.15 163.39 38.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.362 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.489 ' CH2' ' HB3' ' A' ' 23' ' ' ASN . 64.9 m95 -95.98 123.58 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.68 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.856 HG11 HD11 ' A' ' 145' ' ' LEU . 33.0 m -133.14 151.09 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.559 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.2 p -70.1 158.22 87.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.525 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.541 ' HD3' HD11 ' A' ' 28' ' ' ILE . 10.9 Cg_endo -54.44 -19.57 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.0 1.8 . . . . 0.0 112.097 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -92.13 -34.36 14.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.276 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -50.25 46.56 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.935 0.398 . . . . 0.0 110.152 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.928 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.2 tp -53.21 -34.02 55.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.479 0.657 . . . . 0.0 109.871 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.524 HG21 ' NZ ' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -66.48 -28.61 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.673 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -77.39 -32.59 54.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.654 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.928 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.6 mt -74.64 -40.94 61.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.87 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 150' ' ' LYS . 18.3 m -53.53 164.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.221 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.628 HG21 ' CE2' ' A' ' 149' ' ' PHE . 7.3 p -97.37 159.82 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 1.0 OUTLIER -47.24 -43.68 22.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.465 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.628 ' CE2' HG21 ' A' ' 147' ' ' VAL . 39.2 p90 -83.95 7.02 19.64 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.454 ' O ' HG21 ' A' ' 146' ' ' THR . 25.3 mtmt -128.12 -6.31 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.59 0.234 . . . . 0.0 111.33 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.506 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.7 mtpm? -59.42 -60.63 9.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.592 0.235 . . . . 0.0 111.285 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.0 Cg_endo -61.54 -42.3 34.23 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.047 . . . . 0.0 112.15 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.833 HG11 ' CE1' ' A' ' 82' ' ' TYR . 13.4 t -58.1 -26.69 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.229 0.538 . . . . 0.0 110.926 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.5 -52.61 4.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.505 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.524 ' NZ ' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -50.75 -30.66 14.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.617 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 80' ' ' LEU . 7.7 tp10 -67.98 -44.99 75.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.484 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.542 HG21 ' CG ' ' A' ' 107' ' ' TRP . 48.6 t -59.99 -48.77 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 162' ' ' ALA . 59.2 mt -60.8 -48.95 79.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.971 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.0 m -48.89 -42.9 38.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.831 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.826 HG11 ' HA ' ' A' ' 76' ' ' VAL . 93.7 t -72.76 -24.78 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.03 0.443 . . . . 0.0 110.716 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.818 ' CD2' HD13 ' A' ' 109' ' ' LEU . 10.7 m-30 -100.97 -1.51 34.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.272 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.64 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -45.68 -51.84 27.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.539 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 11.0 Cg_endo -54.69 -22.02 27.34 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.301 2.0 . . . . 0.0 112.358 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.596 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 90.4 m-70 -96.09 -17.42 20.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.124 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.8 mp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.22 159.31 53.51 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.543 2.162 . . . . 0.0 112.292 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.612 ' C ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -175.5 150.23 1.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.993 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.79 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 57.6 31.4 63.54 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.477 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.42 120.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 14.6 mmt -122.79 -38.63 2.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.529 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 t70 75.72 22.54 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 170.1 138.07 0.07 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.57 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 60.9 Cg_endo -73.41 114.57 4.07 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.328 2.019 . . . . 0.0 112.268 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -88.35 -170.06 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.837 2.358 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.67 155.67 19.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.46 -35.09 4.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -106.51 135.65 47.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.374 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -81.48 152.3 27.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.017 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -66.75 136.31 55.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.523 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.0 m120 -152.54 156.21 38.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.449 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 m -129.79 121.83 53.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.853 0.359 . . . . 0.0 111.383 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.03 140.18 14.9 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.814 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -114.2 101.69 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.43 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 110' ' ' PHE . 4.2 t -90.18 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.2 tp -103.09 147.13 27.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -128.56 157.14 42.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.821 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 43.7 p-10 -99.87 172.48 7.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.14 -17.8 12.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.313 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -0.11 57.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.815 0.341 . . . . 0.0 110.994 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttt 76.93 25.44 0.83 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.599 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.4 mmtp -93.53 175.58 6.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.589 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -113.89 126.4 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.445 ' CE1' ' CG2' ' A' ' 65' ' ' THR . 32.8 t80 -58.56 109.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.535 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.75 129.89 56.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.349 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.43 138.91 52.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.578 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.5 p -82.04 157.58 24.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.758 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.767 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -73.08 158.45 35.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.311 0.577 . . . . 0.0 111.433 -179.478 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.77 -5.54 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.067 178.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -130.87 -17.76 3.11 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.767 HD12 ' CD ' ' A' ' 33' ' ' ARG . 65.9 mt -118.77 112.19 36.99 Favored Pre-proline 0 N--CA 1.455 -0.178 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.951 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.2 131.72 29.39 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.995 1.797 . . . . 0.0 111.889 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 t70 76.62 4.09 3.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.713 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.623 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.2 97.5 11.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.412 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 145' ' ' LEU . 36.9 m95 -102.95 155.46 18.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.202 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -169.04 171.63 8.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.753 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.414 ' SD ' HD21 ' A' ' 142' ' ' LEU . 1.9 mpp? -95.85 157.72 35.45 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.652 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.54 129.47 15.78 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.483 2.122 . . . . 0.0 112.58 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.06 153.74 32.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.46 167.95 33.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -80.02 133.17 12.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.559 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.646 ' CG1' HG13 ' A' ' 17' ' ' VAL . 5.6 mt -60.12 160.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.487 ' N ' HG22 ' A' ' 47' ' ' ILE . 2.0 m-20 -90.24 149.31 22.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.866 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.96 98.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.22 0.533 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.18 10.25 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.954 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 16.0 tp10 -114.09 145.96 40.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.129 0.49 . . . . 0.0 110.865 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.11 139.6 79.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.429 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.6 Cg_exo -54.01 -55.07 3.78 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.387 2.058 . . . . 0.0 112.599 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -60.29 -27.53 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.214 -179.725 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -82.48 -49.42 9.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.798 0.332 . . . . 0.0 110.761 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.542 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.82 -30.68 67.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.482 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.788 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.85 -53.45 10.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.16 179.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 54' ' ' ARG . 53.1 mt -55.78 -29.79 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.116 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -80.69 -53.51 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.786 0.803 . . . . 0.0 109.73 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -54.97 -33.29 62.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.568 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.769 HD12 ' OG1' ' A' ' 65' ' ' THR . 6.1 tp -56.56 -58.4 8.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.123 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.573 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 9.2 ptt180 -62.12 -11.06 12.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.876 0.369 . . . . 0.0 110.545 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -91.71 -44.34 9.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.47 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -90.87 -29.6 17.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.3 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.769 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.93 -21.33 10.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.278 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.33 6.69 70.53 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.885 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.747 ' HB ' HD11 ' A' ' 61' ' ' LEU . 52.8 t -75.92 130.84 35.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.786 0.327 . . . . 0.0 110.548 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -109.79 -33.01 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.37 78.78 6.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.164 0.507 . . . . 0.0 110.831 -179.924 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.36 131.29 15.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.846 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.0 pt-20 -119.41 140.37 50.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.239 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.2 t -69.76 116.86 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.292 0.568 . . . . 0.0 111.387 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.797 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -90.91 -24.0 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.774 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -158.42 168.64 26.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.214 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -148.51 116.26 6.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.236 179.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.801 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.2 t -57.33 130.29 80.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.1 -15.42 35.83 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.763 2.309 . . . . 0.0 113.626 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.626 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -128.04 170.35 13.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.459 0.647 . . . . 0.0 112.359 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.75 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.8 m95 -96.22 145.99 25.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.978 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 4' ' ' GLY . 2.3 mt -110.24 117.91 34.94 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.171 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.846 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.0 p -107.7 136.23 47.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.49 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.867 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -127.88 170.11 13.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.601 -179.466 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.33 158.29 38.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.954 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -115.89 152.09 47.14 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.798 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.539 ' HG2' HG23 ' A' ' 88' ' ' VAL . 34.2 Cg_endo -63.95 169.82 9.81 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.597 2.198 . . . . 0.0 112.288 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.62 -17.39 59.4 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.77 2.314 . . . . 0.0 113.16 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -92.07 -34.04 14.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.187 0.518 . . . . 0.0 110.178 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.539 HG23 ' HG2' ' A' ' 85' ' ' PRO . 76.2 t -83.26 -47.45 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.234 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 -45.36 91.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.493 0.663 . . . . 0.0 109.449 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.616 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.4 tp10 -68.76 -27.5 65.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.597 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -47.09 19.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 96' ' ' TRP . 95.3 mt -58.89 -46.46 87.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.359 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.4 m-80 -45.82 -31.84 2.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.568 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.37 -49.29 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.278 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -56.26 12.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 92' ' ' LEU . 21.6 m0 -78.3 -35.0 48.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 80.81 34.94 26.26 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.47 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 147.25 47.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.005 0.431 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -111.26 41.93 1.76 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.935 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -99.16 150.31 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.726 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -29.35 60.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.571 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -171.24 -139.13 2.69 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.82 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -157.64 113.92 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.81 0.338 . . . . 0.0 111.462 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.846 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -87.1 105.66 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' NE2' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 pt20 -120.24 150.57 40.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.5 mttp -102.77 95.71 6.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.388 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.544 ' CD2' HG21 ' A' ' 157' ' ' VAL . 43.7 m95 -64.33 143.5 57.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.236 -178.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 67.3 m-85 -128.0 137.69 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.15 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.849 HD13 ' CD2' ' A' ' 161' ' ' PHE . 22.1 tp -79.43 155.18 28.45 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 21' ' ' LEU . 33.1 m-85 -146.47 131.96 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.22 0.533 . . . . 0.0 111.955 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.637 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 1.0 OUTLIER -94.73 119.56 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.507 178.032 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.576 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -67.65 121.44 15.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.613 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.606 HG21 ' OE1' ' A' ' 71' ' ' GLU . 7.8 p -123.92 37.71 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.565 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.93 -145.31 4.74 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.129 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.5 154.24 47.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.49 ' HA ' HD12 ' A' ' 119' ' ' ILE . 6.5 m-20 -49.47 -16.96 0.24 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.603 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -76.33 -21.06 56.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.102 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -77.56 -25.19 49.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 116' ' ' ASP . 15.7 mt -69.23 104.49 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.513 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.671 HD21 HD12 ' A' ' 122' ' ' LEU . 29.4 t-20 -119.96 95.55 4.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.708 179.049 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.799 HD13 ' HB2' ' A' ' 131' ' ' PHE . 41.3 mt -58.82 -24.82 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 -179.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.671 HD12 HD21 ' A' ' 120' ' ' ASN . 6.4 mt -60.1 -55.04 38.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.173 0.511 . . . . 0.0 109.922 179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.39 178.63 17.22 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.397 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -89.64 38.64 0.92 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.212 0.529 . . . . 0.0 109.687 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.93 29.63 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.226 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -107.02 -64.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 -179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.84 165.16 13.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -60.22 151.36 67.8 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.554 ' HG3' HD23 ' A' ' 122' ' ' LEU . 77.6 Cg_exo -49.34 176.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.716 2.277 . . . . 0.0 112.602 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -150.13 -45.24 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.722 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.799 ' HB2' HD13 ' A' ' 121' ' ' LEU . 21.2 m-85 -112.72 159.39 18.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -117.96 -14.6 6.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.637 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.578 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 10.6 mp0 -152.15 174.22 14.0 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.019 0.438 . . . . 0.0 110.357 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.0 p-90 -159.65 152.06 21.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.333 179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.62 153.93 35.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.306 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.466 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 87.8 m95 -89.95 126.13 35.62 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.675 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.72 HG11 HD11 ' A' ' 145' ' ' LEU . 30.9 m -137.46 150.63 25.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.666 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.5 p -68.23 159.33 80.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.574 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.686 ' CA ' HD13 ' A' ' 158' ' ' LEU . 13.4 Cg_endo -56.72 -18.98 28.79 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 121.816 1.677 . . . . 0.0 111.732 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.5 -34.15 15.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.117 179.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -50.84 25.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.907 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -54.14 -30.66 49.83 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.434 0.635 . . . . 0.0 109.864 179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.552 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.4 mm -68.52 -28.78 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 178.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.39 -20.98 42.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.21 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.2 mt -84.64 -39.24 18.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.072 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 150' ' ' LYS . 11.8 m -58.05 164.27 2.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.113 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.715 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 12.7 p -93.01 162.77 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.787 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -59.03 -27.6 65.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -179.433 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.715 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 7.9 p90 -93.28 7.6 43.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.605 ' HB2' HG12 ' A' ' 147' ' ' VAL . 3.1 mtmp? -140.25 11.04 2.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.509 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.7 mtpp -70.54 -62.45 2.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.586 ' CB ' HD23 ' A' ' 3' ' ' LEU . 9.6 Cg_endo -52.99 -46.74 31.77 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.529 2.153 . . . . 0.0 112.121 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.7 t -56.46 -26.09 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.149 0.499 . . . . 0.0 110.959 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.33 -51.43 5.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.656 179.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.84 -34.84 21.02 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -64.62 -45.96 84.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.576 179.162 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.3 t -57.04 -49.52 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.686 HD13 ' CA ' ' A' ' 139' ' ' PRO . 78.0 mt -62.92 -49.14 75.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.824 178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.8 p -50.17 -46.67 54.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.74 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.801 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -69.3 -24.84 28.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.048 0.452 . . . . 0.0 110.475 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.849 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.3 m-30 -102.27 7.08 40.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.013 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.624 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.67 -53.07 54.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.801 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 8.1 Cg_endo -50.59 -24.83 13.41 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.562 2.175 . . . . 0.0 112.52 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.632 ' ND1' HG22 ' A' ' 73' ' ' ILE . 98.1 m-70 -92.88 -22.38 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.883 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.964 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.444 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.21 167.66 24.38 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.685 2.256 . . . . 0.0 112.285 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 tp 59.97 99.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.73 -86.89 1.87 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.436 ' HB3' ' CG ' ' A' ' 78' ' ' TYR . 1.3 m 63.77 125.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -137.27 101.54 4.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.79 12.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.123 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -154.96 128.37 4.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.52 0.2 . . . . 0.0 110.481 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 15' ' ' ARG . 56.0 Cg_endo -70.74 114.65 3.93 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.245 1.963 . . . . 0.0 112.62 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 2.9 Cg_exo -75.12 -175.6 2.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.727 2.285 . . . . 0.0 111.748 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.33 150.02 22.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.951 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.27 -33.74 5.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -87.1 138.17 31.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.144 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 ttp85 -85.79 152.6 22.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 9' ' ' PRO . 1.3 mmp_? -73.38 129.31 37.74 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.317 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.8 t-20 -153.26 156.85 39.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.675 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.79 HG13 HD11 ' A' ' 47' ' ' ILE . 4.5 m -127.38 138.04 55.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.006 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.83 155.13 16.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.877 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.6 mp -128.52 101.77 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.701 0.286 . . . . 0.0 111.345 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' PHE . 18.8 t -89.7 103.38 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 110' ' ' PHE . 31.4 tp -103.02 145.09 30.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.208 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.76 ' SD ' HD23 ' A' ' 165' ' ' LEU . 3.8 ptt? -131.42 157.05 44.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.69 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 27' ' ' LYS . 10.4 p-10 -97.43 175.1 6.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.331 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -14.2 39.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.243 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.2 0.48 56.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.77 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp 75.63 26.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.513 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.756 ' C ' HD13 ' A' ' 28' ' ' ILE . 12.9 mttp -97.88 172.97 7.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.856 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.01 140.74 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 110.667 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HE2' HD13 ' A' ' 119' ' ' ILE . 11.0 t80 -75.6 109.31 9.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.541 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . . . -116.63 132.79 56.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.85 135.23 54.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.38 155.01 24.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -179.75 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -71.24 159.22 35.02 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 111.506 -179.386 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -93.44 -6.85 46.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.838 178.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.93 -18.92 4.55 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.09 -179.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.61 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 52.6 mt -119.4 111.65 36.38 Favored Pre-proline 0 N--CA 1.455 -0.213 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.881 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -64.59 131.27 29.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 121.995 1.797 . . . . 0.0 111.977 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.5 t70 77.35 2.37 3.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.824 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.61 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -85.59 97.22 9.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.654 ' CD1' HD22 ' A' ' 145' ' ' LEU . 51.7 m95 -101.7 154.84 18.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.323 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.31 173.27 6.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -99.26 161.15 25.65 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.03 133.9 24.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.498 2.132 . . . . 0.0 112.759 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.21 155.8 35.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.35 143.58 9.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.683 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -56.8 143.43 39.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.534 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.79 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -76.87 160.72 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 110.702 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.517 ' N ' HG22 ' A' ' 47' ' ' ILE . 5.0 m-20 -90.25 177.54 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.125 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.88 99.28 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 110.39 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.61 47.01 12.94 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.615 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' CG ' ' HB2' ' A' ' 56' ' ' ALA . 5.6 tp10 -110.36 148.55 31.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.185 0.517 . . . . 0.0 110.949 -179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.83 126.11 88.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.366 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.622 ' HA ' HG11 ' A' ' 17' ' ' VAL . 53.7 Cg_exo -53.3 -34.59 70.92 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.385 2.057 . . . . 0.0 112.569 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' O ' HD12 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -76.73 -25.0 53.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.98 179.936 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -87.57 -45.53 10.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.428 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.502 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -59.27 -31.07 68.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.369 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -73.59 -52.55 13.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.292 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.2 mt -56.34 -31.41 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.289 0.566 . . . . 0.0 109.905 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.6 ttp85 -78.58 -53.6 7.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.849 178.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -54.88 -36.08 64.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.602 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.774 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.3 tp -56.15 -54.15 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.586 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -62.22 -11.7 16.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.718 179.121 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -91.52 -41.48 10.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 111.477 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -90.25 -31.17 17.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.923 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.693 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -119.62 -23.8 6.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.091 -179.339 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 69.74 10.13 63.6 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.647 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.774 ' HB ' HD11 ' A' ' 61' ' ' LEU . 25.5 t -69.3 119.08 14.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.829 0.347 . . . . 0.0 110.222 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.62 -34.02 12.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.105 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.2 78.49 6.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.179 0.514 . . . . 0.0 110.962 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.35 131.45 15.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.851 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 111' ' ' LYS . 3.0 pt-20 -119.95 141.9 49.23 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.146 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.8 t -70.87 117.01 13.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.237 0.541 . . . . 0.0 111.437 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.778 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.1 mt -91.03 -26.11 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.572 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -159.41 169.31 24.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.282 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.6 pt-20 -148.44 112.06 5.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 160' ' ' VAL . 2.5 t -57.65 123.82 64.78 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.965 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.5 -3.96 14.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.801 2.334 . . . . 0.0 114.045 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.563 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -131.23 139.45 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.204 0.526 . . . . 0.0 112.131 -179.855 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.458 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 15.2 m95 -75.31 145.06 42.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.296 179.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.693 ' HB3' HG13 ' A' ' 153' ' ' VAL . 89.6 mt -111.2 117.58 33.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.932 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.666 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.1 p -108.52 131.74 54.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.751 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.785 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -129.84 166.26 20.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.555 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.3 158.34 29.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.098 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -113.35 153.18 45.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.738 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.587 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.9 Cg_endo -63.47 170.79 7.64 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 0.0 112.384 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.69 -17.34 59.53 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.896 2.397 . . . . 0.0 113.147 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.3 mtmt -91.35 -33.59 15.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.146 0.498 . . . . 0.0 110.143 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.587 HG23 ' HG2' ' A' ' 85' ' ' PRO . 78.2 t -82.75 -48.64 17.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.306 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -58.29 -46.28 86.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.481 0.658 . . . . 0.0 109.472 179.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.611 ' O ' HD12 ' A' ' 94' ' ' ILE . 46.4 tt0 -67.82 -27.53 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.584 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -46.58 20.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.564 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 96' ' ' TRP . 94.2 mt -58.56 -46.5 86.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 110.496 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -46.01 -31.93 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.523 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.6 mt -96.48 -49.29 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.227 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -56.35 9.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.82 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.457 ' N ' ' O ' ' A' ' 92' ' ' LEU . 14.6 m0 -77.32 -33.59 55.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.654 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.46 36.05 31.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.398 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -127.62 147.44 50.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 110.775 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.17 38.72 1.96 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 98' ' ' SER . 34.2 m95 -93.23 150.44 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -26.99 44.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.04 0.447 . . . . 0.0 110.435 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.66 -138.5 2.47 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.592 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 82' ' ' TYR . 0.7 OUTLIER -158.05 113.76 2.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.666 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -88.22 105.82 17.79 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.73 150.27 52.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 2.7 mttt -97.77 156.5 16.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.47 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.566 ' CD2' HG21 ' A' ' 157' ' ' VAL . 45.2 m95 -120.81 140.32 51.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.118 0.485 . . . . 0.0 112.02 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.4 m-85 -123.46 131.18 53.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.056 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.875 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.26 135.84 36.88 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.146 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.877 ' CD1' HG23 ' A' ' 19' ' ' ILE . 39.4 m-85 -126.82 131.67 51.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.214 0.53 . . . . 0.0 112.02 -179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.67 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 3.5 ttmt -93.76 120.18 33.7 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.374 178.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.669 ' HE1' HG13 ' A' ' 67' ' ' VAL . 4.6 t80 -68.97 122.43 18.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.968 0.413 . . . . 0.0 110.756 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HB3' ' A' ' 69' ' ' SER . 7.4 p -123.96 37.8 4.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.508 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.46 -144.74 4.8 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.141 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.56 154.27 47.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -48.96 -17.45 0.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.523 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.23 -24.21 59.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.319 . . . . 0.0 111.027 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.19 -26.24 58.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.488 HD13 ' HE2' ' A' ' 29' ' ' PHE . 29.8 mt -69.14 101.52 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 123' ' ' GLY . 13.2 p-10 -125.28 96.07 4.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.839 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 131' ' ' PHE . 60.7 mt -55.27 -19.24 7.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.067 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.52 -58.62 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.383 0.611 . . . . 0.0 110.124 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.402 ' O ' ' ND2' ' A' ' 120' ' ' ASN . . . 138.64 179.41 17.22 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.311 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -89.61 38.84 0.93 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 64.1 28.3 72.68 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.224 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.95 -64.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -105.7 165.07 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.239 -179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -71.08 152.3 94.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.042 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.16 169.17 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.678 2.252 . . . . 0.0 112.519 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' C ' HD12 ' A' ' 34' ' ' LEU . 20.7 mm-40 -150.07 -45.2 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.781 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.823 ' HB2' HD13 ' A' ' 121' ' ' LEU . 12.6 m-85 -106.15 159.32 16.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.46 -18.67 5.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.78 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.439 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 9.3 mm-40 -152.17 175.31 12.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.007 0.432 . . . . 0.0 110.398 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 27.5 p-90 -159.08 154.53 25.79 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.33 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -151.56 162.5 40.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.301 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 86.8 m95 -98.97 129.37 45.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 145' ' ' LEU . 28.4 m -139.41 156.19 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.964 -179.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.0 p -73.63 152.98 89.57 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.833 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.2 Cg_endo -49.19 -20.83 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.114 1.876 . . . . 0.0 112.132 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -90.42 -33.82 15.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.437 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.426 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -70.09 -50.8 37.28 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.786 0.327 . . . . 0.0 110.22 179.496 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.932 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -51.94 -36.05 47.97 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.688 0.756 . . . . 0.0 109.515 178.861 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.591 HD12 ' HD2' ' A' ' 155' ' ' LYS . 5.2 mm -63.08 -29.05 46.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.934 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.53 -22.01 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.116 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.6 mt -84.13 -39.13 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 150' ' ' LYS . 9.2 m -59.33 165.64 2.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.868 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 8.3 p -97.35 159.72 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.05 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.528 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 19.1 mt-10 -52.14 -38.44 57.57 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.6 p90 -84.34 5.28 27.55 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 146' ' ' THR . 20.9 mtpp -140.09 9.26 2.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.638 0.256 . . . . 0.0 111.603 179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.528 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 2.6 mtpp -69.07 -62.77 2.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 10.8 Cg_endo -54.33 -39.66 86.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.519 2.146 . . . . 0.0 111.87 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.785 HG11 ' CD1' ' A' ' 82' ' ' TYR . 14.1 t -58.13 -27.02 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 110.799 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -91.33 -50.66 5.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.375 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.591 ' HD2' HD12 ' A' ' 143' ' ' ILE . 3.6 tttt -51.01 -34.63 30.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.471 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.625 ' HB3' HD11 ' A' ' 80' ' ' LEU . 3.4 tp10 -63.91 -46.09 86.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.51 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -60.09 -47.28 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.249 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.583 HD13 ' CA ' ' A' ' 139' ' ' PRO . 69.2 mt -63.36 -48.5 77.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.695 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.5 m -48.77 -47.88 41.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.731 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.811 HG21 HG22 ' A' ' 76' ' ' VAL . 74.6 t -67.52 -24.9 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.875 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.2 m-30 -102.25 7.32 40.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.027 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -50.75 -53.05 50.98 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.602 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 7.8 Cg_endo -50.66 -24.75 13.51 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.545 2.163 . . . . 0.0 112.316 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.677 ' CE1' HG22 ' A' ' 73' ' ' ILE . 98.7 m-70 -89.77 -24.5 21.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.644 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.76 HD23 ' SD ' ' A' ' 22' ' ' MET . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.878 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.444 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.04 170.5 16.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.596 2.198 . . . . 0.0 112.35 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 3' ' ' LEU . 4.0 pp -96.46 138.43 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.18 46.19 1.27 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.576 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 78' ' ' TYR . 4.6 t 164.9 139.83 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.022 0.439 . . . . 0.0 110.46 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.888 ' HG3' HG23 ' A' ' 81' ' ' THR . 7.5 mmt -115.6 -30.15 6.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.256 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 6.0 m-20 61.7 16.29 7.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.545 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p 167.68 141.73 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.721 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 57.1 Cg_endo -71.76 111.83 3.24 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.281 1.987 . . . . 0.0 112.221 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 104' ' ' ALA . 6.8 Cg_exo -73.85 -175.18 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.84 2.36 . . . . 0.0 112.158 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.27 149.3 22.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.19 -19.8 51.31 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.776 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -109.66 135.57 50.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 110.996 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 6.7 mtp-105 -76.07 152.39 36.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -75.22 133.38 41.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.46 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.1 m120 -152.22 161.9 41.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.801 HG13 HD11 ' A' ' 47' ' ' ILE . 1.9 m -132.24 125.63 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.235 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.44 138.79 14.13 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.219 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.821 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -111.69 102.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 111.199 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' PHE . 7.6 t -89.68 102.12 14.81 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 110' ' ' PHE . 23.3 tp -103.09 146.39 28.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 0.0 110.933 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -128.24 157.2 41.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.007 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.475 ' HB2' ' CE3' ' A' ' 136' ' ' TRP . 12.4 t30 -93.65 173.42 7.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.044 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.97 -16.58 61.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.845 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.41 -0.71 57.69 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 81.77 24.6 0.23 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.632 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -93.83 170.48 9.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.559 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.3 mp -109.81 121.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.863 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.73 ' CD2' HD23 ' A' ' 21' ' ' LEU . 1.7 t80 -54.04 107.56 0.28 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.259 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.85 137.72 52.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.746 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -125.96 141.95 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.17 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.511 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.33 158.32 23.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.735 179.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.584 ' HD3' ' HB ' ' A' ' 36' ' ' ILE . 4.8 mtp-105 -72.71 164.04 27.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 111.723 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.5 mt -97.93 -7.0 31.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.44 178.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -128.54 -18.21 3.99 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.587 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 62.9 mt -121.12 112.42 33.26 Favored Pre-proline 0 N--CA 1.457 -0.094 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.189 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.79 132.62 31.09 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 121.816 1.677 . . . . 0.0 111.475 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 77.86 3.8 2.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.683 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.587 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -90.85 97.55 11.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.522 ' CD1' HD22 ' A' ' 145' ' ' LEU . 27.6 m95 -102.28 156.58 17.48 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.065 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.75 -176.68 2.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.703 179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.449 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 76.3 mtm -107.31 156.59 37.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.12 132.35 27.68 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.56 2.173 . . . . 0.0 112.579 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.27 157.39 42.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.695 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.51 171.37 34.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.54 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.02 135.92 13.58 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.574 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.801 HD11 HG13 ' A' ' 17' ' ' VAL . 5.6 mt -68.6 161.03 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.619 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -83.76 -174.85 5.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.767 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.91 99.57 6.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.062 0.458 . . . . 0.0 110.281 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.43 50.73 19.72 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.597 -179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -113.47 155.23 25.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.167 0.508 . . . . 0.0 111.096 -179.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -77.87 130.34 73.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.297 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.588 ' HA ' HG11 ' A' ' 17' ' ' VAL . 52.0 Cg_exo -54.6 -21.66 25.48 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.389 2.059 . . . . 0.0 112.932 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 58' ' ' ILE . 3.1 tpt180 -84.39 -25.44 29.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -88.05 -43.29 11.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 0.0 110.578 179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -63.36 -29.87 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.519 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.584 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -74.79 -51.83 13.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.186 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 54' ' ' ARG . 61.3 mt -57.32 -29.07 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.237 179.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 3.2 ttp-105 -81.85 -53.3 6.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.831 0.824 . . . . 0.0 109.698 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -54.48 -31.83 56.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.474 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.84 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.1 tp -58.43 -63.42 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.215 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.565 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 11.7 ptp180 -60.45 -12.14 8.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.911 0.386 . . . . 0.0 110.596 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -92.08 -40.91 10.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -90.53 -32.08 16.47 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.658 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -116.86 -24.84 7.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.936 0.398 . . . . 0.0 110.899 -179.55 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 82.3 -0.65 88.72 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.743 -0.742 . . . . 0.0 113.063 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.84 ' HB ' HD11 ' A' ' 61' ' ' LEU . 37.5 t -66.82 121.73 16.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.986 0.393 . . . . 0.0 110.331 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.78 -33.8 10.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.4 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.03 77.48 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.116 0.484 . . . . 0.0 110.994 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -149.41 129.16 13.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.919 179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 7.0 mt-10 -120.39 146.44 46.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.627 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 55.8 t -76.46 125.69 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.49 0.662 . . . . 0.0 111.928 -179.06 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.885 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.44 -17.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.248 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.737 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -153.72 159.68 42.06 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.914 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.18 111.63 4.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.409 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.753 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.5 t -57.58 125.32 71.93 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.072 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.05 -8.15 20.75 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.85 2.366 . . . . 0.0 113.785 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.555 ' CD1' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -128.54 146.67 50.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.171 0.51 . . . . 0.0 112.05 -179.601 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.444 ' CD2' ' HG3' ' A' ' 106' ' ' LYS . 16.4 m95 -79.69 145.21 33.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.012 0.434 . . . . 0.0 109.976 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.815 ' HB3' HG13 ' A' ' 153' ' ' VAL . 82.5 mt -111.11 117.55 33.57 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.733 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.888 HG23 ' HG3' ' A' ' 6' ' ' MET . 19.3 p -111.74 130.03 55.92 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.812 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.825 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.56 163.58 26.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 0.0 110.707 179.539 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.68 158.27 35.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.189 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -101.98 155.93 35.84 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.496 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.594 ' HG2' HG23 ' A' ' 88' ' ' VAL . 29.9 Cg_endo -63.25 166.95 13.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.309 2.006 . . . . 0.0 112.196 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.76 -16.1 41.82 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.799 2.333 . . . . 0.0 113.232 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -92.57 -31.57 15.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.107 0.48 . . . . 0.0 110.25 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.594 HG23 ' HG2' ' A' ' 85' ' ' PRO . 78.9 t -84.93 -49.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' NH1' ' ND2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -59.63 -45.68 91.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.25 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.508 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.9 tp10 -65.06 -29.15 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.409 179.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -46.75 17.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.686 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.494 HD22 ' CG ' ' A' ' 96' ' ' TRP . 95.8 mt -57.3 -46.48 83.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.679 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' ND2' ' NH1' ' A' ' 89' ' ' ARG . 3.3 m-20 -44.86 -35.26 2.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.48 -46.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.421 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -69.19 -55.68 9.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.946 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.494 ' CG ' HD22 ' A' ' 92' ' ' LEU . 11.3 m0 -79.48 -31.3 42.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.47 39.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.325 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.15 146.62 49.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.033 0.444 . . . . 0.0 110.638 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -110.28 44.8 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.458 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 56.7 m95 -107.98 144.46 35.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -28.72 62.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -171.22 -139.18 2.7 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.092 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -157.63 117.12 3.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.784 0.326 . . . . 0.0 111.343 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.724 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -86.65 110.58 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -130.85 150.19 52.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.717 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HG3' ' CD2' ' A' ' 79' ' ' TRP . 1.1 mtmt -107.51 102.54 11.79 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.443 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CD2' HG21 ' A' ' 157' ' ' VAL . 29.9 m95 -67.9 143.28 55.77 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.442 ' CD2' ' HD2' ' A' ' 54' ' ' ARG . 61.1 m-85 -125.48 137.77 53.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.035 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.808 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.5 tp -79.36 154.49 28.99 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.947 179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.83 ' O ' HD12 ' A' ' 21' ' ' LEU . 44.4 m-85 -148.0 127.54 13.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.564 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.885 ' HB3' HD11 ' A' ' 73' ' ' ILE . 4.7 tptp -92.48 121.65 34.15 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -65.32 123.46 19.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.955 0.407 . . . . 0.0 110.637 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 111' ' ' LYS . 4.8 p -124.68 37.67 4.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.758 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.4 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.46 -144.88 4.72 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.034 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -129.29 154.27 47.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.09 -17.35 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.522 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -74.69 -22.18 58.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.732 0.301 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -26.24 56.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.497 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 25.2 mt -69.97 94.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.325 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -117.92 95.98 5.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.931 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 131' ' ' PHE . 46.0 mt -52.53 -20.04 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.175 -179.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.424 HD22 ' HG3' ' A' ' 129' ' ' PRO . 98.0 mt -57.9 -59.09 5.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.378 0.609 . . . . 0.0 109.966 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 135.48 -178.56 18.53 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.453 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -89.52 38.77 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.58 26.27 71.87 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.142 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -103.23 -64.63 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.128 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.29 165.19 12.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.136 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -69.29 151.19 97.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.5 ' HB2' HD11 ' A' ' 34' ' ' LEU . 75.5 Cg_exo -48.86 135.85 28.56 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.624 2.216 . . . . 0.0 112.572 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -113.24 -25.87 8.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.6 m-85 -123.17 159.25 29.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.711 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -118.56 -17.62 5.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.72 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.511 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 1.8 mp0 -152.36 173.35 15.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.15 0.5 . . . . 0.0 110.568 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.2 p-90 -160.41 160.56 32.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.426 179.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.5 m -159.3 154.68 25.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.345 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.475 ' CE3' ' HB2' ' A' ' 23' ' ' ASN . 87.3 m95 -88.62 127.18 35.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.729 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.691 HG11 HD11 ' A' ' 145' ' ' LEU . 26.9 m -138.52 150.49 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.161 0.505 . . . . 0.0 111.857 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.3 p -68.5 160.86 74.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.647 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.608 ' CB ' HD13 ' A' ' 158' ' ' LEU . 19.7 Cg_endo -58.66 -17.12 33.79 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 121.773 1.649 . . . . 0.0 111.801 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.06 -34.18 14.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.037 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -51.08 23.86 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.039 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.88 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.2 tp -54.01 -31.73 51.98 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.45 0.643 . . . . 0.0 109.823 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.64 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -67.17 -28.75 43.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.654 178.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -80.68 -20.7 42.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.18 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.88 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.1 mt -85.77 -39.0 17.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.121 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 150' ' ' LYS . 24.2 m -56.48 163.95 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.237 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.672 HG21 ' CE2' ' A' ' 149' ' ' PHE . 7.1 p -93.01 160.37 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.499 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 1.1 mt-10 -49.66 -41.83 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.275 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 147' ' ' VAL . 45.1 p90 -85.36 8.71 17.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.484 ' HB2' HG12 ' A' ' 147' ' ' VAL . 19.0 mttt -129.06 -8.66 4.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.602 0.239 . . . . 0.0 111.31 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.499 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 3.8 mtpm? -57.7 -59.88 11.64 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.311 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.9 Cg_endo -61.09 -42.46 36.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.369 2.046 . . . . 0.0 112.174 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.825 HG11 ' CD1' ' A' ' 82' ' ' TYR . 16.4 t -60.07 -27.28 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.79 -51.4 5.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.452 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.64 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -50.65 -32.27 18.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.418 179.663 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.738 ' HB3' HD11 ' A' ' 80' ' ' LEU . 6.0 tp10 -66.67 -45.73 77.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.529 179.175 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.572 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.6 t -58.84 -47.44 89.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.963 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 139' ' ' PRO . 76.4 mt -63.73 -48.6 76.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.8 t -50.09 -47.36 53.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.861 179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 76' ' ' VAL . 76.0 t -69.54 -25.71 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 110.404 179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.808 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.5 m-30 -102.24 9.64 39.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.975 -179.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -54.32 -57.92 16.22 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.318 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -58.26 -21.88 54.52 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.475 2.117 . . . . 0.0 112.33 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.737 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 93.3 m-70 -89.96 -11.15 42.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.209 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 161' ' ' PHE . 3.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.922 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.454 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.18 -168.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.562 2.175 . . . . 0.0 112.312 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.57 84.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.748 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -160.23 27.57 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.555 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.92 116.87 4.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.428 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.68 -39.55 4.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.179 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 6.3 t0 72.74 24.32 2.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.98 130.6 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.598 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 37.4 Cg_endo -66.67 109.31 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.322 2.015 . . . . 0.0 112.28 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.2 Cg_exo -77.19 -176.31 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.981 2.454 . . . . 0.0 112.1 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.3 153.92 20.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.934 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 -37.45 3.4 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.724 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -89.91 137.97 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -82.2 152.24 26.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.225 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -70.2 131.43 44.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.985 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.554 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 1.1 t30 -152.78 155.0 36.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.797 HG13 HD11 ' A' ' 47' ' ' ILE . 19.2 m -133.11 137.16 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.103 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.92 131.92 9.37 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.128 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.893 HG21 HD22 ' A' ' 61' ' ' LEU . 4.5 mp -97.43 113.0 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.811 0.338 . . . . 0.0 111.863 -179.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 110' ' ' PHE . 8.6 t -96.16 103.17 15.05 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.855 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.5 tp -103.37 149.37 24.84 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 111.132 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.439 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -133.07 157.27 45.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.672 179.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.9 p-10 -98.19 172.31 7.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.614 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -57.82 -17.72 17.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.522 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.81 0.34 56.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 mttm 77.06 25.46 0.8 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.515 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.786 ' C ' HD13 ' A' ' 28' ' ' ILE . 7.4 mttp -93.77 174.41 7.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.867 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -106.75 138.51 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -179.807 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.813 ' CE2' HG21 ' A' ' 65' ' ' THR . 5.2 t80 -76.68 103.7 6.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.494 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.34 139.86 49.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -124.01 137.86 54.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.52 154.43 25.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.646 179.878 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.507 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -71.23 157.66 37.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 111.628 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.45 -5.35 49.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.768 178.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -126.6 -19.42 4.57 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.985 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.622 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 56.9 mt -120.62 112.18 34.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.913 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.04 131.42 28.67 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.856 1.704 . . . . 0.0 111.878 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t70 77.15 3.7 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.773 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.622 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -88.16 97.4 10.98 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.349 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.698 ' CD1' HD22 ' A' ' 145' ' ' LEU . 41.9 m95 -102.41 157.32 17.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.927 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.46 -176.87 2.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.96 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.569 ' HE2' ' CD2' ' A' ' 154' ' ' TYR . 51.7 mtm -106.09 159.51 29.42 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.663 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.67 128.42 14.28 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.504 2.136 . . . . 0.0 112.787 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -150.48 167.42 27.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.37 59.39 0.11 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.864 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . 43.17 -165.75 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.091 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.797 HD11 HG13 ' A' ' 17' ' ' VAL . 4.5 mt -132.12 159.68 42.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.866 0.365 . . . . 0.0 110.578 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 47' ' ' ILE . 22.5 m-20 -90.38 149.81 22.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.09 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.121 0.486 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.99 39.6 11.46 Favored Glycine 0 C--N 1.32 -0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.945 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 9.2 tp10 -109.56 146.25 34.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.165 0.507 . . . . 0.0 110.965 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 128.38 81.91 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.318 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.645 ' HA ' HG11 ' A' ' 17' ' ' VAL . 76.0 Cg_exo -50.58 -25.82 15.45 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.358 2.039 . . . . 0.0 112.688 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -83.85 -24.0 31.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.94 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.91 -43.36 10.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -61.08 -32.1 71.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.175 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.649 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -71.71 -53.38 13.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.084 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.8 mt -56.64 -28.58 27.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.442 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -84.21 -53.3 5.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 109.959 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -50.71 -42.91 57.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.326 -1.307 . . . . 0.0 111.223 -179.667 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.893 HD22 HG21 ' A' ' 19' ' ' ILE . 2.8 tp -57.81 -51.9 67.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.598 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 12.8 ttm-85 -62.87 -13.45 34.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.448 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -38.73 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.878 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -87.59 -35.5 18.06 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.813 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -121.1 -22.78 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.017 0.436 . . . . 0.0 111.164 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 74.48 6.48 76.31 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.86 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.857 ' HB ' HD11 ' A' ' 61' ' ' LEU . 19.2 t -56.71 108.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.911 0.386 . . . . 0.0 110.178 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.98 -34.04 16.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.27 76.13 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.172 0.511 . . . . 0.0 111.054 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.34 129.84 13.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.687 179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.611 ' OE1' HG21 ' A' ' 113' ' ' THR . 3.1 pt-20 -119.92 141.1 49.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.19 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 37.7 t -70.61 116.41 11.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 111.334 -179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.732 ' HB ' HD23 ' A' ' 109' ' ' LEU . 1.2 mt -90.72 -25.04 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.847 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -156.85 169.6 24.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.268 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 11.2 pt-20 -148.59 117.22 6.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.012 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.857 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.5 t -57.05 123.73 61.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.051 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.38 -13.45 39.34 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.885 2.39 . . . . 0.0 113.607 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.648 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -127.1 -179.04 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.349 0.595 . . . . 0.0 112.291 -179.417 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.724 ' C ' HD23 ' A' ' 80' ' ' LEU . 21.3 m95 -107.89 147.5 30.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.052 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.748 HD22 ' O ' ' A' ' 4' ' ' GLY . 3.1 mt -112.51 117.81 33.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.044 179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.84 HG22 ' CB ' ' A' ' 104' ' ' ALA . 6.4 p -112.34 132.4 55.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.435 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.826 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -127.05 170.15 12.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.748 -179.41 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.73 158.27 29.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' ' HA2' ' A' ' 102' ' ' GLY . 11.5 m-85 -118.42 142.53 31.53 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.772 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.631 ' HG2' HG23 ' A' ' 88' ' ' VAL . 27.6 Cg_endo -62.48 171.69 5.24 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.394 2.063 . . . . 0.0 112.234 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -63.65 -16.77 56.68 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.773 2.315 . . . . 0.0 113.307 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.03 -34.55 13.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.159 0.504 . . . . 0.0 110.185 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.631 HG23 ' HG2' ' A' ' 85' ' ' PRO . 96.0 t -83.0 -46.96 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.277 179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -46.21 90.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.47 0.653 . . . . 0.0 109.494 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.78 -26.64 66.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.673 179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.07 -46.04 15.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.732 HD22 ' CD2' ' A' ' 96' ' ' TRP . 48.0 mt -56.43 -42.9 78.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.43 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.418 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -44.83 -34.17 2.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.703 179.749 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 94' ' ' ILE . 3.3 mp -96.25 -48.67 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -56.95 10.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.929 0.395 . . . . 0.0 110.768 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.732 ' CD2' HD22 ' A' ' 92' ' ' LEU . 38.6 m0 -78.83 -36.31 42.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 82.83 33.84 23.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.333 -0.936 . . . . 0.0 112.314 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.426 ' CB ' ' CD1' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -131.17 149.1 52.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 110.785 -179.812 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -112.53 38.7 2.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CD1' ' CB ' ' A' ' 98' ' ' SER . 36.3 m95 -89.24 150.31 22.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.69 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -30.36 64.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.558 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -162.51 -142.85 3.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.975 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -157.01 112.86 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.805 0.336 . . . . 0.0 111.366 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.84 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.66 105.74 17.96 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.454 ' NE2' ' CE2' ' A' ' 107' ' ' TRP . 5.5 pt20 -120.05 161.97 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -116.14 105.15 12.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.217 178.638 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.47 ' CD2' HG21 ' A' ' 157' ' ' VAL . 60.2 m95 -78.35 144.43 36.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 71.0 m-85 -127.83 136.64 51.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.143 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.862 HD13 ' CD2' ' A' ' 161' ' ' PHE . 20.6 tp -79.67 155.04 28.22 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.855 ' O ' HD12 ' A' ' 21' ' ' LEU . 29.4 m-85 -145.92 132.44 19.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.198 0.523 . . . . 0.0 111.967 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.667 ' HB2' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -95.64 118.74 32.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.522 177.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.646 ' HE1' HG13 ' A' ' 67' ' ' VAL . 3.9 t80 -68.73 119.74 13.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.951 0.405 . . . . 0.0 110.604 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.611 HG21 ' OE1' ' A' ' 71' ' ' GLU . 6.3 p -120.84 37.32 4.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.497 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -137.72 -144.79 4.78 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.212 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.01 154.26 46.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -49.01 -17.47 0.2 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -74.0 -21.48 59.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.77 -24.77 56.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.414 HG23 ' CZ ' ' A' ' 29' ' ' PHE . 34.1 mt -70.14 105.66 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.443 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -122.93 95.56 4.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.021 179.219 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 131' ' ' PHE . 37.6 mt -55.73 -21.65 19.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.698 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.631 HD22 ' HG3' ' A' ' 129' ' ' PRO . 17.6 mt -64.47 -58.44 6.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.278 0.561 . . . . 0.0 109.898 178.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 141.49 -170.41 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.393 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -93.7 38.8 1.06 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.038 0.447 . . . . 0.0 109.878 179.068 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.5 25.87 75.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.135 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -116.38 -69.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.846 0.355 . . . . 0.0 111.212 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -89.88 165.12 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.69 148.18 54.01 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.631 ' HG3' HD22 ' A' ' 122' ' ' LEU . 74.2 Cg_exo -50.27 126.62 17.88 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.65 2.233 . . . . 0.0 112.463 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.0 -28.25 9.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.745 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.561 ' HB2' HD13 ' A' ' 121' ' ' LEU . 11.2 m-85 -113.08 159.25 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.476 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.15 -20.79 5.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.711 179.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.469 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.0 mm-40 -152.27 174.63 13.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.076 0.465 . . . . 0.0 110.47 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 p-90 -159.2 157.55 30.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.165 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.3 m -157.59 160.73 38.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.493 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 83.1 m95 -92.87 127.37 38.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.47 179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.738 HG11 HD11 ' A' ' 145' ' ' LEU . 35.7 m -136.15 152.31 30.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.025 0.44 . . . . 0.0 111.851 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -72.62 152.51 91.59 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HD3' HD11 ' A' ' 28' ' ' ILE . 5.2 Cg_endo -49.06 -23.26 6.04 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.105 1.87 . . . . 0.0 111.926 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.96 -33.71 19.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -71.5 -50.45 31.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.041 179.298 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.933 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.8 tp -54.18 -29.3 45.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.488 0.661 . . . . 0.0 109.817 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.592 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.0 mm -70.52 -28.39 34.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.75 178.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.2 -21.84 42.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.14 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.933 HD12 ' HA ' ' A' ' 142' ' ' LEU . 11.4 mt -82.48 -39.67 22.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.124 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.43 HG22 ' N ' ' A' ' 147' ' ' VAL . 24.9 m -58.78 163.6 3.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.023 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.824 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 12.6 p -92.58 161.42 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.932 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.52 ' HA ' ' CD ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.32 -26.64 68.54 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.112 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.824 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 24.6 p90 -91.11 10.88 25.07 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' A' ' 82' ' ' TYR . 5.7 mtmm -152.75 15.24 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.658 0.266 . . . . 0.0 111.698 179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.52 ' CD ' ' HA ' ' A' ' 148' ' ' GLU . 1.1 mtpp -67.04 -62.25 3.94 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.228 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 9.1 Cg_endo -50.77 -40.43 56.71 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.536 2.158 . . . . 0.0 112.097 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.826 HG21 ' HB3' ' A' ' 82' ' ' TYR . 21.4 t -57.15 -27.88 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.26 0.552 . . . . 0.0 110.842 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.569 ' CD2' ' HE2' ' A' ' 42' ' ' MET . 3.2 m-85 -91.22 -48.47 6.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.372 179.019 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HD2' HD12 ' A' ' 143' ' ' ILE . 3.5 tttt -52.68 -32.28 41.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.581 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 160' ' ' VAL . 2.4 tp10 -66.89 -45.72 77.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.385 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.51 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 47.6 t -59.04 -46.78 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.983 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.546 HD13 ' CA ' ' A' ' 139' ' ' PRO . 74.1 mt -66.55 -48.69 68.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.647 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.9 t -50.24 -47.17 55.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.674 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.857 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.5 t -68.49 -24.56 29.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.073 0.463 . . . . 0.0 110.349 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.862 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.3 m-30 -103.26 5.69 37.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.212 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.19 -55.36 31.99 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.609 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.6 Cg_endo -52.72 -22.51 17.6 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.577 2.184 . . . . 0.0 112.351 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.847 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 16.3 m-70 -89.97 -22.2 22.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.748 0.309 . . . . 0.0 110.717 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.694 HD12 ' OXT' ' A' ' 165' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.914 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.455 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.53 -167.77 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.511 2.14 . . . . 0.0 112.29 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.54 161.41 28.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.814 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 88.34 26.51 27.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.572 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.42 121.04 1.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.543 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 20.2 mmt -122.56 -35.42 3.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.53 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 3.1 m-20 69.65 21.08 6.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.806 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 172.91 130.6 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.463 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.1 Cg_endo -64.38 109.41 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.317 2.011 . . . . 0.0 112.346 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 6.0 Cg_exo -78.23 -176.17 3.11 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.059 2.506 . . . . 0.0 112.091 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -90.26 153.92 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.75 -29.89 9.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -103.48 139.56 38.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 5.6 ttm180 -83.36 152.24 25.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.131 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -65.21 131.66 47.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.5 m120 -152.52 159.27 43.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.894 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 1.5 m -132.29 127.68 57.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.254 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.12 144.38 17.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.162 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.886 HG21 HD22 ' A' ' 61' ' ' LEU . 4.8 mp -120.95 102.11 11.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 0.0 111.404 -179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.8 t -89.71 107.65 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 110' ' ' PHE . 37.6 tp -103.08 144.8 30.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.014 0.435 . . . . 0.0 111.196 -179.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.07 157.48 41.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.747 -179.973 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.9 p-10 -103.89 170.38 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.34 -179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -55.08 -18.13 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.476 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -88.94 4.48 47.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.815 0.341 . . . . 0.0 110.911 179.705 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 4.8 mtpp 70.55 27.86 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.525 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 22' ' ' MET . 13.4 mttt -96.73 172.38 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.588 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 119' ' ' ILE . 65.9 t80 -57.19 109.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.183 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.62 132.44 56.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.254 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -115.57 138.03 51.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.082 0.468 . . . . 0.0 111.509 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.575 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.4 p -82.69 158.5 22.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.543 ' CD ' HD12 ' A' ' 36' ' ' ILE . 2.2 mtp-105 -71.26 164.21 26.14 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.41 0.624 . . . . 0.0 111.468 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mt -96.25 -6.06 38.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.69 178.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -136.17 -14.09 1.8 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 64.5 mt -120.67 111.77 34.36 Favored Pre-proline 0 C--O 1.231 0.09 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.358 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 32.8 Cg_endo -66.38 132.97 30.92 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.739 1.626 . . . . 0.0 111.306 179.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 79.12 3.18 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.465 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -94.95 97.74 10.2 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.152 179.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.427 ' CE2' ' HB3' ' A' ' 32' ' ' SER . 23.7 m95 -108.78 160.21 16.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.085 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -168.86 170.81 8.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.859 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.453 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 71.0 mtm -97.91 156.71 35.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.67 137.81 39.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.631 2.221 . . . . 0.0 112.917 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.27 157.02 38.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.378 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.93 153.02 23.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.754 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.69 132.17 17.34 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.626 HD11 HG13 ' A' ' 17' ' ' VAL . 6.4 mt -59.88 160.6 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.761 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.871 179.796 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.13 98.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.18 0.514 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.73 39.3 10.66 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.941 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HB3' HG23 ' A' ' 47' ' ' ILE . 15.5 tp10 -114.22 146.48 40.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.061 0.458 . . . . 0.0 110.93 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.9 139.82 80.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.494 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.64 ' O ' HG11 ' A' ' 17' ' ' VAL . 52.2 Cg_exo -54.51 -52.55 7.91 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.46 2.107 . . . . 0.0 112.608 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' O ' HD12 ' A' ' 58' ' ' ILE . 7.0 ttt180 -62.9 -25.48 68.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.328 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -84.66 -48.88 9.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.699 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -59.04 -28.31 66.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.772 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -75.54 -50.2 16.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.158 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.418 HD12 ' O ' ' A' ' 54' ' ' ARG . 49.1 mt -57.25 -29.34 32.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -82.69 -53.12 6.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.747 0.784 . . . . 0.0 109.956 179.036 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -52.65 -42.33 64.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.471 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.886 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -57.11 -54.25 48.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.686 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.545 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 32.0 ttp180 -61.98 -13.54 26.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.331 178.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.02 -42.73 9.82 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -91.26 -25.66 19.37 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.811 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.8 -20.5 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.002 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.11 6.67 65.12 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.049 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.657 HG13 ' HE1' ' A' ' 112' ' ' PHE . 46.9 t -71.1 117.19 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.506 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.4 p -96.14 -35.73 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.23 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.3 78.56 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.127 0.489 . . . . 0.0 111.141 -179.698 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.53 129.43 13.39 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.931 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.61 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.76 148.96 42.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.06 179.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 39.8 t -79.56 123.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.422 0.629 . . . . 0.0 111.495 -179.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.872 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -106.12 -20.17 6.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.398 179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -154.55 159.35 40.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.435 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 2.2 pt-20 -148.66 117.11 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.989 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.842 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.0 t -57.26 126.76 75.13 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.065 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.94 -19.78 69.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.754 2.302 . . . . 0.0 113.228 -179.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.598 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -122.45 -177.98 3.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.351 0.596 . . . . 0.0 112.049 -179.518 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.699 ' C ' HD23 ' A' ' 80' ' ' LEU . 8.0 m95 -108.48 146.73 32.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.798 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.814 HD22 ' O ' ' A' ' 4' ' ' GLY . 3.4 mt -111.71 117.61 33.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.014 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.832 HG22 ' CB ' ' A' ' 104' ' ' ALA . 4.0 p -111.57 131.89 54.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.946 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.835 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -133.75 163.88 28.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.68 179.824 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -122.23 158.25 29.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -112.65 150.41 42.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.625 ' HG2' HG23 ' A' ' 88' ' ' VAL . 27.3 Cg_endo -62.41 170.49 6.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.553 2.169 . . . . 0.0 112.443 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.8 -16.77 51.14 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.89 2.393 . . . . 0.0 113.257 -179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.6 -39.28 11.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.197 0.523 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.625 HG23 ' HG2' ' A' ' 85' ' ' PRO . 94.8 t -78.46 -46.37 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.318 179.233 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -46.55 88.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.465 0.65 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.525 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.7 tt0 -66.39 -29.11 69.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.574 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -47.22 19.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.676 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' TRP . 92.7 mt -58.04 -45.87 86.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.356 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 2.8 m-80 -45.58 -31.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.567 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.33 -50.2 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.239 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -56.33 12.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.839 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.439 ' N ' ' O ' ' A' ' 92' ' ' LEU . 21.5 m0 -78.54 -34.73 46.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 81.06 34.45 26.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.552 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.81 147.17 47.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.707 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.8 39.29 2.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.003 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.419 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 69.2 m95 -97.41 150.13 21.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.21 -31.15 67.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.608 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -160.32 -143.03 3.54 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.005 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -157.61 114.47 2.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.878 0.37 . . . . 0.0 111.498 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.832 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -94.51 105.78 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -127.81 156.6 42.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.08 97.91 7.54 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.58 178.862 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CZ3' ' CE ' ' A' ' 42' ' ' MET . 28.0 m95 -65.72 141.95 58.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 0.0 112.134 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 62.0 m-85 -125.6 137.24 53.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.316 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.3 tp -79.54 146.14 32.79 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.88 ' CD1' HG23 ' A' ' 19' ' ' ILE . 40.0 m-85 -139.11 127.88 23.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.008 0.432 . . . . 0.0 111.651 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.872 ' HB3' HD11 ' A' ' 73' ' ' ILE . 15.3 tttm -92.02 120.44 32.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.522 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.657 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.5 t80 -64.89 125.53 25.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.798 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.1 p -126.54 37.73 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -139.89 -144.86 4.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.236 179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -127.15 154.27 44.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.917 0.389 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -49.75 -16.67 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.642 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -77.97 -18.16 56.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.266 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.06 -25.36 40.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 29' ' ' PHE . 17.7 mt -74.2 103.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.49 -179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -117.61 95.89 5.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 179.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 131' ' ' PHE . 47.2 mt -55.2 -23.32 21.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.64 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.417 HD22 ' HG3' ' A' ' 129' ' ' PRO . 29.0 mt -62.37 -57.4 11.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.285 0.564 . . . . 0.0 110.065 179.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.81 -176.03 25.0 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.51 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.27 38.84 1.01 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.131 0.491 . . . . 0.0 109.89 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.05 27.79 73.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.222 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.5 t -110.49 -65.97 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.837 0.351 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.57 165.06 11.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.99 149.9 97.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.005 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HG3' HD22 ' A' ' 122' ' ' LEU . 69.3 Cg_exo -50.0 177.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.732 2.288 . . . . 0.0 112.612 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mp0 -150.07 -45.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.552 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.819 ' HB2' HD13 ' A' ' 121' ' ' LEU . 18.9 m-85 -107.41 159.74 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.331 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.12 -16.9 6.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.803 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.575 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -152.47 174.7 13.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.12 0.486 . . . . 0.0 110.705 -179.816 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.5 p-90 -159.51 153.67 23.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.08 179.134 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.06 161.62 42.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.41 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -94.95 123.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.739 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.766 HG11 HD11 ' A' ' 145' ' ' LEU . 27.3 m -135.39 151.05 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.071 0.463 . . . . 0.0 111.641 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -70.85 159.23 86.04 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.687 ' CA ' HD13 ' A' ' 158' ' ' LEU . 11.7 Cg_endo -55.51 -19.38 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.935 1.756 . . . . 0.0 111.873 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.26 -34.25 15.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -72.48 -50.48 25.75 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.989 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.924 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.3 tp -54.01 -29.95 45.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.489 0.661 . . . . 0.0 109.915 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.601 HD12 ' HD2' ' A' ' 155' ' ' LYS . 2.9 mm -68.15 -29.15 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.582 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.6 -22.15 44.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.322 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.6 mt -84.41 -39.24 19.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.005 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 150' ' ' LYS . 4.8 m -58.63 168.56 1.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.3 p -104.64 159.92 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.047 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 147' ' ' VAL . 2.7 mm-40 -45.44 -46.17 13.35 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 147' ' ' VAL . 1.5 p90 -76.8 -1.89 30.47 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.133 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.507 ' O ' HG21 ' A' ' 146' ' ' THR . 1.8 mtmp? -125.73 1.57 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.579 0.228 . . . . 0.0 111.528 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 26.3 mttt -65.36 -62.55 4.46 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.342 -179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.03 -42.44 44.06 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.419 2.08 . . . . 0.0 112.239 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.835 HG11 ' CD1' ' A' ' 82' ' ' TYR . 13.4 t -59.16 -29.07 40.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.273 0.558 . . . . 0.0 110.966 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.3 m-85 -90.78 -50.97 5.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.692 179.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -49.78 -35.01 21.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.669 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -66.58 -44.81 81.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.642 179.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 153' ' ' VAL . 44.2 t -57.76 -46.51 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.084 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.687 HD13 ' CA ' ' A' ' 139' ' ' PRO . 74.3 mt -66.27 -48.87 69.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.75 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.9 m -50.02 -47.17 53.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.842 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.1 t -68.39 -25.09 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.067 0.46 . . . . 0.0 110.307 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.4 m-30 -104.8 12.0 33.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.981 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' A' ' 163' ' ' PRO . . . -53.98 -59.47 9.78 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.404 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 162' ' ' ALA . 12.3 Cg_endo -56.31 -21.53 37.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.586 2.191 . . . . 0.0 112.268 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.419 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 62.6 m-70 -89.95 -12.67 38.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.971 179.769 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.477 ' PA ' " C3'" ' A' ' 166' ' ' ATP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.28 145.1 53.21 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.537 2.158 . . . . 0.0 112.32 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.437 HD23 ' HG3' ' A' ' 152' ' ' PRO . 26.1 tp -153.25 102.47 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.691 ' O ' HD22 ' A' ' 80' ' ' LEU . . . 118.73 65.49 0.3 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.477 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.453 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER 178.59 127.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.595 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 10.1 ptp -140.32 -27.46 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.036 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 75.08 28.79 1.01 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.636 0.255 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 140.99 0.28 Allowed Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.072 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.64 120.35 4.74 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.613 2.209 . . . . 0.0 112.214 179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -91.42 -171.13 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.936 2.424 . . . . 0.0 112.459 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -87.81 151.07 23.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.768 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.28 -28.95 11.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.428 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 13' ' ' TYR . 2.0 m-85 -111.91 140.74 46.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.338 . . . . 0.0 110.725 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.429 ' HD3' ' CE2' ' A' ' 100' ' ' TRP . 2.1 ttp85 -92.48 152.38 19.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -62.12 132.55 53.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.425 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 19.1 t-20 -152.73 154.53 35.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.358 179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.818 HG13 HD11 ' A' ' 47' ' ' ILE . 2.3 m -126.3 131.49 71.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 111.388 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.81 148.3 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.033 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.927 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.5 mp -123.06 102.43 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.761 0.315 . . . . 0.0 111.397 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.2 t -89.48 104.69 17.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.859 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -102.59 145.3 29.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.0 0.429 . . . . 0.0 111.105 -178.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 4.2 ptm -127.65 157.26 40.74 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 42.2 p-10 -106.31 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.308 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -54.05 -18.33 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.377 179.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -88.86 3.94 49.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 179.803 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 20.7 mmtm 70.47 27.38 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.577 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' MET . 11.4 mmtm -96.38 175.32 6.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.594 HD11 ' HD3' ' A' ' 139' ' ' PRO . 5.1 mp -113.65 119.84 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.956 0.408 . . . . 0.0 110.809 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 119' ' ' ILE . 18.8 t80 -52.46 110.29 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.412 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.74 133.6 55.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.412 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -119.89 139.1 52.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.9 p -82.3 155.78 24.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.685 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.737 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.3 mtt85 -72.01 158.09 36.62 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.188 0.518 . . . . 0.0 111.445 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 129' ' ' PRO . 2.5 mt -91.77 -5.66 53.16 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.019 178.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -129.79 -18.18 3.48 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.737 HD12 ' CD ' ' A' ' 33' ' ' ARG . 61.7 mt -118.78 111.84 37.24 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.7 131.24 28.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.981 1.787 . . . . 0.0 111.968 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 t70 77.08 3.26 3.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.856 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.23 97.56 10.84 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.406 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.671 ' CD1' HD22 ' A' ' 145' ' ' LEU . 40.6 m95 -101.59 155.87 17.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.221 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' NE2' ' CE1' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -168.85 -176.92 2.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.651 179.724 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.467 ' SD ' HD21 ' A' ' 142' ' ' LEU . 3.4 mpp? -107.17 158.18 33.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.786 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 128.88 19.89 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.603 2.202 . . . . 0.0 112.417 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.03 157.09 38.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.738 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.76 139.24 5.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.571 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -57.31 137.48 49.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.818 HD11 HG13 ' A' ' 17' ' ' VAL . 9.2 mt -69.22 162.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 110.632 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -75.93 -172.16 1.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.613 179.614 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -90.14 27.45 1.63 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.24 0.543 . . . . 0.0 111.145 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.91 48.68 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.453 -179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 56' ' ' ALA . 5.4 tp10 -124.33 149.61 46.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 110.929 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -77.76 137.73 62.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.1 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.698 ' O ' HG11 ' A' ' 17' ' ' VAL . 77.5 Cg_exo -50.68 -55.18 4.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.363 2.042 . . . . 0.0 112.763 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.56 ' HD3' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.42 -31.55 67.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.316 -179.731 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -80.07 -49.73 11.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.733 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.577 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -56.69 -30.6 63.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.497 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.746 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -73.46 -52.59 13.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.099 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.56 HD11 ' HD3' ' A' ' 54' ' ' ARG . 41.2 mt -56.41 -29.85 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.23 179.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -81.67 -53.15 6.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.762 0.791 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -52.08 -45.71 64.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.597 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.915 HD22 HG21 ' A' ' 19' ' ' ILE . 3.2 tp -56.0 -56.16 24.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.811 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 40.1 ttp180 -60.56 -14.48 20.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.298 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -92.07 -41.35 10.56 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.897 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -91.5 -25.04 19.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.837 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.31 -20.06 9.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.086 -179.31 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 72.24 6.24 64.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.051 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.629 HG13 ' HE1' ' A' ' 112' ' ' PHE . 48.4 t -71.18 123.03 24.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.865 0.333 . . . . 0.0 110.469 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -34.12 9.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.24 76.77 6.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.987 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.26 129.01 13.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.873 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 12.0 mt-10 -120.39 148.5 43.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.765 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 110' ' ' PHE . 38.9 t -78.15 125.39 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.456 0.646 . . . . 0.0 111.694 -179.332 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.28 -21.62 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.237 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.672 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -151.84 159.47 43.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.203 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 3.4 pt-20 -148.52 115.85 6.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.011 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.828 ' HA ' HG11 ' A' ' 160' ' ' VAL . 4.8 t -57.31 130.17 80.36 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.066 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.07 -15.96 40.07 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.721 2.281 . . . . 0.0 113.6 -178.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.553 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.65 -176.05 3.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.417 0.627 . . . . 0.0 112.48 -179.369 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.69 ' C ' HD23 ' A' ' 80' ' ' LEU . 25.6 m95 -106.27 147.48 29.09 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.279 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.691 HD22 ' O ' ' A' ' 4' ' ' GLY . 5.5 mt -114.47 117.94 32.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.996 179.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.86 HG22 ' CB ' ' A' ' 104' ' ' ALA . 7.3 p -111.04 135.07 52.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.435 -179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.899 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -122.71 170.26 10.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.683 -179.355 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.21 158.23 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -117.63 152.51 49.79 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.669 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HG2' HG23 ' A' ' 88' ' ' VAL . 36.5 Cg_endo -64.96 165.41 21.53 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.98 -16.34 44.7 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.847 2.364 . . . . 0.0 113.066 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.66 -34.9 14.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.075 0.464 . . . . 0.0 110.13 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.566 HG23 ' HG2' ' A' ' 85' ' ' PRO . 64.9 t -81.9 -48.18 18.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.353 179.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -44.63 92.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.459 0.647 . . . . 0.0 109.576 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 94' ' ' ILE . 9.1 tt0 -70.78 -31.14 67.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.633 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.39 -48.01 52.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.737 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 96' ' ' TRP . 96.8 mt -59.05 -47.69 84.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.599 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.421 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 3.0 m-80 -46.75 -31.4 2.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.636 179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 90' ' ' GLU . 4.1 mt -96.67 -48.08 12.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.355 179.458 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -52.83 28.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.473 ' N ' ' O ' ' A' ' 92' ' ' LEU . 22.5 m0 -80.89 -35.12 32.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 77.68 38.34 28.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.195 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.9 159.13 34.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.945 -179.812 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -118.08 77.89 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.777 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.429 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 56.9 m95 -135.3 150.24 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.573 179.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.519 ' N ' ' CD ' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -85.72 -23.02 27.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.819 -179.929 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -174.7 -137.58 2.51 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.048 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 90.0 mm-40 -157.3 113.85 2.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.886 0.374 . . . . 0.0 111.346 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.86 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -88.0 105.63 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.3 pt20 -121.64 157.06 31.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.453 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -112.15 95.72 5.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.198 178.569 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.644 ' CD2' HG21 ' A' ' 157' ' ' VAL . 24.2 m95 -64.12 150.5 45.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.308 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CE2' ' CG ' ' A' ' 54' ' ' ARG . 64.9 m-85 -133.15 133.29 42.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.284 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.834 HD13 ' CD2' ' A' ' 161' ' ' PHE . 17.6 tp -79.81 130.23 35.14 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.927 ' CD1' HG23 ' A' ' 19' ' ' ILE . 47.9 m-85 -124.49 129.13 50.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.505 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.844 ' HB3' HD11 ' A' ' 73' ' ' ILE . 5.1 tptt -92.38 123.06 35.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HE1' HG13 ' A' ' 67' ' ' VAL . 6.6 t80 -67.2 124.48 23.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.694 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' SER . 17.6 p -126.73 37.87 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.747 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -138.2 -145.13 4.79 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.031 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -128.54 154.13 46.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.55 ' HA ' HD12 ' A' ' 119' ' ' ILE . 10.6 m-20 -50.25 -16.25 0.31 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.67 179.611 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.71 -18.36 54.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.744 0.307 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -80.12 -25.0 40.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 116' ' ' ASP . 8.6 mt -72.09 103.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.501 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.5 95.61 5.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 131' ' ' PHE . 43.8 mt -56.69 -23.15 39.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.54 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.1 mt -61.85 -56.77 15.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.25 0.548 . . . . 0.0 109.997 179.233 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.38 -178.47 22.3 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.552 179.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -90.72 38.74 0.96 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.1 0.476 . . . . 0.0 109.843 179.208 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.15 28.23 73.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -112.76 -67.32 1.01 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 111.19 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -105.54 165.04 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.235 -179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.54 150.75 95.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' LEU . 59.9 Cg_exo -50.43 138.77 38.39 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.654 2.236 . . . . 0.0 112.506 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -112.4 -31.48 6.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.724 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.539 ' HB2' HD13 ' A' ' 121' ' ' LEU . 7.2 m-85 -118.02 159.56 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.03 -20.07 5.37 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.879 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.435 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.5 mm-40 -152.23 174.66 13.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.248 0.547 . . . . 0.0 110.599 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 p-90 -159.2 154.11 24.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.178 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 82.6 m95 -93.05 125.31 37.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.621 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 142' ' ' LEU . 28.9 m -137.63 150.76 25.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.116 0.484 . . . . 0.0 111.619 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.9 p -69.54 159.83 82.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.472 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.641 ' CB ' HD13 ' A' ' 158' ' ' LEU . 14.0 Cg_endo -56.69 -18.89 28.21 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 121.796 1.664 . . . . 0.0 111.838 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -90.12 -34.2 15.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.054 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -50.9 22.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.112 179.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.1 tp -54.22 -30.28 49.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.393 0.616 . . . . 0.0 109.826 179.111 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 143' ' ' ILE . 5.1 mm -68.97 -28.31 39.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.717 178.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 -17.53 47.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.367 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 142' ' ' LEU . 12.0 mt -87.53 -38.8 15.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.186 179.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 147' ' ' VAL . 67.6 m -59.51 162.26 5.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.046 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.962 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 10.1 p -91.62 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 147' ' ' VAL . 1.8 mt-10 -51.66 -33.18 32.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.962 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 13.3 p90 -87.53 10.9 16.26 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.179 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 8.6 mtmm -136.74 -2.24 2.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 30.1 mttt -55.76 -61.81 5.67 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.201 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.437 ' HG3' HD23 ' A' ' 3' ' ' LEU . 18.3 Cg_endo -59.6 -45.84 23.66 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.377 2.051 . . . . 0.0 112.122 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.899 HG21 ' HB3' ' A' ' 82' ' ' TYR . 39.5 t -56.06 -27.79 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.227 0.537 . . . . 0.0 111.066 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.8 m-30 -91.55 -53.71 4.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.715 179.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' CD ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -49.76 -32.63 14.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 110.522 179.87 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.2 -45.56 80.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.498 179.148 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 107' ' ' TRP . 48.4 t -57.9 -50.38 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.123 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.641 HD13 ' CB ' ' A' ' 139' ' ' PRO . 74.7 mt -61.68 -48.89 78.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.698 178.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 t -49.71 -47.53 50.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.664 179.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 76' ' ' VAL . 99.0 t -67.84 -25.26 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.069 0.461 . . . . 0.0 110.31 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.834 ' CD2' HD13 ' A' ' 109' ' ' LEU . 8.6 m-30 -102.1 7.88 40.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.156 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.64 -57.0 17.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.258 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 13.4 Cg_endo -56.76 -22.39 44.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.44 2.093 . . . . 0.0 112.202 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.672 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 91.5 m-70 -89.97 -14.37 34.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.025 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.894 179.829 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.446 ' N6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -178.51 2.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.588 2.192 . . . . 0.0 112.227 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.442 ' CD1' ' HE2' ' A' ' 6' ' ' MET . 0.2 OUTLIER -63.75 86.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 -179.973 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.17 31.18 9.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.499 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 78' ' ' TYR . 0.5 OUTLIER 173.62 128.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.343 . . . . 0.0 110.547 179.939 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.442 ' HE2' ' CD1' ' A' ' 3' ' ' LEU . 10.9 tpp -124.75 -32.14 3.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.779 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 5.7 m-20 74.61 19.36 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.758 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.87 142.4 0.17 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.392 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 41.7 Cg_endo -68.26 114.93 3.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.279 1.986 . . . . 0.0 112.183 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.695 ' HG2' HG21 ' A' ' 81' ' ' THR . 11.6 Cg_exo -71.13 -176.27 1.8 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.589 2.193 . . . . 0.0 111.87 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.87 151.27 21.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.327 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.559 ' HA3' ' HZ3' ' A' ' 101' ' ' LYS . . . 88.83 -37.15 3.34 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.877 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.68 131.95 34.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.008 0.432 . . . . 0.0 110.71 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.468 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 2.1 ptm85 -73.79 143.52 45.97 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.401 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 38.5 mtm180 -67.02 133.17 49.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.399 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.501 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.3 t-20 -152.55 155.96 38.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.557 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.738 HG13 HD11 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -123.87 130.0 74.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.216 179.786 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.18 146.38 18.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.126 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.906 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.4 mp -124.56 102.03 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.9 t -89.57 101.82 14.51 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 110' ' ' PHE . 27.0 tp -103.03 143.3 32.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 0.0 111.229 -178.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.86 157.41 39.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.751 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 36.2 p-10 -100.71 170.05 8.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.232 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -56.27 -16.67 5.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.56 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.98 0.11 56.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.688 0.28 . . . . 0.0 110.973 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mttm 77.21 26.71 0.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.602 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -98.93 173.27 6.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.537 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.7 mp -111.23 122.97 66.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.746 ' CE1' HG21 ' A' ' 119' ' ' ILE . 66.7 t80 -56.5 110.25 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -179.607 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.8 129.88 56.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.236 179.348 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -117.11 137.54 52.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.409 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -82.62 157.61 23.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.55 179.761 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.56 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -72.94 159.51 33.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.294 0.569 . . . . 0.0 111.534 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.15 -5.65 49.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.996 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.49 -16.81 3.0 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.621 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 54.5 mt -119.65 111.97 35.75 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.015 -179.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.24 131.82 29.66 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.904 1.736 . . . . 0.0 111.8 179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t70 76.92 3.52 3.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.783 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.67 97.51 11.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.414 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.424 ' CD1' HD22 ' A' ' 145' ' ' LEU . 37.7 m95 -104.62 156.65 17.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.044 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -168.8 169.56 9.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.815 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.451 ' CE ' ' CZ3' ' A' ' 107' ' ' TRP . 45.9 mtm -94.15 155.83 39.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.623 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.45 134.11 37.31 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.512 2.142 . . . . 0.0 112.687 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.14 163.54 39.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.493 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.45 142.73 7.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.746 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -60.84 135.61 49.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.59 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.738 HD11 HG13 ' A' ' 17' ' ' VAL . 5.5 mt -66.84 160.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.55 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.494 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -90.17 149.35 22.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 179.824 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -50.73 99.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.219 0.533 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.57 39.83 11.76 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.851 -179.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 6.0 tp10 -113.76 145.18 41.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.91 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 1.4 m-20 -74.43 125.56 89.7 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.236 179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.591 ' O ' HG11 ' A' ' 17' ' ' VAL . 6.6 Cg_endo -50.16 -47.97 21.77 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.46 2.106 . . . . 0.0 112.772 -179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.634 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -59.31 -27.73 66.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.725 0.298 . . . . 0.0 110.875 179.956 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -88.01 -43.44 11.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -60.78 -32.18 71.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.174 179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.11 -54.06 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.034 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 54' ' ' ARG . 41.3 mt -55.79 -29.53 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.278 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.5 ttp85 -82.69 -52.79 6.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.798 0.808 . . . . 0.0 109.981 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -52.92 -44.1 66.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.575 -179.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.787 HD12 ' OG1' ' A' ' 65' ' ' THR . 3.3 tp -56.97 -55.39 35.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.676 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 33.7 ttp180 -62.28 -13.3 26.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.283 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.12 -43.25 9.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.827 -179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -91.18 -25.85 19.35 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.787 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -116.77 -20.35 9.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.451 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 73.88 4.69 67.58 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.103 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.672 HG13 ' HE1' ' A' ' 112' ' ' PHE . 47.4 t -69.86 116.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.834 0.35 . . . . 0.0 110.529 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.65 -34.5 11.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.052 -179.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 113' ' ' THR . 0.7 OUTLIER -90.38 78.4 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.48 129.04 13.09 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.871 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.613 ' HG2' HG21 ' A' ' 113' ' ' THR . 0.0 OUTLIER -118.68 149.02 42.12 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.56 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.634 HG11 ' CZ ' ' A' ' 54' ' ' ARG . 30.6 t -80.06 122.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.4 0.619 . . . . 0.0 111.355 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.901 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -103.03 -20.62 5.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.414 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.94 161.0 40.59 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.286 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -148.68 117.48 6.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.877 179.652 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.864 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.4 t -57.16 128.78 78.59 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.22 -18.18 55.54 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.615 2.21 . . . . 0.0 113.337 -178.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.641 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -125.6 -179.16 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.497 0.665 . . . . 0.0 112.111 -179.505 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.437 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 6.2 m95 -108.45 145.94 33.89 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.839 178.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.706 HD21 ' HG2' ' A' ' 156' ' ' GLU . 66.5 mt -110.66 117.3 33.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.864 HG22 ' CB ' ' A' ' 104' ' ' ALA . 17.4 p -101.63 137.49 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.762 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.724 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -131.85 169.78 15.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.783 -179.417 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.91 158.42 36.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -116.32 145.04 34.2 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.639 ' HG2' HG23 ' A' ' 88' ' ' VAL . 24.4 Cg_endo -62.23 169.56 7.68 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.504 2.136 . . . . 0.0 112.323 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.87 -16.48 44.93 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.868 2.379 . . . . 0.0 113.233 -179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -90.73 -42.85 10.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.274 0.559 . . . . 0.0 109.829 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.639 HG23 ' HG2' ' A' ' 85' ' ' PRO . 96.4 t -74.11 -46.45 45.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.448 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -46.17 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.515 0.674 . . . . 0.0 109.731 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.634 ' O ' HD13 ' A' ' 94' ' ' ILE . 39.4 tt0 -71.35 -21.58 62.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.888 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 -44.87 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.638 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.762 HD22 ' CD2' ' A' ' 96' ' ' TRP . 84.4 mt -60.83 -45.06 95.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.462 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.4 m-80 -46.92 -33.13 4.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.634 HD13 ' O ' ' A' ' 90' ' ' GLU . 1.9 mp -96.72 -47.64 12.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -68.43 -54.87 14.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.853 0.358 . . . . 0.0 111.002 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.762 ' CD2' HD22 ' A' ' 92' ' ' LEU . 27.1 m0 -79.76 -33.34 40.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 76.36 38.51 33.48 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.196 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -125.27 147.52 49.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.903 0.382 . . . . 0.0 110.893 -179.823 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.63 74.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.828 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.468 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 19.0 m95 -135.19 149.42 49.92 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.964 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.559 ' HZ3' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -81.72 -29.23 33.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.634 -179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -155.96 -146.19 4.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.279 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -158.17 129.95 6.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.914 0.388 . . . . 0.0 111.777 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.864 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -111.71 106.84 15.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.889 178.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.406 ' CB ' ' O ' ' A' ' 16' ' ' ASN . 3.3 pt20 -122.06 161.59 22.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.606 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -113.85 101.66 9.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.021 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.54 ' CD2' HG21 ' A' ' 157' ' ' VAL . 33.8 m95 -70.36 153.15 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.199 0.523 . . . . 0.0 112.401 -178.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 73.3 m-85 -137.08 134.12 36.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.199 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.826 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.7 tp -79.88 130.97 35.73 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.424 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.906 ' CD1' HG23 ' A' ' 19' ' ' ILE . 46.3 m-85 -125.55 128.43 47.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.581 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.901 ' HB3' HD11 ' A' ' 73' ' ' ILE . 1.9 tptt -92.25 121.18 33.52 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.672 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -64.86 124.88 23.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.984 0.421 . . . . 0.0 110.816 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.613 HG21 ' HG2' ' A' ' 71' ' ' GLU . 2.2 p -125.66 37.51 4.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.602 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -139.12 -145.18 4.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.13 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -128.09 154.24 45.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.829 0.347 . . . . 0.0 110.067 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -50.03 -16.52 0.3 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.62 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -18.35 54.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.682 0.277 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.34 -25.29 39.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.746 HG21 ' CE1' ' A' ' 29' ' ' PHE . 16.1 mt -72.35 97.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.361 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -111.42 95.71 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.078 179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 131' ' ' PHE . 66.8 mt -55.42 -23.06 22.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.667 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.75 -58.11 8.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.299 0.571 . . . . 0.0 110.001 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.51 -176.85 25.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.554 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -92.44 38.79 1.02 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 109.799 179.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 66.34 28.18 73.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.169 -179.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -112.18 -65.98 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.201 -179.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.04 165.13 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.241 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -66.78 151.87 96.2 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.42 176.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -150.04 -44.85 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.681 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 121' ' ' LEU . 23.0 m-85 -109.44 159.53 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.392 179.644 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -114.83 -19.19 6.12 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.709 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 21.3 mm-40 -152.46 174.69 13.57 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.113 0.482 . . . . 0.0 110.455 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 23.7 p-90 -158.38 151.72 23.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.145 179.064 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.2 m -148.46 158.75 44.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.386 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 73.7 m95 -93.32 123.47 36.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.666 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 145' ' ' LEU . 31.6 m -134.05 151.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.111 0.482 . . . . 0.0 111.716 -179.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.6 p -70.23 158.34 87.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.539 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.537 ' HD3' HD11 ' A' ' 28' ' ' ILE . 11.2 Cg_endo -55.02 -19.1 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.978 1.786 . . . . 0.0 112.046 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.01 -33.46 14.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.128 179.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -50.05 35.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.107 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.896 ' HA ' HD12 ' A' ' 145' ' ' LEU . 4.1 tp -53.34 -31.93 46.7 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.48 0.657 . . . . 0.0 109.891 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.437 HD11 HD12 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -66.35 -29.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.683 178.566 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -32.07 57.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 178.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 142' ' ' LEU . 8.1 mt -75.47 -40.47 57.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.008 179.076 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 150' ' ' LYS . 16.8 m -55.4 165.07 0.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.141 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 148' ' ' GLU . 7.3 p -98.9 160.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.221 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.4 mm-40 -47.34 -43.35 22.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.43 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 12.7 p90 -82.66 4.12 26.19 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.272 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 16.1 mttt -125.25 -3.29 7.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 111.368 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 35.5 mttt -59.95 -61.87 7.03 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 21.0 Cg_endo -61.08 -43.29 30.58 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.456 2.104 . . . . 0.0 112.403 -179.825 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.724 HG21 ' HB3' ' A' ' 82' ' ' TYR . 15.4 t -57.23 -29.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.118 0.485 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.08 -55.25 3.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.8 -32.59 6.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.937 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.706 ' HG2' HD21 ' A' ' 80' ' ' LEU . 3.1 tp10 -69.73 -44.19 70.78 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.785 179.407 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.5 t -59.57 -42.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.136 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 162' ' ' ALA . 51.3 mt -67.46 -48.1 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.619 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.2 t -50.58 -46.84 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.807 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.864 HG11 ' HA ' ' A' ' 76' ' ' VAL . 87.7 t -68.08 -24.54 30.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.123 0.487 . . . . 0.0 110.411 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.826 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.5 m-30 -102.61 6.05 39.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.117 -179.178 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.634 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -50.97 -49.9 77.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.532 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 75.0 Cg_exo -49.73 -25.21 11.09 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.565 2.176 . . . . 0.0 112.559 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.726 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 96.7 m-70 -94.68 -26.71 16.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.455 ' C6 ' ' HB ' ' A' ' 147' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.09 173.65 10.94 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.677 2.251 . . . . 0.0 112.312 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 81' ' ' THR . 4.4 tp -175.63 87.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.7 33.86 2.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.542 179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.79 129.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.834 0.349 . . . . 0.0 110.518 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 6.1 mmt -121.69 -38.17 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.409 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 68.46 18.66 8.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.856 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.2 t 172.86 132.97 0.1 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 33.3 Cg_endo -65.23 109.56 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.337 2.024 . . . . 0.0 112.297 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 5.0 Cg_exo -79.76 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.065 2.51 . . . . 0.0 112.047 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.3 151.7 21.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.64 -25.24 28.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.661 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.56 138.13 43.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.41 . . . . 0.0 110.966 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 4.1 ptm85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -67.32 130.33 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.47 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 7.8 m120 -152.68 159.63 43.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.731 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.5 m -133.61 131.32 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.257 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.34 144.7 16.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.298 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.866 HG23 ' CD1' ' A' ' 110' ' ' PHE . 4.3 mp -120.5 101.81 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 111.172 -179.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 110' ' ' PHE . 51.2 t -89.54 107.21 18.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.228 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 110' ' ' PHE . 45.9 tp -103.42 141.86 35.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 111.097 -179.073 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -127.49 157.46 40.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' HB3' ' CZ2' ' A' ' 136' ' ' TRP . 34.1 p-10 -101.02 171.04 7.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.331 -179.594 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -56.13 -17.62 7.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.586 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.07 0.26 56.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.733 0.302 . . . . 0.0 110.971 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp 77.0 26.21 0.77 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.5 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -96.21 172.11 8.17 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.965 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.589 HD11 ' HD3' ' A' ' 139' ' ' PRO . 4.8 mp -110.91 121.32 63.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.367 . . . . 0.0 110.937 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.824 ' CE2' HG21 ' A' ' 119' ' ' ILE . 37.0 t80 -56.06 109.4 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.233 -179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.7 130.01 56.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.36 179.408 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -114.29 136.1 53.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.35 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.414 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -82.29 155.39 24.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.416 179.637 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.624 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -72.12 157.29 38.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.355 0.597 . . . . 0.0 111.732 -179.223 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.43 -6.44 49.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.828 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -128.53 -18.26 3.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.216 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.629 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 61.7 mt -119.6 110.92 36.64 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 28.5 Cg_endo -65.17 131.83 29.8 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.816 1.677 . . . . 0.0 111.73 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 t70 77.11 5.46 3.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.642 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -92.82 97.84 11.01 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.5 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.53 ' CD1' HD22 ' A' ' 145' ' ' LEU . 19.2 m95 -107.0 156.4 18.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.878 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -168.8 176.69 5.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.498 ' HE2' ' CZ3' ' A' ' 107' ' ' TRP . 2.2 mpp? -101.3 160.44 26.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.34 136.95 24.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.571 2.181 . . . . 0.0 112.786 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 155.77 35.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.14 155.6 26.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.675 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -72.88 132.82 17.95 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.366 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.635 HD11 HG13 ' A' ' 17' ' ' VAL . 5.8 mt -60.23 161.08 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.644 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -90.25 149.33 22.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.91 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.44 98.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.194 0.521 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.51 10.0 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.947 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 6.1 tp10 -114.38 146.27 40.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 110.82 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.16 140.05 76.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.511 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.578 ' O ' HG11 ' A' ' 17' ' ' VAL . 51.2 Cg_exo -53.24 -52.43 8.74 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.383 2.055 . . . . 0.0 112.575 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' O ' HD12 ' A' ' 58' ' ' ILE . 2.2 tmm_? -62.56 -25.62 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.156 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -83.64 -50.02 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.676 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.53 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.25 -31.97 67.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.504 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -72.24 -52.0 18.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.266 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.464 HD12 ' O ' ' A' ' 54' ' ' ARG . 55.1 mt -57.24 -28.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.213 179.22 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -84.0 -53.18 5.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.749 0.785 . . . . 0.0 109.777 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -54.56 -32.7 58.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.29 -179.844 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.874 HD11 ' HB ' ' A' ' 67' ' ' VAL . 3.0 tp -55.73 -54.79 40.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.605 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -61.67 -13.0 18.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.911 0.386 . . . . 0.0 110.461 179.052 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -91.64 -37.92 12.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 0.0 111.395 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -87.7 -36.42 17.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.955 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.506 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -121.07 -23.46 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 111.23 -179.533 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 78.1 3.05 84.48 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.81 -179.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.874 ' HB ' HD11 ' A' ' 61' ' ' LEU . 39.0 t -61.95 115.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.821 0.343 . . . . 0.0 110.461 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -91.83 -36.95 13.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB2' ' N ' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.18 78.98 6.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 110.979 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.17 129.56 13.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.845 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.9 OUTLIER -120.04 147.76 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.859 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.4 t -78.22 125.03 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.405 0.621 . . . . 0.0 111.858 -179.141 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.895 HD11 ' HB3' ' A' ' 111' ' ' LYS . 1.9 mm -107.0 -19.84 6.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.362 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.769 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -152.03 158.26 42.82 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.327 -179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -148.56 116.75 6.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.995 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.888 ' HA ' HG11 ' A' ' 160' ' ' VAL . 10.9 t -57.26 130.79 80.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.094 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.02 -17.66 40.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.647 2.231 . . . . 0.0 113.316 -179.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.624 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -126.35 177.08 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.378 0.609 . . . . 0.0 112.15 -179.497 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.463 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 m95 -104.32 146.05 29.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.976 179.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.914 ' HB3' HG13 ' A' ' 153' ' ' VAL . 94.8 mt -113.19 117.56 32.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.879 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.798 HG22 ' CB ' ' A' ' 104' ' ' ALA . 2.5 p -111.19 131.9 54.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.823 -179.325 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.864 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -132.69 162.81 30.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.616 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.22 158.38 24.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.972 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.47 154.44 47.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.634 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.6 Cg_endo -63.87 172.0 6.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.493 2.129 . . . . 0.0 112.528 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.49 -17.83 60.92 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.879 2.386 . . . . 0.0 113.256 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -90.17 -35.08 15.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 109.979 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 85' ' ' PRO . 73.3 t -80.41 -49.69 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.187 179.252 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -47.4 80.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.515 0.674 . . . . 0.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.585 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -67.54 -27.51 67.02 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.92 179.801 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.89 -46.56 18.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.551 HD21 H5'2 ' A' ' 166' ' ' ATP . 95.2 mt -60.44 -45.72 92.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 110.263 179.477 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.425 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.1 m-80 -45.2 -30.69 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.639 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.7 mt -96.08 -50.66 11.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 179.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -51.76 64.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.74 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.429 ' CZ2' ' O1A' ' A' ' 166' ' ' ATP . 33.9 m0 -81.96 -40.77 21.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.837 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 86.85 34.48 11.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.42 156.19 37.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.76 67.52 0.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 14' ' ' ARG . 51.8 m95 -124.47 150.24 45.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.757 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -31.31 62.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . -156.22 -144.66 3.98 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.991 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.09 114.95 2.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.828 0.347 . . . . 0.0 111.564 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.798 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -92.74 105.97 18.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.874 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -127.32 155.59 43.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 112.539 -178.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.463 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -109.26 96.34 6.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.633 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.498 ' CZ3' ' HE2' ' A' ' 42' ' ' MET . 23.2 m95 -63.7 145.68 55.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.106 -178.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 59.2 m-85 -128.16 137.05 51.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.428 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.79 HD13 ' CD2' ' A' ' 161' ' ' PHE . 19.4 tp -79.71 146.95 32.14 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.866 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.4 m-85 -140.77 127.05 19.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.978 0.418 . . . . 0.0 111.545 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.895 ' HB3' HD11 ' A' ' 73' ' ' ILE . 14.5 tttm -90.47 121.06 32.09 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.3 t80 -65.41 125.17 24.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 -179.587 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 111' ' ' LYS . 10.0 p -127.77 38.14 4.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.549 179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 69' ' ' SER . . . -137.77 -145.47 4.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.153 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.23 154.05 45.33 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -50.5 -16.08 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.7 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -79.74 -19.11 49.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.767 0.318 . . . . 0.0 111.307 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -78.74 -25.28 44.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.824 HG21 ' CE2' ' A' ' 29' ' ' PHE . 16.5 mt -74.78 103.48 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.378 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -113.77 95.51 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.918 178.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 131' ' ' PHE . 31.8 mt -49.82 -26.28 3.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.732 -179.191 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.539 HD22 ' HG3' ' A' ' 129' ' ' PRO . 34.0 mt -63.5 -57.48 10.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 109.982 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 145.63 -173.49 25.98 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.42 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -93.44 38.86 1.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.19 0.519 . . . . 0.0 109.993 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.89 27.51 73.04 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.267 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.6 m -115.13 -68.17 0.94 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -179.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.09 165.01 13.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -78.84 153.88 77.99 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.956 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.539 ' HG3' HD22 ' A' ' 122' ' ' LEU . 87.5 Cg_exo -46.18 162.52 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.836 2.358 . . . . 0.0 112.554 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -149.95 -44.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.823 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' HB2' HD13 ' A' ' 121' ' ' LEU . 20.7 m-85 -106.47 159.12 16.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.389 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.94 -20.36 4.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.696 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.413 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 5.3 mm-40 -152.42 174.56 13.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.092 0.472 . . . . 0.0 110.456 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.6 p-90 -159.17 156.19 28.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.151 178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.96 164.2 38.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.401 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 23' ' ' ASN . 69.0 m95 -94.44 124.95 38.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.672 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 142' ' ' LEU . 29.7 m -138.21 151.49 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.057 0.456 . . . . 0.0 111.626 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 1.5 p -70.2 159.97 82.55 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.491 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.677 ' CA ' HD13 ' A' ' 158' ' ' LEU . 14.6 Cg_endo -57.15 -17.88 27.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 121.775 1.65 . . . . 0.0 111.786 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -34.43 15.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.154 179.172 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -50.78 25.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 109.97 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.917 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.5 tp -54.39 -28.96 47.07 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.387 0.613 . . . . 0.0 109.858 179.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.574 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm -69.45 -28.73 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.812 178.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -80.26 -20.04 45.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.271 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.0 mt -86.32 -39.07 16.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -62.22 166.09 5.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.104 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.978 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 9.3 p -98.41 161.57 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.023 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.5 OUTLIER -52.21 -33.37 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.978 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.8 p90 -86.48 16.0 4.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.937 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.442 ' HD3' ' CE1' ' A' ' 149' ' ' PHE . 2.4 mtpm? -143.93 -26.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.064 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 13.9 mtpt -43.38 -61.61 1.77 Allowed Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.653 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 18.2 Cg_endo -59.42 -44.36 33.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.265 1.976 . . . . 0.0 111.822 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.914 HG13 ' HB3' ' A' ' 80' ' ' LEU . 17.1 t -60.01 -24.99 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.804 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.448 ' CD2' ' CE ' ' A' ' 42' ' ' MET . 3.8 m-30 -90.85 -50.92 5.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.594 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.574 ' HD2' HD12 ' A' ' 143' ' ' ILE . 2.7 tttt -48.9 -36.63 17.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.726 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.0 tp10 -64.92 -45.4 86.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.451 179.073 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 153' ' ' VAL . 37.8 t -58.81 -43.02 87.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.123 179.36 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.677 HD13 ' CA ' ' A' ' 139' ' ' PRO . 53.4 mt -69.09 -49.22 59.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.623 178.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 10.9 t -50.35 -46.78 55.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.718 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.888 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.9 t -67.54 -24.87 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.426 179.146 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.79 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -102.26 2.36 36.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.244 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.567 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -51.79 -56.07 24.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.406 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.9 -21.22 25.45 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.602 2.201 . . . . 0.0 112.391 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.769 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 12.0 m-70 -89.64 -20.02 24.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.748 0.309 . . . . 0.0 110.816 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.87 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.551 H5'2 HD21 ' A' ' 92' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.16 -178.39 2.47 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.545 2.164 . . . . 0.0 112.294 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.66 114.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.78 21.74 5.6 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.62 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.52 129.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 0.0 110.624 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.43 -35.52 1.52 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.623 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.49 14.26 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.156 -179.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 168.62 139.77 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 57.3 Cg_endo -71.9 112.79 3.48 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.357 2.038 . . . . 0.0 112.293 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -92.15 -172.37 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.137 2.558 . . . . 0.0 112.369 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.25 159.84 20.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.36 -35.85 4.09 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -110.4 138.78 46.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.894 0.378 . . . . 0.0 110.849 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.13 152.27 24.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -66.03 132.75 49.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.113 0.483 . . . . 0.0 111.502 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.8 t30 -152.49 158.49 42.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.993 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.744 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.1 m -132.2 133.34 60.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.993 0.425 . . . . 0.0 111.68 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.15 153.61 17.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.938 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.9 HG21 HD22 ' A' ' 61' ' ' LEU . 4.1 mp -127.08 103.37 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.323 . . . . 0.0 111.488 -179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 110' ' ' PHE . 6.6 t -89.7 104.07 16.66 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 110' ' ' PHE . 28.0 tp -103.24 145.28 30.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.211 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -126.94 157.53 39.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.719 -179.968 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 38.7 p-10 -101.55 170.57 8.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.417 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.06 -18.23 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.466 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.0 0.58 56.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.714 0.292 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt 76.03 26.12 1.02 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.485 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.2 mttt -96.64 171.24 8.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.514 HD12 ' O ' ' A' ' 137' ' ' VAL . 4.1 mp -108.16 124.14 64.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.948 0.404 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.759 ' CE1' HG21 ' A' ' 119' ' ' ILE . 67.6 t80 -58.53 110.16 0.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.143 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -116.66 135.29 53.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.315 179.368 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -118.73 136.25 54.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.934 0.397 . . . . 0.0 111.317 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -82.66 153.74 25.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.563 179.778 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.591 ' CD ' HD12 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -70.8 158.3 36.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 0.0 111.532 -179.408 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 130' ' ' GLU . 1.4 mt -92.65 -6.63 48.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.92 178.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -128.75 -17.23 4.07 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.15 -179.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.628 ' CG2' ' HB2' ' A' ' 39' ' ' ALA . 51.6 mt -119.76 107.79 39.92 Favored Pre-proline 0 N--CA 1.456 -0.149 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.898 -179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 25.9 Cg_exo -61.98 128.74 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.164 1.909 . . . . 0.0 111.899 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.2 t70 80.06 1.78 2.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.917 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -87.22 97.62 10.87 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.576 ' CD1' HD22 ' A' ' 145' ' ' LEU . 49.0 m95 -103.55 157.24 17.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.995 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -168.79 -177.01 2.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 71.6 mtm -109.13 156.76 38.68 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.811 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.54 140.26 56.53 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.595 2.196 . . . . 0.0 112.79 -179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 158.79 40.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.519 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.1 147.06 12.48 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.559 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -67.05 136.41 32.73 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.429 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 17' ' ' VAL . 5.3 mt -65.43 159.94 3.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.789 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.474 ' N ' HG22 ' A' ' 47' ' ' ILE . 1.2 m-20 -90.45 150.27 21.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.69 98.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.242 0.544 . . . . 0.0 110.91 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.39 39.14 10.06 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.98 -179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 56' ' ' ALA . 14.2 tp10 -113.85 146.2 40.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.177 0.513 . . . . 0.0 110.844 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 -72.8 139.13 80.06 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.568 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.613 ' O ' HG11 ' A' ' 17' ' ' VAL . 52.5 Cg_exo -54.92 -52.08 8.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.416 2.077 . . . . 0.0 112.658 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' HG3' ' CD2' ' A' ' 108' ' ' PHE . 5.8 ttp85 -62.73 -26.64 68.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.277 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -84.51 -48.77 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' C ' HG21 ' A' ' 17' ' ' VAL . . . -58.55 -28.27 65.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.553 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -75.49 -50.03 16.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.185 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 54' ' ' ARG . 45.2 mt -57.64 -29.63 34.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -82.13 -53.24 6.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.799 178.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -53.01 -41.14 64.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.4 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 19' ' ' ILE . 3.1 tp -56.13 -52.57 63.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.637 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 30.3 ttp180 -61.87 -13.82 28.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 178.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.19 -42.28 9.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.03 -26.17 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.739 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -120.6 -21.18 6.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.845 0.355 . . . . 0.0 111.081 -179.366 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 8.93 62.76 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.562 -0.828 . . . . 0.0 113.059 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.697 ' HB ' HD11 ' A' ' 61' ' ' LEU . 38.9 t -70.19 114.65 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 0.0 110.418 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -35.41 12.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 -179.549 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.27 76.38 6.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.191 0.52 . . . . 0.0 111.107 -179.716 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.43 127.96 12.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.809 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.66 ' OE1' HG21 ' A' ' 113' ' ' THR . 8.7 mt-10 -119.41 147.03 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.732 179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.1 t -77.12 125.8 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.413 0.625 . . . . 0.0 111.817 -179.115 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.897 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -107.77 -16.65 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.366 179.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.66 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -155.57 158.39 38.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.41 115.36 6.08 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.195 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.835 ' HA ' HG11 ' A' ' 160' ' ' VAL . 9.2 t -57.46 127.39 77.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.083 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.33 -18.06 59.56 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.748 2.299 . . . . 0.0 113.349 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.59 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -123.96 -179.28 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.401 0.619 . . . . 0.0 112.204 -179.471 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CE2' ' HG3' ' A' ' 106' ' ' LYS . 7.9 m95 -106.78 147.15 30.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.738 178.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.82 ' HB3' HG13 ' A' ' 153' ' ' VAL . 50.7 mt -113.86 117.84 32.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.103 179.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.781 HG22 ' CB ' ' A' ' 104' ' ' ALA . 1.5 p -112.63 132.49 55.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.834 -179.363 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.871 ' CD1' HG11 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.0 164.01 25.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.651 179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.48 158.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.216 -179.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -114.98 154.77 47.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.595 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.602 ' HG2' HG23 ' A' ' 88' ' ' VAL . 30.7 Cg_endo -63.48 166.72 14.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.516 2.144 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.92 -16.42 44.84 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.881 2.387 . . . . 0.0 113.197 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.8 -34.29 15.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.194 0.521 . . . . 0.0 110.053 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.602 HG23 ' HG2' ' A' ' 85' ' ' PRO . 74.7 t -81.72 -51.21 15.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.222 179.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.4 ' NH1' ' ND2' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -55.09 -49.87 70.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 0.0 109.567 178.781 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.573 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.7 tt0 -63.69 -29.06 70.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.547 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -76.16 -46.52 28.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.536 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.664 HD21 H5'2 ' A' ' 166' ' ' ATP . 92.4 mt -58.74 -47.4 84.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.977 0.418 . . . . 0.0 110.262 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.41 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.1 m-80 -44.96 -30.83 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.672 179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.573 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.5 mt -96.11 -49.73 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.221 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -54.05 37.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.438 ' CE2' ' O2A' ' A' ' 166' ' ' ATP . 25.7 m0 -79.86 -38.45 32.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.849 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 85.15 33.97 16.05 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.469 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.3 147.57 52.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.56 72.34 0.78 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -124.6 149.95 46.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.742 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -30.7 61.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.09 -141.66 3.22 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.017 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -157.65 115.84 3.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.12 106.24 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.808 178.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 16' ' ' ASN . 5.7 pt20 -124.56 153.25 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.377 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -105.84 95.93 6.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.339 178.526 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.563 ' CD2' HG21 ' A' ' 157' ' ' VAL . 35.5 m95 -62.95 142.43 58.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.339 -178.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 106' ' ' LYS . 65.9 m-85 -126.47 137.44 53.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.229 179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.814 HD13 ' CD2' ' A' ' 161' ' ' PHE . 21.7 tp -79.56 154.57 28.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 21' ' ' LEU . 43.9 m-85 -148.17 127.67 13.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.037 0.446 . . . . 0.0 111.786 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.897 ' HB3' HD11 ' A' ' 73' ' ' ILE . 12.1 tttp -92.71 119.5 32.16 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.653 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.8 t80 -65.01 123.89 20.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.948 0.404 . . . . 0.0 110.76 -179.519 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.66 HG21 ' OE1' ' A' ' 71' ' ' GLU . 16.7 p -125.98 37.81 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.619 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -138.38 -144.85 4.72 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.101 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 154.19 45.93 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -49.82 -16.68 0.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.624 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -77.56 -19.14 56.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.725 0.298 . . . . 0.0 111.172 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.55 -25.17 41.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.759 HG21 ' CE1' ' A' ' 29' ' ' PHE . 17.7 mt -74.25 103.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.602 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.467 HD21 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -119.03 95.84 4.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.942 178.949 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.9 mt -54.79 -23.03 16.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.775 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 129' ' ' PRO . 70.2 mt -63.42 -59.54 4.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.25 0.547 . . . . 0.0 110.014 179.328 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 146.23 -176.99 24.87 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.445 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -92.53 39.01 1.02 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.132 0.491 . . . . 0.0 109.697 179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 69.64 26.79 74.08 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.078 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -119.08 -69.3 0.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.179 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.33 165.1 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 153.56 65.54 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 122' ' ' LEU . 77.0 Cg_exo -47.13 162.1 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.74 2.293 . . . . 0.0 112.597 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' C ' HD12 ' A' ' 34' ' ' LEU . 63.5 mm-40 -150.05 -46.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.809 ' HB2' HD13 ' A' ' 121' ' ' LEU . 12.7 m-85 -107.76 159.41 16.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.341 179.682 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.46 5.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.777 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.415 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 11.1 mm-40 -152.37 175.24 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.156 0.503 . . . . 0.0 110.607 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.7 p-90 -156.68 152.5 27.17 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.09 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.6 m -147.93 163.63 36.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.409 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.462 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 69.7 m95 -98.12 122.48 41.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.661 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.87 HG11 HD11 ' A' ' 145' ' ' LEU . 27.0 m -134.91 150.91 30.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.033 0.444 . . . . 0.0 111.58 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -70.93 162.33 72.74 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.699 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.584 ' CA ' HD13 ' A' ' 158' ' ' LEU . 31.5 Cg_exo -56.94 -20.34 36.11 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.84 1.693 . . . . 0.0 111.826 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.26 -35.88 15.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.269 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -69.96 -50.36 42.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.961 0.41 . . . . 0.0 110.06 179.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.903 ' HA ' HD12 ' A' ' 145' ' ' LEU . 3.4 tp -53.96 -31.75 51.62 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.499 0.666 . . . . 0.0 109.81 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.568 HD12 ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm -67.85 -28.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 178.687 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.73 -20.98 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.254 179.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.903 HD12 ' HA ' ' A' ' 142' ' ' LEU . 10.2 mt -85.49 -38.95 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.096 179.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 150' ' ' LYS . 29.8 m -56.14 163.43 1.59 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.249 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 7.4 p -91.42 165.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -57.6 -32.1 66.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.774 -179.653 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 147' ' ' VAL . 17.2 p90 -92.89 13.62 19.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.686 ' HB2' HG12 ' A' ' 147' ' ' VAL . 33.9 mttp -136.23 0.81 2.61 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.327 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 152' ' ' PRO . 6.4 mttm -62.15 -62.83 5.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 18.1 Cg_endo -60.0 -44.72 27.96 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.46 2.107 . . . . 0.0 112.172 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.871 HG11 ' CD1' ' A' ' 82' ' ' TYR . 14.9 t -58.47 -27.12 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 0.0 111.1 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.18 -52.08 5.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.568 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -50.48 -32.71 18.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.48 179.825 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.552 ' HB3' HD11 ' A' ' 80' ' ' LEU . 5.4 tp10 -66.29 -45.69 79.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.559 179.144 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 107' ' ' TRP . 47.2 t -59.09 -46.39 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.934 179.261 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.584 HD13 ' CA ' ' A' ' 139' ' ' PRO . 78.8 mt -66.31 -48.65 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.61 178.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.2 m -50.92 -46.52 60.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.793 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.835 HG11 ' HA ' ' A' ' 76' ' ' VAL . 90.2 t -69.37 -24.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.814 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.9 m-30 -101.08 -2.92 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.274 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.617 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -46.79 -53.56 25.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.599 0.238 . . . . 0.0 111.588 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 10.8 Cg_endo -54.42 -21.88 25.26 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.466 2.111 . . . . 0.0 112.402 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.66 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 77.4 m-70 -96.19 -15.35 22.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 161' ' ' PHE . 5.6 mp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.849 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.664 H5'2 HD21 ' A' ' 92' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -168.78 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.584 2.189 . . . . 0.0 112.326 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.46 42.42 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.776 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -95.57 25.86 22.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.07 114.62 4.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.492 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.9 mmt -116.67 -36.03 4.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.434 ' H ' ' HB2' ' A' ' 78' ' ' TYR . 1.5 t0 68.42 20.86 8.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p 174.45 136.87 0.15 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 15' ' ' ARG . 37.2 Cg_endo -66.27 109.73 1.63 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.349 2.032 . . . . 0.0 112.318 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HG2' HG21 ' A' ' 81' ' ' THR . 7.9 Cg_exo -72.24 -172.91 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.901 2.4 . . . . 0.0 112.202 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -90.18 146.61 24.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.046 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.5 ' HA3' ' HG3' ' A' ' 101' ' ' LYS . . . 92.55 -39.69 2.96 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.567 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 23.9 m-85 -77.18 141.71 39.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.761 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HG3' ' CE2' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -93.37 152.23 19.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.238 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 9' ' ' PRO . 12.6 mmp_? -65.29 126.36 27.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.471 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 17.0 t-20 -152.62 156.37 39.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 57' ' ' ALA . 2.7 m -129.29 136.88 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.71 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -106.44 157.31 15.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.163 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.71 HD13 ' C ' ' A' ' 18' ' ' GLY . 1.6 mm -121.4 102.34 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.795 -0.238 . . . . 0.0 111.335 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 7.8 t -89.73 94.93 10.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 110' ' ' PHE . 29.9 tp -102.67 143.94 31.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.522 . . . . 0.0 111.509 -178.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -129.47 157.27 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 136' ' ' TRP . 35.6 p-10 -98.41 170.92 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.516 -179.534 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -57.72 -16.56 11.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.477 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 0.31 56.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.826 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mttt 77.02 26.9 0.72 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.607 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.811 ' C ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -97.08 174.47 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.005 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.837 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -108.7 125.67 65.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.765 0.317 . . . . 0.0 110.783 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.733 ' HE2' HD13 ' A' ' 119' ' ' ILE . 44.4 t80 -63.42 108.82 1.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.592 179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . . . -116.35 131.27 56.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.672 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -116.71 133.77 55.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 133' ' ' GLU . 1.6 p -82.35 154.61 25.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.782 ' CD ' HD12 ' A' ' 36' ' ' ILE . 1.2 mtp85 -70.43 157.35 37.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.268 0.556 . . . . 0.0 111.411 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -5.09 53.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.005 178.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -131.13 -16.72 3.14 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.782 HD12 ' CD ' ' A' ' 33' ' ' ARG . 66.3 mt -120.62 111.41 34.68 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.0 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 29.2 Cg_endo -65.25 131.9 29.9 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.868 1.712 . . . . 0.0 111.843 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 t70 77.86 2.98 2.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.649 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . . . -89.26 97.31 11.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.22 179.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.539 ' CD1' HD22 ' A' ' 145' ' ' LEU . 59.8 m95 -103.86 157.85 16.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.227 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -168.91 167.94 10.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.443 ' HB2' ' CZ3' ' A' ' 107' ' ' TRP . 3.4 mpp? -101.84 145.1 29.88 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 4.0 Cg_exo -39.55 132.88 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.317 2.678 . . . . 0.0 112.967 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 154.62 33.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.549 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.6 144.21 8.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.624 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -63.52 138.83 43.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.368 179.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.655 HD11 HG13 ' A' ' 17' ' ' VAL . 5.1 mt -68.42 159.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.334 . . . . 0.0 110.638 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' N ' HG22 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -90.3 146.17 24.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.22 96.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.354 0.597 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 36.3 8.13 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.186 -179.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 4.9 tt0 -115.58 142.63 46.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.091 0.472 . . . . 0.0 110.747 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.77 142.29 85.66 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.708 179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.622 ' O ' HG11 ' A' ' 17' ' ' VAL . 50.8 Cg_exo -53.82 -57.15 2.05 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.511 2.14 . . . . 0.0 112.6 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 108' ' ' PHE . 3.4 ttt180 -58.55 -26.79 63.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -83.0 -49.17 9.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.761 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . . . -57.07 -32.46 66.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.667 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . . . -71.98 -54.67 9.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.092 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 54' ' ' ARG . 48.4 mt -53.82 -28.86 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.198 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -82.79 -53.12 6.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.759 0.79 . . . . 0.0 109.791 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -57.43 -33.19 67.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.602 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD11 ' HB ' ' A' ' 67' ' ' VAL . 8.8 tp -53.98 -59.66 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.582 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 4.7 ptt-85 -61.5 -10.94 8.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.674 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -91.44 -44.92 8.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 111.59 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -90.68 -31.41 16.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.192 -178.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.758 ' OG1' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -114.57 -21.93 10.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 0.0 110.961 -179.341 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 62' ' ' ARG . . . 70.85 8.87 64.91 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.825 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.818 ' HB ' HD11 ' A' ' 61' ' ' LEU . 42.7 t -73.91 120.55 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.393 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -34.96 10.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 0.7 OUTLIER -90.28 76.86 6.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.213 0.53 . . . . 0.0 110.823 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -149.16 128.42 12.89 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.837 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 2.7 mt-10 -119.61 148.15 43.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.596 HG23 ' CE2' ' A' ' 110' ' ' PHE . 41.1 t -78.03 126.65 38.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.421 0.629 . . . . 0.0 111.743 -179.221 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.882 HD11 ' HB3' ' A' ' 111' ' ' LYS . 2.0 mm -106.44 -19.79 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.387 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -157.29 162.36 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.327 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.7 117.52 6.68 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.022 179.686 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.833 ' HA ' HG11 ' A' ' 160' ' ' VAL . 6.0 t -57.36 126.15 73.63 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.081 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.42 -18.34 62.72 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.771 2.314 . . . . 0.0 113.23 -179.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.621 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.03 -177.21 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.243 0.544 . . . . 0.0 112.008 -179.583 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.74 ' C ' HD23 ' A' ' 80' ' ' LEU . 20.8 m95 -107.8 147.27 31.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.127 179.21 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 4' ' ' GLY . 3.2 mt -111.32 117.71 33.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.097 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.862 HG22 ' CB ' ' A' ' 104' ' ' ALA . 10.4 p -109.93 136.96 48.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.407 -179.504 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.839 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -129.43 170.02 14.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.603 -179.449 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 158.2 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CE1' H5'1 ' A' ' 166' ' ' ATP . 29.6 m-85 -121.11 146.9 45.38 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.644 ' HG2' HG23 ' A' ' 88' ' ' VAL . 22.1 Cg_endo -61.74 167.55 9.99 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.368 2.045 . . . . 0.0 112.15 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -15.17 37.25 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.874 2.383 . . . . 0.0 113.227 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -30.67 15.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.061 0.457 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.644 HG23 ' HG2' ' A' ' 85' ' ' PRO . 71.8 t -85.1 -51.33 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.468 179.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -57.04 -47.0 81.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.565 0.697 . . . . 0.0 109.393 179.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.6 ' O ' HD12 ' A' ' 94' ' ' ILE . 3.8 tt0 -65.05 -29.15 70.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.395 179.317 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.26 -47.38 24.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.424 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.589 HD22 ' CE2' ' A' ' 96' ' ' TRP . 92.7 mt -56.78 -47.88 79.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.462 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.416 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 1.2 m-80 -45.89 -30.66 1.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.636 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 90' ' ' GLU . 3.7 mt -96.34 -49.61 12.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.492 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -56.83 8.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.695 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.589 ' CE2' HD22 ' A' ' 92' ' ' LEU . 22.7 m0 -76.3 -34.59 59.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.613 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 93' ' ' ASN . . . 78.82 33.89 36.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.323 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.4 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 0.4 OUTLIER -131.38 153.25 49.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.52 77.03 1.03 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.625 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.407 ' CE2' ' HG3' ' A' ' 14' ' ' ARG . 30.5 m95 -121.24 150.36 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.916 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.5 ' HG3' ' HA3' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -70.37 -35.88 73.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.36 0.6 . . . . 0.0 109.654 179.382 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -167.74 -133.29 1.53 Allowed Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.738 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 82' ' ' TYR . 12.3 mm100 -156.31 113.85 3.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.599 179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.862 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -96.42 105.84 17.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.701 178.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -123.23 156.48 35.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.419 0.628 . . . . 0.0 112.69 -178.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -108.86 96.5 6.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.599 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.658 ' CD2' HG21 ' A' ' 157' ' ' VAL . 25.2 m95 -62.91 149.79 43.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.256 0.551 . . . . 0.0 112.35 -178.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 75' ' ' GLU . 60.3 m-85 -132.92 133.44 43.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.995 179.326 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.88 HD13 ' CD2' ' A' ' 161' ' ' PHE . 18.0 tp -79.54 132.05 36.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.524 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.857 ' O ' HD12 ' A' ' 21' ' ' LEU . 53.1 m-85 -126.45 129.44 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.322 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.882 ' HB3' HD11 ' A' ' 73' ' ' ILE . 36.6 tttm -93.68 120.28 33.75 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.658 ' HE1' HG13 ' A' ' 67' ' ' VAL . 5.4 t80 -63.91 125.42 24.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.984 0.421 . . . . 0.0 110.797 -179.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.476 HG21 ' HG3' ' A' ' 71' ' ' GLU . 3.7 p -127.86 37.86 4.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -139.22 -144.94 4.65 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.099 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -128.52 154.22 46.36 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -49.47 -16.92 0.23 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.577 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -22.57 53.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.764 0.316 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.51 -25.18 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.839 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.733 HD13 ' HE2' ' A' ' 29' ' ' PHE . 28.9 mt -71.23 97.31 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.413 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.78 95.73 5.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.958 179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 131' ' ' PHE . 68.2 mt -57.08 -21.87 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.451 -179.256 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 ' HG3' ' A' ' 129' ' ' PRO . 22.3 mt -63.85 -59.19 4.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.255 0.55 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.17 178.48 22.5 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.4 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -90.71 38.85 0.96 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 73.95 26.3 69.32 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.084 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -121.78 -71.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.101 -179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.36 165.16 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.196 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -86.46 147.9 45.43 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.808 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.467 ' HG3' HD22 ' A' ' 122' ' ' LEU . 64.4 Cg_exo -51.05 125.8 17.18 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.544 2.163 . . . . 0.0 112.557 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -109.29 -29.25 8.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.592 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.7 m-85 -112.82 159.52 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.398 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -116.32 -19.9 5.31 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.807 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 6.2 mm-40 -152.35 174.73 13.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.081 0.467 . . . . 0.0 110.419 -179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.1 p-90 -154.6 151.69 29.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.081 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -149.7 161.81 41.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.586 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CE2' ' HB3' ' A' ' 23' ' ' ASN . 72.8 m95 -97.6 128.29 44.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.273 179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.619 HG11 HD11 ' A' ' 145' ' ' LEU . 28.0 m -138.79 155.47 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 p -74.84 151.44 86.61 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HD3' HD11 ' A' ' 28' ' ' ILE . 3.4 Cg_endo -47.89 -22.21 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.037 1.824 . . . . 0.0 112.064 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -34.66 17.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.469 179.24 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.414 ' CB ' ' HB ' ' A' ' 137' ' ' VAL . 37.7 mt-30 -69.14 -51.59 36.79 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.836 0.351 . . . . 0.0 110.304 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.935 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -51.71 -36.5 47.11 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.707 0.765 . . . . 0.0 109.56 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.676 HD12 ' HD2' ' A' ' 155' ' ' LYS . 4.8 mm -62.7 -28.88 45.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.038 178.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 141' ' ' GLN . 33.4 t70 -81.94 -19.85 39.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.161 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 142' ' ' LEU . 9.9 mt -86.88 -38.49 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.126 179.427 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 150' ' ' LYS . 28.3 m -56.55 163.47 1.77 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.079 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 150' ' ' LYS . 8.1 p -93.74 161.34 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' N ' HG22 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -49.86 -41.43 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.276 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' A' ' 150' ' ' LYS . 12.3 p90 -84.23 5.87 24.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.317 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 147' ' ' VAL . 14.6 mtmt -127.79 -3.98 5.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.534 0.206 . . . . 0.0 111.49 179.33 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 22.6 mttt -55.31 -62.43 4.39 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.548 0.213 . . . . 0.0 111.413 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -60.61 -42.81 36.79 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 82' ' ' TYR . 25.2 t -55.26 -29.4 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 111.245 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.437 ' CE1' ' HD2' ' A' ' 150' ' ' LYS . 3.2 m-30 -91.07 -53.31 4.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HD2' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -49.7 -33.95 17.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.591 179.958 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.49 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 tp10 -65.57 -45.46 83.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.589 179.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.658 HG21 ' CD2' ' A' ' 107' ' ' TRP . 60.3 t -58.06 -48.81 83.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.137 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 139' ' ' PRO . 66.8 mt -63.5 -48.66 76.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.721 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.6 m -49.81 -47.28 51.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.676 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.833 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.1 t -69.44 -24.6 27.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.106 0.479 . . . . 0.0 110.363 179.218 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.88 ' CD2' HD13 ' A' ' 109' ' ' LEU . 9.1 m-30 -105.77 13.93 28.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.931 -179.235 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -52.83 -56.58 21.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.459 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 9.5 Cg_endo -52.46 -23.84 20.14 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.472 2.115 . . . . 0.0 112.197 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.621 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 97.6 m-70 -92.87 -20.68 20.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.878 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.526 HD22 HD12 ' A' ' 28' ' ' ILE . 4.1 mt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' ATP . . . . . 0.491 ' PG ' ' CZ2' ' A' ' 96' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_